data_2ks4_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ks4 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.545 HD13 ' H ' ' A' ' 74' ' ' GLY . 1.8 mt . . . . . 0 CA--C 1.548 0.89 0 CA-C-O 121.513 0.673 . . . . 0.0 112.51 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -120.98 94.02 4.21 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 127.637 2.375 . . . . 0.0 109.632 178.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -69.71 -84.05 0.16 Allowed Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.531 1.062 . . . . 0.0 112.665 -175.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 33.7 p -140.24 167.34 22.37 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.705 1.602 . . . . 0.0 111.004 175.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -125.39 14.36 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 CA-C-O 123.174 1.464 . . . . 0.0 111.796 -179.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.2 pt -53.23 167.39 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 125.494 1.517 . . . . 0.0 112.086 175.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -42.31 134.02 3.03 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.72 1.608 . . . . 0.0 112.549 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -54.9 -18.98 12.68 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 124.202 0.906 . . . . 0.0 114.557 -175.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.18 -28.14 69.46 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.718 1.207 . . . . 0.0 111.932 175.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.4 t -102.09 -44.9 5.32 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 126.32 1.848 . . . . 0.0 111.415 175.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.2 tp -75.97 94.16 3.35 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 121.614 0.721 . . . . 0.0 110.463 175.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 65.0 p -125.52 -179.8 4.79 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.507 1.523 . . . . 0.0 112.451 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -45.83 -41.0 10.56 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.446 1.498 . . . . 0.0 112.911 176.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -57.39 -43.39 83.61 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.661 1.185 . . . . 0.0 111.598 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 74.6 t -59.54 -35.4 58.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.733 1.213 . . . . 0.0 110.792 175.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.3 mt -72.52 -42.85 64.31 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.722 -0.611 . . . . 0.0 111.263 177.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -62.42 -49.35 75.81 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.616 -0.678 . . . . 0.0 111.267 178.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.08 -48.86 76.82 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 176.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.6 p -57.38 -30.73 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 CA-C-N 120.269 1.395 . . . . 0.0 113.414 -175.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 17.1 mt -57.4 -34.42 68.87 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.544 1.138 . . . . 0.0 110.806 174.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -85.54 -36.25 10.86 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 124.282 0.944 . . . . 0.0 113.455 177.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -69.62 -57.99 4.49 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.657 1.183 . . . . 0.0 112.38 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -91.32 -15.49 28.99 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.55 1.54 . . . . 0.0 112.005 -175.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -18.19 86.71 0.0 OUTLIER Glycine 0 CA--C 1.536 1.405 0 C-N-CA 129.952 3.644 . . . . 0.0 117.426 177.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.439 ' H ' HD21 ' A' ' 3' ' ' LEU . 15.3 mtpt -59.86 -61.11 2.86 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 127.224 2.21 . . . . 0.0 113.315 -175.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.1 m -132.66 -177.95 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 126.891 2.076 . . . . 0.0 110.835 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.2 t -52.19 -39.89 60.76 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.714 1.606 . . . . 0.0 114.354 -175.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -117.86 116.14 26.38 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 126.228 1.811 . . . . 0.0 108.258 175.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.15 150.54 49.46 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 126.125 1.77 . . . . 0.0 109.52 -175.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -128.21 123.59 60.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 124.336 1.054 . . . . 0.0 111.262 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -125.21 116.64 22.31 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 125.914 1.685 . . . . 0.0 108.558 174.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.3 m -116.1 158.75 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.639 0.776 . . . . 0.0 110.186 176.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -135.84 92.81 0.23 Allowed Glycine 0 CA--C 1.521 0.41 0 C-N-CA 124.073 0.844 . . . . 0.0 112.215 -178.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.8 mp -89.61 137.27 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 117.768 0.784 . . . . 0.0 110.503 175.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -108.15 112.1 24.45 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.989 1.316 . . . . 0.0 111.313 174.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 27.2 t30 -78.69 98.12 6.1 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.84 1.656 . . . . 0.0 111.975 175.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -134.21 13.74 3.87 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-O 122.551 1.167 . . . . 0.0 111.014 174.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.4 t -61.8 -26.88 68.37 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.082 1.753 . . . . 0.0 114.34 176.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 110.14 77.56 0.94 Allowed Glycine 0 CA--C 1.531 1.042 0 C-N-CA 125.247 1.403 . . . . 0.0 112.597 177.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 144.69 155.93 6.63 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 126.016 1.77 . . . . 0.0 112.805 175.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 41.4 p -68.88 129.43 39.9 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 121.526 -0.985 . . . . 0.0 110.289 174.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 45.2 m0 -86.6 111.15 20.35 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.261 0.553 . . . . 0.0 110.706 178.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 88.7 m -90.92 127.89 36.57 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 124.333 1.053 . . . . 0.0 109.501 175.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.21 138.41 58.41 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 122.651 0.38 . . . . 0.0 111.639 174.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.1 pp -120.44 -54.65 2.07 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.059 0.943 . . . . 0.0 111.971 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -170.78 154.38 4.34 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.535 1.934 . . . . 0.0 110.241 178.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -133.17 162.99 30.28 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.679 1.192 . . . . 0.0 110.386 174.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.518 ' HH ' ' NE2' ' A' ' 129' ' ' GLN . 29.3 t80 -140.24 106.2 5.19 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.971 1.309 . . . . 0.0 112.391 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -111.1 118.24 35.48 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.992 1.317 . . . . 0.0 110.982 -175.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.37 -35.9 7.78 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -177.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.3 t -123.96 -41.83 2.2 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.97 1.708 . . . . 0.0 111.654 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -74.03 16.66 2.61 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 125.246 1.403 . . . . 0.0 115.272 -178.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 65.8 p -32.9 110.29 0.08 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 128.689 2.796 . . . . 0.0 114.321 -174.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.7 t -131.37 -177.09 4.25 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.002 1.321 . . . . 0.0 112.845 -174.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -85.41 -64.97 1.06 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.963 1.305 . . . . 0.0 113.205 176.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.6 p -137.4 134.23 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 125.455 1.502 . . . . 0.0 111.638 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.68 -29.97 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.825 1.65 . . . . 0.0 113.799 177.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.0 mt -94.38 97.07 2.07 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 125.298 1.439 . . . . 0.0 109.85 179.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -66.87 154.29 75.07 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.932 3.088 . . . . 0.0 110.922 174.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -50.39 -50.8 50.57 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.634 1.174 . . . . 0.0 113.302 -176.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 80.4 t -149.45 140.9 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 127.902 2.481 . . . . 0.0 108.347 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.3 t -120.87 125.4 27.07 Favored Pre-proline 0 N--CA 1.471 0.583 0 C-N-CA 124.658 1.183 . . . . 0.0 109.508 175.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -66.2 152.02 82.15 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 121.88 1.72 . . . . 0.0 112.373 175.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -74.53 171.04 14.53 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.686 0.794 . . . . 0.0 111.425 174.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 66.5 p 55.41 20.36 3.6 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 127.597 2.359 . . . . 0.0 113.906 -174.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 49.4 mttt -133.57 174.03 10.86 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 127.623 2.369 . . . . 0.0 111.559 -175.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -130.94 166.86 20.03 Favored 'General case' 0 C--O 1.222 -0.373 0 C-N-CA 122.619 0.368 . . . . 0.0 110.549 -177.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.5 pp -140.49 172.66 12.41 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 124.962 1.305 . . . . 0.0 111.516 -178.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -123.4 151.76 42.27 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 124.331 1.052 . . . . 0.0 112.038 178.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -126.21 144.08 50.9 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.464 1.106 . . . . 0.0 108.556 174.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 90.4 p -115.69 152.95 32.21 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 125.879 1.671 . . . . 0.0 110.68 176.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.545 ' H ' HD13 ' A' ' 3' ' ' LEU . . . -173.97 141.91 6.23 Favored Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 174.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 13.3 ptt180 -132.42 163.84 27.85 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 127.098 2.159 . . . . 0.0 108.294 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 24.6 mtmt . . . . . 0 N--CA 1.472 0.627 0 N-CA-C 115.341 1.608 . . . . 0.0 115.341 -174.969 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 56.7 m . . . . . 0 N--CA 1.476 0.841 0 N-CA-C 111.201 0.074 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -53.05 -75.72 0.21 Allowed Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.938 1.732 . . . . 0.0 114.862 -175.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -165.97 102.62 0.66 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.316 1.446 . . . . 0.0 112.844 -178.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.0 t -129.0 124.69 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 O-C-N 120.977 -1.077 . . . . 0.0 110.87 -178.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -167.8 159.47 11.69 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.036 1.334 . . . . 0.0 112.233 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -141.06 143.87 34.61 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 124.396 1.078 . . . . 0.0 109.813 174.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -140.58 168.54 19.56 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 121.402 -0.811 . . . . 0.0 109.958 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -137.1 155.01 50.14 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 175.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -130.89 127.22 38.07 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.925 1.69 . . . . 0.0 111.985 -175.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -82.54 114.56 21.03 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.868 0.366 . . . . 0.0 111.067 -178.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 2.0 mtm -84.1 136.5 33.98 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.647 1.179 . . . . 0.0 111.169 176.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.2 t -64.32 -19.15 65.25 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.77 0.828 . . . . 0.0 113.213 176.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -69.35 -13.72 62.53 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 125.34 1.456 . . . . 0.0 113.496 175.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 104.31 23.07 8.23 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 124.736 1.16 . . . . 0.0 115.09 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -129.98 173.87 10.3 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 118.911 1.356 . . . . 0.0 110.035 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.6 m -130.47 107.75 9.46 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.403 1.081 . . . . 0.0 111.083 178.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 55.4 tp -70.68 105.49 3.18 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.245 1.018 . . . . 0.0 111.079 175.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -97.16 95.09 1.67 Allowed Glycine 0 CA--C 1.525 0.663 0 C-N-CA 125.639 1.59 . . . . 0.0 112.323 176.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 79.4 t -76.25 139.91 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 123.845 0.858 . . . . 0.0 110.51 174.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 2.6 tmm? -129.75 125.75 36.59 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.481 1.112 . . . . 0.0 111.056 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -136.94 134.95 37.29 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 122.417 1.104 . . . . 0.0 113.601 174.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 71.9 m -137.63 121.28 17.37 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.482 1.113 . . . . 0.0 111.563 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 41.4 t . . . . . 0 CA--C 1.541 0.613 0 C-N-CA 126.576 1.95 . . . . 0.0 107.455 175.037 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.7 m . . . . . 0 N--CA 1.473 0.704 0 CA-C-O 121.314 0.578 . . . . 0.0 111.907 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -125.96 72.64 1.3 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.407 1.483 . . . . 0.0 112.258 -175.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 22.8 m0 -71.82 143.99 49.28 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 121.334 -0.854 . . . . 0.0 112.292 -174.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 34.3 p-90 -140.82 137.0 32.98 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.168 0.987 . . . . 0.0 111.881 -179.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -144.76 168.56 19.91 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 125.198 1.399 . . . . 0.0 111.684 -176.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 72.2 t -147.55 129.67 6.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 124.7 1.2 . . . . 0.0 107.894 174.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.58 170.2 15.07 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.434 1.094 . . . . 0.0 110.518 174.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.432 ' HB ' ' CE2' ' A' ' 154' ' ' TYR . 12.7 mt -132.01 104.77 8.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 177.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -62.18 145.8 93.2 Favored Pre-proline 0 CA--C 1.546 0.818 0 O-C-N 121.485 -0.759 . . . . 0.0 110.886 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -73.81 8.91 1.79 Allowed 'Trans proline' 0 CA--C 1.548 1.188 0 C-N-CA 124.413 3.408 . . . . 0.0 114.862 -175.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -172.98 179.77 44.2 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 126.95 2.214 . . . . 0.0 111.406 177.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -53.94 102.71 0.06 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 126.645 1.978 . . . . 0.0 111.565 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 11.1 tpp180 -132.45 141.6 48.89 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.538 1.535 . . . . 0.0 111.776 -177.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 8.7 ptt180 -76.82 179.53 6.06 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.262 1.025 . . . . 0.0 113.536 174.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -124.4 116.39 22.48 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 128.326 2.651 . . . . 0.0 104.681 174.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -140.12 169.18 18.18 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.143 1.377 . . . . 0.0 110.422 177.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.518 ' NE2' ' HH ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -52.77 -43.19 65.65 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.56 1.144 . . . . 0.0 113.261 -178.486 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -56.13 -56.44 24.18 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 123.72 0.676 . . . . 0.0 112.744 174.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 2.9 mtm -64.17 -33.3 75.47 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 118.321 1.06 . . . . 0.0 112.973 177.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.28 -63.91 1.13 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.231 1.013 . . . . 0.0 108.895 174.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -63.81 -32.81 74.45 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.621 0.601 . . . . 0.0 112.621 -176.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -64.18 -34.13 77.38 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.506 1.122 . . . . 0.0 113.446 176.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 6.4 tpp -97.72 -21.88 16.74 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 175.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -51.84 -54.99 22.71 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 126.638 1.975 . . . . 0.0 109.783 174.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -64.61 -12.1 42.0 Favored 'General case' 0 CA--C 1.552 1.045 0 N-CA-C 113.72 1.008 . . . . 0.0 113.72 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -79.16 -33.12 36.99 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 126.832 2.158 . . . . 0.0 113.925 -175.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -127.61 90.73 47.51 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 124.593 1.157 . . . . 0.0 111.21 177.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -72.51 72.92 2.9 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 123.561 2.84 . . . . 0.0 112.376 178.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -113.39 119.48 37.78 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 124.659 1.184 . . . . 0.0 109.848 174.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -89.03 0.43 56.68 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.591 1.557 . . . . 0.0 114.557 175.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 85.01 75.07 1.24 Allowed Glycine 0 CA--C 1.522 0.511 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 -175.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -74.53 122.2 22.72 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.907 0.883 . . . . 0.0 109.229 174.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -56.34 144.16 31.58 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.09 0.956 . . . . 0.0 112.395 -177.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 117.19 -78.97 0.29 Allowed Glycine 0 CA--C 1.532 1.141 0 C-N-CA 126.095 1.807 . . . . 0.0 113.037 -176.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 32.2 m95 171.99 104.84 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 130.816 3.646 . . . . 0.0 108.629 -175.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -134.59 137.0 43.36 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 126.456 1.902 . . . . 0.0 111.868 -177.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -160.38 -172.01 3.4 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -174.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.423 ' HA ' ' HE2' ' A' ' 150' ' ' LYS . 1.5 mmpt? -133.33 155.13 49.99 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 126.285 1.834 . . . . 0.0 111.158 174.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -78.23 144.09 36.55 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 174.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.3 mt -107.38 153.6 22.53 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 122.22 1.009 . . . . 0.0 109.732 178.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -64.38 -166.78 1.18 Allowed Glycine 0 CA--C 1.535 1.304 0 C-N-CA 123.673 0.654 . . . . 0.0 112.262 174.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.432 ' CE2' ' HB ' ' A' ' 120' ' ' ILE . 0.0 OUTLIER 56.78 9.47 0.6 Allowed 'General case' 0 CA--C 1.556 1.2 0 N-CA-C 114.844 1.424 . . . . 0.0 114.844 174.968 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 81.48 38.32 14.88 Favored Glycine 0 CA--C 1.538 1.514 0 C-N-CA 126.736 2.112 . . . . 0.0 114.693 -175.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.7 mp -126.79 159.64 33.21 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 119.868 1.834 . . . . 0.0 113.671 -176.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 74.1 mtt180 -144.69 118.71 9.39 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.316 1.047 . . . . 0.0 110.181 -178.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 3.1 ttp -103.51 138.94 39.52 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 124.313 1.045 . . . . 0.0 108.443 177.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -111.06 133.82 53.14 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 127.031 2.132 . . . . 0.0 110.131 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -141.39 160.88 26.93 Favored Glycine 0 N--CA 1.478 1.459 0 CA-C-N 121.849 2.113 . . . . 0.0 116.191 178.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.4 tp -149.51 127.22 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 125.166 1.386 . . . . 0.0 110.978 -177.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 29.4 mtp -148.48 164.95 32.63 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 128.807 2.843 . . . . 0.0 108.224 174.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 10.2 t -138.0 154.98 49.29 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.999 0.52 . . . . 0.0 111.124 175.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 94.9 p -77.57 13.87 1.16 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.726 1.611 . . . . 0.0 114.275 179.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.26 1.08 0.13 Allowed 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 126.794 2.038 . . . . 0.0 115.548 175.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 87.75 -62.3 3.99 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 126.14 1.829 . . . . 0.0 113.151 174.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -102.53 20.06 17.81 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.32 1.448 . . . . 0.0 113.076 -177.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -60.57 161.58 7.47 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.118 1.367 . . . . 0.0 113.579 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.41 173.41 9.15 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 126.446 1.899 . . . . 0.0 111.653 174.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 44.8 ttp -134.05 118.51 17.86 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.97 1.308 . . . . 0.0 111.794 177.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -124.62 128.55 49.04 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 121.141 -0.975 . . . . 0.0 109.525 177.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 4.6 mp -133.89 124.51 47.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 123.735 0.814 . . . . 0.0 109.915 176.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -123.34 132.11 53.88 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.36 1.464 . . . . 0.0 111.391 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.8 mp -79.31 127.57 39.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 O-C-N 121.207 -0.933 . . . . 0.0 109.338 176.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 4.2 m -132.3 98.9 4.52 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.093 1.357 . . . . 0.0 112.04 178.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 49.9 mtp85 . . . . . 0 C--O 1.253 1.242 0 C-N-CA 127.357 2.263 . . . . 0.0 113.032 175.02 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.5 mt . . . . . 0 N--CA 1.484 1.249 0 CA-C-O 121.016 0.436 . . . . 0.0 111.944 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -115.83 116.24 27.67 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 127.227 2.211 . . . . 0.0 110.491 -175.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -77.85 -82.95 0.58 Allowed Glycine 0 CA--C 1.533 1.201 0 C-N-CA 124.744 1.164 . . . . 0.0 113.551 -178.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 54.2 p -139.27 174.17 10.79 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 126.406 1.882 . . . . 0.0 111.451 -175.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -135.57 15.64 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 C-N-CA 125.702 1.601 . . . . 0.0 111.638 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 15.3 pt -54.36 171.56 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 126.272 1.829 . . . . 0.0 113.402 178.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -43.09 132.42 4.12 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.044 1.737 . . . . 0.0 113.258 178.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -54.75 -31.03 53.54 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 125.487 1.518 . . . . 0.0 116.147 -174.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.47 -22.58 67.0 Favored 'General case' 0 CA--C 1.547 0.834 0 O-C-N 121.648 -0.913 . . . . 0.0 112.636 174.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.3 t -98.25 -45.36 6.21 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.187 2.195 . . . . 0.0 111.722 176.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.2 tp -78.77 88.25 4.64 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.449 1.5 . . . . 0.0 111.062 174.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.2 p -120.28 -179.67 4.02 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 126.994 2.118 . . . . 0.0 111.976 177.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -45.4 -42.03 9.78 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.11 1.764 . . . . 0.0 113.523 175.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -52.91 -44.25 66.82 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 118.953 0.797 . . . . 0.0 111.819 177.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 61.4 t -64.13 -41.87 93.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 125.587 1.555 . . . . 0.0 111.651 175.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 29.3 mt -67.72 -40.13 84.26 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 120.845 -1.159 . . . . 0.0 111.933 179.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -63.64 -45.99 87.72 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.824 0.849 . . . . 0.0 111.786 178.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.74 -32.83 74.38 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-O 118.371 -0.823 . . . . 0.0 112.961 175.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 25.2 t -56.59 -42.02 75.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 CA-C-N 119.796 1.18 . . . . 0.0 111.48 177.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 49.2 mt -59.56 -13.29 8.68 Favored 'General case' 0 CA--C 1.552 1.045 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 175.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -104.67 -49.69 1.01 Allowed Glycine 0 CA--C 1.539 1.539 0 C-N-CA 126.855 2.169 . . . . 0.0 114.229 176.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -74.17 -30.41 62.23 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 119.186 1.493 . . . . 0.0 114.389 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -100.34 171.88 7.5 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.277 1.431 . . . . 0.0 110.463 174.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 154.83 131.49 1.48 Allowed Glycine 0 CA--C 1.534 1.22 0 O-C-N 121.122 -0.986 . . . . 0.0 114.601 177.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.4 mtpm? -113.5 -50.74 2.84 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 126.097 1.759 . . . . 0.0 114.0 176.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.7 m -132.25 -179.32 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 124.285 1.034 . . . . 0.0 112.348 -174.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.3 t -48.88 -42.37 36.49 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 126.082 1.753 . . . . 0.0 114.322 -175.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 8.8 tpp180 -124.69 136.35 53.82 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 126.297 1.839 . . . . 0.0 108.964 174.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.58 167.64 18.39 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.333 1.453 . . . . 0.0 110.8 178.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -137.41 133.04 46.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 124.187 0.995 . . . . 0.0 108.38 174.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -134.21 95.84 3.49 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 127.61 2.364 . . . . 0.0 109.855 -178.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.4 m -98.91 167.02 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 123.212 0.605 . . . . 0.0 111.552 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -142.59 108.69 0.53 Allowed Glycine 0 CA--C 1.523 0.562 0 CA-C-O 119.645 -0.53 . . . . 0.0 113.414 174.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.9 mp -98.51 144.31 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 117.929 0.865 . . . . 0.0 109.184 175.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -119.61 102.83 8.9 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.143 1.377 . . . . 0.0 111.161 -178.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -70.73 85.29 0.65 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 129.44 3.096 . . . . 0.0 113.047 -175.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.57 3.37 13.99 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.746 1.619 . . . . 0.0 113.658 175.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.5 m -55.56 -30.89 61.59 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 115.335 1.605 . . . . 0.0 115.335 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 111.06 95.68 2.31 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.576 1.084 . . . . 0.0 112.098 -177.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 113.51 160.11 13.78 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 126.102 1.81 . . . . 0.0 112.625 -178.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 80.8 p -69.34 148.2 50.03 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 121.975 -0.721 . . . . 0.0 111.563 175.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 34.9 m0 -103.32 105.85 16.22 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.925 0.89 . . . . 0.0 109.584 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 59.4 m -92.75 129.98 38.51 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.269 1.027 . . . . 0.0 110.466 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.85 127.98 33.83 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.045 0.938 . . . . 0.0 112.22 174.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -117.14 -43.6 2.84 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.698 1.199 . . . . 0.0 112.269 175.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -170.04 149.64 3.63 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.467 1.907 . . . . 0.0 110.955 -178.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -133.38 155.84 48.74 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.382 1.473 . . . . 0.0 110.231 175.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -138.2 97.69 3.45 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.048 1.339 . . . . 0.0 111.413 -178.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -99.17 111.99 24.25 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.356 1.062 . . . . 0.0 110.646 177.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.13 -39.45 16.69 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.278 0.631 . . . . 0.0 111.563 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.5 t -129.3 -177.08 4.09 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.623 2.369 . . . . 0.0 107.591 174.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 55.52 24.33 38.56 Favored Glycine 0 CA--C 1.538 1.493 0 O-C-N 121.178 -0.951 . . . . 0.0 113.783 -179.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.3 p -33.18 106.01 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 129.185 2.994 . . . . 0.0 112.719 -175.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.0 t -109.92 -177.22 3.21 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -174.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -92.44 -64.1 1.15 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.781 2.032 . . . . 0.0 112.21 175.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.2 p -144.06 131.91 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.989 1.315 . . . . 0.0 111.686 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.42 ' HB ' ' CD2' ' A' ' 72' ' ' TYR . 0.2 OUTLIER -131.01 -20.01 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 126.046 1.739 . . . . 0.0 113.595 178.21 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.3 mp -106.8 88.47 3.56 Favored Pre-proline 0 N--CA 1.45 -0.434 0 C-N-CA 125.902 1.681 . . . . 0.0 107.279 -174.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -59.14 151.9 63.45 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.615 2.21 . . . . 0.0 110.843 176.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -42.87 -49.02 5.89 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.335 1.854 . . . . 0.0 113.523 -178.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.6 p -160.79 140.63 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 127.039 2.136 . . . . 0.0 109.259 175.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 66.3 t -116.91 127.46 26.71 Favored Pre-proline 0 N--CA 1.477 0.92 0 C-N-CA 124.63 1.172 . . . . 0.0 108.325 175.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -66.23 157.65 58.87 Favored 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 122.123 1.882 . . . . 0.0 112.424 178.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -70.47 160.63 32.06 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 121.785 -0.572 . . . . 0.0 110.66 175.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 31.8 p 60.96 19.14 9.56 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 126.621 1.969 . . . . 0.0 113.697 -174.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 42.2 mttt -131.65 171.24 13.7 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.612 1.565 . . . . 0.0 111.489 -178.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -122.52 179.11 4.7 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 123.855 0.862 . . . . 0.0 111.839 -174.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -149.75 168.99 22.11 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 125.526 1.53 . . . . 0.0 110.948 174.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -119.08 158.14 26.45 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.879 1.672 . . . . 0.0 111.323 178.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.42 ' CD2' ' HB ' ' A' ' 59' ' ' ILE . 9.1 m-85 -130.27 144.25 51.26 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.343 1.057 . . . . 0.0 110.051 174.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.5 p -120.58 138.57 53.81 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 126.812 2.045 . . . . 0.0 110.365 175.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -150.85 129.73 2.98 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 174.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.06 107.2 9.41 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 127.67 2.388 . . . . 0.0 111.599 -175.004 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.476 0.837 0 C-N-CA 126.092 1.757 . . . . 0.0 112.875 176.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 42.2 m . . . . . 0 N--CA 1.483 1.215 0 CA-C-O 117.896 -1.05 . . . . 0.0 108.929 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -21.98 -74.9 0.01 OUTLIER Glycine 0 N--CA 1.485 1.937 0 C-N-CA 127.452 2.453 . . . . 0.0 113.742 -178.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -163.05 120.4 1.92 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.869 1.668 . . . . 0.0 109.839 174.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.9 t -144.1 114.55 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.168 0.987 . . . . 0.0 109.826 -178.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.29 164.36 24.93 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.964 0.888 . . . . 0.0 113.186 -176.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -144.52 162.19 37.19 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.252 1.421 . . . . 0.0 112.076 174.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.41 ' CE1' ' HB ' ' A' ' 101' ' ' VAL . 30.0 p90 -160.78 172.65 16.66 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 124.672 1.189 . . . . 0.0 110.575 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -136.81 160.38 39.04 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 175.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -137.37 131.18 31.72 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.835 1.254 . . . . 0.0 113.892 175.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -79.36 109.04 13.34 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.947 0.899 . . . . 0.0 110.691 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 4.0 ttm -72.1 145.08 48.42 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.143 0.977 . . . . 0.0 111.937 175.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 14.3 t -61.69 -28.16 69.2 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.296 1.038 . . . . 0.0 112.955 175.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 -69.44 -8.09 43.66 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.825 1.25 . . . . 0.0 113.782 175.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 91.95 39.53 5.46 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.318 0.961 . . . . 0.0 113.951 177.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -138.34 171.88 13.72 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.184 1.393 . . . . 0.0 110.484 175.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 53.5 m -122.22 111.9 17.52 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 119.075 0.852 . . . . 0.0 113.163 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 61.9 tp -73.32 101.44 3.42 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.583 1.953 . . . . 0.0 110.404 174.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -91.01 117.6 5.18 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 126.221 1.867 . . . . 0.0 112.318 176.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.41 ' HB ' ' CE1' ' A' ' 89' ' ' PHE . 91.1 t -119.17 141.62 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 125.642 1.577 . . . . 0.0 110.68 -175.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 2.9 ppp? -148.37 170.22 18.44 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.897 0.856 . . . . 0.0 113.296 174.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -152.71 149.28 28.22 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.625 1.57 . . . . 0.0 113.89 175.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 22.4 t -143.1 107.71 4.84 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.585 1.554 . . . . 0.0 110.086 175.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 10.8 m . . . . . 0 CA--C 1.539 0.533 0 C-N-CA 125.597 1.559 . . . . 0.0 109.021 175.03 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 19.3 m . . . . . 0 N--CA 1.468 0.461 0 CA-C-O 120.905 0.383 . . . . 0.0 111.276 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -124.66 95.69 4.61 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.239 1.015 . . . . 0.0 109.898 -176.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 51.9 m0 -110.74 148.24 32.74 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.19 0.519 . . . . 0.0 111.656 -177.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 17.5 p-90 -149.13 135.17 19.03 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.366 0.667 . . . . 0.0 112.566 -174.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -161.4 173.39 14.99 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 122.732 1.253 . . . . 0.0 113.111 175.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 60.3 t -138.59 143.85 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 126.462 1.905 . . . . 0.0 107.98 176.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.67 174.56 11.34 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.601 1.561 . . . . 0.0 110.565 178.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 26.0 mt -127.09 138.77 53.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 174.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 99.7 m-85 -102.35 149.56 36.77 Favored Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 125.103 1.361 . . . . 0.0 111.966 176.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -69.48 113.39 3.31 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.861 3.041 . . . . 0.0 111.321 176.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 69.16 -171.63 39.14 Favored Glycine 0 CA--C 1.537 1.421 0 O-C-N 121.896 -0.503 . . . . 0.0 114.119 -175.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 11.8 tmtt? -58.15 113.15 1.79 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.565 1.546 . . . . 0.0 111.594 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.08 113.69 12.37 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.768 1.227 . . . . 0.0 111.465 -178.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 4.5 ptp180 -57.65 161.72 3.49 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.711 -0.618 . . . . 0.0 112.308 175.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -113.12 99.02 7.51 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 175.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -124.5 167.48 14.38 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.591 1.556 . . . . 0.0 109.988 -177.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -53.25 -38.94 63.46 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.185 0.994 . . . . 0.0 113.425 -177.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -60.61 -57.67 17.77 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 123.753 0.692 . . . . 0.0 112.151 176.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 3.3 mtm -61.4 -37.22 82.65 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.326 0.65 . . . . 0.0 112.524 178.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.82 -62.91 1.46 Allowed 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.768 0.713 . . . . 0.0 110.0 174.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -60.37 -40.4 90.68 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.104 0.962 . . . . 0.0 113.145 -175.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -60.53 -46.48 90.02 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.062 0.945 . . . . 0.0 112.441 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 78.1 mmm -82.25 -30.84 30.49 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 177.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -55.19 -57.21 12.7 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.295 1.838 . . . . 0.0 110.769 175.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.32 -20.09 65.99 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-O 121.439 0.638 . . . . 0.0 112.166 -177.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -80.35 -2.55 89.41 Favored Glycine 0 CA--C 1.538 1.483 0 C-N-CA 126.744 2.116 . . . . 0.0 114.839 175.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -141.77 77.32 19.06 Favored Pre-proline 0 CA--C 1.553 1.081 0 CA-C-N 119.62 1.71 . . . . 0.0 114.145 -175.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.89 101.05 1.27 Allowed 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 123.688 2.925 . . . . 0.0 113.266 -176.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -138.2 123.31 19.16 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.583 1.153 . . . . 0.0 110.704 178.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 4.6 mpt_? -93.34 -157.29 0.53 Allowed 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 125.297 1.439 . . . . 0.0 111.081 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -86.12 77.5 2.03 Favored Glycine 0 CA--C 1.531 1.037 0 O-C-N 120.132 -1.605 . . . . 0.0 110.116 175.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -75.99 85.14 2.89 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.152 1.781 . . . . 0.0 111.171 -175.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -54.43 116.39 2.62 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 -174.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 141.78 -73.01 0.38 Allowed Glycine 0 CA--C 1.533 1.212 0 C-N-CA 125.251 1.405 . . . . 0.0 114.057 175.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 27.9 m95 169.19 106.33 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 131.199 3.8 . . . . 0.0 108.485 -174.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -137.92 132.19 32.04 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 127.327 2.251 . . . . 0.0 110.471 -177.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -158.38 -173.66 4.42 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -175.038 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.3 mtmm -140.4 162.84 34.36 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 126.501 1.921 . . . . 0.0 111.564 175.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -73.29 137.34 44.8 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.431 1.092 . . . . 0.0 109.456 174.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 45.1 mt -92.97 88.74 6.26 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.294 1.038 . . . . 0.0 110.478 177.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 35.81 -76.45 0.0 OUTLIER Glycine 0 N--CA 1.477 1.405 1 C-N-CA 130.83 4.062 . . . . 0.0 116.592 175.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -70.02 -153.45 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 128.311 2.645 . . . . 0.0 110.472 175.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -75.42 24.52 1.42 Allowed Glycine 0 CA--C 1.542 1.742 0 O-C-N 120.15 -1.594 . . . . 0.0 115.072 174.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.84 149.06 24.58 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 120.211 2.005 . . . . 0.0 111.698 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 61.5 mtt85 -140.89 114.33 8.73 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.736 1.214 . . . . 0.0 111.433 177.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 8.0 ttp -94.96 143.17 26.68 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 125.28 1.432 . . . . 0.0 108.803 175.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 4.4 tppt? -121.98 124.9 45.11 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 127.199 2.199 . . . . 0.0 109.853 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -137.58 158.61 24.59 Favored Glycine 0 N--CA 1.478 1.439 0 N-CA-C 117.974 1.95 . . . . 0.0 117.974 -175.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.69 131.72 9.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 C-N-CA 125.372 1.469 . . . . 0.0 111.668 -177.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 3.5 mtm -149.77 160.93 43.16 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 128.537 2.735 . . . . 0.0 108.231 174.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 5.5 t -140.89 133.91 29.28 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 121.133 -0.979 . . . . 0.0 112.003 174.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 45.6 m -74.4 12.29 0.8 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.433 1.493 . . . . 0.0 114.187 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -51.01 -43.0 60.76 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.77 1.628 . . . . 0.0 114.21 176.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 146.91 -77.79 0.25 Allowed Glycine 0 CA--C 1.532 1.105 0 C-N-CA 125.139 1.352 . . . . 0.0 112.845 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 27.5 tp10 -95.83 43.81 1.08 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 125.145 1.378 . . . . 0.0 110.831 -177.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -77.24 172.57 13.07 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.301 1.04 . . . . 0.0 112.928 178.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . 0.404 ' HE2' ' O ' ' A' ' 169' ' ' LYS . 0.0 OUTLIER -114.07 173.93 6.19 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 126.711 2.004 . . . . 0.0 109.633 174.919 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 2.0 tmm? -126.85 123.17 36.7 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 125.385 1.474 . . . . 0.0 109.12 178.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -132.4 128.46 37.6 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.504 0.721 . . . . 0.0 110.532 177.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 4.8 mp -135.61 122.97 35.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 123.428 0.691 . . . . 0.0 110.11 175.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -118.88 136.1 54.22 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.556 1.542 . . . . 0.0 110.043 176.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.8 mp -82.93 137.15 21.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 O-C-N 121.315 -0.866 . . . . 0.0 109.241 175.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 9.3 m -128.78 95.9 4.23 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.229 1.012 . . . . 0.0 111.85 176.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 7.2 mmm180 . . . . . 0 C--O 1.253 1.288 0 C-N-CA 126.296 1.838 . . . . 0.0 111.75 174.945 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 16.1 mt . . . . . 0 N--CA 1.485 1.316 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -75.14 96.08 3.21 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.626 -0.671 . . . . 0.0 110.083 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -60.94 -75.48 0.29 Allowed Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.426 1.013 . . . . 0.0 112.314 -176.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 27.4 p -150.85 172.3 15.85 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 127.189 2.196 . . . . 0.0 110.423 174.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -124.79 5.51 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 124.934 1.294 . . . . 0.0 112.75 175.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 pt -24.42 -75.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 129.591 3.156 . . . . 0.0 116.673 -176.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -162.47 137.59 6.97 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.218 1.407 . . . . 0.0 111.324 -177.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.65 -21.49 58.07 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 124.577 1.084 . . . . 0.0 114.641 -178.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.27 -31.11 72.18 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.233 1.013 . . . . 0.0 113.175 174.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.5 t -102.96 -40.87 6.32 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 125.083 1.353 . . . . 0.0 111.726 175.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 14.3 tp -74.24 82.74 1.85 Allowed 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.235 1.414 . . . . 0.0 111.099 175.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.8 p -113.98 179.68 3.89 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 126.654 1.981 . . . . 0.0 112.425 176.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -47.47 -42.2 22.2 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.064 1.346 . . . . 0.0 113.019 176.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -57.55 -37.88 73.86 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.759 0.823 . . . . 0.0 112.174 178.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.6 t -67.48 -41.16 85.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.083 0.953 . . . . 0.0 110.283 175.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 21.3 mt -63.71 -41.08 98.15 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 121.33 -0.856 . . . . 0.0 110.961 177.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.39 -44.15 92.23 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.793 0.837 . . . . 0.0 112.641 178.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.68 -32.6 62.26 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 175.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.1 t -51.4 -46.49 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 C-N-CA 125.601 1.56 . . . . 0.0 111.933 175.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 15.0 mt -53.97 -20.15 5.76 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.188 1.395 . . . . 0.0 113.716 178.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -108.42 -40.08 1.68 Allowed Glycine 0 CA--C 1.537 1.415 0 C-N-CA 126.134 1.826 . . . . 0.0 114.926 178.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -72.05 -28.61 63.46 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 119.768 1.784 . . . . 0.0 113.965 179.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -92.24 133.36 35.89 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.83 1.252 . . . . 0.0 110.992 176.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.12 125.11 7.19 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 125.261 1.41 . . . . 0.0 113.852 -175.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.94 -172.19 4.15 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 126.366 1.866 . . . . 0.0 112.053 -177.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.9 m -72.47 -177.96 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 126.085 1.754 . . . . 0.0 110.898 174.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 60.9 m -49.7 -50.01 45.53 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.517 1.527 . . . . 0.0 113.529 -177.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -117.43 138.21 51.99 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.041 1.337 . . . . 0.0 110.662 175.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.42 161.09 38.75 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 126.132 1.773 . . . . 0.0 111.593 -175.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -131.25 114.25 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-O 122.238 1.018 . . . . 0.0 112.018 -179.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -117.31 111.51 19.48 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.735 2.014 . . . . 0.0 109.111 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.8 m -116.67 151.98 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 CA-C-O 119.097 -0.478 . . . . 0.0 111.272 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -131.12 101.34 0.48 Allowed Glycine 0 CA--C 1.524 0.649 0 C-N-CA 123.815 0.722 . . . . 0.0 112.872 -179.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.9 mp -91.93 136.22 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-N 118.209 1.005 . . . . 0.0 110.318 175.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -101.13 104.48 15.58 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.185 1.394 . . . . 0.0 110.666 178.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -70.39 82.74 0.56 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 127.889 2.476 . . . . 0.0 111.057 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -120.85 11.64 11.14 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 125.109 1.364 . . . . 0.0 114.144 175.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 99.8 p -60.15 -7.51 1.92 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 126.67 1.988 . . . . 0.0 116.351 174.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 93.57 21.05 30.1 Favored Glycine 0 CA--C 1.54 1.626 0 N-CA-C 116.281 1.272 . . . . 0.0 116.281 177.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -166.49 169.56 40.63 Favored Glycine 0 CA--C 1.535 1.305 0 CA-C-N 119.27 1.535 . . . . 0.0 114.196 176.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.3 p -72.98 141.75 47.75 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.81 1.244 . . . . 0.0 111.396 175.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.553 ' HA ' ' CE1' ' A' ' 91' ' ' TYR . 34.7 m0 -100.97 98.04 8.55 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 123.586 0.755 . . . . 0.0 112.353 -177.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.1 m -81.72 120.41 25.09 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.266 1.026 . . . . 0.0 108.704 175.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.08 150.51 45.33 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.685 -0.634 . . . . 0.0 112.145 174.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.8 pp -124.25 -51.02 1.77 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.639 0.776 . . . . 0.0 112.976 177.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -171.06 142.89 1.88 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 127.043 2.137 . . . . 0.0 109.738 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -121.17 151.44 39.93 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.614 1.166 . . . . 0.0 109.94 174.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -132.67 106.54 7.84 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.413 1.485 . . . . 0.0 111.27 -177.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -111.58 124.64 52.71 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.481 1.112 . . . . 0.0 110.248 -175.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.13 -34.2 6.01 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 114.174 1.175 . . . . 0.0 114.174 -174.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 43.7 t -119.0 -47.92 2.47 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.657 1.183 . . . . 0.0 110.375 175.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -67.55 12.27 0.74 Allowed Glycine 0 CA--C 1.54 1.603 0 C-N-CA 126.865 2.174 . . . . 0.0 117.623 -174.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 76.0 p -27.14 107.69 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 129.597 3.159 . . . . 0.0 114.671 -175.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.9 t -128.75 -177.05 4.04 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.826 2.05 . . . . 0.0 113.509 -175.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -88.44 -54.79 4.01 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.051 1.341 . . . . 0.0 113.897 177.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.9 p -149.89 133.45 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 124.898 1.279 . . . . 0.0 111.99 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.411 ' HB ' ' CE2' ' A' ' 72' ' ' TYR . 0.1 OUTLIER -136.68 -35.18 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 N-CA-C 114.838 1.422 . . . . 0.0 114.838 179.29 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.2 mt -88.5 100.05 1.78 Allowed Pre-proline 0 CA--C 1.543 0.694 0 C-N-CA 125.665 1.586 . . . . 0.0 108.599 176.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -68.51 150.53 75.34 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 122.554 2.17 . . . . 0.0 110.985 176.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -48.1 -45.54 32.85 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.983 1.313 . . . . 0.0 113.446 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.2 p -156.26 136.19 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 126.398 1.879 . . . . 0.0 110.287 175.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 72.7 t -113.71 129.96 24.22 Favored Pre-proline 0 N--CA 1.481 1.079 0 C-N-CA 124.55 1.14 . . . . 0.0 108.691 174.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -70.43 158.25 56.63 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 122.667 2.245 . . . . 0.0 113.271 178.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -72.94 160.72 31.67 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 121.421 -0.799 . . . . 0.0 112.726 175.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . 0.275 51.4 p 57.64 23.77 9.74 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 127.077 2.151 . . . . 0.0 113.689 -175.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -119.03 -178.32 3.54 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 126.765 2.026 . . . . 0.0 110.732 178.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -136.54 152.54 50.61 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 175.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.5 pp -117.7 171.01 8.32 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 124.417 1.087 . . . . 0.0 110.963 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -126.22 153.41 44.75 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.624 1.17 . . . . 0.0 111.004 175.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.424 ' CE2' ' CD2' ' A' ' 89' ' ' PHE . 6.3 m-85 -125.88 153.39 44.24 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.832 1.653 . . . . 0.0 108.835 174.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 95.8 p -133.97 141.36 47.26 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 126.197 1.799 . . . . 0.0 111.3 176.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -162.12 150.38 19.62 Favored Glycine 0 CA--C 1.524 0.624 0 O-C-N 121.916 -0.49 . . . . 0.0 113.092 174.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 11.4 mtm180 -112.24 130.83 55.8 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 126.289 1.836 . . . . 0.0 111.968 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.479 1.002 0 C-N-CA 125.688 1.595 . . . . 0.0 115.12 175.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 42.9 m . . . . . 0 N--CA 1.475 0.81 0 CA-C-O 121.045 0.45 . . . . 0.0 111.263 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 37.82 -114.26 0.28 Allowed Glycine 0 CA--C 1.533 1.193 0 C-N-CA 126.103 1.811 . . . . 0.0 113.969 -178.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -141.45 114.84 8.84 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 118.458 1.129 . . . . 0.0 111.274 176.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.2 t -137.33 122.25 24.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 C-N-CA 124.323 1.049 . . . . 0.0 110.18 -176.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.51 171.34 16.0 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.302 1.441 . . . . 0.0 111.359 175.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -151.48 134.38 15.75 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.889 1.275 . . . . 0.0 109.943 174.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.424 ' CD2' ' CE2' ' A' ' 72' ' ' TYR . 54.3 p90 -129.72 171.24 12.87 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 121.27 -0.894 . . . . 0.0 110.285 177.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -143.26 143.9 31.91 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 175.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.553 ' CE1' ' HA ' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -109.98 131.36 55.13 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.497 1.119 . . . . 0.0 109.995 177.289 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -84.51 107.6 16.84 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.364 0.665 . . . . 0.0 112.593 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -68.38 141.64 55.68 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.45 1.1 . . . . 0.0 112.94 -178.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 58.0 p -60.15 -28.24 67.75 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.845 1.258 . . . . 0.0 112.548 174.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 -72.24 -8.23 53.68 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.731 1.612 . . . . 0.0 112.757 174.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 99.99 -6.71 58.52 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 126.662 2.077 . . . . 0.0 114.362 -178.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 53.5 m-20 -78.12 178.33 7.64 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 118.339 1.07 . . . . 0.0 111.34 178.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 19.0 m -139.31 109.12 6.28 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 120.453 -1.404 . . . . 0.0 111.22 174.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.6 tt -72.8 101.81 3.22 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.566 1.146 . . . . 0.0 111.289 175.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -92.79 127.78 9.14 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 125.171 1.367 . . . . 0.0 113.333 175.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 63.5 t -114.44 127.02 72.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 125.763 1.625 . . . . 0.0 111.224 -175.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.11 118.61 24.71 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 126.733 2.013 . . . . 0.0 112.438 -175.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -141.69 121.28 13.34 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.33 1.452 . . . . 0.0 111.642 -175.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 30.4 t -137.3 92.53 2.72 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.473 1.509 . . . . 0.0 110.92 -175.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.1 m . . . . . 0 N--CA 1.473 0.68 0 C-N-CA 125.105 1.362 . . . . 0.0 109.669 -179.241 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 17.1 m . . . . . 0 N--CA 1.477 0.89 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 32.5 t-20 -74.34 106.29 5.9 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.08 1.752 . . . . 0.0 107.912 175.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 44.3 m0 -113.16 145.68 40.53 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 120.297 1.408 . . . . 0.0 108.31 174.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 39.2 p-90 -149.02 142.82 25.63 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.095 0.958 . . . . 0.0 113.047 -177.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -151.69 165.77 33.34 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 123.292 1.52 . . . . 0.0 113.821 -177.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 94.7 t -147.41 129.54 7.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 125.894 1.678 . . . . 0.0 107.349 175.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.33 171.6 14.23 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.515 1.526 . . . . 0.0 110.127 175.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 35.3 mt -134.32 118.59 27.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.762 0.792 . . . . 0.0 109.231 -176.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -80.59 139.12 50.97 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 124.185 0.994 . . . . 0.0 109.23 178.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -72.97 -1.53 10.63 Favored 'Trans proline' 0 CA--C 1.546 1.119 0 C-N-CA 123.706 2.937 . . . . 0.0 114.948 -178.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -141.74 176.27 22.04 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 126.857 2.17 . . . . 0.0 111.94 175.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 9.9 tttm -64.26 105.61 0.94 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.934 1.294 . . . . 0.0 110.884 176.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 11.2 tpp180 -138.77 117.96 12.67 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 124.381 1.072 . . . . 0.0 113.22 -174.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 15.4 ptt180 -62.98 165.42 6.9 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 175.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -110.22 103.18 11.84 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 174.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -111.8 170.82 7.88 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.329 1.051 . . . . 0.0 109.642 175.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -50.07 -39.52 42.46 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.377 0.99 . . . . 0.0 113.304 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -59.42 -59.72 10.11 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 123.869 0.747 . . . . 0.0 112.175 175.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 14.6 mtm -61.82 -35.33 77.9 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 118.058 0.929 . . . . 0.0 113.298 178.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -60.56 -60.49 3.73 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.088 1.355 . . . . 0.0 109.756 175.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -67.26 -29.75 69.45 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -63.96 -36.73 84.91 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.34 1.056 . . . . 0.0 113.019 176.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 7.9 tpp -94.53 -22.23 18.36 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 119.695 1.134 . . . . 0.0 113.463 175.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -49.28 -56.6 8.88 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.602 1.561 . . . . 0.0 110.316 175.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -71.19 -7.02 43.93 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -178.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -84.89 -12.83 73.52 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 126.983 2.23 . . . . 0.0 114.946 -178.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -145.54 90.27 6.04 Favored Pre-proline 0 CA--C 1.552 1.025 0 CA-C-N 119.309 1.555 . . . . 0.0 112.956 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -75.48 81.8 2.23 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 123.674 2.916 . . . . 0.0 112.19 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -116.97 111.64 19.87 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.985 1.314 . . . . 0.0 110.182 -177.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -92.61 41.36 1.07 Allowed 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 127.564 2.346 . . . . 0.0 114.05 -174.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 55.77 51.76 53.03 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 123.704 0.669 . . . . 0.0 112.538 -177.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -61.01 113.63 2.65 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.613 1.165 . . . . 0.0 111.418 -176.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -75.96 83.18 2.85 Favored 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 -175.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 173.09 55.07 0.05 OUTLIER Glycine 0 CA--C 1.539 1.544 0 C-N-CA 125.107 1.336 . . . . 0.0 114.135 175.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' TRP . . . . . 0.413 ' H ' HD13 ' A' ' 161' ' ' ILE . 7.5 m95 48.16 41.72 16.15 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 126.81 2.044 . . . . 0.0 114.077 -174.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -72.75 126.96 31.15 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 120.845 -1.16 . . . . 0.0 111.784 -175.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.15 -170.23 3.06 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -174.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.71 140.92 36.92 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 126.043 1.737 . . . . 0.0 110.447 175.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -67.0 149.36 50.74 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 174.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 29.3 mt -119.79 158.42 26.59 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-O 123.824 1.773 . . . . 0.0 111.435 178.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -64.45 -157.5 0.23 Allowed Glycine 0 CA--C 1.54 1.623 0 C-N-CA 125.62 1.581 . . . . 0.0 111.2 174.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 51.46 15.12 0.3 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.944 -1.327 . . . . 0.0 114.527 175.016 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 72.66 34.83 59.46 Favored Glycine 0 CA--C 1.54 1.608 0 CA-C-O 117.141 -1.922 . . . . 0.0 113.805 -175.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -139.21 159.41 42.23 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 121.21 2.505 . . . . 0.0 115.188 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 19.4 mtt-85 -135.33 123.7 23.28 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 120.439 -1.413 . . . . 0.0 108.693 -177.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 13.7 ttp -96.14 136.38 36.69 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 176.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.85 129.21 56.33 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 126.803 2.041 . . . . 0.0 109.867 -178.054 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -136.8 156.36 23.16 Favored Glycine 0 N--CA 1.476 1.36 0 CA-C-N 121.684 2.038 . . . . 0.0 116.293 -177.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.413 HD13 ' H ' ' A' ' 147' ' ' TRP . 6.1 tp -154.56 126.43 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 124.96 1.304 . . . . 0.0 112.527 -174.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 19.5 ttm -148.82 -176.27 5.27 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 128.641 2.776 . . . . 0.0 108.509 177.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 8.9 t -163.01 127.31 2.98 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.527 1.131 . . . . 0.0 111.631 174.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.37 19.61 0.1 Allowed 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.027 1.331 . . . . 0.0 114.11 178.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -58.34 -25.94 62.55 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 127.291 2.236 . . . . 0.0 115.631 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 147.14 -57.87 0.49 Allowed Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.562 1.077 . . . . 0.0 114.48 175.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -133.28 37.9 3.34 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.144 1.378 . . . . 0.0 112.001 -178.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.33 174.58 4.65 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-O 122.61 1.195 . . . . 0.0 113.849 175.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.64 176.26 5.22 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 127.741 2.416 . . . . 0.0 111.527 175.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 1.8 tmm? -128.18 130.91 48.76 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 126.277 1.831 . . . . 0.0 109.648 175.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -141.14 131.39 24.96 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.48 1.112 . . . . 0.0 110.203 -178.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 4.0 mp -136.11 126.01 40.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 123.883 0.873 . . . . 0.0 109.612 175.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -119.39 129.27 54.72 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 126.516 1.926 . . . . 0.0 111.119 178.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.6 mp -88.55 93.1 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 O-C-N 121.278 -0.889 . . . . 0.0 109.692 -177.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.04 107.51 19.26 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.628 1.571 . . . . 0.0 112.691 179.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.252 1.188 0 C-N-CA 125.547 1.539 . . . . 0.0 112.836 175.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 13.7 tp . . . . . 0 N--CA 1.48 1.042 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -126.1 141.11 52.08 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 127.813 2.445 . . . . 0.0 109.213 175.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -79.75 -136.95 1.51 Allowed Glycine 0 CA--C 1.538 1.504 0 C-N-CA 124.844 1.212 . . . . 0.0 110.989 174.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.0 p -107.31 176.01 5.3 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 125.5 1.52 . . . . 0.0 112.941 -175.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -119.13 17.26 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 126.352 1.861 . . . . 0.0 111.945 -178.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.3 pt -50.39 159.64 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 125.662 1.585 . . . . 0.0 111.349 175.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -42.82 140.26 1.4 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.456 1.502 . . . . 0.0 113.328 -176.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -56.29 -20.9 31.01 Favored Glycine 0 CA--C 1.543 1.788 0 C-N-CA 124.28 0.943 . . . . 0.0 113.745 -176.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.2 -28.55 69.82 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.621 1.568 . . . . 0.0 112.609 174.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 t -101.28 -44.57 5.61 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.974 1.71 . . . . 0.0 111.515 175.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.7 tp -75.81 88.49 2.84 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.278 1.031 . . . . 0.0 111.429 175.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 55.1 p -124.65 -175.09 3.18 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 126.156 1.782 . . . . 0.0 111.344 176.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -50.3 -31.36 14.13 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.851 1.26 . . . . 0.0 113.645 175.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -59.46 -50.31 74.4 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 118.97 0.805 . . . . 0.0 110.902 175.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 73.8 t -64.53 -39.13 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 123.915 0.886 . . . . 0.0 110.974 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 90.2 mt -70.58 -42.12 71.48 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 123.349 0.66 . . . . 0.0 112.62 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -71.17 -44.21 65.93 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.953 0.901 . . . . 0.0 111.607 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.72 -39.8 95.2 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 118.426 -0.797 . . . . 0.0 110.826 175.012 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.0 t -53.5 -43.59 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 125.054 1.342 . . . . 0.0 112.271 175.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.455 ' HA ' ' HE3' ' A' ' 31' ' ' LYS . 0.1 OUTLIER -60.39 -25.99 66.33 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 175.015 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.57 -48.92 3.33 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.203 0.906 . . . . 0.0 112.979 178.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -70.61 -27.44 64.09 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 17.8 mt -109.31 102.22 11.15 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.737 1.215 . . . . 0.0 110.461 -177.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -131.77 73.15 0.47 Allowed Glycine 0 CA--C 1.534 1.252 0 C-N-CA 125.112 1.339 . . . . 0.0 113.364 -175.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.0 -58.68 6.96 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 126.416 1.886 . . . . 0.0 113.683 -178.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 16.4 m -127.27 -176.92 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 126.497 1.919 . . . . 0.0 110.748 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -47.98 -36.49 12.71 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 115.576 1.695 . . . . 0.0 115.576 -175.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.8 155.69 49.48 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.711 2.004 . . . . 0.0 108.01 174.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.455 ' HE3' ' HA ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -145.67 164.19 32.55 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.919 1.287 . . . . 0.0 110.768 175.988 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -118.49 138.16 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 124.572 1.149 . . . . 0.0 108.439 175.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -138.68 132.04 30.22 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.147 1.379 . . . . 0.0 109.597 175.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.5 t -137.91 148.29 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 123.364 0.666 . . . . 0.0 111.398 -177.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -119.47 93.13 0.54 Allowed Glycine 0 CA--C 1.525 0.677 0 C-N-CA 126.658 2.075 . . . . 0.0 113.161 175.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.7 mp -81.4 136.43 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-N 119.424 1.612 . . . . 0.0 108.788 174.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -112.65 102.46 10.52 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.164 1.786 . . . . 0.0 109.868 178.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -70.32 92.43 0.79 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.867 1.267 . . . . 0.0 109.563 177.182 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -117.29 0.26 12.2 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.052 1.741 . . . . 0.0 112.722 174.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 23.0 t -50.77 -58.89 4.82 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 126.141 1.776 . . . . 0.0 113.249 -178.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 149.49 -26.4 1.21 Allowed Glycine 0 N--CA 1.473 1.15 0 C-N-CA 124.165 0.888 . . . . 0.0 114.113 178.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -115.96 162.79 12.47 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.541 1.544 . . . . 0.0 111.226 175.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.4 t -85.13 155.58 21.41 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 123.879 0.872 . . . . 0.0 110.781 175.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 7.7 m0 -111.46 153.57 25.95 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 125.352 1.461 . . . . 0.0 112.031 176.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 95.0 m -130.24 141.46 50.63 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.853 1.261 . . . . 0.0 109.925 177.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.47 108.83 0.52 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.749 1.22 . . . . 0.0 112.571 177.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.5 pp -104.85 -53.71 2.63 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.286 1.034 . . . . 0.0 112.234 -179.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 29.3 t30 -177.73 144.8 0.38 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 127.907 2.483 . . . . 0.0 110.415 -178.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -130.54 159.31 37.5 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.111 1.365 . . . . 0.0 111.512 175.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -142.92 104.2 4.29 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.878 1.271 . . . . 0.0 112.944 -175.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -94.09 137.37 33.36 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.376 -0.827 . . . . 0.0 111.902 178.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.3 ttt-85 -98.49 -70.12 0.74 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.138 1.775 . . . . 0.0 111.24 178.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -39.72 -54.62 2.05 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 128.21 2.604 . . . . 0.0 113.722 -175.034 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -157.69 -118.53 0.55 Allowed Glycine 0 CA--C 1.526 0.751 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 175.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.6 p -141.93 175.67 9.54 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.822 1.649 . . . . 0.0 111.87 -174.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.7 t -156.51 -176.92 6.23 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.313 1.045 . . . . 0.0 112.755 176.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -102.63 -65.03 1.02 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.39 1.476 . . . . 0.0 112.786 177.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.2 p -130.19 131.68 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 125.551 1.541 . . . . 0.0 111.187 -177.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.468 HG12 ' H ' ' A' ' 60' ' ' LEU . 0.1 OUTLIER -136.85 -63.54 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 125.346 1.458 . . . . 0.0 111.712 -174.969 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.468 ' H ' HG12 ' A' ' 59' ' ' ILE . 80.5 mt -88.37 105.53 9.78 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 125.355 1.462 . . . . 0.0 110.265 175.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -73.33 168.48 24.64 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 123.305 2.67 . . . . 0.0 110.992 175.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -49.45 -44.92 46.02 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.139 0.976 . . . . 0.0 113.544 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 53.7 t -151.13 147.83 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 C-N-CA 126.838 2.055 . . . . 0.0 109.426 -176.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.6 t -125.9 95.07 40.52 Favored Pre-proline 0 N--CA 1.468 0.443 0 C-N-CA 124.913 1.285 . . . . 0.0 108.132 174.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.31 158.04 55.43 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.153 1.902 . . . . 0.0 112.253 176.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -71.53 169.52 15.28 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.092 0.557 . . . . 0.0 111.593 175.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . 0.252 26.0 p 56.79 18.76 3.97 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 127.442 2.297 . . . . 0.0 112.954 -174.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -130.9 172.0 12.54 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 126.86 2.064 . . . . 0.0 110.683 -178.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -134.89 167.43 20.92 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.345 0.658 . . . . 0.0 109.344 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.8 pp -139.16 166.43 24.56 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 124.68 1.192 . . . . 0.0 111.745 177.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.05 152.57 23.84 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 122.134 0.969 . . . . 0.0 111.07 174.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -132.8 149.03 52.31 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 126.64 1.976 . . . . 0.0 109.738 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 94.8 p -148.03 159.9 43.42 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.023 0.929 . . . . 0.0 113.198 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -170.49 148.47 11.54 Favored Glycine 0 N--CA 1.463 0.46 0 CA-C-N 115.738 -0.664 . . . . 0.0 114.316 177.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 58.4 mtm180 -110.33 148.77 31.29 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 125.937 1.695 . . . . 0.0 110.271 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt . . . . . 0 N--CA 1.473 0.703 0 C-N-CA 125.551 1.54 . . . . 0.0 114.053 176.827 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.6 m . . . . . 0 N--CA 1.477 0.908 0 CA-C-O 119.367 -0.349 . . . . 0.0 110.349 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -34.47 -74.98 0.07 OUTLIER Glycine 0 N--CA 1.471 0.991 0 C-N-CA 126.715 2.102 . . . . 0.0 117.518 -175.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -165.63 91.83 0.51 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.329 1.052 . . . . 0.0 111.51 -174.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 20.4 t -140.11 122.38 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 O-C-N 120.566 -1.333 . . . . 0.0 112.616 -175.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.38 167.6 29.86 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 122.353 1.073 . . . . 0.0 112.882 176.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -146.16 149.97 34.99 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 124.064 0.946 . . . . 0.0 109.84 174.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -151.2 174.12 13.62 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 121.039 -1.038 . . . . 0.0 110.356 178.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -138.21 150.61 46.9 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-O 121.176 0.512 . . . . 0.0 112.358 176.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -129.63 117.1 19.84 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 126.939 2.096 . . . . 0.0 112.597 -175.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -80.89 99.72 8.49 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -174.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 20.2 mtm -72.0 127.42 32.51 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.415 1.086 . . . . 0.0 112.237 178.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.6 m -57.56 -18.88 21.79 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.851 1.26 . . . . 0.0 113.414 174.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -64.27 -28.13 69.51 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.631 1.572 . . . . 0.0 112.139 174.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 120.07 19.19 4.03 Favored Glycine 0 CA--C 1.538 1.502 0 C-N-CA 125.819 1.676 . . . . 0.0 115.229 -178.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -128.04 175.82 8.1 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 119.14 1.47 . . . . 0.0 110.899 -178.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 22.7 m -134.48 103.91 5.89 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 121.064 -1.022 . . . . 0.0 111.621 176.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 42.1 tp -68.82 103.49 1.79 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.729 0.812 . . . . 0.0 112.026 175.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -91.71 96.18 2.14 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 126.316 1.912 . . . . 0.0 110.858 175.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 53.8 t -79.93 136.97 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 O-C-N 121.895 -0.768 . . . . 0.0 110.771 175.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.74 141.1 47.37 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.287 1.035 . . . . 0.0 111.593 176.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -153.64 120.08 5.52 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 120.887 -1.133 . . . . 0.0 111.501 -174.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 32.8 t -127.47 107.24 9.78 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.915 1.286 . . . . 0.0 110.987 -177.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 4.4 t . . . . . 0 CA--C 1.542 0.654 0 C-N-CA 126.599 1.96 . . . . 0.0 108.674 -176.88 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 55.0 m . . . . . 0 N--CA 1.471 0.613 0 CA-C-O 120.258 0.075 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -137.76 107.1 6.1 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.645 1.178 . . . . 0.0 110.66 -178.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 41.5 m0 -109.83 162.36 14.56 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 125.284 1.434 . . . . 0.0 113.442 -174.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 61.0 p-90 -145.57 132.41 20.1 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.776 0.798 . . . . 0.0 112.273 177.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -144.25 174.47 10.86 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.826 1.65 . . . . 0.0 111.652 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.5 m -145.03 159.72 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 175.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.63 170.97 14.93 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.764 0.826 . . . . 0.0 111.045 175.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.412 ' HB ' ' CE2' ' A' ' 154' ' ' TYR . 45.5 mt -131.54 104.6 8.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 176.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -71.97 148.91 92.2 Favored Pre-proline 0 CA--C 1.55 0.964 0 O-C-N 121.938 -0.476 . . . . 0.0 110.94 178.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -77.87 82.67 2.36 Favored 'Trans proline' 0 CA--C 1.545 1.037 0 C-N-CA 123.802 3.002 . . . . 0.0 112.37 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 98.54 178.03 32.56 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 125.958 1.742 . . . . 0.0 112.892 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 5.9 mttt -47.7 122.02 4.54 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.116 1.366 . . . . 0.0 112.508 -174.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -135.23 -161.55 1.16 Allowed 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 126.608 1.963 . . . . 0.0 111.433 -177.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 23.5 ptt-85 -140.17 -178.17 5.35 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 128.553 2.741 . . . . 0.0 109.181 175.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -131.67 124.21 29.38 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 174.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -135.72 168.66 18.87 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.375 1.07 . . . . 0.0 111.162 178.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.93 -40.77 73.62 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.538 -0.726 . . . . 0.0 112.5 -176.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -57.22 -58.64 13.56 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 124.53 1.062 . . . . 0.0 112.177 175.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 3.3 mpp? -59.58 -32.67 70.58 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 118.528 1.164 . . . . 0.0 112.5 177.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.27 -63.2 1.31 Allowed 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 175.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -67.17 -30.03 69.88 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -175.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -64.78 -43.46 93.17 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.219 1.008 . . . . 0.0 112.101 175.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.15 -25.81 23.91 Favored 'General case' 0 CA--C 1.546 0.799 0 O-C-N 121.558 -0.714 . . . . 0.0 112.558 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -47.2 -53.65 12.64 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 127.744 2.418 . . . . 0.0 111.859 175.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -63.39 -15.61 58.05 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -74.03 -32.4 58.67 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 128.312 2.863 . . . . 0.0 115.666 -175.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -129.15 90.23 45.82 Favored Pre-proline 0 CA--C 1.546 0.826 0 CA-C-N 119.032 1.416 . . . . 0.0 111.274 175.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -73.2 83.35 1.47 Allowed 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 123.58 2.853 . . . . 0.0 112.87 -176.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -122.46 122.28 38.6 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.739 1.215 . . . . 0.0 112.05 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -104.31 63.91 0.75 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.736 1.614 . . . . 0.0 111.276 -174.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 51.38 60.05 7.71 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 123.971 0.796 . . . . 0.0 112.683 -175.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.83 101.81 3.24 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 126.186 1.794 . . . . 0.0 112.362 -175.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -74.03 55.13 0.55 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 127.627 2.371 . . . . 0.0 116.516 -174.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -166.29 43.78 0.27 Allowed Glycine 0 CA--C 1.533 1.202 0 O-C-N 120.921 -1.112 . . . . 0.0 115.672 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 1.1 m95 52.65 40.51 30.32 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 125.276 1.43 . . . . 0.0 113.773 -176.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -78.9 124.06 27.87 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 126.099 1.76 . . . . 0.0 112.123 -176.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -167.89 -171.54 1.61 Allowed 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.781 0.832 . . . . 0.0 111.785 177.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 4.8 mtpp -138.18 160.91 38.18 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 127.89 2.476 . . . . 0.0 110.977 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 37.7 m-20 -67.26 152.5 45.62 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 122.144 -0.347 . . . . 0.0 110.426 174.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 37.6 mt -108.09 162.03 14.42 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 122.19 0.995 . . . . 0.0 109.06 175.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -62.45 -167.47 0.68 Allowed Glycine 0 CA--C 1.536 1.358 0 C-N-CA 124.512 1.053 . . . . 0.0 111.616 175.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.412 ' CE2' ' HB ' ' A' ' 120' ' ' ILE . 0.0 OUTLIER 55.09 6.28 0.13 Allowed 'General case' 0 CA--C 1.558 1.281 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 174.957 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 82.02 44.88 7.4 Favored Glycine 0 CA--C 1.54 1.607 0 C-N-CA 127.438 2.447 . . . . 0.0 114.427 -175.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.1 mp -127.82 158.03 38.84 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 119.866 1.833 . . . . 0.0 113.123 -178.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -124.65 117.31 23.97 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 121.061 -1.024 . . . . 0.0 110.478 175.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -98.21 150.24 21.71 Favored 'General case' 0 C--N 1.322 -0.623 0 O-C-N 120.623 -1.298 . . . . 0.0 108.784 174.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -131.4 149.02 52.71 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 127.076 2.151 . . . . 0.0 110.35 176.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -157.52 159.39 29.77 Favored Glycine 0 N--CA 1.464 0.525 0 O-C-N 121.542 -0.724 . . . . 0.0 113.446 176.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -155.15 137.54 6.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 125.222 1.409 . . . . 0.0 109.894 -178.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 2.5 mtm -150.1 167.22 27.44 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 127.388 2.275 . . . . 0.0 108.345 174.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 9.7 t -145.42 133.45 21.42 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 118.942 0.792 . . . . 0.0 109.858 174.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 81.9 p -82.05 30.05 0.4 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.526 1.131 . . . . 0.0 113.729 -176.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -65.61 21.64 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 128.322 2.649 . . . . 0.0 115.432 -177.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 79.84 -44.19 2.73 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 127.554 2.502 . . . . 0.0 113.333 -177.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -143.18 77.24 1.56 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.351 1.46 . . . . 0.0 110.153 -177.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -130.71 166.35 20.93 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.033 1.333 . . . . 0.0 114.047 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.14 169.74 10.38 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 126.948 2.099 . . . . 0.0 113.782 -176.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 11.3 ttt -115.87 145.79 42.57 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.255 1.822 . . . . 0.0 110.891 173.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -149.32 119.14 7.06 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 120.753 -1.217 . . . . 0.0 110.237 174.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 1.8 mp -121.25 130.56 74.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 125.485 1.514 . . . . 0.0 108.267 178.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.8 137.79 43.68 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.876 1.27 . . . . 0.0 110.448 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.6 mp -95.3 95.13 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-N 119.352 0.978 . . . . 0.0 109.518 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 19.3 m -64.55 138.62 58.51 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.981 1.312 . . . . 0.0 111.79 175.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 7.0 mtp180 . . . . . 0 C--O 1.253 1.26 0 O-C-N 120.238 -1.539 . . . . 0.0 112.608 174.938 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.6 mt . . . . . 0 N--CA 1.477 0.882 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -113.21 126.77 55.78 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 127.544 2.338 . . . . 0.0 111.391 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -79.69 -121.54 0.37 Allowed Glycine 0 CA--C 1.536 1.402 0 C-N-CA 125.036 1.303 . . . . 0.0 112.79 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 30.8 p -94.78 171.57 8.69 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.754 1.222 . . . . 0.0 112.397 177.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -130.53 12.32 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 C-N-CA 125.764 1.626 . . . . 0.0 112.002 177.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.6 pp -58.63 172.03 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 O-C-N 120.563 -1.336 . . . . 0.0 112.103 176.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -35.38 129.39 0.54 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.798 2.039 . . . . 0.0 114.729 -175.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -55.57 -21.81 29.57 Favored Glycine 0 CA--C 1.537 1.424 0 C-N-CA 124.673 1.13 . . . . 0.0 114.444 -178.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.1 -31.76 72.25 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.874 1.269 . . . . 0.0 112.048 174.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -100.7 -36.61 9.06 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.963 1.705 . . . . 0.0 112.059 175.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 12.5 tp -79.0 86.16 4.88 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-O 122.1 0.952 . . . . 0.0 110.562 174.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -121.23 178.21 4.86 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 127.565 2.346 . . . . 0.0 112.131 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -42.28 -45.3 4.14 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.562 1.545 . . . . 0.0 113.765 174.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -53.4 -43.53 67.96 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 118.934 0.788 . . . . 0.0 112.449 178.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 86.6 t -64.11 -43.96 97.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.738 1.215 . . . . 0.0 110.799 174.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 68.1 mt -63.82 -41.8 97.78 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.2 -0.938 . . . . 0.0 111.737 179.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -67.28 -44.63 78.81 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.734 1.214 . . . . 0.0 112.576 178.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.08 -37.77 78.65 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 121.476 -0.765 . . . . 0.0 111.357 175.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.9 t -56.67 -38.11 56.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.951 1.3 . . . . 0.0 110.956 178.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 11.1 mt -56.65 -25.89 54.78 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.499 1.519 . . . . 0.0 113.239 175.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -106.28 -46.52 1.15 Allowed Glycine 0 CA--C 1.534 1.243 0 C-N-CA 125.566 1.555 . . . . 0.0 114.692 -178.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -63.96 -27.97 69.5 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 119.243 1.521 . . . . 0.0 113.288 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 19.7 mt -96.54 76.8 2.9 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.9 1.28 . . . . 0.0 110.635 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.59 114.9 5.09 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 126.14 1.829 . . . . 0.0 112.387 178.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -132.47 -74.03 0.51 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.655 1.582 . . . . 0.0 111.919 -179.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.3 m -131.68 177.79 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 126.419 1.887 . . . . 0.0 111.129 -177.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.87 -30.08 68.75 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -177.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.79 117.01 10.07 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.755 1.622 . . . . 0.0 111.443 178.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.24 152.56 42.82 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 125.399 1.48 . . . . 0.0 109.559 -177.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -114.62 133.06 61.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 123.58 0.752 . . . . 0.0 109.438 177.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -134.91 104.77 6.11 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 127.119 2.167 . . . . 0.0 109.795 176.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.4 m -103.82 160.77 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 123.517 0.727 . . . . 0.0 110.358 178.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -138.64 109.83 0.69 Allowed Glycine 0 CA--C 1.519 0.328 0 CA-C-N 118.645 0.657 . . . . 0.0 112.69 174.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.46 ' H ' HD11 ' A' ' 70' ' ' LEU . 3.1 mp -103.96 139.14 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-N 117.313 0.556 . . . . 0.0 110.724 176.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -110.55 104.16 12.85 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.006 1.322 . . . . 0.0 110.704 -177.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -72.6 91.5 1.43 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 127.162 2.185 . . . . 0.0 110.616 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -120.88 9.24 10.61 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.498 1.519 . . . . 0.0 113.331 174.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 37.5 t -50.94 -47.04 61.16 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 125.987 1.715 . . . . 0.0 113.672 177.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 139.99 -21.41 2.82 Favored Glycine 0 N--CA 1.473 1.161 0 C-N-CA 124.452 1.025 . . . . 0.0 114.208 175.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -122.56 167.18 14.97 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 125.724 1.631 . . . . 0.0 111.564 174.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 44.3 p -74.28 145.71 43.78 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.177 0.513 . . . . 0.0 110.674 174.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 49.5 m0 -98.95 104.71 16.78 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 123.593 0.757 . . . . 0.0 110.898 178.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.0 m -82.67 125.3 31.06 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.186 0.994 . . . . 0.0 110.117 176.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.79 117.51 5.95 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.109 0.964 . . . . 0.0 111.309 174.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.6 pp -98.23 -48.99 4.87 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.483 0.713 . . . . 0.0 112.758 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -174.56 152.17 1.63 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 128.213 2.605 . . . . 0.0 109.263 -177.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -136.38 160.54 38.43 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.616 1.166 . . . . 0.0 111.793 174.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -137.78 107.48 6.24 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.653 1.181 . . . . 0.0 112.284 -179.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -107.94 128.7 54.87 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.421 1.088 . . . . 0.0 110.987 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.66 -34.27 5.57 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -176.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.9 t -121.47 -49.46 2.14 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 125.602 1.561 . . . . 0.0 110.594 176.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -66.91 12.56 0.54 Allowed Glycine 0 CA--C 1.536 1.373 0 C-N-CA 125.911 1.72 . . . . 0.0 115.658 -176.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 74.6 p -30.95 109.39 0.06 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 129.089 2.956 . . . . 0.0 114.271 -174.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.5 t -129.25 179.17 5.93 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.437 1.495 . . . . 0.0 113.215 -175.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -78.77 -59.15 2.89 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.994 1.718 . . . . 0.0 112.225 174.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.9 p -143.42 136.64 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 125.597 1.559 . . . . 0.0 111.977 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.4 pp -140.2 -26.3 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 126.07 1.748 . . . . 0.0 114.296 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -99.22 93.54 2.22 Favored Pre-proline 0 CA--C 1.541 0.611 0 C-N-CA 125.212 1.405 . . . . 0.0 108.995 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -61.64 143.06 96.37 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.775 2.316 . . . . 0.0 110.389 174.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -40.11 -48.92 2.56 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.429 1.891 . . . . 0.0 113.84 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.7 p -156.1 138.66 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 127.295 2.238 . . . . 0.0 109.188 175.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 22.0 t -112.27 121.99 37.79 Favored Pre-proline 0 N--CA 1.477 0.897 0 C-N-CA 124.233 1.013 . . . . 0.0 108.902 175.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -67.8 157.78 60.23 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 122.015 1.81 . . . . 0.0 112.946 177.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -71.65 168.58 17.39 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.575 0.75 . . . . 0.0 111.52 175.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 43.7 p 54.44 19.11 2.18 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 127.286 2.234 . . . . 0.0 113.79 -174.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.8 mttt -134.29 171.72 13.87 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 126.918 2.087 . . . . 0.0 110.951 -175.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -127.97 177.16 7.06 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.071 0.462 . . . . 0.0 110.146 -175.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.46 HD11 ' H ' ' A' ' 36' ' ' ILE . 1.9 pp -142.84 173.47 11.52 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 124.181 0.992 . . . . 0.0 111.255 -178.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -132.47 151.62 51.83 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.937 1.295 . . . . 0.0 111.007 174.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -124.14 146.04 48.91 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.162 0.985 . . . . 0.0 108.595 174.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.8 p -121.28 137.1 54.84 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 126.401 1.88 . . . . 0.0 110.997 175.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -160.95 133.34 3.17 Favored Glycine 0 CA--C 1.525 0.7 0 O-C-N 121.785 -0.572 . . . . 0.0 113.822 174.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 26.3 mtm180 -90.68 149.7 21.96 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.946 1.298 . . . . 0.0 110.988 -174.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 9.9 ptmt . . . . . 0 N--CA 1.48 1.075 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 174.961 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 97.7 m . . . . . 0 N--CA 1.478 0.948 0 CA-C-O 118.745 -0.645 . . . . 0.0 109.62 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -26.05 -68.07 0.05 OUTLIER Glycine 0 N--CA 1.48 1.628 0 C-N-CA 127.422 2.439 . . . . 0.0 115.013 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -177.58 135.79 0.19 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.371 1.868 . . . . 0.0 111.82 175.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.9 t -154.85 129.42 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 125.139 1.376 . . . . 0.0 109.094 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -173.32 174.48 3.32 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.442 1.497 . . . . 0.0 111.732 177.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -151.18 141.49 22.36 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.108 1.363 . . . . 0.0 110.169 174.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -138.45 171.52 14.25 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 121.233 -0.917 . . . . 0.0 111.231 178.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -139.43 156.24 47.09 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.391 0.615 . . . . 0.0 112.551 177.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -135.08 129.09 33.44 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 125.833 1.653 . . . . 0.0 112.421 -174.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -83.4 135.11 34.82 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -176.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.24 138.18 44.96 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 125.086 1.355 . . . . 0.0 111.917 178.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.8 t -62.8 -22.5 66.67 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.493 1.117 . . . . 0.0 113.164 176.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -67.41 -16.15 64.07 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.121 1.368 . . . . 0.0 113.321 175.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 101.28 33.89 4.71 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 124.845 1.212 . . . . 0.0 114.558 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 -140.6 177.07 8.28 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-N 119.204 1.502 . . . . 0.0 110.95 177.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 19.2 m -130.67 105.83 8.08 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.668 1.587 . . . . 0.0 112.457 -176.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 59.6 tp -68.4 104.42 1.89 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.715 1.206 . . . . 0.0 111.271 175.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -99.32 116.95 5.72 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 125.947 1.737 . . . . 0.0 113.084 179.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 57.3 t -105.14 129.07 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 126.218 1.807 . . . . 0.0 111.341 -174.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -127.12 130.24 49.44 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.673 1.589 . . . . 0.0 112.273 -174.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -146.02 140.56 26.91 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.644 1.177 . . . . 0.0 112.484 -176.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.28 123.37 10.79 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.181 1.392 . . . . 0.0 111.967 -174.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 96.4 t . . . . . 0 N--CA 1.481 1.084 0 C-N-CA 125.065 1.346 . . . . 0.0 111.686 -177.432 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.4 m . . . . . 0 N--CA 1.468 0.461 0 CA-C-O 121.186 0.517 . . . . 0.0 111.623 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -73.36 117.68 15.4 Favored 'General case' 0 C--O 1.226 -0.18 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 174.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 34.4 m0 -113.68 143.59 44.35 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 176.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 37.3 p-90 -148.85 138.58 21.99 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.206 1.002 . . . . 0.0 111.268 -177.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -150.04 162.86 39.57 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 122.801 1.286 . . . . 0.0 113.279 -177.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 61.7 t -145.53 144.34 21.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 124.24 1.016 . . . . 0.0 108.311 175.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.454 ' HE2' ' SD ' ' A' ' 135' ' ' MET . 0.0 OUTLIER -155.9 176.71 12.28 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.908 1.683 . . . . 0.0 110.141 175.577 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.483 ' HB ' ' CE1' ' A' ' 154' ' ' TYR . 11.7 mt -126.32 99.59 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-O 121.86 0.838 . . . . 0.0 108.955 178.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -59.68 148.25 75.64 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 124.105 0.962 . . . . 0.0 111.84 178.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -70.5 135.54 28.94 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.986 2.457 . . . . 0.0 111.838 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 59.13 -157.82 22.42 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 124.057 0.837 . . . . 0.0 113.528 -177.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 9.9 tttt -72.75 120.02 17.78 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.975 0.91 . . . . 0.0 108.735 174.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 25.0 tpp180 -130.68 169.62 15.42 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 125.868 1.667 . . . . 0.0 109.447 175.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 25.6 ptt180 -119.89 175.33 5.95 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 126.549 1.94 . . . . 0.0 110.6 174.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -120.3 108.11 13.77 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 175.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -126.27 165.7 18.48 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.901 1.28 . . . . 0.0 110.01 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -55.66 -36.81 67.49 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 121.302 -0.874 . . . . 0.0 113.203 -176.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -59.7 -61.29 7.39 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.442 -0.663 . . . . 0.0 111.442 174.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -62.98 -33.11 74.7 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 118.367 1.084 . . . . 0.0 112.833 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -58.35 -63.11 1.39 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.625 1.17 . . . . 0.0 108.987 174.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -69.27 -27.2 65.22 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -177.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -68.23 -32.06 71.99 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.741 1.216 . . . . 0.0 113.418 175.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' MET . . . . . 0.454 ' SD ' ' HE2' ' A' ' 119' ' ' LYS . 0.7 OUTLIER -94.89 -25.48 16.56 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 121.274 -0.891 . . . . 0.0 112.076 176.667 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -51.99 -57.6 9.01 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.769 2.028 . . . . 0.0 110.02 174.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -67.22 -10.19 48.01 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 113.526 0.935 . . . . 0.0 113.526 -178.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -83.6 -16.03 69.45 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 126.638 2.066 . . . . 0.0 114.273 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -142.14 87.26 9.76 Favored Pre-proline 0 CA--C 1.549 0.925 0 CA-C-N 118.661 1.231 . . . . 0.0 112.001 179.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.95 77.97 1.85 Allowed 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 123.675 2.916 . . . . 0.0 112.472 177.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -108.59 115.05 29.36 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.32 1.448 . . . . 0.0 109.826 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 9.5 mtp180 -92.93 26.88 2.6 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 126.909 2.083 . . . . 0.0 115.969 -174.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 62.38 59.69 9.01 Favored Glycine 0 CA--C 1.531 1.051 0 N-CA-C 109.106 -1.597 . . . . 0.0 109.106 -175.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -64.28 105.81 0.98 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.182 0.993 . . . . 0.0 110.006 176.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -68.02 83.48 0.22 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.213 1.405 . . . . 0.0 114.33 -174.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 170.24 48.71 0.03 OUTLIER Glycine 0 CA--C 1.537 1.462 0 C-N-CA 124.967 1.27 . . . . 0.0 114.468 177.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 2.2 m95 54.65 44.09 29.16 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 125.782 1.633 . . . . 0.0 114.728 -177.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -79.62 130.62 35.53 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 120.61 -1.306 . . . . 0.0 112.77 -175.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.02 -175.16 4.93 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -175.015 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.2 pttt -131.0 156.72 44.64 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.194 1.397 . . . . 0.0 111.672 174.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 28.6 m-80 -78.14 124.17 27.74 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 174.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 69.3 mt -81.52 149.11 28.85 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 122.201 1.001 . . . . 0.0 109.33 174.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -66.08 -166.48 2.04 Favored Glycine 0 CA--C 1.535 1.303 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 174.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.483 ' CE1' ' HB ' ' A' ' 120' ' ' ILE . 0.0 OUTLIER 54.3 11.49 0.4 Allowed 'General case' 0 CA--C 1.557 1.233 0 N-CA-C 114.988 1.477 . . . . 0.0 114.988 174.969 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 84.94 37.3 10.26 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 126.542 2.02 . . . . 0.0 113.208 -178.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.7 mp -122.74 160.21 26.41 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 119.843 1.822 . . . . 0.0 113.038 -178.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 72.2 mtt85 -149.06 109.77 4.26 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 120.636 -1.29 . . . . 0.0 111.082 -178.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 9.0 ttp -104.73 132.77 50.58 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 124.025 0.93 . . . . 0.0 108.893 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 7.1 tppt? -111.14 129.65 55.87 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 127.967 2.507 . . . . 0.0 110.593 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -137.21 156.17 23.25 Favored Glycine 0 N--CA 1.474 1.208 0 CA-C-N 120.7 1.591 . . . . 0.0 115.959 -177.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 4.5 tp -148.58 127.8 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 124.77 1.228 . . . . 0.0 112.069 -175.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 16.1 mtm -151.5 169.81 21.17 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 128.489 2.716 . . . . 0.0 109.892 174.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 14.5 t -156.23 135.27 12.0 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.714 1.606 . . . . 0.0 109.597 174.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 61.7 p -81.32 20.04 0.9 Allowed 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 179.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.85 -34.7 65.68 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.486 1.914 . . . . 0.0 115.108 -177.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 154.01 -63.45 0.36 Allowed Glycine 0 CA--C 1.533 1.176 0 C-N-CA 124.386 0.993 . . . . 0.0 114.29 176.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -119.79 27.82 8.49 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 125.718 1.607 . . . . 0.0 112.669 -175.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -64.03 174.59 1.47 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.839 1.255 . . . . 0.0 113.269 174.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.57 168.14 13.01 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.735 2.014 . . . . 0.0 111.248 177.015 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 48.5 ttp -111.51 123.87 51.11 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.816 1.246 . . . . 0.0 110.45 176.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -137.46 128.02 26.77 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 123.255 0.622 . . . . 0.0 110.325 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 5.1 mp -134.9 119.27 27.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 123.461 0.704 . . . . 0.0 109.853 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -114.57 134.96 54.64 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.188 1.395 . . . . 0.0 111.067 177.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.8 mp -81.83 129.97 36.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 O-C-N 120.906 -1.121 . . . . 0.0 109.013 175.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -137.93 94.43 2.89 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.854 1.262 . . . . 0.0 112.328 177.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 72.1 mtp180 . . . . . 0 C--O 1.252 1.185 0 C-N-CA 126.604 1.961 . . . . 0.0 113.245 175.002 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.0 mm? . . . . . 0 N--CA 1.48 1.059 0 N-CA-C 115.724 1.75 . . . . 0.0 115.724 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.54 78.67 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.121 1.368 . . . . 0.0 112.425 175.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -72.63 -66.3 2.1 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 125.984 1.754 . . . . 0.0 112.238 -175.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 39.7 p -142.61 166.83 23.59 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.73 1.612 . . . . 0.0 112.097 176.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -131.48 10.06 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 125.993 1.717 . . . . 0.0 112.607 175.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -53.67 163.32 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 O-C-N 120.223 -1.548 . . . . 0.0 112.648 177.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -38.92 136.29 0.79 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 127.001 2.121 . . . . 0.0 113.82 -174.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -55.38 -21.22 26.03 Favored Glycine 0 CA--C 1.54 1.605 0 C-N-CA 124.858 1.218 . . . . 0.0 114.399 -176.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.66 -29.04 69.81 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.032 1.333 . . . . 0.0 112.577 174.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.5 t -104.99 -43.98 4.92 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.808 1.643 . . . . 0.0 111.299 175.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.4 tp -75.16 93.47 2.81 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.81 0.844 . . . . 0.0 111.537 175.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 44.1 p -130.69 -177.99 4.59 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 126.901 2.081 . . . . 0.0 111.583 177.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -39.89 -43.99 1.58 Allowed 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 127.207 2.203 . . . . 0.0 113.59 175.022 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -54.67 -41.44 70.19 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.651 0.78 . . . . 0.0 112.055 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.0 t -68.35 -38.19 79.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.804 1.242 . . . . 0.0 111.233 175.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 24.5 mt -68.62 -42.47 78.03 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 121.355 -0.841 . . . . 0.0 111.414 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -65.38 -50.45 65.46 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.498 1.119 . . . . 0.0 111.915 178.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.13 -33.88 76.42 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 118.876 -0.583 . . . . 0.0 112.062 174.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.9 t -55.38 -47.0 78.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 124.85 1.26 . . . . 0.0 112.355 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.82 -23.86 46.88 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 119.838 1.199 . . . . 0.0 113.022 175.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -82.45 -61.44 1.98 Allowed Glycine 0 CA--C 1.534 1.233 0 C-N-CA 126.049 1.785 . . . . 0.0 112.919 174.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -66.49 -35.86 81.31 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -177.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -94.88 73.65 3.54 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 122.773 1.273 . . . . 0.0 110.468 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -76.2 64.13 2.82 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 126.302 1.906 . . . . 0.0 115.151 -174.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.1 mttt -55.59 -75.47 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 126.69 1.996 . . . . 0.0 113.972 178.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 18.0 m -141.77 -179.37 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 127.438 2.295 . . . . 0.0 110.708 178.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 36.8 m -52.39 -34.31 47.43 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 126.721 2.009 . . . . 0.0 114.878 -177.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.8 mmp_? -136.7 111.99 9.14 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 127.23 2.212 . . . . 0.0 109.185 175.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.0 166.06 15.72 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.381 1.472 . . . . 0.0 110.543 178.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -128.85 123.16 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 123.949 0.9 . . . . 0.0 110.911 -178.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -120.13 118.17 29.86 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.883 1.673 . . . . 0.0 109.806 175.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.4 m -124.47 148.4 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 122.715 0.406 . . . . 0.0 110.602 175.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -121.52 111.06 1.78 Allowed Glycine 0 C--N 1.329 0.16 0 C-N-CA 124.285 0.945 . . . . 0.0 111.044 -178.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 mp -100.24 139.94 20.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 117.703 0.752 . . . . 0.0 109.282 175.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -114.91 101.91 9.48 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.893 1.277 . . . . 0.0 109.305 -178.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 40.9 t-20 -73.68 107.17 5.78 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.051 1.34 . . . . 0.0 110.515 -178.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -135.12 19.27 3.43 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.386 1.474 . . . . 0.0 111.8 175.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.8 p -76.19 178.21 6.59 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.072 1.749 . . . . 0.0 112.433 176.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -91.25 56.06 3.2 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 126.379 1.942 . . . . 0.0 113.167 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 157.34 137.5 2.31 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.453 1.025 . . . . 0.0 113.636 177.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 37.9 p -62.47 141.19 58.51 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.456 0.702 . . . . 0.0 110.428 175.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 30.0 m0 -97.56 109.2 22.0 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.694 0.283 . . . . 0.0 111.553 178.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 37.4 m -87.75 142.74 27.59 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.172 0.589 . . . . 0.0 109.541 175.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.67 126.86 29.38 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.689 0.796 . . . . 0.0 111.457 174.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.1 pp -116.7 -58.6 2.06 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.271 1.028 . . . . 0.0 111.854 177.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -176.07 152.38 1.17 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 127.215 2.206 . . . . 0.0 110.617 -177.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -134.28 158.84 42.74 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.151 1.38 . . . . 0.0 111.063 175.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 91.2 t80 -140.04 100.21 3.87 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.036 1.334 . . . . 0.0 112.169 -175.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -105.04 124.26 49.23 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.559 1.144 . . . . 0.0 111.614 -175.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.71 -37.4 7.92 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -177.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 29.5 t -120.61 -49.59 2.23 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.33 1.452 . . . . 0.0 110.725 177.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -68.63 17.37 0.49 Allowed Glycine 0 CA--C 1.533 1.166 0 C-N-CA 126.587 2.042 . . . . 0.0 115.272 -175.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.2 p -35.52 121.02 0.59 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 128.739 2.816 . . . . 0.0 112.995 -175.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -139.13 172.4 12.89 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.651 1.181 . . . . 0.0 113.571 -174.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -76.82 -68.85 0.56 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.524 1.53 . . . . 0.0 113.309 175.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.7 p -135.9 129.67 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 125.126 1.371 . . . . 0.0 112.425 -176.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -138.43 -34.3 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.672 1.589 . . . . 0.0 114.443 -175.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 48.5 mt -91.33 104.14 9.15 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 125.169 1.388 . . . . 0.0 109.621 175.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -72.52 165.24 33.26 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.763 2.975 . . . . 0.0 110.413 175.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -47.57 -44.23 26.08 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.9 p -157.81 152.26 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 127.014 2.125 . . . . 0.0 110.057 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.46 ' HA ' ' HE3' ' A' ' 68' ' ' LYS . 60.5 t -126.89 99.14 29.56 Favored Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 126.375 1.87 . . . . 0.0 106.778 175.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -69.71 171.62 14.08 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 120.97 1.113 . . . . 0.0 112.628 175.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -75.71 166.13 24.0 Favored 'General case' 0 CA--C 1.548 0.869 0 O-C-N 121.297 -0.877 . . . . 0.0 110.355 174.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . 0.276 5.8 p 62.39 18.27 10.15 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 128.058 2.543 . . . . 0.0 115.141 -177.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.46 ' HE3' ' HA ' ' A' ' 64' ' ' VAL . 0.0 OUTLIER -131.34 170.9 14.01 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 126.086 1.755 . . . . 0.0 111.585 -177.986 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -131.18 165.76 22.61 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-O 121.637 0.732 . . . . 0.0 111.633 177.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.42 ' CD1' ' HH ' ' A' ' 91' ' ' TYR . 2.0 pt? -134.79 171.45 14.36 Favored 'General case' 0 C--N 1.321 -0.667 0 O-C-N 120.225 -1.547 . . . . 0.0 110.806 175.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -112.91 162.83 15.38 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 125.315 1.446 . . . . 0.0 108.654 174.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -136.55 149.66 48.22 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 125.118 1.367 . . . . 0.0 108.938 175.054 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 85.8 p -129.49 148.81 51.43 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.924 1.69 . . . . 0.0 112.191 -177.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -171.8 146.4 9.37 Favored Glycine 0 CA--C 1.521 0.45 0 N-CA-C 111.984 -0.446 . . . . 0.0 111.984 174.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 41.6 mtm-85 -108.31 150.44 27.32 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.784 1.234 . . . . 0.0 110.733 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.48 1.03 0 N-CA-C 114.934 1.457 . . . . 0.0 114.934 175.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 24.9 m . . . . . 0 N--CA 1.474 0.755 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -45.28 -67.41 1.23 Allowed Glycine 0 N--CA 1.473 1.127 0 C-N-CA 125.899 1.714 . . . . 0.0 113.888 -174.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -171.77 119.78 0.45 Allowed 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.482 1.113 . . . . 0.0 111.339 175.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.418 HG11 ' HG ' ' A' ' 104' ' ' SER . 4.8 t -141.35 118.64 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 O-C-N 121.765 -0.585 . . . . 0.0 110.081 -178.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.66 157.9 37.42 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 122.53 1.157 . . . . 0.0 112.074 -179.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -137.5 147.99 45.66 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.88 1.272 . . . . 0.0 108.442 175.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -155.13 166.51 33.34 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 121.03 -1.044 . . . . 0.0 109.127 178.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -137.4 156.16 48.51 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.42 ' HH ' ' CD1' ' A' ' 70' ' ' LEU . 2.3 m-85 -132.46 130.62 40.75 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.272 1.029 . . . . 0.0 113.504 -174.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -82.76 112.99 20.11 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -175.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -93.81 143.01 26.72 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.097 1.359 . . . . 0.0 113.107 -178.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.24 -20.67 64.48 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.556 1.142 . . . . 0.0 113.61 177.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 48.1 m-20 -67.53 -11.6 58.38 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.563 1.145 . . . . 0.0 112.727 174.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 96.58 27.03 10.11 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 124.993 1.282 . . . . 0.0 113.746 -178.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -132.5 172.84 11.97 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.986 1.314 . . . . 0.0 111.588 -176.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.5 m -126.38 107.57 10.41 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.06 1.344 . . . . 0.0 111.641 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.0 tt -70.53 98.84 1.53 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.978 1.711 . . . . 0.0 111.918 179.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -94.19 97.07 2.13 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 124.765 1.174 . . . . 0.0 114.881 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 99.3 t -75.45 140.53 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.381 1.072 . . . . 0.0 110.123 174.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 3.1 tmm? -136.13 129.16 31.36 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.651 1.581 . . . . 0.0 110.348 177.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -144.79 142.85 30.3 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.442 -0.786 . . . . 0.0 112.426 175.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.418 ' HG ' HG11 ' A' ' 86' ' ' VAL . 13.2 m -142.9 114.48 8.01 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.395 1.078 . . . . 0.0 112.361 -177.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 26.1 t . . . . . 0 CA--C 1.538 0.488 0 C-N-CA 127.445 2.298 . . . . 0.0 109.229 178.496 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 31.7 m . . . . . 0 N--CA 1.463 0.199 0 CA-C-O 121.243 0.544 . . . . 0.0 111.378 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -67.51 101.39 0.98 Allowed 'General case' 0 C--O 1.223 -0.316 0 C-N-CA 125.041 1.336 . . . . 0.0 107.929 174.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 47.7 m0 -107.78 144.27 35.18 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 120.622 1.555 . . . . 0.0 110.185 176.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 43.9 p-90 -147.99 139.9 24.01 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.659 0.784 . . . . 0.0 111.509 -177.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -149.86 159.42 44.38 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 122.656 1.217 . . . . 0.0 112.294 -177.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 22.0 t -144.43 136.27 21.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 174.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.98 179.91 6.9 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 126.242 1.817 . . . . 0.0 109.191 176.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 10.5 mt -132.41 134.04 59.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 123.197 0.599 . . . . 0.0 109.399 176.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -90.43 151.68 44.6 Favored Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 125.329 1.452 . . . . 0.0 112.493 177.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.74 139.9 28.48 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 123.198 2.599 . . . . 0.0 110.939 174.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 61.29 -166.21 15.17 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 123.726 0.679 . . . . 0.0 113.475 -176.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.46 99.5 5.67 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.716 1.606 . . . . 0.0 109.771 174.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -111.44 -172.38 2.02 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 125.744 1.618 . . . . 0.0 111.199 -177.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 25.7 ptt180 -139.01 177.54 7.82 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 127.222 2.209 . . . . 0.0 111.229 175.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -118.46 121.22 39.77 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 174.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -129.81 167.11 18.62 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.703 1.601 . . . . 0.0 109.353 175.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -48.87 -45.83 41.56 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 119.641 1.109 . . . . 0.0 113.232 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -52.55 -62.94 5.35 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 123.997 0.808 . . . . 0.0 112.252 175.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 5.0 mpp? -60.76 -38.42 85.17 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 113.583 0.956 . . . . 0.0 113.583 178.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -57.0 -61.87 2.15 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.934 0.788 . . . . 0.0 109.527 175.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -62.97 -37.17 86.03 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.863 0.865 . . . . 0.0 112.731 -177.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -63.65 -43.54 96.47 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.012 1.325 . . . . 0.0 112.36 179.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.81 -26.16 24.22 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 121.053 -1.029 . . . . 0.0 113.42 176.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -52.02 -58.29 6.97 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.257 1.823 . . . . 0.0 110.678 175.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -70.47 -12.85 61.84 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -177.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -81.69 -5.63 89.71 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 127.203 2.335 . . . . 0.0 114.345 177.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -145.11 86.45 7.63 Favored Pre-proline 0 CA--C 1.548 0.87 0 CA-C-N 119.052 1.426 . . . . 0.0 113.301 175.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -76.64 74.79 4.68 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 123.513 2.809 . . . . 0.0 112.946 -179.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -107.26 107.36 18.26 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.022 0.929 . . . . 0.0 111.385 -175.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 59.1 mtm180 -89.76 48.14 1.55 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 126.074 1.75 . . . . 0.0 114.505 -175.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 49.46 57.86 8.83 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.815 -176.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -63.14 106.52 0.87 Allowed 'General case' 0 CA--C 1.546 0.802 0 CA-C-O 122.141 0.972 . . . . 0.0 109.86 -176.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 17.3 p-10 -68.23 73.69 0.21 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 127.336 2.255 . . . . 0.0 114.968 -174.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 178.35 48.75 0.07 OUTLIER Glycine 0 CA--C 1.536 1.4 0 C-N-CA 124.382 0.991 . . . . 0.0 115.003 175.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' TRP . . . . . 0.486 ' H ' HD11 ' A' ' 161' ' ' ILE . 8.1 m95 49.33 56.28 8.05 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 126.204 1.802 . . . . 0.0 112.795 -175.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -85.9 127.5 34.61 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.281 1.032 . . . . 0.0 112.818 -178.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -157.86 -176.09 5.73 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -175.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 5.7 mtmt -140.24 169.33 17.88 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 126.144 1.777 . . . . 0.0 111.581 175.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -72.66 155.66 39.77 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 174.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 71.0 mt -109.01 89.02 2.87 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.736 0.814 . . . . 0.0 110.375 177.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 40.86 -82.06 0.0 OUTLIER Glycine 0 N--CA 1.476 1.341 0 C-N-CA 129.608 3.48 . . . . 0.0 115.27 175.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -68.53 -154.2 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 128.839 2.855 . . . . 0.0 110.541 174.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -73.68 20.24 1.41 Allowed Glycine 0 CA--C 1.541 1.693 0 O-C-N 120.217 -1.552 . . . . 0.0 114.928 175.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.04 154.07 17.34 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 120.448 2.124 . . . . 0.0 112.038 177.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 87.4 mtt180 -145.95 115.82 7.32 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.322 1.449 . . . . 0.0 110.877 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 5.9 ttp -114.25 132.42 56.15 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 124.273 1.029 . . . . 0.0 109.682 -178.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -103.84 132.83 49.72 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 128.477 2.711 . . . . 0.0 110.005 -179.039 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -135.2 150.83 20.31 Favored Glycine 0 N--CA 1.47 0.918 0 CA-C-N 120.313 1.415 . . . . 0.0 114.23 178.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.486 HD11 ' H ' ' A' ' 147' ' ' TRP . 6.6 tp -145.81 131.93 13.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 125.147 1.379 . . . . 0.0 110.957 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 3.6 ttt -152.42 176.4 11.69 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 127.606 2.362 . . . . 0.0 107.717 175.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 10.1 t -152.39 163.62 39.15 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.194 1.397 . . . . 0.0 109.161 175.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 5.4 t -106.52 31.43 5.22 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.396 1.478 . . . . 0.0 111.511 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -68.44 23.76 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 128.09 2.556 . . . . 0.0 115.112 179.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 84.36 -60.24 4.85 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 126.181 1.848 . . . . 0.0 113.342 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -126.5 63.0 1.28 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.333 1.453 . . . . 0.0 111.051 178.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -86.61 -177.46 6.15 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.311 1.044 . . . . 0.0 112.794 174.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . 0.44 ' O ' ' HE2' ' A' ' 169' ' ' LYS . 0.0 OUTLIER -124.85 174.43 7.95 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 127.991 2.516 . . . . 0.0 109.708 174.993 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 42.5 ttp -126.12 132.12 51.93 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.055 1.342 . . . . 0.0 110.189 176.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -135.86 127.18 28.38 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.104 0.962 . . . . 0.0 110.163 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 4.6 mp -129.58 120.66 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 C-N-CA 123.19 0.596 . . . . 0.0 109.95 177.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.06 132.42 56.03 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.827 1.651 . . . . 0.0 111.341 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.8 mp -76.81 133.67 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 O-C-N 120.683 -1.26 . . . . 0.0 110.382 175.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 6.7 m -140.24 92.5 2.54 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 125.144 1.378 . . . . 0.0 112.22 177.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 60.5 mtp180 . . . . . 0 C--O 1.254 1.29 0 C-N-CA 126.311 1.844 . . . . 0.0 111.48 175.033 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 15.5 tp . . . . . 0 N--CA 1.476 0.831 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -75.62 129.96 38.0 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 175.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -71.93 -113.02 0.05 OUTLIER Glycine 0 CA--C 1.533 1.192 0 C-N-CA 124.036 0.827 . . . . 0.0 112.636 177.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 19.3 p -113.58 172.82 6.74 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.872 1.269 . . . . 0.0 111.578 176.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -124.81 24.56 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 125.226 1.41 . . . . 0.0 111.871 175.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -52.49 166.4 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 O-C-N 120.633 -1.292 . . . . 0.0 112.684 174.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -48.87 144.3 4.71 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.947 1.299 . . . . 0.0 113.404 -177.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.06 -24.33 54.37 Favored Glycine 0 CA--C 1.538 1.492 0 N-CA-C 115.78 1.072 . . . . 0.0 115.78 -174.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.89 -34.43 64.42 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 121.289 -1.124 . . . . 0.0 111.797 174.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.9 t -84.21 -41.27 17.14 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.684 1.993 . . . . 0.0 112.837 175.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 13.0 tp -89.23 96.29 10.66 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 127.415 2.286 . . . . 0.0 111.357 175.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.58 178.77 6.49 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 126.734 2.014 . . . . 0.0 110.731 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -41.36 -40.91 1.83 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.683 1.593 . . . . 0.0 113.786 175.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -49.89 -45.23 50.56 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.219 1.407 . . . . 0.0 112.639 175.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 88.0 t -69.86 -38.88 76.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 125.777 1.631 . . . . 0.0 111.669 175.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 44.6 mt -70.75 -36.77 73.29 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 120.706 -1.246 . . . . 0.0 112.457 -178.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -65.48 -51.14 62.19 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.343 1.457 . . . . 0.0 111.186 175.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.71 -34.31 75.56 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 118.08 -0.962 . . . . 0.0 111.915 175.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.2 t -56.35 -48.53 79.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-N 119.679 1.127 . . . . 0.0 111.485 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 55.4 mt -56.85 -19.8 19.44 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 175.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.03 -61.24 1.28 Allowed Glycine 0 CA--C 1.535 1.293 0 C-N-CA 126.306 1.908 . . . . 0.0 113.12 175.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -64.11 -32.54 74.14 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -178.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -90.55 97.76 11.37 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.179 0.992 . . . . 0.0 109.917 176.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -109.82 109.42 2.7 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 126.333 1.921 . . . . 0.0 112.475 -178.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.7 mtpt -129.59 -69.86 0.67 Allowed 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 125.793 1.637 . . . . 0.0 112.07 -176.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.4 m -121.17 169.36 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 127.848 2.459 . . . . 0.0 110.491 -176.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.0 t -65.76 -31.85 73.07 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -179.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.5 mmt180 -132.4 105.58 7.36 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.303 1.841 . . . . 0.0 111.041 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.4 ptpt -120.56 159.43 25.26 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 126.539 1.935 . . . . 0.0 110.149 -177.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -128.75 132.95 67.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 123.941 0.897 . . . . 0.0 109.437 175.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.33 102.63 4.85 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.077 1.751 . . . . 0.0 109.673 177.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.3 m -107.7 162.29 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 123.73 0.812 . . . . 0.0 110.927 178.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -134.84 124.28 3.39 Favored Glycine 0 N--CA 1.463 0.452 0 N-CA-C 111.531 -0.628 . . . . 0.0 111.531 177.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.3 mp -113.02 132.35 62.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-N 118.459 1.13 . . . . 0.0 110.536 175.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -96.22 99.69 11.39 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.67 1.588 . . . . 0.0 110.214 177.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -67.73 94.35 0.44 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.319 1.448 . . . . 0.0 110.552 175.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -125.34 7.29 7.75 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 125.576 1.55 . . . . 0.0 111.801 174.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 42.8 p -57.03 -34.9 68.67 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.366 1.066 . . . . 0.0 113.616 -177.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 158.47 -63.52 0.3 Allowed Glycine 0 CA--C 1.53 1.02 0 C-N-CA 125.271 1.415 . . . . 0.0 113.639 175.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -107.18 171.08 16.29 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 125.549 1.547 . . . . 0.0 113.092 -178.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.17 150.84 28.64 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.803 -0.822 . . . . 0.0 110.874 175.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 45.2 m0 -104.35 100.52 10.23 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 124.876 1.271 . . . . 0.0 111.346 -177.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.5 m -80.73 117.97 21.86 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 124.689 1.195 . . . . 0.0 108.44 175.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.86 126.46 27.08 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.129 0.571 . . . . 0.0 111.676 175.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.1 pp -100.37 -53.48 3.1 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 122.844 0.458 . . . . 0.0 111.937 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -171.6 138.87 1.17 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.618 1.967 . . . . 0.0 109.56 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -121.31 155.53 34.51 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.797 1.239 . . . . 0.0 111.404 175.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -136.45 113.42 10.44 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.589 1.555 . . . . 0.0 111.409 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -114.31 132.5 56.15 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 123.772 0.829 . . . . 0.0 110.02 -178.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.58 -31.33 4.31 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 114.973 1.471 . . . . 0.0 114.973 -175.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.0 t -123.18 -46.58 2.06 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.503 1.521 . . . . 0.0 110.943 175.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -72.48 10.97 4.48 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 124.711 1.148 . . . . 0.0 115.046 -178.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.3 p -31.06 104.03 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 128.982 2.913 . . . . 0.0 114.182 -174.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.6 t -120.92 178.6 4.66 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.945 1.298 . . . . 0.0 112.786 -174.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -77.42 -59.03 2.95 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.86 1.264 . . . . 0.0 111.554 174.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.3 p -138.09 131.41 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 125.918 1.687 . . . . 0.0 112.32 -178.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.1 pp -140.78 -39.62 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.92 1.688 . . . . 0.0 114.154 -177.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.9 mt -92.17 94.94 0.87 Allowed Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 124.933 1.293 . . . . 0.0 108.883 175.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -61.83 132.91 42.03 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 123.137 2.558 . . . . 0.0 110.258 175.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -40.0 -44.43 1.73 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 126.457 1.903 . . . . 0.0 113.962 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.4 p -155.13 139.7 9.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 C-N-CA 126.613 1.965 . . . . 0.0 110.028 176.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 58.6 t -133.72 121.35 16.02 Favored Pre-proline 0 N--CA 1.484 1.246 0 C-N-CA 124.623 1.169 . . . . 0.0 110.672 178.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -58.17 152.32 53.3 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.982 2.455 . . . . 0.0 113.21 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -72.49 168.21 19.01 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.51 0.724 . . . . 0.0 110.657 175.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 72.7 p 51.72 28.56 4.95 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 126.904 2.082 . . . . 0.0 112.687 -175.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.25 171.85 12.83 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 128.443 2.697 . . . . 0.0 109.42 -175.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -131.15 167.36 19.27 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 121.716 -0.615 . . . . 0.0 109.746 177.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.9 pp -137.14 174.16 10.91 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 125.045 1.338 . . . . 0.0 111.03 -176.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.95 152.65 47.63 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.819 1.248 . . . . 0.0 111.397 176.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.453 ' CE2' ' CD2' ' A' ' 89' ' ' PHE . 8.2 m-85 -127.25 136.68 52.33 Favored 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 125.109 1.364 . . . . 0.0 107.76 174.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.0 p -114.96 153.29 30.87 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 125.666 1.587 . . . . 0.0 110.935 176.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -170.84 145.45 8.98 Favored Glycine 0 N--CA 1.452 -0.263 0 CA-C-O 121.587 0.548 . . . . 0.0 112.422 176.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 19.0 mtm180 -128.45 132.43 48.41 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 125.942 1.697 . . . . 0.0 109.759 -175.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.8 ptmt . . . . . 0 N--CA 1.474 0.753 0 C-N-CA 123.894 0.878 . . . . 0.0 112.734 174.994 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.48 1.069 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -68.26 -64.59 3.04 Favored Glycine 0 N--CA 1.474 1.193 0 O-C-N 120.598 -1.314 . . . . 0.0 113.191 -177.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -158.44 114.08 2.67 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.238 1.015 . . . . 0.0 111.058 178.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.8 t -147.57 123.23 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 O-C-N 121.246 -0.909 . . . . 0.0 110.577 -176.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -165.03 167.24 18.58 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.974 1.31 . . . . 0.0 112.022 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -150.1 139.72 21.62 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.655 1.182 . . . . 0.0 110.645 174.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.453 ' CD2' ' CE2' ' A' ' 72' ' ' TYR . 46.8 p90 -139.73 170.91 15.01 Favored 'General case' 0 N--CA 1.467 0.383 0 O-C-N 121.012 -1.055 . . . . 0.0 110.622 176.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -137.16 156.39 48.4 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.843 -0.536 . . . . 0.0 112.295 175.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -130.39 129.14 42.71 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 125.492 1.517 . . . . 0.0 112.314 -177.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -85.88 117.29 24.64 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.065 0.46 . . . . 0.0 111.133 -178.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 7.6 mtp -93.92 132.17 38.62 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.05 1.34 . . . . 0.0 110.981 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 39.5 m -57.92 -18.21 21.64 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 125.246 1.418 . . . . 0.0 113.856 175.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -69.48 -9.18 52.66 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 124.911 1.285 . . . . 0.0 113.06 175.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 99.54 19.77 19.39 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 125.746 1.641 . . . . 0.0 114.549 178.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 16.4 m-80 -130.55 175.86 8.64 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.003 1.321 . . . . 0.0 111.053 -175.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 16.4 m -128.85 114.21 16.23 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.852 0.861 . . . . 0.0 111.955 177.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 52.1 tp -79.39 104.43 10.0 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.598 1.159 . . . . 0.0 109.737 175.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -99.21 113.92 4.87 Favored Glycine 0 N--CA 1.466 0.69 0 C-N-CA 124.477 1.037 . . . . 0.0 112.737 -179.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 90.1 t -96.31 135.46 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.529 1.131 . . . . 0.0 111.076 -178.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -134.51 125.65 27.79 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.927 1.291 . . . . 0.0 110.772 -175.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -145.94 122.94 11.39 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.759 1.224 . . . . 0.0 111.599 -174.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 38.3 t -133.92 136.31 44.17 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 124.179 0.992 . . . . 0.0 110.46 176.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 45.4 t . . . . . 0 C--O 1.238 0.47 0 C-N-CA 127.897 2.479 . . . . 0.0 106.533 -178.358 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.7 m . . . . . 0 N--CA 1.474 0.732 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -81.37 130.93 35.24 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.627 1.971 . . . . 0.0 106.759 175.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 9.7 m0 -117.8 120.64 38.55 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.983 1.313 . . . . 0.0 110.233 176.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 11.6 p-90 -144.46 152.65 40.92 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 126.361 1.865 . . . . 0.0 111.728 -175.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 9.7 t70 164.76 150.17 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 128.743 2.817 . . . . 0.0 109.648 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 62.0 t -120.83 139.49 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.183 1.393 . . . . 0.0 109.035 -175.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.456 ' HE2' ' HG3' ' A' ' 135' ' ' MET . 0.0 OUTLIER -129.46 171.19 12.81 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.287 1.035 . . . . 0.0 111.795 -178.968 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 54.5 mt -124.96 116.78 48.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 175.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -77.12 149.76 79.94 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 123.119 0.568 . . . . 0.0 110.589 174.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.78 -0.67 7.26 Favored 'Trans proline' 0 CA--C 1.545 1.051 0 C-N-CA 124.471 3.448 . . . . 0.0 115.027 -176.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -174.0 -175.49 41.68 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 127.055 2.264 . . . . 0.0 111.003 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 24.6 tttt -52.77 116.83 2.52 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.117 1.367 . . . . 0.0 112.059 -177.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -133.24 117.71 17.72 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.382 1.473 . . . . 0.0 111.738 -177.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.3 ptt180 -65.12 175.11 1.71 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.026 0.93 . . . . 0.0 111.855 174.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -127.58 103.27 7.24 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.989 1.716 . . . . 0.0 106.809 176.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -132.51 172.63 12.25 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.69 1.996 . . . . 0.0 109.425 177.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -53.72 -38.85 64.71 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -177.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -60.96 -58.72 12.29 Favored Glycine 0 N--CA 1.469 0.86 0 CA-C-N 118.885 0.766 . . . . 0.0 111.376 174.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 2.2 mpp? -59.1 -39.59 82.68 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 117.851 0.825 . . . . 0.0 112.171 178.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -59.78 -59.01 6.11 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.367 1.067 . . . . 0.0 110.75 175.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -67.97 -34.31 76.3 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 118.927 0.785 . . . . 0.0 113.01 -177.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -63.45 -41.53 98.63 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.447 0.699 . . . . 0.0 111.382 175.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' MET . . . . . 0.456 ' HG3' ' HE2' ' A' ' 119' ' ' LYS . 37.4 mmm -77.48 -28.47 52.27 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 121.06 -1.025 . . . . 0.0 113.033 175.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -54.56 -55.19 31.87 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 119.412 1.005 . . . . 0.0 111.386 176.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -65.11 -18.99 65.76 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 119.659 -0.816 . . . . 0.0 112.129 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -81.38 3.8 75.91 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 126.773 2.13 . . . . 0.0 114.472 174.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 34.9 m-20 -115.67 64.31 2.22 Favored Pre-proline 0 CA--C 1.552 1.045 0 C-N-CA 125.804 1.642 . . . . 0.0 114.966 -175.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -76.1 73.33 4.97 Favored 'Trans proline' 0 CA--C 1.546 1.08 0 C-N-CA 123.551 2.834 . . . . 0.0 112.87 -177.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.98 116.43 7.05 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.423 1.089 . . . . 0.0 109.723 -178.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 2.9 ttm105 -81.79 -172.81 4.09 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.534 1.533 . . . . 0.0 111.362 177.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -78.06 57.13 3.98 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 124.114 0.864 . . . . 0.0 111.027 174.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -62.61 98.81 0.13 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 128.095 2.558 . . . . 0.0 110.376 175.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 11.2 p-10 -64.08 66.04 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 127.851 2.46 . . . . 0.0 116.343 -175.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -178.44 167.94 38.78 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 128.368 2.89 . . . . 0.0 109.825 175.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' TRP . . . . . 0.432 ' CE3' ' HG3' ' A' ' 159' ' ' LYS . 59.6 m95 -64.78 67.91 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.998 2.119 . . . . 0.0 111.215 175.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -85.73 116.12 23.81 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 128.796 2.838 . . . . 0.0 111.452 -177.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -166.55 -172.63 2.23 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 177.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.68 167.37 22.27 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.494 1.918 . . . . 0.0 112.543 177.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 54.5 m-20 -64.56 142.59 58.37 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.904 -0.498 . . . . 0.0 109.782 175.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 11.0 mt -89.97 158.76 17.23 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 122.165 0.983 . . . . 0.0 109.359 175.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -65.6 -171.87 3.64 Favored Glycine 0 CA--C 1.536 1.399 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 175.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 54.73 8.78 0.24 Allowed 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 175.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 82.07 42.51 8.73 Favored Glycine 0 CA--C 1.54 1.645 0 C-N-CA 126.279 1.895 . . . . 0.0 113.087 -175.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.7 mp -120.17 172.33 7.85 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 119.025 1.413 . . . . 0.0 112.678 179.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 24.2 mtt180 -137.99 117.32 12.77 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 120.746 -1.221 . . . . 0.0 111.548 176.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 5.3 ttt -98.45 151.37 20.66 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 120.108 -1.62 . . . . 0.0 108.636 174.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.432 ' HG3' ' CE3' ' A' ' 147' ' ' TRP . 5.4 tppt? -136.86 142.47 42.82 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.503 1.921 . . . . 0.0 109.877 176.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -155.79 152.19 23.66 Favored Glycine 0 N--CA 1.473 1.146 0 O-C-N 120.64 -1.287 . . . . 0.0 112.858 176.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 2.2 tp -135.19 124.53 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 126.676 1.99 . . . . 0.0 108.143 -176.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 8.7 mtp -145.29 113.02 6.33 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.662 1.585 . . . . 0.0 108.991 174.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 9.5 t -100.66 125.17 47.05 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 118.517 0.599 . . . . 0.0 110.997 178.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 23.1 p -74.18 39.01 0.11 Allowed 'General case' 0 N--CA 1.481 1.097 0 O-C-N 120.738 -1.226 . . . . 0.0 113.764 175.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -72.41 -2.29 18.85 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 126.192 1.797 . . . . 0.0 114.516 177.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 108.89 -59.77 0.35 Allowed Glycine 0 CA--C 1.531 1.088 0 C-N-CA 126.264 1.887 . . . . 0.0 113.03 176.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -118.79 27.02 9.15 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.416 1.486 . . . . 0.0 112.482 -177.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.91 170.59 6.44 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 122.558 1.17 . . . . 0.0 114.129 175.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.67 -178.88 3.92 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 126.819 2.047 . . . . 0.0 110.89 175.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 14.8 ttp -125.85 139.12 53.75 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.588 1.555 . . . . 0.0 110.288 171.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 39.8 tt0 -143.48 126.9 16.78 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 121.981 -0.449 . . . . 0.0 110.67 174.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 2.7 mp -123.28 133.95 67.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.664 1.186 . . . . 0.0 108.642 176.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -133.14 132.76 42.02 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.852 1.661 . . . . 0.0 109.473 178.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.9 mp -96.04 92.04 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 O-C-N 121.197 -0.939 . . . . 0.0 109.63 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.41 165.1 8.16 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-O 122.276 1.036 . . . . 0.0 112.839 175.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 18.2 mmm180 . . . . . 0 C--O 1.252 1.227 0 C-N-CA 125.182 1.393 . . . . 0.0 111.171 -176.82 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 32.1 tp . . . . . 0 N--CA 1.484 1.23 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -128.95 120.98 27.07 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 127.273 2.229 . . . . 0.0 107.776 178.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -73.05 -101.16 0.07 OUTLIER Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.046 0.831 . . . . 0.0 112.305 -178.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 38.8 p -131.18 170.67 14.25 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.756 1.222 . . . . 0.0 111.33 175.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -124.47 16.19 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 125.248 1.419 . . . . 0.0 111.886 179.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.3 pt -53.31 168.69 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 124.945 1.298 . . . . 0.0 111.561 175.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -40.6 132.64 2.12 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.62 1.168 . . . . 0.0 112.873 -178.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -53.71 -22.5 18.28 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 124.937 1.256 . . . . 0.0 114.322 -176.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.18 -33.07 71.69 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.273 1.429 . . . . 0.0 112.452 175.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.2 t -96.36 -44.52 7.18 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.214 1.406 . . . . 0.0 112.314 175.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.3 tp -69.15 89.55 0.45 Allowed 'General case' 0 CA--C 1.545 0.752 0 CA-C-O 122.168 0.985 . . . . 0.0 110.632 175.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 58.1 p -126.93 -176.14 3.62 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 126.884 2.074 . . . . 0.0 111.512 -178.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -52.19 -36.93 53.3 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.165 0.986 . . . . 0.0 113.174 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -56.02 -43.63 77.96 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.645 1.178 . . . . 0.0 112.001 176.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 88.5 t -65.97 -42.52 91.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 124.342 1.057 . . . . 0.0 110.85 175.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 42.4 mt -68.52 -38.36 80.84 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 120.837 -1.164 . . . . 0.0 112.5 -179.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -64.6 -47.93 76.8 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.725 1.21 . . . . 0.0 111.105 178.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.32 -35.18 77.41 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 118.064 -0.97 . . . . 0.0 113.083 175.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.4 t -53.93 -44.08 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 CA-C-N 120.209 1.368 . . . . 0.0 111.982 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 71.0 mt -60.33 -13.78 14.87 Favored 'General case' 0 CA--C 1.55 0.964 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 175.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -106.06 -46.86 1.13 Allowed Glycine 0 CA--C 1.536 1.354 0 C-N-CA 126.681 2.086 . . . . 0.0 114.034 178.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -66.24 -25.5 66.92 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 119.075 1.438 . . . . 0.0 113.445 175.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -111.06 158.42 18.85 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.84 1.256 . . . . 0.0 111.656 175.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -175.77 86.49 0.07 OUTLIER Glycine 0 CA--C 1.53 1.015 0 O-C-N 121.474 -0.766 . . . . 0.0 113.901 -175.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.7 mttt -74.82 -54.8 6.64 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.946 1.298 . . . . 0.0 112.525 177.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 16.2 m -141.03 -179.11 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 127.917 2.487 . . . . 0.0 111.158 -178.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 25.9 m -49.54 -48.69 48.17 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 126.334 1.854 . . . . 0.0 114.517 -177.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.0 tpm_? -120.42 129.6 53.98 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.318 1.447 . . . . 0.0 109.497 175.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.9 ptpt -131.93 152.53 51.02 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.824 2.05 . . . . 0.0 110.502 -174.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -121.37 131.12 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 124.674 1.19 . . . . 0.0 109.559 177.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -134.61 97.54 3.82 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.473 1.909 . . . . 0.0 110.318 177.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.6 m -99.52 160.78 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 C-N-CA 123.305 0.642 . . . . 0.0 111.189 178.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -133.53 112.11 1.05 Allowed Glycine 0 CA--C 1.526 0.749 0 CA-C-O 119.308 -0.718 . . . . 0.0 113.526 174.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.9 mp -100.68 147.05 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 119.286 1.543 . . . . 0.0 109.456 175.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -117.2 102.76 9.55 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.116 1.366 . . . . 0.0 110.645 177.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -71.54 92.25 1.12 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 127.14 2.176 . . . . 0.0 111.221 176.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -119.01 -0.19 11.19 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.445 1.098 . . . . 0.0 113.802 175.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 30.3 t -47.81 -34.56 8.82 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 127.024 2.13 . . . . 0.0 114.63 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 110.23 60.49 0.5 Allowed Glycine 0 N--CA 1.468 0.777 0 C-N-CA 124.822 1.201 . . . . 0.0 112.264 177.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 167.81 150.34 6.49 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 125.327 1.441 . . . . 0.0 111.918 177.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.0 p -68.43 130.99 44.5 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.504 1.122 . . . . 0.0 110.92 174.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 43.1 m0 -91.35 101.79 14.49 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 123.849 0.86 . . . . 0.0 111.634 -179.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.9 m -83.45 125.4 31.68 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.069 1.348 . . . . 0.0 109.907 175.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.77 131.69 47.52 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.036 0.534 . . . . 0.0 110.582 174.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -117.12 -45.37 2.75 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.034 0.934 . . . . 0.0 112.125 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -174.25 149.14 1.36 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.76 2.024 . . . . 0.0 111.436 -178.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -131.26 164.82 24.74 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.778 1.631 . . . . 0.0 111.945 176.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -142.89 109.13 5.27 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.902 1.281 . . . . 0.0 111.45 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -113.62 128.01 56.27 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.914 0.886 . . . . 0.0 110.498 -177.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.57 -39.77 4.53 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -177.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.8 t -116.74 -53.89 2.47 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 126.099 1.759 . . . . 0.0 109.801 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -65.36 12.46 0.3 Allowed Glycine 0 CA--C 1.534 1.239 0 C-N-CA 126.929 2.204 . . . . 0.0 115.754 -175.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 53.1 p -31.16 111.15 0.08 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 129.288 3.035 . . . . 0.0 112.938 -174.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 t -129.42 179.62 5.69 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.794 1.238 . . . . 0.0 113.713 -175.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -82.51 -69.65 0.61 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.29 1.436 . . . . 0.0 111.573 176.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.1 p -132.4 130.28 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 125.688 1.595 . . . . 0.0 111.685 -177.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.5 pp -141.15 -26.15 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.896 1.678 . . . . 0.0 114.478 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -99.35 95.26 3.34 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 125.45 1.5 . . . . 0.0 109.181 178.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -65.57 151.55 84.42 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.781 2.987 . . . . 0.0 111.026 176.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -46.52 -49.19 18.89 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.991 1.316 . . . . 0.0 113.595 -179.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.7 p -157.5 139.91 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 126.497 1.919 . . . . 0.0 110.073 175.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 46.1 t -113.89 130.12 24.13 Favored Pre-proline 0 N--CA 1.474 0.753 0 C-N-CA 124.542 1.137 . . . . 0.0 109.069 174.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -67.71 152.84 77.32 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.436 2.091 . . . . 0.0 112.527 176.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -67.12 166.01 14.77 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.05 174.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . 0.267 66.8 p 52.9 22.65 2.47 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 127.668 2.387 . . . . 0.0 114.574 -174.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 20.9 mttt -124.57 172.84 8.9 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 126.834 2.053 . . . . 0.0 112.351 -178.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -131.48 163.94 26.86 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 122.799 0.439 . . . . 0.0 110.123 -178.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -143.76 171.0 14.81 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 124.267 1.027 . . . . 0.0 112.49 -178.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -117.49 154.78 30.85 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.91 1.284 . . . . 0.0 113.45 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.46 ' CE2' ' CE2' ' A' ' 89' ' ' PHE . 16.1 m-85 -129.34 133.5 47.45 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.034 1.334 . . . . 0.0 109.258 175.017 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.0 p -107.82 149.2 28.53 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 126.443 1.897 . . . . 0.0 110.287 175.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -167.9 144.52 8.96 Favored Glycine 0 CA--C 1.522 0.524 0 O-C-N 121.738 -0.601 . . . . 0.0 112.852 174.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 40.2 mtm180 -107.09 140.52 39.79 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.47 1.508 . . . . 0.0 110.676 -176.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.925 0 C-N-CA 125.439 1.496 . . . . 0.0 114.564 175.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 97.6 m . . . . . 0 N--CA 1.478 0.963 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -54.32 -82.44 0.05 OUTLIER Glycine 0 N--CA 1.475 1.299 0 C-N-CA 124.968 1.27 . . . . 0.0 114.526 -174.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -158.82 109.45 2.06 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.509 0.671 . . . . 0.0 111.723 174.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.9 t -138.24 121.07 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 124.897 1.279 . . . . 0.0 109.375 -177.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.66 167.47 30.01 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 122.211 1.005 . . . . 0.0 110.982 176.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -147.91 158.15 43.9 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.208 1.003 . . . . 0.0 109.501 175.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.504 ' CZ ' HG11 ' A' ' 101' ' ' VAL . 48.0 p90 -155.19 174.48 15.14 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 121.323 -0.861 . . . . 0.0 110.101 175.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -133.52 148.28 51.66 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.537 175.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -125.93 148.57 49.19 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.372 1.069 . . . . 0.0 113.8 176.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -89.12 123.69 33.63 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -178.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 5.8 tpp -89.22 144.07 26.37 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.586 0.754 . . . . 0.0 111.345 176.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 10.8 t -66.34 -23.08 66.29 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.828 0.851 . . . . 0.0 112.829 175.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -73.84 -11.15 60.28 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.981 1.313 . . . . 0.0 112.605 174.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 96.71 38.81 4.31 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 125.051 1.31 . . . . 0.0 114.649 178.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -135.7 173.15 12.04 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 118.812 1.306 . . . . 0.0 110.998 -179.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.4 m -122.63 103.44 8.68 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.731 1.212 . . . . 0.0 112.221 -177.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.3 tt -64.53 92.51 0.09 Allowed 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 126.369 1.868 . . . . 0.0 111.957 175.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -91.96 95.2 2.01 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 125.924 1.726 . . . . 0.0 112.211 -178.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.504 HG11 ' CZ ' ' A' ' 89' ' ' PHE . 2.3 p -82.33 153.63 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 123.704 0.802 . . . . 0.0 111.635 177.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.74 116.67 7.77 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.697 1.599 . . . . 0.0 110.583 177.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -134.49 131.08 37.63 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 122.201 1.001 . . . . 0.0 112.706 -176.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 23.3 t -143.56 97.38 3.06 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 124.564 1.146 . . . . 0.0 110.643 -175.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 24.1 t . . . . . 0 CA--C 1.541 0.623 0 C-N-CA 126.19 1.796 . . . . 0.0 108.975 177.453 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 7.3 m . . . . . 0 N--CA 1.469 0.515 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -123.11 116.23 23.12 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 124.944 1.297 . . . . 0.0 111.359 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 44.5 m0 -109.03 161.23 15.36 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.251 1.421 . . . . 0.0 111.1 -175.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 43.7 p-90 -150.21 137.2 19.37 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.004 0.922 . . . . 0.0 111.771 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -147.75 163.96 35.07 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 122.881 1.324 . . . . 0.0 113.598 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 19.6 t -145.98 140.73 21.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 C-N-CA 124.699 1.199 . . . . 0.0 108.656 175.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.6 173.36 14.74 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 128.032 2.533 . . . . 0.0 108.85 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.465 ' HB ' ' CE2' ' A' ' 154' ' ' TYR . 7.4 mt -129.86 113.34 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 123.883 0.873 . . . . 0.0 109.135 177.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -64.76 138.14 97.37 Favored Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 124.108 0.963 . . . . 0.0 111.521 177.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -74.48 84.07 1.62 Allowed 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 124.336 3.357 . . . . 0.0 112.124 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 114.62 175.76 18.74 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 126.348 1.928 . . . . 0.0 112.955 -178.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 7.5 tttt -61.84 102.36 0.26 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.289 1.436 . . . . 0.0 111.015 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 1.4 mmt85 -123.18 -175.2 3.12 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 126.434 1.894 . . . . 0.0 111.959 -175.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.3 ptp180 -132.12 175.92 8.83 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.735 1.214 . . . . 0.0 112.581 175.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -119.53 111.69 18.41 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 105.258 -2.127 . . . . 0.0 105.258 174.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -128.9 166.26 19.47 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.485 1.514 . . . . 0.0 109.275 177.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -50.01 -40.23 43.93 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 119.8 1.182 . . . . 0.0 113.389 -178.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -56.23 -62.59 6.16 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 124.065 0.841 . . . . 0.0 111.843 174.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 4.6 mtm -60.79 -37.3 81.46 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.045 1.338 . . . . 0.0 113.723 178.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -57.84 -62.49 1.76 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.256 1.422 . . . . 0.0 109.494 175.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -69.47 -31.54 69.89 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -177.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -57.05 -59.1 5.57 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.032 1.333 . . . . 0.0 110.864 174.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.13 -20.54 59.36 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -53.75 -57.27 11.48 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.639 1.176 . . . . 0.0 109.954 175.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -71.4 -0.73 10.94 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -89.82 -9.55 65.99 Favored Glycine 0 CA--C 1.537 1.454 0 C-N-CA 126.112 1.815 . . . . 0.0 114.924 177.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -145.6 91.33 5.74 Favored Pre-proline 0 CA--C 1.549 0.918 0 CA-C-N 119.64 1.72 . . . . 0.0 113.43 179.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -74.41 81.12 2.11 Favored 'Trans proline' 0 CA--C 1.543 0.968 0 C-N-CA 123.556 2.837 . . . . 0.0 112.656 -178.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -113.41 116.16 29.21 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.493 1.517 . . . . 0.0 109.233 177.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 4.4 ttm180 -103.43 50.6 0.8 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.992 1.317 . . . . 0.0 114.052 -174.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 56.96 56.21 26.15 Favored Glycine 0 CA--C 1.534 1.239 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 -175.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -68.08 108.09 2.97 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.002 1.321 . . . . 0.0 110.873 -175.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -77.04 91.81 3.68 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.171 1.388 . . . . 0.0 114.24 -174.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.71 50.77 0.01 OUTLIER Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.318 0.961 . . . . 0.0 114.381 174.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 8.8 m95 46.36 62.38 2.32 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.602 1.561 . . . . 0.0 112.704 -174.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -90.51 125.37 35.58 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.112 1.365 . . . . 0.0 112.361 179.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -160.03 -175.12 4.91 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.235 1.014 . . . . 0.0 113.104 -175.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 8.9 mtmt -134.76 160.8 37.04 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.375 1.47 . . . . 0.0 111.176 174.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -81.36 146.62 30.24 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.066 0.946 . . . . 0.0 109.397 175.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -102.03 128.2 48.58 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 122.733 0.413 . . . . 0.0 110.013 -177.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -53.32 -24.67 23.63 Favored Glycine 0 N--CA 1.475 1.289 0 C-N-CA 125.628 1.585 . . . . 0.0 116.005 -175.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.465 ' CE2' ' HB ' ' A' ' 120' ' ' ILE . 0.1 OUTLIER -74.06 1.54 10.79 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 127.539 2.336 . . . . 0.0 113.453 177.612 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 90.28 10.85 63.53 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.882 1.706 . . . . 0.0 114.381 -177.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 2.6 mt -98.32 166.44 11.39 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.722 2.009 . . . . 0.0 111.187 -178.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 57.7 mtt180 -139.87 105.6 5.14 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.294 1.038 . . . . 0.0 110.524 178.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 18.0 ttp -91.68 135.5 33.84 Favored 'General case' 0 C--N 1.318 -0.762 0 O-C-N 120.755 -1.215 . . . . 0.0 107.888 176.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.21 124.57 52.36 Favored 'General case' 0 C--O 1.221 -0.414 0 C-N-CA 126.145 1.778 . . . . 0.0 109.482 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -133.1 155.6 21.74 Favored Glycine 0 N--CA 1.469 0.842 0 CA-C-N 120.807 1.64 . . . . 0.0 114.833 -178.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 4.2 tp -152.7 135.06 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-O 122.777 1.275 . . . . 0.0 110.846 -175.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 11.5 mtp -153.05 168.94 24.2 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 128.058 2.543 . . . . 0.0 109.209 176.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 13.2 t -151.66 162.66 40.62 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.726 1.21 . . . . 0.0 109.451 174.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 89.5 p -97.68 26.2 5.24 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.047 1.339 . . . . 0.0 113.115 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -68.48 12.77 0.11 Allowed 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 126.843 2.057 . . . . 0.0 115.4 -176.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 85.93 -62.82 4.33 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 125.735 1.636 . . . . 0.0 112.69 178.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -95.61 9.96 38.4 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 177.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -58.04 159.75 5.44 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 123.116 1.436 . . . . 0.0 114.189 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.45 175.41 6.2 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 128.002 2.521 . . . . 0.0 110.758 -177.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 35.6 ttp -118.97 130.5 55.73 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 125.012 1.325 . . . . 0.0 110.363 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -137.03 126.84 25.61 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.148 0.579 . . . . 0.0 110.806 175.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 4.8 mp -131.11 113.75 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 C-N-CA 123.668 0.787 . . . . 0.0 110.068 176.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -109.61 129.09 55.61 Favored 'General case' 0 C--O 1.222 -0.352 0 C-N-CA 125.11 1.364 . . . . 0.0 111.693 176.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.8 mp -79.61 137.18 22.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 175.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 3.2 m -122.21 159.21 27.75 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.699 2.0 . . . . 0.0 110.631 175.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 39.1 mtp180 . . . . . 0 C--O 1.251 1.182 0 C-N-CA 126.403 1.881 . . . . 0.0 112.161 -178.586 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 11.9 tp . . . . . 0 N--CA 1.477 0.892 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -132.3 137.78 47.59 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.706 1.602 . . . . 0.0 110.805 175.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -81.75 -153.88 11.88 Favored Glycine 0 CA--C 1.544 1.878 0 C-N-CA 125.351 1.453 . . . . 0.0 110.257 176.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 42.5 p -76.06 173.76 10.88 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.609 1.164 . . . . 0.0 113.063 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -129.77 15.91 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.987 0 C-N-CA 125.92 1.688 . . . . 0.0 112.16 176.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.7 pt -52.92 166.3 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 O-C-N 120.587 -1.32 . . . . 0.0 111.733 175.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -39.81 132.42 1.72 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.267 1.427 . . . . 0.0 113.244 -179.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -57.36 -16.89 22.9 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 124.889 1.233 . . . . 0.0 114.402 -177.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.2 -23.63 67.38 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.542 1.137 . . . . 0.0 111.701 174.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.1 t -109.82 -40.29 4.84 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.592 1.957 . . . . 0.0 112.604 175.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.6 tp -76.47 97.43 4.32 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 121.476 -0.765 . . . . 0.0 109.827 175.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -134.99 -177.82 4.81 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 126.541 1.937 . . . . 0.0 111.87 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -50.23 -36.24 30.13 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.212 1.405 . . . . 0.0 112.91 -178.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -52.85 -37.83 60.69 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.015 1.326 . . . . 0.0 112.543 175.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 78.5 t -73.25 -42.01 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 125.788 1.635 . . . . 0.0 111.115 175.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 57.7 mt -65.4 -42.24 92.81 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 120.961 -1.087 . . . . 0.0 111.964 178.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -61.04 -41.21 96.15 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.289 1.036 . . . . 0.0 111.882 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.98 -38.47 64.16 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 118.834 -0.603 . . . . 0.0 111.215 175.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.3 t -56.01 -39.66 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 C-N-CA 125.398 1.479 . . . . 0.0 111.534 177.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -56.57 -20.57 21.41 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 125.865 1.666 . . . . 0.0 112.727 174.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -108.38 -50.3 0.77 Allowed Glycine 0 CA--C 1.533 1.206 0 C-N-CA 126.356 1.931 . . . . 0.0 114.151 -178.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -64.19 -27.41 69.05 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 118.966 1.383 . . . . 0.0 113.503 178.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 14.3 mt -109.99 119.64 39.96 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.114 1.366 . . . . 0.0 109.549 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -162.32 81.1 0.13 Allowed Glycine 0 CA--C 1.534 1.24 0 O-C-N 121.604 -0.685 . . . . 0.0 114.156 -175.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.6 mttt -72.69 -60.13 2.38 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.945 1.698 . . . . 0.0 112.985 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.5 m -109.46 -178.7 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 126.794 2.038 . . . . 0.0 110.756 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.6 t -51.27 -46.64 62.47 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.512 1.125 . . . . 0.0 113.568 -175.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.69 144.2 51.17 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.948 1.699 . . . . 0.0 111.176 174.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.92 166.35 22.54 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.194 1.797 . . . . 0.0 111.615 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -129.07 137.42 57.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 124.927 1.291 . . . . 0.0 109.387 176.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -141.0 119.24 12.08 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 126.004 1.721 . . . . 0.0 109.416 175.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.6 m -124.77 139.03 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 123.084 0.553 . . . . 0.0 110.779 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -111.51 103.6 1.58 Allowed Glycine 0 N--CA 1.461 0.334 0 C-N-CA 124.754 1.168 . . . . 0.0 110.857 -178.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.4 mp -100.16 132.81 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 121.527 0.68 . . . . 0.0 110.806 175.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -100.99 104.15 15.3 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.755 2.022 . . . . 0.0 109.859 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 29.1 t30 -78.51 99.05 6.31 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.651 0.78 . . . . 0.0 111.033 175.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.54 13.41 10.13 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.002 0.921 . . . . 0.0 112.2 175.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.43 -34.88 71.29 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.892 1.277 . . . . 0.0 114.072 -175.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 139.0 -35.75 1.95 Allowed Glycine 0 CA--C 1.531 1.051 0 C-N-CA 125.535 1.54 . . . . 0.0 113.817 175.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -114.54 158.24 14.45 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 125.167 1.365 . . . . 0.0 112.935 175.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.42 149.17 34.89 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.922 0.867 . . . . 0.0 110.964 175.001 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 40.9 m0 -101.26 107.81 19.29 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 125.139 1.376 . . . . 0.0 110.199 178.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 54.2 m -92.91 128.62 38.84 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 124.805 1.242 . . . . 0.0 109.054 175.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.47 138.15 58.26 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.654 -0.653 . . . . 0.0 111.705 174.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.1 pp -118.65 -51.58 2.38 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.054 0.942 . . . . 0.0 112.241 177.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 25.1 t30 -170.83 150.07 3.15 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.09 1.756 . . . . 0.0 109.954 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -131.32 158.52 40.45 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.089 1.356 . . . . 0.0 110.849 175.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -136.82 108.6 7.05 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.699 1.6 . . . . 0.0 111.151 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -112.59 127.23 56.03 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 120.989 -1.069 . . . . 0.0 110.205 -176.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.55 -32.09 6.57 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -175.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 38.1 t -130.94 -36.06 1.37 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.361 1.464 . . . . 0.0 112.128 175.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -69.64 12.33 1.49 Allowed Glycine 0 CA--C 1.537 1.433 0 C-N-CA 125.553 1.549 . . . . 0.0 115.871 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 75.8 p -28.34 99.36 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 129.992 3.317 . . . . 0.0 114.436 -174.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.2 t -119.25 177.59 4.84 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.467 1.507 . . . . 0.0 112.655 -174.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -82.16 -52.08 7.34 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.442 1.097 . . . . 0.0 112.421 175.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.2 p -155.62 139.19 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.752 1.621 . . . . 0.0 111.618 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.492 ' HB ' ' CE2' ' A' ' 72' ' ' TYR . 0.1 OUTLIER -133.83 -46.28 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 125.53 1.532 . . . . 0.0 112.693 179.14 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.9 mt -79.33 103.46 1.59 Allowed Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 127.002 2.121 . . . . 0.0 109.272 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -73.44 159.18 46.95 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 123.874 3.05 . . . . 0.0 110.549 177.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -52.97 -48.77 67.16 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 57.7 t -152.98 136.3 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 127.184 2.194 . . . . 0.0 109.272 -175.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 57.9 t -128.43 114.48 19.69 Favored Pre-proline 0 N--CA 1.479 1.016 0 C-N-CA 124.208 1.003 . . . . 0.0 110.583 174.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -59.93 145.56 98.01 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.495 2.13 . . . . 0.0 112.385 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -68.11 166.36 16.24 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.692 0.797 . . . . 0.0 110.703 175.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 39.8 p 62.39 16.92 8.99 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 127.198 2.199 . . . . 0.0 113.531 -175.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 19.0 mttt -125.86 -173.76 2.92 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.518 1.927 . . . . 0.0 111.102 -178.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -138.8 166.74 23.62 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 122.912 0.485 . . . . 0.0 109.988 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.8 pp -139.29 171.39 14.35 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 124.549 1.139 . . . . 0.0 111.145 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -119.13 153.98 33.98 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 124.746 1.218 . . . . 0.0 110.475 175.013 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.492 ' CE2' ' HB ' ' A' ' 59' ' ' ILE . 2.7 m-85 -126.41 151.73 47.29 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 126.215 1.806 . . . . 0.0 109.931 177.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.0 p -128.7 148.2 50.81 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.85 2.06 . . . . 0.0 111.747 -179.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -169.26 146.62 10.33 Favored Glycine 0 CA--C 1.519 0.306 0 CA-C-O 121.627 0.57 . . . . 0.0 112.619 175.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 63.5 mtm180 -128.64 138.59 52.26 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 126.74 2.016 . . . . 0.0 109.21 -174.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt . . . . . 0 CA--C 1.542 0.665 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 174.961 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.547 0.86 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 76.98 -98.48 1.32 Allowed Glycine 0 CA--C 1.528 0.892 0 C-N-CA 126.518 2.009 . . . . 0.0 112.269 -175.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -148.46 93.44 2.15 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 117.677 0.739 . . . . 0.0 110.866 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.4 t -122.2 120.69 61.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 124.46 1.104 . . . . 0.0 112.066 -175.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -160.02 168.71 25.0 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.489 1.116 . . . . 0.0 112.282 178.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -150.5 132.96 15.63 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.42 1.088 . . . . 0.0 109.326 174.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.463 ' CD2' ' CE2' ' A' ' 72' ' ' TYR . 43.9 p90 -132.17 170.01 15.6 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 120.946 -1.096 . . . . 0.0 110.27 177.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -139.61 142.87 37.06 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -179.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -120.43 139.12 53.3 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.675 1.19 . . . . 0.0 112.788 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -84.76 126.9 33.81 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.997 -0.439 . . . . 0.0 111.453 -177.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -97.53 141.12 30.97 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.016 1.327 . . . . 0.0 111.855 178.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 24.9 m -64.04 -20.26 65.79 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.47 1.108 . . . . 0.0 113.731 174.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 36.2 m-80 -72.22 -10.59 59.98 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.445 1.098 . . . . 0.0 112.81 174.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 89.68 44.32 4.91 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 124.755 1.169 . . . . 0.0 112.987 -176.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -140.06 175.11 9.86 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.956 1.302 . . . . 0.0 110.481 175.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 12.9 m -126.87 110.7 13.32 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.395 1.478 . . . . 0.0 112.045 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.7 tt -70.86 98.02 1.5 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.954 1.302 . . . . 0.0 112.208 174.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -91.22 104.28 3.15 Favored Glycine 0 N--CA 1.469 0.896 0 C-N-CA 125.142 1.353 . . . . 0.0 113.372 177.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 94.0 t -85.39 130.62 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 125.106 1.363 . . . . 0.0 111.344 175.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 2.4 tmm? -119.99 124.27 45.52 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.798 1.639 . . . . 0.0 110.337 178.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -148.95 122.67 9.24 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 122.901 1.334 . . . . 0.0 111.946 -178.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 15.1 p -139.94 100.53 3.96 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 124.418 1.087 . . . . 0.0 110.008 -175.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 97.0 t . . . . . 0 CA--C 1.54 0.583 0 C-N-CA 127.125 2.17 . . . . 0.0 108.654 178.535 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.2 p . . . . . 0 N--CA 1.483 1.177 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -98.81 108.5 21.2 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.418 1.887 . . . . 0.0 108.093 175.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 35.7 m0 -105.66 142.75 34.86 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 119.671 1.123 . . . . 0.0 109.942 175.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 29.7 p-90 -146.86 143.65 28.72 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 121.309 -0.87 . . . . 0.0 113.112 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -151.38 164.49 36.58 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 122.654 1.216 . . . . 0.0 112.957 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 54.6 t -153.41 136.66 7.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 175.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.37 177.81 10.2 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 126.645 1.978 . . . . 0.0 109.552 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.49 ' HB ' ' CE2' ' A' ' 154' ' ' TYR . 15.8 mt -126.52 141.79 44.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -101.05 144.4 28.48 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 125.172 1.389 . . . . 0.0 110.312 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.06 132.48 21.33 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 123.077 2.518 . . . . 0.0 111.455 179.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 62.85 -160.87 33.36 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 123.47 0.557 . . . . 0.0 113.017 -175.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.8 tttt -73.88 114.46 12.2 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.292 1.037 . . . . 0.0 109.532 175.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 2.4 mmt-85 -133.09 148.85 52.17 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.542 1.137 . . . . 0.0 111.057 175.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -93.64 179.57 5.33 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-O 121.686 0.755 . . . . 0.0 110.256 176.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -126.07 113.77 17.53 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 127.205 2.202 . . . . 0.0 105.093 175.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -126.91 172.83 10.09 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.388 1.475 . . . . 0.0 110.406 178.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -53.75 -40.78 66.48 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 119.62 1.1 . . . . 0.0 113.323 -178.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -59.73 -54.89 33.81 Favored Glycine 0 N--CA 1.467 0.736 0 CA-C-O 119.364 -0.687 . . . . 0.0 111.824 176.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 4.5 mpp? -62.24 -42.37 99.25 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 118.199 1.0 . . . . 0.0 112.388 177.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -54.94 -56.28 21.4 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.811 0.845 . . . . 0.0 109.646 176.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -66.37 -37.18 84.71 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -60.77 -44.49 96.7 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.298 1.439 . . . . 0.0 112.305 177.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 42.4 mmm -81.6 -30.01 33.08 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.074 -1.016 . . . . 0.0 112.615 177.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -54.47 -57.99 9.18 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.969 1.308 . . . . 0.0 109.457 174.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -73.8 -10.51 59.74 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -177.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -79.92 -15.42 79.12 Favored Glycine 0 CA--C 1.537 1.432 0 C-N-CA 125.893 1.711 . . . . 0.0 114.868 177.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -140.91 90.61 9.42 Favored Pre-proline 0 CA--C 1.552 1.041 0 CA-C-N 119.37 1.585 . . . . 0.0 112.522 176.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -74.66 78.08 2.85 Favored 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 123.912 3.074 . . . . 0.0 112.434 178.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -111.87 120.43 41.9 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.654 1.182 . . . . 0.0 110.462 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.38 -173.82 4.93 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.562 1.145 . . . . 0.0 112.584 176.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -75.16 53.07 2.63 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 125.602 1.572 . . . . 0.0 111.076 175.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -64.72 97.11 0.2 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 127.14 2.176 . . . . 0.0 110.039 178.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -75.31 93.43 2.88 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.554 1.142 . . . . 0.0 113.005 -174.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 162.89 54.93 0.02 OUTLIER Glycine 0 CA--C 1.537 1.407 0 C-N-CA 124.376 0.989 . . . . 0.0 115.011 175.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 8.0 m95 52.1 44.97 29.14 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.619 1.568 . . . . 0.0 114.667 -177.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -78.15 129.5 35.23 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 120.862 -1.148 . . . . 0.0 111.857 -177.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.64 -174.59 4.71 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.394 -0.816 . . . . 0.0 113.165 -175.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.96 151.89 51.64 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.972 1.309 . . . . 0.0 110.733 175.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -69.64 150.63 46.83 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 175.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 60.8 mt -109.91 145.54 36.69 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 175.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -64.5 -166.62 1.19 Allowed Glycine 0 CA--C 1.545 1.917 0 N-CA-C 110.266 -1.134 . . . . 0.0 110.266 176.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.49 ' CE2' ' HB ' ' A' ' 120' ' ' ILE . 0.0 OUTLIER 54.76 10.77 0.39 Allowed 'General case' 0 CA--C 1.558 1.275 0 N-CA-C 115.316 1.598 . . . . 0.0 115.316 175.038 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 80.96 41.27 10.64 Favored Glycine 0 CA--C 1.539 1.584 0 C-N-CA 126.416 1.96 . . . . 0.0 114.666 -175.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 2.4 mp -123.91 160.11 28.22 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 119.445 1.623 . . . . 0.0 112.305 177.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 10.5 mtt-85 -147.37 121.63 9.58 Favored 'General case' 0 N--CA 1.481 1.086 0 O-C-N 120.424 -1.423 . . . . 0.0 110.397 174.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 9.1 ttp -108.9 132.99 53.52 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 123.589 0.756 . . . . 0.0 109.069 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 2.7 tppt? -107.36 129.53 54.9 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 127.226 2.21 . . . . 0.0 110.385 -178.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -138.4 158.44 24.92 Favored Glycine 0 N--CA 1.473 1.106 0 CA-C-N 121.255 1.843 . . . . 0.0 115.57 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 3.4 tp -148.1 124.69 2.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-O 122.607 1.194 . . . . 0.0 111.362 -178.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 51.4 mtp -137.56 149.19 46.51 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 128.06 2.544 . . . . 0.0 107.998 175.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 8.8 t -134.66 161.16 35.9 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.335 1.054 . . . . 0.0 110.196 175.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 55.0 p -108.04 21.87 16.76 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.981 1.712 . . . . 0.0 112.428 -176.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -64.3 20.73 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.237 0 C-N-CA 128.617 2.767 . . . . 0.0 115.395 178.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 82.76 -68.64 3.51 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 126.995 2.236 . . . . 0.0 112.177 -177.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 -111.93 67.33 0.65 Allowed 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.538 1.535 . . . . 0.0 110.221 -177.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -95.76 174.66 6.86 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.946 1.698 . . . . 0.0 112.796 175.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.95 -178.78 3.94 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.845 2.058 . . . . 0.0 110.768 175.008 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 20.4 ttp -128.78 122.1 29.8 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.087 1.355 . . . . 0.0 109.812 176.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -131.47 130.31 42.28 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.053 0.941 . . . . 0.0 110.06 177.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 4.3 mp -135.28 125.6 43.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 123.989 0.915 . . . . 0.0 109.297 177.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.85 128.88 50.97 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 125.811 1.644 . . . . 0.0 111.635 177.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.8 mp -74.69 133.06 32.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 175.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 1.2 m -144.87 97.08 2.96 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.044 1.337 . . . . 0.0 111.691 176.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 72.6 mtp180 . . . . . 0 C--O 1.254 1.327 0 C-N-CA 126.676 1.99 . . . . 0.0 113.018 177.581 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.541 0.61 0 CA-C-O 121.038 0.447 . . . . 0.0 111.445 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -68.41 126.86 30.96 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 121.507 -0.745 . . . . 0.0 109.365 174.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -69.73 -90.69 0.07 OUTLIER Glycine 0 CA--C 1.535 1.293 0 C-N-CA 123.851 0.739 . . . . 0.0 113.181 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.7 p -149.81 166.28 29.95 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 125.776 1.631 . . . . 0.0 111.845 -175.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -114.04 22.74 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 CA-C-O 123.032 1.396 . . . . 0.0 112.996 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -45.24 152.38 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 125.624 1.57 . . . . 0.0 111.959 174.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -44.77 139.31 3.04 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 126.041 1.737 . . . . 0.0 112.901 -176.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -54.35 -25.98 35.5 Favored Glycine 0 CA--C 1.54 1.603 0 C-N-CA 124.225 0.917 . . . . 0.0 114.713 -175.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.83 -33.6 76.04 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.257 1.423 . . . . 0.0 112.551 174.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.4 m -96.47 -38.35 10.05 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.991 2.116 . . . . 0.0 112.637 175.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.4 tp -78.33 85.08 4.48 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.961 1.304 . . . . 0.0 110.674 176.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 48.6 p -114.12 176.07 5.2 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.771 2.028 . . . . 0.0 110.534 179.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -51.09 -39.47 56.18 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.404 -0.81 . . . . 0.0 112.569 177.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -54.89 -37.51 66.4 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 118.54 0.609 . . . . 0.0 112.432 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 92.4 t -68.13 -40.34 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.067 1.347 . . . . 0.0 111.169 174.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 41.1 mt -68.2 -40.45 82.18 Favored 'General case' 0 N--CA 1.471 0.575 0 O-C-N 120.865 -1.147 . . . . 0.0 112.229 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -61.88 -49.52 75.88 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.317 1.047 . . . . 0.0 111.609 177.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.58 -33.58 76.25 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 118.155 -0.926 . . . . 0.0 113.089 174.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.1 t -54.7 -42.3 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-N 119.792 1.178 . . . . 0.0 111.594 177.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.5 mt -55.77 -23.55 30.28 Favored 'General case' 0 CA--C 1.55 0.972 0 CA-C-N 119.544 1.065 . . . . 0.0 113.486 175.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -93.65 -60.76 1.14 Allowed Glycine 0 CA--C 1.532 1.132 0 C-N-CA 125.689 1.614 . . . . 0.0 112.7 177.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -67.47 -27.04 66.69 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 -177.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -111.94 87.95 2.69 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.663 1.585 . . . . 0.0 110.298 177.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -134.77 155.26 21.88 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 125.06 1.314 . . . . 0.0 113.004 175.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.3 mtpt -141.85 -49.37 0.39 Allowed 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 125.549 1.539 . . . . 0.0 112.143 -177.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.2 m -115.89 -177.17 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 C-N-CA 126.297 1.839 . . . . 0.0 110.636 176.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.8 t -49.3 -44.4 44.11 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 126.374 1.869 . . . . 0.0 115.068 -176.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.8 161.61 35.1 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 126.28 1.832 . . . . 0.0 111.074 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.31 165.61 36.11 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.089 0.956 . . . . 0.0 112.711 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -119.34 123.73 71.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 124.125 0.97 . . . . 0.0 108.44 175.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -127.64 120.8 28.88 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 126.513 1.925 . . . . 0.0 106.706 174.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.56 140.43 43.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 126.459 1.904 . . . . 0.0 108.527 -174.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -123.07 132.75 8.73 Favored Glycine 0 CA--C 1.523 0.575 0 CA-C-O 119.981 -0.344 . . . . 0.0 112.538 175.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.4 mp -112.64 152.22 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 117.71 0.755 . . . . 0.0 109.343 174.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -122.22 106.61 11.29 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 122.63 1.205 . . . . 0.0 110.709 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -76.07 85.15 2.94 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 128.451 2.7 . . . . 0.0 111.054 -175.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -120.99 4.65 10.43 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.644 1.177 . . . . 0.0 113.926 176.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -53.98 -50.41 66.6 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.475 1.11 . . . . 0.0 112.133 174.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 127.7 103.87 1.23 Allowed Glycine 0 CA--C 1.526 0.776 0 C-N-CA 123.928 0.775 . . . . 0.0 111.684 177.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 114.48 153.93 10.82 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 126.15 1.833 . . . . 0.0 111.127 -174.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 68.4 p -69.72 142.18 53.36 Favored 'General case' 0 N--CA 1.466 0.359 0 O-C-N 121.887 -0.773 . . . . 0.0 111.062 175.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 39.4 m0 -96.64 107.6 20.07 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.367 0.667 . . . . 0.0 109.434 -179.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 36.4 m -87.58 127.33 35.26 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.609 0.763 . . . . 0.0 109.972 178.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.42 130.39 44.25 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 122.763 0.425 . . . . 0.0 111.429 174.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.8 pp -114.13 -55.76 2.46 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.79 0.836 . . . . 0.0 111.632 178.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -166.68 160.32 14.82 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.894 1.677 . . . . 0.0 110.867 175.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -140.69 165.71 26.74 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.427 1.091 . . . . 0.0 111.981 174.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -142.0 119.69 11.8 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.704 1.202 . . . . 0.0 111.887 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -108.74 139.2 43.88 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.362 -0.836 . . . . 0.0 111.646 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.1 tpp180 -110.78 -65.91 1.12 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.859 1.663 . . . . 0.0 111.262 -177.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -37.58 -58.06 0.9 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 128.257 2.623 . . . . 0.0 113.52 -175.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -153.05 -116.63 0.65 Allowed Glycine 0 CA--C 1.526 0.731 0 C-N-CA 125.971 1.748 . . . . 0.0 109.133 175.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 39.0 p -143.33 178.52 7.68 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.036 1.334 . . . . 0.0 112.23 -175.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.2 t -154.0 179.58 8.78 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.43 1.492 . . . . 0.0 111.417 174.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -111.67 -38.5 4.87 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.02 1.328 . . . . 0.0 112.41 179.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.9 p -159.28 127.76 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 126.076 1.75 . . . . 0.0 110.636 175.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.422 ' HB ' ' CE2' ' A' ' 72' ' ' TYR . 1.7 pp -132.8 -32.36 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 114.606 1.335 . . . . 0.0 114.606 175.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.4 mt -100.85 95.53 4.64 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 125.43 1.492 . . . . 0.0 109.403 178.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -65.97 151.62 83.52 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 123.402 2.735 . . . . 0.0 110.676 174.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -44.35 -49.64 9.46 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.894 1.677 . . . . 0.0 114.023 -177.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 5.1 p -159.42 137.73 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 126.978 2.111 . . . . 0.0 109.208 175.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 98.8 t -114.74 125.88 28.55 Favored Pre-proline 0 N--CA 1.479 0.988 0 C-N-CA 123.927 0.891 . . . . 0.0 109.211 175.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -65.64 155.73 67.49 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 122.882 2.388 . . . . 0.0 113.099 177.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -71.71 169.59 15.31 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.582 0.753 . . . . 0.0 111.374 175.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 65.2 p 52.34 26.25 3.97 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 126.415 1.886 . . . . 0.0 113.217 -175.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.3 mttt -138.25 174.68 10.3 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 126.441 1.896 . . . . 0.0 111.107 -175.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -135.66 160.81 37.36 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -176.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.441 HD11 ' HH ' ' A' ' 91' ' ' TYR . 2.4 pt? -133.18 170.49 15.34 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.786 1.234 . . . . 0.0 111.552 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -114.29 149.91 35.24 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 124.494 1.118 . . . . 0.0 109.995 175.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.422 ' CE2' ' HB ' ' A' ' 59' ' ' ILE . 1.5 m-85 -122.36 160.32 25.66 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 127.353 2.261 . . . . 0.0 108.775 175.072 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.9 p -145.34 166.77 24.61 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 125.443 1.497 . . . . 0.0 112.105 -175.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 173.9 151.76 8.48 Favored Glycine 0 C--O 1.237 0.301 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.681 174.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.427 HH11 ' HA ' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -111.9 139.17 47.6 Favored 'General case' 0 CA--C 1.521 -0.145 0 C-N-CA 124.883 1.273 . . . . 0.0 111.88 179.321 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.469 0.518 0 C-N-CA 124.172 0.989 . . . . 0.0 112.853 174.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 34.7 m . . . . . 0 N--CA 1.484 1.234 0 CA-C-O 119.04 -0.505 . . . . 0.0 110.363 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -26.75 -66.96 0.06 OUTLIER Glycine 0 N--CA 1.473 1.127 0 C-N-CA 127.991 2.71 . . . . 0.0 116.693 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -167.47 106.66 0.56 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.066 0.947 . . . . 0.0 112.219 -178.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.7 t -149.51 109.67 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 124.749 1.22 . . . . 0.0 112.062 -174.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.69 169.64 22.81 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 179.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -147.2 160.61 42.26 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.92 1.288 . . . . 0.0 112.543 175.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -164.11 171.41 15.14 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.332 1.053 . . . . 0.0 111.62 -178.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -143.95 155.94 44.24 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.468 -0.77 . . . . 0.0 112.201 174.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.441 ' HH ' HD11 ' A' ' 70' ' ' LEU . 11.7 m-85 -131.72 129.29 40.48 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 126.472 1.909 . . . . 0.0 113.19 -175.015 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -90.66 130.53 36.66 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 120.882 0.372 . . . . 0.0 111.343 -176.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 3.9 mtm -108.27 139.01 43.6 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 125.503 1.521 . . . . 0.0 111.705 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.2 t -64.79 -18.7 65.32 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.223 1.409 . . . . 0.0 112.962 176.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -69.74 -17.5 63.45 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.998 1.319 . . . . 0.0 113.616 175.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 106.47 21.32 8.41 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.92 1.248 . . . . 0.0 115.362 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -131.44 174.81 9.71 Favored 'General case' 0 CA--C 1.555 1.142 0 CA-C-N 119.824 1.812 . . . . 0.0 111.422 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.8 m -129.31 105.87 8.42 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.403 1.081 . . . . 0.0 112.959 -178.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 59.0 tp -68.81 101.23 1.3 Allowed 'General case' 0 N--CA 1.47 0.567 0 O-C-N 121.762 -0.586 . . . . 0.0 110.247 174.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -94.65 138.65 14.12 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 124.176 0.893 . . . . 0.0 112.232 175.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 54.1 t -128.17 133.03 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.225 1.41 . . . . 0.0 110.71 -175.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.84 124.29 20.74 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.895 1.678 . . . . 0.0 109.386 -177.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 26.9 p90 -138.42 135.35 35.16 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -178.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 12.2 m -148.79 100.51 3.1 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 122.224 1.011 . . . . 0.0 111.193 -175.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 51.3 t . . . . . 0 N--CA 1.471 0.588 0 C-N-CA 127.144 2.178 . . . . 0.0 109.761 -177.091 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 5.5 m . . . . . 0 N--CA 1.468 0.433 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -80.58 115.81 20.29 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 124.324 1.05 . . . . 0.0 108.973 174.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 42.1 m0 -116.25 145.66 42.96 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.134 0.973 . . . . 0.0 109.45 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 34.3 p-90 -150.78 139.83 21.07 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.403 0.681 . . . . 0.0 112.248 -179.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -140.57 145.85 37.28 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 122.299 1.047 . . . . 0.0 112.81 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 86.1 t -146.8 123.96 3.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 125.093 1.357 . . . . 0.0 107.783 176.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.401 ' HE2' ' CZ ' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -156.14 176.18 13.0 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.403 1.081 . . . . 0.0 111.336 174.969 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.473 ' HB ' ' CE2' ' A' ' 154' ' ' TYR . 38.8 mt -111.51 105.31 18.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 123.765 0.826 . . . . 0.0 109.804 -177.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.401 ' CZ ' ' HE2' ' A' ' 119' ' ' LYS . 91.0 m-85 -60.3 143.82 88.65 Favored Pre-proline 0 CA--C 1.548 0.899 0 O-C-N 121.318 -0.864 . . . . 0.0 111.889 178.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -76.11 80.25 2.72 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 124.449 3.432 . . . . 0.0 112.435 -176.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 118.89 -170.83 13.96 Favored Glycine 0 N--CA 1.471 1.004 0 C-N-CA 125.684 1.611 . . . . 0.0 112.778 -178.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 23.3 tttt -66.27 109.53 2.7 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.018 0.927 . . . . 0.0 109.51 174.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.43 ' HG3' ' H ' ' A' ' 126' ' ' ARG . 5.7 tpt180 -120.01 173.04 7.32 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.723 1.609 . . . . 0.0 110.242 176.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.43 ' H ' ' HG3' ' A' ' 125' ' ' ARG . 2.2 ptp180 -127.04 173.17 9.88 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 127.172 2.189 . . . . 0.0 111.292 174.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -128.35 98.01 4.92 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 126.44 1.896 . . . . 0.0 107.422 175.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -117.73 173.1 6.93 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.425 1.89 . . . . 0.0 109.115 175.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -49.84 -42.74 48.01 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.057 0.943 . . . . 0.0 113.477 177.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -57.34 -63.66 5.1 Favored Glycine 0 C--N 1.339 0.718 0 C-N-CA 124.173 0.892 . . . . 0.0 111.624 175.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 15.0 mtm -59.81 -34.12 72.63 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 118.141 0.97 . . . . 0.0 113.297 178.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -59.53 -60.42 3.87 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 119.304 0.956 . . . . 0.0 109.93 175.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -70.03 -30.7 68.06 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -177.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -60.75 -54.23 47.74 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.417 1.087 . . . . 0.0 110.024 174.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 2.0 tpp -75.21 -26.48 58.98 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -177.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -52.44 -55.84 19.11 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.464 1.505 . . . . 0.0 110.586 174.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -69.8 -8.65 50.07 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 179.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -79.21 -31.33 42.75 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 126.224 1.869 . . . . 0.0 115.076 -177.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -128.65 85.19 60.95 Favored Pre-proline 0 CA--C 1.548 0.887 0 CA-C-N 118.717 1.259 . . . . 0.0 111.047 178.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -73.42 75.94 2.83 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 123.661 2.908 . . . . 0.0 112.086 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -111.28 114.41 27.57 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.058 0.943 . . . . 0.0 110.86 -177.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 57.4 mtp180 -81.65 -71.41 0.48 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.813 1.245 . . . . 0.0 111.499 175.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 136.86 122.62 2.16 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 124.568 1.08 . . . . 0.0 113.589 -177.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.9 7.1 9.5 Favored 'General case' 0 CA--C 1.559 1.296 0 C-N-CA 127.175 2.19 . . . . 0.0 115.081 177.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 57.57 55.83 5.36 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 128.282 2.633 . . . . 0.0 112.595 -175.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -158.24 -66.73 0.01 OUTLIER Glycine 0 CA--C 1.538 1.479 0 N-CA-C 115.971 1.148 . . . . 0.0 115.971 -177.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 29.8 m95 174.11 117.1 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 130.414 3.486 . . . . 0.0 108.361 -174.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -129.9 121.03 25.86 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 126.801 2.04 . . . . 0.0 111.846 -175.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -162.33 178.3 8.81 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 -175.072 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.76 154.46 48.52 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.542 1.537 . . . . 0.0 110.849 175.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -71.34 137.69 48.65 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 175.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 91.1 mt -93.92 102.76 14.87 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.667 0.787 . . . . 0.0 109.947 -176.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -36.22 -37.51 0.19 Allowed Glycine 0 N--CA 1.476 1.32 0 C-N-CA 128.711 3.053 . . . . 0.0 117.629 -174.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.473 ' CE2' ' HB ' ' A' ' 120' ' ' ILE . 0.1 OUTLIER -61.61 -30.85 70.95 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.968 2.107 . . . . 0.0 113.239 -179.252 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 132.65 30.38 0.5 Allowed Glycine 0 CA--C 1.536 1.397 0 C-N-CA 125.763 1.649 . . . . 0.0 114.582 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 12.8 mt -130.6 175.85 8.66 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 126.082 1.753 . . . . 0.0 110.555 -174.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 60.7 mtt-85 -147.21 100.7 3.31 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.534 -1.354 . . . . 0.0 112.701 178.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -82.1 148.69 28.41 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 124.157 0.983 . . . . 0.0 108.632 175.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 3.3 tppt? -139.68 120.46 14.37 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.331 1.852 . . . . 0.0 111.214 178.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -131.59 154.89 21.11 Favored Glycine 0 N--CA 1.479 1.518 0 CA-C-N 121.123 1.783 . . . . 0.0 116.311 -176.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 2.1 tp -146.19 130.55 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.132 1.373 . . . . 0.0 110.651 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 1.9 ttp -154.61 117.62 4.44 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.958 1.703 . . . . 0.0 110.249 174.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 4.9 t -110.4 101.44 10.15 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 121.122 -0.986 . . . . 0.0 111.411 -177.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 49.0 p -69.12 28.45 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.02 -27.2 68.15 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.309 1.844 . . . . 0.0 114.332 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 159.78 -53.75 0.36 Allowed Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.776 1.179 . . . . 0.0 113.507 175.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -134.5 87.32 2.34 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.81 1.244 . . . . 0.0 110.771 178.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -136.26 -174.6 3.73 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.682 1.593 . . . . 0.0 111.582 175.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.51 175.35 9.5 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 127.462 2.305 . . . . 0.0 111.437 -178.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 32.6 ttp -110.04 138.3 46.61 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 123.965 0.906 . . . . 0.0 110.479 173.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -143.86 123.72 13.47 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 123.595 0.758 . . . . 0.0 110.361 176.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 4.7 mp -127.48 121.02 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 123.481 0.712 . . . . 0.0 109.754 176.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 2.8 tmmm? -121.05 139.07 53.82 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 125.32 1.448 . . . . 0.0 110.705 177.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.6 mp -87.4 125.79 41.11 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 174.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -137.4 96.64 3.3 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.256 1.422 . . . . 0.0 111.724 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 10.8 mtp-105 . . . . . 0 C--O 1.254 1.29 0 C-N-CA 128.119 2.568 . . . . 0.0 113.638 -177.737 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 10.4 tp . . . . . 0 N--CA 1.471 0.61 0 CA-C-O 121.112 0.482 . . . . 0.0 111.835 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -85.78 130.26 34.61 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.9 1.28 . . . . 0.0 108.464 174.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -77.12 -151.23 4.2 Favored Glycine 0 CA--C 1.538 1.503 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 175.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.6 p -78.86 169.96 17.42 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 121.441 -1.035 . . . . 0.0 113.747 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -120.64 20.72 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 126.339 1.856 . . . . 0.0 112.593 177.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -48.82 159.85 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 125.221 1.409 . . . . 0.0 112.517 175.008 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -46.75 140.47 4.55 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.682 1.593 . . . . 0.0 112.564 -175.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -57.24 -20.22 35.18 Favored Glycine 0 CA--C 1.542 1.751 0 C-N-CA 124.083 0.849 . . . . 0.0 114.418 -175.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.74 -27.47 66.81 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.008 1.323 . . . . 0.0 112.357 175.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.7 t -104.55 -42.35 5.46 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 127.15 2.18 . . . . 0.0 111.334 177.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 12.4 tp -83.33 98.59 9.53 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.644 1.578 . . . . 0.0 110.366 174.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 69.0 p -126.57 177.34 6.57 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.997 1.319 . . . . 0.0 110.898 177.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.408 ' CD1' ' C ' ' A' ' 15' ' ' PHE . 0.1 OUTLIER -45.73 -37.89 6.39 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.446 1.098 . . . . 0.0 112.827 177.801 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -57.62 -42.72 83.92 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.329 1.452 . . . . 0.0 112.289 -179.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.4 t -61.97 -37.29 77.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.72 1.208 . . . . 0.0 110.933 174.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.7 mt -71.73 -40.4 69.45 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.549 1.14 . . . . 0.0 111.663 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -60.77 -43.95 97.38 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.55 1.14 . . . . 0.0 110.429 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.35 -28.1 59.44 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.207 1.003 . . . . 0.0 113.127 174.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -55.79 -38.22 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 124.301 1.04 . . . . 0.0 111.461 177.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 15.7 mt -55.6 -20.85 14.96 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.287 1.435 . . . . 0.0 113.977 174.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -98.11 -63.27 0.87 Allowed Glycine 0 CA--C 1.532 1.113 0 C-N-CA 125.172 1.368 . . . . 0.0 112.584 175.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -65.65 -33.82 76.78 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 -174.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -105.37 94.98 5.51 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.66 1.584 . . . . 0.0 108.025 175.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -140.88 145.06 15.52 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 123.954 0.788 . . . . 0.0 113.648 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.7 mtpp -127.31 -39.08 1.91 Allowed 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 126.294 1.838 . . . . 0.0 113.788 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.3 m -133.0 174.71 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 126.425 1.89 . . . . 0.0 111.06 -178.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 54.4 m -54.29 -46.5 72.78 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.241 1.816 . . . . 0.0 114.557 -176.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.72 126.95 44.34 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.99 1.316 . . . . 0.0 111.051 175.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.39 161.29 31.66 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 124.85 1.26 . . . . 0.0 111.485 179.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -107.48 140.87 24.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 174.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -132.91 131.52 40.98 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 126.483 1.913 . . . . 0.0 109.819 175.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 25.2 t -140.62 156.15 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 123.305 0.642 . . . . 0.0 110.306 178.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -138.57 98.51 0.26 Allowed Glycine 0 CA--C 1.524 0.598 0 C-N-CA 125.677 1.608 . . . . 0.0 111.904 176.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.7 mp -81.71 144.84 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-N 117.272 0.536 . . . . 0.0 109.739 175.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -116.29 99.43 7.2 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.024 1.73 . . . . 0.0 110.66 178.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -67.68 97.17 0.6 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.818 1.647 . . . . 0.0 110.203 175.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -124.89 4.87 8.05 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.625 0.77 . . . . 0.0 112.326 174.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.9 t -57.59 -45.25 85.51 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.376 1.47 . . . . 0.0 112.875 -176.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 130.11 40.33 0.26 Allowed Glycine 0 CA--C 1.535 1.29 0 C-N-CA 124.31 0.957 . . . . 0.0 115.25 177.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -178.09 165.71 35.34 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.561 1.077 . . . . 0.0 112.605 175.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.4 p -68.76 137.68 54.23 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.485 -1.009 . . . . 0.0 110.34 174.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.542 ' HA ' ' CE1' ' A' ' 91' ' ' TYR . 35.6 m0 -93.87 100.52 12.68 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 123.232 0.613 . . . . 0.0 111.546 -178.205 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 29.1 m -84.6 115.48 22.65 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.004 0.922 . . . . 0.0 109.121 177.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.05 143.5 51.83 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 122.709 0.403 . . . . 0.0 111.547 175.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.5 pp -119.2 -55.07 2.18 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.651 0.781 . . . . 0.0 111.966 178.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 22.7 t30 -173.15 150.47 1.94 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.991 2.117 . . . . 0.0 109.997 -177.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -129.05 163.67 24.91 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.837 1.255 . . . . 0.0 111.489 175.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -131.77 106.87 8.39 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.324 1.45 . . . . 0.0 110.663 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -115.58 112.18 21.79 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.948 0.899 . . . . 0.0 110.118 -174.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.05 -41.27 7.63 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -178.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.0 t -116.13 -45.72 2.84 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.549 1.539 . . . . 0.0 111.002 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -69.26 11.57 1.46 Allowed Glycine 0 CA--C 1.538 1.503 0 CA-C-O 118.226 -1.319 . . . . 0.0 115.764 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.7 p -32.75 108.27 0.05 Allowed 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 128.472 2.709 . . . . 0.0 113.987 -175.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.5 t -130.02 175.41 8.91 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 114.125 1.158 . . . . 0.0 114.125 -174.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -79.58 -48.84 13.13 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.64 1.176 . . . . 0.0 112.79 -178.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.4 p -144.07 132.44 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.818 1.647 . . . . 0.0 111.604 176.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -137.02 -47.92 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.171 1.388 . . . . 0.0 113.903 179.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 8.2 mt -86.69 102.6 3.11 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 123.977 0.911 . . . . 0.0 109.836 174.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -68.0 141.64 53.94 Favored 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 122.729 2.286 . . . . 0.0 110.898 174.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -38.73 -52.96 1.69 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 126.949 2.1 . . . . 0.0 114.116 178.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.6 p -153.24 135.45 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 126.475 1.91 . . . . 0.0 109.927 174.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 59.5 t -116.24 131.18 23.93 Favored Pre-proline 0 N--CA 1.483 1.207 0 C-N-CA 124.671 1.188 . . . . 0.0 109.681 176.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -65.93 152.91 80.17 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 122.714 2.276 . . . . 0.0 113.656 177.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -69.24 162.95 26.06 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.17 0.988 . . . . 0.0 111.232 175.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . 0.257 76.4 p 51.37 28.22 4.22 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 126.787 2.035 . . . . 0.0 114.006 -174.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.8 mttp -131.1 175.98 8.64 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 127.537 2.335 . . . . 0.0 111.34 -178.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -127.35 158.92 35.97 Favored 'General case' 0 C--O 1.224 -0.249 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -178.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.4 pp -121.84 171.85 8.6 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.313 1.445 . . . . 0.0 110.52 175.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -117.17 145.6 43.74 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 124.051 0.94 . . . . 0.0 108.95 174.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -127.16 143.74 51.19 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 125.585 1.554 . . . . 0.0 108.845 177.16 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 82.9 p -143.57 170.8 15.14 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.963 -178.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 174.48 142.84 4.17 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.223 -0.899 . . . . 0.0 112.357 176.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -109.44 128.97 55.54 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 124.869 1.267 . . . . 0.0 108.087 177.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.7 ptpt . . . . . 0 N--CA 1.472 0.65 0 C-N-CA 124.724 1.21 . . . . 0.0 113.291 176.474 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.1 m . . . . . 0 N--CA 1.475 0.801 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -84.03 -90.21 0.77 Allowed Glycine 0 N--CA 1.47 0.948 0 O-C-N 120.538 -1.351 . . . . 0.0 114.524 -175.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -143.33 82.73 1.75 Allowed 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 124.815 1.246 . . . . 0.0 109.066 -175.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.7 t -122.29 111.95 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 124.929 1.292 . . . . 0.0 111.007 -175.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.03 167.7 29.16 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 122.177 0.989 . . . . 0.0 111.166 177.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -148.92 160.88 42.87 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.284 1.433 . . . . 0.0 109.58 175.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -156.41 174.67 15.08 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 121.42 -0.8 . . . . 0.0 112.122 175.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -145.16 150.89 37.58 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.849 0.833 . . . . 0.0 113.203 174.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.542 ' CE1' ' HA ' ' A' ' 44' ' ' TRP . 0.1 OUTLIER -121.87 127.07 50.07 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 127.205 2.202 . . . . 0.0 109.181 -179.232 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -84.11 104.68 14.37 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.269 0.627 . . . . 0.0 112.423 179.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -72.38 126.2 29.26 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 125.401 1.48 . . . . 0.0 112.657 -176.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 37.1 m -58.62 -21.18 52.88 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.652 0.781 . . . . 0.0 113.095 175.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 23.7 m-20 -69.38 -14.02 62.68 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 124.693 1.197 . . . . 0.0 112.907 174.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 109.26 31.99 3.13 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 125.295 1.426 . . . . 0.0 115.055 177.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -142.72 -179.44 6.33 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.855 1.262 . . . . 0.0 112.044 -175.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 25.1 m -132.55 107.26 8.33 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 120.994 -1.067 . . . . 0.0 111.973 177.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 35.7 tp -74.69 107.74 7.0 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 121.224 -0.923 . . . . 0.0 110.57 175.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -107.13 114.6 4.36 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 124.79 1.186 . . . . 0.0 113.742 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 98.4 t -97.27 137.28 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.134 1.374 . . . . 0.0 112.614 -175.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -129.11 126.06 38.51 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 126.352 1.861 . . . . 0.0 111.788 -175.258 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -148.48 123.82 10.27 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.6 1.16 . . . . 0.0 112.018 -178.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 22.4 t -137.47 133.94 35.23 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.758 0.823 . . . . 0.0 111.612 178.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 19.0 t . . . . . 0 CA--C 1.539 0.556 0 C-N-CA 126.88 2.072 . . . . 0.0 108.885 -176.629 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 20.1 m . . . . . 0 N--CA 1.467 0.383 0 CA-C-O 121.142 0.496 . . . . 0.0 112.131 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -77.03 91.8 3.67 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.954 1.302 . . . . 0.0 111.297 176.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 42.8 m0 -98.01 149.16 22.75 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 119.463 1.029 . . . . 0.0 111.226 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 31.6 p-90 -155.95 135.64 12.57 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.653 0.781 . . . . 0.0 112.498 -176.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -145.57 174.84 10.82 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 120.553 -1.342 . . . . 0.0 112.825 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 99.3 t -148.9 139.81 17.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 C-N-CA 123.768 0.827 . . . . 0.0 109.135 175.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.453 ' HE2' ' CG ' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -144.4 169.54 17.73 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 125.566 1.546 . . . . 0.0 109.538 175.133 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 59.9 mt -113.27 128.47 70.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 175.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.453 ' CG ' ' HE2' ' A' ' 119' ' ' LYS . 96.2 m-85 -88.38 147.5 40.14 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 124.683 1.193 . . . . 0.0 110.48 175.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -70.01 130.92 19.84 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 123.151 2.568 . . . . 0.0 111.075 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 59.96 -141.64 47.64 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 123.607 0.622 . . . . 0.0 113.133 -178.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 4.6 tmtt? -86.49 118.05 25.66 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.492 1.517 . . . . 0.0 110.4 176.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 12.2 tpp180 -135.51 170.61 15.68 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 126.088 1.755 . . . . 0.0 109.998 175.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 24.8 ptt180 -116.2 -176.55 2.97 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 127.133 2.173 . . . . 0.0 111.258 175.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -127.16 105.48 8.6 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 175.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -121.81 168.04 12.3 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.788 1.635 . . . . 0.0 109.751 177.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -51.84 -41.1 61.55 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 -177.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -59.12 -56.25 26.31 Favored Glycine 0 N--CA 1.47 0.912 0 CA-C-N 119.278 0.945 . . . . 0.0 112.164 175.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 4.9 mtt -59.01 -46.19 88.79 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.414 1.086 . . . . 0.0 111.287 177.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -51.78 -58.48 6.3 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.554 1.542 . . . . 0.0 111.096 174.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -68.89 -30.62 69.16 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -178.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -59.49 -41.75 90.56 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.998 0.919 . . . . 0.0 111.446 174.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 12.8 mmm -86.18 -27.66 24.42 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -51.2 -63.71 1.05 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.861 1.665 . . . . 0.0 110.883 175.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -69.42 -6.23 28.82 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -175.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -88.18 -15.57 60.52 Favored Glycine 0 CA--C 1.537 1.442 0 C-N-CA 126.974 2.226 . . . . 0.0 115.459 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -144.77 95.49 5.28 Favored Pre-proline 0 CA--C 1.552 1.049 0 CA-C-N 119.771 1.786 . . . . 0.0 112.688 178.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -75.95 77.31 3.47 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 123.783 2.989 . . . . 0.0 112.591 -178.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -107.98 110.01 21.62 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.346 1.458 . . . . 0.0 109.827 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 9.6 mtp180 -118.56 111.39 18.53 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 126.944 2.098 . . . . 0.0 111.541 -175.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 76.96 -56.73 3.55 Favored Glycine 0 C--O 1.218 -0.867 0 CA-C-O 118.609 -1.106 . . . . 0.0 111.728 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 57.21 33.86 23.94 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 119.975 1.887 . . . . 0.0 114.655 174.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -70.31 40.9 0.05 Allowed 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 127.933 2.493 . . . . 0.0 115.163 -177.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -160.17 34.29 0.43 Allowed Glycine 0 CA--C 1.539 1.576 0 C-N-CA 126.319 1.914 . . . . 0.0 114.555 178.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' TRP . . . . . 0.495 ' H ' HD12 ' A' ' 161' ' ' ILE . 3.6 m95 57.5 49.48 12.72 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 126.769 2.028 . . . . 0.0 112.372 -174.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -84.68 130.56 34.69 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 121.319 -0.863 . . . . 0.0 111.23 -177.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -171.29 -176.93 2.0 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.034 0.933 . . . . 0.0 112.797 177.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 9.8 ttpp -126.48 157.14 39.44 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 126.339 1.855 . . . . 0.0 111.37 -174.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -68.48 158.13 34.43 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.293 0.568 . . . . 0.0 110.559 174.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 98.5 mt -112.81 159.77 18.67 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.996 1.319 . . . . 0.0 109.45 175.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -63.33 -171.57 1.79 Allowed Glycine 0 CA--C 1.538 1.501 0 C-N-CA 124.085 0.85 . . . . 0.0 111.743 174.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 52.74 13.22 0.32 Allowed 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 125.486 1.515 . . . . 0.0 114.954 175.358 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 79.26 36.93 25.97 Favored Glycine 0 CA--C 1.54 1.6 0 C-N-CA 125.724 1.63 . . . . 0.0 113.803 -175.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -115.93 167.12 11.24 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 119.181 1.491 . . . . 0.0 112.436 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 80.2 mtt85 -146.48 127.55 14.64 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 120.924 -1.11 . . . . 0.0 111.053 175.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 7.3 ttp -99.99 154.23 18.56 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 174.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.43 147.89 49.72 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 127.691 2.396 . . . . 0.0 110.972 176.236 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -152.39 151.44 23.29 Favored Glycine 0 CA--C 1.524 0.65 0 CA-C-O 121.933 0.74 . . . . 0.0 113.47 175.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.495 HD12 ' H ' ' A' ' 147' ' ' TRP . 1.1 tp -142.72 133.76 24.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 127.005 2.122 . . . . 0.0 108.8 -179.147 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 1.4 mtp -149.02 -176.07 5.2 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 127.313 2.245 . . . . 0.0 107.698 175.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 1.3 t -162.32 149.18 13.47 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 174.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 36.0 p -106.2 26.15 10.13 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.067 1.747 . . . . 0.0 112.001 -178.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.82 14.85 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.266 0 C-N-CA 127.864 2.466 . . . . 0.0 115.701 176.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 82.71 -37.19 2.64 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 127.605 2.526 . . . . 0.0 114.216 -178.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -135.05 75.74 1.59 Allowed 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 126.678 1.991 . . . . 0.0 108.272 -176.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -135.89 162.65 32.22 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.397 1.479 . . . . 0.0 113.204 -175.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.28 172.06 7.09 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 128.998 2.919 . . . . 0.0 112.261 -175.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 12.9 ttt -117.66 143.11 46.48 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 126.017 1.727 . . . . 0.0 112.177 176.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -149.13 123.85 9.85 Favored 'General case' 0 N--CA 1.466 0.325 0 O-C-N 120.627 -1.296 . . . . 0.0 110.691 174.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 1.9 mp -125.08 125.77 69.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 124.786 1.235 . . . . 0.0 108.744 179.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.52 142.78 51.3 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.827 1.251 . . . . 0.0 109.987 178.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.7 mp -89.44 114.15 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 O-C-N 121.173 -0.955 . . . . 0.0 109.162 176.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 5.4 m -85.5 154.36 21.83 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.434 1.094 . . . . 0.0 112.192 174.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 69.3 mtp180 . . . . . 0 C--O 1.252 1.224 0 C-N-CA 125.379 1.472 . . . . 0.0 111.175 176.528 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.8 mt . . . . . 0 N--CA 1.483 1.212 0 N-CA-C 113.264 0.839 . . . . 0.0 113.264 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -72.74 78.05 1.12 Allowed 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 125.68 1.592 . . . . 0.0 109.56 175.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -68.05 -90.68 0.06 OUTLIER Glycine 0 CA--C 1.536 1.374 0 C-N-CA 125.614 1.578 . . . . 0.0 114.689 -175.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 24.2 p -128.18 164.57 22.22 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.408 1.483 . . . . 0.0 110.949 175.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -125.85 19.76 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 CA-C-O 123.545 1.64 . . . . 0.0 111.695 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.9 pp -54.97 166.57 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 125.21 1.404 . . . . 0.0 111.877 175.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -40.44 129.24 2.42 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.261 1.824 . . . . 0.0 114.83 -174.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -55.49 -21.11 26.35 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 125.169 1.366 . . . . 0.0 114.607 -176.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.39 -30.98 70.89 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.013 1.325 . . . . 0.0 112.041 174.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.4 t -101.95 -38.7 7.67 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.878 1.671 . . . . 0.0 111.558 174.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 45.4 tp -79.39 90.71 5.03 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.895 0.878 . . . . 0.0 112.069 176.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 70.8 p -123.17 -176.98 3.56 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 126.326 1.85 . . . . 0.0 112.292 -178.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -55.02 -37.66 66.93 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.337 1.055 . . . . 0.0 112.261 -175.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -57.58 -38.29 74.61 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 125.379 1.472 . . . . 0.0 111.605 178.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 89.4 t -66.51 -37.7 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.336 1.054 . . . . 0.0 111.38 175.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.4 mt -68.17 -44.39 76.02 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.897 0.879 . . . . 0.0 110.69 178.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -58.27 -50.89 72.0 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.879 1.272 . . . . 0.0 111.926 176.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.55 -32.56 73.99 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 118.381 -0.819 . . . . 0.0 113.147 174.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -54.96 -40.18 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 CA-C-N 119.636 1.107 . . . . 0.0 111.518 -179.005 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 16.2 mt -57.18 -20.66 27.98 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.99 1.716 . . . . 0.0 113.355 178.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -108.77 -51.4 0.7 Allowed Glycine 0 CA--C 1.533 1.192 0 C-N-CA 126.356 1.931 . . . . 0.0 113.855 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -63.92 -28.34 69.76 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 119.031 1.416 . . . . 0.0 113.643 -178.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -97.59 86.77 3.91 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.542 1.137 . . . . 0.0 109.266 174.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -54.29 119.1 10.64 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 125.363 1.459 . . . . 0.0 113.537 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.1 mtpp -142.0 -173.35 3.79 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 127.726 2.41 . . . . 0.0 111.357 179.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.7 m -57.81 168.4 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 126.23 1.812 . . . . 0.0 112.329 175.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.8 m -51.3 -37.69 48.87 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 116.389 1.996 . . . . 0.0 116.389 -175.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.71 131.79 54.28 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.574 1.549 . . . . 0.0 108.547 174.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.52 150.15 37.08 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 126.095 1.758 . . . . 0.0 109.745 -175.01 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -116.26 120.58 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 123.998 0.919 . . . . 0.0 110.434 177.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -117.47 124.89 49.88 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 124.516 1.126 . . . . 0.0 109.573 175.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.7 p -142.56 139.92 28.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.731 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -125.37 125.07 5.5 Favored Glycine 0 CA--C 1.522 0.505 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.491 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.457 ' H ' HD12 ' A' ' 70' ' ' LEU . 2.9 mp -112.48 142.27 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 123.822 0.849 . . . . 0.0 110.371 176.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -105.59 106.48 17.01 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.486 1.114 . . . . 0.0 111.127 178.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -74.86 93.0 2.58 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.359 1.864 . . . . 0.0 110.577 176.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -121.57 8.1 10.09 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.906 1.282 . . . . 0.0 113.131 175.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 30.0 t -46.03 -51.01 14.4 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.149 1.78 . . . . 0.0 113.343 178.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 154.5 -26.33 0.67 Allowed Glycine 0 N--CA 1.472 1.065 0 O-C-N 121.281 -0.887 . . . . 0.0 114.517 175.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -128.18 171.47 19.36 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 125.682 1.61 . . . . 0.0 112.178 174.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 76.5 p -64.68 149.65 48.64 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.618 0.767 . . . . 0.0 112.147 176.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 38.4 m0 -101.62 108.27 19.76 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 124.654 1.182 . . . . 0.0 111.048 178.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 33.2 m -90.7 128.74 36.75 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.993 1.317 . . . . 0.0 110.123 177.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.29 114.5 3.51 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.915 0.886 . . . . 0.0 111.729 174.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.6 pp -98.44 -51.65 3.89 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 123.556 0.742 . . . . 0.0 111.536 177.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -172.92 154.47 2.87 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 127.5 2.32 . . . . 0.0 109.848 -177.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -137.64 168.0 20.55 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.916 1.286 . . . . 0.0 112.052 174.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -141.42 114.07 8.34 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.424 1.09 . . . . 0.0 111.652 179.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -116.06 139.18 50.54 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.38 -0.825 . . . . 0.0 110.941 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -117.54 -67.05 1.02 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 126.071 1.749 . . . . 0.0 111.492 -175.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 26.3 t -105.39 -38.67 6.4 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 126.8 2.04 . . . . 0.0 110.28 -176.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -68.77 10.2 1.63 Allowed Glycine 0 CA--C 1.537 1.45 0 C-N-CA 126.792 2.139 . . . . 0.0 115.491 178.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 34.0 p -30.22 123.94 0.18 Allowed 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 129.014 2.925 . . . . 0.0 114.832 -175.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.5 t -146.39 178.28 8.38 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.47 1.108 . . . . 0.0 113.513 -174.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -83.24 -62.8 1.49 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.364 1.465 . . . . 0.0 112.4 177.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.2 p -138.93 138.21 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.901 1.68 . . . . 0.0 111.824 178.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.4 pp -141.09 -27.75 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.921 1.688 . . . . 0.0 114.048 -179.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 mp -97.45 96.35 3.06 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 125.687 1.595 . . . . 0.0 109.06 177.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -64.02 152.28 81.62 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.878 2.385 . . . . 0.0 110.503 175.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -43.66 -50.2 7.53 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.011 1.725 . . . . 0.0 113.477 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 5.6 p -158.59 143.81 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 C-N-CA 126.93 2.092 . . . . 0.0 109.511 175.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 99.7 t -118.0 128.95 25.67 Favored Pre-proline 0 N--CA 1.476 0.828 0 C-N-CA 124.956 1.302 . . . . 0.0 108.771 175.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -67.13 150.36 82.12 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.611 2.207 . . . . 0.0 113.139 176.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -65.23 163.65 14.87 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.293 0.637 . . . . 0.0 111.033 175.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . 0.312 50.1 p 55.48 20.75 3.9 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 127.779 2.431 . . . . 0.0 114.742 -174.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 20.0 mttt -120.35 -178.49 3.7 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 126.459 1.903 . . . . 0.0 112.115 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.76 166.19 23.21 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 175.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.457 HD12 ' H ' ' A' ' 36' ' ' ILE . 0.5 OUTLIER -134.25 174.26 10.7 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 124.3 1.04 . . . . 0.0 110.993 179.539 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -127.33 154.89 44.4 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 124.699 1.199 . . . . 0.0 111.481 175.185 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.464 ' CE2' ' CE2' ' A' ' 89' ' ' PHE . 12.4 m-85 -129.49 148.09 51.36 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 125.987 1.715 . . . . 0.0 109.795 178.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 54.5 p -126.21 146.69 49.87 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 126.186 1.795 . . . . 0.0 111.129 175.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -163.26 148.78 15.67 Favored Glycine 0 CA--C 1.519 0.286 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 174.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.48 173.61 6.66 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.16 1.384 . . . . 0.0 110.134 177.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 12.2 ptmt . . . . . 0 N--CA 1.482 1.171 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 174.948 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 90.1 m . . . . . 0 N--CA 1.475 0.798 0 CA-C-O 119.108 -0.472 . . . . 0.0 110.08 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 179.74 -93.09 0.09 OUTLIER Glycine 0 CA--C 1.531 1.069 0 CA-C-N 119.696 1.135 . . . . 0.0 113.253 -175.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -153.56 100.62 2.42 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.137 0.975 . . . . 0.0 111.585 176.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.2 t -141.23 115.27 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 124.455 1.102 . . . . 0.0 109.753 -177.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.45 170.93 21.32 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.374 1.07 . . . . 0.0 112.05 175.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -152.11 160.84 43.33 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.47 1.508 . . . . 0.0 111.082 175.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.488 ' CZ ' HG11 ' A' ' 101' ' ' VAL . 41.6 p90 -155.33 170.07 22.75 Favored 'General case' 0 C--O 1.234 0.285 0 O-C-N 121.079 -1.013 . . . . 0.0 111.154 175.042 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -136.31 151.7 49.9 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 176.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -131.29 134.88 46.81 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.545 1.538 . . . . 0.0 112.727 -177.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -82.62 123.56 29.35 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 111.618 0.229 . . . . 0.0 111.618 -179.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 4.6 tpp -88.55 145.49 25.69 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.317 1.047 . . . . 0.0 112.165 175.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 61.3 m -69.65 -23.35 63.47 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 175.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -70.98 -13.94 62.18 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.852 1.261 . . . . 0.0 113.787 175.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 98.54 42.63 2.89 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 124.546 1.069 . . . . 0.0 114.176 -179.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 17.0 m-80 -141.33 174.15 10.81 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.354 1.462 . . . . 0.0 110.431 178.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 6.0 m -128.55 107.18 9.5 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.178 0.991 . . . . 0.0 112.424 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 21.1 tp -68.03 105.02 1.9 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.756 0.823 . . . . 0.0 109.65 174.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -106.63 103.09 1.98 Allowed Glycine 0 CA--C 1.525 0.695 0 C-N-CA 125.395 1.474 . . . . 0.0 112.337 177.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.488 HG11 ' CZ ' ' A' ' 89' ' ' PHE . 9.5 p -86.32 161.47 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 123.755 0.822 . . . . 0.0 112.407 175.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 2.5 tmm? -150.3 126.96 10.91 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.257 1.823 . . . . 0.0 109.725 178.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -139.03 118.51 12.9 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 122.158 0.98 . . . . 0.0 112.948 177.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 26.0 t -124.6 118.34 26.32 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.452 1.501 . . . . 0.0 110.723 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 96.2 t . . . . . 0 CA--C 1.539 0.557 0 C-N-CA 126.728 2.011 . . . . 0.0 108.852 178.775 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 11.0 m . . . . . 0 N--CA 1.467 0.424 0 CA-C-O 121.497 0.665 . . . . 0.0 112.359 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -100.05 118.11 35.73 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.285 1.434 . . . . 0.0 107.382 174.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 36.7 m0 -116.73 135.65 53.59 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 19.8 p-90 -145.82 143.49 29.68 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.548 0.739 . . . . 0.0 112.029 -176.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -148.59 161.83 40.89 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.981 0.896 . . . . 0.0 112.571 -176.321 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 5.6 p -166.12 127.76 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 125.028 1.331 . . . . 0.0 109.269 175.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.497 ' HE3' ' CE1' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -151.78 168.44 25.05 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 126.199 1.799 . . . . 0.0 109.566 178.31 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.433 ' HB ' ' CE2' ' A' ' 154' ' ' TYR . 24.6 mt -111.1 111.73 37.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -177.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.497 ' CE1' ' HE3' ' A' ' 119' ' ' LYS . 54.2 m-85 -63.01 142.66 97.67 Favored Pre-proline 0 CA--C 1.544 0.731 0 O-C-N 121.203 -0.936 . . . . 0.0 111.063 -179.099 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -73.92 92.5 0.89 Allowed 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 124.2 3.266 . . . . 0.0 110.902 -179.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 101.2 -171.69 22.61 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 124.805 1.193 . . . . 0.0 112.736 -174.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 8.8 tttt -67.57 118.51 10.97 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.893 0.877 . . . . 0.0 110.931 176.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.435 ' HG3' ' H ' ' A' ' 126' ' ' ARG . 9.4 tpp180 -134.18 178.25 7.12 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.222 1.409 . . . . 0.0 109.704 175.049 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.435 ' H ' ' HG3' ' A' ' 125' ' ' ARG . 8.6 ptt180 -123.34 179.74 4.61 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 126.372 1.869 . . . . 0.0 110.231 174.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -131.7 103.65 6.48 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 126.572 1.949 . . . . 0.0 107.016 175.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -126.66 171.37 11.21 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.348 1.859 . . . . 0.0 110.093 178.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -50.69 -41.73 56.13 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -177.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -60.72 -53.76 42.6 Favored Glycine 0 N--CA 1.468 0.775 0 CA-C-O 119.484 -0.62 . . . . 0.0 112.267 176.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -63.24 -40.05 96.34 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 118.176 0.988 . . . . 0.0 111.916 178.085 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -55.84 -63.73 1.08 Allowed 'General case' 0 C--N 1.34 0.167 0 C-N-CA 124.224 1.01 . . . . 0.0 108.846 175.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -64.62 -33.9 77.01 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 118.667 0.667 . . . . 0.0 112.739 -175.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -64.56 -42.94 95.36 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.272 1.029 . . . . 0.0 113.069 176.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -86.32 -29.01 23.34 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 121.28 -0.888 . . . . 0.0 112.291 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -52.04 -57.61 9.02 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 126.831 2.053 . . . . 0.0 108.902 174.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -71.85 -12.1 61.12 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -177.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -86.72 -8.14 77.21 Favored Glycine 0 CA--C 1.54 1.599 0 C-N-CA 126.701 2.096 . . . . 0.0 114.958 176.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -140.09 80.3 20.52 Favored Pre-proline 0 CA--C 1.55 0.954 0 CA-C-N 119.105 1.452 . . . . 0.0 111.192 175.012 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -73.16 70.25 3.82 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 124.109 3.206 . . . . 0.0 112.471 177.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -102.43 116.76 33.28 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.97 0.908 . . . . 0.0 110.637 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 34.5 mtm180 -83.59 -68.43 0.71 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.11 1.364 . . . . 0.0 111.884 174.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 134.73 114.43 1.43 Allowed Glycine 0 CA--C 1.53 0.981 0 C-N-CA 124.976 1.274 . . . . 0.0 113.569 -178.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.58 14.73 0.32 Allowed 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 126.912 2.085 . . . . 0.0 115.295 176.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . 0.258 0.8 OUTLIER 45.51 65.01 1.23 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 126.953 2.101 . . . . 0.0 112.56 -175.011 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -168.44 -67.33 0.03 OUTLIER Glycine 0 CA--C 1.541 1.672 0 C-N-CA 125.098 1.332 . . . . 0.0 115.926 -174.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 43.2 m95 173.23 114.19 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 130.86 3.664 . . . . 0.0 108.799 -175.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -131.93 126.09 33.24 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 128.463 2.705 . . . . 0.0 110.277 -177.376 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -166.76 -175.31 3.06 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.08 0.952 . . . . 0.0 112.078 -174.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.3 mtmt -139.54 145.51 38.76 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.702 1.201 . . . . 0.0 109.946 175.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -67.6 149.79 49.63 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 175.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 66.7 mt -108.78 102.32 11.37 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.277 0.631 . . . . 0.0 110.4 -174.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -43.52 -30.58 1.43 Allowed Glycine 0 N--CA 1.475 1.283 0 C-N-CA 127.722 2.582 . . . . 0.0 117.136 -175.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.433 ' CE2' ' HB ' ' A' ' 120' ' ' ILE . 0.0 OUTLIER -64.29 -18.85 64.98 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.623 1.969 . . . . 0.0 113.799 178.164 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 118.86 30.14 1.7 Allowed Glycine 0 CA--C 1.537 1.409 0 C-N-CA 125.915 1.721 . . . . 0.0 114.288 -178.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 2.2 mt -128.96 174.92 9.08 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.508 1.923 . . . . 0.0 110.859 -176.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 80.7 mtt180 -143.75 108.77 4.97 Favored 'General case' 0 N--CA 1.479 1.007 0 O-C-N 120.913 -1.117 . . . . 0.0 111.081 178.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.73 148.54 26.31 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 175.049 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.9 122.28 17.16 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 126.087 1.755 . . . . 0.0 110.899 176.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -138.85 158.74 25.26 Favored Glycine 0 N--CA 1.479 1.56 0 CA-C-N 121.552 1.978 . . . . 0.0 116.62 -177.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -151.3 134.3 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-N 118.896 1.348 . . . . 0.0 111.051 179.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 1.1 ttt -156.91 105.98 2.21 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.752 1.621 . . . . 0.0 110.089 174.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 4.0 t -81.66 126.76 32.16 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 120.921 -1.112 . . . . 0.0 109.977 175.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 34.9 p -75.15 21.89 0.12 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.1 1.36 . . . . 0.0 114.292 177.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -56.06 -45.33 79.33 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.282 1.833 . . . . 0.0 114.692 -175.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 164.45 -60.59 0.25 Allowed Glycine 0 CA--C 1.533 1.192 0 C-N-CA 123.685 0.66 . . . . 0.0 114.706 178.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -120.07 21.77 11.7 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.625 1.17 . . . . 0.0 112.819 -178.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -64.16 168.59 5.28 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 122.784 1.278 . . . . 0.0 112.887 175.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.09 167.05 11.83 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 127.089 2.156 . . . . 0.0 110.976 -179.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 13.7 ttp -108.3 135.5 49.51 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.634 1.174 . . . . 0.0 110.329 178.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -141.62 127.64 19.52 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.007 0.923 . . . . 0.0 110.896 175.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 5.1 mp -133.38 121.32 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 124.241 1.016 . . . . 0.0 110.01 175.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -116.61 132.31 56.72 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 125.409 1.484 . . . . 0.0 110.321 175.002 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.7 mp -84.3 119.5 33.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 175.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 5.0 m -92.61 171.08 9.24 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.64 1.576 . . . . 0.0 109.825 174.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 2.2 mtt180 . . . . . 0 C--O 1.253 1.274 0 C-N-CA 125.335 1.454 . . . . 0.0 112.624 176.363 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 11.8 tp . . . . . 0 N--CA 1.474 0.731 0 N-CA-C 113.847 1.054 . . . . 0.0 113.847 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -86.58 138.7 31.49 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.313 1.045 . . . . 0.0 109.124 175.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -79.66 -122.81 0.4 Allowed Glycine 0 CA--C 1.535 1.319 0 C-N-CA 124.143 0.877 . . . . 0.0 112.031 175.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 35.8 p -113.74 173.43 6.42 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.482 1.513 . . . . 0.0 112.018 -178.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -123.14 19.84 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.326 1.05 . . . . 0.0 112.121 178.165 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -47.15 156.87 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.784 1.234 . . . . 0.0 112.846 175.007 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -41.92 130.45 3.44 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.279 1.832 . . . . 0.0 112.999 -175.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -54.03 -22.86 21.8 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 124.869 1.223 . . . . 0.0 114.885 -174.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.93 -30.58 71.65 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.417 1.087 . . . . 0.0 112.077 175.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -100.89 -41.92 6.64 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.629 1.972 . . . . 0.0 111.872 176.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.2 tp -73.29 94.23 1.99 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.139 0.976 . . . . 0.0 110.898 175.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 82.6 p -129.19 -175.3 3.52 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.422 1.889 . . . . 0.0 112.046 -178.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -51.52 -33.11 30.45 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.959 1.304 . . . . 0.0 113.993 179.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -57.83 -43.17 85.64 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.102 0.561 . . . . 0.0 111.852 174.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 72.8 t -67.03 -40.23 85.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.229 1.012 . . . . 0.0 110.922 175.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 59.8 mt -67.54 -40.08 85.02 Favored 'General case' 0 N--CA 1.469 0.475 0 O-C-N 120.963 -1.086 . . . . 0.0 112.059 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -63.91 -47.57 80.02 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.164 0.986 . . . . 0.0 111.781 176.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.51 -36.7 84.6 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 118.456 -0.783 . . . . 0.0 112.287 174.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.0 t -55.03 -46.12 77.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-N 119.295 0.952 . . . . 0.0 110.92 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.3 mt -54.89 -19.62 7.01 Favored 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 176.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.62 -60.48 1.09 Allowed Glycine 0 CA--C 1.535 1.323 0 C-N-CA 126.324 1.916 . . . . 0.0 113.182 175.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -65.75 -34.89 79.23 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -178.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -100.8 133.56 45.09 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.637 1.575 . . . . 0.0 109.923 175.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 170.27 145.72 4.84 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 124.504 1.049 . . . . 0.0 112.155 -178.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -129.73 -76.91 0.54 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.027 1.331 . . . . 0.0 110.938 -178.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 26.9 m -78.08 173.93 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 126.107 1.763 . . . . 0.0 111.361 175.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -53.67 -35.31 60.92 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 115.546 1.684 . . . . 0.0 115.546 -175.04 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -127.32 152.13 47.86 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 127.544 2.337 . . . . 0.0 109.035 175.003 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.02 159.47 44.53 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.803 1.641 . . . . 0.0 111.012 -178.088 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -122.26 129.9 74.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 125.075 1.35 . . . . 0.0 108.214 175.078 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -135.79 115.3 12.72 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.11 1.364 . . . . 0.0 108.965 175.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.6 m -125.72 144.1 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 123.313 0.645 . . . . 0.0 111.146 -177.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -111.03 115.26 3.92 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 124.255 0.931 . . . . 0.0 111.656 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 mp -105.1 144.16 15.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 118.037 0.918 . . . . 0.0 108.782 174.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -115.95 111.5 20.48 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 124.588 1.155 . . . . 0.0 111.049 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.465 ' HA ' ' CZ2' ' A' ' 44' ' ' TRP . 1.6 m-20 -80.54 78.25 7.29 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 128.141 2.576 . . . . 0.0 111.226 -175.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -113.99 3.43 15.35 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.779 1.232 . . . . 0.0 112.389 178.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.452 ' HG ' HG23 ' A' ' 174' ' ' ILE . 0.7 OUTLIER -61.31 -54.5 43.15 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.918 1.687 . . . . 0.0 114.304 -175.032 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 151.93 99.52 0.19 Allowed Glycine 0 CA--C 1.533 1.195 0 O-C-N 121.478 -0.764 . . . . 0.0 114.278 178.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.15 163.74 38.94 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 125.871 1.701 . . . . 0.0 112.94 -177.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 69.1 p -63.98 138.74 58.6 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 121.965 -0.727 . . . . 0.0 111.616 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.465 ' CZ2' ' HA ' ' A' ' 38' ' ' ASN . 40.6 m0 -87.99 106.47 18.15 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.077 0.551 . . . . 0.0 110.827 -178.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 15.9 m -86.27 122.64 30.54 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.319 1.048 . . . . 0.0 109.577 175.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.41 140.02 57.4 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.087 0.47 . . . . 0.0 111.671 175.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.0 pp -121.92 -56.84 1.83 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.912 1.285 . . . . 0.0 111.312 -178.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -171.16 156.22 4.66 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.65 1.98 . . . . 0.0 110.596 176.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -133.57 165.45 24.88 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.269 1.428 . . . . 0.0 110.718 174.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -141.12 101.8 4.11 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.953 1.701 . . . . 0.0 111.444 -178.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -107.74 127.32 53.59 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.127 0.971 . . . . 0.0 110.582 -177.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.67 -37.75 4.8 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.372 1.069 . . . . 0.0 113.486 -179.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.8 t -123.36 -41.93 2.27 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 126.31 1.844 . . . . 0.0 111.556 -178.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -69.01 16.2 0.63 Allowed Glycine 0 CA--C 1.536 1.362 0 C-N-CA 125.145 1.355 . . . . 0.0 115.529 179.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.6 p -27.35 115.25 0.07 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 129.604 3.161 . . . . 0.0 113.863 -176.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.1 t -139.11 176.71 8.46 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.779 0.831 . . . . 0.0 112.794 -175.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -80.94 -57.4 3.56 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.909 1.284 . . . . 0.0 110.668 175.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.4 p -151.0 137.23 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 126.071 1.748 . . . . 0.0 111.573 -177.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.8 -42.5 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 125.337 1.455 . . . . 0.0 112.778 176.001 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 13.8 mt -82.59 100.15 0.79 Allowed Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 126.398 1.879 . . . . 0.0 109.725 179.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -69.43 155.31 67.38 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.57 2.846 . . . . 0.0 110.385 175.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -48.52 -52.14 23.96 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.902 0.881 . . . . 0.0 112.966 -176.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.4 t -154.6 135.43 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 128.307 2.643 . . . . 0.0 108.694 -178.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 48.3 t -120.43 134.19 24.12 Favored Pre-proline 0 N--CA 1.479 1.016 0 C-N-CA 123.94 0.896 . . . . 0.0 109.448 174.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -63.09 151.1 86.5 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.202 1.935 . . . . 0.0 113.157 176.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -74.59 173.1 10.9 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.537 0.735 . . . . 0.0 110.428 175.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 78.8 p 49.23 27.78 1.97 Allowed 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 126.79 2.036 . . . . 0.0 112.789 -175.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 8.2 tttt -133.58 178.41 6.95 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 126.611 1.964 . . . . 0.0 111.633 -175.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -137.69 161.14 37.29 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 121.35 -0.843 . . . . 0.0 109.4 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -137.88 168.56 19.45 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.255 1.022 . . . . 0.0 111.681 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -109.17 149.68 29.0 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 124.165 0.986 . . . . 0.0 110.748 175.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -126.83 149.46 49.7 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 127.371 2.268 . . . . 0.0 109.686 177.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.5 p -131.75 151.67 51.49 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 127.023 2.129 . . . . 0.0 111.879 -175.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -170.51 135.52 3.56 Favored Glycine 0 CA--C 1.521 0.433 0 O-C-N 121.396 -0.815 . . . . 0.0 113.142 174.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 27.7 mtm180 -104.06 121.35 43.01 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.57 1.148 . . . . 0.0 110.368 -177.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.715 0 C-N-CA 126.221 1.808 . . . . 0.0 115.236 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.2 p . . . . . 0 N--CA 1.476 0.871 0 N-CA-C 110.76 -0.089 . . . . 0.0 110.76 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -104.96 -105.79 3.06 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 125.335 1.445 . . . . 0.0 112.042 -177.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -139.63 93.2 2.64 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.423 -1.045 . . . . 0.0 110.056 177.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.3 t -133.12 116.6 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 123.904 0.882 . . . . 0.0 110.266 -176.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.55 161.26 23.86 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.916 0.865 . . . . 0.0 111.382 178.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -142.82 151.17 40.86 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.678 1.191 . . . . 0.0 110.166 175.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -149.92 170.03 19.76 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 124.236 1.014 . . . . 0.0 110.061 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -142.52 157.4 44.77 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.389 -0.819 . . . . 0.0 111.891 175.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -132.12 141.44 49.15 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 126.131 1.773 . . . . 0.0 112.446 -174.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -98.32 119.12 36.45 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 120.673 0.273 . . . . 0.0 110.678 -175.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 15.4 mtm -95.88 133.69 39.75 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 123.906 0.882 . . . . 0.0 110.713 -176.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.4 t -58.84 -23.84 61.25 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.781 1.232 . . . . 0.0 112.624 178.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -64.53 -18.88 65.24 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.438 1.495 . . . . 0.0 113.515 175.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 108.53 14.0 17.27 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 124.959 1.266 . . . . 0.0 115.312 -179.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -122.51 172.25 8.51 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-N 119.171 1.486 . . . . 0.0 111.394 -179.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 95.6 m -124.91 102.16 7.41 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.598 1.159 . . . . 0.0 111.734 -177.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 21.4 tp -66.73 97.09 0.44 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.016 1.327 . . . . 0.0 111.682 176.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -90.61 124.65 7.6 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 125.534 1.54 . . . . 0.0 112.22 176.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 47.7 t -124.88 142.7 40.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 124.894 1.277 . . . . 0.0 110.777 -175.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' MET . . . . . 0.404 ' CE ' ' HA ' ' A' ' 116' ' ' TRP . 0.0 OUTLIER -149.33 160.09 43.71 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.427 -0.795 . . . . 0.0 112.026 175.04 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -143.23 143.07 31.6 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.13 0.972 . . . . 0.0 110.436 176.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 9.9 t -134.25 119.96 19.39 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.833 1.253 . . . . 0.0 110.662 179.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 62.4 t . . . . . 0 N--CA 1.469 0.513 0 C-N-CA 126.061 1.744 . . . . 0.0 109.206 -176.011 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 31.9 m . . . . . 0 N--CA 1.474 0.761 0 CA-C-O 121.02 0.438 . . . . 0.0 111.872 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -84.18 104.03 13.89 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.549 1.14 . . . . 0.0 110.064 175.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 53.6 m0 -114.3 152.26 31.66 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 119.825 1.193 . . . . 0.0 112.673 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' TRP . . . . . 0.404 ' HA ' ' CE ' ' A' ' 102' ' ' MET . 53.9 p-90 -144.1 133.6 23.41 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -134.4 161.65 34.42 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.37 1.868 . . . . 0.0 111.829 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 78.5 t -154.62 150.19 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 126.961 2.104 . . . . 0.0 108.077 175.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.75 166.21 29.1 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.591 1.956 . . . . 0.0 109.97 175.203 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.445 ' HB ' ' CE2' ' A' ' 154' ' ' TYR . 3.1 mt -118.18 112.05 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-O 121.787 0.803 . . . . 0.0 109.454 176.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -68.76 145.05 96.64 Favored Pre-proline 0 CA--C 1.548 0.883 0 O-C-N 121.478 -0.764 . . . . 0.0 111.629 179.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -75.79 91.33 1.09 Allowed 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 123.834 3.023 . . . . 0.0 112.005 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 97.28 179.0 34.21 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 125.827 1.68 . . . . 0.0 112.952 -178.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 6.6 tttt -51.6 121.66 6.82 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.837 1.255 . . . . 0.0 111.567 -176.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.98 -173.45 3.38 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.606 1.563 . . . . 0.0 112.101 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.8 ptt180 -134.14 -179.22 5.43 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 126.9 2.08 . . . . 0.0 110.948 175.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -126.63 115.92 20.22 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 127.539 2.336 . . . . 0.0 104.984 175.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -135.55 169.6 17.27 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.835 1.254 . . . . 0.0 110.303 175.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -56.61 -36.15 69.09 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.049 0.94 . . . . 0.0 112.962 -178.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -60.9 -58.78 12.01 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-N 118.742 0.701 . . . . 0.0 111.998 175.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 1.4 null -62.73 -36.94 84.64 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 118.07 0.935 . . . . 0.0 112.801 178.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.41 -64.39 0.97 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.48 1.112 . . . . 0.0 109.151 174.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -65.27 -28.65 69.49 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -175.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -63.69 -36.88 85.3 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.778 1.231 . . . . 0.0 112.569 175.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 8.8 tpp -94.07 -23.63 17.91 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 177.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -49.89 -56.9 8.74 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.779 1.631 . . . . 0.0 111.145 175.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -70.4 -13.37 62.11 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -85.04 -30.61 25.31 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 127.153 2.311 . . . . 0.0 112.987 -175.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -123.57 81.96 53.98 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 123.833 0.853 . . . . 0.0 112.46 175.01 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -75.04 73.06 4.46 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 123.928 3.086 . . . . 0.0 112.775 -179.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -103.84 114.98 29.64 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.698 0.799 . . . . 0.0 111.552 176.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 46.8 mtm180 -86.26 -82.18 0.2 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.049 1.339 . . . . 0.0 111.138 175.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -115.88 -76.72 0.65 Allowed Glycine 0 C--N 1.328 0.102 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 178.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 56.69 43.26 25.68 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-O 122.044 0.926 . . . . 0.0 109.796 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -49.69 91.81 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 127.67 2.388 . . . . 0.0 113.805 -175.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 161.5 50.51 0.02 OUTLIER Glycine 0 CA--C 1.535 1.314 0 C-N-CA 124.993 1.283 . . . . 0.0 114.178 -175.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' TRP . . . . . 0.477 ' H ' HD11 ' A' ' 161' ' ' ILE . 4.7 m95 48.79 51.05 16.51 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.219 1.808 . . . . 0.0 113.953 -178.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -81.67 124.53 29.66 Favored 'General case' 0 N--CA 1.467 0.425 0 O-C-N 121.31 -0.869 . . . . 0.0 111.971 -177.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -167.27 -169.22 1.2 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.433 0.693 . . . . 0.0 112.754 178.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.77 164.49 25.03 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 126.64 1.976 . . . . 0.0 111.53 -178.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -81.8 157.7 24.37 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.872 0.869 . . . . 0.0 109.838 175.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.408 ' HB3' ' CE2' ' A' ' 154' ' ' TYR . 3.0 mm? -104.71 118.06 35.62 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.125 0.57 . . . . 0.0 110.536 175.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -48.99 -29.57 8.54 Favored Glycine 0 CA--C 1.537 1.45 0 C-N-CA 125.8 1.667 . . . . 0.0 115.977 -177.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.445 ' CE2' ' HB ' ' A' ' 120' ' ' ILE . 0.1 OUTLIER -62.5 -25.39 67.99 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.4 1.88 . . . . 0.0 113.112 176.977 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 125.18 7.75 5.78 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 126.626 2.06 . . . . 0.0 114.961 -179.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 5.3 mp -101.5 176.78 5.12 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.216 1.406 . . . . 0.0 112.235 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 38.5 mtt180 -139.16 113.52 8.92 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.963 1.305 . . . . 0.0 110.703 -178.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 4.3 ttt -98.15 147.36 24.66 Favored 'General case' 0 C--N 1.319 -0.755 0 O-C-N 120.305 -1.497 . . . . 0.0 107.88 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.09 144.56 51.41 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 125.949 1.699 . . . . 0.0 110.163 177.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -152.02 156.97 26.99 Favored Glycine 0 CA--C 1.519 0.297 0 CA-C-O 121.893 0.719 . . . . 0.0 112.043 177.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.477 HD11 ' H ' ' A' ' 147' ' ' TRP . 4.7 tp -153.21 123.62 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 122.686 1.231 . . . . 0.0 110.175 -175.122 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.58 171.97 14.29 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 125.475 1.51 . . . . 0.0 110.21 175.165 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 15.1 t -162.2 166.82 25.03 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.251 1.42 . . . . 0.0 108.977 176.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 60.2 p -116.66 30.9 7.06 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.741 1.616 . . . . 0.0 111.604 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -65.38 23.2 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 128.541 2.736 . . . . 0.0 115.113 177.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 81.01 -55.49 4.79 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 127.14 2.305 . . . . 0.0 113.433 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -116.05 24.02 11.76 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.67 1.588 . . . . 0.0 112.818 -175.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -61.83 168.31 3.17 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 127.021 2.128 . . . . 0.0 114.599 175.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.5 171.35 10.58 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 127.661 2.385 . . . . 0.0 111.651 177.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 3.0 tmm? -118.76 135.58 54.43 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.223 1.409 . . . . 0.0 111.151 175.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 6.2 tm0? -145.06 131.56 19.77 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.124 0.97 . . . . 0.0 110.156 178.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 1.8 mp -131.74 127.97 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 125.382 1.473 . . . . 0.0 109.613 175.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -130.87 131.11 44.35 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.933 1.693 . . . . 0.0 110.335 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.452 HG23 ' HG ' ' A' ' 40' ' ' SER . 1.7 mp -89.17 96.56 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 O-C-N 121.527 -0.733 . . . . 0.0 111.426 177.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 2.5 t -66.06 173.02 3.28 Favored 'General case' 0 CA--C 1.565 1.521 0 C-N-CA 123.631 0.772 . . . . 0.0 111.477 177.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 18.1 mtp180 . . . . . 0 C--O 1.252 1.208 0 C-N-CA 125.73 1.612 . . . . 0.0 112.618 175.711 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.5 mt . . . . . 0 N--CA 1.485 1.283 0 N-CA-C 112.168 0.432 . . . . 0.0 112.168 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -114.98 114.36 25.33 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.884 1.674 . . . . 0.0 111.024 -175.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -72.73 -155.52 2.89 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 125.29 1.424 . . . . 0.0 113.137 178.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 25.7 p -61.9 161.4 10.55 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.61 0.764 . . . . 0.0 111.791 174.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -122.81 18.07 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 CA-C-O 122.993 1.378 . . . . 0.0 111.47 174.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.8 pp -58.62 172.63 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 C-N-CA 125.463 1.505 . . . . 0.0 112.642 174.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -42.27 130.93 3.7 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 127.177 2.191 . . . . 0.0 114.155 -174.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.76 -19.47 43.31 Favored Glycine 0 CA--C 1.538 1.491 0 C-N-CA 124.187 0.899 . . . . 0.0 114.213 -175.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.97 -31.97 72.37 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.504 1.122 . . . . 0.0 112.539 174.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.6 t -101.39 -37.78 8.31 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.644 1.578 . . . . 0.0 111.69 175.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 13.0 tp -78.45 87.99 4.44 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.214 1.005 . . . . 0.0 110.802 175.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.2 p -121.46 178.96 4.6 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 127.188 2.195 . . . . 0.0 111.913 176.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -40.96 -42.01 1.77 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.834 1.654 . . . . 0.0 113.927 175.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -53.73 -46.46 70.85 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 119.159 0.89 . . . . 0.0 111.744 178.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 93.9 t -64.42 -39.57 86.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 125.383 1.473 . . . . 0.0 111.138 174.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 24.2 mt -66.11 -41.86 90.01 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 121.189 -0.944 . . . . 0.0 111.303 178.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -64.74 -46.26 82.96 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.979 1.311 . . . . 0.0 111.57 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.5 -37.25 84.66 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 118.798 -0.62 . . . . 0.0 111.441 174.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.8 t -54.74 -45.75 73.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 124.504 1.122 . . . . 0.0 111.196 -179.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.443 ' HB3' ' HE2' ' A' ' 31' ' ' LYS . 1.4 mt -59.19 -22.48 61.07 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 119.125 0.875 . . . . 0.0 113.356 178.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -89.37 -59.34 1.56 Allowed Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.574 1.559 . . . . 0.0 112.552 178.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -66.13 -30.37 70.84 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.3 mt -111.83 109.61 19.52 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.737 1.615 . . . . 0.0 110.001 -174.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -148.72 139.9 7.89 Favored Glycine 0 CA--C 1.54 1.643 0 C-N-CA 124.563 1.078 . . . . 0.0 114.781 -174.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.3 mtpt -109.22 -67.12 1.0 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 126.243 1.817 . . . . 0.0 112.136 178.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 15.3 m -118.2 -172.12 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 126.127 1.771 . . . . 0.0 110.891 -177.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.2 m -46.9 -38.38 10.38 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 125.359 1.464 . . . . 0.0 114.251 179.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 -127.63 162.0 27.54 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.742 1.617 . . . . 0.0 109.844 174.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.443 ' HE2' ' HB3' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -155.16 155.87 34.71 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 125.937 1.695 . . . . 0.0 108.98 -176.121 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -120.65 129.41 75.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 124.633 1.173 . . . . 0.0 107.838 174.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -133.26 121.89 23.12 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.237 1.415 . . . . 0.0 109.564 175.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -128.49 144.48 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.111 0.964 . . . . 0.0 110.685 -176.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -124.79 110.22 1.35 Allowed Glycine 0 CA--C 1.519 0.323 0 C-N-CA 123.716 0.674 . . . . 0.0 112.44 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.464 ' H ' HD13 ' A' ' 70' ' ' LEU . 3.5 mp -100.3 129.43 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 117.767 0.784 . . . . 0.0 110.687 175.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.73 106.3 18.27 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.639 1.576 . . . . 0.0 110.38 175.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.79 96.25 3.04 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.304 1.442 . . . . 0.0 109.585 176.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -129.73 6.63 5.15 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.836 1.254 . . . . 0.0 113.484 176.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.5 t -58.44 -18.4 28.24 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.62 1.568 . . . . 0.0 113.921 175.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 94.94 5.96 60.71 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 125.747 1.641 . . . . 0.0 114.573 176.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -128.8 147.41 17.59 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 125.813 1.673 . . . . 0.0 111.509 175.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 32.4 p -74.24 129.39 37.73 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 174.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 38.9 m0 -93.38 132.03 37.99 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 122.084 -0.385 . . . . 0.0 110.892 178.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 97.6 m -114.64 128.61 56.41 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.439 1.096 . . . . 0.0 110.073 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.65 106.99 0.74 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.266 1.026 . . . . 0.0 111.877 175.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.2 pp -98.91 -40.12 8.24 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.121 0.568 . . . . 0.0 112.516 179.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -170.58 163.35 8.24 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.875 2.07 . . . . 0.0 111.639 176.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -156.54 154.38 30.2 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.195 0.998 . . . . 0.0 111.355 174.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -132.46 107.24 8.36 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.422 1.489 . . . . 0.0 111.744 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -98.82 110.85 23.39 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.844 0.858 . . . . 0.0 110.476 175.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.3 tpp180 -74.19 -73.33 0.23 Allowed 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.935 1.294 . . . . 0.0 109.291 175.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 9.3 t -106.37 -178.34 3.62 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 126.607 1.963 . . . . 0.0 109.081 176.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 48.65 35.4 16.45 Favored Glycine 0 CA--C 1.54 1.648 0 CA-C-O 119.581 -0.566 . . . . 0.0 112.314 -174.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.7 p -48.7 141.45 7.22 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.596 1.958 . . . . 0.0 112.199 -174.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.2 t -136.95 173.41 11.73 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 121.346 -0.846 . . . . 0.0 113.135 -175.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -80.47 -58.1 3.28 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.648 1.179 . . . . 0.0 111.337 176.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.2 p -142.75 133.07 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.418 1.487 . . . . 0.0 111.615 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.1 pp -138.13 -24.33 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 126.372 1.869 . . . . 0.0 113.863 178.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.4 mp -97.65 98.96 5.76 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 124.797 1.239 . . . . 0.0 110.233 179.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -67.33 159.94 49.97 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 124.714 3.61 . . . . 0.0 111.031 174.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -57.93 -48.25 80.49 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -178.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 87.7 t -149.16 143.7 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 127.196 2.198 . . . . 0.0 108.809 -176.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.2 t -125.78 102.12 29.07 Favored Pre-proline 0 C--N 1.33 -0.259 0 C-N-CA 125.69 1.596 . . . . 0.0 107.451 175.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -72.12 161.39 44.8 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 121.234 1.289 . . . . 0.0 112.492 175.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -69.37 172.27 7.38 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.05 0.54 . . . . 0.0 110.259 174.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 58.8 p 57.03 20.64 5.59 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 125.494 1.518 . . . . 0.0 111.954 -174.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.79 173.35 11.46 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 125.359 1.464 . . . . 0.0 111.06 -174.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -142.8 156.52 44.98 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 175.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.464 HD13 ' H ' ' A' ' 36' ' ' ILE . 1.0 OUTLIER -121.04 175.67 5.96 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 123.882 0.873 . . . . 0.0 111.073 -179.529 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -132.62 149.53 52.29 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.699 1.2 . . . . 0.0 110.965 175.052 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -123.3 147.06 47.37 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.713 1.205 . . . . 0.0 109.286 174.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.2 p -121.3 147.84 45.12 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 127.047 2.139 . . . . 0.0 110.138 174.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -165.2 130.72 2.22 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 124.351 0.977 . . . . 0.0 112.695 174.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 7.5 ptt180 -123.09 149.31 44.62 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.943 1.697 . . . . 0.0 110.687 -175.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 11.8 mtpt . . . . . 0 N--CA 1.475 0.784 0 O-C-N 121.212 -0.93 . . . . 0.0 111.862 -176.841 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 53.0 m . . . . . 0 N--CA 1.474 0.737 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -43.67 -77.05 0.1 OUTLIER Glycine 0 N--CA 1.476 1.339 0 C-N-CA 126.962 2.22 . . . . 0.0 115.416 -175.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -169.1 123.59 0.84 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.534 1.934 . . . . 0.0 109.865 178.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.5 t -151.41 114.3 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.845 0.858 . . . . 0.0 110.716 -175.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -159.23 157.75 31.29 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -141.93 132.66 25.6 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.478 1.111 . . . . 0.0 112.173 178.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -136.01 171.62 14.21 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.189 -0.944 . . . . 0.0 111.688 -178.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -137.67 155.92 48.59 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.26 -0.9 . . . . 0.0 112.906 174.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -133.17 118.33 18.53 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 126.025 1.73 . . . . 0.0 114.409 -175.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -77.13 122.78 25.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.666 -0.243 . . . . 0.0 110.972 -178.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 13.3 mtm -101.67 134.47 44.76 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.514 1.526 . . . . 0.0 111.304 177.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 98.5 p -61.68 -17.26 54.83 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 178.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -69.05 -0.32 5.61 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 125.965 1.706 . . . . 0.0 113.037 174.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 91.1 24.9 25.82 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.456 1.503 . . . . 0.0 113.276 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -132.58 174.82 9.88 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.906 1.283 . . . . 0.0 111.702 -175.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 71.1 m -136.57 113.92 10.82 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.355 1.062 . . . . 0.0 111.504 174.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 65.1 tp -76.03 104.48 6.58 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.512 1.125 . . . . 0.0 110.506 175.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -93.63 117.94 5.58 Favored Glycine 0 CA--C 1.529 0.947 0 O-C-N 121.239 -0.913 . . . . 0.0 112.973 175.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 93.3 t -104.83 147.5 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 125.525 1.53 . . . . 0.0 111.067 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 1.5 tpt -151.55 126.1 9.5 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.546 1.138 . . . . 0.0 111.03 -178.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -133.81 139.95 46.61 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.456 1.503 . . . . 0.0 114.159 177.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -136.3 138.96 42.26 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.245 1.818 . . . . 0.0 111.294 -177.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 96.3 t . . . . . 0 N--CA 1.469 0.494 0 C-N-CA 125.098 1.359 . . . . 0.0 110.776 -178.785 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 51.6 m . . . . . 0 N--CA 1.472 0.638 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -88.2 113.82 24.2 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 124.44 1.096 . . . . 0.0 110.974 174.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 31.5 m0 -118.52 135.58 54.32 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.112 0.965 . . . . 0.0 109.673 -176.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 30.5 p-90 -142.19 134.47 27.74 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.49 1.116 . . . . 0.0 111.873 -175.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -160.3 164.46 32.56 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 122.526 1.155 . . . . 0.0 112.989 -176.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.2 t -138.64 124.7 24.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 125.142 1.377 . . . . 0.0 107.747 -179.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.66 166.0 13.29 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.208 1.403 . . . . 0.0 110.198 175.053 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 41.7 mt -122.97 147.76 27.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 174.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -110.2 143.37 27.89 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 124.87 1.268 . . . . 0.0 110.071 177.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -77.21 12.5 1.78 Allowed 'Trans proline' 0 CA--C 1.548 1.219 0 C-N-CA 124.594 3.529 . . . . 0.0 114.407 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -161.12 -179.86 36.12 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 126.475 1.988 . . . . 0.0 111.44 176.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.93 101.83 0.71 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.825 1.25 . . . . 0.0 110.807 177.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 3.8 mmt-85 -124.79 141.8 51.86 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.71 1.204 . . . . 0.0 112.466 -178.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.41 171.99 12.13 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 177.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -128.35 91.63 3.29 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.5 1.92 . . . . 0.0 108.503 176.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -107.37 173.99 6.08 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.793 1.637 . . . . 0.0 109.922 174.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -49.76 -37.0 27.92 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.805 0.842 . . . . 0.0 113.265 176.477 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -59.14 -65.72 3.27 Favored Glycine 0 CA--C 1.531 1.035 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 174.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -58.08 -36.74 73.27 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 118.176 0.988 . . . . 0.0 113.522 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -56.28 -64.21 0.94 Allowed 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 125.267 1.427 . . . . 0.0 109.718 174.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -67.78 -32.8 73.64 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -176.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -57.87 -47.65 82.12 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.01 0.924 . . . . 0.0 112.265 177.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 5.2 tpp -84.51 -21.86 30.41 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 113.669 0.989 . . . . 0.0 113.669 176.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -49.33 -57.97 5.92 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.741 1.216 . . . . 0.0 109.773 174.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -74.64 5.05 5.24 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -178.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -93.9 -11.9 57.23 Favored Glycine 0 CA--C 1.539 1.59 0 C-N-CA 126.015 1.769 . . . . 0.0 114.765 178.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -145.26 94.71 5.2 Favored Pre-proline 0 CA--C 1.552 1.053 0 CA-C-N 119.523 1.662 . . . . 0.0 112.397 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -74.02 81.84 1.88 Allowed 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 123.587 2.858 . . . . 0.0 112.584 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -116.88 110.2 18.03 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.446 1.499 . . . . 0.0 110.846 -178.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 37.2 mtm105 -96.27 50.94 1.18 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 126.907 2.083 . . . . 0.0 111.336 -178.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 85.95 -53.06 4.63 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 124.117 0.865 . . . . 0.0 111.185 -174.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 51.38 52.71 14.22 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.235 1.814 . . . . 0.0 111.399 178.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 14.7 p-10 -48.17 92.82 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 128.48 2.712 . . . . 0.0 115.115 -174.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 160.46 40.12 0.02 OUTLIER Glycine 0 CA--C 1.537 1.427 0 C-N-CA 125.232 1.396 . . . . 0.0 114.506 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 7.5 m95 53.42 48.81 21.03 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.81 1.644 . . . . 0.0 113.363 -176.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -82.66 126.3 32.19 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.987 0.915 . . . . 0.0 112.094 -179.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . 0.503 ' HG3' ' H ' ' A' ' 150' ' ' LYS . 10.5 tp60 -161.65 -168.98 2.11 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.345 0.658 . . . . 0.0 112.312 175.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.503 ' H ' ' HG3' ' A' ' 149' ' ' GLN . 0.6 OUTLIER -131.59 160.67 34.64 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.245 1.818 . . . . 0.0 110.781 -179.205 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 18.7 m-80 -75.55 148.98 38.47 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.391 1.076 . . . . 0.0 109.95 174.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 94.3 mt -100.93 136.9 40.04 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.955 0.902 . . . . 0.0 110.621 178.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -53.0 -35.59 49.1 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 125.717 1.627 . . . . 0.0 116.476 -174.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -73.46 14.21 0.37 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 128.081 2.552 . . . . 0.0 113.942 -178.326 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 76.36 20.5 76.96 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 124.908 1.242 . . . . 0.0 113.58 -174.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.1 mt -101.01 169.01 9.24 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 127.144 2.178 . . . . 0.0 110.519 178.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 50.4 mtt180 -138.76 114.03 9.54 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 120.841 -1.162 . . . . 0.0 110.451 177.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -92.16 150.79 20.72 Favored 'General case' 0 C--N 1.32 -0.711 0 O-C-N 120.138 -1.601 . . . . 0.0 108.433 174.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 2.3 tptt -133.45 142.5 48.33 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.578 1.551 . . . . 0.0 111.097 175.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -147.59 143.43 11.22 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-N 118.885 0.766 . . . . 0.0 113.671 175.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -130.55 126.16 60.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 126.36 1.864 . . . . 0.0 110.604 177.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -149.93 148.49 29.16 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 125.412 1.485 . . . . 0.0 109.297 175.02 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 13.5 t -139.81 112.84 8.15 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.0 0.52 . . . . 0.0 110.543 178.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 67.7 m -72.51 35.02 0.07 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.566 1.146 . . . . 0.0 113.232 178.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -65.99 -44.23 85.45 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.653 1.981 . . . . 0.0 113.019 -179.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 165.13 -68.72 0.2 Allowed Glycine 0 CA--C 1.531 1.059 0 C-N-CA 124.546 1.069 . . . . 0.0 113.838 178.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -111.88 17.01 20.14 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 125.054 1.341 . . . . 0.0 114.392 -174.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -60.98 175.36 0.52 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.349 1.859 . . . . 0.0 114.289 174.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.14 174.83 7.8 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 126.986 2.114 . . . . 0.0 112.042 -178.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 5.5 ttt -115.21 132.9 56.46 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.172 1.389 . . . . 0.0 110.685 175.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -144.79 120.88 10.76 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 123.351 0.66 . . . . 0.0 110.293 177.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 2.7 mp -119.67 126.03 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 C-N-CA 125.125 1.37 . . . . 0.0 107.471 177.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -127.43 126.52 42.53 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 120.879 -1.138 . . . . 0.0 108.794 176.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.8 mp -78.1 124.9 37.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 175.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 2.1 m -95.83 168.01 10.91 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.882 1.673 . . . . 0.0 109.984 175.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 49.3 mtp85 . . . . . 0 C--O 1.253 1.254 0 C-N-CA 125.37 1.468 . . . . 0.0 111.856 176.708 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.338 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -119.42 125.25 48.52 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.669 1.988 . . . . 0.0 111.056 178.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -77.37 -147.74 2.87 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 125.036 1.303 . . . . 0.0 112.443 175.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 18.3 p -68.06 169.08 10.74 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.076 1.35 . . . . 0.0 112.867 176.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -128.89 21.0 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 126.131 1.772 . . . . 0.0 111.257 176.299 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.2 pt -57.07 171.92 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 O-C-N 120.276 -1.515 . . . . 0.0 112.798 176.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -44.12 131.63 5.89 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.734 1.614 . . . . 0.0 112.292 -177.102 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -54.79 -20.94 20.86 Favored Glycine 0 CA--C 1.54 1.651 0 C-N-CA 124.367 0.984 . . . . 0.0 114.303 -177.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.73 -36.25 78.39 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.732 1.613 . . . . 0.0 112.031 175.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.44 -40.2 8.39 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.302 1.441 . . . . 0.0 111.528 175.193 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.4 tp -71.78 87.32 0.97 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.663 1.185 . . . . 0.0 111.205 175.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 80.6 p -123.33 -177.9 3.84 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.741 2.016 . . . . 0.0 111.401 -176.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -45.49 -37.9 5.74 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.426 1.49 . . . . 0.0 113.985 176.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -59.66 -40.94 89.4 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.676 0.791 . . . . 0.0 111.958 178.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 85.6 t -70.66 -37.72 70.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 123.754 0.822 . . . . 0.0 111.055 174.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 32.2 mt -65.54 -41.17 93.34 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 120.971 -1.081 . . . . 0.0 111.32 177.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -75.06 -42.92 56.02 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.85 0.86 . . . . 0.0 112.815 -179.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.88 -37.86 88.57 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 118.764 0.711 . . . . 0.0 111.543 175.1 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 20.2 t -56.35 -46.85 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 124.922 1.289 . . . . 0.0 111.738 176.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 78.1 mt -56.27 -25.32 47.68 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 119.213 0.915 . . . . 0.0 112.887 175.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -86.3 -57.81 2.06 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 124.899 1.237 . . . . 0.0 113.202 176.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -66.47 -27.54 67.88 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -177.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 19.3 mt -108.18 88.05 2.64 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.33 1.452 . . . . 0.0 110.838 -175.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -125.34 85.24 0.35 Allowed Glycine 0 CA--C 1.533 1.193 0 C-N-CA 125.129 1.347 . . . . 0.0 115.302 -175.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -75.41 -43.01 52.26 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.096 0.959 . . . . 0.0 113.467 175.052 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.8 m -137.12 -177.12 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 126.351 1.86 . . . . 0.0 112.078 -174.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -46.65 -45.54 19.29 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 126.448 1.899 . . . . 0.0 114.289 179.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 17.4 mtt85 -139.02 149.12 44.29 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.768 1.627 . . . . 0.0 111.548 178.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.12 157.44 45.94 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 127.234 2.214 . . . . 0.0 110.632 -175.015 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -118.2 128.33 75.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 125.14 1.376 . . . . 0.0 107.597 174.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -135.9 104.12 5.61 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.727 2.011 . . . . 0.0 109.335 176.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.1 m -107.46 158.64 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 123.753 0.821 . . . . 0.0 111.123 178.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -135.68 109.45 0.75 Allowed Glycine 0 N--CA 1.462 0.384 0 CA-C-N 118.293 0.497 . . . . 0.0 113.298 175.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.8 mp -101.73 132.35 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-N 117.108 0.454 . . . . 0.0 111.185 176.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -93.11 105.87 17.9 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.555 1.542 . . . . 0.0 110.972 177.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -71.62 100.69 2.34 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.223 1.809 . . . . 0.0 110.481 175.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -140.09 11.64 2.4 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.988 0.915 . . . . 0.0 112.522 175.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 12.7 t -57.89 -31.9 67.19 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.895 1.678 . . . . 0.0 114.027 179.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 124.82 53.93 0.18 Allowed Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.75 1.167 . . . . 0.0 115.148 174.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 152.5 171.4 20.0 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 125.442 1.496 . . . . 0.0 112.263 175.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 75.6 p -63.6 145.72 55.14 Favored 'General case' 0 N--CA 1.471 0.625 0 O-C-N 121.601 -0.941 . . . . 0.0 111.212 176.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.53 ' HA ' ' CE1' ' A' ' 91' ' ' TYR . 38.0 m0 -93.57 98.35 11.1 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 121.619 -0.676 . . . . 0.0 111.334 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.3 m -83.63 108.52 16.78 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.469 1.107 . . . . 0.0 108.776 176.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.9 142.85 52.85 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.842 -0.536 . . . . 0.0 112.405 175.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.2 pp -119.14 -52.37 2.3 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.048 0.939 . . . . 0.0 112.876 176.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -163.7 153.98 15.42 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.557 1.543 . . . . 0.0 110.72 174.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -131.6 152.37 50.86 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.83 0.852 . . . . 0.0 110.365 175.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -128.05 95.81 4.29 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.687 1.595 . . . . 0.0 110.007 -178.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.473 ' CZ ' HG22 ' A' ' 59' ' ' ILE . 1.5 m-85 -94.54 111.04 22.8 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.852 0.861 . . . . 0.0 110.34 176.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.54 -38.03 12.15 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.048 0.939 . . . . 0.0 111.949 -178.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.2 t -126.63 -173.82 2.97 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 128.415 2.686 . . . . 0.0 107.45 175.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 44.42 49.37 8.42 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-O 118.428 -1.207 . . . . 0.0 111.189 -179.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.9 p -44.8 145.21 0.97 Allowed 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 118.35 1.075 . . . . 0.0 112.8 -175.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.6 t -155.33 179.04 9.55 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.249 -0.907 . . . . 0.0 113.047 -175.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -98.71 -62.76 1.2 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.479 1.511 . . . . 0.0 112.208 178.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.0 p -129.4 131.54 67.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 125.232 1.413 . . . . 0.0 110.921 -177.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.473 HG22 ' CZ ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -137.22 -49.17 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 C-N-CA 125.071 1.348 . . . . 0.0 112.593 -175.117 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.3 mt -85.49 104.09 4.52 Favored Pre-proline 0 N--CA 1.449 -0.478 0 C-N-CA 124.313 1.045 . . . . 0.0 109.948 175.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -66.08 128.57 19.89 Favored 'Trans proline' 0 CA--C 1.535 0.547 0 C-N-CA 122.789 2.326 . . . . 0.0 110.366 175.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -35.29 -47.86 0.43 Allowed 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 127.474 2.31 . . . . 0.0 113.79 176.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 5.9 p -154.09 134.57 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 126.576 1.95 . . . . 0.0 109.424 174.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 95.5 t -122.17 133.58 24.41 Favored Pre-proline 0 N--CA 1.482 1.16 0 C-N-CA 124.986 1.314 . . . . 0.0 109.865 175.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -62.41 148.85 92.62 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.871 2.381 . . . . 0.0 113.209 175.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 13.1 p30 -67.83 170.19 8.46 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.206 1.002 . . . . 0.0 113.071 175.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 74.4 p 48.1 28.62 1.55 Allowed 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 127.109 2.164 . . . . 0.0 114.235 -175.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.51 -179.84 4.8 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 127.442 2.297 . . . . 0.0 110.817 -174.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -136.37 152.79 51.02 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 120.77 -1.206 . . . . 0.0 109.86 175.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -117.88 172.51 7.34 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 124.642 1.177 . . . . 0.0 111.279 -178.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -129.05 151.85 49.3 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.133 1.373 . . . . 0.0 111.191 175.14 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.449 ' CE2' ' CD2' ' A' ' 89' ' ' PHE . 5.2 m-85 -127.2 133.54 50.25 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.395 1.078 . . . . 0.0 110.214 174.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.3 p -102.41 154.88 18.65 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 126.491 1.917 . . . . 0.0 111.36 175.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -176.37 126.91 1.17 Allowed Glycine 0 CA--C 1.529 0.917 0 N-CA-C 114.269 0.468 . . . . 0.0 114.269 175.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 9.3 ptt180 -116.26 105.03 12.1 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.513 1.925 . . . . 0.0 112.751 -175.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.586 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 53.8 m . . . . . 0 N--CA 1.48 1.03 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -27.71 -77.61 0.01 OUTLIER Glycine 0 N--CA 1.477 1.381 0 C-N-CA 127.69 2.567 . . . . 0.0 116.177 -178.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -165.73 112.55 0.92 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.363 1.865 . . . . 0.0 110.599 -176.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.8 t -149.97 120.68 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 O-C-N 121.211 -0.931 . . . . 0.0 111.631 -177.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -162.03 173.39 14.47 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 122.67 1.224 . . . . 0.0 113.397 175.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -147.69 157.38 43.52 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.686 1.594 . . . . 0.0 110.755 174.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.449 ' CD2' ' CE2' ' A' ' 72' ' ' TYR . 49.0 p90 -158.05 172.1 19.04 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 124.41 1.084 . . . . 0.0 110.858 175.174 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.76 147.82 31.31 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 175.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.53 ' CE1' ' HA ' ' A' ' 44' ' ' TRP . 0.1 OUTLIER -114.54 126.98 55.55 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 126.309 1.844 . . . . 0.0 109.726 -178.281 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -82.83 108.23 16.02 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 123.518 0.727 . . . . 0.0 111.768 178.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -79.91 137.8 36.98 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.441 1.096 . . . . 0.0 111.603 -174.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.9 t -59.44 -22.63 61.77 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.791 0.837 . . . . 0.0 113.206 177.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 28.3 m-80 -69.23 -1.79 8.89 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 125.69 1.596 . . . . 0.0 113.529 174.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 89.75 16.33 56.7 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 125.066 1.317 . . . . 0.0 113.894 -179.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 23.6 m-20 -116.47 177.32 4.74 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.878 1.671 . . . . 0.0 111.07 -176.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.2 m -131.66 117.51 18.77 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 121.473 -0.767 . . . . 0.0 112.007 175.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 13.5 tp -80.09 97.53 6.88 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 175.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -91.21 135.76 12.98 Favored Glycine 0 CA--C 1.532 1.126 0 O-C-N 121.347 -0.845 . . . . 0.0 112.067 176.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 74.3 t -122.46 133.87 67.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 126.951 2.1 . . . . 0.0 111.61 -174.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -137.78 128.36 26.68 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 126.009 1.724 . . . . 0.0 111.01 -176.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -145.77 121.83 10.75 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.873 1.269 . . . . 0.0 112.312 -175.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 19.3 m -139.07 110.8 7.14 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.878 1.271 . . . . 0.0 112.064 -175.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.7 m . . . . . 0 N--CA 1.479 1.021 0 N-CA-C 112.654 0.612 . . . . 0.0 112.654 -179.091 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 2.1 m . . . . . 0 N--CA 1.475 0.796 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -79.89 107.41 12.65 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.18 0.992 . . . . 0.0 110.272 174.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 31.2 m0 -112.03 141.82 45.23 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 55.6 p-90 -146.82 130.73 17.15 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 123.864 0.865 . . . . 0.0 112.007 -174.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -132.49 144.46 50.46 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 122.81 1.291 . . . . 0.0 112.192 179.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.418 ' HB ' ' CE ' ' A' ' 158' ' ' MET . 79.6 t -151.17 131.5 3.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 175.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.86 165.99 13.68 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 125.161 1.384 . . . . 0.0 110.505 175.169 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 14.3 mt -86.24 148.51 4.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 175.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -110.38 142.63 26.43 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 126.771 2.028 . . . . 0.0 109.519 -178.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -74.77 87.24 1.31 Allowed 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 124.319 3.346 . . . . 0.0 111.547 -177.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.53 -174.97 19.96 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 125.112 1.339 . . . . 0.0 113.201 -174.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 2.3 tttt -69.73 105.81 2.87 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.234 1.414 . . . . 0.0 110.714 177.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 17.4 tpp180 -135.45 101.18 4.73 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.241 1.417 . . . . 0.0 111.451 178.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.8 168.58 1.2 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.711 0.804 . . . . 0.0 112.954 175.014 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -111.06 101.73 10.25 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.784 1.234 . . . . 0.0 107.882 177.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -113.23 171.17 7.71 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.794 1.238 . . . . 0.0 109.848 174.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -50.24 -36.61 31.81 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.006 -1.059 . . . . 0.0 112.775 175.108 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -60.02 -61.6 6.98 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 124.087 0.851 . . . . 0.0 111.634 174.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.48 -34.63 74.32 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 118.43 1.115 . . . . 0.0 112.324 178.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -58.4 -66.2 0.53 Allowed 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.866 0.866 . . . . 0.0 109.277 174.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -67.67 -30.89 70.54 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -175.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -63.88 -54.4 35.44 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.976 1.31 . . . . 0.0 112.142 175.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 51.8 mmm -75.13 -24.14 57.95 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.159 -0.963 . . . . 0.0 113.266 178.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -55.68 -56.58 18.78 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.383 1.473 . . . . 0.0 108.903 174.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -66.91 -23.11 65.95 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -75.3 -19.09 79.81 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 125.868 1.699 . . . . 0.0 115.212 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -132.56 83.64 53.36 Favored Pre-proline 0 CA--C 1.549 0.942 0 CA-C-N 119.024 1.412 . . . . 0.0 111.102 175.03 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -72.97 72.63 3.23 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 124.239 3.293 . . . . 0.0 112.1 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -96.64 112.01 23.93 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 121.372 -0.83 . . . . 0.0 110.551 -175.031 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 10.0 mtm180 -113.41 -3.45 13.75 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 115.467 1.655 . . . . 0.0 115.467 176.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -50.43 152.15 4.55 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 125.159 1.361 . . . . 0.0 114.427 177.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 10.4 p30 -119.35 -155.75 0.63 Allowed 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 -175.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -49.52 114.28 1.01 Allowed 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.79 1.636 . . . . 0.0 113.027 -178.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 152.8 24.79 0.05 OUTLIER Glycine 0 CA--C 1.535 1.342 0 N-CA-C 115.425 0.93 . . . . 0.0 115.425 -175.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 3.4 m95 49.6 47.57 22.56 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.545 1.538 . . . . 0.0 113.393 -175.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -66.9 109.57 2.98 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 126.999 2.12 . . . . 0.0 112.787 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -158.65 -169.01 2.58 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 175.006 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.4 mtmt -134.86 172.32 13.15 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 127.564 2.346 . . . . 0.0 110.277 -179.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -71.1 160.62 32.55 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.042 0.537 . . . . 0.0 109.898 174.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 10.3 mt -118.7 155.48 30.98 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 122.385 1.088 . . . . 0.0 110.659 175.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -62.46 -175.45 2.48 Favored Glycine 0 CA--C 1.537 1.415 0 CA-C-N 114.92 -1.036 . . . . 0.0 111.17 175.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 55.82 12.05 0.8 Allowed 'General case' 0 N--CA 1.482 1.141 0 O-C-N 121.055 -1.262 . . . . 0.0 114.127 178.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 79.41 24.33 61.16 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 125.576 1.56 . . . . 0.0 114.079 -174.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 52.7 mt -103.94 176.66 5.08 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 118.699 1.249 . . . . 0.0 111.534 -175.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -145.85 131.6 18.99 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 120.862 -1.149 . . . . 0.0 110.598 177.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' MET . . . . . 0.418 ' CE ' ' HB ' ' A' ' 118' ' ' VAL . 2.9 ttt -106.32 150.94 25.47 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 119.892 -1.755 . . . . 0.0 107.154 175.06 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 1.9 tppt? -126.54 136.96 53.25 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 126.236 1.814 . . . . 0.0 108.834 175.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -147.95 157.79 27.47 Favored Glycine 0 N--CA 1.463 0.477 0 O-C-N 121.152 -0.968 . . . . 0.0 112.733 -178.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -158.21 128.34 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 122.137 0.97 . . . . 0.0 110.334 -179.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -155.23 117.68 4.23 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.708 1.603 . . . . 0.0 110.088 174.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 8.6 t -103.4 151.57 22.62 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 175.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 8.4 t -105.87 36.73 2.45 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.623 1.169 . . . . 0.0 111.384 -177.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -72.29 23.73 0.05 Allowed 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 127.795 2.438 . . . . 0.0 114.565 -178.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 80.83 -61.65 4.5 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 126.239 1.875 . . . . 0.0 113.015 -177.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -114.58 84.03 1.99 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 126.152 1.781 . . . . 0.0 109.992 177.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -136.7 163.93 29.43 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.318 1.847 . . . . 0.0 111.872 177.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.62 177.72 4.54 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 127.772 2.429 . . . . 0.0 111.523 -177.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 1.5 tmt? -121.97 131.07 53.82 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.864 1.266 . . . . 0.0 111.218 179.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -143.26 124.01 14.18 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.43 0.692 . . . . 0.0 111.739 179.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 1.9 mp -128.78 130.95 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 125.805 1.642 . . . . 0.0 108.57 178.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 1.9 tmmm? -130.67 129.16 42.27 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 126.069 1.748 . . . . 0.0 108.993 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.7 mp -83.89 133.4 29.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 174.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 87.4 p -116.79 161.75 18.77 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.932 1.693 . . . . 0.0 112.45 176.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 19.0 mtp180 . . . . . 0 C--O 1.253 1.269 0 O-C-N 120.315 -1.49 . . . . 0.0 111.825 -175.307 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.451 ' CD2' ' H ' ' A' ' 27' ' ' LYS . 1.9 mt . . . . . 0 N--CA 1.484 1.231 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -99.42 114.02 26.7 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 127.404 2.282 . . . . 0.0 109.14 178.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -63.3 -89.12 0.03 OUTLIER Glycine 0 CA--C 1.535 1.295 0 C-N-CA 124.243 0.925 . . . . 0.0 113.934 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 17.2 p -143.85 174.47 10.8 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.86 1.664 . . . . 0.0 111.452 -175.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -124.95 15.2 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 125.38 1.472 . . . . 0.0 112.011 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.5 pt -50.11 156.73 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 124.481 1.112 . . . . 0.0 110.976 174.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -40.06 140.27 0.59 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.896 1.678 . . . . 0.0 112.695 -176.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -53.42 -24.2 22.35 Favored Glycine 0 CA--C 1.543 1.798 0 C-N-CA 124.028 0.823 . . . . 0.0 113.982 -174.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.24 -32.69 72.49 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.662 1.585 . . . . 0.0 112.618 175.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -93.41 -50.93 5.21 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 125.886 1.674 . . . . 0.0 110.911 175.058 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.2 tp -71.05 91.2 0.88 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.537 1.135 . . . . 0.0 111.086 177.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 62.5 p -126.68 -178.54 4.41 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.376 1.87 . . . . 0.0 111.6 -178.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -53.97 -37.65 64.17 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.512 1.125 . . . . 0.0 113.077 178.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -58.91 -46.76 87.16 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.372 0.669 . . . . 0.0 110.961 175.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 81.6 t -61.63 -43.66 97.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.669 1.188 . . . . 0.0 111.339 175.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 96.7 mt -64.6 -43.45 93.74 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 121.267 -0.895 . . . . 0.0 111.987 178.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -69.36 -42.37 75.32 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.275 0.63 . . . . 0.0 112.243 -179.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.01 -36.35 83.04 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 118.791 0.723 . . . . 0.0 111.716 175.008 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.2 t -56.17 -41.43 69.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 124.013 0.925 . . . . 0.0 110.923 179.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 41.0 mt -55.18 -20.23 9.94 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 175.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -92.71 -59.68 1.25 Allowed Glycine 0 CA--C 1.534 1.245 0 C-N-CA 125.246 1.403 . . . . 0.0 112.722 175.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -68.45 -29.41 68.06 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 -176.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -109.05 118.14 36.01 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 126.605 1.962 . . . . 0.0 109.365 -179.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -160.87 117.5 0.77 Allowed Glycine 0 CA--C 1.542 1.762 0 C-N-CA 125.701 1.619 . . . . 0.0 114.732 -175.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.451 ' H ' ' CD2' ' A' ' 3' ' ' LEU . 9.1 mttm -87.54 -57.92 2.77 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 126.882 2.073 . . . . 0.0 112.988 176.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.3 m -132.36 -172.36 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 127.143 2.177 . . . . 0.0 112.066 -174.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.2 t -50.48 -37.15 37.11 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.778 1.631 . . . . 0.0 114.081 -175.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.5 tpt180 -130.28 144.93 51.66 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.129 1.372 . . . . 0.0 109.581 174.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.82 133.94 22.77 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 125.707 1.603 . . . . 0.0 110.357 -175.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -103.84 131.31 52.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 124.054 0.942 . . . . 0.0 108.882 175.028 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -130.11 105.61 8.06 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.501 1.92 . . . . 0.0 109.901 175.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.2 m -108.19 162.89 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 C-N-CA 123.979 0.912 . . . . 0.0 110.747 176.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -135.02 109.15 0.75 Allowed Glycine 0 C--O 1.228 -0.251 0 C-N-CA 123.275 0.465 . . . . 0.0 112.603 175.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.3 mp -92.35 133.86 32.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 174.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -109.31 99.63 8.86 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.436 1.894 . . . . 0.0 110.342 178.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -73.43 112.13 9.21 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.98 1.712 . . . . 0.0 112.199 175.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -140.06 18.68 2.45 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.785 0.834 . . . . 0.0 112.005 174.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 44.1 t -64.61 -39.06 93.04 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 120.889 -1.132 . . . . 0.0 113.15 -178.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 119.97 63.01 0.26 Allowed Glycine 0 CA--C 1.53 0.99 0 C-N-CA 124.805 1.193 . . . . 0.0 112.715 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 157.15 161.13 10.58 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 125.674 1.606 . . . . 0.0 112.444 176.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 71.5 p -67.82 148.47 51.17 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 121.784 -0.833 . . . . 0.0 111.732 175.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.551 ' HA ' ' CE1' ' A' ' 91' ' ' TYR . 35.3 m0 -103.72 98.25 8.14 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.415 1.086 . . . . 0.0 111.866 -177.508 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 35.9 m -84.24 116.66 23.07 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 125.07 1.348 . . . . 0.0 109.86 177.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.02 141.84 58.62 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 121.686 -0.634 . . . . 0.0 111.647 174.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.0 pp -114.31 -48.41 2.88 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.153 0.981 . . . . 0.0 112.587 177.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -170.19 148.88 3.39 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.964 2.106 . . . . 0.0 109.53 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -125.98 147.59 49.49 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.151 1.38 . . . . 0.0 109.803 174.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -124.52 101.61 7.22 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 125.344 1.458 . . . . 0.0 109.629 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -105.13 133.53 49.75 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.586 -0.696 . . . . 0.0 110.427 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -107.07 -68.45 0.89 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.334 1.453 . . . . 0.0 111.244 -177.17 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.9 t -102.6 -38.92 7.3 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.671 1.588 . . . . 0.0 110.056 -179.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -69.44 7.7 3.49 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 125.482 1.515 . . . . 0.0 114.338 -178.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 53.4 p -33.2 123.25 0.4 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 128.151 2.581 . . . . 0.0 113.532 -175.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.9 t -138.35 177.96 7.49 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.175 0.99 . . . . 0.0 112.754 -174.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -77.37 -60.81 2.21 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.764 1.226 . . . . 0.0 112.538 177.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.8 p -141.57 138.27 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 126.161 1.784 . . . . 0.0 111.348 176.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.1 pp -144.58 -34.2 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 126.114 1.765 . . . . 0.0 113.793 -177.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 mp -95.13 98.19 3.19 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 125.154 1.382 . . . . 0.0 109.681 176.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -66.83 151.87 81.54 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.749 2.299 . . . . 0.0 110.332 175.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -50.04 -50.25 48.23 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.686 0.794 . . . . 0.0 112.893 -177.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 60.0 t -150.14 142.15 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 128.296 2.638 . . . . 0.0 108.691 178.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 98.9 t -120.64 133.97 24.15 Favored Pre-proline 0 N--CA 1.477 0.893 0 C-N-CA 124.742 1.217 . . . . 0.0 109.117 175.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -65.06 154.58 72.73 Favored 'Trans proline' 0 CA--C 1.544 1.014 0 C-N-CA 122.707 2.271 . . . . 0.0 113.565 177.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -70.23 160.24 32.54 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.566 1.146 . . . . 0.0 113.273 175.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 40.9 p 52.7 23.78 2.87 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 126.314 1.846 . . . . 0.0 114.405 -175.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 18.6 mttt -119.48 -172.81 2.39 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 126.087 1.755 . . . . 0.0 111.31 -177.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -143.9 157.94 44.02 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 122.068 -0.395 . . . . 0.0 109.997 179.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -134.81 167.21 21.29 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 124.58 1.152 . . . . 0.0 111.689 177.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -114.0 154.85 26.94 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 125.121 1.369 . . . . 0.0 111.849 -179.118 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -129.19 137.82 51.37 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.356 1.062 . . . . 0.0 110.764 175.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 8.7 p -111.93 144.04 41.9 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 126.86 2.064 . . . . 0.0 110.241 174.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -165.63 133.69 3.05 Favored Glycine 0 CA--C 1.523 0.592 0 CA-C-O 121.388 0.438 . . . . 0.0 113.119 175.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 66.3 mtm180 -90.62 172.14 8.89 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.343 1.457 . . . . 0.0 110.617 -175.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.587 0 O-C-N 121.823 -0.548 . . . . 0.0 109.824 174.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 87.7 m . . . . . 0 N--CA 1.471 0.59 0 N-CA-C 110.598 -0.149 . . . . 0.0 110.598 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -57.34 -76.06 0.22 Allowed Glycine 0 CA--C 1.532 1.141 0 C-N-CA 125.726 1.631 . . . . 0.0 114.644 -174.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -162.24 104.96 1.13 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.377 1.071 . . . . 0.0 111.376 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 41.8 t -127.67 114.58 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 O-C-N 121.086 -1.009 . . . . 0.0 109.891 -177.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.26 169.45 24.72 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 122.693 1.235 . . . . 0.0 112.061 179.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -150.88 161.38 42.8 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.828 1.651 . . . . 0.0 109.563 175.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -159.97 176.47 11.82 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 121.093 -1.004 . . . . 0.0 111.342 175.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.03 156.47 43.5 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.666 0.746 . . . . 0.0 112.556 174.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.551 ' CE1' ' HA ' ' A' ' 44' ' ' TRP . 0.1 OUTLIER -119.94 127.5 52.72 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.697 1.999 . . . . 0.0 109.184 -178.81 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -83.45 105.59 14.51 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.494 0.718 . . . . 0.0 111.911 178.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -75.37 137.59 41.17 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.576 1.151 . . . . 0.0 112.009 -175.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.3 m -59.95 -17.31 36.86 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 113.583 0.956 . . . . 0.0 113.583 175.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -74.32 -2.53 25.56 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 125.142 1.377 . . . . 0.0 112.532 174.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.41 14.89 58.0 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 125.352 1.453 . . . . 0.0 114.168 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -117.25 178.18 4.46 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.504 1.522 . . . . 0.0 110.655 -177.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 16.3 m -130.29 114.01 15.1 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 120.998 -1.064 . . . . 0.0 111.839 178.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 32.5 tp -78.99 98.77 6.57 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.391 0.996 . . . . 0.0 109.383 174.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.6 139.33 15.08 Favored Glycine 0 CA--C 1.532 1.154 0 O-C-N 121.075 -1.016 . . . . 0.0 112.294 175.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 60.9 t -122.55 134.21 66.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 128.174 2.589 . . . . 0.0 112.002 -175.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -131.75 125.39 31.85 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 126.163 1.785 . . . . 0.0 111.779 -175.307 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -146.03 116.04 7.37 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.362 1.065 . . . . 0.0 113.521 -177.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 72.3 m -123.36 122.26 37.87 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.397 1.479 . . . . 0.0 111.719 -177.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 47.4 t . . . . . 0 N--CA 1.469 0.506 0 C-N-CA 126.124 1.77 . . . . 0.0 108.873 -179.861 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 67.8 m . . . . . 0 N--CA 1.471 0.609 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -84.11 106.67 15.93 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.965 1.306 . . . . 0.0 109.081 174.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 53.5 m0 -110.73 155.83 21.92 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.398 0.999 . . . . 0.0 108.912 174.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 58.1 p-90 -154.32 132.93 12.12 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.132 0.973 . . . . 0.0 111.214 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -135.94 154.97 50.95 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 122.84 1.305 . . . . 0.0 112.097 178.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 95.1 t -152.6 135.2 6.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 175.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.03 170.68 11.78 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.943 1.697 . . . . 0.0 110.014 175.026 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 20.5 mt -91.29 154.1 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 CA-C-O 121.507 0.67 . . . . 0.0 109.312 179.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -117.77 144.04 33.66 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 125.296 1.438 . . . . 0.0 109.64 178.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -70.96 108.11 2.24 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 123.891 3.06 . . . . 0.0 111.301 -178.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 83.61 -178.55 52.48 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 124.447 1.022 . . . . 0.0 113.711 -175.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 14.2 tttt -63.61 104.58 0.67 Allowed 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.911 1.285 . . . . 0.0 110.659 175.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 19.6 tpp180 -132.34 101.47 5.37 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.82 1.248 . . . . 0.0 111.29 -175.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.7 163.33 1.9 Allowed 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.852 0.834 . . . . 0.0 111.754 174.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -109.64 105.1 14.24 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 106.565 -1.642 . . . . 0.0 106.565 174.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -112.32 173.9 6.14 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.029 1.332 . . . . 0.0 109.86 175.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -50.57 -40.27 51.72 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 119.276 0.944 . . . . 0.0 113.282 176.119 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -58.28 -62.01 6.77 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 123.659 0.647 . . . . 0.0 111.717 175.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 5.3 mpp? -58.44 -39.33 79.53 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 118.134 0.967 . . . . 0.0 112.742 177.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -55.14 -60.87 2.79 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.397 1.079 . . . . 0.0 109.962 175.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -68.25 -33.29 74.11 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -178.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -61.1 -46.81 89.08 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.079 0.951 . . . . 0.0 111.599 176.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 46.6 mmm -84.88 -22.65 29.26 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -178.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -54.1 -55.54 26.63 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.765 1.626 . . . . 0.0 109.844 175.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -69.53 -16.49 63.44 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 179.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -74.29 -24.84 72.26 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 125.841 1.686 . . . . 0.0 114.333 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -135.74 87.98 24.47 Favored Pre-proline 0 CA--C 1.546 0.796 0 CA-C-N 118.721 1.26 . . . . 0.0 112.607 175.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -74.19 76.68 2.99 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 123.752 2.968 . . . . 0.0 112.773 -178.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -104.29 105.32 15.42 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.991 0.916 . . . . 0.0 111.316 179.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 23.2 mtm105 -91.0 74.43 6.38 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.268 1.427 . . . . 0.0 111.472 174.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 31.37 64.79 0.2 Allowed Glycine 0 CA--C 1.534 1.242 0 C-N-CA 125.613 1.577 . . . . 0.0 112.948 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -71.86 93.92 1.37 Allowed 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 122.284 1.04 . . . . 0.0 110.153 -175.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 -54.76 98.94 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 126.934 2.093 . . . . 0.0 114.373 -175.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 146.7 54.6 0.02 OUTLIER Glycine 0 CA--C 1.535 1.335 0 C-N-CA 125.431 1.491 . . . . 0.0 114.38 177.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 5.0 m95 44.12 50.08 7.49 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.796 1.638 . . . . 0.0 114.129 -176.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -81.39 131.68 35.29 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 121.149 -0.97 . . . . 0.0 112.476 -177.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . 0.574 ' NE2' ' H ' ' A' ' 150' ' ' LYS . 0.0 OUTLIER -167.77 -169.59 1.2 Allowed 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.845 178.92 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.574 ' H ' ' NE2' ' A' ' 149' ' ' GLN . 0.0 OUTLIER -123.83 160.52 27.22 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.701 2.001 . . . . 0.0 111.851 175.33 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -87.87 127.9 35.35 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.631 1.173 . . . . 0.0 108.217 174.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 12.8 mt -73.41 112.23 9.28 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.191 0.996 . . . . 0.0 112.052 -174.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -43.76 -46.16 7.41 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 127.349 2.404 . . . . 0.0 117.769 -175.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.411 ' CD1' ' N ' ' A' ' 154' ' ' TYR . 0.0 OUTLIER -51.77 -33.74 36.54 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 127.378 2.271 . . . . 0.0 113.658 178.162 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 132.17 40.88 0.2 Allowed Glycine 0 CA--C 1.533 1.215 0 C-N-CA 125.459 1.504 . . . . 0.0 113.896 -178.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 4.8 mp -134.56 179.46 6.27 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.605 1.562 . . . . 0.0 110.874 178.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 5.8 mtt180 -136.88 142.11 42.77 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.709 1.204 . . . . 0.0 109.028 174.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 3.5 ttt -134.75 145.57 48.56 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 121.076 -1.015 . . . . 0.0 108.692 175.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 4.9 tptt -124.59 147.93 48.17 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 127.12 2.168 . . . . 0.0 111.172 178.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -150.24 147.81 18.37 Favored Glycine 0 CA--C 1.528 0.848 0 O-C-N 121.458 -0.776 . . . . 0.0 112.872 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 4.8 tp -146.59 124.94 4.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 124.943 1.297 . . . . 0.0 110.42 179.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -151.32 156.01 39.9 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.933 2.093 . . . . 0.0 107.412 174.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.51 132.42 15.12 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.199 1.4 . . . . 0.0 107.923 174.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -105.5 32.75 4.08 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.342 1.057 . . . . 0.0 112.127 -176.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.424 ' C ' ' H ' ' A' ' 167' ' ' GLU . . . -116.3 -71.42 0.74 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.341 1.056 . . . . 0.0 112.583 -175.019 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -77.29 14.07 9.27 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 125.974 1.749 . . . . 0.0 111.384 175.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . 0.424 ' H ' ' C ' ' A' ' 165' ' ' ALA . 3.4 tm-20 56.28 56.14 6.05 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 127.551 2.34 . . . . 0.0 112.063 176.278 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -78.54 -170.71 2.18 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 113.779 -1.555 . . . . 0.0 112.857 178.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.3 165.97 12.58 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 128.665 2.786 . . . . 0.0 111.435 -178.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 17.9 ttp -95.59 136.88 35.42 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.732 1.213 . . . . 0.0 111.527 179.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -144.82 119.27 9.65 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.251 1.02 . . . . 0.0 110.329 176.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 1.9 mp -114.31 120.79 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 124.905 1.282 . . . . 0.0 108.158 175.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.435 ' HE2' ' O ' ' A' ' 174' ' ' ILE . 0.0 OUTLIER -121.54 127.31 50.85 Favored 'General case' 0 CA--C 1.51 -0.574 0 C-N-CA 126.447 1.899 . . . . 0.0 108.88 -179.224 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.435 ' O ' ' HE2' ' A' ' 173' ' ' LYS . 1.3 mp -79.0 117.83 25.31 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 O-C-N 121.141 -0.975 . . . . 0.0 111.957 177.373 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 6.1 t -84.67 172.63 11.39 Favored 'General case' 0 N--CA 1.479 1.005 0 O-C-N 120.864 -1.147 . . . . 0.0 109.88 175.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 1.1 mtt-85 . . . . . 0 C--O 1.251 1.147 0 O-C-N 120.432 -1.417 . . . . 0.0 114.418 174.942 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.2 mt . . . . . 0 N--CA 1.48 1.064 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -116.29 130.07 56.59 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 127.366 2.266 . . . . 0.0 110.361 -176.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -85.65 -96.04 0.76 Allowed Glycine 0 CA--C 1.531 1.087 0 C-N-CA 123.929 0.776 . . . . 0.0 112.865 -178.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 36.1 p -120.93 170.02 9.89 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.965 1.706 . . . . 0.0 111.764 -179.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -129.65 18.68 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 125.928 1.691 . . . . 0.0 111.712 177.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 pt -56.9 171.62 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 O-C-N 120.367 -1.458 . . . . 0.0 112.258 176.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -43.02 126.96 4.06 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.331 1.452 . . . . 0.0 113.335 -174.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -54.5 -23.3 27.12 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 125.229 1.395 . . . . 0.0 114.292 -177.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.14 -29.06 70.08 Favored 'General case' 0 CA--C 1.548 0.894 0 O-C-N 121.678 -0.895 . . . . 0.0 111.99 175.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.0 t -101.99 -40.11 7.02 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.956 1.702 . . . . 0.0 112.064 175.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 12.8 tp -73.44 90.11 1.69 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.265 1.026 . . . . 0.0 110.567 175.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.9 p -125.9 -178.95 4.46 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.918 2.087 . . . . 0.0 111.634 178.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -48.26 -38.82 19.62 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.801 1.641 . . . . 0.0 113.289 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -55.06 -40.53 70.4 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 118.685 0.675 . . . . 0.0 112.497 176.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 96.2 t -70.05 -39.77 77.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.301 1.44 . . . . 0.0 110.804 174.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 28.1 mt -65.49 -43.75 89.2 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.166 -0.959 . . . . 0.0 111.419 179.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -57.22 -51.41 69.44 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.222 1.409 . . . . 0.0 110.716 178.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.76 -36.86 84.76 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 118.03 -0.986 . . . . 0.0 112.846 175.007 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.7 t -55.42 -47.07 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 CA-C-N 119.864 1.211 . . . . 0.0 110.996 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.413 ' HB3' ' HE2' ' A' ' 31' ' ' LYS . 1.9 mt -55.63 -24.66 34.68 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.067 0.947 . . . . 0.0 113.069 177.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -88.2 -61.66 1.47 Allowed Glycine 0 CA--C 1.532 1.097 0 C-N-CA 125.986 1.755 . . . . 0.0 112.633 176.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -62.87 -39.08 93.33 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 118.533 1.167 . . . . 0.0 113.768 -178.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -90.41 1.18 56.87 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.872 1.269 . . . . 0.0 112.124 175.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -52.91 96.9 0.02 OUTLIER Glycine 0 CA--C 1.537 1.455 0 C-N-CA 127.047 2.261 . . . . 0.0 114.366 178.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -87.3 -79.93 0.27 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.596 1.558 . . . . 0.0 111.947 178.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 23.8 m -87.51 173.07 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.564 1.546 . . . . 0.0 111.793 -177.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 58.0 m -63.29 -26.65 68.87 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 175.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.04 96.49 4.06 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.421 1.088 . . . . 0.0 112.236 176.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.413 ' HE2' ' HB3' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -111.32 155.04 23.66 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 128.551 2.74 . . . . 0.0 111.558 -179.71 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -128.21 133.01 67.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 126.328 1.851 . . . . 0.0 108.689 174.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.59 105.69 5.71 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.13 1.772 . . . . 0.0 109.357 175.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.0 m -111.28 151.58 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 123.203 0.601 . . . . 0.0 111.13 179.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -123.97 111.68 1.68 Allowed Glycine 0 CA--C 1.523 0.567 0 C-N-CA 124.088 0.851 . . . . 0.0 112.912 179.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.5 mp -104.59 134.55 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-N 119.018 1.409 . . . . 0.0 110.981 176.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -102.06 102.47 12.97 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 124.714 1.206 . . . . 0.0 110.51 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.9 t30 -73.73 92.47 2.0 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.963 1.305 . . . . 0.0 110.825 175.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -121.29 13.05 11.06 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.723 1.209 . . . . 0.0 112.212 175.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.8 t -61.81 -42.3 98.85 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.932 1.693 . . . . 0.0 113.87 -176.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 130.88 32.48 0.51 Allowed Glycine 0 CA--C 1.533 1.173 0 N-CA-C 115.11 0.804 . . . . 0.0 115.11 178.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -178.09 162.19 29.58 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 118.061 0.931 . . . . 0.0 112.852 175.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 80.6 p -68.23 129.75 40.86 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 121.858 -0.789 . . . . 0.0 110.999 175.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 42.2 m0 -87.04 107.5 18.46 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 123.813 0.845 . . . . 0.0 110.07 179.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 92.9 m -91.44 128.72 37.38 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.206 1.002 . . . . 0.0 109.747 177.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.86 131.42 48.71 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 122.823 0.449 . . . . 0.0 111.513 174.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.9 pp -113.74 -52.03 2.77 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.729 1.211 . . . . 0.0 111.616 179.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -171.73 145.74 2.01 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.343 1.857 . . . . 0.0 110.419 179.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -125.09 164.32 20.47 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.721 1.208 . . . . 0.0 110.837 174.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.461 ' HH ' ' NE2' ' A' ' 129' ' ' GLN . 48.5 t80 -141.9 102.02 4.06 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.157 1.383 . . . . 0.0 111.778 179.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.427 ' CZ ' HG12 ' A' ' 59' ' ' ILE . 3.3 m-85 -110.67 123.91 50.91 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.457 1.103 . . . . 0.0 110.211 -178.283 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.437 ' HD2' HE22 ' A' ' 129' ' ' GLN . 0.0 OUTLIER -114.77 -47.1 2.9 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -175.16 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.6 t -103.5 -48.14 4.06 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.135 1.374 . . . . 0.0 111.038 175.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -75.64 12.59 7.85 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 125.393 1.473 . . . . 0.0 114.564 -175.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 54.8 p -30.38 105.53 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 129.239 3.016 . . . . 0.0 113.961 -175.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.4 t -118.22 175.71 5.57 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.726 1.211 . . . . 0.0 112.171 -175.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -74.52 -55.45 5.93 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.516 1.126 . . . . 0.0 112.585 175.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.4 p -147.59 143.11 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 126.139 1.776 . . . . 0.0 110.893 175.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.448 ' HB ' ' CE2' ' A' ' 72' ' ' TYR . 1.3 pp -143.21 -34.01 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 125.779 1.632 . . . . 0.0 113.947 179.045 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.3 mt -89.66 98.11 1.21 Allowed Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 125.267 1.427 . . . . 0.0 109.135 175.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -66.03 148.62 85.83 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 123.887 3.058 . . . . 0.0 110.669 174.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -46.78 -51.15 17.0 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.834 1.254 . . . . 0.0 113.342 -177.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 63.2 t -149.31 139.88 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 128.026 2.531 . . . . 0.0 108.699 177.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 60.3 t -120.04 125.42 27.34 Favored Pre-proline 0 N--CA 1.473 0.683 0 C-N-CA 124.442 1.097 . . . . 0.0 108.457 175.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -64.45 151.64 84.75 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 121.934 1.756 . . . . 0.0 112.898 175.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -71.52 170.65 12.9 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.549 0.74 . . . . 0.0 109.254 174.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . 0.272 2.7 t 53.67 23.31 3.56 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.612 1.565 . . . . 0.0 113.817 -175.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.3 mttt -134.93 172.93 12.3 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.375 1.87 . . . . 0.0 111.645 -179.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -129.43 164.46 23.61 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 -178.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.2 pp -137.08 171.14 14.94 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 123.983 0.913 . . . . 0.0 111.078 -175.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -123.44 153.69 40.1 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.497 1.119 . . . . 0.0 111.035 177.033 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.507 ' CE2' ' CD2' ' A' ' 89' ' ' PHE . 5.8 m-85 -129.46 134.94 48.07 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 126.176 1.791 . . . . 0.0 109.377 176.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 59.6 p -107.7 153.87 22.3 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.145 1.778 . . . . 0.0 111.019 175.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -176.8 131.93 1.94 Allowed Glycine 0 CA--C 1.518 0.257 0 O-C-N 121.196 -0.94 . . . . 0.0 113.017 175.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 9.2 ptt85 -129.46 155.16 46.17 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 125.767 1.627 . . . . 0.0 110.491 -175.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.9 ptpt . . . . . 0 CA--C 1.543 0.708 0 C-N-CA 125.509 1.524 . . . . 0.0 112.886 174.947 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 17.8 p . . . . . 0 CA--C 1.537 0.462 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -52.62 -81.38 0.06 OUTLIER Glycine 0 CA--C 1.537 1.411 0 C-N-CA 126.337 1.922 . . . . 0.0 114.021 -175.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -160.4 112.86 2.01 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.298 1.439 . . . . 0.0 111.077 175.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.0 t -139.16 125.53 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.471 1.109 . . . . 0.0 110.665 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.425 ' HB1' ' CE1' ' A' ' 51' ' ' PHE . . . -161.57 165.62 28.18 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 122.701 1.239 . . . . 0.0 112.063 177.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -149.22 146.22 27.5 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 124.913 1.285 . . . . 0.0 108.99 174.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.507 ' CD2' ' CE2' ' A' ' 72' ' ' TYR . 48.8 p90 -144.02 172.72 12.49 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 121.236 -0.915 . . . . 0.0 110.03 176.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -138.43 149.04 45.08 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 175.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -125.41 140.15 53.04 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.632 1.173 . . . . 0.0 113.123 178.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -87.44 122.16 30.81 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.873 -175.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 31.8 mtm -101.73 128.14 48.19 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.495 1.118 . . . . 0.0 110.742 -176.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.4 t -56.26 -22.41 29.79 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.936 1.294 . . . . 0.0 113.493 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -67.05 -9.96 44.78 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 125.941 1.696 . . . . 0.0 113.154 175.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 101.52 28.3 6.78 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.754 1.645 . . . . 0.0 114.366 177.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -135.44 175.18 9.82 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.857 1.263 . . . . 0.0 112.558 -174.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 38.3 m -130.31 108.69 10.2 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.353 1.061 . . . . 0.0 112.683 177.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.5 tt -69.89 94.24 0.82 Allowed 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 127.151 2.18 . . . . 0.0 111.999 177.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -87.21 96.18 2.14 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 125.568 1.556 . . . . 0.0 113.595 178.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 55.5 t -78.07 138.59 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 124.718 1.207 . . . . 0.0 110.827 174.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.33 128.22 31.33 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.581 1.552 . . . . 0.0 110.303 179.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -148.08 120.31 8.36 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.008 1.323 . . . . 0.0 111.465 -177.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 39.6 t -140.82 129.96 23.48 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.531 1.133 . . . . 0.0 110.22 -175.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.6 m . . . . . 0 N--CA 1.471 0.604 0 C-N-CA 124.147 0.979 . . . . 0.0 110.848 178.35 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.473 0.697 0 N-CA-C 110.357 -0.238 . . . . 0.0 110.357 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -132.95 82.61 2.01 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.25 1.42 . . . . 0.0 112.286 -177.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 21.1 m0 -92.67 162.26 14.23 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 121.441 -0.787 . . . . 0.0 111.843 -175.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 40.2 p-90 -160.53 132.38 5.96 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 121.561 -0.712 . . . . 0.0 111.24 -176.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -145.87 173.55 12.03 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 121.3 -0.875 . . . . 0.0 111.744 178.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 98.5 t -137.69 133.18 45.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 175.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.59 168.2 12.94 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 125.584 1.554 . . . . 0.0 110.244 175.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 32.3 mt -135.87 121.74 30.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 175.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -83.81 145.42 47.03 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 123.311 0.644 . . . . 0.0 111.289 178.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -76.23 83.74 1.96 Allowed 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 124.133 3.222 . . . . 0.0 111.929 179.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 101.45 175.53 28.61 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 126.494 1.997 . . . . 0.0 112.811 -177.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 1.3 mttt -45.01 106.67 0.08 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 126.47 1.908 . . . . 0.0 112.737 -176.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -141.37 138.21 32.87 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.48 1.112 . . . . 0.0 113.402 -179.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -80.4 173.69 12.35 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.722 0.809 . . . . 0.0 110.729 174.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -117.01 104.86 11.69 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.149 1.779 . . . . 0.0 107.028 175.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -108.0 169.94 8.3 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.385 1.074 . . . . 0.0 111.831 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.461 ' NE2' ' HH ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -53.38 -45.83 69.39 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.535 0.734 . . . . 0.0 112.827 177.567 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -54.58 -56.05 24.1 Favored Glycine 0 N--CA 1.469 0.836 0 CA-C-O 119.38 -0.678 . . . . 0.0 112.239 176.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 4.1 mpp? -63.76 -33.65 76.12 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 118.533 1.167 . . . . 0.0 113.376 176.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -61.39 -61.56 2.45 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 119.642 1.11 . . . . 0.0 108.958 175.013 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -62.45 -43.86 97.81 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.178 0.991 . . . . 0.0 112.526 -176.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -62.81 -45.67 91.57 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.626 1.17 . . . . 0.0 111.711 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.23 -33.33 59.22 Favored 'General case' 0 CA--C 1.547 0.829 0 O-C-N 120.468 -1.395 . . . . 0.0 112.752 176.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -54.2 -60.38 3.41 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 126.587 1.955 . . . . 0.0 109.758 175.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -72.65 4.45 3.97 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-O 121.726 0.774 . . . . 0.0 112.596 -176.394 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -101.57 -7.75 47.75 Favored Glycine 0 CA--C 1.541 1.678 0 C-N-CA 126.964 2.221 . . . . 0.0 114.975 175.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -144.06 88.61 7.45 Favored Pre-proline 0 CA--C 1.553 1.059 0 CA-C-N 119.897 1.849 . . . . 0.0 113.268 -178.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -73.51 81.36 1.82 Allowed 'Trans proline' 0 CA--C 1.545 1.056 0 C-N-CA 124.096 3.197 . . . . 0.0 113.024 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -104.22 9.95 35.89 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.894 1.277 . . . . 0.0 114.337 -178.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 28.4 ptt85 -29.97 119.93 0.17 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 129.03 2.932 . . . . 0.0 115.728 175.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 39.25 68.4 0.5 Allowed Glycine 0 N--CA 1.468 0.804 0 C-N-CA 126.31 1.909 . . . . 0.0 112.151 -175.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.91 -24.4 37.41 Favored 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -174.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . 0.267 0.2 OUTLIER 13.93 72.18 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 130.766 3.626 . . . . 0.0 116.349 177.959 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 154.39 42.79 0.02 OUTLIER Glycine 0 CA--C 1.532 1.118 0 C-N-CA 123.865 0.745 . . . . 0.0 114.576 178.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER 49.79 48.55 21.51 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 125.434 1.494 . . . . 0.0 113.035 -176.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -91.31 134.27 34.73 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 122.325 1.059 . . . . 0.0 113.026 -174.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -156.52 -177.19 6.41 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.067 0.947 . . . . 0.0 112.884 -174.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 21.1 ttpp -131.97 148.13 52.5 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.753 1.221 . . . . 0.0 110.905 174.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -63.75 149.53 46.56 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 175.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 98.7 mt -107.9 145.26 34.01 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 175.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -64.48 -165.67 1.02 Allowed Glycine 0 CA--C 1.538 1.47 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 175.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 54.5 11.2 0.4 Allowed 'General case' 0 CA--C 1.557 1.242 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 175.27 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 81.33 40.9 10.62 Favored Glycine 0 CA--C 1.539 1.562 0 C-N-CA 126.557 2.027 . . . . 0.0 114.424 -175.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.2 mp -124.82 162.19 24.85 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 119.267 1.533 . . . . 0.0 112.813 -178.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -150.63 118.48 6.21 Favored 'General case' 0 N--CA 1.482 1.128 0 O-C-N 120.691 -1.256 . . . . 0.0 111.594 176.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 6.6 ttp -111.3 130.85 55.54 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 118.108 -0.949 . . . . 0.0 109.093 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 6.3 tppt? -106.9 134.14 50.5 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 127.681 2.393 . . . . 0.0 110.089 -179.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -136.41 152.31 21.14 Favored Glycine 0 N--CA 1.476 1.34 0 CA-C-N 121.208 1.822 . . . . 0.0 115.79 179.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 6.1 tp -148.66 122.42 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 125.134 1.374 . . . . 0.0 113.332 -177.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 5.3 ttp -153.61 145.37 23.43 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 128.968 2.907 . . . . 0.0 109.589 177.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 9.6 t -120.22 146.3 46.18 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 120.87 -1.144 . . . . 0.0 109.778 175.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 28.8 p -91.34 18.96 6.45 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.305 1.442 . . . . 0.0 113.29 -178.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.8 -33.73 64.66 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.012 1.725 . . . . 0.0 115.005 -176.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 157.8 -62.76 0.32 Allowed Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.534 1.064 . . . . 0.0 114.17 176.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -125.25 27.02 6.73 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 125.652 1.581 . . . . 0.0 112.656 -174.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.87 175.66 2.37 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.28 1.432 . . . . 0.0 113.388 175.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . 0.436 ' HE3' ' O ' ' A' ' 169' ' ' LYS . 0.2 OUTLIER -115.78 178.81 4.17 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 127.453 2.301 . . . . 0.0 111.914 -177.814 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 40.2 ttp -126.89 137.89 53.22 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 125.381 1.473 . . . . 0.0 109.825 178.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -143.08 131.9 22.72 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 121.562 -0.711 . . . . 0.0 109.657 174.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 3.8 mp -129.79 120.87 51.12 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.296 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 176.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -115.82 129.91 56.63 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 125.232 1.413 . . . . 0.0 111.125 177.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.8 mp -78.94 131.84 33.5 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 O-C-N 121.064 -1.023 . . . . 0.0 109.398 174.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 13.8 m -137.66 94.03 2.86 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.497 1.519 . . . . 0.0 113.116 176.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 79.0 mtp180 . . . . . 0 C--O 1.253 1.272 0 C-N-CA 125.544 1.538 . . . . 0.0 112.433 174.972 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 17.1 tp . . . . . 0 N--CA 1.483 1.182 0 CA-C-O 123.046 1.403 . . . . 0.0 114.45 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -136.53 130.27 32.19 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 128.037 2.535 . . . . 0.0 107.087 176.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -73.08 -126.49 0.1 OUTLIER Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.171 0.891 . . . . 0.0 111.2 174.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 25.4 p -101.95 174.64 5.85 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.389 1.076 . . . . 0.0 111.413 177.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -124.65 16.07 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 125.498 1.519 . . . . 0.0 110.971 175.007 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.9 pp -55.05 165.57 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 125.352 1.461 . . . . 0.0 112.111 174.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -40.99 130.16 2.66 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.727 1.611 . . . . 0.0 113.246 -174.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -54.77 -21.14 21.55 Favored Glycine 0 N--CA 1.472 1.097 0 C-N-CA 124.766 1.174 . . . . 0.0 114.456 -177.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.75 -31.87 68.73 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.65 1.18 . . . . 0.0 111.306 174.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.63 -43.24 5.42 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.392 1.477 . . . . 0.0 111.602 174.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 14.3 tp -71.26 94.22 1.17 Allowed 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.902 0.858 . . . . 0.0 110.849 174.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.0 p -131.42 -179.92 5.65 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 126.982 2.113 . . . . 0.0 111.899 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -46.91 -39.99 13.28 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.55 1.54 . . . . 0.0 113.051 177.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -54.85 -39.51 68.68 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.448 1.099 . . . . 0.0 112.077 177.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 65.2 t -70.45 -36.92 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 125.862 1.665 . . . . 0.0 111.182 174.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.2 mt -71.1 -43.13 68.31 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 120.965 -1.084 . . . . 0.0 111.249 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -58.34 -47.06 84.97 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.459 1.104 . . . . 0.0 111.308 178.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.68 -37.71 82.71 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 118.15 -0.929 . . . . 0.0 111.953 175.069 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.2 t -54.36 -42.47 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 CA-C-N 119.923 1.238 . . . . 0.0 111.26 179.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.6 mt -58.65 -17.33 21.47 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.397 1.079 . . . . 0.0 113.845 177.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -105.38 -45.05 1.38 Allowed Glycine 0 CA--C 1.536 1.395 0 C-N-CA 126.992 2.234 . . . . 0.0 114.05 -179.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -67.82 -31.82 71.93 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 119.134 1.467 . . . . 0.0 112.725 175.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -101.66 173.33 6.46 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 125.181 1.392 . . . . 0.0 111.049 174.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 154.02 86.72 0.06 OUTLIER Glycine 0 CA--C 1.534 1.252 0 C-N-CA 124.332 0.967 . . . . 0.0 113.827 -178.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.5 mtpt -67.9 -46.11 72.52 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.714 1.206 . . . . 0.0 112.966 176.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 33.4 m -133.64 -176.96 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 126.799 2.04 . . . . 0.0 111.596 -178.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.9 m -47.28 -46.44 24.82 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 126.436 1.894 . . . . 0.0 115.123 -178.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.419 ' CB ' ' HE3' ' A' ' 76' ' ' LYS . 0.1 OUTLIER -128.91 146.02 51.06 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.534 1.133 . . . . 0.0 110.541 174.963 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.81 161.18 39.29 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 124.466 1.106 . . . . 0.0 111.62 -175.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -120.08 133.28 67.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 124.78 1.232 . . . . 0.0 108.999 175.007 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -136.0 100.93 4.57 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.131 1.772 . . . . 0.0 109.065 175.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.5 m -103.97 161.44 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 123.859 0.864 . . . . 0.0 111.728 178.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -140.62 101.05 0.28 Allowed Glycine 0 N--CA 1.461 0.361 0 C-N-CA 123.613 0.625 . . . . 0.0 113.156 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 mp -93.98 151.11 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 117.91 0.855 . . . . 0.0 110.761 175.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -116.42 104.43 11.44 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.327 1.051 . . . . 0.0 110.822 174.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -72.62 98.84 2.42 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.743 1.617 . . . . 0.0 111.05 174.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -135.31 22.63 3.45 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.971 1.309 . . . . 0.0 110.444 174.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 33.1 t -61.79 -42.69 99.31 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 120.788 -1.195 . . . . 0.0 112.749 174.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 132.35 33.97 0.38 Allowed Glycine 0 CA--C 1.534 1.244 0 C-N-CA 124.375 0.988 . . . . 0.0 115.181 176.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -174.52 162.28 32.4 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 124.673 1.13 . . . . 0.0 112.094 175.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 50.4 p -70.42 139.32 51.79 Favored 'General case' 0 C--O 1.234 0.261 0 O-C-N 121.782 -0.834 . . . . 0.0 110.893 174.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.417 ' HB3' ' CD1' ' A' ' 91' ' ' TYR . 40.2 m0 -96.05 104.14 16.07 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 124.172 0.989 . . . . 0.0 110.767 -178.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.9 m -87.36 139.29 30.7 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.019 1.328 . . . . 0.0 110.539 178.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.74 131.44 48.9 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.456 0.702 . . . . 0.0 111.249 174.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.6 pp -120.2 -48.36 2.33 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.029 0.931 . . . . 0.0 112.854 177.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 178.36 153.88 0.35 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 127.189 2.196 . . . . 0.0 110.378 -175.167 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -138.67 164.78 28.64 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.497 1.519 . . . . 0.0 111.215 174.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -136.7 102.87 5.03 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 125.309 1.443 . . . . 0.0 110.092 176.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.4 ' CZ ' HG12 ' A' ' 59' ' ' ILE . 3.0 m-85 -111.03 131.43 55.06 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.719 0.808 . . . . 0.0 109.962 -179.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.38 -33.16 4.16 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -177.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 33.9 t -125.43 -46.62 1.75 Allowed 'General case' 0 C--O 1.219 -0.541 0 C-N-CA 124.961 1.304 . . . . 0.0 109.202 174.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -60.35 -0.15 1.14 Allowed Glycine 0 CA--C 1.544 1.868 0 O-C-N 119.586 -1.946 . . . . 0.0 116.449 176.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.1 p -27.15 89.01 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 130.97 3.708 . . . . 0.0 114.564 -175.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -105.28 175.2 5.57 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.928 -174.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -73.17 -56.16 5.49 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.388 1.075 . . . . 0.0 111.127 174.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.4 p -144.44 137.69 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 125.806 1.643 . . . . 0.0 112.021 176.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.421 ' HB ' ' CE2' ' A' ' 72' ' ' TYR . 1.2 pp -135.82 -33.58 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 125.885 1.674 . . . . 0.0 114.298 176.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 16.0 mt -89.09 100.32 2.09 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 125.312 1.445 . . . . 0.0 109.34 176.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -65.43 154.64 72.72 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.38 2.72 . . . . 0.0 109.27 175.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -45.02 -50.98 10.44 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.504 1.522 . . . . 0.0 113.415 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.7 p -160.17 137.77 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 127.053 2.141 . . . . 0.0 109.612 176.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 94.6 t -113.56 130.75 23.44 Favored Pre-proline 0 N--CA 1.482 1.128 0 C-N-CA 124.495 1.118 . . . . 0.0 109.311 175.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -65.37 161.65 37.01 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 122.469 2.112 . . . . 0.0 112.801 177.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -76.69 170.51 16.3 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.83 0.852 . . . . 0.0 109.897 174.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . 0.266 10.7 t 46.95 30.55 1.27 Allowed 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 126.892 2.077 . . . . 0.0 113.376 -174.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.9 mttt -135.78 171.94 13.73 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 127.262 2.225 . . . . 0.0 111.821 -174.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -128.63 166.08 19.57 Favored 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 122.77 0.428 . . . . 0.0 110.245 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -143.78 171.07 14.72 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 124.617 1.167 . . . . 0.0 111.656 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -117.66 156.1 28.76 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.442 1.097 . . . . 0.0 112.503 177.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.476 ' CE2' ' CD2' ' A' ' 89' ' ' PHE . 7.5 m-85 -128.03 134.39 49.21 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.72 1.608 . . . . 0.0 109.103 174.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.1 p -108.08 142.76 37.78 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 126.831 2.053 . . . . 0.0 110.741 176.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -163.79 142.68 8.0 Favored Glycine 0 N--CA 1.461 0.326 0 O-C-N 120.514 -1.366 . . . . 0.0 111.898 174.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 3.8 ptm180 -129.26 104.33 7.46 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.289 1.436 . . . . 0.0 111.353 -174.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.504 ' HE2' ' O ' ' A' ' 83' ' ' THR . 2.6 ptpt . . . . . 0 N--CA 1.474 0.731 0 C-N-CA 127.492 2.317 . . . . 0.0 114.597 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.504 ' O ' ' HE2' ' A' ' 76' ' ' LYS . 3.7 m . . . . . 0 N--CA 1.487 1.386 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -78.65 -154.27 7.58 Favored Glycine 0 N--CA 1.47 0.934 0 O-C-N 119.741 -1.849 . . . . 0.0 113.323 176.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -94.7 97.98 10.46 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.081 -1.247 . . . . 0.0 110.526 -179.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.9 t -124.76 107.15 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 124.299 1.04 . . . . 0.0 110.578 -175.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -159.94 167.57 27.68 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.867 0.842 . . . . 0.0 111.494 178.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -150.86 159.8 44.31 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.758 1.223 . . . . 0.0 109.937 175.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.476 ' CD2' ' CE2' ' A' ' 72' ' ' TYR . 52.9 p90 -155.78 174.55 15.14 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 121.422 -0.799 . . . . 0.0 110.554 175.028 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -138.65 151.34 47.13 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 176.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.417 ' CD1' ' HB3' ' A' ' 44' ' ' TRP . 10.4 m-85 -126.3 140.11 52.78 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.38 1.072 . . . . 0.0 113.789 179.164 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -84.59 118.73 24.53 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 111.592 0.219 . . . . 0.0 111.592 -177.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 4.7 ttm -86.97 147.0 25.93 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.776 0.831 . . . . 0.0 112.31 177.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 24.6 m -67.1 -23.96 65.89 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 174.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -70.5 -17.39 62.96 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 175.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 100.71 40.13 3.0 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.845 1.212 . . . . 0.0 113.412 -175.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -135.5 175.1 9.9 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 118.382 1.091 . . . . 0.0 110.476 177.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 12.4 m -129.49 106.15 8.57 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.026 1.331 . . . . 0.0 111.946 -177.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.2 tt -70.79 96.35 1.24 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.699 1.6 . . . . 0.0 112.154 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -91.87 95.43 2.04 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 126.065 1.793 . . . . 0.0 113.876 -178.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 72.5 t -78.08 138.18 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 125.211 1.405 . . . . 0.0 111.444 176.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.6 126.54 29.43 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.367 1.467 . . . . 0.0 111.383 -178.359 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -146.64 121.79 10.15 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.0 1.32 . . . . 0.0 112.016 -177.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 47.1 t -142.45 109.73 5.63 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.657 1.183 . . . . 0.0 110.039 -178.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 17.5 m . . . . . 0 N--CA 1.469 0.523 0 C-N-CA 124.831 1.252 . . . . 0.0 108.365 175.003 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 45.1 p . . . . . 0 N--CA 1.475 0.781 0 CA-C-O 121.809 0.814 . . . . 0.0 112.24 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -121.87 101.53 7.62 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.132 1.773 . . . . 0.0 109.138 175.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 32.0 m0 -102.52 144.98 30.26 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.398 0.679 . . . . 0.0 109.94 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 27.4 p-90 -146.77 138.53 24.5 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.119 0.968 . . . . 0.0 111.978 -177.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -149.31 170.05 19.4 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 122.285 1.041 . . . . 0.0 113.072 179.115 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.3 t -150.27 139.31 15.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 C-N-CA 125.226 1.41 . . . . 0.0 107.655 175.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.79 175.44 10.18 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 126.27 1.828 . . . . 0.0 109.72 175.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.42 ' HB ' ' CE2' ' A' ' 154' ' ' TYR . 50.9 mt -130.56 105.74 11.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.953 0.882 . . . . 0.0 108.967 178.196 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -67.38 149.54 98.34 Favored Pre-proline 0 CA--C 1.546 0.793 0 O-C-N 121.522 -0.736 . . . . 0.0 111.842 178.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.6 131.73 17.8 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 123.212 2.608 . . . . 0.0 111.727 178.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 61.86 -165.99 18.75 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 124.549 1.071 . . . . 0.0 113.9 -176.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -67.89 110.78 4.0 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.654 1.182 . . . . 0.0 108.985 175.004 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 20.0 tpp180 -123.32 157.84 32.34 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.692 1.597 . . . . 0.0 110.066 178.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -96.99 -173.72 2.77 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.261 1.424 . . . . 0.0 110.397 174.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -138.58 121.45 16.55 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 127.317 2.247 . . . . 0.0 106.504 174.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -132.68 169.69 16.3 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.579 1.552 . . . . 0.0 110.016 175.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -52.71 -39.9 62.48 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.337 1.055 . . . . 0.0 113.086 176.386 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -59.03 -53.64 44.72 Favored Glycine 0 N--CA 1.469 0.853 0 CA-C-N 118.875 0.761 . . . . 0.0 112.094 176.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 1.2 mpp? -61.48 -42.97 99.6 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 118.036 0.918 . . . . 0.0 112.049 176.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -54.0 -58.44 7.29 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.381 0.672 . . . . 0.0 110.171 175.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -65.85 -38.07 87.87 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 -177.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -61.73 -45.3 94.53 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.55 1.14 . . . . 0.0 112.096 178.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 73.8 mmm -79.17 -32.59 44.29 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.351 -0.843 . . . . 0.0 112.879 176.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -54.08 -59.08 5.12 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.772 1.629 . . . . 0.0 109.511 174.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -71.24 -6.06 36.79 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -176.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -88.42 -9.27 69.78 Favored Glycine 0 CA--C 1.539 1.59 0 C-N-CA 126.292 1.901 . . . . 0.0 114.937 177.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -144.14 86.72 8.22 Favored Pre-proline 0 CA--C 1.553 1.058 0 CA-C-N 119.448 1.624 . . . . 0.0 111.89 -179.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -74.0 79.21 2.38 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 123.643 2.895 . . . . 0.0 112.274 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -119.07 126.21 51.14 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.287 1.435 . . . . 0.0 111.044 -176.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.1 ptt180 -99.17 -162.63 0.97 Allowed 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 127.285 2.234 . . . . 0.0 113.74 -175.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -71.95 62.27 1.31 Allowed Glycine 0 CA--C 1.538 1.471 0 C-N-CA 126.421 1.962 . . . . 0.0 113.72 175.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 10.1 p30 -67.49 74.99 0.16 Allowed 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 130.163 3.385 . . . . 0.0 114.796 177.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -70.29 62.83 0.23 Allowed 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 126.948 2.099 . . . . 0.0 114.875 -175.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -169.66 31.44 0.16 Allowed Glycine 0 CA--C 1.536 1.355 0 C-N-CA 124.536 1.065 . . . . 0.0 115.709 -175.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 5.1 m95 53.88 56.53 7.01 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.31 1.444 . . . . 0.0 113.154 -174.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -89.68 131.14 35.81 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.661 1.584 . . . . 0.0 112.613 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -160.12 -175.8 5.28 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -174.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 4.8 mtmt -130.19 160.38 33.99 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.159 1.384 . . . . 0.0 110.711 174.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -80.07 131.78 35.84 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.848 0.859 . . . . 0.0 108.918 175.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 78.2 mt -83.99 127.38 33.83 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.479 0.712 . . . . 0.0 110.599 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -51.74 -27.45 19.91 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 126.063 1.792 . . . . 0.0 116.49 -174.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.42 ' CE2' ' HB ' ' A' ' 120' ' ' ILE . 0.2 OUTLIER -74.95 6.88 3.63 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 128.076 2.55 . . . . 0.0 113.621 -179.459 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 84.58 10.58 79.24 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 125.602 1.572 . . . . 0.0 114.194 -175.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 17.5 mt -96.54 171.48 8.52 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.33 1.852 . . . . 0.0 110.475 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 3.4 mtt-85 -146.05 107.39 4.21 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 120.973 -1.08 . . . . 0.0 110.225 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 9.3 ttp -98.73 131.07 45.17 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 117.795 -1.098 . . . . 0.0 108.327 178.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 1.5 tppp? -109.44 129.41 55.55 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 127.915 2.486 . . . . 0.0 110.149 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -135.17 154.42 21.6 Favored Glycine 0 N--CA 1.474 1.197 0 CA-C-N 121.17 1.804 . . . . 0.0 115.562 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.31 129.42 6.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 C-N-CA 124.282 1.033 . . . . 0.0 112.402 -178.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -146.62 160.69 41.86 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 126.975 2.11 . . . . 0.0 109.554 175.001 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 9.4 t -131.38 168.76 17.03 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.589 1.155 . . . . 0.0 108.99 175.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 4.3 t -111.67 28.92 8.3 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.022 1.329 . . . . 0.0 111.414 178.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -67.65 21.76 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 127.77 2.428 . . . . 0.0 115.028 179.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 80.6 -59.51 4.65 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 126.641 2.067 . . . . 0.0 113.168 -178.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -116.39 65.36 0.71 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.072 1.749 . . . . 0.0 110.313 176.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.19 179.01 7.84 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 121.915 0.864 . . . . 0.0 111.708 174.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.3 176.84 5.64 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.456 1.902 . . . . 0.0 110.108 175.001 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 2.3 tmm? -125.51 125.59 43.5 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.918 1.287 . . . . 0.0 110.395 175.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 17.5 tt0 -138.11 124.59 20.72 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 123.772 0.829 . . . . 0.0 110.529 176.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 5.0 mp -132.66 119.71 39.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 123.974 0.91 . . . . 0.0 110.508 176.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.63 134.39 55.1 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.488 1.515 . . . . 0.0 111.939 177.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.8 mp -82.35 127.01 40.03 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 O-C-N 121.019 -1.05 . . . . 0.0 108.633 175.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 1.7 m -126.3 93.48 3.82 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.524 1.53 . . . . 0.0 111.499 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 80.0 mtm-85 . . . . . 0 C--O 1.253 1.27 0 C-N-CA 124.509 1.124 . . . . 0.0 113.214 176.528 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.483 1.204 0 CA-C-O 121.988 0.899 . . . . 0.0 111.999 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -144.58 121.2 11.12 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.856 2.062 . . . . 0.0 109.833 -175.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -73.91 -92.45 0.13 Allowed Glycine 0 CA--C 1.531 1.052 0 C-N-CA 123.988 0.804 . . . . 0.0 112.917 -176.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 41.0 p -141.4 173.61 11.33 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.544 1.538 . . . . 0.0 111.079 177.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -120.42 10.35 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 125.623 1.569 . . . . 0.0 112.213 -178.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -29.05 -77.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 127.627 2.371 . . . . 0.0 115.014 -176.481 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -158.2 147.55 19.51 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.56 1.944 . . . . 0.0 110.745 175.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -64.3 -26.96 70.96 Favored Glycine 0 N--CA 1.476 1.304 0 C-N-CA 124.592 1.091 . . . . 0.0 115.474 -178.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.43 -35.11 73.41 Favored 'General case' 0 CA--C 1.546 0.816 0 O-C-N 121.755 -0.85 . . . . 0.0 111.789 175.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.4 t -96.2 -37.89 10.36 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.082 1.353 . . . . 0.0 111.611 174.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 58.2 tp -82.77 84.41 7.35 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.651 1.981 . . . . 0.0 111.977 176.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.4 p -120.55 178.8 4.54 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 126.595 1.958 . . . . 0.0 111.396 175.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -40.14 -44.63 1.85 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.768 1.627 . . . . 0.0 113.474 175.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -52.92 -44.66 67.16 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 118.801 0.728 . . . . 0.0 112.154 178.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 93.1 t -64.54 -40.77 90.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 124.546 1.138 . . . . 0.0 111.135 175.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 39.4 mt -66.82 -38.12 85.83 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.355 -0.841 . . . . 0.0 111.593 178.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -68.16 -47.69 67.33 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 120.94 -1.1 . . . . 0.0 111.624 177.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.92 -37.51 87.29 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-O 118.594 -0.717 . . . . 0.0 111.495 175.045 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -62.84 -36.33 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 119.15 0.886 . . . . 0.0 111.159 -176.104 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.28 -25.41 48.12 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 119.112 0.869 . . . . 0.0 112.413 175.076 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -81.87 -65.3 1.67 Allowed Glycine 0 CA--C 1.533 1.179 0 O-C-N 120.603 -1.311 . . . . 0.0 112.173 174.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -66.65 -35.6 80.55 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 115.149 1.537 . . . . 0.0 115.149 -175.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -106.42 104.77 14.54 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 126.76 2.024 . . . . 0.0 108.358 -177.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -161.59 135.4 3.91 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 125.243 1.401 . . . . 0.0 114.381 -175.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.2 mtpt -112.35 -45.99 3.22 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 126.437 1.895 . . . . 0.0 113.286 177.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 20.8 m -116.9 177.96 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 126.202 1.801 . . . . 0.0 110.929 -176.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.6 t -51.86 -49.46 62.86 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.896 1.279 . . . . 0.0 112.909 -175.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.9 mtt-85 -122.86 129.34 51.53 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.751 1.62 . . . . 0.0 110.527 174.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.38 157.45 27.14 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 126.12 1.768 . . . . 0.0 110.665 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -118.25 130.78 72.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 175.045 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -134.77 99.44 4.32 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 126.75 2.02 . . . . 0.0 109.232 178.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.8 m -100.9 160.23 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-O 118.489 -0.767 . . . . 0.0 111.249 179.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -137.4 109.44 0.7 Allowed Glycine 0 N--CA 1.464 0.538 0 CA-C-N 119.112 0.869 . . . . 0.0 114.215 175.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.3 mp -100.66 145.57 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 CA-C-N 118.639 1.22 . . . . 0.0 110.722 176.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -108.55 105.86 15.68 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.905 1.282 . . . . 0.0 110.495 175.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -69.97 96.66 1.05 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.534 1.534 . . . . 0.0 111.222 175.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -126.56 3.43 6.85 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.26 1.824 . . . . 0.0 112.837 176.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.87 4.71 0.16 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 126.087 1.755 . . . . 0.0 115.663 177.086 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.01 61.96 4.28 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 125.977 1.751 . . . . 0.0 113.166 177.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 165.19 143.42 3.72 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 125.229 1.395 . . . . 0.0 111.079 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 31.9 p -67.15 142.57 57.0 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.682 0.753 . . . . 0.0 111.302 174.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.435 ' CZ2' ' CD2' ' A' ' 99' ' ' LEU . 48.6 m0 -101.97 102.66 13.22 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.627 1.171 . . . . 0.0 110.502 -179.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 28.0 m -90.27 128.63 36.46 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.01 0.924 . . . . 0.0 109.436 177.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.8 108.69 0.69 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.934 0.894 . . . . 0.0 112.429 175.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.1 pp -93.38 -45.7 7.68 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.637 0.775 . . . . 0.0 111.799 178.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -171.6 146.13 2.13 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 127.22 2.208 . . . . 0.0 110.294 179.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -134.99 151.27 50.67 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.346 1.458 . . . . 0.0 110.981 175.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -139.19 109.78 6.63 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.189 1.396 . . . . 0.0 112.013 -175.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -106.66 127.75 53.62 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 120.991 -1.068 . . . . 0.0 111.142 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -88.76 -68.32 0.78 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.508 1.523 . . . . 0.0 111.178 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 32.5 t -107.46 -35.29 6.8 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.989 1.315 . . . . 0.0 112.16 -174.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -61.91 -26.41 67.16 Favored Glycine 0 CA--C 1.536 1.36 0 CA-C-O 118.831 -0.983 . . . . 0.0 114.02 177.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.5 p 21.14 55.13 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 128.046 2.538 . . . . 0.0 116.128 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.9 t -75.89 173.24 11.45 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.16 -175.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -82.21 -51.91 7.48 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.388 0.675 . . . . 0.0 112.084 176.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.5 p -148.18 135.82 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.08 1.352 . . . . 0.0 112.217 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -143.42 -32.09 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 126.059 1.744 . . . . 0.0 113.816 -175.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -94.69 96.88 2.07 Favored Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 125.748 1.619 . . . . 0.0 109.256 177.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -64.49 157.84 52.81 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.809 2.339 . . . . 0.0 110.404 175.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -45.22 -49.96 11.94 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.723 1.609 . . . . 0.0 113.379 178.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 5.5 p -160.17 142.28 4.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 126.247 1.819 . . . . 0.0 110.078 175.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 73.6 t -113.79 122.62 34.53 Favored Pre-proline 0 N--CA 1.473 0.676 0 C-N-CA 124.472 1.109 . . . . 0.0 108.325 174.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.12 159.42 53.19 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.767 2.312 . . . . 0.0 112.875 175.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -71.15 168.2 17.71 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.952 0.901 . . . . 0.0 110.705 175.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 30.5 p 53.1 21.9 2.33 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 127.11 2.164 . . . . 0.0 113.991 -175.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.8 172.67 10.17 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 127.648 2.379 . . . . 0.0 110.497 -175.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -134.9 161.84 34.1 Favored 'General case' 0 C--O 1.222 -0.381 0 O-C-N 121.85 -0.532 . . . . 0.0 110.009 176.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -136.38 171.11 14.96 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 124.387 1.075 . . . . 0.0 112.454 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -119.47 156.01 31.02 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 124.826 1.25 . . . . 0.0 113.138 -179.061 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -133.22 133.66 43.01 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 124.217 1.007 . . . . 0.0 112.191 175.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.1 p -101.44 151.53 21.82 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 126.155 1.782 . . . . 0.0 110.692 175.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -169.0 124.43 1.17 Allowed Glycine 0 CA--C 1.531 1.08 0 C-N-CA 124.212 0.91 . . . . 0.0 113.192 175.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 22.9 mtm180 -96.04 80.89 3.32 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 129.462 3.105 . . . . 0.0 111.245 -174.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 10.2 ptpt . . . . . 0 N--CA 1.471 0.585 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -179.745 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 24.6 m . . . . . 0 N--CA 1.479 0.978 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 114.83 -171.45 13.71 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 125.829 1.68 . . . . 0.0 112.137 178.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.11 84.52 1.01 Allowed 'General case' 0 CA--C 1.547 0.855 0 O-C-N 120.956 -1.32 . . . . 0.0 110.983 179.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.2 t -125.65 118.21 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 124.155 0.982 . . . . 0.0 113.031 -174.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.87 168.65 17.46 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.144 1.377 . . . . 0.0 113.09 176.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -154.19 137.67 15.9 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.346 1.059 . . . . 0.0 111.961 174.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -137.59 169.28 18.06 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 120.595 -1.316 . . . . 0.0 111.574 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -141.46 160.62 39.75 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 175.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -137.82 143.35 40.95 Favored 'General case' 0 CA--C 1.513 -0.463 0 C-N-CA 125.779 1.632 . . . . 0.0 114.33 -174.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -97.94 106.53 18.85 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.352 -175.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 1.9 mtm -78.87 128.95 34.01 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 124.051 0.94 . . . . 0.0 110.789 178.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -58.96 -20.66 54.52 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 177.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -70.01 -12.52 61.67 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 124.521 1.128 . . . . 0.0 113.853 176.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 109.79 25.61 5.35 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 125.34 1.448 . . . . 0.0 114.963 177.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -134.3 173.84 11.18 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.928 1.291 . . . . 0.0 112.108 -175.028 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 16.8 m -129.33 108.44 10.31 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 177.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.435 ' CD2' ' CZ2' ' A' ' 44' ' ' TRP . 69.3 tp -75.12 108.07 7.62 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.675 0.79 . . . . 0.0 112.267 175.072 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -102.42 135.49 12.29 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 123.816 0.722 . . . . 0.0 112.344 174.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 95.6 t -115.7 136.6 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.952 1.301 . . . . 0.0 111.25 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -133.34 122.8 24.34 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.739 1.616 . . . . 0.0 111.945 -174.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -147.17 117.53 7.41 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.735 1.214 . . . . 0.0 111.562 -176.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 48.4 t -139.02 105.98 5.43 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.186 0.994 . . . . 0.0 112.598 -177.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 19.6 t . . . . . 0 C--N 1.328 -0.338 0 C-N-CA 125.893 1.677 . . . . 0.0 109.008 179.398 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 2.0 t . . . . . 0 CA--C 1.543 0.711 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.425 HD22 ' CE ' ' A' ' 162' ' ' MET . 0.4 OUTLIER -102.29 101.52 11.81 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.942 1.697 . . . . 0.0 109.454 175.487 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 38.5 m0 -100.52 141.31 33.55 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.961 1.255 . . . . 0.0 110.476 178.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 37.7 p-90 -137.51 129.0 28.24 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.143 0.977 . . . . 0.0 111.268 -177.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -133.54 156.12 48.37 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 122.509 1.147 . . . . 0.0 112.553 176.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 95.9 t -148.22 123.76 2.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 176.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.91 170.89 21.08 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.596 1.158 . . . . 0.0 110.885 175.021 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.489 ' HB ' ' CZ ' ' A' ' 154' ' ' TYR . 7.2 mt -104.27 136.19 38.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.917 0.865 . . . . 0.0 110.523 176.1 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -89.58 153.09 47.88 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 125.302 1.441 . . . . 0.0 111.18 176.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -74.19 88.98 1.08 Allowed 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 124.248 3.299 . . . . 0.0 112.107 179.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 91.64 -172.51 35.89 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 125.239 1.399 . . . . 0.0 113.006 -177.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 12.3 tttt -51.85 118.08 3.17 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.997 1.319 . . . . 0.0 111.571 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.38 147.67 41.8 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.023 0.929 . . . . 0.0 112.225 177.027 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 19.6 ptt-85 -99.07 -178.34 3.9 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.25 1.02 . . . . 0.0 110.409 175.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -128.8 107.47 9.68 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 104.91 -2.255 . . . . 0.0 104.91 174.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -128.39 171.24 12.23 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.277 1.431 . . . . 0.0 109.299 176.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -51.87 -44.29 63.65 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 119.642 1.11 . . . . 0.0 113.595 -177.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -56.75 -58.44 14.47 Favored Glycine 0 N--CA 1.471 0.986 0 CA-C-N 119.327 0.967 . . . . 0.0 112.57 175.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 6.1 mtm -60.89 -39.92 91.07 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 118.068 0.934 . . . . 0.0 112.714 178.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -56.2 -60.89 2.85 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.071 1.349 . . . . 0.0 109.569 174.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -67.06 -32.57 73.84 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -178.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -62.02 -47.15 86.04 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.752 0.821 . . . . 0.0 111.562 176.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 46.8 mmm -84.45 -20.36 31.91 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -54.5 -55.67 26.69 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.664 1.586 . . . . 0.0 109.252 174.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -68.65 -9.68 51.5 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -73.44 -41.6 44.3 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 125.825 1.679 . . . . 0.0 114.036 -177.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -123.0 91.32 49.94 Favored Pre-proline 0 CA--C 1.547 0.831 0 CA-C-N 118.215 1.007 . . . . 0.0 111.452 179.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -72.45 78.64 1.94 Allowed 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 123.776 2.984 . . . . 0.0 112.156 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -114.84 124.15 51.01 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.953 1.301 . . . . 0.0 110.233 174.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.87 96.93 3.31 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 127.101 2.16 . . . . 0.0 112.6 -174.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 52.53 37.83 50.41 Favored Glycine 0 CA--C 1.537 1.423 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.462 -177.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.67 79.65 0.6 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.408 1.883 . . . . 0.0 110.93 -178.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -65.84 123.37 19.61 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.185 1.794 . . . . 0.0 110.611 175.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 128.02 41.41 0.28 Allowed Glycine 0 CA--C 1.534 1.258 0 C-N-CA 125.341 1.448 . . . . 0.0 114.754 178.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 9.7 m95 45.29 60.09 3.21 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.803 1.641 . . . . 0.0 112.738 -175.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -85.05 128.31 34.58 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.456 1.102 . . . . 0.0 113.229 179.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -162.68 -170.28 2.34 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.219 1.008 . . . . 0.0 112.693 -174.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -137.9 151.53 48.11 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.562 1.145 . . . . 0.0 110.159 174.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -70.6 153.18 43.13 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 122.99 0.516 . . . . 0.0 110.95 176.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.46 ' HB3' ' CD2' ' A' ' 154' ' ' TYR . 1.9 mm? -115.7 127.67 55.32 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 122.189 0.995 . . . . 0.0 112.398 -178.278 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -58.07 -18.37 33.87 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 125.436 1.493 . . . . 0.0 116.02 179.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.489 ' CZ ' ' HB ' ' A' ' 120' ' ' ILE . 0.1 OUTLIER -74.35 14.33 0.46 Allowed 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 126.62 1.968 . . . . 0.0 113.776 179.778 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 75.16 24.86 70.2 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 124.171 0.891 . . . . 0.0 113.751 -174.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.6 pp -135.33 177.58 7.71 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.152 1.381 . . . . 0.0 113.215 -178.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -142.37 124.33 15.27 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.602 1.561 . . . . 0.0 109.448 -178.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 5.1 ttp -98.24 142.06 30.38 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 175.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 3.5 tppt? -123.78 121.72 36.17 Favored 'General case' 0 C--O 1.219 -0.543 0 C-N-CA 125.707 1.603 . . . . 0.0 109.383 -176.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -130.35 152.1 19.67 Favored Glycine 0 N--CA 1.466 0.682 0 CA-C-N 120.305 1.412 . . . . 0.0 114.581 -176.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 4.4 tp -146.35 128.27 7.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 C-N-CA 124.516 1.126 . . . . 0.0 110.589 -176.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' MET . . . . . 0.425 ' CE ' HD22 ' A' ' 114' ' ' ASN . 1.1 tmm? -151.37 157.2 42.14 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 125.296 1.438 . . . . 0.0 109.982 177.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 12.8 t -148.67 148.45 30.08 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.506 0.722 . . . . 0.0 110.329 174.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 75.1 m -117.08 32.11 6.35 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.277 1.031 . . . . 0.0 111.352 -177.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.85 -24.41 65.88 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.692 1.597 . . . . 0.0 113.713 176.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 158.4 -54.7 0.37 Allowed Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.22 1.39 . . . . 0.0 113.414 175.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -139.96 61.2 1.54 Allowed 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 122.311 1.053 . . . . 0.0 112.161 -175.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -98.08 -174.09 2.77 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 122.44 1.114 . . . . 0.0 112.727 175.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.5 178.68 6.12 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 128.167 2.587 . . . . 0.0 111.035 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' MET . . . . . 0.411 ' HA ' ' HG2' ' A' ' 162' ' ' MET . 4.7 tmm? -119.39 136.46 54.27 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.328 1.451 . . . . 0.0 111.207 174.359 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -146.74 129.73 16.37 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 121.591 -0.693 . . . . 0.0 110.279 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 4.6 mp -134.18 118.57 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 123.572 0.749 . . . . 0.0 110.363 175.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.83 133.13 55.59 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 125.411 1.485 . . . . 0.0 111.583 176.161 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.8 mp -82.59 136.68 22.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 O-C-N 121.466 -0.771 . . . . 0.0 109.498 175.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -118.23 130.85 56.31 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.164 1.386 . . . . 0.0 111.593 175.028 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 8.2 mmm180 . . . . . 0 C--O 1.252 1.231 0 C-N-CA 126.778 2.031 . . . . 0.0 110.869 -175.008 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 10.4 tp . . . . . 0 N--CA 1.479 1.007 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -77.56 130.62 37.17 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.316 1.047 . . . . 0.0 109.41 174.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -64.55 -101.14 0.01 OUTLIER Glycine 0 CA--C 1.537 1.453 0 CA-C-N 120.211 1.369 . . . . 0.0 114.764 -178.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 16.5 p -133.25 167.4 20.44 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.307 1.443 . . . . 0.0 110.16 176.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -120.73 14.59 6.34 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 C-N-CA 125.021 1.328 . . . . 0.0 112.406 -178.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -30.95 -72.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 128.427 2.691 . . . . 0.0 114.092 -179.38 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -171.62 151.5 2.95 Favored 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 125.127 1.371 . . . . 0.0 110.947 175.173 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -59.57 -33.23 75.99 Favored Glycine 0 N--CA 1.468 0.798 0 N-CA-C 115.605 1.002 . . . . 0.0 115.605 -174.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.09 -38.44 88.84 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 122.022 -0.693 . . . . 0.0 111.188 174.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.9 t -92.22 -11.77 34.5 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.398 1.879 . . . . 0.0 113.778 177.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 67.8 tp -119.53 80.67 1.6 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 128.851 2.86 . . . . 0.0 109.845 179.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -111.84 177.34 4.68 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.591 1.557 . . . . 0.0 111.981 176.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -39.98 -45.29 1.86 Allowed 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 126.125 1.77 . . . . 0.0 113.439 175.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -52.59 -44.86 66.24 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.921 0.888 . . . . 0.0 111.623 178.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 59.3 t -67.87 -40.82 84.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 125.54 1.536 . . . . 0.0 110.887 176.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 25.7 mt -65.4 -42.67 92.34 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 120.704 -1.247 . . . . 0.0 111.331 178.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -59.76 -51.52 69.4 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.79 1.236 . . . . 0.0 112.059 175.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.57 -36.37 83.56 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-O 118.424 -0.798 . . . . 0.0 112.52 175.141 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.2 t -53.65 -46.31 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.234 1.014 . . . . 0.0 110.363 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 18.5 mt -53.53 -18.49 2.85 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.562 1.545 . . . . 0.0 114.464 178.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -99.64 -62.24 0.83 Allowed Glycine 0 CA--C 1.534 1.268 0 C-N-CA 126.646 2.07 . . . . 0.0 112.899 175.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -60.85 -35.43 76.55 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -178.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -114.41 105.89 13.66 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.267 1.827 . . . . 0.0 108.092 175.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -143.78 162.74 27.72 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 125.502 1.525 . . . . 0.0 111.405 178.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.22 -83.14 0.57 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.733 1.213 . . . . 0.0 110.638 174.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 30.6 m -91.43 173.72 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 126.014 1.725 . . . . 0.0 109.282 178.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -51.28 -44.8 61.92 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.977 0.911 . . . . 0.0 112.439 -178.435 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.63 120.81 43.63 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.47 1.908 . . . . 0.0 112.514 177.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.46 163.12 30.08 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 125.46 1.504 . . . . 0.0 111.115 -179.049 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -128.95 132.67 67.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 124.709 1.204 . . . . 0.0 109.037 175.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -136.73 104.76 5.62 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.146 1.778 . . . . 0.0 109.439 174.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.3 m -106.4 159.09 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 124.233 1.013 . . . . 0.0 111.901 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -137.44 109.1 0.68 Allowed Glycine 0 N--CA 1.465 0.569 0 CA-C-N 119.072 0.851 . . . . 0.0 113.643 -178.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 mp -99.43 142.07 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 117.632 0.716 . . . . 0.0 110.136 176.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -108.87 101.99 11.05 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 124.873 1.269 . . . . 0.0 109.848 176.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.62 100.09 1.08 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.584 1.554 . . . . 0.0 109.343 176.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -133.79 13.39 4.02 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.908 1.283 . . . . 0.0 112.282 175.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.0 p -62.31 -12.95 23.78 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 126.082 1.753 . . . . 0.0 114.834 175.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.38 16.29 66.93 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 125.499 1.523 . . . . 0.0 114.183 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -140.49 136.47 7.67 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 126.506 2.003 . . . . 0.0 110.633 175.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 19.9 p -73.63 127.47 32.85 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.281 0.632 . . . . 0.0 109.939 174.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 15.8 m0 -88.02 159.1 18.42 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 122.066 -0.396 . . . . 0.0 111.742 177.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 89.4 m -136.61 143.86 43.77 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.574 1.15 . . . . 0.0 110.288 -179.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.7 110.85 0.86 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.466 1.106 . . . . 0.0 111.829 175.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.2 pp -101.25 -57.67 2.04 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.475 0.71 . . . . 0.0 111.284 175.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -173.43 140.03 0.79 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.446 1.898 . . . . 0.0 110.262 -175.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -121.83 150.61 41.67 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.354 1.062 . . . . 0.0 110.195 175.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -138.52 94.32 2.83 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 123.037 1.399 . . . . 0.0 112.104 -175.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -101.91 133.15 47.15 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 121.16 -0.962 . . . . 0.0 110.393 -175.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.38 -37.77 6.13 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.217 1.007 . . . . 0.0 113.64 -178.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 37.5 t -122.58 -47.74 2.08 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.494 1.518 . . . . 0.0 110.92 178.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -69.76 11.44 1.82 Allowed Glycine 0 CA--C 1.533 1.173 0 C-N-CA 126.051 1.786 . . . . 0.0 115.002 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 67.8 p -35.22 113.28 0.19 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 128.864 2.866 . . . . 0.0 112.773 -176.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.1 t -126.75 179.94 5.11 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.803 1.241 . . . . 0.0 112.014 -175.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -79.29 -53.98 6.4 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.959 0.904 . . . . 0.0 112.75 177.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.2 p -151.48 138.84 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.673 1.589 . . . . 0.0 111.386 -178.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.503 ' HB ' ' CE2' ' A' ' 72' ' ' TYR . 0.0 OUTLIER -136.72 -47.27 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 C-N-CA 125.083 1.353 . . . . 0.0 112.982 -178.772 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 73.3 mt -71.42 108.62 4.1 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 124.717 1.207 . . . . 0.0 109.474 175.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -72.07 168.02 25.15 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 124.046 3.164 . . . . 0.0 110.819 175.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -53.52 -45.57 69.82 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 178.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 85.5 t -150.09 146.75 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 127.526 2.33 . . . . 0.0 108.83 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.0 t -116.66 97.26 50.01 Favored Pre-proline 0 C--N 1.331 -0.21 0 C-N-CA 125.567 1.547 . . . . 0.0 107.247 174.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -67.71 144.78 67.12 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 121.328 1.352 . . . . 0.0 111.99 175.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -69.11 168.89 13.0 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.438 0.695 . . . . 0.0 110.658 174.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 29.1 p 62.94 13.85 7.0 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 126.614 1.966 . . . . 0.0 111.889 -175.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 27.6 mttp -138.41 169.05 18.47 Favored 'General case' 0 C--N 1.343 0.302 0 C-N-CA 126.525 1.93 . . . . 0.0 111.655 -176.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.35 159.72 39.45 Favored 'General case' 0 C--O 1.222 -0.359 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -175.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -136.76 167.86 20.63 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 124.296 1.038 . . . . 0.0 111.966 -177.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -117.35 153.55 32.81 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.253 1.021 . . . . 0.0 112.139 179.068 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.557 ' CE2' ' CE2' ' A' ' 89' ' ' PHE . 6.7 m-85 -125.56 142.2 51.63 Favored 'General case' 0 CA--C 1.511 -0.521 0 C-N-CA 125.047 1.339 . . . . 0.0 109.335 174.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 58.3 p -109.41 156.45 20.03 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 125.035 1.334 . . . . 0.0 110.346 174.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -174.13 135.45 3.18 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.872 175.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 30.5 mtm105 -117.5 142.5 47.09 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 125.428 1.491 . . . . 0.0 108.852 -177.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.5 ptpt . . . . . 0 CA--C 1.542 0.65 0 C-N-CA 124.038 0.935 . . . . 0.0 112.346 175.035 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.481 1.089 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -61.6 -68.58 1.61 Allowed Glycine 0 N--CA 1.475 1.246 0 O-C-N 120.282 -1.511 . . . . 0.0 113.654 -179.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -160.14 114.98 2.29 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.838 1.255 . . . . 0.0 110.923 175.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.42 ' CG1' ' HG ' ' A' ' 104' ' ' SER . 9.9 t -141.83 119.12 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 123.796 0.838 . . . . 0.0 109.933 -177.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.79 153.86 29.01 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.901 0.858 . . . . 0.0 112.031 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -134.57 139.43 45.37 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.401 1.48 . . . . 0.0 108.985 178.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.557 ' CE2' ' CE2' ' A' ' 72' ' ' TYR . 26.3 p90 -149.49 171.3 16.82 Favored 'General case' 0 C--N 1.323 -0.58 0 O-C-N 120.521 -1.362 . . . . 0.0 109.346 174.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -138.58 161.7 36.43 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 120.908 0.385 . . . . 0.0 111.977 174.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -130.16 135.52 48.27 Favored 'General case' 0 CA--C 1.518 -0.269 0 C-N-CA 125.718 1.607 . . . . 0.0 113.471 -174.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -86.53 116.78 24.89 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -175.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 3.3 mtm -93.2 140.89 29.03 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.01 0.924 . . . . 0.0 112.297 -177.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.14 -21.64 65.2 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 114.309 1.225 . . . . 0.0 114.309 177.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -72.09 -2.22 17.67 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.257 1.023 . . . . 0.0 113.146 175.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 85.83 42.39 6.81 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.62 1.105 . . . . 0.0 112.543 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -140.96 176.48 8.77 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.222 1.409 . . . . 0.0 111.549 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 12.9 m -130.07 107.54 9.4 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.285 1.034 . . . . 0.0 112.929 178.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 57.1 tp -69.94 96.31 1.01 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.764 1.625 . . . . 0.0 111.217 174.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -91.43 120.38 5.98 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 125.485 1.516 . . . . 0.0 112.76 178.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.475 HG11 ' CE2' ' A' ' 89' ' ' PHE . 0.3 OUTLIER -104.79 161.65 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 125.419 1.488 . . . . 0.0 111.127 178.436 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 5.0 tpt -155.91 123.22 5.44 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.66 1.184 . . . . 0.0 111.031 174.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -135.18 124.18 24.19 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.933 1.293 . . . . 0.0 114.226 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.42 ' HG ' ' CG1' ' A' ' 86' ' ' VAL . 1.6 t -133.02 102.32 5.56 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.086 0.954 . . . . 0.0 111.557 -176.151 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.0 m . . . . . 0 N--CA 1.47 0.543 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.409 -178.186 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.468 0.429 0 CA-C-O 121.466 0.65 . . . . 0.0 110.64 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -63.16 99.55 0.18 Allowed 'General case' 0 CA--C 1.521 -0.164 0 C-N-CA 126.134 1.774 . . . . 0.0 111.807 175.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 46.5 m0 -119.56 142.11 48.65 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.691 1.197 . . . . 0.0 110.129 -175.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 31.5 p-90 -145.82 133.83 21.43 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.195 0.998 . . . . 0.0 110.658 -175.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -146.92 157.38 43.62 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 122.464 1.126 . . . . 0.0 113.441 -178.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 21.4 t -149.19 128.14 3.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 114.394 -1.275 . . . . 0.0 108.277 -178.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.0 162.99 40.79 Favored 'General case' 0 CA--C 1.514 -0.434 0 C-N-CA 125.614 1.566 . . . . 0.0 109.13 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 20.4 mt -108.47 146.28 14.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 121.487 0.66 . . . . 0.0 109.998 176.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -103.19 145.81 31.29 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 126.244 1.818 . . . . 0.0 111.023 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.62 103.0 1.37 Allowed 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 124.152 3.235 . . . . 0.0 111.558 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 88.06 -177.06 45.98 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.518 1.056 . . . . 0.0 114.068 -177.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 16.4 tttt -64.56 102.13 0.53 Allowed 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.462 1.105 . . . . 0.0 109.426 175.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 6.4 mmt180 -116.35 158.25 23.75 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.803 1.641 . . . . 0.0 109.54 178.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.82 -174.0 2.77 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.506 1.122 . . . . 0.0 110.265 175.041 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -138.27 113.25 9.19 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 126.315 1.846 . . . . 0.0 106.113 174.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -127.5 175.56 8.14 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.707 2.003 . . . . 0.0 109.253 174.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -47.97 -49.4 30.65 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.112 0.965 . . . . 0.0 113.473 177.231 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -56.94 -52.99 47.74 Favored Glycine 0 N--CA 1.471 0.967 0 CA-C-N 119.052 0.842 . . . . 0.0 112.832 178.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 20.4 mtm -62.88 -41.6 99.46 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 117.828 0.814 . . . . 0.0 112.558 176.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -56.95 -62.74 1.54 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.767 0.827 . . . . 0.0 109.623 175.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -59.22 -42.09 90.18 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 118.561 -0.733 . . . . 0.0 112.184 -176.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -58.09 -42.11 84.92 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.426 1.09 . . . . 0.0 113.027 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 40.9 mmm -84.48 -36.29 22.37 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 177.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -53.47 -57.27 11.27 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.501 1.52 . . . . 0.0 109.444 174.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -70.95 -9.7 58.36 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -178.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -87.02 -11.23 70.36 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 126.254 1.883 . . . . 0.0 114.624 178.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -138.67 88.67 13.93 Favored Pre-proline 0 CA--C 1.548 0.884 0 CA-C-N 119.205 1.503 . . . . 0.0 112.636 177.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -74.76 77.86 2.94 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.857 3.038 . . . . 0.0 112.46 178.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -114.71 124.21 51.21 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.061 0.944 . . . . 0.0 110.684 -178.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -92.59 -167.9 1.85 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.406 1.082 . . . . 0.0 111.72 179.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -73.94 66.51 1.78 Allowed Glycine 0 CA--C 1.53 0.989 0 C-N-CA 125.824 1.678 . . . . 0.0 111.433 175.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.96 88.75 5.89 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 125.404 1.481 . . . . 0.0 109.805 -178.07 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -70.38 86.41 0.61 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.862 1.665 . . . . 0.0 112.347 -176.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 169.04 40.7 0.03 OUTLIER Glycine 0 N--CA 1.472 1.099 0 O-C-N 121.171 -0.956 . . . . 0.0 114.614 -178.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 2.3 m95 53.56 55.17 8.94 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 125.576 1.55 . . . . 0.0 113.909 -177.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -86.23 124.4 32.57 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.443 1.497 . . . . 0.0 112.684 -178.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -159.0 -179.36 7.97 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.108 0.963 . . . . 0.0 112.902 -175.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -136.57 166.42 23.58 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.24 1.416 . . . . 0.0 111.086 174.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -69.14 143.65 54.06 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.888 0.875 . . . . 0.0 109.735 174.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 48.4 mt -99.48 92.64 5.48 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.275 1.03 . . . . 0.0 110.744 176.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 33.05 -79.9 0.0 OUTLIER Glycine 0 N--CA 1.478 1.473 0 C-N-CA 130.051 3.691 . . . . 0.0 116.247 175.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -67.89 -157.02 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 128.266 2.626 . . . . 0.0 110.372 175.023 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -79.09 42.91 2.39 Favored Glycine 0 CA--C 1.539 1.557 0 O-C-N 119.813 -1.804 . . . . 0.0 112.253 175.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.54 149.98 33.64 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 119.571 1.686 . . . . 0.0 111.061 175.179 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 23.8 mtm180 -142.54 109.26 5.41 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.496 1.118 . . . . 0.0 111.015 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 9.9 ttp -101.53 132.23 47.27 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 118.038 -0.982 . . . . 0.0 108.934 179.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.74 130.45 54.46 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 127.075 2.15 . . . . 0.0 110.893 178.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -135.72 160.11 24.42 Favored Glycine 0 N--CA 1.47 0.937 0 CA-C-N 120.312 1.414 . . . . 0.0 115.45 178.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.63 134.57 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 123.954 0.901 . . . . 0.0 111.366 179.395 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 7.0 mtm -148.36 167.29 25.61 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 127.09 2.156 . . . . 0.0 109.974 175.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 3.6 t -140.35 148.9 42.01 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.989 1.316 . . . . 0.0 109.479 174.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 77.4 p -92.25 26.57 2.5 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.508 1.123 . . . . 0.0 112.805 177.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -67.18 22.68 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 127.601 2.36 . . . . 0.0 115.232 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 81.4 -60.64 4.7 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 126.664 2.078 . . . . 0.0 112.901 -176.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -122.77 71.04 1.02 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.786 1.234 . . . . 0.0 111.47 -179.267 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -92.89 -177.06 4.4 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.733 1.213 . . . . 0.0 112.707 175.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.42 163.84 20.06 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 126.842 2.057 . . . . 0.0 109.532 174.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' MET . . . . . 0.413 ' SD ' ' CD1' ' A' ' 172' ' ' ILE . 1.3 tmt? -113.12 127.13 56.11 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 124.876 1.27 . . . . 0.0 109.459 174.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -138.21 127.66 24.74 Favored 'General case' 0 CA--C 1.518 -0.253 0 C-N-CA 123.279 0.632 . . . . 0.0 110.044 177.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.413 ' CD1' ' SD ' ' A' ' 170' ' ' MET . 4.2 mp -136.43 119.68 22.59 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.279 0 C-N-CA 122.978 0.511 . . . . 0.0 110.505 178.537 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -112.36 131.89 55.29 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.987 1.315 . . . . 0.0 111.578 175.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.8 mp -82.07 131.46 33.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 175.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -135.42 102.47 5.15 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.219 1.007 . . . . 0.0 111.442 175.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 5.9 mtt180 . . . . . 0 C--O 1.253 1.285 0 C-N-CA 124.846 1.259 . . . . 0.0 112.852 174.983 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 25.5 m . . . . . 0 N--CA 1.479 0.996 0 CA-C-O 120.919 0.39 . . . . 0.0 111.427 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -84.17 156.55 22.02 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 120.75 -1.219 . . . . 0.0 111.074 174.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.545 HD13 ' H ' ' A' ' 74' ' ' GLY . 1.8 mt -74.64 43.65 0.19 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.73 1.612 . . . . 0.0 112.51 -175.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -120.98 94.02 4.21 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 127.637 2.375 . . . . 0.0 109.632 178.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -69.71 -84.05 0.16 Allowed Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.531 1.062 . . . . 0.0 112.665 -175.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 33.7 p -140.24 167.34 22.37 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.705 1.602 . . . . 0.0 111.004 175.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -125.39 14.36 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 CA-C-O 123.174 1.464 . . . . 0.0 111.796 -179.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.2 pt -53.23 167.39 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 125.494 1.517 . . . . 0.0 112.086 175.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -42.31 134.02 3.03 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.72 1.608 . . . . 0.0 112.549 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -54.9 -18.98 12.68 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 124.202 0.906 . . . . 0.0 114.557 -175.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.18 -28.14 69.46 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.718 1.207 . . . . 0.0 111.932 175.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.4 t -102.09 -44.9 5.32 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 126.32 1.848 . . . . 0.0 111.415 175.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.2 tp -75.97 94.16 3.35 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 121.614 0.721 . . . . 0.0 110.463 175.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 65.0 p -125.52 -179.8 4.79 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.507 1.523 . . . . 0.0 112.451 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -45.83 -41.0 10.56 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.446 1.498 . . . . 0.0 112.911 176.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -57.39 -43.39 83.61 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.661 1.185 . . . . 0.0 111.598 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 74.6 t -59.54 -35.4 58.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.733 1.213 . . . . 0.0 110.792 175.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.3 mt -72.52 -42.85 64.31 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.722 -0.611 . . . . 0.0 111.263 177.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -62.42 -49.35 75.81 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.616 -0.678 . . . . 0.0 111.267 178.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.08 -48.86 76.82 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 176.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.6 p -57.38 -30.73 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 CA-C-N 120.269 1.395 . . . . 0.0 113.414 -175.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 17.1 mt -57.4 -34.42 68.87 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.544 1.138 . . . . 0.0 110.806 174.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -85.54 -36.25 10.86 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 124.282 0.944 . . . . 0.0 113.455 177.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -69.62 -57.99 4.49 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.657 1.183 . . . . 0.0 112.38 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -91.32 -15.49 28.99 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.55 1.54 . . . . 0.0 112.005 -175.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -18.19 86.71 0.0 OUTLIER Glycine 0 CA--C 1.536 1.405 0 C-N-CA 129.952 3.644 . . . . 0.0 117.426 177.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.439 ' H ' HD21 ' A' ' 3' ' ' LEU . 15.3 mtpt -59.86 -61.11 2.86 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 127.224 2.21 . . . . 0.0 113.315 -175.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.1 m -132.66 -177.95 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 126.891 2.076 . . . . 0.0 110.835 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.2 t -52.19 -39.89 60.76 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.714 1.606 . . . . 0.0 114.354 -175.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -117.86 116.14 26.38 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 126.228 1.811 . . . . 0.0 108.258 175.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.15 150.54 49.46 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 126.125 1.77 . . . . 0.0 109.52 -175.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -128.21 123.59 60.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 124.336 1.054 . . . . 0.0 111.262 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -125.21 116.64 22.31 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 125.914 1.685 . . . . 0.0 108.558 174.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.3 m -116.1 158.75 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.639 0.776 . . . . 0.0 110.186 176.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -135.84 92.81 0.23 Allowed Glycine 0 CA--C 1.521 0.41 0 C-N-CA 124.073 0.844 . . . . 0.0 112.215 -178.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.8 mp -89.61 137.27 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 117.768 0.784 . . . . 0.0 110.503 175.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -108.15 112.1 24.45 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.989 1.316 . . . . 0.0 111.313 174.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 27.2 t30 -78.69 98.12 6.1 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.84 1.656 . . . . 0.0 111.975 175.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -134.21 13.74 3.87 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-O 122.551 1.167 . . . . 0.0 111.014 174.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.4 t -61.8 -26.88 68.37 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.082 1.753 . . . . 0.0 114.34 176.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 110.14 77.56 0.94 Allowed Glycine 0 CA--C 1.531 1.042 0 C-N-CA 125.247 1.403 . . . . 0.0 112.597 177.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 144.69 155.93 6.63 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 126.016 1.77 . . . . 0.0 112.805 175.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 41.4 p -68.88 129.43 39.9 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 121.526 -0.985 . . . . 0.0 110.289 174.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 45.2 m0 -86.6 111.15 20.35 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.261 0.553 . . . . 0.0 110.706 178.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 88.7 m -90.92 127.89 36.57 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 124.333 1.053 . . . . 0.0 109.501 175.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.21 138.41 58.41 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 122.651 0.38 . . . . 0.0 111.639 174.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.1 pp -120.44 -54.65 2.07 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.059 0.943 . . . . 0.0 111.971 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -170.78 154.38 4.34 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.535 1.934 . . . . 0.0 110.241 178.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -133.17 162.99 30.28 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.679 1.192 . . . . 0.0 110.386 174.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.518 ' HH ' ' NE2' ' A' ' 129' ' ' GLN . 29.3 t80 -140.24 106.2 5.19 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.971 1.309 . . . . 0.0 112.391 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -111.1 118.24 35.48 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.992 1.317 . . . . 0.0 110.982 -175.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.37 -35.9 7.78 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -177.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.3 t -123.96 -41.83 2.2 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.97 1.708 . . . . 0.0 111.654 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -74.03 16.66 2.61 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 125.246 1.403 . . . . 0.0 115.272 -178.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 65.8 p -32.9 110.29 0.08 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 128.689 2.796 . . . . 0.0 114.321 -174.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.7 t -131.37 -177.09 4.25 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.002 1.321 . . . . 0.0 112.845 -174.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -85.41 -64.97 1.06 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.963 1.305 . . . . 0.0 113.205 176.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.6 p -137.4 134.23 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 125.455 1.502 . . . . 0.0 111.638 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.68 -29.97 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.825 1.65 . . . . 0.0 113.799 177.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.0 mt -94.38 97.07 2.07 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 125.298 1.439 . . . . 0.0 109.85 179.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -66.87 154.29 75.07 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.932 3.088 . . . . 0.0 110.922 174.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -50.39 -50.8 50.57 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.634 1.174 . . . . 0.0 113.302 -176.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 80.4 t -149.45 140.9 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 127.902 2.481 . . . . 0.0 108.347 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.3 t -120.87 125.4 27.07 Favored Pre-proline 0 N--CA 1.471 0.583 0 C-N-CA 124.658 1.183 . . . . 0.0 109.508 175.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -66.2 152.02 82.15 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 121.88 1.72 . . . . 0.0 112.373 175.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -74.53 171.04 14.53 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.686 0.794 . . . . 0.0 111.425 174.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 66.5 p 55.41 20.36 3.6 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 127.597 2.359 . . . . 0.0 113.906 -174.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 49.4 mttt -133.57 174.03 10.86 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 127.623 2.369 . . . . 0.0 111.559 -175.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -130.94 166.86 20.03 Favored 'General case' 0 C--O 1.222 -0.373 0 C-N-CA 122.619 0.368 . . . . 0.0 110.549 -177.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.5 pp -140.49 172.66 12.41 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 124.962 1.305 . . . . 0.0 111.516 -178.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -123.4 151.76 42.27 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 124.331 1.052 . . . . 0.0 112.038 178.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -126.21 144.08 50.9 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.464 1.106 . . . . 0.0 108.556 174.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 90.4 p -115.69 152.95 32.21 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 125.879 1.671 . . . . 0.0 110.68 176.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.545 ' H ' HD13 ' A' ' 3' ' ' LEU . . . -173.97 141.91 6.23 Favored Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 174.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 13.3 ptt180 -132.42 163.84 27.85 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 127.098 2.159 . . . . 0.0 108.294 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 24.6 mtmt -60.65 162.79 6.13 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 115.341 1.608 . . . . 0.0 115.341 -174.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 27.0 t -67.71 -62.91 1.19 Allowed 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.317 1.447 . . . . 0.0 111.654 -175.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.24 -27.09 62.29 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.84 0.856 . . . . 0.0 113.036 174.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 113.55 -81.07 0.29 Allowed Glycine 0 CA--C 1.536 1.392 0 C-N-CA 126.14 1.828 . . . . 0.0 112.759 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -75.76 -36.88 1.9 Allowed 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 123.04 2.494 . . . . 0.0 113.216 -176.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 30.2 m -135.72 122.8 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 126.276 1.83 . . . . 0.0 110.803 -179.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 172.95 -177.02 0.06 Allowed 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 128.366 2.666 . . . . 0.0 110.41 -175.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 56.7 m -60.66 150.09 33.15 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.866 1.666 . . . . 0.0 111.201 174.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -53.05 -75.72 0.21 Allowed Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.938 1.732 . . . . 0.0 114.862 -175.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -165.97 102.62 0.66 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.316 1.446 . . . . 0.0 112.844 -178.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.0 t -129.0 124.69 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 O-C-N 120.977 -1.077 . . . . 0.0 110.87 -178.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -167.8 159.47 11.69 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.036 1.334 . . . . 0.0 112.233 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -141.06 143.87 34.61 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 124.396 1.078 . . . . 0.0 109.813 174.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -140.58 168.54 19.56 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 121.402 -0.811 . . . . 0.0 109.958 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -137.1 155.01 50.14 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 175.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -130.89 127.22 38.07 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.925 1.69 . . . . 0.0 111.985 -175.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -82.54 114.56 21.03 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.868 0.366 . . . . 0.0 111.067 -178.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 2.0 mtm -84.1 136.5 33.98 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.647 1.179 . . . . 0.0 111.169 176.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.2 t -64.32 -19.15 65.25 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.77 0.828 . . . . 0.0 113.213 176.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -69.35 -13.72 62.53 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 125.34 1.456 . . . . 0.0 113.496 175.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 104.31 23.07 8.23 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 124.736 1.16 . . . . 0.0 115.09 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -129.98 173.87 10.3 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 118.911 1.356 . . . . 0.0 110.035 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.6 m -130.47 107.75 9.46 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.403 1.081 . . . . 0.0 111.083 178.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 55.4 tp -70.68 105.49 3.18 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.245 1.018 . . . . 0.0 111.079 175.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -97.16 95.09 1.67 Allowed Glycine 0 CA--C 1.525 0.663 0 C-N-CA 125.639 1.59 . . . . 0.0 112.323 176.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 79.4 t -76.25 139.91 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 123.845 0.858 . . . . 0.0 110.51 174.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 2.6 tmm? -129.75 125.75 36.59 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.481 1.112 . . . . 0.0 111.056 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -136.94 134.95 37.29 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 122.417 1.104 . . . . 0.0 113.601 174.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 71.9 m -137.63 121.28 17.37 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.482 1.113 . . . . 0.0 111.563 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 41.4 t -125.76 98.86 33.28 Favored Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 126.576 1.95 . . . . 0.0 107.455 175.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -71.35 -158.08 0.05 OUTLIER 'Trans proline' 0 CA--C 1.547 1.149 0 C-N-CA 124.675 3.583 . . . . 0.0 111.215 175.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -131.94 -34.33 1.3 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.988 1.315 . . . . 0.0 111.816 175.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -90.01 52.38 2.26 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.128 1.371 . . . . 0.0 111.309 175.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -56.12 -19.34 12.87 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.058 1.343 . . . . 0.0 113.164 175.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 59.9 m-80 -58.99 -18.72 36.77 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.918 2.087 . . . . 0.0 113.493 174.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 6.8 m95 -132.25 -63.87 0.79 Allowed 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 126.37 1.868 . . . . 0.0 111.161 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -80.81 126.54 31.46 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.117 1.367 . . . . 0.0 111.714 -176.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.7 m -74.46 171.64 13.41 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 121.689 -0.632 . . . . 0.0 111.907 175.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -125.96 72.64 1.3 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.407 1.483 . . . . 0.0 112.258 -175.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 22.8 m0 -71.82 143.99 49.28 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 121.334 -0.854 . . . . 0.0 112.292 -174.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 34.3 p-90 -140.82 137.0 32.98 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.168 0.987 . . . . 0.0 111.881 -179.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -144.76 168.56 19.91 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 125.198 1.399 . . . . 0.0 111.684 -176.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 72.2 t -147.55 129.67 6.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 124.7 1.2 . . . . 0.0 107.894 174.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.58 170.2 15.07 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.434 1.094 . . . . 0.0 110.518 174.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.432 ' HB ' ' CE2' ' A' ' 154' ' ' TYR . 12.7 mt -132.01 104.77 8.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 177.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -62.18 145.8 93.2 Favored Pre-proline 0 CA--C 1.546 0.818 0 O-C-N 121.485 -0.759 . . . . 0.0 110.886 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -73.81 8.91 1.79 Allowed 'Trans proline' 0 CA--C 1.548 1.188 0 C-N-CA 124.413 3.408 . . . . 0.0 114.862 -175.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -172.98 179.77 44.2 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 126.95 2.214 . . . . 0.0 111.406 177.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -53.94 102.71 0.06 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 126.645 1.978 . . . . 0.0 111.565 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 11.1 tpp180 -132.45 141.6 48.89 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.538 1.535 . . . . 0.0 111.776 -177.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 8.7 ptt180 -76.82 179.53 6.06 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.262 1.025 . . . . 0.0 113.536 174.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -124.4 116.39 22.48 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 128.326 2.651 . . . . 0.0 104.681 174.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -140.12 169.18 18.18 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.143 1.377 . . . . 0.0 110.422 177.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.518 ' NE2' ' HH ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -52.77 -43.19 65.65 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.56 1.144 . . . . 0.0 113.261 -178.486 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -56.13 -56.44 24.18 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 123.72 0.676 . . . . 0.0 112.744 174.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 2.9 mtm -64.17 -33.3 75.47 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 118.321 1.06 . . . . 0.0 112.973 177.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.28 -63.91 1.13 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.231 1.013 . . . . 0.0 108.895 174.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -63.81 -32.81 74.45 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.621 0.601 . . . . 0.0 112.621 -176.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -64.18 -34.13 77.38 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.506 1.122 . . . . 0.0 113.446 176.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 6.4 tpp -97.72 -21.88 16.74 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 175.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -51.84 -54.99 22.71 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 126.638 1.975 . . . . 0.0 109.783 174.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -64.61 -12.1 42.0 Favored 'General case' 0 CA--C 1.552 1.045 0 N-CA-C 113.72 1.008 . . . . 0.0 113.72 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -79.16 -33.12 36.99 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 126.832 2.158 . . . . 0.0 113.925 -175.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -127.61 90.73 47.51 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 124.593 1.157 . . . . 0.0 111.21 177.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -72.51 72.92 2.9 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 123.561 2.84 . . . . 0.0 112.376 178.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -113.39 119.48 37.78 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 124.659 1.184 . . . . 0.0 109.848 174.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -89.03 0.43 56.68 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.591 1.557 . . . . 0.0 114.557 175.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 85.01 75.07 1.24 Allowed Glycine 0 CA--C 1.522 0.511 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 -175.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -74.53 122.2 22.72 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.907 0.883 . . . . 0.0 109.229 174.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -56.34 144.16 31.58 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.09 0.956 . . . . 0.0 112.395 -177.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 117.19 -78.97 0.29 Allowed Glycine 0 CA--C 1.532 1.141 0 C-N-CA 126.095 1.807 . . . . 0.0 113.037 -176.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 32.2 m95 171.99 104.84 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 130.816 3.646 . . . . 0.0 108.629 -175.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -134.59 137.0 43.36 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 126.456 1.902 . . . . 0.0 111.868 -177.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -160.38 -172.01 3.4 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -174.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.423 ' HA ' ' HE2' ' A' ' 150' ' ' LYS . 1.5 mmpt? -133.33 155.13 49.99 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 126.285 1.834 . . . . 0.0 111.158 174.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -78.23 144.09 36.55 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 174.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.3 mt -107.38 153.6 22.53 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 122.22 1.009 . . . . 0.0 109.732 178.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -64.38 -166.78 1.18 Allowed Glycine 0 CA--C 1.535 1.304 0 C-N-CA 123.673 0.654 . . . . 0.0 112.262 174.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.432 ' CE2' ' HB ' ' A' ' 120' ' ' ILE . 0.0 OUTLIER 56.78 9.47 0.6 Allowed 'General case' 0 CA--C 1.556 1.2 0 N-CA-C 114.844 1.424 . . . . 0.0 114.844 174.968 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 81.48 38.32 14.88 Favored Glycine 0 CA--C 1.538 1.514 0 C-N-CA 126.736 2.112 . . . . 0.0 114.693 -175.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.7 mp -126.79 159.64 33.21 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 119.868 1.834 . . . . 0.0 113.671 -176.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 74.1 mtt180 -144.69 118.71 9.39 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.316 1.047 . . . . 0.0 110.181 -178.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 3.1 ttp -103.51 138.94 39.52 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 124.313 1.045 . . . . 0.0 108.443 177.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -111.06 133.82 53.14 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 127.031 2.132 . . . . 0.0 110.131 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -141.39 160.88 26.93 Favored Glycine 0 N--CA 1.478 1.459 0 CA-C-N 121.849 2.113 . . . . 0.0 116.191 178.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.4 tp -149.51 127.22 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 125.166 1.386 . . . . 0.0 110.978 -177.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 29.4 mtp -148.48 164.95 32.63 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 128.807 2.843 . . . . 0.0 108.224 174.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 10.2 t -138.0 154.98 49.29 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.999 0.52 . . . . 0.0 111.124 175.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 94.9 p -77.57 13.87 1.16 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.726 1.611 . . . . 0.0 114.275 179.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.26 1.08 0.13 Allowed 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 126.794 2.038 . . . . 0.0 115.548 175.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 87.75 -62.3 3.99 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 126.14 1.829 . . . . 0.0 113.151 174.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -102.53 20.06 17.81 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.32 1.448 . . . . 0.0 113.076 -177.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -60.57 161.58 7.47 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.118 1.367 . . . . 0.0 113.579 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.41 173.41 9.15 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 126.446 1.899 . . . . 0.0 111.653 174.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 44.8 ttp -134.05 118.51 17.86 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.97 1.308 . . . . 0.0 111.794 177.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -124.62 128.55 49.04 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 121.141 -0.975 . . . . 0.0 109.525 177.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 4.6 mp -133.89 124.51 47.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 123.735 0.814 . . . . 0.0 109.915 176.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -123.34 132.11 53.88 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.36 1.464 . . . . 0.0 111.391 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.8 mp -79.31 127.57 39.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 O-C-N 121.207 -0.933 . . . . 0.0 109.338 176.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 4.2 m -132.3 98.9 4.52 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.093 1.357 . . . . 0.0 112.04 178.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 49.9 mtp85 . . . . . 0 C--O 1.253 1.242 0 C-N-CA 127.357 2.263 . . . . 0.0 113.032 175.02 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 6.3 t . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.246 0.069 . . . . 0.0 110.835 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -136.4 -175.83 4.13 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 128.305 2.642 . . . . 0.0 110.595 177.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.5 mt -128.51 15.42 6.56 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 126.664 1.986 . . . . 0.0 111.944 178.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -115.83 116.24 27.67 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 127.227 2.211 . . . . 0.0 110.491 -175.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -77.85 -82.95 0.58 Allowed Glycine 0 CA--C 1.533 1.201 0 C-N-CA 124.744 1.164 . . . . 0.0 113.551 -178.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 54.2 p -139.27 174.17 10.79 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 126.406 1.882 . . . . 0.0 111.451 -175.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -135.57 15.64 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 C-N-CA 125.702 1.601 . . . . 0.0 111.638 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 15.3 pt -54.36 171.56 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 126.272 1.829 . . . . 0.0 113.402 178.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -43.09 132.42 4.12 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.044 1.737 . . . . 0.0 113.258 178.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -54.75 -31.03 53.54 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 125.487 1.518 . . . . 0.0 116.147 -174.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.47 -22.58 67.0 Favored 'General case' 0 CA--C 1.547 0.834 0 O-C-N 121.648 -0.913 . . . . 0.0 112.636 174.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.3 t -98.25 -45.36 6.21 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.187 2.195 . . . . 0.0 111.722 176.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.2 tp -78.77 88.25 4.64 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.449 1.5 . . . . 0.0 111.062 174.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.2 p -120.28 -179.67 4.02 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 126.994 2.118 . . . . 0.0 111.976 177.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -45.4 -42.03 9.78 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.11 1.764 . . . . 0.0 113.523 175.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -52.91 -44.25 66.82 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 118.953 0.797 . . . . 0.0 111.819 177.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 61.4 t -64.13 -41.87 93.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 125.587 1.555 . . . . 0.0 111.651 175.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 29.3 mt -67.72 -40.13 84.26 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 120.845 -1.159 . . . . 0.0 111.933 179.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -63.64 -45.99 87.72 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.824 0.849 . . . . 0.0 111.786 178.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.74 -32.83 74.38 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-O 118.371 -0.823 . . . . 0.0 112.961 175.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 25.2 t -56.59 -42.02 75.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 CA-C-N 119.796 1.18 . . . . 0.0 111.48 177.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 49.2 mt -59.56 -13.29 8.68 Favored 'General case' 0 CA--C 1.552 1.045 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 175.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -104.67 -49.69 1.01 Allowed Glycine 0 CA--C 1.539 1.539 0 C-N-CA 126.855 2.169 . . . . 0.0 114.229 176.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -74.17 -30.41 62.23 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 119.186 1.493 . . . . 0.0 114.389 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -100.34 171.88 7.5 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.277 1.431 . . . . 0.0 110.463 174.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 154.83 131.49 1.48 Allowed Glycine 0 CA--C 1.534 1.22 0 O-C-N 121.122 -0.986 . . . . 0.0 114.601 177.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.4 mtpm? -113.5 -50.74 2.84 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 126.097 1.759 . . . . 0.0 114.0 176.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.7 m -132.25 -179.32 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 124.285 1.034 . . . . 0.0 112.348 -174.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.3 t -48.88 -42.37 36.49 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 126.082 1.753 . . . . 0.0 114.322 -175.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 8.8 tpp180 -124.69 136.35 53.82 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 126.297 1.839 . . . . 0.0 108.964 174.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.58 167.64 18.39 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.333 1.453 . . . . 0.0 110.8 178.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -137.41 133.04 46.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 124.187 0.995 . . . . 0.0 108.38 174.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -134.21 95.84 3.49 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 127.61 2.364 . . . . 0.0 109.855 -178.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.4 m -98.91 167.02 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 123.212 0.605 . . . . 0.0 111.552 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -142.59 108.69 0.53 Allowed Glycine 0 CA--C 1.523 0.562 0 CA-C-O 119.645 -0.53 . . . . 0.0 113.414 174.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.9 mp -98.51 144.31 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 117.929 0.865 . . . . 0.0 109.184 175.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -119.61 102.83 8.9 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.143 1.377 . . . . 0.0 111.161 -178.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -70.73 85.29 0.65 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 129.44 3.096 . . . . 0.0 113.047 -175.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.57 3.37 13.99 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.746 1.619 . . . . 0.0 113.658 175.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.5 m -55.56 -30.89 61.59 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 115.335 1.605 . . . . 0.0 115.335 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 111.06 95.68 2.31 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.576 1.084 . . . . 0.0 112.098 -177.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 113.51 160.11 13.78 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 126.102 1.81 . . . . 0.0 112.625 -178.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 80.8 p -69.34 148.2 50.03 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 121.975 -0.721 . . . . 0.0 111.563 175.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 34.9 m0 -103.32 105.85 16.22 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.925 0.89 . . . . 0.0 109.584 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 59.4 m -92.75 129.98 38.51 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.269 1.027 . . . . 0.0 110.466 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.85 127.98 33.83 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.045 0.938 . . . . 0.0 112.22 174.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -117.14 -43.6 2.84 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.698 1.199 . . . . 0.0 112.269 175.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -170.04 149.64 3.63 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.467 1.907 . . . . 0.0 110.955 -178.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -133.38 155.84 48.74 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.382 1.473 . . . . 0.0 110.231 175.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -138.2 97.69 3.45 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.048 1.339 . . . . 0.0 111.413 -178.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -99.17 111.99 24.25 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.356 1.062 . . . . 0.0 110.646 177.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.13 -39.45 16.69 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.278 0.631 . . . . 0.0 111.563 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.5 t -129.3 -177.08 4.09 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.623 2.369 . . . . 0.0 107.591 174.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 55.52 24.33 38.56 Favored Glycine 0 CA--C 1.538 1.493 0 O-C-N 121.178 -0.951 . . . . 0.0 113.783 -179.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.3 p -33.18 106.01 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 129.185 2.994 . . . . 0.0 112.719 -175.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.0 t -109.92 -177.22 3.21 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -174.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -92.44 -64.1 1.15 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.781 2.032 . . . . 0.0 112.21 175.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.2 p -144.06 131.91 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.989 1.315 . . . . 0.0 111.686 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.42 ' HB ' ' CD2' ' A' ' 72' ' ' TYR . 0.2 OUTLIER -131.01 -20.01 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 126.046 1.739 . . . . 0.0 113.595 178.21 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.3 mp -106.8 88.47 3.56 Favored Pre-proline 0 N--CA 1.45 -0.434 0 C-N-CA 125.902 1.681 . . . . 0.0 107.279 -174.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -59.14 151.9 63.45 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.615 2.21 . . . . 0.0 110.843 176.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -42.87 -49.02 5.89 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.335 1.854 . . . . 0.0 113.523 -178.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.6 p -160.79 140.63 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 127.039 2.136 . . . . 0.0 109.259 175.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 66.3 t -116.91 127.46 26.71 Favored Pre-proline 0 N--CA 1.477 0.92 0 C-N-CA 124.63 1.172 . . . . 0.0 108.325 175.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -66.23 157.65 58.87 Favored 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 122.123 1.882 . . . . 0.0 112.424 178.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -70.47 160.63 32.06 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 121.785 -0.572 . . . . 0.0 110.66 175.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 31.8 p 60.96 19.14 9.56 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 126.621 1.969 . . . . 0.0 113.697 -174.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 42.2 mttt -131.65 171.24 13.7 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.612 1.565 . . . . 0.0 111.489 -178.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -122.52 179.11 4.7 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 123.855 0.862 . . . . 0.0 111.839 -174.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -149.75 168.99 22.11 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 125.526 1.53 . . . . 0.0 110.948 174.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -119.08 158.14 26.45 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.879 1.672 . . . . 0.0 111.323 178.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.42 ' CD2' ' HB ' ' A' ' 59' ' ' ILE . 9.1 m-85 -130.27 144.25 51.26 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.343 1.057 . . . . 0.0 110.051 174.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.5 p -120.58 138.57 53.81 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 126.812 2.045 . . . . 0.0 110.365 175.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -150.85 129.73 2.98 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 174.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.06 107.2 9.41 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 127.67 2.388 . . . . 0.0 111.599 -175.004 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.96 -174.11 0.43 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 126.092 1.757 . . . . 0.0 112.875 176.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.4 t 69.57 37.74 1.88 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.883 1.673 . . . . 0.0 113.476 175.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.7 t -66.53 -24.12 66.33 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.833 1.253 . . . . 0.0 114.119 177.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 130.13 -64.98 0.6 Allowed Glycine 0 CA--C 1.538 1.507 0 C-N-CA 125.259 1.409 . . . . 0.0 113.373 -175.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -71.74 -31.97 12.34 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.97 2.447 . . . . 0.0 114.017 -175.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.8 p -151.13 157.1 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 125.365 1.466 . . . . 0.0 111.083 177.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -153.5 96.84 2.07 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.213 1.405 . . . . 0.0 112.021 -177.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 42.2 m -124.29 141.39 52.11 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 125.658 1.583 . . . . 0.0 108.929 175.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -21.98 -74.9 0.01 OUTLIER Glycine 0 N--CA 1.485 1.937 0 C-N-CA 127.452 2.453 . . . . 0.0 113.742 -178.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -163.05 120.4 1.92 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.869 1.668 . . . . 0.0 109.839 174.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.9 t -144.1 114.55 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.168 0.987 . . . . 0.0 109.826 -178.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.29 164.36 24.93 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.964 0.888 . . . . 0.0 113.186 -176.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -144.52 162.19 37.19 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.252 1.421 . . . . 0.0 112.076 174.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.41 ' CE1' ' HB ' ' A' ' 101' ' ' VAL . 30.0 p90 -160.78 172.65 16.66 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 124.672 1.189 . . . . 0.0 110.575 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -136.81 160.38 39.04 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 175.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -137.37 131.18 31.72 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.835 1.254 . . . . 0.0 113.892 175.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -79.36 109.04 13.34 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.947 0.899 . . . . 0.0 110.691 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 4.0 ttm -72.1 145.08 48.42 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.143 0.977 . . . . 0.0 111.937 175.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 14.3 t -61.69 -28.16 69.2 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.296 1.038 . . . . 0.0 112.955 175.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 -69.44 -8.09 43.66 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.825 1.25 . . . . 0.0 113.782 175.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 91.95 39.53 5.46 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.318 0.961 . . . . 0.0 113.951 177.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -138.34 171.88 13.72 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.184 1.393 . . . . 0.0 110.484 175.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 53.5 m -122.22 111.9 17.52 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 119.075 0.852 . . . . 0.0 113.163 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 61.9 tp -73.32 101.44 3.42 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.583 1.953 . . . . 0.0 110.404 174.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -91.01 117.6 5.18 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 126.221 1.867 . . . . 0.0 112.318 176.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.41 ' HB ' ' CE1' ' A' ' 89' ' ' PHE . 91.1 t -119.17 141.62 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 125.642 1.577 . . . . 0.0 110.68 -175.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 2.9 ppp? -148.37 170.22 18.44 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.897 0.856 . . . . 0.0 113.296 174.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -152.71 149.28 28.22 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.625 1.57 . . . . 0.0 113.89 175.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 22.4 t -143.1 107.71 4.84 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.585 1.554 . . . . 0.0 110.086 175.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 10.8 m -127.48 97.69 30.46 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 125.597 1.559 . . . . 0.0 109.021 175.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -69.54 172.09 13.05 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 122.564 2.176 . . . . 0.0 111.46 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -87.62 -58.18 2.67 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.387 0.675 . . . . 0.0 110.732 174.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -61.93 -35.53 78.69 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.249 1.42 . . . . 0.0 113.961 -174.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 54.38 9.16 0.23 Allowed 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 126.805 2.042 . . . . 0.0 115.886 -176.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -74.62 -75.55 0.16 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.111 1.765 . . . . 0.0 113.82 -175.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 75.7 m95 -108.05 -42.18 4.73 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.327 1.451 . . . . 0.0 114.105 -175.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -59.22 109.03 0.77 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.73 1.212 . . . . 0.0 111.437 178.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 19.3 m -57.0 143.21 39.03 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.528 1.131 . . . . 0.0 111.276 175.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -124.66 95.69 4.61 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.239 1.015 . . . . 0.0 109.898 -176.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 51.9 m0 -110.74 148.24 32.74 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.19 0.519 . . . . 0.0 111.656 -177.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 17.5 p-90 -149.13 135.17 19.03 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.366 0.667 . . . . 0.0 112.566 -174.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -161.4 173.39 14.99 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 122.732 1.253 . . . . 0.0 113.111 175.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 60.3 t -138.59 143.85 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 126.462 1.905 . . . . 0.0 107.98 176.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.67 174.56 11.34 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.601 1.561 . . . . 0.0 110.565 178.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 26.0 mt -127.09 138.77 53.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 174.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 99.7 m-85 -102.35 149.56 36.77 Favored Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 125.103 1.361 . . . . 0.0 111.966 176.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -69.48 113.39 3.31 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.861 3.041 . . . . 0.0 111.321 176.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 69.16 -171.63 39.14 Favored Glycine 0 CA--C 1.537 1.421 0 O-C-N 121.896 -0.503 . . . . 0.0 114.119 -175.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 11.8 tmtt? -58.15 113.15 1.79 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.565 1.546 . . . . 0.0 111.594 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.08 113.69 12.37 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.768 1.227 . . . . 0.0 111.465 -178.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 4.5 ptp180 -57.65 161.72 3.49 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.711 -0.618 . . . . 0.0 112.308 175.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -113.12 99.02 7.51 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 175.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -124.5 167.48 14.38 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.591 1.556 . . . . 0.0 109.988 -177.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -53.25 -38.94 63.46 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.185 0.994 . . . . 0.0 113.425 -177.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -60.61 -57.67 17.77 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 123.753 0.692 . . . . 0.0 112.151 176.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 3.3 mtm -61.4 -37.22 82.65 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.326 0.65 . . . . 0.0 112.524 178.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.82 -62.91 1.46 Allowed 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.768 0.713 . . . . 0.0 110.0 174.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -60.37 -40.4 90.68 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.104 0.962 . . . . 0.0 113.145 -175.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -60.53 -46.48 90.02 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.062 0.945 . . . . 0.0 112.441 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 78.1 mmm -82.25 -30.84 30.49 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 177.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -55.19 -57.21 12.7 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.295 1.838 . . . . 0.0 110.769 175.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.32 -20.09 65.99 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-O 121.439 0.638 . . . . 0.0 112.166 -177.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -80.35 -2.55 89.41 Favored Glycine 0 CA--C 1.538 1.483 0 C-N-CA 126.744 2.116 . . . . 0.0 114.839 175.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -141.77 77.32 19.06 Favored Pre-proline 0 CA--C 1.553 1.081 0 CA-C-N 119.62 1.71 . . . . 0.0 114.145 -175.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.89 101.05 1.27 Allowed 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 123.688 2.925 . . . . 0.0 113.266 -176.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -138.2 123.31 19.16 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.583 1.153 . . . . 0.0 110.704 178.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 4.6 mpt_? -93.34 -157.29 0.53 Allowed 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 125.297 1.439 . . . . 0.0 111.081 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -86.12 77.5 2.03 Favored Glycine 0 CA--C 1.531 1.037 0 O-C-N 120.132 -1.605 . . . . 0.0 110.116 175.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -75.99 85.14 2.89 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.152 1.781 . . . . 0.0 111.171 -175.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -54.43 116.39 2.62 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 -174.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 141.78 -73.01 0.38 Allowed Glycine 0 CA--C 1.533 1.212 0 C-N-CA 125.251 1.405 . . . . 0.0 114.057 175.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 27.9 m95 169.19 106.33 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 131.199 3.8 . . . . 0.0 108.485 -174.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -137.92 132.19 32.04 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 127.327 2.251 . . . . 0.0 110.471 -177.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -158.38 -173.66 4.42 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -175.038 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.3 mtmm -140.4 162.84 34.36 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 126.501 1.921 . . . . 0.0 111.564 175.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -73.29 137.34 44.8 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.431 1.092 . . . . 0.0 109.456 174.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 45.1 mt -92.97 88.74 6.26 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.294 1.038 . . . . 0.0 110.478 177.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 35.81 -76.45 0.0 OUTLIER Glycine 0 N--CA 1.477 1.405 1 C-N-CA 130.83 4.062 . . . . 0.0 116.592 175.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -70.02 -153.45 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 128.311 2.645 . . . . 0.0 110.472 175.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -75.42 24.52 1.42 Allowed Glycine 0 CA--C 1.542 1.742 0 O-C-N 120.15 -1.594 . . . . 0.0 115.072 174.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.84 149.06 24.58 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 120.211 2.005 . . . . 0.0 111.698 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 61.5 mtt85 -140.89 114.33 8.73 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.736 1.214 . . . . 0.0 111.433 177.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 8.0 ttp -94.96 143.17 26.68 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 125.28 1.432 . . . . 0.0 108.803 175.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 4.4 tppt? -121.98 124.9 45.11 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 127.199 2.199 . . . . 0.0 109.853 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -137.58 158.61 24.59 Favored Glycine 0 N--CA 1.478 1.439 0 N-CA-C 117.974 1.95 . . . . 0.0 117.974 -175.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.69 131.72 9.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 C-N-CA 125.372 1.469 . . . . 0.0 111.668 -177.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 3.5 mtm -149.77 160.93 43.16 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 128.537 2.735 . . . . 0.0 108.231 174.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 5.5 t -140.89 133.91 29.28 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 121.133 -0.979 . . . . 0.0 112.003 174.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 45.6 m -74.4 12.29 0.8 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.433 1.493 . . . . 0.0 114.187 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -51.01 -43.0 60.76 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.77 1.628 . . . . 0.0 114.21 176.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 146.91 -77.79 0.25 Allowed Glycine 0 CA--C 1.532 1.105 0 C-N-CA 125.139 1.352 . . . . 0.0 112.845 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 27.5 tp10 -95.83 43.81 1.08 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 125.145 1.378 . . . . 0.0 110.831 -177.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -77.24 172.57 13.07 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.301 1.04 . . . . 0.0 112.928 178.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . 0.404 ' HE2' ' O ' ' A' ' 169' ' ' LYS . 0.0 OUTLIER -114.07 173.93 6.19 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 126.711 2.004 . . . . 0.0 109.633 174.919 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 2.0 tmm? -126.85 123.17 36.7 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 125.385 1.474 . . . . 0.0 109.12 178.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -132.4 128.46 37.6 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.504 0.721 . . . . 0.0 110.532 177.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 4.8 mp -135.61 122.97 35.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 123.428 0.691 . . . . 0.0 110.11 175.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -118.88 136.1 54.22 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.556 1.542 . . . . 0.0 110.043 176.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.8 mp -82.93 137.15 21.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 O-C-N 121.315 -0.866 . . . . 0.0 109.241 175.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 9.3 m -128.78 95.9 4.23 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.229 1.012 . . . . 0.0 111.85 176.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 7.2 mmm180 . . . . . 0 C--O 1.253 1.288 0 C-N-CA 126.296 1.838 . . . . 0.0 111.75 174.945 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 37.4 m . . . . . 0 N--CA 1.478 0.954 0 CA-C-O 121.042 0.448 . . . . 0.0 110.555 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -143.4 177.87 8.14 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 128.295 2.638 . . . . 0.0 109.615 -177.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 16.1 mt -121.28 -10.84 8.88 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.736 1.214 . . . . 0.0 112.908 174.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -75.14 96.08 3.21 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.626 -0.671 . . . . 0.0 110.083 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -60.94 -75.48 0.29 Allowed Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.426 1.013 . . . . 0.0 112.314 -176.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 27.4 p -150.85 172.3 15.85 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 127.189 2.196 . . . . 0.0 110.423 174.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -124.79 5.51 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 124.934 1.294 . . . . 0.0 112.75 175.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 pt -24.42 -75.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 129.591 3.156 . . . . 0.0 116.673 -176.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -162.47 137.59 6.97 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.218 1.407 . . . . 0.0 111.324 -177.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.65 -21.49 58.07 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 124.577 1.084 . . . . 0.0 114.641 -178.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.27 -31.11 72.18 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.233 1.013 . . . . 0.0 113.175 174.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.5 t -102.96 -40.87 6.32 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 125.083 1.353 . . . . 0.0 111.726 175.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 14.3 tp -74.24 82.74 1.85 Allowed 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.235 1.414 . . . . 0.0 111.099 175.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.8 p -113.98 179.68 3.89 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 126.654 1.981 . . . . 0.0 112.425 176.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -47.47 -42.2 22.2 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.064 1.346 . . . . 0.0 113.019 176.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -57.55 -37.88 73.86 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.759 0.823 . . . . 0.0 112.174 178.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.6 t -67.48 -41.16 85.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.083 0.953 . . . . 0.0 110.283 175.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 21.3 mt -63.71 -41.08 98.15 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 121.33 -0.856 . . . . 0.0 110.961 177.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.39 -44.15 92.23 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.793 0.837 . . . . 0.0 112.641 178.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.68 -32.6 62.26 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 175.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.1 t -51.4 -46.49 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 C-N-CA 125.601 1.56 . . . . 0.0 111.933 175.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 15.0 mt -53.97 -20.15 5.76 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.188 1.395 . . . . 0.0 113.716 178.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -108.42 -40.08 1.68 Allowed Glycine 0 CA--C 1.537 1.415 0 C-N-CA 126.134 1.826 . . . . 0.0 114.926 178.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -72.05 -28.61 63.46 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 119.768 1.784 . . . . 0.0 113.965 179.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -92.24 133.36 35.89 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.83 1.252 . . . . 0.0 110.992 176.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.12 125.11 7.19 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 125.261 1.41 . . . . 0.0 113.852 -175.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.94 -172.19 4.15 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 126.366 1.866 . . . . 0.0 112.053 -177.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.9 m -72.47 -177.96 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 126.085 1.754 . . . . 0.0 110.898 174.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 60.9 m -49.7 -50.01 45.53 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.517 1.527 . . . . 0.0 113.529 -177.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -117.43 138.21 51.99 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.041 1.337 . . . . 0.0 110.662 175.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.42 161.09 38.75 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 126.132 1.773 . . . . 0.0 111.593 -175.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -131.25 114.25 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-O 122.238 1.018 . . . . 0.0 112.018 -179.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -117.31 111.51 19.48 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.735 2.014 . . . . 0.0 109.111 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.8 m -116.67 151.98 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 CA-C-O 119.097 -0.478 . . . . 0.0 111.272 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -131.12 101.34 0.48 Allowed Glycine 0 CA--C 1.524 0.649 0 C-N-CA 123.815 0.722 . . . . 0.0 112.872 -179.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.9 mp -91.93 136.22 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-N 118.209 1.005 . . . . 0.0 110.318 175.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -101.13 104.48 15.58 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.185 1.394 . . . . 0.0 110.666 178.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -70.39 82.74 0.56 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 127.889 2.476 . . . . 0.0 111.057 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -120.85 11.64 11.14 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 125.109 1.364 . . . . 0.0 114.144 175.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 99.8 p -60.15 -7.51 1.92 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 126.67 1.988 . . . . 0.0 116.351 174.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 93.57 21.05 30.1 Favored Glycine 0 CA--C 1.54 1.626 0 N-CA-C 116.281 1.272 . . . . 0.0 116.281 177.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -166.49 169.56 40.63 Favored Glycine 0 CA--C 1.535 1.305 0 CA-C-N 119.27 1.535 . . . . 0.0 114.196 176.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.3 p -72.98 141.75 47.75 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.81 1.244 . . . . 0.0 111.396 175.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.553 ' HA ' ' CE1' ' A' ' 91' ' ' TYR . 34.7 m0 -100.97 98.04 8.55 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 123.586 0.755 . . . . 0.0 112.353 -177.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.1 m -81.72 120.41 25.09 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.266 1.026 . . . . 0.0 108.704 175.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.08 150.51 45.33 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.685 -0.634 . . . . 0.0 112.145 174.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.8 pp -124.25 -51.02 1.77 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.639 0.776 . . . . 0.0 112.976 177.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -171.06 142.89 1.88 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 127.043 2.137 . . . . 0.0 109.738 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -121.17 151.44 39.93 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.614 1.166 . . . . 0.0 109.94 174.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -132.67 106.54 7.84 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.413 1.485 . . . . 0.0 111.27 -177.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -111.58 124.64 52.71 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.481 1.112 . . . . 0.0 110.248 -175.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.13 -34.2 6.01 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 114.174 1.175 . . . . 0.0 114.174 -174.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 43.7 t -119.0 -47.92 2.47 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.657 1.183 . . . . 0.0 110.375 175.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -67.55 12.27 0.74 Allowed Glycine 0 CA--C 1.54 1.603 0 C-N-CA 126.865 2.174 . . . . 0.0 117.623 -174.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 76.0 p -27.14 107.69 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 129.597 3.159 . . . . 0.0 114.671 -175.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.9 t -128.75 -177.05 4.04 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.826 2.05 . . . . 0.0 113.509 -175.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -88.44 -54.79 4.01 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.051 1.341 . . . . 0.0 113.897 177.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.9 p -149.89 133.45 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 124.898 1.279 . . . . 0.0 111.99 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.411 ' HB ' ' CE2' ' A' ' 72' ' ' TYR . 0.1 OUTLIER -136.68 -35.18 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 N-CA-C 114.838 1.422 . . . . 0.0 114.838 179.29 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.2 mt -88.5 100.05 1.78 Allowed Pre-proline 0 CA--C 1.543 0.694 0 C-N-CA 125.665 1.586 . . . . 0.0 108.599 176.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -68.51 150.53 75.34 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 122.554 2.17 . . . . 0.0 110.985 176.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -48.1 -45.54 32.85 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.983 1.313 . . . . 0.0 113.446 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.2 p -156.26 136.19 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 126.398 1.879 . . . . 0.0 110.287 175.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 72.7 t -113.71 129.96 24.22 Favored Pre-proline 0 N--CA 1.481 1.079 0 C-N-CA 124.55 1.14 . . . . 0.0 108.691 174.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -70.43 158.25 56.63 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 122.667 2.245 . . . . 0.0 113.271 178.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -72.94 160.72 31.67 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 121.421 -0.799 . . . . 0.0 112.726 175.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . 0.275 51.4 p 57.64 23.77 9.74 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 127.077 2.151 . . . . 0.0 113.689 -175.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -119.03 -178.32 3.54 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 126.765 2.026 . . . . 0.0 110.732 178.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -136.54 152.54 50.61 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 175.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.5 pp -117.7 171.01 8.32 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 124.417 1.087 . . . . 0.0 110.963 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -126.22 153.41 44.75 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.624 1.17 . . . . 0.0 111.004 175.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.424 ' CE2' ' CD2' ' A' ' 89' ' ' PHE . 6.3 m-85 -125.88 153.39 44.24 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.832 1.653 . . . . 0.0 108.835 174.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 95.8 p -133.97 141.36 47.26 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 126.197 1.799 . . . . 0.0 111.3 176.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -162.12 150.38 19.62 Favored Glycine 0 CA--C 1.524 0.624 0 O-C-N 121.916 -0.49 . . . . 0.0 113.092 174.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 11.4 mtm180 -112.24 130.83 55.8 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 126.289 1.836 . . . . 0.0 111.968 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -61.15 -30.85 70.63 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.688 1.595 . . . . 0.0 115.12 175.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 26.0 m -74.69 72.99 2.02 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 127.25 2.22 . . . . 0.0 113.898 -175.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 52.2 p -66.61 -21.68 66.13 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 177.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 126.37 -74.69 0.42 Allowed Glycine 0 CA--C 1.537 1.448 0 C-N-CA 126.494 1.997 . . . . 0.0 112.036 -175.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.62 -50.46 0.29 Allowed 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 123.723 2.949 . . . . 0.0 113.946 -175.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.1 m -142.67 126.94 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 125.695 1.598 . . . . 0.0 111.646 -176.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -83.38 103.64 12.91 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.48 1.112 . . . . 0.0 111.965 178.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 42.9 m -112.63 71.69 0.75 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.064 1.346 . . . . 0.0 111.263 -174.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 37.82 -114.26 0.28 Allowed Glycine 0 CA--C 1.533 1.193 0 C-N-CA 126.103 1.811 . . . . 0.0 113.969 -178.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -141.45 114.84 8.84 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 118.458 1.129 . . . . 0.0 111.274 176.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.2 t -137.33 122.25 24.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 C-N-CA 124.323 1.049 . . . . 0.0 110.18 -176.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.51 171.34 16.0 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.302 1.441 . . . . 0.0 111.359 175.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -151.48 134.38 15.75 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.889 1.275 . . . . 0.0 109.943 174.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.424 ' CD2' ' CE2' ' A' ' 72' ' ' TYR . 54.3 p90 -129.72 171.24 12.87 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 121.27 -0.894 . . . . 0.0 110.285 177.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -143.26 143.9 31.91 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 175.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.553 ' CE1' ' HA ' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -109.98 131.36 55.13 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.497 1.119 . . . . 0.0 109.995 177.289 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -84.51 107.6 16.84 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.364 0.665 . . . . 0.0 112.593 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -68.38 141.64 55.68 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.45 1.1 . . . . 0.0 112.94 -178.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 58.0 p -60.15 -28.24 67.75 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.845 1.258 . . . . 0.0 112.548 174.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 -72.24 -8.23 53.68 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.731 1.612 . . . . 0.0 112.757 174.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 99.99 -6.71 58.52 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 126.662 2.077 . . . . 0.0 114.362 -178.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 53.5 m-20 -78.12 178.33 7.64 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 118.339 1.07 . . . . 0.0 111.34 178.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 19.0 m -139.31 109.12 6.28 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 120.453 -1.404 . . . . 0.0 111.22 174.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.6 tt -72.8 101.81 3.22 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.566 1.146 . . . . 0.0 111.289 175.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -92.79 127.78 9.14 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 125.171 1.367 . . . . 0.0 113.333 175.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 63.5 t -114.44 127.02 72.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 125.763 1.625 . . . . 0.0 111.224 -175.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.11 118.61 24.71 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 126.733 2.013 . . . . 0.0 112.438 -175.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -141.69 121.28 13.34 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.33 1.452 . . . . 0.0 111.642 -175.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 30.4 t -137.3 92.53 2.72 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.473 1.509 . . . . 0.0 110.92 -175.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.1 m -103.09 125.73 34.4 Favored Pre-proline 0 N--CA 1.473 0.68 0 C-N-CA 125.105 1.362 . . . . 0.0 109.669 -179.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -75.72 175.25 11.53 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 122.933 2.422 . . . . 0.0 111.582 176.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -95.98 -52.62 3.98 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.581 1.153 . . . . 0.0 112.401 178.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 26.1 p30 -95.0 -4.5 46.47 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.691 1.596 . . . . 0.0 114.72 -176.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 47.15 31.25 1.6 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 127.005 2.122 . . . . 0.0 113.974 -177.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -122.06 143.5 49.48 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.189 1.795 . . . . 0.0 111.716 -175.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 22.8 m95 55.89 14.48 1.38 Allowed 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 126.574 1.95 . . . . 0.0 114.636 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -149.86 175.94 11.18 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 127.408 2.283 . . . . 0.0 111.858 -174.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 17.1 m -139.37 136.11 34.41 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.648 1.179 . . . . 0.0 113.93 175.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 32.5 t-20 -74.34 106.29 5.9 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.08 1.752 . . . . 0.0 107.912 175.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 44.3 m0 -113.16 145.68 40.53 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 120.297 1.408 . . . . 0.0 108.31 174.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 39.2 p-90 -149.02 142.82 25.63 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.095 0.958 . . . . 0.0 113.047 -177.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -151.69 165.77 33.34 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 123.292 1.52 . . . . 0.0 113.821 -177.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 94.7 t -147.41 129.54 7.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 125.894 1.678 . . . . 0.0 107.349 175.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.33 171.6 14.23 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.515 1.526 . . . . 0.0 110.127 175.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 35.3 mt -134.32 118.59 27.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.762 0.792 . . . . 0.0 109.231 -176.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -80.59 139.12 50.97 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 124.185 0.994 . . . . 0.0 109.23 178.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -72.97 -1.53 10.63 Favored 'Trans proline' 0 CA--C 1.546 1.119 0 C-N-CA 123.706 2.937 . . . . 0.0 114.948 -178.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -141.74 176.27 22.04 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 126.857 2.17 . . . . 0.0 111.94 175.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 9.9 tttm -64.26 105.61 0.94 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.934 1.294 . . . . 0.0 110.884 176.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 11.2 tpp180 -138.77 117.96 12.67 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 124.381 1.072 . . . . 0.0 113.22 -174.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 15.4 ptt180 -62.98 165.42 6.9 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 175.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -110.22 103.18 11.84 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 174.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -111.8 170.82 7.88 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.329 1.051 . . . . 0.0 109.642 175.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -50.07 -39.52 42.46 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.377 0.99 . . . . 0.0 113.304 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -59.42 -59.72 10.11 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 123.869 0.747 . . . . 0.0 112.175 175.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 14.6 mtm -61.82 -35.33 77.9 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 118.058 0.929 . . . . 0.0 113.298 178.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -60.56 -60.49 3.73 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.088 1.355 . . . . 0.0 109.756 175.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -67.26 -29.75 69.45 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -63.96 -36.73 84.91 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.34 1.056 . . . . 0.0 113.019 176.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 7.9 tpp -94.53 -22.23 18.36 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 119.695 1.134 . . . . 0.0 113.463 175.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -49.28 -56.6 8.88 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.602 1.561 . . . . 0.0 110.316 175.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -71.19 -7.02 43.93 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -178.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -84.89 -12.83 73.52 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 126.983 2.23 . . . . 0.0 114.946 -178.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -145.54 90.27 6.04 Favored Pre-proline 0 CA--C 1.552 1.025 0 CA-C-N 119.309 1.555 . . . . 0.0 112.956 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -75.48 81.8 2.23 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 123.674 2.916 . . . . 0.0 112.19 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -116.97 111.64 19.87 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.985 1.314 . . . . 0.0 110.182 -177.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -92.61 41.36 1.07 Allowed 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 127.564 2.346 . . . . 0.0 114.05 -174.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 55.77 51.76 53.03 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 123.704 0.669 . . . . 0.0 112.538 -177.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -61.01 113.63 2.65 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.613 1.165 . . . . 0.0 111.418 -176.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -75.96 83.18 2.85 Favored 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 -175.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 173.09 55.07 0.05 OUTLIER Glycine 0 CA--C 1.539 1.544 0 C-N-CA 125.107 1.336 . . . . 0.0 114.135 175.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' TRP . . . . . 0.413 ' H ' HD13 ' A' ' 161' ' ' ILE . 7.5 m95 48.16 41.72 16.15 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 126.81 2.044 . . . . 0.0 114.077 -174.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -72.75 126.96 31.15 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 120.845 -1.16 . . . . 0.0 111.784 -175.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.15 -170.23 3.06 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -174.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.71 140.92 36.92 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 126.043 1.737 . . . . 0.0 110.447 175.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -67.0 149.36 50.74 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 174.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 29.3 mt -119.79 158.42 26.59 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-O 123.824 1.773 . . . . 0.0 111.435 178.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -64.45 -157.5 0.23 Allowed Glycine 0 CA--C 1.54 1.623 0 C-N-CA 125.62 1.581 . . . . 0.0 111.2 174.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 51.46 15.12 0.3 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.944 -1.327 . . . . 0.0 114.527 175.016 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 72.66 34.83 59.46 Favored Glycine 0 CA--C 1.54 1.608 0 CA-C-O 117.141 -1.922 . . . . 0.0 113.805 -175.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -139.21 159.41 42.23 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 121.21 2.505 . . . . 0.0 115.188 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 19.4 mtt-85 -135.33 123.7 23.28 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 120.439 -1.413 . . . . 0.0 108.693 -177.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 13.7 ttp -96.14 136.38 36.69 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 176.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.85 129.21 56.33 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 126.803 2.041 . . . . 0.0 109.867 -178.054 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -136.8 156.36 23.16 Favored Glycine 0 N--CA 1.476 1.36 0 CA-C-N 121.684 2.038 . . . . 0.0 116.293 -177.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.413 HD13 ' H ' ' A' ' 147' ' ' TRP . 6.1 tp -154.56 126.43 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 124.96 1.304 . . . . 0.0 112.527 -174.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 19.5 ttm -148.82 -176.27 5.27 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 128.641 2.776 . . . . 0.0 108.509 177.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 8.9 t -163.01 127.31 2.98 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.527 1.131 . . . . 0.0 111.631 174.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.37 19.61 0.1 Allowed 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.027 1.331 . . . . 0.0 114.11 178.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -58.34 -25.94 62.55 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 127.291 2.236 . . . . 0.0 115.631 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 147.14 -57.87 0.49 Allowed Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.562 1.077 . . . . 0.0 114.48 175.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -133.28 37.9 3.34 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.144 1.378 . . . . 0.0 112.001 -178.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.33 174.58 4.65 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-O 122.61 1.195 . . . . 0.0 113.849 175.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.64 176.26 5.22 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 127.741 2.416 . . . . 0.0 111.527 175.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 1.8 tmm? -128.18 130.91 48.76 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 126.277 1.831 . . . . 0.0 109.648 175.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -141.14 131.39 24.96 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.48 1.112 . . . . 0.0 110.203 -178.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 4.0 mp -136.11 126.01 40.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 123.883 0.873 . . . . 0.0 109.612 175.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -119.39 129.27 54.72 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 126.516 1.926 . . . . 0.0 111.119 178.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.6 mp -88.55 93.1 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 O-C-N 121.278 -0.889 . . . . 0.0 109.692 -177.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.04 107.51 19.26 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.628 1.571 . . . . 0.0 112.691 179.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.252 1.188 0 C-N-CA 125.547 1.539 . . . . 0.0 112.836 175.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 16.0 m . . . . . 0 N--CA 1.482 1.138 0 CA-C-O 120.33 0.11 . . . . 0.0 110.815 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -84.3 169.43 14.69 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.785 1.234 . . . . 0.0 112.781 177.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 13.7 tp -130.11 -7.82 4.35 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.716 1.206 . . . . 0.0 113.779 174.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -126.1 141.11 52.08 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 127.813 2.445 . . . . 0.0 109.213 175.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -79.75 -136.95 1.51 Allowed Glycine 0 CA--C 1.538 1.504 0 C-N-CA 124.844 1.212 . . . . 0.0 110.989 174.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.0 p -107.31 176.01 5.3 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 125.5 1.52 . . . . 0.0 112.941 -175.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -119.13 17.26 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 126.352 1.861 . . . . 0.0 111.945 -178.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.3 pt -50.39 159.64 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 125.662 1.585 . . . . 0.0 111.349 175.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -42.82 140.26 1.4 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.456 1.502 . . . . 0.0 113.328 -176.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -56.29 -20.9 31.01 Favored Glycine 0 CA--C 1.543 1.788 0 C-N-CA 124.28 0.943 . . . . 0.0 113.745 -176.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.2 -28.55 69.82 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.621 1.568 . . . . 0.0 112.609 174.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 t -101.28 -44.57 5.61 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.974 1.71 . . . . 0.0 111.515 175.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.7 tp -75.81 88.49 2.84 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.278 1.031 . . . . 0.0 111.429 175.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 55.1 p -124.65 -175.09 3.18 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 126.156 1.782 . . . . 0.0 111.344 176.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -50.3 -31.36 14.13 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.851 1.26 . . . . 0.0 113.645 175.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -59.46 -50.31 74.4 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 118.97 0.805 . . . . 0.0 110.902 175.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 73.8 t -64.53 -39.13 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 123.915 0.886 . . . . 0.0 110.974 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 90.2 mt -70.58 -42.12 71.48 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 123.349 0.66 . . . . 0.0 112.62 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -71.17 -44.21 65.93 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.953 0.901 . . . . 0.0 111.607 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.72 -39.8 95.2 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 118.426 -0.797 . . . . 0.0 110.826 175.012 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.0 t -53.5 -43.59 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 125.054 1.342 . . . . 0.0 112.271 175.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.455 ' HA ' ' HE3' ' A' ' 31' ' ' LYS . 0.1 OUTLIER -60.39 -25.99 66.33 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 175.015 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.57 -48.92 3.33 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.203 0.906 . . . . 0.0 112.979 178.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -70.61 -27.44 64.09 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 17.8 mt -109.31 102.22 11.15 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.737 1.215 . . . . 0.0 110.461 -177.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -131.77 73.15 0.47 Allowed Glycine 0 CA--C 1.534 1.252 0 C-N-CA 125.112 1.339 . . . . 0.0 113.364 -175.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.0 -58.68 6.96 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 126.416 1.886 . . . . 0.0 113.683 -178.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 16.4 m -127.27 -176.92 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 126.497 1.919 . . . . 0.0 110.748 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -47.98 -36.49 12.71 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 115.576 1.695 . . . . 0.0 115.576 -175.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.8 155.69 49.48 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.711 2.004 . . . . 0.0 108.01 174.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.455 ' HE3' ' HA ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -145.67 164.19 32.55 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.919 1.287 . . . . 0.0 110.768 175.988 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -118.49 138.16 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 124.572 1.149 . . . . 0.0 108.439 175.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -138.68 132.04 30.22 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.147 1.379 . . . . 0.0 109.597 175.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.5 t -137.91 148.29 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 123.364 0.666 . . . . 0.0 111.398 -177.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -119.47 93.13 0.54 Allowed Glycine 0 CA--C 1.525 0.677 0 C-N-CA 126.658 2.075 . . . . 0.0 113.161 175.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.7 mp -81.4 136.43 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-N 119.424 1.612 . . . . 0.0 108.788 174.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -112.65 102.46 10.52 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.164 1.786 . . . . 0.0 109.868 178.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -70.32 92.43 0.79 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.867 1.267 . . . . 0.0 109.563 177.182 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -117.29 0.26 12.2 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.052 1.741 . . . . 0.0 112.722 174.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 23.0 t -50.77 -58.89 4.82 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 126.141 1.776 . . . . 0.0 113.249 -178.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 149.49 -26.4 1.21 Allowed Glycine 0 N--CA 1.473 1.15 0 C-N-CA 124.165 0.888 . . . . 0.0 114.113 178.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -115.96 162.79 12.47 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.541 1.544 . . . . 0.0 111.226 175.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.4 t -85.13 155.58 21.41 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 123.879 0.872 . . . . 0.0 110.781 175.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 7.7 m0 -111.46 153.57 25.95 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 125.352 1.461 . . . . 0.0 112.031 176.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 95.0 m -130.24 141.46 50.63 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.853 1.261 . . . . 0.0 109.925 177.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.47 108.83 0.52 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.749 1.22 . . . . 0.0 112.571 177.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.5 pp -104.85 -53.71 2.63 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.286 1.034 . . . . 0.0 112.234 -179.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 29.3 t30 -177.73 144.8 0.38 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 127.907 2.483 . . . . 0.0 110.415 -178.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -130.54 159.31 37.5 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.111 1.365 . . . . 0.0 111.512 175.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -142.92 104.2 4.29 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.878 1.271 . . . . 0.0 112.944 -175.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -94.09 137.37 33.36 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.376 -0.827 . . . . 0.0 111.902 178.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.3 ttt-85 -98.49 -70.12 0.74 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.138 1.775 . . . . 0.0 111.24 178.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -39.72 -54.62 2.05 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 128.21 2.604 . . . . 0.0 113.722 -175.034 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -157.69 -118.53 0.55 Allowed Glycine 0 CA--C 1.526 0.751 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 175.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.6 p -141.93 175.67 9.54 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.822 1.649 . . . . 0.0 111.87 -174.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.7 t -156.51 -176.92 6.23 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.313 1.045 . . . . 0.0 112.755 176.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -102.63 -65.03 1.02 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.39 1.476 . . . . 0.0 112.786 177.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.2 p -130.19 131.68 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 125.551 1.541 . . . . 0.0 111.187 -177.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.468 HG12 ' H ' ' A' ' 60' ' ' LEU . 0.1 OUTLIER -136.85 -63.54 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 125.346 1.458 . . . . 0.0 111.712 -174.969 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.468 ' H ' HG12 ' A' ' 59' ' ' ILE . 80.5 mt -88.37 105.53 9.78 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 125.355 1.462 . . . . 0.0 110.265 175.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -73.33 168.48 24.64 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 123.305 2.67 . . . . 0.0 110.992 175.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -49.45 -44.92 46.02 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.139 0.976 . . . . 0.0 113.544 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 53.7 t -151.13 147.83 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 C-N-CA 126.838 2.055 . . . . 0.0 109.426 -176.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.6 t -125.9 95.07 40.52 Favored Pre-proline 0 N--CA 1.468 0.443 0 C-N-CA 124.913 1.285 . . . . 0.0 108.132 174.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.31 158.04 55.43 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.153 1.902 . . . . 0.0 112.253 176.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -71.53 169.52 15.28 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.092 0.557 . . . . 0.0 111.593 175.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . 0.252 26.0 p 56.79 18.76 3.97 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 127.442 2.297 . . . . 0.0 112.954 -174.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -130.9 172.0 12.54 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 126.86 2.064 . . . . 0.0 110.683 -178.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -134.89 167.43 20.92 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.345 0.658 . . . . 0.0 109.344 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.8 pp -139.16 166.43 24.56 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 124.68 1.192 . . . . 0.0 111.745 177.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.05 152.57 23.84 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 122.134 0.969 . . . . 0.0 111.07 174.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -132.8 149.03 52.31 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 126.64 1.976 . . . . 0.0 109.738 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 94.8 p -148.03 159.9 43.42 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.023 0.929 . . . . 0.0 113.198 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -170.49 148.47 11.54 Favored Glycine 0 N--CA 1.463 0.46 0 CA-C-N 115.738 -0.664 . . . . 0.0 114.316 177.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 58.4 mtm180 -110.33 148.77 31.29 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 125.937 1.695 . . . . 0.0 110.271 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -89.35 -33.52 16.87 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.551 1.54 . . . . 0.0 114.053 176.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 28.6 t -64.31 105.47 0.92 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.634 1.174 . . . . 0.0 112.363 -174.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 42.8 t -112.32 -18.31 12.53 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.817 1.647 . . . . 0.0 113.125 178.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 121.48 -75.2 0.34 Allowed Glycine 0 CA--C 1.537 1.468 0 C-N-CA 125.842 1.687 . . . . 0.0 112.595 -178.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -73.17 -37.36 3.46 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.371 2.714 . . . . 0.0 113.5 -175.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.2 p -146.56 155.79 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 126.935 2.094 . . . . 0.0 109.31 179.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -136.47 83.98 2.04 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.16 0.984 . . . . 0.0 111.319 -178.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.6 m -66.26 138.04 57.37 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.306 1.042 . . . . 0.0 110.349 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -34.47 -74.98 0.07 OUTLIER Glycine 0 N--CA 1.471 0.991 0 C-N-CA 126.715 2.102 . . . . 0.0 117.518 -175.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -165.63 91.83 0.51 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.329 1.052 . . . . 0.0 111.51 -174.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 20.4 t -140.11 122.38 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 O-C-N 120.566 -1.333 . . . . 0.0 112.616 -175.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.38 167.6 29.86 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 122.353 1.073 . . . . 0.0 112.882 176.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -146.16 149.97 34.99 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 124.064 0.946 . . . . 0.0 109.84 174.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -151.2 174.12 13.62 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 121.039 -1.038 . . . . 0.0 110.356 178.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -138.21 150.61 46.9 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-O 121.176 0.512 . . . . 0.0 112.358 176.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -129.63 117.1 19.84 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 126.939 2.096 . . . . 0.0 112.597 -175.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -80.89 99.72 8.49 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -174.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 20.2 mtm -72.0 127.42 32.51 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.415 1.086 . . . . 0.0 112.237 178.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.6 m -57.56 -18.88 21.79 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.851 1.26 . . . . 0.0 113.414 174.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -64.27 -28.13 69.51 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.631 1.572 . . . . 0.0 112.139 174.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 120.07 19.19 4.03 Favored Glycine 0 CA--C 1.538 1.502 0 C-N-CA 125.819 1.676 . . . . 0.0 115.229 -178.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -128.04 175.82 8.1 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 119.14 1.47 . . . . 0.0 110.899 -178.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 22.7 m -134.48 103.91 5.89 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 121.064 -1.022 . . . . 0.0 111.621 176.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 42.1 tp -68.82 103.49 1.79 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.729 0.812 . . . . 0.0 112.026 175.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -91.71 96.18 2.14 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 126.316 1.912 . . . . 0.0 110.858 175.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 53.8 t -79.93 136.97 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 O-C-N 121.895 -0.768 . . . . 0.0 110.771 175.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.74 141.1 47.37 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.287 1.035 . . . . 0.0 111.593 176.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -153.64 120.08 5.52 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 120.887 -1.133 . . . . 0.0 111.501 -174.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 32.8 t -127.47 107.24 9.78 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.915 1.286 . . . . 0.0 110.987 -177.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 4.4 t -118.69 127.3 26.63 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 126.599 1.96 . . . . 0.0 108.674 -176.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -72.77 169.78 21.19 Favored 'Trans proline' 0 CA--C 1.532 0.403 0 C-N-CA 123.388 2.726 . . . . 0.0 113.407 -175.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -74.62 -66.48 0.73 Allowed 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.323 1.049 . . . . 0.0 111.562 175.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -106.22 7.22 31.39 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.215 1.806 . . . . 0.0 115.063 -174.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 54.88 41.99 31.46 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 125.65 1.58 . . . . 0.0 113.467 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 40.5 p-10 -60.56 -179.23 0.11 Allowed 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 126.932 2.093 . . . . 0.0 114.945 176.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 4.2 p90 -53.5 -30.01 39.21 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 126.986 2.114 . . . . 0.0 114.665 176.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -59.29 120.28 8.97 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.408 1.083 . . . . 0.0 108.663 175.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 55.0 m -62.48 150.45 40.08 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 121.426 -0.796 . . . . 0.0 110.907 177.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -137.76 107.1 6.1 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.645 1.178 . . . . 0.0 110.66 -178.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 41.5 m0 -109.83 162.36 14.56 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 125.284 1.434 . . . . 0.0 113.442 -174.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 61.0 p-90 -145.57 132.41 20.1 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.776 0.798 . . . . 0.0 112.273 177.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -144.25 174.47 10.86 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.826 1.65 . . . . 0.0 111.652 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.5 m -145.03 159.72 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 175.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.63 170.97 14.93 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.764 0.826 . . . . 0.0 111.045 175.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.412 ' HB ' ' CE2' ' A' ' 154' ' ' TYR . 45.5 mt -131.54 104.6 8.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 176.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -71.97 148.91 92.2 Favored Pre-proline 0 CA--C 1.55 0.964 0 O-C-N 121.938 -0.476 . . . . 0.0 110.94 178.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -77.87 82.67 2.36 Favored 'Trans proline' 0 CA--C 1.545 1.037 0 C-N-CA 123.802 3.002 . . . . 0.0 112.37 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 98.54 178.03 32.56 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 125.958 1.742 . . . . 0.0 112.892 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 5.9 mttt -47.7 122.02 4.54 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.116 1.366 . . . . 0.0 112.508 -174.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -135.23 -161.55 1.16 Allowed 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 126.608 1.963 . . . . 0.0 111.433 -177.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 23.5 ptt-85 -140.17 -178.17 5.35 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 128.553 2.741 . . . . 0.0 109.181 175.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -131.67 124.21 29.38 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 174.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -135.72 168.66 18.87 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.375 1.07 . . . . 0.0 111.162 178.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.93 -40.77 73.62 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.538 -0.726 . . . . 0.0 112.5 -176.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -57.22 -58.64 13.56 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 124.53 1.062 . . . . 0.0 112.177 175.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 3.3 mpp? -59.58 -32.67 70.58 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 118.528 1.164 . . . . 0.0 112.5 177.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.27 -63.2 1.31 Allowed 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 175.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -67.17 -30.03 69.88 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -175.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -64.78 -43.46 93.17 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.219 1.008 . . . . 0.0 112.101 175.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.15 -25.81 23.91 Favored 'General case' 0 CA--C 1.546 0.799 0 O-C-N 121.558 -0.714 . . . . 0.0 112.558 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -47.2 -53.65 12.64 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 127.744 2.418 . . . . 0.0 111.859 175.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -63.39 -15.61 58.05 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -74.03 -32.4 58.67 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 128.312 2.863 . . . . 0.0 115.666 -175.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -129.15 90.23 45.82 Favored Pre-proline 0 CA--C 1.546 0.826 0 CA-C-N 119.032 1.416 . . . . 0.0 111.274 175.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -73.2 83.35 1.47 Allowed 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 123.58 2.853 . . . . 0.0 112.87 -176.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -122.46 122.28 38.6 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.739 1.215 . . . . 0.0 112.05 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -104.31 63.91 0.75 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.736 1.614 . . . . 0.0 111.276 -174.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 51.38 60.05 7.71 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 123.971 0.796 . . . . 0.0 112.683 -175.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.83 101.81 3.24 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 126.186 1.794 . . . . 0.0 112.362 -175.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -74.03 55.13 0.55 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 127.627 2.371 . . . . 0.0 116.516 -174.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -166.29 43.78 0.27 Allowed Glycine 0 CA--C 1.533 1.202 0 O-C-N 120.921 -1.112 . . . . 0.0 115.672 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 1.1 m95 52.65 40.51 30.32 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 125.276 1.43 . . . . 0.0 113.773 -176.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -78.9 124.06 27.87 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 126.099 1.76 . . . . 0.0 112.123 -176.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -167.89 -171.54 1.61 Allowed 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.781 0.832 . . . . 0.0 111.785 177.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 4.8 mtpp -138.18 160.91 38.18 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 127.89 2.476 . . . . 0.0 110.977 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 37.7 m-20 -67.26 152.5 45.62 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 122.144 -0.347 . . . . 0.0 110.426 174.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 37.6 mt -108.09 162.03 14.42 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 122.19 0.995 . . . . 0.0 109.06 175.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -62.45 -167.47 0.68 Allowed Glycine 0 CA--C 1.536 1.358 0 C-N-CA 124.512 1.053 . . . . 0.0 111.616 175.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.412 ' CE2' ' HB ' ' A' ' 120' ' ' ILE . 0.0 OUTLIER 55.09 6.28 0.13 Allowed 'General case' 0 CA--C 1.558 1.281 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 174.957 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 82.02 44.88 7.4 Favored Glycine 0 CA--C 1.54 1.607 0 C-N-CA 127.438 2.447 . . . . 0.0 114.427 -175.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.1 mp -127.82 158.03 38.84 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 119.866 1.833 . . . . 0.0 113.123 -178.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -124.65 117.31 23.97 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 121.061 -1.024 . . . . 0.0 110.478 175.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -98.21 150.24 21.71 Favored 'General case' 0 C--N 1.322 -0.623 0 O-C-N 120.623 -1.298 . . . . 0.0 108.784 174.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -131.4 149.02 52.71 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 127.076 2.151 . . . . 0.0 110.35 176.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -157.52 159.39 29.77 Favored Glycine 0 N--CA 1.464 0.525 0 O-C-N 121.542 -0.724 . . . . 0.0 113.446 176.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -155.15 137.54 6.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 125.222 1.409 . . . . 0.0 109.894 -178.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 2.5 mtm -150.1 167.22 27.44 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 127.388 2.275 . . . . 0.0 108.345 174.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 9.7 t -145.42 133.45 21.42 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 118.942 0.792 . . . . 0.0 109.858 174.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 81.9 p -82.05 30.05 0.4 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.526 1.131 . . . . 0.0 113.729 -176.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -65.61 21.64 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 128.322 2.649 . . . . 0.0 115.432 -177.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 79.84 -44.19 2.73 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 127.554 2.502 . . . . 0.0 113.333 -177.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -143.18 77.24 1.56 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.351 1.46 . . . . 0.0 110.153 -177.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -130.71 166.35 20.93 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.033 1.333 . . . . 0.0 114.047 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.14 169.74 10.38 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 126.948 2.099 . . . . 0.0 113.782 -176.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 11.3 ttt -115.87 145.79 42.57 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.255 1.822 . . . . 0.0 110.891 173.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -149.32 119.14 7.06 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 120.753 -1.217 . . . . 0.0 110.237 174.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 1.8 mp -121.25 130.56 74.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 125.485 1.514 . . . . 0.0 108.267 178.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.8 137.79 43.68 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.876 1.27 . . . . 0.0 110.448 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.6 mp -95.3 95.13 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-N 119.352 0.978 . . . . 0.0 109.518 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 19.3 m -64.55 138.62 58.51 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.981 1.312 . . . . 0.0 111.79 175.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 7.0 mtp180 . . . . . 0 C--O 1.253 1.26 0 O-C-N 120.238 -1.539 . . . . 0.0 112.608 174.938 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 6.9 t . . . . . 0 N--CA 1.488 1.46 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -64.42 178.64 0.7 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.884 1.273 . . . . 0.0 111.878 174.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.6 mt -109.65 9.21 25.08 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.833 1.653 . . . . 0.0 112.603 178.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -113.21 126.77 55.78 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 127.544 2.338 . . . . 0.0 111.391 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -79.69 -121.54 0.37 Allowed Glycine 0 CA--C 1.536 1.402 0 C-N-CA 125.036 1.303 . . . . 0.0 112.79 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 30.8 p -94.78 171.57 8.69 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.754 1.222 . . . . 0.0 112.397 177.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -130.53 12.32 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 C-N-CA 125.764 1.626 . . . . 0.0 112.002 177.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.6 pp -58.63 172.03 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 O-C-N 120.563 -1.336 . . . . 0.0 112.103 176.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -35.38 129.39 0.54 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.798 2.039 . . . . 0.0 114.729 -175.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -55.57 -21.81 29.57 Favored Glycine 0 CA--C 1.537 1.424 0 C-N-CA 124.673 1.13 . . . . 0.0 114.444 -178.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.1 -31.76 72.25 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.874 1.269 . . . . 0.0 112.048 174.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -100.7 -36.61 9.06 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.963 1.705 . . . . 0.0 112.059 175.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 12.5 tp -79.0 86.16 4.88 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-O 122.1 0.952 . . . . 0.0 110.562 174.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -121.23 178.21 4.86 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 127.565 2.346 . . . . 0.0 112.131 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -42.28 -45.3 4.14 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.562 1.545 . . . . 0.0 113.765 174.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -53.4 -43.53 67.96 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 118.934 0.788 . . . . 0.0 112.449 178.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 86.6 t -64.11 -43.96 97.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.738 1.215 . . . . 0.0 110.799 174.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 68.1 mt -63.82 -41.8 97.78 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.2 -0.938 . . . . 0.0 111.737 179.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -67.28 -44.63 78.81 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.734 1.214 . . . . 0.0 112.576 178.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.08 -37.77 78.65 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 121.476 -0.765 . . . . 0.0 111.357 175.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.9 t -56.67 -38.11 56.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.951 1.3 . . . . 0.0 110.956 178.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 11.1 mt -56.65 -25.89 54.78 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.499 1.519 . . . . 0.0 113.239 175.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -106.28 -46.52 1.15 Allowed Glycine 0 CA--C 1.534 1.243 0 C-N-CA 125.566 1.555 . . . . 0.0 114.692 -178.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -63.96 -27.97 69.5 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 119.243 1.521 . . . . 0.0 113.288 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 19.7 mt -96.54 76.8 2.9 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.9 1.28 . . . . 0.0 110.635 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.59 114.9 5.09 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 126.14 1.829 . . . . 0.0 112.387 178.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -132.47 -74.03 0.51 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.655 1.582 . . . . 0.0 111.919 -179.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.3 m -131.68 177.79 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 126.419 1.887 . . . . 0.0 111.129 -177.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.87 -30.08 68.75 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -177.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.79 117.01 10.07 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.755 1.622 . . . . 0.0 111.443 178.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.24 152.56 42.82 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 125.399 1.48 . . . . 0.0 109.559 -177.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -114.62 133.06 61.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 123.58 0.752 . . . . 0.0 109.438 177.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -134.91 104.77 6.11 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 127.119 2.167 . . . . 0.0 109.795 176.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.4 m -103.82 160.77 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 123.517 0.727 . . . . 0.0 110.358 178.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -138.64 109.83 0.69 Allowed Glycine 0 CA--C 1.519 0.328 0 CA-C-N 118.645 0.657 . . . . 0.0 112.69 174.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.46 ' H ' HD11 ' A' ' 70' ' ' LEU . 3.1 mp -103.96 139.14 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-N 117.313 0.556 . . . . 0.0 110.724 176.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -110.55 104.16 12.85 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.006 1.322 . . . . 0.0 110.704 -177.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -72.6 91.5 1.43 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 127.162 2.185 . . . . 0.0 110.616 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -120.88 9.24 10.61 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.498 1.519 . . . . 0.0 113.331 174.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 37.5 t -50.94 -47.04 61.16 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 125.987 1.715 . . . . 0.0 113.672 177.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 139.99 -21.41 2.82 Favored Glycine 0 N--CA 1.473 1.161 0 C-N-CA 124.452 1.025 . . . . 0.0 114.208 175.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -122.56 167.18 14.97 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 125.724 1.631 . . . . 0.0 111.564 174.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 44.3 p -74.28 145.71 43.78 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.177 0.513 . . . . 0.0 110.674 174.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 49.5 m0 -98.95 104.71 16.78 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 123.593 0.757 . . . . 0.0 110.898 178.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.0 m -82.67 125.3 31.06 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.186 0.994 . . . . 0.0 110.117 176.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.79 117.51 5.95 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.109 0.964 . . . . 0.0 111.309 174.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.6 pp -98.23 -48.99 4.87 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.483 0.713 . . . . 0.0 112.758 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -174.56 152.17 1.63 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 128.213 2.605 . . . . 0.0 109.263 -177.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -136.38 160.54 38.43 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.616 1.166 . . . . 0.0 111.793 174.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -137.78 107.48 6.24 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.653 1.181 . . . . 0.0 112.284 -179.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -107.94 128.7 54.87 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.421 1.088 . . . . 0.0 110.987 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.66 -34.27 5.57 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -176.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.9 t -121.47 -49.46 2.14 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 125.602 1.561 . . . . 0.0 110.594 176.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -66.91 12.56 0.54 Allowed Glycine 0 CA--C 1.536 1.373 0 C-N-CA 125.911 1.72 . . . . 0.0 115.658 -176.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 74.6 p -30.95 109.39 0.06 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 129.089 2.956 . . . . 0.0 114.271 -174.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.5 t -129.25 179.17 5.93 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.437 1.495 . . . . 0.0 113.215 -175.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -78.77 -59.15 2.89 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.994 1.718 . . . . 0.0 112.225 174.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.9 p -143.42 136.64 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 125.597 1.559 . . . . 0.0 111.977 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.4 pp -140.2 -26.3 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 126.07 1.748 . . . . 0.0 114.296 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -99.22 93.54 2.22 Favored Pre-proline 0 CA--C 1.541 0.611 0 C-N-CA 125.212 1.405 . . . . 0.0 108.995 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -61.64 143.06 96.37 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.775 2.316 . . . . 0.0 110.389 174.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -40.11 -48.92 2.56 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.429 1.891 . . . . 0.0 113.84 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.7 p -156.1 138.66 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 127.295 2.238 . . . . 0.0 109.188 175.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 22.0 t -112.27 121.99 37.79 Favored Pre-proline 0 N--CA 1.477 0.897 0 C-N-CA 124.233 1.013 . . . . 0.0 108.902 175.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -67.8 157.78 60.23 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 122.015 1.81 . . . . 0.0 112.946 177.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -71.65 168.58 17.39 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.575 0.75 . . . . 0.0 111.52 175.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 43.7 p 54.44 19.11 2.18 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 127.286 2.234 . . . . 0.0 113.79 -174.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.8 mttt -134.29 171.72 13.87 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 126.918 2.087 . . . . 0.0 110.951 -175.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -127.97 177.16 7.06 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.071 0.462 . . . . 0.0 110.146 -175.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.46 HD11 ' H ' ' A' ' 36' ' ' ILE . 1.9 pp -142.84 173.47 11.52 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 124.181 0.992 . . . . 0.0 111.255 -178.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -132.47 151.62 51.83 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.937 1.295 . . . . 0.0 111.007 174.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -124.14 146.04 48.91 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.162 0.985 . . . . 0.0 108.595 174.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.8 p -121.28 137.1 54.84 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 126.401 1.88 . . . . 0.0 110.997 175.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -160.95 133.34 3.17 Favored Glycine 0 CA--C 1.525 0.7 0 O-C-N 121.785 -0.572 . . . . 0.0 113.822 174.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 26.3 mtm180 -90.68 149.7 21.96 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.946 1.298 . . . . 0.0 110.988 -174.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 9.9 ptmt -76.56 -20.47 56.81 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 174.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.4 t -81.76 74.41 8.75 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.027 1.331 . . . . 0.0 112.719 -174.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.9 t -65.9 -26.94 67.84 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.512 0.931 . . . . 0.0 113.512 178.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 123.21 -72.96 0.4 Allowed Glycine 0 CA--C 1.538 1.485 0 C-N-CA 126.027 1.775 . . . . 0.0 112.797 -178.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -70.82 -44.16 1.47 Allowed 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.399 2.733 . . . . 0.0 112.731 -177.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.5 m -137.64 126.37 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 126.268 1.827 . . . . 0.0 110.925 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -78.38 125.81 29.88 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.998 1.319 . . . . 0.0 111.012 174.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 97.7 m -144.17 131.45 20.78 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.143 1.377 . . . . 0.0 109.62 -177.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -26.05 -68.07 0.05 OUTLIER Glycine 0 N--CA 1.48 1.628 0 C-N-CA 127.422 2.439 . . . . 0.0 115.013 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -177.58 135.79 0.19 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.371 1.868 . . . . 0.0 111.82 175.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.9 t -154.85 129.42 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 125.139 1.376 . . . . 0.0 109.094 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -173.32 174.48 3.32 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.442 1.497 . . . . 0.0 111.732 177.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -151.18 141.49 22.36 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.108 1.363 . . . . 0.0 110.169 174.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -138.45 171.52 14.25 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 121.233 -0.917 . . . . 0.0 111.231 178.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -139.43 156.24 47.09 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.391 0.615 . . . . 0.0 112.551 177.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -135.08 129.09 33.44 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 125.833 1.653 . . . . 0.0 112.421 -174.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -83.4 135.11 34.82 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -176.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.24 138.18 44.96 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 125.086 1.355 . . . . 0.0 111.917 178.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.8 t -62.8 -22.5 66.67 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.493 1.117 . . . . 0.0 113.164 176.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -67.41 -16.15 64.07 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.121 1.368 . . . . 0.0 113.321 175.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 101.28 33.89 4.71 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 124.845 1.212 . . . . 0.0 114.558 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 -140.6 177.07 8.28 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-N 119.204 1.502 . . . . 0.0 110.95 177.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 19.2 m -130.67 105.83 8.08 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.668 1.587 . . . . 0.0 112.457 -176.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 59.6 tp -68.4 104.42 1.89 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.715 1.206 . . . . 0.0 111.271 175.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -99.32 116.95 5.72 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 125.947 1.737 . . . . 0.0 113.084 179.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 57.3 t -105.14 129.07 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 126.218 1.807 . . . . 0.0 111.341 -174.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -127.12 130.24 49.44 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.673 1.589 . . . . 0.0 112.273 -174.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -146.02 140.56 26.91 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.644 1.177 . . . . 0.0 112.484 -176.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.28 123.37 10.79 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.181 1.392 . . . . 0.0 111.967 -174.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 96.4 t -100.33 123.74 45.47 Favored Pre-proline 0 N--CA 1.481 1.084 0 C-N-CA 125.065 1.346 . . . . 0.0 111.686 -177.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.441 ' HA ' ' CE2' ' A' ' 109' ' ' TYR . 76.5 Cg_endo -71.02 84.26 0.87 Allowed 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 124.795 3.663 . . . . 0.0 112.768 -178.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -128.43 -29.53 2.44 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.081 1.352 . . . . 0.0 113.073 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -98.91 -37.88 9.23 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.837 1.255 . . . . 0.0 111.519 174.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.441 ' CE2' ' HA ' ' A' ' 106' ' ' PRO . 0.1 OUTLIER -85.41 84.25 7.7 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.386 1.474 . . . . 0.0 111.641 177.996 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -74.65 -9.78 58.9 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 123.881 0.873 . . . . 0.0 113.05 175.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 55.8 m95 -115.95 -46.01 2.84 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 127.017 2.127 . . . . 0.0 111.622 -176.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -68.56 173.07 5.37 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.708 1.203 . . . . 0.0 110.13 174.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.4 m -109.57 153.97 23.4 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 121.389 -0.819 . . . . 0.0 111.623 174.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -73.36 117.68 15.4 Favored 'General case' 0 C--O 1.226 -0.18 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 174.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 34.4 m0 -113.68 143.59 44.35 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 176.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 37.3 p-90 -148.85 138.58 21.99 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.206 1.002 . . . . 0.0 111.268 -177.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -150.04 162.86 39.57 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 122.801 1.286 . . . . 0.0 113.279 -177.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 61.7 t -145.53 144.34 21.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 124.24 1.016 . . . . 0.0 108.311 175.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.454 ' HE2' ' SD ' ' A' ' 135' ' ' MET . 0.0 OUTLIER -155.9 176.71 12.28 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.908 1.683 . . . . 0.0 110.141 175.577 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.483 ' HB ' ' CE1' ' A' ' 154' ' ' TYR . 11.7 mt -126.32 99.59 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-O 121.86 0.838 . . . . 0.0 108.955 178.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -59.68 148.25 75.64 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 124.105 0.962 . . . . 0.0 111.84 178.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -70.5 135.54 28.94 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.986 2.457 . . . . 0.0 111.838 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 59.13 -157.82 22.42 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 124.057 0.837 . . . . 0.0 113.528 -177.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 9.9 tttt -72.75 120.02 17.78 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.975 0.91 . . . . 0.0 108.735 174.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 25.0 tpp180 -130.68 169.62 15.42 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 125.868 1.667 . . . . 0.0 109.447 175.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 25.6 ptt180 -119.89 175.33 5.95 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 126.549 1.94 . . . . 0.0 110.6 174.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -120.3 108.11 13.77 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 175.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -126.27 165.7 18.48 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.901 1.28 . . . . 0.0 110.01 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -55.66 -36.81 67.49 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 121.302 -0.874 . . . . 0.0 113.203 -176.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -59.7 -61.29 7.39 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.442 -0.663 . . . . 0.0 111.442 174.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -62.98 -33.11 74.7 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 118.367 1.084 . . . . 0.0 112.833 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -58.35 -63.11 1.39 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.625 1.17 . . . . 0.0 108.987 174.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -69.27 -27.2 65.22 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -177.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -68.23 -32.06 71.99 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.741 1.216 . . . . 0.0 113.418 175.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' MET . . . . . 0.454 ' SD ' ' HE2' ' A' ' 119' ' ' LYS . 0.7 OUTLIER -94.89 -25.48 16.56 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 121.274 -0.891 . . . . 0.0 112.076 176.667 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -51.99 -57.6 9.01 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.769 2.028 . . . . 0.0 110.02 174.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -67.22 -10.19 48.01 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 113.526 0.935 . . . . 0.0 113.526 -178.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -83.6 -16.03 69.45 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 126.638 2.066 . . . . 0.0 114.273 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -142.14 87.26 9.76 Favored Pre-proline 0 CA--C 1.549 0.925 0 CA-C-N 118.661 1.231 . . . . 0.0 112.001 179.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.95 77.97 1.85 Allowed 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 123.675 2.916 . . . . 0.0 112.472 177.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -108.59 115.05 29.36 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.32 1.448 . . . . 0.0 109.826 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 9.5 mtp180 -92.93 26.88 2.6 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 126.909 2.083 . . . . 0.0 115.969 -174.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 62.38 59.69 9.01 Favored Glycine 0 CA--C 1.531 1.051 0 N-CA-C 109.106 -1.597 . . . . 0.0 109.106 -175.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -64.28 105.81 0.98 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.182 0.993 . . . . 0.0 110.006 176.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -68.02 83.48 0.22 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.213 1.405 . . . . 0.0 114.33 -174.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 170.24 48.71 0.03 OUTLIER Glycine 0 CA--C 1.537 1.462 0 C-N-CA 124.967 1.27 . . . . 0.0 114.468 177.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 2.2 m95 54.65 44.09 29.16 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 125.782 1.633 . . . . 0.0 114.728 -177.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -79.62 130.62 35.53 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 120.61 -1.306 . . . . 0.0 112.77 -175.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.02 -175.16 4.93 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -175.015 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.2 pttt -131.0 156.72 44.64 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.194 1.397 . . . . 0.0 111.672 174.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 28.6 m-80 -78.14 124.17 27.74 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 174.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 69.3 mt -81.52 149.11 28.85 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 122.201 1.001 . . . . 0.0 109.33 174.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -66.08 -166.48 2.04 Favored Glycine 0 CA--C 1.535 1.303 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 174.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.483 ' CE1' ' HB ' ' A' ' 120' ' ' ILE . 0.0 OUTLIER 54.3 11.49 0.4 Allowed 'General case' 0 CA--C 1.557 1.233 0 N-CA-C 114.988 1.477 . . . . 0.0 114.988 174.969 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 84.94 37.3 10.26 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 126.542 2.02 . . . . 0.0 113.208 -178.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.7 mp -122.74 160.21 26.41 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 119.843 1.822 . . . . 0.0 113.038 -178.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 72.2 mtt85 -149.06 109.77 4.26 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 120.636 -1.29 . . . . 0.0 111.082 -178.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 9.0 ttp -104.73 132.77 50.58 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 124.025 0.93 . . . . 0.0 108.893 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 7.1 tppt? -111.14 129.65 55.87 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 127.967 2.507 . . . . 0.0 110.593 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -137.21 156.17 23.25 Favored Glycine 0 N--CA 1.474 1.208 0 CA-C-N 120.7 1.591 . . . . 0.0 115.959 -177.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 4.5 tp -148.58 127.8 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 124.77 1.228 . . . . 0.0 112.069 -175.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 16.1 mtm -151.5 169.81 21.17 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 128.489 2.716 . . . . 0.0 109.892 174.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 14.5 t -156.23 135.27 12.0 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.714 1.606 . . . . 0.0 109.597 174.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 61.7 p -81.32 20.04 0.9 Allowed 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 179.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.85 -34.7 65.68 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.486 1.914 . . . . 0.0 115.108 -177.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 154.01 -63.45 0.36 Allowed Glycine 0 CA--C 1.533 1.176 0 C-N-CA 124.386 0.993 . . . . 0.0 114.29 176.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -119.79 27.82 8.49 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 125.718 1.607 . . . . 0.0 112.669 -175.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -64.03 174.59 1.47 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.839 1.255 . . . . 0.0 113.269 174.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.57 168.14 13.01 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.735 2.014 . . . . 0.0 111.248 177.015 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 48.5 ttp -111.51 123.87 51.11 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.816 1.246 . . . . 0.0 110.45 176.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -137.46 128.02 26.77 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 123.255 0.622 . . . . 0.0 110.325 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 5.1 mp -134.9 119.27 27.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 123.461 0.704 . . . . 0.0 109.853 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -114.57 134.96 54.64 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.188 1.395 . . . . 0.0 111.067 177.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.8 mp -81.83 129.97 36.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 O-C-N 120.906 -1.121 . . . . 0.0 109.013 175.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -137.93 94.43 2.89 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.854 1.262 . . . . 0.0 112.328 177.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 72.1 mtp180 . . . . . 0 C--O 1.252 1.185 0 C-N-CA 126.604 1.961 . . . . 0.0 113.245 175.002 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 74.6 m . . . . . 0 N--CA 1.482 1.136 0 N-CA-C 111.695 0.258 . . . . 0.0 111.695 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.91 177.09 6.77 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.854 1.261 . . . . 0.0 111.113 174.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -44.28 -26.47 0.33 Allowed 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 115.724 1.75 . . . . 0.0 115.724 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.54 78.67 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.121 1.368 . . . . 0.0 112.425 175.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -72.63 -66.3 2.1 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 125.984 1.754 . . . . 0.0 112.238 -175.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 39.7 p -142.61 166.83 23.59 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.73 1.612 . . . . 0.0 112.097 176.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -131.48 10.06 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 125.993 1.717 . . . . 0.0 112.607 175.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -53.67 163.32 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 O-C-N 120.223 -1.548 . . . . 0.0 112.648 177.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -38.92 136.29 0.79 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 127.001 2.121 . . . . 0.0 113.82 -174.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -55.38 -21.22 26.03 Favored Glycine 0 CA--C 1.54 1.605 0 C-N-CA 124.858 1.218 . . . . 0.0 114.399 -176.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.66 -29.04 69.81 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.032 1.333 . . . . 0.0 112.577 174.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.5 t -104.99 -43.98 4.92 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.808 1.643 . . . . 0.0 111.299 175.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.4 tp -75.16 93.47 2.81 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.81 0.844 . . . . 0.0 111.537 175.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 44.1 p -130.69 -177.99 4.59 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 126.901 2.081 . . . . 0.0 111.583 177.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -39.89 -43.99 1.58 Allowed 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 127.207 2.203 . . . . 0.0 113.59 175.022 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -54.67 -41.44 70.19 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.651 0.78 . . . . 0.0 112.055 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.0 t -68.35 -38.19 79.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.804 1.242 . . . . 0.0 111.233 175.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 24.5 mt -68.62 -42.47 78.03 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 121.355 -0.841 . . . . 0.0 111.414 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -65.38 -50.45 65.46 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.498 1.119 . . . . 0.0 111.915 178.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.13 -33.88 76.42 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 118.876 -0.583 . . . . 0.0 112.062 174.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.9 t -55.38 -47.0 78.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 124.85 1.26 . . . . 0.0 112.355 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.82 -23.86 46.88 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 119.838 1.199 . . . . 0.0 113.022 175.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -82.45 -61.44 1.98 Allowed Glycine 0 CA--C 1.534 1.233 0 C-N-CA 126.049 1.785 . . . . 0.0 112.919 174.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -66.49 -35.86 81.31 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -177.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -94.88 73.65 3.54 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 122.773 1.273 . . . . 0.0 110.468 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -76.2 64.13 2.82 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 126.302 1.906 . . . . 0.0 115.151 -174.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.1 mttt -55.59 -75.47 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 126.69 1.996 . . . . 0.0 113.972 178.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 18.0 m -141.77 -179.37 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 127.438 2.295 . . . . 0.0 110.708 178.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 36.8 m -52.39 -34.31 47.43 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 126.721 2.009 . . . . 0.0 114.878 -177.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.8 mmp_? -136.7 111.99 9.14 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 127.23 2.212 . . . . 0.0 109.185 175.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.0 166.06 15.72 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.381 1.472 . . . . 0.0 110.543 178.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -128.85 123.16 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 123.949 0.9 . . . . 0.0 110.911 -178.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -120.13 118.17 29.86 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.883 1.673 . . . . 0.0 109.806 175.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.4 m -124.47 148.4 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 122.715 0.406 . . . . 0.0 110.602 175.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -121.52 111.06 1.78 Allowed Glycine 0 C--N 1.329 0.16 0 C-N-CA 124.285 0.945 . . . . 0.0 111.044 -178.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 mp -100.24 139.94 20.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 117.703 0.752 . . . . 0.0 109.282 175.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -114.91 101.91 9.48 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.893 1.277 . . . . 0.0 109.305 -178.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 40.9 t-20 -73.68 107.17 5.78 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.051 1.34 . . . . 0.0 110.515 -178.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -135.12 19.27 3.43 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.386 1.474 . . . . 0.0 111.8 175.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.8 p -76.19 178.21 6.59 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.072 1.749 . . . . 0.0 112.433 176.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -91.25 56.06 3.2 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 126.379 1.942 . . . . 0.0 113.167 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 157.34 137.5 2.31 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.453 1.025 . . . . 0.0 113.636 177.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 37.9 p -62.47 141.19 58.51 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.456 0.702 . . . . 0.0 110.428 175.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 30.0 m0 -97.56 109.2 22.0 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.694 0.283 . . . . 0.0 111.553 178.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 37.4 m -87.75 142.74 27.59 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.172 0.589 . . . . 0.0 109.541 175.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.67 126.86 29.38 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.689 0.796 . . . . 0.0 111.457 174.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.1 pp -116.7 -58.6 2.06 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.271 1.028 . . . . 0.0 111.854 177.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -176.07 152.38 1.17 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 127.215 2.206 . . . . 0.0 110.617 -177.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -134.28 158.84 42.74 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.151 1.38 . . . . 0.0 111.063 175.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 91.2 t80 -140.04 100.21 3.87 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.036 1.334 . . . . 0.0 112.169 -175.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -105.04 124.26 49.23 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.559 1.144 . . . . 0.0 111.614 -175.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.71 -37.4 7.92 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -177.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 29.5 t -120.61 -49.59 2.23 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.33 1.452 . . . . 0.0 110.725 177.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -68.63 17.37 0.49 Allowed Glycine 0 CA--C 1.533 1.166 0 C-N-CA 126.587 2.042 . . . . 0.0 115.272 -175.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.2 p -35.52 121.02 0.59 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 128.739 2.816 . . . . 0.0 112.995 -175.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -139.13 172.4 12.89 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.651 1.181 . . . . 0.0 113.571 -174.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -76.82 -68.85 0.56 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.524 1.53 . . . . 0.0 113.309 175.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.7 p -135.9 129.67 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 125.126 1.371 . . . . 0.0 112.425 -176.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -138.43 -34.3 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.672 1.589 . . . . 0.0 114.443 -175.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 48.5 mt -91.33 104.14 9.15 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 125.169 1.388 . . . . 0.0 109.621 175.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -72.52 165.24 33.26 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.763 2.975 . . . . 0.0 110.413 175.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -47.57 -44.23 26.08 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.9 p -157.81 152.26 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 127.014 2.125 . . . . 0.0 110.057 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.46 ' HA ' ' HE3' ' A' ' 68' ' ' LYS . 60.5 t -126.89 99.14 29.56 Favored Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 126.375 1.87 . . . . 0.0 106.778 175.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -69.71 171.62 14.08 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 120.97 1.113 . . . . 0.0 112.628 175.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -75.71 166.13 24.0 Favored 'General case' 0 CA--C 1.548 0.869 0 O-C-N 121.297 -0.877 . . . . 0.0 110.355 174.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . 0.276 5.8 p 62.39 18.27 10.15 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 128.058 2.543 . . . . 0.0 115.141 -177.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.46 ' HE3' ' HA ' ' A' ' 64' ' ' VAL . 0.0 OUTLIER -131.34 170.9 14.01 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 126.086 1.755 . . . . 0.0 111.585 -177.986 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -131.18 165.76 22.61 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-O 121.637 0.732 . . . . 0.0 111.633 177.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.42 ' CD1' ' HH ' ' A' ' 91' ' ' TYR . 2.0 pt? -134.79 171.45 14.36 Favored 'General case' 0 C--N 1.321 -0.667 0 O-C-N 120.225 -1.547 . . . . 0.0 110.806 175.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -112.91 162.83 15.38 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 125.315 1.446 . . . . 0.0 108.654 174.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -136.55 149.66 48.22 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 125.118 1.367 . . . . 0.0 108.938 175.054 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 85.8 p -129.49 148.81 51.43 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.924 1.69 . . . . 0.0 112.191 -177.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -171.8 146.4 9.37 Favored Glycine 0 CA--C 1.521 0.45 0 N-CA-C 111.984 -0.446 . . . . 0.0 111.984 174.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 41.6 mtm-85 -108.31 150.44 27.32 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.784 1.234 . . . . 0.0 110.733 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.33 -21.27 63.85 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 114.934 1.457 . . . . 0.0 114.934 175.039 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 6.5 t -83.59 83.44 7.9 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.239 1.416 . . . . 0.0 113.299 -174.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 21.1 t -75.42 -31.8 60.5 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.399 0.888 . . . . 0.0 113.399 175.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 126.06 -71.34 0.47 Allowed Glycine 0 CA--C 1.537 1.447 0 C-N-CA 125.606 1.574 . . . . 0.0 113.068 -175.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -70.68 -40.8 3.57 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 123.276 2.65 . . . . 0.0 112.874 -176.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 35.3 m -136.46 158.69 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 126.47 1.908 . . . . 0.0 110.536 178.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -116.75 87.43 2.69 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.913 1.685 . . . . 0.0 109.613 -178.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 24.9 m -100.49 151.68 21.28 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.172 1.389 . . . . 0.0 108.592 176.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -45.28 -67.41 1.23 Allowed Glycine 0 N--CA 1.473 1.127 0 C-N-CA 125.899 1.714 . . . . 0.0 113.888 -174.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -171.77 119.78 0.45 Allowed 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.482 1.113 . . . . 0.0 111.339 175.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.418 HG11 ' HG ' ' A' ' 104' ' ' SER . 4.8 t -141.35 118.64 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 O-C-N 121.765 -0.585 . . . . 0.0 110.081 -178.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.66 157.9 37.42 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 122.53 1.157 . . . . 0.0 112.074 -179.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -137.5 147.99 45.66 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.88 1.272 . . . . 0.0 108.442 175.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -155.13 166.51 33.34 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 121.03 -1.044 . . . . 0.0 109.127 178.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -137.4 156.16 48.51 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.42 ' HH ' ' CD1' ' A' ' 70' ' ' LEU . 2.3 m-85 -132.46 130.62 40.75 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.272 1.029 . . . . 0.0 113.504 -174.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -82.76 112.99 20.11 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -175.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -93.81 143.01 26.72 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.097 1.359 . . . . 0.0 113.107 -178.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.24 -20.67 64.48 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.556 1.142 . . . . 0.0 113.61 177.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 48.1 m-20 -67.53 -11.6 58.38 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.563 1.145 . . . . 0.0 112.727 174.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 96.58 27.03 10.11 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 124.993 1.282 . . . . 0.0 113.746 -178.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -132.5 172.84 11.97 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.986 1.314 . . . . 0.0 111.588 -176.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.5 m -126.38 107.57 10.41 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.06 1.344 . . . . 0.0 111.641 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.0 tt -70.53 98.84 1.53 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.978 1.711 . . . . 0.0 111.918 179.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -94.19 97.07 2.13 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 124.765 1.174 . . . . 0.0 114.881 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 99.3 t -75.45 140.53 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.381 1.072 . . . . 0.0 110.123 174.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 3.1 tmm? -136.13 129.16 31.36 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.651 1.581 . . . . 0.0 110.348 177.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -144.79 142.85 30.3 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.442 -0.786 . . . . 0.0 112.426 175.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.418 ' HG ' HG11 ' A' ' 86' ' ' VAL . 13.2 m -142.9 114.48 8.01 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.395 1.078 . . . . 0.0 112.361 -177.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 26.1 t -113.16 97.35 42.38 Favored Pre-proline 0 CA--C 1.538 0.488 0 C-N-CA 127.445 2.298 . . . . 0.0 109.229 178.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.7 127.35 15.31 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 122.712 2.274 . . . . 0.0 109.73 175.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -73.98 -58.52 3.24 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 121.585 -0.697 . . . . 0.0 110.597 176.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -63.85 -28.91 70.17 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.661 0.785 . . . . 0.0 111.508 -175.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 55.57 7.68 0.26 Allowed 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 127.679 2.391 . . . . 0.0 114.233 -177.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.34 112.52 1.98 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 127.986 2.514 . . . . 0.0 110.003 -177.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER 43.57 30.6 0.36 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 126.593 1.957 . . . . 0.0 114.091 -178.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.28 171.89 12.42 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.738 1.615 . . . . 0.0 111.941 -175.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 31.7 m -142.63 139.67 31.35 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 124.729 1.212 . . . . 0.0 111.378 -178.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -67.51 101.39 0.98 Allowed 'General case' 0 C--O 1.223 -0.316 0 C-N-CA 125.041 1.336 . . . . 0.0 107.929 174.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 47.7 m0 -107.78 144.27 35.18 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 120.622 1.555 . . . . 0.0 110.185 176.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 43.9 p-90 -147.99 139.9 24.01 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.659 0.784 . . . . 0.0 111.509 -177.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -149.86 159.42 44.38 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 122.656 1.217 . . . . 0.0 112.294 -177.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 22.0 t -144.43 136.27 21.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 174.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.98 179.91 6.9 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 126.242 1.817 . . . . 0.0 109.191 176.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 10.5 mt -132.41 134.04 59.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 123.197 0.599 . . . . 0.0 109.399 176.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -90.43 151.68 44.6 Favored Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 125.329 1.452 . . . . 0.0 112.493 177.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.74 139.9 28.48 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 123.198 2.599 . . . . 0.0 110.939 174.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 61.29 -166.21 15.17 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 123.726 0.679 . . . . 0.0 113.475 -176.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.46 99.5 5.67 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.716 1.606 . . . . 0.0 109.771 174.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -111.44 -172.38 2.02 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 125.744 1.618 . . . . 0.0 111.199 -177.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 25.7 ptt180 -139.01 177.54 7.82 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 127.222 2.209 . . . . 0.0 111.229 175.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -118.46 121.22 39.77 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 174.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -129.81 167.11 18.62 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.703 1.601 . . . . 0.0 109.353 175.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -48.87 -45.83 41.56 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 119.641 1.109 . . . . 0.0 113.232 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -52.55 -62.94 5.35 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 123.997 0.808 . . . . 0.0 112.252 175.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 5.0 mpp? -60.76 -38.42 85.17 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 113.583 0.956 . . . . 0.0 113.583 178.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -57.0 -61.87 2.15 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.934 0.788 . . . . 0.0 109.527 175.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -62.97 -37.17 86.03 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.863 0.865 . . . . 0.0 112.731 -177.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -63.65 -43.54 96.47 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.012 1.325 . . . . 0.0 112.36 179.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.81 -26.16 24.22 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 121.053 -1.029 . . . . 0.0 113.42 176.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -52.02 -58.29 6.97 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.257 1.823 . . . . 0.0 110.678 175.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -70.47 -12.85 61.84 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -177.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -81.69 -5.63 89.71 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 127.203 2.335 . . . . 0.0 114.345 177.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -145.11 86.45 7.63 Favored Pre-proline 0 CA--C 1.548 0.87 0 CA-C-N 119.052 1.426 . . . . 0.0 113.301 175.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -76.64 74.79 4.68 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 123.513 2.809 . . . . 0.0 112.946 -179.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -107.26 107.36 18.26 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.022 0.929 . . . . 0.0 111.385 -175.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 59.1 mtm180 -89.76 48.14 1.55 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 126.074 1.75 . . . . 0.0 114.505 -175.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 49.46 57.86 8.83 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.815 -176.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -63.14 106.52 0.87 Allowed 'General case' 0 CA--C 1.546 0.802 0 CA-C-O 122.141 0.972 . . . . 0.0 109.86 -176.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 17.3 p-10 -68.23 73.69 0.21 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 127.336 2.255 . . . . 0.0 114.968 -174.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 178.35 48.75 0.07 OUTLIER Glycine 0 CA--C 1.536 1.4 0 C-N-CA 124.382 0.991 . . . . 0.0 115.003 175.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' TRP . . . . . 0.486 ' H ' HD11 ' A' ' 161' ' ' ILE . 8.1 m95 49.33 56.28 8.05 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 126.204 1.802 . . . . 0.0 112.795 -175.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -85.9 127.5 34.61 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.281 1.032 . . . . 0.0 112.818 -178.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -157.86 -176.09 5.73 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -175.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 5.7 mtmt -140.24 169.33 17.88 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 126.144 1.777 . . . . 0.0 111.581 175.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -72.66 155.66 39.77 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 174.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 71.0 mt -109.01 89.02 2.87 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.736 0.814 . . . . 0.0 110.375 177.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 40.86 -82.06 0.0 OUTLIER Glycine 0 N--CA 1.476 1.341 0 C-N-CA 129.608 3.48 . . . . 0.0 115.27 175.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -68.53 -154.2 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 128.839 2.855 . . . . 0.0 110.541 174.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -73.68 20.24 1.41 Allowed Glycine 0 CA--C 1.541 1.693 0 O-C-N 120.217 -1.552 . . . . 0.0 114.928 175.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.04 154.07 17.34 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 120.448 2.124 . . . . 0.0 112.038 177.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 87.4 mtt180 -145.95 115.82 7.32 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.322 1.449 . . . . 0.0 110.877 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 5.9 ttp -114.25 132.42 56.15 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 124.273 1.029 . . . . 0.0 109.682 -178.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -103.84 132.83 49.72 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 128.477 2.711 . . . . 0.0 110.005 -179.039 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -135.2 150.83 20.31 Favored Glycine 0 N--CA 1.47 0.918 0 CA-C-N 120.313 1.415 . . . . 0.0 114.23 178.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.486 HD11 ' H ' ' A' ' 147' ' ' TRP . 6.6 tp -145.81 131.93 13.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 125.147 1.379 . . . . 0.0 110.957 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 3.6 ttt -152.42 176.4 11.69 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 127.606 2.362 . . . . 0.0 107.717 175.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 10.1 t -152.39 163.62 39.15 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.194 1.397 . . . . 0.0 109.161 175.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 5.4 t -106.52 31.43 5.22 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.396 1.478 . . . . 0.0 111.511 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -68.44 23.76 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 128.09 2.556 . . . . 0.0 115.112 179.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 84.36 -60.24 4.85 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 126.181 1.848 . . . . 0.0 113.342 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -126.5 63.0 1.28 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.333 1.453 . . . . 0.0 111.051 178.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -86.61 -177.46 6.15 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.311 1.044 . . . . 0.0 112.794 174.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . 0.44 ' O ' ' HE2' ' A' ' 169' ' ' LYS . 0.0 OUTLIER -124.85 174.43 7.95 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 127.991 2.516 . . . . 0.0 109.708 174.993 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 42.5 ttp -126.12 132.12 51.93 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.055 1.342 . . . . 0.0 110.189 176.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -135.86 127.18 28.38 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.104 0.962 . . . . 0.0 110.163 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 4.6 mp -129.58 120.66 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 C-N-CA 123.19 0.596 . . . . 0.0 109.95 177.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.06 132.42 56.03 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.827 1.651 . . . . 0.0 111.341 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.8 mp -76.81 133.67 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 O-C-N 120.683 -1.26 . . . . 0.0 110.382 175.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 6.7 m -140.24 92.5 2.54 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 125.144 1.378 . . . . 0.0 112.22 177.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 60.5 mtp180 . . . . . 0 C--O 1.254 1.29 0 C-N-CA 126.311 1.844 . . . . 0.0 111.48 175.033 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 38.4 m . . . . . 0 N--CA 1.482 1.169 0 CA-C-O 121.57 0.7 . . . . 0.0 111.283 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -136.65 166.39 23.66 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 126.798 2.039 . . . . 0.0 110.303 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 15.5 tp -132.5 -35.42 1.14 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.902 1.281 . . . . 0.0 112.385 176.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -75.62 129.96 38.0 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 175.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -71.93 -113.02 0.05 OUTLIER Glycine 0 CA--C 1.533 1.192 0 C-N-CA 124.036 0.827 . . . . 0.0 112.636 177.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 19.3 p -113.58 172.82 6.74 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.872 1.269 . . . . 0.0 111.578 176.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -124.81 24.56 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 125.226 1.41 . . . . 0.0 111.871 175.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -52.49 166.4 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 O-C-N 120.633 -1.292 . . . . 0.0 112.684 174.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -48.87 144.3 4.71 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.947 1.299 . . . . 0.0 113.404 -177.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.06 -24.33 54.37 Favored Glycine 0 CA--C 1.538 1.492 0 N-CA-C 115.78 1.072 . . . . 0.0 115.78 -174.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.89 -34.43 64.42 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 121.289 -1.124 . . . . 0.0 111.797 174.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.9 t -84.21 -41.27 17.14 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.684 1.993 . . . . 0.0 112.837 175.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 13.0 tp -89.23 96.29 10.66 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 127.415 2.286 . . . . 0.0 111.357 175.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.58 178.77 6.49 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 126.734 2.014 . . . . 0.0 110.731 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -41.36 -40.91 1.83 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.683 1.593 . . . . 0.0 113.786 175.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -49.89 -45.23 50.56 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.219 1.407 . . . . 0.0 112.639 175.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 88.0 t -69.86 -38.88 76.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 125.777 1.631 . . . . 0.0 111.669 175.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 44.6 mt -70.75 -36.77 73.29 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 120.706 -1.246 . . . . 0.0 112.457 -178.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -65.48 -51.14 62.19 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.343 1.457 . . . . 0.0 111.186 175.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.71 -34.31 75.56 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 118.08 -0.962 . . . . 0.0 111.915 175.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.2 t -56.35 -48.53 79.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-N 119.679 1.127 . . . . 0.0 111.485 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 55.4 mt -56.85 -19.8 19.44 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 175.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.03 -61.24 1.28 Allowed Glycine 0 CA--C 1.535 1.293 0 C-N-CA 126.306 1.908 . . . . 0.0 113.12 175.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -64.11 -32.54 74.14 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -178.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -90.55 97.76 11.37 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.179 0.992 . . . . 0.0 109.917 176.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -109.82 109.42 2.7 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 126.333 1.921 . . . . 0.0 112.475 -178.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.7 mtpt -129.59 -69.86 0.67 Allowed 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 125.793 1.637 . . . . 0.0 112.07 -176.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.4 m -121.17 169.36 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 127.848 2.459 . . . . 0.0 110.491 -176.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.0 t -65.76 -31.85 73.07 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -179.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.5 mmt180 -132.4 105.58 7.36 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.303 1.841 . . . . 0.0 111.041 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.4 ptpt -120.56 159.43 25.26 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 126.539 1.935 . . . . 0.0 110.149 -177.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -128.75 132.95 67.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 123.941 0.897 . . . . 0.0 109.437 175.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.33 102.63 4.85 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.077 1.751 . . . . 0.0 109.673 177.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.3 m -107.7 162.29 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 123.73 0.812 . . . . 0.0 110.927 178.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -134.84 124.28 3.39 Favored Glycine 0 N--CA 1.463 0.452 0 N-CA-C 111.531 -0.628 . . . . 0.0 111.531 177.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.3 mp -113.02 132.35 62.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-N 118.459 1.13 . . . . 0.0 110.536 175.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -96.22 99.69 11.39 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.67 1.588 . . . . 0.0 110.214 177.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -67.73 94.35 0.44 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.319 1.448 . . . . 0.0 110.552 175.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -125.34 7.29 7.75 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 125.576 1.55 . . . . 0.0 111.801 174.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 42.8 p -57.03 -34.9 68.67 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.366 1.066 . . . . 0.0 113.616 -177.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 158.47 -63.52 0.3 Allowed Glycine 0 CA--C 1.53 1.02 0 C-N-CA 125.271 1.415 . . . . 0.0 113.639 175.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -107.18 171.08 16.29 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 125.549 1.547 . . . . 0.0 113.092 -178.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.17 150.84 28.64 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.803 -0.822 . . . . 0.0 110.874 175.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 45.2 m0 -104.35 100.52 10.23 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 124.876 1.271 . . . . 0.0 111.346 -177.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.5 m -80.73 117.97 21.86 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 124.689 1.195 . . . . 0.0 108.44 175.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.86 126.46 27.08 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.129 0.571 . . . . 0.0 111.676 175.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.1 pp -100.37 -53.48 3.1 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 122.844 0.458 . . . . 0.0 111.937 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -171.6 138.87 1.17 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.618 1.967 . . . . 0.0 109.56 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -121.31 155.53 34.51 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.797 1.239 . . . . 0.0 111.404 175.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -136.45 113.42 10.44 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.589 1.555 . . . . 0.0 111.409 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -114.31 132.5 56.15 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 123.772 0.829 . . . . 0.0 110.02 -178.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.58 -31.33 4.31 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 114.973 1.471 . . . . 0.0 114.973 -175.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.0 t -123.18 -46.58 2.06 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.503 1.521 . . . . 0.0 110.943 175.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -72.48 10.97 4.48 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 124.711 1.148 . . . . 0.0 115.046 -178.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.3 p -31.06 104.03 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 128.982 2.913 . . . . 0.0 114.182 -174.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.6 t -120.92 178.6 4.66 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.945 1.298 . . . . 0.0 112.786 -174.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -77.42 -59.03 2.95 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.86 1.264 . . . . 0.0 111.554 174.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.3 p -138.09 131.41 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 125.918 1.687 . . . . 0.0 112.32 -178.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.1 pp -140.78 -39.62 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.92 1.688 . . . . 0.0 114.154 -177.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.9 mt -92.17 94.94 0.87 Allowed Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 124.933 1.293 . . . . 0.0 108.883 175.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -61.83 132.91 42.03 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 123.137 2.558 . . . . 0.0 110.258 175.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -40.0 -44.43 1.73 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 126.457 1.903 . . . . 0.0 113.962 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.4 p -155.13 139.7 9.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 C-N-CA 126.613 1.965 . . . . 0.0 110.028 176.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 58.6 t -133.72 121.35 16.02 Favored Pre-proline 0 N--CA 1.484 1.246 0 C-N-CA 124.623 1.169 . . . . 0.0 110.672 178.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -58.17 152.32 53.3 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.982 2.455 . . . . 0.0 113.21 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -72.49 168.21 19.01 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.51 0.724 . . . . 0.0 110.657 175.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 72.7 p 51.72 28.56 4.95 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 126.904 2.082 . . . . 0.0 112.687 -175.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.25 171.85 12.83 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 128.443 2.697 . . . . 0.0 109.42 -175.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -131.15 167.36 19.27 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 121.716 -0.615 . . . . 0.0 109.746 177.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.9 pp -137.14 174.16 10.91 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 125.045 1.338 . . . . 0.0 111.03 -176.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.95 152.65 47.63 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.819 1.248 . . . . 0.0 111.397 176.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.453 ' CE2' ' CD2' ' A' ' 89' ' ' PHE . 8.2 m-85 -127.25 136.68 52.33 Favored 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 125.109 1.364 . . . . 0.0 107.76 174.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.0 p -114.96 153.29 30.87 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 125.666 1.587 . . . . 0.0 110.935 176.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -170.84 145.45 8.98 Favored Glycine 0 N--CA 1.452 -0.263 0 CA-C-O 121.587 0.548 . . . . 0.0 112.422 176.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 19.0 mtm180 -128.45 132.43 48.41 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 125.942 1.697 . . . . 0.0 109.759 -175.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.8 ptmt -65.61 -177.97 0.49 Allowed 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.894 0.878 . . . . 0.0 112.734 174.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 64.93 54.24 1.32 Allowed 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.667 1.587 . . . . 0.0 112.47 174.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 27.3 t -54.42 -32.82 58.16 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.679 1.592 . . . . 0.0 112.502 175.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 129.91 -70.65 0.51 Allowed Glycine 0 CA--C 1.533 1.192 0 C-N-CA 126.085 1.802 . . . . 0.0 111.862 177.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.58 -19.71 27.82 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 123.347 2.698 . . . . 0.0 113.329 176.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 6.3 p -139.33 146.47 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 126.218 1.807 . . . . 0.0 111.064 175.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -131.15 104.88 7.33 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.631 1.973 . . . . 0.0 110.32 177.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -129.9 171.77 12.39 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.912 1.685 . . . . 0.0 109.078 175.045 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -68.26 -64.59 3.04 Favored Glycine 0 N--CA 1.474 1.193 0 O-C-N 120.598 -1.314 . . . . 0.0 113.191 -177.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -158.44 114.08 2.67 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.238 1.015 . . . . 0.0 111.058 178.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.8 t -147.57 123.23 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 O-C-N 121.246 -0.909 . . . . 0.0 110.577 -176.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -165.03 167.24 18.58 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.974 1.31 . . . . 0.0 112.022 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -150.1 139.72 21.62 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.655 1.182 . . . . 0.0 110.645 174.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.453 ' CD2' ' CE2' ' A' ' 72' ' ' TYR . 46.8 p90 -139.73 170.91 15.01 Favored 'General case' 0 N--CA 1.467 0.383 0 O-C-N 121.012 -1.055 . . . . 0.0 110.622 176.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -137.16 156.39 48.4 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.843 -0.536 . . . . 0.0 112.295 175.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -130.39 129.14 42.71 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 125.492 1.517 . . . . 0.0 112.314 -177.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -85.88 117.29 24.64 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.065 0.46 . . . . 0.0 111.133 -178.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 7.6 mtp -93.92 132.17 38.62 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.05 1.34 . . . . 0.0 110.981 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 39.5 m -57.92 -18.21 21.64 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 125.246 1.418 . . . . 0.0 113.856 175.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -69.48 -9.18 52.66 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 124.911 1.285 . . . . 0.0 113.06 175.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 99.54 19.77 19.39 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 125.746 1.641 . . . . 0.0 114.549 178.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 16.4 m-80 -130.55 175.86 8.64 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.003 1.321 . . . . 0.0 111.053 -175.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 16.4 m -128.85 114.21 16.23 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.852 0.861 . . . . 0.0 111.955 177.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 52.1 tp -79.39 104.43 10.0 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.598 1.159 . . . . 0.0 109.737 175.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -99.21 113.92 4.87 Favored Glycine 0 N--CA 1.466 0.69 0 C-N-CA 124.477 1.037 . . . . 0.0 112.737 -179.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 90.1 t -96.31 135.46 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.529 1.131 . . . . 0.0 111.076 -178.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -134.51 125.65 27.79 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.927 1.291 . . . . 0.0 110.772 -175.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -145.94 122.94 11.39 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.759 1.224 . . . . 0.0 111.599 -174.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 38.3 t -133.92 136.31 44.17 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 124.179 0.992 . . . . 0.0 110.46 176.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 45.4 t -126.42 88.83 53.56 Favored Pre-proline 0 C--O 1.238 0.47 0 C-N-CA 127.897 2.479 . . . . 0.0 106.533 -178.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -67.29 102.07 0.66 Allowed 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 123.157 2.572 . . . . 0.0 109.48 177.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -49.29 -30.87 7.97 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.57 1.148 . . . . 0.0 112.559 176.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.47 44.56 0.44 Allowed 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 125.358 1.463 . . . . 0.0 110.969 174.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -49.05 -33.27 11.09 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 125.896 1.679 . . . . 0.0 112.572 -176.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -49.49 111.08 0.44 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 127.585 2.354 . . . . 0.0 109.993 174.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 16.4 m95 63.67 22.74 13.25 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 125.336 1.454 . . . . 0.0 113.701 177.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -129.49 178.74 6.25 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.594 1.958 . . . . 0.0 112.063 -175.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.7 m -142.06 141.57 32.78 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.653 1.181 . . . . 0.0 113.843 176.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -81.37 130.93 35.24 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.627 1.971 . . . . 0.0 106.759 175.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 9.7 m0 -117.8 120.64 38.55 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.983 1.313 . . . . 0.0 110.233 176.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 11.6 p-90 -144.46 152.65 40.92 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 126.361 1.865 . . . . 0.0 111.728 -175.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 9.7 t70 164.76 150.17 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 128.743 2.817 . . . . 0.0 109.648 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 62.0 t -120.83 139.49 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.183 1.393 . . . . 0.0 109.035 -175.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.456 ' HE2' ' HG3' ' A' ' 135' ' ' MET . 0.0 OUTLIER -129.46 171.19 12.81 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.287 1.035 . . . . 0.0 111.795 -178.968 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 54.5 mt -124.96 116.78 48.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 175.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -77.12 149.76 79.94 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 123.119 0.568 . . . . 0.0 110.589 174.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.78 -0.67 7.26 Favored 'Trans proline' 0 CA--C 1.545 1.051 0 C-N-CA 124.471 3.448 . . . . 0.0 115.027 -176.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -174.0 -175.49 41.68 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 127.055 2.264 . . . . 0.0 111.003 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 24.6 tttt -52.77 116.83 2.52 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.117 1.367 . . . . 0.0 112.059 -177.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -133.24 117.71 17.72 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.382 1.473 . . . . 0.0 111.738 -177.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.3 ptt180 -65.12 175.11 1.71 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.026 0.93 . . . . 0.0 111.855 174.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -127.58 103.27 7.24 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.989 1.716 . . . . 0.0 106.809 176.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -132.51 172.63 12.25 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.69 1.996 . . . . 0.0 109.425 177.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -53.72 -38.85 64.71 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -177.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -60.96 -58.72 12.29 Favored Glycine 0 N--CA 1.469 0.86 0 CA-C-N 118.885 0.766 . . . . 0.0 111.376 174.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 2.2 mpp? -59.1 -39.59 82.68 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 117.851 0.825 . . . . 0.0 112.171 178.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -59.78 -59.01 6.11 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.367 1.067 . . . . 0.0 110.75 175.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -67.97 -34.31 76.3 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 118.927 0.785 . . . . 0.0 113.01 -177.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -63.45 -41.53 98.63 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.447 0.699 . . . . 0.0 111.382 175.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' MET . . . . . 0.456 ' HG3' ' HE2' ' A' ' 119' ' ' LYS . 37.4 mmm -77.48 -28.47 52.27 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 121.06 -1.025 . . . . 0.0 113.033 175.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -54.56 -55.19 31.87 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 119.412 1.005 . . . . 0.0 111.386 176.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -65.11 -18.99 65.76 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 119.659 -0.816 . . . . 0.0 112.129 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -81.38 3.8 75.91 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 126.773 2.13 . . . . 0.0 114.472 174.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 34.9 m-20 -115.67 64.31 2.22 Favored Pre-proline 0 CA--C 1.552 1.045 0 C-N-CA 125.804 1.642 . . . . 0.0 114.966 -175.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -76.1 73.33 4.97 Favored 'Trans proline' 0 CA--C 1.546 1.08 0 C-N-CA 123.551 2.834 . . . . 0.0 112.87 -177.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.98 116.43 7.05 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.423 1.089 . . . . 0.0 109.723 -178.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 2.9 ttm105 -81.79 -172.81 4.09 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.534 1.533 . . . . 0.0 111.362 177.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -78.06 57.13 3.98 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 124.114 0.864 . . . . 0.0 111.027 174.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -62.61 98.81 0.13 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 128.095 2.558 . . . . 0.0 110.376 175.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 11.2 p-10 -64.08 66.04 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 127.851 2.46 . . . . 0.0 116.343 -175.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -178.44 167.94 38.78 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 128.368 2.89 . . . . 0.0 109.825 175.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' TRP . . . . . 0.432 ' CE3' ' HG3' ' A' ' 159' ' ' LYS . 59.6 m95 -64.78 67.91 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.998 2.119 . . . . 0.0 111.215 175.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -85.73 116.12 23.81 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 128.796 2.838 . . . . 0.0 111.452 -177.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -166.55 -172.63 2.23 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 177.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.68 167.37 22.27 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.494 1.918 . . . . 0.0 112.543 177.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 54.5 m-20 -64.56 142.59 58.37 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.904 -0.498 . . . . 0.0 109.782 175.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 11.0 mt -89.97 158.76 17.23 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 122.165 0.983 . . . . 0.0 109.359 175.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -65.6 -171.87 3.64 Favored Glycine 0 CA--C 1.536 1.399 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 175.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 54.73 8.78 0.24 Allowed 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 175.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 82.07 42.51 8.73 Favored Glycine 0 CA--C 1.54 1.645 0 C-N-CA 126.279 1.895 . . . . 0.0 113.087 -175.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.7 mp -120.17 172.33 7.85 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 119.025 1.413 . . . . 0.0 112.678 179.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 24.2 mtt180 -137.99 117.32 12.77 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 120.746 -1.221 . . . . 0.0 111.548 176.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 5.3 ttt -98.45 151.37 20.66 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 120.108 -1.62 . . . . 0.0 108.636 174.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.432 ' HG3' ' CE3' ' A' ' 147' ' ' TRP . 5.4 tppt? -136.86 142.47 42.82 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.503 1.921 . . . . 0.0 109.877 176.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -155.79 152.19 23.66 Favored Glycine 0 N--CA 1.473 1.146 0 O-C-N 120.64 -1.287 . . . . 0.0 112.858 176.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 2.2 tp -135.19 124.53 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 126.676 1.99 . . . . 0.0 108.143 -176.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 8.7 mtp -145.29 113.02 6.33 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.662 1.585 . . . . 0.0 108.991 174.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 9.5 t -100.66 125.17 47.05 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 118.517 0.599 . . . . 0.0 110.997 178.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 23.1 p -74.18 39.01 0.11 Allowed 'General case' 0 N--CA 1.481 1.097 0 O-C-N 120.738 -1.226 . . . . 0.0 113.764 175.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -72.41 -2.29 18.85 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 126.192 1.797 . . . . 0.0 114.516 177.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 108.89 -59.77 0.35 Allowed Glycine 0 CA--C 1.531 1.088 0 C-N-CA 126.264 1.887 . . . . 0.0 113.03 176.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -118.79 27.02 9.15 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.416 1.486 . . . . 0.0 112.482 -177.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.91 170.59 6.44 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 122.558 1.17 . . . . 0.0 114.129 175.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.67 -178.88 3.92 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 126.819 2.047 . . . . 0.0 110.89 175.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 14.8 ttp -125.85 139.12 53.75 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.588 1.555 . . . . 0.0 110.288 171.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 39.8 tt0 -143.48 126.9 16.78 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 121.981 -0.449 . . . . 0.0 110.67 174.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 2.7 mp -123.28 133.95 67.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.664 1.186 . . . . 0.0 108.642 176.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -133.14 132.76 42.02 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.852 1.661 . . . . 0.0 109.473 178.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.9 mp -96.04 92.04 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 O-C-N 121.197 -0.939 . . . . 0.0 109.63 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.41 165.1 8.16 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-O 122.276 1.036 . . . . 0.0 112.839 175.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 18.2 mmm180 . . . . . 0 C--O 1.252 1.227 0 C-N-CA 125.182 1.393 . . . . 0.0 111.171 -176.82 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 60.0 m . . . . . 0 N--CA 1.482 1.152 0 CA-C-O 120.816 0.341 . . . . 0.0 111.51 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -133.26 -72.29 0.51 Allowed 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.483 1.513 . . . . 0.0 111.116 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 32.1 tp 52.76 15.01 0.48 Allowed 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 127.041 2.137 . . . . 0.0 114.928 -175.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -128.95 120.98 27.07 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 127.273 2.229 . . . . 0.0 107.776 178.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -73.05 -101.16 0.07 OUTLIER Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.046 0.831 . . . . 0.0 112.305 -178.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 38.8 p -131.18 170.67 14.25 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.756 1.222 . . . . 0.0 111.33 175.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -124.47 16.19 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 125.248 1.419 . . . . 0.0 111.886 179.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.3 pt -53.31 168.69 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 124.945 1.298 . . . . 0.0 111.561 175.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -40.6 132.64 2.12 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.62 1.168 . . . . 0.0 112.873 -178.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -53.71 -22.5 18.28 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 124.937 1.256 . . . . 0.0 114.322 -176.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.18 -33.07 71.69 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.273 1.429 . . . . 0.0 112.452 175.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.2 t -96.36 -44.52 7.18 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.214 1.406 . . . . 0.0 112.314 175.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.3 tp -69.15 89.55 0.45 Allowed 'General case' 0 CA--C 1.545 0.752 0 CA-C-O 122.168 0.985 . . . . 0.0 110.632 175.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 58.1 p -126.93 -176.14 3.62 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 126.884 2.074 . . . . 0.0 111.512 -178.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -52.19 -36.93 53.3 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.165 0.986 . . . . 0.0 113.174 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -56.02 -43.63 77.96 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.645 1.178 . . . . 0.0 112.001 176.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 88.5 t -65.97 -42.52 91.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 124.342 1.057 . . . . 0.0 110.85 175.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 42.4 mt -68.52 -38.36 80.84 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 120.837 -1.164 . . . . 0.0 112.5 -179.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -64.6 -47.93 76.8 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.725 1.21 . . . . 0.0 111.105 178.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.32 -35.18 77.41 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 118.064 -0.97 . . . . 0.0 113.083 175.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.4 t -53.93 -44.08 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 CA-C-N 120.209 1.368 . . . . 0.0 111.982 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 71.0 mt -60.33 -13.78 14.87 Favored 'General case' 0 CA--C 1.55 0.964 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 175.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -106.06 -46.86 1.13 Allowed Glycine 0 CA--C 1.536 1.354 0 C-N-CA 126.681 2.086 . . . . 0.0 114.034 178.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -66.24 -25.5 66.92 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 119.075 1.438 . . . . 0.0 113.445 175.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -111.06 158.42 18.85 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.84 1.256 . . . . 0.0 111.656 175.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -175.77 86.49 0.07 OUTLIER Glycine 0 CA--C 1.53 1.015 0 O-C-N 121.474 -0.766 . . . . 0.0 113.901 -175.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.7 mttt -74.82 -54.8 6.64 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.946 1.298 . . . . 0.0 112.525 177.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 16.2 m -141.03 -179.11 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 127.917 2.487 . . . . 0.0 111.158 -178.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 25.9 m -49.54 -48.69 48.17 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 126.334 1.854 . . . . 0.0 114.517 -177.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.0 tpm_? -120.42 129.6 53.98 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.318 1.447 . . . . 0.0 109.497 175.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.9 ptpt -131.93 152.53 51.02 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.824 2.05 . . . . 0.0 110.502 -174.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -121.37 131.12 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 124.674 1.19 . . . . 0.0 109.559 177.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -134.61 97.54 3.82 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.473 1.909 . . . . 0.0 110.318 177.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.6 m -99.52 160.78 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 C-N-CA 123.305 0.642 . . . . 0.0 111.189 178.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -133.53 112.11 1.05 Allowed Glycine 0 CA--C 1.526 0.749 0 CA-C-O 119.308 -0.718 . . . . 0.0 113.526 174.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.9 mp -100.68 147.05 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 119.286 1.543 . . . . 0.0 109.456 175.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -117.2 102.76 9.55 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.116 1.366 . . . . 0.0 110.645 177.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -71.54 92.25 1.12 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 127.14 2.176 . . . . 0.0 111.221 176.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -119.01 -0.19 11.19 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.445 1.098 . . . . 0.0 113.802 175.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 30.3 t -47.81 -34.56 8.82 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 127.024 2.13 . . . . 0.0 114.63 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 110.23 60.49 0.5 Allowed Glycine 0 N--CA 1.468 0.777 0 C-N-CA 124.822 1.201 . . . . 0.0 112.264 177.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 167.81 150.34 6.49 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 125.327 1.441 . . . . 0.0 111.918 177.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.0 p -68.43 130.99 44.5 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.504 1.122 . . . . 0.0 110.92 174.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 43.1 m0 -91.35 101.79 14.49 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 123.849 0.86 . . . . 0.0 111.634 -179.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.9 m -83.45 125.4 31.68 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.069 1.348 . . . . 0.0 109.907 175.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.77 131.69 47.52 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.036 0.534 . . . . 0.0 110.582 174.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -117.12 -45.37 2.75 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.034 0.934 . . . . 0.0 112.125 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -174.25 149.14 1.36 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.76 2.024 . . . . 0.0 111.436 -178.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -131.26 164.82 24.74 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.778 1.631 . . . . 0.0 111.945 176.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -142.89 109.13 5.27 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.902 1.281 . . . . 0.0 111.45 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -113.62 128.01 56.27 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.914 0.886 . . . . 0.0 110.498 -177.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.57 -39.77 4.53 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -177.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.8 t -116.74 -53.89 2.47 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 126.099 1.759 . . . . 0.0 109.801 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -65.36 12.46 0.3 Allowed Glycine 0 CA--C 1.534 1.239 0 C-N-CA 126.929 2.204 . . . . 0.0 115.754 -175.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 53.1 p -31.16 111.15 0.08 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 129.288 3.035 . . . . 0.0 112.938 -174.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 t -129.42 179.62 5.69 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.794 1.238 . . . . 0.0 113.713 -175.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -82.51 -69.65 0.61 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.29 1.436 . . . . 0.0 111.573 176.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.1 p -132.4 130.28 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 125.688 1.595 . . . . 0.0 111.685 -177.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.5 pp -141.15 -26.15 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.896 1.678 . . . . 0.0 114.478 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -99.35 95.26 3.34 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 125.45 1.5 . . . . 0.0 109.181 178.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -65.57 151.55 84.42 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.781 2.987 . . . . 0.0 111.026 176.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -46.52 -49.19 18.89 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.991 1.316 . . . . 0.0 113.595 -179.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.7 p -157.5 139.91 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 126.497 1.919 . . . . 0.0 110.073 175.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 46.1 t -113.89 130.12 24.13 Favored Pre-proline 0 N--CA 1.474 0.753 0 C-N-CA 124.542 1.137 . . . . 0.0 109.069 174.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -67.71 152.84 77.32 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.436 2.091 . . . . 0.0 112.527 176.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -67.12 166.01 14.77 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.05 174.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . 0.267 66.8 p 52.9 22.65 2.47 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 127.668 2.387 . . . . 0.0 114.574 -174.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 20.9 mttt -124.57 172.84 8.9 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 126.834 2.053 . . . . 0.0 112.351 -178.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -131.48 163.94 26.86 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 122.799 0.439 . . . . 0.0 110.123 -178.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -143.76 171.0 14.81 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 124.267 1.027 . . . . 0.0 112.49 -178.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -117.49 154.78 30.85 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.91 1.284 . . . . 0.0 113.45 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.46 ' CE2' ' CE2' ' A' ' 89' ' ' PHE . 16.1 m-85 -129.34 133.5 47.45 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.034 1.334 . . . . 0.0 109.258 175.017 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.0 p -107.82 149.2 28.53 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 126.443 1.897 . . . . 0.0 110.287 175.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -167.9 144.52 8.96 Favored Glycine 0 CA--C 1.522 0.524 0 O-C-N 121.738 -0.601 . . . . 0.0 112.852 174.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 40.2 mtm180 -107.09 140.52 39.79 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.47 1.508 . . . . 0.0 110.676 -176.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.27 -33.59 74.92 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.439 1.496 . . . . 0.0 114.564 175.004 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 49.5 m -71.23 89.73 0.88 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 127.369 2.268 . . . . 0.0 113.456 -177.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 35.6 t -78.88 -33.12 45.97 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 176.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 122.0 -74.66 0.36 Allowed Glycine 0 CA--C 1.537 1.467 0 C-N-CA 125.797 1.665 . . . . 0.0 112.501 -174.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -71.3 -42.32 2.02 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 123.196 2.597 . . . . 0.0 113.095 -178.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 20.9 m -140.9 111.38 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 126.322 1.849 . . . . 0.0 111.49 -175.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.51 125.76 27.19 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 121.401 -0.812 . . . . 0.0 110.814 175.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 97.6 m -135.19 154.57 51.56 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 126.237 1.815 . . . . 0.0 108.877 178.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -54.32 -82.44 0.05 OUTLIER Glycine 0 N--CA 1.475 1.299 0 C-N-CA 124.968 1.27 . . . . 0.0 114.526 -174.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -158.82 109.45 2.06 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.509 0.671 . . . . 0.0 111.723 174.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.9 t -138.24 121.07 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 124.897 1.279 . . . . 0.0 109.375 -177.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.66 167.47 30.01 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 122.211 1.005 . . . . 0.0 110.982 176.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -147.91 158.15 43.9 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.208 1.003 . . . . 0.0 109.501 175.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.504 ' CZ ' HG11 ' A' ' 101' ' ' VAL . 48.0 p90 -155.19 174.48 15.14 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 121.323 -0.861 . . . . 0.0 110.101 175.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -133.52 148.28 51.66 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.537 175.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -125.93 148.57 49.19 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.372 1.069 . . . . 0.0 113.8 176.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -89.12 123.69 33.63 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -178.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 5.8 tpp -89.22 144.07 26.37 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.586 0.754 . . . . 0.0 111.345 176.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 10.8 t -66.34 -23.08 66.29 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.828 0.851 . . . . 0.0 112.829 175.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -73.84 -11.15 60.28 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.981 1.313 . . . . 0.0 112.605 174.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 96.71 38.81 4.31 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 125.051 1.31 . . . . 0.0 114.649 178.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -135.7 173.15 12.04 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 118.812 1.306 . . . . 0.0 110.998 -179.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.4 m -122.63 103.44 8.68 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.731 1.212 . . . . 0.0 112.221 -177.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.3 tt -64.53 92.51 0.09 Allowed 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 126.369 1.868 . . . . 0.0 111.957 175.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -91.96 95.2 2.01 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 125.924 1.726 . . . . 0.0 112.211 -178.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.504 HG11 ' CZ ' ' A' ' 89' ' ' PHE . 2.3 p -82.33 153.63 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 123.704 0.802 . . . . 0.0 111.635 177.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.74 116.67 7.77 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.697 1.599 . . . . 0.0 110.583 177.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -134.49 131.08 37.63 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 122.201 1.001 . . . . 0.0 112.706 -176.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 23.3 t -143.56 97.38 3.06 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 124.564 1.146 . . . . 0.0 110.643 -175.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 24.1 t -94.37 119.62 66.24 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 126.19 1.796 . . . . 0.0 108.975 177.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.421 ' HD3' ' CB ' ' A' ' 114' ' ' ASN . 59.8 Cg_endo -70.29 162.74 41.22 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 122.54 2.16 . . . . 0.0 111.927 179.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -97.34 -62.35 1.27 Allowed 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.919 0.888 . . . . 0.0 111.47 174.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -63.43 -36.87 85.16 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.44 1.496 . . . . 0.0 112.955 -176.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 52.9 21.17 1.89 Allowed 'General case' 0 CA--C 1.556 1.187 0 C-N-CA 126.262 1.825 . . . . 0.0 114.496 -177.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -91.6 -71.41 0.64 Allowed 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.316 1.447 . . . . 0.0 113.967 -174.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -126.4 25.04 6.64 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 127.248 2.219 . . . . 0.0 114.077 -174.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -119.91 124.63 46.5 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.379 1.471 . . . . 0.0 112.883 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 7.3 m -80.73 122.2 26.84 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.283 1.433 . . . . 0.0 110.191 174.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.421 ' CB ' ' HD3' ' A' ' 106' ' ' PRO . 2.4 m120 -123.11 116.23 23.12 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 124.944 1.297 . . . . 0.0 111.359 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 44.5 m0 -109.03 161.23 15.36 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.251 1.421 . . . . 0.0 111.1 -175.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 43.7 p-90 -150.21 137.2 19.37 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.004 0.922 . . . . 0.0 111.771 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -147.75 163.96 35.07 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 122.881 1.324 . . . . 0.0 113.598 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 19.6 t -145.98 140.73 21.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 C-N-CA 124.699 1.199 . . . . 0.0 108.656 175.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.6 173.36 14.74 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 128.032 2.533 . . . . 0.0 108.85 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.465 ' HB ' ' CE2' ' A' ' 154' ' ' TYR . 7.4 mt -129.86 113.34 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 123.883 0.873 . . . . 0.0 109.135 177.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -64.76 138.14 97.37 Favored Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 124.108 0.963 . . . . 0.0 111.521 177.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -74.48 84.07 1.62 Allowed 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 124.336 3.357 . . . . 0.0 112.124 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 114.62 175.76 18.74 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 126.348 1.928 . . . . 0.0 112.955 -178.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 7.5 tttt -61.84 102.36 0.26 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.289 1.436 . . . . 0.0 111.015 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 1.4 mmt85 -123.18 -175.2 3.12 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 126.434 1.894 . . . . 0.0 111.959 -175.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.3 ptp180 -132.12 175.92 8.83 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.735 1.214 . . . . 0.0 112.581 175.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -119.53 111.69 18.41 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 105.258 -2.127 . . . . 0.0 105.258 174.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -128.9 166.26 19.47 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.485 1.514 . . . . 0.0 109.275 177.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -50.01 -40.23 43.93 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 119.8 1.182 . . . . 0.0 113.389 -178.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -56.23 -62.59 6.16 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 124.065 0.841 . . . . 0.0 111.843 174.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 4.6 mtm -60.79 -37.3 81.46 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.045 1.338 . . . . 0.0 113.723 178.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -57.84 -62.49 1.76 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.256 1.422 . . . . 0.0 109.494 175.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -69.47 -31.54 69.89 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -177.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -57.05 -59.1 5.57 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.032 1.333 . . . . 0.0 110.864 174.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.13 -20.54 59.36 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -53.75 -57.27 11.48 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.639 1.176 . . . . 0.0 109.954 175.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -71.4 -0.73 10.94 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -89.82 -9.55 65.99 Favored Glycine 0 CA--C 1.537 1.454 0 C-N-CA 126.112 1.815 . . . . 0.0 114.924 177.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -145.6 91.33 5.74 Favored Pre-proline 0 CA--C 1.549 0.918 0 CA-C-N 119.64 1.72 . . . . 0.0 113.43 179.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -74.41 81.12 2.11 Favored 'Trans proline' 0 CA--C 1.543 0.968 0 C-N-CA 123.556 2.837 . . . . 0.0 112.656 -178.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -113.41 116.16 29.21 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.493 1.517 . . . . 0.0 109.233 177.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 4.4 ttm180 -103.43 50.6 0.8 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.992 1.317 . . . . 0.0 114.052 -174.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 56.96 56.21 26.15 Favored Glycine 0 CA--C 1.534 1.239 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 -175.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -68.08 108.09 2.97 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.002 1.321 . . . . 0.0 110.873 -175.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -77.04 91.81 3.68 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.171 1.388 . . . . 0.0 114.24 -174.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.71 50.77 0.01 OUTLIER Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.318 0.961 . . . . 0.0 114.381 174.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 8.8 m95 46.36 62.38 2.32 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.602 1.561 . . . . 0.0 112.704 -174.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -90.51 125.37 35.58 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.112 1.365 . . . . 0.0 112.361 179.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -160.03 -175.12 4.91 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.235 1.014 . . . . 0.0 113.104 -175.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 8.9 mtmt -134.76 160.8 37.04 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.375 1.47 . . . . 0.0 111.176 174.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -81.36 146.62 30.24 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.066 0.946 . . . . 0.0 109.397 175.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -102.03 128.2 48.58 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 122.733 0.413 . . . . 0.0 110.013 -177.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -53.32 -24.67 23.63 Favored Glycine 0 N--CA 1.475 1.289 0 C-N-CA 125.628 1.585 . . . . 0.0 116.005 -175.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.465 ' CE2' ' HB ' ' A' ' 120' ' ' ILE . 0.1 OUTLIER -74.06 1.54 10.79 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 127.539 2.336 . . . . 0.0 113.453 177.612 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 90.28 10.85 63.53 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.882 1.706 . . . . 0.0 114.381 -177.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 2.6 mt -98.32 166.44 11.39 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.722 2.009 . . . . 0.0 111.187 -178.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 57.7 mtt180 -139.87 105.6 5.14 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.294 1.038 . . . . 0.0 110.524 178.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 18.0 ttp -91.68 135.5 33.84 Favored 'General case' 0 C--N 1.318 -0.762 0 O-C-N 120.755 -1.215 . . . . 0.0 107.888 176.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.21 124.57 52.36 Favored 'General case' 0 C--O 1.221 -0.414 0 C-N-CA 126.145 1.778 . . . . 0.0 109.482 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -133.1 155.6 21.74 Favored Glycine 0 N--CA 1.469 0.842 0 CA-C-N 120.807 1.64 . . . . 0.0 114.833 -178.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 4.2 tp -152.7 135.06 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-O 122.777 1.275 . . . . 0.0 110.846 -175.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 11.5 mtp -153.05 168.94 24.2 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 128.058 2.543 . . . . 0.0 109.209 176.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 13.2 t -151.66 162.66 40.62 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.726 1.21 . . . . 0.0 109.451 174.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 89.5 p -97.68 26.2 5.24 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.047 1.339 . . . . 0.0 113.115 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -68.48 12.77 0.11 Allowed 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 126.843 2.057 . . . . 0.0 115.4 -176.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 85.93 -62.82 4.33 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 125.735 1.636 . . . . 0.0 112.69 178.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -95.61 9.96 38.4 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 177.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -58.04 159.75 5.44 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 123.116 1.436 . . . . 0.0 114.189 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.45 175.41 6.2 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 128.002 2.521 . . . . 0.0 110.758 -177.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 35.6 ttp -118.97 130.5 55.73 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 125.012 1.325 . . . . 0.0 110.363 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -137.03 126.84 25.61 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.148 0.579 . . . . 0.0 110.806 175.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 4.8 mp -131.11 113.75 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 C-N-CA 123.668 0.787 . . . . 0.0 110.068 176.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -109.61 129.09 55.61 Favored 'General case' 0 C--O 1.222 -0.352 0 C-N-CA 125.11 1.364 . . . . 0.0 111.693 176.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.8 mp -79.61 137.18 22.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 175.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 3.2 m -122.21 159.21 27.75 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.699 2.0 . . . . 0.0 110.631 175.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 39.1 mtp180 . . . . . 0 C--O 1.251 1.182 0 C-N-CA 126.403 1.881 . . . . 0.0 112.161 -178.586 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 5.4 t . . . . . 0 N--CA 1.482 1.172 0 N-CA-C 110.695 -0.113 . . . . 0.0 110.695 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -67.8 174.29 3.75 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.397 1.079 . . . . 0.0 112.342 175.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 11.9 tp -131.66 8.21 4.52 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 175.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -132.3 137.78 47.59 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.706 1.602 . . . . 0.0 110.805 175.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -81.75 -153.88 11.88 Favored Glycine 0 CA--C 1.544 1.878 0 C-N-CA 125.351 1.453 . . . . 0.0 110.257 176.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 42.5 p -76.06 173.76 10.88 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.609 1.164 . . . . 0.0 113.063 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -129.77 15.91 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.987 0 C-N-CA 125.92 1.688 . . . . 0.0 112.16 176.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.7 pt -52.92 166.3 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 O-C-N 120.587 -1.32 . . . . 0.0 111.733 175.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -39.81 132.42 1.72 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.267 1.427 . . . . 0.0 113.244 -179.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -57.36 -16.89 22.9 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 124.889 1.233 . . . . 0.0 114.402 -177.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.2 -23.63 67.38 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.542 1.137 . . . . 0.0 111.701 174.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.1 t -109.82 -40.29 4.84 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.592 1.957 . . . . 0.0 112.604 175.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.6 tp -76.47 97.43 4.32 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 121.476 -0.765 . . . . 0.0 109.827 175.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -134.99 -177.82 4.81 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 126.541 1.937 . . . . 0.0 111.87 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -50.23 -36.24 30.13 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.212 1.405 . . . . 0.0 112.91 -178.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -52.85 -37.83 60.69 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.015 1.326 . . . . 0.0 112.543 175.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 78.5 t -73.25 -42.01 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 125.788 1.635 . . . . 0.0 111.115 175.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 57.7 mt -65.4 -42.24 92.81 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 120.961 -1.087 . . . . 0.0 111.964 178.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -61.04 -41.21 96.15 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.289 1.036 . . . . 0.0 111.882 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.98 -38.47 64.16 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 118.834 -0.603 . . . . 0.0 111.215 175.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.3 t -56.01 -39.66 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 C-N-CA 125.398 1.479 . . . . 0.0 111.534 177.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -56.57 -20.57 21.41 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 125.865 1.666 . . . . 0.0 112.727 174.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -108.38 -50.3 0.77 Allowed Glycine 0 CA--C 1.533 1.206 0 C-N-CA 126.356 1.931 . . . . 0.0 114.151 -178.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -64.19 -27.41 69.05 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 118.966 1.383 . . . . 0.0 113.503 178.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 14.3 mt -109.99 119.64 39.96 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.114 1.366 . . . . 0.0 109.549 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -162.32 81.1 0.13 Allowed Glycine 0 CA--C 1.534 1.24 0 O-C-N 121.604 -0.685 . . . . 0.0 114.156 -175.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.6 mttt -72.69 -60.13 2.38 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.945 1.698 . . . . 0.0 112.985 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.5 m -109.46 -178.7 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 126.794 2.038 . . . . 0.0 110.756 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.6 t -51.27 -46.64 62.47 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.512 1.125 . . . . 0.0 113.568 -175.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.69 144.2 51.17 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.948 1.699 . . . . 0.0 111.176 174.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.92 166.35 22.54 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.194 1.797 . . . . 0.0 111.615 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -129.07 137.42 57.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 124.927 1.291 . . . . 0.0 109.387 176.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -141.0 119.24 12.08 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 126.004 1.721 . . . . 0.0 109.416 175.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.6 m -124.77 139.03 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 123.084 0.553 . . . . 0.0 110.779 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -111.51 103.6 1.58 Allowed Glycine 0 N--CA 1.461 0.334 0 C-N-CA 124.754 1.168 . . . . 0.0 110.857 -178.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.4 mp -100.16 132.81 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 121.527 0.68 . . . . 0.0 110.806 175.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -100.99 104.15 15.3 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.755 2.022 . . . . 0.0 109.859 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 29.1 t30 -78.51 99.05 6.31 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.651 0.78 . . . . 0.0 111.033 175.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.54 13.41 10.13 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.002 0.921 . . . . 0.0 112.2 175.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.43 -34.88 71.29 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.892 1.277 . . . . 0.0 114.072 -175.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 139.0 -35.75 1.95 Allowed Glycine 0 CA--C 1.531 1.051 0 C-N-CA 125.535 1.54 . . . . 0.0 113.817 175.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -114.54 158.24 14.45 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 125.167 1.365 . . . . 0.0 112.935 175.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.42 149.17 34.89 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.922 0.867 . . . . 0.0 110.964 175.001 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 40.9 m0 -101.26 107.81 19.29 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 125.139 1.376 . . . . 0.0 110.199 178.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 54.2 m -92.91 128.62 38.84 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 124.805 1.242 . . . . 0.0 109.054 175.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.47 138.15 58.26 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.654 -0.653 . . . . 0.0 111.705 174.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.1 pp -118.65 -51.58 2.38 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.054 0.942 . . . . 0.0 112.241 177.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 25.1 t30 -170.83 150.07 3.15 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.09 1.756 . . . . 0.0 109.954 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -131.32 158.52 40.45 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.089 1.356 . . . . 0.0 110.849 175.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -136.82 108.6 7.05 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.699 1.6 . . . . 0.0 111.151 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -112.59 127.23 56.03 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 120.989 -1.069 . . . . 0.0 110.205 -176.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.55 -32.09 6.57 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -175.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 38.1 t -130.94 -36.06 1.37 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.361 1.464 . . . . 0.0 112.128 175.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -69.64 12.33 1.49 Allowed Glycine 0 CA--C 1.537 1.433 0 C-N-CA 125.553 1.549 . . . . 0.0 115.871 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 75.8 p -28.34 99.36 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 129.992 3.317 . . . . 0.0 114.436 -174.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.2 t -119.25 177.59 4.84 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.467 1.507 . . . . 0.0 112.655 -174.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -82.16 -52.08 7.34 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.442 1.097 . . . . 0.0 112.421 175.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.2 p -155.62 139.19 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.752 1.621 . . . . 0.0 111.618 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.492 ' HB ' ' CE2' ' A' ' 72' ' ' TYR . 0.1 OUTLIER -133.83 -46.28 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 125.53 1.532 . . . . 0.0 112.693 179.14 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.9 mt -79.33 103.46 1.59 Allowed Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 127.002 2.121 . . . . 0.0 109.272 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -73.44 159.18 46.95 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 123.874 3.05 . . . . 0.0 110.549 177.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -52.97 -48.77 67.16 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 57.7 t -152.98 136.3 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 127.184 2.194 . . . . 0.0 109.272 -175.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 57.9 t -128.43 114.48 19.69 Favored Pre-proline 0 N--CA 1.479 1.016 0 C-N-CA 124.208 1.003 . . . . 0.0 110.583 174.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -59.93 145.56 98.01 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.495 2.13 . . . . 0.0 112.385 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -68.11 166.36 16.24 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.692 0.797 . . . . 0.0 110.703 175.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 39.8 p 62.39 16.92 8.99 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 127.198 2.199 . . . . 0.0 113.531 -175.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 19.0 mttt -125.86 -173.76 2.92 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.518 1.927 . . . . 0.0 111.102 -178.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -138.8 166.74 23.62 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 122.912 0.485 . . . . 0.0 109.988 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.8 pp -139.29 171.39 14.35 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 124.549 1.139 . . . . 0.0 111.145 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -119.13 153.98 33.98 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 124.746 1.218 . . . . 0.0 110.475 175.013 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.492 ' CE2' ' HB ' ' A' ' 59' ' ' ILE . 2.7 m-85 -126.41 151.73 47.29 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 126.215 1.806 . . . . 0.0 109.931 177.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.0 p -128.7 148.2 50.81 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.85 2.06 . . . . 0.0 111.747 -179.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -169.26 146.62 10.33 Favored Glycine 0 CA--C 1.519 0.306 0 CA-C-O 121.627 0.57 . . . . 0.0 112.619 175.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 63.5 mtm180 -128.64 138.59 52.26 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 126.74 2.016 . . . . 0.0 109.21 -174.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -66.37 172.69 3.77 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 174.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 63.8 p -120.49 -171.71 2.22 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 127.452 2.301 . . . . 0.0 112.473 179.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 72.7 m 52.64 34.41 15.82 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 175.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 53.19 -98.31 0.03 OUTLIER Glycine 0 CA--C 1.539 1.58 0 C-N-CA 127.325 2.393 . . . . 0.0 113.585 176.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -66.69 -82.55 0.01 OUTLIER 'Trans proline' 0 CA--C 1.546 1.093 0 C-N-CA 124.055 3.17 . . . . 0.0 113.169 177.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 16.4 m -70.68 143.64 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.665 1.186 . . . . 0.0 111.185 177.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -154.87 178.82 9.74 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.47 1.108 . . . . 0.0 110.559 177.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -81.62 13.37 3.15 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.552 1.541 . . . . 0.0 113.064 174.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 76.98 -98.48 1.32 Allowed Glycine 0 CA--C 1.528 0.892 0 C-N-CA 126.518 2.009 . . . . 0.0 112.269 -175.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -148.46 93.44 2.15 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 117.677 0.739 . . . . 0.0 110.866 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.4 t -122.2 120.69 61.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 124.46 1.104 . . . . 0.0 112.066 -175.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -160.02 168.71 25.0 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.489 1.116 . . . . 0.0 112.282 178.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -150.5 132.96 15.63 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.42 1.088 . . . . 0.0 109.326 174.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.463 ' CD2' ' CE2' ' A' ' 72' ' ' TYR . 43.9 p90 -132.17 170.01 15.6 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 120.946 -1.096 . . . . 0.0 110.27 177.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -139.61 142.87 37.06 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -179.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -120.43 139.12 53.3 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.675 1.19 . . . . 0.0 112.788 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -84.76 126.9 33.81 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.997 -0.439 . . . . 0.0 111.453 -177.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -97.53 141.12 30.97 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.016 1.327 . . . . 0.0 111.855 178.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 24.9 m -64.04 -20.26 65.79 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.47 1.108 . . . . 0.0 113.731 174.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 36.2 m-80 -72.22 -10.59 59.98 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.445 1.098 . . . . 0.0 112.81 174.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 89.68 44.32 4.91 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 124.755 1.169 . . . . 0.0 112.987 -176.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -140.06 175.11 9.86 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.956 1.302 . . . . 0.0 110.481 175.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 12.9 m -126.87 110.7 13.32 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.395 1.478 . . . . 0.0 112.045 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.7 tt -70.86 98.02 1.5 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.954 1.302 . . . . 0.0 112.208 174.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -91.22 104.28 3.15 Favored Glycine 0 N--CA 1.469 0.896 0 C-N-CA 125.142 1.353 . . . . 0.0 113.372 177.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 94.0 t -85.39 130.62 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 125.106 1.363 . . . . 0.0 111.344 175.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 2.4 tmm? -119.99 124.27 45.52 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.798 1.639 . . . . 0.0 110.337 178.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -148.95 122.67 9.24 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 122.901 1.334 . . . . 0.0 111.946 -178.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 15.1 p -139.94 100.53 3.96 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 124.418 1.087 . . . . 0.0 110.008 -175.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 97.0 t -90.52 95.85 0.82 Allowed Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 127.125 2.17 . . . . 0.0 108.654 178.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.18 121.36 7.46 Favored 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 123.145 2.563 . . . . 0.0 112.273 -177.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -64.67 -28.64 69.75 Favored 'General case' 0 CA--C 1.548 0.885 0 O-C-N 121.547 -0.721 . . . . 0.0 111.496 174.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 24.5 p30 -73.52 45.7 0.19 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 126.103 1.761 . . . . 0.0 114.619 176.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -49.96 -18.1 0.48 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 126.341 1.856 . . . . 0.0 114.905 175.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -58.89 -19.73 44.96 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 125.875 1.67 . . . . 0.0 112.452 174.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 24.5 m95 -97.55 -20.56 17.62 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 128.306 2.642 . . . . 0.0 114.012 175.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER 58.23 42.26 22.19 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 127.002 2.121 . . . . 0.0 115.271 177.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.2 p -124.2 74.11 1.28 Allowed 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 125.372 1.469 . . . . 0.0 114.715 -176.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -98.81 108.5 21.2 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.418 1.887 . . . . 0.0 108.093 175.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 35.7 m0 -105.66 142.75 34.86 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 119.671 1.123 . . . . 0.0 109.942 175.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 29.7 p-90 -146.86 143.65 28.72 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 121.309 -0.87 . . . . 0.0 113.112 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -151.38 164.49 36.58 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 122.654 1.216 . . . . 0.0 112.957 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 54.6 t -153.41 136.66 7.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 175.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.37 177.81 10.2 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 126.645 1.978 . . . . 0.0 109.552 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.49 ' HB ' ' CE2' ' A' ' 154' ' ' TYR . 15.8 mt -126.52 141.79 44.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -101.05 144.4 28.48 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 125.172 1.389 . . . . 0.0 110.312 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.06 132.48 21.33 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 123.077 2.518 . . . . 0.0 111.455 179.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 62.85 -160.87 33.36 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 123.47 0.557 . . . . 0.0 113.017 -175.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.8 tttt -73.88 114.46 12.2 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.292 1.037 . . . . 0.0 109.532 175.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 2.4 mmt-85 -133.09 148.85 52.17 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.542 1.137 . . . . 0.0 111.057 175.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -93.64 179.57 5.33 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-O 121.686 0.755 . . . . 0.0 110.256 176.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -126.07 113.77 17.53 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 127.205 2.202 . . . . 0.0 105.093 175.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -126.91 172.83 10.09 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.388 1.475 . . . . 0.0 110.406 178.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -53.75 -40.78 66.48 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 119.62 1.1 . . . . 0.0 113.323 -178.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -59.73 -54.89 33.81 Favored Glycine 0 N--CA 1.467 0.736 0 CA-C-O 119.364 -0.687 . . . . 0.0 111.824 176.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 4.5 mpp? -62.24 -42.37 99.25 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 118.199 1.0 . . . . 0.0 112.388 177.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -54.94 -56.28 21.4 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.811 0.845 . . . . 0.0 109.646 176.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -66.37 -37.18 84.71 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -60.77 -44.49 96.7 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.298 1.439 . . . . 0.0 112.305 177.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 42.4 mmm -81.6 -30.01 33.08 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.074 -1.016 . . . . 0.0 112.615 177.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -54.47 -57.99 9.18 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.969 1.308 . . . . 0.0 109.457 174.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -73.8 -10.51 59.74 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -177.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -79.92 -15.42 79.12 Favored Glycine 0 CA--C 1.537 1.432 0 C-N-CA 125.893 1.711 . . . . 0.0 114.868 177.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -140.91 90.61 9.42 Favored Pre-proline 0 CA--C 1.552 1.041 0 CA-C-N 119.37 1.585 . . . . 0.0 112.522 176.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -74.66 78.08 2.85 Favored 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 123.912 3.074 . . . . 0.0 112.434 178.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -111.87 120.43 41.9 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.654 1.182 . . . . 0.0 110.462 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.38 -173.82 4.93 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.562 1.145 . . . . 0.0 112.584 176.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -75.16 53.07 2.63 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 125.602 1.572 . . . . 0.0 111.076 175.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -64.72 97.11 0.2 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 127.14 2.176 . . . . 0.0 110.039 178.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -75.31 93.43 2.88 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.554 1.142 . . . . 0.0 113.005 -174.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 162.89 54.93 0.02 OUTLIER Glycine 0 CA--C 1.537 1.407 0 C-N-CA 124.376 0.989 . . . . 0.0 115.011 175.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 8.0 m95 52.1 44.97 29.14 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.619 1.568 . . . . 0.0 114.667 -177.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -78.15 129.5 35.23 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 120.862 -1.148 . . . . 0.0 111.857 -177.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.64 -174.59 4.71 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.394 -0.816 . . . . 0.0 113.165 -175.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.96 151.89 51.64 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.972 1.309 . . . . 0.0 110.733 175.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -69.64 150.63 46.83 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 175.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 60.8 mt -109.91 145.54 36.69 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 175.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -64.5 -166.62 1.19 Allowed Glycine 0 CA--C 1.545 1.917 0 N-CA-C 110.266 -1.134 . . . . 0.0 110.266 176.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.49 ' CE2' ' HB ' ' A' ' 120' ' ' ILE . 0.0 OUTLIER 54.76 10.77 0.39 Allowed 'General case' 0 CA--C 1.558 1.275 0 N-CA-C 115.316 1.598 . . . . 0.0 115.316 175.038 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 80.96 41.27 10.64 Favored Glycine 0 CA--C 1.539 1.584 0 C-N-CA 126.416 1.96 . . . . 0.0 114.666 -175.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 2.4 mp -123.91 160.11 28.22 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 119.445 1.623 . . . . 0.0 112.305 177.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 10.5 mtt-85 -147.37 121.63 9.58 Favored 'General case' 0 N--CA 1.481 1.086 0 O-C-N 120.424 -1.423 . . . . 0.0 110.397 174.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 9.1 ttp -108.9 132.99 53.52 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 123.589 0.756 . . . . 0.0 109.069 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 2.7 tppt? -107.36 129.53 54.9 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 127.226 2.21 . . . . 0.0 110.385 -178.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -138.4 158.44 24.92 Favored Glycine 0 N--CA 1.473 1.106 0 CA-C-N 121.255 1.843 . . . . 0.0 115.57 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 3.4 tp -148.1 124.69 2.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-O 122.607 1.194 . . . . 0.0 111.362 -178.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 51.4 mtp -137.56 149.19 46.51 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 128.06 2.544 . . . . 0.0 107.998 175.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 8.8 t -134.66 161.16 35.9 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.335 1.054 . . . . 0.0 110.196 175.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 55.0 p -108.04 21.87 16.76 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.981 1.712 . . . . 0.0 112.428 -176.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -64.3 20.73 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.237 0 C-N-CA 128.617 2.767 . . . . 0.0 115.395 178.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 82.76 -68.64 3.51 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 126.995 2.236 . . . . 0.0 112.177 -177.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 -111.93 67.33 0.65 Allowed 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.538 1.535 . . . . 0.0 110.221 -177.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -95.76 174.66 6.86 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.946 1.698 . . . . 0.0 112.796 175.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.95 -178.78 3.94 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.845 2.058 . . . . 0.0 110.768 175.008 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 20.4 ttp -128.78 122.1 29.8 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.087 1.355 . . . . 0.0 109.812 176.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -131.47 130.31 42.28 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.053 0.941 . . . . 0.0 110.06 177.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 4.3 mp -135.28 125.6 43.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 123.989 0.915 . . . . 0.0 109.297 177.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.85 128.88 50.97 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 125.811 1.644 . . . . 0.0 111.635 177.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.8 mp -74.69 133.06 32.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 175.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 1.2 m -144.87 97.08 2.96 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.044 1.337 . . . . 0.0 111.691 176.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 72.6 mtp180 . . . . . 0 C--O 1.254 1.327 0 C-N-CA 126.676 1.99 . . . . 0.0 113.018 177.581 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 37.2 m . . . . . 0 N--CA 1.48 1.065 0 CA-C-O 120.583 0.23 . . . . 0.0 111.526 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -98.48 -178.97 4.18 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.469 1.908 . . . . 0.0 112.59 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -130.35 -59.54 1.03 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.688 1.595 . . . . 0.0 111.445 177.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -68.41 126.86 30.96 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 121.507 -0.745 . . . . 0.0 109.365 174.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -69.73 -90.69 0.07 OUTLIER Glycine 0 CA--C 1.535 1.293 0 C-N-CA 123.851 0.739 . . . . 0.0 113.181 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.7 p -149.81 166.28 29.95 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 125.776 1.631 . . . . 0.0 111.845 -175.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -114.04 22.74 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 CA-C-O 123.032 1.396 . . . . 0.0 112.996 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -45.24 152.38 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 125.624 1.57 . . . . 0.0 111.959 174.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -44.77 139.31 3.04 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 126.041 1.737 . . . . 0.0 112.901 -176.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -54.35 -25.98 35.5 Favored Glycine 0 CA--C 1.54 1.603 0 C-N-CA 124.225 0.917 . . . . 0.0 114.713 -175.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.83 -33.6 76.04 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.257 1.423 . . . . 0.0 112.551 174.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.4 m -96.47 -38.35 10.05 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.991 2.116 . . . . 0.0 112.637 175.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.4 tp -78.33 85.08 4.48 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.961 1.304 . . . . 0.0 110.674 176.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 48.6 p -114.12 176.07 5.2 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.771 2.028 . . . . 0.0 110.534 179.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -51.09 -39.47 56.18 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.404 -0.81 . . . . 0.0 112.569 177.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -54.89 -37.51 66.4 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 118.54 0.609 . . . . 0.0 112.432 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 92.4 t -68.13 -40.34 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.067 1.347 . . . . 0.0 111.169 174.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 41.1 mt -68.2 -40.45 82.18 Favored 'General case' 0 N--CA 1.471 0.575 0 O-C-N 120.865 -1.147 . . . . 0.0 112.229 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -61.88 -49.52 75.88 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.317 1.047 . . . . 0.0 111.609 177.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.58 -33.58 76.25 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 118.155 -0.926 . . . . 0.0 113.089 174.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.1 t -54.7 -42.3 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-N 119.792 1.178 . . . . 0.0 111.594 177.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.5 mt -55.77 -23.55 30.28 Favored 'General case' 0 CA--C 1.55 0.972 0 CA-C-N 119.544 1.065 . . . . 0.0 113.486 175.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -93.65 -60.76 1.14 Allowed Glycine 0 CA--C 1.532 1.132 0 C-N-CA 125.689 1.614 . . . . 0.0 112.7 177.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -67.47 -27.04 66.69 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 -177.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -111.94 87.95 2.69 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.663 1.585 . . . . 0.0 110.298 177.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -134.77 155.26 21.88 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 125.06 1.314 . . . . 0.0 113.004 175.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.3 mtpt -141.85 -49.37 0.39 Allowed 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 125.549 1.539 . . . . 0.0 112.143 -177.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.2 m -115.89 -177.17 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 C-N-CA 126.297 1.839 . . . . 0.0 110.636 176.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.8 t -49.3 -44.4 44.11 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 126.374 1.869 . . . . 0.0 115.068 -176.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.8 161.61 35.1 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 126.28 1.832 . . . . 0.0 111.074 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.31 165.61 36.11 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.089 0.956 . . . . 0.0 112.711 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -119.34 123.73 71.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 124.125 0.97 . . . . 0.0 108.44 175.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -127.64 120.8 28.88 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 126.513 1.925 . . . . 0.0 106.706 174.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.56 140.43 43.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 126.459 1.904 . . . . 0.0 108.527 -174.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -123.07 132.75 8.73 Favored Glycine 0 CA--C 1.523 0.575 0 CA-C-O 119.981 -0.344 . . . . 0.0 112.538 175.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.4 mp -112.64 152.22 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 117.71 0.755 . . . . 0.0 109.343 174.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -122.22 106.61 11.29 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 122.63 1.205 . . . . 0.0 110.709 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -76.07 85.15 2.94 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 128.451 2.7 . . . . 0.0 111.054 -175.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -120.99 4.65 10.43 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.644 1.177 . . . . 0.0 113.926 176.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -53.98 -50.41 66.6 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.475 1.11 . . . . 0.0 112.133 174.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 127.7 103.87 1.23 Allowed Glycine 0 CA--C 1.526 0.776 0 C-N-CA 123.928 0.775 . . . . 0.0 111.684 177.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 114.48 153.93 10.82 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 126.15 1.833 . . . . 0.0 111.127 -174.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 68.4 p -69.72 142.18 53.36 Favored 'General case' 0 N--CA 1.466 0.359 0 O-C-N 121.887 -0.773 . . . . 0.0 111.062 175.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 39.4 m0 -96.64 107.6 20.07 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.367 0.667 . . . . 0.0 109.434 -179.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 36.4 m -87.58 127.33 35.26 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.609 0.763 . . . . 0.0 109.972 178.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.42 130.39 44.25 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 122.763 0.425 . . . . 0.0 111.429 174.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.8 pp -114.13 -55.76 2.46 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.79 0.836 . . . . 0.0 111.632 178.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -166.68 160.32 14.82 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.894 1.677 . . . . 0.0 110.867 175.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -140.69 165.71 26.74 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.427 1.091 . . . . 0.0 111.981 174.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -142.0 119.69 11.8 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.704 1.202 . . . . 0.0 111.887 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -108.74 139.2 43.88 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.362 -0.836 . . . . 0.0 111.646 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.1 tpp180 -110.78 -65.91 1.12 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.859 1.663 . . . . 0.0 111.262 -177.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -37.58 -58.06 0.9 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 128.257 2.623 . . . . 0.0 113.52 -175.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -153.05 -116.63 0.65 Allowed Glycine 0 CA--C 1.526 0.731 0 C-N-CA 125.971 1.748 . . . . 0.0 109.133 175.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 39.0 p -143.33 178.52 7.68 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.036 1.334 . . . . 0.0 112.23 -175.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.2 t -154.0 179.58 8.78 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.43 1.492 . . . . 0.0 111.417 174.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -111.67 -38.5 4.87 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.02 1.328 . . . . 0.0 112.41 179.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.9 p -159.28 127.76 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 126.076 1.75 . . . . 0.0 110.636 175.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.422 ' HB ' ' CE2' ' A' ' 72' ' ' TYR . 1.7 pp -132.8 -32.36 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 114.606 1.335 . . . . 0.0 114.606 175.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.4 mt -100.85 95.53 4.64 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 125.43 1.492 . . . . 0.0 109.403 178.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -65.97 151.62 83.52 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 123.402 2.735 . . . . 0.0 110.676 174.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -44.35 -49.64 9.46 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.894 1.677 . . . . 0.0 114.023 -177.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 5.1 p -159.42 137.73 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 126.978 2.111 . . . . 0.0 109.208 175.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 98.8 t -114.74 125.88 28.55 Favored Pre-proline 0 N--CA 1.479 0.988 0 C-N-CA 123.927 0.891 . . . . 0.0 109.211 175.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -65.64 155.73 67.49 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 122.882 2.388 . . . . 0.0 113.099 177.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -71.71 169.59 15.31 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.582 0.753 . . . . 0.0 111.374 175.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 65.2 p 52.34 26.25 3.97 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 126.415 1.886 . . . . 0.0 113.217 -175.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.3 mttt -138.25 174.68 10.3 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 126.441 1.896 . . . . 0.0 111.107 -175.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -135.66 160.81 37.36 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -176.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.441 HD11 ' HH ' ' A' ' 91' ' ' TYR . 2.4 pt? -133.18 170.49 15.34 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.786 1.234 . . . . 0.0 111.552 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -114.29 149.91 35.24 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 124.494 1.118 . . . . 0.0 109.995 175.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.422 ' CE2' ' HB ' ' A' ' 59' ' ' ILE . 1.5 m-85 -122.36 160.32 25.66 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 127.353 2.261 . . . . 0.0 108.775 175.072 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.9 p -145.34 166.77 24.61 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 125.443 1.497 . . . . 0.0 112.105 -175.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 173.9 151.76 8.48 Favored Glycine 0 C--O 1.237 0.301 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.681 174.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.427 HH11 ' HA ' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -111.9 139.17 47.6 Favored 'General case' 0 CA--C 1.521 -0.145 0 C-N-CA 124.883 1.273 . . . . 0.0 111.88 179.321 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.17 -32.52 66.92 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.172 0.989 . . . . 0.0 112.853 174.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 24.8 m -54.85 128.04 31.34 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 126.817 2.047 . . . . 0.0 113.019 -174.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -161.27 112.49 1.77 Allowed 'General case' 0 C--O 1.233 0.205 0 C-N-CA 125.371 1.468 . . . . 0.0 108.905 -175.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -35.98 -50.07 1.15 Allowed Glycine 0 CA--C 1.545 1.94 0 C-N-CA 126.181 1.848 . . . . 0.0 115.215 175.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -69.76 -59.62 0.08 OUTLIER 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 122.713 2.275 . . . . 0.0 113.118 175.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.4 p -155.67 103.33 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 125.138 1.375 . . . . 0.0 112.11 -175.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.81 129.6 39.51 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 123.524 0.73 . . . . 0.0 111.422 175.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 34.7 m -126.41 134.98 50.87 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.903 1.281 . . . . 0.0 110.363 178.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -26.75 -66.96 0.06 OUTLIER Glycine 0 N--CA 1.473 1.127 0 C-N-CA 127.991 2.71 . . . . 0.0 116.693 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -167.47 106.66 0.56 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.066 0.947 . . . . 0.0 112.219 -178.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.7 t -149.51 109.67 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 124.749 1.22 . . . . 0.0 112.062 -174.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.69 169.64 22.81 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 179.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -147.2 160.61 42.26 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.92 1.288 . . . . 0.0 112.543 175.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -164.11 171.41 15.14 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.332 1.053 . . . . 0.0 111.62 -178.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -143.95 155.94 44.24 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.468 -0.77 . . . . 0.0 112.201 174.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.441 ' HH ' HD11 ' A' ' 70' ' ' LEU . 11.7 m-85 -131.72 129.29 40.48 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 126.472 1.909 . . . . 0.0 113.19 -175.015 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -90.66 130.53 36.66 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 120.882 0.372 . . . . 0.0 111.343 -176.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 3.9 mtm -108.27 139.01 43.6 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 125.503 1.521 . . . . 0.0 111.705 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.2 t -64.79 -18.7 65.32 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.223 1.409 . . . . 0.0 112.962 176.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -69.74 -17.5 63.45 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.998 1.319 . . . . 0.0 113.616 175.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 106.47 21.32 8.41 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.92 1.248 . . . . 0.0 115.362 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -131.44 174.81 9.71 Favored 'General case' 0 CA--C 1.555 1.142 0 CA-C-N 119.824 1.812 . . . . 0.0 111.422 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.8 m -129.31 105.87 8.42 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.403 1.081 . . . . 0.0 112.959 -178.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 59.0 tp -68.81 101.23 1.3 Allowed 'General case' 0 N--CA 1.47 0.567 0 O-C-N 121.762 -0.586 . . . . 0.0 110.247 174.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -94.65 138.65 14.12 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 124.176 0.893 . . . . 0.0 112.232 175.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 54.1 t -128.17 133.03 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.225 1.41 . . . . 0.0 110.71 -175.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.84 124.29 20.74 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.895 1.678 . . . . 0.0 109.386 -177.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 26.9 p90 -138.42 135.35 35.16 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -178.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 12.2 m -148.79 100.51 3.1 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 122.224 1.011 . . . . 0.0 111.193 -175.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 51.3 t -80.45 141.77 53.26 Favored Pre-proline 0 N--CA 1.471 0.588 0 C-N-CA 127.144 2.178 . . . . 0.0 109.761 -177.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -69.84 128.88 16.58 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.278 1.985 . . . . 0.0 112.697 -178.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -138.21 -72.54 0.41 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.446 1.099 . . . . 0.0 111.88 178.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -117.22 11.75 14.18 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.911 1.685 . . . . 0.0 113.955 -177.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -44.87 112.51 0.44 Allowed 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.118 1.367 . . . . 0.0 112.932 177.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -58.53 -13.54 5.87 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.301 1.44 . . . . 0.0 113.884 175.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 28.5 m95 -122.12 6.32 9.75 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 127.641 2.376 . . . . 0.0 113.354 -179.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 1.1 p90 42.84 46.27 4.49 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 126.562 1.945 . . . . 0.0 112.518 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 5.5 m -127.07 93.57 3.79 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.714 2.006 . . . . 0.0 114.042 -174.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -80.58 115.81 20.29 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 124.324 1.05 . . . . 0.0 108.973 174.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 42.1 m0 -116.25 145.66 42.96 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.134 0.973 . . . . 0.0 109.45 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 34.3 p-90 -150.78 139.83 21.07 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.403 0.681 . . . . 0.0 112.248 -179.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -140.57 145.85 37.28 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 122.299 1.047 . . . . 0.0 112.81 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 86.1 t -146.8 123.96 3.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 125.093 1.357 . . . . 0.0 107.783 176.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.401 ' HE2' ' CZ ' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -156.14 176.18 13.0 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.403 1.081 . . . . 0.0 111.336 174.969 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.473 ' HB ' ' CE2' ' A' ' 154' ' ' TYR . 38.8 mt -111.51 105.31 18.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 123.765 0.826 . . . . 0.0 109.804 -177.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.401 ' CZ ' ' HE2' ' A' ' 119' ' ' LYS . 91.0 m-85 -60.3 143.82 88.65 Favored Pre-proline 0 CA--C 1.548 0.899 0 O-C-N 121.318 -0.864 . . . . 0.0 111.889 178.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -76.11 80.25 2.72 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 124.449 3.432 . . . . 0.0 112.435 -176.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 118.89 -170.83 13.96 Favored Glycine 0 N--CA 1.471 1.004 0 C-N-CA 125.684 1.611 . . . . 0.0 112.778 -178.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 23.3 tttt -66.27 109.53 2.7 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.018 0.927 . . . . 0.0 109.51 174.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.43 ' HG3' ' H ' ' A' ' 126' ' ' ARG . 5.7 tpt180 -120.01 173.04 7.32 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.723 1.609 . . . . 0.0 110.242 176.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.43 ' H ' ' HG3' ' A' ' 125' ' ' ARG . 2.2 ptp180 -127.04 173.17 9.88 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 127.172 2.189 . . . . 0.0 111.292 174.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -128.35 98.01 4.92 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 126.44 1.896 . . . . 0.0 107.422 175.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -117.73 173.1 6.93 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.425 1.89 . . . . 0.0 109.115 175.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -49.84 -42.74 48.01 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.057 0.943 . . . . 0.0 113.477 177.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -57.34 -63.66 5.1 Favored Glycine 0 C--N 1.339 0.718 0 C-N-CA 124.173 0.892 . . . . 0.0 111.624 175.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 15.0 mtm -59.81 -34.12 72.63 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 118.141 0.97 . . . . 0.0 113.297 178.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -59.53 -60.42 3.87 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 119.304 0.956 . . . . 0.0 109.93 175.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -70.03 -30.7 68.06 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -177.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -60.75 -54.23 47.74 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.417 1.087 . . . . 0.0 110.024 174.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 2.0 tpp -75.21 -26.48 58.98 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -177.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -52.44 -55.84 19.11 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.464 1.505 . . . . 0.0 110.586 174.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -69.8 -8.65 50.07 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 179.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -79.21 -31.33 42.75 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 126.224 1.869 . . . . 0.0 115.076 -177.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -128.65 85.19 60.95 Favored Pre-proline 0 CA--C 1.548 0.887 0 CA-C-N 118.717 1.259 . . . . 0.0 111.047 178.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -73.42 75.94 2.83 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 123.661 2.908 . . . . 0.0 112.086 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -111.28 114.41 27.57 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.058 0.943 . . . . 0.0 110.86 -177.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 57.4 mtp180 -81.65 -71.41 0.48 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.813 1.245 . . . . 0.0 111.499 175.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 136.86 122.62 2.16 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 124.568 1.08 . . . . 0.0 113.589 -177.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.9 7.1 9.5 Favored 'General case' 0 CA--C 1.559 1.296 0 C-N-CA 127.175 2.19 . . . . 0.0 115.081 177.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 57.57 55.83 5.36 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 128.282 2.633 . . . . 0.0 112.595 -175.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -158.24 -66.73 0.01 OUTLIER Glycine 0 CA--C 1.538 1.479 0 N-CA-C 115.971 1.148 . . . . 0.0 115.971 -177.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 29.8 m95 174.11 117.1 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 130.414 3.486 . . . . 0.0 108.361 -174.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -129.9 121.03 25.86 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 126.801 2.04 . . . . 0.0 111.846 -175.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -162.33 178.3 8.81 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 -175.072 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.76 154.46 48.52 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.542 1.537 . . . . 0.0 110.849 175.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -71.34 137.69 48.65 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 175.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 91.1 mt -93.92 102.76 14.87 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.667 0.787 . . . . 0.0 109.947 -176.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -36.22 -37.51 0.19 Allowed Glycine 0 N--CA 1.476 1.32 0 C-N-CA 128.711 3.053 . . . . 0.0 117.629 -174.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.473 ' CE2' ' HB ' ' A' ' 120' ' ' ILE . 0.1 OUTLIER -61.61 -30.85 70.95 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.968 2.107 . . . . 0.0 113.239 -179.252 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 132.65 30.38 0.5 Allowed Glycine 0 CA--C 1.536 1.397 0 C-N-CA 125.763 1.649 . . . . 0.0 114.582 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 12.8 mt -130.6 175.85 8.66 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 126.082 1.753 . . . . 0.0 110.555 -174.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 60.7 mtt-85 -147.21 100.7 3.31 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.534 -1.354 . . . . 0.0 112.701 178.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -82.1 148.69 28.41 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 124.157 0.983 . . . . 0.0 108.632 175.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 3.3 tppt? -139.68 120.46 14.37 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.331 1.852 . . . . 0.0 111.214 178.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -131.59 154.89 21.11 Favored Glycine 0 N--CA 1.479 1.518 0 CA-C-N 121.123 1.783 . . . . 0.0 116.311 -176.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 2.1 tp -146.19 130.55 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.132 1.373 . . . . 0.0 110.651 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 1.9 ttp -154.61 117.62 4.44 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.958 1.703 . . . . 0.0 110.249 174.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 4.9 t -110.4 101.44 10.15 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 121.122 -0.986 . . . . 0.0 111.411 -177.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 49.0 p -69.12 28.45 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.02 -27.2 68.15 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.309 1.844 . . . . 0.0 114.332 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 159.78 -53.75 0.36 Allowed Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.776 1.179 . . . . 0.0 113.507 175.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -134.5 87.32 2.34 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.81 1.244 . . . . 0.0 110.771 178.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -136.26 -174.6 3.73 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.682 1.593 . . . . 0.0 111.582 175.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.51 175.35 9.5 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 127.462 2.305 . . . . 0.0 111.437 -178.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 32.6 ttp -110.04 138.3 46.61 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 123.965 0.906 . . . . 0.0 110.479 173.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -143.86 123.72 13.47 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 123.595 0.758 . . . . 0.0 110.361 176.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 4.7 mp -127.48 121.02 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 123.481 0.712 . . . . 0.0 109.754 176.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 2.8 tmmm? -121.05 139.07 53.82 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 125.32 1.448 . . . . 0.0 110.705 177.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.6 mp -87.4 125.79 41.11 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 174.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -137.4 96.64 3.3 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.256 1.422 . . . . 0.0 111.724 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 10.8 mtp-105 . . . . . 0 C--O 1.254 1.29 0 C-N-CA 128.119 2.568 . . . . 0.0 113.638 -177.737 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.1 t . . . . . 0 N--CA 1.484 1.232 0 CA-C-O 120.836 0.35 . . . . 0.0 111.392 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -98.17 167.69 10.72 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.768 1.627 . . . . 0.0 112.449 178.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 10.4 tp -123.46 -37.99 2.6 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.313 1.445 . . . . 0.0 111.835 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -85.78 130.26 34.61 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.9 1.28 . . . . 0.0 108.464 174.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -77.12 -151.23 4.2 Favored Glycine 0 CA--C 1.538 1.503 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 175.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.6 p -78.86 169.96 17.42 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 121.441 -1.035 . . . . 0.0 113.747 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -120.64 20.72 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 126.339 1.856 . . . . 0.0 112.593 177.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -48.82 159.85 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 125.221 1.409 . . . . 0.0 112.517 175.008 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -46.75 140.47 4.55 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.682 1.593 . . . . 0.0 112.564 -175.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -57.24 -20.22 35.18 Favored Glycine 0 CA--C 1.542 1.751 0 C-N-CA 124.083 0.849 . . . . 0.0 114.418 -175.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.74 -27.47 66.81 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.008 1.323 . . . . 0.0 112.357 175.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.7 t -104.55 -42.35 5.46 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 127.15 2.18 . . . . 0.0 111.334 177.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 12.4 tp -83.33 98.59 9.53 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.644 1.578 . . . . 0.0 110.366 174.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 69.0 p -126.57 177.34 6.57 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.997 1.319 . . . . 0.0 110.898 177.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.408 ' CD1' ' C ' ' A' ' 15' ' ' PHE . 0.1 OUTLIER -45.73 -37.89 6.39 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.446 1.098 . . . . 0.0 112.827 177.801 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -57.62 -42.72 83.92 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.329 1.452 . . . . 0.0 112.289 -179.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.4 t -61.97 -37.29 77.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.72 1.208 . . . . 0.0 110.933 174.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.7 mt -71.73 -40.4 69.45 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.549 1.14 . . . . 0.0 111.663 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -60.77 -43.95 97.38 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.55 1.14 . . . . 0.0 110.429 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.35 -28.1 59.44 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.207 1.003 . . . . 0.0 113.127 174.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -55.79 -38.22 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 124.301 1.04 . . . . 0.0 111.461 177.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 15.7 mt -55.6 -20.85 14.96 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.287 1.435 . . . . 0.0 113.977 174.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -98.11 -63.27 0.87 Allowed Glycine 0 CA--C 1.532 1.113 0 C-N-CA 125.172 1.368 . . . . 0.0 112.584 175.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -65.65 -33.82 76.78 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 -174.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -105.37 94.98 5.51 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.66 1.584 . . . . 0.0 108.025 175.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -140.88 145.06 15.52 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 123.954 0.788 . . . . 0.0 113.648 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.7 mtpp -127.31 -39.08 1.91 Allowed 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 126.294 1.838 . . . . 0.0 113.788 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.3 m -133.0 174.71 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 126.425 1.89 . . . . 0.0 111.06 -178.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 54.4 m -54.29 -46.5 72.78 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.241 1.816 . . . . 0.0 114.557 -176.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.72 126.95 44.34 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.99 1.316 . . . . 0.0 111.051 175.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.39 161.29 31.66 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 124.85 1.26 . . . . 0.0 111.485 179.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -107.48 140.87 24.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 174.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -132.91 131.52 40.98 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 126.483 1.913 . . . . 0.0 109.819 175.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 25.2 t -140.62 156.15 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 123.305 0.642 . . . . 0.0 110.306 178.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -138.57 98.51 0.26 Allowed Glycine 0 CA--C 1.524 0.598 0 C-N-CA 125.677 1.608 . . . . 0.0 111.904 176.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.7 mp -81.71 144.84 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-N 117.272 0.536 . . . . 0.0 109.739 175.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -116.29 99.43 7.2 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.024 1.73 . . . . 0.0 110.66 178.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -67.68 97.17 0.6 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.818 1.647 . . . . 0.0 110.203 175.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -124.89 4.87 8.05 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.625 0.77 . . . . 0.0 112.326 174.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.9 t -57.59 -45.25 85.51 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.376 1.47 . . . . 0.0 112.875 -176.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 130.11 40.33 0.26 Allowed Glycine 0 CA--C 1.535 1.29 0 C-N-CA 124.31 0.957 . . . . 0.0 115.25 177.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -178.09 165.71 35.34 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.561 1.077 . . . . 0.0 112.605 175.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.4 p -68.76 137.68 54.23 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.485 -1.009 . . . . 0.0 110.34 174.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.542 ' HA ' ' CE1' ' A' ' 91' ' ' TYR . 35.6 m0 -93.87 100.52 12.68 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 123.232 0.613 . . . . 0.0 111.546 -178.205 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 29.1 m -84.6 115.48 22.65 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.004 0.922 . . . . 0.0 109.121 177.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.05 143.5 51.83 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 122.709 0.403 . . . . 0.0 111.547 175.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.5 pp -119.2 -55.07 2.18 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.651 0.781 . . . . 0.0 111.966 178.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 22.7 t30 -173.15 150.47 1.94 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.991 2.117 . . . . 0.0 109.997 -177.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -129.05 163.67 24.91 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.837 1.255 . . . . 0.0 111.489 175.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -131.77 106.87 8.39 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.324 1.45 . . . . 0.0 110.663 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -115.58 112.18 21.79 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.948 0.899 . . . . 0.0 110.118 -174.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.05 -41.27 7.63 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -178.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.0 t -116.13 -45.72 2.84 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.549 1.539 . . . . 0.0 111.002 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -69.26 11.57 1.46 Allowed Glycine 0 CA--C 1.538 1.503 0 CA-C-O 118.226 -1.319 . . . . 0.0 115.764 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.7 p -32.75 108.27 0.05 Allowed 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 128.472 2.709 . . . . 0.0 113.987 -175.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.5 t -130.02 175.41 8.91 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 114.125 1.158 . . . . 0.0 114.125 -174.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -79.58 -48.84 13.13 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.64 1.176 . . . . 0.0 112.79 -178.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.4 p -144.07 132.44 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.818 1.647 . . . . 0.0 111.604 176.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -137.02 -47.92 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.171 1.388 . . . . 0.0 113.903 179.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 8.2 mt -86.69 102.6 3.11 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 123.977 0.911 . . . . 0.0 109.836 174.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -68.0 141.64 53.94 Favored 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 122.729 2.286 . . . . 0.0 110.898 174.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -38.73 -52.96 1.69 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 126.949 2.1 . . . . 0.0 114.116 178.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.6 p -153.24 135.45 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 126.475 1.91 . . . . 0.0 109.927 174.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 59.5 t -116.24 131.18 23.93 Favored Pre-proline 0 N--CA 1.483 1.207 0 C-N-CA 124.671 1.188 . . . . 0.0 109.681 176.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -65.93 152.91 80.17 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 122.714 2.276 . . . . 0.0 113.656 177.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -69.24 162.95 26.06 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.17 0.988 . . . . 0.0 111.232 175.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . 0.257 76.4 p 51.37 28.22 4.22 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 126.787 2.035 . . . . 0.0 114.006 -174.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.8 mttp -131.1 175.98 8.64 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 127.537 2.335 . . . . 0.0 111.34 -178.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -127.35 158.92 35.97 Favored 'General case' 0 C--O 1.224 -0.249 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -178.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.4 pp -121.84 171.85 8.6 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.313 1.445 . . . . 0.0 110.52 175.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -117.17 145.6 43.74 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 124.051 0.94 . . . . 0.0 108.95 174.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -127.16 143.74 51.19 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 125.585 1.554 . . . . 0.0 108.845 177.16 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 82.9 p -143.57 170.8 15.14 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.963 -178.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 174.48 142.84 4.17 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.223 -0.899 . . . . 0.0 112.357 176.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -109.44 128.97 55.54 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 124.869 1.267 . . . . 0.0 108.087 177.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.7 ptpt -48.45 147.85 2.23 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.724 1.21 . . . . 0.0 113.291 176.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -165.27 146.23 7.29 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 125.149 1.38 . . . . 0.0 111.524 178.001 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.8 t 176.73 114.77 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 127.906 2.483 . . . . 0.0 108.744 175.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -38.82 -54.56 2.34 Favored Glycine 0 CA--C 1.547 2.046 0 C-N-CA 125.844 1.688 . . . . 0.0 115.516 175.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.75 -76.53 0.01 OUTLIER 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 123.637 2.891 . . . . 0.0 113.147 176.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 15.7 m -127.52 109.06 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 126.575 1.95 . . . . 0.0 110.336 -178.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -41.49 113.81 0.45 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.149 1.78 . . . . 0.0 112.741 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.1 m -75.4 175.01 8.83 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.885 1.274 . . . . 0.0 110.193 177.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -84.03 -90.21 0.77 Allowed Glycine 0 N--CA 1.47 0.948 0 O-C-N 120.538 -1.351 . . . . 0.0 114.524 -175.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -143.33 82.73 1.75 Allowed 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 124.815 1.246 . . . . 0.0 109.066 -175.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.7 t -122.29 111.95 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 124.929 1.292 . . . . 0.0 111.007 -175.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.03 167.7 29.16 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 122.177 0.989 . . . . 0.0 111.166 177.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -148.92 160.88 42.87 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.284 1.433 . . . . 0.0 109.58 175.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -156.41 174.67 15.08 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 121.42 -0.8 . . . . 0.0 112.122 175.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -145.16 150.89 37.58 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.849 0.833 . . . . 0.0 113.203 174.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.542 ' CE1' ' HA ' ' A' ' 44' ' ' TRP . 0.1 OUTLIER -121.87 127.07 50.07 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 127.205 2.202 . . . . 0.0 109.181 -179.232 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -84.11 104.68 14.37 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.269 0.627 . . . . 0.0 112.423 179.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -72.38 126.2 29.26 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 125.401 1.48 . . . . 0.0 112.657 -176.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 37.1 m -58.62 -21.18 52.88 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.652 0.781 . . . . 0.0 113.095 175.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 23.7 m-20 -69.38 -14.02 62.68 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 124.693 1.197 . . . . 0.0 112.907 174.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 109.26 31.99 3.13 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 125.295 1.426 . . . . 0.0 115.055 177.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -142.72 -179.44 6.33 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.855 1.262 . . . . 0.0 112.044 -175.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 25.1 m -132.55 107.26 8.33 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 120.994 -1.067 . . . . 0.0 111.973 177.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 35.7 tp -74.69 107.74 7.0 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 121.224 -0.923 . . . . 0.0 110.57 175.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -107.13 114.6 4.36 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 124.79 1.186 . . . . 0.0 113.742 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 98.4 t -97.27 137.28 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.134 1.374 . . . . 0.0 112.614 -175.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -129.11 126.06 38.51 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 126.352 1.861 . . . . 0.0 111.788 -175.258 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -148.48 123.82 10.27 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.6 1.16 . . . . 0.0 112.018 -178.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 22.4 t -137.47 133.94 35.23 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.758 0.823 . . . . 0.0 111.612 178.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 19.0 t -139.24 134.23 16.52 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 126.88 2.072 . . . . 0.0 108.885 -176.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -72.54 168.03 25.46 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 123.7 2.933 . . . . 0.0 112.338 176.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -97.28 -33.15 11.56 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.662 1.185 . . . . 0.0 111.872 174.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -89.27 -22.8 22.52 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -174.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 49.67 32.2 4.91 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 126.564 1.946 . . . . 0.0 114.824 -179.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -121.43 118.45 29.43 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.535 1.534 . . . . 0.0 111.42 -178.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 67.3 m95 53.79 21.22 2.61 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.756 1.622 . . . . 0.0 114.647 178.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -100.87 176.53 5.25 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 126.29 1.836 . . . . 0.0 113.39 -174.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 20.1 m -139.87 93.46 2.65 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 125.275 1.43 . . . . 0.0 112.131 -175.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -77.03 91.8 3.67 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.954 1.302 . . . . 0.0 111.297 176.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 42.8 m0 -98.01 149.16 22.75 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 119.463 1.029 . . . . 0.0 111.226 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 31.6 p-90 -155.95 135.64 12.57 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.653 0.781 . . . . 0.0 112.498 -176.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -145.57 174.84 10.82 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 120.553 -1.342 . . . . 0.0 112.825 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 99.3 t -148.9 139.81 17.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 C-N-CA 123.768 0.827 . . . . 0.0 109.135 175.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.453 ' HE2' ' CG ' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -144.4 169.54 17.73 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 125.566 1.546 . . . . 0.0 109.538 175.133 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 59.9 mt -113.27 128.47 70.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 175.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.453 ' CG ' ' HE2' ' A' ' 119' ' ' LYS . 96.2 m-85 -88.38 147.5 40.14 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 124.683 1.193 . . . . 0.0 110.48 175.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -70.01 130.92 19.84 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 123.151 2.568 . . . . 0.0 111.075 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 59.96 -141.64 47.64 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 123.607 0.622 . . . . 0.0 113.133 -178.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 4.6 tmtt? -86.49 118.05 25.66 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.492 1.517 . . . . 0.0 110.4 176.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 12.2 tpp180 -135.51 170.61 15.68 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 126.088 1.755 . . . . 0.0 109.998 175.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 24.8 ptt180 -116.2 -176.55 2.97 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 127.133 2.173 . . . . 0.0 111.258 175.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -127.16 105.48 8.6 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 175.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -121.81 168.04 12.3 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.788 1.635 . . . . 0.0 109.751 177.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -51.84 -41.1 61.55 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 -177.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -59.12 -56.25 26.31 Favored Glycine 0 N--CA 1.47 0.912 0 CA-C-N 119.278 0.945 . . . . 0.0 112.164 175.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 4.9 mtt -59.01 -46.19 88.79 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.414 1.086 . . . . 0.0 111.287 177.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -51.78 -58.48 6.3 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.554 1.542 . . . . 0.0 111.096 174.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -68.89 -30.62 69.16 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -178.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -59.49 -41.75 90.56 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.998 0.919 . . . . 0.0 111.446 174.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 12.8 mmm -86.18 -27.66 24.42 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -51.2 -63.71 1.05 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.861 1.665 . . . . 0.0 110.883 175.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -69.42 -6.23 28.82 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -175.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -88.18 -15.57 60.52 Favored Glycine 0 CA--C 1.537 1.442 0 C-N-CA 126.974 2.226 . . . . 0.0 115.459 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -144.77 95.49 5.28 Favored Pre-proline 0 CA--C 1.552 1.049 0 CA-C-N 119.771 1.786 . . . . 0.0 112.688 178.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -75.95 77.31 3.47 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 123.783 2.989 . . . . 0.0 112.591 -178.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -107.98 110.01 21.62 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.346 1.458 . . . . 0.0 109.827 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 9.6 mtp180 -118.56 111.39 18.53 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 126.944 2.098 . . . . 0.0 111.541 -175.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 76.96 -56.73 3.55 Favored Glycine 0 C--O 1.218 -0.867 0 CA-C-O 118.609 -1.106 . . . . 0.0 111.728 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 57.21 33.86 23.94 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 119.975 1.887 . . . . 0.0 114.655 174.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -70.31 40.9 0.05 Allowed 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 127.933 2.493 . . . . 0.0 115.163 -177.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -160.17 34.29 0.43 Allowed Glycine 0 CA--C 1.539 1.576 0 C-N-CA 126.319 1.914 . . . . 0.0 114.555 178.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' TRP . . . . . 0.495 ' H ' HD12 ' A' ' 161' ' ' ILE . 3.6 m95 57.5 49.48 12.72 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 126.769 2.028 . . . . 0.0 112.372 -174.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -84.68 130.56 34.69 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 121.319 -0.863 . . . . 0.0 111.23 -177.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -171.29 -176.93 2.0 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.034 0.933 . . . . 0.0 112.797 177.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 9.8 ttpp -126.48 157.14 39.44 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 126.339 1.855 . . . . 0.0 111.37 -174.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -68.48 158.13 34.43 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.293 0.568 . . . . 0.0 110.559 174.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 98.5 mt -112.81 159.77 18.67 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.996 1.319 . . . . 0.0 109.45 175.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -63.33 -171.57 1.79 Allowed Glycine 0 CA--C 1.538 1.501 0 C-N-CA 124.085 0.85 . . . . 0.0 111.743 174.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 52.74 13.22 0.32 Allowed 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 125.486 1.515 . . . . 0.0 114.954 175.358 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 79.26 36.93 25.97 Favored Glycine 0 CA--C 1.54 1.6 0 C-N-CA 125.724 1.63 . . . . 0.0 113.803 -175.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -115.93 167.12 11.24 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 119.181 1.491 . . . . 0.0 112.436 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 80.2 mtt85 -146.48 127.55 14.64 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 120.924 -1.11 . . . . 0.0 111.053 175.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 7.3 ttp -99.99 154.23 18.56 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 174.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.43 147.89 49.72 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 127.691 2.396 . . . . 0.0 110.972 176.236 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -152.39 151.44 23.29 Favored Glycine 0 CA--C 1.524 0.65 0 CA-C-O 121.933 0.74 . . . . 0.0 113.47 175.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.495 HD12 ' H ' ' A' ' 147' ' ' TRP . 1.1 tp -142.72 133.76 24.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 127.005 2.122 . . . . 0.0 108.8 -179.147 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 1.4 mtp -149.02 -176.07 5.2 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 127.313 2.245 . . . . 0.0 107.698 175.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 1.3 t -162.32 149.18 13.47 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 174.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 36.0 p -106.2 26.15 10.13 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.067 1.747 . . . . 0.0 112.001 -178.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.82 14.85 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.266 0 C-N-CA 127.864 2.466 . . . . 0.0 115.701 176.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 82.71 -37.19 2.64 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 127.605 2.526 . . . . 0.0 114.216 -178.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -135.05 75.74 1.59 Allowed 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 126.678 1.991 . . . . 0.0 108.272 -176.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -135.89 162.65 32.22 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.397 1.479 . . . . 0.0 113.204 -175.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.28 172.06 7.09 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 128.998 2.919 . . . . 0.0 112.261 -175.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 12.9 ttt -117.66 143.11 46.48 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 126.017 1.727 . . . . 0.0 112.177 176.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -149.13 123.85 9.85 Favored 'General case' 0 N--CA 1.466 0.325 0 O-C-N 120.627 -1.296 . . . . 0.0 110.691 174.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 1.9 mp -125.08 125.77 69.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 124.786 1.235 . . . . 0.0 108.744 179.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.52 142.78 51.3 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.827 1.251 . . . . 0.0 109.987 178.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.7 mp -89.44 114.15 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 O-C-N 121.173 -0.955 . . . . 0.0 109.162 176.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 5.4 m -85.5 154.36 21.83 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.434 1.094 . . . . 0.0 112.192 174.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 69.3 mtp180 . . . . . 0 C--O 1.252 1.224 0 C-N-CA 125.379 1.472 . . . . 0.0 111.175 176.528 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.4 t . . . . . 0 N--CA 1.485 1.278 0 CA-C-O 121.932 0.872 . . . . 0.0 110.801 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -128.92 156.64 43.41 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 126.475 1.91 . . . . 0.0 109.691 176.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.8 mt -48.83 -20.75 0.53 Allowed 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 126.698 1.999 . . . . 0.0 113.264 -178.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -72.74 78.05 1.12 Allowed 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 125.68 1.592 . . . . 0.0 109.56 175.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -68.05 -90.68 0.06 OUTLIER Glycine 0 CA--C 1.536 1.374 0 C-N-CA 125.614 1.578 . . . . 0.0 114.689 -175.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 24.2 p -128.18 164.57 22.22 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.408 1.483 . . . . 0.0 110.949 175.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -125.85 19.76 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 CA-C-O 123.545 1.64 . . . . 0.0 111.695 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.9 pp -54.97 166.57 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 125.21 1.404 . . . . 0.0 111.877 175.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -40.44 129.24 2.42 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.261 1.824 . . . . 0.0 114.83 -174.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -55.49 -21.11 26.35 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 125.169 1.366 . . . . 0.0 114.607 -176.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.39 -30.98 70.89 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.013 1.325 . . . . 0.0 112.041 174.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.4 t -101.95 -38.7 7.67 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.878 1.671 . . . . 0.0 111.558 174.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 45.4 tp -79.39 90.71 5.03 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.895 0.878 . . . . 0.0 112.069 176.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 70.8 p -123.17 -176.98 3.56 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 126.326 1.85 . . . . 0.0 112.292 -178.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -55.02 -37.66 66.93 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.337 1.055 . . . . 0.0 112.261 -175.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -57.58 -38.29 74.61 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 125.379 1.472 . . . . 0.0 111.605 178.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 89.4 t -66.51 -37.7 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.336 1.054 . . . . 0.0 111.38 175.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.4 mt -68.17 -44.39 76.02 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.897 0.879 . . . . 0.0 110.69 178.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -58.27 -50.89 72.0 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.879 1.272 . . . . 0.0 111.926 176.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.55 -32.56 73.99 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 118.381 -0.819 . . . . 0.0 113.147 174.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -54.96 -40.18 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 CA-C-N 119.636 1.107 . . . . 0.0 111.518 -179.005 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 16.2 mt -57.18 -20.66 27.98 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.99 1.716 . . . . 0.0 113.355 178.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -108.77 -51.4 0.7 Allowed Glycine 0 CA--C 1.533 1.192 0 C-N-CA 126.356 1.931 . . . . 0.0 113.855 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -63.92 -28.34 69.76 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 119.031 1.416 . . . . 0.0 113.643 -178.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -97.59 86.77 3.91 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.542 1.137 . . . . 0.0 109.266 174.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -54.29 119.1 10.64 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 125.363 1.459 . . . . 0.0 113.537 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.1 mtpp -142.0 -173.35 3.79 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 127.726 2.41 . . . . 0.0 111.357 179.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.7 m -57.81 168.4 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 126.23 1.812 . . . . 0.0 112.329 175.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.8 m -51.3 -37.69 48.87 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 116.389 1.996 . . . . 0.0 116.389 -175.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.71 131.79 54.28 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.574 1.549 . . . . 0.0 108.547 174.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.52 150.15 37.08 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 126.095 1.758 . . . . 0.0 109.745 -175.01 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -116.26 120.58 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 123.998 0.919 . . . . 0.0 110.434 177.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -117.47 124.89 49.88 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 124.516 1.126 . . . . 0.0 109.573 175.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.7 p -142.56 139.92 28.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.731 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -125.37 125.07 5.5 Favored Glycine 0 CA--C 1.522 0.505 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.491 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.457 ' H ' HD12 ' A' ' 70' ' ' LEU . 2.9 mp -112.48 142.27 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 123.822 0.849 . . . . 0.0 110.371 176.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -105.59 106.48 17.01 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.486 1.114 . . . . 0.0 111.127 178.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -74.86 93.0 2.58 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.359 1.864 . . . . 0.0 110.577 176.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -121.57 8.1 10.09 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.906 1.282 . . . . 0.0 113.131 175.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 30.0 t -46.03 -51.01 14.4 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.149 1.78 . . . . 0.0 113.343 178.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 154.5 -26.33 0.67 Allowed Glycine 0 N--CA 1.472 1.065 0 O-C-N 121.281 -0.887 . . . . 0.0 114.517 175.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -128.18 171.47 19.36 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 125.682 1.61 . . . . 0.0 112.178 174.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 76.5 p -64.68 149.65 48.64 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.618 0.767 . . . . 0.0 112.147 176.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 38.4 m0 -101.62 108.27 19.76 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 124.654 1.182 . . . . 0.0 111.048 178.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 33.2 m -90.7 128.74 36.75 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.993 1.317 . . . . 0.0 110.123 177.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.29 114.5 3.51 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.915 0.886 . . . . 0.0 111.729 174.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.6 pp -98.44 -51.65 3.89 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 123.556 0.742 . . . . 0.0 111.536 177.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -172.92 154.47 2.87 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 127.5 2.32 . . . . 0.0 109.848 -177.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -137.64 168.0 20.55 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.916 1.286 . . . . 0.0 112.052 174.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -141.42 114.07 8.34 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.424 1.09 . . . . 0.0 111.652 179.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -116.06 139.18 50.54 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.38 -0.825 . . . . 0.0 110.941 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -117.54 -67.05 1.02 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 126.071 1.749 . . . . 0.0 111.492 -175.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 26.3 t -105.39 -38.67 6.4 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 126.8 2.04 . . . . 0.0 110.28 -176.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -68.77 10.2 1.63 Allowed Glycine 0 CA--C 1.537 1.45 0 C-N-CA 126.792 2.139 . . . . 0.0 115.491 178.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 34.0 p -30.22 123.94 0.18 Allowed 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 129.014 2.925 . . . . 0.0 114.832 -175.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.5 t -146.39 178.28 8.38 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.47 1.108 . . . . 0.0 113.513 -174.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -83.24 -62.8 1.49 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.364 1.465 . . . . 0.0 112.4 177.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.2 p -138.93 138.21 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.901 1.68 . . . . 0.0 111.824 178.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.4 pp -141.09 -27.75 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.921 1.688 . . . . 0.0 114.048 -179.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 mp -97.45 96.35 3.06 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 125.687 1.595 . . . . 0.0 109.06 177.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -64.02 152.28 81.62 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.878 2.385 . . . . 0.0 110.503 175.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -43.66 -50.2 7.53 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.011 1.725 . . . . 0.0 113.477 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 5.6 p -158.59 143.81 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 C-N-CA 126.93 2.092 . . . . 0.0 109.511 175.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 99.7 t -118.0 128.95 25.67 Favored Pre-proline 0 N--CA 1.476 0.828 0 C-N-CA 124.956 1.302 . . . . 0.0 108.771 175.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -67.13 150.36 82.12 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.611 2.207 . . . . 0.0 113.139 176.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -65.23 163.65 14.87 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.293 0.637 . . . . 0.0 111.033 175.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . 0.312 50.1 p 55.48 20.75 3.9 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 127.779 2.431 . . . . 0.0 114.742 -174.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 20.0 mttt -120.35 -178.49 3.7 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 126.459 1.903 . . . . 0.0 112.115 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.76 166.19 23.21 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 175.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.457 HD12 ' H ' ' A' ' 36' ' ' ILE . 0.5 OUTLIER -134.25 174.26 10.7 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 124.3 1.04 . . . . 0.0 110.993 179.539 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -127.33 154.89 44.4 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 124.699 1.199 . . . . 0.0 111.481 175.185 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.464 ' CE2' ' CE2' ' A' ' 89' ' ' PHE . 12.4 m-85 -129.49 148.09 51.36 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 125.987 1.715 . . . . 0.0 109.795 178.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 54.5 p -126.21 146.69 49.87 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 126.186 1.795 . . . . 0.0 111.129 175.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -163.26 148.78 15.67 Favored Glycine 0 CA--C 1.519 0.286 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 174.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.48 173.61 6.66 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.16 1.384 . . . . 0.0 110.134 177.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 12.2 ptmt -101.0 -19.66 15.74 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 174.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.2 t -81.76 80.87 7.97 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 125.334 1.453 . . . . 0.0 109.98 -174.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.5 t -55.75 -28.36 55.56 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.236 1.414 . . . . 0.0 112.77 178.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 123.06 -69.07 0.45 Allowed Glycine 0 CA--C 1.535 1.329 0 C-N-CA 126.644 2.069 . . . . 0.0 112.175 -178.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.36 -49.42 0.36 Allowed 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.245 2.63 . . . . 0.0 112.796 -177.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 83.9 t -141.89 130.23 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 126.455 1.902 . . . . 0.0 109.61 -177.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.17 125.63 27.0 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.241 1.016 . . . . 0.0 111.122 175.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 90.1 m -112.1 -85.38 0.57 Allowed 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.853 0.861 . . . . 0.0 110.08 178.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 179.74 -93.09 0.09 OUTLIER Glycine 0 CA--C 1.531 1.069 0 CA-C-N 119.696 1.135 . . . . 0.0 113.253 -175.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -153.56 100.62 2.42 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.137 0.975 . . . . 0.0 111.585 176.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.2 t -141.23 115.27 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 124.455 1.102 . . . . 0.0 109.753 -177.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.45 170.93 21.32 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.374 1.07 . . . . 0.0 112.05 175.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -152.11 160.84 43.33 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.47 1.508 . . . . 0.0 111.082 175.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.488 ' CZ ' HG11 ' A' ' 101' ' ' VAL . 41.6 p90 -155.33 170.07 22.75 Favored 'General case' 0 C--O 1.234 0.285 0 O-C-N 121.079 -1.013 . . . . 0.0 111.154 175.042 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -136.31 151.7 49.9 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 176.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -131.29 134.88 46.81 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.545 1.538 . . . . 0.0 112.727 -177.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -82.62 123.56 29.35 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 111.618 0.229 . . . . 0.0 111.618 -179.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 4.6 tpp -88.55 145.49 25.69 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.317 1.047 . . . . 0.0 112.165 175.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 61.3 m -69.65 -23.35 63.47 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 175.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -70.98 -13.94 62.18 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.852 1.261 . . . . 0.0 113.787 175.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 98.54 42.63 2.89 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 124.546 1.069 . . . . 0.0 114.176 -179.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 17.0 m-80 -141.33 174.15 10.81 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.354 1.462 . . . . 0.0 110.431 178.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 6.0 m -128.55 107.18 9.5 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.178 0.991 . . . . 0.0 112.424 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 21.1 tp -68.03 105.02 1.9 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.756 0.823 . . . . 0.0 109.65 174.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -106.63 103.09 1.98 Allowed Glycine 0 CA--C 1.525 0.695 0 C-N-CA 125.395 1.474 . . . . 0.0 112.337 177.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.488 HG11 ' CZ ' ' A' ' 89' ' ' PHE . 9.5 p -86.32 161.47 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 123.755 0.822 . . . . 0.0 112.407 175.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 2.5 tmm? -150.3 126.96 10.91 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.257 1.823 . . . . 0.0 109.725 178.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -139.03 118.51 12.9 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 122.158 0.98 . . . . 0.0 112.948 177.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 26.0 t -124.6 118.34 26.32 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.452 1.501 . . . . 0.0 110.723 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 96.2 t -105.88 134.42 19.74 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 126.728 2.011 . . . . 0.0 108.852 178.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -65.28 139.17 58.87 Favored 'Trans proline' 0 CA--C 1.534 0.486 0 C-N-CA 123.63 2.887 . . . . 0.0 110.196 178.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -44.27 -50.79 8.77 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.625 1.97 . . . . 0.0 114.631 -174.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -132.74 20.08 4.21 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.63 1.572 . . . . 0.0 112.077 -176.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 53.74 30.95 12.0 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.079 1.752 . . . . 0.0 113.738 -175.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -71.74 -170.75 0.59 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 128.066 2.546 . . . . 0.0 111.669 174.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 2.0 p90 -51.75 -21.15 2.55 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 126.424 1.889 . . . . 0.0 115.122 176.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -56.48 115.04 2.28 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.775 1.63 . . . . 0.0 111.465 175.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 11.0 m -61.5 144.58 54.01 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.497 0.665 . . . . 0.0 112.359 177.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -100.05 118.11 35.73 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.285 1.434 . . . . 0.0 107.382 174.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 36.7 m0 -116.73 135.65 53.59 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 19.8 p-90 -145.82 143.49 29.68 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.548 0.739 . . . . 0.0 112.029 -176.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -148.59 161.83 40.89 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.981 0.896 . . . . 0.0 112.571 -176.321 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 5.6 p -166.12 127.76 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 125.028 1.331 . . . . 0.0 109.269 175.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.497 ' HE3' ' CE1' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -151.78 168.44 25.05 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 126.199 1.799 . . . . 0.0 109.566 178.31 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.433 ' HB ' ' CE2' ' A' ' 154' ' ' TYR . 24.6 mt -111.1 111.73 37.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -177.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.497 ' CE1' ' HE3' ' A' ' 119' ' ' LYS . 54.2 m-85 -63.01 142.66 97.67 Favored Pre-proline 0 CA--C 1.544 0.731 0 O-C-N 121.203 -0.936 . . . . 0.0 111.063 -179.099 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -73.92 92.5 0.89 Allowed 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 124.2 3.266 . . . . 0.0 110.902 -179.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 101.2 -171.69 22.61 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 124.805 1.193 . . . . 0.0 112.736 -174.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 8.8 tttt -67.57 118.51 10.97 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.893 0.877 . . . . 0.0 110.931 176.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.435 ' HG3' ' H ' ' A' ' 126' ' ' ARG . 9.4 tpp180 -134.18 178.25 7.12 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.222 1.409 . . . . 0.0 109.704 175.049 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.435 ' H ' ' HG3' ' A' ' 125' ' ' ARG . 8.6 ptt180 -123.34 179.74 4.61 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 126.372 1.869 . . . . 0.0 110.231 174.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -131.7 103.65 6.48 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 126.572 1.949 . . . . 0.0 107.016 175.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -126.66 171.37 11.21 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.348 1.859 . . . . 0.0 110.093 178.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -50.69 -41.73 56.13 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -177.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -60.72 -53.76 42.6 Favored Glycine 0 N--CA 1.468 0.775 0 CA-C-O 119.484 -0.62 . . . . 0.0 112.267 176.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -63.24 -40.05 96.34 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 118.176 0.988 . . . . 0.0 111.916 178.085 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -55.84 -63.73 1.08 Allowed 'General case' 0 C--N 1.34 0.167 0 C-N-CA 124.224 1.01 . . . . 0.0 108.846 175.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -64.62 -33.9 77.01 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 118.667 0.667 . . . . 0.0 112.739 -175.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -64.56 -42.94 95.36 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.272 1.029 . . . . 0.0 113.069 176.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -86.32 -29.01 23.34 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 121.28 -0.888 . . . . 0.0 112.291 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -52.04 -57.61 9.02 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 126.831 2.053 . . . . 0.0 108.902 174.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -71.85 -12.1 61.12 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -177.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -86.72 -8.14 77.21 Favored Glycine 0 CA--C 1.54 1.599 0 C-N-CA 126.701 2.096 . . . . 0.0 114.958 176.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -140.09 80.3 20.52 Favored Pre-proline 0 CA--C 1.55 0.954 0 CA-C-N 119.105 1.452 . . . . 0.0 111.192 175.012 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -73.16 70.25 3.82 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 124.109 3.206 . . . . 0.0 112.471 177.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -102.43 116.76 33.28 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.97 0.908 . . . . 0.0 110.637 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 34.5 mtm180 -83.59 -68.43 0.71 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.11 1.364 . . . . 0.0 111.884 174.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 134.73 114.43 1.43 Allowed Glycine 0 CA--C 1.53 0.981 0 C-N-CA 124.976 1.274 . . . . 0.0 113.569 -178.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.58 14.73 0.32 Allowed 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 126.912 2.085 . . . . 0.0 115.295 176.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . 0.258 0.8 OUTLIER 45.51 65.01 1.23 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 126.953 2.101 . . . . 0.0 112.56 -175.011 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -168.44 -67.33 0.03 OUTLIER Glycine 0 CA--C 1.541 1.672 0 C-N-CA 125.098 1.332 . . . . 0.0 115.926 -174.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 43.2 m95 173.23 114.19 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 130.86 3.664 . . . . 0.0 108.799 -175.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -131.93 126.09 33.24 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 128.463 2.705 . . . . 0.0 110.277 -177.376 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -166.76 -175.31 3.06 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.08 0.952 . . . . 0.0 112.078 -174.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.3 mtmt -139.54 145.51 38.76 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.702 1.201 . . . . 0.0 109.946 175.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -67.6 149.79 49.63 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 175.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 66.7 mt -108.78 102.32 11.37 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.277 0.631 . . . . 0.0 110.4 -174.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -43.52 -30.58 1.43 Allowed Glycine 0 N--CA 1.475 1.283 0 C-N-CA 127.722 2.582 . . . . 0.0 117.136 -175.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.433 ' CE2' ' HB ' ' A' ' 120' ' ' ILE . 0.0 OUTLIER -64.29 -18.85 64.98 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.623 1.969 . . . . 0.0 113.799 178.164 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 118.86 30.14 1.7 Allowed Glycine 0 CA--C 1.537 1.409 0 C-N-CA 125.915 1.721 . . . . 0.0 114.288 -178.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 2.2 mt -128.96 174.92 9.08 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.508 1.923 . . . . 0.0 110.859 -176.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 80.7 mtt180 -143.75 108.77 4.97 Favored 'General case' 0 N--CA 1.479 1.007 0 O-C-N 120.913 -1.117 . . . . 0.0 111.081 178.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.73 148.54 26.31 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 175.049 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.9 122.28 17.16 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 126.087 1.755 . . . . 0.0 110.899 176.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -138.85 158.74 25.26 Favored Glycine 0 N--CA 1.479 1.56 0 CA-C-N 121.552 1.978 . . . . 0.0 116.62 -177.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -151.3 134.3 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-N 118.896 1.348 . . . . 0.0 111.051 179.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 1.1 ttt -156.91 105.98 2.21 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.752 1.621 . . . . 0.0 110.089 174.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 4.0 t -81.66 126.76 32.16 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 120.921 -1.112 . . . . 0.0 109.977 175.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 34.9 p -75.15 21.89 0.12 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.1 1.36 . . . . 0.0 114.292 177.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -56.06 -45.33 79.33 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.282 1.833 . . . . 0.0 114.692 -175.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 164.45 -60.59 0.25 Allowed Glycine 0 CA--C 1.533 1.192 0 C-N-CA 123.685 0.66 . . . . 0.0 114.706 178.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -120.07 21.77 11.7 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.625 1.17 . . . . 0.0 112.819 -178.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -64.16 168.59 5.28 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 122.784 1.278 . . . . 0.0 112.887 175.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.09 167.05 11.83 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 127.089 2.156 . . . . 0.0 110.976 -179.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 13.7 ttp -108.3 135.5 49.51 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.634 1.174 . . . . 0.0 110.329 178.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -141.62 127.64 19.52 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.007 0.923 . . . . 0.0 110.896 175.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 5.1 mp -133.38 121.32 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 124.241 1.016 . . . . 0.0 110.01 175.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -116.61 132.31 56.72 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 125.409 1.484 . . . . 0.0 110.321 175.002 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.7 mp -84.3 119.5 33.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 175.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 5.0 m -92.61 171.08 9.24 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.64 1.576 . . . . 0.0 109.825 174.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 2.2 mtt180 . . . . . 0 C--O 1.253 1.274 0 C-N-CA 125.335 1.454 . . . . 0.0 112.624 176.363 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 75.3 m . . . . . 0 N--CA 1.484 1.227 0 CA-C-O 121.806 0.812 . . . . 0.0 112.098 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -87.22 176.59 7.49 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 126.333 1.853 . . . . 0.0 112.13 176.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 11.8 tp -128.74 -34.66 1.96 Allowed 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 113.847 1.054 . . . . 0.0 113.847 175.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -86.58 138.7 31.49 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.313 1.045 . . . . 0.0 109.124 175.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -79.66 -122.81 0.4 Allowed Glycine 0 CA--C 1.535 1.319 0 C-N-CA 124.143 0.877 . . . . 0.0 112.031 175.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 35.8 p -113.74 173.43 6.42 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.482 1.513 . . . . 0.0 112.018 -178.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -123.14 19.84 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.326 1.05 . . . . 0.0 112.121 178.165 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -47.15 156.87 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.784 1.234 . . . . 0.0 112.846 175.007 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -41.92 130.45 3.44 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.279 1.832 . . . . 0.0 112.999 -175.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -54.03 -22.86 21.8 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 124.869 1.223 . . . . 0.0 114.885 -174.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.93 -30.58 71.65 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.417 1.087 . . . . 0.0 112.077 175.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -100.89 -41.92 6.64 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.629 1.972 . . . . 0.0 111.872 176.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.2 tp -73.29 94.23 1.99 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.139 0.976 . . . . 0.0 110.898 175.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 82.6 p -129.19 -175.3 3.52 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.422 1.889 . . . . 0.0 112.046 -178.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -51.52 -33.11 30.45 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.959 1.304 . . . . 0.0 113.993 179.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -57.83 -43.17 85.64 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.102 0.561 . . . . 0.0 111.852 174.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 72.8 t -67.03 -40.23 85.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.229 1.012 . . . . 0.0 110.922 175.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 59.8 mt -67.54 -40.08 85.02 Favored 'General case' 0 N--CA 1.469 0.475 0 O-C-N 120.963 -1.086 . . . . 0.0 112.059 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -63.91 -47.57 80.02 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.164 0.986 . . . . 0.0 111.781 176.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.51 -36.7 84.6 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 118.456 -0.783 . . . . 0.0 112.287 174.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.0 t -55.03 -46.12 77.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-N 119.295 0.952 . . . . 0.0 110.92 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.3 mt -54.89 -19.62 7.01 Favored 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 176.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.62 -60.48 1.09 Allowed Glycine 0 CA--C 1.535 1.323 0 C-N-CA 126.324 1.916 . . . . 0.0 113.182 175.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -65.75 -34.89 79.23 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -178.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -100.8 133.56 45.09 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.637 1.575 . . . . 0.0 109.923 175.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 170.27 145.72 4.84 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 124.504 1.049 . . . . 0.0 112.155 -178.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -129.73 -76.91 0.54 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.027 1.331 . . . . 0.0 110.938 -178.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 26.9 m -78.08 173.93 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 126.107 1.763 . . . . 0.0 111.361 175.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -53.67 -35.31 60.92 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 115.546 1.684 . . . . 0.0 115.546 -175.04 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -127.32 152.13 47.86 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 127.544 2.337 . . . . 0.0 109.035 175.003 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.02 159.47 44.53 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.803 1.641 . . . . 0.0 111.012 -178.088 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -122.26 129.9 74.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 125.075 1.35 . . . . 0.0 108.214 175.078 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -135.79 115.3 12.72 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.11 1.364 . . . . 0.0 108.965 175.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.6 m -125.72 144.1 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 123.313 0.645 . . . . 0.0 111.146 -177.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -111.03 115.26 3.92 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 124.255 0.931 . . . . 0.0 111.656 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 mp -105.1 144.16 15.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 118.037 0.918 . . . . 0.0 108.782 174.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -115.95 111.5 20.48 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 124.588 1.155 . . . . 0.0 111.049 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.465 ' HA ' ' CZ2' ' A' ' 44' ' ' TRP . 1.6 m-20 -80.54 78.25 7.29 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 128.141 2.576 . . . . 0.0 111.226 -175.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -113.99 3.43 15.35 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.779 1.232 . . . . 0.0 112.389 178.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.452 ' HG ' HG23 ' A' ' 174' ' ' ILE . 0.7 OUTLIER -61.31 -54.5 43.15 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.918 1.687 . . . . 0.0 114.304 -175.032 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 151.93 99.52 0.19 Allowed Glycine 0 CA--C 1.533 1.195 0 O-C-N 121.478 -0.764 . . . . 0.0 114.278 178.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.15 163.74 38.94 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 125.871 1.701 . . . . 0.0 112.94 -177.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 69.1 p -63.98 138.74 58.6 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 121.965 -0.727 . . . . 0.0 111.616 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.465 ' CZ2' ' HA ' ' A' ' 38' ' ' ASN . 40.6 m0 -87.99 106.47 18.15 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.077 0.551 . . . . 0.0 110.827 -178.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 15.9 m -86.27 122.64 30.54 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.319 1.048 . . . . 0.0 109.577 175.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.41 140.02 57.4 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.087 0.47 . . . . 0.0 111.671 175.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.0 pp -121.92 -56.84 1.83 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.912 1.285 . . . . 0.0 111.312 -178.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -171.16 156.22 4.66 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.65 1.98 . . . . 0.0 110.596 176.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -133.57 165.45 24.88 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.269 1.428 . . . . 0.0 110.718 174.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -141.12 101.8 4.11 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.953 1.701 . . . . 0.0 111.444 -178.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -107.74 127.32 53.59 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.127 0.971 . . . . 0.0 110.582 -177.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.67 -37.75 4.8 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.372 1.069 . . . . 0.0 113.486 -179.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.8 t -123.36 -41.93 2.27 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 126.31 1.844 . . . . 0.0 111.556 -178.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -69.01 16.2 0.63 Allowed Glycine 0 CA--C 1.536 1.362 0 C-N-CA 125.145 1.355 . . . . 0.0 115.529 179.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.6 p -27.35 115.25 0.07 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 129.604 3.161 . . . . 0.0 113.863 -176.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.1 t -139.11 176.71 8.46 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.779 0.831 . . . . 0.0 112.794 -175.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -80.94 -57.4 3.56 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.909 1.284 . . . . 0.0 110.668 175.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.4 p -151.0 137.23 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 126.071 1.748 . . . . 0.0 111.573 -177.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.8 -42.5 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 125.337 1.455 . . . . 0.0 112.778 176.001 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 13.8 mt -82.59 100.15 0.79 Allowed Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 126.398 1.879 . . . . 0.0 109.725 179.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -69.43 155.31 67.38 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.57 2.846 . . . . 0.0 110.385 175.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -48.52 -52.14 23.96 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.902 0.881 . . . . 0.0 112.966 -176.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.4 t -154.6 135.43 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 128.307 2.643 . . . . 0.0 108.694 -178.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 48.3 t -120.43 134.19 24.12 Favored Pre-proline 0 N--CA 1.479 1.016 0 C-N-CA 123.94 0.896 . . . . 0.0 109.448 174.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -63.09 151.1 86.5 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.202 1.935 . . . . 0.0 113.157 176.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -74.59 173.1 10.9 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.537 0.735 . . . . 0.0 110.428 175.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 78.8 p 49.23 27.78 1.97 Allowed 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 126.79 2.036 . . . . 0.0 112.789 -175.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 8.2 tttt -133.58 178.41 6.95 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 126.611 1.964 . . . . 0.0 111.633 -175.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -137.69 161.14 37.29 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 121.35 -0.843 . . . . 0.0 109.4 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -137.88 168.56 19.45 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.255 1.022 . . . . 0.0 111.681 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -109.17 149.68 29.0 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 124.165 0.986 . . . . 0.0 110.748 175.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -126.83 149.46 49.7 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 127.371 2.268 . . . . 0.0 109.686 177.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.5 p -131.75 151.67 51.49 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 127.023 2.129 . . . . 0.0 111.879 -175.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -170.51 135.52 3.56 Favored Glycine 0 CA--C 1.521 0.433 0 O-C-N 121.396 -0.815 . . . . 0.0 113.142 174.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 27.7 mtm180 -104.06 121.35 43.01 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.57 1.148 . . . . 0.0 110.368 -177.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.27 -33.49 69.47 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 126.221 1.808 . . . . 0.0 115.236 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 29.3 p -75.62 86.71 2.69 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.699 2.0 . . . . 0.0 111.971 -177.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 29.6 t -61.9 -32.74 73.15 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.834 0.853 . . . . 0.0 113.238 178.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 121.24 -74.51 0.34 Allowed Glycine 0 CA--C 1.535 1.297 0 C-N-CA 125.996 1.76 . . . . 0.0 112.041 -179.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.15 -24.55 16.89 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 123.467 2.778 . . . . 0.0 113.692 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.6 p -134.86 145.29 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 126.329 1.851 . . . . 0.0 110.019 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -98.78 123.11 42.81 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.104 1.362 . . . . 0.0 110.401 175.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.2 p -130.81 -170.99 2.45 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 126.473 1.909 . . . . 0.0 110.76 -178.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -104.96 -105.79 3.06 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 125.335 1.445 . . . . 0.0 112.042 -177.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -139.63 93.2 2.64 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.423 -1.045 . . . . 0.0 110.056 177.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.3 t -133.12 116.6 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 123.904 0.882 . . . . 0.0 110.266 -176.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.55 161.26 23.86 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.916 0.865 . . . . 0.0 111.382 178.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -142.82 151.17 40.86 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.678 1.191 . . . . 0.0 110.166 175.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -149.92 170.03 19.76 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 124.236 1.014 . . . . 0.0 110.061 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -142.52 157.4 44.77 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.389 -0.819 . . . . 0.0 111.891 175.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -132.12 141.44 49.15 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 126.131 1.773 . . . . 0.0 112.446 -174.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -98.32 119.12 36.45 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 120.673 0.273 . . . . 0.0 110.678 -175.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 15.4 mtm -95.88 133.69 39.75 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 123.906 0.882 . . . . 0.0 110.713 -176.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.4 t -58.84 -23.84 61.25 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.781 1.232 . . . . 0.0 112.624 178.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -64.53 -18.88 65.24 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.438 1.495 . . . . 0.0 113.515 175.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 108.53 14.0 17.27 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 124.959 1.266 . . . . 0.0 115.312 -179.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -122.51 172.25 8.51 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-N 119.171 1.486 . . . . 0.0 111.394 -179.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 95.6 m -124.91 102.16 7.41 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.598 1.159 . . . . 0.0 111.734 -177.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 21.4 tp -66.73 97.09 0.44 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.016 1.327 . . . . 0.0 111.682 176.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -90.61 124.65 7.6 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 125.534 1.54 . . . . 0.0 112.22 176.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 47.7 t -124.88 142.7 40.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 124.894 1.277 . . . . 0.0 110.777 -175.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' MET . . . . . 0.404 ' CE ' ' HA ' ' A' ' 116' ' ' TRP . 0.0 OUTLIER -149.33 160.09 43.71 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.427 -0.795 . . . . 0.0 112.026 175.04 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -143.23 143.07 31.6 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.13 0.972 . . . . 0.0 110.436 176.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 9.9 t -134.25 119.96 19.39 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.833 1.253 . . . . 0.0 110.662 179.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 62.4 t -129.96 134.87 26.65 Favored Pre-proline 0 N--CA 1.469 0.513 0 C-N-CA 126.061 1.744 . . . . 0.0 109.206 -176.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -64.4 157.08 56.56 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 123.742 2.961 . . . . 0.0 113.581 -179.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -82.23 -54.62 5.11 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.519 1.127 . . . . 0.0 110.631 178.041 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.79 -25.74 32.46 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.258 1.423 . . . . 0.0 113.637 -178.099 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 58.6 26.33 14.3 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 126.395 1.878 . . . . 0.0 114.834 179.078 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 29.6 m-20 -93.36 -77.59 0.45 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.981 1.312 . . . . 0.0 113.677 -178.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 33.8 p-90 -119.43 12.04 12.32 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 126.946 2.099 . . . . 0.0 114.501 -174.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -80.2 175.58 10.52 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 125.453 1.501 . . . . 0.0 113.084 176.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 31.9 m -117.8 108.92 15.94 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 127.068 2.147 . . . . 0.0 111.872 178.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -84.18 104.03 13.89 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.549 1.14 . . . . 0.0 110.064 175.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 53.6 m0 -114.3 152.26 31.66 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 119.825 1.193 . . . . 0.0 112.673 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' TRP . . . . . 0.404 ' HA ' ' CE ' ' A' ' 102' ' ' MET . 53.9 p-90 -144.1 133.6 23.41 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -134.4 161.65 34.42 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.37 1.868 . . . . 0.0 111.829 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 78.5 t -154.62 150.19 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 126.961 2.104 . . . . 0.0 108.077 175.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.75 166.21 29.1 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.591 1.956 . . . . 0.0 109.97 175.203 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.445 ' HB ' ' CE2' ' A' ' 154' ' ' TYR . 3.1 mt -118.18 112.05 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-O 121.787 0.803 . . . . 0.0 109.454 176.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -68.76 145.05 96.64 Favored Pre-proline 0 CA--C 1.548 0.883 0 O-C-N 121.478 -0.764 . . . . 0.0 111.629 179.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -75.79 91.33 1.09 Allowed 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 123.834 3.023 . . . . 0.0 112.005 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 97.28 179.0 34.21 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 125.827 1.68 . . . . 0.0 112.952 -178.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 6.6 tttt -51.6 121.66 6.82 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.837 1.255 . . . . 0.0 111.567 -176.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.98 -173.45 3.38 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.606 1.563 . . . . 0.0 112.101 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.8 ptt180 -134.14 -179.22 5.43 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 126.9 2.08 . . . . 0.0 110.948 175.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -126.63 115.92 20.22 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 127.539 2.336 . . . . 0.0 104.984 175.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -135.55 169.6 17.27 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.835 1.254 . . . . 0.0 110.303 175.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -56.61 -36.15 69.09 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.049 0.94 . . . . 0.0 112.962 -178.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -60.9 -58.78 12.01 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-N 118.742 0.701 . . . . 0.0 111.998 175.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 1.4 null -62.73 -36.94 84.64 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 118.07 0.935 . . . . 0.0 112.801 178.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.41 -64.39 0.97 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.48 1.112 . . . . 0.0 109.151 174.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -65.27 -28.65 69.49 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -175.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -63.69 -36.88 85.3 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.778 1.231 . . . . 0.0 112.569 175.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 8.8 tpp -94.07 -23.63 17.91 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 177.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -49.89 -56.9 8.74 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.779 1.631 . . . . 0.0 111.145 175.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -70.4 -13.37 62.11 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -85.04 -30.61 25.31 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 127.153 2.311 . . . . 0.0 112.987 -175.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -123.57 81.96 53.98 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 123.833 0.853 . . . . 0.0 112.46 175.01 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -75.04 73.06 4.46 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 123.928 3.086 . . . . 0.0 112.775 -179.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -103.84 114.98 29.64 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.698 0.799 . . . . 0.0 111.552 176.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 46.8 mtm180 -86.26 -82.18 0.2 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.049 1.339 . . . . 0.0 111.138 175.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -115.88 -76.72 0.65 Allowed Glycine 0 C--N 1.328 0.102 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 178.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 56.69 43.26 25.68 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-O 122.044 0.926 . . . . 0.0 109.796 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -49.69 91.81 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 127.67 2.388 . . . . 0.0 113.805 -175.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 161.5 50.51 0.02 OUTLIER Glycine 0 CA--C 1.535 1.314 0 C-N-CA 124.993 1.283 . . . . 0.0 114.178 -175.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' TRP . . . . . 0.477 ' H ' HD11 ' A' ' 161' ' ' ILE . 4.7 m95 48.79 51.05 16.51 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.219 1.808 . . . . 0.0 113.953 -178.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -81.67 124.53 29.66 Favored 'General case' 0 N--CA 1.467 0.425 0 O-C-N 121.31 -0.869 . . . . 0.0 111.971 -177.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -167.27 -169.22 1.2 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.433 0.693 . . . . 0.0 112.754 178.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.77 164.49 25.03 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 126.64 1.976 . . . . 0.0 111.53 -178.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -81.8 157.7 24.37 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.872 0.869 . . . . 0.0 109.838 175.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.408 ' HB3' ' CE2' ' A' ' 154' ' ' TYR . 3.0 mm? -104.71 118.06 35.62 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.125 0.57 . . . . 0.0 110.536 175.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -48.99 -29.57 8.54 Favored Glycine 0 CA--C 1.537 1.45 0 C-N-CA 125.8 1.667 . . . . 0.0 115.977 -177.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.445 ' CE2' ' HB ' ' A' ' 120' ' ' ILE . 0.1 OUTLIER -62.5 -25.39 67.99 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.4 1.88 . . . . 0.0 113.112 176.977 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 125.18 7.75 5.78 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 126.626 2.06 . . . . 0.0 114.961 -179.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 5.3 mp -101.5 176.78 5.12 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.216 1.406 . . . . 0.0 112.235 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 38.5 mtt180 -139.16 113.52 8.92 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.963 1.305 . . . . 0.0 110.703 -178.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 4.3 ttt -98.15 147.36 24.66 Favored 'General case' 0 C--N 1.319 -0.755 0 O-C-N 120.305 -1.497 . . . . 0.0 107.88 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.09 144.56 51.41 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 125.949 1.699 . . . . 0.0 110.163 177.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -152.02 156.97 26.99 Favored Glycine 0 CA--C 1.519 0.297 0 CA-C-O 121.893 0.719 . . . . 0.0 112.043 177.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.477 HD11 ' H ' ' A' ' 147' ' ' TRP . 4.7 tp -153.21 123.62 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 122.686 1.231 . . . . 0.0 110.175 -175.122 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.58 171.97 14.29 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 125.475 1.51 . . . . 0.0 110.21 175.165 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 15.1 t -162.2 166.82 25.03 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.251 1.42 . . . . 0.0 108.977 176.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 60.2 p -116.66 30.9 7.06 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.741 1.616 . . . . 0.0 111.604 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -65.38 23.2 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 128.541 2.736 . . . . 0.0 115.113 177.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 81.01 -55.49 4.79 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 127.14 2.305 . . . . 0.0 113.433 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -116.05 24.02 11.76 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.67 1.588 . . . . 0.0 112.818 -175.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -61.83 168.31 3.17 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 127.021 2.128 . . . . 0.0 114.599 175.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.5 171.35 10.58 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 127.661 2.385 . . . . 0.0 111.651 177.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 3.0 tmm? -118.76 135.58 54.43 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.223 1.409 . . . . 0.0 111.151 175.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 6.2 tm0? -145.06 131.56 19.77 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.124 0.97 . . . . 0.0 110.156 178.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 1.8 mp -131.74 127.97 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 125.382 1.473 . . . . 0.0 109.613 175.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -130.87 131.11 44.35 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.933 1.693 . . . . 0.0 110.335 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.452 HG23 ' HG ' ' A' ' 40' ' ' SER . 1.7 mp -89.17 96.56 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 O-C-N 121.527 -0.733 . . . . 0.0 111.426 177.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 2.5 t -66.06 173.02 3.28 Favored 'General case' 0 CA--C 1.565 1.521 0 C-N-CA 123.631 0.772 . . . . 0.0 111.477 177.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 18.1 mtp180 . . . . . 0 C--O 1.252 1.208 0 C-N-CA 125.73 1.612 . . . . 0.0 112.618 175.711 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 77.0 p . . . . . 0 N--CA 1.484 1.244 0 CA-C-O 118.423 -0.799 . . . . 0.0 109.443 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.21 -173.72 0.07 Allowed 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 121.013 1.733 . . . . 0.0 112.363 174.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.5 mt -126.3 8.18 7.17 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 125.18 1.392 . . . . 0.0 112.168 175.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -114.98 114.36 25.33 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.884 1.674 . . . . 0.0 111.024 -175.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -72.73 -155.52 2.89 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 125.29 1.424 . . . . 0.0 113.137 178.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 25.7 p -61.9 161.4 10.55 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.61 0.764 . . . . 0.0 111.791 174.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -122.81 18.07 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 CA-C-O 122.993 1.378 . . . . 0.0 111.47 174.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.8 pp -58.62 172.63 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 C-N-CA 125.463 1.505 . . . . 0.0 112.642 174.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -42.27 130.93 3.7 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 127.177 2.191 . . . . 0.0 114.155 -174.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.76 -19.47 43.31 Favored Glycine 0 CA--C 1.538 1.491 0 C-N-CA 124.187 0.899 . . . . 0.0 114.213 -175.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.97 -31.97 72.37 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.504 1.122 . . . . 0.0 112.539 174.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.6 t -101.39 -37.78 8.31 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.644 1.578 . . . . 0.0 111.69 175.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 13.0 tp -78.45 87.99 4.44 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.214 1.005 . . . . 0.0 110.802 175.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.2 p -121.46 178.96 4.6 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 127.188 2.195 . . . . 0.0 111.913 176.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -40.96 -42.01 1.77 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.834 1.654 . . . . 0.0 113.927 175.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -53.73 -46.46 70.85 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 119.159 0.89 . . . . 0.0 111.744 178.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 93.9 t -64.42 -39.57 86.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 125.383 1.473 . . . . 0.0 111.138 174.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 24.2 mt -66.11 -41.86 90.01 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 121.189 -0.944 . . . . 0.0 111.303 178.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -64.74 -46.26 82.96 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.979 1.311 . . . . 0.0 111.57 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.5 -37.25 84.66 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 118.798 -0.62 . . . . 0.0 111.441 174.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.8 t -54.74 -45.75 73.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 124.504 1.122 . . . . 0.0 111.196 -179.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.443 ' HB3' ' HE2' ' A' ' 31' ' ' LYS . 1.4 mt -59.19 -22.48 61.07 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 119.125 0.875 . . . . 0.0 113.356 178.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -89.37 -59.34 1.56 Allowed Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.574 1.559 . . . . 0.0 112.552 178.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -66.13 -30.37 70.84 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.3 mt -111.83 109.61 19.52 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.737 1.615 . . . . 0.0 110.001 -174.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -148.72 139.9 7.89 Favored Glycine 0 CA--C 1.54 1.643 0 C-N-CA 124.563 1.078 . . . . 0.0 114.781 -174.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.3 mtpt -109.22 -67.12 1.0 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 126.243 1.817 . . . . 0.0 112.136 178.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 15.3 m -118.2 -172.12 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 126.127 1.771 . . . . 0.0 110.891 -177.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.2 m -46.9 -38.38 10.38 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 125.359 1.464 . . . . 0.0 114.251 179.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 -127.63 162.0 27.54 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.742 1.617 . . . . 0.0 109.844 174.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.443 ' HE2' ' HB3' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -155.16 155.87 34.71 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 125.937 1.695 . . . . 0.0 108.98 -176.121 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -120.65 129.41 75.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 124.633 1.173 . . . . 0.0 107.838 174.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -133.26 121.89 23.12 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.237 1.415 . . . . 0.0 109.564 175.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -128.49 144.48 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.111 0.964 . . . . 0.0 110.685 -176.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -124.79 110.22 1.35 Allowed Glycine 0 CA--C 1.519 0.323 0 C-N-CA 123.716 0.674 . . . . 0.0 112.44 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.464 ' H ' HD13 ' A' ' 70' ' ' LEU . 3.5 mp -100.3 129.43 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 117.767 0.784 . . . . 0.0 110.687 175.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.73 106.3 18.27 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.639 1.576 . . . . 0.0 110.38 175.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.79 96.25 3.04 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.304 1.442 . . . . 0.0 109.585 176.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -129.73 6.63 5.15 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.836 1.254 . . . . 0.0 113.484 176.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.5 t -58.44 -18.4 28.24 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.62 1.568 . . . . 0.0 113.921 175.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 94.94 5.96 60.71 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 125.747 1.641 . . . . 0.0 114.573 176.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -128.8 147.41 17.59 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 125.813 1.673 . . . . 0.0 111.509 175.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 32.4 p -74.24 129.39 37.73 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 174.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 38.9 m0 -93.38 132.03 37.99 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 122.084 -0.385 . . . . 0.0 110.892 178.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 97.6 m -114.64 128.61 56.41 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.439 1.096 . . . . 0.0 110.073 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.65 106.99 0.74 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.266 1.026 . . . . 0.0 111.877 175.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.2 pp -98.91 -40.12 8.24 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.121 0.568 . . . . 0.0 112.516 179.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -170.58 163.35 8.24 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.875 2.07 . . . . 0.0 111.639 176.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -156.54 154.38 30.2 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.195 0.998 . . . . 0.0 111.355 174.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -132.46 107.24 8.36 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.422 1.489 . . . . 0.0 111.744 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -98.82 110.85 23.39 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.844 0.858 . . . . 0.0 110.476 175.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.3 tpp180 -74.19 -73.33 0.23 Allowed 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.935 1.294 . . . . 0.0 109.291 175.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 9.3 t -106.37 -178.34 3.62 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 126.607 1.963 . . . . 0.0 109.081 176.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 48.65 35.4 16.45 Favored Glycine 0 CA--C 1.54 1.648 0 CA-C-O 119.581 -0.566 . . . . 0.0 112.314 -174.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.7 p -48.7 141.45 7.22 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.596 1.958 . . . . 0.0 112.199 -174.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.2 t -136.95 173.41 11.73 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 121.346 -0.846 . . . . 0.0 113.135 -175.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -80.47 -58.1 3.28 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.648 1.179 . . . . 0.0 111.337 176.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.2 p -142.75 133.07 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.418 1.487 . . . . 0.0 111.615 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.1 pp -138.13 -24.33 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 126.372 1.869 . . . . 0.0 113.863 178.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.4 mp -97.65 98.96 5.76 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 124.797 1.239 . . . . 0.0 110.233 179.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -67.33 159.94 49.97 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 124.714 3.61 . . . . 0.0 111.031 174.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -57.93 -48.25 80.49 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -178.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 87.7 t -149.16 143.7 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 127.196 2.198 . . . . 0.0 108.809 -176.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.2 t -125.78 102.12 29.07 Favored Pre-proline 0 C--N 1.33 -0.259 0 C-N-CA 125.69 1.596 . . . . 0.0 107.451 175.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -72.12 161.39 44.8 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 121.234 1.289 . . . . 0.0 112.492 175.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -69.37 172.27 7.38 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.05 0.54 . . . . 0.0 110.259 174.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 58.8 p 57.03 20.64 5.59 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 125.494 1.518 . . . . 0.0 111.954 -174.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.79 173.35 11.46 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 125.359 1.464 . . . . 0.0 111.06 -174.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -142.8 156.52 44.98 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 175.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.464 HD13 ' H ' ' A' ' 36' ' ' ILE . 1.0 OUTLIER -121.04 175.67 5.96 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 123.882 0.873 . . . . 0.0 111.073 -179.529 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -132.62 149.53 52.29 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.699 1.2 . . . . 0.0 110.965 175.052 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -123.3 147.06 47.37 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.713 1.205 . . . . 0.0 109.286 174.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.2 p -121.3 147.84 45.12 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 127.047 2.139 . . . . 0.0 110.138 174.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -165.2 130.72 2.22 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 124.351 0.977 . . . . 0.0 112.695 174.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 7.5 ptt180 -123.09 149.31 44.62 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.943 1.697 . . . . 0.0 110.687 -175.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 11.8 mtpt -62.86 149.17 45.04 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 121.212 -0.93 . . . . 0.0 111.862 -176.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.5 t -104.17 -165.8 1.18 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.525 1.53 . . . . 0.0 112.272 -177.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 58.2 m 50.74 39.67 22.52 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 126.183 1.793 . . . . 0.0 114.359 174.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 45.14 -94.38 0.01 OUTLIER Glycine 0 CA--C 1.541 1.68 0 C-N-CA 128.24 2.829 . . . . 0.0 114.089 178.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -65.56 -83.02 0.01 OUTLIER 'Trans proline' 0 CA--C 1.55 1.296 0 C-N-CA 124.264 3.309 . . . . 0.0 113.604 175.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 15.5 m -70.67 135.47 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 126.271 1.828 . . . . 0.0 112.316 -178.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -156.69 179.95 8.78 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -178.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 53.0 m -113.2 148.5 35.32 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.633 1.973 . . . . 0.0 109.015 175.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -43.67 -77.05 0.1 OUTLIER Glycine 0 N--CA 1.476 1.339 0 C-N-CA 126.962 2.22 . . . . 0.0 115.416 -175.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -169.1 123.59 0.84 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.534 1.934 . . . . 0.0 109.865 178.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.5 t -151.41 114.3 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.845 0.858 . . . . 0.0 110.716 -175.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -159.23 157.75 31.29 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -141.93 132.66 25.6 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.478 1.111 . . . . 0.0 112.173 178.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -136.01 171.62 14.21 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.189 -0.944 . . . . 0.0 111.688 -178.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -137.67 155.92 48.59 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.26 -0.9 . . . . 0.0 112.906 174.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -133.17 118.33 18.53 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 126.025 1.73 . . . . 0.0 114.409 -175.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -77.13 122.78 25.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.666 -0.243 . . . . 0.0 110.972 -178.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 13.3 mtm -101.67 134.47 44.76 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.514 1.526 . . . . 0.0 111.304 177.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 98.5 p -61.68 -17.26 54.83 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 178.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -69.05 -0.32 5.61 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 125.965 1.706 . . . . 0.0 113.037 174.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 91.1 24.9 25.82 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.456 1.503 . . . . 0.0 113.276 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -132.58 174.82 9.88 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.906 1.283 . . . . 0.0 111.702 -175.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 71.1 m -136.57 113.92 10.82 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.355 1.062 . . . . 0.0 111.504 174.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 65.1 tp -76.03 104.48 6.58 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.512 1.125 . . . . 0.0 110.506 175.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -93.63 117.94 5.58 Favored Glycine 0 CA--C 1.529 0.947 0 O-C-N 121.239 -0.913 . . . . 0.0 112.973 175.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 93.3 t -104.83 147.5 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 125.525 1.53 . . . . 0.0 111.067 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 1.5 tpt -151.55 126.1 9.5 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.546 1.138 . . . . 0.0 111.03 -178.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -133.81 139.95 46.61 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.456 1.503 . . . . 0.0 114.159 177.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -136.3 138.96 42.26 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.245 1.818 . . . . 0.0 111.294 -177.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 96.3 t -118.92 124.35 28.38 Favored Pre-proline 0 N--CA 1.469 0.494 0 C-N-CA 125.098 1.359 . . . . 0.0 110.776 -178.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -66.84 114.55 3.19 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.891 3.061 . . . . 0.0 111.684 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -134.9 -57.61 0.82 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.01 0.924 . . . . 0.0 112.08 179.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -96.29 -22.15 17.39 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.789 1.236 . . . . 0.0 113.758 176.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 8.7 m-30 -40.72 99.2 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 127.508 2.323 . . . . 0.0 113.527 -174.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -62.5 -12.44 22.23 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.582 1.153 . . . . 0.0 113.588 -176.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -115.37 4.11 14.3 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 128.79 2.836 . . . . 0.0 112.975 -178.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 47.13 45.66 16.11 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 126.186 1.794 . . . . 0.0 113.587 -177.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 51.6 m -113.71 80.66 1.4 Allowed 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.225 1.41 . . . . 0.0 112.263 -174.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -88.2 113.82 24.2 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 124.44 1.096 . . . . 0.0 110.974 174.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 31.5 m0 -118.52 135.58 54.32 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.112 0.965 . . . . 0.0 109.673 -176.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 30.5 p-90 -142.19 134.47 27.74 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.49 1.116 . . . . 0.0 111.873 -175.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -160.3 164.46 32.56 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 122.526 1.155 . . . . 0.0 112.989 -176.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.2 t -138.64 124.7 24.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 125.142 1.377 . . . . 0.0 107.747 -179.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.66 166.0 13.29 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.208 1.403 . . . . 0.0 110.198 175.053 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 41.7 mt -122.97 147.76 27.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 174.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -110.2 143.37 27.89 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 124.87 1.268 . . . . 0.0 110.071 177.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -77.21 12.5 1.78 Allowed 'Trans proline' 0 CA--C 1.548 1.219 0 C-N-CA 124.594 3.529 . . . . 0.0 114.407 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -161.12 -179.86 36.12 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 126.475 1.988 . . . . 0.0 111.44 176.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.93 101.83 0.71 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.825 1.25 . . . . 0.0 110.807 177.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 3.8 mmt-85 -124.79 141.8 51.86 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.71 1.204 . . . . 0.0 112.466 -178.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.41 171.99 12.13 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 177.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -128.35 91.63 3.29 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.5 1.92 . . . . 0.0 108.503 176.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -107.37 173.99 6.08 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.793 1.637 . . . . 0.0 109.922 174.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -49.76 -37.0 27.92 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.805 0.842 . . . . 0.0 113.265 176.477 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -59.14 -65.72 3.27 Favored Glycine 0 CA--C 1.531 1.035 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 174.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -58.08 -36.74 73.27 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 118.176 0.988 . . . . 0.0 113.522 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -56.28 -64.21 0.94 Allowed 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 125.267 1.427 . . . . 0.0 109.718 174.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -67.78 -32.8 73.64 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -176.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -57.87 -47.65 82.12 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.01 0.924 . . . . 0.0 112.265 177.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 5.2 tpp -84.51 -21.86 30.41 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 113.669 0.989 . . . . 0.0 113.669 176.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -49.33 -57.97 5.92 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.741 1.216 . . . . 0.0 109.773 174.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -74.64 5.05 5.24 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -178.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -93.9 -11.9 57.23 Favored Glycine 0 CA--C 1.539 1.59 0 C-N-CA 126.015 1.769 . . . . 0.0 114.765 178.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -145.26 94.71 5.2 Favored Pre-proline 0 CA--C 1.552 1.053 0 CA-C-N 119.523 1.662 . . . . 0.0 112.397 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -74.02 81.84 1.88 Allowed 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 123.587 2.858 . . . . 0.0 112.584 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -116.88 110.2 18.03 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.446 1.499 . . . . 0.0 110.846 -178.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 37.2 mtm105 -96.27 50.94 1.18 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 126.907 2.083 . . . . 0.0 111.336 -178.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 85.95 -53.06 4.63 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 124.117 0.865 . . . . 0.0 111.185 -174.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 51.38 52.71 14.22 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.235 1.814 . . . . 0.0 111.399 178.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 14.7 p-10 -48.17 92.82 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 128.48 2.712 . . . . 0.0 115.115 -174.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 160.46 40.12 0.02 OUTLIER Glycine 0 CA--C 1.537 1.427 0 C-N-CA 125.232 1.396 . . . . 0.0 114.506 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 7.5 m95 53.42 48.81 21.03 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.81 1.644 . . . . 0.0 113.363 -176.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -82.66 126.3 32.19 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.987 0.915 . . . . 0.0 112.094 -179.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . 0.503 ' HG3' ' H ' ' A' ' 150' ' ' LYS . 10.5 tp60 -161.65 -168.98 2.11 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.345 0.658 . . . . 0.0 112.312 175.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.503 ' H ' ' HG3' ' A' ' 149' ' ' GLN . 0.6 OUTLIER -131.59 160.67 34.64 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.245 1.818 . . . . 0.0 110.781 -179.205 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 18.7 m-80 -75.55 148.98 38.47 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.391 1.076 . . . . 0.0 109.95 174.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 94.3 mt -100.93 136.9 40.04 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.955 0.902 . . . . 0.0 110.621 178.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -53.0 -35.59 49.1 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 125.717 1.627 . . . . 0.0 116.476 -174.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -73.46 14.21 0.37 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 128.081 2.552 . . . . 0.0 113.942 -178.326 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 76.36 20.5 76.96 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 124.908 1.242 . . . . 0.0 113.58 -174.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.1 mt -101.01 169.01 9.24 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 127.144 2.178 . . . . 0.0 110.519 178.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 50.4 mtt180 -138.76 114.03 9.54 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 120.841 -1.162 . . . . 0.0 110.451 177.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -92.16 150.79 20.72 Favored 'General case' 0 C--N 1.32 -0.711 0 O-C-N 120.138 -1.601 . . . . 0.0 108.433 174.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 2.3 tptt -133.45 142.5 48.33 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.578 1.551 . . . . 0.0 111.097 175.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -147.59 143.43 11.22 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-N 118.885 0.766 . . . . 0.0 113.671 175.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -130.55 126.16 60.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 126.36 1.864 . . . . 0.0 110.604 177.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -149.93 148.49 29.16 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 125.412 1.485 . . . . 0.0 109.297 175.02 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 13.5 t -139.81 112.84 8.15 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.0 0.52 . . . . 0.0 110.543 178.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 67.7 m -72.51 35.02 0.07 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.566 1.146 . . . . 0.0 113.232 178.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -65.99 -44.23 85.45 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.653 1.981 . . . . 0.0 113.019 -179.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 165.13 -68.72 0.2 Allowed Glycine 0 CA--C 1.531 1.059 0 C-N-CA 124.546 1.069 . . . . 0.0 113.838 178.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -111.88 17.01 20.14 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 125.054 1.341 . . . . 0.0 114.392 -174.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -60.98 175.36 0.52 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.349 1.859 . . . . 0.0 114.289 174.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.14 174.83 7.8 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 126.986 2.114 . . . . 0.0 112.042 -178.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 5.5 ttt -115.21 132.9 56.46 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.172 1.389 . . . . 0.0 110.685 175.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -144.79 120.88 10.76 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 123.351 0.66 . . . . 0.0 110.293 177.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 2.7 mp -119.67 126.03 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 C-N-CA 125.125 1.37 . . . . 0.0 107.471 177.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -127.43 126.52 42.53 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 120.879 -1.138 . . . . 0.0 108.794 176.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.8 mp -78.1 124.9 37.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 175.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 2.1 m -95.83 168.01 10.91 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.882 1.673 . . . . 0.0 109.984 175.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 49.3 mtp85 . . . . . 0 C--O 1.253 1.254 0 C-N-CA 125.37 1.468 . . . . 0.0 111.856 176.708 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 118.602 -0.713 . . . . 0.0 110.922 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.92 174.14 0.67 Allowed 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 121.09 1.768 . . . . 0.0 111.497 174.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -106.16 16.37 25.03 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 125.539 1.536 . . . . 0.0 112.687 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -119.42 125.25 48.52 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.669 1.988 . . . . 0.0 111.056 178.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -77.37 -147.74 2.87 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 125.036 1.303 . . . . 0.0 112.443 175.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 18.3 p -68.06 169.08 10.74 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.076 1.35 . . . . 0.0 112.867 176.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -128.89 21.0 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 126.131 1.772 . . . . 0.0 111.257 176.299 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.2 pt -57.07 171.92 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 O-C-N 120.276 -1.515 . . . . 0.0 112.798 176.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -44.12 131.63 5.89 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.734 1.614 . . . . 0.0 112.292 -177.102 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -54.79 -20.94 20.86 Favored Glycine 0 CA--C 1.54 1.651 0 C-N-CA 124.367 0.984 . . . . 0.0 114.303 -177.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.73 -36.25 78.39 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.732 1.613 . . . . 0.0 112.031 175.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.44 -40.2 8.39 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.302 1.441 . . . . 0.0 111.528 175.193 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.4 tp -71.78 87.32 0.97 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.663 1.185 . . . . 0.0 111.205 175.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 80.6 p -123.33 -177.9 3.84 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.741 2.016 . . . . 0.0 111.401 -176.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -45.49 -37.9 5.74 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.426 1.49 . . . . 0.0 113.985 176.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -59.66 -40.94 89.4 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.676 0.791 . . . . 0.0 111.958 178.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 85.6 t -70.66 -37.72 70.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 123.754 0.822 . . . . 0.0 111.055 174.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 32.2 mt -65.54 -41.17 93.34 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 120.971 -1.081 . . . . 0.0 111.32 177.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -75.06 -42.92 56.02 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.85 0.86 . . . . 0.0 112.815 -179.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.88 -37.86 88.57 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 118.764 0.711 . . . . 0.0 111.543 175.1 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 20.2 t -56.35 -46.85 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 124.922 1.289 . . . . 0.0 111.738 176.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 78.1 mt -56.27 -25.32 47.68 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 119.213 0.915 . . . . 0.0 112.887 175.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -86.3 -57.81 2.06 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 124.899 1.237 . . . . 0.0 113.202 176.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -66.47 -27.54 67.88 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -177.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 19.3 mt -108.18 88.05 2.64 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.33 1.452 . . . . 0.0 110.838 -175.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -125.34 85.24 0.35 Allowed Glycine 0 CA--C 1.533 1.193 0 C-N-CA 125.129 1.347 . . . . 0.0 115.302 -175.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -75.41 -43.01 52.26 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.096 0.959 . . . . 0.0 113.467 175.052 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.8 m -137.12 -177.12 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 126.351 1.86 . . . . 0.0 112.078 -174.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -46.65 -45.54 19.29 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 126.448 1.899 . . . . 0.0 114.289 179.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 17.4 mtt85 -139.02 149.12 44.29 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.768 1.627 . . . . 0.0 111.548 178.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.12 157.44 45.94 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 127.234 2.214 . . . . 0.0 110.632 -175.015 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -118.2 128.33 75.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 125.14 1.376 . . . . 0.0 107.597 174.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -135.9 104.12 5.61 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.727 2.011 . . . . 0.0 109.335 176.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.1 m -107.46 158.64 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 123.753 0.821 . . . . 0.0 111.123 178.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -135.68 109.45 0.75 Allowed Glycine 0 N--CA 1.462 0.384 0 CA-C-N 118.293 0.497 . . . . 0.0 113.298 175.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.8 mp -101.73 132.35 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-N 117.108 0.454 . . . . 0.0 111.185 176.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -93.11 105.87 17.9 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.555 1.542 . . . . 0.0 110.972 177.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -71.62 100.69 2.34 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.223 1.809 . . . . 0.0 110.481 175.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -140.09 11.64 2.4 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.988 0.915 . . . . 0.0 112.522 175.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 12.7 t -57.89 -31.9 67.19 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.895 1.678 . . . . 0.0 114.027 179.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 124.82 53.93 0.18 Allowed Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.75 1.167 . . . . 0.0 115.148 174.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 152.5 171.4 20.0 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 125.442 1.496 . . . . 0.0 112.263 175.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 75.6 p -63.6 145.72 55.14 Favored 'General case' 0 N--CA 1.471 0.625 0 O-C-N 121.601 -0.941 . . . . 0.0 111.212 176.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.53 ' HA ' ' CE1' ' A' ' 91' ' ' TYR . 38.0 m0 -93.57 98.35 11.1 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 121.619 -0.676 . . . . 0.0 111.334 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.3 m -83.63 108.52 16.78 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.469 1.107 . . . . 0.0 108.776 176.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.9 142.85 52.85 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.842 -0.536 . . . . 0.0 112.405 175.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.2 pp -119.14 -52.37 2.3 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.048 0.939 . . . . 0.0 112.876 176.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -163.7 153.98 15.42 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.557 1.543 . . . . 0.0 110.72 174.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -131.6 152.37 50.86 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.83 0.852 . . . . 0.0 110.365 175.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -128.05 95.81 4.29 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.687 1.595 . . . . 0.0 110.007 -178.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.473 ' CZ ' HG22 ' A' ' 59' ' ' ILE . 1.5 m-85 -94.54 111.04 22.8 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.852 0.861 . . . . 0.0 110.34 176.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.54 -38.03 12.15 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.048 0.939 . . . . 0.0 111.949 -178.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.2 t -126.63 -173.82 2.97 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 128.415 2.686 . . . . 0.0 107.45 175.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 44.42 49.37 8.42 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-O 118.428 -1.207 . . . . 0.0 111.189 -179.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.9 p -44.8 145.21 0.97 Allowed 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 118.35 1.075 . . . . 0.0 112.8 -175.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.6 t -155.33 179.04 9.55 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.249 -0.907 . . . . 0.0 113.047 -175.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -98.71 -62.76 1.2 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.479 1.511 . . . . 0.0 112.208 178.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.0 p -129.4 131.54 67.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 125.232 1.413 . . . . 0.0 110.921 -177.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.473 HG22 ' CZ ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -137.22 -49.17 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 C-N-CA 125.071 1.348 . . . . 0.0 112.593 -175.117 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.3 mt -85.49 104.09 4.52 Favored Pre-proline 0 N--CA 1.449 -0.478 0 C-N-CA 124.313 1.045 . . . . 0.0 109.948 175.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -66.08 128.57 19.89 Favored 'Trans proline' 0 CA--C 1.535 0.547 0 C-N-CA 122.789 2.326 . . . . 0.0 110.366 175.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -35.29 -47.86 0.43 Allowed 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 127.474 2.31 . . . . 0.0 113.79 176.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 5.9 p -154.09 134.57 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 126.576 1.95 . . . . 0.0 109.424 174.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 95.5 t -122.17 133.58 24.41 Favored Pre-proline 0 N--CA 1.482 1.16 0 C-N-CA 124.986 1.314 . . . . 0.0 109.865 175.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -62.41 148.85 92.62 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.871 2.381 . . . . 0.0 113.209 175.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 13.1 p30 -67.83 170.19 8.46 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.206 1.002 . . . . 0.0 113.071 175.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 74.4 p 48.1 28.62 1.55 Allowed 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 127.109 2.164 . . . . 0.0 114.235 -175.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.51 -179.84 4.8 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 127.442 2.297 . . . . 0.0 110.817 -174.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -136.37 152.79 51.02 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 120.77 -1.206 . . . . 0.0 109.86 175.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -117.88 172.51 7.34 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 124.642 1.177 . . . . 0.0 111.279 -178.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -129.05 151.85 49.3 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.133 1.373 . . . . 0.0 111.191 175.14 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.449 ' CE2' ' CD2' ' A' ' 89' ' ' PHE . 5.2 m-85 -127.2 133.54 50.25 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.395 1.078 . . . . 0.0 110.214 174.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.3 p -102.41 154.88 18.65 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 126.491 1.917 . . . . 0.0 111.36 175.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -176.37 126.91 1.17 Allowed Glycine 0 CA--C 1.529 0.917 0 N-CA-C 114.269 0.468 . . . . 0.0 114.269 175.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 9.3 ptt180 -116.26 105.03 12.1 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.513 1.925 . . . . 0.0 112.751 -175.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.03 -34.33 77.35 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 -179.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 22.8 t -68.47 88.73 0.34 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.683 1.193 . . . . 0.0 111.734 178.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 61.0 m -110.46 -21.0 12.39 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.493 1.517 . . . . 0.0 113.703 175.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 117.44 -66.97 0.33 Allowed Glycine 0 CA--C 1.54 1.643 0 C-N-CA 125.414 1.483 . . . . 0.0 113.78 -175.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -71.67 -41.64 2.15 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 123.321 2.68 . . . . 0.0 113.632 -174.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.9 m -132.78 149.07 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 126.283 1.833 . . . . 0.0 110.241 177.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -154.07 76.36 1.05 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.518 1.527 . . . . 0.0 110.967 -178.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 53.8 m -92.3 141.32 28.68 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 125.545 1.538 . . . . 0.0 110.05 174.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -27.71 -77.61 0.01 OUTLIER Glycine 0 N--CA 1.477 1.381 0 C-N-CA 127.69 2.567 . . . . 0.0 116.177 -178.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -165.73 112.55 0.92 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.363 1.865 . . . . 0.0 110.599 -176.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.8 t -149.97 120.68 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 O-C-N 121.211 -0.931 . . . . 0.0 111.631 -177.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -162.03 173.39 14.47 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 122.67 1.224 . . . . 0.0 113.397 175.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -147.69 157.38 43.52 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.686 1.594 . . . . 0.0 110.755 174.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.449 ' CD2' ' CE2' ' A' ' 72' ' ' TYR . 49.0 p90 -158.05 172.1 19.04 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 124.41 1.084 . . . . 0.0 110.858 175.174 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.76 147.82 31.31 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 175.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.53 ' CE1' ' HA ' ' A' ' 44' ' ' TRP . 0.1 OUTLIER -114.54 126.98 55.55 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 126.309 1.844 . . . . 0.0 109.726 -178.281 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -82.83 108.23 16.02 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 123.518 0.727 . . . . 0.0 111.768 178.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -79.91 137.8 36.98 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.441 1.096 . . . . 0.0 111.603 -174.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.9 t -59.44 -22.63 61.77 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.791 0.837 . . . . 0.0 113.206 177.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 28.3 m-80 -69.23 -1.79 8.89 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 125.69 1.596 . . . . 0.0 113.529 174.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 89.75 16.33 56.7 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 125.066 1.317 . . . . 0.0 113.894 -179.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 23.6 m-20 -116.47 177.32 4.74 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.878 1.671 . . . . 0.0 111.07 -176.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.2 m -131.66 117.51 18.77 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 121.473 -0.767 . . . . 0.0 112.007 175.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 13.5 tp -80.09 97.53 6.88 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 175.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -91.21 135.76 12.98 Favored Glycine 0 CA--C 1.532 1.126 0 O-C-N 121.347 -0.845 . . . . 0.0 112.067 176.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 74.3 t -122.46 133.87 67.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 126.951 2.1 . . . . 0.0 111.61 -174.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -137.78 128.36 26.68 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 126.009 1.724 . . . . 0.0 111.01 -176.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -145.77 121.83 10.75 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.873 1.269 . . . . 0.0 112.312 -175.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 19.3 m -139.07 110.8 7.14 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.878 1.271 . . . . 0.0 112.064 -175.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.7 m -84.21 151.23 59.51 Favored Pre-proline 0 N--CA 1.479 1.021 0 N-CA-C 112.654 0.612 . . . . 0.0 112.654 -179.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.438 ' HA ' ' CE2' ' A' ' 109' ' ' TYR . 67.6 Cg_endo -73.29 109.26 2.8 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 123.628 2.885 . . . . 0.0 112.154 177.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -131.6 -47.65 0.97 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.177 0.991 . . . . 0.0 113.264 177.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -107.56 -8.54 16.15 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 177.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.438 ' CE2' ' HA ' ' A' ' 106' ' ' PRO . 6.5 m-30 -59.64 106.71 0.5 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.853 1.261 . . . . 0.0 111.969 -175.1 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 99.8 m-20 -62.16 -4.49 1.74 Allowed 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 124.923 1.289 . . . . 0.0 114.03 176.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 18.9 m95 -123.46 3.84 9.04 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 127.546 2.338 . . . . 0.0 113.711 -177.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 49.92 40.74 21.59 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 125.839 1.656 . . . . 0.0 114.19 -176.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 2.1 m -106.91 83.95 1.91 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.491 1.516 . . . . 0.0 113.157 -175.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -79.89 107.41 12.65 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.18 0.992 . . . . 0.0 110.272 174.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 31.2 m0 -112.03 141.82 45.23 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 55.6 p-90 -146.82 130.73 17.15 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 123.864 0.865 . . . . 0.0 112.007 -174.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -132.49 144.46 50.46 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 122.81 1.291 . . . . 0.0 112.192 179.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.418 ' HB ' ' CE ' ' A' ' 158' ' ' MET . 79.6 t -151.17 131.5 3.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 175.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.86 165.99 13.68 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 125.161 1.384 . . . . 0.0 110.505 175.169 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 14.3 mt -86.24 148.51 4.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 175.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -110.38 142.63 26.43 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 126.771 2.028 . . . . 0.0 109.519 -178.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -74.77 87.24 1.31 Allowed 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 124.319 3.346 . . . . 0.0 111.547 -177.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.53 -174.97 19.96 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 125.112 1.339 . . . . 0.0 113.201 -174.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 2.3 tttt -69.73 105.81 2.87 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.234 1.414 . . . . 0.0 110.714 177.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 17.4 tpp180 -135.45 101.18 4.73 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.241 1.417 . . . . 0.0 111.451 178.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.8 168.58 1.2 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.711 0.804 . . . . 0.0 112.954 175.014 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -111.06 101.73 10.25 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.784 1.234 . . . . 0.0 107.882 177.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -113.23 171.17 7.71 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.794 1.238 . . . . 0.0 109.848 174.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -50.24 -36.61 31.81 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.006 -1.059 . . . . 0.0 112.775 175.108 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -60.02 -61.6 6.98 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 124.087 0.851 . . . . 0.0 111.634 174.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.48 -34.63 74.32 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 118.43 1.115 . . . . 0.0 112.324 178.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -58.4 -66.2 0.53 Allowed 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.866 0.866 . . . . 0.0 109.277 174.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -67.67 -30.89 70.54 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -175.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -63.88 -54.4 35.44 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.976 1.31 . . . . 0.0 112.142 175.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 51.8 mmm -75.13 -24.14 57.95 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.159 -0.963 . . . . 0.0 113.266 178.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -55.68 -56.58 18.78 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.383 1.473 . . . . 0.0 108.903 174.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -66.91 -23.11 65.95 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -75.3 -19.09 79.81 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 125.868 1.699 . . . . 0.0 115.212 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -132.56 83.64 53.36 Favored Pre-proline 0 CA--C 1.549 0.942 0 CA-C-N 119.024 1.412 . . . . 0.0 111.102 175.03 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -72.97 72.63 3.23 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 124.239 3.293 . . . . 0.0 112.1 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -96.64 112.01 23.93 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 121.372 -0.83 . . . . 0.0 110.551 -175.031 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 10.0 mtm180 -113.41 -3.45 13.75 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 115.467 1.655 . . . . 0.0 115.467 176.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -50.43 152.15 4.55 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 125.159 1.361 . . . . 0.0 114.427 177.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 10.4 p30 -119.35 -155.75 0.63 Allowed 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 -175.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -49.52 114.28 1.01 Allowed 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.79 1.636 . . . . 0.0 113.027 -178.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 152.8 24.79 0.05 OUTLIER Glycine 0 CA--C 1.535 1.342 0 N-CA-C 115.425 0.93 . . . . 0.0 115.425 -175.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 3.4 m95 49.6 47.57 22.56 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.545 1.538 . . . . 0.0 113.393 -175.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -66.9 109.57 2.98 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 126.999 2.12 . . . . 0.0 112.787 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -158.65 -169.01 2.58 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 175.006 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.4 mtmt -134.86 172.32 13.15 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 127.564 2.346 . . . . 0.0 110.277 -179.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -71.1 160.62 32.55 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.042 0.537 . . . . 0.0 109.898 174.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 10.3 mt -118.7 155.48 30.98 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 122.385 1.088 . . . . 0.0 110.659 175.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -62.46 -175.45 2.48 Favored Glycine 0 CA--C 1.537 1.415 0 CA-C-N 114.92 -1.036 . . . . 0.0 111.17 175.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 55.82 12.05 0.8 Allowed 'General case' 0 N--CA 1.482 1.141 0 O-C-N 121.055 -1.262 . . . . 0.0 114.127 178.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 79.41 24.33 61.16 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 125.576 1.56 . . . . 0.0 114.079 -174.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 52.7 mt -103.94 176.66 5.08 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 118.699 1.249 . . . . 0.0 111.534 -175.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -145.85 131.6 18.99 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 120.862 -1.149 . . . . 0.0 110.598 177.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' MET . . . . . 0.418 ' CE ' ' HB ' ' A' ' 118' ' ' VAL . 2.9 ttt -106.32 150.94 25.47 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 119.892 -1.755 . . . . 0.0 107.154 175.06 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 1.9 tppt? -126.54 136.96 53.25 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 126.236 1.814 . . . . 0.0 108.834 175.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -147.95 157.79 27.47 Favored Glycine 0 N--CA 1.463 0.477 0 O-C-N 121.152 -0.968 . . . . 0.0 112.733 -178.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -158.21 128.34 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 122.137 0.97 . . . . 0.0 110.334 -179.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -155.23 117.68 4.23 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.708 1.603 . . . . 0.0 110.088 174.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 8.6 t -103.4 151.57 22.62 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 175.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 8.4 t -105.87 36.73 2.45 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.623 1.169 . . . . 0.0 111.384 -177.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -72.29 23.73 0.05 Allowed 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 127.795 2.438 . . . . 0.0 114.565 -178.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 80.83 -61.65 4.5 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 126.239 1.875 . . . . 0.0 113.015 -177.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -114.58 84.03 1.99 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 126.152 1.781 . . . . 0.0 109.992 177.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -136.7 163.93 29.43 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.318 1.847 . . . . 0.0 111.872 177.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.62 177.72 4.54 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 127.772 2.429 . . . . 0.0 111.523 -177.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 1.5 tmt? -121.97 131.07 53.82 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.864 1.266 . . . . 0.0 111.218 179.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -143.26 124.01 14.18 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.43 0.692 . . . . 0.0 111.739 179.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 1.9 mp -128.78 130.95 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 125.805 1.642 . . . . 0.0 108.57 178.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 1.9 tmmm? -130.67 129.16 42.27 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 126.069 1.748 . . . . 0.0 108.993 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.7 mp -83.89 133.4 29.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 174.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 87.4 p -116.79 161.75 18.77 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.932 1.693 . . . . 0.0 112.45 176.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 19.0 mtp180 . . . . . 0 C--O 1.253 1.269 0 O-C-N 120.315 -1.49 . . . . 0.0 111.825 -175.307 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 57.3 p . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 118.076 -0.964 . . . . 0.0 109.564 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -63.86 -172.17 0.06 Allowed 'General case' 0 N--CA 1.485 1.287 0 CA-C-N 120.606 1.548 . . . . 0.0 113.241 175.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.451 ' CD2' ' H ' ' A' ' 27' ' ' LYS . 1.9 mt -121.06 -9.08 9.25 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.588 1.155 . . . . 0.0 112.921 178.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -99.42 114.02 26.7 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 127.404 2.282 . . . . 0.0 109.14 178.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -63.3 -89.12 0.03 OUTLIER Glycine 0 CA--C 1.535 1.295 0 C-N-CA 124.243 0.925 . . . . 0.0 113.934 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 17.2 p -143.85 174.47 10.8 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.86 1.664 . . . . 0.0 111.452 -175.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -124.95 15.2 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 125.38 1.472 . . . . 0.0 112.011 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.5 pt -50.11 156.73 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 124.481 1.112 . . . . 0.0 110.976 174.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -40.06 140.27 0.59 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.896 1.678 . . . . 0.0 112.695 -176.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -53.42 -24.2 22.35 Favored Glycine 0 CA--C 1.543 1.798 0 C-N-CA 124.028 0.823 . . . . 0.0 113.982 -174.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.24 -32.69 72.49 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.662 1.585 . . . . 0.0 112.618 175.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -93.41 -50.93 5.21 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 125.886 1.674 . . . . 0.0 110.911 175.058 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.2 tp -71.05 91.2 0.88 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.537 1.135 . . . . 0.0 111.086 177.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 62.5 p -126.68 -178.54 4.41 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.376 1.87 . . . . 0.0 111.6 -178.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -53.97 -37.65 64.17 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.512 1.125 . . . . 0.0 113.077 178.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -58.91 -46.76 87.16 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.372 0.669 . . . . 0.0 110.961 175.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 81.6 t -61.63 -43.66 97.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.669 1.188 . . . . 0.0 111.339 175.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 96.7 mt -64.6 -43.45 93.74 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 121.267 -0.895 . . . . 0.0 111.987 178.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -69.36 -42.37 75.32 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.275 0.63 . . . . 0.0 112.243 -179.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.01 -36.35 83.04 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 118.791 0.723 . . . . 0.0 111.716 175.008 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.2 t -56.17 -41.43 69.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 124.013 0.925 . . . . 0.0 110.923 179.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 41.0 mt -55.18 -20.23 9.94 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 175.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -92.71 -59.68 1.25 Allowed Glycine 0 CA--C 1.534 1.245 0 C-N-CA 125.246 1.403 . . . . 0.0 112.722 175.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -68.45 -29.41 68.06 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 -176.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -109.05 118.14 36.01 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 126.605 1.962 . . . . 0.0 109.365 -179.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -160.87 117.5 0.77 Allowed Glycine 0 CA--C 1.542 1.762 0 C-N-CA 125.701 1.619 . . . . 0.0 114.732 -175.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.451 ' H ' ' CD2' ' A' ' 3' ' ' LEU . 9.1 mttm -87.54 -57.92 2.77 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 126.882 2.073 . . . . 0.0 112.988 176.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.3 m -132.36 -172.36 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 127.143 2.177 . . . . 0.0 112.066 -174.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.2 t -50.48 -37.15 37.11 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.778 1.631 . . . . 0.0 114.081 -175.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.5 tpt180 -130.28 144.93 51.66 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.129 1.372 . . . . 0.0 109.581 174.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.82 133.94 22.77 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 125.707 1.603 . . . . 0.0 110.357 -175.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -103.84 131.31 52.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 124.054 0.942 . . . . 0.0 108.882 175.028 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -130.11 105.61 8.06 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.501 1.92 . . . . 0.0 109.901 175.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.2 m -108.19 162.89 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 C-N-CA 123.979 0.912 . . . . 0.0 110.747 176.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -135.02 109.15 0.75 Allowed Glycine 0 C--O 1.228 -0.251 0 C-N-CA 123.275 0.465 . . . . 0.0 112.603 175.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.3 mp -92.35 133.86 32.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 174.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -109.31 99.63 8.86 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.436 1.894 . . . . 0.0 110.342 178.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -73.43 112.13 9.21 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.98 1.712 . . . . 0.0 112.199 175.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -140.06 18.68 2.45 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.785 0.834 . . . . 0.0 112.005 174.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 44.1 t -64.61 -39.06 93.04 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 120.889 -1.132 . . . . 0.0 113.15 -178.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 119.97 63.01 0.26 Allowed Glycine 0 CA--C 1.53 0.99 0 C-N-CA 124.805 1.193 . . . . 0.0 112.715 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 157.15 161.13 10.58 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 125.674 1.606 . . . . 0.0 112.444 176.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 71.5 p -67.82 148.47 51.17 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 121.784 -0.833 . . . . 0.0 111.732 175.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.551 ' HA ' ' CE1' ' A' ' 91' ' ' TYR . 35.3 m0 -103.72 98.25 8.14 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.415 1.086 . . . . 0.0 111.866 -177.508 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 35.9 m -84.24 116.66 23.07 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 125.07 1.348 . . . . 0.0 109.86 177.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.02 141.84 58.62 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 121.686 -0.634 . . . . 0.0 111.647 174.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.0 pp -114.31 -48.41 2.88 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.153 0.981 . . . . 0.0 112.587 177.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -170.19 148.88 3.39 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.964 2.106 . . . . 0.0 109.53 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -125.98 147.59 49.49 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.151 1.38 . . . . 0.0 109.803 174.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -124.52 101.61 7.22 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 125.344 1.458 . . . . 0.0 109.629 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -105.13 133.53 49.75 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.586 -0.696 . . . . 0.0 110.427 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -107.07 -68.45 0.89 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.334 1.453 . . . . 0.0 111.244 -177.17 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.9 t -102.6 -38.92 7.3 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.671 1.588 . . . . 0.0 110.056 -179.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -69.44 7.7 3.49 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 125.482 1.515 . . . . 0.0 114.338 -178.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 53.4 p -33.2 123.25 0.4 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 128.151 2.581 . . . . 0.0 113.532 -175.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.9 t -138.35 177.96 7.49 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.175 0.99 . . . . 0.0 112.754 -174.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -77.37 -60.81 2.21 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.764 1.226 . . . . 0.0 112.538 177.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.8 p -141.57 138.27 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 126.161 1.784 . . . . 0.0 111.348 176.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.1 pp -144.58 -34.2 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 126.114 1.765 . . . . 0.0 113.793 -177.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 mp -95.13 98.19 3.19 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 125.154 1.382 . . . . 0.0 109.681 176.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -66.83 151.87 81.54 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.749 2.299 . . . . 0.0 110.332 175.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -50.04 -50.25 48.23 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.686 0.794 . . . . 0.0 112.893 -177.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 60.0 t -150.14 142.15 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 128.296 2.638 . . . . 0.0 108.691 178.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 98.9 t -120.64 133.97 24.15 Favored Pre-proline 0 N--CA 1.477 0.893 0 C-N-CA 124.742 1.217 . . . . 0.0 109.117 175.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -65.06 154.58 72.73 Favored 'Trans proline' 0 CA--C 1.544 1.014 0 C-N-CA 122.707 2.271 . . . . 0.0 113.565 177.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -70.23 160.24 32.54 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.566 1.146 . . . . 0.0 113.273 175.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 40.9 p 52.7 23.78 2.87 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 126.314 1.846 . . . . 0.0 114.405 -175.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 18.6 mttt -119.48 -172.81 2.39 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 126.087 1.755 . . . . 0.0 111.31 -177.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -143.9 157.94 44.02 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 122.068 -0.395 . . . . 0.0 109.997 179.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -134.81 167.21 21.29 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 124.58 1.152 . . . . 0.0 111.689 177.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -114.0 154.85 26.94 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 125.121 1.369 . . . . 0.0 111.849 -179.118 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -129.19 137.82 51.37 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.356 1.062 . . . . 0.0 110.764 175.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 8.7 p -111.93 144.04 41.9 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 126.86 2.064 . . . . 0.0 110.241 174.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -165.63 133.69 3.05 Favored Glycine 0 CA--C 1.523 0.592 0 CA-C-O 121.388 0.438 . . . . 0.0 113.119 175.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 66.3 mtm180 -90.62 172.14 8.89 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.343 1.457 . . . . 0.0 110.617 -175.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.39 140.42 31.07 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.823 -0.548 . . . . 0.0 109.824 174.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.5 m -171.39 152.01 3.2 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.988 1.315 . . . . 0.0 112.337 175.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.435 ' HB2' ' H ' ' A' ' 83' ' ' THR . 0.5 OUTLIER 175.99 118.79 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 127.91 2.484 . . . . 0.0 108.596 175.527 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -38.69 -50.83 2.49 Favored Glycine 0 CA--C 1.545 1.937 0 C-N-CA 126.009 1.766 . . . . 0.0 115.64 174.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.88 -54.74 0.16 Allowed 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.667 2.245 . . . . 0.0 113.077 176.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.4 p -156.41 116.4 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 126.603 1.961 . . . . 0.0 110.02 -177.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -42.49 101.89 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 126.656 1.982 . . . . 0.0 114.803 -179.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.435 ' H ' ' HB2' ' A' ' 78' ' ' SER . 87.7 m -74.29 152.29 39.69 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.814 1.646 . . . . 0.0 110.598 178.52 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -57.34 -76.06 0.22 Allowed Glycine 0 CA--C 1.532 1.141 0 C-N-CA 125.726 1.631 . . . . 0.0 114.644 -174.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -162.24 104.96 1.13 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.377 1.071 . . . . 0.0 111.376 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 41.8 t -127.67 114.58 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 O-C-N 121.086 -1.009 . . . . 0.0 109.891 -177.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.26 169.45 24.72 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 122.693 1.235 . . . . 0.0 112.061 179.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -150.88 161.38 42.8 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.828 1.651 . . . . 0.0 109.563 175.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -159.97 176.47 11.82 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 121.093 -1.004 . . . . 0.0 111.342 175.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.03 156.47 43.5 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.666 0.746 . . . . 0.0 112.556 174.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.551 ' CE1' ' HA ' ' A' ' 44' ' ' TRP . 0.1 OUTLIER -119.94 127.5 52.72 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.697 1.999 . . . . 0.0 109.184 -178.81 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -83.45 105.59 14.51 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.494 0.718 . . . . 0.0 111.911 178.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -75.37 137.59 41.17 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.576 1.151 . . . . 0.0 112.009 -175.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.3 m -59.95 -17.31 36.86 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 113.583 0.956 . . . . 0.0 113.583 175.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -74.32 -2.53 25.56 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 125.142 1.377 . . . . 0.0 112.532 174.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.41 14.89 58.0 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 125.352 1.453 . . . . 0.0 114.168 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -117.25 178.18 4.46 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.504 1.522 . . . . 0.0 110.655 -177.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 16.3 m -130.29 114.01 15.1 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 120.998 -1.064 . . . . 0.0 111.839 178.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 32.5 tp -78.99 98.77 6.57 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.391 0.996 . . . . 0.0 109.383 174.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.6 139.33 15.08 Favored Glycine 0 CA--C 1.532 1.154 0 O-C-N 121.075 -1.016 . . . . 0.0 112.294 175.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 60.9 t -122.55 134.21 66.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 128.174 2.589 . . . . 0.0 112.002 -175.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -131.75 125.39 31.85 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 126.163 1.785 . . . . 0.0 111.779 -175.307 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -146.03 116.04 7.37 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.362 1.065 . . . . 0.0 113.521 -177.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 72.3 m -123.36 122.26 37.87 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.397 1.479 . . . . 0.0 111.719 -177.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 47.4 t -120.97 93.77 48.88 Favored Pre-proline 0 N--CA 1.469 0.506 0 C-N-CA 126.124 1.77 . . . . 0.0 108.873 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.27 139.6 42.33 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 123.281 2.654 . . . . 0.0 110.975 178.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -75.62 -55.62 5.48 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.047 0.939 . . . . 0.0 111.725 177.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -63.94 -37.53 87.74 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.164 0.985 . . . . 0.0 113.456 -177.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER 49.67 45.34 24.52 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 125.981 1.712 . . . . 0.0 113.278 179.021 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -113.62 -76.41 0.58 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.557 1.143 . . . . 0.0 112.29 -175.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -97.97 13.47 30.68 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 127.643 2.377 . . . . 0.0 113.159 -179.098 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -143.65 103.11 4.03 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.182 1.393 . . . . 0.0 111.216 -177.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 67.8 m -65.6 148.71 51.29 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.055 0.942 . . . . 0.0 112.512 175.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -84.11 106.67 15.93 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.965 1.306 . . . . 0.0 109.081 174.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 53.5 m0 -110.73 155.83 21.92 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.398 0.999 . . . . 0.0 108.912 174.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 58.1 p-90 -154.32 132.93 12.12 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.132 0.973 . . . . 0.0 111.214 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -135.94 154.97 50.95 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 122.84 1.305 . . . . 0.0 112.097 178.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 95.1 t -152.6 135.2 6.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 175.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.03 170.68 11.78 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.943 1.697 . . . . 0.0 110.014 175.026 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 20.5 mt -91.29 154.1 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 CA-C-O 121.507 0.67 . . . . 0.0 109.312 179.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -117.77 144.04 33.66 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 125.296 1.438 . . . . 0.0 109.64 178.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -70.96 108.11 2.24 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 123.891 3.06 . . . . 0.0 111.301 -178.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 83.61 -178.55 52.48 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 124.447 1.022 . . . . 0.0 113.711 -175.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 14.2 tttt -63.61 104.58 0.67 Allowed 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.911 1.285 . . . . 0.0 110.659 175.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 19.6 tpp180 -132.34 101.47 5.37 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.82 1.248 . . . . 0.0 111.29 -175.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.7 163.33 1.9 Allowed 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.852 0.834 . . . . 0.0 111.754 174.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -109.64 105.1 14.24 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 106.565 -1.642 . . . . 0.0 106.565 174.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -112.32 173.9 6.14 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.029 1.332 . . . . 0.0 109.86 175.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -50.57 -40.27 51.72 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 119.276 0.944 . . . . 0.0 113.282 176.119 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -58.28 -62.01 6.77 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 123.659 0.647 . . . . 0.0 111.717 175.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 5.3 mpp? -58.44 -39.33 79.53 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 118.134 0.967 . . . . 0.0 112.742 177.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -55.14 -60.87 2.79 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.397 1.079 . . . . 0.0 109.962 175.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -68.25 -33.29 74.11 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -178.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -61.1 -46.81 89.08 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.079 0.951 . . . . 0.0 111.599 176.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 46.6 mmm -84.88 -22.65 29.26 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -178.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -54.1 -55.54 26.63 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.765 1.626 . . . . 0.0 109.844 175.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -69.53 -16.49 63.44 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 179.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -74.29 -24.84 72.26 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 125.841 1.686 . . . . 0.0 114.333 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -135.74 87.98 24.47 Favored Pre-proline 0 CA--C 1.546 0.796 0 CA-C-N 118.721 1.26 . . . . 0.0 112.607 175.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -74.19 76.68 2.99 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 123.752 2.968 . . . . 0.0 112.773 -178.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -104.29 105.32 15.42 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.991 0.916 . . . . 0.0 111.316 179.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 23.2 mtm105 -91.0 74.43 6.38 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.268 1.427 . . . . 0.0 111.472 174.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 31.37 64.79 0.2 Allowed Glycine 0 CA--C 1.534 1.242 0 C-N-CA 125.613 1.577 . . . . 0.0 112.948 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -71.86 93.92 1.37 Allowed 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 122.284 1.04 . . . . 0.0 110.153 -175.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 -54.76 98.94 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 126.934 2.093 . . . . 0.0 114.373 -175.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 146.7 54.6 0.02 OUTLIER Glycine 0 CA--C 1.535 1.335 0 C-N-CA 125.431 1.491 . . . . 0.0 114.38 177.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 5.0 m95 44.12 50.08 7.49 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.796 1.638 . . . . 0.0 114.129 -176.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -81.39 131.68 35.29 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 121.149 -0.97 . . . . 0.0 112.476 -177.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . 0.574 ' NE2' ' H ' ' A' ' 150' ' ' LYS . 0.0 OUTLIER -167.77 -169.59 1.2 Allowed 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.845 178.92 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.574 ' H ' ' NE2' ' A' ' 149' ' ' GLN . 0.0 OUTLIER -123.83 160.52 27.22 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.701 2.001 . . . . 0.0 111.851 175.33 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -87.87 127.9 35.35 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.631 1.173 . . . . 0.0 108.217 174.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 12.8 mt -73.41 112.23 9.28 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.191 0.996 . . . . 0.0 112.052 -174.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -43.76 -46.16 7.41 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 127.349 2.404 . . . . 0.0 117.769 -175.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.411 ' CD1' ' N ' ' A' ' 154' ' ' TYR . 0.0 OUTLIER -51.77 -33.74 36.54 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 127.378 2.271 . . . . 0.0 113.658 178.162 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 132.17 40.88 0.2 Allowed Glycine 0 CA--C 1.533 1.215 0 C-N-CA 125.459 1.504 . . . . 0.0 113.896 -178.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 4.8 mp -134.56 179.46 6.27 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.605 1.562 . . . . 0.0 110.874 178.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 5.8 mtt180 -136.88 142.11 42.77 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.709 1.204 . . . . 0.0 109.028 174.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 3.5 ttt -134.75 145.57 48.56 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 121.076 -1.015 . . . . 0.0 108.692 175.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 4.9 tptt -124.59 147.93 48.17 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 127.12 2.168 . . . . 0.0 111.172 178.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -150.24 147.81 18.37 Favored Glycine 0 CA--C 1.528 0.848 0 O-C-N 121.458 -0.776 . . . . 0.0 112.872 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 4.8 tp -146.59 124.94 4.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 124.943 1.297 . . . . 0.0 110.42 179.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -151.32 156.01 39.9 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.933 2.093 . . . . 0.0 107.412 174.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.51 132.42 15.12 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.199 1.4 . . . . 0.0 107.923 174.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -105.5 32.75 4.08 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.342 1.057 . . . . 0.0 112.127 -176.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.424 ' C ' ' H ' ' A' ' 167' ' ' GLU . . . -116.3 -71.42 0.74 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.341 1.056 . . . . 0.0 112.583 -175.019 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -77.29 14.07 9.27 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 125.974 1.749 . . . . 0.0 111.384 175.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . 0.424 ' H ' ' C ' ' A' ' 165' ' ' ALA . 3.4 tm-20 56.28 56.14 6.05 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 127.551 2.34 . . . . 0.0 112.063 176.278 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -78.54 -170.71 2.18 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 113.779 -1.555 . . . . 0.0 112.857 178.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.3 165.97 12.58 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 128.665 2.786 . . . . 0.0 111.435 -178.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 17.9 ttp -95.59 136.88 35.42 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.732 1.213 . . . . 0.0 111.527 179.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -144.82 119.27 9.65 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.251 1.02 . . . . 0.0 110.329 176.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 1.9 mp -114.31 120.79 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 124.905 1.282 . . . . 0.0 108.158 175.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.435 ' HE2' ' O ' ' A' ' 174' ' ' ILE . 0.0 OUTLIER -121.54 127.31 50.85 Favored 'General case' 0 CA--C 1.51 -0.574 0 C-N-CA 126.447 1.899 . . . . 0.0 108.88 -179.224 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.435 ' O ' ' HE2' ' A' ' 173' ' ' LYS . 1.3 mp -79.0 117.83 25.31 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 O-C-N 121.141 -0.975 . . . . 0.0 111.957 177.373 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 6.1 t -84.67 172.63 11.39 Favored 'General case' 0 N--CA 1.479 1.005 0 O-C-N 120.864 -1.147 . . . . 0.0 109.88 175.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 1.1 mtt-85 . . . . . 0 C--O 1.251 1.147 0 O-C-N 120.432 -1.417 . . . . 0.0 114.418 174.942 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 71.0 m . . . . . 0 N--CA 1.486 1.332 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -137.84 169.92 16.95 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 126.436 1.894 . . . . 0.0 109.265 174.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.2 mt -108.68 15.62 23.54 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.527 1.531 . . . . 0.0 112.496 177.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -116.29 130.07 56.59 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 127.366 2.266 . . . . 0.0 110.361 -176.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -85.65 -96.04 0.76 Allowed Glycine 0 CA--C 1.531 1.087 0 C-N-CA 123.929 0.776 . . . . 0.0 112.865 -178.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 36.1 p -120.93 170.02 9.89 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.965 1.706 . . . . 0.0 111.764 -179.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -129.65 18.68 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 125.928 1.691 . . . . 0.0 111.712 177.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 pt -56.9 171.62 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 O-C-N 120.367 -1.458 . . . . 0.0 112.258 176.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -43.02 126.96 4.06 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.331 1.452 . . . . 0.0 113.335 -174.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -54.5 -23.3 27.12 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 125.229 1.395 . . . . 0.0 114.292 -177.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.14 -29.06 70.08 Favored 'General case' 0 CA--C 1.548 0.894 0 O-C-N 121.678 -0.895 . . . . 0.0 111.99 175.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.0 t -101.99 -40.11 7.02 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.956 1.702 . . . . 0.0 112.064 175.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 12.8 tp -73.44 90.11 1.69 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.265 1.026 . . . . 0.0 110.567 175.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.9 p -125.9 -178.95 4.46 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.918 2.087 . . . . 0.0 111.634 178.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -48.26 -38.82 19.62 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.801 1.641 . . . . 0.0 113.289 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -55.06 -40.53 70.4 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 118.685 0.675 . . . . 0.0 112.497 176.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 96.2 t -70.05 -39.77 77.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.301 1.44 . . . . 0.0 110.804 174.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 28.1 mt -65.49 -43.75 89.2 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.166 -0.959 . . . . 0.0 111.419 179.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -57.22 -51.41 69.44 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.222 1.409 . . . . 0.0 110.716 178.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.76 -36.86 84.76 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 118.03 -0.986 . . . . 0.0 112.846 175.007 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.7 t -55.42 -47.07 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 CA-C-N 119.864 1.211 . . . . 0.0 110.996 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.413 ' HB3' ' HE2' ' A' ' 31' ' ' LYS . 1.9 mt -55.63 -24.66 34.68 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.067 0.947 . . . . 0.0 113.069 177.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -88.2 -61.66 1.47 Allowed Glycine 0 CA--C 1.532 1.097 0 C-N-CA 125.986 1.755 . . . . 0.0 112.633 176.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -62.87 -39.08 93.33 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 118.533 1.167 . . . . 0.0 113.768 -178.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -90.41 1.18 56.87 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.872 1.269 . . . . 0.0 112.124 175.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -52.91 96.9 0.02 OUTLIER Glycine 0 CA--C 1.537 1.455 0 C-N-CA 127.047 2.261 . . . . 0.0 114.366 178.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -87.3 -79.93 0.27 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.596 1.558 . . . . 0.0 111.947 178.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 23.8 m -87.51 173.07 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.564 1.546 . . . . 0.0 111.793 -177.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 58.0 m -63.29 -26.65 68.87 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 175.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.04 96.49 4.06 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.421 1.088 . . . . 0.0 112.236 176.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.413 ' HE2' ' HB3' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -111.32 155.04 23.66 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 128.551 2.74 . . . . 0.0 111.558 -179.71 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -128.21 133.01 67.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 126.328 1.851 . . . . 0.0 108.689 174.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.59 105.69 5.71 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.13 1.772 . . . . 0.0 109.357 175.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.0 m -111.28 151.58 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 123.203 0.601 . . . . 0.0 111.13 179.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -123.97 111.68 1.68 Allowed Glycine 0 CA--C 1.523 0.567 0 C-N-CA 124.088 0.851 . . . . 0.0 112.912 179.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.5 mp -104.59 134.55 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-N 119.018 1.409 . . . . 0.0 110.981 176.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -102.06 102.47 12.97 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 124.714 1.206 . . . . 0.0 110.51 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.9 t30 -73.73 92.47 2.0 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.963 1.305 . . . . 0.0 110.825 175.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -121.29 13.05 11.06 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.723 1.209 . . . . 0.0 112.212 175.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.8 t -61.81 -42.3 98.85 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.932 1.693 . . . . 0.0 113.87 -176.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 130.88 32.48 0.51 Allowed Glycine 0 CA--C 1.533 1.173 0 N-CA-C 115.11 0.804 . . . . 0.0 115.11 178.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -178.09 162.19 29.58 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 118.061 0.931 . . . . 0.0 112.852 175.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 80.6 p -68.23 129.75 40.86 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 121.858 -0.789 . . . . 0.0 110.999 175.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 42.2 m0 -87.04 107.5 18.46 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 123.813 0.845 . . . . 0.0 110.07 179.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 92.9 m -91.44 128.72 37.38 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.206 1.002 . . . . 0.0 109.747 177.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.86 131.42 48.71 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 122.823 0.449 . . . . 0.0 111.513 174.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.9 pp -113.74 -52.03 2.77 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.729 1.211 . . . . 0.0 111.616 179.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -171.73 145.74 2.01 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.343 1.857 . . . . 0.0 110.419 179.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -125.09 164.32 20.47 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.721 1.208 . . . . 0.0 110.837 174.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.461 ' HH ' ' NE2' ' A' ' 129' ' ' GLN . 48.5 t80 -141.9 102.02 4.06 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.157 1.383 . . . . 0.0 111.778 179.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.427 ' CZ ' HG12 ' A' ' 59' ' ' ILE . 3.3 m-85 -110.67 123.91 50.91 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.457 1.103 . . . . 0.0 110.211 -178.283 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.437 ' HD2' HE22 ' A' ' 129' ' ' GLN . 0.0 OUTLIER -114.77 -47.1 2.9 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -175.16 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.6 t -103.5 -48.14 4.06 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.135 1.374 . . . . 0.0 111.038 175.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -75.64 12.59 7.85 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 125.393 1.473 . . . . 0.0 114.564 -175.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 54.8 p -30.38 105.53 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 129.239 3.016 . . . . 0.0 113.961 -175.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.4 t -118.22 175.71 5.57 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.726 1.211 . . . . 0.0 112.171 -175.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -74.52 -55.45 5.93 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.516 1.126 . . . . 0.0 112.585 175.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.4 p -147.59 143.11 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 126.139 1.776 . . . . 0.0 110.893 175.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.448 ' HB ' ' CE2' ' A' ' 72' ' ' TYR . 1.3 pp -143.21 -34.01 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 125.779 1.632 . . . . 0.0 113.947 179.045 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.3 mt -89.66 98.11 1.21 Allowed Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 125.267 1.427 . . . . 0.0 109.135 175.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -66.03 148.62 85.83 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 123.887 3.058 . . . . 0.0 110.669 174.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -46.78 -51.15 17.0 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.834 1.254 . . . . 0.0 113.342 -177.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 63.2 t -149.31 139.88 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 128.026 2.531 . . . . 0.0 108.699 177.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 60.3 t -120.04 125.42 27.34 Favored Pre-proline 0 N--CA 1.473 0.683 0 C-N-CA 124.442 1.097 . . . . 0.0 108.457 175.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -64.45 151.64 84.75 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 121.934 1.756 . . . . 0.0 112.898 175.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -71.52 170.65 12.9 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.549 0.74 . . . . 0.0 109.254 174.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . 0.272 2.7 t 53.67 23.31 3.56 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.612 1.565 . . . . 0.0 113.817 -175.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.3 mttt -134.93 172.93 12.3 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.375 1.87 . . . . 0.0 111.645 -179.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -129.43 164.46 23.61 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 -178.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.2 pp -137.08 171.14 14.94 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 123.983 0.913 . . . . 0.0 111.078 -175.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -123.44 153.69 40.1 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.497 1.119 . . . . 0.0 111.035 177.033 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.507 ' CE2' ' CD2' ' A' ' 89' ' ' PHE . 5.8 m-85 -129.46 134.94 48.07 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 126.176 1.791 . . . . 0.0 109.377 176.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 59.6 p -107.7 153.87 22.3 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.145 1.778 . . . . 0.0 111.019 175.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -176.8 131.93 1.94 Allowed Glycine 0 CA--C 1.518 0.257 0 O-C-N 121.196 -0.94 . . . . 0.0 113.017 175.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 9.2 ptt85 -129.46 155.16 46.17 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 125.767 1.627 . . . . 0.0 110.491 -175.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.9 ptpt -61.97 174.91 0.76 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.509 1.524 . . . . 0.0 112.886 174.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.1 t -127.16 26.7 6.02 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 -175.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.0 107.66 1.67 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.788 1.235 . . . . 0.0 111.069 177.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -36.49 -54.05 1.34 Allowed Glycine 0 CA--C 1.548 2.14 0 C-N-CA 125.272 1.415 . . . . 0.0 115.363 174.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.27 -80.8 0.0 OUTLIER 'Trans proline' 0 CA--C 1.548 1.207 0 C-N-CA 123.75 2.967 . . . . 0.0 113.92 177.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.0 m -117.56 108.72 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 127.137 2.175 . . . . 0.0 111.169 -175.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -135.89 175.89 9.18 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.746 1.218 . . . . 0.0 112.251 -179.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 17.8 p -78.38 139.0 38.8 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.117 0.967 . . . . 0.0 109.4 175.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -52.62 -81.38 0.06 OUTLIER Glycine 0 CA--C 1.537 1.411 0 C-N-CA 126.337 1.922 . . . . 0.0 114.021 -175.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -160.4 112.86 2.01 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.298 1.439 . . . . 0.0 111.077 175.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.0 t -139.16 125.53 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.471 1.109 . . . . 0.0 110.665 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.425 ' HB1' ' CE1' ' A' ' 51' ' ' PHE . . . -161.57 165.62 28.18 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 122.701 1.239 . . . . 0.0 112.063 177.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -149.22 146.22 27.5 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 124.913 1.285 . . . . 0.0 108.99 174.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.507 ' CD2' ' CE2' ' A' ' 72' ' ' TYR . 48.8 p90 -144.02 172.72 12.49 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 121.236 -0.915 . . . . 0.0 110.03 176.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -138.43 149.04 45.08 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 175.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -125.41 140.15 53.04 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.632 1.173 . . . . 0.0 113.123 178.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -87.44 122.16 30.81 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.873 -175.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 31.8 mtm -101.73 128.14 48.19 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.495 1.118 . . . . 0.0 110.742 -176.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.4 t -56.26 -22.41 29.79 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.936 1.294 . . . . 0.0 113.493 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -67.05 -9.96 44.78 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 125.941 1.696 . . . . 0.0 113.154 175.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 101.52 28.3 6.78 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.754 1.645 . . . . 0.0 114.366 177.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -135.44 175.18 9.82 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.857 1.263 . . . . 0.0 112.558 -174.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 38.3 m -130.31 108.69 10.2 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.353 1.061 . . . . 0.0 112.683 177.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.5 tt -69.89 94.24 0.82 Allowed 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 127.151 2.18 . . . . 0.0 111.999 177.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -87.21 96.18 2.14 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 125.568 1.556 . . . . 0.0 113.595 178.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 55.5 t -78.07 138.59 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 124.718 1.207 . . . . 0.0 110.827 174.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.33 128.22 31.33 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.581 1.552 . . . . 0.0 110.303 179.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -148.08 120.31 8.36 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.008 1.323 . . . . 0.0 111.465 -177.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 39.6 t -140.82 129.96 23.48 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.531 1.133 . . . . 0.0 110.22 -175.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.6 m -118.55 148.48 44.23 Favored Pre-proline 0 N--CA 1.471 0.604 0 C-N-CA 124.147 0.979 . . . . 0.0 110.848 178.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.26 142.28 45.3 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 123.815 3.01 . . . . 0.0 109.804 -177.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -71.19 -50.91 28.19 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -175.026 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -84.12 -11.38 56.71 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.127 1.371 . . . . 0.0 113.169 178.153 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 59.19 28.25 17.49 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 127.587 2.355 . . . . 0.0 115.463 177.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -154.34 147.6 24.86 Favored 'General case' 0 CA--C 1.55 0.957 0 O-C-N 120.79 -1.194 . . . . 0.0 112.048 -175.175 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 22.6 m95 55.03 23.49 5.2 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 125.373 1.469 . . . . 0.0 114.632 175.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -134.74 155.76 50.01 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.597 1.959 . . . . 0.0 112.174 -176.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.63 138.71 31.35 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.342 1.457 . . . . 0.0 110.357 174.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -132.95 82.61 2.01 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.25 1.42 . . . . 0.0 112.286 -177.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 21.1 m0 -92.67 162.26 14.23 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 121.441 -0.787 . . . . 0.0 111.843 -175.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 40.2 p-90 -160.53 132.38 5.96 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 121.561 -0.712 . . . . 0.0 111.24 -176.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -145.87 173.55 12.03 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 121.3 -0.875 . . . . 0.0 111.744 178.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 98.5 t -137.69 133.18 45.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 175.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.59 168.2 12.94 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 125.584 1.554 . . . . 0.0 110.244 175.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 32.3 mt -135.87 121.74 30.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 175.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -83.81 145.42 47.03 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 123.311 0.644 . . . . 0.0 111.289 178.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -76.23 83.74 1.96 Allowed 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 124.133 3.222 . . . . 0.0 111.929 179.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 101.45 175.53 28.61 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 126.494 1.997 . . . . 0.0 112.811 -177.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 1.3 mttt -45.01 106.67 0.08 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 126.47 1.908 . . . . 0.0 112.737 -176.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -141.37 138.21 32.87 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.48 1.112 . . . . 0.0 113.402 -179.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -80.4 173.69 12.35 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.722 0.809 . . . . 0.0 110.729 174.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -117.01 104.86 11.69 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.149 1.779 . . . . 0.0 107.028 175.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -108.0 169.94 8.3 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.385 1.074 . . . . 0.0 111.831 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.461 ' NE2' ' HH ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -53.38 -45.83 69.39 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.535 0.734 . . . . 0.0 112.827 177.567 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -54.58 -56.05 24.1 Favored Glycine 0 N--CA 1.469 0.836 0 CA-C-O 119.38 -0.678 . . . . 0.0 112.239 176.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 4.1 mpp? -63.76 -33.65 76.12 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 118.533 1.167 . . . . 0.0 113.376 176.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -61.39 -61.56 2.45 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 119.642 1.11 . . . . 0.0 108.958 175.013 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -62.45 -43.86 97.81 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.178 0.991 . . . . 0.0 112.526 -176.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -62.81 -45.67 91.57 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.626 1.17 . . . . 0.0 111.711 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.23 -33.33 59.22 Favored 'General case' 0 CA--C 1.547 0.829 0 O-C-N 120.468 -1.395 . . . . 0.0 112.752 176.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -54.2 -60.38 3.41 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 126.587 1.955 . . . . 0.0 109.758 175.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -72.65 4.45 3.97 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-O 121.726 0.774 . . . . 0.0 112.596 -176.394 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -101.57 -7.75 47.75 Favored Glycine 0 CA--C 1.541 1.678 0 C-N-CA 126.964 2.221 . . . . 0.0 114.975 175.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -144.06 88.61 7.45 Favored Pre-proline 0 CA--C 1.553 1.059 0 CA-C-N 119.897 1.849 . . . . 0.0 113.268 -178.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -73.51 81.36 1.82 Allowed 'Trans proline' 0 CA--C 1.545 1.056 0 C-N-CA 124.096 3.197 . . . . 0.0 113.024 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -104.22 9.95 35.89 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.894 1.277 . . . . 0.0 114.337 -178.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 28.4 ptt85 -29.97 119.93 0.17 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 129.03 2.932 . . . . 0.0 115.728 175.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 39.25 68.4 0.5 Allowed Glycine 0 N--CA 1.468 0.804 0 C-N-CA 126.31 1.909 . . . . 0.0 112.151 -175.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.91 -24.4 37.41 Favored 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -174.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . 0.267 0.2 OUTLIER 13.93 72.18 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 130.766 3.626 . . . . 0.0 116.349 177.959 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 154.39 42.79 0.02 OUTLIER Glycine 0 CA--C 1.532 1.118 0 C-N-CA 123.865 0.745 . . . . 0.0 114.576 178.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER 49.79 48.55 21.51 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 125.434 1.494 . . . . 0.0 113.035 -176.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -91.31 134.27 34.73 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 122.325 1.059 . . . . 0.0 113.026 -174.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -156.52 -177.19 6.41 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.067 0.947 . . . . 0.0 112.884 -174.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 21.1 ttpp -131.97 148.13 52.5 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.753 1.221 . . . . 0.0 110.905 174.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -63.75 149.53 46.56 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 175.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 98.7 mt -107.9 145.26 34.01 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 175.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -64.48 -165.67 1.02 Allowed Glycine 0 CA--C 1.538 1.47 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 175.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 54.5 11.2 0.4 Allowed 'General case' 0 CA--C 1.557 1.242 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 175.27 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 81.33 40.9 10.62 Favored Glycine 0 CA--C 1.539 1.562 0 C-N-CA 126.557 2.027 . . . . 0.0 114.424 -175.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.2 mp -124.82 162.19 24.85 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 119.267 1.533 . . . . 0.0 112.813 -178.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -150.63 118.48 6.21 Favored 'General case' 0 N--CA 1.482 1.128 0 O-C-N 120.691 -1.256 . . . . 0.0 111.594 176.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 6.6 ttp -111.3 130.85 55.54 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 118.108 -0.949 . . . . 0.0 109.093 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 6.3 tppt? -106.9 134.14 50.5 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 127.681 2.393 . . . . 0.0 110.089 -179.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -136.41 152.31 21.14 Favored Glycine 0 N--CA 1.476 1.34 0 CA-C-N 121.208 1.822 . . . . 0.0 115.79 179.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 6.1 tp -148.66 122.42 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 125.134 1.374 . . . . 0.0 113.332 -177.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 5.3 ttp -153.61 145.37 23.43 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 128.968 2.907 . . . . 0.0 109.589 177.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 9.6 t -120.22 146.3 46.18 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 120.87 -1.144 . . . . 0.0 109.778 175.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 28.8 p -91.34 18.96 6.45 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.305 1.442 . . . . 0.0 113.29 -178.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.8 -33.73 64.66 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.012 1.725 . . . . 0.0 115.005 -176.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 157.8 -62.76 0.32 Allowed Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.534 1.064 . . . . 0.0 114.17 176.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -125.25 27.02 6.73 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 125.652 1.581 . . . . 0.0 112.656 -174.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.87 175.66 2.37 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.28 1.432 . . . . 0.0 113.388 175.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . 0.436 ' HE3' ' O ' ' A' ' 169' ' ' LYS . 0.2 OUTLIER -115.78 178.81 4.17 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 127.453 2.301 . . . . 0.0 111.914 -177.814 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 40.2 ttp -126.89 137.89 53.22 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 125.381 1.473 . . . . 0.0 109.825 178.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -143.08 131.9 22.72 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 121.562 -0.711 . . . . 0.0 109.657 174.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 3.8 mp -129.79 120.87 51.12 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.296 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 176.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -115.82 129.91 56.63 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 125.232 1.413 . . . . 0.0 111.125 177.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.8 mp -78.94 131.84 33.5 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 O-C-N 121.064 -1.023 . . . . 0.0 109.398 174.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 13.8 m -137.66 94.03 2.86 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.497 1.519 . . . . 0.0 113.116 176.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 79.0 mtp180 . . . . . 0 C--O 1.253 1.272 0 C-N-CA 125.544 1.538 . . . . 0.0 112.433 174.972 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 7.9 t . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 122.009 0.909 . . . . 0.0 110.887 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -131.91 -73.37 0.52 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.418 1.487 . . . . 0.0 110.042 -179.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 17.1 tp 55.5 17.37 2.2 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 125.958 1.703 . . . . 0.0 114.45 -177.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -136.53 130.27 32.19 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 128.037 2.535 . . . . 0.0 107.087 176.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -73.08 -126.49 0.1 OUTLIER Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.171 0.891 . . . . 0.0 111.2 174.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 25.4 p -101.95 174.64 5.85 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.389 1.076 . . . . 0.0 111.413 177.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -124.65 16.07 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 125.498 1.519 . . . . 0.0 110.971 175.007 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.9 pp -55.05 165.57 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 125.352 1.461 . . . . 0.0 112.111 174.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -40.99 130.16 2.66 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.727 1.611 . . . . 0.0 113.246 -174.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -54.77 -21.14 21.55 Favored Glycine 0 N--CA 1.472 1.097 0 C-N-CA 124.766 1.174 . . . . 0.0 114.456 -177.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.75 -31.87 68.73 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.65 1.18 . . . . 0.0 111.306 174.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.63 -43.24 5.42 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.392 1.477 . . . . 0.0 111.602 174.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 14.3 tp -71.26 94.22 1.17 Allowed 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.902 0.858 . . . . 0.0 110.849 174.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.0 p -131.42 -179.92 5.65 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 126.982 2.113 . . . . 0.0 111.899 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -46.91 -39.99 13.28 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.55 1.54 . . . . 0.0 113.051 177.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -54.85 -39.51 68.68 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.448 1.099 . . . . 0.0 112.077 177.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 65.2 t -70.45 -36.92 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 125.862 1.665 . . . . 0.0 111.182 174.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.2 mt -71.1 -43.13 68.31 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 120.965 -1.084 . . . . 0.0 111.249 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -58.34 -47.06 84.97 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.459 1.104 . . . . 0.0 111.308 178.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.68 -37.71 82.71 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 118.15 -0.929 . . . . 0.0 111.953 175.069 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.2 t -54.36 -42.47 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 CA-C-N 119.923 1.238 . . . . 0.0 111.26 179.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.6 mt -58.65 -17.33 21.47 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.397 1.079 . . . . 0.0 113.845 177.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -105.38 -45.05 1.38 Allowed Glycine 0 CA--C 1.536 1.395 0 C-N-CA 126.992 2.234 . . . . 0.0 114.05 -179.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -67.82 -31.82 71.93 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 119.134 1.467 . . . . 0.0 112.725 175.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -101.66 173.33 6.46 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 125.181 1.392 . . . . 0.0 111.049 174.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 154.02 86.72 0.06 OUTLIER Glycine 0 CA--C 1.534 1.252 0 C-N-CA 124.332 0.967 . . . . 0.0 113.827 -178.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.5 mtpt -67.9 -46.11 72.52 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.714 1.206 . . . . 0.0 112.966 176.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 33.4 m -133.64 -176.96 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 126.799 2.04 . . . . 0.0 111.596 -178.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.9 m -47.28 -46.44 24.82 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 126.436 1.894 . . . . 0.0 115.123 -178.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.419 ' CB ' ' HE3' ' A' ' 76' ' ' LYS . 0.1 OUTLIER -128.91 146.02 51.06 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.534 1.133 . . . . 0.0 110.541 174.963 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.81 161.18 39.29 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 124.466 1.106 . . . . 0.0 111.62 -175.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -120.08 133.28 67.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 124.78 1.232 . . . . 0.0 108.999 175.007 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -136.0 100.93 4.57 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.131 1.772 . . . . 0.0 109.065 175.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.5 m -103.97 161.44 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 123.859 0.864 . . . . 0.0 111.728 178.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -140.62 101.05 0.28 Allowed Glycine 0 N--CA 1.461 0.361 0 C-N-CA 123.613 0.625 . . . . 0.0 113.156 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 mp -93.98 151.11 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 117.91 0.855 . . . . 0.0 110.761 175.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -116.42 104.43 11.44 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.327 1.051 . . . . 0.0 110.822 174.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -72.62 98.84 2.42 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.743 1.617 . . . . 0.0 111.05 174.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -135.31 22.63 3.45 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.971 1.309 . . . . 0.0 110.444 174.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 33.1 t -61.79 -42.69 99.31 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 120.788 -1.195 . . . . 0.0 112.749 174.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 132.35 33.97 0.38 Allowed Glycine 0 CA--C 1.534 1.244 0 C-N-CA 124.375 0.988 . . . . 0.0 115.181 176.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -174.52 162.28 32.4 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 124.673 1.13 . . . . 0.0 112.094 175.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 50.4 p -70.42 139.32 51.79 Favored 'General case' 0 C--O 1.234 0.261 0 O-C-N 121.782 -0.834 . . . . 0.0 110.893 174.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.417 ' HB3' ' CD1' ' A' ' 91' ' ' TYR . 40.2 m0 -96.05 104.14 16.07 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 124.172 0.989 . . . . 0.0 110.767 -178.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.9 m -87.36 139.29 30.7 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.019 1.328 . . . . 0.0 110.539 178.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.74 131.44 48.9 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.456 0.702 . . . . 0.0 111.249 174.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.6 pp -120.2 -48.36 2.33 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.029 0.931 . . . . 0.0 112.854 177.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 178.36 153.88 0.35 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 127.189 2.196 . . . . 0.0 110.378 -175.167 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -138.67 164.78 28.64 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.497 1.519 . . . . 0.0 111.215 174.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -136.7 102.87 5.03 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 125.309 1.443 . . . . 0.0 110.092 176.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.4 ' CZ ' HG12 ' A' ' 59' ' ' ILE . 3.0 m-85 -111.03 131.43 55.06 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.719 0.808 . . . . 0.0 109.962 -179.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.38 -33.16 4.16 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -177.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 33.9 t -125.43 -46.62 1.75 Allowed 'General case' 0 C--O 1.219 -0.541 0 C-N-CA 124.961 1.304 . . . . 0.0 109.202 174.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -60.35 -0.15 1.14 Allowed Glycine 0 CA--C 1.544 1.868 0 O-C-N 119.586 -1.946 . . . . 0.0 116.449 176.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.1 p -27.15 89.01 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 130.97 3.708 . . . . 0.0 114.564 -175.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -105.28 175.2 5.57 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.928 -174.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -73.17 -56.16 5.49 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.388 1.075 . . . . 0.0 111.127 174.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.4 p -144.44 137.69 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 125.806 1.643 . . . . 0.0 112.021 176.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.421 ' HB ' ' CE2' ' A' ' 72' ' ' TYR . 1.2 pp -135.82 -33.58 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 125.885 1.674 . . . . 0.0 114.298 176.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 16.0 mt -89.09 100.32 2.09 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 125.312 1.445 . . . . 0.0 109.34 176.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -65.43 154.64 72.72 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.38 2.72 . . . . 0.0 109.27 175.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -45.02 -50.98 10.44 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.504 1.522 . . . . 0.0 113.415 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.7 p -160.17 137.77 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 127.053 2.141 . . . . 0.0 109.612 176.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 94.6 t -113.56 130.75 23.44 Favored Pre-proline 0 N--CA 1.482 1.128 0 C-N-CA 124.495 1.118 . . . . 0.0 109.311 175.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -65.37 161.65 37.01 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 122.469 2.112 . . . . 0.0 112.801 177.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -76.69 170.51 16.3 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.83 0.852 . . . . 0.0 109.897 174.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . 0.266 10.7 t 46.95 30.55 1.27 Allowed 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 126.892 2.077 . . . . 0.0 113.376 -174.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.9 mttt -135.78 171.94 13.73 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 127.262 2.225 . . . . 0.0 111.821 -174.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -128.63 166.08 19.57 Favored 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 122.77 0.428 . . . . 0.0 110.245 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -143.78 171.07 14.72 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 124.617 1.167 . . . . 0.0 111.656 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -117.66 156.1 28.76 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.442 1.097 . . . . 0.0 112.503 177.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.476 ' CE2' ' CD2' ' A' ' 89' ' ' PHE . 7.5 m-85 -128.03 134.39 49.21 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.72 1.608 . . . . 0.0 109.103 174.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.1 p -108.08 142.76 37.78 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 126.831 2.053 . . . . 0.0 110.741 176.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -163.79 142.68 8.0 Favored Glycine 0 N--CA 1.461 0.326 0 O-C-N 120.514 -1.366 . . . . 0.0 111.898 174.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 3.8 ptm180 -129.26 104.33 7.46 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.289 1.436 . . . . 0.0 111.353 -174.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.504 ' HE2' ' O ' ' A' ' 83' ' ' THR . 2.6 ptpt -29.91 -70.07 0.06 Allowed 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 127.492 2.317 . . . . 0.0 114.597 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 11.5 t 17.79 54.02 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 128.57 2.748 . . . . 0.0 114.837 175.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.87 -24.81 67.99 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 121.371 -0.831 . . . . 0.0 112.61 -174.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 120.31 -76.44 0.32 Allowed Glycine 0 CA--C 1.531 1.047 0 C-N-CA 127.042 2.258 . . . . 0.0 110.613 175.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.84 -35.18 3.48 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 123.204 2.603 . . . . 0.0 113.169 -178.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 26.8 m -137.29 129.01 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 126.52 1.928 . . . . 0.0 109.68 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -77.0 76.22 3.56 Favored 'General case' 0 CA--C 1.549 0.939 0 O-C-N 121.015 -1.053 . . . . 0.0 111.826 -178.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.504 ' O ' ' HE2' ' A' ' 76' ' ' LYS . 3.7 m -59.22 174.33 0.4 Allowed 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 127.869 2.468 . . . . 0.0 112.811 -177.243 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -78.65 -154.27 7.58 Favored Glycine 0 N--CA 1.47 0.934 0 O-C-N 119.741 -1.849 . . . . 0.0 113.323 176.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -94.7 97.98 10.46 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.081 -1.247 . . . . 0.0 110.526 -179.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.9 t -124.76 107.15 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 124.299 1.04 . . . . 0.0 110.578 -175.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -159.94 167.57 27.68 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.867 0.842 . . . . 0.0 111.494 178.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -150.86 159.8 44.31 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.758 1.223 . . . . 0.0 109.937 175.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.476 ' CD2' ' CE2' ' A' ' 72' ' ' TYR . 52.9 p90 -155.78 174.55 15.14 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 121.422 -0.799 . . . . 0.0 110.554 175.028 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -138.65 151.34 47.13 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 176.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.417 ' CD1' ' HB3' ' A' ' 44' ' ' TRP . 10.4 m-85 -126.3 140.11 52.78 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.38 1.072 . . . . 0.0 113.789 179.164 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -84.59 118.73 24.53 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 111.592 0.219 . . . . 0.0 111.592 -177.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 4.7 ttm -86.97 147.0 25.93 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.776 0.831 . . . . 0.0 112.31 177.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 24.6 m -67.1 -23.96 65.89 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 174.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -70.5 -17.39 62.96 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 175.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 100.71 40.13 3.0 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.845 1.212 . . . . 0.0 113.412 -175.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -135.5 175.1 9.9 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 118.382 1.091 . . . . 0.0 110.476 177.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 12.4 m -129.49 106.15 8.57 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.026 1.331 . . . . 0.0 111.946 -177.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.2 tt -70.79 96.35 1.24 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.699 1.6 . . . . 0.0 112.154 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -91.87 95.43 2.04 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 126.065 1.793 . . . . 0.0 113.876 -178.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 72.5 t -78.08 138.18 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 125.211 1.405 . . . . 0.0 111.444 176.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.6 126.54 29.43 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.367 1.467 . . . . 0.0 111.383 -178.359 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -146.64 121.79 10.15 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.0 1.32 . . . . 0.0 112.016 -177.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 47.1 t -142.45 109.73 5.63 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.657 1.183 . . . . 0.0 110.039 -178.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 17.5 m -118.51 110.91 38.46 Favored Pre-proline 0 N--CA 1.469 0.523 0 C-N-CA 124.831 1.252 . . . . 0.0 108.365 175.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.2 136.6 37.96 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 122.389 2.059 . . . . 0.0 110.689 177.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -78.61 -43.54 26.13 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 120.808 -1.183 . . . . 0.0 110.526 174.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.1 p30 -67.62 9.75 0.24 Allowed 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 126.706 2.003 . . . . 0.0 115.922 -174.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -10.42 85.0 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 130.174 3.39 . . . . 0.0 115.303 -178.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -121.61 -10.3 8.81 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.015 1.326 . . . . 0.0 113.287 -178.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 21.8 m95 -130.47 -12.69 3.91 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.67 1.988 . . . . 0.0 113.876 -175.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 58.23 49.75 10.75 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.156 1.782 . . . . 0.0 113.522 -178.335 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 45.1 p -125.47 91.19 3.36 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.197 1.799 . . . . 0.0 112.24 -178.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -121.87 101.53 7.62 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.132 1.773 . . . . 0.0 109.138 175.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 32.0 m0 -102.52 144.98 30.26 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.398 0.679 . . . . 0.0 109.94 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 27.4 p-90 -146.77 138.53 24.5 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.119 0.968 . . . . 0.0 111.978 -177.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -149.31 170.05 19.4 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 122.285 1.041 . . . . 0.0 113.072 179.115 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.3 t -150.27 139.31 15.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 C-N-CA 125.226 1.41 . . . . 0.0 107.655 175.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.79 175.44 10.18 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 126.27 1.828 . . . . 0.0 109.72 175.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.42 ' HB ' ' CE2' ' A' ' 154' ' ' TYR . 50.9 mt -130.56 105.74 11.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.953 0.882 . . . . 0.0 108.967 178.196 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -67.38 149.54 98.34 Favored Pre-proline 0 CA--C 1.546 0.793 0 O-C-N 121.522 -0.736 . . . . 0.0 111.842 178.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.6 131.73 17.8 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 123.212 2.608 . . . . 0.0 111.727 178.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 61.86 -165.99 18.75 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 124.549 1.071 . . . . 0.0 113.9 -176.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -67.89 110.78 4.0 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.654 1.182 . . . . 0.0 108.985 175.004 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 20.0 tpp180 -123.32 157.84 32.34 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.692 1.597 . . . . 0.0 110.066 178.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -96.99 -173.72 2.77 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.261 1.424 . . . . 0.0 110.397 174.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -138.58 121.45 16.55 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 127.317 2.247 . . . . 0.0 106.504 174.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -132.68 169.69 16.3 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.579 1.552 . . . . 0.0 110.016 175.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -52.71 -39.9 62.48 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.337 1.055 . . . . 0.0 113.086 176.386 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -59.03 -53.64 44.72 Favored Glycine 0 N--CA 1.469 0.853 0 CA-C-N 118.875 0.761 . . . . 0.0 112.094 176.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 1.2 mpp? -61.48 -42.97 99.6 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 118.036 0.918 . . . . 0.0 112.049 176.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -54.0 -58.44 7.29 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.381 0.672 . . . . 0.0 110.171 175.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -65.85 -38.07 87.87 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 -177.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -61.73 -45.3 94.53 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.55 1.14 . . . . 0.0 112.096 178.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 73.8 mmm -79.17 -32.59 44.29 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.351 -0.843 . . . . 0.0 112.879 176.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -54.08 -59.08 5.12 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.772 1.629 . . . . 0.0 109.511 174.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -71.24 -6.06 36.79 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -176.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -88.42 -9.27 69.78 Favored Glycine 0 CA--C 1.539 1.59 0 C-N-CA 126.292 1.901 . . . . 0.0 114.937 177.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -144.14 86.72 8.22 Favored Pre-proline 0 CA--C 1.553 1.058 0 CA-C-N 119.448 1.624 . . . . 0.0 111.89 -179.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -74.0 79.21 2.38 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 123.643 2.895 . . . . 0.0 112.274 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -119.07 126.21 51.14 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.287 1.435 . . . . 0.0 111.044 -176.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.1 ptt180 -99.17 -162.63 0.97 Allowed 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 127.285 2.234 . . . . 0.0 113.74 -175.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -71.95 62.27 1.31 Allowed Glycine 0 CA--C 1.538 1.471 0 C-N-CA 126.421 1.962 . . . . 0.0 113.72 175.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 10.1 p30 -67.49 74.99 0.16 Allowed 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 130.163 3.385 . . . . 0.0 114.796 177.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -70.29 62.83 0.23 Allowed 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 126.948 2.099 . . . . 0.0 114.875 -175.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -169.66 31.44 0.16 Allowed Glycine 0 CA--C 1.536 1.355 0 C-N-CA 124.536 1.065 . . . . 0.0 115.709 -175.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 5.1 m95 53.88 56.53 7.01 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.31 1.444 . . . . 0.0 113.154 -174.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -89.68 131.14 35.81 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.661 1.584 . . . . 0.0 112.613 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -160.12 -175.8 5.28 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -174.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 4.8 mtmt -130.19 160.38 33.99 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.159 1.384 . . . . 0.0 110.711 174.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -80.07 131.78 35.84 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.848 0.859 . . . . 0.0 108.918 175.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 78.2 mt -83.99 127.38 33.83 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.479 0.712 . . . . 0.0 110.599 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -51.74 -27.45 19.91 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 126.063 1.792 . . . . 0.0 116.49 -174.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.42 ' CE2' ' HB ' ' A' ' 120' ' ' ILE . 0.2 OUTLIER -74.95 6.88 3.63 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 128.076 2.55 . . . . 0.0 113.621 -179.459 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 84.58 10.58 79.24 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 125.602 1.572 . . . . 0.0 114.194 -175.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 17.5 mt -96.54 171.48 8.52 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.33 1.852 . . . . 0.0 110.475 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 3.4 mtt-85 -146.05 107.39 4.21 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 120.973 -1.08 . . . . 0.0 110.225 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 9.3 ttp -98.73 131.07 45.17 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 117.795 -1.098 . . . . 0.0 108.327 178.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 1.5 tppp? -109.44 129.41 55.55 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 127.915 2.486 . . . . 0.0 110.149 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -135.17 154.42 21.6 Favored Glycine 0 N--CA 1.474 1.197 0 CA-C-N 121.17 1.804 . . . . 0.0 115.562 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.31 129.42 6.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 C-N-CA 124.282 1.033 . . . . 0.0 112.402 -178.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -146.62 160.69 41.86 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 126.975 2.11 . . . . 0.0 109.554 175.001 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 9.4 t -131.38 168.76 17.03 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.589 1.155 . . . . 0.0 108.99 175.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 4.3 t -111.67 28.92 8.3 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.022 1.329 . . . . 0.0 111.414 178.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -67.65 21.76 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 127.77 2.428 . . . . 0.0 115.028 179.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 80.6 -59.51 4.65 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 126.641 2.067 . . . . 0.0 113.168 -178.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -116.39 65.36 0.71 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.072 1.749 . . . . 0.0 110.313 176.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.19 179.01 7.84 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 121.915 0.864 . . . . 0.0 111.708 174.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.3 176.84 5.64 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.456 1.902 . . . . 0.0 110.108 175.001 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 2.3 tmm? -125.51 125.59 43.5 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.918 1.287 . . . . 0.0 110.395 175.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 17.5 tt0 -138.11 124.59 20.72 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 123.772 0.829 . . . . 0.0 110.529 176.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 5.0 mp -132.66 119.71 39.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 123.974 0.91 . . . . 0.0 110.508 176.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.63 134.39 55.1 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.488 1.515 . . . . 0.0 111.939 177.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.8 mp -82.35 127.01 40.03 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 O-C-N 121.019 -1.05 . . . . 0.0 108.633 175.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 1.7 m -126.3 93.48 3.82 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.524 1.53 . . . . 0.0 111.499 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 80.0 mtm-85 . . . . . 0 C--O 1.253 1.27 0 C-N-CA 124.509 1.124 . . . . 0.0 113.214 176.528 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.483 1.192 0 CA-C-O 117.785 -1.103 . . . . 0.0 109.332 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.04 -172.63 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 125.034 1.334 . . . . 0.0 113.366 -179.431 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.71 30.06 7.09 Favored 'General case' 0 N--CA 1.483 1.204 0 O-C-N 120.603 -1.311 . . . . 0.0 111.999 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -144.58 121.2 11.12 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.856 2.062 . . . . 0.0 109.833 -175.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -73.91 -92.45 0.13 Allowed Glycine 0 CA--C 1.531 1.052 0 C-N-CA 123.988 0.804 . . . . 0.0 112.917 -176.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 41.0 p -141.4 173.61 11.33 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.544 1.538 . . . . 0.0 111.079 177.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -120.42 10.35 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 125.623 1.569 . . . . 0.0 112.213 -178.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -29.05 -77.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 127.627 2.371 . . . . 0.0 115.014 -176.481 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -158.2 147.55 19.51 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.56 1.944 . . . . 0.0 110.745 175.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -64.3 -26.96 70.96 Favored Glycine 0 N--CA 1.476 1.304 0 C-N-CA 124.592 1.091 . . . . 0.0 115.474 -178.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.43 -35.11 73.41 Favored 'General case' 0 CA--C 1.546 0.816 0 O-C-N 121.755 -0.85 . . . . 0.0 111.789 175.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.4 t -96.2 -37.89 10.36 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.082 1.353 . . . . 0.0 111.611 174.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 58.2 tp -82.77 84.41 7.35 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.651 1.981 . . . . 0.0 111.977 176.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.4 p -120.55 178.8 4.54 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 126.595 1.958 . . . . 0.0 111.396 175.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -40.14 -44.63 1.85 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.768 1.627 . . . . 0.0 113.474 175.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -52.92 -44.66 67.16 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 118.801 0.728 . . . . 0.0 112.154 178.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 93.1 t -64.54 -40.77 90.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 124.546 1.138 . . . . 0.0 111.135 175.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 39.4 mt -66.82 -38.12 85.83 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.355 -0.841 . . . . 0.0 111.593 178.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -68.16 -47.69 67.33 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 120.94 -1.1 . . . . 0.0 111.624 177.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.92 -37.51 87.29 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-O 118.594 -0.717 . . . . 0.0 111.495 175.045 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -62.84 -36.33 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 119.15 0.886 . . . . 0.0 111.159 -176.104 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.28 -25.41 48.12 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 119.112 0.869 . . . . 0.0 112.413 175.076 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -81.87 -65.3 1.67 Allowed Glycine 0 CA--C 1.533 1.179 0 O-C-N 120.603 -1.311 . . . . 0.0 112.173 174.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -66.65 -35.6 80.55 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 115.149 1.537 . . . . 0.0 115.149 -175.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -106.42 104.77 14.54 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 126.76 2.024 . . . . 0.0 108.358 -177.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -161.59 135.4 3.91 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 125.243 1.401 . . . . 0.0 114.381 -175.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.2 mtpt -112.35 -45.99 3.22 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 126.437 1.895 . . . . 0.0 113.286 177.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 20.8 m -116.9 177.96 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 126.202 1.801 . . . . 0.0 110.929 -176.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.6 t -51.86 -49.46 62.86 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.896 1.279 . . . . 0.0 112.909 -175.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.9 mtt-85 -122.86 129.34 51.53 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.751 1.62 . . . . 0.0 110.527 174.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.38 157.45 27.14 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 126.12 1.768 . . . . 0.0 110.665 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -118.25 130.78 72.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 175.045 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -134.77 99.44 4.32 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 126.75 2.02 . . . . 0.0 109.232 178.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.8 m -100.9 160.23 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-O 118.489 -0.767 . . . . 0.0 111.249 179.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -137.4 109.44 0.7 Allowed Glycine 0 N--CA 1.464 0.538 0 CA-C-N 119.112 0.869 . . . . 0.0 114.215 175.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.3 mp -100.66 145.57 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 CA-C-N 118.639 1.22 . . . . 0.0 110.722 176.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -108.55 105.86 15.68 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.905 1.282 . . . . 0.0 110.495 175.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -69.97 96.66 1.05 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.534 1.534 . . . . 0.0 111.222 175.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -126.56 3.43 6.85 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.26 1.824 . . . . 0.0 112.837 176.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.87 4.71 0.16 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 126.087 1.755 . . . . 0.0 115.663 177.086 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.01 61.96 4.28 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 125.977 1.751 . . . . 0.0 113.166 177.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 165.19 143.42 3.72 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 125.229 1.395 . . . . 0.0 111.079 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 31.9 p -67.15 142.57 57.0 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.682 0.753 . . . . 0.0 111.302 174.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.435 ' CZ2' ' CD2' ' A' ' 99' ' ' LEU . 48.6 m0 -101.97 102.66 13.22 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.627 1.171 . . . . 0.0 110.502 -179.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 28.0 m -90.27 128.63 36.46 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.01 0.924 . . . . 0.0 109.436 177.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.8 108.69 0.69 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.934 0.894 . . . . 0.0 112.429 175.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.1 pp -93.38 -45.7 7.68 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.637 0.775 . . . . 0.0 111.799 178.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -171.6 146.13 2.13 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 127.22 2.208 . . . . 0.0 110.294 179.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -134.99 151.27 50.67 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.346 1.458 . . . . 0.0 110.981 175.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -139.19 109.78 6.63 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.189 1.396 . . . . 0.0 112.013 -175.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -106.66 127.75 53.62 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 120.991 -1.068 . . . . 0.0 111.142 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -88.76 -68.32 0.78 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.508 1.523 . . . . 0.0 111.178 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 32.5 t -107.46 -35.29 6.8 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.989 1.315 . . . . 0.0 112.16 -174.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -61.91 -26.41 67.16 Favored Glycine 0 CA--C 1.536 1.36 0 CA-C-O 118.831 -0.983 . . . . 0.0 114.02 177.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.5 p 21.14 55.13 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 128.046 2.538 . . . . 0.0 116.128 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.9 t -75.89 173.24 11.45 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.16 -175.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -82.21 -51.91 7.48 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.388 0.675 . . . . 0.0 112.084 176.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.5 p -148.18 135.82 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.08 1.352 . . . . 0.0 112.217 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -143.42 -32.09 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 126.059 1.744 . . . . 0.0 113.816 -175.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -94.69 96.88 2.07 Favored Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 125.748 1.619 . . . . 0.0 109.256 177.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -64.49 157.84 52.81 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.809 2.339 . . . . 0.0 110.404 175.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -45.22 -49.96 11.94 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.723 1.609 . . . . 0.0 113.379 178.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 5.5 p -160.17 142.28 4.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 126.247 1.819 . . . . 0.0 110.078 175.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 73.6 t -113.79 122.62 34.53 Favored Pre-proline 0 N--CA 1.473 0.676 0 C-N-CA 124.472 1.109 . . . . 0.0 108.325 174.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.12 159.42 53.19 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.767 2.312 . . . . 0.0 112.875 175.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -71.15 168.2 17.71 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.952 0.901 . . . . 0.0 110.705 175.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 30.5 p 53.1 21.9 2.33 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 127.11 2.164 . . . . 0.0 113.991 -175.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.8 172.67 10.17 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 127.648 2.379 . . . . 0.0 110.497 -175.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -134.9 161.84 34.1 Favored 'General case' 0 C--O 1.222 -0.381 0 O-C-N 121.85 -0.532 . . . . 0.0 110.009 176.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -136.38 171.11 14.96 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 124.387 1.075 . . . . 0.0 112.454 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -119.47 156.01 31.02 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 124.826 1.25 . . . . 0.0 113.138 -179.061 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -133.22 133.66 43.01 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 124.217 1.007 . . . . 0.0 112.191 175.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.1 p -101.44 151.53 21.82 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 126.155 1.782 . . . . 0.0 110.692 175.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -169.0 124.43 1.17 Allowed Glycine 0 CA--C 1.531 1.08 0 C-N-CA 124.212 0.91 . . . . 0.0 113.192 175.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 22.9 mtm180 -96.04 80.89 3.32 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 129.462 3.105 . . . . 0.0 111.245 -174.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 10.2 ptpt -56.0 -37.05 68.6 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 30.7 p -98.32 78.72 2.47 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.737 1.615 . . . . 0.0 112.091 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.6 m -69.99 -18.74 63.34 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 176.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 121.43 -65.78 0.47 Allowed Glycine 0 CA--C 1.538 1.498 0 C-N-CA 125.189 1.376 . . . . 0.0 113.672 -176.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.73 -41.14 3.23 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 123.177 2.585 . . . . 0.0 112.962 -175.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.3 p -141.49 142.07 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 C-N-CA 126.556 1.943 . . . . 0.0 109.107 178.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -129.04 96.52 4.36 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.824 1.25 . . . . 0.0 108.092 175.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 24.6 m -85.46 -16.97 37.88 Favored 'General case' 0 N--CA 1.479 0.978 0 O-C-N 121.913 -0.492 . . . . 0.0 111.772 178.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 114.83 -171.45 13.71 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 125.829 1.68 . . . . 0.0 112.137 178.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.11 84.52 1.01 Allowed 'General case' 0 CA--C 1.547 0.855 0 O-C-N 120.956 -1.32 . . . . 0.0 110.983 179.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.2 t -125.65 118.21 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 124.155 0.982 . . . . 0.0 113.031 -174.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.87 168.65 17.46 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.144 1.377 . . . . 0.0 113.09 176.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -154.19 137.67 15.9 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.346 1.059 . . . . 0.0 111.961 174.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -137.59 169.28 18.06 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 120.595 -1.316 . . . . 0.0 111.574 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -141.46 160.62 39.75 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 175.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -137.82 143.35 40.95 Favored 'General case' 0 CA--C 1.513 -0.463 0 C-N-CA 125.779 1.632 . . . . 0.0 114.33 -174.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -97.94 106.53 18.85 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.352 -175.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 1.9 mtm -78.87 128.95 34.01 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 124.051 0.94 . . . . 0.0 110.789 178.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -58.96 -20.66 54.52 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 177.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -70.01 -12.52 61.67 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 124.521 1.128 . . . . 0.0 113.853 176.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 109.79 25.61 5.35 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 125.34 1.448 . . . . 0.0 114.963 177.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -134.3 173.84 11.18 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.928 1.291 . . . . 0.0 112.108 -175.028 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 16.8 m -129.33 108.44 10.31 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 177.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.435 ' CD2' ' CZ2' ' A' ' 44' ' ' TRP . 69.3 tp -75.12 108.07 7.62 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.675 0.79 . . . . 0.0 112.267 175.072 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -102.42 135.49 12.29 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 123.816 0.722 . . . . 0.0 112.344 174.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 95.6 t -115.7 136.6 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.952 1.301 . . . . 0.0 111.25 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -133.34 122.8 24.34 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.739 1.616 . . . . 0.0 111.945 -174.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -147.17 117.53 7.41 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.735 1.214 . . . . 0.0 111.562 -176.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 48.4 t -139.02 105.98 5.43 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.186 0.994 . . . . 0.0 112.598 -177.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 19.6 t -110.02 125.44 31.09 Favored Pre-proline 0 C--N 1.328 -0.338 0 C-N-CA 125.893 1.677 . . . . 0.0 109.008 179.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.32 141.52 39.24 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 124.077 3.185 . . . . 0.0 110.357 174.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -59.73 -34.69 73.28 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.654 1.182 . . . . 0.0 112.688 175.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -91.73 -46.24 8.0 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.555 1.142 . . . . 0.0 113.43 -178.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER 59.49 36.51 23.0 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.569 1.548 . . . . 0.0 113.478 -175.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -126.87 -1.58 6.6 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.323 1.449 . . . . 0.0 114.42 -179.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 12.6 m95 -133.55 -65.45 0.68 Allowed 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 125.198 1.399 . . . . 0.0 111.227 -175.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -91.14 152.56 20.53 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.11 1.364 . . . . 0.0 111.527 175.084 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 2.0 t -85.07 159.95 20.09 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.273 1.029 . . . . 0.0 109.211 175.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.425 HD22 ' CE ' ' A' ' 162' ' ' MET . 0.4 OUTLIER -102.29 101.52 11.81 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.942 1.697 . . . . 0.0 109.454 175.487 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 38.5 m0 -100.52 141.31 33.55 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.961 1.255 . . . . 0.0 110.476 178.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 37.7 p-90 -137.51 129.0 28.24 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.143 0.977 . . . . 0.0 111.268 -177.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -133.54 156.12 48.37 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 122.509 1.147 . . . . 0.0 112.553 176.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 95.9 t -148.22 123.76 2.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 176.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.91 170.89 21.08 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.596 1.158 . . . . 0.0 110.885 175.021 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.489 ' HB ' ' CZ ' ' A' ' 154' ' ' TYR . 7.2 mt -104.27 136.19 38.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.917 0.865 . . . . 0.0 110.523 176.1 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -89.58 153.09 47.88 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 125.302 1.441 . . . . 0.0 111.18 176.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -74.19 88.98 1.08 Allowed 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 124.248 3.299 . . . . 0.0 112.107 179.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 91.64 -172.51 35.89 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 125.239 1.399 . . . . 0.0 113.006 -177.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 12.3 tttt -51.85 118.08 3.17 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.997 1.319 . . . . 0.0 111.571 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.38 147.67 41.8 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.023 0.929 . . . . 0.0 112.225 177.027 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 19.6 ptt-85 -99.07 -178.34 3.9 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.25 1.02 . . . . 0.0 110.409 175.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -128.8 107.47 9.68 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 104.91 -2.255 . . . . 0.0 104.91 174.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -128.39 171.24 12.23 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.277 1.431 . . . . 0.0 109.299 176.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -51.87 -44.29 63.65 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 119.642 1.11 . . . . 0.0 113.595 -177.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -56.75 -58.44 14.47 Favored Glycine 0 N--CA 1.471 0.986 0 CA-C-N 119.327 0.967 . . . . 0.0 112.57 175.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 6.1 mtm -60.89 -39.92 91.07 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 118.068 0.934 . . . . 0.0 112.714 178.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -56.2 -60.89 2.85 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.071 1.349 . . . . 0.0 109.569 174.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -67.06 -32.57 73.84 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -178.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -62.02 -47.15 86.04 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.752 0.821 . . . . 0.0 111.562 176.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 46.8 mmm -84.45 -20.36 31.91 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -54.5 -55.67 26.69 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.664 1.586 . . . . 0.0 109.252 174.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -68.65 -9.68 51.5 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -73.44 -41.6 44.3 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 125.825 1.679 . . . . 0.0 114.036 -177.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -123.0 91.32 49.94 Favored Pre-proline 0 CA--C 1.547 0.831 0 CA-C-N 118.215 1.007 . . . . 0.0 111.452 179.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -72.45 78.64 1.94 Allowed 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 123.776 2.984 . . . . 0.0 112.156 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -114.84 124.15 51.01 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.953 1.301 . . . . 0.0 110.233 174.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.87 96.93 3.31 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 127.101 2.16 . . . . 0.0 112.6 -174.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 52.53 37.83 50.41 Favored Glycine 0 CA--C 1.537 1.423 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.462 -177.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.67 79.65 0.6 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.408 1.883 . . . . 0.0 110.93 -178.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -65.84 123.37 19.61 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.185 1.794 . . . . 0.0 110.611 175.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 128.02 41.41 0.28 Allowed Glycine 0 CA--C 1.534 1.258 0 C-N-CA 125.341 1.448 . . . . 0.0 114.754 178.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 9.7 m95 45.29 60.09 3.21 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.803 1.641 . . . . 0.0 112.738 -175.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -85.05 128.31 34.58 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.456 1.102 . . . . 0.0 113.229 179.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -162.68 -170.28 2.34 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.219 1.008 . . . . 0.0 112.693 -174.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -137.9 151.53 48.11 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.562 1.145 . . . . 0.0 110.159 174.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -70.6 153.18 43.13 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 122.99 0.516 . . . . 0.0 110.95 176.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.46 ' HB3' ' CD2' ' A' ' 154' ' ' TYR . 1.9 mm? -115.7 127.67 55.32 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 122.189 0.995 . . . . 0.0 112.398 -178.278 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -58.07 -18.37 33.87 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 125.436 1.493 . . . . 0.0 116.02 179.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.489 ' CZ ' ' HB ' ' A' ' 120' ' ' ILE . 0.1 OUTLIER -74.35 14.33 0.46 Allowed 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 126.62 1.968 . . . . 0.0 113.776 179.778 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 75.16 24.86 70.2 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 124.171 0.891 . . . . 0.0 113.751 -174.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.6 pp -135.33 177.58 7.71 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.152 1.381 . . . . 0.0 113.215 -178.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -142.37 124.33 15.27 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.602 1.561 . . . . 0.0 109.448 -178.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 5.1 ttp -98.24 142.06 30.38 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 175.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 3.5 tppt? -123.78 121.72 36.17 Favored 'General case' 0 C--O 1.219 -0.543 0 C-N-CA 125.707 1.603 . . . . 0.0 109.383 -176.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -130.35 152.1 19.67 Favored Glycine 0 N--CA 1.466 0.682 0 CA-C-N 120.305 1.412 . . . . 0.0 114.581 -176.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 4.4 tp -146.35 128.27 7.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 C-N-CA 124.516 1.126 . . . . 0.0 110.589 -176.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' MET . . . . . 0.425 ' CE ' HD22 ' A' ' 114' ' ' ASN . 1.1 tmm? -151.37 157.2 42.14 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 125.296 1.438 . . . . 0.0 109.982 177.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 12.8 t -148.67 148.45 30.08 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.506 0.722 . . . . 0.0 110.329 174.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 75.1 m -117.08 32.11 6.35 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.277 1.031 . . . . 0.0 111.352 -177.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.85 -24.41 65.88 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.692 1.597 . . . . 0.0 113.713 176.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 158.4 -54.7 0.37 Allowed Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.22 1.39 . . . . 0.0 113.414 175.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -139.96 61.2 1.54 Allowed 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 122.311 1.053 . . . . 0.0 112.161 -175.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -98.08 -174.09 2.77 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 122.44 1.114 . . . . 0.0 112.727 175.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.5 178.68 6.12 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 128.167 2.587 . . . . 0.0 111.035 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' MET . . . . . 0.411 ' HA ' ' HG2' ' A' ' 162' ' ' MET . 4.7 tmm? -119.39 136.46 54.27 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.328 1.451 . . . . 0.0 111.207 174.359 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -146.74 129.73 16.37 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 121.591 -0.693 . . . . 0.0 110.279 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 4.6 mp -134.18 118.57 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 123.572 0.749 . . . . 0.0 110.363 175.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.83 133.13 55.59 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 125.411 1.485 . . . . 0.0 111.583 176.161 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.8 mp -82.59 136.68 22.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 O-C-N 121.466 -0.771 . . . . 0.0 109.498 175.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -118.23 130.85 56.31 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.164 1.386 . . . . 0.0 111.593 175.028 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 8.2 mmm180 . . . . . 0 C--O 1.252 1.231 0 C-N-CA 126.778 2.031 . . . . 0.0 110.869 -175.008 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.482 1.148 0 CA-C-O 121.145 0.498 . . . . 0.0 110.69 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -83.06 -174.36 5.24 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 124.557 1.143 . . . . 0.0 111.92 177.319 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 10.4 tp -120.62 -39.44 2.75 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.382 1.073 . . . . 0.0 113.239 175.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -77.56 130.62 37.17 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.316 1.047 . . . . 0.0 109.41 174.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -64.55 -101.14 0.01 OUTLIER Glycine 0 CA--C 1.537 1.453 0 CA-C-N 120.211 1.369 . . . . 0.0 114.764 -178.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 16.5 p -133.25 167.4 20.44 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.307 1.443 . . . . 0.0 110.16 176.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -120.73 14.59 6.34 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 C-N-CA 125.021 1.328 . . . . 0.0 112.406 -178.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -30.95 -72.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 128.427 2.691 . . . . 0.0 114.092 -179.38 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -171.62 151.5 2.95 Favored 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 125.127 1.371 . . . . 0.0 110.947 175.173 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -59.57 -33.23 75.99 Favored Glycine 0 N--CA 1.468 0.798 0 N-CA-C 115.605 1.002 . . . . 0.0 115.605 -174.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.09 -38.44 88.84 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 122.022 -0.693 . . . . 0.0 111.188 174.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.9 t -92.22 -11.77 34.5 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.398 1.879 . . . . 0.0 113.778 177.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 67.8 tp -119.53 80.67 1.6 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 128.851 2.86 . . . . 0.0 109.845 179.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -111.84 177.34 4.68 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.591 1.557 . . . . 0.0 111.981 176.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -39.98 -45.29 1.86 Allowed 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 126.125 1.77 . . . . 0.0 113.439 175.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -52.59 -44.86 66.24 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.921 0.888 . . . . 0.0 111.623 178.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 59.3 t -67.87 -40.82 84.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 125.54 1.536 . . . . 0.0 110.887 176.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 25.7 mt -65.4 -42.67 92.34 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 120.704 -1.247 . . . . 0.0 111.331 178.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -59.76 -51.52 69.4 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.79 1.236 . . . . 0.0 112.059 175.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.57 -36.37 83.56 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-O 118.424 -0.798 . . . . 0.0 112.52 175.141 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.2 t -53.65 -46.31 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.234 1.014 . . . . 0.0 110.363 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 18.5 mt -53.53 -18.49 2.85 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.562 1.545 . . . . 0.0 114.464 178.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -99.64 -62.24 0.83 Allowed Glycine 0 CA--C 1.534 1.268 0 C-N-CA 126.646 2.07 . . . . 0.0 112.899 175.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -60.85 -35.43 76.55 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -178.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -114.41 105.89 13.66 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.267 1.827 . . . . 0.0 108.092 175.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -143.78 162.74 27.72 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 125.502 1.525 . . . . 0.0 111.405 178.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.22 -83.14 0.57 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.733 1.213 . . . . 0.0 110.638 174.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 30.6 m -91.43 173.72 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 126.014 1.725 . . . . 0.0 109.282 178.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -51.28 -44.8 61.92 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.977 0.911 . . . . 0.0 112.439 -178.435 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.63 120.81 43.63 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.47 1.908 . . . . 0.0 112.514 177.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.46 163.12 30.08 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 125.46 1.504 . . . . 0.0 111.115 -179.049 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -128.95 132.67 67.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 124.709 1.204 . . . . 0.0 109.037 175.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -136.73 104.76 5.62 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.146 1.778 . . . . 0.0 109.439 174.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.3 m -106.4 159.09 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 124.233 1.013 . . . . 0.0 111.901 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -137.44 109.1 0.68 Allowed Glycine 0 N--CA 1.465 0.569 0 CA-C-N 119.072 0.851 . . . . 0.0 113.643 -178.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 mp -99.43 142.07 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 117.632 0.716 . . . . 0.0 110.136 176.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -108.87 101.99 11.05 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 124.873 1.269 . . . . 0.0 109.848 176.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.62 100.09 1.08 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.584 1.554 . . . . 0.0 109.343 176.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -133.79 13.39 4.02 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.908 1.283 . . . . 0.0 112.282 175.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.0 p -62.31 -12.95 23.78 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 126.082 1.753 . . . . 0.0 114.834 175.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.38 16.29 66.93 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 125.499 1.523 . . . . 0.0 114.183 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -140.49 136.47 7.67 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 126.506 2.003 . . . . 0.0 110.633 175.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 19.9 p -73.63 127.47 32.85 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.281 0.632 . . . . 0.0 109.939 174.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 15.8 m0 -88.02 159.1 18.42 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 122.066 -0.396 . . . . 0.0 111.742 177.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 89.4 m -136.61 143.86 43.77 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.574 1.15 . . . . 0.0 110.288 -179.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.7 110.85 0.86 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.466 1.106 . . . . 0.0 111.829 175.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.2 pp -101.25 -57.67 2.04 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.475 0.71 . . . . 0.0 111.284 175.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -173.43 140.03 0.79 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.446 1.898 . . . . 0.0 110.262 -175.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -121.83 150.61 41.67 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.354 1.062 . . . . 0.0 110.195 175.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -138.52 94.32 2.83 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 123.037 1.399 . . . . 0.0 112.104 -175.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -101.91 133.15 47.15 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 121.16 -0.962 . . . . 0.0 110.393 -175.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.38 -37.77 6.13 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.217 1.007 . . . . 0.0 113.64 -178.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 37.5 t -122.58 -47.74 2.08 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.494 1.518 . . . . 0.0 110.92 178.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -69.76 11.44 1.82 Allowed Glycine 0 CA--C 1.533 1.173 0 C-N-CA 126.051 1.786 . . . . 0.0 115.002 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 67.8 p -35.22 113.28 0.19 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 128.864 2.866 . . . . 0.0 112.773 -176.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.1 t -126.75 179.94 5.11 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.803 1.241 . . . . 0.0 112.014 -175.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -79.29 -53.98 6.4 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.959 0.904 . . . . 0.0 112.75 177.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.2 p -151.48 138.84 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.673 1.589 . . . . 0.0 111.386 -178.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.503 ' HB ' ' CE2' ' A' ' 72' ' ' TYR . 0.0 OUTLIER -136.72 -47.27 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 C-N-CA 125.083 1.353 . . . . 0.0 112.982 -178.772 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 73.3 mt -71.42 108.62 4.1 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 124.717 1.207 . . . . 0.0 109.474 175.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -72.07 168.02 25.15 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 124.046 3.164 . . . . 0.0 110.819 175.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -53.52 -45.57 69.82 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 178.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 85.5 t -150.09 146.75 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 127.526 2.33 . . . . 0.0 108.83 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.0 t -116.66 97.26 50.01 Favored Pre-proline 0 C--N 1.331 -0.21 0 C-N-CA 125.567 1.547 . . . . 0.0 107.247 174.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -67.71 144.78 67.12 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 121.328 1.352 . . . . 0.0 111.99 175.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -69.11 168.89 13.0 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.438 0.695 . . . . 0.0 110.658 174.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 29.1 p 62.94 13.85 7.0 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 126.614 1.966 . . . . 0.0 111.889 -175.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 27.6 mttp -138.41 169.05 18.47 Favored 'General case' 0 C--N 1.343 0.302 0 C-N-CA 126.525 1.93 . . . . 0.0 111.655 -176.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.35 159.72 39.45 Favored 'General case' 0 C--O 1.222 -0.359 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -175.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -136.76 167.86 20.63 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 124.296 1.038 . . . . 0.0 111.966 -177.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -117.35 153.55 32.81 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.253 1.021 . . . . 0.0 112.139 179.068 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.557 ' CE2' ' CE2' ' A' ' 89' ' ' PHE . 6.7 m-85 -125.56 142.2 51.63 Favored 'General case' 0 CA--C 1.511 -0.521 0 C-N-CA 125.047 1.339 . . . . 0.0 109.335 174.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 58.3 p -109.41 156.45 20.03 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 125.035 1.334 . . . . 0.0 110.346 174.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -174.13 135.45 3.18 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.872 175.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 30.5 mtm105 -117.5 142.5 47.09 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 125.428 1.491 . . . . 0.0 108.852 -177.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.5 ptpt -71.7 -168.14 0.33 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.038 0.935 . . . . 0.0 112.346 175.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.3 t 62.96 57.14 1.71 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.828 1.651 . . . . 0.0 111.636 176.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 52.0 p -60.8 -20.48 61.64 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.842 1.257 . . . . 0.0 113.87 177.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 126.9 -72.22 0.46 Allowed Glycine 0 CA--C 1.533 1.187 0 C-N-CA 126.995 2.236 . . . . 0.0 111.428 179.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.36 -42.67 1.8 Allowed 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 123.163 2.576 . . . . 0.0 113.247 -178.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 28.6 m -133.5 110.09 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 126.082 1.753 . . . . 0.0 111.156 -174.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -88.31 81.78 7.2 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 120.572 -1.33 . . . . 0.0 111.843 176.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -85.26 170.2 13.05 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 175.007 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -61.6 -68.58 1.61 Allowed Glycine 0 N--CA 1.475 1.246 0 O-C-N 120.282 -1.511 . . . . 0.0 113.654 -179.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -160.14 114.98 2.29 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.838 1.255 . . . . 0.0 110.923 175.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.42 ' CG1' ' HG ' ' A' ' 104' ' ' SER . 9.9 t -141.83 119.12 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 123.796 0.838 . . . . 0.0 109.933 -177.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.79 153.86 29.01 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.901 0.858 . . . . 0.0 112.031 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -134.57 139.43 45.37 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.401 1.48 . . . . 0.0 108.985 178.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.557 ' CE2' ' CE2' ' A' ' 72' ' ' TYR . 26.3 p90 -149.49 171.3 16.82 Favored 'General case' 0 C--N 1.323 -0.58 0 O-C-N 120.521 -1.362 . . . . 0.0 109.346 174.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -138.58 161.7 36.43 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 120.908 0.385 . . . . 0.0 111.977 174.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -130.16 135.52 48.27 Favored 'General case' 0 CA--C 1.518 -0.269 0 C-N-CA 125.718 1.607 . . . . 0.0 113.471 -174.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -86.53 116.78 24.89 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -175.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 3.3 mtm -93.2 140.89 29.03 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.01 0.924 . . . . 0.0 112.297 -177.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.14 -21.64 65.2 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 114.309 1.225 . . . . 0.0 114.309 177.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -72.09 -2.22 17.67 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.257 1.023 . . . . 0.0 113.146 175.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 85.83 42.39 6.81 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.62 1.105 . . . . 0.0 112.543 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -140.96 176.48 8.77 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.222 1.409 . . . . 0.0 111.549 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 12.9 m -130.07 107.54 9.4 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.285 1.034 . . . . 0.0 112.929 178.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 57.1 tp -69.94 96.31 1.01 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.764 1.625 . . . . 0.0 111.217 174.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -91.43 120.38 5.98 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 125.485 1.516 . . . . 0.0 112.76 178.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.475 HG11 ' CE2' ' A' ' 89' ' ' PHE . 0.3 OUTLIER -104.79 161.65 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 125.419 1.488 . . . . 0.0 111.127 178.436 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 5.0 tpt -155.91 123.22 5.44 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.66 1.184 . . . . 0.0 111.031 174.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -135.18 124.18 24.19 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.933 1.293 . . . . 0.0 114.226 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.42 ' HG ' ' CG1' ' A' ' 86' ' ' VAL . 1.6 t -133.02 102.32 5.56 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.086 0.954 . . . . 0.0 111.557 -176.151 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.0 m -77.13 144.94 72.4 Favored Pre-proline 0 N--CA 1.47 0.543 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.409 -178.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.443 ' HA ' ' CD2' ' A' ' 109' ' ' TYR . 30.7 Cg_endo -72.11 134.77 23.83 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.502 2.134 . . . . 0.0 112.978 175.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -142.37 -74.23 0.3 Allowed 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.987 -179.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -124.4 26.29 7.38 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.018 1.727 . . . . 0.0 111.552 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.443 ' CD2' ' HA ' ' A' ' 106' ' ' PRO . 10.7 m-85 -53.32 99.38 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.057 1.743 . . . . 0.0 112.756 176.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 43.2 m-20 -110.02 -6.47 15.14 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.124 1.77 . . . . 0.0 113.043 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 9.4 m95 -133.8 -49.42 0.82 Allowed 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.946 1.698 . . . . 0.0 112.196 -175.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -100.66 -173.03 2.3 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.88 2.072 . . . . 0.0 111.651 175.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -132.0 163.17 28.99 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.942 1.697 . . . . 0.0 110.64 174.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -63.16 99.55 0.18 Allowed 'General case' 0 CA--C 1.521 -0.164 0 C-N-CA 126.134 1.774 . . . . 0.0 111.807 175.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 46.5 m0 -119.56 142.11 48.65 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.691 1.197 . . . . 0.0 110.129 -175.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 31.5 p-90 -145.82 133.83 21.43 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.195 0.998 . . . . 0.0 110.658 -175.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -146.92 157.38 43.62 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 122.464 1.126 . . . . 0.0 113.441 -178.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 21.4 t -149.19 128.14 3.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 114.394 -1.275 . . . . 0.0 108.277 -178.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.0 162.99 40.79 Favored 'General case' 0 CA--C 1.514 -0.434 0 C-N-CA 125.614 1.566 . . . . 0.0 109.13 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 20.4 mt -108.47 146.28 14.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 121.487 0.66 . . . . 0.0 109.998 176.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -103.19 145.81 31.29 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 126.244 1.818 . . . . 0.0 111.023 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.62 103.0 1.37 Allowed 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 124.152 3.235 . . . . 0.0 111.558 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 88.06 -177.06 45.98 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.518 1.056 . . . . 0.0 114.068 -177.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 16.4 tttt -64.56 102.13 0.53 Allowed 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.462 1.105 . . . . 0.0 109.426 175.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 6.4 mmt180 -116.35 158.25 23.75 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.803 1.641 . . . . 0.0 109.54 178.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.82 -174.0 2.77 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.506 1.122 . . . . 0.0 110.265 175.041 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -138.27 113.25 9.19 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 126.315 1.846 . . . . 0.0 106.113 174.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -127.5 175.56 8.14 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.707 2.003 . . . . 0.0 109.253 174.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -47.97 -49.4 30.65 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.112 0.965 . . . . 0.0 113.473 177.231 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -56.94 -52.99 47.74 Favored Glycine 0 N--CA 1.471 0.967 0 CA-C-N 119.052 0.842 . . . . 0.0 112.832 178.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 20.4 mtm -62.88 -41.6 99.46 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 117.828 0.814 . . . . 0.0 112.558 176.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -56.95 -62.74 1.54 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.767 0.827 . . . . 0.0 109.623 175.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -59.22 -42.09 90.18 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 118.561 -0.733 . . . . 0.0 112.184 -176.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -58.09 -42.11 84.92 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.426 1.09 . . . . 0.0 113.027 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 40.9 mmm -84.48 -36.29 22.37 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 177.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -53.47 -57.27 11.27 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.501 1.52 . . . . 0.0 109.444 174.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -70.95 -9.7 58.36 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -178.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -87.02 -11.23 70.36 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 126.254 1.883 . . . . 0.0 114.624 178.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -138.67 88.67 13.93 Favored Pre-proline 0 CA--C 1.548 0.884 0 CA-C-N 119.205 1.503 . . . . 0.0 112.636 177.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -74.76 77.86 2.94 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.857 3.038 . . . . 0.0 112.46 178.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -114.71 124.21 51.21 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.061 0.944 . . . . 0.0 110.684 -178.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -92.59 -167.9 1.85 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.406 1.082 . . . . 0.0 111.72 179.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -73.94 66.51 1.78 Allowed Glycine 0 CA--C 1.53 0.989 0 C-N-CA 125.824 1.678 . . . . 0.0 111.433 175.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.96 88.75 5.89 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 125.404 1.481 . . . . 0.0 109.805 -178.07 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -70.38 86.41 0.61 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.862 1.665 . . . . 0.0 112.347 -176.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 169.04 40.7 0.03 OUTLIER Glycine 0 N--CA 1.472 1.099 0 O-C-N 121.171 -0.956 . . . . 0.0 114.614 -178.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 2.3 m95 53.56 55.17 8.94 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 125.576 1.55 . . . . 0.0 113.909 -177.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -86.23 124.4 32.57 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.443 1.497 . . . . 0.0 112.684 -178.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -159.0 -179.36 7.97 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.108 0.963 . . . . 0.0 112.902 -175.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -136.57 166.42 23.58 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.24 1.416 . . . . 0.0 111.086 174.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -69.14 143.65 54.06 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.888 0.875 . . . . 0.0 109.735 174.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 48.4 mt -99.48 92.64 5.48 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.275 1.03 . . . . 0.0 110.744 176.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 33.05 -79.9 0.0 OUTLIER Glycine 0 N--CA 1.478 1.473 0 C-N-CA 130.051 3.691 . . . . 0.0 116.247 175.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -67.89 -157.02 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 128.266 2.626 . . . . 0.0 110.372 175.023 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -79.09 42.91 2.39 Favored Glycine 0 CA--C 1.539 1.557 0 O-C-N 119.813 -1.804 . . . . 0.0 112.253 175.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.54 149.98 33.64 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 119.571 1.686 . . . . 0.0 111.061 175.179 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 23.8 mtm180 -142.54 109.26 5.41 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.496 1.118 . . . . 0.0 111.015 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 9.9 ttp -101.53 132.23 47.27 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 118.038 -0.982 . . . . 0.0 108.934 179.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.74 130.45 54.46 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 127.075 2.15 . . . . 0.0 110.893 178.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -135.72 160.11 24.42 Favored Glycine 0 N--CA 1.47 0.937 0 CA-C-N 120.312 1.414 . . . . 0.0 115.45 178.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.63 134.57 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 123.954 0.901 . . . . 0.0 111.366 179.395 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 7.0 mtm -148.36 167.29 25.61 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 127.09 2.156 . . . . 0.0 109.974 175.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 3.6 t -140.35 148.9 42.01 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.989 1.316 . . . . 0.0 109.479 174.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 77.4 p -92.25 26.57 2.5 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.508 1.123 . . . . 0.0 112.805 177.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -67.18 22.68 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 127.601 2.36 . . . . 0.0 115.232 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 81.4 -60.64 4.7 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 126.664 2.078 . . . . 0.0 112.901 -176.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -122.77 71.04 1.02 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.786 1.234 . . . . 0.0 111.47 -179.267 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -92.89 -177.06 4.4 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.733 1.213 . . . . 0.0 112.707 175.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.42 163.84 20.06 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 126.842 2.057 . . . . 0.0 109.532 174.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' MET . . . . . 0.413 ' SD ' ' CD1' ' A' ' 172' ' ' ILE . 1.3 tmt? -113.12 127.13 56.11 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 124.876 1.27 . . . . 0.0 109.459 174.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -138.21 127.66 24.74 Favored 'General case' 0 CA--C 1.518 -0.253 0 C-N-CA 123.279 0.632 . . . . 0.0 110.044 177.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.413 ' CD1' ' SD ' ' A' ' 170' ' ' MET . 4.2 mp -136.43 119.68 22.59 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.279 0 C-N-CA 122.978 0.511 . . . . 0.0 110.505 178.537 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -112.36 131.89 55.29 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.987 1.315 . . . . 0.0 111.578 175.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.8 mp -82.07 131.46 33.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 175.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -135.42 102.47 5.15 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.219 1.007 . . . . 0.0 111.442 175.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 5.9 mtt180 . . . . . 0 C--O 1.253 1.285 0 C-N-CA 124.846 1.259 . . . . 0.0 112.852 174.983 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.578 HD12 ' H ' ' A' ' 74' ' ' GLY . 1.8 mt . . . . . 0 CA--C 1.548 0.89 0 CA-C-O 121.513 0.673 . . . . 0.0 112.51 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.417 ' HA ' ' HB3' ' A' ' 71' ' ' LEU . . . -120.98 94.02 4.21 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 127.637 2.375 . . . . 0.0 109.632 178.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -69.71 -84.05 0.16 Allowed Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.531 1.062 . . . . 0.0 112.665 -175.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 33.7 p -140.24 167.34 22.37 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.705 1.602 . . . . 0.0 111.004 175.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -125.39 14.36 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 CA-C-O 123.174 1.464 . . . . 0.0 111.796 -179.326 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.419 HD12 ' HB3' ' A' ' 12' ' ' SER . 8.2 pt -53.23 167.39 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 125.494 1.517 . . . . 0.0 112.086 175.356 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -42.31 134.02 3.03 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.72 1.608 . . . . 0.0 112.549 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -54.9 -18.98 12.68 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 124.202 0.906 . . . . 0.0 114.557 -175.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.18 -28.14 69.46 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.718 1.207 . . . . 0.0 111.932 175.066 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.419 ' HB3' HD12 ' A' ' 8' ' ' ILE . 6.4 t -102.09 -44.9 5.32 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 126.32 1.848 . . . . 0.0 111.415 175.145 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.2 tp -75.97 94.16 3.35 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 121.614 0.721 . . . . 0.0 110.463 175.014 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 65.0 p -125.52 -179.8 4.79 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.507 1.523 . . . . 0.0 112.451 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -45.83 -41.0 10.56 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.446 1.498 . . . . 0.0 112.911 176.681 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -57.39 -43.39 83.61 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.661 1.185 . . . . 0.0 111.598 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 74.6 t -59.54 -35.4 58.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.733 1.213 . . . . 0.0 110.792 175.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.3 mt -72.52 -42.85 64.31 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.722 -0.611 . . . . 0.0 111.263 177.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -62.42 -49.35 75.81 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.616 -0.678 . . . . 0.0 111.267 178.001 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.08 -48.86 76.82 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 176.133 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.423 HG23 HD23 ' A' ' 25' ' ' LEU . 1.6 p -57.38 -30.73 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 CA-C-N 120.269 1.395 . . . . 0.0 113.414 -175.017 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 17.1 mt -57.4 -34.42 68.87 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.544 1.138 . . . . 0.0 110.806 174.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -85.54 -36.25 10.86 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 124.282 0.944 . . . . 0.0 113.455 177.493 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -69.62 -57.99 4.49 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.657 1.183 . . . . 0.0 112.38 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.423 HD23 HG23 ' A' ' 21' ' ' VAL . 3.1 mm? -91.32 -15.49 28.99 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.55 1.54 . . . . 0.0 112.005 -175.138 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -18.19 86.71 0.0 OUTLIER Glycine 0 CA--C 1.536 1.405 0 C-N-CA 129.952 3.644 . . . . 0.0 117.426 177.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.455 ' H ' HD21 ' A' ' 3' ' ' LEU . 15.3 mtpt -59.86 -61.11 2.86 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 127.224 2.21 . . . . 0.0 113.315 -175.424 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.1 m -132.66 -177.95 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 126.891 2.076 . . . . 0.0 110.835 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.2 t -52.19 -39.89 60.76 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.714 1.606 . . . . 0.0 114.354 -175.074 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -117.86 116.14 26.38 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 126.228 1.811 . . . . 0.0 108.258 175.009 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.15 150.54 49.46 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 126.125 1.77 . . . . 0.0 109.52 -175.036 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -128.21 123.59 60.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 124.336 1.054 . . . . 0.0 111.262 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -125.21 116.64 22.31 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 125.914 1.685 . . . . 0.0 108.558 174.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.732 HG22 ' HB2' ' A' ' 72' ' ' TYR . 1.3 m -116.1 158.75 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.639 0.776 . . . . 0.0 110.186 176.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -135.84 92.81 0.23 Allowed Glycine 0 CA--C 1.521 0.41 0 C-N-CA 124.073 0.844 . . . . 0.0 112.215 -178.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.8 mp -89.61 137.27 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 117.768 0.784 . . . . 0.0 110.503 175.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -108.15 112.1 24.45 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.989 1.316 . . . . 0.0 111.313 174.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 27.2 t30 -78.69 98.12 6.1 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.84 1.656 . . . . 0.0 111.975 175.016 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -134.21 13.74 3.87 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-O 122.551 1.167 . . . . 0.0 111.014 174.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.4 t -61.8 -26.88 68.37 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.082 1.753 . . . . 0.0 114.34 176.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 110.14 77.56 0.94 Allowed Glycine 0 CA--C 1.531 1.042 0 C-N-CA 125.247 1.403 . . . . 0.0 112.597 177.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 144.69 155.93 6.63 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 126.016 1.77 . . . . 0.0 112.805 175.034 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 41.4 p -68.88 129.43 39.9 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 121.526 -0.985 . . . . 0.0 110.289 174.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 45.2 m0 -86.6 111.15 20.35 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.261 0.553 . . . . 0.0 110.706 178.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 88.7 m -90.92 127.89 36.57 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 124.333 1.053 . . . . 0.0 109.501 175.257 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.414 ' HB1' ' HB3' ' A' ' 60' ' ' LEU . . . -62.21 138.41 58.41 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 122.651 0.38 . . . . 0.0 111.639 174.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.593 HD12 ' N ' ' A' ' 48' ' ' ASN . 4.1 pp -120.44 -54.65 2.07 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.059 0.943 . . . . 0.0 111.971 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.593 ' N ' HD12 ' A' ' 47' ' ' LEU . 0.1 OUTLIER -170.78 154.38 4.34 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.535 1.934 . . . . 0.0 110.241 178.704 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -133.17 162.99 30.28 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.679 1.192 . . . . 0.0 110.386 174.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 29.3 t80 -140.24 106.2 5.19 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.971 1.309 . . . . 0.0 112.391 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.541 ' CD1' ' HB1' ' A' ' 87' ' ' ALA . 3.1 m-85 -111.1 118.24 35.48 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.992 1.317 . . . . 0.0 110.982 -175.018 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.37 -35.9 7.78 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -177.134 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.421 ' HB3' ' HB ' ' A' ' 86' ' ' VAL . 11.3 t -123.96 -41.83 2.2 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.97 1.708 . . . . 0.0 111.654 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -74.03 16.66 2.61 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 125.246 1.403 . . . . 0.0 115.272 -178.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 65.8 p -32.9 110.29 0.08 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 128.689 2.796 . . . . 0.0 114.321 -174.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.536 HG21 HG23 ' A' ' 59' ' ' ILE . 1.7 t -131.37 -177.09 4.25 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.002 1.321 . . . . 0.0 112.845 -174.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -85.41 -64.97 1.06 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.963 1.305 . . . . 0.0 113.205 176.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.6 p -137.4 134.23 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 125.455 1.502 . . . . 0.0 111.638 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.536 HG23 HG21 ' A' ' 56' ' ' THR . 0.1 OUTLIER -136.68 -29.97 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.825 1.65 . . . . 0.0 113.799 177.596 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.414 ' HB3' ' HB1' ' A' ' 46' ' ' ALA . 11.0 mt -94.38 97.07 2.07 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 125.298 1.439 . . . . 0.0 109.85 179.095 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -66.87 154.29 75.07 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.932 3.088 . . . . 0.0 110.922 174.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -50.39 -50.8 50.57 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.634 1.174 . . . . 0.0 113.302 -176.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 80.4 t -149.45 140.9 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 127.902 2.481 . . . . 0.0 108.347 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.3 t -120.87 125.4 27.07 Favored Pre-proline 0 N--CA 1.471 0.583 0 C-N-CA 124.658 1.183 . . . . 0.0 109.508 175.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -66.2 152.02 82.15 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 121.88 1.72 . . . . 0.0 112.373 175.03 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -74.53 171.04 14.53 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.686 0.794 . . . . 0.0 111.425 174.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 66.5 p 55.41 20.36 3.6 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 127.597 2.359 . . . . 0.0 113.906 -174.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 49.4 mttt -133.57 174.03 10.86 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 127.623 2.369 . . . . 0.0 111.559 -175.021 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -130.94 166.86 20.03 Favored 'General case' 0 C--O 1.222 -0.373 0 C-N-CA 122.619 0.368 . . . . 0.0 110.549 -177.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.5 pp -140.49 172.66 12.41 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 124.962 1.305 . . . . 0.0 111.516 -178.089 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.417 ' HB3' ' HA ' ' A' ' 4' ' ' ALA . 0.5 OUTLIER -123.4 151.76 42.27 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 124.331 1.052 . . . . 0.0 112.038 178.991 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.732 ' HB2' HG22 ' A' ' 34' ' ' VAL . 3.5 m-85 -126.21 144.08 50.9 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.464 1.106 . . . . 0.0 108.556 174.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 90.4 p -115.69 152.95 32.21 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 125.879 1.671 . . . . 0.0 110.68 176.238 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.578 ' H ' HD12 ' A' ' 3' ' ' LEU . . . -173.97 141.91 6.23 Favored Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 174.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 13.3 ptt180 -132.42 163.84 27.85 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 127.098 2.159 . . . . 0.0 108.294 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 24.6 mtmt . . . . . 0 N--CA 1.472 0.627 0 N-CA-C 115.341 1.608 . . . . 0.0 115.341 -174.969 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 56.7 m . . . . . 0 N--CA 1.476 0.841 0 N-CA-C 111.201 0.074 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -53.05 -75.72 0.21 Allowed Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.938 1.732 . . . . 0.0 114.862 -175.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -165.97 102.62 0.66 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.316 1.446 . . . . 0.0 112.844 -178.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.421 ' HB ' ' HB3' ' A' ' 53' ' ' SER . 6.0 t -129.0 124.69 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 O-C-N 120.977 -1.077 . . . . 0.0 110.87 -178.498 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.593 ' HB3' ' CZ ' ' A' ' 103' ' ' PHE . . . -167.8 159.47 11.69 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.036 1.334 . . . . 0.0 112.233 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -141.06 143.87 34.61 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 124.396 1.078 . . . . 0.0 109.813 174.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -140.58 168.54 19.56 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 121.402 -0.811 . . . . 0.0 109.958 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -137.1 155.01 50.14 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 175.018 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -130.89 127.22 38.07 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.925 1.69 . . . . 0.0 111.985 -175.119 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -82.54 114.56 21.03 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.868 0.366 . . . . 0.0 111.067 -178.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 2.0 mtm -84.1 136.5 33.98 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.647 1.179 . . . . 0.0 111.169 176.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.2 t -64.32 -19.15 65.25 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.77 0.828 . . . . 0.0 113.213 176.262 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -69.35 -13.72 62.53 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 125.34 1.456 . . . . 0.0 113.496 175.009 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 104.31 23.07 8.23 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 124.736 1.16 . . . . 0.0 115.09 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.507 ' HB3' HG22 ' A' ' 120' ' ' ILE . 7.5 m-80 -129.98 173.87 10.3 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 118.911 1.356 . . . . 0.0 110.035 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.6 m -130.47 107.75 9.46 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.403 1.081 . . . . 0.0 111.083 178.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 55.4 tp -70.68 105.49 3.18 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.245 1.018 . . . . 0.0 111.079 175.065 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -97.16 95.09 1.67 Allowed Glycine 0 CA--C 1.525 0.663 0 C-N-CA 125.639 1.59 . . . . 0.0 112.323 176.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 79.4 t -76.25 139.91 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 123.845 0.858 . . . . 0.0 110.51 174.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 2.6 tmm? -129.75 125.75 36.59 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.481 1.112 . . . . 0.0 111.056 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.593 ' CZ ' ' HB3' ' A' ' 87' ' ' ALA . 48.9 p90 -136.94 134.95 37.29 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 122.417 1.104 . . . . 0.0 113.601 174.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 71.9 m -137.63 121.28 17.37 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.482 1.113 . . . . 0.0 111.563 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 41.4 t . . . . . 0 CA--C 1.541 0.613 0 C-N-CA 126.576 1.95 . . . . 0.0 107.455 175.037 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.7 m . . . . . 0 N--CA 1.473 0.704 0 CA-C-O 121.314 0.578 . . . . 0.0 111.907 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -125.96 72.64 1.3 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.407 1.483 . . . . 0.0 112.258 -175.022 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 22.8 m0 -71.82 143.99 49.28 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 121.334 -0.854 . . . . 0.0 112.292 -174.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 34.3 p-90 -140.82 137.0 32.98 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.168 0.987 . . . . 0.0 111.881 -179.194 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -144.76 168.56 19.91 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 125.198 1.399 . . . . 0.0 111.684 -176.057 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 72.2 t -147.55 129.67 6.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 124.7 1.2 . . . . 0.0 107.894 174.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.58 170.2 15.07 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.434 1.094 . . . . 0.0 110.518 174.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.507 HG22 ' HB3' ' A' ' 97' ' ' ASN . 12.7 mt -132.01 104.77 8.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 177.565 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -62.18 145.8 93.2 Favored Pre-proline 0 CA--C 1.546 0.818 0 O-C-N 121.485 -0.759 . . . . 0.0 110.886 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -73.81 8.91 1.79 Allowed 'Trans proline' 0 CA--C 1.548 1.188 0 C-N-CA 124.413 3.408 . . . . 0.0 114.862 -175.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -172.98 179.77 44.2 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 126.95 2.214 . . . . 0.0 111.406 177.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -53.94 102.71 0.06 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 126.645 1.978 . . . . 0.0 111.565 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 11.1 tpp180 -132.45 141.6 48.89 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.538 1.535 . . . . 0.0 111.776 -177.285 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 8.7 ptt180 -76.82 179.53 6.06 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.262 1.025 . . . . 0.0 113.536 174.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -124.4 116.39 22.48 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 128.326 2.651 . . . . 0.0 104.681 174.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -140.12 169.18 18.18 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.143 1.377 . . . . 0.0 110.422 177.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -52.77 -43.19 65.65 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.56 1.144 . . . . 0.0 113.261 -178.486 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -56.13 -56.44 24.18 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 123.72 0.676 . . . . 0.0 112.744 174.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 2.9 mtm -64.17 -33.3 75.47 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 118.321 1.06 . . . . 0.0 112.973 177.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.28 -63.91 1.13 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.231 1.013 . . . . 0.0 108.895 174.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -63.81 -32.81 74.45 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.621 0.601 . . . . 0.0 112.621 -176.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -64.18 -34.13 77.38 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.506 1.122 . . . . 0.0 113.446 176.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 6.4 tpp -97.72 -21.88 16.74 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 175.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -51.84 -54.99 22.71 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 126.638 1.975 . . . . 0.0 109.783 174.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -64.61 -12.1 42.0 Favored 'General case' 0 CA--C 1.552 1.045 0 N-CA-C 113.72 1.008 . . . . 0.0 113.72 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -79.16 -33.12 36.99 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 126.832 2.158 . . . . 0.0 113.925 -175.05 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -127.61 90.73 47.51 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 124.593 1.157 . . . . 0.0 111.21 177.266 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -72.51 72.92 2.9 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 123.561 2.84 . . . . 0.0 112.376 178.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -113.39 119.48 37.78 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 124.659 1.184 . . . . 0.0 109.848 174.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -89.03 0.43 56.68 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.591 1.557 . . . . 0.0 114.557 175.029 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 85.01 75.07 1.24 Allowed Glycine 0 CA--C 1.522 0.511 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 -175.015 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -74.53 122.2 22.72 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.907 0.883 . . . . 0.0 109.229 174.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -56.34 144.16 31.58 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.09 0.956 . . . . 0.0 112.395 -177.343 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' GLY . . . . . 0.477 ' C ' HD13 ' A' ' 161' ' ' ILE . . . 117.19 -78.97 0.29 Allowed Glycine 0 CA--C 1.532 1.141 0 C-N-CA 126.095 1.807 . . . . 0.0 113.037 -176.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 32.2 m95 171.99 104.84 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 130.816 3.646 . . . . 0.0 108.629 -175.03 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -134.59 137.0 43.36 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 126.456 1.902 . . . . 0.0 111.868 -177.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -160.38 -172.01 3.4 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -174.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.422 ' HA ' ' HE2' ' A' ' 150' ' ' LYS . 1.5 mmpt? -133.33 155.13 49.99 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 126.285 1.834 . . . . 0.0 111.158 174.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -78.23 144.09 36.55 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 174.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.3 mt -107.38 153.6 22.53 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 122.22 1.009 . . . . 0.0 109.732 178.276 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -64.38 -166.78 1.18 Allowed Glycine 0 CA--C 1.535 1.304 0 C-N-CA 123.673 0.654 . . . . 0.0 112.262 174.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.47 ' CE2' ' HB ' ' A' ' 120' ' ' ILE . 0.0 OUTLIER 56.78 9.47 0.6 Allowed 'General case' 0 CA--C 1.556 1.2 0 N-CA-C 114.844 1.424 . . . . 0.0 114.844 174.968 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 81.48 38.32 14.88 Favored Glycine 0 CA--C 1.538 1.514 0 C-N-CA 126.736 2.112 . . . . 0.0 114.693 -175.056 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.7 mp -126.79 159.64 33.21 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 119.868 1.834 . . . . 0.0 113.671 -176.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 74.1 mtt180 -144.69 118.71 9.39 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.316 1.047 . . . . 0.0 110.181 -178.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 3.1 ttp -103.51 138.94 39.52 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 124.313 1.045 . . . . 0.0 108.443 177.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -111.06 133.82 53.14 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 127.031 2.132 . . . . 0.0 110.131 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -141.39 160.88 26.93 Favored Glycine 0 N--CA 1.478 1.459 0 CA-C-N 121.849 2.113 . . . . 0.0 116.191 178.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.477 HD13 ' C ' ' A' ' 146' ' ' GLY . 1.4 tp -149.51 127.22 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 125.166 1.386 . . . . 0.0 110.978 -177.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' MET . . . . . 0.423 ' N ' HD12 ' A' ' 161' ' ' ILE . 29.4 mtp -148.48 164.95 32.63 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 128.807 2.843 . . . . 0.0 108.224 174.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 10.2 t -138.0 154.98 49.29 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.999 0.52 . . . . 0.0 111.124 175.001 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 94.9 p -77.57 13.87 1.16 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.726 1.611 . . . . 0.0 114.275 179.088 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.26 1.08 0.13 Allowed 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 126.794 2.038 . . . . 0.0 115.548 175.011 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 87.75 -62.3 3.99 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 126.14 1.829 . . . . 0.0 113.151 174.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -102.53 20.06 17.81 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.32 1.448 . . . . 0.0 113.076 -177.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -60.57 161.58 7.47 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.118 1.367 . . . . 0.0 113.579 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.41 173.41 9.15 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 126.446 1.899 . . . . 0.0 111.653 174.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 44.8 ttp -134.05 118.51 17.86 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.97 1.308 . . . . 0.0 111.794 177.006 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -124.62 128.55 49.04 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 121.141 -0.975 . . . . 0.0 109.525 177.19 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 4.6 mp -133.89 124.51 47.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 123.735 0.814 . . . . 0.0 109.915 176.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -123.34 132.11 53.88 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.36 1.464 . . . . 0.0 111.391 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.8 mp -79.31 127.57 39.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 O-C-N 121.207 -0.933 . . . . 0.0 109.338 176.207 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 4.2 m -132.3 98.9 4.52 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.093 1.357 . . . . 0.0 112.04 178.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 49.9 mtp85 . . . . . 0 C--O 1.253 1.242 0 C-N-CA 127.357 2.263 . . . . 0.0 113.032 175.02 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.537 HD13 ' HB2' ' A' ' 31' ' ' LYS . 1.5 mt . . . . . 0 N--CA 1.484 1.249 0 CA-C-O 121.016 0.436 . . . . 0.0 111.944 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -115.83 116.24 27.67 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 127.227 2.211 . . . . 0.0 110.491 -175.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -77.85 -82.95 0.58 Allowed Glycine 0 CA--C 1.533 1.201 0 C-N-CA 124.744 1.164 . . . . 0.0 113.551 -178.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 54.2 p -139.27 174.17 10.79 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 126.406 1.882 . . . . 0.0 111.451 -175.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -135.57 15.64 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 C-N-CA 125.702 1.601 . . . . 0.0 111.638 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 15.3 pt -54.36 171.56 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 126.272 1.829 . . . . 0.0 113.402 178.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -43.09 132.42 4.12 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.044 1.737 . . . . 0.0 113.258 178.299 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -54.75 -31.03 53.54 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 125.487 1.518 . . . . 0.0 116.147 -174.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.47 -22.58 67.0 Favored 'General case' 0 CA--C 1.547 0.834 0 O-C-N 121.648 -0.913 . . . . 0.0 112.636 174.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.3 t -98.25 -45.36 6.21 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.187 2.195 . . . . 0.0 111.722 176.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.522 HD23 ' HB3' ' A' ' 69' ' ' ALA . 3.2 tp -78.77 88.25 4.64 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.449 1.5 . . . . 0.0 111.062 174.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.2 p -120.28 -179.67 4.02 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 126.994 2.118 . . . . 0.0 111.976 177.17 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -45.4 -42.03 9.78 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.11 1.764 . . . . 0.0 113.523 175.551 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -52.91 -44.25 66.82 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 118.953 0.797 . . . . 0.0 111.819 177.14 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 61.4 t -64.13 -41.87 93.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 125.587 1.555 . . . . 0.0 111.651 175.357 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 29.3 mt -67.72 -40.13 84.26 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 120.845 -1.159 . . . . 0.0 111.933 179.191 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -63.64 -45.99 87.72 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.824 0.849 . . . . 0.0 111.786 178.129 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.74 -32.83 74.38 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-O 118.371 -0.823 . . . . 0.0 112.961 175.011 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 25.2 t -56.59 -42.02 75.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 CA-C-N 119.796 1.18 . . . . 0.0 111.48 177.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 49.2 mt -59.56 -13.29 8.68 Favored 'General case' 0 CA--C 1.552 1.045 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 175.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -104.67 -49.69 1.01 Allowed Glycine 0 CA--C 1.539 1.539 0 C-N-CA 126.855 2.169 . . . . 0.0 114.229 176.31 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -74.17 -30.41 62.23 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 119.186 1.493 . . . . 0.0 114.389 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -100.34 171.88 7.5 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.277 1.431 . . . . 0.0 110.463 174.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 154.83 131.49 1.48 Allowed Glycine 0 CA--C 1.534 1.22 0 O-C-N 121.122 -0.986 . . . . 0.0 114.601 177.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.4 mtpm? -113.5 -50.74 2.84 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 126.097 1.759 . . . . 0.0 114.0 176.116 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.7 m -132.25 -179.32 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 124.285 1.034 . . . . 0.0 112.348 -174.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.3 t -48.88 -42.37 36.49 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 126.082 1.753 . . . . 0.0 114.322 -175.014 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 8.8 tpp180 -124.69 136.35 53.82 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 126.297 1.839 . . . . 0.0 108.964 174.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.537 ' HB2' HD13 ' A' ' 3' ' ' LEU . 0.1 OUTLIER -130.58 167.64 18.39 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.333 1.453 . . . . 0.0 110.8 178.292 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -137.41 133.04 46.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 124.187 0.995 . . . . 0.0 108.38 174.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -134.21 95.84 3.49 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 127.61 2.364 . . . . 0.0 109.855 -178.394 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.672 HG22 ' HB2' ' A' ' 72' ' ' TYR . 1.4 m -98.91 167.02 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 123.212 0.605 . . . . 0.0 111.552 179.113 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -142.59 108.69 0.53 Allowed Glycine 0 CA--C 1.523 0.562 0 CA-C-O 119.645 -0.53 . . . . 0.0 113.414 174.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.9 mp -98.51 144.31 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 117.929 0.865 . . . . 0.0 109.184 175.035 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -119.61 102.83 8.9 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.143 1.377 . . . . 0.0 111.161 -178.056 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -70.73 85.29 0.65 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 129.44 3.096 . . . . 0.0 113.047 -175.009 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.57 3.37 13.99 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.746 1.619 . . . . 0.0 113.658 175.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.5 m -55.56 -30.89 61.59 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 115.335 1.605 . . . . 0.0 115.335 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 111.06 95.68 2.31 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.576 1.084 . . . . 0.0 112.098 -177.348 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 113.51 160.11 13.78 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 126.102 1.81 . . . . 0.0 112.625 -178.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.623 HG22 ' HA ' ' A' ' 65' ' ' PRO . 80.8 p -69.34 148.2 50.03 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 121.975 -0.721 . . . . 0.0 111.563 175.238 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 34.9 m0 -103.32 105.85 16.22 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.925 0.89 . . . . 0.0 109.584 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 59.4 m -92.75 129.98 38.51 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.269 1.027 . . . . 0.0 110.466 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.85 127.98 33.83 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.045 0.938 . . . . 0.0 112.22 174.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -117.14 -43.6 2.84 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.698 1.199 . . . . 0.0 112.269 175.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -170.04 149.64 3.63 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.467 1.907 . . . . 0.0 110.955 -178.34 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -133.38 155.84 48.74 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.382 1.473 . . . . 0.0 110.231 175.007 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -138.2 97.69 3.45 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.048 1.339 . . . . 0.0 111.413 -178.085 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.496 ' CD1' ' HB1' ' A' ' 87' ' ' ALA . 2.3 m-85 -99.17 111.99 24.25 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.356 1.062 . . . . 0.0 110.646 177.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.13 -39.45 16.69 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.278 0.631 . . . . 0.0 111.563 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.5 t -129.3 -177.08 4.09 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.623 2.369 . . . . 0.0 107.591 174.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 55.52 24.33 38.56 Favored Glycine 0 CA--C 1.538 1.493 0 O-C-N 121.178 -0.951 . . . . 0.0 113.783 -179.077 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.3 p -33.18 106.01 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 129.185 2.994 . . . . 0.0 112.719 -175.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.509 HG21 HG23 ' A' ' 59' ' ' ILE . 5.0 t -109.92 -177.22 3.21 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -174.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -92.44 -64.1 1.15 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.781 2.032 . . . . 0.0 112.21 175.11 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.2 p -144.06 131.91 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.989 1.315 . . . . 0.0 111.686 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.509 HG23 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -131.01 -20.01 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 126.046 1.739 . . . . 0.0 113.595 178.21 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.3 mp -106.8 88.47 3.56 Favored Pre-proline 0 N--CA 1.45 -0.434 0 C-N-CA 125.902 1.681 . . . . 0.0 107.279 -174.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -59.14 151.9 63.45 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.615 2.21 . . . . 0.0 110.843 176.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -42.87 -49.02 5.89 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.335 1.854 . . . . 0.0 113.523 -178.373 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.6 p -160.79 140.63 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 127.039 2.136 . . . . 0.0 109.259 175.056 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 66.3 t -116.91 127.46 26.71 Favored Pre-proline 0 N--CA 1.477 0.92 0 C-N-CA 124.63 1.172 . . . . 0.0 108.325 175.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.623 ' HA ' HG22 ' A' ' 43' ' ' THR . 60.4 Cg_endo -66.23 157.65 58.87 Favored 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 122.123 1.882 . . . . 0.0 112.424 178.168 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -70.47 160.63 32.06 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 121.785 -0.572 . . . . 0.0 110.66 175.008 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 31.8 p 60.96 19.14 9.56 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 126.621 1.969 . . . . 0.0 113.697 -174.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 42.2 mttt -131.65 171.24 13.7 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.612 1.565 . . . . 0.0 111.489 -178.156 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.522 ' HB3' HD23 ' A' ' 13' ' ' LEU . . . -122.52 179.11 4.7 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 123.855 0.862 . . . . 0.0 111.839 -174.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -149.75 168.99 22.11 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 125.526 1.53 . . . . 0.0 110.948 174.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.412 HD13 ' O ' ' A' ' 34' ' ' VAL . 0.4 OUTLIER -119.08 158.14 26.45 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.879 1.672 . . . . 0.0 111.323 178.548 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.672 ' HB2' HG22 ' A' ' 34' ' ' VAL . 9.1 m-85 -130.27 144.25 51.26 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.343 1.057 . . . . 0.0 110.051 174.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.5 p -120.58 138.57 53.81 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 126.812 2.045 . . . . 0.0 110.365 175.097 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.503 ' N ' HD12 ' A' ' 3' ' ' LEU . . . -150.85 129.73 2.98 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 174.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.06 107.2 9.41 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 127.67 2.388 . . . . 0.0 111.599 -175.004 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.476 0.837 0 C-N-CA 126.092 1.757 . . . . 0.0 112.875 176.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 42.2 m . . . . . 0 N--CA 1.483 1.215 0 CA-C-O 117.896 -1.05 . . . . 0.0 108.929 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -21.98 -74.9 0.01 OUTLIER Glycine 0 N--CA 1.485 1.937 0 C-N-CA 127.452 2.453 . . . . 0.0 113.742 -178.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -163.05 120.4 1.92 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.869 1.668 . . . . 0.0 109.839 174.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.9 t -144.1 114.55 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.168 0.987 . . . . 0.0 109.826 -178.208 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.566 ' HB3' ' CZ ' ' A' ' 103' ' ' PHE . . . -163.29 164.36 24.93 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.964 0.888 . . . . 0.0 113.186 -176.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -144.52 162.19 37.19 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.252 1.421 . . . . 0.0 112.076 174.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -160.78 172.65 16.66 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 124.672 1.189 . . . . 0.0 110.575 179.399 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.49 ' HB2' ' HB2' ' A' ' 127' ' ' ALA . . . -136.81 160.38 39.04 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 175.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -137.37 131.18 31.72 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.835 1.254 . . . . 0.0 113.892 175.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -79.36 109.04 13.34 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.947 0.899 . . . . 0.0 110.691 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 4.0 ttm -72.1 145.08 48.42 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.143 0.977 . . . . 0.0 111.937 175.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 14.3 t -61.69 -28.16 69.2 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.296 1.038 . . . . 0.0 112.955 175.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 -69.44 -8.09 43.66 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.825 1.25 . . . . 0.0 113.782 175.013 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 91.95 39.53 5.46 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.318 0.961 . . . . 0.0 113.951 177.053 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -138.34 171.88 13.72 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.184 1.393 . . . . 0.0 110.484 175.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.432 HG21 ' O ' ' A' ' 125' ' ' ARG . 53.5 m -122.22 111.9 17.52 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 119.075 0.852 . . . . 0.0 113.163 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 61.9 tp -73.32 101.44 3.42 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.583 1.953 . . . . 0.0 110.404 174.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -91.01 117.6 5.18 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 126.221 1.867 . . . . 0.0 112.318 176.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 91.1 t -119.17 141.62 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 125.642 1.577 . . . . 0.0 110.68 -175.036 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 2.9 ppp? -148.37 170.22 18.44 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.897 0.856 . . . . 0.0 113.296 174.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.566 ' CZ ' ' HB3' ' A' ' 87' ' ' ALA . 18.0 p90 -152.71 149.28 28.22 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.625 1.57 . . . . 0.0 113.89 175.396 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 22.4 t -143.1 107.71 4.84 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.585 1.554 . . . . 0.0 110.086 175.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 10.8 m . . . . . 0 CA--C 1.539 0.533 0 C-N-CA 125.597 1.559 . . . . 0.0 109.021 175.03 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 19.3 m . . . . . 0 N--CA 1.468 0.461 0 CA-C-O 120.905 0.383 . . . . 0.0 111.276 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -124.66 95.69 4.61 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.239 1.015 . . . . 0.0 109.898 -176.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 51.9 m0 -110.74 148.24 32.74 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.19 0.519 . . . . 0.0 111.656 -177.332 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 17.5 p-90 -149.13 135.17 19.03 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.366 0.667 . . . . 0.0 112.566 -174.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -161.4 173.39 14.99 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 122.732 1.253 . . . . 0.0 113.111 175.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 60.3 t -138.59 143.85 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 126.462 1.905 . . . . 0.0 107.98 176.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.67 174.56 11.34 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.601 1.561 . . . . 0.0 110.565 178.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 26.0 mt -127.09 138.77 53.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 174.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 99.7 m-85 -102.35 149.56 36.77 Favored Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 125.103 1.361 . . . . 0.0 111.966 176.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -69.48 113.39 3.31 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.861 3.041 . . . . 0.0 111.321 176.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 69.16 -171.63 39.14 Favored Glycine 0 CA--C 1.537 1.421 0 O-C-N 121.896 -0.503 . . . . 0.0 114.119 -175.038 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 11.8 tmtt? -58.15 113.15 1.79 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.565 1.546 . . . . 0.0 111.594 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.432 ' O ' HG21 ' A' ' 98' ' ' THR . 0.0 OUTLIER -134.08 113.69 12.37 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.768 1.227 . . . . 0.0 111.465 -178.782 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 4.5 ptp180 -57.65 161.72 3.49 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.711 -0.618 . . . . 0.0 112.308 175.185 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.49 ' HB2' ' HB2' ' A' ' 90' ' ' ALA . . . -113.12 99.02 7.51 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 175.031 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -124.5 167.48 14.38 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.591 1.556 . . . . 0.0 109.988 -177.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -53.25 -38.94 63.46 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.185 0.994 . . . . 0.0 113.425 -177.222 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -60.61 -57.67 17.77 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 123.753 0.692 . . . . 0.0 112.151 176.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 3.3 mtm -61.4 -37.22 82.65 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.326 0.65 . . . . 0.0 112.524 178.045 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.82 -62.91 1.46 Allowed 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.768 0.713 . . . . 0.0 110.0 174.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -60.37 -40.4 90.68 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.104 0.962 . . . . 0.0 113.145 -175.032 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -60.53 -46.48 90.02 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.062 0.945 . . . . 0.0 112.441 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 78.1 mmm -82.25 -30.84 30.49 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 177.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -55.19 -57.21 12.7 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.295 1.838 . . . . 0.0 110.769 175.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.32 -20.09 65.99 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-O 121.439 0.638 . . . . 0.0 112.166 -177.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -80.35 -2.55 89.41 Favored Glycine 0 CA--C 1.538 1.483 0 C-N-CA 126.744 2.116 . . . . 0.0 114.839 175.002 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -141.77 77.32 19.06 Favored Pre-proline 0 CA--C 1.553 1.081 0 CA-C-N 119.62 1.71 . . . . 0.0 114.145 -175.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.89 101.05 1.27 Allowed 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 123.688 2.925 . . . . 0.0 113.266 -176.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -138.2 123.31 19.16 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.583 1.153 . . . . 0.0 110.704 178.39 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 4.6 mpt_? -93.34 -157.29 0.53 Allowed 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 125.297 1.439 . . . . 0.0 111.081 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -86.12 77.5 2.03 Favored Glycine 0 CA--C 1.531 1.037 0 O-C-N 120.132 -1.605 . . . . 0.0 110.116 175.002 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -75.99 85.14 2.89 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.152 1.781 . . . . 0.0 111.171 -175.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -54.43 116.39 2.62 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 -174.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 141.78 -73.01 0.38 Allowed Glycine 0 CA--C 1.533 1.212 0 C-N-CA 125.251 1.405 . . . . 0.0 114.057 175.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 27.9 m95 169.19 106.33 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 131.199 3.8 . . . . 0.0 108.485 -174.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -137.92 132.19 32.04 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 127.327 2.251 . . . . 0.0 110.471 -177.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -158.38 -173.66 4.42 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -175.038 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.3 mtmm -140.4 162.84 34.36 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 126.501 1.921 . . . . 0.0 111.564 175.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -73.29 137.34 44.8 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.431 1.092 . . . . 0.0 109.456 174.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 45.1 mt -92.97 88.74 6.26 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.294 1.038 . . . . 0.0 110.478 177.046 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 35.81 -76.45 0.0 OUTLIER Glycine 0 N--CA 1.477 1.405 1 C-N-CA 130.83 4.062 . . . . 0.0 116.592 175.059 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -70.02 -153.45 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 128.311 2.645 . . . . 0.0 110.472 175.024 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -75.42 24.52 1.42 Allowed Glycine 0 CA--C 1.542 1.742 0 O-C-N 120.15 -1.594 . . . . 0.0 115.072 174.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.84 149.06 24.58 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 120.211 2.005 . . . . 0.0 111.698 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 61.5 mtt85 -140.89 114.33 8.73 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.736 1.214 . . . . 0.0 111.433 177.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' MET . . . . . 0.402 ' SD ' HG21 ' A' ' 172' ' ' ILE . 8.0 ttp -94.96 143.17 26.68 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 125.28 1.432 . . . . 0.0 108.803 175.449 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 4.4 tppt? -121.98 124.9 45.11 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 127.199 2.199 . . . . 0.0 109.853 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -137.58 158.61 24.59 Favored Glycine 0 N--CA 1.478 1.439 0 N-CA-C 117.974 1.95 . . . . 0.0 117.974 -175.013 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.518 HD13 ' N ' ' A' ' 162' ' ' MET . 0.0 OUTLIER -147.69 131.72 9.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 C-N-CA 125.372 1.469 . . . . 0.0 111.668 -177.049 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 162' ' ' MET . . . . . 0.518 ' N ' HD13 ' A' ' 161' ' ' ILE . 3.5 mtm -149.77 160.93 43.16 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 128.537 2.735 . . . . 0.0 108.231 174.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 5.5 t -140.89 133.91 29.28 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 121.133 -0.979 . . . . 0.0 112.003 174.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 45.6 m -74.4 12.29 0.8 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.433 1.493 . . . . 0.0 114.187 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -51.01 -43.0 60.76 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.77 1.628 . . . . 0.0 114.21 176.563 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 146.91 -77.79 0.25 Allowed Glycine 0 CA--C 1.532 1.105 0 C-N-CA 125.139 1.352 . . . . 0.0 112.845 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 27.5 tp10 -95.83 43.81 1.08 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 125.145 1.378 . . . . 0.0 110.831 -177.078 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -77.24 172.57 13.07 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.301 1.04 . . . . 0.0 112.928 178.262 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' LYS . . . . . 0.402 ' HE2' ' O ' ' A' ' 169' ' ' LYS . 0.0 OUTLIER -114.07 173.93 6.19 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 126.711 2.004 . . . . 0.0 109.633 174.919 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 2.0 tmm? -126.85 123.17 36.7 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 125.385 1.474 . . . . 0.0 109.12 178.007 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -132.4 128.46 37.6 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.504 0.721 . . . . 0.0 110.532 177.142 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.402 HG21 ' SD ' ' A' ' 158' ' ' MET . 4.8 mp -135.61 122.97 35.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 123.428 0.691 . . . . 0.0 110.11 175.047 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -118.88 136.1 54.22 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.556 1.542 . . . . 0.0 110.043 176.28 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.8 mp -82.93 137.15 21.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 O-C-N 121.315 -0.866 . . . . 0.0 109.241 175.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 9.3 m -128.78 95.9 4.23 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.229 1.012 . . . . 0.0 111.85 176.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 7.2 mmm180 . . . . . 0 C--O 1.253 1.288 0 C-N-CA 126.296 1.838 . . . . 0.0 111.75 174.945 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.502 HD11 ' HB2' ' A' ' 31' ' ' LYS . 16.1 mt . . . . . 0 N--CA 1.485 1.316 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -75.14 96.08 3.21 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.626 -0.671 . . . . 0.0 110.083 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -60.94 -75.48 0.29 Allowed Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.426 1.013 . . . . 0.0 112.314 -176.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 27.4 p -150.85 172.3 15.85 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 127.189 2.196 . . . . 0.0 110.423 174.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -124.79 5.51 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 124.934 1.294 . . . . 0.0 112.75 175.067 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 pt -24.42 -75.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 129.591 3.156 . . . . 0.0 116.673 -176.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -162.47 137.59 6.97 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.218 1.407 . . . . 0.0 111.324 -177.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.65 -21.49 58.07 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 124.577 1.084 . . . . 0.0 114.641 -178.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.27 -31.11 72.18 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.233 1.013 . . . . 0.0 113.175 174.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.5 t -102.96 -40.87 6.32 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 125.083 1.353 . . . . 0.0 111.726 175.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 14.3 tp -74.24 82.74 1.85 Allowed 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.235 1.414 . . . . 0.0 111.099 175.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.8 p -113.98 179.68 3.89 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 126.654 1.981 . . . . 0.0 112.425 176.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -47.47 -42.2 22.2 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.064 1.346 . . . . 0.0 113.019 176.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -57.55 -37.88 73.86 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.759 0.823 . . . . 0.0 112.174 178.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.6 t -67.48 -41.16 85.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.083 0.953 . . . . 0.0 110.283 175.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 21.3 mt -63.71 -41.08 98.15 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 121.33 -0.856 . . . . 0.0 110.961 177.145 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.39 -44.15 92.23 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.793 0.837 . . . . 0.0 112.641 178.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.68 -32.6 62.26 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 175.478 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.1 t -51.4 -46.49 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 C-N-CA 125.601 1.56 . . . . 0.0 111.933 175.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 15.0 mt -53.97 -20.15 5.76 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.188 1.395 . . . . 0.0 113.716 178.004 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -108.42 -40.08 1.68 Allowed Glycine 0 CA--C 1.537 1.415 0 C-N-CA 126.134 1.826 . . . . 0.0 114.926 178.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -72.05 -28.61 63.46 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 119.768 1.784 . . . . 0.0 113.965 179.181 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -92.24 133.36 35.89 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.83 1.252 . . . . 0.0 110.992 176.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.12 125.11 7.19 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 125.261 1.41 . . . . 0.0 113.852 -175.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.94 -172.19 4.15 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 126.366 1.866 . . . . 0.0 112.053 -177.024 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.9 m -72.47 -177.96 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 126.085 1.754 . . . . 0.0 110.898 174.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 60.9 m -49.7 -50.01 45.53 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.517 1.527 . . . . 0.0 113.529 -177.079 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -117.43 138.21 51.99 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.041 1.337 . . . . 0.0 110.662 175.057 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.502 ' HB2' HD11 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -141.42 161.09 38.75 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 126.132 1.773 . . . . 0.0 111.593 -175.062 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -131.25 114.25 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-O 122.238 1.018 . . . . 0.0 112.018 -179.382 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -117.31 111.51 19.48 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.735 2.014 . . . . 0.0 109.111 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.811 HG22 ' HB2' ' A' ' 72' ' ' TYR . 1.8 m -116.67 151.98 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 CA-C-O 119.097 -0.478 . . . . 0.0 111.272 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -131.12 101.34 0.48 Allowed Glycine 0 CA--C 1.524 0.649 0 C-N-CA 123.815 0.722 . . . . 0.0 112.872 -179.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.9 mp -91.93 136.22 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-N 118.209 1.005 . . . . 0.0 110.318 175.025 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -101.13 104.48 15.58 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.185 1.394 . . . . 0.0 110.666 178.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -70.39 82.74 0.56 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 127.889 2.476 . . . . 0.0 111.057 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -120.85 11.64 11.14 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 125.109 1.364 . . . . 0.0 114.144 175.007 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 99.8 p -60.15 -7.51 1.92 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 126.67 1.988 . . . . 0.0 116.351 174.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 93.57 21.05 30.1 Favored Glycine 0 CA--C 1.54 1.626 0 N-CA-C 116.281 1.272 . . . . 0.0 116.281 177.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -166.49 169.56 40.63 Favored Glycine 0 CA--C 1.535 1.305 0 CA-C-N 119.27 1.535 . . . . 0.0 114.196 176.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.556 HG22 ' HA ' ' A' ' 65' ' ' PRO . 7.3 p -72.98 141.75 47.75 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.81 1.244 . . . . 0.0 111.396 175.006 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.56 ' HA ' ' CE1' ' A' ' 91' ' ' TYR . 34.7 m0 -100.97 98.04 8.55 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 123.586 0.755 . . . . 0.0 112.353 -177.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.1 m -81.72 120.41 25.09 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.266 1.026 . . . . 0.0 108.704 175.027 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.08 150.51 45.33 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.685 -0.634 . . . . 0.0 112.145 174.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.8 pp -124.25 -51.02 1.77 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.639 0.776 . . . . 0.0 112.976 177.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -171.06 142.89 1.88 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 127.043 2.137 . . . . 0.0 109.738 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.431 ' HB2' HD12 ' A' ' 60' ' ' LEU . . . -121.17 151.44 39.93 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.614 1.166 . . . . 0.0 109.94 174.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -132.67 106.54 7.84 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.413 1.485 . . . . 0.0 111.27 -177.007 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.498 ' CD1' ' HB1' ' A' ' 87' ' ' ALA . 2.7 m-85 -111.58 124.64 52.71 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.481 1.112 . . . . 0.0 110.248 -175.287 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.13 -34.2 6.01 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 114.174 1.175 . . . . 0.0 114.174 -174.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 43.7 t -119.0 -47.92 2.47 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.657 1.183 . . . . 0.0 110.375 175.05 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -67.55 12.27 0.74 Allowed Glycine 0 CA--C 1.54 1.603 0 C-N-CA 126.865 2.174 . . . . 0.0 117.623 -174.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 76.0 p -27.14 107.69 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 129.597 3.159 . . . . 0.0 114.671 -175.016 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.482 HG21 HG23 ' A' ' 59' ' ' ILE . 3.9 t -128.75 -177.05 4.04 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.826 2.05 . . . . 0.0 113.509 -175.032 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -88.44 -54.79 4.01 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.051 1.341 . . . . 0.0 113.897 177.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.9 p -149.89 133.45 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 124.898 1.279 . . . . 0.0 111.99 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.482 HG23 HG21 ' A' ' 56' ' ' THR . 0.1 OUTLIER -136.68 -35.18 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 N-CA-C 114.838 1.422 . . . . 0.0 114.838 179.29 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.431 HD12 ' HB2' ' A' ' 49' ' ' ALA . 7.2 mt -88.5 100.05 1.78 Allowed Pre-proline 0 CA--C 1.543 0.694 0 C-N-CA 125.665 1.586 . . . . 0.0 108.599 176.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.576 ' HG2' HG23 ' A' ' 64' ' ' VAL . 89.3 Cg_endo -68.51 150.53 75.34 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 122.554 2.17 . . . . 0.0 110.985 176.241 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -48.1 -45.54 32.85 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.983 1.313 . . . . 0.0 113.446 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.2 p -156.26 136.19 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 126.398 1.879 . . . . 0.0 110.287 175.015 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.576 HG23 ' HG2' ' A' ' 61' ' ' PRO . 72.7 t -113.71 129.96 24.22 Favored Pre-proline 0 N--CA 1.481 1.079 0 C-N-CA 124.55 1.14 . . . . 0.0 108.691 174.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.556 ' HA ' HG22 ' A' ' 43' ' ' THR . 66.4 Cg_endo -70.43 158.25 56.63 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 122.667 2.245 . . . . 0.0 113.271 178.211 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -72.94 160.72 31.67 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 121.421 -0.799 . . . . 0.0 112.726 175.097 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . 0.275 51.4 p 57.64 23.77 9.74 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 127.077 2.151 . . . . 0.0 113.689 -175.002 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -119.03 -178.32 3.54 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 126.765 2.026 . . . . 0.0 110.732 178.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -136.54 152.54 50.61 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 175.003 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.452 HD23 HG21 ' A' ' 64' ' ' VAL . 1.5 pp -117.7 171.01 8.32 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 124.417 1.087 . . . . 0.0 110.963 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.464 HD13 ' O ' ' A' ' 34' ' ' VAL . 0.3 OUTLIER -126.22 153.41 44.75 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.624 1.17 . . . . 0.0 111.004 175.47 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.811 ' HB2' HG22 ' A' ' 34' ' ' VAL . 6.3 m-85 -125.88 153.39 44.24 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.832 1.653 . . . . 0.0 108.835 174.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.402 ' H ' HG22 ' A' ' 59' ' ' ILE . 95.8 p -133.97 141.36 47.26 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 126.197 1.799 . . . . 0.0 111.3 176.286 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.473 ' H ' HD12 ' A' ' 3' ' ' LEU . . . -162.12 150.38 19.62 Favored Glycine 0 CA--C 1.524 0.624 0 O-C-N 121.916 -0.49 . . . . 0.0 113.092 174.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 11.4 mtm180 -112.24 130.83 55.8 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 126.289 1.836 . . . . 0.0 111.968 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.479 1.002 0 C-N-CA 125.688 1.595 . . . . 0.0 115.12 175.006 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 42.9 m . . . . . 0 N--CA 1.475 0.81 0 CA-C-O 121.045 0.45 . . . . 0.0 111.263 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 37.82 -114.26 0.28 Allowed Glycine 0 CA--C 1.533 1.193 0 C-N-CA 126.103 1.811 . . . . 0.0 113.969 -178.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.593 ' HB3' HG22 ' A' ' 105' ' ' VAL . . . -141.45 114.84 8.84 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 118.458 1.129 . . . . 0.0 111.274 176.193 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.2 t -137.33 122.25 24.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 C-N-CA 124.323 1.049 . . . . 0.0 110.18 -176.382 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.498 ' HB1' ' CD1' ' A' ' 51' ' ' PHE . . . -163.51 171.34 16.0 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.302 1.441 . . . . 0.0 111.359 175.043 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -151.48 134.38 15.75 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.889 1.275 . . . . 0.0 109.943 174.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.424 ' CD2' ' CE2' ' A' ' 72' ' ' TYR . 54.3 p90 -129.72 171.24 12.87 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 121.27 -0.894 . . . . 0.0 110.285 177.388 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -143.26 143.9 31.91 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 175.048 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.56 ' CE1' ' HA ' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -109.98 131.36 55.13 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.497 1.119 . . . . 0.0 109.995 177.289 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -84.51 107.6 16.84 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.364 0.665 . . . . 0.0 112.593 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -68.38 141.64 55.68 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.45 1.1 . . . . 0.0 112.94 -178.717 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 58.0 p -60.15 -28.24 67.75 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.845 1.258 . . . . 0.0 112.548 174.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 -72.24 -8.23 53.68 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.731 1.612 . . . . 0.0 112.757 174.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 99.99 -6.71 58.52 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 126.662 2.077 . . . . 0.0 114.362 -178.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 53.5 m-20 -78.12 178.33 7.64 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 118.339 1.07 . . . . 0.0 111.34 178.083 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 19.0 m -139.31 109.12 6.28 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 120.453 -1.404 . . . . 0.0 111.22 174.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.6 tt -72.8 101.81 3.22 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.566 1.146 . . . . 0.0 111.289 175.069 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -92.79 127.78 9.14 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 125.171 1.367 . . . . 0.0 113.333 175.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 63.5 t -114.44 127.02 72.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 125.763 1.625 . . . . 0.0 111.224 -175.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.11 118.61 24.71 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 126.733 2.013 . . . . 0.0 112.438 -175.052 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -141.69 121.28 13.34 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.33 1.452 . . . . 0.0 111.642 -175.277 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 30.4 t -137.3 92.53 2.72 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.473 1.509 . . . . 0.0 110.92 -175.045 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.593 HG22 ' HB3' ' A' ' 85' ' ' ALA . 2.1 m . . . . . 0 N--CA 1.473 0.68 0 C-N-CA 125.105 1.362 . . . . 0.0 109.669 -179.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 17.1 m . . . . . 0 N--CA 1.477 0.89 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 32.5 t-20 -74.34 106.29 5.9 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.08 1.752 . . . . 0.0 107.912 175.048 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 44.3 m0 -113.16 145.68 40.53 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 120.297 1.408 . . . . 0.0 108.31 174.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 39.2 p-90 -149.02 142.82 25.63 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.095 0.958 . . . . 0.0 113.047 -177.33 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -151.69 165.77 33.34 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 123.292 1.52 . . . . 0.0 113.821 -177.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 94.7 t -147.41 129.54 7.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 125.894 1.678 . . . . 0.0 107.349 175.014 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.33 171.6 14.23 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.515 1.526 . . . . 0.0 110.127 175.083 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 35.3 mt -134.32 118.59 27.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.762 0.792 . . . . 0.0 109.231 -176.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -80.59 139.12 50.97 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 124.185 0.994 . . . . 0.0 109.23 178.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -72.97 -1.53 10.63 Favored 'Trans proline' 0 CA--C 1.546 1.119 0 C-N-CA 123.706 2.937 . . . . 0.0 114.948 -178.005 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -141.74 176.27 22.04 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 126.857 2.17 . . . . 0.0 111.94 175.02 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 9.9 tttm -64.26 105.61 0.94 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.934 1.294 . . . . 0.0 110.884 176.17 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 11.2 tpp180 -138.77 117.96 12.67 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 124.381 1.072 . . . . 0.0 113.22 -174.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 15.4 ptt180 -62.98 165.42 6.9 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 175.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -110.22 103.18 11.84 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 174.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -111.8 170.82 7.88 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.329 1.051 . . . . 0.0 109.642 175.018 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -50.07 -39.52 42.46 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.377 0.99 . . . . 0.0 113.304 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -59.42 -59.72 10.11 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 123.869 0.747 . . . . 0.0 112.175 175.013 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 14.6 mtm -61.82 -35.33 77.9 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 118.058 0.929 . . . . 0.0 113.298 178.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -60.56 -60.49 3.73 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.088 1.355 . . . . 0.0 109.756 175.017 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -67.26 -29.75 69.45 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -63.96 -36.73 84.91 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.34 1.056 . . . . 0.0 113.019 176.008 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 7.9 tpp -94.53 -22.23 18.36 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 119.695 1.134 . . . . 0.0 113.463 175.041 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -49.28 -56.6 8.88 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.602 1.561 . . . . 0.0 110.316 175.025 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -71.19 -7.02 43.93 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -178.396 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -84.89 -12.83 73.52 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 126.983 2.23 . . . . 0.0 114.946 -178.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -145.54 90.27 6.04 Favored Pre-proline 0 CA--C 1.552 1.025 0 CA-C-N 119.309 1.555 . . . . 0.0 112.956 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -75.48 81.8 2.23 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 123.674 2.916 . . . . 0.0 112.19 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -116.97 111.64 19.87 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.985 1.314 . . . . 0.0 110.182 -177.253 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -92.61 41.36 1.07 Allowed 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 127.564 2.346 . . . . 0.0 114.05 -174.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 55.77 51.76 53.03 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 123.704 0.669 . . . . 0.0 112.538 -177.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -61.01 113.63 2.65 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.613 1.165 . . . . 0.0 111.418 -176.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -75.96 83.18 2.85 Favored 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 -175.022 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 173.09 55.07 0.05 OUTLIER Glycine 0 CA--C 1.539 1.544 0 C-N-CA 125.107 1.336 . . . . 0.0 114.135 175.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' TRP . . . . . 0.63 ' H ' HD13 ' A' ' 161' ' ' ILE . 7.5 m95 48.16 41.72 16.15 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 126.81 2.044 . . . . 0.0 114.077 -174.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -72.75 126.96 31.15 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 120.845 -1.16 . . . . 0.0 111.784 -175.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.15 -170.23 3.06 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -174.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.71 140.92 36.92 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 126.043 1.737 . . . . 0.0 110.447 175.043 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -67.0 149.36 50.74 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 174.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 29.3 mt -119.79 158.42 26.59 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-O 123.824 1.773 . . . . 0.0 111.435 178.014 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -64.45 -157.5 0.23 Allowed Glycine 0 CA--C 1.54 1.623 0 C-N-CA 125.62 1.581 . . . . 0.0 111.2 174.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 51.46 15.12 0.3 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.944 -1.327 . . . . 0.0 114.527 175.016 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 72.66 34.83 59.46 Favored Glycine 0 CA--C 1.54 1.608 0 CA-C-O 117.141 -1.922 . . . . 0.0 113.805 -175.13 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -139.21 159.41 42.23 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 121.21 2.505 . . . . 0.0 115.188 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 19.4 mtt-85 -135.33 123.7 23.28 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 120.439 -1.413 . . . . 0.0 108.693 -177.431 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 13.7 ttp -96.14 136.38 36.69 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 176.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.85 129.21 56.33 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 126.803 2.041 . . . . 0.0 109.867 -178.054 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -136.8 156.36 23.16 Favored Glycine 0 N--CA 1.476 1.36 0 CA-C-N 121.684 2.038 . . . . 0.0 116.293 -177.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.63 HD13 ' H ' ' A' ' 147' ' ' TRP . 6.1 tp -154.56 126.43 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 124.96 1.304 . . . . 0.0 112.527 -174.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 19.5 ttm -148.82 -176.27 5.27 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 128.641 2.776 . . . . 0.0 108.509 177.329 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 8.9 t -163.01 127.31 2.98 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.527 1.131 . . . . 0.0 111.631 174.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.37 19.61 0.1 Allowed 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.027 1.331 . . . . 0.0 114.11 178.101 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -58.34 -25.94 62.55 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 127.291 2.236 . . . . 0.0 115.631 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 147.14 -57.87 0.49 Allowed Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.562 1.077 . . . . 0.0 114.48 175.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -133.28 37.9 3.34 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.144 1.378 . . . . 0.0 112.001 -178.079 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.33 174.58 4.65 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-O 122.61 1.195 . . . . 0.0 113.849 175.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.64 176.26 5.22 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 127.741 2.416 . . . . 0.0 111.527 175.023 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 1.8 tmm? -128.18 130.91 48.76 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 126.277 1.831 . . . . 0.0 109.648 175.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.448 ' C ' HD12 ' A' ' 172' ' ' ILE . 47.1 tt0 -141.14 131.39 24.96 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.48 1.112 . . . . 0.0 110.203 -178.218 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.448 HD12 ' C ' ' A' ' 171' ' ' GLN . 4.0 mp -136.11 126.01 40.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 123.883 0.873 . . . . 0.0 109.612 175.032 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -119.39 129.27 54.72 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 126.516 1.926 . . . . 0.0 111.119 178.365 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.6 mp -88.55 93.1 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 O-C-N 121.278 -0.889 . . . . 0.0 109.692 -177.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.04 107.51 19.26 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.628 1.571 . . . . 0.0 112.691 179.096 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.252 1.188 0 C-N-CA 125.547 1.539 . . . . 0.0 112.836 175.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.479 HD22 ' HD3' ' A' ' 27' ' ' LYS . 13.7 tp . . . . . 0 N--CA 1.48 1.042 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -126.1 141.11 52.08 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 127.813 2.445 . . . . 0.0 109.213 175.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -79.75 -136.95 1.51 Allowed Glycine 0 CA--C 1.538 1.504 0 C-N-CA 124.844 1.212 . . . . 0.0 110.989 174.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.0 p -107.31 176.01 5.3 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 125.5 1.52 . . . . 0.0 112.941 -175.075 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -119.13 17.26 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 126.352 1.861 . . . . 0.0 111.945 -178.16 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.3 pt -50.39 159.64 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 125.662 1.585 . . . . 0.0 111.349 175.006 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -42.82 140.26 1.4 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.456 1.502 . . . . 0.0 113.328 -176.505 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -56.29 -20.9 31.01 Favored Glycine 0 CA--C 1.543 1.788 0 C-N-CA 124.28 0.943 . . . . 0.0 113.745 -176.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.2 -28.55 69.82 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.621 1.568 . . . . 0.0 112.609 174.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 t -101.28 -44.57 5.61 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.974 1.71 . . . . 0.0 111.515 175.097 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.7 tp -75.81 88.49 2.84 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.278 1.031 . . . . 0.0 111.429 175.088 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 55.1 p -124.65 -175.09 3.18 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 126.156 1.782 . . . . 0.0 111.344 176.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -50.3 -31.36 14.13 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.851 1.26 . . . . 0.0 113.645 175.078 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -59.46 -50.31 74.4 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 118.97 0.805 . . . . 0.0 110.902 175.043 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 73.8 t -64.53 -39.13 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 123.915 0.886 . . . . 0.0 110.974 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 90.2 mt -70.58 -42.12 71.48 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 123.349 0.66 . . . . 0.0 112.62 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -71.17 -44.21 65.93 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.953 0.901 . . . . 0.0 111.607 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.72 -39.8 95.2 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 118.426 -0.797 . . . . 0.0 110.826 175.012 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.0 t -53.5 -43.59 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 125.054 1.342 . . . . 0.0 112.271 175.008 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.486 ' HA ' ' HE3' ' A' ' 31' ' ' LYS . 0.1 OUTLIER -60.39 -25.99 66.33 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 175.015 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.57 -48.92 3.33 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.203 0.906 . . . . 0.0 112.979 178.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -70.61 -27.44 64.09 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 17.8 mt -109.31 102.22 11.15 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.737 1.215 . . . . 0.0 110.461 -177.361 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -131.77 73.15 0.47 Allowed Glycine 0 CA--C 1.534 1.252 0 C-N-CA 125.112 1.339 . . . . 0.0 113.364 -175.288 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.479 ' HD3' HD22 ' A' ' 3' ' ' LEU . 0.1 OUTLIER -62.0 -58.68 6.96 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 126.416 1.886 . . . . 0.0 113.683 -178.646 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 16.4 m -127.27 -176.92 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 126.497 1.919 . . . . 0.0 110.748 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -47.98 -36.49 12.71 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 115.576 1.695 . . . . 0.0 115.576 -175.023 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.8 155.69 49.48 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.711 2.004 . . . . 0.0 108.01 174.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.486 ' HE3' ' HA ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -145.67 164.19 32.55 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.919 1.287 . . . . 0.0 110.768 175.988 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.501 ' CG1' ' HB1' ' A' ' 85' ' ' ALA . 0.3 OUTLIER -118.49 138.16 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 124.572 1.149 . . . . 0.0 108.439 175.018 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.452 ' HB3' HD12 ' A' ' 22' ' ' LEU . . . -138.68 132.04 30.22 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.147 1.379 . . . . 0.0 109.597 175.018 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.402 HG22 ' HB3' ' A' ' 170' ' ' MET . 16.5 t -137.91 148.29 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 123.364 0.666 . . . . 0.0 111.398 -177.095 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -119.47 93.13 0.54 Allowed Glycine 0 CA--C 1.525 0.677 0 C-N-CA 126.658 2.075 . . . . 0.0 113.161 175.098 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.7 mp -81.4 136.43 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-N 119.424 1.612 . . . . 0.0 108.788 174.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -112.65 102.46 10.52 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.164 1.786 . . . . 0.0 109.868 178.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -70.32 92.43 0.79 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.867 1.267 . . . . 0.0 109.563 177.182 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -117.29 0.26 12.2 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.052 1.741 . . . . 0.0 112.722 174.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 23.0 t -50.77 -58.89 4.82 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 126.141 1.776 . . . . 0.0 113.249 -178.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 149.49 -26.4 1.21 Allowed Glycine 0 N--CA 1.473 1.15 0 C-N-CA 124.165 0.888 . . . . 0.0 114.113 178.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -115.96 162.79 12.47 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.541 1.544 . . . . 0.0 111.226 175.001 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.4 t -85.13 155.58 21.41 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 123.879 0.872 . . . . 0.0 110.781 175.02 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 7.7 m0 -111.46 153.57 25.95 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 125.352 1.461 . . . . 0.0 112.031 176.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 95.0 m -130.24 141.46 50.63 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.853 1.261 . . . . 0.0 109.925 177.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.47 108.83 0.52 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.749 1.22 . . . . 0.0 112.571 177.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.508 HD11 ' HB3' ' A' ' 90' ' ' ALA . 3.5 pp -104.85 -53.71 2.63 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.286 1.034 . . . . 0.0 112.234 -179.333 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.476 ' N ' HD12 ' A' ' 47' ' ' LEU . 29.3 t30 -177.73 144.8 0.38 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 127.907 2.483 . . . . 0.0 110.415 -178.472 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -130.54 159.31 37.5 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.111 1.365 . . . . 0.0 111.512 175.042 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -142.92 104.2 4.29 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.878 1.271 . . . . 0.0 112.944 -175.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.482 ' CD1' ' HB1' ' A' ' 87' ' ' ALA . 3.1 m-85 -94.09 137.37 33.36 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.376 -0.827 . . . . 0.0 111.902 178.067 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.3 ttt-85 -98.49 -70.12 0.74 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.138 1.775 . . . . 0.0 111.24 178.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.428 ' CB ' ' H ' ' A' ' 86' ' ' VAL . 0.9 OUTLIER -39.72 -54.62 2.05 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 128.21 2.604 . . . . 0.0 113.722 -175.034 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -157.69 -118.53 0.55 Allowed Glycine 0 CA--C 1.526 0.751 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 175.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.6 p -141.93 175.67 9.54 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.822 1.649 . . . . 0.0 111.87 -174.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.497 ' CG2' HD12 ' A' ' 59' ' ' ILE . 5.7 t -156.51 -176.92 6.23 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.313 1.045 . . . . 0.0 112.755 176.797 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -102.63 -65.03 1.02 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.39 1.476 . . . . 0.0 112.786 177.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.2 p -130.19 131.68 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 125.551 1.541 . . . . 0.0 111.187 -177.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.497 HD12 ' CG2' ' A' ' 56' ' ' THR . 0.1 OUTLIER -136.85 -63.54 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 125.346 1.458 . . . . 0.0 111.712 -174.969 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.461 ' H ' HG12 ' A' ' 59' ' ' ILE . 80.5 mt -88.37 105.53 9.78 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 125.355 1.462 . . . . 0.0 110.265 175.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -73.33 168.48 24.64 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 123.305 2.67 . . . . 0.0 110.992 175.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -49.45 -44.92 46.02 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.139 0.976 . . . . 0.0 113.544 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 53.7 t -151.13 147.83 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 C-N-CA 126.838 2.055 . . . . 0.0 109.426 -176.404 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.6 t -125.9 95.07 40.52 Favored Pre-proline 0 N--CA 1.468 0.443 0 C-N-CA 124.913 1.285 . . . . 0.0 108.132 174.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.31 158.04 55.43 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.153 1.902 . . . . 0.0 112.253 176.21 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -71.53 169.52 15.28 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.092 0.557 . . . . 0.0 111.593 175.14 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . 0.252 26.0 p 56.79 18.76 3.97 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 127.442 2.297 . . . . 0.0 112.954 -174.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -130.9 172.0 12.54 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 126.86 2.064 . . . . 0.0 110.683 -178.586 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -134.89 167.43 20.92 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.345 0.658 . . . . 0.0 109.344 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.8 pp -139.16 166.43 24.56 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 124.68 1.192 . . . . 0.0 111.745 177.48 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.05 152.57 23.84 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 122.134 0.969 . . . . 0.0 111.07 174.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -132.8 149.03 52.31 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 126.64 1.976 . . . . 0.0 109.738 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 94.8 p -148.03 159.9 43.42 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.023 0.929 . . . . 0.0 113.198 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -170.49 148.47 11.54 Favored Glycine 0 N--CA 1.463 0.46 0 CA-C-N 115.738 -0.664 . . . . 0.0 114.316 177.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 58.4 mtm180 -110.33 148.77 31.29 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 125.937 1.695 . . . . 0.0 110.271 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt . . . . . 0 N--CA 1.473 0.703 0 C-N-CA 125.551 1.54 . . . . 0.0 114.053 176.827 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.6 m . . . . . 0 N--CA 1.477 0.908 0 CA-C-O 119.367 -0.349 . . . . 0.0 110.349 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -34.47 -74.98 0.07 OUTLIER Glycine 0 N--CA 1.471 0.991 0 C-N-CA 126.715 2.102 . . . . 0.0 117.518 -175.009 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.564 ' HB3' ' HB ' ' A' ' 105' ' ' VAL . . . -165.63 91.83 0.51 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.329 1.052 . . . . 0.0 111.51 -174.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.428 ' H ' ' CB ' ' A' ' 53' ' ' SER . 20.4 t -140.11 122.38 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 O-C-N 120.566 -1.333 . . . . 0.0 112.616 -175.022 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.482 ' HB1' ' CD1' ' A' ' 51' ' ' PHE . . . -155.38 167.6 29.86 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 122.353 1.073 . . . . 0.0 112.882 176.223 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -146.16 149.97 34.99 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 124.064 0.946 . . . . 0.0 109.84 174.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -151.2 174.12 13.62 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 121.039 -1.038 . . . . 0.0 110.356 178.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.508 ' HB3' HD11 ' A' ' 47' ' ' LEU . . . -138.21 150.61 46.9 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-O 121.176 0.512 . . . . 0.0 112.358 176.235 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -129.63 117.1 19.84 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 126.939 2.096 . . . . 0.0 112.597 -175.006 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -80.89 99.72 8.49 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -174.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 20.2 mtm -72.0 127.42 32.51 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.415 1.086 . . . . 0.0 112.237 178.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.6 m -57.56 -18.88 21.79 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.851 1.26 . . . . 0.0 113.414 174.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -64.27 -28.13 69.51 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.631 1.572 . . . . 0.0 112.139 174.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 120.07 19.19 4.03 Favored Glycine 0 CA--C 1.538 1.502 0 C-N-CA 125.819 1.676 . . . . 0.0 115.229 -178.249 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -128.04 175.82 8.1 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 119.14 1.47 . . . . 0.0 110.899 -178.156 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 22.7 m -134.48 103.91 5.89 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 121.064 -1.022 . . . . 0.0 111.621 176.03 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 42.1 tp -68.82 103.49 1.79 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.729 0.812 . . . . 0.0 112.026 175.031 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -91.71 96.18 2.14 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 126.316 1.912 . . . . 0.0 110.858 175.038 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 53.8 t -79.93 136.97 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 O-C-N 121.895 -0.768 . . . . 0.0 110.771 175.04 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.74 141.1 47.37 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.287 1.035 . . . . 0.0 111.593 176.659 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.47 ' CZ ' ' HB3' ' A' ' 87' ' ' ALA . 3.4 p90 -153.64 120.08 5.52 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 120.887 -1.133 . . . . 0.0 111.501 -174.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 32.8 t -127.47 107.24 9.78 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.915 1.286 . . . . 0.0 110.987 -177.059 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.564 ' HB ' ' HB3' ' A' ' 85' ' ' ALA . 4.4 t . . . . . 0 CA--C 1.542 0.654 0 C-N-CA 126.599 1.96 . . . . 0.0 108.674 -176.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 55.0 m . . . . . 0 N--CA 1.471 0.613 0 CA-C-O 120.258 0.075 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -137.76 107.1 6.1 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.645 1.178 . . . . 0.0 110.66 -178.48 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 41.5 m0 -109.83 162.36 14.56 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 125.284 1.434 . . . . 0.0 113.442 -174.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 61.0 p-90 -145.57 132.41 20.1 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.776 0.798 . . . . 0.0 112.273 177.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -144.25 174.47 10.86 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.826 1.65 . . . . 0.0 111.652 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.445 HG22 ' SD ' ' A' ' 158' ' ' MET . 2.5 m -145.03 159.72 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 175.101 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.63 170.97 14.93 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.764 0.826 . . . . 0.0 111.045 175.051 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.423 ' HB ' ' CE2' ' A' ' 154' ' ' TYR . 45.5 mt -131.54 104.6 8.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 176.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -71.97 148.91 92.2 Favored Pre-proline 0 CA--C 1.55 0.964 0 O-C-N 121.938 -0.476 . . . . 0.0 110.94 178.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -77.87 82.67 2.36 Favored 'Trans proline' 0 CA--C 1.545 1.037 0 C-N-CA 123.802 3.002 . . . . 0.0 112.37 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 98.54 178.03 32.56 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 125.958 1.742 . . . . 0.0 112.892 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 5.9 mttt -47.7 122.02 4.54 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.116 1.366 . . . . 0.0 112.508 -174.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -135.23 -161.55 1.16 Allowed 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 126.608 1.963 . . . . 0.0 111.433 -177.414 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 23.5 ptt-85 -140.17 -178.17 5.35 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 128.553 2.741 . . . . 0.0 109.181 175.008 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -131.67 124.21 29.38 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 174.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -135.72 168.66 18.87 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.375 1.07 . . . . 0.0 111.162 178.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.93 -40.77 73.62 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.538 -0.726 . . . . 0.0 112.5 -176.418 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -57.22 -58.64 13.56 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 124.53 1.062 . . . . 0.0 112.177 175.005 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 3.3 mpp? -59.58 -32.67 70.58 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 118.528 1.164 . . . . 0.0 112.5 177.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.27 -63.2 1.31 Allowed 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 175.035 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -67.17 -30.03 69.88 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -175.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -64.78 -43.46 93.17 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.219 1.008 . . . . 0.0 112.101 175.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.15 -25.81 23.91 Favored 'General case' 0 CA--C 1.546 0.799 0 O-C-N 121.558 -0.714 . . . . 0.0 112.558 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -47.2 -53.65 12.64 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 127.744 2.418 . . . . 0.0 111.859 175.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -63.39 -15.61 58.05 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -74.03 -32.4 58.67 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 128.312 2.863 . . . . 0.0 115.666 -175.003 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -129.15 90.23 45.82 Favored Pre-proline 0 CA--C 1.546 0.826 0 CA-C-N 119.032 1.416 . . . . 0.0 111.274 175.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -73.2 83.35 1.47 Allowed 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 123.58 2.853 . . . . 0.0 112.87 -176.234 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -122.46 122.28 38.6 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.739 1.215 . . . . 0.0 112.05 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -104.31 63.91 0.75 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.736 1.614 . . . . 0.0 111.276 -174.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 51.38 60.05 7.71 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 123.971 0.796 . . . . 0.0 112.683 -175.041 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.83 101.81 3.24 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 126.186 1.794 . . . . 0.0 112.362 -175.115 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -74.03 55.13 0.55 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 127.627 2.371 . . . . 0.0 116.516 -174.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -166.29 43.78 0.27 Allowed Glycine 0 CA--C 1.533 1.202 0 O-C-N 120.921 -1.112 . . . . 0.0 115.672 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 1.1 m95 52.65 40.51 30.32 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 125.276 1.43 . . . . 0.0 113.773 -176.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -78.9 124.06 27.87 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 126.099 1.76 . . . . 0.0 112.123 -176.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -167.89 -171.54 1.61 Allowed 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.781 0.832 . . . . 0.0 111.785 177.009 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 4.8 mtpp -138.18 160.91 38.18 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 127.89 2.476 . . . . 0.0 110.977 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 37.7 m-20 -67.26 152.5 45.62 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 122.144 -0.347 . . . . 0.0 110.426 174.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 37.6 mt -108.09 162.03 14.42 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 122.19 0.995 . . . . 0.0 109.06 175.027 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -62.45 -167.47 0.68 Allowed Glycine 0 CA--C 1.536 1.358 0 C-N-CA 124.512 1.053 . . . . 0.0 111.616 175.031 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.423 ' CE2' ' HB ' ' A' ' 120' ' ' ILE . 0.0 OUTLIER 55.09 6.28 0.13 Allowed 'General case' 0 CA--C 1.558 1.281 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 174.957 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 82.02 44.88 7.4 Favored Glycine 0 CA--C 1.54 1.607 0 C-N-CA 127.438 2.447 . . . . 0.0 114.427 -175.011 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.1 mp -127.82 158.03 38.84 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 119.866 1.833 . . . . 0.0 113.123 -178.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -124.65 117.31 23.97 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 121.061 -1.024 . . . . 0.0 110.478 175.56 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' MET . . . . . 0.445 ' SD ' HG22 ' A' ' 118' ' ' VAL . 0.0 OUTLIER -98.21 150.24 21.71 Favored 'General case' 0 C--N 1.322 -0.623 0 O-C-N 120.623 -1.298 . . . . 0.0 108.784 174.996 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -131.4 149.02 52.71 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 127.076 2.151 . . . . 0.0 110.35 176.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -157.52 159.39 29.77 Favored Glycine 0 N--CA 1.464 0.525 0 O-C-N 121.542 -0.724 . . . . 0.0 113.446 176.254 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.43 HD13 ' N ' ' A' ' 162' ' ' MET . 0.0 OUTLIER -155.15 137.54 6.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 125.222 1.409 . . . . 0.0 109.894 -178.174 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 162' ' ' MET . . . . . 0.43 ' N ' HD13 ' A' ' 161' ' ' ILE . 2.5 mtm -150.1 167.22 27.44 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 127.388 2.275 . . . . 0.0 108.345 174.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 9.7 t -145.42 133.45 21.42 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 118.942 0.792 . . . . 0.0 109.858 174.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 81.9 p -82.05 30.05 0.4 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.526 1.131 . . . . 0.0 113.729 -176.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -65.61 21.64 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 128.322 2.649 . . . . 0.0 115.432 -177.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 79.84 -44.19 2.73 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 127.554 2.502 . . . . 0.0 113.333 -177.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -143.18 77.24 1.56 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.351 1.46 . . . . 0.0 110.153 -177.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -130.71 166.35 20.93 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.033 1.333 . . . . 0.0 114.047 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.14 169.74 10.38 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 126.948 2.099 . . . . 0.0 113.782 -176.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' MET . . . . . 0.408 ' HE2' HD13 ' A' ' 172' ' ' ILE . 11.3 ttt -115.87 145.79 42.57 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.255 1.822 . . . . 0.0 110.891 173.322 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.45 ' C ' HD12 ' A' ' 172' ' ' ILE . 24.8 tt0 -149.32 119.14 7.06 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 120.753 -1.217 . . . . 0.0 110.237 174.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.45 HD12 ' C ' ' A' ' 171' ' ' GLN . 1.8 mp -121.25 130.56 74.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 125.485 1.514 . . . . 0.0 108.267 178.702 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.8 137.79 43.68 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.876 1.27 . . . . 0.0 110.448 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.6 mp -95.3 95.13 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-N 119.352 0.978 . . . . 0.0 109.518 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 19.3 m -64.55 138.62 58.51 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.981 1.312 . . . . 0.0 111.79 175.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 7.0 mtp180 . . . . . 0 C--O 1.253 1.26 0 O-C-N 120.238 -1.539 . . . . 0.0 112.608 174.938 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.672 HD13 ' HB2' ' A' ' 31' ' ' LYS . 2.6 mt . . . . . 0 N--CA 1.477 0.882 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.45 ' HB1' ' HB3' ' A' ' 71' ' ' LEU . . . -113.21 126.77 55.78 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 127.544 2.338 . . . . 0.0 111.391 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -79.69 -121.54 0.37 Allowed Glycine 0 CA--C 1.536 1.402 0 C-N-CA 125.036 1.303 . . . . 0.0 112.79 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 30.8 p -94.78 171.57 8.69 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.754 1.222 . . . . 0.0 112.397 177.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -130.53 12.32 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 C-N-CA 125.764 1.626 . . . . 0.0 112.002 177.217 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.6 pp -58.63 172.03 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 O-C-N 120.563 -1.336 . . . . 0.0 112.103 176.117 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -35.38 129.39 0.54 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.798 2.039 . . . . 0.0 114.729 -175.405 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -55.57 -21.81 29.57 Favored Glycine 0 CA--C 1.537 1.424 0 C-N-CA 124.673 1.13 . . . . 0.0 114.444 -178.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.1 -31.76 72.25 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.874 1.269 . . . . 0.0 112.048 174.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -100.7 -36.61 9.06 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.963 1.705 . . . . 0.0 112.059 175.288 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.451 HD23 ' HB3' ' A' ' 69' ' ' ALA . 12.5 tp -79.0 86.16 4.88 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-O 122.1 0.952 . . . . 0.0 110.562 174.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -121.23 178.21 4.86 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 127.565 2.346 . . . . 0.0 112.131 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -42.28 -45.3 4.14 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.562 1.545 . . . . 0.0 113.765 174.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -53.4 -43.53 67.96 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 118.934 0.788 . . . . 0.0 112.449 178.019 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 86.6 t -64.11 -43.96 97.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.738 1.215 . . . . 0.0 110.799 174.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 68.1 mt -63.82 -41.8 97.78 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.2 -0.938 . . . . 0.0 111.737 179.193 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -67.28 -44.63 78.81 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.734 1.214 . . . . 0.0 112.576 178.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.08 -37.77 78.65 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 121.476 -0.765 . . . . 0.0 111.357 175.011 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.9 t -56.67 -38.11 56.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.951 1.3 . . . . 0.0 110.956 178.285 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.676 HD23 ' HD2' ' A' ' 31' ' ' LYS . 11.1 mt -56.65 -25.89 54.78 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.499 1.519 . . . . 0.0 113.239 175.017 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -106.28 -46.52 1.15 Allowed Glycine 0 CA--C 1.534 1.243 0 C-N-CA 125.566 1.555 . . . . 0.0 114.692 -178.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -63.96 -27.97 69.5 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 119.243 1.521 . . . . 0.0 113.288 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 19.7 mt -96.54 76.8 2.9 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.9 1.28 . . . . 0.0 110.635 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.59 114.9 5.09 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 126.14 1.829 . . . . 0.0 112.387 178.123 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -132.47 -74.03 0.51 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.655 1.582 . . . . 0.0 111.919 -179.079 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.3 m -131.68 177.79 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 126.419 1.887 . . . . 0.0 111.129 -177.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.87 -30.08 68.75 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -177.236 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.79 117.01 10.07 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.755 1.622 . . . . 0.0 111.443 178.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.676 ' HD2' HD23 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -124.24 152.56 42.82 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 125.399 1.48 . . . . 0.0 109.559 -177.845 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -114.62 133.06 61.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 123.58 0.752 . . . . 0.0 109.438 177.141 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -134.91 104.77 6.11 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 127.119 2.167 . . . . 0.0 109.795 176.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.704 HG22 ' HB2' ' A' ' 72' ' ' TYR . 1.4 m -103.82 160.77 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 123.517 0.727 . . . . 0.0 110.358 178.087 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -138.64 109.83 0.69 Allowed Glycine 0 CA--C 1.519 0.328 0 CA-C-N 118.645 0.657 . . . . 0.0 112.69 174.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.482 ' HB ' HD11 ' A' ' 70' ' ' LEU . 3.1 mp -103.96 139.14 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-N 117.313 0.556 . . . . 0.0 110.724 176.269 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -110.55 104.16 12.85 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.006 1.322 . . . . 0.0 110.704 -177.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 45.7 t-20 -72.6 91.5 1.43 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 127.162 2.185 . . . . 0.0 110.616 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -120.88 9.24 10.61 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.498 1.519 . . . . 0.0 113.331 174.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 37.5 t -50.94 -47.04 61.16 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 125.987 1.715 . . . . 0.0 113.672 177.291 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 139.99 -21.41 2.82 Favored Glycine 0 N--CA 1.473 1.161 0 C-N-CA 124.452 1.025 . . . . 0.0 114.208 175.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -122.56 167.18 14.97 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 125.724 1.631 . . . . 0.0 111.564 174.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.656 HG22 ' HA ' ' A' ' 65' ' ' PRO . 44.3 p -74.28 145.71 43.78 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.177 0.513 . . . . 0.0 110.674 174.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 49.5 m0 -98.95 104.71 16.78 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 123.593 0.757 . . . . 0.0 110.898 178.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.0 m -82.67 125.3 31.06 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.186 0.994 . . . . 0.0 110.117 176.033 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.79 117.51 5.95 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.109 0.964 . . . . 0.0 111.309 174.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.551 HD12 ' N ' ' A' ' 48' ' ' ASN . 4.6 pp -98.23 -48.99 4.87 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.483 0.713 . . . . 0.0 112.758 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.551 ' N ' HD12 ' A' ' 47' ' ' LEU . 10.4 t30 -174.56 152.17 1.63 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 128.213 2.605 . . . . 0.0 109.263 -177.029 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -136.38 160.54 38.43 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.616 1.166 . . . . 0.0 111.793 174.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -137.78 107.48 6.24 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.653 1.181 . . . . 0.0 112.284 -179.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.497 ' CD1' ' HB1' ' A' ' 87' ' ' ALA . 2.9 m-85 -107.94 128.7 54.87 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.421 1.088 . . . . 0.0 110.987 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.66 -34.27 5.57 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -176.712 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.9 t -121.47 -49.46 2.14 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 125.602 1.561 . . . . 0.0 110.594 176.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -66.91 12.56 0.54 Allowed Glycine 0 CA--C 1.536 1.373 0 C-N-CA 125.911 1.72 . . . . 0.0 115.658 -176.111 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 74.6 p -30.95 109.39 0.06 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 129.089 2.956 . . . . 0.0 114.271 -174.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.529 HG21 HG23 ' A' ' 59' ' ' ILE . 2.5 t -129.25 179.17 5.93 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.437 1.495 . . . . 0.0 113.215 -175.016 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -78.77 -59.15 2.89 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.994 1.718 . . . . 0.0 112.225 174.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.9 p -143.42 136.64 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 125.597 1.559 . . . . 0.0 111.977 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.529 HG23 HG21 ' A' ' 56' ' ' THR . 1.4 pp -140.2 -26.3 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 126.07 1.748 . . . . 0.0 114.296 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -99.22 93.54 2.22 Favored Pre-proline 0 CA--C 1.541 0.611 0 C-N-CA 125.212 1.405 . . . . 0.0 108.995 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -61.64 143.06 96.37 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.775 2.316 . . . . 0.0 110.389 174.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -40.11 -48.92 2.56 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.429 1.891 . . . . 0.0 113.84 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.7 p -156.1 138.66 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 127.295 2.238 . . . . 0.0 109.188 175.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.468 HG21 HD23 ' A' ' 70' ' ' LEU . 22.0 t -112.27 121.99 37.79 Favored Pre-proline 0 N--CA 1.477 0.897 0 C-N-CA 124.233 1.013 . . . . 0.0 108.902 175.074 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.656 ' HA ' HG22 ' A' ' 43' ' ' THR . 58.6 Cg_endo -67.8 157.78 60.23 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 122.015 1.81 . . . . 0.0 112.946 177.186 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -71.65 168.58 17.39 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.575 0.75 . . . . 0.0 111.52 175.017 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 43.7 p 54.44 19.11 2.18 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 127.286 2.234 . . . . 0.0 113.79 -174.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.8 mttt -134.29 171.72 13.87 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 126.918 2.087 . . . . 0.0 110.951 -175.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.451 ' HB3' HD23 ' A' ' 13' ' ' LEU . . . -127.97 177.16 7.06 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.071 0.462 . . . . 0.0 110.146 -175.005 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.482 HD11 ' HB ' ' A' ' 36' ' ' ILE . 1.9 pp -142.84 173.47 11.52 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 124.181 0.992 . . . . 0.0 111.255 -178.311 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.526 HD13 ' O ' ' A' ' 34' ' ' VAL . 0.5 OUTLIER -132.47 151.62 51.83 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.937 1.295 . . . . 0.0 111.007 174.964 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.704 ' HB2' HG22 ' A' ' 34' ' ' VAL . 4.2 m-85 -124.14 146.04 48.91 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.162 0.985 . . . . 0.0 108.595 174.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.8 p -121.28 137.1 54.84 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 126.401 1.88 . . . . 0.0 110.997 175.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.606 ' H ' HD12 ' A' ' 3' ' ' LEU . . . -160.95 133.34 3.17 Favored Glycine 0 CA--C 1.525 0.7 0 O-C-N 121.785 -0.572 . . . . 0.0 113.822 174.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 26.3 mtm180 -90.68 149.7 21.96 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.946 1.298 . . . . 0.0 110.988 -174.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 9.9 ptmt . . . . . 0 N--CA 1.48 1.075 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 174.961 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 97.7 m . . . . . 0 N--CA 1.478 0.948 0 CA-C-O 118.745 -0.645 . . . . 0.0 109.62 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -26.05 -68.07 0.05 OUTLIER Glycine 0 N--CA 1.48 1.628 0 C-N-CA 127.422 2.439 . . . . 0.0 115.013 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -177.58 135.79 0.19 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.371 1.868 . . . . 0.0 111.82 175.009 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.9 t -154.85 129.42 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 125.139 1.376 . . . . 0.0 109.094 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.497 ' HB1' ' CD1' ' A' ' 51' ' ' PHE . . . -173.32 174.48 3.32 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.442 1.497 . . . . 0.0 111.732 177.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -151.18 141.49 22.36 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.108 1.363 . . . . 0.0 110.169 174.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -138.45 171.52 14.25 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 121.233 -0.917 . . . . 0.0 111.231 178.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.501 ' HB3' HD11 ' A' ' 47' ' ' LEU . . . -139.43 156.24 47.09 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.391 0.615 . . . . 0.0 112.551 177.584 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -135.08 129.09 33.44 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 125.833 1.653 . . . . 0.0 112.421 -174.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -83.4 135.11 34.82 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -176.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.24 138.18 44.96 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 125.086 1.355 . . . . 0.0 111.917 178.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.8 t -62.8 -22.5 66.67 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.493 1.117 . . . . 0.0 113.164 176.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -67.41 -16.15 64.07 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.121 1.368 . . . . 0.0 113.321 175.002 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 101.28 33.89 4.71 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 124.845 1.212 . . . . 0.0 114.558 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.559 ' HB3' HG22 ' A' ' 120' ' ' ILE . 48.3 m-80 -140.6 177.07 8.28 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-N 119.204 1.502 . . . . 0.0 110.95 177.528 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.473 HG23 HD21 ' A' ' 47' ' ' LEU . 19.2 m -130.67 105.83 8.08 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.668 1.587 . . . . 0.0 112.457 -176.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 59.6 tp -68.4 104.42 1.89 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.715 1.206 . . . . 0.0 111.271 175.047 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -99.32 116.95 5.72 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 125.947 1.737 . . . . 0.0 113.084 179.117 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 57.3 t -105.14 129.07 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 126.218 1.807 . . . . 0.0 111.341 -174.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -127.12 130.24 49.44 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.673 1.589 . . . . 0.0 112.273 -174.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.445 ' CZ ' ' HB3' ' A' ' 87' ' ' ALA . 5.4 p90 -146.02 140.56 26.91 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.644 1.177 . . . . 0.0 112.484 -176.03 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.28 123.37 10.79 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.181 1.392 . . . . 0.0 111.967 -174.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 96.4 t . . . . . 0 N--CA 1.481 1.084 0 C-N-CA 125.065 1.346 . . . . 0.0 111.686 -177.432 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.4 m . . . . . 0 N--CA 1.468 0.461 0 CA-C-O 121.186 0.517 . . . . 0.0 111.623 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -73.36 117.68 15.4 Favored 'General case' 0 C--O 1.226 -0.18 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 174.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 34.4 m0 -113.68 143.59 44.35 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 176.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 37.3 p-90 -148.85 138.58 21.99 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.206 1.002 . . . . 0.0 111.268 -177.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -150.04 162.86 39.57 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 122.801 1.286 . . . . 0.0 113.279 -177.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 61.7 t -145.53 144.34 21.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 124.24 1.016 . . . . 0.0 108.311 175.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.448 ' HE2' ' SD ' ' A' ' 135' ' ' MET . 0.0 OUTLIER -155.9 176.71 12.28 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.908 1.683 . . . . 0.0 110.141 175.577 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.559 HG22 ' HB3' ' A' ' 97' ' ' ASN . 11.7 mt -126.32 99.59 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-O 121.86 0.838 . . . . 0.0 108.955 178.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -59.68 148.25 75.64 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 124.105 0.962 . . . . 0.0 111.84 178.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -70.5 135.54 28.94 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.986 2.457 . . . . 0.0 111.838 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 59.13 -157.82 22.42 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 124.057 0.837 . . . . 0.0 113.528 -177.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 9.9 tttt -72.75 120.02 17.78 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.975 0.91 . . . . 0.0 108.735 174.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 25.0 tpp180 -130.68 169.62 15.42 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 125.868 1.667 . . . . 0.0 109.447 175.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 25.6 ptt180 -119.89 175.33 5.95 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 126.549 1.94 . . . . 0.0 110.6 174.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -120.3 108.11 13.77 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 175.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -126.27 165.7 18.48 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.901 1.28 . . . . 0.0 110.01 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -55.66 -36.81 67.49 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 121.302 -0.874 . . . . 0.0 113.203 -176.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -59.7 -61.29 7.39 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.442 -0.663 . . . . 0.0 111.442 174.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -62.98 -33.11 74.7 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 118.367 1.084 . . . . 0.0 112.833 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -58.35 -63.11 1.39 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.625 1.17 . . . . 0.0 108.987 174.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -69.27 -27.2 65.22 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -177.218 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -68.23 -32.06 71.99 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.741 1.216 . . . . 0.0 113.418 175.017 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' MET . . . . . 0.448 ' SD ' ' HE2' ' A' ' 119' ' ' LYS . 0.7 OUTLIER -94.89 -25.48 16.56 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 121.274 -0.891 . . . . 0.0 112.076 176.667 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -51.99 -57.6 9.01 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.769 2.028 . . . . 0.0 110.02 174.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -67.22 -10.19 48.01 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 113.526 0.935 . . . . 0.0 113.526 -178.467 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -83.6 -16.03 69.45 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 126.638 2.066 . . . . 0.0 114.273 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -142.14 87.26 9.76 Favored Pre-proline 0 CA--C 1.549 0.925 0 CA-C-N 118.661 1.231 . . . . 0.0 112.001 179.293 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.95 77.97 1.85 Allowed 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 123.675 2.916 . . . . 0.0 112.472 177.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -108.59 115.05 29.36 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.32 1.448 . . . . 0.0 109.826 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 9.5 mtp180 -92.93 26.88 2.6 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 126.909 2.083 . . . . 0.0 115.969 -174.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 62.38 59.69 9.01 Favored Glycine 0 CA--C 1.531 1.051 0 N-CA-C 109.106 -1.597 . . . . 0.0 109.106 -175.001 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -64.28 105.81 0.98 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.182 0.993 . . . . 0.0 110.006 176.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -68.02 83.48 0.22 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.213 1.405 . . . . 0.0 114.33 -174.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 170.24 48.71 0.03 OUTLIER Glycine 0 CA--C 1.537 1.462 0 C-N-CA 124.967 1.27 . . . . 0.0 114.468 177.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' TRP . . . . . 0.56 ' H ' HD13 ' A' ' 161' ' ' ILE . 2.2 m95 54.65 44.09 29.16 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 125.782 1.633 . . . . 0.0 114.728 -177.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -79.62 130.62 35.53 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 120.61 -1.306 . . . . 0.0 112.77 -175.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' GLN . . . . . 0.419 ' HG3' ' HA ' ' A' ' 159' ' ' LYS . 0.0 OUTLIER -160.02 -175.16 4.93 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -175.015 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.2 pttt -131.0 156.72 44.64 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.194 1.397 . . . . 0.0 111.672 174.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 28.6 m-80 -78.14 124.17 27.74 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 174.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 69.3 mt -81.52 149.11 28.85 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 122.201 1.001 . . . . 0.0 109.33 174.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -66.08 -166.48 2.04 Favored Glycine 0 CA--C 1.535 1.303 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 174.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.52 ' CE1' ' HB ' ' A' ' 120' ' ' ILE . 0.0 OUTLIER 54.3 11.49 0.4 Allowed 'General case' 0 CA--C 1.557 1.233 0 N-CA-C 114.988 1.477 . . . . 0.0 114.988 174.969 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 84.94 37.3 10.26 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 126.542 2.02 . . . . 0.0 113.208 -178.067 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.7 mp -122.74 160.21 26.41 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 119.843 1.822 . . . . 0.0 113.038 -178.432 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 72.2 mtt85 -149.06 109.77 4.26 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 120.636 -1.29 . . . . 0.0 111.082 -178.021 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' MET . . . . . 0.451 ' SD ' HG21 ' A' ' 172' ' ' ILE . 9.0 ttp -104.73 132.77 50.58 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 124.025 0.93 . . . . 0.0 108.893 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.419 ' HA ' ' HG3' ' A' ' 149' ' ' GLN . 7.1 tppt? -111.14 129.65 55.87 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 127.967 2.507 . . . . 0.0 110.593 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -137.21 156.17 23.25 Favored Glycine 0 N--CA 1.474 1.208 0 CA-C-N 120.7 1.591 . . . . 0.0 115.959 -177.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.56 HD13 ' H ' ' A' ' 147' ' ' TRP . 4.5 tp -148.58 127.8 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 124.77 1.228 . . . . 0.0 112.069 -175.62 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 16.1 mtm -151.5 169.81 21.17 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 128.489 2.716 . . . . 0.0 109.892 174.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 14.5 t -156.23 135.27 12.0 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.714 1.606 . . . . 0.0 109.597 174.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 61.7 p -81.32 20.04 0.9 Allowed 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 179.021 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.85 -34.7 65.68 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.486 1.914 . . . . 0.0 115.108 -177.057 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 154.01 -63.45 0.36 Allowed Glycine 0 CA--C 1.533 1.176 0 C-N-CA 124.386 0.993 . . . . 0.0 114.29 176.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -119.79 27.82 8.49 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 125.718 1.607 . . . . 0.0 112.669 -175.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -64.03 174.59 1.47 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.839 1.255 . . . . 0.0 113.269 174.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.57 168.14 13.01 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.735 2.014 . . . . 0.0 111.248 177.015 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 48.5 ttp -111.51 123.87 51.11 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.816 1.246 . . . . 0.0 110.45 176.25 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -137.46 128.02 26.77 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 123.255 0.622 . . . . 0.0 110.325 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.451 HG21 ' SD ' ' A' ' 158' ' ' MET . 5.1 mp -134.9 119.27 27.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 123.461 0.704 . . . . 0.0 109.853 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -114.57 134.96 54.64 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.188 1.395 . . . . 0.0 111.067 177.436 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.8 mp -81.83 129.97 36.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 O-C-N 120.906 -1.121 . . . . 0.0 109.013 175.001 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -137.93 94.43 2.89 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.854 1.262 . . . . 0.0 112.328 177.163 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 72.1 mtp180 . . . . . 0 C--O 1.252 1.185 0 C-N-CA 126.604 1.961 . . . . 0.0 113.245 175.002 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.559 HD11 ' HG3' ' A' ' 31' ' ' LYS . 3.0 mm? . . . . . 0 N--CA 1.48 1.059 0 N-CA-C 115.724 1.75 . . . . 0.0 115.724 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.54 78.67 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.121 1.368 . . . . 0.0 112.425 175.009 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -72.63 -66.3 2.1 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 125.984 1.754 . . . . 0.0 112.238 -175.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 39.7 p -142.61 166.83 23.59 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.73 1.612 . . . . 0.0 112.097 176.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -131.48 10.06 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 125.993 1.717 . . . . 0.0 112.607 175.159 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.524 HD12 ' HB3' ' A' ' 12' ' ' SER . 1.0 OUTLIER -53.67 163.32 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 O-C-N 120.223 -1.548 . . . . 0.0 112.648 177.017 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -38.92 136.29 0.79 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 127.001 2.121 . . . . 0.0 113.82 -174.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -55.38 -21.22 26.03 Favored Glycine 0 CA--C 1.54 1.605 0 C-N-CA 124.858 1.218 . . . . 0.0 114.399 -176.077 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.66 -29.04 69.81 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.032 1.333 . . . . 0.0 112.577 174.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.524 ' HB3' HD12 ' A' ' 8' ' ' ILE . 20.5 t -104.99 -43.98 4.92 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.808 1.643 . . . . 0.0 111.299 175.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.4 tp -75.16 93.47 2.81 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.81 0.844 . . . . 0.0 111.537 175.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 44.1 p -130.69 -177.99 4.59 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 126.901 2.081 . . . . 0.0 111.583 177.47 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -39.89 -43.99 1.58 Allowed 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 127.207 2.203 . . . . 0.0 113.59 175.022 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -54.67 -41.44 70.19 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.651 0.78 . . . . 0.0 112.055 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.0 t -68.35 -38.19 79.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.804 1.242 . . . . 0.0 111.233 175.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 24.5 mt -68.62 -42.47 78.03 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 121.355 -0.841 . . . . 0.0 111.414 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -65.38 -50.45 65.46 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.498 1.119 . . . . 0.0 111.915 178.467 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.13 -33.88 76.42 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 118.876 -0.583 . . . . 0.0 112.062 174.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.9 t -55.38 -47.0 78.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 124.85 1.26 . . . . 0.0 112.355 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.82 -23.86 46.88 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 119.838 1.199 . . . . 0.0 113.022 175.035 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -82.45 -61.44 1.98 Allowed Glycine 0 CA--C 1.534 1.233 0 C-N-CA 126.049 1.785 . . . . 0.0 112.919 174.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -66.49 -35.86 81.31 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -177.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -94.88 73.65 3.54 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 122.773 1.273 . . . . 0.0 110.468 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -76.2 64.13 2.82 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 126.302 1.906 . . . . 0.0 115.151 -174.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.506 ' HD2' HD22 ' A' ' 3' ' ' LEU . 6.1 mttt -55.59 -75.47 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 126.69 1.996 . . . . 0.0 113.972 178.303 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 18.0 m -141.77 -179.37 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 127.438 2.295 . . . . 0.0 110.708 178.211 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 36.8 m -52.39 -34.31 47.43 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 126.721 2.009 . . . . 0.0 114.878 -177.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.8 mmp_? -136.7 111.99 9.14 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 127.23 2.212 . . . . 0.0 109.185 175.003 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.559 ' HG3' HD11 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -123.0 166.06 15.72 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.381 1.472 . . . . 0.0 110.543 178.696 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -128.85 123.16 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 123.949 0.9 . . . . 0.0 110.911 -178.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -120.13 118.17 29.86 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.883 1.673 . . . . 0.0 109.806 175.003 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.402 HG22 ' HB2' ' A' ' 72' ' ' TYR . 2.4 m -124.47 148.4 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 122.715 0.406 . . . . 0.0 110.602 175.034 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -121.52 111.06 1.78 Allowed Glycine 0 C--N 1.329 0.16 0 C-N-CA 124.285 0.945 . . . . 0.0 111.044 -178.025 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 mp -100.24 139.94 20.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 117.703 0.752 . . . . 0.0 109.282 175.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -114.91 101.91 9.48 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.893 1.277 . . . . 0.0 109.305 -178.027 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 40.9 t-20 -73.68 107.17 5.78 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.051 1.34 . . . . 0.0 110.515 -178.206 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -135.12 19.27 3.43 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.386 1.474 . . . . 0.0 111.8 175.634 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.8 p -76.19 178.21 6.59 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.072 1.749 . . . . 0.0 112.433 176.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -91.25 56.06 3.2 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 126.379 1.942 . . . . 0.0 113.167 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 157.34 137.5 2.31 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.453 1.025 . . . . 0.0 113.636 177.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.79 HG22 ' HA ' ' A' ' 65' ' ' PRO . 37.9 p -62.47 141.19 58.51 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.456 0.702 . . . . 0.0 110.428 175.022 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.445 ' HB3' ' CD1' ' A' ' 91' ' ' TYR . 30.0 m0 -97.56 109.2 22.0 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.694 0.283 . . . . 0.0 111.553 178.012 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 37.4 m -87.75 142.74 27.59 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.172 0.589 . . . . 0.0 109.541 175.035 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.67 126.86 29.38 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.689 0.796 . . . . 0.0 111.457 174.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.56 HD12 ' N ' ' A' ' 48' ' ' ASN . 4.1 pp -116.7 -58.6 2.06 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.271 1.028 . . . . 0.0 111.854 177.532 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.56 ' N ' HD12 ' A' ' 47' ' ' LEU . 13.1 t30 -176.07 152.38 1.17 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 127.215 2.206 . . . . 0.0 110.617 -177.009 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -134.28 158.84 42.74 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.151 1.38 . . . . 0.0 111.063 175.021 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 91.2 t80 -140.04 100.21 3.87 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.036 1.334 . . . . 0.0 112.169 -175.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.477 ' CD1' ' HB1' ' A' ' 87' ' ' ALA . 3.8 m-30 -105.04 124.26 49.23 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.559 1.144 . . . . 0.0 111.614 -175.006 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.71 -37.4 7.92 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -177.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 29.5 t -120.61 -49.59 2.23 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.33 1.452 . . . . 0.0 110.725 177.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -68.63 17.37 0.49 Allowed Glycine 0 CA--C 1.533 1.166 0 C-N-CA 126.587 2.042 . . . . 0.0 115.272 -175.013 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.2 p -35.52 121.02 0.59 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 128.739 2.816 . . . . 0.0 112.995 -175.042 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -139.13 172.4 12.89 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.651 1.181 . . . . 0.0 113.571 -174.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -76.82 -68.85 0.56 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.524 1.53 . . . . 0.0 113.309 175.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.7 p -135.9 129.67 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 125.126 1.371 . . . . 0.0 112.425 -176.457 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -138.43 -34.3 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.672 1.589 . . . . 0.0 114.443 -175.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 48.5 mt -91.33 104.14 9.15 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 125.169 1.388 . . . . 0.0 109.621 175.085 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -72.52 165.24 33.26 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.763 2.975 . . . . 0.0 110.413 175.141 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -47.57 -44.23 26.08 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.9 p -157.81 152.26 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 127.014 2.125 . . . . 0.0 110.057 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.526 ' HA ' ' HE3' ' A' ' 68' ' ' LYS . 60.5 t -126.89 99.14 29.56 Favored Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 126.375 1.87 . . . . 0.0 106.778 175.491 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.79 ' HA ' HG22 ' A' ' 43' ' ' THR . 42.2 Cg_endo -69.71 171.62 14.08 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 120.97 1.113 . . . . 0.0 112.628 175.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -75.71 166.13 24.0 Favored 'General case' 0 CA--C 1.548 0.869 0 O-C-N 121.297 -0.877 . . . . 0.0 110.355 174.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . 0.276 5.8 p 62.39 18.27 10.15 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 128.058 2.543 . . . . 0.0 115.141 -177.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.526 ' HE3' ' HA ' ' A' ' 64' ' ' VAL . 0.0 OUTLIER -131.34 170.9 14.01 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 126.086 1.755 . . . . 0.0 111.585 -177.986 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -131.18 165.76 22.61 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-O 121.637 0.732 . . . . 0.0 111.633 177.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -134.79 171.45 14.36 Favored 'General case' 0 C--N 1.321 -0.667 0 O-C-N 120.225 -1.547 . . . . 0.0 110.806 175.006 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -112.91 162.83 15.38 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 125.315 1.446 . . . . 0.0 108.654 174.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.402 ' HB2' HG22 ' A' ' 34' ' ' VAL . 0.2 OUTLIER -136.55 149.66 48.22 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 125.118 1.367 . . . . 0.0 108.938 175.054 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 85.8 p -129.49 148.81 51.43 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.924 1.69 . . . . 0.0 112.191 -177.098 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -171.8 146.4 9.37 Favored Glycine 0 CA--C 1.521 0.45 0 N-CA-C 111.984 -0.446 . . . . 0.0 111.984 174.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 41.6 mtm-85 -108.31 150.44 27.32 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.784 1.234 . . . . 0.0 110.733 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.48 1.03 0 N-CA-C 114.934 1.457 . . . . 0.0 114.934 175.039 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 24.9 m . . . . . 0 N--CA 1.474 0.755 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -45.28 -67.41 1.23 Allowed Glycine 0 N--CA 1.473 1.127 0 C-N-CA 125.899 1.714 . . . . 0.0 113.888 -174.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -171.77 119.78 0.45 Allowed 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.482 1.113 . . . . 0.0 111.339 175.056 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.8 t -141.35 118.64 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 O-C-N 121.765 -0.585 . . . . 0.0 110.081 -178.129 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.482 ' HB3' ' CE1' ' A' ' 103' ' ' PHE . . . -155.66 157.9 37.42 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 122.53 1.157 . . . . 0.0 112.074 -179.168 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -137.5 147.99 45.66 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.88 1.272 . . . . 0.0 108.442 175.033 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -155.13 166.51 33.34 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 121.03 -1.044 . . . . 0.0 109.127 178.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.544 ' HB1' ' CG2' ' A' ' 98' ' ' THR . . . -137.4 156.16 48.51 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -179.537 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.445 ' CD1' ' HB3' ' A' ' 44' ' ' TRP . 2.3 m-85 -132.46 130.62 40.75 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.272 1.029 . . . . 0.0 113.504 -174.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -82.76 112.99 20.11 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -175.052 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -93.81 143.01 26.72 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.097 1.359 . . . . 0.0 113.107 -178.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.24 -20.67 64.48 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.556 1.142 . . . . 0.0 113.61 177.641 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 48.1 m-20 -67.53 -11.6 58.38 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.563 1.145 . . . . 0.0 112.727 174.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 96.58 27.03 10.11 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 124.993 1.282 . . . . 0.0 113.746 -178.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -132.5 172.84 11.97 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.986 1.314 . . . . 0.0 111.588 -176.221 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.544 ' CG2' ' HB1' ' A' ' 90' ' ' ALA . 3.5 m -126.38 107.57 10.41 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.06 1.344 . . . . 0.0 111.641 -179.361 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.0 tt -70.53 98.84 1.53 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.978 1.711 . . . . 0.0 111.918 179.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -94.19 97.07 2.13 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 124.765 1.174 . . . . 0.0 114.881 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 99.3 t -75.45 140.53 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.381 1.072 . . . . 0.0 110.123 174.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 3.1 tmm? -136.13 129.16 31.36 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.651 1.581 . . . . 0.0 110.348 177.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.482 ' CE1' ' HB3' ' A' ' 87' ' ' ALA . 22.7 p90 -144.79 142.85 30.3 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.442 -0.786 . . . . 0.0 112.426 175.002 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 13.2 m -142.9 114.48 8.01 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.395 1.078 . . . . 0.0 112.361 -177.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 26.1 t . . . . . 0 CA--C 1.538 0.488 0 C-N-CA 127.445 2.298 . . . . 0.0 109.229 178.496 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 31.7 m . . . . . 0 N--CA 1.463 0.199 0 CA-C-O 121.243 0.544 . . . . 0.0 111.378 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -67.51 101.39 0.98 Allowed 'General case' 0 C--O 1.223 -0.316 0 C-N-CA 125.041 1.336 . . . . 0.0 107.929 174.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 47.7 m0 -107.78 144.27 35.18 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 120.622 1.555 . . . . 0.0 110.185 176.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 43.9 p-90 -147.99 139.9 24.01 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.659 0.784 . . . . 0.0 111.509 -177.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -149.86 159.42 44.38 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 122.656 1.217 . . . . 0.0 112.294 -177.353 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 22.0 t -144.43 136.27 21.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 174.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.98 179.91 6.9 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 126.242 1.817 . . . . 0.0 109.191 176.206 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 10.5 mt -132.41 134.04 59.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 123.197 0.599 . . . . 0.0 109.399 176.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -90.43 151.68 44.6 Favored Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 125.329 1.452 . . . . 0.0 112.493 177.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.74 139.9 28.48 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 123.198 2.599 . . . . 0.0 110.939 174.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 61.29 -166.21 15.17 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 123.726 0.679 . . . . 0.0 113.475 -176.023 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.46 99.5 5.67 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.716 1.606 . . . . 0.0 109.771 174.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -111.44 -172.38 2.02 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 125.744 1.618 . . . . 0.0 111.199 -177.614 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 25.7 ptt180 -139.01 177.54 7.82 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 127.222 2.209 . . . . 0.0 111.229 175.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -118.46 121.22 39.77 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 174.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -129.81 167.11 18.62 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.703 1.601 . . . . 0.0 109.353 175.017 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -48.87 -45.83 41.56 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 119.641 1.109 . . . . 0.0 113.232 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -52.55 -62.94 5.35 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 123.997 0.808 . . . . 0.0 112.252 175.229 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 5.0 mpp? -60.76 -38.42 85.17 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 113.583 0.956 . . . . 0.0 113.583 178.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -57.0 -61.87 2.15 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.934 0.788 . . . . 0.0 109.527 175.031 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -62.97 -37.17 86.03 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.863 0.865 . . . . 0.0 112.731 -177.424 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -63.65 -43.54 96.47 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.012 1.325 . . . . 0.0 112.36 179.015 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.81 -26.16 24.22 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 121.053 -1.029 . . . . 0.0 113.42 176.212 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -52.02 -58.29 6.97 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.257 1.823 . . . . 0.0 110.678 175.033 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -70.47 -12.85 61.84 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -177.561 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -81.69 -5.63 89.71 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 127.203 2.335 . . . . 0.0 114.345 177.063 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -145.11 86.45 7.63 Favored Pre-proline 0 CA--C 1.548 0.87 0 CA-C-N 119.052 1.426 . . . . 0.0 113.301 175.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -76.64 74.79 4.68 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 123.513 2.809 . . . . 0.0 112.946 -179.041 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -107.26 107.36 18.26 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.022 0.929 . . . . 0.0 111.385 -175.208 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 59.1 mtm180 -89.76 48.14 1.55 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 126.074 1.75 . . . . 0.0 114.505 -175.007 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 49.46 57.86 8.83 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.815 -176.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -63.14 106.52 0.87 Allowed 'General case' 0 CA--C 1.546 0.802 0 CA-C-O 122.141 0.972 . . . . 0.0 109.86 -176.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 17.3 p-10 -68.23 73.69 0.21 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 127.336 2.255 . . . . 0.0 114.968 -174.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 178.35 48.75 0.07 OUTLIER Glycine 0 CA--C 1.536 1.4 0 C-N-CA 124.382 0.991 . . . . 0.0 115.003 175.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' TRP . . . . . 0.708 ' H ' HD13 ' A' ' 161' ' ' ILE . 8.1 m95 49.33 56.28 8.05 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 126.204 1.802 . . . . 0.0 112.795 -175.028 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -85.9 127.5 34.61 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.281 1.032 . . . . 0.0 112.818 -178.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -157.86 -176.09 5.73 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -175.042 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 5.7 mtmt -140.24 169.33 17.88 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 126.144 1.777 . . . . 0.0 111.581 175.192 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -72.66 155.66 39.77 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 174.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.542 HD11 ' HB2' ' A' ' 158' ' ' MET . 71.0 mt -109.01 89.02 2.87 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.736 0.814 . . . . 0.0 110.375 177.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 40.86 -82.06 0.0 OUTLIER Glycine 0 N--CA 1.476 1.341 0 C-N-CA 129.608 3.48 . . . . 0.0 115.27 175.279 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -68.53 -154.2 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 128.839 2.855 . . . . 0.0 110.541 174.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -73.68 20.24 1.41 Allowed Glycine 0 CA--C 1.541 1.693 0 O-C-N 120.217 -1.552 . . . . 0.0 114.928 175.022 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.04 154.07 17.34 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 120.448 2.124 . . . . 0.0 112.038 177.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 87.4 mtt180 -145.95 115.82 7.32 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.322 1.449 . . . . 0.0 110.877 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' MET . . . . . 0.542 ' HB2' HD11 ' A' ' 152' ' ' LEU . 5.9 ttp -114.25 132.42 56.15 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 124.273 1.029 . . . . 0.0 109.682 -178.127 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -103.84 132.83 49.72 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 128.477 2.711 . . . . 0.0 110.005 -179.039 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -135.2 150.83 20.31 Favored Glycine 0 N--CA 1.47 0.918 0 CA-C-N 120.313 1.415 . . . . 0.0 114.23 178.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.708 HD13 ' H ' ' A' ' 147' ' ' TRP . 6.6 tp -145.81 131.93 13.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 125.147 1.379 . . . . 0.0 110.957 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 3.6 ttt -152.42 176.4 11.69 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 127.606 2.362 . . . . 0.0 107.717 175.032 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 10.1 t -152.39 163.62 39.15 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.194 1.397 . . . . 0.0 109.161 175.001 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 5.4 t -106.52 31.43 5.22 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.396 1.478 . . . . 0.0 111.511 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -68.44 23.76 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 128.09 2.556 . . . . 0.0 115.112 179.002 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 84.36 -60.24 4.85 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 126.181 1.848 . . . . 0.0 113.342 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -126.5 63.0 1.28 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.333 1.453 . . . . 0.0 111.051 178.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -86.61 -177.46 6.15 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.311 1.044 . . . . 0.0 112.794 174.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' LYS . . . . . 0.447 ' HE2' ' O ' ' A' ' 169' ' ' LYS . 0.0 OUTLIER -124.85 174.43 7.95 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 127.991 2.516 . . . . 0.0 109.708 174.993 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 42.5 ttp -126.12 132.12 51.93 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.055 1.342 . . . . 0.0 110.189 176.307 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -135.86 127.18 28.38 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.104 0.962 . . . . 0.0 110.163 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.413 HG21 ' SD ' ' A' ' 158' ' ' MET . 4.6 mp -129.58 120.66 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 C-N-CA 123.19 0.596 . . . . 0.0 109.95 177.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.06 132.42 56.03 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.827 1.651 . . . . 0.0 111.341 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.8 mp -76.81 133.67 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 O-C-N 120.683 -1.26 . . . . 0.0 110.382 175.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 6.7 m -140.24 92.5 2.54 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 125.144 1.378 . . . . 0.0 112.22 177.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 60.5 mtp180 . . . . . 0 C--O 1.254 1.29 0 C-N-CA 126.311 1.844 . . . . 0.0 111.48 175.033 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.448 ' HB2' ' HD2' ' A' ' 27' ' ' LYS . 15.5 tp . . . . . 0 N--CA 1.476 0.831 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -75.62 129.96 38.0 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 175.001 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -71.93 -113.02 0.05 OUTLIER Glycine 0 CA--C 1.533 1.192 0 C-N-CA 124.036 0.827 . . . . 0.0 112.636 177.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 19.3 p -113.58 172.82 6.74 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.872 1.269 . . . . 0.0 111.578 176.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -124.81 24.56 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 125.226 1.41 . . . . 0.0 111.871 175.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -52.49 166.4 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 O-C-N 120.633 -1.292 . . . . 0.0 112.684 174.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -48.87 144.3 4.71 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.947 1.299 . . . . 0.0 113.404 -177.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.06 -24.33 54.37 Favored Glycine 0 CA--C 1.538 1.492 0 N-CA-C 115.78 1.072 . . . . 0.0 115.78 -174.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.89 -34.43 64.42 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 121.289 -1.124 . . . . 0.0 111.797 174.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.9 t -84.21 -41.27 17.14 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.684 1.993 . . . . 0.0 112.837 175.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 13.0 tp -89.23 96.29 10.66 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 127.415 2.286 . . . . 0.0 111.357 175.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.58 178.77 6.49 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 126.734 2.014 . . . . 0.0 110.731 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -41.36 -40.91 1.83 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.683 1.593 . . . . 0.0 113.786 175.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -49.89 -45.23 50.56 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.219 1.407 . . . . 0.0 112.639 175.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 88.0 t -69.86 -38.88 76.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 125.777 1.631 . . . . 0.0 111.669 175.291 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 44.6 mt -70.75 -36.77 73.29 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 120.706 -1.246 . . . . 0.0 112.457 -178.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -65.48 -51.14 62.19 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.343 1.457 . . . . 0.0 111.186 175.022 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.71 -34.31 75.56 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 118.08 -0.962 . . . . 0.0 111.915 175.337 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.2 t -56.35 -48.53 79.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-N 119.679 1.127 . . . . 0.0 111.485 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 55.4 mt -56.85 -19.8 19.44 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 175.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.03 -61.24 1.28 Allowed Glycine 0 CA--C 1.535 1.293 0 C-N-CA 126.306 1.908 . . . . 0.0 113.12 175.024 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -64.11 -32.54 74.14 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -178.177 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -90.55 97.76 11.37 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.179 0.992 . . . . 0.0 109.917 176.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -109.82 109.42 2.7 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 126.333 1.921 . . . . 0.0 112.475 -178.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.448 ' HD2' ' HB2' ' A' ' 3' ' ' LEU . 17.7 mtpt -129.59 -69.86 0.67 Allowed 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 125.793 1.637 . . . . 0.0 112.07 -176.031 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.4 m -121.17 169.36 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 127.848 2.459 . . . . 0.0 110.491 -176.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.0 t -65.76 -31.85 73.07 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -179.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.5 mmt180 -132.4 105.58 7.36 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.303 1.841 . . . . 0.0 111.041 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.4 ptpt -120.56 159.43 25.26 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 126.539 1.935 . . . . 0.0 110.149 -177.079 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -128.75 132.95 67.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 123.941 0.897 . . . . 0.0 109.437 175.411 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.33 102.63 4.85 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.077 1.751 . . . . 0.0 109.673 177.177 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.799 HG22 ' HB2' ' A' ' 72' ' ' TYR . 1.3 m -107.7 162.29 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 123.73 0.812 . . . . 0.0 110.927 178.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -134.84 124.28 3.39 Favored Glycine 0 N--CA 1.463 0.452 0 N-CA-C 111.531 -0.628 . . . . 0.0 111.531 177.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.42 ' HB ' HD11 ' A' ' 70' ' ' LEU . 3.3 mp -113.02 132.35 62.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-N 118.459 1.13 . . . . 0.0 110.536 175.192 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -96.22 99.69 11.39 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.67 1.588 . . . . 0.0 110.214 177.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -67.73 94.35 0.44 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.319 1.448 . . . . 0.0 110.552 175.102 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -125.34 7.29 7.75 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 125.576 1.55 . . . . 0.0 111.801 174.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 42.8 p -57.03 -34.9 68.67 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.366 1.066 . . . . 0.0 113.616 -177.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 158.47 -63.52 0.3 Allowed Glycine 0 CA--C 1.53 1.02 0 C-N-CA 125.271 1.415 . . . . 0.0 113.639 175.159 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -107.18 171.08 16.29 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 125.549 1.547 . . . . 0.0 113.092 -178.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.17 150.84 28.64 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.803 -0.822 . . . . 0.0 110.874 175.199 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.404 ' HB3' ' CD1' ' A' ' 91' ' ' TYR . 45.2 m0 -104.35 100.52 10.23 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 124.876 1.271 . . . . 0.0 111.346 -177.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.5 m -80.73 117.97 21.86 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 124.689 1.195 . . . . 0.0 108.44 175.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.86 126.46 27.08 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.129 0.571 . . . . 0.0 111.676 175.021 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.47 HD12 ' N ' ' A' ' 48' ' ' ASN . 3.1 pp -100.37 -53.48 3.1 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 122.844 0.458 . . . . 0.0 111.937 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.47 ' N ' HD12 ' A' ' 47' ' ' LEU . 5.8 t30 -171.6 138.87 1.17 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.618 1.967 . . . . 0.0 109.56 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.599 ' HB2' HD12 ' A' ' 60' ' ' LEU . . . -121.31 155.53 34.51 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.797 1.239 . . . . 0.0 111.404 175.098 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -136.45 113.42 10.44 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.589 1.555 . . . . 0.0 111.409 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.533 ' CD1' ' HB1' ' A' ' 87' ' ' ALA . 2.8 m-85 -114.31 132.5 56.15 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 123.772 0.829 . . . . 0.0 110.02 -178.74 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.58 -31.33 4.31 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 114.973 1.471 . . . . 0.0 114.973 -175.007 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.0 t -123.18 -46.58 2.06 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.503 1.521 . . . . 0.0 110.943 175.017 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -72.48 10.97 4.48 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 124.711 1.148 . . . . 0.0 115.046 -178.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.3 p -31.06 104.03 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 128.982 2.913 . . . . 0.0 114.182 -174.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.642 HG21 HG23 ' A' ' 59' ' ' ILE . 1.6 t -120.92 178.6 4.66 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.945 1.298 . . . . 0.0 112.786 -174.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -77.42 -59.03 2.95 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.86 1.264 . . . . 0.0 111.554 174.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.3 p -138.09 131.41 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 125.918 1.687 . . . . 0.0 112.32 -178.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.642 HG23 HG21 ' A' ' 56' ' ' THR . 1.1 pp -140.78 -39.62 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.92 1.688 . . . . 0.0 114.154 -177.345 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.606 ' H ' HD12 ' A' ' 59' ' ' ILE . 4.9 mt -92.17 94.94 0.87 Allowed Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 124.933 1.293 . . . . 0.0 108.883 175.11 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -61.83 132.91 42.03 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 123.137 2.558 . . . . 0.0 110.258 175.145 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -40.0 -44.43 1.73 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 126.457 1.903 . . . . 0.0 113.962 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.4 p -155.13 139.7 9.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 C-N-CA 126.613 1.965 . . . . 0.0 110.028 176.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 58.6 t -133.72 121.35 16.02 Favored Pre-proline 0 N--CA 1.484 1.246 0 C-N-CA 124.623 1.169 . . . . 0.0 110.672 178.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -58.17 152.32 53.3 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.982 2.455 . . . . 0.0 113.21 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -72.49 168.21 19.01 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.51 0.724 . . . . 0.0 110.657 175.013 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 72.7 p 51.72 28.56 4.95 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 126.904 2.082 . . . . 0.0 112.687 -175.095 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.25 171.85 12.83 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 128.443 2.697 . . . . 0.0 109.42 -175.307 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -131.15 167.36 19.27 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 121.716 -0.615 . . . . 0.0 109.746 177.089 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.42 HD11 ' HB ' ' A' ' 36' ' ' ILE . 2.9 pp -137.14 174.16 10.91 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 125.045 1.338 . . . . 0.0 111.03 -176.209 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.461 HD13 ' O ' ' A' ' 34' ' ' VAL . 0.5 OUTLIER -127.95 152.65 47.63 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.819 1.248 . . . . 0.0 111.397 176.166 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.799 ' HB2' HG22 ' A' ' 34' ' ' VAL . 8.2 m-85 -127.25 136.68 52.33 Favored 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 125.109 1.364 . . . . 0.0 107.76 174.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.0 p -114.96 153.29 30.87 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 125.666 1.587 . . . . 0.0 110.935 176.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -170.84 145.45 8.98 Favored Glycine 0 N--CA 1.452 -0.263 0 CA-C-O 121.587 0.548 . . . . 0.0 112.422 176.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 19.0 mtm180 -128.45 132.43 48.41 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 125.942 1.697 . . . . 0.0 109.759 -175.281 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.8 ptmt . . . . . 0 N--CA 1.474 0.753 0 C-N-CA 123.894 0.878 . . . . 0.0 112.734 174.994 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.48 1.069 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -68.26 -64.59 3.04 Favored Glycine 0 N--CA 1.474 1.193 0 O-C-N 120.598 -1.314 . . . . 0.0 113.191 -177.157 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -158.44 114.08 2.67 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.238 1.015 . . . . 0.0 111.058 178.016 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.8 t -147.57 123.23 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 O-C-N 121.246 -0.909 . . . . 0.0 110.577 -176.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.533 ' HB1' ' CD1' ' A' ' 51' ' ' PHE . . . -165.03 167.24 18.58 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.974 1.31 . . . . 0.0 112.022 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -150.1 139.72 21.62 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.655 1.182 . . . . 0.0 110.645 174.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.453 ' CD2' ' CE2' ' A' ' 72' ' ' TYR . 46.8 p90 -139.73 170.91 15.01 Favored 'General case' 0 N--CA 1.467 0.383 0 O-C-N 121.012 -1.055 . . . . 0.0 110.622 176.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -137.16 156.39 48.4 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.843 -0.536 . . . . 0.0 112.295 175.005 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.404 ' CD1' ' HB3' ' A' ' 44' ' ' TRP . 8.5 m-85 -130.39 129.14 42.71 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 125.492 1.517 . . . . 0.0 112.314 -177.099 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -85.88 117.29 24.64 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.065 0.46 . . . . 0.0 111.133 -178.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 7.6 mtp -93.92 132.17 38.62 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.05 1.34 . . . . 0.0 110.981 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 39.5 m -57.92 -18.21 21.64 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 125.246 1.418 . . . . 0.0 113.856 175.252 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -69.48 -9.18 52.66 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 124.911 1.285 . . . . 0.0 113.06 175.018 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 99.54 19.77 19.39 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 125.746 1.641 . . . . 0.0 114.549 178.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 16.4 m-80 -130.55 175.86 8.64 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.003 1.321 . . . . 0.0 111.053 -175.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 16.4 m -128.85 114.21 16.23 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.852 0.861 . . . . 0.0 111.955 177.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 52.1 tp -79.39 104.43 10.0 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.598 1.159 . . . . 0.0 109.737 175.016 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -99.21 113.92 4.87 Favored Glycine 0 N--CA 1.466 0.69 0 C-N-CA 124.477 1.037 . . . . 0.0 112.737 -179.199 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 90.1 t -96.31 135.46 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.529 1.131 . . . . 0.0 111.076 -178.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -134.51 125.65 27.79 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.927 1.291 . . . . 0.0 110.772 -175.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.465 ' CZ ' ' HB3' ' A' ' 87' ' ' ALA . 5.6 p90 -145.94 122.94 11.39 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.759 1.224 . . . . 0.0 111.599 -174.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 38.3 t -133.92 136.31 44.17 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 124.179 0.992 . . . . 0.0 110.46 176.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 45.4 t . . . . . 0 C--O 1.238 0.47 0 C-N-CA 127.897 2.479 . . . . 0.0 106.533 -178.358 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.7 m . . . . . 0 N--CA 1.474 0.732 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -81.37 130.93 35.24 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.627 1.971 . . . . 0.0 106.759 175.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 9.7 m0 -117.8 120.64 38.55 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.983 1.313 . . . . 0.0 110.233 176.211 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 11.6 p-90 -144.46 152.65 40.92 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 126.361 1.865 . . . . 0.0 111.728 -175.244 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 9.7 t70 164.76 150.17 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 128.743 2.817 . . . . 0.0 109.648 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 62.0 t -120.83 139.49 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.183 1.393 . . . . 0.0 109.035 -175.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.485 ' HE2' ' HG3' ' A' ' 135' ' ' MET . 0.0 OUTLIER -129.46 171.19 12.81 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.287 1.035 . . . . 0.0 111.795 -178.968 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 54.5 mt -124.96 116.78 48.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 175.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -77.12 149.76 79.94 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 123.119 0.568 . . . . 0.0 110.589 174.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.78 -0.67 7.26 Favored 'Trans proline' 0 CA--C 1.545 1.051 0 C-N-CA 124.471 3.448 . . . . 0.0 115.027 -176.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -174.0 -175.49 41.68 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 127.055 2.264 . . . . 0.0 111.003 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 24.6 tttt -52.77 116.83 2.52 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.117 1.367 . . . . 0.0 112.059 -177.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -133.24 117.71 17.72 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.382 1.473 . . . . 0.0 111.738 -177.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.3 ptt180 -65.12 175.11 1.71 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.026 0.93 . . . . 0.0 111.855 174.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -127.58 103.27 7.24 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.989 1.716 . . . . 0.0 106.809 176.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -132.51 172.63 12.25 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.69 1.996 . . . . 0.0 109.425 177.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -53.72 -38.85 64.71 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -177.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -60.96 -58.72 12.29 Favored Glycine 0 N--CA 1.469 0.86 0 CA-C-N 118.885 0.766 . . . . 0.0 111.376 174.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 2.2 mpp? -59.1 -39.59 82.68 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 117.851 0.825 . . . . 0.0 112.171 178.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -59.78 -59.01 6.11 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.367 1.067 . . . . 0.0 110.75 175.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -67.97 -34.31 76.3 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 118.927 0.785 . . . . 0.0 113.01 -177.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -63.45 -41.53 98.63 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.447 0.699 . . . . 0.0 111.382 175.034 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' MET . . . . . 0.485 ' HG3' ' HE2' ' A' ' 119' ' ' LYS . 37.4 mmm -77.48 -28.47 52.27 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 121.06 -1.025 . . . . 0.0 113.033 175.24 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -54.56 -55.19 31.87 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 119.412 1.005 . . . . 0.0 111.386 176.087 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -65.11 -18.99 65.76 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 119.659 -0.816 . . . . 0.0 112.129 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -81.38 3.8 75.91 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 126.773 2.13 . . . . 0.0 114.472 174.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 34.9 m-20 -115.67 64.31 2.22 Favored Pre-proline 0 CA--C 1.552 1.045 0 C-N-CA 125.804 1.642 . . . . 0.0 114.966 -175.012 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -76.1 73.33 4.97 Favored 'Trans proline' 0 CA--C 1.546 1.08 0 C-N-CA 123.551 2.834 . . . . 0.0 112.87 -177.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.98 116.43 7.05 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.423 1.089 . . . . 0.0 109.723 -178.273 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 2.9 ttm105 -81.79 -172.81 4.09 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.534 1.533 . . . . 0.0 111.362 177.012 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -78.06 57.13 3.98 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 124.114 0.864 . . . . 0.0 111.027 174.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -62.61 98.81 0.13 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 128.095 2.558 . . . . 0.0 110.376 175.285 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 11.2 p-10 -64.08 66.04 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 127.851 2.46 . . . . 0.0 116.343 -175.024 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -178.44 167.94 38.78 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 128.368 2.89 . . . . 0.0 109.825 175.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' TRP . . . . . 0.44 ' CE3' ' HG3' ' A' ' 159' ' ' LYS . 59.6 m95 -64.78 67.91 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.998 2.119 . . . . 0.0 111.215 175.215 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -85.73 116.12 23.81 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 128.796 2.838 . . . . 0.0 111.452 -177.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -166.55 -172.63 2.23 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 177.736 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.68 167.37 22.27 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.494 1.918 . . . . 0.0 112.543 177.344 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 54.5 m-20 -64.56 142.59 58.37 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.904 -0.498 . . . . 0.0 109.782 175.097 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 11.0 mt -89.97 158.76 17.23 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 122.165 0.983 . . . . 0.0 109.359 175.02 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -65.6 -171.87 3.64 Favored Glycine 0 CA--C 1.536 1.399 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 175.021 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 54.73 8.78 0.24 Allowed 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 175.241 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 82.07 42.51 8.73 Favored Glycine 0 CA--C 1.54 1.645 0 C-N-CA 126.279 1.895 . . . . 0.0 113.087 -175.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.7 mp -120.17 172.33 7.85 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 119.025 1.413 . . . . 0.0 112.678 179.022 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 24.2 mtt180 -137.99 117.32 12.77 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 120.746 -1.221 . . . . 0.0 111.548 176.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 5.3 ttt -98.45 151.37 20.66 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 120.108 -1.62 . . . . 0.0 108.636 174.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.44 ' HG3' ' CE3' ' A' ' 147' ' ' TRP . 5.4 tppt? -136.86 142.47 42.82 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.503 1.921 . . . . 0.0 109.877 176.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -155.79 152.19 23.66 Favored Glycine 0 N--CA 1.473 1.146 0 O-C-N 120.64 -1.287 . . . . 0.0 112.858 176.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 2.2 tp -135.19 124.53 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 126.676 1.99 . . . . 0.0 108.143 -176.467 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 8.7 mtp -145.29 113.02 6.33 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.662 1.585 . . . . 0.0 108.991 174.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 9.5 t -100.66 125.17 47.05 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 118.517 0.599 . . . . 0.0 110.997 178.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 23.1 p -74.18 39.01 0.11 Allowed 'General case' 0 N--CA 1.481 1.097 0 O-C-N 120.738 -1.226 . . . . 0.0 113.764 175.046 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -72.41 -2.29 18.85 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 126.192 1.797 . . . . 0.0 114.516 177.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 108.89 -59.77 0.35 Allowed Glycine 0 CA--C 1.531 1.088 0 C-N-CA 126.264 1.887 . . . . 0.0 113.03 176.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -118.79 27.02 9.15 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.416 1.486 . . . . 0.0 112.482 -177.14 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.91 170.59 6.44 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 122.558 1.17 . . . . 0.0 114.129 175.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.67 -178.88 3.92 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 126.819 2.047 . . . . 0.0 110.89 175.053 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 14.8 ttp -125.85 139.12 53.75 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.588 1.555 . . . . 0.0 110.288 171.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.418 ' C ' HD12 ' A' ' 172' ' ' ILE . 39.8 tt0 -143.48 126.9 16.78 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 121.981 -0.449 . . . . 0.0 110.67 174.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.418 HD12 ' C ' ' A' ' 171' ' ' GLN . 2.7 mp -123.28 133.95 67.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.664 1.186 . . . . 0.0 108.642 176.378 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -133.14 132.76 42.02 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.852 1.661 . . . . 0.0 109.473 178.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.9 mp -96.04 92.04 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 O-C-N 121.197 -0.939 . . . . 0.0 109.63 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.41 165.1 8.16 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-O 122.276 1.036 . . . . 0.0 112.839 175.124 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 18.2 mmm180 . . . . . 0 C--O 1.252 1.227 0 C-N-CA 125.182 1.393 . . . . 0.0 111.171 -176.82 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 32.1 tp . . . . . 0 N--CA 1.484 1.23 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -128.95 120.98 27.07 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 127.273 2.229 . . . . 0.0 107.776 178.181 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -73.05 -101.16 0.07 OUTLIER Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.046 0.831 . . . . 0.0 112.305 -178.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 38.8 p -131.18 170.67 14.25 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.756 1.222 . . . . 0.0 111.33 175.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -124.47 16.19 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 125.248 1.419 . . . . 0.0 111.886 179.508 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.3 pt -53.31 168.69 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 124.945 1.298 . . . . 0.0 111.561 175.003 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -40.6 132.64 2.12 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.62 1.168 . . . . 0.0 112.873 -178.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -53.71 -22.5 18.28 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 124.937 1.256 . . . . 0.0 114.322 -176.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.18 -33.07 71.69 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.273 1.429 . . . . 0.0 112.452 175.001 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.2 t -96.36 -44.52 7.18 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.214 1.406 . . . . 0.0 112.314 175.221 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.3 tp -69.15 89.55 0.45 Allowed 'General case' 0 CA--C 1.545 0.752 0 CA-C-O 122.168 0.985 . . . . 0.0 110.632 175.223 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 58.1 p -126.93 -176.14 3.62 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 126.884 2.074 . . . . 0.0 111.512 -178.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -52.19 -36.93 53.3 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.165 0.986 . . . . 0.0 113.174 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -56.02 -43.63 77.96 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.645 1.178 . . . . 0.0 112.001 176.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 88.5 t -65.97 -42.52 91.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 124.342 1.057 . . . . 0.0 110.85 175.011 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 42.4 mt -68.52 -38.36 80.84 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 120.837 -1.164 . . . . 0.0 112.5 -179.226 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -64.6 -47.93 76.8 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.725 1.21 . . . . 0.0 111.105 178.004 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.32 -35.18 77.41 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 118.064 -0.97 . . . . 0.0 113.083 175.014 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.4 t -53.93 -44.08 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 CA-C-N 120.209 1.368 . . . . 0.0 111.982 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 71.0 mt -60.33 -13.78 14.87 Favored 'General case' 0 CA--C 1.55 0.964 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 175.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -106.06 -46.86 1.13 Allowed Glycine 0 CA--C 1.536 1.354 0 C-N-CA 126.681 2.086 . . . . 0.0 114.034 178.46 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -66.24 -25.5 66.92 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 119.075 1.438 . . . . 0.0 113.445 175.079 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -111.06 158.42 18.85 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.84 1.256 . . . . 0.0 111.656 175.008 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -175.77 86.49 0.07 OUTLIER Glycine 0 CA--C 1.53 1.015 0 O-C-N 121.474 -0.766 . . . . 0.0 113.901 -175.005 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.7 mttt -74.82 -54.8 6.64 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.946 1.298 . . . . 0.0 112.525 177.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 16.2 m -141.03 -179.11 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 127.917 2.487 . . . . 0.0 111.158 -178.254 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 25.9 m -49.54 -48.69 48.17 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 126.334 1.854 . . . . 0.0 114.517 -177.372 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.0 tpm_? -120.42 129.6 53.98 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.318 1.447 . . . . 0.0 109.497 175.129 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.9 ptpt -131.93 152.53 51.02 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.824 2.05 . . . . 0.0 110.502 -174.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -121.37 131.12 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 124.674 1.19 . . . . 0.0 109.559 177.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -134.61 97.54 3.82 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.473 1.909 . . . . 0.0 110.318 177.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.769 HG22 ' HB2' ' A' ' 72' ' ' TYR . 1.6 m -99.52 160.78 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 C-N-CA 123.305 0.642 . . . . 0.0 111.189 178.523 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -133.53 112.11 1.05 Allowed Glycine 0 CA--C 1.526 0.749 0 CA-C-O 119.308 -0.718 . . . . 0.0 113.526 174.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.9 mp -100.68 147.05 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 119.286 1.543 . . . . 0.0 109.456 175.016 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.448 ' HB3' ' HA ' ' A' ' 173' ' ' LYS . 21.7 t0 -117.2 102.76 9.55 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.116 1.366 . . . . 0.0 110.645 177.029 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -71.54 92.25 1.12 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 127.14 2.176 . . . . 0.0 111.221 176.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -119.01 -0.19 11.19 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.445 1.098 . . . . 0.0 113.802 175.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 30.3 t -47.81 -34.56 8.82 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 127.024 2.13 . . . . 0.0 114.63 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 110.23 60.49 0.5 Allowed Glycine 0 N--CA 1.468 0.777 0 C-N-CA 124.822 1.201 . . . . 0.0 112.264 177.456 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 167.81 150.34 6.49 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 125.327 1.441 . . . . 0.0 111.918 177.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.673 HG22 ' HA ' ' A' ' 65' ' ' PRO . 10.0 p -68.43 130.99 44.5 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.504 1.122 . . . . 0.0 110.92 174.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 43.1 m0 -91.35 101.79 14.49 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 123.849 0.86 . . . . 0.0 111.634 -179.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.9 m -83.45 125.4 31.68 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.069 1.348 . . . . 0.0 109.907 175.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.77 131.69 47.52 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.036 0.534 . . . . 0.0 110.582 174.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -117.12 -45.37 2.75 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.034 0.934 . . . . 0.0 112.125 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -174.25 149.14 1.36 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.76 2.024 . . . . 0.0 111.436 -178.31 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -131.26 164.82 24.74 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.778 1.631 . . . . 0.0 111.945 176.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -142.89 109.13 5.27 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.902 1.281 . . . . 0.0 111.45 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.498 ' CE1' ' HB1' ' A' ' 87' ' ' ALA . 3.0 m-85 -113.62 128.01 56.27 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.914 0.886 . . . . 0.0 110.498 -177.168 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.57 -39.77 4.53 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -177.024 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.8 t -116.74 -53.89 2.47 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 126.099 1.759 . . . . 0.0 109.801 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -65.36 12.46 0.3 Allowed Glycine 0 CA--C 1.534 1.239 0 C-N-CA 126.929 2.204 . . . . 0.0 115.754 -175.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 53.1 p -31.16 111.15 0.08 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 129.288 3.035 . . . . 0.0 112.938 -174.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 t -129.42 179.62 5.69 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.794 1.238 . . . . 0.0 113.713 -175.043 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -82.51 -69.65 0.61 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.29 1.436 . . . . 0.0 111.573 176.244 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.1 p -132.4 130.28 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 125.688 1.595 . . . . 0.0 111.685 -177.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.5 pp -141.15 -26.15 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.896 1.678 . . . . 0.0 114.478 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -99.35 95.26 3.34 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 125.45 1.5 . . . . 0.0 109.181 178.466 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -65.57 151.55 84.42 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.781 2.987 . . . . 0.0 111.026 176.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -46.52 -49.19 18.89 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.991 1.316 . . . . 0.0 113.595 -179.144 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.7 p -157.5 139.91 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 126.497 1.919 . . . . 0.0 110.073 175.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.407 HG21 HD13 ' A' ' 70' ' ' LEU . 46.1 t -113.89 130.12 24.13 Favored Pre-proline 0 N--CA 1.474 0.753 0 C-N-CA 124.542 1.137 . . . . 0.0 109.069 174.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.673 ' HA ' HG22 ' A' ' 43' ' ' THR . 66.5 Cg_endo -67.71 152.84 77.32 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.436 2.091 . . . . 0.0 112.527 176.135 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -67.12 166.01 14.77 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.05 174.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . 0.267 66.8 p 52.9 22.65 2.47 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 127.668 2.387 . . . . 0.0 114.574 -174.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 20.9 mttt -124.57 172.84 8.9 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 126.834 2.053 . . . . 0.0 112.351 -178.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -131.48 163.94 26.86 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 122.799 0.439 . . . . 0.0 110.123 -178.143 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.407 HD13 HG21 ' A' ' 64' ' ' VAL . 2.4 pt? -143.76 171.0 14.81 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 124.267 1.027 . . . . 0.0 112.49 -178.7 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.583 HD13 ' O ' ' A' ' 34' ' ' VAL . 0.9 OUTLIER -117.49 154.78 30.85 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.91 1.284 . . . . 0.0 113.45 179.667 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.769 ' HB2' HG22 ' A' ' 34' ' ' VAL . 16.1 m-85 -129.34 133.5 47.45 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.034 1.334 . . . . 0.0 109.258 175.017 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.0 p -107.82 149.2 28.53 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 126.443 1.897 . . . . 0.0 110.287 175.089 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -167.9 144.52 8.96 Favored Glycine 0 CA--C 1.522 0.524 0 O-C-N 121.738 -0.601 . . . . 0.0 112.852 174.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 40.2 mtm180 -107.09 140.52 39.79 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.47 1.508 . . . . 0.0 110.676 -176.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.925 0 C-N-CA 125.439 1.496 . . . . 0.0 114.564 175.004 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 97.6 m . . . . . 0 N--CA 1.478 0.963 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -54.32 -82.44 0.05 OUTLIER Glycine 0 N--CA 1.475 1.299 0 C-N-CA 124.968 1.27 . . . . 0.0 114.526 -174.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -158.82 109.45 2.06 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.509 0.671 . . . . 0.0 111.723 174.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.9 t -138.24 121.07 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 124.897 1.279 . . . . 0.0 109.375 -177.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.498 ' HB1' ' CE1' ' A' ' 51' ' ' PHE . . . -157.66 167.47 30.01 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 122.211 1.005 . . . . 0.0 110.982 176.123 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -147.91 158.15 43.9 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.208 1.003 . . . . 0.0 109.501 175.068 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.482 ' CZ ' HG11 ' A' ' 101' ' ' VAL . 48.0 p90 -155.19 174.48 15.14 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 121.323 -0.861 . . . . 0.0 110.101 175.038 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.482 ' HB1' ' CG2' ' A' ' 98' ' ' THR . . . -133.52 148.28 51.66 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.537 175.071 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -125.93 148.57 49.19 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.372 1.069 . . . . 0.0 113.8 176.138 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -89.12 123.69 33.63 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -178.363 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 5.8 tpp -89.22 144.07 26.37 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.586 0.754 . . . . 0.0 111.345 176.089 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 10.8 t -66.34 -23.08 66.29 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.828 0.851 . . . . 0.0 112.829 175.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -73.84 -11.15 60.28 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.981 1.313 . . . . 0.0 112.605 174.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 96.71 38.81 4.31 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 125.051 1.31 . . . . 0.0 114.649 178.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -135.7 173.15 12.04 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 118.812 1.306 . . . . 0.0 110.998 -179.434 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.482 ' CG2' ' HB1' ' A' ' 90' ' ' ALA . 3.4 m -122.63 103.44 8.68 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.731 1.212 . . . . 0.0 112.221 -177.074 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.3 tt -64.53 92.51 0.09 Allowed 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 126.369 1.868 . . . . 0.0 111.957 175.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -91.96 95.2 2.01 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 125.924 1.726 . . . . 0.0 112.211 -178.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.503 HG23 HG22 ' A' ' 118' ' ' VAL . 2.3 p -82.33 153.63 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 123.704 0.802 . . . . 0.0 111.635 177.22 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.74 116.67 7.77 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.697 1.599 . . . . 0.0 110.583 177.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.449 ' CE2' ' HB3' ' A' ' 87' ' ' ALA . 24.6 p90 -134.49 131.08 37.63 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 122.201 1.001 . . . . 0.0 112.706 -176.258 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 23.3 t -143.56 97.38 3.06 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 124.564 1.146 . . . . 0.0 110.643 -175.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 24.1 t . . . . . 0 CA--C 1.541 0.623 0 C-N-CA 126.19 1.796 . . . . 0.0 108.975 177.453 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 7.3 m . . . . . 0 N--CA 1.469 0.515 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -123.11 116.23 23.12 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 124.944 1.297 . . . . 0.0 111.359 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 44.5 m0 -109.03 161.23 15.36 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.251 1.421 . . . . 0.0 111.1 -175.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 43.7 p-90 -150.21 137.2 19.37 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.004 0.922 . . . . 0.0 111.771 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -147.75 163.96 35.07 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 122.881 1.324 . . . . 0.0 113.598 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.503 HG22 HG23 ' A' ' 101' ' ' VAL . 19.6 t -145.98 140.73 21.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 C-N-CA 124.699 1.199 . . . . 0.0 108.656 175.033 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.6 173.36 14.74 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 128.032 2.533 . . . . 0.0 108.85 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.486 ' HB ' ' CE2' ' A' ' 154' ' ' TYR . 7.4 mt -129.86 113.34 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 123.883 0.873 . . . . 0.0 109.135 177.543 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -64.76 138.14 97.37 Favored Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 124.108 0.963 . . . . 0.0 111.521 177.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -74.48 84.07 1.62 Allowed 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 124.336 3.357 . . . . 0.0 112.124 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 114.62 175.76 18.74 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 126.348 1.928 . . . . 0.0 112.955 -178.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 7.5 tttt -61.84 102.36 0.26 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.289 1.436 . . . . 0.0 111.015 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 1.4 mmt85 -123.18 -175.2 3.12 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 126.434 1.894 . . . . 0.0 111.959 -175.155 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.3 ptp180 -132.12 175.92 8.83 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.735 1.214 . . . . 0.0 112.581 175.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -119.53 111.69 18.41 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 105.258 -2.127 . . . . 0.0 105.258 174.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -128.9 166.26 19.47 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.485 1.514 . . . . 0.0 109.275 177.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -50.01 -40.23 43.93 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 119.8 1.182 . . . . 0.0 113.389 -178.388 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -56.23 -62.59 6.16 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 124.065 0.841 . . . . 0.0 111.843 174.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 4.6 mtm -60.79 -37.3 81.46 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.045 1.338 . . . . 0.0 113.723 178.508 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -57.84 -62.49 1.76 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.256 1.422 . . . . 0.0 109.494 175.027 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -69.47 -31.54 69.89 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -177.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -57.05 -59.1 5.57 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.032 1.333 . . . . 0.0 110.864 174.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.13 -20.54 59.36 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -53.75 -57.27 11.48 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.639 1.176 . . . . 0.0 109.954 175.029 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -71.4 -0.73 10.94 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -89.82 -9.55 65.99 Favored Glycine 0 CA--C 1.537 1.454 0 C-N-CA 126.112 1.815 . . . . 0.0 114.924 177.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -145.6 91.33 5.74 Favored Pre-proline 0 CA--C 1.549 0.918 0 CA-C-N 119.64 1.72 . . . . 0.0 113.43 179.208 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -74.41 81.12 2.11 Favored 'Trans proline' 0 CA--C 1.543 0.968 0 C-N-CA 123.556 2.837 . . . . 0.0 112.656 -178.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -113.41 116.16 29.21 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.493 1.517 . . . . 0.0 109.233 177.315 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 4.4 ttm180 -103.43 50.6 0.8 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.992 1.317 . . . . 0.0 114.052 -174.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 56.96 56.21 26.15 Favored Glycine 0 CA--C 1.534 1.239 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 -175.007 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -68.08 108.09 2.97 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.002 1.321 . . . . 0.0 110.873 -175.086 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -77.04 91.81 3.68 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.171 1.388 . . . . 0.0 114.24 -174.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.71 50.77 0.01 OUTLIER Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.318 0.961 . . . . 0.0 114.381 174.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' TRP . . . . . 0.535 ' H ' HD13 ' A' ' 161' ' ' ILE . 8.8 m95 46.36 62.38 2.32 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.602 1.561 . . . . 0.0 112.704 -174.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -90.51 125.37 35.58 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.112 1.365 . . . . 0.0 112.361 179.162 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -160.03 -175.12 4.91 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.235 1.014 . . . . 0.0 113.104 -175.076 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 8.9 mtmt -134.76 160.8 37.04 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.375 1.47 . . . . 0.0 111.176 174.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -81.36 146.62 30.24 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.066 0.946 . . . . 0.0 109.397 175.017 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.427 ' CD2' ' H ' ' A' ' 158' ' ' MET . 3.1 mm? -102.03 128.2 48.58 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 122.733 0.413 . . . . 0.0 110.013 -177.062 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -53.32 -24.67 23.63 Favored Glycine 0 N--CA 1.475 1.289 0 C-N-CA 125.628 1.585 . . . . 0.0 116.005 -175.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.486 ' CE2' ' HB ' ' A' ' 120' ' ' ILE . 0.1 OUTLIER -74.06 1.54 10.79 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 127.539 2.336 . . . . 0.0 113.453 177.612 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 90.28 10.85 63.53 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.882 1.706 . . . . 0.0 114.381 -177.263 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 2.6 mt -98.32 166.44 11.39 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.722 2.009 . . . . 0.0 111.187 -178.466 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 57.7 mtt180 -139.87 105.6 5.14 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.294 1.038 . . . . 0.0 110.524 178.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' MET . . . . . 0.427 ' H ' ' CD2' ' A' ' 152' ' ' LEU . 18.0 ttp -91.68 135.5 33.84 Favored 'General case' 0 C--N 1.318 -0.762 0 O-C-N 120.755 -1.215 . . . . 0.0 107.888 176.29 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.21 124.57 52.36 Favored 'General case' 0 C--O 1.221 -0.414 0 C-N-CA 126.145 1.778 . . . . 0.0 109.482 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -133.1 155.6 21.74 Favored Glycine 0 N--CA 1.469 0.842 0 CA-C-N 120.807 1.64 . . . . 0.0 114.833 -178.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.535 HD13 ' H ' ' A' ' 147' ' ' TRP . 4.2 tp -152.7 135.06 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-O 122.777 1.275 . . . . 0.0 110.846 -175.361 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 11.5 mtp -153.05 168.94 24.2 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 128.058 2.543 . . . . 0.0 109.209 176.056 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 13.2 t -151.66 162.66 40.62 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.726 1.21 . . . . 0.0 109.451 174.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 89.5 p -97.68 26.2 5.24 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.047 1.339 . . . . 0.0 113.115 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -68.48 12.77 0.11 Allowed 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 126.843 2.057 . . . . 0.0 115.4 -176.073 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 85.93 -62.82 4.33 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 125.735 1.636 . . . . 0.0 112.69 178.024 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -95.61 9.96 38.4 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 177.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -58.04 159.75 5.44 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 123.116 1.436 . . . . 0.0 114.189 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.45 175.41 6.2 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 128.002 2.521 . . . . 0.0 110.758 -177.013 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 35.6 ttp -118.97 130.5 55.73 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 125.012 1.325 . . . . 0.0 110.363 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -137.03 126.84 25.61 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.148 0.579 . . . . 0.0 110.806 175.001 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.403 HG21 ' SD ' ' A' ' 158' ' ' MET . 4.8 mp -131.11 113.75 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 C-N-CA 123.668 0.787 . . . . 0.0 110.068 176.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.448 ' HA ' ' HB3' ' A' ' 37' ' ' ASP . 0.3 OUTLIER -109.61 129.09 55.61 Favored 'General case' 0 C--O 1.222 -0.352 0 C-N-CA 125.11 1.364 . . . . 0.0 111.693 176.277 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.8 mp -79.61 137.18 22.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 175.004 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 3.2 m -122.21 159.21 27.75 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.699 2.0 . . . . 0.0 110.631 175.34 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 39.1 mtp180 . . . . . 0 C--O 1.251 1.182 0 C-N-CA 126.403 1.881 . . . . 0.0 112.161 -178.586 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 11.9 tp . . . . . 0 N--CA 1.477 0.892 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -132.3 137.78 47.59 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.706 1.602 . . . . 0.0 110.805 175.332 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.425 ' H ' ' HG ' ' A' ' 71' ' ' LEU . . . -81.75 -153.88 11.88 Favored Glycine 0 CA--C 1.544 1.878 0 C-N-CA 125.351 1.453 . . . . 0.0 110.257 176.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 42.5 p -76.06 173.76 10.88 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.609 1.164 . . . . 0.0 113.063 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -129.77 15.91 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.987 0 C-N-CA 125.92 1.688 . . . . 0.0 112.16 176.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.419 HD12 ' HB3' ' A' ' 12' ' ' SER . 4.7 pt -52.92 166.3 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 O-C-N 120.587 -1.32 . . . . 0.0 111.733 175.01 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -39.81 132.42 1.72 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.267 1.427 . . . . 0.0 113.244 -179.566 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -57.36 -16.89 22.9 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 124.889 1.233 . . . . 0.0 114.402 -177.204 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.2 -23.63 67.38 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.542 1.137 . . . . 0.0 111.701 174.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.419 ' HB3' HD12 ' A' ' 8' ' ' ILE . 4.1 t -109.82 -40.29 4.84 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.592 1.957 . . . . 0.0 112.604 175.703 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.6 tp -76.47 97.43 4.32 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 121.476 -0.765 . . . . 0.0 109.827 175.014 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -134.99 -177.82 4.81 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 126.541 1.937 . . . . 0.0 111.87 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -50.23 -36.24 30.13 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.212 1.405 . . . . 0.0 112.91 -178.505 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -52.85 -37.83 60.69 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.015 1.326 . . . . 0.0 112.543 175.138 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 78.5 t -73.25 -42.01 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 125.788 1.635 . . . . 0.0 111.115 175.067 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 57.7 mt -65.4 -42.24 92.81 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 120.961 -1.087 . . . . 0.0 111.964 178.182 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -61.04 -41.21 96.15 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.289 1.036 . . . . 0.0 111.882 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.98 -38.47 64.16 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 118.834 -0.603 . . . . 0.0 111.215 175.002 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.402 HG13 HD12 ' A' ' 25' ' ' LEU . 19.3 t -56.01 -39.66 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 C-N-CA 125.398 1.479 . . . . 0.0 111.534 177.673 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -56.57 -20.57 21.41 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 125.865 1.666 . . . . 0.0 112.727 174.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -108.38 -50.3 0.77 Allowed Glycine 0 CA--C 1.533 1.206 0 C-N-CA 126.356 1.931 . . . . 0.0 114.151 -178.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -64.19 -27.41 69.05 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 118.966 1.383 . . . . 0.0 113.503 178.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.402 HD12 HG13 ' A' ' 21' ' ' VAL . 14.3 mt -109.99 119.64 39.96 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.114 1.366 . . . . 0.0 109.549 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -162.32 81.1 0.13 Allowed Glycine 0 CA--C 1.534 1.24 0 O-C-N 121.604 -0.685 . . . . 0.0 114.156 -175.025 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.6 mttt -72.69 -60.13 2.38 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.945 1.698 . . . . 0.0 112.985 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.5 m -109.46 -178.7 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 126.794 2.038 . . . . 0.0 110.756 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.6 t -51.27 -46.64 62.47 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.512 1.125 . . . . 0.0 113.568 -175.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.69 144.2 51.17 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.948 1.699 . . . . 0.0 111.176 174.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.92 166.35 22.54 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.194 1.797 . . . . 0.0 111.615 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -129.07 137.42 57.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 124.927 1.291 . . . . 0.0 109.387 176.506 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -141.0 119.24 12.08 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 126.004 1.721 . . . . 0.0 109.416 175.047 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.532 HG22 ' HB2' ' A' ' 72' ' ' TYR . 2.6 m -124.77 139.03 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 123.084 0.553 . . . . 0.0 110.779 -179.189 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -111.51 103.6 1.58 Allowed Glycine 0 N--CA 1.461 0.334 0 C-N-CA 124.754 1.168 . . . . 0.0 110.857 -178.299 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.4 mp -100.16 132.81 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 121.527 0.68 . . . . 0.0 110.806 175.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -100.99 104.15 15.3 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.755 2.022 . . . . 0.0 109.859 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 29.1 t30 -78.51 99.05 6.31 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.651 0.78 . . . . 0.0 111.033 175.229 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.54 13.41 10.13 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.002 0.921 . . . . 0.0 112.2 175.228 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.43 -34.88 71.29 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.892 1.277 . . . . 0.0 114.072 -175.279 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 139.0 -35.75 1.95 Allowed Glycine 0 CA--C 1.531 1.051 0 C-N-CA 125.535 1.54 . . . . 0.0 113.817 175.1 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -114.54 158.24 14.45 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 125.167 1.365 . . . . 0.0 112.935 175.607 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.42 149.17 34.89 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.922 0.867 . . . . 0.0 110.964 175.001 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.401 ' HB3' ' CD1' ' A' ' 91' ' ' TYR . 40.9 m0 -101.26 107.81 19.29 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 125.139 1.376 . . . . 0.0 110.199 178.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 54.2 m -92.91 128.62 38.84 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 124.805 1.242 . . . . 0.0 109.054 175.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.47 138.15 58.26 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.654 -0.653 . . . . 0.0 111.705 174.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.603 HD21 HG23 ' A' ' 98' ' ' THR . 3.1 pp -118.65 -51.58 2.38 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.054 0.942 . . . . 0.0 112.241 177.696 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 25.1 t30 -170.83 150.07 3.15 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.09 1.756 . . . . 0.0 109.954 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.611 ' HB2' HD12 ' A' ' 60' ' ' LEU . . . -131.32 158.52 40.45 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.089 1.356 . . . . 0.0 110.849 175.376 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -136.82 108.6 7.05 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.699 1.6 . . . . 0.0 111.151 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.475 ' CE1' ' HB1' ' A' ' 87' ' ' ALA . 2.9 m-85 -112.59 127.23 56.03 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 120.989 -1.069 . . . . 0.0 110.205 -176.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.55 -32.09 6.57 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -175.042 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 38.1 t -130.94 -36.06 1.37 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.361 1.464 . . . . 0.0 112.128 175.038 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -69.64 12.33 1.49 Allowed Glycine 0 CA--C 1.537 1.433 0 C-N-CA 125.553 1.549 . . . . 0.0 115.871 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 75.8 p -28.34 99.36 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 129.992 3.317 . . . . 0.0 114.436 -174.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.606 HG21 HG23 ' A' ' 59' ' ' ILE . 3.2 t -119.25 177.59 4.84 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.467 1.507 . . . . 0.0 112.655 -174.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -82.16 -52.08 7.34 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.442 1.097 . . . . 0.0 112.421 175.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.2 p -155.62 139.19 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.752 1.621 . . . . 0.0 111.618 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.606 HG23 HG21 ' A' ' 56' ' ' THR . 0.1 OUTLIER -133.83 -46.28 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 125.53 1.532 . . . . 0.0 112.693 179.14 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.611 HD12 ' HB2' ' A' ' 49' ' ' ALA . 11.9 mt -79.33 103.46 1.59 Allowed Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 127.002 2.121 . . . . 0.0 109.272 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.5 ' HG2' HG23 ' A' ' 64' ' ' VAL . 48.7 Cg_endo -73.44 159.18 46.95 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 123.874 3.05 . . . . 0.0 110.549 177.615 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -52.97 -48.77 67.16 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 57.7 t -152.98 136.3 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 127.184 2.194 . . . . 0.0 109.272 -175.059 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.584 HG21 HD23 ' A' ' 70' ' ' LEU . 57.9 t -128.43 114.48 19.69 Favored Pre-proline 0 N--CA 1.479 1.016 0 C-N-CA 124.208 1.003 . . . . 0.0 110.583 174.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -59.93 145.56 98.01 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.495 2.13 . . . . 0.0 112.385 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -68.11 166.36 16.24 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.692 0.797 . . . . 0.0 110.703 175.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 39.8 p 62.39 16.92 8.99 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 127.198 2.199 . . . . 0.0 113.531 -175.03 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 19.0 mttt -125.86 -173.76 2.92 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.518 1.927 . . . . 0.0 111.102 -178.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -138.8 166.74 23.62 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 122.912 0.485 . . . . 0.0 109.988 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.584 HD23 HG21 ' A' ' 64' ' ' VAL . 2.8 pp -139.29 171.39 14.35 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 124.549 1.139 . . . . 0.0 111.145 -179.055 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.425 ' HG ' ' H ' ' A' ' 5' ' ' GLY . 0.9 OUTLIER -119.13 153.98 33.98 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 124.746 1.218 . . . . 0.0 110.475 175.013 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.532 ' HB2' HG22 ' A' ' 34' ' ' VAL . 2.7 m-85 -126.41 151.73 47.29 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 126.215 1.806 . . . . 0.0 109.931 177.442 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.403 ' H ' HG22 ' A' ' 59' ' ' ILE . 11.0 p -128.7 148.2 50.81 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.85 2.06 . . . . 0.0 111.747 -179.252 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -169.26 146.62 10.33 Favored Glycine 0 CA--C 1.519 0.306 0 CA-C-O 121.627 0.57 . . . . 0.0 112.619 175.015 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 63.5 mtm180 -128.64 138.59 52.26 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 126.74 2.016 . . . . 0.0 109.21 -174.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt . . . . . 0 CA--C 1.542 0.665 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 174.961 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.547 0.86 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 76.98 -98.48 1.32 Allowed Glycine 0 CA--C 1.528 0.892 0 C-N-CA 126.518 2.009 . . . . 0.0 112.269 -175.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -148.46 93.44 2.15 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 117.677 0.739 . . . . 0.0 110.866 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.4 t -122.2 120.69 61.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 124.46 1.104 . . . . 0.0 112.066 -175.016 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.475 ' HB1' ' CE1' ' A' ' 51' ' ' PHE . . . -160.02 168.71 25.0 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.489 1.116 . . . . 0.0 112.282 178.138 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -150.5 132.96 15.63 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.42 1.088 . . . . 0.0 109.326 174.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.463 ' CD2' ' CE2' ' A' ' 72' ' ' TYR . 43.9 p90 -132.17 170.01 15.6 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 120.946 -1.096 . . . . 0.0 110.27 177.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.438 ' HB1' ' CG2' ' A' ' 98' ' ' THR . . . -139.61 142.87 37.06 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -179.194 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.401 ' CD1' ' HB3' ' A' ' 44' ' ' TRP . 20.0 m-85 -120.43 139.12 53.3 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.675 1.19 . . . . 0.0 112.788 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -84.76 126.9 33.81 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.997 -0.439 . . . . 0.0 111.453 -177.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -97.53 141.12 30.97 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.016 1.327 . . . . 0.0 111.855 178.63 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 24.9 m -64.04 -20.26 65.79 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.47 1.108 . . . . 0.0 113.731 174.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 36.2 m-80 -72.22 -10.59 59.98 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.445 1.098 . . . . 0.0 112.81 174.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 89.68 44.32 4.91 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 124.755 1.169 . . . . 0.0 112.987 -176.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.497 ' HB3' HG22 ' A' ' 120' ' ' ILE . 37.3 m-80 -140.06 175.11 9.86 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.956 1.302 . . . . 0.0 110.481 175.596 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.603 HG23 HD21 ' A' ' 47' ' ' LEU . 12.9 m -126.87 110.7 13.32 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.395 1.478 . . . . 0.0 112.045 178.694 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.7 tt -70.86 98.02 1.5 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.954 1.302 . . . . 0.0 112.208 174.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -91.22 104.28 3.15 Favored Glycine 0 N--CA 1.469 0.896 0 C-N-CA 125.142 1.353 . . . . 0.0 113.372 177.174 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 94.0 t -85.39 130.62 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 125.106 1.363 . . . . 0.0 111.344 175.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 2.4 tmm? -119.99 124.27 45.52 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.798 1.639 . . . . 0.0 110.337 178.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.469 ' CZ ' ' HB3' ' A' ' 87' ' ' ALA . 4.3 p90 -148.95 122.67 9.24 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 122.901 1.334 . . . . 0.0 111.946 -178.482 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 15.1 p -139.94 100.53 3.96 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 124.418 1.087 . . . . 0.0 110.008 -175.01 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 97.0 t . . . . . 0 CA--C 1.54 0.583 0 C-N-CA 127.125 2.17 . . . . 0.0 108.654 178.535 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.2 p . . . . . 0 N--CA 1.483 1.177 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -98.81 108.5 21.2 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.418 1.887 . . . . 0.0 108.093 175.016 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 35.7 m0 -105.66 142.75 34.86 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 119.671 1.123 . . . . 0.0 109.942 175.584 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 29.7 p-90 -146.86 143.65 28.72 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 121.309 -0.87 . . . . 0.0 113.112 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -151.38 164.49 36.58 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 122.654 1.216 . . . . 0.0 112.957 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 54.6 t -153.41 136.66 7.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 175.036 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.37 177.81 10.2 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 126.645 1.978 . . . . 0.0 109.552 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.518 ' HB ' ' CE2' ' A' ' 154' ' ' TYR . 15.8 mt -126.52 141.79 44.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -101.05 144.4 28.48 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 125.172 1.389 . . . . 0.0 110.312 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.06 132.48 21.33 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 123.077 2.518 . . . . 0.0 111.455 179.184 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 62.85 -160.87 33.36 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 123.47 0.557 . . . . 0.0 113.017 -175.317 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.8 tttt -73.88 114.46 12.2 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.292 1.037 . . . . 0.0 109.532 175.018 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 2.4 mmt-85 -133.09 148.85 52.17 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.542 1.137 . . . . 0.0 111.057 175.017 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -93.64 179.57 5.33 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-O 121.686 0.755 . . . . 0.0 110.256 176.334 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -126.07 113.77 17.53 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 127.205 2.202 . . . . 0.0 105.093 175.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -126.91 172.83 10.09 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.388 1.475 . . . . 0.0 110.406 178.377 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -53.75 -40.78 66.48 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 119.62 1.1 . . . . 0.0 113.323 -178.225 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -59.73 -54.89 33.81 Favored Glycine 0 N--CA 1.467 0.736 0 CA-C-O 119.364 -0.687 . . . . 0.0 111.824 176.093 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 4.5 mpp? -62.24 -42.37 99.25 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 118.199 1.0 . . . . 0.0 112.388 177.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -54.94 -56.28 21.4 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.811 0.845 . . . . 0.0 109.646 176.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -66.37 -37.18 84.71 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -60.77 -44.49 96.7 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.298 1.439 . . . . 0.0 112.305 177.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 42.4 mmm -81.6 -30.01 33.08 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.074 -1.016 . . . . 0.0 112.615 177.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -54.47 -57.99 9.18 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.969 1.308 . . . . 0.0 109.457 174.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -73.8 -10.51 59.74 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -177.554 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -79.92 -15.42 79.12 Favored Glycine 0 CA--C 1.537 1.432 0 C-N-CA 125.893 1.711 . . . . 0.0 114.868 177.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -140.91 90.61 9.42 Favored Pre-proline 0 CA--C 1.552 1.041 0 CA-C-N 119.37 1.585 . . . . 0.0 112.522 176.403 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -74.66 78.08 2.85 Favored 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 123.912 3.074 . . . . 0.0 112.434 178.313 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -111.87 120.43 41.9 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.654 1.182 . . . . 0.0 110.462 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.38 -173.82 4.93 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.562 1.145 . . . . 0.0 112.584 176.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -75.16 53.07 2.63 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 125.602 1.572 . . . . 0.0 111.076 175.021 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -64.72 97.11 0.2 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 127.14 2.176 . . . . 0.0 110.039 178.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -75.31 93.43 2.88 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.554 1.142 . . . . 0.0 113.005 -174.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 162.89 54.93 0.02 OUTLIER Glycine 0 CA--C 1.537 1.407 0 C-N-CA 124.376 0.989 . . . . 0.0 115.011 175.045 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 8.0 m95 52.1 44.97 29.14 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.619 1.568 . . . . 0.0 114.667 -177.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -78.15 129.5 35.23 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 120.862 -1.148 . . . . 0.0 111.857 -177.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.64 -174.59 4.71 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.394 -0.816 . . . . 0.0 113.165 -175.137 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.96 151.89 51.64 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.972 1.309 . . . . 0.0 110.733 175.097 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -69.64 150.63 46.83 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 175.172 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 60.8 mt -109.91 145.54 36.69 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 175.119 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -64.5 -166.62 1.19 Allowed Glycine 0 CA--C 1.545 1.917 0 N-CA-C 110.266 -1.134 . . . . 0.0 110.266 176.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.518 ' CE2' ' HB ' ' A' ' 120' ' ' ILE . 0.0 OUTLIER 54.76 10.77 0.39 Allowed 'General case' 0 CA--C 1.558 1.275 0 N-CA-C 115.316 1.598 . . . . 0.0 115.316 175.038 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 80.96 41.27 10.64 Favored Glycine 0 CA--C 1.539 1.584 0 C-N-CA 126.416 1.96 . . . . 0.0 114.666 -175.162 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 2.4 mp -123.91 160.11 28.22 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 119.445 1.623 . . . . 0.0 112.305 177.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 10.5 mtt-85 -147.37 121.63 9.58 Favored 'General case' 0 N--CA 1.481 1.086 0 O-C-N 120.424 -1.423 . . . . 0.0 110.397 174.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' MET . . . . . 0.421 ' SD ' HG21 ' A' ' 172' ' ' ILE . 9.1 ttp -108.9 132.99 53.52 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 123.589 0.756 . . . . 0.0 109.069 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 2.7 tppt? -107.36 129.53 54.9 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 127.226 2.21 . . . . 0.0 110.385 -178.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -138.4 158.44 24.92 Favored Glycine 0 N--CA 1.473 1.106 0 CA-C-N 121.255 1.843 . . . . 0.0 115.57 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 3.4 tp -148.1 124.69 2.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-O 122.607 1.194 . . . . 0.0 111.362 -178.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 51.4 mtp -137.56 149.19 46.51 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 128.06 2.544 . . . . 0.0 107.998 175.004 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 8.8 t -134.66 161.16 35.9 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.335 1.054 . . . . 0.0 110.196 175.138 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 55.0 p -108.04 21.87 16.76 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.981 1.712 . . . . 0.0 112.428 -176.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -64.3 20.73 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.237 0 C-N-CA 128.617 2.767 . . . . 0.0 115.395 178.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 82.76 -68.64 3.51 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 126.995 2.236 . . . . 0.0 112.177 -177.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 -111.93 67.33 0.65 Allowed 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.538 1.535 . . . . 0.0 110.221 -177.017 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -95.76 174.66 6.86 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.946 1.698 . . . . 0.0 112.796 175.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.95 -178.78 3.94 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.845 2.058 . . . . 0.0 110.768 175.008 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' MET . . . . . 0.459 ' HB3' HG12 ' A' ' 34' ' ' VAL . 20.4 ttp -128.78 122.1 29.8 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.087 1.355 . . . . 0.0 109.812 176.644 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.482 ' C ' HD12 ' A' ' 172' ' ' ILE . 1.9 tt0 -131.47 130.31 42.28 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.053 0.941 . . . . 0.0 110.06 177.004 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.482 HD12 ' C ' ' A' ' 171' ' ' GLN . 4.3 mp -135.28 125.6 43.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 123.989 0.915 . . . . 0.0 109.297 177.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.85 128.88 50.97 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 125.811 1.644 . . . . 0.0 111.635 177.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.8 mp -74.69 133.06 32.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 175.018 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 1.2 m -144.87 97.08 2.96 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.044 1.337 . . . . 0.0 111.691 176.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 72.6 mtp180 . . . . . 0 C--O 1.254 1.327 0 C-N-CA 126.676 1.99 . . . . 0.0 113.018 177.581 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.59 HD21 ' HB2' ' A' ' 31' ' ' LYS . 0.1 OUTLIER . . . . . 0 CA--C 1.541 0.61 0 CA-C-O 121.038 0.447 . . . . 0.0 111.445 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -68.41 126.86 30.96 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 121.507 -0.745 . . . . 0.0 109.365 174.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -69.73 -90.69 0.07 OUTLIER Glycine 0 CA--C 1.535 1.293 0 C-N-CA 123.851 0.739 . . . . 0.0 113.181 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.7 p -149.81 166.28 29.95 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 125.776 1.631 . . . . 0.0 111.845 -175.026 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -114.04 22.74 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 CA-C-O 123.032 1.396 . . . . 0.0 112.996 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -45.24 152.38 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 125.624 1.57 . . . . 0.0 111.959 174.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -44.77 139.31 3.04 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 126.041 1.737 . . . . 0.0 112.901 -176.367 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -54.35 -25.98 35.5 Favored Glycine 0 CA--C 1.54 1.603 0 C-N-CA 124.225 0.917 . . . . 0.0 114.713 -175.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.83 -33.6 76.04 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.257 1.423 . . . . 0.0 112.551 174.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.4 m -96.47 -38.35 10.05 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.991 2.116 . . . . 0.0 112.637 175.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.4 tp -78.33 85.08 4.48 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.961 1.304 . . . . 0.0 110.674 176.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 48.6 p -114.12 176.07 5.2 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.771 2.028 . . . . 0.0 110.534 179.116 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -51.09 -39.47 56.18 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.404 -0.81 . . . . 0.0 112.569 177.648 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -54.89 -37.51 66.4 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 118.54 0.609 . . . . 0.0 112.432 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 92.4 t -68.13 -40.34 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.067 1.347 . . . . 0.0 111.169 174.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 41.1 mt -68.2 -40.45 82.18 Favored 'General case' 0 N--CA 1.471 0.575 0 O-C-N 120.865 -1.147 . . . . 0.0 112.229 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -61.88 -49.52 75.88 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.317 1.047 . . . . 0.0 111.609 177.047 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.58 -33.58 76.25 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 118.155 -0.926 . . . . 0.0 113.089 174.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.1 t -54.7 -42.3 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-N 119.792 1.178 . . . . 0.0 111.594 177.116 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.5 mt -55.77 -23.55 30.28 Favored 'General case' 0 CA--C 1.55 0.972 0 CA-C-N 119.544 1.065 . . . . 0.0 113.486 175.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -93.65 -60.76 1.14 Allowed Glycine 0 CA--C 1.532 1.132 0 C-N-CA 125.689 1.614 . . . . 0.0 112.7 177.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -67.47 -27.04 66.69 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 -177.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -111.94 87.95 2.69 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.663 1.585 . . . . 0.0 110.298 177.14 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -134.77 155.26 21.88 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 125.06 1.314 . . . . 0.0 113.004 175.32 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.529 ' HD3' ' HE ' ' A' ' 75' ' ' ARG . 16.3 mtpt -141.85 -49.37 0.39 Allowed 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 125.549 1.539 . . . . 0.0 112.143 -177.071 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.475 HG22 ' CZ ' ' A' ' 75' ' ' ARG . 3.2 m -115.89 -177.17 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 C-N-CA 126.297 1.839 . . . . 0.0 110.636 176.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.8 t -49.3 -44.4 44.11 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 126.374 1.869 . . . . 0.0 115.068 -176.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.8 161.61 35.1 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 126.28 1.832 . . . . 0.0 111.074 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.59 ' HB2' HD21 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -155.31 165.61 36.11 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.089 0.956 . . . . 0.0 112.711 179.604 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.564 HD12 HG12 ' A' ' 34' ' ' VAL . 0.3 OUTLIER -119.34 123.73 71.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 124.125 0.97 . . . . 0.0 108.44 175.0 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -127.64 120.8 28.88 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 126.513 1.925 . . . . 0.0 106.706 174.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.642 HG13 ' CB ' ' A' ' 72' ' ' TYR . 0.2 OUTLIER -136.56 140.43 43.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 126.459 1.904 . . . . 0.0 108.527 -174.993 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -123.07 132.75 8.73 Favored Glycine 0 CA--C 1.523 0.575 0 CA-C-O 119.981 -0.344 . . . . 0.0 112.538 175.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.4 mp -112.64 152.22 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 117.71 0.755 . . . . 0.0 109.343 174.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -122.22 106.61 11.29 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 122.63 1.205 . . . . 0.0 110.709 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -76.07 85.15 2.94 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 128.451 2.7 . . . . 0.0 111.054 -175.01 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -120.99 4.65 10.43 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.644 1.177 . . . . 0.0 113.926 176.544 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.418 ' HA ' HG21 ' A' ' 174' ' ' ILE . 0.6 OUTLIER -53.98 -50.41 66.6 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.475 1.11 . . . . 0.0 112.133 174.982 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 127.7 103.87 1.23 Allowed Glycine 0 CA--C 1.526 0.776 0 C-N-CA 123.928 0.775 . . . . 0.0 111.684 177.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 114.48 153.93 10.82 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 126.15 1.833 . . . . 0.0 111.127 -174.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.705 HG22 ' HA ' ' A' ' 65' ' ' PRO . 68.4 p -69.72 142.18 53.36 Favored 'General case' 0 N--CA 1.466 0.359 0 O-C-N 121.887 -0.773 . . . . 0.0 111.062 175.093 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 39.4 m0 -96.64 107.6 20.07 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.367 0.667 . . . . 0.0 109.434 -179.279 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 36.4 m -87.58 127.33 35.26 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.609 0.763 . . . . 0.0 109.972 178.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.409 ' HB1' ' HB3' ' A' ' 60' ' ' LEU . . . -63.42 130.39 44.25 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 122.763 0.425 . . . . 0.0 111.429 174.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.8 pp -114.13 -55.76 2.46 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.79 0.836 . . . . 0.0 111.632 178.243 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -166.68 160.32 14.82 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.894 1.677 . . . . 0.0 110.867 175.011 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -140.69 165.71 26.74 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.427 1.091 . . . . 0.0 111.981 174.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -142.0 119.69 11.8 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.704 1.202 . . . . 0.0 111.887 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.474 ' CE1' ' HB1' ' A' ' 87' ' ' ALA . 2.6 m-85 -108.74 139.2 43.88 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.362 -0.836 . . . . 0.0 111.646 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.1 tpp180 -110.78 -65.91 1.12 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.859 1.663 . . . . 0.0 111.262 -177.081 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -37.58 -58.06 0.9 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 128.257 2.623 . . . . 0.0 113.52 -175.49 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -153.05 -116.63 0.65 Allowed Glycine 0 CA--C 1.526 0.731 0 C-N-CA 125.971 1.748 . . . . 0.0 109.133 175.032 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 39.0 p -143.33 178.52 7.68 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.036 1.334 . . . . 0.0 112.23 -175.05 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.2 t -154.0 179.58 8.78 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.43 1.492 . . . . 0.0 111.417 174.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -111.67 -38.5 4.87 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.02 1.328 . . . . 0.0 112.41 179.293 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.9 p -159.28 127.76 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 126.076 1.75 . . . . 0.0 110.636 175.049 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.429 HG22 ' H ' ' A' ' 73' ' ' SER . 1.7 pp -132.8 -32.36 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 114.606 1.335 . . . . 0.0 114.606 175.014 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.409 ' HB3' ' HB1' ' A' ' 46' ' ' ALA . 10.4 mt -100.85 95.53 4.64 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 125.43 1.492 . . . . 0.0 109.403 178.659 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.453 ' HG2' HG23 ' A' ' 64' ' ' VAL . 98.8 Cg_endo -65.97 151.62 83.52 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 123.402 2.735 . . . . 0.0 110.676 174.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -44.35 -49.64 9.46 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.894 1.677 . . . . 0.0 114.023 -177.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 5.1 p -159.42 137.73 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 126.978 2.111 . . . . 0.0 109.208 175.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.494 HG21 HD13 ' A' ' 70' ' ' LEU . 98.8 t -114.74 125.88 28.55 Favored Pre-proline 0 N--CA 1.479 0.988 0 C-N-CA 123.927 0.891 . . . . 0.0 109.211 175.263 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.705 ' HA ' HG22 ' A' ' 43' ' ' THR . 60.5 Cg_endo -65.64 155.73 67.49 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 122.882 2.388 . . . . 0.0 113.099 177.594 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -71.71 169.59 15.31 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.582 0.753 . . . . 0.0 111.374 175.011 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 65.2 p 52.34 26.25 3.97 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 126.415 1.886 . . . . 0.0 113.217 -175.005 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.3 mttt -138.25 174.68 10.3 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 126.441 1.896 . . . . 0.0 111.107 -175.037 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -135.66 160.81 37.36 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -176.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.494 HD13 HG21 ' A' ' 64' ' ' VAL . 2.4 pt? -133.18 170.49 15.34 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.786 1.234 . . . . 0.0 111.552 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -114.29 149.91 35.24 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 124.494 1.118 . . . . 0.0 109.995 175.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.642 ' CB ' HG13 ' A' ' 34' ' ' VAL . 1.5 m-85 -122.36 160.32 25.66 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 127.353 2.261 . . . . 0.0 108.775 175.072 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.429 ' H ' HG22 ' A' ' 59' ' ' ILE . 5.9 p -145.34 166.77 24.61 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 125.443 1.497 . . . . 0.0 112.105 -175.174 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 173.9 151.76 8.48 Favored Glycine 0 C--O 1.237 0.301 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.681 174.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.529 ' HE ' ' HD3' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -111.9 139.17 47.6 Favored 'General case' 0 CA--C 1.521 -0.145 0 C-N-CA 124.883 1.273 . . . . 0.0 111.88 179.321 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.469 0.518 0 C-N-CA 124.172 0.989 . . . . 0.0 112.853 174.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 34.7 m . . . . . 0 N--CA 1.484 1.234 0 CA-C-O 119.04 -0.505 . . . . 0.0 110.363 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -26.75 -66.96 0.06 OUTLIER Glycine 0 N--CA 1.473 1.127 0 C-N-CA 127.991 2.71 . . . . 0.0 116.693 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.461 ' HB3' ' HB ' ' A' ' 105' ' ' VAL . . . -167.47 106.66 0.56 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.066 0.947 . . . . 0.0 112.219 -178.081 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.7 t -149.51 109.67 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 124.749 1.22 . . . . 0.0 112.062 -174.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.645 ' HB3' ' CZ ' ' A' ' 103' ' ' PHE . . . -153.69 169.64 22.81 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 179.131 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -147.2 160.61 42.26 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.92 1.288 . . . . 0.0 112.543 175.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.451 ' CZ ' HG11 ' A' ' 101' ' ' VAL . 37.4 p90 -164.11 171.41 15.14 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.332 1.053 . . . . 0.0 111.62 -178.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -143.95 155.94 44.24 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.468 -0.77 . . . . 0.0 112.201 174.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -131.72 129.29 40.48 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 126.472 1.909 . . . . 0.0 113.19 -175.015 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -90.66 130.53 36.66 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 120.882 0.372 . . . . 0.0 111.343 -176.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 3.9 mtm -108.27 139.01 43.6 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 125.503 1.521 . . . . 0.0 111.705 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.2 t -64.79 -18.7 65.32 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.223 1.409 . . . . 0.0 112.962 176.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -69.74 -17.5 63.45 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.998 1.319 . . . . 0.0 113.616 175.167 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 106.47 21.32 8.41 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.92 1.248 . . . . 0.0 115.362 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -131.44 174.81 9.71 Favored 'General case' 0 CA--C 1.555 1.142 0 CA-C-N 119.824 1.812 . . . . 0.0 111.422 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.8 m -129.31 105.87 8.42 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.403 1.081 . . . . 0.0 112.959 -178.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 59.0 tp -68.81 101.23 1.3 Allowed 'General case' 0 N--CA 1.47 0.567 0 O-C-N 121.762 -0.586 . . . . 0.0 110.247 174.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -94.65 138.65 14.12 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 124.176 0.893 . . . . 0.0 112.232 175.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.451 HG11 ' CZ ' ' A' ' 89' ' ' PHE . 54.1 t -128.17 133.03 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.225 1.41 . . . . 0.0 110.71 -175.012 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.84 124.29 20.74 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.895 1.678 . . . . 0.0 109.386 -177.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.645 ' CZ ' ' HB3' ' A' ' 87' ' ' ALA . 26.9 p90 -138.42 135.35 35.16 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -178.695 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 12.2 m -148.79 100.51 3.1 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 122.224 1.011 . . . . 0.0 111.193 -175.052 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.461 ' HB ' ' HB3' ' A' ' 85' ' ' ALA . 51.3 t . . . . . 0 N--CA 1.471 0.588 0 C-N-CA 127.144 2.178 . . . . 0.0 109.761 -177.091 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 5.5 m . . . . . 0 N--CA 1.468 0.433 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -80.58 115.81 20.29 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 124.324 1.05 . . . . 0.0 108.973 174.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 42.1 m0 -116.25 145.66 42.96 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.134 0.973 . . . . 0.0 109.45 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 34.3 p-90 -150.78 139.83 21.07 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.403 0.681 . . . . 0.0 112.248 -179.16 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -140.57 145.85 37.28 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 122.299 1.047 . . . . 0.0 112.81 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 86.1 t -146.8 123.96 3.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 125.093 1.357 . . . . 0.0 107.783 176.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.426 ' HE2' ' CZ ' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -156.14 176.18 13.0 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.403 1.081 . . . . 0.0 111.336 174.969 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.524 ' HB ' ' CE2' ' A' ' 154' ' ' TYR . 38.8 mt -111.51 105.31 18.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 123.765 0.826 . . . . 0.0 109.804 -177.053 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.426 ' CZ ' ' HE2' ' A' ' 119' ' ' LYS . 91.0 m-85 -60.3 143.82 88.65 Favored Pre-proline 0 CA--C 1.548 0.899 0 O-C-N 121.318 -0.864 . . . . 0.0 111.889 178.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -76.11 80.25 2.72 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 124.449 3.432 . . . . 0.0 112.435 -176.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 118.89 -170.83 13.96 Favored Glycine 0 N--CA 1.471 1.004 0 C-N-CA 125.684 1.611 . . . . 0.0 112.778 -178.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 23.3 tttt -66.27 109.53 2.7 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.018 0.927 . . . . 0.0 109.51 174.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.413 ' HG3' ' H ' ' A' ' 126' ' ' ARG . 5.7 tpt180 -120.01 173.04 7.32 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.723 1.609 . . . . 0.0 110.242 176.67 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.413 ' H ' ' HG3' ' A' ' 125' ' ' ARG . 2.2 ptp180 -127.04 173.17 9.88 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 127.172 2.189 . . . . 0.0 111.292 174.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -128.35 98.01 4.92 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 126.44 1.896 . . . . 0.0 107.422 175.015 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -117.73 173.1 6.93 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.425 1.89 . . . . 0.0 109.115 175.026 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -49.84 -42.74 48.01 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.057 0.943 . . . . 0.0 113.477 177.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -57.34 -63.66 5.1 Favored Glycine 0 C--N 1.339 0.718 0 C-N-CA 124.173 0.892 . . . . 0.0 111.624 175.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 15.0 mtm -59.81 -34.12 72.63 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 118.141 0.97 . . . . 0.0 113.297 178.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -59.53 -60.42 3.87 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 119.304 0.956 . . . . 0.0 109.93 175.027 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -70.03 -30.7 68.06 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -177.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -60.75 -54.23 47.74 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.417 1.087 . . . . 0.0 110.024 174.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 2.0 tpp -75.21 -26.48 58.98 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -177.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -52.44 -55.84 19.11 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.464 1.505 . . . . 0.0 110.586 174.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -69.8 -8.65 50.07 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 179.036 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -79.21 -31.33 42.75 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 126.224 1.869 . . . . 0.0 115.076 -177.009 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -128.65 85.19 60.95 Favored Pre-proline 0 CA--C 1.548 0.887 0 CA-C-N 118.717 1.259 . . . . 0.0 111.047 178.158 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -73.42 75.94 2.83 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 123.661 2.908 . . . . 0.0 112.086 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -111.28 114.41 27.57 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.058 0.943 . . . . 0.0 110.86 -177.191 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 57.4 mtp180 -81.65 -71.41 0.48 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.813 1.245 . . . . 0.0 111.499 175.031 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 136.86 122.62 2.16 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 124.568 1.08 . . . . 0.0 113.589 -177.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.9 7.1 9.5 Favored 'General case' 0 CA--C 1.559 1.296 0 C-N-CA 127.175 2.19 . . . . 0.0 115.081 177.693 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 57.57 55.83 5.36 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 128.282 2.633 . . . . 0.0 112.595 -175.056 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -158.24 -66.73 0.01 OUTLIER Glycine 0 CA--C 1.538 1.479 0 N-CA-C 115.971 1.148 . . . . 0.0 115.971 -177.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 29.8 m95 174.11 117.1 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 130.414 3.486 . . . . 0.0 108.361 -174.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -129.9 121.03 25.86 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 126.801 2.04 . . . . 0.0 111.846 -175.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -162.33 178.3 8.81 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 -175.072 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.76 154.46 48.52 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.542 1.537 . . . . 0.0 110.849 175.373 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -71.34 137.69 48.65 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 175.012 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 91.1 mt -93.92 102.76 14.87 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.667 0.787 . . . . 0.0 109.947 -176.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -36.22 -37.51 0.19 Allowed Glycine 0 N--CA 1.476 1.32 0 C-N-CA 128.711 3.053 . . . . 0.0 117.629 -174.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.524 ' CE2' ' HB ' ' A' ' 120' ' ' ILE . 0.1 OUTLIER -61.61 -30.85 70.95 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.968 2.107 . . . . 0.0 113.239 -179.252 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 132.65 30.38 0.5 Allowed Glycine 0 CA--C 1.536 1.397 0 C-N-CA 125.763 1.649 . . . . 0.0 114.582 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 12.8 mt -130.6 175.85 8.66 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 126.082 1.753 . . . . 0.0 110.555 -174.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 60.7 mtt-85 -147.21 100.7 3.31 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.534 -1.354 . . . . 0.0 112.701 178.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -82.1 148.69 28.41 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 124.157 0.983 . . . . 0.0 108.632 175.314 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 3.3 tppt? -139.68 120.46 14.37 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.331 1.852 . . . . 0.0 111.214 178.243 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -131.59 154.89 21.11 Favored Glycine 0 N--CA 1.479 1.518 0 CA-C-N 121.123 1.783 . . . . 0.0 116.311 -176.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 2.1 tp -146.19 130.55 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.132 1.373 . . . . 0.0 110.651 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 1.9 ttp -154.61 117.62 4.44 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.958 1.703 . . . . 0.0 110.249 174.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 4.9 t -110.4 101.44 10.15 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 121.122 -0.986 . . . . 0.0 111.411 -177.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 49.0 p -69.12 28.45 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.02 -27.2 68.15 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.309 1.844 . . . . 0.0 114.332 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 159.78 -53.75 0.36 Allowed Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.776 1.179 . . . . 0.0 113.507 175.032 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -134.5 87.32 2.34 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.81 1.244 . . . . 0.0 110.771 178.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -136.26 -174.6 3.73 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.682 1.593 . . . . 0.0 111.582 175.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' LYS . . . . . 0.402 ' HE2' ' O ' ' A' ' 169' ' ' LYS . 0.0 OUTLIER -133.51 175.35 9.5 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 127.462 2.305 . . . . 0.0 111.437 -178.671 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 32.6 ttp -110.04 138.3 46.61 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 123.965 0.906 . . . . 0.0 110.479 173.021 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -143.86 123.72 13.47 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 123.595 0.758 . . . . 0.0 110.361 176.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 4.7 mp -127.48 121.02 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 123.481 0.712 . . . . 0.0 109.754 176.015 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 2.8 tmmm? -121.05 139.07 53.82 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 125.32 1.448 . . . . 0.0 110.705 177.007 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.418 HG21 ' HA ' ' A' ' 40' ' ' SER . 1.6 mp -87.4 125.79 41.11 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 174.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -137.4 96.64 3.3 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.256 1.422 . . . . 0.0 111.724 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 10.8 mtp-105 . . . . . 0 C--O 1.254 1.29 0 C-N-CA 128.119 2.568 . . . . 0.0 113.638 -177.737 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 3' ' ' LEU . 10.4 tp . . . . . 0 N--CA 1.471 0.61 0 CA-C-O 121.112 0.482 . . . . 0.0 111.835 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -85.78 130.26 34.61 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.9 1.28 . . . . 0.0 108.464 174.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -77.12 -151.23 4.2 Favored Glycine 0 CA--C 1.538 1.503 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 175.005 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.6 p -78.86 169.96 17.42 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 121.441 -1.035 . . . . 0.0 113.747 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -120.64 20.72 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 126.339 1.856 . . . . 0.0 112.593 177.435 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -48.82 159.85 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 125.221 1.409 . . . . 0.0 112.517 175.008 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -46.75 140.47 4.55 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.682 1.593 . . . . 0.0 112.564 -175.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -57.24 -20.22 35.18 Favored Glycine 0 CA--C 1.542 1.751 0 C-N-CA 124.083 0.849 . . . . 0.0 114.418 -175.195 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.74 -27.47 66.81 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.008 1.323 . . . . 0.0 112.357 175.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.7 t -104.55 -42.35 5.46 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 127.15 2.18 . . . . 0.0 111.334 177.054 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 12.4 tp -83.33 98.59 9.53 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.644 1.578 . . . . 0.0 110.366 174.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 69.0 p -126.57 177.34 6.57 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.997 1.319 . . . . 0.0 110.898 177.252 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.408 ' C ' ' CD1' ' A' ' 15' ' ' PHE . 0.1 OUTLIER -45.73 -37.89 6.39 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.446 1.098 . . . . 0.0 112.827 177.801 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -57.62 -42.72 83.92 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.329 1.452 . . . . 0.0 112.289 -179.316 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.4 t -61.97 -37.29 77.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.72 1.208 . . . . 0.0 110.933 174.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.7 mt -71.73 -40.4 69.45 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.549 1.14 . . . . 0.0 111.663 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -60.77 -43.95 97.38 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.55 1.14 . . . . 0.0 110.429 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.35 -28.1 59.44 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.207 1.003 . . . . 0.0 113.127 174.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -55.79 -38.22 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 124.301 1.04 . . . . 0.0 111.461 177.607 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 15.7 mt -55.6 -20.85 14.96 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.287 1.435 . . . . 0.0 113.977 174.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -98.11 -63.27 0.87 Allowed Glycine 0 CA--C 1.532 1.113 0 C-N-CA 125.172 1.368 . . . . 0.0 112.584 175.527 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -65.65 -33.82 76.78 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 -174.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -105.37 94.98 5.51 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.66 1.584 . . . . 0.0 108.025 175.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -140.88 145.06 15.52 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 123.954 0.788 . . . . 0.0 113.648 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.7 mtpp -127.31 -39.08 1.91 Allowed 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 126.294 1.838 . . . . 0.0 113.788 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.3 m -133.0 174.71 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 126.425 1.89 . . . . 0.0 111.06 -178.392 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 54.4 m -54.29 -46.5 72.78 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.241 1.816 . . . . 0.0 114.557 -176.599 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.72 126.95 44.34 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.99 1.316 . . . . 0.0 111.051 175.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.39 161.29 31.66 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 124.85 1.26 . . . . 0.0 111.485 179.492 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.486 HD13 ' H ' ' A' ' 33' ' ' ALA . 0.3 OUTLIER -107.48 140.87 24.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 174.955 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.486 ' H ' HD13 ' A' ' 32' ' ' ILE . . . -132.91 131.52 40.98 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 126.483 1.913 . . . . 0.0 109.819 175.706 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.483 ' O ' HD13 ' A' ' 71' ' ' LEU . 25.2 t -140.62 156.15 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 123.305 0.642 . . . . 0.0 110.306 178.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -138.57 98.51 0.26 Allowed Glycine 0 CA--C 1.524 0.598 0 C-N-CA 125.677 1.608 . . . . 0.0 111.904 176.393 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.7 mp -81.71 144.84 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-N 117.272 0.536 . . . . 0.0 109.739 175.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -116.29 99.43 7.2 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.024 1.73 . . . . 0.0 110.66 178.382 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -67.68 97.17 0.6 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.818 1.647 . . . . 0.0 110.203 175.002 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -124.89 4.87 8.05 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.625 0.77 . . . . 0.0 112.326 174.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.9 t -57.59 -45.25 85.51 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.376 1.47 . . . . 0.0 112.875 -176.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 130.11 40.33 0.26 Allowed Glycine 0 CA--C 1.535 1.29 0 C-N-CA 124.31 0.957 . . . . 0.0 115.25 177.082 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -178.09 165.71 35.34 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.561 1.077 . . . . 0.0 112.605 175.015 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.534 HG22 ' HA ' ' A' ' 65' ' ' PRO . 8.4 p -68.76 137.68 54.23 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.485 -1.009 . . . . 0.0 110.34 174.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.548 ' HA ' ' CE1' ' A' ' 91' ' ' TYR . 35.6 m0 -93.87 100.52 12.68 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 123.232 0.613 . . . . 0.0 111.546 -178.205 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 29.1 m -84.6 115.48 22.65 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.004 0.922 . . . . 0.0 109.121 177.069 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.421 ' HB1' ' HB3' ' A' ' 60' ' ' LEU . . . -60.05 143.5 51.83 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 122.709 0.403 . . . . 0.0 111.547 175.002 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.5 pp -119.2 -55.07 2.18 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.651 0.781 . . . . 0.0 111.966 178.104 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 22.7 t30 -173.15 150.47 1.94 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.991 2.117 . . . . 0.0 109.997 -177.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -129.05 163.67 24.91 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.837 1.255 . . . . 0.0 111.489 175.003 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -131.77 106.87 8.39 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.324 1.45 . . . . 0.0 110.663 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.624 ' CE1' ' HB1' ' A' ' 87' ' ' ALA . 2.7 m-85 -115.58 112.18 21.79 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.948 0.899 . . . . 0.0 110.118 -174.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.05 -41.27 7.63 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -178.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.0 t -116.13 -45.72 2.84 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.549 1.539 . . . . 0.0 111.002 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -69.26 11.57 1.46 Allowed Glycine 0 CA--C 1.538 1.503 0 CA-C-O 118.226 -1.319 . . . . 0.0 115.764 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.7 p -32.75 108.27 0.05 Allowed 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 128.472 2.709 . . . . 0.0 113.987 -175.03 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.523 HG21 HG23 ' A' ' 59' ' ' ILE . 1.5 t -130.02 175.41 8.91 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 114.125 1.158 . . . . 0.0 114.125 -174.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -79.58 -48.84 13.13 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.64 1.176 . . . . 0.0 112.79 -178.227 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.4 p -144.07 132.44 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.818 1.647 . . . . 0.0 111.604 176.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.592 HD12 ' H ' ' A' ' 60' ' ' LEU . 1.0 OUTLIER -137.02 -47.92 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.171 1.388 . . . . 0.0 113.903 179.315 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.592 ' H ' HD12 ' A' ' 59' ' ' ILE . 8.2 mt -86.69 102.6 3.11 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 123.977 0.911 . . . . 0.0 109.836 174.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.44 ' HG2' HG23 ' A' ' 64' ' ' VAL . 73.3 Cg_endo -68.0 141.64 53.94 Favored 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 122.729 2.286 . . . . 0.0 110.898 174.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -38.73 -52.96 1.69 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 126.949 2.1 . . . . 0.0 114.116 178.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.6 p -153.24 135.45 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 126.475 1.91 . . . . 0.0 109.927 174.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.44 HG23 ' HG2' ' A' ' 61' ' ' PRO . 59.5 t -116.24 131.18 23.93 Favored Pre-proline 0 N--CA 1.483 1.207 0 C-N-CA 124.671 1.188 . . . . 0.0 109.681 176.202 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.534 ' HA ' HG22 ' A' ' 43' ' ' THR . 56.8 Cg_endo -65.93 152.91 80.17 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 122.714 2.276 . . . . 0.0 113.656 177.559 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -69.24 162.95 26.06 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.17 0.988 . . . . 0.0 111.232 175.006 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . 0.257 76.4 p 51.37 28.22 4.22 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 126.787 2.035 . . . . 0.0 114.006 -174.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.8 mttp -131.1 175.98 8.64 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 127.537 2.335 . . . . 0.0 111.34 -178.208 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -127.35 158.92 35.97 Favored 'General case' 0 C--O 1.224 -0.249 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -178.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.413 ' C ' HD12 ' A' ' 70' ' ' LEU . 2.4 pp -121.84 171.85 8.6 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.313 1.445 . . . . 0.0 110.52 175.076 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.483 HD13 ' O ' ' A' ' 34' ' ' VAL . 0.3 OUTLIER -117.17 145.6 43.74 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 124.051 0.94 . . . . 0.0 108.95 174.959 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -127.16 143.74 51.19 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 125.585 1.554 . . . . 0.0 108.845 177.16 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 82.9 p -143.57 170.8 15.14 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.963 -178.141 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 174.48 142.84 4.17 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.223 -0.899 . . . . 0.0 112.357 176.359 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -109.44 128.97 55.54 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 124.869 1.267 . . . . 0.0 108.087 177.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.7 ptpt . . . . . 0 N--CA 1.472 0.65 0 C-N-CA 124.724 1.21 . . . . 0.0 113.291 176.474 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.1 m . . . . . 0 N--CA 1.475 0.801 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -84.03 -90.21 0.77 Allowed Glycine 0 N--CA 1.47 0.948 0 O-C-N 120.538 -1.351 . . . . 0.0 114.524 -175.03 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.596 ' HB3' ' HB ' ' A' ' 105' ' ' VAL . . . -143.33 82.73 1.75 Allowed 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 124.815 1.246 . . . . 0.0 109.066 -175.017 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.7 t -122.29 111.95 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 124.929 1.292 . . . . 0.0 111.007 -175.037 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.624 ' HB1' ' CE1' ' A' ' 51' ' ' PHE . . . -158.03 167.7 29.16 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 122.177 0.989 . . . . 0.0 111.166 177.489 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -148.92 160.88 42.87 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.284 1.433 . . . . 0.0 109.58 175.018 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -156.41 174.67 15.08 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 121.42 -0.8 . . . . 0.0 112.122 175.068 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -145.16 150.89 37.58 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.849 0.833 . . . . 0.0 113.203 174.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.548 ' CE1' ' HA ' ' A' ' 44' ' ' TRP . 0.1 OUTLIER -121.87 127.07 50.07 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 127.205 2.202 . . . . 0.0 109.181 -179.232 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -84.11 104.68 14.37 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.269 0.627 . . . . 0.0 112.423 179.179 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -72.38 126.2 29.26 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 125.401 1.48 . . . . 0.0 112.657 -176.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 37.1 m -58.62 -21.18 52.88 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.652 0.781 . . . . 0.0 113.095 175.048 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 23.7 m-20 -69.38 -14.02 62.68 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 124.693 1.197 . . . . 0.0 112.907 174.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 109.26 31.99 3.13 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 125.295 1.426 . . . . 0.0 115.055 177.016 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -142.72 -179.44 6.33 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.855 1.262 . . . . 0.0 112.044 -175.23 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 25.1 m -132.55 107.26 8.33 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 120.994 -1.067 . . . . 0.0 111.973 177.454 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 35.7 tp -74.69 107.74 7.0 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 121.224 -0.923 . . . . 0.0 110.57 175.053 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -107.13 114.6 4.36 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 124.79 1.186 . . . . 0.0 113.742 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.464 ' HA ' HG22 ' A' ' 118' ' ' VAL . 98.4 t -97.27 137.28 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.134 1.374 . . . . 0.0 112.614 -175.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -129.11 126.06 38.51 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 126.352 1.861 . . . . 0.0 111.788 -175.258 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.422 ' CE2' ' HB3' ' A' ' 87' ' ' ALA . 3.8 p90 -148.48 123.82 10.27 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.6 1.16 . . . . 0.0 112.018 -178.278 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 22.4 t -137.47 133.94 35.23 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.758 0.823 . . . . 0.0 111.612 178.439 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.596 ' HB ' ' HB3' ' A' ' 85' ' ' ALA . 19.0 t . . . . . 0 CA--C 1.539 0.556 0 C-N-CA 126.88 2.072 . . . . 0.0 108.885 -176.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 20.1 m . . . . . 0 N--CA 1.467 0.383 0 CA-C-O 121.142 0.496 . . . . 0.0 112.131 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -77.03 91.8 3.67 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.954 1.302 . . . . 0.0 111.297 176.033 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 42.8 m0 -98.01 149.16 22.75 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 119.463 1.029 . . . . 0.0 111.226 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 31.6 p-90 -155.95 135.64 12.57 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.653 0.781 . . . . 0.0 112.498 -176.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -145.57 174.84 10.82 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 120.553 -1.342 . . . . 0.0 112.825 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.464 HG22 ' HA ' ' A' ' 101' ' ' VAL . 99.3 t -148.9 139.81 17.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 C-N-CA 123.768 0.827 . . . . 0.0 109.135 175.22 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.467 ' HE2' ' CG ' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -144.4 169.54 17.73 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 125.566 1.546 . . . . 0.0 109.538 175.133 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 59.9 mt -113.27 128.47 70.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 175.036 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.467 ' CG ' ' HE2' ' A' ' 119' ' ' LYS . 96.2 m-85 -88.38 147.5 40.14 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 124.683 1.193 . . . . 0.0 110.48 175.554 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -70.01 130.92 19.84 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 123.151 2.568 . . . . 0.0 111.075 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 59.96 -141.64 47.64 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 123.607 0.622 . . . . 0.0 113.133 -178.391 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 4.6 tmtt? -86.49 118.05 25.66 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.492 1.517 . . . . 0.0 110.4 176.362 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 12.2 tpp180 -135.51 170.61 15.68 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 126.088 1.755 . . . . 0.0 109.998 175.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 24.8 ptt180 -116.2 -176.55 2.97 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 127.133 2.173 . . . . 0.0 111.258 175.275 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -127.16 105.48 8.6 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 175.046 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -121.81 168.04 12.3 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.788 1.635 . . . . 0.0 109.751 177.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -51.84 -41.1 61.55 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 -177.584 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -59.12 -56.25 26.31 Favored Glycine 0 N--CA 1.47 0.912 0 CA-C-N 119.278 0.945 . . . . 0.0 112.164 175.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 4.9 mtt -59.01 -46.19 88.79 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.414 1.086 . . . . 0.0 111.287 177.733 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -51.78 -58.48 6.3 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.554 1.542 . . . . 0.0 111.096 174.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -68.89 -30.62 69.16 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -178.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -59.49 -41.75 90.56 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.998 0.919 . . . . 0.0 111.446 174.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 12.8 mmm -86.18 -27.66 24.42 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -51.2 -63.71 1.05 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.861 1.665 . . . . 0.0 110.883 175.018 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -69.42 -6.23 28.82 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -175.778 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -88.18 -15.57 60.52 Favored Glycine 0 CA--C 1.537 1.442 0 C-N-CA 126.974 2.226 . . . . 0.0 115.459 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -144.77 95.49 5.28 Favored Pre-proline 0 CA--C 1.552 1.049 0 CA-C-N 119.771 1.786 . . . . 0.0 112.688 178.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -75.95 77.31 3.47 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 123.783 2.989 . . . . 0.0 112.591 -178.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -107.98 110.01 21.62 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.346 1.458 . . . . 0.0 109.827 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 9.6 mtp180 -118.56 111.39 18.53 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 126.944 2.098 . . . . 0.0 111.541 -175.031 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 76.96 -56.73 3.55 Favored Glycine 0 C--O 1.218 -0.867 0 CA-C-O 118.609 -1.106 . . . . 0.0 111.728 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 57.21 33.86 23.94 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 119.975 1.887 . . . . 0.0 114.655 174.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -70.31 40.9 0.05 Allowed 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 127.933 2.493 . . . . 0.0 115.163 -177.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -160.17 34.29 0.43 Allowed Glycine 0 CA--C 1.539 1.576 0 C-N-CA 126.319 1.914 . . . . 0.0 114.555 178.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' TRP . . . . . 0.588 ' H ' HD12 ' A' ' 161' ' ' ILE . 3.6 m95 57.5 49.48 12.72 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 126.769 2.028 . . . . 0.0 112.372 -174.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -84.68 130.56 34.69 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 121.319 -0.863 . . . . 0.0 111.23 -177.129 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -171.29 -176.93 2.0 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.034 0.933 . . . . 0.0 112.797 177.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 9.8 ttpp -126.48 157.14 39.44 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 126.339 1.855 . . . . 0.0 111.37 -174.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -68.48 158.13 34.43 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.293 0.568 . . . . 0.0 110.559 174.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.465 HD11 ' HB2' ' A' ' 158' ' ' MET . 98.5 mt -112.81 159.77 18.67 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.996 1.319 . . . . 0.0 109.45 175.176 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -63.33 -171.57 1.79 Allowed Glycine 0 CA--C 1.538 1.501 0 C-N-CA 124.085 0.85 . . . . 0.0 111.743 174.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 52.74 13.22 0.32 Allowed 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 125.486 1.515 . . . . 0.0 114.954 175.358 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 79.26 36.93 25.97 Favored Glycine 0 CA--C 1.54 1.6 0 C-N-CA 125.724 1.63 . . . . 0.0 113.803 -175.008 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -115.93 167.12 11.24 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 119.181 1.491 . . . . 0.0 112.436 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 80.2 mtt85 -146.48 127.55 14.64 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 120.924 -1.11 . . . . 0.0 111.053 175.034 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' MET . . . . . 0.465 ' HB2' HD11 ' A' ' 152' ' ' LEU . 7.3 ttp -99.99 154.23 18.56 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 174.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.42 ' N ' ' HG2' ' A' ' 158' ' ' MET . 0.0 OUTLIER -126.43 147.89 49.72 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 127.691 2.396 . . . . 0.0 110.972 176.236 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -152.39 151.44 23.29 Favored Glycine 0 CA--C 1.524 0.65 0 CA-C-O 121.933 0.74 . . . . 0.0 113.47 175.037 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.588 HD12 ' H ' ' A' ' 147' ' ' TRP . 1.1 tp -142.72 133.76 24.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 127.005 2.122 . . . . 0.0 108.8 -179.147 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 1.4 mtp -149.02 -176.07 5.2 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 127.313 2.245 . . . . 0.0 107.698 175.055 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' THR . . . . . 0.515 HG23 ' HB1' ' A' ' 168' ' ' ALA . 1.3 t -162.32 149.18 13.47 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 174.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 36.0 p -106.2 26.15 10.13 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.067 1.747 . . . . 0.0 112.001 -178.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.82 14.85 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.266 0 C-N-CA 127.864 2.466 . . . . 0.0 115.701 176.598 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 82.71 -37.19 2.64 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 127.605 2.526 . . . . 0.0 114.216 -178.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -135.05 75.74 1.59 Allowed 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 126.678 1.991 . . . . 0.0 108.272 -176.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.515 ' HB1' HG23 ' A' ' 163' ' ' THR . . . -135.89 162.65 32.22 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.397 1.479 . . . . 0.0 113.204 -175.034 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' LYS . . . . . 0.4 ' H ' ' HG3' ' A' ' 169' ' ' LYS . 0.0 OUTLIER -110.28 172.06 7.09 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 128.998 2.919 . . . . 0.0 112.261 -175.029 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 170' ' ' MET . . . . . 0.428 ' HB3' HG22 ' A' ' 34' ' ' VAL . 12.9 ttt -117.66 143.11 46.48 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 126.017 1.727 . . . . 0.0 112.177 176.628 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.485 ' C ' HD12 ' A' ' 172' ' ' ILE . 7.5 tt0 -149.13 123.85 9.85 Favored 'General case' 0 N--CA 1.466 0.325 0 O-C-N 120.627 -1.296 . . . . 0.0 110.691 174.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.485 HD12 ' C ' ' A' ' 171' ' ' GLN . 1.9 mp -125.08 125.77 69.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 124.786 1.235 . . . . 0.0 108.744 179.158 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.52 142.78 51.3 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.827 1.251 . . . . 0.0 109.987 178.696 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.7 mp -89.44 114.15 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 O-C-N 121.173 -0.955 . . . . 0.0 109.162 176.203 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 5.4 m -85.5 154.36 21.83 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.434 1.094 . . . . 0.0 112.192 174.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 69.3 mtp180 . . . . . 0 C--O 1.252 1.224 0 C-N-CA 125.379 1.472 . . . . 0.0 111.175 176.528 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.8 mt . . . . . 0 N--CA 1.483 1.212 0 N-CA-C 113.264 0.839 . . . . 0.0 113.264 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.432 ' HA ' ' HB3' ' A' ' 71' ' ' LEU . . . -72.74 78.05 1.12 Allowed 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 125.68 1.592 . . . . 0.0 109.56 175.076 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -68.05 -90.68 0.06 OUTLIER Glycine 0 CA--C 1.536 1.374 0 C-N-CA 125.614 1.578 . . . . 0.0 114.689 -175.076 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 24.2 p -128.18 164.57 22.22 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.408 1.483 . . . . 0.0 110.949 175.331 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -125.85 19.76 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 CA-C-O 123.545 1.64 . . . . 0.0 111.695 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.9 pp -54.97 166.57 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 125.21 1.404 . . . . 0.0 111.877 175.037 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -40.44 129.24 2.42 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.261 1.824 . . . . 0.0 114.83 -174.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -55.49 -21.11 26.35 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 125.169 1.366 . . . . 0.0 114.607 -176.201 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.39 -30.98 70.89 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.013 1.325 . . . . 0.0 112.041 174.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.4 t -101.95 -38.7 7.67 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.878 1.671 . . . . 0.0 111.558 174.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.567 HD11 ' CD2' ' A' ' 71' ' ' LEU . 45.4 tp -79.39 90.71 5.03 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.895 0.878 . . . . 0.0 112.069 176.757 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 70.8 p -123.17 -176.98 3.56 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 126.326 1.85 . . . . 0.0 112.292 -178.164 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -55.02 -37.66 66.93 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.337 1.055 . . . . 0.0 112.261 -175.659 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -57.58 -38.29 74.61 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 125.379 1.472 . . . . 0.0 111.605 178.051 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 89.4 t -66.51 -37.7 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.336 1.054 . . . . 0.0 111.38 175.009 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.475 ' CD2' HD21 ' A' ' 71' ' ' LEU . 9.4 mt -68.17 -44.39 76.02 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.897 0.879 . . . . 0.0 110.69 178.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -58.27 -50.89 72.0 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.879 1.272 . . . . 0.0 111.926 176.282 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.55 -32.56 73.99 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 118.381 -0.819 . . . . 0.0 113.147 174.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -54.96 -40.18 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 CA-C-N 119.636 1.107 . . . . 0.0 111.518 -179.005 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 16.2 mt -57.18 -20.66 27.98 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.99 1.716 . . . . 0.0 113.355 178.196 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -108.77 -51.4 0.7 Allowed Glycine 0 CA--C 1.533 1.192 0 C-N-CA 126.356 1.931 . . . . 0.0 113.855 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -63.92 -28.34 69.76 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 119.031 1.416 . . . . 0.0 113.643 -178.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -97.59 86.77 3.91 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.542 1.137 . . . . 0.0 109.266 174.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -54.29 119.1 10.64 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 125.363 1.459 . . . . 0.0 113.537 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.1 mtpp -142.0 -173.35 3.79 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 127.726 2.41 . . . . 0.0 111.357 179.367 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.7 m -57.81 168.4 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 126.23 1.812 . . . . 0.0 112.329 175.04 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.8 m -51.3 -37.69 48.87 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 116.389 1.996 . . . . 0.0 116.389 -175.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.71 131.79 54.28 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.574 1.549 . . . . 0.0 108.547 174.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.52 150.15 37.08 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 126.095 1.758 . . . . 0.0 109.745 -175.01 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -116.26 120.58 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 123.998 0.919 . . . . 0.0 110.434 177.852 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -117.47 124.89 49.88 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 124.516 1.126 . . . . 0.0 109.573 175.016 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.521 HG13 ' HB2' ' A' ' 72' ' ' TYR . 2.7 p -142.56 139.92 28.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.731 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -125.37 125.07 5.5 Favored Glycine 0 CA--C 1.522 0.505 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.491 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.44 ' H ' HD12 ' A' ' 70' ' ' LEU . 2.9 mp -112.48 142.27 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 123.822 0.849 . . . . 0.0 110.371 176.801 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -105.59 106.48 17.01 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.486 1.114 . . . . 0.0 111.127 178.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -74.86 93.0 2.58 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.359 1.864 . . . . 0.0 110.577 176.134 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -121.57 8.1 10.09 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.906 1.282 . . . . 0.0 113.131 175.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 30.0 t -46.03 -51.01 14.4 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.149 1.78 . . . . 0.0 113.343 178.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 154.5 -26.33 0.67 Allowed Glycine 0 N--CA 1.472 1.065 0 O-C-N 121.281 -0.887 . . . . 0.0 114.517 175.003 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -128.18 171.47 19.36 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 125.682 1.61 . . . . 0.0 112.178 174.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.762 HG22 ' HA ' ' A' ' 65' ' ' PRO . 76.5 p -64.68 149.65 48.64 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.618 0.767 . . . . 0.0 112.147 176.758 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 38.4 m0 -101.62 108.27 19.76 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 124.654 1.182 . . . . 0.0 111.048 178.435 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 33.2 m -90.7 128.74 36.75 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.993 1.317 . . . . 0.0 110.123 177.378 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.29 114.5 3.51 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.915 0.886 . . . . 0.0 111.729 174.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.489 HD21 HG23 ' A' ' 98' ' ' THR . 3.6 pp -98.44 -51.65 3.89 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 123.556 0.742 . . . . 0.0 111.536 177.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.487 ' HB3' HD12 ' A' ' 47' ' ' LEU . 7.8 t30 -172.92 154.47 2.87 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 127.5 2.32 . . . . 0.0 109.848 -177.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -137.64 168.0 20.55 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.916 1.286 . . . . 0.0 112.052 174.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -141.42 114.07 8.34 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.424 1.09 . . . . 0.0 111.652 179.211 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.408 ' CD1' ' HB1' ' A' ' 87' ' ' ALA . 3.2 m-85 -116.06 139.18 50.54 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.38 -0.825 . . . . 0.0 110.941 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -117.54 -67.05 1.02 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 126.071 1.749 . . . . 0.0 111.492 -175.431 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 26.3 t -105.39 -38.67 6.4 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 126.8 2.04 . . . . 0.0 110.28 -176.235 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -68.77 10.2 1.63 Allowed Glycine 0 CA--C 1.537 1.45 0 C-N-CA 126.792 2.139 . . . . 0.0 115.491 178.017 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 34.0 p -30.22 123.94 0.18 Allowed 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 129.014 2.925 . . . . 0.0 114.832 -175.025 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.423 HG21 HG23 ' A' ' 59' ' ' ILE . 1.5 t -146.39 178.28 8.38 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.47 1.108 . . . . 0.0 113.513 -174.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -83.24 -62.8 1.49 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.364 1.465 . . . . 0.0 112.4 177.129 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.2 p -138.93 138.21 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.901 1.68 . . . . 0.0 111.824 178.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.423 HG23 HG21 ' A' ' 56' ' ' THR . 1.4 pp -141.09 -27.75 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.921 1.688 . . . . 0.0 114.048 -179.145 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 mp -97.45 96.35 3.06 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 125.687 1.595 . . . . 0.0 109.06 177.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -64.02 152.28 81.62 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.878 2.385 . . . . 0.0 110.503 175.013 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -43.66 -50.2 7.53 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.011 1.725 . . . . 0.0 113.477 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 5.6 p -158.59 143.81 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 C-N-CA 126.93 2.092 . . . . 0.0 109.511 175.088 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.702 HG21 HD23 ' A' ' 70' ' ' LEU . 99.7 t -118.0 128.95 25.67 Favored Pre-proline 0 N--CA 1.476 0.828 0 C-N-CA 124.956 1.302 . . . . 0.0 108.771 175.063 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.762 ' HA ' HG22 ' A' ' 43' ' ' THR . 53.9 Cg_endo -67.13 150.36 82.12 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.611 2.207 . . . . 0.0 113.139 176.751 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -65.23 163.65 14.87 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.293 0.637 . . . . 0.0 111.033 175.034 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . 0.312 50.1 p 55.48 20.75 3.9 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 127.779 2.431 . . . . 0.0 114.742 -174.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 20.0 mttt -120.35 -178.49 3.7 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 126.459 1.903 . . . . 0.0 112.115 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.402 ' HB3' HD23 ' A' ' 13' ' ' LEU . . . -133.76 166.19 23.21 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 175.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.702 HD23 HG21 ' A' ' 64' ' ' VAL . 0.5 OUTLIER -134.25 174.26 10.7 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 124.3 1.04 . . . . 0.0 110.993 179.539 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.567 ' CD2' HD11 ' A' ' 13' ' ' LEU . 0.9 OUTLIER -127.33 154.89 44.4 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 124.699 1.199 . . . . 0.0 111.481 175.185 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.521 ' HB2' HG13 ' A' ' 34' ' ' VAL . 12.4 m-85 -129.49 148.09 51.36 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 125.987 1.715 . . . . 0.0 109.795 178.407 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 54.5 p -126.21 146.69 49.87 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 126.186 1.795 . . . . 0.0 111.129 175.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -163.26 148.78 15.67 Favored Glycine 0 CA--C 1.519 0.286 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 174.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.48 173.61 6.66 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.16 1.384 . . . . 0.0 110.134 177.557 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 12.2 ptmt . . . . . 0 N--CA 1.482 1.171 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 174.948 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 90.1 m . . . . . 0 N--CA 1.475 0.798 0 CA-C-O 119.108 -0.472 . . . . 0.0 110.08 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 179.74 -93.09 0.09 OUTLIER Glycine 0 CA--C 1.531 1.069 0 CA-C-N 119.696 1.135 . . . . 0.0 113.253 -175.514 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -153.56 100.62 2.42 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.137 0.975 . . . . 0.0 111.585 176.278 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.2 t -141.23 115.27 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 124.455 1.102 . . . . 0.0 109.753 -177.22 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.408 ' HB1' ' CD1' ' A' ' 51' ' ' PHE . . . -157.45 170.93 21.32 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.374 1.07 . . . . 0.0 112.05 175.533 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -152.11 160.84 43.33 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.47 1.508 . . . . 0.0 111.082 175.421 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.587 ' CZ ' HG11 ' A' ' 101' ' ' VAL . 41.6 p90 -155.33 170.07 22.75 Favored 'General case' 0 C--O 1.234 0.285 0 O-C-N 121.079 -1.013 . . . . 0.0 111.154 175.042 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.403 ' HA ' ' O ' ' A' ' 99' ' ' LEU . . . -136.31 151.7 49.9 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 176.323 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -131.29 134.88 46.81 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.545 1.538 . . . . 0.0 112.727 -177.012 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -82.62 123.56 29.35 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 111.618 0.229 . . . . 0.0 111.618 -179.524 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 4.6 tpp -88.55 145.49 25.69 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.317 1.047 . . . . 0.0 112.165 175.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 61.3 m -69.65 -23.35 63.47 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 175.006 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -70.98 -13.94 62.18 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.852 1.261 . . . . 0.0 113.787 175.24 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 98.54 42.63 2.89 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 124.546 1.069 . . . . 0.0 114.176 -179.02 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.511 ' HB3' HG22 ' A' ' 120' ' ' ILE . 17.0 m-80 -141.33 174.15 10.81 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.354 1.462 . . . . 0.0 110.431 178.766 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.489 HG23 HD21 ' A' ' 47' ' ' LEU . 6.0 m -128.55 107.18 9.5 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.178 0.991 . . . . 0.0 112.424 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.403 ' O ' ' HA ' ' A' ' 90' ' ' ALA . 21.1 tp -68.03 105.02 1.9 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.756 0.823 . . . . 0.0 109.65 174.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -106.63 103.09 1.98 Allowed Glycine 0 CA--C 1.525 0.695 0 C-N-CA 125.395 1.474 . . . . 0.0 112.337 177.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.587 HG11 ' CZ ' ' A' ' 89' ' ' PHE . 9.5 p -86.32 161.47 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 123.755 0.822 . . . . 0.0 112.407 175.582 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 2.5 tmm? -150.3 126.96 10.91 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.257 1.823 . . . . 0.0 109.725 178.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -139.03 118.51 12.9 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 122.158 0.98 . . . . 0.0 112.948 177.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 26.0 t -124.6 118.34 26.32 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.452 1.501 . . . . 0.0 110.723 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 96.2 t . . . . . 0 CA--C 1.539 0.557 0 C-N-CA 126.728 2.011 . . . . 0.0 108.852 178.775 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 11.0 m . . . . . 0 N--CA 1.467 0.424 0 CA-C-O 121.497 0.665 . . . . 0.0 112.359 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -100.05 118.11 35.73 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.285 1.434 . . . . 0.0 107.382 174.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 36.7 m0 -116.73 135.65 53.59 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 19.8 p-90 -145.82 143.49 29.68 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.548 0.739 . . . . 0.0 112.029 -176.444 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -148.59 161.83 40.89 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.981 0.896 . . . . 0.0 112.571 -176.321 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.453 HG13 ' SD ' ' A' ' 158' ' ' MET . 5.6 p -166.12 127.76 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 125.028 1.331 . . . . 0.0 109.269 175.017 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.546 ' HE3' ' CE1' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -151.78 168.44 25.05 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 126.199 1.799 . . . . 0.0 109.566 178.31 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.511 HG22 ' HB3' ' A' ' 97' ' ' ASN . 24.6 mt -111.1 111.73 37.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -177.385 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.546 ' CE1' ' HE3' ' A' ' 119' ' ' LYS . 54.2 m-85 -63.01 142.66 97.67 Favored Pre-proline 0 CA--C 1.544 0.731 0 O-C-N 121.203 -0.936 . . . . 0.0 111.063 -179.099 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -73.92 92.5 0.89 Allowed 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 124.2 3.266 . . . . 0.0 110.902 -179.162 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 101.2 -171.69 22.61 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 124.805 1.193 . . . . 0.0 112.736 -174.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 8.8 tttt -67.57 118.51 10.97 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.893 0.877 . . . . 0.0 110.931 176.404 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 9.4 tpp180 -134.18 178.25 7.12 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.222 1.409 . . . . 0.0 109.704 175.049 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 8.6 ptt180 -123.34 179.74 4.61 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 126.372 1.869 . . . . 0.0 110.231 174.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -131.7 103.65 6.48 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 126.572 1.949 . . . . 0.0 107.016 175.112 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -126.66 171.37 11.21 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.348 1.859 . . . . 0.0 110.093 178.535 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -50.69 -41.73 56.13 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -177.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -60.72 -53.76 42.6 Favored Glycine 0 N--CA 1.468 0.775 0 CA-C-O 119.484 -0.62 . . . . 0.0 112.267 176.439 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -63.24 -40.05 96.34 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 118.176 0.988 . . . . 0.0 111.916 178.085 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -55.84 -63.73 1.08 Allowed 'General case' 0 C--N 1.34 0.167 0 C-N-CA 124.224 1.01 . . . . 0.0 108.846 175.038 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -64.62 -33.9 77.01 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 118.667 0.667 . . . . 0.0 112.739 -175.14 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -64.56 -42.94 95.36 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.272 1.029 . . . . 0.0 113.069 176.264 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -86.32 -29.01 23.34 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 121.28 -0.888 . . . . 0.0 112.291 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -52.04 -57.61 9.02 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 126.831 2.053 . . . . 0.0 108.902 174.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -71.85 -12.1 61.12 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -177.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -86.72 -8.14 77.21 Favored Glycine 0 CA--C 1.54 1.599 0 C-N-CA 126.701 2.096 . . . . 0.0 114.958 176.643 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -140.09 80.3 20.52 Favored Pre-proline 0 CA--C 1.55 0.954 0 CA-C-N 119.105 1.452 . . . . 0.0 111.192 175.012 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -73.16 70.25 3.82 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 124.109 3.206 . . . . 0.0 112.471 177.151 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -102.43 116.76 33.28 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.97 0.908 . . . . 0.0 110.637 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 34.5 mtm180 -83.59 -68.43 0.71 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.11 1.364 . . . . 0.0 111.884 174.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 134.73 114.43 1.43 Allowed Glycine 0 CA--C 1.53 0.981 0 C-N-CA 124.976 1.274 . . . . 0.0 113.569 -178.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.58 14.73 0.32 Allowed 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 126.912 2.085 . . . . 0.0 115.295 176.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . 0.258 0.8 OUTLIER 45.51 65.01 1.23 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 126.953 2.101 . . . . 0.0 112.56 -175.011 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -168.44 -67.33 0.03 OUTLIER Glycine 0 CA--C 1.541 1.672 0 C-N-CA 125.098 1.332 . . . . 0.0 115.926 -174.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 43.2 m95 173.23 114.19 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 130.86 3.664 . . . . 0.0 108.799 -175.035 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -131.93 126.09 33.24 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 128.463 2.705 . . . . 0.0 110.277 -177.376 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -166.76 -175.31 3.06 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.08 0.952 . . . . 0.0 112.078 -174.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.3 mtmt -139.54 145.51 38.76 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.702 1.201 . . . . 0.0 109.946 175.047 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -67.6 149.79 49.63 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 175.006 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 66.7 mt -108.78 102.32 11.37 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.277 0.631 . . . . 0.0 110.4 -174.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -43.52 -30.58 1.43 Allowed Glycine 0 N--CA 1.475 1.283 0 C-N-CA 127.722 2.582 . . . . 0.0 117.136 -175.022 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.47 ' CE2' ' HB ' ' A' ' 120' ' ' ILE . 0.0 OUTLIER -64.29 -18.85 64.98 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.623 1.969 . . . . 0.0 113.799 178.164 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 118.86 30.14 1.7 Allowed Glycine 0 CA--C 1.537 1.409 0 C-N-CA 125.915 1.721 . . . . 0.0 114.288 -178.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 2.2 mt -128.96 174.92 9.08 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.508 1.923 . . . . 0.0 110.859 -176.473 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 80.7 mtt180 -143.75 108.77 4.97 Favored 'General case' 0 N--CA 1.479 1.007 0 O-C-N 120.913 -1.117 . . . . 0.0 111.081 178.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' MET . . . . . 0.453 ' SD ' HG13 ' A' ' 118' ' ' VAL . 0.0 OUTLIER -84.73 148.54 26.31 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 175.049 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.9 122.28 17.16 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 126.087 1.755 . . . . 0.0 110.899 176.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -138.85 158.74 25.26 Favored Glycine 0 N--CA 1.479 1.56 0 CA-C-N 121.552 1.978 . . . . 0.0 116.62 -177.353 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.523 HD13 ' N ' ' A' ' 162' ' ' MET . 0.0 OUTLIER -151.3 134.3 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-N 118.896 1.348 . . . . 0.0 111.051 179.407 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 162' ' ' MET . . . . . 0.523 ' N ' HD13 ' A' ' 161' ' ' ILE . 1.1 ttt -156.91 105.98 2.21 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.752 1.621 . . . . 0.0 110.089 174.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 4.0 t -81.66 126.76 32.16 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 120.921 -1.112 . . . . 0.0 109.977 175.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 34.9 p -75.15 21.89 0.12 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.1 1.36 . . . . 0.0 114.292 177.555 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -56.06 -45.33 79.33 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.282 1.833 . . . . 0.0 114.692 -175.191 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 164.45 -60.59 0.25 Allowed Glycine 0 CA--C 1.533 1.192 0 C-N-CA 123.685 0.66 . . . . 0.0 114.706 178.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -120.07 21.77 11.7 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.625 1.17 . . . . 0.0 112.819 -178.23 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -64.16 168.59 5.28 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 122.784 1.278 . . . . 0.0 112.887 175.193 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.09 167.05 11.83 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 127.089 2.156 . . . . 0.0 110.976 -179.253 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 13.7 ttp -108.3 135.5 49.51 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.634 1.174 . . . . 0.0 110.329 178.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -141.62 127.64 19.52 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.007 0.923 . . . . 0.0 110.896 175.019 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 5.1 mp -133.38 121.32 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 124.241 1.016 . . . . 0.0 110.01 175.111 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -116.61 132.31 56.72 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 125.409 1.484 . . . . 0.0 110.321 175.002 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.7 mp -84.3 119.5 33.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 175.076 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 5.0 m -92.61 171.08 9.24 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.64 1.576 . . . . 0.0 109.825 174.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 2.2 mtt180 . . . . . 0 C--O 1.253 1.274 0 C-N-CA 125.335 1.454 . . . . 0.0 112.624 176.363 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.447 HD11 ' HB2' ' A' ' 31' ' ' LYS . 11.8 tp . . . . . 0 N--CA 1.474 0.731 0 N-CA-C 113.847 1.054 . . . . 0.0 113.847 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -86.58 138.7 31.49 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.313 1.045 . . . . 0.0 109.124 175.062 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -79.66 -122.81 0.4 Allowed Glycine 0 CA--C 1.535 1.319 0 C-N-CA 124.143 0.877 . . . . 0.0 112.031 175.03 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 35.8 p -113.74 173.43 6.42 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.482 1.513 . . . . 0.0 112.018 -178.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -123.14 19.84 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.326 1.05 . . . . 0.0 112.121 178.165 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.42 HD12 ' HB3' ' A' ' 12' ' ' SER . 0.9 OUTLIER -47.15 156.87 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.784 1.234 . . . . 0.0 112.846 175.007 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -41.92 130.45 3.44 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.279 1.832 . . . . 0.0 112.999 -175.166 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -54.03 -22.86 21.8 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 124.869 1.223 . . . . 0.0 114.885 -174.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.93 -30.58 71.65 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.417 1.087 . . . . 0.0 112.077 175.069 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.42 ' HB3' HD12 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -100.89 -41.92 6.64 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.629 1.972 . . . . 0.0 111.872 176.75 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.2 tp -73.29 94.23 1.99 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.139 0.976 . . . . 0.0 110.898 175.035 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 82.6 p -129.19 -175.3 3.52 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.422 1.889 . . . . 0.0 112.046 -178.803 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.478 ' CE1' HG21 ' A' ' 161' ' ' ILE . 6.4 m-85 -51.52 -33.11 30.45 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.959 1.304 . . . . 0.0 113.993 179.076 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -57.83 -43.17 85.64 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.102 0.561 . . . . 0.0 111.852 174.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.416 ' O ' HG23 ' A' ' 21' ' ' VAL . 72.8 t -67.03 -40.23 85.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.229 1.012 . . . . 0.0 110.922 175.483 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 59.8 mt -67.54 -40.08 85.02 Favored 'General case' 0 N--CA 1.469 0.475 0 O-C-N 120.963 -1.086 . . . . 0.0 112.059 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -63.91 -47.57 80.02 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.164 0.986 . . . . 0.0 111.781 176.58 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.51 -36.7 84.6 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 118.456 -0.783 . . . . 0.0 112.287 174.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 17' ' ' VAL . 19.0 t -55.03 -46.12 77.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-N 119.295 0.952 . . . . 0.0 110.92 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.3 mt -54.89 -19.62 7.01 Favored 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 176.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.62 -60.48 1.09 Allowed Glycine 0 CA--C 1.535 1.323 0 C-N-CA 126.324 1.916 . . . . 0.0 113.182 175.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -65.75 -34.89 79.23 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -178.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -100.8 133.56 45.09 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.637 1.575 . . . . 0.0 109.923 175.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 170.27 145.72 4.84 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 124.504 1.049 . . . . 0.0 112.155 -178.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -129.73 -76.91 0.54 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.027 1.331 . . . . 0.0 110.938 -178.448 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 30' ' ' ARG . 26.9 m -78.08 173.93 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 126.107 1.763 . . . . 0.0 111.361 175.197 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -53.67 -35.31 60.92 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 115.546 1.684 . . . . 0.0 115.546 -175.04 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.534 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.2 OUTLIER -127.32 152.13 47.86 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 127.544 2.337 . . . . 0.0 109.035 175.003 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.447 ' HB2' HD11 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -151.02 159.47 44.53 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.803 1.641 . . . . 0.0 111.012 -178.088 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.465 HG13 ' HB1' ' A' ' 85' ' ' ALA . 0.3 OUTLIER -122.26 129.9 74.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 125.075 1.35 . . . . 0.0 108.214 175.078 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -135.79 115.3 12.72 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.11 1.364 . . . . 0.0 108.965 175.209 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.475 HG12 ' HB3' ' A' ' 170' ' ' MET . 2.6 m -125.72 144.1 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 123.313 0.645 . . . . 0.0 111.146 -177.182 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -111.03 115.26 3.92 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 124.255 0.931 . . . . 0.0 111.656 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 mp -105.1 144.16 15.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 118.037 0.918 . . . . 0.0 108.782 174.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -115.95 111.5 20.48 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 124.588 1.155 . . . . 0.0 111.049 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.474 ' HA ' ' CZ2' ' A' ' 44' ' ' TRP . 1.6 m-20 -80.54 78.25 7.29 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 128.141 2.576 . . . . 0.0 111.226 -175.123 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -113.99 3.43 15.35 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.779 1.232 . . . . 0.0 112.389 178.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.31 -54.5 43.15 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.918 1.687 . . . . 0.0 114.304 -175.032 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 151.93 99.52 0.19 Allowed Glycine 0 CA--C 1.533 1.195 0 O-C-N 121.478 -0.764 . . . . 0.0 114.278 178.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.15 163.74 38.94 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 125.871 1.701 . . . . 0.0 112.94 -177.374 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.669 HG22 ' HA ' ' A' ' 65' ' ' PRO . 69.1 p -63.98 138.74 58.6 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 121.965 -0.727 . . . . 0.0 111.616 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.474 ' CZ2' ' HA ' ' A' ' 38' ' ' ASN . 40.6 m0 -87.99 106.47 18.15 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.077 0.551 . . . . 0.0 110.827 -178.676 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 15.9 m -86.27 122.64 30.54 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.319 1.048 . . . . 0.0 109.577 175.614 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.41 140.02 57.4 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.087 0.47 . . . . 0.0 111.671 175.018 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.546 HD12 ' N ' ' A' ' 48' ' ' ASN . 4.0 pp -121.92 -56.84 1.83 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.912 1.285 . . . . 0.0 111.312 -178.207 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.546 ' N ' HD12 ' A' ' 47' ' ' LEU . 0.1 OUTLIER -171.16 156.22 4.66 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.65 1.98 . . . . 0.0 110.596 176.5 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.416 ' HB2' HD12 ' A' ' 60' ' ' LEU . . . -133.57 165.45 24.88 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.269 1.428 . . . . 0.0 110.718 174.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -141.12 101.8 4.11 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.953 1.701 . . . . 0.0 111.444 -178.55 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.506 ' CD1' ' HB1' ' A' ' 87' ' ' ALA . 3.1 m-85 -107.74 127.32 53.59 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.127 0.971 . . . . 0.0 110.582 -177.702 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.67 -37.75 4.8 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.372 1.069 . . . . 0.0 113.486 -179.62 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.8 t -123.36 -41.93 2.27 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 126.31 1.844 . . . . 0.0 111.556 -178.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -69.01 16.2 0.63 Allowed Glycine 0 CA--C 1.536 1.362 0 C-N-CA 125.145 1.355 . . . . 0.0 115.529 179.277 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.6 p -27.35 115.25 0.07 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 129.604 3.161 . . . . 0.0 113.863 -176.156 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.639 HG21 HG23 ' A' ' 59' ' ' ILE . 3.1 t -139.11 176.71 8.46 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.779 0.831 . . . . 0.0 112.794 -175.054 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -80.94 -57.4 3.56 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.909 1.284 . . . . 0.0 110.668 175.101 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.4 p -151.0 137.23 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 126.071 1.748 . . . . 0.0 111.573 -177.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.639 HG23 HG21 ' A' ' 56' ' ' THR . 0.1 OUTLIER -130.8 -42.5 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 125.337 1.455 . . . . 0.0 112.778 176.001 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.416 HD12 ' HB2' ' A' ' 49' ' ' ALA . 13.8 mt -82.59 100.15 0.79 Allowed Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 126.398 1.879 . . . . 0.0 109.725 179.21 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.479 ' HG2' HG23 ' A' ' 64' ' ' VAL . 84.0 Cg_endo -69.43 155.31 67.38 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.57 2.846 . . . . 0.0 110.385 175.014 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -48.52 -52.14 23.96 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.902 0.881 . . . . 0.0 112.966 -176.591 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.4 t -154.6 135.43 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 128.307 2.643 . . . . 0.0 108.694 -178.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.555 HG21 HD13 ' A' ' 70' ' ' LEU . 48.3 t -120.43 134.19 24.12 Favored Pre-proline 0 N--CA 1.479 1.016 0 C-N-CA 123.94 0.896 . . . . 0.0 109.448 174.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.669 ' HA ' HG22 ' A' ' 43' ' ' THR . 51.8 Cg_endo -63.09 151.1 86.5 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.202 1.935 . . . . 0.0 113.157 176.66 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -74.59 173.1 10.9 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.537 0.735 . . . . 0.0 110.428 175.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 78.8 p 49.23 27.78 1.97 Allowed 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 126.79 2.036 . . . . 0.0 112.789 -175.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 8.2 tttt -133.58 178.41 6.95 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 126.611 1.964 . . . . 0.0 111.633 -175.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -137.69 161.14 37.29 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 121.35 -0.843 . . . . 0.0 109.4 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.555 HD13 HG21 ' A' ' 64' ' ' VAL . 2.0 pt? -137.88 168.56 19.45 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.255 1.022 . . . . 0.0 111.681 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.411 HD13 ' O ' ' A' ' 34' ' ' VAL . 1.4 mm? -109.17 149.68 29.0 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 124.165 0.986 . . . . 0.0 110.748 175.031 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -126.83 149.46 49.7 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 127.371 2.268 . . . . 0.0 109.686 177.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.5 p -131.75 151.67 51.49 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 127.023 2.129 . . . . 0.0 111.879 -175.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -170.51 135.52 3.56 Favored Glycine 0 CA--C 1.521 0.433 0 O-C-N 121.396 -0.815 . . . . 0.0 113.142 174.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 27.7 mtm180 -104.06 121.35 43.01 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.57 1.148 . . . . 0.0 110.368 -177.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.715 0 C-N-CA 126.221 1.808 . . . . 0.0 115.236 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.2 p . . . . . 0 N--CA 1.476 0.871 0 N-CA-C 110.76 -0.089 . . . . 0.0 110.76 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -104.96 -105.79 3.06 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 125.335 1.445 . . . . 0.0 112.042 -177.158 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.465 ' HB1' HG13 ' A' ' 32' ' ' ILE . . . -139.63 93.2 2.64 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.423 -1.045 . . . . 0.0 110.056 177.392 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.3 t -133.12 116.6 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 123.904 0.882 . . . . 0.0 110.266 -176.112 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.754 ' HB3' ' CZ ' ' A' ' 103' ' ' PHE . . . -163.55 161.26 23.86 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.916 0.865 . . . . 0.0 111.382 178.157 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -142.82 151.17 40.86 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.678 1.191 . . . . 0.0 110.166 175.148 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -149.92 170.03 19.76 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 124.236 1.014 . . . . 0.0 110.061 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.473 ' HB3' HD11 ' A' ' 47' ' ' LEU . . . -142.52 157.4 44.77 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.389 -0.819 . . . . 0.0 111.891 175.002 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -132.12 141.44 49.15 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 126.131 1.773 . . . . 0.0 112.446 -174.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -98.32 119.12 36.45 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 120.673 0.273 . . . . 0.0 110.678 -175.587 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 15.4 mtm -95.88 133.69 39.75 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 123.906 0.882 . . . . 0.0 110.713 -176.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.4 t -58.84 -23.84 61.25 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.781 1.232 . . . . 0.0 112.624 178.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -64.53 -18.88 65.24 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.438 1.495 . . . . 0.0 113.515 175.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 108.53 14.0 17.27 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 124.959 1.266 . . . . 0.0 115.312 -179.203 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.425 ' HB3' HG22 ' A' ' 120' ' ' ILE . 15.3 m-80 -122.51 172.25 8.51 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-N 119.171 1.486 . . . . 0.0 111.394 -179.659 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 95.6 m -124.91 102.16 7.41 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.598 1.159 . . . . 0.0 111.734 -177.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 21.4 tp -66.73 97.09 0.44 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.016 1.327 . . . . 0.0 111.682 176.47 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -90.61 124.65 7.6 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 125.534 1.54 . . . . 0.0 112.22 176.685 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 47.7 t -124.88 142.7 40.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 124.894 1.277 . . . . 0.0 110.777 -175.197 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' MET . . . . . 0.423 ' CE ' ' HA ' ' A' ' 116' ' ' TRP . 0.0 OUTLIER -149.33 160.09 43.71 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.427 -0.795 . . . . 0.0 112.026 175.04 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.754 ' CZ ' ' HB3' ' A' ' 87' ' ' ALA . 44.4 p90 -143.23 143.07 31.6 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.13 0.972 . . . . 0.0 110.436 176.273 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 9.9 t -134.25 119.96 19.39 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.833 1.253 . . . . 0.0 110.662 179.183 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 62.4 t . . . . . 0 N--CA 1.469 0.513 0 C-N-CA 126.061 1.744 . . . . 0.0 109.206 -176.011 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 31.9 m . . . . . 0 N--CA 1.474 0.761 0 CA-C-O 121.02 0.438 . . . . 0.0 111.872 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -84.18 104.03 13.89 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.549 1.14 . . . . 0.0 110.064 175.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 53.6 m0 -114.3 152.26 31.66 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 119.825 1.193 . . . . 0.0 112.673 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' TRP . . . . . 0.423 ' HA ' ' CE ' ' A' ' 102' ' ' MET . 53.9 p-90 -144.1 133.6 23.41 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -134.4 161.65 34.42 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.37 1.868 . . . . 0.0 111.829 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 78.5 t -154.62 150.19 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 126.961 2.104 . . . . 0.0 108.077 175.097 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.75 166.21 29.1 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.591 1.956 . . . . 0.0 109.97 175.203 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.474 ' HB ' ' CE2' ' A' ' 154' ' ' TYR . 3.1 mt -118.18 112.05 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-O 121.787 0.803 . . . . 0.0 109.454 176.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -68.76 145.05 96.64 Favored Pre-proline 0 CA--C 1.548 0.883 0 O-C-N 121.478 -0.764 . . . . 0.0 111.629 179.303 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -75.79 91.33 1.09 Allowed 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 123.834 3.023 . . . . 0.0 112.005 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 97.28 179.0 34.21 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 125.827 1.68 . . . . 0.0 112.952 -178.189 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 6.6 tttt -51.6 121.66 6.82 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.837 1.255 . . . . 0.0 111.567 -176.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.98 -173.45 3.38 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.606 1.563 . . . . 0.0 112.101 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.8 ptt180 -134.14 -179.22 5.43 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 126.9 2.08 . . . . 0.0 110.948 175.287 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -126.63 115.92 20.22 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 127.539 2.336 . . . . 0.0 104.984 175.048 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -135.55 169.6 17.27 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.835 1.254 . . . . 0.0 110.303 175.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -56.61 -36.15 69.09 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.049 0.94 . . . . 0.0 112.962 -178.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -60.9 -58.78 12.01 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-N 118.742 0.701 . . . . 0.0 111.998 175.026 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 1.4 null -62.73 -36.94 84.64 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 118.07 0.935 . . . . 0.0 112.801 178.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.41 -64.39 0.97 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.48 1.112 . . . . 0.0 109.151 174.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -65.27 -28.65 69.49 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -175.034 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -63.69 -36.88 85.3 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.778 1.231 . . . . 0.0 112.569 175.042 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 8.8 tpp -94.07 -23.63 17.91 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 177.011 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -49.89 -56.9 8.74 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.779 1.631 . . . . 0.0 111.145 175.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -70.4 -13.37 62.11 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -85.04 -30.61 25.31 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 127.153 2.311 . . . . 0.0 112.987 -175.415 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -123.57 81.96 53.98 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 123.833 0.853 . . . . 0.0 112.46 175.01 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -75.04 73.06 4.46 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 123.928 3.086 . . . . 0.0 112.775 -179.143 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -103.84 114.98 29.64 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.698 0.799 . . . . 0.0 111.552 176.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 46.8 mtm180 -86.26 -82.18 0.2 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.049 1.339 . . . . 0.0 111.138 175.027 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -115.88 -76.72 0.65 Allowed Glycine 0 C--N 1.328 0.102 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 178.494 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 56.69 43.26 25.68 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-O 122.044 0.926 . . . . 0.0 109.796 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -49.69 91.81 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 127.67 2.388 . . . . 0.0 113.805 -175.014 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 161.5 50.51 0.02 OUTLIER Glycine 0 CA--C 1.535 1.314 0 C-N-CA 124.993 1.283 . . . . 0.0 114.178 -175.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' TRP . . . . . 0.641 ' H ' HD13 ' A' ' 161' ' ' ILE . 4.7 m95 48.79 51.05 16.51 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.219 1.808 . . . . 0.0 113.953 -178.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -81.67 124.53 29.66 Favored 'General case' 0 N--CA 1.467 0.425 0 O-C-N 121.31 -0.869 . . . . 0.0 111.971 -177.063 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -167.27 -169.22 1.2 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.433 0.693 . . . . 0.0 112.754 178.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.77 164.49 25.03 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 126.64 1.976 . . . . 0.0 111.53 -178.703 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -81.8 157.7 24.37 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.872 0.869 . . . . 0.0 109.838 175.015 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.709 HD21 ' HB2' ' A' ' 158' ' ' MET . 3.0 mm? -104.71 118.06 35.62 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.125 0.57 . . . . 0.0 110.536 175.62 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -48.99 -29.57 8.54 Favored Glycine 0 CA--C 1.537 1.45 0 C-N-CA 125.8 1.667 . . . . 0.0 115.977 -177.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.474 ' CE2' ' HB ' ' A' ' 120' ' ' ILE . 0.1 OUTLIER -62.5 -25.39 67.99 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.4 1.88 . . . . 0.0 113.112 176.977 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 125.18 7.75 5.78 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 126.626 2.06 . . . . 0.0 114.961 -179.221 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 5.3 mp -101.5 176.78 5.12 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.216 1.406 . . . . 0.0 112.235 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 38.5 mtt180 -139.16 113.52 8.92 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.963 1.305 . . . . 0.0 110.703 -178.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' MET . . . . . 0.709 ' HB2' HD21 ' A' ' 152' ' ' LEU . 4.3 ttt -98.15 147.36 24.66 Favored 'General case' 0 C--N 1.319 -0.755 0 O-C-N 120.305 -1.497 . . . . 0.0 107.88 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.09 144.56 51.41 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 125.949 1.699 . . . . 0.0 110.163 177.056 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -152.02 156.97 26.99 Favored Glycine 0 CA--C 1.519 0.297 0 CA-C-O 121.893 0.719 . . . . 0.0 112.043 177.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.641 HD13 ' H ' ' A' ' 147' ' ' TRP . 4.7 tp -153.21 123.62 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 122.686 1.231 . . . . 0.0 110.175 -175.122 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.58 171.97 14.29 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 125.475 1.51 . . . . 0.0 110.21 175.165 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 15.1 t -162.2 166.82 25.03 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.251 1.42 . . . . 0.0 108.977 176.12 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 60.2 p -116.66 30.9 7.06 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.741 1.616 . . . . 0.0 111.604 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -65.38 23.2 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 128.541 2.736 . . . . 0.0 115.113 177.726 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 81.01 -55.49 4.79 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 127.14 2.305 . . . . 0.0 113.433 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -116.05 24.02 11.76 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.67 1.588 . . . . 0.0 112.818 -175.125 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -61.83 168.31 3.17 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 127.021 2.128 . . . . 0.0 114.599 175.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.5 171.35 10.58 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 127.661 2.385 . . . . 0.0 111.651 177.733 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' MET . . . . . 0.475 ' HB3' HG12 ' A' ' 34' ' ' VAL . 3.0 tmm? -118.76 135.58 54.43 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.223 1.409 . . . . 0.0 111.151 175.752 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.453 ' C ' HD12 ' A' ' 172' ' ' ILE . 6.2 tm0? -145.06 131.56 19.77 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.124 0.97 . . . . 0.0 110.156 178.011 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.453 HD12 ' C ' ' A' ' 171' ' ' GLN . 1.8 mp -131.74 127.97 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 125.382 1.473 . . . . 0.0 109.613 175.022 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -130.87 131.11 44.35 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.933 1.693 . . . . 0.0 110.335 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.7 mp -89.17 96.56 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 O-C-N 121.527 -0.733 . . . . 0.0 111.426 177.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 2.5 t -66.06 173.02 3.28 Favored 'General case' 0 CA--C 1.565 1.521 0 C-N-CA 123.631 0.772 . . . . 0.0 111.477 177.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 18.1 mtp180 . . . . . 0 C--O 1.252 1.208 0 C-N-CA 125.73 1.612 . . . . 0.0 112.618 175.711 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.814 HD12 ' H ' ' A' ' 74' ' ' GLY . 1.5 mt . . . . . 0 N--CA 1.485 1.283 0 N-CA-C 112.168 0.432 . . . . 0.0 112.168 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -114.98 114.36 25.33 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.884 1.674 . . . . 0.0 111.024 -175.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -72.73 -155.52 2.89 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 125.29 1.424 . . . . 0.0 113.137 178.231 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 25.7 p -61.9 161.4 10.55 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.61 0.764 . . . . 0.0 111.791 174.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -122.81 18.07 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 CA-C-O 122.993 1.378 . . . . 0.0 111.47 174.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.8 pp -58.62 172.63 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 C-N-CA 125.463 1.505 . . . . 0.0 112.642 174.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -42.27 130.93 3.7 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 127.177 2.191 . . . . 0.0 114.155 -174.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.76 -19.47 43.31 Favored Glycine 0 CA--C 1.538 1.491 0 C-N-CA 124.187 0.899 . . . . 0.0 114.213 -175.271 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.97 -31.97 72.37 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.504 1.122 . . . . 0.0 112.539 174.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.6 t -101.39 -37.78 8.31 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.644 1.578 . . . . 0.0 111.69 175.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.442 HD23 ' HB3' ' A' ' 69' ' ' ALA . 13.0 tp -78.45 87.99 4.44 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.214 1.005 . . . . 0.0 110.802 175.023 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.2 p -121.46 178.96 4.6 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 127.188 2.195 . . . . 0.0 111.913 176.327 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -40.96 -42.01 1.77 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.834 1.654 . . . . 0.0 113.927 175.02 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -53.73 -46.46 70.85 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 119.159 0.89 . . . . 0.0 111.744 178.152 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 93.9 t -64.42 -39.57 86.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 125.383 1.473 . . . . 0.0 111.138 174.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 24.2 mt -66.11 -41.86 90.01 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 121.189 -0.944 . . . . 0.0 111.303 178.013 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -64.74 -46.26 82.96 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.979 1.311 . . . . 0.0 111.57 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.5 -37.25 84.66 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 118.798 -0.62 . . . . 0.0 111.441 174.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.8 t -54.74 -45.75 73.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 124.504 1.122 . . . . 0.0 111.196 -179.163 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.562 HD11 ' HB3' ' A' ' 169' ' ' LYS . 1.4 mt -59.19 -22.48 61.07 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 119.125 0.875 . . . . 0.0 113.356 178.025 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -89.37 -59.34 1.56 Allowed Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.574 1.559 . . . . 0.0 112.552 178.58 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -66.13 -30.37 70.84 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.3 mt -111.83 109.61 19.52 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.737 1.615 . . . . 0.0 110.001 -174.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -148.72 139.9 7.89 Favored Glycine 0 CA--C 1.54 1.643 0 C-N-CA 124.563 1.078 . . . . 0.0 114.781 -174.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.3 mtpt -109.22 -67.12 1.0 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 126.243 1.817 . . . . 0.0 112.136 178.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 15.3 m -118.2 -172.12 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 126.127 1.771 . . . . 0.0 110.891 -177.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.2 m -46.9 -38.38 10.38 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 125.359 1.464 . . . . 0.0 114.251 179.048 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 -127.63 162.0 27.54 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.742 1.617 . . . . 0.0 109.844 174.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.46 ' HB2' HD13 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -155.16 155.87 34.71 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 125.937 1.695 . . . . 0.0 108.98 -176.121 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -120.65 129.41 75.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 124.633 1.173 . . . . 0.0 107.838 174.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -133.26 121.89 23.12 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.237 1.415 . . . . 0.0 109.564 175.055 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.718 HG22 ' HB2' ' A' ' 72' ' ' TYR . 1.0 OUTLIER -128.49 144.48 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.111 0.964 . . . . 0.0 110.685 -176.721 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -124.79 110.22 1.35 Allowed Glycine 0 CA--C 1.519 0.323 0 C-N-CA 123.716 0.674 . . . . 0.0 112.44 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.46 ' HB ' HD11 ' A' ' 70' ' ' LEU . 3.5 mp -100.3 129.43 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 117.767 0.784 . . . . 0.0 110.687 175.561 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.73 106.3 18.27 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.639 1.576 . . . . 0.0 110.38 175.713 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.79 96.25 3.04 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.304 1.442 . . . . 0.0 109.585 176.607 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -129.73 6.63 5.15 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.836 1.254 . . . . 0.0 113.484 176.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.5 t -58.44 -18.4 28.24 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.62 1.568 . . . . 0.0 113.921 175.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 94.94 5.96 60.71 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 125.747 1.641 . . . . 0.0 114.573 176.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -128.8 147.41 17.59 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 125.813 1.673 . . . . 0.0 111.509 175.351 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.8 HG22 ' HA ' ' A' ' 65' ' ' PRO . 32.4 p -74.24 129.39 37.73 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 174.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 38.9 m0 -93.38 132.03 37.99 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 122.084 -0.385 . . . . 0.0 110.892 178.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 97.6 m -114.64 128.61 56.41 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.439 1.096 . . . . 0.0 110.073 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.65 106.99 0.74 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.266 1.026 . . . . 0.0 111.877 175.696 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.2 pp -98.91 -40.12 8.24 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.121 0.568 . . . . 0.0 112.516 179.325 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -170.58 163.35 8.24 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.875 2.07 . . . . 0.0 111.639 176.53 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -156.54 154.38 30.2 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.195 0.998 . . . . 0.0 111.355 174.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -132.46 107.24 8.36 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.422 1.489 . . . . 0.0 111.744 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.547 ' CD1' ' HB1' ' A' ' 87' ' ' ALA . 2.1 m-85 -98.82 110.85 23.39 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.844 0.858 . . . . 0.0 110.476 175.056 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.3 tpp180 -74.19 -73.33 0.23 Allowed 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.935 1.294 . . . . 0.0 109.291 175.012 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 9.3 t -106.37 -178.34 3.62 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 126.607 1.963 . . . . 0.0 109.081 176.006 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 48.65 35.4 16.45 Favored Glycine 0 CA--C 1.54 1.648 0 CA-C-O 119.581 -0.566 . . . . 0.0 112.314 -174.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.7 p -48.7 141.45 7.22 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.596 1.958 . . . . 0.0 112.199 -174.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.405 HG21 HG23 ' A' ' 59' ' ' ILE . 3.2 t -136.95 173.41 11.73 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 121.346 -0.846 . . . . 0.0 113.135 -175.191 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -80.47 -58.1 3.28 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.648 1.179 . . . . 0.0 111.337 176.298 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.2 p -142.75 133.07 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.418 1.487 . . . . 0.0 111.615 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.405 HG23 HG21 ' A' ' 56' ' ' THR . 1.1 pp -138.13 -24.33 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 126.372 1.869 . . . . 0.0 113.863 178.553 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.4 mp -97.65 98.96 5.76 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 124.797 1.239 . . . . 0.0 110.233 179.542 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -67.33 159.94 49.97 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 124.714 3.61 . . . . 0.0 111.031 174.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -57.93 -48.25 80.49 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -178.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 87.7 t -149.16 143.7 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 127.196 2.198 . . . . 0.0 108.809 -176.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.486 HG21 HD23 ' A' ' 70' ' ' LEU . 11.2 t -125.78 102.12 29.07 Favored Pre-proline 0 C--N 1.33 -0.259 0 C-N-CA 125.69 1.596 . . . . 0.0 107.451 175.548 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.8 ' HA ' HG22 ' A' ' 43' ' ' THR . 64.8 Cg_endo -72.12 161.39 44.8 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 121.234 1.289 . . . . 0.0 112.492 175.505 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -69.37 172.27 7.38 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.05 0.54 . . . . 0.0 110.259 174.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 58.8 p 57.03 20.64 5.59 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 125.494 1.518 . . . . 0.0 111.954 -174.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.79 173.35 11.46 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 125.359 1.464 . . . . 0.0 111.06 -174.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.442 ' HB3' HD23 ' A' ' 13' ' ' LEU . . . -142.8 156.52 44.98 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 175.028 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.486 HD23 HG21 ' A' ' 64' ' ' VAL . 1.0 OUTLIER -121.04 175.67 5.96 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 123.882 0.873 . . . . 0.0 111.073 -179.529 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.498 HD13 ' O ' ' A' ' 34' ' ' VAL . 0.8 OUTLIER -132.62 149.53 52.29 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.699 1.2 . . . . 0.0 110.965 175.052 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.718 ' HB2' HG22 ' A' ' 34' ' ' VAL . 3.7 m-85 -123.3 147.06 47.37 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.713 1.205 . . . . 0.0 109.286 174.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.2 p -121.3 147.84 45.12 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 127.047 2.139 . . . . 0.0 110.138 174.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.814 ' H ' HD12 ' A' ' 3' ' ' LEU . . . -165.2 130.72 2.22 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 124.351 0.977 . . . . 0.0 112.695 174.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 7.5 ptt180 -123.09 149.31 44.62 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.943 1.697 . . . . 0.0 110.687 -175.042 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 11.8 mtpt . . . . . 0 N--CA 1.475 0.784 0 O-C-N 121.212 -0.93 . . . . 0.0 111.862 -176.841 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 53.0 m . . . . . 0 N--CA 1.474 0.737 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -43.67 -77.05 0.1 OUTLIER Glycine 0 N--CA 1.476 1.339 0 C-N-CA 126.962 2.22 . . . . 0.0 115.416 -175.008 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -169.1 123.59 0.84 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.534 1.934 . . . . 0.0 109.865 178.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.5 t -151.41 114.3 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.845 0.858 . . . . 0.0 110.716 -175.045 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.547 ' HB1' ' CD1' ' A' ' 51' ' ' PHE . . . -159.23 157.75 31.29 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -141.93 132.66 25.6 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.478 1.111 . . . . 0.0 112.173 178.432 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -136.01 171.62 14.21 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.189 -0.944 . . . . 0.0 111.688 -178.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -137.67 155.92 48.59 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.26 -0.9 . . . . 0.0 112.906 174.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -133.17 118.33 18.53 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 126.025 1.73 . . . . 0.0 114.409 -175.023 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -77.13 122.78 25.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.666 -0.243 . . . . 0.0 110.972 -178.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 13.3 mtm -101.67 134.47 44.76 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.514 1.526 . . . . 0.0 111.304 177.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 98.5 p -61.68 -17.26 54.83 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 178.157 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -69.05 -0.32 5.61 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 125.965 1.706 . . . . 0.0 113.037 174.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 91.1 24.9 25.82 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.456 1.503 . . . . 0.0 113.276 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -132.58 174.82 9.88 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.906 1.283 . . . . 0.0 111.702 -175.012 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 71.1 m -136.57 113.92 10.82 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.355 1.062 . . . . 0.0 111.504 174.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 65.1 tp -76.03 104.48 6.58 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.512 1.125 . . . . 0.0 110.506 175.004 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -93.63 117.94 5.58 Favored Glycine 0 CA--C 1.529 0.947 0 O-C-N 121.239 -0.913 . . . . 0.0 112.973 175.005 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 93.3 t -104.83 147.5 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 125.525 1.53 . . . . 0.0 111.067 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 1.5 tpt -151.55 126.1 9.5 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.546 1.138 . . . . 0.0 111.03 -178.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.479 ' CZ ' ' HB3' ' A' ' 87' ' ' ALA . 44.7 p90 -133.81 139.95 46.61 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.456 1.503 . . . . 0.0 114.159 177.36 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -136.3 138.96 42.26 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.245 1.818 . . . . 0.0 111.294 -177.44 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 96.3 t . . . . . 0 N--CA 1.469 0.494 0 C-N-CA 125.098 1.359 . . . . 0.0 110.776 -178.785 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 51.6 m . . . . . 0 N--CA 1.472 0.638 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -88.2 113.82 24.2 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 124.44 1.096 . . . . 0.0 110.974 174.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 31.5 m0 -118.52 135.58 54.32 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.112 0.965 . . . . 0.0 109.673 -176.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' TRP . . . . . 0.413 ' HE1' ' CA ' ' A' ' 143' ' ' GLY . 30.5 p-90 -142.19 134.47 27.74 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.49 1.116 . . . . 0.0 111.873 -175.006 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -160.3 164.46 32.56 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 122.526 1.155 . . . . 0.0 112.989 -176.529 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.2 t -138.64 124.7 24.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 125.142 1.377 . . . . 0.0 107.747 -179.195 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.66 166.0 13.29 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.208 1.403 . . . . 0.0 110.198 175.053 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.416 ' CD1' HD13 ' A' ' 152' ' ' LEU . 41.7 mt -122.97 147.76 27.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 174.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -110.2 143.37 27.89 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 124.87 1.268 . . . . 0.0 110.071 177.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -77.21 12.5 1.78 Allowed 'Trans proline' 0 CA--C 1.548 1.219 0 C-N-CA 124.594 3.529 . . . . 0.0 114.407 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -161.12 -179.86 36.12 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 126.475 1.988 . . . . 0.0 111.44 176.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.93 101.83 0.71 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.825 1.25 . . . . 0.0 110.807 177.507 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 3.8 mmt-85 -124.79 141.8 51.86 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.71 1.204 . . . . 0.0 112.466 -178.223 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.41 171.99 12.13 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 177.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -128.35 91.63 3.29 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.5 1.92 . . . . 0.0 108.503 176.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -107.37 173.99 6.08 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.793 1.637 . . . . 0.0 109.922 174.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -49.76 -37.0 27.92 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.805 0.842 . . . . 0.0 113.265 176.477 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -59.14 -65.72 3.27 Favored Glycine 0 CA--C 1.531 1.035 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 174.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -58.08 -36.74 73.27 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 118.176 0.988 . . . . 0.0 113.522 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -56.28 -64.21 0.94 Allowed 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 125.267 1.427 . . . . 0.0 109.718 174.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -67.78 -32.8 73.64 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -176.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -57.87 -47.65 82.12 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.01 0.924 . . . . 0.0 112.265 177.056 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 5.2 tpp -84.51 -21.86 30.41 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 113.669 0.989 . . . . 0.0 113.669 176.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -49.33 -57.97 5.92 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.741 1.216 . . . . 0.0 109.773 174.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -74.64 5.05 5.24 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -178.493 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -93.9 -11.9 57.23 Favored Glycine 0 CA--C 1.539 1.59 0 C-N-CA 126.015 1.769 . . . . 0.0 114.765 178.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -145.26 94.71 5.2 Favored Pre-proline 0 CA--C 1.552 1.053 0 CA-C-N 119.523 1.662 . . . . 0.0 112.397 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -74.02 81.84 1.88 Allowed 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 123.587 2.858 . . . . 0.0 112.584 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -116.88 110.2 18.03 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.446 1.499 . . . . 0.0 110.846 -178.708 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 37.2 mtm105 -96.27 50.94 1.18 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 126.907 2.083 . . . . 0.0 111.336 -178.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.413 ' CA ' ' HE1' ' A' ' 116' ' ' TRP . . . 85.95 -53.06 4.63 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 124.117 0.865 . . . . 0.0 111.185 -174.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 51.38 52.71 14.22 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.235 1.814 . . . . 0.0 111.399 178.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 14.7 p-10 -48.17 92.82 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 128.48 2.712 . . . . 0.0 115.115 -174.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 160.46 40.12 0.02 OUTLIER Glycine 0 CA--C 1.537 1.427 0 C-N-CA 125.232 1.396 . . . . 0.0 114.506 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' TRP . . . . . 0.723 ' H ' HD12 ' A' ' 161' ' ' ILE . 7.5 m95 53.42 48.81 21.03 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.81 1.644 . . . . 0.0 113.363 -176.021 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -82.66 126.3 32.19 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.987 0.915 . . . . 0.0 112.094 -179.049 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' GLN . . . . . 0.5 ' HG3' ' H ' ' A' ' 150' ' ' LYS . 10.5 tp60 -161.65 -168.98 2.11 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.345 0.658 . . . . 0.0 112.312 175.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.5 ' H ' ' HG3' ' A' ' 149' ' ' GLN . 0.6 OUTLIER -131.59 160.67 34.64 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.245 1.818 . . . . 0.0 110.781 -179.205 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 18.7 m-80 -75.55 148.98 38.47 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.391 1.076 . . . . 0.0 109.95 174.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.416 HD13 ' CD1' ' A' ' 120' ' ' ILE . 94.3 mt -100.93 136.9 40.04 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.955 0.902 . . . . 0.0 110.621 178.354 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -53.0 -35.59 49.1 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 125.717 1.627 . . . . 0.0 116.476 -174.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.536 ' HB2' HD12 ' A' ' 156' ' ' LEU . 0.1 OUTLIER -73.46 14.21 0.37 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 128.081 2.552 . . . . 0.0 113.942 -178.326 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 76.36 20.5 76.96 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 124.908 1.242 . . . . 0.0 113.58 -174.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.536 HD12 ' HB2' ' A' ' 154' ' ' TYR . 6.1 mt -101.01 169.01 9.24 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 127.144 2.178 . . . . 0.0 110.519 178.716 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 50.4 mtt180 -138.76 114.03 9.54 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 120.841 -1.162 . . . . 0.0 110.451 177.075 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -92.16 150.79 20.72 Favored 'General case' 0 C--N 1.32 -0.711 0 O-C-N 120.138 -1.601 . . . . 0.0 108.433 174.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 2.3 tptt -133.45 142.5 48.33 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.578 1.551 . . . . 0.0 111.097 175.041 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -147.59 143.43 11.22 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-N 118.885 0.766 . . . . 0.0 113.671 175.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.723 HD12 ' H ' ' A' ' 147' ' ' TRP . 0.5 OUTLIER -130.55 126.16 60.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 126.36 1.864 . . . . 0.0 110.604 177.509 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -149.93 148.49 29.16 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 125.412 1.485 . . . . 0.0 109.297 175.02 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 13.5 t -139.81 112.84 8.15 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.0 0.52 . . . . 0.0 110.543 178.504 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 67.7 m -72.51 35.02 0.07 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.566 1.146 . . . . 0.0 113.232 178.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -65.99 -44.23 85.45 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.653 1.981 . . . . 0.0 113.019 -179.133 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 165.13 -68.72 0.2 Allowed Glycine 0 CA--C 1.531 1.059 0 C-N-CA 124.546 1.069 . . . . 0.0 113.838 178.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -111.88 17.01 20.14 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 125.054 1.341 . . . . 0.0 114.392 -174.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -60.98 175.36 0.52 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.349 1.859 . . . . 0.0 114.289 174.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' LYS . . . . . 0.562 ' HB3' HD11 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -125.14 174.83 7.8 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 126.986 2.114 . . . . 0.0 112.042 -178.6 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 5.5 ttt -115.21 132.9 56.46 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.172 1.389 . . . . 0.0 110.685 175.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -144.79 120.88 10.76 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 123.351 0.66 . . . . 0.0 110.293 177.683 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 2.7 mp -119.67 126.03 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 C-N-CA 125.125 1.37 . . . . 0.0 107.471 177.381 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -127.43 126.52 42.53 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 120.879 -1.138 . . . . 0.0 108.794 176.25 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.8 mp -78.1 124.9 37.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 175.048 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 2.1 m -95.83 168.01 10.91 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.882 1.673 . . . . 0.0 109.984 175.091 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 49.3 mtp85 . . . . . 0 C--O 1.253 1.254 0 C-N-CA 125.37 1.468 . . . . 0.0 111.856 176.708 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.678 HD12 ' H ' ' A' ' 74' ' ' GLY . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.338 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.475 ' HB1' ' HB3' ' A' ' 71' ' ' LEU . . . -119.42 125.25 48.52 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.669 1.988 . . . . 0.0 111.056 178.026 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -77.37 -147.74 2.87 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 125.036 1.303 . . . . 0.0 112.443 175.007 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 18.3 p -68.06 169.08 10.74 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.076 1.35 . . . . 0.0 112.867 176.525 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -128.89 21.0 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 126.131 1.772 . . . . 0.0 111.257 176.299 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.2 pt -57.07 171.92 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 O-C-N 120.276 -1.515 . . . . 0.0 112.798 176.054 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -44.12 131.63 5.89 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.734 1.614 . . . . 0.0 112.292 -177.102 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -54.79 -20.94 20.86 Favored Glycine 0 CA--C 1.54 1.651 0 C-N-CA 124.367 0.984 . . . . 0.0 114.303 -177.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.73 -36.25 78.39 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.732 1.613 . . . . 0.0 112.031 175.003 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.44 -40.2 8.39 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.302 1.441 . . . . 0.0 111.528 175.193 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.405 HD23 ' HB3' ' A' ' 69' ' ' ALA . 9.4 tp -71.78 87.32 0.97 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.663 1.185 . . . . 0.0 111.205 175.042 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 80.6 p -123.33 -177.9 3.84 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.741 2.016 . . . . 0.0 111.401 -176.33 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -45.49 -37.9 5.74 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.426 1.49 . . . . 0.0 113.985 176.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -59.66 -40.94 89.4 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.676 0.791 . . . . 0.0 111.958 178.28 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 85.6 t -70.66 -37.72 70.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 123.754 0.822 . . . . 0.0 111.055 174.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 32.2 mt -65.54 -41.17 93.34 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 120.971 -1.081 . . . . 0.0 111.32 177.546 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -75.06 -42.92 56.02 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.85 0.86 . . . . 0.0 112.815 -179.313 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.88 -37.86 88.57 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 118.764 0.711 . . . . 0.0 111.543 175.1 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.508 HG13 HD12 ' A' ' 25' ' ' LEU . 20.2 t -56.35 -46.85 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 124.922 1.289 . . . . 0.0 111.738 176.011 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 78.1 mt -56.27 -25.32 47.68 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 119.213 0.915 . . . . 0.0 112.887 175.028 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -86.3 -57.81 2.06 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 124.899 1.237 . . . . 0.0 113.202 176.292 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -66.47 -27.54 67.88 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -177.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.508 HD12 HG13 ' A' ' 21' ' ' VAL . 19.3 mt -108.18 88.05 2.64 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.33 1.452 . . . . 0.0 110.838 -175.785 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -125.34 85.24 0.35 Allowed Glycine 0 CA--C 1.533 1.193 0 C-N-CA 125.129 1.347 . . . . 0.0 115.302 -175.027 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -75.41 -43.01 52.26 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.096 0.959 . . . . 0.0 113.467 175.052 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.8 m -137.12 -177.12 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 126.351 1.86 . . . . 0.0 112.078 -174.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -46.65 -45.54 19.29 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 126.448 1.899 . . . . 0.0 114.289 179.383 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 17.4 mtt85 -139.02 149.12 44.29 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.768 1.627 . . . . 0.0 111.548 178.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.671 ' HB2' HD13 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -139.12 157.44 45.94 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 127.234 2.214 . . . . 0.0 110.632 -175.015 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.717 HG13 ' HB1' ' A' ' 85' ' ' ALA . 0.3 OUTLIER -118.2 128.33 75.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 125.14 1.376 . . . . 0.0 107.597 174.974 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -135.9 104.12 5.61 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.727 2.011 . . . . 0.0 109.335 176.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.728 HG22 ' HB2' ' A' ' 72' ' ' TYR . 2.1 m -107.46 158.64 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 123.753 0.821 . . . . 0.0 111.123 178.005 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -135.68 109.45 0.75 Allowed Glycine 0 N--CA 1.462 0.384 0 CA-C-N 118.293 0.497 . . . . 0.0 113.298 175.379 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.464 ' HB ' HD11 ' A' ' 70' ' ' LEU . 2.8 mp -101.73 132.35 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-N 117.108 0.454 . . . . 0.0 111.185 176.108 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -93.11 105.87 17.9 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.555 1.542 . . . . 0.0 110.972 177.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -71.62 100.69 2.34 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.223 1.809 . . . . 0.0 110.481 175.025 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -140.09 11.64 2.4 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.988 0.915 . . . . 0.0 112.522 175.152 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 12.7 t -57.89 -31.9 67.19 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.895 1.678 . . . . 0.0 114.027 179.317 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 124.82 53.93 0.18 Allowed Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.75 1.167 . . . . 0.0 115.148 174.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 152.5 171.4 20.0 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 125.442 1.496 . . . . 0.0 112.263 175.446 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.565 HG22 ' HA ' ' A' ' 65' ' ' PRO . 75.6 p -63.6 145.72 55.14 Favored 'General case' 0 N--CA 1.471 0.625 0 O-C-N 121.601 -0.941 . . . . 0.0 111.212 176.524 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.539 ' HA ' ' CE1' ' A' ' 91' ' ' TYR . 38.0 m0 -93.57 98.35 11.1 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 121.619 -0.676 . . . . 0.0 111.334 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.3 m -83.63 108.52 16.78 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.469 1.107 . . . . 0.0 108.776 176.602 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.9 142.85 52.85 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.842 -0.536 . . . . 0.0 112.405 175.346 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.2 pp -119.14 -52.37 2.3 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.048 0.939 . . . . 0.0 112.876 176.463 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -163.7 153.98 15.42 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.557 1.543 . . . . 0.0 110.72 174.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -131.6 152.37 50.86 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.83 0.852 . . . . 0.0 110.365 175.045 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -128.05 95.81 4.29 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.687 1.595 . . . . 0.0 110.007 -178.169 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.532 ' CZ ' HG21 ' A' ' 59' ' ' ILE . 1.5 m-85 -94.54 111.04 22.8 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.852 0.861 . . . . 0.0 110.34 176.106 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.54 -38.03 12.15 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.048 0.939 . . . . 0.0 111.949 -178.808 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.2 t -126.63 -173.82 2.97 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 128.415 2.686 . . . . 0.0 107.45 175.036 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 44.42 49.37 8.42 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-O 118.428 -1.207 . . . . 0.0 111.189 -179.316 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.9 p -44.8 145.21 0.97 Allowed 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 118.35 1.075 . . . . 0.0 112.8 -175.07 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.518 ' CG2' HD12 ' A' ' 59' ' ' ILE . 2.6 t -155.33 179.04 9.55 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.249 -0.907 . . . . 0.0 113.047 -175.168 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -98.71 -62.76 1.2 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.479 1.511 . . . . 0.0 112.208 178.177 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.0 p -129.4 131.54 67.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 125.232 1.413 . . . . 0.0 110.921 -177.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.532 HG21 ' CZ ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -137.22 -49.17 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 C-N-CA 125.071 1.348 . . . . 0.0 112.593 -175.117 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.404 ' HA ' ' HD2' ' A' ' 61' ' ' PRO . 4.3 mt -85.49 104.09 4.52 Favored Pre-proline 0 N--CA 1.449 -0.478 0 C-N-CA 124.313 1.045 . . . . 0.0 109.948 175.114 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 60' ' ' LEU . 56.6 Cg_endo -66.08 128.57 19.89 Favored 'Trans proline' 0 CA--C 1.535 0.547 0 C-N-CA 122.789 2.326 . . . . 0.0 110.366 175.028 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -35.29 -47.86 0.43 Allowed 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 127.474 2.31 . . . . 0.0 113.79 176.248 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 5.9 p -154.09 134.57 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 126.576 1.95 . . . . 0.0 109.424 174.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 95.5 t -122.17 133.58 24.41 Favored Pre-proline 0 N--CA 1.482 1.16 0 C-N-CA 124.986 1.314 . . . . 0.0 109.865 175.636 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.565 ' HA ' HG22 ' A' ' 43' ' ' THR . 58.0 Cg_endo -62.41 148.85 92.62 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.871 2.381 . . . . 0.0 113.209 175.043 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 13.1 p30 -67.83 170.19 8.46 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.206 1.002 . . . . 0.0 113.071 175.037 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 74.4 p 48.1 28.62 1.55 Allowed 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 127.109 2.164 . . . . 0.0 114.235 -175.3 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.51 -179.84 4.8 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 127.442 2.297 . . . . 0.0 110.817 -174.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.405 ' HB3' HD23 ' A' ' 13' ' ' LEU . . . -136.37 152.79 51.02 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 120.77 -1.206 . . . . 0.0 109.86 175.597 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.464 HD11 ' HB ' ' A' ' 36' ' ' ILE . 0.8 OUTLIER -117.88 172.51 7.34 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 124.642 1.177 . . . . 0.0 111.279 -178.407 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.537 HD13 ' O ' ' A' ' 34' ' ' VAL . 0.5 OUTLIER -129.05 151.85 49.3 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.133 1.373 . . . . 0.0 111.191 175.14 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.728 ' HB2' HG22 ' A' ' 34' ' ' VAL . 5.2 m-85 -127.2 133.54 50.25 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.395 1.078 . . . . 0.0 110.214 174.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.3 p -102.41 154.88 18.65 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 126.491 1.917 . . . . 0.0 111.36 175.045 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.678 ' H ' HD12 ' A' ' 3' ' ' LEU . . . -176.37 126.91 1.17 Allowed Glycine 0 CA--C 1.529 0.917 0 N-CA-C 114.269 0.468 . . . . 0.0 114.269 175.189 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 9.3 ptt180 -116.26 105.03 12.1 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.513 1.925 . . . . 0.0 112.751 -175.046 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.586 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 53.8 m . . . . . 0 N--CA 1.48 1.03 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -27.71 -77.61 0.01 OUTLIER Glycine 0 N--CA 1.477 1.381 0 C-N-CA 127.69 2.567 . . . . 0.0 116.177 -178.379 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.717 ' HB1' HG13 ' A' ' 32' ' ' ILE . . . -165.73 112.55 0.92 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.363 1.865 . . . . 0.0 110.599 -176.767 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.8 t -149.97 120.68 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 O-C-N 121.211 -0.931 . . . . 0.0 111.631 -177.176 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.513 ' HB3' ' CE2' ' A' ' 103' ' ' PHE . . . -162.03 173.39 14.47 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 122.67 1.224 . . . . 0.0 113.397 175.389 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -147.69 157.38 43.52 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.686 1.594 . . . . 0.0 110.755 174.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.449 ' CD2' ' CE2' ' A' ' 72' ' ' TYR . 49.0 p90 -158.05 172.1 19.04 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 124.41 1.084 . . . . 0.0 110.858 175.174 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.76 147.82 31.31 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 175.05 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.539 ' CE1' ' HA ' ' A' ' 44' ' ' TRP . 0.1 OUTLIER -114.54 126.98 55.55 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 126.309 1.844 . . . . 0.0 109.726 -178.281 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -82.83 108.23 16.02 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 123.518 0.727 . . . . 0.0 111.768 178.614 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.416 ' HE2' HG21 ' A' ' 120' ' ' ILE . 0.5 OUTLIER -79.91 137.8 36.98 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.441 1.096 . . . . 0.0 111.603 -174.998 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.9 t -59.44 -22.63 61.77 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.791 0.837 . . . . 0.0 113.206 177.531 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 28.3 m-80 -69.23 -1.79 8.89 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 125.69 1.596 . . . . 0.0 113.529 174.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 89.75 16.33 56.7 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 125.066 1.317 . . . . 0.0 113.894 -179.569 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 23.6 m-20 -116.47 177.32 4.74 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.878 1.671 . . . . 0.0 111.07 -176.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.2 m -131.66 117.51 18.77 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 121.473 -0.767 . . . . 0.0 112.007 175.11 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 13.5 tp -80.09 97.53 6.88 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 175.003 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -91.21 135.76 12.98 Favored Glycine 0 CA--C 1.532 1.126 0 O-C-N 121.347 -0.845 . . . . 0.0 112.067 176.089 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 74.3 t -122.46 133.87 67.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 126.951 2.1 . . . . 0.0 111.61 -174.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -137.78 128.36 26.68 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 126.009 1.724 . . . . 0.0 111.01 -176.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.513 ' CE2' ' HB3' ' A' ' 87' ' ' ALA . 3.6 p90 -145.77 121.83 10.75 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.873 1.269 . . . . 0.0 112.312 -175.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 19.3 m -139.07 110.8 7.14 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.878 1.271 . . . . 0.0 112.064 -175.022 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.7 m . . . . . 0 N--CA 1.479 1.021 0 N-CA-C 112.654 0.612 . . . . 0.0 112.654 -179.091 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 2.1 m . . . . . 0 N--CA 1.475 0.796 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -79.89 107.41 12.65 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.18 0.992 . . . . 0.0 110.272 174.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 31.2 m0 -112.03 141.82 45.23 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 55.6 p-90 -146.82 130.73 17.15 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 123.864 0.865 . . . . 0.0 112.007 -174.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -132.49 144.46 50.46 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 122.81 1.291 . . . . 0.0 112.192 179.378 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.419 ' HB ' ' CE ' ' A' ' 158' ' ' MET . 79.6 t -151.17 131.5 3.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 175.326 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.86 165.99 13.68 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 125.161 1.384 . . . . 0.0 110.505 175.169 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.416 HG21 ' HE2' ' A' ' 93' ' ' MET . 14.3 mt -86.24 148.51 4.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 175.075 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -110.38 142.63 26.43 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 126.771 2.028 . . . . 0.0 109.519 -178.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -74.77 87.24 1.31 Allowed 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 124.319 3.346 . . . . 0.0 111.547 -177.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.53 -174.97 19.96 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 125.112 1.339 . . . . 0.0 113.201 -174.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 2.3 tttt -69.73 105.81 2.87 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.234 1.414 . . . . 0.0 110.714 177.33 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 17.4 tpp180 -135.45 101.18 4.73 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.241 1.417 . . . . 0.0 111.451 178.597 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.8 168.58 1.2 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.711 0.804 . . . . 0.0 112.954 175.014 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -111.06 101.73 10.25 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.784 1.234 . . . . 0.0 107.882 177.334 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -113.23 171.17 7.71 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.794 1.238 . . . . 0.0 109.848 174.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -50.24 -36.61 31.81 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.006 -1.059 . . . . 0.0 112.775 175.108 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -60.02 -61.6 6.98 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 124.087 0.851 . . . . 0.0 111.634 174.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.48 -34.63 74.32 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 118.43 1.115 . . . . 0.0 112.324 178.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -58.4 -66.2 0.53 Allowed 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.866 0.866 . . . . 0.0 109.277 174.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -67.67 -30.89 70.54 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -175.018 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -63.88 -54.4 35.44 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.976 1.31 . . . . 0.0 112.142 175.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 51.8 mmm -75.13 -24.14 57.95 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.159 -0.963 . . . . 0.0 113.266 178.542 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -55.68 -56.58 18.78 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.383 1.473 . . . . 0.0 108.903 174.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -66.91 -23.11 65.95 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -75.3 -19.09 79.81 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 125.868 1.699 . . . . 0.0 115.212 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -132.56 83.64 53.36 Favored Pre-proline 0 CA--C 1.549 0.942 0 CA-C-N 119.024 1.412 . . . . 0.0 111.102 175.03 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -72.97 72.63 3.23 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 124.239 3.293 . . . . 0.0 112.1 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -96.64 112.01 23.93 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 121.372 -0.83 . . . . 0.0 110.551 -175.031 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 10.0 mtm180 -113.41 -3.45 13.75 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 115.467 1.655 . . . . 0.0 115.467 176.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -50.43 152.15 4.55 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 125.159 1.361 . . . . 0.0 114.427 177.346 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 10.4 p30 -119.35 -155.75 0.63 Allowed 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 -175.011 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -49.52 114.28 1.01 Allowed 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.79 1.636 . . . . 0.0 113.027 -178.527 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 152.8 24.79 0.05 OUTLIER Glycine 0 CA--C 1.535 1.342 0 N-CA-C 115.425 0.93 . . . . 0.0 115.425 -175.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 3.4 m95 49.6 47.57 22.56 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.545 1.538 . . . . 0.0 113.393 -175.035 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -66.9 109.57 2.98 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 126.999 2.12 . . . . 0.0 112.787 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -158.65 -169.01 2.58 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 175.006 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.4 mtmt -134.86 172.32 13.15 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 127.564 2.346 . . . . 0.0 110.277 -179.13 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -71.1 160.62 32.55 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.042 0.537 . . . . 0.0 109.898 174.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 10.3 mt -118.7 155.48 30.98 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 122.385 1.088 . . . . 0.0 110.659 175.005 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -62.46 -175.45 2.48 Favored Glycine 0 CA--C 1.537 1.415 0 CA-C-N 114.92 -1.036 . . . . 0.0 111.17 175.012 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 55.82 12.05 0.8 Allowed 'General case' 0 N--CA 1.482 1.141 0 O-C-N 121.055 -1.262 . . . . 0.0 114.127 178.814 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 79.41 24.33 61.16 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 125.576 1.56 . . . . 0.0 114.079 -174.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 52.7 mt -103.94 176.66 5.08 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 118.699 1.249 . . . . 0.0 111.534 -175.05 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -145.85 131.6 18.99 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 120.862 -1.149 . . . . 0.0 110.598 177.095 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' MET . . . . . 0.419 ' CE ' ' HB ' ' A' ' 118' ' ' VAL . 2.9 ttt -106.32 150.94 25.47 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 119.892 -1.755 . . . . 0.0 107.154 175.06 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 1.9 tppt? -126.54 136.96 53.25 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 126.236 1.814 . . . . 0.0 108.834 175.052 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -147.95 157.79 27.47 Favored Glycine 0 N--CA 1.463 0.477 0 O-C-N 121.152 -0.968 . . . . 0.0 112.733 -178.352 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -158.21 128.34 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 122.137 0.97 . . . . 0.0 110.334 -179.398 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -155.23 117.68 4.23 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.708 1.603 . . . . 0.0 110.088 174.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 8.6 t -103.4 151.57 22.62 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 175.042 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 8.4 t -105.87 36.73 2.45 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.623 1.169 . . . . 0.0 111.384 -177.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -72.29 23.73 0.05 Allowed 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 127.795 2.438 . . . . 0.0 114.565 -178.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 80.83 -61.65 4.5 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 126.239 1.875 . . . . 0.0 113.015 -177.184 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -114.58 84.03 1.99 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 126.152 1.781 . . . . 0.0 109.992 177.305 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -136.7 163.93 29.43 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.318 1.847 . . . . 0.0 111.872 177.122 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.62 177.72 4.54 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 127.772 2.429 . . . . 0.0 111.523 -177.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' MET . . . . . 0.475 ' SD ' HD13 ' A' ' 172' ' ' ILE . 1.5 tmt? -121.97 131.07 53.82 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.864 1.266 . . . . 0.0 111.218 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.499 ' C ' HD12 ' A' ' 172' ' ' ILE . 5.7 tt0 -143.26 124.01 14.18 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.43 0.692 . . . . 0.0 111.739 179.075 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.499 HD12 ' C ' ' A' ' 171' ' ' GLN . 1.9 mp -128.78 130.95 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 125.805 1.642 . . . . 0.0 108.57 178.624 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 1.9 tmmm? -130.67 129.16 42.27 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 126.069 1.748 . . . . 0.0 108.993 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.7 mp -83.89 133.4 29.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 174.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 87.4 p -116.79 161.75 18.77 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.932 1.693 . . . . 0.0 112.45 176.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 19.0 mtp180 . . . . . 0 C--O 1.253 1.269 0 O-C-N 120.315 -1.49 . . . . 0.0 111.825 -175.307 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.61 HD12 ' H ' ' A' ' 74' ' ' GLY . 1.9 mt . . . . . 0 N--CA 1.484 1.231 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.537 ' HA ' HD12 ' A' ' 71' ' ' LEU . . . -99.42 114.02 26.7 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 127.404 2.282 . . . . 0.0 109.14 178.856 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -63.3 -89.12 0.03 OUTLIER Glycine 0 CA--C 1.535 1.295 0 C-N-CA 124.243 0.925 . . . . 0.0 113.934 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 17.2 p -143.85 174.47 10.8 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.86 1.664 . . . . 0.0 111.452 -175.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -124.95 15.2 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 125.38 1.472 . . . . 0.0 112.011 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.5 pt -50.11 156.73 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 124.481 1.112 . . . . 0.0 110.976 174.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -40.06 140.27 0.59 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.896 1.678 . . . . 0.0 112.695 -176.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -53.42 -24.2 22.35 Favored Glycine 0 CA--C 1.543 1.798 0 C-N-CA 124.028 0.823 . . . . 0.0 113.982 -174.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.24 -32.69 72.49 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.662 1.585 . . . . 0.0 112.618 175.005 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -93.41 -50.93 5.21 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 125.886 1.674 . . . . 0.0 110.911 175.058 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.2 tp -71.05 91.2 0.88 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.537 1.135 . . . . 0.0 111.086 177.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 62.5 p -126.68 -178.54 4.41 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.376 1.87 . . . . 0.0 111.6 -178.393 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -53.97 -37.65 64.17 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.512 1.125 . . . . 0.0 113.077 178.242 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -58.91 -46.76 87.16 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.372 0.669 . . . . 0.0 110.961 175.008 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 81.6 t -61.63 -43.66 97.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.669 1.188 . . . . 0.0 111.339 175.45 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 96.7 mt -64.6 -43.45 93.74 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 121.267 -0.895 . . . . 0.0 111.987 178.609 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -69.36 -42.37 75.32 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.275 0.63 . . . . 0.0 112.243 -179.494 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.01 -36.35 83.04 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 118.791 0.723 . . . . 0.0 111.716 175.008 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.2 t -56.17 -41.43 69.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 124.013 0.925 . . . . 0.0 110.923 179.035 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.417 HD22 ' HE3' ' A' ' 31' ' ' LYS . 41.0 mt -55.18 -20.23 9.94 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 175.419 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -92.71 -59.68 1.25 Allowed Glycine 0 CA--C 1.534 1.245 0 C-N-CA 125.246 1.403 . . . . 0.0 112.722 175.068 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -68.45 -29.41 68.06 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 -176.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -109.05 118.14 36.01 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 126.605 1.962 . . . . 0.0 109.365 -179.108 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -160.87 117.5 0.77 Allowed Glycine 0 CA--C 1.542 1.762 0 C-N-CA 125.701 1.619 . . . . 0.0 114.732 -175.316 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.543 ' HB2' HD21 ' A' ' 3' ' ' LEU . 9.1 mttm -87.54 -57.92 2.77 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 126.882 2.073 . . . . 0.0 112.988 176.619 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.3 m -132.36 -172.36 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 127.143 2.177 . . . . 0.0 112.066 -174.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.2 t -50.48 -37.15 37.11 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.778 1.631 . . . . 0.0 114.081 -175.228 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.5 tpt180 -130.28 144.93 51.66 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.129 1.372 . . . . 0.0 109.581 174.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.456 ' CB ' HD22 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -144.82 133.94 22.77 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 125.707 1.603 . . . . 0.0 110.357 -175.067 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -103.84 131.31 52.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 124.054 0.942 . . . . 0.0 108.882 175.028 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -130.11 105.61 8.06 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.501 1.92 . . . . 0.0 109.901 175.232 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.681 HG22 ' HB2' ' A' ' 72' ' ' TYR . 1.2 m -108.19 162.89 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 C-N-CA 123.979 0.912 . . . . 0.0 110.747 176.479 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -135.02 109.15 0.75 Allowed Glycine 0 C--O 1.228 -0.251 0 C-N-CA 123.275 0.465 . . . . 0.0 112.603 175.586 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.3 mp -92.35 133.86 32.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 174.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -109.31 99.63 8.86 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.436 1.894 . . . . 0.0 110.342 178.31 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -73.43 112.13 9.21 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.98 1.712 . . . . 0.0 112.199 175.603 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -140.06 18.68 2.45 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.785 0.834 . . . . 0.0 112.005 174.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 44.1 t -64.61 -39.06 93.04 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 120.889 -1.132 . . . . 0.0 113.15 -178.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 119.97 63.01 0.26 Allowed Glycine 0 CA--C 1.53 0.99 0 C-N-CA 124.805 1.193 . . . . 0.0 112.715 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 157.15 161.13 10.58 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 125.674 1.606 . . . . 0.0 112.444 176.527 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.61 HG22 ' HA ' ' A' ' 65' ' ' PRO . 71.5 p -67.82 148.47 51.17 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 121.784 -0.833 . . . . 0.0 111.732 175.413 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.562 ' HA ' ' CE1' ' A' ' 91' ' ' TYR . 35.3 m0 -103.72 98.25 8.14 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.415 1.086 . . . . 0.0 111.866 -177.508 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 35.9 m -84.24 116.66 23.07 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 125.07 1.348 . . . . 0.0 109.86 177.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.496 ' HB1' HD23 ' A' ' 60' ' ' LEU . . . -64.02 141.84 58.62 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 121.686 -0.634 . . . . 0.0 111.647 174.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.534 HD12 ' HB3' ' A' ' 48' ' ' ASN . 3.0 pp -114.31 -48.41 2.88 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.153 0.981 . . . . 0.0 112.587 177.265 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.534 ' HB3' HD12 ' A' ' 47' ' ' LEU . 2.4 t30 -170.19 148.88 3.39 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.964 2.106 . . . . 0.0 109.53 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.48 ' HB2' HD22 ' A' ' 60' ' ' LEU . . . -125.98 147.59 49.49 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.151 1.38 . . . . 0.0 109.803 174.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -124.52 101.61 7.22 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 125.344 1.458 . . . . 0.0 109.629 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.478 ' CD1' ' HB1' ' A' ' 87' ' ' ALA . 3.1 m-85 -105.13 133.53 49.75 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.586 -0.696 . . . . 0.0 110.427 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -107.07 -68.45 0.89 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.334 1.453 . . . . 0.0 111.244 -177.17 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.9 t -102.6 -38.92 7.3 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.671 1.588 . . . . 0.0 110.056 -179.379 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -69.44 7.7 3.49 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 125.482 1.515 . . . . 0.0 114.338 -178.185 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 53.4 p -33.2 123.25 0.4 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 128.151 2.581 . . . . 0.0 113.532 -175.023 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.478 HG21 HG23 ' A' ' 59' ' ' ILE . 1.9 t -138.35 177.96 7.49 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.175 0.99 . . . . 0.0 112.754 -174.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -77.37 -60.81 2.21 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.764 1.226 . . . . 0.0 112.538 177.433 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.8 p -141.57 138.27 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 126.161 1.784 . . . . 0.0 111.348 176.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.478 HG23 HG21 ' A' ' 56' ' ' THR . 1.1 pp -144.58 -34.2 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 126.114 1.765 . . . . 0.0 113.793 -177.317 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.496 HD23 ' HB1' ' A' ' 46' ' ' ALA . 1.1 mp -95.13 98.19 3.19 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 125.154 1.382 . . . . 0.0 109.681 176.067 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -66.83 151.87 81.54 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.749 2.299 . . . . 0.0 110.332 175.289 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -50.04 -50.25 48.23 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.686 0.794 . . . . 0.0 112.893 -177.655 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 60.0 t -150.14 142.15 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 128.296 2.638 . . . . 0.0 108.691 178.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.555 HG21 HD13 ' A' ' 70' ' ' LEU . 98.9 t -120.64 133.97 24.15 Favored Pre-proline 0 N--CA 1.477 0.893 0 C-N-CA 124.742 1.217 . . . . 0.0 109.117 175.017 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.61 ' HA ' HG22 ' A' ' 43' ' ' THR . 55.7 Cg_endo -65.06 154.58 72.73 Favored 'Trans proline' 0 CA--C 1.544 1.014 0 C-N-CA 122.707 2.271 . . . . 0.0 113.565 177.482 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -70.23 160.24 32.54 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.566 1.146 . . . . 0.0 113.273 175.125 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 40.9 p 52.7 23.78 2.87 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 126.314 1.846 . . . . 0.0 114.405 -175.02 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 18.6 mttt -119.48 -172.81 2.39 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 126.087 1.755 . . . . 0.0 111.31 -177.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -143.9 157.94 44.02 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 122.068 -0.395 . . . . 0.0 109.997 179.069 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.555 HD13 HG21 ' A' ' 64' ' ' VAL . 2.4 pt? -134.81 167.21 21.29 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 124.58 1.152 . . . . 0.0 111.689 177.365 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.541 HD13 ' O ' ' A' ' 34' ' ' VAL . 0.6 OUTLIER -114.0 154.85 26.94 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 125.121 1.369 . . . . 0.0 111.849 -179.118 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.681 ' HB2' HG22 ' A' ' 34' ' ' VAL . 29.0 m-85 -129.19 137.82 51.37 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.356 1.062 . . . . 0.0 110.764 175.079 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 8.7 p -111.93 144.04 41.9 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 126.86 2.064 . . . . 0.0 110.241 174.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.61 ' H ' HD12 ' A' ' 3' ' ' LEU . . . -165.63 133.69 3.05 Favored Glycine 0 CA--C 1.523 0.592 0 CA-C-O 121.388 0.438 . . . . 0.0 113.119 175.004 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 66.3 mtm180 -90.62 172.14 8.89 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.343 1.457 . . . . 0.0 110.617 -175.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.587 0 O-C-N 121.823 -0.548 . . . . 0.0 109.824 174.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 87.7 m . . . . . 0 N--CA 1.471 0.59 0 N-CA-C 110.598 -0.149 . . . . 0.0 110.598 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -57.34 -76.06 0.22 Allowed Glycine 0 CA--C 1.532 1.141 0 C-N-CA 125.726 1.631 . . . . 0.0 114.644 -174.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -162.24 104.96 1.13 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.377 1.071 . . . . 0.0 111.376 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 41.8 t -127.67 114.58 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 O-C-N 121.086 -1.009 . . . . 0.0 109.891 -177.063 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.529 ' HB3' ' CE2' ' A' ' 103' ' ' PHE . . . -157.26 169.45 24.72 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 122.693 1.235 . . . . 0.0 112.061 179.49 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -150.88 161.38 42.8 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.828 1.651 . . . . 0.0 109.563 175.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -159.97 176.47 11.82 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 121.093 -1.004 . . . . 0.0 111.342 175.079 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.03 156.47 43.5 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.666 0.746 . . . . 0.0 112.556 174.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.562 ' CE1' ' HA ' ' A' ' 44' ' ' TRP . 0.1 OUTLIER -119.94 127.5 52.72 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.697 1.999 . . . . 0.0 109.184 -178.81 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -83.45 105.59 14.51 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.494 0.718 . . . . 0.0 111.911 178.609 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -75.37 137.59 41.17 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.576 1.151 . . . . 0.0 112.009 -175.708 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.3 m -59.95 -17.31 36.86 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 113.583 0.956 . . . . 0.0 113.583 175.027 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -74.32 -2.53 25.56 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 125.142 1.377 . . . . 0.0 112.532 174.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.41 14.89 58.0 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 125.352 1.453 . . . . 0.0 114.168 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -117.25 178.18 4.46 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.504 1.522 . . . . 0.0 110.655 -177.174 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.416 HG21 ' O ' ' A' ' 125' ' ' ARG . 16.3 m -130.29 114.01 15.1 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 120.998 -1.064 . . . . 0.0 111.839 178.364 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 32.5 tp -78.99 98.77 6.57 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.391 0.996 . . . . 0.0 109.383 174.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.6 139.33 15.08 Favored Glycine 0 CA--C 1.532 1.154 0 O-C-N 121.075 -1.016 . . . . 0.0 112.294 175.433 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 60.9 t -122.55 134.21 66.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 128.174 2.589 . . . . 0.0 112.002 -175.156 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -131.75 125.39 31.85 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 126.163 1.785 . . . . 0.0 111.779 -175.307 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.529 ' CE2' ' HB3' ' A' ' 87' ' ' ALA . 10.8 p90 -146.03 116.04 7.37 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.362 1.065 . . . . 0.0 113.521 -177.125 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 72.3 m -123.36 122.26 37.87 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.397 1.479 . . . . 0.0 111.719 -177.36 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 47.4 t . . . . . 0 N--CA 1.469 0.506 0 C-N-CA 126.124 1.77 . . . . 0.0 108.873 -179.861 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 67.8 m . . . . . 0 N--CA 1.471 0.609 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -84.11 106.67 15.93 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.965 1.306 . . . . 0.0 109.081 174.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' TRP . . . . . 0.414 ' CG ' ' HA ' ' A' ' 140' ' ' PRO . 53.5 m0 -110.73 155.83 21.92 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.398 0.999 . . . . 0.0 108.912 174.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 58.1 p-90 -154.32 132.93 12.12 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.132 0.973 . . . . 0.0 111.214 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -135.94 154.97 50.95 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 122.84 1.305 . . . . 0.0 112.097 178.489 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 95.1 t -152.6 135.2 6.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 175.239 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.03 170.68 11.78 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.943 1.697 . . . . 0.0 110.014 175.026 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 20.5 mt -91.29 154.1 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 CA-C-O 121.507 0.67 . . . . 0.0 109.312 179.03 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -117.77 144.04 33.66 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 125.296 1.438 . . . . 0.0 109.64 178.321 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -70.96 108.11 2.24 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 123.891 3.06 . . . . 0.0 111.301 -178.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 83.61 -178.55 52.48 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 124.447 1.022 . . . . 0.0 113.711 -175.018 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 14.2 tttt -63.61 104.58 0.67 Allowed 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.911 1.285 . . . . 0.0 110.659 175.72 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.416 ' O ' HG21 ' A' ' 98' ' ' THR . 19.6 tpp180 -132.34 101.47 5.37 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.82 1.248 . . . . 0.0 111.29 -175.517 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.7 163.33 1.9 Allowed 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.852 0.834 . . . . 0.0 111.754 174.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -109.64 105.1 14.24 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 106.565 -1.642 . . . . 0.0 106.565 174.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -112.32 173.9 6.14 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.029 1.332 . . . . 0.0 109.86 175.007 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -50.57 -40.27 51.72 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 119.276 0.944 . . . . 0.0 113.282 176.119 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -58.28 -62.01 6.77 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 123.659 0.647 . . . . 0.0 111.717 175.046 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 5.3 mpp? -58.44 -39.33 79.53 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 118.134 0.967 . . . . 0.0 112.742 177.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -55.14 -60.87 2.79 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.397 1.079 . . . . 0.0 109.962 175.013 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -68.25 -33.29 74.11 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -178.035 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -61.1 -46.81 89.08 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.079 0.951 . . . . 0.0 111.599 176.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 46.6 mmm -84.88 -22.65 29.26 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -178.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -54.1 -55.54 26.63 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.765 1.626 . . . . 0.0 109.844 175.012 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -69.53 -16.49 63.44 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 179.605 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -74.29 -24.84 72.26 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 125.841 1.686 . . . . 0.0 114.333 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -135.74 87.98 24.47 Favored Pre-proline 0 CA--C 1.546 0.796 0 CA-C-N 118.721 1.26 . . . . 0.0 112.607 175.47 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.414 ' HA ' ' CG ' ' A' ' 115' ' ' TRP . 95.5 Cg_endo -74.19 76.68 2.99 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 123.752 2.968 . . . . 0.0 112.773 -178.814 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -104.29 105.32 15.42 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.991 0.916 . . . . 0.0 111.316 179.606 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 23.2 mtm105 -91.0 74.43 6.38 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.268 1.427 . . . . 0.0 111.472 174.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 31.37 64.79 0.2 Allowed Glycine 0 CA--C 1.534 1.242 0 C-N-CA 125.613 1.577 . . . . 0.0 112.948 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -71.86 93.92 1.37 Allowed 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 122.284 1.04 . . . . 0.0 110.153 -175.003 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 -54.76 98.94 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 126.934 2.093 . . . . 0.0 114.373 -175.006 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' GLY . . . . . 0.475 ' H ' HD13 ' A' ' 161' ' ' ILE . . . 146.7 54.6 0.02 OUTLIER Glycine 0 CA--C 1.535 1.335 0 C-N-CA 125.431 1.491 . . . . 0.0 114.38 177.145 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 5.0 m95 44.12 50.08 7.49 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.796 1.638 . . . . 0.0 114.129 -176.546 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -81.39 131.68 35.29 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 121.149 -0.97 . . . . 0.0 112.476 -177.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -167.77 -169.59 1.2 Allowed 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.845 178.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.83 160.52 27.22 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.701 2.001 . . . . 0.0 111.851 175.33 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -87.87 127.9 35.35 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.631 1.173 . . . . 0.0 108.217 174.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 12.8 mt -73.41 112.23 9.28 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.191 0.996 . . . . 0.0 112.052 -174.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -43.76 -46.16 7.41 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 127.349 2.404 . . . . 0.0 117.769 -175.005 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.411 ' CD1' ' N ' ' A' ' 154' ' ' TYR . 0.0 OUTLIER -51.77 -33.74 36.54 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 127.378 2.271 . . . . 0.0 113.658 178.162 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 132.17 40.88 0.2 Allowed Glycine 0 CA--C 1.533 1.215 0 C-N-CA 125.459 1.504 . . . . 0.0 113.896 -178.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 4.8 mp -134.56 179.46 6.27 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.605 1.562 . . . . 0.0 110.874 178.328 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 5.8 mtt180 -136.88 142.11 42.77 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.709 1.204 . . . . 0.0 109.028 174.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 3.5 ttt -134.75 145.57 48.56 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 121.076 -1.015 . . . . 0.0 108.692 175.411 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 4.9 tptt -124.59 147.93 48.17 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 127.12 2.168 . . . . 0.0 111.172 178.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -150.24 147.81 18.37 Favored Glycine 0 CA--C 1.528 0.848 0 O-C-N 121.458 -0.776 . . . . 0.0 112.872 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.475 HD13 ' H ' ' A' ' 146' ' ' GLY . 4.8 tp -146.59 124.94 4.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 124.943 1.297 . . . . 0.0 110.42 179.281 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -151.32 156.01 39.9 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.933 2.093 . . . . 0.0 107.412 174.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' THR . . . . . 0.496 HG23 ' HB3' ' A' ' 168' ' ' ALA . 0.1 OUTLIER -150.51 132.42 15.12 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.199 1.4 . . . . 0.0 107.923 174.952 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -105.5 32.75 4.08 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.342 1.057 . . . . 0.0 112.127 -176.271 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -116.3 -71.42 0.74 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.341 1.056 . . . . 0.0 112.583 -175.019 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -77.29 14.07 9.27 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 125.974 1.749 . . . . 0.0 111.384 175.031 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 56.28 56.14 6.05 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 127.551 2.34 . . . . 0.0 112.063 176.278 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.496 ' HB3' HG23 ' A' ' 163' ' ' THR . . . -78.54 -170.71 2.18 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 113.779 -1.555 . . . . 0.0 112.857 178.087 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' LYS . . . . . 0.402 ' H ' ' HD3' ' A' ' 169' ' ' LYS . 0.0 OUTLIER -116.3 165.97 12.58 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 128.665 2.786 . . . . 0.0 111.435 -178.571 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 17.9 ttp -95.59 136.88 35.42 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.732 1.213 . . . . 0.0 111.527 179.345 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -144.82 119.27 9.65 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.251 1.02 . . . . 0.0 110.329 176.137 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 1.9 mp -114.31 120.79 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 124.905 1.282 . . . . 0.0 108.158 175.037 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.435 ' HE2' ' O ' ' A' ' 174' ' ' ILE . 0.0 OUTLIER -121.54 127.31 50.85 Favored 'General case' 0 CA--C 1.51 -0.574 0 C-N-CA 126.447 1.899 . . . . 0.0 108.88 -179.224 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.435 ' O ' ' HE2' ' A' ' 173' ' ' LYS . 1.3 mp -79.0 117.83 25.31 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 O-C-N 121.141 -0.975 . . . . 0.0 111.957 177.373 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 6.1 t -84.67 172.63 11.39 Favored 'General case' 0 N--CA 1.479 1.005 0 O-C-N 120.864 -1.147 . . . . 0.0 109.88 175.058 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 1.1 mtt-85 . . . . . 0 C--O 1.251 1.147 0 O-C-N 120.432 -1.417 . . . . 0.0 114.418 174.942 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.739 HD12 ' H ' ' A' ' 74' ' ' GLY . 2.2 mt . . . . . 0 N--CA 1.48 1.064 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -116.29 130.07 56.59 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 127.366 2.266 . . . . 0.0 110.361 -176.281 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -85.65 -96.04 0.76 Allowed Glycine 0 CA--C 1.531 1.087 0 C-N-CA 123.929 0.776 . . . . 0.0 112.865 -178.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 36.1 p -120.93 170.02 9.89 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.965 1.706 . . . . 0.0 111.764 -179.094 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -129.65 18.68 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 125.928 1.691 . . . . 0.0 111.712 177.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 pt -56.9 171.62 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 O-C-N 120.367 -1.458 . . . . 0.0 112.258 176.364 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -43.02 126.96 4.06 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.331 1.452 . . . . 0.0 113.335 -174.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -54.5 -23.3 27.12 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 125.229 1.395 . . . . 0.0 114.292 -177.113 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.14 -29.06 70.08 Favored 'General case' 0 CA--C 1.548 0.894 0 O-C-N 121.678 -0.895 . . . . 0.0 111.99 175.213 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.0 t -101.99 -40.11 7.02 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.956 1.702 . . . . 0.0 112.064 175.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 12.8 tp -73.44 90.11 1.69 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.265 1.026 . . . . 0.0 110.567 175.013 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.9 p -125.9 -178.95 4.46 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.918 2.087 . . . . 0.0 111.634 178.555 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -48.26 -38.82 19.62 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.801 1.641 . . . . 0.0 113.289 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -55.06 -40.53 70.4 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 118.685 0.675 . . . . 0.0 112.497 176.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.416 ' O ' HG23 ' A' ' 21' ' ' VAL . 96.2 t -70.05 -39.77 77.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.301 1.44 . . . . 0.0 110.804 174.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 28.1 mt -65.49 -43.75 89.2 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.166 -0.959 . . . . 0.0 111.419 179.142 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.408 ' HA ' HD12 ' A' ' 22' ' ' LEU . 24.7 t0 -57.22 -51.41 69.44 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.222 1.409 . . . . 0.0 110.716 178.773 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.76 -36.86 84.76 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 118.03 -0.986 . . . . 0.0 112.846 175.007 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 17' ' ' VAL . 17.7 t -55.42 -47.07 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 CA-C-N 119.864 1.211 . . . . 0.0 110.996 -179.532 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.581 HD11 ' HB3' ' A' ' 169' ' ' LYS . 1.9 mt -55.63 -24.66 34.68 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.067 0.947 . . . . 0.0 113.069 177.641 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -88.2 -61.66 1.47 Allowed Glycine 0 CA--C 1.532 1.097 0 C-N-CA 125.986 1.755 . . . . 0.0 112.633 176.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -62.87 -39.08 93.33 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 118.533 1.167 . . . . 0.0 113.768 -178.396 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -90.41 1.18 56.87 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.872 1.269 . . . . 0.0 112.124 175.023 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -52.91 96.9 0.02 OUTLIER Glycine 0 CA--C 1.537 1.455 0 C-N-CA 127.047 2.261 . . . . 0.0 114.366 178.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -87.3 -79.93 0.27 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.596 1.558 . . . . 0.0 111.947 178.316 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 23.8 m -87.51 173.07 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.564 1.546 . . . . 0.0 111.793 -177.369 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 58.0 m -63.29 -26.65 68.87 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 175.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.04 96.49 4.06 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.421 1.088 . . . . 0.0 112.236 176.775 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.415 ' HE2' ' HB3' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -111.32 155.04 23.66 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 128.551 2.74 . . . . 0.0 111.558 -179.71 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -128.21 133.01 67.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 126.328 1.851 . . . . 0.0 108.689 174.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.59 105.69 5.71 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.13 1.772 . . . . 0.0 109.357 175.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.727 HG22 ' HB2' ' A' ' 72' ' ' TYR . 2.0 m -111.28 151.58 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 123.203 0.601 . . . . 0.0 111.13 179.238 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -123.97 111.68 1.68 Allowed Glycine 0 CA--C 1.523 0.567 0 C-N-CA 124.088 0.851 . . . . 0.0 112.912 179.087 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.5 mp -104.59 134.55 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-N 119.018 1.409 . . . . 0.0 110.981 176.477 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -102.06 102.47 12.97 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 124.714 1.206 . . . . 0.0 110.51 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.9 t30 -73.73 92.47 2.0 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.963 1.305 . . . . 0.0 110.825 175.011 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -121.29 13.05 11.06 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.723 1.209 . . . . 0.0 112.212 175.103 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.8 t -61.81 -42.3 98.85 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.932 1.693 . . . . 0.0 113.87 -176.029 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 130.88 32.48 0.51 Allowed Glycine 0 CA--C 1.533 1.173 0 N-CA-C 115.11 0.804 . . . . 0.0 115.11 178.406 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -178.09 162.19 29.58 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 118.061 0.931 . . . . 0.0 112.852 175.053 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.716 HG22 ' HA ' ' A' ' 65' ' ' PRO . 80.6 p -68.23 129.75 40.86 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 121.858 -0.789 . . . . 0.0 110.999 175.002 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 42.2 m0 -87.04 107.5 18.46 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 123.813 0.845 . . . . 0.0 110.07 179.182 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 92.9 m -91.44 128.72 37.38 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.206 1.002 . . . . 0.0 109.747 177.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.86 131.42 48.71 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 122.823 0.449 . . . . 0.0 111.513 174.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.453 HD11 ' HB3' ' A' ' 90' ' ' ALA . 2.9 pp -113.74 -52.03 2.77 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.729 1.211 . . . . 0.0 111.616 179.719 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -171.73 145.74 2.01 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.343 1.857 . . . . 0.0 110.419 179.053 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.512 ' HB2' HD12 ' A' ' 60' ' ' LEU . . . -125.09 164.32 20.47 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.721 1.208 . . . . 0.0 110.837 174.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -141.9 102.02 4.06 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.157 1.383 . . . . 0.0 111.778 179.084 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.567 ' CE1' ' HB1' ' A' ' 87' ' ' ALA . 3.3 m-85 -110.67 123.91 50.91 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.457 1.103 . . . . 0.0 110.211 -178.283 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.77 -47.1 2.9 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -175.16 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.442 ' HB3' ' HB ' ' A' ' 86' ' ' VAL . 11.6 t -103.5 -48.14 4.06 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.135 1.374 . . . . 0.0 111.038 175.026 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -75.64 12.59 7.85 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 125.393 1.473 . . . . 0.0 114.564 -175.496 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 54.8 p -30.38 105.53 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 129.239 3.016 . . . . 0.0 113.961 -175.286 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.62 HG21 HG23 ' A' ' 59' ' ' ILE . 2.4 t -118.22 175.71 5.57 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.726 1.211 . . . . 0.0 112.171 -175.265 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -74.52 -55.45 5.93 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.516 1.126 . . . . 0.0 112.585 175.249 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.4 p -147.59 143.11 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 126.139 1.776 . . . . 0.0 110.893 175.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.62 HG23 HG21 ' A' ' 56' ' ' THR . 1.3 pp -143.21 -34.01 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 125.779 1.632 . . . . 0.0 113.947 179.045 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.539 ' H ' HD12 ' A' ' 59' ' ' ILE . 7.3 mt -89.66 98.11 1.21 Allowed Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 125.267 1.427 . . . . 0.0 109.135 175.533 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -66.03 148.62 85.83 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 123.887 3.058 . . . . 0.0 110.669 174.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -46.78 -51.15 17.0 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.834 1.254 . . . . 0.0 113.342 -177.534 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 63.2 t -149.31 139.88 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 128.026 2.531 . . . . 0.0 108.699 177.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.551 HG21 HD23 ' A' ' 70' ' ' LEU . 60.3 t -120.04 125.42 27.34 Favored Pre-proline 0 N--CA 1.473 0.683 0 C-N-CA 124.442 1.097 . . . . 0.0 108.457 175.029 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.716 ' HA ' HG22 ' A' ' 43' ' ' THR . 58.4 Cg_endo -64.45 151.64 84.75 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 121.934 1.756 . . . . 0.0 112.898 175.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -71.52 170.65 12.9 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.549 0.74 . . . . 0.0 109.254 174.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . 0.272 2.7 t 53.67 23.31 3.56 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.612 1.565 . . . . 0.0 113.817 -175.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.3 mttt -134.93 172.93 12.3 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.375 1.87 . . . . 0.0 111.645 -179.031 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -129.43 164.46 23.61 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 -178.062 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.551 HD23 HG21 ' A' ' 64' ' ' VAL . 3.2 pp -137.08 171.14 14.94 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 123.983 0.913 . . . . 0.0 111.078 -175.367 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.496 HD13 ' O ' ' A' ' 34' ' ' VAL . 0.8 OUTLIER -123.44 153.69 40.1 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.497 1.119 . . . . 0.0 111.035 177.033 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.727 ' HB2' HG22 ' A' ' 34' ' ' VAL . 5.8 m-85 -129.46 134.94 48.07 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 126.176 1.791 . . . . 0.0 109.377 176.54 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 59.6 p -107.7 153.87 22.3 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.145 1.778 . . . . 0.0 111.019 175.534 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.739 ' H ' HD12 ' A' ' 3' ' ' LEU . . . -176.8 131.93 1.94 Allowed Glycine 0 CA--C 1.518 0.257 0 O-C-N 121.196 -0.94 . . . . 0.0 113.017 175.312 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 9.2 ptt85 -129.46 155.16 46.17 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 125.767 1.627 . . . . 0.0 110.491 -175.07 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.9 ptpt . . . . . 0 CA--C 1.543 0.708 0 C-N-CA 125.509 1.524 . . . . 0.0 112.886 174.947 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 17.8 p . . . . . 0 CA--C 1.537 0.462 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -52.62 -81.38 0.06 OUTLIER Glycine 0 CA--C 1.537 1.411 0 C-N-CA 126.337 1.922 . . . . 0.0 114.021 -175.059 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -160.4 112.86 2.01 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.298 1.439 . . . . 0.0 111.077 175.018 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.442 ' HB ' ' HB3' ' A' ' 53' ' ' SER . 5.0 t -139.16 125.53 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.471 1.109 . . . . 0.0 110.665 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.567 ' HB1' ' CE1' ' A' ' 51' ' ' PHE . . . -161.57 165.62 28.18 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 122.701 1.239 . . . . 0.0 112.063 177.694 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -149.22 146.22 27.5 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 124.913 1.285 . . . . 0.0 108.99 174.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.507 ' CD2' ' CE2' ' A' ' 72' ' ' TYR . 48.8 p90 -144.02 172.72 12.49 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 121.236 -0.915 . . . . 0.0 110.03 176.548 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.453 ' HB3' HD11 ' A' ' 47' ' ' LEU . . . -138.43 149.04 45.08 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 175.754 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -125.41 140.15 53.04 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.632 1.173 . . . . 0.0 113.123 178.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -87.44 122.16 30.81 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.873 -175.565 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 31.8 mtm -101.73 128.14 48.19 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.495 1.118 . . . . 0.0 110.742 -176.613 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.4 t -56.26 -22.41 29.79 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.936 1.294 . . . . 0.0 113.493 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -67.05 -9.96 44.78 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 125.941 1.696 . . . . 0.0 113.154 175.011 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 101.52 28.3 6.78 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.754 1.645 . . . . 0.0 114.366 177.257 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.43 ' HA ' ' H ' ' A' ' 123' ' ' GLY . 29.0 m-80 -135.44 175.18 9.82 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.857 1.263 . . . . 0.0 112.558 -174.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.575 HG21 ' O ' ' A' ' 125' ' ' ARG . 38.3 m -130.31 108.69 10.2 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.353 1.061 . . . . 0.0 112.683 177.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.5 tt -69.89 94.24 0.82 Allowed 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 127.151 2.18 . . . . 0.0 111.999 177.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -87.21 96.18 2.14 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 125.568 1.556 . . . . 0.0 113.595 178.311 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.411 HG11 ' CZ ' ' A' ' 89' ' ' PHE . 55.5 t -78.07 138.59 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 124.718 1.207 . . . . 0.0 110.827 174.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.33 128.22 31.33 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.581 1.552 . . . . 0.0 110.303 179.156 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.531 ' CZ ' ' HB3' ' A' ' 87' ' ' ALA . 10.3 p90 -148.08 120.31 8.36 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.008 1.323 . . . . 0.0 111.465 -177.779 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 39.6 t -140.82 129.96 23.48 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.531 1.133 . . . . 0.0 110.22 -175.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.6 m . . . . . 0 N--CA 1.471 0.604 0 C-N-CA 124.147 0.979 . . . . 0.0 110.848 178.35 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.473 0.697 0 N-CA-C 110.357 -0.238 . . . . 0.0 110.357 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -132.95 82.61 2.01 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.25 1.42 . . . . 0.0 112.286 -177.102 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 21.1 m0 -92.67 162.26 14.23 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 121.441 -0.787 . . . . 0.0 111.843 -175.131 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 40.2 p-90 -160.53 132.38 5.96 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 121.561 -0.712 . . . . 0.0 111.24 -176.388 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -145.87 173.55 12.03 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 121.3 -0.875 . . . . 0.0 111.744 178.781 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 98.5 t -137.69 133.18 45.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 175.186 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.59 168.2 12.94 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 125.584 1.554 . . . . 0.0 110.244 175.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.693 HD11 HD13 ' A' ' 152' ' ' LEU . 32.3 mt -135.87 121.74 30.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 175.001 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -83.81 145.42 47.03 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 123.311 0.644 . . . . 0.0 111.289 178.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -76.23 83.74 1.96 Allowed 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 124.133 3.222 . . . . 0.0 111.929 179.15 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.43 ' H ' ' HA ' ' A' ' 97' ' ' ASN . . . 101.45 175.53 28.61 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 126.494 1.997 . . . . 0.0 112.811 -177.439 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 1.3 mttt -45.01 106.67 0.08 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 126.47 1.908 . . . . 0.0 112.737 -176.372 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.575 ' O ' HG21 ' A' ' 98' ' ' THR . 7.9 tpt180 -141.37 138.21 32.87 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.48 1.112 . . . . 0.0 113.402 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -80.4 173.69 12.35 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.722 0.809 . . . . 0.0 110.729 174.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -117.01 104.86 11.69 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.149 1.779 . . . . 0.0 107.028 175.034 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -108.0 169.94 8.3 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.385 1.074 . . . . 0.0 111.831 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -53.38 -45.83 69.39 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.535 0.734 . . . . 0.0 112.827 177.567 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -54.58 -56.05 24.1 Favored Glycine 0 N--CA 1.469 0.836 0 CA-C-O 119.38 -0.678 . . . . 0.0 112.239 176.604 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 4.1 mpp? -63.76 -33.65 76.12 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 118.533 1.167 . . . . 0.0 113.376 176.083 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -61.39 -61.56 2.45 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 119.642 1.11 . . . . 0.0 108.958 175.013 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -62.45 -43.86 97.81 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.178 0.991 . . . . 0.0 112.526 -176.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -62.81 -45.67 91.57 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.626 1.17 . . . . 0.0 111.711 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.23 -33.33 59.22 Favored 'General case' 0 CA--C 1.547 0.829 0 O-C-N 120.468 -1.395 . . . . 0.0 112.752 176.625 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -54.2 -60.38 3.41 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 126.587 1.955 . . . . 0.0 109.758 175.077 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -72.65 4.45 3.97 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-O 121.726 0.774 . . . . 0.0 112.596 -176.394 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -101.57 -7.75 47.75 Favored Glycine 0 CA--C 1.541 1.678 0 C-N-CA 126.964 2.221 . . . . 0.0 114.975 175.118 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -144.06 88.61 7.45 Favored Pre-proline 0 CA--C 1.553 1.059 0 CA-C-N 119.897 1.849 . . . . 0.0 113.268 -178.272 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -73.51 81.36 1.82 Allowed 'Trans proline' 0 CA--C 1.545 1.056 0 C-N-CA 124.096 3.197 . . . . 0.0 113.024 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -104.22 9.95 35.89 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.894 1.277 . . . . 0.0 114.337 -178.026 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 28.4 ptt85 -29.97 119.93 0.17 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 129.03 2.932 . . . . 0.0 115.728 175.039 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 39.25 68.4 0.5 Allowed Glycine 0 N--CA 1.468 0.804 0 C-N-CA 126.31 1.909 . . . . 0.0 112.151 -175.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.91 -24.4 37.41 Favored 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -174.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . 0.267 0.2 OUTLIER 13.93 72.18 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 130.766 3.626 . . . . 0.0 116.349 177.959 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 154.39 42.79 0.02 OUTLIER Glycine 0 CA--C 1.532 1.118 0 C-N-CA 123.865 0.745 . . . . 0.0 114.576 178.246 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' TRP . . . . . 0.834 ' H ' HD13 ' A' ' 161' ' ' ILE . 0.1 OUTLIER 49.79 48.55 21.51 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 125.434 1.494 . . . . 0.0 113.035 -176.836 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -91.31 134.27 34.73 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 122.325 1.059 . . . . 0.0 113.026 -174.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -156.52 -177.19 6.41 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.067 0.947 . . . . 0.0 112.884 -174.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 21.1 ttpp -131.97 148.13 52.5 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.753 1.221 . . . . 0.0 110.905 174.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -63.75 149.53 46.56 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 175.001 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.693 HD13 HD11 ' A' ' 120' ' ' ILE . 98.7 mt -107.9 145.26 34.01 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 175.005 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -64.48 -165.67 1.02 Allowed Glycine 0 CA--C 1.538 1.47 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 175.31 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 54.5 11.2 0.4 Allowed 'General case' 0 CA--C 1.557 1.242 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 175.27 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 81.33 40.9 10.62 Favored Glycine 0 CA--C 1.539 1.562 0 C-N-CA 126.557 2.027 . . . . 0.0 114.424 -175.007 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.2 mp -124.82 162.19 24.85 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 119.267 1.533 . . . . 0.0 112.813 -178.459 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -150.63 118.48 6.21 Favored 'General case' 0 N--CA 1.482 1.128 0 O-C-N 120.691 -1.256 . . . . 0.0 111.594 176.007 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 6.6 ttp -111.3 130.85 55.54 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 118.108 -0.949 . . . . 0.0 109.093 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 6.3 tppt? -106.9 134.14 50.5 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 127.681 2.393 . . . . 0.0 110.089 -179.211 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -136.41 152.31 21.14 Favored Glycine 0 N--CA 1.476 1.34 0 CA-C-N 121.208 1.822 . . . . 0.0 115.79 179.498 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.834 HD13 ' H ' ' A' ' 147' ' ' TRP . 6.1 tp -148.66 122.42 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 125.134 1.374 . . . . 0.0 113.332 -177.712 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 5.3 ttp -153.61 145.37 23.43 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 128.968 2.907 . . . . 0.0 109.589 177.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 9.6 t -120.22 146.3 46.18 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 120.87 -1.144 . . . . 0.0 109.778 175.366 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 28.8 p -91.34 18.96 6.45 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.305 1.442 . . . . 0.0 113.29 -178.371 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.8 -33.73 64.66 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.012 1.725 . . . . 0.0 115.005 -176.335 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 157.8 -62.76 0.32 Allowed Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.534 1.064 . . . . 0.0 114.17 176.27 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -125.25 27.02 6.73 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 125.652 1.581 . . . . 0.0 112.656 -174.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.87 175.66 2.37 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.28 1.432 . . . . 0.0 113.388 175.008 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' LYS . . . . . 0.581 ' HB3' HD11 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -115.78 178.81 4.17 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 127.453 2.301 . . . . 0.0 111.914 -177.814 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 40.2 ttp -126.89 137.89 53.22 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 125.381 1.473 . . . . 0.0 109.825 178.62 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.404 ' C ' HD12 ' A' ' 172' ' ' ILE . 5.8 tt0 -143.08 131.9 22.72 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 121.562 -0.711 . . . . 0.0 109.657 174.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.404 HD12 ' C ' ' A' ' 171' ' ' GLN . 3.8 mp -129.79 120.87 51.12 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.296 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 176.401 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -115.82 129.91 56.63 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 125.232 1.413 . . . . 0.0 111.125 177.833 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.8 mp -78.94 131.84 33.5 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 O-C-N 121.064 -1.023 . . . . 0.0 109.398 174.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 13.8 m -137.66 94.03 2.86 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.497 1.519 . . . . 0.0 113.116 176.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 79.0 mtp180 . . . . . 0 C--O 1.253 1.272 0 C-N-CA 125.544 1.538 . . . . 0.0 112.433 174.972 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.652 HD11 ' HB2' ' A' ' 31' ' ' LYS . 17.1 tp . . . . . 0 N--CA 1.483 1.182 0 CA-C-O 123.046 1.403 . . . . 0.0 114.45 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -136.53 130.27 32.19 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 128.037 2.535 . . . . 0.0 107.087 176.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.406 ' H ' ' HG ' ' A' ' 71' ' ' LEU . . . -73.08 -126.49 0.1 OUTLIER Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.171 0.891 . . . . 0.0 111.2 174.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 25.4 p -101.95 174.64 5.85 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.389 1.076 . . . . 0.0 111.413 177.095 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -124.65 16.07 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 125.498 1.519 . . . . 0.0 110.971 175.007 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.9 pp -55.05 165.57 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 125.352 1.461 . . . . 0.0 112.111 174.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -40.99 130.16 2.66 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.727 1.611 . . . . 0.0 113.246 -174.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -54.77 -21.14 21.55 Favored Glycine 0 N--CA 1.472 1.097 0 C-N-CA 124.766 1.174 . . . . 0.0 114.456 -177.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.75 -31.87 68.73 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.65 1.18 . . . . 0.0 111.306 174.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.63 -43.24 5.42 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.392 1.477 . . . . 0.0 111.602 174.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.427 HD23 ' HB3' ' A' ' 69' ' ' ALA . 14.3 tp -71.26 94.22 1.17 Allowed 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.902 0.858 . . . . 0.0 110.849 174.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.0 p -131.42 -179.92 5.65 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 126.982 2.113 . . . . 0.0 111.899 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -46.91 -39.99 13.28 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.55 1.54 . . . . 0.0 113.051 177.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -54.85 -39.51 68.68 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.448 1.099 . . . . 0.0 112.077 177.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.4 ' O ' HG23 ' A' ' 21' ' ' VAL . 65.2 t -70.45 -36.92 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 125.862 1.665 . . . . 0.0 111.182 174.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.408 ' CD2' HD21 ' A' ' 71' ' ' LEU . 9.2 mt -71.1 -43.13 68.31 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 120.965 -1.084 . . . . 0.0 111.249 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -58.34 -47.06 84.97 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.459 1.104 . . . . 0.0 111.308 178.468 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.68 -37.71 82.71 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 118.15 -0.929 . . . . 0.0 111.953 175.069 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 17' ' ' VAL . 16.2 t -54.36 -42.47 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 CA-C-N 119.923 1.238 . . . . 0.0 111.26 179.091 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.6 mt -58.65 -17.33 21.47 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.397 1.079 . . . . 0.0 113.845 177.201 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -105.38 -45.05 1.38 Allowed Glycine 0 CA--C 1.536 1.395 0 C-N-CA 126.992 2.234 . . . . 0.0 114.05 -179.474 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -67.82 -31.82 71.93 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 119.134 1.467 . . . . 0.0 112.725 175.029 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -101.66 173.33 6.46 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 125.181 1.392 . . . . 0.0 111.049 174.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 154.02 86.72 0.06 OUTLIER Glycine 0 CA--C 1.534 1.252 0 C-N-CA 124.332 0.967 . . . . 0.0 113.827 -178.53 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.5 mtpt -67.9 -46.11 72.52 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.714 1.206 . . . . 0.0 112.966 176.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 33.4 m -133.64 -176.96 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 126.799 2.04 . . . . 0.0 111.596 -178.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.9 m -47.28 -46.44 24.82 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 126.436 1.894 . . . . 0.0 115.123 -178.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.429 ' CB ' ' HE3' ' A' ' 76' ' ' LYS . 0.1 OUTLIER -128.91 146.02 51.06 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.534 1.133 . . . . 0.0 110.541 174.963 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.652 ' HB2' HD11 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -143.81 161.18 39.29 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 124.466 1.106 . . . . 0.0 111.62 -175.855 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.428 HD12 ' CG1' ' A' ' 34' ' ' VAL . 0.3 OUTLIER -120.08 133.28 67.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 124.78 1.232 . . . . 0.0 108.999 175.007 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -136.0 100.93 4.57 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.131 1.772 . . . . 0.0 109.065 175.01 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.91 HG22 ' HB2' ' A' ' 72' ' ' TYR . 1.5 m -103.97 161.44 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 123.859 0.864 . . . . 0.0 111.728 178.687 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -140.62 101.05 0.28 Allowed Glycine 0 N--CA 1.461 0.361 0 C-N-CA 123.613 0.625 . . . . 0.0 113.156 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 mp -93.98 151.11 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 117.91 0.855 . . . . 0.0 110.761 175.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -116.42 104.43 11.44 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.327 1.051 . . . . 0.0 110.822 174.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -72.62 98.84 2.42 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.743 1.617 . . . . 0.0 111.05 174.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -135.31 22.63 3.45 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.971 1.309 . . . . 0.0 110.444 174.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 33.1 t -61.79 -42.69 99.31 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 120.788 -1.195 . . . . 0.0 112.749 174.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 132.35 33.97 0.38 Allowed Glycine 0 CA--C 1.534 1.244 0 C-N-CA 124.375 0.988 . . . . 0.0 115.181 176.735 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -174.52 162.28 32.4 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 124.673 1.13 . . . . 0.0 112.094 175.235 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.711 HG22 ' HA ' ' A' ' 65' ' ' PRO . 50.4 p -70.42 139.32 51.79 Favored 'General case' 0 C--O 1.234 0.261 0 O-C-N 121.782 -0.834 . . . . 0.0 110.893 174.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.43 ' HB3' ' CD1' ' A' ' 91' ' ' TYR . 40.2 m0 -96.05 104.14 16.07 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 124.172 0.989 . . . . 0.0 110.767 -178.511 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.9 m -87.36 139.29 30.7 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.019 1.328 . . . . 0.0 110.539 178.401 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.74 131.44 48.9 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.456 0.702 . . . . 0.0 111.249 174.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.701 HD11 ' HB3' ' A' ' 90' ' ' ALA . 4.6 pp -120.2 -48.36 2.33 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.029 0.931 . . . . 0.0 112.854 177.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.502 ' N ' HD12 ' A' ' 47' ' ' LEU . 0.2 OUTLIER 178.36 153.88 0.35 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 127.189 2.196 . . . . 0.0 110.378 -175.167 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -138.67 164.78 28.64 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.497 1.519 . . . . 0.0 111.215 174.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -136.7 102.87 5.03 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 125.309 1.443 . . . . 0.0 110.092 176.743 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.549 ' CE1' ' HB1' ' A' ' 87' ' ' ALA . 3.0 m-85 -111.03 131.43 55.06 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.719 0.808 . . . . 0.0 109.962 -179.275 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.38 -33.16 4.16 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -177.551 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 33.9 t -125.43 -46.62 1.75 Allowed 'General case' 0 C--O 1.219 -0.541 0 C-N-CA 124.961 1.304 . . . . 0.0 109.202 174.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -60.35 -0.15 1.14 Allowed Glycine 0 CA--C 1.544 1.868 0 O-C-N 119.586 -1.946 . . . . 0.0 116.449 176.658 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.1 p -27.15 89.01 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 130.97 3.708 . . . . 0.0 114.564 -175.043 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.676 HG21 HG23 ' A' ' 59' ' ' ILE . 0.7 OUTLIER -105.28 175.2 5.57 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.928 -174.911 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -73.17 -56.16 5.49 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.388 1.075 . . . . 0.0 111.127 174.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.4 p -144.44 137.69 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 125.806 1.643 . . . . 0.0 112.021 176.719 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.676 HG23 HG21 ' A' ' 56' ' ' THR . 1.2 pp -135.82 -33.58 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 125.885 1.674 . . . . 0.0 114.298 176.5 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.415 ' H ' HD12 ' A' ' 59' ' ' ILE . 16.0 mt -89.09 100.32 2.09 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 125.312 1.445 . . . . 0.0 109.34 176.806 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.506 ' HG2' HG23 ' A' ' 64' ' ' VAL . 90.8 Cg_endo -65.43 154.64 72.72 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.38 2.72 . . . . 0.0 109.27 175.06 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -45.02 -50.98 10.44 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.504 1.522 . . . . 0.0 113.415 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.7 p -160.17 137.77 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 127.053 2.141 . . . . 0.0 109.612 176.182 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.635 HG21 HD13 ' A' ' 70' ' ' LEU . 94.6 t -113.56 130.75 23.44 Favored Pre-proline 0 N--CA 1.482 1.128 0 C-N-CA 124.495 1.118 . . . . 0.0 109.311 175.162 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.711 ' HA ' HG22 ' A' ' 43' ' ' THR . 59.9 Cg_endo -65.37 161.65 37.01 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 122.469 2.112 . . . . 0.0 112.801 177.71 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -76.69 170.51 16.3 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.83 0.852 . . . . 0.0 109.897 174.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . 0.266 10.7 t 46.95 30.55 1.27 Allowed 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 126.892 2.077 . . . . 0.0 113.376 -174.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.9 mttt -135.78 171.94 13.73 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 127.262 2.225 . . . . 0.0 111.821 -174.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.427 ' HB3' HD23 ' A' ' 13' ' ' LEU . . . -128.63 166.08 19.57 Favored 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 122.77 0.428 . . . . 0.0 110.245 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.635 HD13 HG21 ' A' ' 64' ' ' VAL . 2.0 pt? -143.78 171.07 14.72 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 124.617 1.167 . . . . 0.0 111.656 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.536 HD13 ' O ' ' A' ' 34' ' ' VAL . 0.6 OUTLIER -117.66 156.1 28.76 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.442 1.097 . . . . 0.0 112.503 177.566 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.91 ' HB2' HG22 ' A' ' 34' ' ' VAL . 7.5 m-85 -128.03 134.39 49.21 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.72 1.608 . . . . 0.0 109.103 174.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.1 p -108.08 142.76 37.78 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 126.831 2.053 . . . . 0.0 110.741 176.327 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -163.79 142.68 8.0 Favored Glycine 0 N--CA 1.461 0.326 0 O-C-N 120.514 -1.366 . . . . 0.0 111.898 174.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 3.8 ptm180 -129.26 104.33 7.46 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.289 1.436 . . . . 0.0 111.353 -174.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.515 ' HE2' ' O ' ' A' ' 83' ' ' THR . 2.6 ptpt . . . . . 0 N--CA 1.474 0.731 0 C-N-CA 127.492 2.317 . . . . 0.0 114.597 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.515 ' O ' ' HE2' ' A' ' 76' ' ' LYS . 3.7 m . . . . . 0 N--CA 1.487 1.386 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.479 ' H ' HG22 ' A' ' 83' ' ' THR . . . -78.65 -154.27 7.58 Favored Glycine 0 N--CA 1.47 0.934 0 O-C-N 119.741 -1.849 . . . . 0.0 113.323 176.735 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.566 ' HB3' HG22 ' A' ' 105' ' ' VAL . . . -94.7 97.98 10.46 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.081 -1.247 . . . . 0.0 110.526 -179.387 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.9 t -124.76 107.15 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 124.299 1.04 . . . . 0.0 110.578 -175.438 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.549 ' HB1' ' CE1' ' A' ' 51' ' ' PHE . . . -159.94 167.57 27.68 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.867 0.842 . . . . 0.0 111.494 178.532 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -150.86 159.8 44.31 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.758 1.223 . . . . 0.0 109.937 175.005 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.476 ' CD2' ' CE2' ' A' ' 72' ' ' TYR . 52.9 p90 -155.78 174.55 15.14 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 121.422 -0.799 . . . . 0.0 110.554 175.028 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.701 ' HB3' HD11 ' A' ' 47' ' ' LEU . . . -138.65 151.34 47.13 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 176.412 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.43 ' CD1' ' HB3' ' A' ' 44' ' ' TRP . 10.4 m-85 -126.3 140.11 52.78 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.38 1.072 . . . . 0.0 113.789 179.164 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -84.59 118.73 24.53 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 111.592 0.219 . . . . 0.0 111.592 -177.489 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 4.7 ttm -86.97 147.0 25.93 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.776 0.831 . . . . 0.0 112.31 177.563 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 24.6 m -67.1 -23.96 65.89 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 174.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -70.5 -17.39 62.96 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 175.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 100.71 40.13 3.0 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.845 1.212 . . . . 0.0 113.412 -175.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -135.5 175.1 9.9 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 118.382 1.091 . . . . 0.0 110.476 177.407 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.56 HG23 HD21 ' A' ' 47' ' ' LEU . 12.4 m -129.49 106.15 8.57 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.026 1.331 . . . . 0.0 111.946 -177.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.2 tt -70.79 96.35 1.24 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.699 1.6 . . . . 0.0 112.154 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -91.87 95.43 2.04 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 126.065 1.793 . . . . 0.0 113.876 -178.239 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 72.5 t -78.08 138.18 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 125.211 1.405 . . . . 0.0 111.444 176.446 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.6 126.54 29.43 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.367 1.467 . . . . 0.0 111.383 -178.359 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -146.64 121.79 10.15 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.0 1.32 . . . . 0.0 112.016 -177.113 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 47.1 t -142.45 109.73 5.63 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.657 1.183 . . . . 0.0 110.039 -178.493 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.566 HG22 ' HB3' ' A' ' 85' ' ' ALA . 17.5 m . . . . . 0 N--CA 1.469 0.523 0 C-N-CA 124.831 1.252 . . . . 0.0 108.365 175.003 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 45.1 p . . . . . 0 N--CA 1.475 0.781 0 CA-C-O 121.809 0.814 . . . . 0.0 112.24 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -121.87 101.53 7.62 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.132 1.773 . . . . 0.0 109.138 175.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 32.0 m0 -102.52 144.98 30.26 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.398 0.679 . . . . 0.0 109.94 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 27.4 p-90 -146.77 138.53 24.5 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.119 0.968 . . . . 0.0 111.978 -177.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -149.31 170.05 19.4 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 122.285 1.041 . . . . 0.0 113.072 179.115 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.3 t -150.27 139.31 15.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 C-N-CA 125.226 1.41 . . . . 0.0 107.655 175.008 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.79 175.44 10.18 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 126.27 1.828 . . . . 0.0 109.72 175.626 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.458 ' HB ' ' CE2' ' A' ' 154' ' ' TYR . 50.9 mt -130.56 105.74 11.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.953 0.882 . . . . 0.0 108.967 178.196 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -67.38 149.54 98.34 Favored Pre-proline 0 CA--C 1.546 0.793 0 O-C-N 121.522 -0.736 . . . . 0.0 111.842 178.653 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.6 131.73 17.8 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 123.212 2.608 . . . . 0.0 111.727 178.293 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 61.86 -165.99 18.75 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 124.549 1.071 . . . . 0.0 113.9 -176.693 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -67.89 110.78 4.0 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.654 1.182 . . . . 0.0 108.985 175.004 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 20.0 tpp180 -123.32 157.84 32.34 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.692 1.597 . . . . 0.0 110.066 178.221 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -96.99 -173.72 2.77 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.261 1.424 . . . . 0.0 110.397 174.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -138.58 121.45 16.55 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 127.317 2.247 . . . . 0.0 106.504 174.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -132.68 169.69 16.3 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.579 1.552 . . . . 0.0 110.016 175.156 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -52.71 -39.9 62.48 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.337 1.055 . . . . 0.0 113.086 176.386 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -59.03 -53.64 44.72 Favored Glycine 0 N--CA 1.469 0.853 0 CA-C-N 118.875 0.761 . . . . 0.0 112.094 176.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 1.2 mpp? -61.48 -42.97 99.6 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 118.036 0.918 . . . . 0.0 112.049 176.413 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -54.0 -58.44 7.29 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.381 0.672 . . . . 0.0 110.171 175.015 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -65.85 -38.07 87.87 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 -177.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -61.73 -45.3 94.53 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.55 1.14 . . . . 0.0 112.096 178.592 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 73.8 mmm -79.17 -32.59 44.29 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.351 -0.843 . . . . 0.0 112.879 176.656 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -54.08 -59.08 5.12 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.772 1.629 . . . . 0.0 109.511 174.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -71.24 -6.06 36.79 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -176.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -88.42 -9.27 69.78 Favored Glycine 0 CA--C 1.539 1.59 0 C-N-CA 126.292 1.901 . . . . 0.0 114.937 177.064 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -144.14 86.72 8.22 Favored Pre-proline 0 CA--C 1.553 1.058 0 CA-C-N 119.448 1.624 . . . . 0.0 111.89 -179.519 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -74.0 79.21 2.38 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 123.643 2.895 . . . . 0.0 112.274 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -119.07 126.21 51.14 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.287 1.435 . . . . 0.0 111.044 -176.793 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.1 ptt180 -99.17 -162.63 0.97 Allowed 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 127.285 2.234 . . . . 0.0 113.74 -175.534 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -71.95 62.27 1.31 Allowed Glycine 0 CA--C 1.538 1.471 0 C-N-CA 126.421 1.962 . . . . 0.0 113.72 175.292 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 10.1 p30 -67.49 74.99 0.16 Allowed 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 130.163 3.385 . . . . 0.0 114.796 177.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -70.29 62.83 0.23 Allowed 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 126.948 2.099 . . . . 0.0 114.875 -175.024 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -169.66 31.44 0.16 Allowed Glycine 0 CA--C 1.536 1.355 0 C-N-CA 124.536 1.065 . . . . 0.0 115.709 -175.461 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 5.1 m95 53.88 56.53 7.01 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.31 1.444 . . . . 0.0 113.154 -174.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -89.68 131.14 35.81 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.661 1.584 . . . . 0.0 112.613 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -160.12 -175.8 5.28 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -174.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 4.8 mtmt -130.19 160.38 33.99 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.159 1.384 . . . . 0.0 110.711 174.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -80.07 131.78 35.84 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.848 0.859 . . . . 0.0 108.918 175.01 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 78.2 mt -83.99 127.38 33.83 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.479 0.712 . . . . 0.0 110.599 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -51.74 -27.45 19.91 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 126.063 1.792 . . . . 0.0 116.49 -174.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.458 ' CE2' ' HB ' ' A' ' 120' ' ' ILE . 0.2 OUTLIER -74.95 6.88 3.63 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 128.076 2.55 . . . . 0.0 113.621 -179.459 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 84.58 10.58 79.24 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 125.602 1.572 . . . . 0.0 114.194 -175.01 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 17.5 mt -96.54 171.48 8.52 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.33 1.852 . . . . 0.0 110.475 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 3.4 mtt-85 -146.05 107.39 4.21 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 120.973 -1.08 . . . . 0.0 110.225 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 9.3 ttp -98.73 131.07 45.17 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 117.795 -1.098 . . . . 0.0 108.327 178.394 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 1.5 tppp? -109.44 129.41 55.55 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 127.915 2.486 . . . . 0.0 110.149 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -135.17 154.42 21.6 Favored Glycine 0 N--CA 1.474 1.197 0 CA-C-N 121.17 1.804 . . . . 0.0 115.562 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.31 129.42 6.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 C-N-CA 124.282 1.033 . . . . 0.0 112.402 -178.837 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -146.62 160.69 41.86 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 126.975 2.11 . . . . 0.0 109.554 175.001 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 9.4 t -131.38 168.76 17.03 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.589 1.155 . . . . 0.0 108.99 175.004 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 4.3 t -111.67 28.92 8.3 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.022 1.329 . . . . 0.0 111.414 178.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -67.65 21.76 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 127.77 2.428 . . . . 0.0 115.028 179.07 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 80.6 -59.51 4.65 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 126.641 2.067 . . . . 0.0 113.168 -178.299 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -116.39 65.36 0.71 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.072 1.749 . . . . 0.0 110.313 176.153 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.19 179.01 7.84 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 121.915 0.864 . . . . 0.0 111.708 174.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.3 176.84 5.64 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.456 1.902 . . . . 0.0 110.108 175.001 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 2.3 tmm? -125.51 125.59 43.5 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.918 1.287 . . . . 0.0 110.395 175.674 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 17.5 tt0 -138.11 124.59 20.72 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 123.772 0.829 . . . . 0.0 110.529 176.519 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 5.0 mp -132.66 119.71 39.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 123.974 0.91 . . . . 0.0 110.508 176.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.63 134.39 55.1 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.488 1.515 . . . . 0.0 111.939 177.606 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.8 mp -82.35 127.01 40.03 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 O-C-N 121.019 -1.05 . . . . 0.0 108.633 175.022 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 1.7 m -126.3 93.48 3.82 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.524 1.53 . . . . 0.0 111.499 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 80.0 mtm-85 . . . . . 0 C--O 1.253 1.27 0 C-N-CA 124.509 1.124 . . . . 0.0 113.214 176.528 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.81 HD12 ' H ' ' A' ' 74' ' ' GLY . 0.2 OUTLIER . . . . . 0 N--CA 1.483 1.204 0 CA-C-O 121.988 0.899 . . . . 0.0 111.999 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.41 ' HA ' HD12 ' A' ' 71' ' ' LEU . . . -144.58 121.2 11.12 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.856 2.062 . . . . 0.0 109.833 -175.538 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -73.91 -92.45 0.13 Allowed Glycine 0 CA--C 1.531 1.052 0 C-N-CA 123.988 0.804 . . . . 0.0 112.917 -176.283 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 41.0 p -141.4 173.61 11.33 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.544 1.538 . . . . 0.0 111.079 177.034 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -120.42 10.35 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 125.623 1.569 . . . . 0.0 112.213 -178.852 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -29.05 -77.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 127.627 2.371 . . . . 0.0 115.014 -176.481 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -158.2 147.55 19.51 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.56 1.944 . . . . 0.0 110.745 175.012 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -64.3 -26.96 70.96 Favored Glycine 0 N--CA 1.476 1.304 0 C-N-CA 124.592 1.091 . . . . 0.0 115.474 -178.182 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.43 -35.11 73.41 Favored 'General case' 0 CA--C 1.546 0.816 0 O-C-N 121.755 -0.85 . . . . 0.0 111.789 175.41 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.4 t -96.2 -37.89 10.36 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.082 1.353 . . . . 0.0 111.611 174.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.528 HD11 ' CD2' ' A' ' 71' ' ' LEU . 58.2 tp -82.77 84.41 7.35 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.651 1.981 . . . . 0.0 111.977 176.377 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.4 p -120.55 178.8 4.54 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 126.595 1.958 . . . . 0.0 111.396 175.047 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -40.14 -44.63 1.85 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.768 1.627 . . . . 0.0 113.474 175.196 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -52.92 -44.66 67.16 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 118.801 0.728 . . . . 0.0 112.154 178.074 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 93.1 t -64.54 -40.77 90.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 124.546 1.138 . . . . 0.0 111.135 175.034 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.475 ' CD2' HD21 ' A' ' 71' ' ' LEU . 39.4 mt -66.82 -38.12 85.83 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.355 -0.841 . . . . 0.0 111.593 178.849 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -68.16 -47.69 67.33 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 120.94 -1.1 . . . . 0.0 111.624 177.292 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.92 -37.51 87.29 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-O 118.594 -0.717 . . . . 0.0 111.495 175.045 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.445 HG22 ' HB2' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -62.84 -36.33 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 119.15 0.886 . . . . 0.0 111.159 -176.104 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.416 HD12 ' HB3' ' A' ' 33' ' ' ALA . 0.3 OUTLIER -56.28 -25.41 48.12 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 119.112 0.869 . . . . 0.0 112.413 175.076 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -81.87 -65.3 1.67 Allowed Glycine 0 CA--C 1.533 1.179 0 O-C-N 120.603 -1.311 . . . . 0.0 112.173 174.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -66.65 -35.6 80.55 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 115.149 1.537 . . . . 0.0 115.149 -175.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.445 ' HB2' HG22 ' A' ' 21' ' ' VAL . 3.3 mm? -106.42 104.77 14.54 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 126.76 2.024 . . . . 0.0 108.358 -177.13 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -161.59 135.4 3.91 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 125.243 1.401 . . . . 0.0 114.381 -175.02 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.2 mtpt -112.35 -45.99 3.22 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 126.437 1.895 . . . . 0.0 113.286 177.362 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 20.8 m -116.9 177.96 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 126.202 1.801 . . . . 0.0 110.929 -176.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.6 t -51.86 -49.46 62.86 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.896 1.279 . . . . 0.0 112.909 -175.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.9 mtt-85 -122.86 129.34 51.53 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.751 1.62 . . . . 0.0 110.527 174.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.603 ' HB2' HD13 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -118.38 157.45 27.14 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 126.12 1.768 . . . . 0.0 110.665 179.894 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.682 HG13 ' HB1' ' A' ' 85' ' ' ALA . 0.3 OUTLIER -118.25 130.78 72.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 175.045 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.416 ' HB3' HD12 ' A' ' 22' ' ' LEU . . . -134.77 99.44 4.32 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 126.75 2.02 . . . . 0.0 109.232 178.685 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.838 HG22 ' HB2' ' A' ' 72' ' ' TYR . 1.8 m -100.9 160.23 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-O 118.489 -0.767 . . . . 0.0 111.249 179.161 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -137.4 109.44 0.7 Allowed Glycine 0 N--CA 1.464 0.538 0 CA-C-N 119.112 0.869 . . . . 0.0 114.215 175.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.3 mp -100.66 145.57 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 CA-C-N 118.639 1.22 . . . . 0.0 110.722 176.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.419 ' HB3' ' HA ' ' A' ' 173' ' ' LYS . 24.7 t0 -108.55 105.86 15.68 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.905 1.282 . . . . 0.0 110.495 175.532 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -69.97 96.66 1.05 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.534 1.534 . . . . 0.0 111.222 175.052 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -126.56 3.43 6.85 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.26 1.824 . . . . 0.0 112.837 176.724 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.87 4.71 0.16 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 126.087 1.755 . . . . 0.0 115.663 177.086 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.01 61.96 4.28 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 125.977 1.751 . . . . 0.0 113.166 177.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 165.19 143.42 3.72 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 125.229 1.395 . . . . 0.0 111.079 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.753 HG22 ' HA ' ' A' ' 65' ' ' PRO . 31.9 p -67.15 142.57 57.0 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.682 0.753 . . . . 0.0 111.302 174.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.435 ' CZ2' ' CD2' ' A' ' 99' ' ' LEU . 48.6 m0 -101.97 102.66 13.22 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.627 1.171 . . . . 0.0 110.502 -179.477 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 28.0 m -90.27 128.63 36.46 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.01 0.924 . . . . 0.0 109.436 177.566 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.8 108.69 0.69 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.934 0.894 . . . . 0.0 112.429 175.282 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.545 HD12 ' HB3' ' A' ' 48' ' ' ASN . 3.1 pp -93.38 -45.7 7.68 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.637 0.775 . . . . 0.0 111.799 178.189 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.545 ' HB3' HD12 ' A' ' 47' ' ' LEU . 5.1 t30 -171.6 146.13 2.13 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 127.22 2.208 . . . . 0.0 110.294 179.254 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.673 ' HB2' HD22 ' A' ' 60' ' ' LEU . . . -134.99 151.27 50.67 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.346 1.458 . . . . 0.0 110.981 175.029 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -139.19 109.78 6.63 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.189 1.396 . . . . 0.0 112.013 -175.398 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.506 ' CD1' ' HB1' ' A' ' 87' ' ' ALA . 3.1 m-85 -106.66 127.75 53.62 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 120.991 -1.068 . . . . 0.0 111.142 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -88.76 -68.32 0.78 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.508 1.523 . . . . 0.0 111.178 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 32.5 t -107.46 -35.29 6.8 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.989 1.315 . . . . 0.0 112.16 -174.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -61.91 -26.41 67.16 Favored Glycine 0 CA--C 1.536 1.36 0 CA-C-O 118.831 -0.983 . . . . 0.0 114.02 177.024 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.5 p 21.14 55.13 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 128.046 2.538 . . . . 0.0 116.128 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.433 HG21 HG23 ' A' ' 59' ' ' ILE . 3.9 t -75.89 173.24 11.45 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.16 -175.676 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -82.21 -51.91 7.48 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.388 0.675 . . . . 0.0 112.084 176.177 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.5 p -148.18 135.82 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.08 1.352 . . . . 0.0 112.217 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.433 HG23 HG21 ' A' ' 56' ' ' THR . 1.0 OUTLIER -143.42 -32.09 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 126.059 1.744 . . . . 0.0 113.816 -175.595 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.673 HD22 ' HB2' ' A' ' 49' ' ' ALA . 1.0 OUTLIER -94.69 96.88 2.07 Favored Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 125.748 1.619 . . . . 0.0 109.256 177.823 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.44 ' HG2' HG23 ' A' ' 64' ' ' VAL . 77.6 Cg_endo -64.49 157.84 52.81 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.809 2.339 . . . . 0.0 110.404 175.037 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -45.22 -49.96 11.94 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.723 1.609 . . . . 0.0 113.379 178.376 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 5.5 p -160.17 142.28 4.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 126.247 1.819 . . . . 0.0 110.078 175.009 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.698 HG21 HD13 ' A' ' 70' ' ' LEU . 73.6 t -113.79 122.62 34.53 Favored Pre-proline 0 N--CA 1.473 0.676 0 C-N-CA 124.472 1.109 . . . . 0.0 108.325 174.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.753 ' HA ' HG22 ' A' ' 43' ' ' THR . 56.3 Cg_endo -68.12 159.42 53.19 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.767 2.312 . . . . 0.0 112.875 175.402 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -71.15 168.2 17.71 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.952 0.901 . . . . 0.0 110.705 175.015 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 30.5 p 53.1 21.9 2.33 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 127.11 2.164 . . . . 0.0 113.991 -175.086 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.8 172.67 10.17 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 127.648 2.379 . . . . 0.0 110.497 -175.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.469 ' HB3' HD23 ' A' ' 13' ' ' LEU . . . -134.9 161.84 34.1 Favored 'General case' 0 C--O 1.222 -0.381 0 O-C-N 121.85 -0.532 . . . . 0.0 110.009 176.251 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.698 HD13 HG21 ' A' ' 64' ' ' VAL . 2.6 pt? -136.38 171.11 14.96 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 124.387 1.075 . . . . 0.0 112.454 -179.42 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.528 ' CD2' HD11 ' A' ' 13' ' ' LEU . 0.6 OUTLIER -119.47 156.01 31.02 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 124.826 1.25 . . . . 0.0 113.138 -179.061 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.838 ' HB2' HG22 ' A' ' 34' ' ' VAL . 23.8 m-85 -133.22 133.66 43.01 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 124.217 1.007 . . . . 0.0 112.191 175.105 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.1 p -101.44 151.53 21.82 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 126.155 1.782 . . . . 0.0 110.692 175.261 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.81 ' H ' HD12 ' A' ' 3' ' ' LEU . . . -169.0 124.43 1.17 Allowed Glycine 0 CA--C 1.531 1.08 0 C-N-CA 124.212 0.91 . . . . 0.0 113.192 175.033 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.546 ' HG2' HD11 ' A' ' 3' ' ' LEU . 22.9 mtm180 -96.04 80.89 3.32 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 129.462 3.105 . . . . 0.0 111.245 -174.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.482 ' HE2' ' HB2' ' A' ' 85' ' ' ALA . 10.2 ptpt . . . . . 0 N--CA 1.471 0.585 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 24.6 m . . . . . 0 N--CA 1.479 0.978 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 114.83 -171.45 13.71 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 125.829 1.68 . . . . 0.0 112.137 178.005 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.682 ' HB1' HG13 ' A' ' 32' ' ' ILE . . . -72.11 84.52 1.01 Allowed 'General case' 0 CA--C 1.547 0.855 0 O-C-N 120.956 -1.32 . . . . 0.0 110.983 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.2 t -125.65 118.21 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 124.155 0.982 . . . . 0.0 113.031 -174.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.56 ' HB3' ' CZ ' ' A' ' 103' ' ' PHE . . . -164.87 168.65 17.46 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.144 1.377 . . . . 0.0 113.09 176.505 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -154.19 137.67 15.9 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.346 1.059 . . . . 0.0 111.961 174.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -137.59 169.28 18.06 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 120.595 -1.316 . . . . 0.0 111.574 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -141.46 160.62 39.75 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 175.616 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -137.82 143.35 40.95 Favored 'General case' 0 CA--C 1.513 -0.463 0 C-N-CA 125.779 1.632 . . . . 0.0 114.33 -174.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -97.94 106.53 18.85 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.352 -175.018 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 1.9 mtm -78.87 128.95 34.01 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 124.051 0.94 . . . . 0.0 110.789 178.287 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -58.96 -20.66 54.52 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 177.651 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -70.01 -12.52 61.67 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 124.521 1.128 . . . . 0.0 113.853 176.257 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 109.79 25.61 5.35 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 125.34 1.448 . . . . 0.0 114.963 177.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -134.3 173.84 11.18 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.928 1.291 . . . . 0.0 112.108 -175.028 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 16.8 m -129.33 108.44 10.31 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 177.36 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.435 ' CD2' ' CZ2' ' A' ' 44' ' ' TRP . 69.3 tp -75.12 108.07 7.62 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.675 0.79 . . . . 0.0 112.267 175.072 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -102.42 135.49 12.29 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 123.816 0.722 . . . . 0.0 112.344 174.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 95.6 t -115.7 136.6 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.952 1.301 . . . . 0.0 111.25 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -133.34 122.8 24.34 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.739 1.616 . . . . 0.0 111.945 -174.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.56 ' CZ ' ' HB3' ' A' ' 87' ' ' ALA . 2.1 p90 -147.17 117.53 7.41 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.735 1.214 . . . . 0.0 111.562 -176.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 48.4 t -139.02 105.98 5.43 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.186 0.994 . . . . 0.0 112.598 -177.346 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.486 ' HB ' ' HB3' ' A' ' 85' ' ' ALA . 19.6 t . . . . . 0 C--N 1.328 -0.338 0 C-N-CA 125.893 1.677 . . . . 0.0 109.008 179.398 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 2.0 t . . . . . 0 CA--C 1.543 0.711 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -102.29 101.52 11.81 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.942 1.697 . . . . 0.0 109.454 175.487 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 38.5 m0 -100.52 141.31 33.55 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.961 1.255 . . . . 0.0 110.476 178.113 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 37.7 p-90 -137.51 129.0 28.24 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.143 0.977 . . . . 0.0 111.268 -177.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -133.54 156.12 48.37 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 122.509 1.147 . . . . 0.0 112.553 176.516 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 95.9 t -148.22 123.76 2.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 176.2 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.91 170.89 21.08 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.596 1.158 . . . . 0.0 110.885 175.021 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.521 ' HB ' ' CZ ' ' A' ' 154' ' ' TYR . 7.2 mt -104.27 136.19 38.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.917 0.865 . . . . 0.0 110.523 176.1 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -89.58 153.09 47.88 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 125.302 1.441 . . . . 0.0 111.18 176.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -74.19 88.98 1.08 Allowed 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 124.248 3.299 . . . . 0.0 112.107 179.182 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 91.64 -172.51 35.89 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 125.239 1.399 . . . . 0.0 113.006 -177.694 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 12.3 tttt -51.85 118.08 3.17 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.997 1.319 . . . . 0.0 111.571 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.38 147.67 41.8 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.023 0.929 . . . . 0.0 112.225 177.027 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 19.6 ptt-85 -99.07 -178.34 3.9 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.25 1.02 . . . . 0.0 110.409 175.096 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -128.8 107.47 9.68 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 104.91 -2.255 . . . . 0.0 104.91 174.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -128.39 171.24 12.23 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.277 1.431 . . . . 0.0 109.299 176.045 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -51.87 -44.29 63.65 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 119.642 1.11 . . . . 0.0 113.595 -177.744 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -56.75 -58.44 14.47 Favored Glycine 0 N--CA 1.471 0.986 0 CA-C-N 119.327 0.967 . . . . 0.0 112.57 175.259 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 6.1 mtm -60.89 -39.92 91.07 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 118.068 0.934 . . . . 0.0 112.714 178.279 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -56.2 -60.89 2.85 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.071 1.349 . . . . 0.0 109.569 174.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -67.06 -32.57 73.84 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -178.452 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -62.02 -47.15 86.04 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.752 0.821 . . . . 0.0 111.562 176.215 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 46.8 mmm -84.45 -20.36 31.91 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -54.5 -55.67 26.69 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.664 1.586 . . . . 0.0 109.252 174.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -68.65 -9.68 51.5 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -73.44 -41.6 44.3 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 125.825 1.679 . . . . 0.0 114.036 -177.408 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -123.0 91.32 49.94 Favored Pre-proline 0 CA--C 1.547 0.831 0 CA-C-N 118.215 1.007 . . . . 0.0 111.452 179.111 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -72.45 78.64 1.94 Allowed 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 123.776 2.984 . . . . 0.0 112.156 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -114.84 124.15 51.01 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.953 1.301 . . . . 0.0 110.233 174.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.87 96.93 3.31 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 127.101 2.16 . . . . 0.0 112.6 -174.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 52.53 37.83 50.41 Favored Glycine 0 CA--C 1.537 1.423 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.462 -177.509 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.67 79.65 0.6 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.408 1.883 . . . . 0.0 110.93 -178.374 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -65.84 123.37 19.61 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.185 1.794 . . . . 0.0 110.611 175.313 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 128.02 41.41 0.28 Allowed Glycine 0 CA--C 1.534 1.258 0 C-N-CA 125.341 1.448 . . . . 0.0 114.754 178.546 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' TRP . . . . . 0.453 ' H ' HD13 ' A' ' 161' ' ' ILE . 9.7 m95 45.29 60.09 3.21 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.803 1.641 . . . . 0.0 112.738 -175.1 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -85.05 128.31 34.58 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.456 1.102 . . . . 0.0 113.229 179.347 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -162.68 -170.28 2.34 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.219 1.008 . . . . 0.0 112.693 -174.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -137.9 151.53 48.11 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.562 1.145 . . . . 0.0 110.159 174.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -70.6 153.18 43.13 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 122.99 0.516 . . . . 0.0 110.95 176.14 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.482 ' HB3' ' CD2' ' A' ' 154' ' ' TYR . 1.9 mm? -115.7 127.67 55.32 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 122.189 0.995 . . . . 0.0 112.398 -178.278 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -58.07 -18.37 33.87 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 125.436 1.493 . . . . 0.0 116.02 179.127 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.521 ' CZ ' ' HB ' ' A' ' 120' ' ' ILE . 0.1 OUTLIER -74.35 14.33 0.46 Allowed 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 126.62 1.968 . . . . 0.0 113.776 179.778 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 75.16 24.86 70.2 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 124.171 0.891 . . . . 0.0 113.751 -174.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.6 pp -135.33 177.58 7.71 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.152 1.381 . . . . 0.0 113.215 -178.363 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -142.37 124.33 15.27 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.602 1.561 . . . . 0.0 109.448 -178.777 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 5.1 ttp -98.24 142.06 30.38 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 175.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 3.5 tppt? -123.78 121.72 36.17 Favored 'General case' 0 C--O 1.219 -0.543 0 C-N-CA 125.707 1.603 . . . . 0.0 109.383 -176.53 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -130.35 152.1 19.67 Favored Glycine 0 N--CA 1.466 0.682 0 CA-C-N 120.305 1.412 . . . . 0.0 114.581 -176.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.453 HD13 ' H ' ' A' ' 147' ' ' TRP . 4.4 tp -146.35 128.27 7.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 C-N-CA 124.516 1.126 . . . . 0.0 110.589 -176.588 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' MET . . . . . 0.42 ' HG2' ' HA ' ' A' ' 170' ' ' MET . 1.1 tmm? -151.37 157.2 42.14 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 125.296 1.438 . . . . 0.0 109.982 177.639 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' THR . . . . . 0.424 ' O ' ' HB3' ' A' ' 168' ' ' ALA . 12.8 t -148.67 148.45 30.08 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.506 0.722 . . . . 0.0 110.329 174.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 75.1 m -117.08 32.11 6.35 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.277 1.031 . . . . 0.0 111.352 -177.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.85 -24.41 65.88 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.692 1.597 . . . . 0.0 113.713 176.347 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 158.4 -54.7 0.37 Allowed Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.22 1.39 . . . . 0.0 113.414 175.005 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -139.96 61.2 1.54 Allowed 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 122.311 1.053 . . . . 0.0 112.161 -175.024 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 163' ' ' THR . . . -98.08 -174.09 2.77 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 122.44 1.114 . . . . 0.0 112.727 175.033 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.5 178.68 6.12 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 128.167 2.587 . . . . 0.0 111.035 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 170' ' ' MET . . . . . 0.42 ' HA ' ' HG2' ' A' ' 162' ' ' MET . 4.7 tmm? -119.39 136.46 54.27 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.328 1.451 . . . . 0.0 111.207 174.359 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -146.74 129.73 16.37 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 121.591 -0.693 . . . . 0.0 110.279 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 4.6 mp -134.18 118.57 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 123.572 0.749 . . . . 0.0 110.363 175.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.419 ' HA ' ' HB3' ' A' ' 37' ' ' ASP . 0.0 OUTLIER -113.83 133.13 55.59 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 125.411 1.485 . . . . 0.0 111.583 176.161 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.8 mp -82.59 136.68 22.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 O-C-N 121.466 -0.771 . . . . 0.0 109.498 175.01 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -118.23 130.85 56.31 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.164 1.386 . . . . 0.0 111.593 175.028 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 8.2 mmm180 . . . . . 0 C--O 1.252 1.231 0 C-N-CA 126.778 2.031 . . . . 0.0 110.869 -175.008 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.421 ' HA ' ' HB3' ' A' ' 25' ' ' LEU . 10.4 tp . . . . . 0 N--CA 1.479 1.007 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.619 ' HB1' ' HB3' ' A' ' 71' ' ' LEU . . . -77.56 130.62 37.17 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.316 1.047 . . . . 0.0 109.41 174.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -64.55 -101.14 0.01 OUTLIER Glycine 0 CA--C 1.537 1.453 0 CA-C-N 120.211 1.369 . . . . 0.0 114.764 -178.214 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 16.5 p -133.25 167.4 20.44 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.307 1.443 . . . . 0.0 110.16 176.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -120.73 14.59 6.34 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 C-N-CA 125.021 1.328 . . . . 0.0 112.406 -178.803 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.439 HD12 ' HB3' ' A' ' 12' ' ' SER . 0.8 OUTLIER -30.95 -72.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 128.427 2.691 . . . . 0.0 114.092 -179.38 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -171.62 151.5 2.95 Favored 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 125.127 1.371 . . . . 0.0 110.947 175.173 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -59.57 -33.23 75.99 Favored Glycine 0 N--CA 1.468 0.798 0 N-CA-C 115.605 1.002 . . . . 0.0 115.605 -174.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.09 -38.44 88.84 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 122.022 -0.693 . . . . 0.0 111.188 174.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.439 ' HB3' HD12 ' A' ' 8' ' ' ILE . 5.9 t -92.22 -11.77 34.5 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.398 1.879 . . . . 0.0 113.778 177.599 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.572 HD23 ' CB ' ' A' ' 69' ' ' ALA . 67.8 tp -119.53 80.67 1.6 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 128.851 2.86 . . . . 0.0 109.845 179.016 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -111.84 177.34 4.68 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.591 1.557 . . . . 0.0 111.981 176.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -39.98 -45.29 1.86 Allowed 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 126.125 1.77 . . . . 0.0 113.439 175.022 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -52.59 -44.86 66.24 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.921 0.888 . . . . 0.0 111.623 178.667 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.494 ' O ' HG23 ' A' ' 21' ' ' VAL . 59.3 t -67.87 -40.82 84.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 125.54 1.536 . . . . 0.0 110.887 176.214 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.476 ' CD2' HD21 ' A' ' 71' ' ' LEU . 25.7 mt -65.4 -42.67 92.34 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 120.704 -1.247 . . . . 0.0 111.331 178.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -59.76 -51.52 69.4 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.79 1.236 . . . . 0.0 112.059 175.58 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.57 -36.37 83.56 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-O 118.424 -0.798 . . . . 0.0 112.52 175.141 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 17' ' ' VAL . 24.2 t -53.65 -46.31 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.234 1.014 . . . . 0.0 110.363 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.573 HD22 ' HE3' ' A' ' 31' ' ' LYS . 18.5 mt -53.53 -18.49 2.85 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.562 1.545 . . . . 0.0 114.464 178.34 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -99.64 -62.24 0.83 Allowed Glycine 0 CA--C 1.534 1.268 0 C-N-CA 126.646 2.07 . . . . 0.0 112.899 175.513 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -60.85 -35.43 76.55 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -178.57 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.421 ' HB3' ' HA ' ' A' ' 3' ' ' LEU . 3.1 mm? -114.41 105.89 13.66 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.267 1.827 . . . . 0.0 108.092 175.012 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -143.78 162.74 27.72 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 125.502 1.525 . . . . 0.0 111.405 178.204 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.22 -83.14 0.57 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.733 1.213 . . . . 0.0 110.638 174.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 30.6 m -91.43 173.72 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 126.014 1.725 . . . . 0.0 109.282 178.365 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -51.28 -44.8 61.92 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.977 0.911 . . . . 0.0 112.439 -178.435 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.63 120.81 43.63 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.47 1.908 . . . . 0.0 112.514 177.32 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.573 ' HE3' HD22 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -133.46 163.12 30.08 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 125.46 1.504 . . . . 0.0 111.115 -179.049 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -128.95 132.67 67.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 124.709 1.204 . . . . 0.0 109.037 175.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -136.73 104.76 5.62 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.146 1.778 . . . . 0.0 109.439 174.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.821 HG22 ' HB2' ' A' ' 72' ' ' TYR . 1.3 m -106.4 159.09 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 124.233 1.013 . . . . 0.0 111.901 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -137.44 109.1 0.68 Allowed Glycine 0 N--CA 1.465 0.569 0 CA-C-N 119.072 0.851 . . . . 0.0 113.643 -178.855 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 mp -99.43 142.07 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 117.632 0.716 . . . . 0.0 110.136 176.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -108.87 101.99 11.05 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 124.873 1.269 . . . . 0.0 109.848 176.141 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.62 100.09 1.08 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.584 1.554 . . . . 0.0 109.343 176.528 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -133.79 13.39 4.02 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.908 1.283 . . . . 0.0 112.282 175.455 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.0 p -62.31 -12.95 23.78 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 126.082 1.753 . . . . 0.0 114.834 175.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.38 16.29 66.93 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 125.499 1.523 . . . . 0.0 114.183 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -140.49 136.47 7.67 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 126.506 2.003 . . . . 0.0 110.633 175.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.803 HG22 ' HA ' ' A' ' 65' ' ' PRO . 19.9 p -73.63 127.47 32.85 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.281 0.632 . . . . 0.0 109.939 174.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 15.8 m0 -88.02 159.1 18.42 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 122.066 -0.396 . . . . 0.0 111.742 177.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 89.4 m -136.61 143.86 43.77 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.574 1.15 . . . . 0.0 110.288 -179.461 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.7 110.85 0.86 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.466 1.106 . . . . 0.0 111.829 175.019 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.602 HD12 ' N ' ' A' ' 48' ' ' ASN . 4.2 pp -101.25 -57.67 2.04 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.475 0.71 . . . . 0.0 111.284 175.073 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.602 ' N ' HD12 ' A' ' 47' ' ' LEU . 4.1 t30 -173.43 140.03 0.79 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.446 1.898 . . . . 0.0 110.262 -175.654 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -121.83 150.61 41.67 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.354 1.062 . . . . 0.0 110.195 175.105 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -138.52 94.32 2.83 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 123.037 1.399 . . . . 0.0 112.104 -175.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.611 ' CD1' ' HB1' ' A' ' 87' ' ' ALA . 5.2 m-30 -101.91 133.15 47.15 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 121.16 -0.962 . . . . 0.0 110.393 -175.714 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.38 -37.77 6.13 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.217 1.007 . . . . 0.0 113.64 -178.594 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 37.5 t -122.58 -47.74 2.08 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.494 1.518 . . . . 0.0 110.92 178.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -69.76 11.44 1.82 Allowed Glycine 0 CA--C 1.533 1.173 0 C-N-CA 126.051 1.786 . . . . 0.0 115.002 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 67.8 p -35.22 113.28 0.19 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 128.864 2.866 . . . . 0.0 112.773 -176.253 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.663 HG21 HG23 ' A' ' 59' ' ' ILE . 1.1 t -126.75 179.94 5.11 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.803 1.241 . . . . 0.0 112.014 -175.023 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -79.29 -53.98 6.4 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.959 0.904 . . . . 0.0 112.75 177.005 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.2 p -151.48 138.84 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.673 1.589 . . . . 0.0 111.386 -178.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.663 HG23 HG21 ' A' ' 56' ' ' THR . 0.0 OUTLIER -136.72 -47.27 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 C-N-CA 125.083 1.353 . . . . 0.0 112.982 -178.772 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 73.3 mt -71.42 108.62 4.1 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 124.717 1.207 . . . . 0.0 109.474 175.316 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -72.07 168.02 25.15 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 124.046 3.164 . . . . 0.0 110.819 175.271 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -53.52 -45.57 69.82 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 178.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 85.5 t -150.09 146.75 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 127.526 2.33 . . . . 0.0 108.83 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.0 t -116.66 97.26 50.01 Favored Pre-proline 0 C--N 1.331 -0.21 0 C-N-CA 125.567 1.547 . . . . 0.0 107.247 174.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.803 ' HA ' HG22 ' A' ' 43' ' ' THR . 51.4 Cg_endo -67.71 144.78 67.12 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 121.328 1.352 . . . . 0.0 111.99 175.475 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -69.11 168.89 13.0 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.438 0.695 . . . . 0.0 110.658 174.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 29.1 p 62.94 13.85 7.0 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 126.614 1.966 . . . . 0.0 111.889 -175.011 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 27.6 mttp -138.41 169.05 18.47 Favored 'General case' 0 C--N 1.343 0.302 0 C-N-CA 126.525 1.93 . . . . 0.0 111.655 -176.239 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.572 ' CB ' HD23 ' A' ' 13' ' ' LEU . . . -133.35 159.72 39.45 Favored 'General case' 0 C--O 1.222 -0.359 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -175.054 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.519 HD23 ' H ' ' A' ' 70' ' ' LEU . 2.2 pt? -136.76 167.86 20.63 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 124.296 1.038 . . . . 0.0 111.966 -177.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.619 ' HB3' ' HB1' ' A' ' 4' ' ' ALA . 0.6 OUTLIER -117.35 153.55 32.81 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.253 1.021 . . . . 0.0 112.139 179.068 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.821 ' HB2' HG22 ' A' ' 34' ' ' VAL . 6.7 m-85 -125.56 142.2 51.63 Favored 'General case' 0 CA--C 1.511 -0.521 0 C-N-CA 125.047 1.339 . . . . 0.0 109.335 174.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 58.3 p -109.41 156.45 20.03 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 125.035 1.334 . . . . 0.0 110.346 174.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -174.13 135.45 3.18 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.872 175.018 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 30.5 mtm105 -117.5 142.5 47.09 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 125.428 1.491 . . . . 0.0 108.852 -177.598 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.5 ptpt . . . . . 0 CA--C 1.542 0.65 0 C-N-CA 124.038 0.935 . . . . 0.0 112.346 175.035 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.481 1.089 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -61.6 -68.58 1.61 Allowed Glycine 0 N--CA 1.475 1.246 0 O-C-N 120.282 -1.511 . . . . 0.0 113.654 -179.389 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -160.14 114.98 2.29 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.838 1.255 . . . . 0.0 110.923 175.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.9 t -141.83 119.12 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 123.796 0.838 . . . . 0.0 109.933 -177.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.611 ' HB1' ' CD1' ' A' ' 51' ' ' PHE . . . -156.79 153.86 29.01 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.901 0.858 . . . . 0.0 112.031 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -134.57 139.43 45.37 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.401 1.48 . . . . 0.0 108.985 178.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.557 ' CE2' ' CE2' ' A' ' 72' ' ' TYR . 26.3 p90 -149.49 171.3 16.82 Favored 'General case' 0 C--N 1.323 -0.58 0 O-C-N 120.521 -1.362 . . . . 0.0 109.346 174.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.476 ' HB3' HD11 ' A' ' 47' ' ' LEU . . . -138.58 161.7 36.43 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 120.908 0.385 . . . . 0.0 111.977 174.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -130.16 135.52 48.27 Favored 'General case' 0 CA--C 1.518 -0.269 0 C-N-CA 125.718 1.607 . . . . 0.0 113.471 -174.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -86.53 116.78 24.89 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -175.015 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 3.3 mtm -93.2 140.89 29.03 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.01 0.924 . . . . 0.0 112.297 -177.229 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.14 -21.64 65.2 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 114.309 1.225 . . . . 0.0 114.309 177.652 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -72.09 -2.22 17.67 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.257 1.023 . . . . 0.0 113.146 175.116 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 85.83 42.39 6.81 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.62 1.105 . . . . 0.0 112.543 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -140.96 176.48 8.77 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.222 1.409 . . . . 0.0 111.549 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.441 HG23 HD21 ' A' ' 47' ' ' LEU . 12.9 m -130.07 107.54 9.4 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.285 1.034 . . . . 0.0 112.929 178.627 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 57.1 tp -69.94 96.31 1.01 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.764 1.625 . . . . 0.0 111.217 174.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -91.43 120.38 5.98 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 125.485 1.516 . . . . 0.0 112.76 178.355 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.557 HG11 ' CE2' ' A' ' 89' ' ' PHE . 0.3 OUTLIER -104.79 161.65 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 125.419 1.488 . . . . 0.0 111.127 178.436 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 5.0 tpt -155.91 123.22 5.44 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.66 1.184 . . . . 0.0 111.031 174.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.491 ' CZ ' ' HB3' ' A' ' 87' ' ' ALA . 15.5 p90 -135.18 124.18 24.19 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.933 1.293 . . . . 0.0 114.226 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.6 t -133.02 102.32 5.56 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.086 0.954 . . . . 0.0 111.557 -176.151 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.0 m . . . . . 0 N--CA 1.47 0.543 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.409 -178.186 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.468 0.429 0 CA-C-O 121.466 0.65 . . . . 0.0 110.64 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -63.16 99.55 0.18 Allowed 'General case' 0 CA--C 1.521 -0.164 0 C-N-CA 126.134 1.774 . . . . 0.0 111.807 175.087 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 46.5 m0 -119.56 142.11 48.65 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.691 1.197 . . . . 0.0 110.129 -175.611 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 31.5 p-90 -145.82 133.83 21.43 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.195 0.998 . . . . 0.0 110.658 -175.634 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -146.92 157.38 43.62 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 122.464 1.126 . . . . 0.0 113.441 -178.703 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.419 HG22 HG23 ' A' ' 101' ' ' VAL . 21.4 t -149.19 128.14 3.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 114.394 -1.275 . . . . 0.0 108.277 -178.648 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.0 162.99 40.79 Favored 'General case' 0 CA--C 1.514 -0.434 0 C-N-CA 125.614 1.566 . . . . 0.0 109.13 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 20.4 mt -108.47 146.28 14.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 121.487 0.66 . . . . 0.0 109.998 176.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -103.19 145.81 31.29 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 126.244 1.818 . . . . 0.0 111.023 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.62 103.0 1.37 Allowed 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 124.152 3.235 . . . . 0.0 111.558 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 88.06 -177.06 45.98 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.518 1.056 . . . . 0.0 114.068 -177.139 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 16.4 tttt -64.56 102.13 0.53 Allowed 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.462 1.105 . . . . 0.0 109.426 175.028 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 6.4 mmt180 -116.35 158.25 23.75 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.803 1.641 . . . . 0.0 109.54 178.597 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.82 -174.0 2.77 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.506 1.122 . . . . 0.0 110.265 175.041 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -138.27 113.25 9.19 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 126.315 1.846 . . . . 0.0 106.113 174.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -127.5 175.56 8.14 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.707 2.003 . . . . 0.0 109.253 174.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -47.97 -49.4 30.65 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.112 0.965 . . . . 0.0 113.473 177.231 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -56.94 -52.99 47.74 Favored Glycine 0 N--CA 1.471 0.967 0 CA-C-N 119.052 0.842 . . . . 0.0 112.832 178.521 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 20.4 mtm -62.88 -41.6 99.46 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 117.828 0.814 . . . . 0.0 112.558 176.058 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -56.95 -62.74 1.54 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.767 0.827 . . . . 0.0 109.623 175.004 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -59.22 -42.09 90.18 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 118.561 -0.733 . . . . 0.0 112.184 -176.468 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -58.09 -42.11 84.92 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.426 1.09 . . . . 0.0 113.027 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 40.9 mmm -84.48 -36.29 22.37 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 177.383 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -53.47 -57.27 11.27 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.501 1.52 . . . . 0.0 109.444 174.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -70.95 -9.7 58.36 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -178.444 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -87.02 -11.23 70.36 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 126.254 1.883 . . . . 0.0 114.624 178.456 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -138.67 88.67 13.93 Favored Pre-proline 0 CA--C 1.548 0.884 0 CA-C-N 119.205 1.503 . . . . 0.0 112.636 177.407 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -74.76 77.86 2.94 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.857 3.038 . . . . 0.0 112.46 178.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -114.71 124.21 51.21 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.061 0.944 . . . . 0.0 110.684 -178.793 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -92.59 -167.9 1.85 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.406 1.082 . . . . 0.0 111.72 179.165 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -73.94 66.51 1.78 Allowed Glycine 0 CA--C 1.53 0.989 0 C-N-CA 125.824 1.678 . . . . 0.0 111.433 175.032 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' ASP . . . . . 0.418 ' HB3' ' CG ' ' A' ' 148' ' ' TYR . 0.9 OUTLIER -80.96 88.75 5.89 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 125.404 1.481 . . . . 0.0 109.805 -178.07 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -70.38 86.41 0.61 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.862 1.665 . . . . 0.0 112.347 -176.806 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 169.04 40.7 0.03 OUTLIER Glycine 0 N--CA 1.472 1.099 0 O-C-N 121.171 -0.956 . . . . 0.0 114.614 -178.544 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 2.3 m95 53.56 55.17 8.94 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 125.576 1.55 . . . . 0.0 113.909 -177.608 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' TYR . . . . . 0.418 ' CG ' ' HB3' ' A' ' 144' ' ' ASP . 26.0 m-85 -86.23 124.4 32.57 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.443 1.497 . . . . 0.0 112.684 -178.782 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -159.0 -179.36 7.97 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.108 0.963 . . . . 0.0 112.902 -175.654 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -136.57 166.42 23.58 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.24 1.416 . . . . 0.0 111.086 174.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -69.14 143.65 54.06 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.888 0.875 . . . . 0.0 109.735 174.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.475 HD11 ' HB2' ' A' ' 158' ' ' MET . 48.4 mt -99.48 92.64 5.48 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.275 1.03 . . . . 0.0 110.744 176.236 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 33.05 -79.9 0.0 OUTLIER Glycine 0 N--CA 1.478 1.473 0 C-N-CA 130.051 3.691 . . . . 0.0 116.247 175.092 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -67.89 -157.02 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 128.266 2.626 . . . . 0.0 110.372 175.023 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -79.09 42.91 2.39 Favored Glycine 0 CA--C 1.539 1.557 0 O-C-N 119.813 -1.804 . . . . 0.0 112.253 175.077 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.54 149.98 33.64 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 119.571 1.686 . . . . 0.0 111.061 175.179 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 23.8 mtm180 -142.54 109.26 5.41 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.496 1.118 . . . . 0.0 111.015 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' MET . . . . . 0.508 ' SD ' HG21 ' A' ' 172' ' ' ILE . 9.9 ttp -101.53 132.23 47.27 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 118.038 -0.982 . . . . 0.0 108.934 179.398 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.74 130.45 54.46 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 127.075 2.15 . . . . 0.0 110.893 178.616 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -135.72 160.11 24.42 Favored Glycine 0 N--CA 1.47 0.937 0 CA-C-N 120.312 1.414 . . . . 0.0 115.45 178.506 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.518 HG23 ' HZ1' ' A' ' 169' ' ' LYS . 0.0 OUTLIER -150.63 134.57 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 123.954 0.901 . . . . 0.0 111.366 179.395 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 7.0 mtm -148.36 167.29 25.61 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 127.09 2.156 . . . . 0.0 109.974 175.466 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 3.6 t -140.35 148.9 42.01 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.989 1.316 . . . . 0.0 109.479 174.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 77.4 p -92.25 26.57 2.5 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.508 1.123 . . . . 0.0 112.805 177.287 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -67.18 22.68 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 127.601 2.36 . . . . 0.0 115.232 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 81.4 -60.64 4.7 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 126.664 2.078 . . . . 0.0 112.901 -176.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -122.77 71.04 1.02 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.786 1.234 . . . . 0.0 111.47 -179.267 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -92.89 -177.06 4.4 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.733 1.213 . . . . 0.0 112.707 175.855 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' LYS . . . . . 0.518 ' HZ1' HG23 ' A' ' 161' ' ' ILE . 0.0 OUTLIER -123.42 163.84 20.06 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 126.842 2.057 . . . . 0.0 109.532 174.966 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 170' ' ' MET . . . . . 0.413 ' SD ' ' CD1' ' A' ' 172' ' ' ILE . 1.3 tmt? -113.12 127.13 56.11 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 124.876 1.27 . . . . 0.0 109.459 174.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -138.21 127.66 24.74 Favored 'General case' 0 CA--C 1.518 -0.253 0 C-N-CA 123.279 0.632 . . . . 0.0 110.044 177.271 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.508 HG21 ' SD ' ' A' ' 158' ' ' MET . 4.2 mp -136.43 119.68 22.59 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.279 0 C-N-CA 122.978 0.511 . . . . 0.0 110.505 178.537 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -112.36 131.89 55.29 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.987 1.315 . . . . 0.0 111.578 175.552 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.8 mp -82.07 131.46 33.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 175.041 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -135.42 102.47 5.15 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.219 1.007 . . . . 0.0 111.442 175.669 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 5.9 mtt180 . . . . . 0 C--O 1.253 1.285 0 C-N-CA 124.846 1.259 . . . . 0.0 112.852 174.983 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 25.5 m . . . . . 0 N--CA 1.479 0.996 0 CA-C-O 120.919 0.39 . . . . 0.0 111.427 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -84.17 156.55 22.02 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 120.75 -1.219 . . . . 0.0 111.074 174.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.578 HD12 ' H ' ' A' ' 74' ' ' GLY . 1.8 mt -74.64 43.65 0.19 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.73 1.612 . . . . 0.0 112.51 -175.024 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.417 ' HA ' ' HB3' ' A' ' 71' ' ' LEU . . . -120.98 94.02 4.21 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 127.637 2.375 . . . . 0.0 109.632 178.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -69.71 -84.05 0.16 Allowed Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.531 1.062 . . . . 0.0 112.665 -175.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 33.7 p -140.24 167.34 22.37 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.705 1.602 . . . . 0.0 111.004 175.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -125.39 14.36 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 CA-C-O 123.174 1.464 . . . . 0.0 111.796 -179.326 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.419 HD12 ' HB3' ' A' ' 12' ' ' SER . 8.2 pt -53.23 167.39 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 125.494 1.517 . . . . 0.0 112.086 175.356 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -42.31 134.02 3.03 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.72 1.608 . . . . 0.0 112.549 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -54.9 -18.98 12.68 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 124.202 0.906 . . . . 0.0 114.557 -175.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.18 -28.14 69.46 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.718 1.207 . . . . 0.0 111.932 175.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.419 ' HB3' HD12 ' A' ' 8' ' ' ILE . 6.4 t -102.09 -44.9 5.32 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 126.32 1.848 . . . . 0.0 111.415 175.145 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.2 tp -75.97 94.16 3.35 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 121.614 0.721 . . . . 0.0 110.463 175.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 65.0 p -125.52 -179.8 4.79 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.507 1.523 . . . . 0.0 112.451 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -45.83 -41.0 10.56 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.446 1.498 . . . . 0.0 112.911 176.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -57.39 -43.39 83.61 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.661 1.185 . . . . 0.0 111.598 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 74.6 t -59.54 -35.4 58.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.733 1.213 . . . . 0.0 110.792 175.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.3 mt -72.52 -42.85 64.31 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.722 -0.611 . . . . 0.0 111.263 177.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -62.42 -49.35 75.81 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.616 -0.678 . . . . 0.0 111.267 178.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.08 -48.86 76.82 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 176.133 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.423 HG23 HD23 ' A' ' 25' ' ' LEU . 1.6 p -57.38 -30.73 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 CA-C-N 120.269 1.395 . . . . 0.0 113.414 -175.017 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 17.1 mt -57.4 -34.42 68.87 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.544 1.138 . . . . 0.0 110.806 174.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -85.54 -36.25 10.86 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 124.282 0.944 . . . . 0.0 113.455 177.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -69.62 -57.99 4.49 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.657 1.183 . . . . 0.0 112.38 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.423 HD23 HG23 ' A' ' 21' ' ' VAL . 3.1 mm? -91.32 -15.49 28.99 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.55 1.54 . . . . 0.0 112.005 -175.138 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -18.19 86.71 0.0 OUTLIER Glycine 0 CA--C 1.536 1.405 0 C-N-CA 129.952 3.644 . . . . 0.0 117.426 177.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.455 ' H ' HD21 ' A' ' 3' ' ' LEU . 15.3 mtpt -59.86 -61.11 2.86 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 127.224 2.21 . . . . 0.0 113.315 -175.424 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.1 m -132.66 -177.95 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 126.891 2.076 . . . . 0.0 110.835 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.2 t -52.19 -39.89 60.76 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.714 1.606 . . . . 0.0 114.354 -175.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -117.86 116.14 26.38 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 126.228 1.811 . . . . 0.0 108.258 175.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.15 150.54 49.46 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 126.125 1.77 . . . . 0.0 109.52 -175.036 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -128.21 123.59 60.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 124.336 1.054 . . . . 0.0 111.262 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -125.21 116.64 22.31 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 125.914 1.685 . . . . 0.0 108.558 174.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.732 HG22 ' HB2' ' A' ' 72' ' ' TYR . 1.3 m -116.1 158.75 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.639 0.776 . . . . 0.0 110.186 176.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -135.84 92.81 0.23 Allowed Glycine 0 CA--C 1.521 0.41 0 C-N-CA 124.073 0.844 . . . . 0.0 112.215 -178.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.8 mp -89.61 137.27 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 117.768 0.784 . . . . 0.0 110.503 175.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -108.15 112.1 24.45 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.989 1.316 . . . . 0.0 111.313 174.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 27.2 t30 -78.69 98.12 6.1 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.84 1.656 . . . . 0.0 111.975 175.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -134.21 13.74 3.87 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-O 122.551 1.167 . . . . 0.0 111.014 174.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.4 t -61.8 -26.88 68.37 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.082 1.753 . . . . 0.0 114.34 176.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 110.14 77.56 0.94 Allowed Glycine 0 CA--C 1.531 1.042 0 C-N-CA 125.247 1.403 . . . . 0.0 112.597 177.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 144.69 155.93 6.63 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 126.016 1.77 . . . . 0.0 112.805 175.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 41.4 p -68.88 129.43 39.9 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 121.526 -0.985 . . . . 0.0 110.289 174.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 45.2 m0 -86.6 111.15 20.35 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.261 0.553 . . . . 0.0 110.706 178.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 88.7 m -90.92 127.89 36.57 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 124.333 1.053 . . . . 0.0 109.501 175.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.414 ' HB1' ' HB3' ' A' ' 60' ' ' LEU . . . -62.21 138.41 58.41 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 122.651 0.38 . . . . 0.0 111.639 174.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.593 HD12 ' N ' ' A' ' 48' ' ' ASN . 4.1 pp -120.44 -54.65 2.07 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.059 0.943 . . . . 0.0 111.971 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.593 ' N ' HD12 ' A' ' 47' ' ' LEU . 0.1 OUTLIER -170.78 154.38 4.34 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.535 1.934 . . . . 0.0 110.241 178.704 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -133.17 162.99 30.28 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.679 1.192 . . . . 0.0 110.386 174.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 29.3 t80 -140.24 106.2 5.19 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.971 1.309 . . . . 0.0 112.391 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.541 ' CD1' ' HB1' ' A' ' 87' ' ' ALA . 3.1 m-85 -111.1 118.24 35.48 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.992 1.317 . . . . 0.0 110.982 -175.018 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.37 -35.9 7.78 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -177.134 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.421 ' HB3' ' HB ' ' A' ' 86' ' ' VAL . 11.3 t -123.96 -41.83 2.2 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.97 1.708 . . . . 0.0 111.654 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -74.03 16.66 2.61 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 125.246 1.403 . . . . 0.0 115.272 -178.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 65.8 p -32.9 110.29 0.08 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 128.689 2.796 . . . . 0.0 114.321 -174.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.536 HG21 HG23 ' A' ' 59' ' ' ILE . 1.7 t -131.37 -177.09 4.25 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.002 1.321 . . . . 0.0 112.845 -174.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -85.41 -64.97 1.06 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.963 1.305 . . . . 0.0 113.205 176.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.6 p -137.4 134.23 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 125.455 1.502 . . . . 0.0 111.638 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.536 HG23 HG21 ' A' ' 56' ' ' THR . 0.1 OUTLIER -136.68 -29.97 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.825 1.65 . . . . 0.0 113.799 177.596 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.414 ' HB3' ' HB1' ' A' ' 46' ' ' ALA . 11.0 mt -94.38 97.07 2.07 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 125.298 1.439 . . . . 0.0 109.85 179.095 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -66.87 154.29 75.07 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.932 3.088 . . . . 0.0 110.922 174.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -50.39 -50.8 50.57 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.634 1.174 . . . . 0.0 113.302 -176.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 80.4 t -149.45 140.9 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 127.902 2.481 . . . . 0.0 108.347 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.3 t -120.87 125.4 27.07 Favored Pre-proline 0 N--CA 1.471 0.583 0 C-N-CA 124.658 1.183 . . . . 0.0 109.508 175.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -66.2 152.02 82.15 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 121.88 1.72 . . . . 0.0 112.373 175.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -74.53 171.04 14.53 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.686 0.794 . . . . 0.0 111.425 174.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 66.5 p 55.41 20.36 3.6 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 127.597 2.359 . . . . 0.0 113.906 -174.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 49.4 mttt -133.57 174.03 10.86 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 127.623 2.369 . . . . 0.0 111.559 -175.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -130.94 166.86 20.03 Favored 'General case' 0 C--O 1.222 -0.373 0 C-N-CA 122.619 0.368 . . . . 0.0 110.549 -177.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.5 pp -140.49 172.66 12.41 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 124.962 1.305 . . . . 0.0 111.516 -178.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.417 ' HB3' ' HA ' ' A' ' 4' ' ' ALA . 0.5 OUTLIER -123.4 151.76 42.27 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 124.331 1.052 . . . . 0.0 112.038 178.991 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.732 ' HB2' HG22 ' A' ' 34' ' ' VAL . 3.5 m-85 -126.21 144.08 50.9 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.464 1.106 . . . . 0.0 108.556 174.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 90.4 p -115.69 152.95 32.21 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 125.879 1.671 . . . . 0.0 110.68 176.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.578 ' H ' HD12 ' A' ' 3' ' ' LEU . . . -173.97 141.91 6.23 Favored Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 174.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 13.3 ptt180 -132.42 163.84 27.85 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 127.098 2.159 . . . . 0.0 108.294 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.613 ' HB3' ' HB3' ' A' ' 82' ' ' ALA . 24.6 mtmt -60.65 162.79 6.13 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 115.341 1.608 . . . . 0.0 115.341 -174.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 27.0 t -67.71 -62.91 1.19 Allowed 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.317 1.447 . . . . 0.0 111.654 -175.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.24 -27.09 62.29 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.84 0.856 . . . . 0.0 113.036 174.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 113.55 -81.07 0.29 Allowed Glycine 0 CA--C 1.536 1.392 0 C-N-CA 126.14 1.828 . . . . 0.0 112.759 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -75.76 -36.88 1.9 Allowed 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 123.04 2.494 . . . . 0.0 113.216 -176.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 30.2 m -135.72 122.8 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 126.276 1.83 . . . . 0.0 110.803 -179.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.613 ' HB3' ' HB3' ' A' ' 76' ' ' LYS . . . 172.95 -177.02 0.06 Allowed 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 128.366 2.666 . . . . 0.0 110.41 -175.168 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 56.7 m -60.66 150.09 33.15 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.866 1.666 . . . . 0.0 111.201 174.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -53.05 -75.72 0.21 Allowed Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.938 1.732 . . . . 0.0 114.862 -175.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -165.97 102.62 0.66 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.316 1.446 . . . . 0.0 112.844 -178.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.421 ' HB ' ' HB3' ' A' ' 53' ' ' SER . 6.0 t -129.0 124.69 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 O-C-N 120.977 -1.077 . . . . 0.0 110.87 -178.498 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.593 ' HB3' ' CZ ' ' A' ' 103' ' ' PHE . . . -167.8 159.47 11.69 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.036 1.334 . . . . 0.0 112.233 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -141.06 143.87 34.61 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 124.396 1.078 . . . . 0.0 109.813 174.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -140.58 168.54 19.56 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 121.402 -0.811 . . . . 0.0 109.958 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -137.1 155.01 50.14 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 175.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -130.89 127.22 38.07 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.925 1.69 . . . . 0.0 111.985 -175.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -82.54 114.56 21.03 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.868 0.366 . . . . 0.0 111.067 -178.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 2.0 mtm -84.1 136.5 33.98 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.647 1.179 . . . . 0.0 111.169 176.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.2 t -64.32 -19.15 65.25 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.77 0.828 . . . . 0.0 113.213 176.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -69.35 -13.72 62.53 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 125.34 1.456 . . . . 0.0 113.496 175.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 104.31 23.07 8.23 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 124.736 1.16 . . . . 0.0 115.09 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.507 ' HB3' HG22 ' A' ' 120' ' ' ILE . 7.5 m-80 -129.98 173.87 10.3 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 118.911 1.356 . . . . 0.0 110.035 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.6 m -130.47 107.75 9.46 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.403 1.081 . . . . 0.0 111.083 178.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 55.4 tp -70.68 105.49 3.18 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.245 1.018 . . . . 0.0 111.079 175.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -97.16 95.09 1.67 Allowed Glycine 0 CA--C 1.525 0.663 0 C-N-CA 125.639 1.59 . . . . 0.0 112.323 176.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 79.4 t -76.25 139.91 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 123.845 0.858 . . . . 0.0 110.51 174.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 2.6 tmm? -129.75 125.75 36.59 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.481 1.112 . . . . 0.0 111.056 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.593 ' CZ ' ' HB3' ' A' ' 87' ' ' ALA . 48.9 p90 -136.94 134.95 37.29 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 122.417 1.104 . . . . 0.0 113.601 174.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 71.9 m -137.63 121.28 17.37 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.482 1.113 . . . . 0.0 111.563 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 41.4 t -125.76 98.86 33.28 Favored Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 126.576 1.95 . . . . 0.0 107.455 175.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -71.35 -158.08 0.05 OUTLIER 'Trans proline' 0 CA--C 1.547 1.149 0 C-N-CA 124.675 3.583 . . . . 0.0 111.215 175.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -131.94 -34.33 1.3 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.988 1.315 . . . . 0.0 111.816 175.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -90.01 52.38 2.26 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.128 1.371 . . . . 0.0 111.309 175.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -56.12 -19.34 12.87 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.058 1.343 . . . . 0.0 113.164 175.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 59.9 m-80 -58.99 -18.72 36.77 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.918 2.087 . . . . 0.0 113.493 174.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 6.8 m95 -132.25 -63.87 0.79 Allowed 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 126.37 1.868 . . . . 0.0 111.161 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -80.81 126.54 31.46 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.117 1.367 . . . . 0.0 111.714 -176.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.7 m -74.46 171.64 13.41 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 121.689 -0.632 . . . . 0.0 111.907 175.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -125.96 72.64 1.3 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.407 1.483 . . . . 0.0 112.258 -175.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 22.8 m0 -71.82 143.99 49.28 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 121.334 -0.854 . . . . 0.0 112.292 -174.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 34.3 p-90 -140.82 137.0 32.98 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.168 0.987 . . . . 0.0 111.881 -179.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -144.76 168.56 19.91 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 125.198 1.399 . . . . 0.0 111.684 -176.057 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 72.2 t -147.55 129.67 6.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 124.7 1.2 . . . . 0.0 107.894 174.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.58 170.2 15.07 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.434 1.094 . . . . 0.0 110.518 174.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.507 HG22 ' HB3' ' A' ' 97' ' ' ASN . 12.7 mt -132.01 104.77 8.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 177.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -62.18 145.8 93.2 Favored Pre-proline 0 CA--C 1.546 0.818 0 O-C-N 121.485 -0.759 . . . . 0.0 110.886 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -73.81 8.91 1.79 Allowed 'Trans proline' 0 CA--C 1.548 1.188 0 C-N-CA 124.413 3.408 . . . . 0.0 114.862 -175.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -172.98 179.77 44.2 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 126.95 2.214 . . . . 0.0 111.406 177.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -53.94 102.71 0.06 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 126.645 1.978 . . . . 0.0 111.565 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 11.1 tpp180 -132.45 141.6 48.89 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.538 1.535 . . . . 0.0 111.776 -177.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 8.7 ptt180 -76.82 179.53 6.06 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.262 1.025 . . . . 0.0 113.536 174.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -124.4 116.39 22.48 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 128.326 2.651 . . . . 0.0 104.681 174.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -140.12 169.18 18.18 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.143 1.377 . . . . 0.0 110.422 177.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -52.77 -43.19 65.65 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.56 1.144 . . . . 0.0 113.261 -178.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -56.13 -56.44 24.18 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 123.72 0.676 . . . . 0.0 112.744 174.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 2.9 mtm -64.17 -33.3 75.47 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 118.321 1.06 . . . . 0.0 112.973 177.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.28 -63.91 1.13 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.231 1.013 . . . . 0.0 108.895 174.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -63.81 -32.81 74.45 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.621 0.601 . . . . 0.0 112.621 -176.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -64.18 -34.13 77.38 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.506 1.122 . . . . 0.0 113.446 176.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 6.4 tpp -97.72 -21.88 16.74 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 175.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -51.84 -54.99 22.71 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 126.638 1.975 . . . . 0.0 109.783 174.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -64.61 -12.1 42.0 Favored 'General case' 0 CA--C 1.552 1.045 0 N-CA-C 113.72 1.008 . . . . 0.0 113.72 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -79.16 -33.12 36.99 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 126.832 2.158 . . . . 0.0 113.925 -175.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -127.61 90.73 47.51 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 124.593 1.157 . . . . 0.0 111.21 177.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -72.51 72.92 2.9 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 123.561 2.84 . . . . 0.0 112.376 178.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -113.39 119.48 37.78 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 124.659 1.184 . . . . 0.0 109.848 174.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -89.03 0.43 56.68 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.591 1.557 . . . . 0.0 114.557 175.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 85.01 75.07 1.24 Allowed Glycine 0 CA--C 1.522 0.511 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 -175.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -74.53 122.2 22.72 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.907 0.883 . . . . 0.0 109.229 174.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -56.34 144.16 31.58 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.09 0.956 . . . . 0.0 112.395 -177.343 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLY . . . . . 0.477 ' C ' HD13 ' A' ' 161' ' ' ILE . . . 117.19 -78.97 0.29 Allowed Glycine 0 CA--C 1.532 1.141 0 C-N-CA 126.095 1.807 . . . . 0.0 113.037 -176.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 32.2 m95 171.99 104.84 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 130.816 3.646 . . . . 0.0 108.629 -175.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -134.59 137.0 43.36 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 126.456 1.902 . . . . 0.0 111.868 -177.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -160.38 -172.01 3.4 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -174.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.422 ' HA ' ' HE2' ' A' ' 150' ' ' LYS . 1.5 mmpt? -133.33 155.13 49.99 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 126.285 1.834 . . . . 0.0 111.158 174.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -78.23 144.09 36.55 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 174.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.3 mt -107.38 153.6 22.53 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 122.22 1.009 . . . . 0.0 109.732 178.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -64.38 -166.78 1.18 Allowed Glycine 0 CA--C 1.535 1.304 0 C-N-CA 123.673 0.654 . . . . 0.0 112.262 174.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.47 ' CE2' ' HB ' ' A' ' 120' ' ' ILE . 0.0 OUTLIER 56.78 9.47 0.6 Allowed 'General case' 0 CA--C 1.556 1.2 0 N-CA-C 114.844 1.424 . . . . 0.0 114.844 174.968 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 81.48 38.32 14.88 Favored Glycine 0 CA--C 1.538 1.514 0 C-N-CA 126.736 2.112 . . . . 0.0 114.693 -175.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.7 mp -126.79 159.64 33.21 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 119.868 1.834 . . . . 0.0 113.671 -176.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 74.1 mtt180 -144.69 118.71 9.39 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.316 1.047 . . . . 0.0 110.181 -178.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 3.1 ttp -103.51 138.94 39.52 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 124.313 1.045 . . . . 0.0 108.443 177.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -111.06 133.82 53.14 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 127.031 2.132 . . . . 0.0 110.131 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -141.39 160.88 26.93 Favored Glycine 0 N--CA 1.478 1.459 0 CA-C-N 121.849 2.113 . . . . 0.0 116.191 178.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.477 HD13 ' C ' ' A' ' 146' ' ' GLY . 1.4 tp -149.51 127.22 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 125.166 1.386 . . . . 0.0 110.978 -177.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' MET . . . . . 0.423 ' N ' HD12 ' A' ' 161' ' ' ILE . 29.4 mtp -148.48 164.95 32.63 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 128.807 2.843 . . . . 0.0 108.224 174.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 10.2 t -138.0 154.98 49.29 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.999 0.52 . . . . 0.0 111.124 175.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 94.9 p -77.57 13.87 1.16 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.726 1.611 . . . . 0.0 114.275 179.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.26 1.08 0.13 Allowed 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 126.794 2.038 . . . . 0.0 115.548 175.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 87.75 -62.3 3.99 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 126.14 1.829 . . . . 0.0 113.151 174.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -102.53 20.06 17.81 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.32 1.448 . . . . 0.0 113.076 -177.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -60.57 161.58 7.47 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.118 1.367 . . . . 0.0 113.579 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.41 173.41 9.15 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 126.446 1.899 . . . . 0.0 111.653 174.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 44.8 ttp -134.05 118.51 17.86 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.97 1.308 . . . . 0.0 111.794 177.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -124.62 128.55 49.04 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 121.141 -0.975 . . . . 0.0 109.525 177.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 4.6 mp -133.89 124.51 47.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 123.735 0.814 . . . . 0.0 109.915 176.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -123.34 132.11 53.88 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.36 1.464 . . . . 0.0 111.391 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.8 mp -79.31 127.57 39.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 O-C-N 121.207 -0.933 . . . . 0.0 109.338 176.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 4.2 m -132.3 98.9 4.52 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.093 1.357 . . . . 0.0 112.04 178.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 49.9 mtp85 . . . . . 0 C--O 1.253 1.242 0 C-N-CA 127.357 2.263 . . . . 0.0 113.032 175.02 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 6.3 t . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.246 0.069 . . . . 0.0 110.835 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.453 ' O ' HD23 ' A' ' 3' ' ' LEU . 0.5 OUTLIER -136.4 -175.83 4.13 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 128.305 2.642 . . . . 0.0 110.595 177.014 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.537 HD13 ' HB2' ' A' ' 31' ' ' LYS . 1.5 mt -128.51 15.42 6.56 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 126.664 1.986 . . . . 0.0 111.944 178.18 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -115.83 116.24 27.67 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 127.227 2.211 . . . . 0.0 110.491 -175.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -77.85 -82.95 0.58 Allowed Glycine 0 CA--C 1.533 1.201 0 C-N-CA 124.744 1.164 . . . . 0.0 113.551 -178.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 54.2 p -139.27 174.17 10.79 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 126.406 1.882 . . . . 0.0 111.451 -175.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -135.57 15.64 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 C-N-CA 125.702 1.601 . . . . 0.0 111.638 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 15.3 pt -54.36 171.56 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 126.272 1.829 . . . . 0.0 113.402 178.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -43.09 132.42 4.12 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.044 1.737 . . . . 0.0 113.258 178.299 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -54.75 -31.03 53.54 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 125.487 1.518 . . . . 0.0 116.147 -174.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.47 -22.58 67.0 Favored 'General case' 0 CA--C 1.547 0.834 0 O-C-N 121.648 -0.913 . . . . 0.0 112.636 174.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.3 t -98.25 -45.36 6.21 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.187 2.195 . . . . 0.0 111.722 176.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.522 HD23 ' HB3' ' A' ' 69' ' ' ALA . 3.2 tp -78.77 88.25 4.64 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.449 1.5 . . . . 0.0 111.062 174.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.2 p -120.28 -179.67 4.02 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 126.994 2.118 . . . . 0.0 111.976 177.17 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -45.4 -42.03 9.78 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.11 1.764 . . . . 0.0 113.523 175.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -52.91 -44.25 66.82 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 118.953 0.797 . . . . 0.0 111.819 177.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 61.4 t -64.13 -41.87 93.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 125.587 1.555 . . . . 0.0 111.651 175.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 29.3 mt -67.72 -40.13 84.26 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 120.845 -1.159 . . . . 0.0 111.933 179.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -63.64 -45.99 87.72 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.824 0.849 . . . . 0.0 111.786 178.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.74 -32.83 74.38 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-O 118.371 -0.823 . . . . 0.0 112.961 175.011 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 25.2 t -56.59 -42.02 75.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 CA-C-N 119.796 1.18 . . . . 0.0 111.48 177.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 49.2 mt -59.56 -13.29 8.68 Favored 'General case' 0 CA--C 1.552 1.045 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 175.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -104.67 -49.69 1.01 Allowed Glycine 0 CA--C 1.539 1.539 0 C-N-CA 126.855 2.169 . . . . 0.0 114.229 176.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -74.17 -30.41 62.23 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 119.186 1.493 . . . . 0.0 114.389 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -100.34 171.88 7.5 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.277 1.431 . . . . 0.0 110.463 174.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 154.83 131.49 1.48 Allowed Glycine 0 CA--C 1.534 1.22 0 O-C-N 121.122 -0.986 . . . . 0.0 114.601 177.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.4 mtpm? -113.5 -50.74 2.84 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 126.097 1.759 . . . . 0.0 114.0 176.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.7 m -132.25 -179.32 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 124.285 1.034 . . . . 0.0 112.348 -174.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.3 t -48.88 -42.37 36.49 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 126.082 1.753 . . . . 0.0 114.322 -175.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 8.8 tpp180 -124.69 136.35 53.82 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 126.297 1.839 . . . . 0.0 108.964 174.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.537 ' HB2' HD13 ' A' ' 3' ' ' LEU . 0.1 OUTLIER -130.58 167.64 18.39 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.333 1.453 . . . . 0.0 110.8 178.292 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -137.41 133.04 46.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 124.187 0.995 . . . . 0.0 108.38 174.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -134.21 95.84 3.49 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 127.61 2.364 . . . . 0.0 109.855 -178.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.672 HG22 ' HB2' ' A' ' 72' ' ' TYR . 1.4 m -98.91 167.02 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 123.212 0.605 . . . . 0.0 111.552 179.113 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -142.59 108.69 0.53 Allowed Glycine 0 CA--C 1.523 0.562 0 CA-C-O 119.645 -0.53 . . . . 0.0 113.414 174.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.9 mp -98.51 144.31 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 117.929 0.865 . . . . 0.0 109.184 175.035 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -119.61 102.83 8.9 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.143 1.377 . . . . 0.0 111.161 -178.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -70.73 85.29 0.65 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 129.44 3.096 . . . . 0.0 113.047 -175.009 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.57 3.37 13.99 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.746 1.619 . . . . 0.0 113.658 175.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.5 m -55.56 -30.89 61.59 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 115.335 1.605 . . . . 0.0 115.335 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 111.06 95.68 2.31 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.576 1.084 . . . . 0.0 112.098 -177.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 113.51 160.11 13.78 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 126.102 1.81 . . . . 0.0 112.625 -178.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.623 HG22 ' HA ' ' A' ' 65' ' ' PRO . 80.8 p -69.34 148.2 50.03 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 121.975 -0.721 . . . . 0.0 111.563 175.238 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 34.9 m0 -103.32 105.85 16.22 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.925 0.89 . . . . 0.0 109.584 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 59.4 m -92.75 129.98 38.51 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.269 1.027 . . . . 0.0 110.466 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.85 127.98 33.83 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.045 0.938 . . . . 0.0 112.22 174.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -117.14 -43.6 2.84 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.698 1.199 . . . . 0.0 112.269 175.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -170.04 149.64 3.63 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.467 1.907 . . . . 0.0 110.955 -178.34 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -133.38 155.84 48.74 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.382 1.473 . . . . 0.0 110.231 175.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -138.2 97.69 3.45 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.048 1.339 . . . . 0.0 111.413 -178.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.496 ' CD1' ' HB1' ' A' ' 87' ' ' ALA . 2.3 m-85 -99.17 111.99 24.25 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.356 1.062 . . . . 0.0 110.646 177.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.13 -39.45 16.69 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.278 0.631 . . . . 0.0 111.563 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.5 t -129.3 -177.08 4.09 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.623 2.369 . . . . 0.0 107.591 174.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 55.52 24.33 38.56 Favored Glycine 0 CA--C 1.538 1.493 0 O-C-N 121.178 -0.951 . . . . 0.0 113.783 -179.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.3 p -33.18 106.01 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 129.185 2.994 . . . . 0.0 112.719 -175.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.509 HG21 HG23 ' A' ' 59' ' ' ILE . 5.0 t -109.92 -177.22 3.21 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -174.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -92.44 -64.1 1.15 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.781 2.032 . . . . 0.0 112.21 175.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.2 p -144.06 131.91 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.989 1.315 . . . . 0.0 111.686 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.509 HG23 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -131.01 -20.01 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 126.046 1.739 . . . . 0.0 113.595 178.21 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.3 mp -106.8 88.47 3.56 Favored Pre-proline 0 N--CA 1.45 -0.434 0 C-N-CA 125.902 1.681 . . . . 0.0 107.279 -174.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -59.14 151.9 63.45 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.615 2.21 . . . . 0.0 110.843 176.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -42.87 -49.02 5.89 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.335 1.854 . . . . 0.0 113.523 -178.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.6 p -160.79 140.63 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 127.039 2.136 . . . . 0.0 109.259 175.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 66.3 t -116.91 127.46 26.71 Favored Pre-proline 0 N--CA 1.477 0.92 0 C-N-CA 124.63 1.172 . . . . 0.0 108.325 175.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.623 ' HA ' HG22 ' A' ' 43' ' ' THR . 60.4 Cg_endo -66.23 157.65 58.87 Favored 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 122.123 1.882 . . . . 0.0 112.424 178.168 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -70.47 160.63 32.06 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 121.785 -0.572 . . . . 0.0 110.66 175.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 31.8 p 60.96 19.14 9.56 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 126.621 1.969 . . . . 0.0 113.697 -174.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 42.2 mttt -131.65 171.24 13.7 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.612 1.565 . . . . 0.0 111.489 -178.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.522 ' HB3' HD23 ' A' ' 13' ' ' LEU . . . -122.52 179.11 4.7 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 123.855 0.862 . . . . 0.0 111.839 -174.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -149.75 168.99 22.11 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 125.526 1.53 . . . . 0.0 110.948 174.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.412 HD13 ' O ' ' A' ' 34' ' ' VAL . 0.4 OUTLIER -119.08 158.14 26.45 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.879 1.672 . . . . 0.0 111.323 178.548 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.672 ' HB2' HG22 ' A' ' 34' ' ' VAL . 9.1 m-85 -130.27 144.25 51.26 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.343 1.057 . . . . 0.0 110.051 174.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.5 p -120.58 138.57 53.81 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 126.812 2.045 . . . . 0.0 110.365 175.097 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.503 ' N ' HD12 ' A' ' 3' ' ' LEU . . . -150.85 129.73 2.98 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 174.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.06 107.2 9.41 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 127.67 2.388 . . . . 0.0 111.599 -175.004 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.96 -174.11 0.43 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 126.092 1.757 . . . . 0.0 112.875 176.016 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.4 t 69.57 37.74 1.88 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.883 1.673 . . . . 0.0 113.476 175.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.7 t -66.53 -24.12 66.33 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.833 1.253 . . . . 0.0 114.119 177.054 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 130.13 -64.98 0.6 Allowed Glycine 0 CA--C 1.538 1.507 0 C-N-CA 125.259 1.409 . . . . 0.0 113.373 -175.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -71.74 -31.97 12.34 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.97 2.447 . . . . 0.0 114.017 -175.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.8 p -151.13 157.1 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 125.365 1.466 . . . . 0.0 111.083 177.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -153.5 96.84 2.07 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.213 1.405 . . . . 0.0 112.021 -177.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 42.2 m -124.29 141.39 52.11 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 125.658 1.583 . . . . 0.0 108.929 175.025 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -21.98 -74.9 0.01 OUTLIER Glycine 0 N--CA 1.485 1.937 0 C-N-CA 127.452 2.453 . . . . 0.0 113.742 -178.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -163.05 120.4 1.92 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.869 1.668 . . . . 0.0 109.839 174.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.9 t -144.1 114.55 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.168 0.987 . . . . 0.0 109.826 -178.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.566 ' HB3' ' CZ ' ' A' ' 103' ' ' PHE . . . -163.29 164.36 24.93 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.964 0.888 . . . . 0.0 113.186 -176.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -144.52 162.19 37.19 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.252 1.421 . . . . 0.0 112.076 174.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -160.78 172.65 16.66 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 124.672 1.189 . . . . 0.0 110.575 179.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.49 ' HB2' ' HB2' ' A' ' 127' ' ' ALA . . . -136.81 160.38 39.04 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 175.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -137.37 131.18 31.72 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.835 1.254 . . . . 0.0 113.892 175.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -79.36 109.04 13.34 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.947 0.899 . . . . 0.0 110.691 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 4.0 ttm -72.1 145.08 48.42 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.143 0.977 . . . . 0.0 111.937 175.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 14.3 t -61.69 -28.16 69.2 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.296 1.038 . . . . 0.0 112.955 175.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 -69.44 -8.09 43.66 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.825 1.25 . . . . 0.0 113.782 175.013 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 91.95 39.53 5.46 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.318 0.961 . . . . 0.0 113.951 177.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -138.34 171.88 13.72 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.184 1.393 . . . . 0.0 110.484 175.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.432 HG21 ' O ' ' A' ' 125' ' ' ARG . 53.5 m -122.22 111.9 17.52 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 119.075 0.852 . . . . 0.0 113.163 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 61.9 tp -73.32 101.44 3.42 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.583 1.953 . . . . 0.0 110.404 174.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -91.01 117.6 5.18 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 126.221 1.867 . . . . 0.0 112.318 176.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 91.1 t -119.17 141.62 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 125.642 1.577 . . . . 0.0 110.68 -175.036 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 2.9 ppp? -148.37 170.22 18.44 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.897 0.856 . . . . 0.0 113.296 174.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.566 ' CZ ' ' HB3' ' A' ' 87' ' ' ALA . 18.0 p90 -152.71 149.28 28.22 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.625 1.57 . . . . 0.0 113.89 175.396 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 22.4 t -143.1 107.71 4.84 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.585 1.554 . . . . 0.0 110.086 175.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 10.8 m -127.48 97.69 30.46 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 125.597 1.559 . . . . 0.0 109.021 175.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -69.54 172.09 13.05 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 122.564 2.176 . . . . 0.0 111.46 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -87.62 -58.18 2.67 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.387 0.675 . . . . 0.0 110.732 174.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -61.93 -35.53 78.69 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.249 1.42 . . . . 0.0 113.961 -174.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 54.38 9.16 0.23 Allowed 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 126.805 2.042 . . . . 0.0 115.886 -176.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -74.62 -75.55 0.16 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.111 1.765 . . . . 0.0 113.82 -175.01 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 75.7 m95 -108.05 -42.18 4.73 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.327 1.451 . . . . 0.0 114.105 -175.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -59.22 109.03 0.77 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.73 1.212 . . . . 0.0 111.437 178.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 19.3 m -57.0 143.21 39.03 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.528 1.131 . . . . 0.0 111.276 175.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -124.66 95.69 4.61 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.239 1.015 . . . . 0.0 109.898 -176.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 51.9 m0 -110.74 148.24 32.74 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.19 0.519 . . . . 0.0 111.656 -177.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 17.5 p-90 -149.13 135.17 19.03 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.366 0.667 . . . . 0.0 112.566 -174.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -161.4 173.39 14.99 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 122.732 1.253 . . . . 0.0 113.111 175.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 60.3 t -138.59 143.85 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 126.462 1.905 . . . . 0.0 107.98 176.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.67 174.56 11.34 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.601 1.561 . . . . 0.0 110.565 178.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 26.0 mt -127.09 138.77 53.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 174.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 99.7 m-85 -102.35 149.56 36.77 Favored Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 125.103 1.361 . . . . 0.0 111.966 176.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -69.48 113.39 3.31 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.861 3.041 . . . . 0.0 111.321 176.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 69.16 -171.63 39.14 Favored Glycine 0 CA--C 1.537 1.421 0 O-C-N 121.896 -0.503 . . . . 0.0 114.119 -175.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 11.8 tmtt? -58.15 113.15 1.79 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.565 1.546 . . . . 0.0 111.594 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.432 ' O ' HG21 ' A' ' 98' ' ' THR . 0.0 OUTLIER -134.08 113.69 12.37 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.768 1.227 . . . . 0.0 111.465 -178.782 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 4.5 ptp180 -57.65 161.72 3.49 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.711 -0.618 . . . . 0.0 112.308 175.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.49 ' HB2' ' HB2' ' A' ' 90' ' ' ALA . . . -113.12 99.02 7.51 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 175.031 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -124.5 167.48 14.38 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.591 1.556 . . . . 0.0 109.988 -177.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -53.25 -38.94 63.46 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.185 0.994 . . . . 0.0 113.425 -177.222 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -60.61 -57.67 17.77 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 123.753 0.692 . . . . 0.0 112.151 176.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 3.3 mtm -61.4 -37.22 82.65 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.326 0.65 . . . . 0.0 112.524 178.045 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.82 -62.91 1.46 Allowed 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.768 0.713 . . . . 0.0 110.0 174.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -60.37 -40.4 90.68 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.104 0.962 . . . . 0.0 113.145 -175.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -60.53 -46.48 90.02 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.062 0.945 . . . . 0.0 112.441 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 78.1 mmm -82.25 -30.84 30.49 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 177.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -55.19 -57.21 12.7 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.295 1.838 . . . . 0.0 110.769 175.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.32 -20.09 65.99 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-O 121.439 0.638 . . . . 0.0 112.166 -177.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -80.35 -2.55 89.41 Favored Glycine 0 CA--C 1.538 1.483 0 C-N-CA 126.744 2.116 . . . . 0.0 114.839 175.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -141.77 77.32 19.06 Favored Pre-proline 0 CA--C 1.553 1.081 0 CA-C-N 119.62 1.71 . . . . 0.0 114.145 -175.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.89 101.05 1.27 Allowed 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 123.688 2.925 . . . . 0.0 113.266 -176.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -138.2 123.31 19.16 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.583 1.153 . . . . 0.0 110.704 178.39 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 4.6 mpt_? -93.34 -157.29 0.53 Allowed 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 125.297 1.439 . . . . 0.0 111.081 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -86.12 77.5 2.03 Favored Glycine 0 CA--C 1.531 1.037 0 O-C-N 120.132 -1.605 . . . . 0.0 110.116 175.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -75.99 85.14 2.89 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.152 1.781 . . . . 0.0 111.171 -175.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -54.43 116.39 2.62 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 -174.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 141.78 -73.01 0.38 Allowed Glycine 0 CA--C 1.533 1.212 0 C-N-CA 125.251 1.405 . . . . 0.0 114.057 175.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 27.9 m95 169.19 106.33 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 131.199 3.8 . . . . 0.0 108.485 -174.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -137.92 132.19 32.04 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 127.327 2.251 . . . . 0.0 110.471 -177.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -158.38 -173.66 4.42 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -175.038 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.3 mtmm -140.4 162.84 34.36 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 126.501 1.921 . . . . 0.0 111.564 175.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -73.29 137.34 44.8 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.431 1.092 . . . . 0.0 109.456 174.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 45.1 mt -92.97 88.74 6.26 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.294 1.038 . . . . 0.0 110.478 177.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 35.81 -76.45 0.0 OUTLIER Glycine 0 N--CA 1.477 1.405 1 C-N-CA 130.83 4.062 . . . . 0.0 116.592 175.059 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -70.02 -153.45 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 128.311 2.645 . . . . 0.0 110.472 175.024 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -75.42 24.52 1.42 Allowed Glycine 0 CA--C 1.542 1.742 0 O-C-N 120.15 -1.594 . . . . 0.0 115.072 174.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.84 149.06 24.58 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 120.211 2.005 . . . . 0.0 111.698 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 61.5 mtt85 -140.89 114.33 8.73 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.736 1.214 . . . . 0.0 111.433 177.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' MET . . . . . 0.402 ' SD ' HG21 ' A' ' 172' ' ' ILE . 8.0 ttp -94.96 143.17 26.68 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 125.28 1.432 . . . . 0.0 108.803 175.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 4.4 tppt? -121.98 124.9 45.11 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 127.199 2.199 . . . . 0.0 109.853 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -137.58 158.61 24.59 Favored Glycine 0 N--CA 1.478 1.439 0 N-CA-C 117.974 1.95 . . . . 0.0 117.974 -175.013 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.518 HD13 ' N ' ' A' ' 162' ' ' MET . 0.0 OUTLIER -147.69 131.72 9.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 C-N-CA 125.372 1.469 . . . . 0.0 111.668 -177.049 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 162' ' ' MET . . . . . 0.518 ' N ' HD13 ' A' ' 161' ' ' ILE . 3.5 mtm -149.77 160.93 43.16 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 128.537 2.735 . . . . 0.0 108.231 174.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 5.5 t -140.89 133.91 29.28 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 121.133 -0.979 . . . . 0.0 112.003 174.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 45.6 m -74.4 12.29 0.8 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.433 1.493 . . . . 0.0 114.187 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -51.01 -43.0 60.76 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.77 1.628 . . . . 0.0 114.21 176.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 146.91 -77.79 0.25 Allowed Glycine 0 CA--C 1.532 1.105 0 C-N-CA 125.139 1.352 . . . . 0.0 112.845 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 27.5 tp10 -95.83 43.81 1.08 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 125.145 1.378 . . . . 0.0 110.831 -177.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -77.24 172.57 13.07 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.301 1.04 . . . . 0.0 112.928 178.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.402 ' HE2' ' O ' ' A' ' 169' ' ' LYS . 0.0 OUTLIER -114.07 173.93 6.19 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 126.711 2.004 . . . . 0.0 109.633 174.919 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 2.0 tmm? -126.85 123.17 36.7 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 125.385 1.474 . . . . 0.0 109.12 178.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -132.4 128.46 37.6 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.504 0.721 . . . . 0.0 110.532 177.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.402 HG21 ' SD ' ' A' ' 158' ' ' MET . 4.8 mp -135.61 122.97 35.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 123.428 0.691 . . . . 0.0 110.11 175.047 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -118.88 136.1 54.22 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.556 1.542 . . . . 0.0 110.043 176.28 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.8 mp -82.93 137.15 21.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 O-C-N 121.315 -0.866 . . . . 0.0 109.241 175.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 9.3 m -128.78 95.9 4.23 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.229 1.012 . . . . 0.0 111.85 176.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 7.2 mmm180 . . . . . 0 C--O 1.253 1.288 0 C-N-CA 126.296 1.838 . . . . 0.0 111.75 174.945 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 37.4 m . . . . . 0 N--CA 1.478 0.954 0 CA-C-O 121.042 0.448 . . . . 0.0 110.555 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -143.4 177.87 8.14 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 128.295 2.638 . . . . 0.0 109.615 -177.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.502 HD11 ' HB2' ' A' ' 31' ' ' LYS . 16.1 mt -121.28 -10.84 8.88 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.736 1.214 . . . . 0.0 112.908 174.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -75.14 96.08 3.21 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.626 -0.671 . . . . 0.0 110.083 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -60.94 -75.48 0.29 Allowed Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.426 1.013 . . . . 0.0 112.314 -176.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 27.4 p -150.85 172.3 15.85 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 127.189 2.196 . . . . 0.0 110.423 174.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -124.79 5.51 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 124.934 1.294 . . . . 0.0 112.75 175.067 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 pt -24.42 -75.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 129.591 3.156 . . . . 0.0 116.673 -176.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -162.47 137.59 6.97 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.218 1.407 . . . . 0.0 111.324 -177.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.65 -21.49 58.07 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 124.577 1.084 . . . . 0.0 114.641 -178.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.27 -31.11 72.18 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.233 1.013 . . . . 0.0 113.175 174.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.5 t -102.96 -40.87 6.32 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 125.083 1.353 . . . . 0.0 111.726 175.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 14.3 tp -74.24 82.74 1.85 Allowed 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.235 1.414 . . . . 0.0 111.099 175.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.8 p -113.98 179.68 3.89 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 126.654 1.981 . . . . 0.0 112.425 176.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -47.47 -42.2 22.2 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.064 1.346 . . . . 0.0 113.019 176.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -57.55 -37.88 73.86 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.759 0.823 . . . . 0.0 112.174 178.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.6 t -67.48 -41.16 85.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.083 0.953 . . . . 0.0 110.283 175.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 21.3 mt -63.71 -41.08 98.15 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 121.33 -0.856 . . . . 0.0 110.961 177.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.39 -44.15 92.23 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.793 0.837 . . . . 0.0 112.641 178.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.68 -32.6 62.26 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 175.478 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.1 t -51.4 -46.49 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 C-N-CA 125.601 1.56 . . . . 0.0 111.933 175.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 15.0 mt -53.97 -20.15 5.76 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.188 1.395 . . . . 0.0 113.716 178.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -108.42 -40.08 1.68 Allowed Glycine 0 CA--C 1.537 1.415 0 C-N-CA 126.134 1.826 . . . . 0.0 114.926 178.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -72.05 -28.61 63.46 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 119.768 1.784 . . . . 0.0 113.965 179.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -92.24 133.36 35.89 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.83 1.252 . . . . 0.0 110.992 176.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.12 125.11 7.19 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 125.261 1.41 . . . . 0.0 113.852 -175.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.94 -172.19 4.15 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 126.366 1.866 . . . . 0.0 112.053 -177.024 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.9 m -72.47 -177.96 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 126.085 1.754 . . . . 0.0 110.898 174.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 60.9 m -49.7 -50.01 45.53 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.517 1.527 . . . . 0.0 113.529 -177.079 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -117.43 138.21 51.99 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.041 1.337 . . . . 0.0 110.662 175.057 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.502 ' HB2' HD11 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -141.42 161.09 38.75 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 126.132 1.773 . . . . 0.0 111.593 -175.062 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -131.25 114.25 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-O 122.238 1.018 . . . . 0.0 112.018 -179.382 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -117.31 111.51 19.48 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.735 2.014 . . . . 0.0 109.111 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.811 HG22 ' HB2' ' A' ' 72' ' ' TYR . 1.8 m -116.67 151.98 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 CA-C-O 119.097 -0.478 . . . . 0.0 111.272 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -131.12 101.34 0.48 Allowed Glycine 0 CA--C 1.524 0.649 0 C-N-CA 123.815 0.722 . . . . 0.0 112.872 -179.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.9 mp -91.93 136.22 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-N 118.209 1.005 . . . . 0.0 110.318 175.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -101.13 104.48 15.58 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.185 1.394 . . . . 0.0 110.666 178.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -70.39 82.74 0.56 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 127.889 2.476 . . . . 0.0 111.057 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -120.85 11.64 11.14 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 125.109 1.364 . . . . 0.0 114.144 175.007 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 99.8 p -60.15 -7.51 1.92 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 126.67 1.988 . . . . 0.0 116.351 174.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 93.57 21.05 30.1 Favored Glycine 0 CA--C 1.54 1.626 0 N-CA-C 116.281 1.272 . . . . 0.0 116.281 177.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -166.49 169.56 40.63 Favored Glycine 0 CA--C 1.535 1.305 0 CA-C-N 119.27 1.535 . . . . 0.0 114.196 176.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.556 HG22 ' HA ' ' A' ' 65' ' ' PRO . 7.3 p -72.98 141.75 47.75 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.81 1.244 . . . . 0.0 111.396 175.006 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.56 ' HA ' ' CE1' ' A' ' 91' ' ' TYR . 34.7 m0 -100.97 98.04 8.55 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 123.586 0.755 . . . . 0.0 112.353 -177.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.1 m -81.72 120.41 25.09 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.266 1.026 . . . . 0.0 108.704 175.027 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.08 150.51 45.33 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.685 -0.634 . . . . 0.0 112.145 174.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.8 pp -124.25 -51.02 1.77 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.639 0.776 . . . . 0.0 112.976 177.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -171.06 142.89 1.88 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 127.043 2.137 . . . . 0.0 109.738 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.431 ' HB2' HD12 ' A' ' 60' ' ' LEU . . . -121.17 151.44 39.93 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.614 1.166 . . . . 0.0 109.94 174.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -132.67 106.54 7.84 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.413 1.485 . . . . 0.0 111.27 -177.007 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.498 ' CD1' ' HB1' ' A' ' 87' ' ' ALA . 2.7 m-85 -111.58 124.64 52.71 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.481 1.112 . . . . 0.0 110.248 -175.287 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.13 -34.2 6.01 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 114.174 1.175 . . . . 0.0 114.174 -174.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 43.7 t -119.0 -47.92 2.47 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.657 1.183 . . . . 0.0 110.375 175.05 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -67.55 12.27 0.74 Allowed Glycine 0 CA--C 1.54 1.603 0 C-N-CA 126.865 2.174 . . . . 0.0 117.623 -174.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 76.0 p -27.14 107.69 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 129.597 3.159 . . . . 0.0 114.671 -175.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.482 HG21 HG23 ' A' ' 59' ' ' ILE . 3.9 t -128.75 -177.05 4.04 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.826 2.05 . . . . 0.0 113.509 -175.032 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -88.44 -54.79 4.01 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.051 1.341 . . . . 0.0 113.897 177.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.9 p -149.89 133.45 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 124.898 1.279 . . . . 0.0 111.99 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.482 HG23 HG21 ' A' ' 56' ' ' THR . 0.1 OUTLIER -136.68 -35.18 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 N-CA-C 114.838 1.422 . . . . 0.0 114.838 179.29 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.431 HD12 ' HB2' ' A' ' 49' ' ' ALA . 7.2 mt -88.5 100.05 1.78 Allowed Pre-proline 0 CA--C 1.543 0.694 0 C-N-CA 125.665 1.586 . . . . 0.0 108.599 176.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.576 ' HG2' HG23 ' A' ' 64' ' ' VAL . 89.3 Cg_endo -68.51 150.53 75.34 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 122.554 2.17 . . . . 0.0 110.985 176.241 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -48.1 -45.54 32.85 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.983 1.313 . . . . 0.0 113.446 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.2 p -156.26 136.19 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 126.398 1.879 . . . . 0.0 110.287 175.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.576 HG23 ' HG2' ' A' ' 61' ' ' PRO . 72.7 t -113.71 129.96 24.22 Favored Pre-proline 0 N--CA 1.481 1.079 0 C-N-CA 124.55 1.14 . . . . 0.0 108.691 174.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.556 ' HA ' HG22 ' A' ' 43' ' ' THR . 66.4 Cg_endo -70.43 158.25 56.63 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 122.667 2.245 . . . . 0.0 113.271 178.211 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -72.94 160.72 31.67 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 121.421 -0.799 . . . . 0.0 112.726 175.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . 0.275 51.4 p 57.64 23.77 9.74 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 127.077 2.151 . . . . 0.0 113.689 -175.002 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -119.03 -178.32 3.54 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 126.765 2.026 . . . . 0.0 110.732 178.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -136.54 152.54 50.61 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 175.003 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.452 HD23 HG21 ' A' ' 64' ' ' VAL . 1.5 pp -117.7 171.01 8.32 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 124.417 1.087 . . . . 0.0 110.963 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.464 HD13 ' O ' ' A' ' 34' ' ' VAL . 0.3 OUTLIER -126.22 153.41 44.75 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.624 1.17 . . . . 0.0 111.004 175.47 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.811 ' HB2' HG22 ' A' ' 34' ' ' VAL . 6.3 m-85 -125.88 153.39 44.24 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.832 1.653 . . . . 0.0 108.835 174.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.402 ' H ' HG22 ' A' ' 59' ' ' ILE . 95.8 p -133.97 141.36 47.26 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 126.197 1.799 . . . . 0.0 111.3 176.286 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.473 ' H ' HD12 ' A' ' 3' ' ' LEU . . . -162.12 150.38 19.62 Favored Glycine 0 CA--C 1.524 0.624 0 O-C-N 121.916 -0.49 . . . . 0.0 113.092 174.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 11.4 mtm180 -112.24 130.83 55.8 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 126.289 1.836 . . . . 0.0 111.968 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -61.15 -30.85 70.63 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.688 1.595 . . . . 0.0 115.12 175.006 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 26.0 m -74.69 72.99 2.02 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 127.25 2.22 . . . . 0.0 113.898 -175.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 52.2 p -66.61 -21.68 66.13 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 177.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 126.37 -74.69 0.42 Allowed Glycine 0 CA--C 1.537 1.448 0 C-N-CA 126.494 1.997 . . . . 0.0 112.036 -175.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.62 -50.46 0.29 Allowed 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 123.723 2.949 . . . . 0.0 113.946 -175.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.1 m -142.67 126.94 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 125.695 1.598 . . . . 0.0 111.646 -176.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -83.38 103.64 12.91 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.48 1.112 . . . . 0.0 111.965 178.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 42.9 m -112.63 71.69 0.75 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.064 1.346 . . . . 0.0 111.263 -174.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 37.82 -114.26 0.28 Allowed Glycine 0 CA--C 1.533 1.193 0 C-N-CA 126.103 1.811 . . . . 0.0 113.969 -178.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.593 ' HB3' HG22 ' A' ' 105' ' ' VAL . . . -141.45 114.84 8.84 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 118.458 1.129 . . . . 0.0 111.274 176.193 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.2 t -137.33 122.25 24.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 C-N-CA 124.323 1.049 . . . . 0.0 110.18 -176.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.498 ' HB1' ' CD1' ' A' ' 51' ' ' PHE . . . -163.51 171.34 16.0 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.302 1.441 . . . . 0.0 111.359 175.043 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -151.48 134.38 15.75 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.889 1.275 . . . . 0.0 109.943 174.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.424 ' CD2' ' CE2' ' A' ' 72' ' ' TYR . 54.3 p90 -129.72 171.24 12.87 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 121.27 -0.894 . . . . 0.0 110.285 177.388 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -143.26 143.9 31.91 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 175.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.56 ' CE1' ' HA ' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -109.98 131.36 55.13 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.497 1.119 . . . . 0.0 109.995 177.289 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -84.51 107.6 16.84 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.364 0.665 . . . . 0.0 112.593 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -68.38 141.64 55.68 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.45 1.1 . . . . 0.0 112.94 -178.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 58.0 p -60.15 -28.24 67.75 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.845 1.258 . . . . 0.0 112.548 174.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 -72.24 -8.23 53.68 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.731 1.612 . . . . 0.0 112.757 174.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 99.99 -6.71 58.52 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 126.662 2.077 . . . . 0.0 114.362 -178.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 53.5 m-20 -78.12 178.33 7.64 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 118.339 1.07 . . . . 0.0 111.34 178.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 19.0 m -139.31 109.12 6.28 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 120.453 -1.404 . . . . 0.0 111.22 174.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.6 tt -72.8 101.81 3.22 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.566 1.146 . . . . 0.0 111.289 175.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -92.79 127.78 9.14 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 125.171 1.367 . . . . 0.0 113.333 175.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 63.5 t -114.44 127.02 72.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 125.763 1.625 . . . . 0.0 111.224 -175.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.11 118.61 24.71 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 126.733 2.013 . . . . 0.0 112.438 -175.052 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -141.69 121.28 13.34 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.33 1.452 . . . . 0.0 111.642 -175.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 30.4 t -137.3 92.53 2.72 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.473 1.509 . . . . 0.0 110.92 -175.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.593 HG22 ' HB3' ' A' ' 85' ' ' ALA . 2.1 m -103.09 125.73 34.4 Favored Pre-proline 0 N--CA 1.473 0.68 0 C-N-CA 125.105 1.362 . . . . 0.0 109.669 -179.241 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -75.72 175.25 11.53 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 122.933 2.422 . . . . 0.0 111.582 176.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -95.98 -52.62 3.98 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.581 1.153 . . . . 0.0 112.401 178.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 26.1 p30 -95.0 -4.5 46.47 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.691 1.596 . . . . 0.0 114.72 -176.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 47.15 31.25 1.6 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 127.005 2.122 . . . . 0.0 113.974 -177.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -122.06 143.5 49.48 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.189 1.795 . . . . 0.0 111.716 -175.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 22.8 m95 55.89 14.48 1.38 Allowed 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 126.574 1.95 . . . . 0.0 114.636 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -149.86 175.94 11.18 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 127.408 2.283 . . . . 0.0 111.858 -174.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 17.1 m -139.37 136.11 34.41 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.648 1.179 . . . . 0.0 113.93 175.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 32.5 t-20 -74.34 106.29 5.9 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.08 1.752 . . . . 0.0 107.912 175.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 44.3 m0 -113.16 145.68 40.53 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 120.297 1.408 . . . . 0.0 108.31 174.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 39.2 p-90 -149.02 142.82 25.63 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.095 0.958 . . . . 0.0 113.047 -177.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -151.69 165.77 33.34 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 123.292 1.52 . . . . 0.0 113.821 -177.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 94.7 t -147.41 129.54 7.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 125.894 1.678 . . . . 0.0 107.349 175.014 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.33 171.6 14.23 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.515 1.526 . . . . 0.0 110.127 175.083 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 35.3 mt -134.32 118.59 27.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.762 0.792 . . . . 0.0 109.231 -176.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -80.59 139.12 50.97 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 124.185 0.994 . . . . 0.0 109.23 178.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -72.97 -1.53 10.63 Favored 'Trans proline' 0 CA--C 1.546 1.119 0 C-N-CA 123.706 2.937 . . . . 0.0 114.948 -178.005 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -141.74 176.27 22.04 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 126.857 2.17 . . . . 0.0 111.94 175.02 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 9.9 tttm -64.26 105.61 0.94 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.934 1.294 . . . . 0.0 110.884 176.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 11.2 tpp180 -138.77 117.96 12.67 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 124.381 1.072 . . . . 0.0 113.22 -174.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 15.4 ptt180 -62.98 165.42 6.9 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 175.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -110.22 103.18 11.84 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 174.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -111.8 170.82 7.88 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.329 1.051 . . . . 0.0 109.642 175.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -50.07 -39.52 42.46 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.377 0.99 . . . . 0.0 113.304 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -59.42 -59.72 10.11 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 123.869 0.747 . . . . 0.0 112.175 175.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 14.6 mtm -61.82 -35.33 77.9 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 118.058 0.929 . . . . 0.0 113.298 178.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -60.56 -60.49 3.73 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.088 1.355 . . . . 0.0 109.756 175.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -67.26 -29.75 69.45 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -63.96 -36.73 84.91 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.34 1.056 . . . . 0.0 113.019 176.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 7.9 tpp -94.53 -22.23 18.36 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 119.695 1.134 . . . . 0.0 113.463 175.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -49.28 -56.6 8.88 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.602 1.561 . . . . 0.0 110.316 175.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -71.19 -7.02 43.93 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -178.396 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -84.89 -12.83 73.52 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 126.983 2.23 . . . . 0.0 114.946 -178.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -145.54 90.27 6.04 Favored Pre-proline 0 CA--C 1.552 1.025 0 CA-C-N 119.309 1.555 . . . . 0.0 112.956 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -75.48 81.8 2.23 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 123.674 2.916 . . . . 0.0 112.19 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -116.97 111.64 19.87 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.985 1.314 . . . . 0.0 110.182 -177.253 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -92.61 41.36 1.07 Allowed 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 127.564 2.346 . . . . 0.0 114.05 -174.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 55.77 51.76 53.03 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 123.704 0.669 . . . . 0.0 112.538 -177.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -61.01 113.63 2.65 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.613 1.165 . . . . 0.0 111.418 -176.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -75.96 83.18 2.85 Favored 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 -175.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 173.09 55.07 0.05 OUTLIER Glycine 0 CA--C 1.539 1.544 0 C-N-CA 125.107 1.336 . . . . 0.0 114.135 175.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' TRP . . . . . 0.63 ' H ' HD13 ' A' ' 161' ' ' ILE . 7.5 m95 48.16 41.72 16.15 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 126.81 2.044 . . . . 0.0 114.077 -174.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -72.75 126.96 31.15 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 120.845 -1.16 . . . . 0.0 111.784 -175.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.15 -170.23 3.06 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -174.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.71 140.92 36.92 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 126.043 1.737 . . . . 0.0 110.447 175.043 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -67.0 149.36 50.74 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 174.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 29.3 mt -119.79 158.42 26.59 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-O 123.824 1.773 . . . . 0.0 111.435 178.014 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -64.45 -157.5 0.23 Allowed Glycine 0 CA--C 1.54 1.623 0 C-N-CA 125.62 1.581 . . . . 0.0 111.2 174.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 51.46 15.12 0.3 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.944 -1.327 . . . . 0.0 114.527 175.016 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 72.66 34.83 59.46 Favored Glycine 0 CA--C 1.54 1.608 0 CA-C-O 117.141 -1.922 . . . . 0.0 113.805 -175.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -139.21 159.41 42.23 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 121.21 2.505 . . . . 0.0 115.188 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 19.4 mtt-85 -135.33 123.7 23.28 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 120.439 -1.413 . . . . 0.0 108.693 -177.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 13.7 ttp -96.14 136.38 36.69 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 176.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.85 129.21 56.33 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 126.803 2.041 . . . . 0.0 109.867 -178.054 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -136.8 156.36 23.16 Favored Glycine 0 N--CA 1.476 1.36 0 CA-C-N 121.684 2.038 . . . . 0.0 116.293 -177.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.63 HD13 ' H ' ' A' ' 147' ' ' TRP . 6.1 tp -154.56 126.43 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 124.96 1.304 . . . . 0.0 112.527 -174.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 19.5 ttm -148.82 -176.27 5.27 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 128.641 2.776 . . . . 0.0 108.509 177.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 8.9 t -163.01 127.31 2.98 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.527 1.131 . . . . 0.0 111.631 174.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.37 19.61 0.1 Allowed 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.027 1.331 . . . . 0.0 114.11 178.101 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -58.34 -25.94 62.55 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 127.291 2.236 . . . . 0.0 115.631 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 147.14 -57.87 0.49 Allowed Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.562 1.077 . . . . 0.0 114.48 175.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -133.28 37.9 3.34 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.144 1.378 . . . . 0.0 112.001 -178.079 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.33 174.58 4.65 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-O 122.61 1.195 . . . . 0.0 113.849 175.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.64 176.26 5.22 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 127.741 2.416 . . . . 0.0 111.527 175.023 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 1.8 tmm? -128.18 130.91 48.76 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 126.277 1.831 . . . . 0.0 109.648 175.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.448 ' C ' HD12 ' A' ' 172' ' ' ILE . 47.1 tt0 -141.14 131.39 24.96 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.48 1.112 . . . . 0.0 110.203 -178.218 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.448 HD12 ' C ' ' A' ' 171' ' ' GLN . 4.0 mp -136.11 126.01 40.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 123.883 0.873 . . . . 0.0 109.612 175.032 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -119.39 129.27 54.72 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 126.516 1.926 . . . . 0.0 111.119 178.365 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.6 mp -88.55 93.1 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 O-C-N 121.278 -0.889 . . . . 0.0 109.692 -177.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.04 107.51 19.26 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.628 1.571 . . . . 0.0 112.691 179.096 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.252 1.188 0 C-N-CA 125.547 1.539 . . . . 0.0 112.836 175.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 16.0 m . . . . . 0 N--CA 1.482 1.138 0 CA-C-O 120.33 0.11 . . . . 0.0 110.815 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -84.3 169.43 14.69 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.785 1.234 . . . . 0.0 112.781 177.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.479 HD22 ' HD3' ' A' ' 27' ' ' LYS . 13.7 tp -130.11 -7.82 4.35 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.716 1.206 . . . . 0.0 113.779 174.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -126.1 141.11 52.08 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 127.813 2.445 . . . . 0.0 109.213 175.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -79.75 -136.95 1.51 Allowed Glycine 0 CA--C 1.538 1.504 0 C-N-CA 124.844 1.212 . . . . 0.0 110.989 174.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.0 p -107.31 176.01 5.3 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 125.5 1.52 . . . . 0.0 112.941 -175.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -119.13 17.26 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 126.352 1.861 . . . . 0.0 111.945 -178.16 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.3 pt -50.39 159.64 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 125.662 1.585 . . . . 0.0 111.349 175.006 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -42.82 140.26 1.4 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.456 1.502 . . . . 0.0 113.328 -176.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -56.29 -20.9 31.01 Favored Glycine 0 CA--C 1.543 1.788 0 C-N-CA 124.28 0.943 . . . . 0.0 113.745 -176.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.2 -28.55 69.82 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.621 1.568 . . . . 0.0 112.609 174.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 t -101.28 -44.57 5.61 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.974 1.71 . . . . 0.0 111.515 175.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.7 tp -75.81 88.49 2.84 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.278 1.031 . . . . 0.0 111.429 175.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 55.1 p -124.65 -175.09 3.18 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 126.156 1.782 . . . . 0.0 111.344 176.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -50.3 -31.36 14.13 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.851 1.26 . . . . 0.0 113.645 175.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -59.46 -50.31 74.4 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 118.97 0.805 . . . . 0.0 110.902 175.043 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 73.8 t -64.53 -39.13 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 123.915 0.886 . . . . 0.0 110.974 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 90.2 mt -70.58 -42.12 71.48 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 123.349 0.66 . . . . 0.0 112.62 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -71.17 -44.21 65.93 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.953 0.901 . . . . 0.0 111.607 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.72 -39.8 95.2 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 118.426 -0.797 . . . . 0.0 110.826 175.012 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.0 t -53.5 -43.59 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 125.054 1.342 . . . . 0.0 112.271 175.008 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.486 ' HA ' ' HE3' ' A' ' 31' ' ' LYS . 0.1 OUTLIER -60.39 -25.99 66.33 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 175.015 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.57 -48.92 3.33 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.203 0.906 . . . . 0.0 112.979 178.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -70.61 -27.44 64.09 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 17.8 mt -109.31 102.22 11.15 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.737 1.215 . . . . 0.0 110.461 -177.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -131.77 73.15 0.47 Allowed Glycine 0 CA--C 1.534 1.252 0 C-N-CA 125.112 1.339 . . . . 0.0 113.364 -175.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.479 ' HD3' HD22 ' A' ' 3' ' ' LEU . 0.1 OUTLIER -62.0 -58.68 6.96 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 126.416 1.886 . . . . 0.0 113.683 -178.646 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 16.4 m -127.27 -176.92 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 126.497 1.919 . . . . 0.0 110.748 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -47.98 -36.49 12.71 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 115.576 1.695 . . . . 0.0 115.576 -175.023 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.8 155.69 49.48 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.711 2.004 . . . . 0.0 108.01 174.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.486 ' HE3' ' HA ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -145.67 164.19 32.55 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.919 1.287 . . . . 0.0 110.768 175.988 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.501 ' CG1' ' HB1' ' A' ' 85' ' ' ALA . 0.3 OUTLIER -118.49 138.16 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 124.572 1.149 . . . . 0.0 108.439 175.018 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.452 ' HB3' HD12 ' A' ' 22' ' ' LEU . . . -138.68 132.04 30.22 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.147 1.379 . . . . 0.0 109.597 175.018 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.402 HG22 ' HB3' ' A' ' 170' ' ' MET . 16.5 t -137.91 148.29 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 123.364 0.666 . . . . 0.0 111.398 -177.095 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -119.47 93.13 0.54 Allowed Glycine 0 CA--C 1.525 0.677 0 C-N-CA 126.658 2.075 . . . . 0.0 113.161 175.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.7 mp -81.4 136.43 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-N 119.424 1.612 . . . . 0.0 108.788 174.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -112.65 102.46 10.52 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.164 1.786 . . . . 0.0 109.868 178.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -70.32 92.43 0.79 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.867 1.267 . . . . 0.0 109.563 177.182 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -117.29 0.26 12.2 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.052 1.741 . . . . 0.0 112.722 174.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 23.0 t -50.77 -58.89 4.82 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 126.141 1.776 . . . . 0.0 113.249 -178.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 149.49 -26.4 1.21 Allowed Glycine 0 N--CA 1.473 1.15 0 C-N-CA 124.165 0.888 . . . . 0.0 114.113 178.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -115.96 162.79 12.47 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.541 1.544 . . . . 0.0 111.226 175.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.4 t -85.13 155.58 21.41 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 123.879 0.872 . . . . 0.0 110.781 175.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 7.7 m0 -111.46 153.57 25.95 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 125.352 1.461 . . . . 0.0 112.031 176.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 95.0 m -130.24 141.46 50.63 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.853 1.261 . . . . 0.0 109.925 177.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.47 108.83 0.52 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.749 1.22 . . . . 0.0 112.571 177.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.508 HD11 ' HB3' ' A' ' 90' ' ' ALA . 3.5 pp -104.85 -53.71 2.63 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.286 1.034 . . . . 0.0 112.234 -179.333 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.476 ' N ' HD12 ' A' ' 47' ' ' LEU . 29.3 t30 -177.73 144.8 0.38 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 127.907 2.483 . . . . 0.0 110.415 -178.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -130.54 159.31 37.5 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.111 1.365 . . . . 0.0 111.512 175.042 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -142.92 104.2 4.29 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.878 1.271 . . . . 0.0 112.944 -175.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.482 ' CD1' ' HB1' ' A' ' 87' ' ' ALA . 3.1 m-85 -94.09 137.37 33.36 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.376 -0.827 . . . . 0.0 111.902 178.067 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.3 ttt-85 -98.49 -70.12 0.74 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.138 1.775 . . . . 0.0 111.24 178.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.428 ' CB ' ' H ' ' A' ' 86' ' ' VAL . 0.9 OUTLIER -39.72 -54.62 2.05 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 128.21 2.604 . . . . 0.0 113.722 -175.034 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -157.69 -118.53 0.55 Allowed Glycine 0 CA--C 1.526 0.751 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 175.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.6 p -141.93 175.67 9.54 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.822 1.649 . . . . 0.0 111.87 -174.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.497 ' CG2' HD12 ' A' ' 59' ' ' ILE . 5.7 t -156.51 -176.92 6.23 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.313 1.045 . . . . 0.0 112.755 176.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -102.63 -65.03 1.02 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.39 1.476 . . . . 0.0 112.786 177.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.2 p -130.19 131.68 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 125.551 1.541 . . . . 0.0 111.187 -177.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.497 HD12 ' CG2' ' A' ' 56' ' ' THR . 0.1 OUTLIER -136.85 -63.54 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 125.346 1.458 . . . . 0.0 111.712 -174.969 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.461 ' H ' HG12 ' A' ' 59' ' ' ILE . 80.5 mt -88.37 105.53 9.78 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 125.355 1.462 . . . . 0.0 110.265 175.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -73.33 168.48 24.64 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 123.305 2.67 . . . . 0.0 110.992 175.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -49.45 -44.92 46.02 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.139 0.976 . . . . 0.0 113.544 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 53.7 t -151.13 147.83 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 C-N-CA 126.838 2.055 . . . . 0.0 109.426 -176.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.6 t -125.9 95.07 40.52 Favored Pre-proline 0 N--CA 1.468 0.443 0 C-N-CA 124.913 1.285 . . . . 0.0 108.132 174.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.31 158.04 55.43 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.153 1.902 . . . . 0.0 112.253 176.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -71.53 169.52 15.28 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.092 0.557 . . . . 0.0 111.593 175.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . 0.252 26.0 p 56.79 18.76 3.97 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 127.442 2.297 . . . . 0.0 112.954 -174.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -130.9 172.0 12.54 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 126.86 2.064 . . . . 0.0 110.683 -178.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -134.89 167.43 20.92 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.345 0.658 . . . . 0.0 109.344 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.8 pp -139.16 166.43 24.56 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 124.68 1.192 . . . . 0.0 111.745 177.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.05 152.57 23.84 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 122.134 0.969 . . . . 0.0 111.07 174.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -132.8 149.03 52.31 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 126.64 1.976 . . . . 0.0 109.738 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 94.8 p -148.03 159.9 43.42 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.023 0.929 . . . . 0.0 113.198 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -170.49 148.47 11.54 Favored Glycine 0 N--CA 1.463 0.46 0 CA-C-N 115.738 -0.664 . . . . 0.0 114.316 177.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 58.4 mtm180 -110.33 148.77 31.29 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 125.937 1.695 . . . . 0.0 110.271 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -89.35 -33.52 16.87 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.551 1.54 . . . . 0.0 114.053 176.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 28.6 t -64.31 105.47 0.92 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.634 1.174 . . . . 0.0 112.363 -174.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 42.8 t -112.32 -18.31 12.53 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.817 1.647 . . . . 0.0 113.125 178.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 121.48 -75.2 0.34 Allowed Glycine 0 CA--C 1.537 1.468 0 C-N-CA 125.842 1.687 . . . . 0.0 112.595 -178.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -73.17 -37.36 3.46 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.371 2.714 . . . . 0.0 113.5 -175.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.2 p -146.56 155.79 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 126.935 2.094 . . . . 0.0 109.31 179.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -136.47 83.98 2.04 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.16 0.984 . . . . 0.0 111.319 -178.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.6 m -66.26 138.04 57.37 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.306 1.042 . . . . 0.0 110.349 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -34.47 -74.98 0.07 OUTLIER Glycine 0 N--CA 1.471 0.991 0 C-N-CA 126.715 2.102 . . . . 0.0 117.518 -175.009 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.564 ' HB3' ' HB ' ' A' ' 105' ' ' VAL . . . -165.63 91.83 0.51 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.329 1.052 . . . . 0.0 111.51 -174.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.428 ' H ' ' CB ' ' A' ' 53' ' ' SER . 20.4 t -140.11 122.38 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 O-C-N 120.566 -1.333 . . . . 0.0 112.616 -175.022 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.482 ' HB1' ' CD1' ' A' ' 51' ' ' PHE . . . -155.38 167.6 29.86 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 122.353 1.073 . . . . 0.0 112.882 176.223 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -146.16 149.97 34.99 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 124.064 0.946 . . . . 0.0 109.84 174.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -151.2 174.12 13.62 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 121.039 -1.038 . . . . 0.0 110.356 178.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.508 ' HB3' HD11 ' A' ' 47' ' ' LEU . . . -138.21 150.61 46.9 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-O 121.176 0.512 . . . . 0.0 112.358 176.235 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -129.63 117.1 19.84 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 126.939 2.096 . . . . 0.0 112.597 -175.006 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -80.89 99.72 8.49 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -174.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 20.2 mtm -72.0 127.42 32.51 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.415 1.086 . . . . 0.0 112.237 178.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.6 m -57.56 -18.88 21.79 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.851 1.26 . . . . 0.0 113.414 174.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -64.27 -28.13 69.51 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.631 1.572 . . . . 0.0 112.139 174.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 120.07 19.19 4.03 Favored Glycine 0 CA--C 1.538 1.502 0 C-N-CA 125.819 1.676 . . . . 0.0 115.229 -178.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -128.04 175.82 8.1 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 119.14 1.47 . . . . 0.0 110.899 -178.156 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 22.7 m -134.48 103.91 5.89 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 121.064 -1.022 . . . . 0.0 111.621 176.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 42.1 tp -68.82 103.49 1.79 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.729 0.812 . . . . 0.0 112.026 175.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -91.71 96.18 2.14 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 126.316 1.912 . . . . 0.0 110.858 175.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 53.8 t -79.93 136.97 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 O-C-N 121.895 -0.768 . . . . 0.0 110.771 175.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.74 141.1 47.37 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.287 1.035 . . . . 0.0 111.593 176.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.47 ' CZ ' ' HB3' ' A' ' 87' ' ' ALA . 3.4 p90 -153.64 120.08 5.52 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 120.887 -1.133 . . . . 0.0 111.501 -174.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 32.8 t -127.47 107.24 9.78 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.915 1.286 . . . . 0.0 110.987 -177.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.564 ' HB ' ' HB3' ' A' ' 85' ' ' ALA . 4.4 t -118.69 127.3 26.63 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 126.599 1.96 . . . . 0.0 108.674 -176.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -72.77 169.78 21.19 Favored 'Trans proline' 0 CA--C 1.532 0.403 0 C-N-CA 123.388 2.726 . . . . 0.0 113.407 -175.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -74.62 -66.48 0.73 Allowed 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.323 1.049 . . . . 0.0 111.562 175.009 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -106.22 7.22 31.39 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.215 1.806 . . . . 0.0 115.063 -174.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 54.88 41.99 31.46 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 125.65 1.58 . . . . 0.0 113.467 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 40.5 p-10 -60.56 -179.23 0.11 Allowed 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 126.932 2.093 . . . . 0.0 114.945 176.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 4.2 p90 -53.5 -30.01 39.21 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 126.986 2.114 . . . . 0.0 114.665 176.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -59.29 120.28 8.97 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.408 1.083 . . . . 0.0 108.663 175.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 55.0 m -62.48 150.45 40.08 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 121.426 -0.796 . . . . 0.0 110.907 177.203 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 27.0 m120 -137.76 107.1 6.1 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.645 1.178 . . . . 0.0 110.66 -178.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 41.5 m0 -109.83 162.36 14.56 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 125.284 1.434 . . . . 0.0 113.442 -174.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 61.0 p-90 -145.57 132.41 20.1 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.776 0.798 . . . . 0.0 112.273 177.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -144.25 174.47 10.86 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.826 1.65 . . . . 0.0 111.652 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.445 HG22 ' SD ' ' A' ' 158' ' ' MET . 2.5 m -145.03 159.72 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 175.101 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.63 170.97 14.93 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.764 0.826 . . . . 0.0 111.045 175.051 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.423 ' HB ' ' CE2' ' A' ' 154' ' ' TYR . 45.5 mt -131.54 104.6 8.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 176.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -71.97 148.91 92.2 Favored Pre-proline 0 CA--C 1.55 0.964 0 O-C-N 121.938 -0.476 . . . . 0.0 110.94 178.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -77.87 82.67 2.36 Favored 'Trans proline' 0 CA--C 1.545 1.037 0 C-N-CA 123.802 3.002 . . . . 0.0 112.37 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 98.54 178.03 32.56 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 125.958 1.742 . . . . 0.0 112.892 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 5.9 mttt -47.7 122.02 4.54 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.116 1.366 . . . . 0.0 112.508 -174.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -135.23 -161.55 1.16 Allowed 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 126.608 1.963 . . . . 0.0 111.433 -177.414 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 23.5 ptt-85 -140.17 -178.17 5.35 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 128.553 2.741 . . . . 0.0 109.181 175.008 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -131.67 124.21 29.38 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 174.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -135.72 168.66 18.87 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.375 1.07 . . . . 0.0 111.162 178.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.93 -40.77 73.62 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.538 -0.726 . . . . 0.0 112.5 -176.418 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -57.22 -58.64 13.56 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 124.53 1.062 . . . . 0.0 112.177 175.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 3.3 mpp? -59.58 -32.67 70.58 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 118.528 1.164 . . . . 0.0 112.5 177.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.27 -63.2 1.31 Allowed 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 175.035 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -67.17 -30.03 69.88 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -175.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -64.78 -43.46 93.17 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.219 1.008 . . . . 0.0 112.101 175.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.15 -25.81 23.91 Favored 'General case' 0 CA--C 1.546 0.799 0 O-C-N 121.558 -0.714 . . . . 0.0 112.558 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -47.2 -53.65 12.64 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 127.744 2.418 . . . . 0.0 111.859 175.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -63.39 -15.61 58.05 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -74.03 -32.4 58.67 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 128.312 2.863 . . . . 0.0 115.666 -175.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -129.15 90.23 45.82 Favored Pre-proline 0 CA--C 1.546 0.826 0 CA-C-N 119.032 1.416 . . . . 0.0 111.274 175.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -73.2 83.35 1.47 Allowed 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 123.58 2.853 . . . . 0.0 112.87 -176.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -122.46 122.28 38.6 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.739 1.215 . . . . 0.0 112.05 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -104.31 63.91 0.75 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.736 1.614 . . . . 0.0 111.276 -174.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 51.38 60.05 7.71 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 123.971 0.796 . . . . 0.0 112.683 -175.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.83 101.81 3.24 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 126.186 1.794 . . . . 0.0 112.362 -175.115 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -74.03 55.13 0.55 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 127.627 2.371 . . . . 0.0 116.516 -174.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -166.29 43.78 0.27 Allowed Glycine 0 CA--C 1.533 1.202 0 O-C-N 120.921 -1.112 . . . . 0.0 115.672 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 1.1 m95 52.65 40.51 30.32 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 125.276 1.43 . . . . 0.0 113.773 -176.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -78.9 124.06 27.87 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 126.099 1.76 . . . . 0.0 112.123 -176.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -167.89 -171.54 1.61 Allowed 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.781 0.832 . . . . 0.0 111.785 177.009 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 4.8 mtpp -138.18 160.91 38.18 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 127.89 2.476 . . . . 0.0 110.977 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 37.7 m-20 -67.26 152.5 45.62 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 122.144 -0.347 . . . . 0.0 110.426 174.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 37.6 mt -108.09 162.03 14.42 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 122.19 0.995 . . . . 0.0 109.06 175.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -62.45 -167.47 0.68 Allowed Glycine 0 CA--C 1.536 1.358 0 C-N-CA 124.512 1.053 . . . . 0.0 111.616 175.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.423 ' CE2' ' HB ' ' A' ' 120' ' ' ILE . 0.0 OUTLIER 55.09 6.28 0.13 Allowed 'General case' 0 CA--C 1.558 1.281 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 174.957 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 82.02 44.88 7.4 Favored Glycine 0 CA--C 1.54 1.607 0 C-N-CA 127.438 2.447 . . . . 0.0 114.427 -175.011 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.1 mp -127.82 158.03 38.84 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 119.866 1.833 . . . . 0.0 113.123 -178.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -124.65 117.31 23.97 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 121.061 -1.024 . . . . 0.0 110.478 175.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' MET . . . . . 0.445 ' SD ' HG22 ' A' ' 118' ' ' VAL . 0.0 OUTLIER -98.21 150.24 21.71 Favored 'General case' 0 C--N 1.322 -0.623 0 O-C-N 120.623 -1.298 . . . . 0.0 108.784 174.996 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -131.4 149.02 52.71 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 127.076 2.151 . . . . 0.0 110.35 176.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -157.52 159.39 29.77 Favored Glycine 0 N--CA 1.464 0.525 0 O-C-N 121.542 -0.724 . . . . 0.0 113.446 176.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.43 HD13 ' N ' ' A' ' 162' ' ' MET . 0.0 OUTLIER -155.15 137.54 6.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 125.222 1.409 . . . . 0.0 109.894 -178.174 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 162' ' ' MET . . . . . 0.43 ' N ' HD13 ' A' ' 161' ' ' ILE . 2.5 mtm -150.1 167.22 27.44 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 127.388 2.275 . . . . 0.0 108.345 174.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 9.7 t -145.42 133.45 21.42 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 118.942 0.792 . . . . 0.0 109.858 174.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 81.9 p -82.05 30.05 0.4 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.526 1.131 . . . . 0.0 113.729 -176.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -65.61 21.64 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 128.322 2.649 . . . . 0.0 115.432 -177.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 79.84 -44.19 2.73 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 127.554 2.502 . . . . 0.0 113.333 -177.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -143.18 77.24 1.56 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.351 1.46 . . . . 0.0 110.153 -177.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -130.71 166.35 20.93 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.033 1.333 . . . . 0.0 114.047 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.14 169.74 10.38 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 126.948 2.099 . . . . 0.0 113.782 -176.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' MET . . . . . 0.408 ' HE2' HD13 ' A' ' 172' ' ' ILE . 11.3 ttt -115.87 145.79 42.57 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.255 1.822 . . . . 0.0 110.891 173.322 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.45 ' C ' HD12 ' A' ' 172' ' ' ILE . 24.8 tt0 -149.32 119.14 7.06 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 120.753 -1.217 . . . . 0.0 110.237 174.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.45 HD12 ' C ' ' A' ' 171' ' ' GLN . 1.8 mp -121.25 130.56 74.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 125.485 1.514 . . . . 0.0 108.267 178.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.8 137.79 43.68 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.876 1.27 . . . . 0.0 110.448 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.6 mp -95.3 95.13 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-N 119.352 0.978 . . . . 0.0 109.518 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 19.3 m -64.55 138.62 58.51 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.981 1.312 . . . . 0.0 111.79 175.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 7.0 mtp180 . . . . . 0 C--O 1.253 1.26 0 O-C-N 120.238 -1.539 . . . . 0.0 112.608 174.938 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 6.9 t . . . . . 0 N--CA 1.488 1.46 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -64.42 178.64 0.7 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.884 1.273 . . . . 0.0 111.878 174.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.672 HD13 ' HB2' ' A' ' 31' ' ' LYS . 2.6 mt -109.65 9.21 25.08 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.833 1.653 . . . . 0.0 112.603 178.49 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.45 ' HB1' ' HB3' ' A' ' 71' ' ' LEU . . . -113.21 126.77 55.78 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 127.544 2.338 . . . . 0.0 111.391 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -79.69 -121.54 0.37 Allowed Glycine 0 CA--C 1.536 1.402 0 C-N-CA 125.036 1.303 . . . . 0.0 112.79 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 30.8 p -94.78 171.57 8.69 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.754 1.222 . . . . 0.0 112.397 177.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -130.53 12.32 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 C-N-CA 125.764 1.626 . . . . 0.0 112.002 177.217 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.6 pp -58.63 172.03 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 O-C-N 120.563 -1.336 . . . . 0.0 112.103 176.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -35.38 129.39 0.54 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.798 2.039 . . . . 0.0 114.729 -175.405 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -55.57 -21.81 29.57 Favored Glycine 0 CA--C 1.537 1.424 0 C-N-CA 124.673 1.13 . . . . 0.0 114.444 -178.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.1 -31.76 72.25 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.874 1.269 . . . . 0.0 112.048 174.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -100.7 -36.61 9.06 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.963 1.705 . . . . 0.0 112.059 175.288 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.451 HD23 ' HB3' ' A' ' 69' ' ' ALA . 12.5 tp -79.0 86.16 4.88 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-O 122.1 0.952 . . . . 0.0 110.562 174.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -121.23 178.21 4.86 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 127.565 2.346 . . . . 0.0 112.131 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -42.28 -45.3 4.14 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.562 1.545 . . . . 0.0 113.765 174.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -53.4 -43.53 67.96 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 118.934 0.788 . . . . 0.0 112.449 178.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 86.6 t -64.11 -43.96 97.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.738 1.215 . . . . 0.0 110.799 174.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 68.1 mt -63.82 -41.8 97.78 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.2 -0.938 . . . . 0.0 111.737 179.193 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -67.28 -44.63 78.81 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.734 1.214 . . . . 0.0 112.576 178.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.08 -37.77 78.65 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 121.476 -0.765 . . . . 0.0 111.357 175.011 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.9 t -56.67 -38.11 56.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.951 1.3 . . . . 0.0 110.956 178.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.676 HD23 ' HD2' ' A' ' 31' ' ' LYS . 11.1 mt -56.65 -25.89 54.78 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.499 1.519 . . . . 0.0 113.239 175.017 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -106.28 -46.52 1.15 Allowed Glycine 0 CA--C 1.534 1.243 0 C-N-CA 125.566 1.555 . . . . 0.0 114.692 -178.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -63.96 -27.97 69.5 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 119.243 1.521 . . . . 0.0 113.288 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 19.7 mt -96.54 76.8 2.9 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.9 1.28 . . . . 0.0 110.635 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.59 114.9 5.09 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 126.14 1.829 . . . . 0.0 112.387 178.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -132.47 -74.03 0.51 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.655 1.582 . . . . 0.0 111.919 -179.079 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.3 m -131.68 177.79 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 126.419 1.887 . . . . 0.0 111.129 -177.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.87 -30.08 68.75 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -177.236 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.79 117.01 10.07 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.755 1.622 . . . . 0.0 111.443 178.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.676 ' HD2' HD23 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -124.24 152.56 42.82 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 125.399 1.48 . . . . 0.0 109.559 -177.845 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -114.62 133.06 61.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 123.58 0.752 . . . . 0.0 109.438 177.141 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -134.91 104.77 6.11 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 127.119 2.167 . . . . 0.0 109.795 176.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.704 HG22 ' HB2' ' A' ' 72' ' ' TYR . 1.4 m -103.82 160.77 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 123.517 0.727 . . . . 0.0 110.358 178.087 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -138.64 109.83 0.69 Allowed Glycine 0 CA--C 1.519 0.328 0 CA-C-N 118.645 0.657 . . . . 0.0 112.69 174.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.482 ' HB ' HD11 ' A' ' 70' ' ' LEU . 3.1 mp -103.96 139.14 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-N 117.313 0.556 . . . . 0.0 110.724 176.269 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -110.55 104.16 12.85 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.006 1.322 . . . . 0.0 110.704 -177.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 45.7 t-20 -72.6 91.5 1.43 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 127.162 2.185 . . . . 0.0 110.616 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -120.88 9.24 10.61 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.498 1.519 . . . . 0.0 113.331 174.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 37.5 t -50.94 -47.04 61.16 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 125.987 1.715 . . . . 0.0 113.672 177.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 139.99 -21.41 2.82 Favored Glycine 0 N--CA 1.473 1.161 0 C-N-CA 124.452 1.025 . . . . 0.0 114.208 175.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -122.56 167.18 14.97 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 125.724 1.631 . . . . 0.0 111.564 174.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.656 HG22 ' HA ' ' A' ' 65' ' ' PRO . 44.3 p -74.28 145.71 43.78 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.177 0.513 . . . . 0.0 110.674 174.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 49.5 m0 -98.95 104.71 16.78 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 123.593 0.757 . . . . 0.0 110.898 178.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.0 m -82.67 125.3 31.06 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.186 0.994 . . . . 0.0 110.117 176.033 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.79 117.51 5.95 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.109 0.964 . . . . 0.0 111.309 174.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.551 HD12 ' N ' ' A' ' 48' ' ' ASN . 4.6 pp -98.23 -48.99 4.87 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.483 0.713 . . . . 0.0 112.758 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.551 ' N ' HD12 ' A' ' 47' ' ' LEU . 10.4 t30 -174.56 152.17 1.63 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 128.213 2.605 . . . . 0.0 109.263 -177.029 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -136.38 160.54 38.43 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.616 1.166 . . . . 0.0 111.793 174.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -137.78 107.48 6.24 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.653 1.181 . . . . 0.0 112.284 -179.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.497 ' CD1' ' HB1' ' A' ' 87' ' ' ALA . 2.9 m-85 -107.94 128.7 54.87 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.421 1.088 . . . . 0.0 110.987 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.66 -34.27 5.57 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -176.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.9 t -121.47 -49.46 2.14 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 125.602 1.561 . . . . 0.0 110.594 176.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -66.91 12.56 0.54 Allowed Glycine 0 CA--C 1.536 1.373 0 C-N-CA 125.911 1.72 . . . . 0.0 115.658 -176.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 74.6 p -30.95 109.39 0.06 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 129.089 2.956 . . . . 0.0 114.271 -174.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.529 HG21 HG23 ' A' ' 59' ' ' ILE . 2.5 t -129.25 179.17 5.93 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.437 1.495 . . . . 0.0 113.215 -175.016 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -78.77 -59.15 2.89 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.994 1.718 . . . . 0.0 112.225 174.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.9 p -143.42 136.64 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 125.597 1.559 . . . . 0.0 111.977 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.529 HG23 HG21 ' A' ' 56' ' ' THR . 1.4 pp -140.2 -26.3 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 126.07 1.748 . . . . 0.0 114.296 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -99.22 93.54 2.22 Favored Pre-proline 0 CA--C 1.541 0.611 0 C-N-CA 125.212 1.405 . . . . 0.0 108.995 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -61.64 143.06 96.37 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.775 2.316 . . . . 0.0 110.389 174.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -40.11 -48.92 2.56 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.429 1.891 . . . . 0.0 113.84 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.7 p -156.1 138.66 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 127.295 2.238 . . . . 0.0 109.188 175.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.468 HG21 HD23 ' A' ' 70' ' ' LEU . 22.0 t -112.27 121.99 37.79 Favored Pre-proline 0 N--CA 1.477 0.897 0 C-N-CA 124.233 1.013 . . . . 0.0 108.902 175.074 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.656 ' HA ' HG22 ' A' ' 43' ' ' THR . 58.6 Cg_endo -67.8 157.78 60.23 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 122.015 1.81 . . . . 0.0 112.946 177.186 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -71.65 168.58 17.39 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.575 0.75 . . . . 0.0 111.52 175.017 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 43.7 p 54.44 19.11 2.18 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 127.286 2.234 . . . . 0.0 113.79 -174.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.8 mttt -134.29 171.72 13.87 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 126.918 2.087 . . . . 0.0 110.951 -175.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.451 ' HB3' HD23 ' A' ' 13' ' ' LEU . . . -127.97 177.16 7.06 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.071 0.462 . . . . 0.0 110.146 -175.005 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.482 HD11 ' HB ' ' A' ' 36' ' ' ILE . 1.9 pp -142.84 173.47 11.52 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 124.181 0.992 . . . . 0.0 111.255 -178.311 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.526 HD13 ' O ' ' A' ' 34' ' ' VAL . 0.5 OUTLIER -132.47 151.62 51.83 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.937 1.295 . . . . 0.0 111.007 174.964 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.704 ' HB2' HG22 ' A' ' 34' ' ' VAL . 4.2 m-85 -124.14 146.04 48.91 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.162 0.985 . . . . 0.0 108.595 174.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.8 p -121.28 137.1 54.84 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 126.401 1.88 . . . . 0.0 110.997 175.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.606 ' H ' HD12 ' A' ' 3' ' ' LEU . . . -160.95 133.34 3.17 Favored Glycine 0 CA--C 1.525 0.7 0 O-C-N 121.785 -0.572 . . . . 0.0 113.822 174.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 26.3 mtm180 -90.68 149.7 21.96 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.946 1.298 . . . . 0.0 110.988 -174.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.583 ' CE ' ' HB1' ' A' ' 82' ' ' ALA . 9.9 ptmt -76.56 -20.47 56.81 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 174.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.4 t -81.76 74.41 8.75 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.027 1.331 . . . . 0.0 112.719 -174.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.9 t -65.9 -26.94 67.84 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.512 0.931 . . . . 0.0 113.512 178.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 123.21 -72.96 0.4 Allowed Glycine 0 CA--C 1.538 1.485 0 C-N-CA 126.027 1.775 . . . . 0.0 112.797 -178.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -70.82 -44.16 1.47 Allowed 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.399 2.733 . . . . 0.0 112.731 -177.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.5 m -137.64 126.37 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 126.268 1.827 . . . . 0.0 110.925 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.583 ' HB1' ' CE ' ' A' ' 76' ' ' LYS . . . -78.38 125.81 29.88 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.998 1.319 . . . . 0.0 111.012 174.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 97.7 m -144.17 131.45 20.78 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.143 1.377 . . . . 0.0 109.62 -177.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -26.05 -68.07 0.05 OUTLIER Glycine 0 N--CA 1.48 1.628 0 C-N-CA 127.422 2.439 . . . . 0.0 115.013 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -177.58 135.79 0.19 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.371 1.868 . . . . 0.0 111.82 175.009 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.9 t -154.85 129.42 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 125.139 1.376 . . . . 0.0 109.094 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.497 ' HB1' ' CD1' ' A' ' 51' ' ' PHE . . . -173.32 174.48 3.32 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.442 1.497 . . . . 0.0 111.732 177.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -151.18 141.49 22.36 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.108 1.363 . . . . 0.0 110.169 174.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -138.45 171.52 14.25 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 121.233 -0.917 . . . . 0.0 111.231 178.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.501 ' HB3' HD11 ' A' ' 47' ' ' LEU . . . -139.43 156.24 47.09 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.391 0.615 . . . . 0.0 112.551 177.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -135.08 129.09 33.44 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 125.833 1.653 . . . . 0.0 112.421 -174.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -83.4 135.11 34.82 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -176.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.24 138.18 44.96 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 125.086 1.355 . . . . 0.0 111.917 178.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.8 t -62.8 -22.5 66.67 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.493 1.117 . . . . 0.0 113.164 176.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -67.41 -16.15 64.07 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.121 1.368 . . . . 0.0 113.321 175.002 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 101.28 33.89 4.71 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 124.845 1.212 . . . . 0.0 114.558 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.559 ' HB3' HG22 ' A' ' 120' ' ' ILE . 48.3 m-80 -140.6 177.07 8.28 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-N 119.204 1.502 . . . . 0.0 110.95 177.528 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.473 HG23 HD21 ' A' ' 47' ' ' LEU . 19.2 m -130.67 105.83 8.08 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.668 1.587 . . . . 0.0 112.457 -176.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 59.6 tp -68.4 104.42 1.89 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.715 1.206 . . . . 0.0 111.271 175.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -99.32 116.95 5.72 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 125.947 1.737 . . . . 0.0 113.084 179.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 57.3 t -105.14 129.07 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 126.218 1.807 . . . . 0.0 111.341 -174.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -127.12 130.24 49.44 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.673 1.589 . . . . 0.0 112.273 -174.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.445 ' CZ ' ' HB3' ' A' ' 87' ' ' ALA . 5.4 p90 -146.02 140.56 26.91 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.644 1.177 . . . . 0.0 112.484 -176.03 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.28 123.37 10.79 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.181 1.392 . . . . 0.0 111.967 -174.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 96.4 t -100.33 123.74 45.47 Favored Pre-proline 0 N--CA 1.481 1.084 0 C-N-CA 125.065 1.346 . . . . 0.0 111.686 -177.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.406 ' HA ' ' CE2' ' A' ' 109' ' ' TYR . 76.5 Cg_endo -71.02 84.26 0.87 Allowed 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 124.795 3.663 . . . . 0.0 112.768 -178.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -128.43 -29.53 2.44 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.081 1.352 . . . . 0.0 113.073 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -98.91 -37.88 9.23 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.837 1.255 . . . . 0.0 111.519 174.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.406 ' CE2' ' HA ' ' A' ' 106' ' ' PRO . 0.1 OUTLIER -85.41 84.25 7.7 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.386 1.474 . . . . 0.0 111.641 177.996 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -74.65 -9.78 58.9 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 123.881 0.873 . . . . 0.0 113.05 175.025 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 55.8 m95 -115.95 -46.01 2.84 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 127.017 2.127 . . . . 0.0 111.622 -176.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -68.56 173.07 5.37 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.708 1.203 . . . . 0.0 110.13 174.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.4 m -109.57 153.97 23.4 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 121.389 -0.819 . . . . 0.0 111.623 174.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -73.36 117.68 15.4 Favored 'General case' 0 C--O 1.226 -0.18 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 174.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 34.4 m0 -113.68 143.59 44.35 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 176.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 37.3 p-90 -148.85 138.58 21.99 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.206 1.002 . . . . 0.0 111.268 -177.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -150.04 162.86 39.57 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 122.801 1.286 . . . . 0.0 113.279 -177.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 61.7 t -145.53 144.34 21.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 124.24 1.016 . . . . 0.0 108.311 175.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.448 ' HE2' ' SD ' ' A' ' 135' ' ' MET . 0.0 OUTLIER -155.9 176.71 12.28 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.908 1.683 . . . . 0.0 110.141 175.577 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.559 HG22 ' HB3' ' A' ' 97' ' ' ASN . 11.7 mt -126.32 99.59 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-O 121.86 0.838 . . . . 0.0 108.955 178.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -59.68 148.25 75.64 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 124.105 0.962 . . . . 0.0 111.84 178.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -70.5 135.54 28.94 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.986 2.457 . . . . 0.0 111.838 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 59.13 -157.82 22.42 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 124.057 0.837 . . . . 0.0 113.528 -177.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 9.9 tttt -72.75 120.02 17.78 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.975 0.91 . . . . 0.0 108.735 174.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 25.0 tpp180 -130.68 169.62 15.42 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 125.868 1.667 . . . . 0.0 109.447 175.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 25.6 ptt180 -119.89 175.33 5.95 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 126.549 1.94 . . . . 0.0 110.6 174.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -120.3 108.11 13.77 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 175.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -126.27 165.7 18.48 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.901 1.28 . . . . 0.0 110.01 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -55.66 -36.81 67.49 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 121.302 -0.874 . . . . 0.0 113.203 -176.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -59.7 -61.29 7.39 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.442 -0.663 . . . . 0.0 111.442 174.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -62.98 -33.11 74.7 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 118.367 1.084 . . . . 0.0 112.833 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -58.35 -63.11 1.39 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.625 1.17 . . . . 0.0 108.987 174.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -69.27 -27.2 65.22 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -177.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -68.23 -32.06 71.99 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.741 1.216 . . . . 0.0 113.418 175.017 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' MET . . . . . 0.448 ' SD ' ' HE2' ' A' ' 119' ' ' LYS . 0.7 OUTLIER -94.89 -25.48 16.56 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 121.274 -0.891 . . . . 0.0 112.076 176.667 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -51.99 -57.6 9.01 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.769 2.028 . . . . 0.0 110.02 174.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -67.22 -10.19 48.01 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 113.526 0.935 . . . . 0.0 113.526 -178.467 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -83.6 -16.03 69.45 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 126.638 2.066 . . . . 0.0 114.273 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -142.14 87.26 9.76 Favored Pre-proline 0 CA--C 1.549 0.925 0 CA-C-N 118.661 1.231 . . . . 0.0 112.001 179.293 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.95 77.97 1.85 Allowed 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 123.675 2.916 . . . . 0.0 112.472 177.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -108.59 115.05 29.36 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.32 1.448 . . . . 0.0 109.826 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 9.5 mtp180 -92.93 26.88 2.6 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 126.909 2.083 . . . . 0.0 115.969 -174.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 62.38 59.69 9.01 Favored Glycine 0 CA--C 1.531 1.051 0 N-CA-C 109.106 -1.597 . . . . 0.0 109.106 -175.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -64.28 105.81 0.98 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.182 0.993 . . . . 0.0 110.006 176.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -68.02 83.48 0.22 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.213 1.405 . . . . 0.0 114.33 -174.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 170.24 48.71 0.03 OUTLIER Glycine 0 CA--C 1.537 1.462 0 C-N-CA 124.967 1.27 . . . . 0.0 114.468 177.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' TRP . . . . . 0.56 ' H ' HD13 ' A' ' 161' ' ' ILE . 2.2 m95 54.65 44.09 29.16 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 125.782 1.633 . . . . 0.0 114.728 -177.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -79.62 130.62 35.53 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 120.61 -1.306 . . . . 0.0 112.77 -175.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' GLN . . . . . 0.419 ' HG3' ' HA ' ' A' ' 159' ' ' LYS . 0.0 OUTLIER -160.02 -175.16 4.93 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -175.015 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.2 pttt -131.0 156.72 44.64 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.194 1.397 . . . . 0.0 111.672 174.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 28.6 m-80 -78.14 124.17 27.74 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 174.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 69.3 mt -81.52 149.11 28.85 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 122.201 1.001 . . . . 0.0 109.33 174.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -66.08 -166.48 2.04 Favored Glycine 0 CA--C 1.535 1.303 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 174.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.52 ' CE1' ' HB ' ' A' ' 120' ' ' ILE . 0.0 OUTLIER 54.3 11.49 0.4 Allowed 'General case' 0 CA--C 1.557 1.233 0 N-CA-C 114.988 1.477 . . . . 0.0 114.988 174.969 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 84.94 37.3 10.26 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 126.542 2.02 . . . . 0.0 113.208 -178.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.7 mp -122.74 160.21 26.41 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 119.843 1.822 . . . . 0.0 113.038 -178.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 72.2 mtt85 -149.06 109.77 4.26 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 120.636 -1.29 . . . . 0.0 111.082 -178.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' MET . . . . . 0.451 ' SD ' HG21 ' A' ' 172' ' ' ILE . 9.0 ttp -104.73 132.77 50.58 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 124.025 0.93 . . . . 0.0 108.893 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.419 ' HA ' ' HG3' ' A' ' 149' ' ' GLN . 7.1 tppt? -111.14 129.65 55.87 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 127.967 2.507 . . . . 0.0 110.593 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -137.21 156.17 23.25 Favored Glycine 0 N--CA 1.474 1.208 0 CA-C-N 120.7 1.591 . . . . 0.0 115.959 -177.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.56 HD13 ' H ' ' A' ' 147' ' ' TRP . 4.5 tp -148.58 127.8 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 124.77 1.228 . . . . 0.0 112.069 -175.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 16.1 mtm -151.5 169.81 21.17 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 128.489 2.716 . . . . 0.0 109.892 174.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 14.5 t -156.23 135.27 12.0 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.714 1.606 . . . . 0.0 109.597 174.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 61.7 p -81.32 20.04 0.9 Allowed 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 179.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.85 -34.7 65.68 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.486 1.914 . . . . 0.0 115.108 -177.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 154.01 -63.45 0.36 Allowed Glycine 0 CA--C 1.533 1.176 0 C-N-CA 124.386 0.993 . . . . 0.0 114.29 176.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -119.79 27.82 8.49 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 125.718 1.607 . . . . 0.0 112.669 -175.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -64.03 174.59 1.47 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.839 1.255 . . . . 0.0 113.269 174.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.57 168.14 13.01 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.735 2.014 . . . . 0.0 111.248 177.015 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 48.5 ttp -111.51 123.87 51.11 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.816 1.246 . . . . 0.0 110.45 176.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -137.46 128.02 26.77 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 123.255 0.622 . . . . 0.0 110.325 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.451 HG21 ' SD ' ' A' ' 158' ' ' MET . 5.1 mp -134.9 119.27 27.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 123.461 0.704 . . . . 0.0 109.853 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -114.57 134.96 54.64 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.188 1.395 . . . . 0.0 111.067 177.436 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.8 mp -81.83 129.97 36.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 O-C-N 120.906 -1.121 . . . . 0.0 109.013 175.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -137.93 94.43 2.89 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.854 1.262 . . . . 0.0 112.328 177.163 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 72.1 mtp180 . . . . . 0 C--O 1.252 1.185 0 C-N-CA 126.604 1.961 . . . . 0.0 113.245 175.002 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 74.6 m . . . . . 0 N--CA 1.482 1.136 0 N-CA-C 111.695 0.258 . . . . 0.0 111.695 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.91 177.09 6.77 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.854 1.261 . . . . 0.0 111.113 174.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.559 HD11 ' HG3' ' A' ' 31' ' ' LYS . 3.0 mm? -44.28 -26.47 0.33 Allowed 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 115.724 1.75 . . . . 0.0 115.724 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.54 78.67 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.121 1.368 . . . . 0.0 112.425 175.009 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -72.63 -66.3 2.1 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 125.984 1.754 . . . . 0.0 112.238 -175.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 39.7 p -142.61 166.83 23.59 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.73 1.612 . . . . 0.0 112.097 176.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -131.48 10.06 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 125.993 1.717 . . . . 0.0 112.607 175.159 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.524 HD12 ' HB3' ' A' ' 12' ' ' SER . 1.0 OUTLIER -53.67 163.32 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 O-C-N 120.223 -1.548 . . . . 0.0 112.648 177.017 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -38.92 136.29 0.79 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 127.001 2.121 . . . . 0.0 113.82 -174.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -55.38 -21.22 26.03 Favored Glycine 0 CA--C 1.54 1.605 0 C-N-CA 124.858 1.218 . . . . 0.0 114.399 -176.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.66 -29.04 69.81 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.032 1.333 . . . . 0.0 112.577 174.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.524 ' HB3' HD12 ' A' ' 8' ' ' ILE . 20.5 t -104.99 -43.98 4.92 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.808 1.643 . . . . 0.0 111.299 175.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.4 tp -75.16 93.47 2.81 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.81 0.844 . . . . 0.0 111.537 175.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 44.1 p -130.69 -177.99 4.59 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 126.901 2.081 . . . . 0.0 111.583 177.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -39.89 -43.99 1.58 Allowed 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 127.207 2.203 . . . . 0.0 113.59 175.022 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -54.67 -41.44 70.19 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.651 0.78 . . . . 0.0 112.055 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.0 t -68.35 -38.19 79.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.804 1.242 . . . . 0.0 111.233 175.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 24.5 mt -68.62 -42.47 78.03 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 121.355 -0.841 . . . . 0.0 111.414 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -65.38 -50.45 65.46 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.498 1.119 . . . . 0.0 111.915 178.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.13 -33.88 76.42 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 118.876 -0.583 . . . . 0.0 112.062 174.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.9 t -55.38 -47.0 78.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 124.85 1.26 . . . . 0.0 112.355 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.82 -23.86 46.88 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 119.838 1.199 . . . . 0.0 113.022 175.035 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -82.45 -61.44 1.98 Allowed Glycine 0 CA--C 1.534 1.233 0 C-N-CA 126.049 1.785 . . . . 0.0 112.919 174.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -66.49 -35.86 81.31 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -177.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -94.88 73.65 3.54 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 122.773 1.273 . . . . 0.0 110.468 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -76.2 64.13 2.82 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 126.302 1.906 . . . . 0.0 115.151 -174.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.506 ' HD2' HD22 ' A' ' 3' ' ' LEU . 6.1 mttt -55.59 -75.47 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 126.69 1.996 . . . . 0.0 113.972 178.303 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 18.0 m -141.77 -179.37 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 127.438 2.295 . . . . 0.0 110.708 178.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 36.8 m -52.39 -34.31 47.43 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 126.721 2.009 . . . . 0.0 114.878 -177.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.8 mmp_? -136.7 111.99 9.14 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 127.23 2.212 . . . . 0.0 109.185 175.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.559 ' HG3' HD11 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -123.0 166.06 15.72 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.381 1.472 . . . . 0.0 110.543 178.696 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -128.85 123.16 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 123.949 0.9 . . . . 0.0 110.911 -178.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -120.13 118.17 29.86 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.883 1.673 . . . . 0.0 109.806 175.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.402 HG22 ' HB2' ' A' ' 72' ' ' TYR . 2.4 m -124.47 148.4 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 122.715 0.406 . . . . 0.0 110.602 175.034 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -121.52 111.06 1.78 Allowed Glycine 0 C--N 1.329 0.16 0 C-N-CA 124.285 0.945 . . . . 0.0 111.044 -178.025 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 mp -100.24 139.94 20.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 117.703 0.752 . . . . 0.0 109.282 175.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -114.91 101.91 9.48 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.893 1.277 . . . . 0.0 109.305 -178.027 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 40.9 t-20 -73.68 107.17 5.78 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.051 1.34 . . . . 0.0 110.515 -178.206 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -135.12 19.27 3.43 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.386 1.474 . . . . 0.0 111.8 175.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.8 p -76.19 178.21 6.59 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.072 1.749 . . . . 0.0 112.433 176.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -91.25 56.06 3.2 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 126.379 1.942 . . . . 0.0 113.167 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 157.34 137.5 2.31 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.453 1.025 . . . . 0.0 113.636 177.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.79 HG22 ' HA ' ' A' ' 65' ' ' PRO . 37.9 p -62.47 141.19 58.51 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.456 0.702 . . . . 0.0 110.428 175.022 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.445 ' HB3' ' CD1' ' A' ' 91' ' ' TYR . 30.0 m0 -97.56 109.2 22.0 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.694 0.283 . . . . 0.0 111.553 178.012 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 37.4 m -87.75 142.74 27.59 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.172 0.589 . . . . 0.0 109.541 175.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.67 126.86 29.38 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.689 0.796 . . . . 0.0 111.457 174.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.56 HD12 ' N ' ' A' ' 48' ' ' ASN . 4.1 pp -116.7 -58.6 2.06 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.271 1.028 . . . . 0.0 111.854 177.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.56 ' N ' HD12 ' A' ' 47' ' ' LEU . 13.1 t30 -176.07 152.38 1.17 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 127.215 2.206 . . . . 0.0 110.617 -177.009 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -134.28 158.84 42.74 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.151 1.38 . . . . 0.0 111.063 175.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 91.2 t80 -140.04 100.21 3.87 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.036 1.334 . . . . 0.0 112.169 -175.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.477 ' CD1' ' HB1' ' A' ' 87' ' ' ALA . 3.8 m-30 -105.04 124.26 49.23 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.559 1.144 . . . . 0.0 111.614 -175.006 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.71 -37.4 7.92 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -177.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 29.5 t -120.61 -49.59 2.23 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.33 1.452 . . . . 0.0 110.725 177.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -68.63 17.37 0.49 Allowed Glycine 0 CA--C 1.533 1.166 0 C-N-CA 126.587 2.042 . . . . 0.0 115.272 -175.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.2 p -35.52 121.02 0.59 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 128.739 2.816 . . . . 0.0 112.995 -175.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -139.13 172.4 12.89 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.651 1.181 . . . . 0.0 113.571 -174.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -76.82 -68.85 0.56 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.524 1.53 . . . . 0.0 113.309 175.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.7 p -135.9 129.67 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 125.126 1.371 . . . . 0.0 112.425 -176.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -138.43 -34.3 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.672 1.589 . . . . 0.0 114.443 -175.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 48.5 mt -91.33 104.14 9.15 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 125.169 1.388 . . . . 0.0 109.621 175.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -72.52 165.24 33.26 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.763 2.975 . . . . 0.0 110.413 175.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -47.57 -44.23 26.08 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.9 p -157.81 152.26 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 127.014 2.125 . . . . 0.0 110.057 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.526 ' HA ' ' HE3' ' A' ' 68' ' ' LYS . 60.5 t -126.89 99.14 29.56 Favored Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 126.375 1.87 . . . . 0.0 106.778 175.491 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.79 ' HA ' HG22 ' A' ' 43' ' ' THR . 42.2 Cg_endo -69.71 171.62 14.08 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 120.97 1.113 . . . . 0.0 112.628 175.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -75.71 166.13 24.0 Favored 'General case' 0 CA--C 1.548 0.869 0 O-C-N 121.297 -0.877 . . . . 0.0 110.355 174.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . 0.276 5.8 p 62.39 18.27 10.15 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 128.058 2.543 . . . . 0.0 115.141 -177.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.526 ' HE3' ' HA ' ' A' ' 64' ' ' VAL . 0.0 OUTLIER -131.34 170.9 14.01 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 126.086 1.755 . . . . 0.0 111.585 -177.986 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -131.18 165.76 22.61 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-O 121.637 0.732 . . . . 0.0 111.633 177.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -134.79 171.45 14.36 Favored 'General case' 0 C--N 1.321 -0.667 0 O-C-N 120.225 -1.547 . . . . 0.0 110.806 175.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -112.91 162.83 15.38 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 125.315 1.446 . . . . 0.0 108.654 174.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.402 ' HB2' HG22 ' A' ' 34' ' ' VAL . 0.2 OUTLIER -136.55 149.66 48.22 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 125.118 1.367 . . . . 0.0 108.938 175.054 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 85.8 p -129.49 148.81 51.43 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.924 1.69 . . . . 0.0 112.191 -177.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -171.8 146.4 9.37 Favored Glycine 0 CA--C 1.521 0.45 0 N-CA-C 111.984 -0.446 . . . . 0.0 111.984 174.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 41.6 mtm-85 -108.31 150.44 27.32 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.784 1.234 . . . . 0.0 110.733 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.536 ' CE ' ' HB1' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -69.33 -21.27 63.85 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 114.934 1.457 . . . . 0.0 114.934 175.039 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 6.5 t -83.59 83.44 7.9 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.239 1.416 . . . . 0.0 113.299 -174.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 21.1 t -75.42 -31.8 60.5 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.399 0.888 . . . . 0.0 113.399 175.018 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 126.06 -71.34 0.47 Allowed Glycine 0 CA--C 1.537 1.447 0 C-N-CA 125.606 1.574 . . . . 0.0 113.068 -175.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -70.68 -40.8 3.57 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 123.276 2.65 . . . . 0.0 112.874 -176.08 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 35.3 m -136.46 158.69 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 126.47 1.908 . . . . 0.0 110.536 178.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.536 ' HB1' ' CE ' ' A' ' 76' ' ' LYS . . . -116.75 87.43 2.69 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.913 1.685 . . . . 0.0 109.613 -178.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 24.9 m -100.49 151.68 21.28 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.172 1.389 . . . . 0.0 108.592 176.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -45.28 -67.41 1.23 Allowed Glycine 0 N--CA 1.473 1.127 0 C-N-CA 125.899 1.714 . . . . 0.0 113.888 -174.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -171.77 119.78 0.45 Allowed 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.482 1.113 . . . . 0.0 111.339 175.056 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.8 t -141.35 118.64 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 O-C-N 121.765 -0.585 . . . . 0.0 110.081 -178.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.482 ' HB3' ' CE1' ' A' ' 103' ' ' PHE . . . -155.66 157.9 37.42 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 122.53 1.157 . . . . 0.0 112.074 -179.168 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -137.5 147.99 45.66 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.88 1.272 . . . . 0.0 108.442 175.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -155.13 166.51 33.34 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 121.03 -1.044 . . . . 0.0 109.127 178.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.544 ' HB1' ' CG2' ' A' ' 98' ' ' THR . . . -137.4 156.16 48.51 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -179.537 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.445 ' CD1' ' HB3' ' A' ' 44' ' ' TRP . 2.3 m-85 -132.46 130.62 40.75 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.272 1.029 . . . . 0.0 113.504 -174.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -82.76 112.99 20.11 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -175.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -93.81 143.01 26.72 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.097 1.359 . . . . 0.0 113.107 -178.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.24 -20.67 64.48 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.556 1.142 . . . . 0.0 113.61 177.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 48.1 m-20 -67.53 -11.6 58.38 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.563 1.145 . . . . 0.0 112.727 174.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 96.58 27.03 10.11 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 124.993 1.282 . . . . 0.0 113.746 -178.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -132.5 172.84 11.97 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.986 1.314 . . . . 0.0 111.588 -176.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.544 ' CG2' ' HB1' ' A' ' 90' ' ' ALA . 3.5 m -126.38 107.57 10.41 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.06 1.344 . . . . 0.0 111.641 -179.361 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.0 tt -70.53 98.84 1.53 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.978 1.711 . . . . 0.0 111.918 179.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -94.19 97.07 2.13 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 124.765 1.174 . . . . 0.0 114.881 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 99.3 t -75.45 140.53 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.381 1.072 . . . . 0.0 110.123 174.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 3.1 tmm? -136.13 129.16 31.36 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.651 1.581 . . . . 0.0 110.348 177.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.482 ' CE1' ' HB3' ' A' ' 87' ' ' ALA . 22.7 p90 -144.79 142.85 30.3 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.442 -0.786 . . . . 0.0 112.426 175.002 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 13.2 m -142.9 114.48 8.01 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.395 1.078 . . . . 0.0 112.361 -177.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 26.1 t -113.16 97.35 42.38 Favored Pre-proline 0 CA--C 1.538 0.488 0 C-N-CA 127.445 2.298 . . . . 0.0 109.229 178.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.7 127.35 15.31 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 122.712 2.274 . . . . 0.0 109.73 175.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -73.98 -58.52 3.24 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 121.585 -0.697 . . . . 0.0 110.597 176.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -63.85 -28.91 70.17 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.661 0.785 . . . . 0.0 111.508 -175.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 55.57 7.68 0.26 Allowed 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 127.679 2.391 . . . . 0.0 114.233 -177.615 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.34 112.52 1.98 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 127.986 2.514 . . . . 0.0 110.003 -177.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER 43.57 30.6 0.36 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 126.593 1.957 . . . . 0.0 114.091 -178.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.28 171.89 12.42 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.738 1.615 . . . . 0.0 111.941 -175.51 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 31.7 m -142.63 139.67 31.35 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 124.729 1.212 . . . . 0.0 111.378 -178.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -67.51 101.39 0.98 Allowed 'General case' 0 C--O 1.223 -0.316 0 C-N-CA 125.041 1.336 . . . . 0.0 107.929 174.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 47.7 m0 -107.78 144.27 35.18 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 120.622 1.555 . . . . 0.0 110.185 176.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 43.9 p-90 -147.99 139.9 24.01 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.659 0.784 . . . . 0.0 111.509 -177.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -149.86 159.42 44.38 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 122.656 1.217 . . . . 0.0 112.294 -177.353 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 22.0 t -144.43 136.27 21.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 174.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.98 179.91 6.9 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 126.242 1.817 . . . . 0.0 109.191 176.206 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 10.5 mt -132.41 134.04 59.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 123.197 0.599 . . . . 0.0 109.399 176.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -90.43 151.68 44.6 Favored Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 125.329 1.452 . . . . 0.0 112.493 177.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.74 139.9 28.48 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 123.198 2.599 . . . . 0.0 110.939 174.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 61.29 -166.21 15.17 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 123.726 0.679 . . . . 0.0 113.475 -176.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.46 99.5 5.67 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.716 1.606 . . . . 0.0 109.771 174.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -111.44 -172.38 2.02 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 125.744 1.618 . . . . 0.0 111.199 -177.614 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 25.7 ptt180 -139.01 177.54 7.82 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 127.222 2.209 . . . . 0.0 111.229 175.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -118.46 121.22 39.77 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 174.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -129.81 167.11 18.62 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.703 1.601 . . . . 0.0 109.353 175.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -48.87 -45.83 41.56 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 119.641 1.109 . . . . 0.0 113.232 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -52.55 -62.94 5.35 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 123.997 0.808 . . . . 0.0 112.252 175.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 5.0 mpp? -60.76 -38.42 85.17 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 113.583 0.956 . . . . 0.0 113.583 178.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -57.0 -61.87 2.15 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.934 0.788 . . . . 0.0 109.527 175.031 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -62.97 -37.17 86.03 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.863 0.865 . . . . 0.0 112.731 -177.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -63.65 -43.54 96.47 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.012 1.325 . . . . 0.0 112.36 179.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.81 -26.16 24.22 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 121.053 -1.029 . . . . 0.0 113.42 176.212 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -52.02 -58.29 6.97 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.257 1.823 . . . . 0.0 110.678 175.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -70.47 -12.85 61.84 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -177.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -81.69 -5.63 89.71 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 127.203 2.335 . . . . 0.0 114.345 177.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -145.11 86.45 7.63 Favored Pre-proline 0 CA--C 1.548 0.87 0 CA-C-N 119.052 1.426 . . . . 0.0 113.301 175.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -76.64 74.79 4.68 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 123.513 2.809 . . . . 0.0 112.946 -179.041 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -107.26 107.36 18.26 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.022 0.929 . . . . 0.0 111.385 -175.208 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 59.1 mtm180 -89.76 48.14 1.55 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 126.074 1.75 . . . . 0.0 114.505 -175.007 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 49.46 57.86 8.83 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.815 -176.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -63.14 106.52 0.87 Allowed 'General case' 0 CA--C 1.546 0.802 0 CA-C-O 122.141 0.972 . . . . 0.0 109.86 -176.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 17.3 p-10 -68.23 73.69 0.21 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 127.336 2.255 . . . . 0.0 114.968 -174.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 178.35 48.75 0.07 OUTLIER Glycine 0 CA--C 1.536 1.4 0 C-N-CA 124.382 0.991 . . . . 0.0 115.003 175.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' TRP . . . . . 0.708 ' H ' HD13 ' A' ' 161' ' ' ILE . 8.1 m95 49.33 56.28 8.05 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 126.204 1.802 . . . . 0.0 112.795 -175.028 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -85.9 127.5 34.61 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.281 1.032 . . . . 0.0 112.818 -178.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -157.86 -176.09 5.73 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -175.042 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 5.7 mtmt -140.24 169.33 17.88 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 126.144 1.777 . . . . 0.0 111.581 175.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -72.66 155.66 39.77 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 174.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.542 HD11 ' HB2' ' A' ' 158' ' ' MET . 71.0 mt -109.01 89.02 2.87 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.736 0.814 . . . . 0.0 110.375 177.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 40.86 -82.06 0.0 OUTLIER Glycine 0 N--CA 1.476 1.341 0 C-N-CA 129.608 3.48 . . . . 0.0 115.27 175.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -68.53 -154.2 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 128.839 2.855 . . . . 0.0 110.541 174.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -73.68 20.24 1.41 Allowed Glycine 0 CA--C 1.541 1.693 0 O-C-N 120.217 -1.552 . . . . 0.0 114.928 175.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.04 154.07 17.34 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 120.448 2.124 . . . . 0.0 112.038 177.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 87.4 mtt180 -145.95 115.82 7.32 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.322 1.449 . . . . 0.0 110.877 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' MET . . . . . 0.542 ' HB2' HD11 ' A' ' 152' ' ' LEU . 5.9 ttp -114.25 132.42 56.15 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 124.273 1.029 . . . . 0.0 109.682 -178.127 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -103.84 132.83 49.72 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 128.477 2.711 . . . . 0.0 110.005 -179.039 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -135.2 150.83 20.31 Favored Glycine 0 N--CA 1.47 0.918 0 CA-C-N 120.313 1.415 . . . . 0.0 114.23 178.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.708 HD13 ' H ' ' A' ' 147' ' ' TRP . 6.6 tp -145.81 131.93 13.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 125.147 1.379 . . . . 0.0 110.957 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 3.6 ttt -152.42 176.4 11.69 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 127.606 2.362 . . . . 0.0 107.717 175.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 10.1 t -152.39 163.62 39.15 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.194 1.397 . . . . 0.0 109.161 175.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 5.4 t -106.52 31.43 5.22 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.396 1.478 . . . . 0.0 111.511 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -68.44 23.76 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 128.09 2.556 . . . . 0.0 115.112 179.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 84.36 -60.24 4.85 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 126.181 1.848 . . . . 0.0 113.342 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -126.5 63.0 1.28 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.333 1.453 . . . . 0.0 111.051 178.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -86.61 -177.46 6.15 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.311 1.044 . . . . 0.0 112.794 174.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.447 ' HE2' ' O ' ' A' ' 169' ' ' LYS . 0.0 OUTLIER -124.85 174.43 7.95 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 127.991 2.516 . . . . 0.0 109.708 174.993 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 42.5 ttp -126.12 132.12 51.93 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.055 1.342 . . . . 0.0 110.189 176.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -135.86 127.18 28.38 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.104 0.962 . . . . 0.0 110.163 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.413 HG21 ' SD ' ' A' ' 158' ' ' MET . 4.6 mp -129.58 120.66 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 C-N-CA 123.19 0.596 . . . . 0.0 109.95 177.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.06 132.42 56.03 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.827 1.651 . . . . 0.0 111.341 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.8 mp -76.81 133.67 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 O-C-N 120.683 -1.26 . . . . 0.0 110.382 175.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 6.7 m -140.24 92.5 2.54 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 125.144 1.378 . . . . 0.0 112.22 177.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 60.5 mtp180 . . . . . 0 C--O 1.254 1.29 0 C-N-CA 126.311 1.844 . . . . 0.0 111.48 175.033 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 38.4 m . . . . . 0 N--CA 1.482 1.169 0 CA-C-O 121.57 0.7 . . . . 0.0 111.283 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.515 ' O ' HD12 ' A' ' 25' ' ' LEU . 1.0 OUTLIER -136.65 166.39 23.66 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 126.798 2.039 . . . . 0.0 110.303 179.68 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.448 ' HB2' ' HD2' ' A' ' 27' ' ' LYS . 15.5 tp -132.5 -35.42 1.14 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.902 1.281 . . . . 0.0 112.385 176.108 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -75.62 129.96 38.0 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 175.001 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -71.93 -113.02 0.05 OUTLIER Glycine 0 CA--C 1.533 1.192 0 C-N-CA 124.036 0.827 . . . . 0.0 112.636 177.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 19.3 p -113.58 172.82 6.74 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.872 1.269 . . . . 0.0 111.578 176.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -124.81 24.56 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 125.226 1.41 . . . . 0.0 111.871 175.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -52.49 166.4 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 O-C-N 120.633 -1.292 . . . . 0.0 112.684 174.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -48.87 144.3 4.71 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.947 1.299 . . . . 0.0 113.404 -177.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.06 -24.33 54.37 Favored Glycine 0 CA--C 1.538 1.492 0 N-CA-C 115.78 1.072 . . . . 0.0 115.78 -174.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.89 -34.43 64.42 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 121.289 -1.124 . . . . 0.0 111.797 174.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.9 t -84.21 -41.27 17.14 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.684 1.993 . . . . 0.0 112.837 175.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 13.0 tp -89.23 96.29 10.66 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 127.415 2.286 . . . . 0.0 111.357 175.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.58 178.77 6.49 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 126.734 2.014 . . . . 0.0 110.731 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -41.36 -40.91 1.83 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.683 1.593 . . . . 0.0 113.786 175.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -49.89 -45.23 50.56 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.219 1.407 . . . . 0.0 112.639 175.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 88.0 t -69.86 -38.88 76.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 125.777 1.631 . . . . 0.0 111.669 175.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 44.6 mt -70.75 -36.77 73.29 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 120.706 -1.246 . . . . 0.0 112.457 -178.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -65.48 -51.14 62.19 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.343 1.457 . . . . 0.0 111.186 175.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.71 -34.31 75.56 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 118.08 -0.962 . . . . 0.0 111.915 175.337 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.2 t -56.35 -48.53 79.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-N 119.679 1.127 . . . . 0.0 111.485 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 55.4 mt -56.85 -19.8 19.44 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 175.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.03 -61.24 1.28 Allowed Glycine 0 CA--C 1.535 1.293 0 C-N-CA 126.306 1.908 . . . . 0.0 113.12 175.024 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -64.11 -32.54 74.14 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -178.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.515 HD12 ' O ' ' A' ' 2' ' ' GLU . 2.6 mm? -90.55 97.76 11.37 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.179 0.992 . . . . 0.0 109.917 176.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -109.82 109.42 2.7 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 126.333 1.921 . . . . 0.0 112.475 -178.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.448 ' HD2' ' HB2' ' A' ' 3' ' ' LEU . 17.7 mtpt -129.59 -69.86 0.67 Allowed 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 125.793 1.637 . . . . 0.0 112.07 -176.031 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.4 m -121.17 169.36 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 127.848 2.459 . . . . 0.0 110.491 -176.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.0 t -65.76 -31.85 73.07 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -179.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.5 mmt180 -132.4 105.58 7.36 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.303 1.841 . . . . 0.0 111.041 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.4 ptpt -120.56 159.43 25.26 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 126.539 1.935 . . . . 0.0 110.149 -177.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -128.75 132.95 67.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 123.941 0.897 . . . . 0.0 109.437 175.411 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.33 102.63 4.85 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.077 1.751 . . . . 0.0 109.673 177.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.799 HG22 ' HB2' ' A' ' 72' ' ' TYR . 1.3 m -107.7 162.29 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 123.73 0.812 . . . . 0.0 110.927 178.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -134.84 124.28 3.39 Favored Glycine 0 N--CA 1.463 0.452 0 N-CA-C 111.531 -0.628 . . . . 0.0 111.531 177.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.42 ' HB ' HD11 ' A' ' 70' ' ' LEU . 3.3 mp -113.02 132.35 62.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-N 118.459 1.13 . . . . 0.0 110.536 175.192 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -96.22 99.69 11.39 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.67 1.588 . . . . 0.0 110.214 177.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -67.73 94.35 0.44 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.319 1.448 . . . . 0.0 110.552 175.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -125.34 7.29 7.75 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 125.576 1.55 . . . . 0.0 111.801 174.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 42.8 p -57.03 -34.9 68.67 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.366 1.066 . . . . 0.0 113.616 -177.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 158.47 -63.52 0.3 Allowed Glycine 0 CA--C 1.53 1.02 0 C-N-CA 125.271 1.415 . . . . 0.0 113.639 175.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -107.18 171.08 16.29 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 125.549 1.547 . . . . 0.0 113.092 -178.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.17 150.84 28.64 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.803 -0.822 . . . . 0.0 110.874 175.199 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.404 ' HB3' ' CD1' ' A' ' 91' ' ' TYR . 45.2 m0 -104.35 100.52 10.23 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 124.876 1.271 . . . . 0.0 111.346 -177.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.5 m -80.73 117.97 21.86 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 124.689 1.195 . . . . 0.0 108.44 175.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.86 126.46 27.08 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.129 0.571 . . . . 0.0 111.676 175.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.47 HD12 ' N ' ' A' ' 48' ' ' ASN . 3.1 pp -100.37 -53.48 3.1 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 122.844 0.458 . . . . 0.0 111.937 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.47 ' N ' HD12 ' A' ' 47' ' ' LEU . 5.8 t30 -171.6 138.87 1.17 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.618 1.967 . . . . 0.0 109.56 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.599 ' HB2' HD12 ' A' ' 60' ' ' LEU . . . -121.31 155.53 34.51 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.797 1.239 . . . . 0.0 111.404 175.098 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -136.45 113.42 10.44 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.589 1.555 . . . . 0.0 111.409 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.533 ' CD1' ' HB1' ' A' ' 87' ' ' ALA . 2.8 m-85 -114.31 132.5 56.15 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 123.772 0.829 . . . . 0.0 110.02 -178.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.58 -31.33 4.31 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 114.973 1.471 . . . . 0.0 114.973 -175.007 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.0 t -123.18 -46.58 2.06 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.503 1.521 . . . . 0.0 110.943 175.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -72.48 10.97 4.48 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 124.711 1.148 . . . . 0.0 115.046 -178.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.3 p -31.06 104.03 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 128.982 2.913 . . . . 0.0 114.182 -174.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.642 HG21 HG23 ' A' ' 59' ' ' ILE . 1.6 t -120.92 178.6 4.66 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.945 1.298 . . . . 0.0 112.786 -174.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -77.42 -59.03 2.95 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.86 1.264 . . . . 0.0 111.554 174.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.3 p -138.09 131.41 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 125.918 1.687 . . . . 0.0 112.32 -178.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.642 HG23 HG21 ' A' ' 56' ' ' THR . 1.1 pp -140.78 -39.62 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.92 1.688 . . . . 0.0 114.154 -177.345 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.606 ' H ' HD12 ' A' ' 59' ' ' ILE . 4.9 mt -92.17 94.94 0.87 Allowed Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 124.933 1.293 . . . . 0.0 108.883 175.11 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -61.83 132.91 42.03 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 123.137 2.558 . . . . 0.0 110.258 175.145 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -40.0 -44.43 1.73 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 126.457 1.903 . . . . 0.0 113.962 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.4 p -155.13 139.7 9.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 C-N-CA 126.613 1.965 . . . . 0.0 110.028 176.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 58.6 t -133.72 121.35 16.02 Favored Pre-proline 0 N--CA 1.484 1.246 0 C-N-CA 124.623 1.169 . . . . 0.0 110.672 178.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -58.17 152.32 53.3 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.982 2.455 . . . . 0.0 113.21 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -72.49 168.21 19.01 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.51 0.724 . . . . 0.0 110.657 175.013 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 72.7 p 51.72 28.56 4.95 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 126.904 2.082 . . . . 0.0 112.687 -175.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.25 171.85 12.83 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 128.443 2.697 . . . . 0.0 109.42 -175.307 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -131.15 167.36 19.27 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 121.716 -0.615 . . . . 0.0 109.746 177.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.42 HD11 ' HB ' ' A' ' 36' ' ' ILE . 2.9 pp -137.14 174.16 10.91 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 125.045 1.338 . . . . 0.0 111.03 -176.209 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.461 HD13 ' O ' ' A' ' 34' ' ' VAL . 0.5 OUTLIER -127.95 152.65 47.63 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.819 1.248 . . . . 0.0 111.397 176.166 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.799 ' HB2' HG22 ' A' ' 34' ' ' VAL . 8.2 m-85 -127.25 136.68 52.33 Favored 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 125.109 1.364 . . . . 0.0 107.76 174.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.0 p -114.96 153.29 30.87 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 125.666 1.587 . . . . 0.0 110.935 176.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -170.84 145.45 8.98 Favored Glycine 0 N--CA 1.452 -0.263 0 CA-C-O 121.587 0.548 . . . . 0.0 112.422 176.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 19.0 mtm180 -128.45 132.43 48.41 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 125.942 1.697 . . . . 0.0 109.759 -175.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.8 ptmt -65.61 -177.97 0.49 Allowed 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.894 0.878 . . . . 0.0 112.734 174.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 64.93 54.24 1.32 Allowed 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.667 1.587 . . . . 0.0 112.47 174.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 27.3 t -54.42 -32.82 58.16 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.679 1.592 . . . . 0.0 112.502 175.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 129.91 -70.65 0.51 Allowed Glycine 0 CA--C 1.533 1.192 0 C-N-CA 126.085 1.802 . . . . 0.0 111.862 177.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.58 -19.71 27.82 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 123.347 2.698 . . . . 0.0 113.329 176.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 6.3 p -139.33 146.47 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 126.218 1.807 . . . . 0.0 111.064 175.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -131.15 104.88 7.33 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.631 1.973 . . . . 0.0 110.32 177.07 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -129.9 171.77 12.39 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.912 1.685 . . . . 0.0 109.078 175.045 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -68.26 -64.59 3.04 Favored Glycine 0 N--CA 1.474 1.193 0 O-C-N 120.598 -1.314 . . . . 0.0 113.191 -177.157 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -158.44 114.08 2.67 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.238 1.015 . . . . 0.0 111.058 178.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.8 t -147.57 123.23 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 O-C-N 121.246 -0.909 . . . . 0.0 110.577 -176.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.533 ' HB1' ' CD1' ' A' ' 51' ' ' PHE . . . -165.03 167.24 18.58 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.974 1.31 . . . . 0.0 112.022 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -150.1 139.72 21.62 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.655 1.182 . . . . 0.0 110.645 174.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.453 ' CD2' ' CE2' ' A' ' 72' ' ' TYR . 46.8 p90 -139.73 170.91 15.01 Favored 'General case' 0 N--CA 1.467 0.383 0 O-C-N 121.012 -1.055 . . . . 0.0 110.622 176.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -137.16 156.39 48.4 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.843 -0.536 . . . . 0.0 112.295 175.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.404 ' CD1' ' HB3' ' A' ' 44' ' ' TRP . 8.5 m-85 -130.39 129.14 42.71 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 125.492 1.517 . . . . 0.0 112.314 -177.099 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -85.88 117.29 24.64 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.065 0.46 . . . . 0.0 111.133 -178.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 7.6 mtp -93.92 132.17 38.62 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.05 1.34 . . . . 0.0 110.981 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 39.5 m -57.92 -18.21 21.64 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 125.246 1.418 . . . . 0.0 113.856 175.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -69.48 -9.18 52.66 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 124.911 1.285 . . . . 0.0 113.06 175.018 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 99.54 19.77 19.39 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 125.746 1.641 . . . . 0.0 114.549 178.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 16.4 m-80 -130.55 175.86 8.64 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.003 1.321 . . . . 0.0 111.053 -175.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 16.4 m -128.85 114.21 16.23 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.852 0.861 . . . . 0.0 111.955 177.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 52.1 tp -79.39 104.43 10.0 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.598 1.159 . . . . 0.0 109.737 175.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -99.21 113.92 4.87 Favored Glycine 0 N--CA 1.466 0.69 0 C-N-CA 124.477 1.037 . . . . 0.0 112.737 -179.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 90.1 t -96.31 135.46 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.529 1.131 . . . . 0.0 111.076 -178.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -134.51 125.65 27.79 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.927 1.291 . . . . 0.0 110.772 -175.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.465 ' CZ ' ' HB3' ' A' ' 87' ' ' ALA . 5.6 p90 -145.94 122.94 11.39 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.759 1.224 . . . . 0.0 111.599 -174.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 38.3 t -133.92 136.31 44.17 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 124.179 0.992 . . . . 0.0 110.46 176.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 45.4 t -126.42 88.83 53.56 Favored Pre-proline 0 C--O 1.238 0.47 0 C-N-CA 127.897 2.479 . . . . 0.0 106.533 -178.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -67.29 102.07 0.66 Allowed 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 123.157 2.572 . . . . 0.0 109.48 177.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -49.29 -30.87 7.97 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.57 1.148 . . . . 0.0 112.559 176.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.47 44.56 0.44 Allowed 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 125.358 1.463 . . . . 0.0 110.969 174.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -49.05 -33.27 11.09 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 125.896 1.679 . . . . 0.0 112.572 -176.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -49.49 111.08 0.44 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 127.585 2.354 . . . . 0.0 109.993 174.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 16.4 m95 63.67 22.74 13.25 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 125.336 1.454 . . . . 0.0 113.701 177.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -129.49 178.74 6.25 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.594 1.958 . . . . 0.0 112.063 -175.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.7 m -142.06 141.57 32.78 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.653 1.181 . . . . 0.0 113.843 176.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -81.37 130.93 35.24 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.627 1.971 . . . . 0.0 106.759 175.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 9.7 m0 -117.8 120.64 38.55 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.983 1.313 . . . . 0.0 110.233 176.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 11.6 p-90 -144.46 152.65 40.92 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 126.361 1.865 . . . . 0.0 111.728 -175.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 9.7 t70 164.76 150.17 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 128.743 2.817 . . . . 0.0 109.648 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 62.0 t -120.83 139.49 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.183 1.393 . . . . 0.0 109.035 -175.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.485 ' HE2' ' HG3' ' A' ' 135' ' ' MET . 0.0 OUTLIER -129.46 171.19 12.81 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.287 1.035 . . . . 0.0 111.795 -178.968 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 54.5 mt -124.96 116.78 48.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 175.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -77.12 149.76 79.94 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 123.119 0.568 . . . . 0.0 110.589 174.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.78 -0.67 7.26 Favored 'Trans proline' 0 CA--C 1.545 1.051 0 C-N-CA 124.471 3.448 . . . . 0.0 115.027 -176.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -174.0 -175.49 41.68 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 127.055 2.264 . . . . 0.0 111.003 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 24.6 tttt -52.77 116.83 2.52 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.117 1.367 . . . . 0.0 112.059 -177.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -133.24 117.71 17.72 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.382 1.473 . . . . 0.0 111.738 -177.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.3 ptt180 -65.12 175.11 1.71 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.026 0.93 . . . . 0.0 111.855 174.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -127.58 103.27 7.24 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.989 1.716 . . . . 0.0 106.809 176.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -132.51 172.63 12.25 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.69 1.996 . . . . 0.0 109.425 177.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -53.72 -38.85 64.71 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -177.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -60.96 -58.72 12.29 Favored Glycine 0 N--CA 1.469 0.86 0 CA-C-N 118.885 0.766 . . . . 0.0 111.376 174.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 2.2 mpp? -59.1 -39.59 82.68 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 117.851 0.825 . . . . 0.0 112.171 178.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -59.78 -59.01 6.11 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.367 1.067 . . . . 0.0 110.75 175.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -67.97 -34.31 76.3 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 118.927 0.785 . . . . 0.0 113.01 -177.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -63.45 -41.53 98.63 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.447 0.699 . . . . 0.0 111.382 175.034 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' MET . . . . . 0.485 ' HG3' ' HE2' ' A' ' 119' ' ' LYS . 37.4 mmm -77.48 -28.47 52.27 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 121.06 -1.025 . . . . 0.0 113.033 175.24 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -54.56 -55.19 31.87 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 119.412 1.005 . . . . 0.0 111.386 176.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -65.11 -18.99 65.76 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 119.659 -0.816 . . . . 0.0 112.129 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -81.38 3.8 75.91 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 126.773 2.13 . . . . 0.0 114.472 174.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 34.9 m-20 -115.67 64.31 2.22 Favored Pre-proline 0 CA--C 1.552 1.045 0 C-N-CA 125.804 1.642 . . . . 0.0 114.966 -175.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -76.1 73.33 4.97 Favored 'Trans proline' 0 CA--C 1.546 1.08 0 C-N-CA 123.551 2.834 . . . . 0.0 112.87 -177.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.98 116.43 7.05 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.423 1.089 . . . . 0.0 109.723 -178.273 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 2.9 ttm105 -81.79 -172.81 4.09 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.534 1.533 . . . . 0.0 111.362 177.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -78.06 57.13 3.98 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 124.114 0.864 . . . . 0.0 111.027 174.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -62.61 98.81 0.13 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 128.095 2.558 . . . . 0.0 110.376 175.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 11.2 p-10 -64.08 66.04 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 127.851 2.46 . . . . 0.0 116.343 -175.024 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -178.44 167.94 38.78 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 128.368 2.89 . . . . 0.0 109.825 175.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' TRP . . . . . 0.44 ' CE3' ' HG3' ' A' ' 159' ' ' LYS . 59.6 m95 -64.78 67.91 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.998 2.119 . . . . 0.0 111.215 175.215 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -85.73 116.12 23.81 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 128.796 2.838 . . . . 0.0 111.452 -177.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -166.55 -172.63 2.23 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 177.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.68 167.37 22.27 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.494 1.918 . . . . 0.0 112.543 177.344 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 54.5 m-20 -64.56 142.59 58.37 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.904 -0.498 . . . . 0.0 109.782 175.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 11.0 mt -89.97 158.76 17.23 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 122.165 0.983 . . . . 0.0 109.359 175.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -65.6 -171.87 3.64 Favored Glycine 0 CA--C 1.536 1.399 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 175.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 54.73 8.78 0.24 Allowed 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 175.241 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 82.07 42.51 8.73 Favored Glycine 0 CA--C 1.54 1.645 0 C-N-CA 126.279 1.895 . . . . 0.0 113.087 -175.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.7 mp -120.17 172.33 7.85 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 119.025 1.413 . . . . 0.0 112.678 179.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 24.2 mtt180 -137.99 117.32 12.77 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 120.746 -1.221 . . . . 0.0 111.548 176.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 5.3 ttt -98.45 151.37 20.66 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 120.108 -1.62 . . . . 0.0 108.636 174.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.44 ' HG3' ' CE3' ' A' ' 147' ' ' TRP . 5.4 tppt? -136.86 142.47 42.82 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.503 1.921 . . . . 0.0 109.877 176.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -155.79 152.19 23.66 Favored Glycine 0 N--CA 1.473 1.146 0 O-C-N 120.64 -1.287 . . . . 0.0 112.858 176.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 2.2 tp -135.19 124.53 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 126.676 1.99 . . . . 0.0 108.143 -176.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 8.7 mtp -145.29 113.02 6.33 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.662 1.585 . . . . 0.0 108.991 174.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 9.5 t -100.66 125.17 47.05 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 118.517 0.599 . . . . 0.0 110.997 178.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 23.1 p -74.18 39.01 0.11 Allowed 'General case' 0 N--CA 1.481 1.097 0 O-C-N 120.738 -1.226 . . . . 0.0 113.764 175.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -72.41 -2.29 18.85 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 126.192 1.797 . . . . 0.0 114.516 177.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 108.89 -59.77 0.35 Allowed Glycine 0 CA--C 1.531 1.088 0 C-N-CA 126.264 1.887 . . . . 0.0 113.03 176.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -118.79 27.02 9.15 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.416 1.486 . . . . 0.0 112.482 -177.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.91 170.59 6.44 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 122.558 1.17 . . . . 0.0 114.129 175.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.67 -178.88 3.92 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 126.819 2.047 . . . . 0.0 110.89 175.053 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 14.8 ttp -125.85 139.12 53.75 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.588 1.555 . . . . 0.0 110.288 171.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.418 ' C ' HD12 ' A' ' 172' ' ' ILE . 39.8 tt0 -143.48 126.9 16.78 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 121.981 -0.449 . . . . 0.0 110.67 174.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.418 HD12 ' C ' ' A' ' 171' ' ' GLN . 2.7 mp -123.28 133.95 67.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.664 1.186 . . . . 0.0 108.642 176.378 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -133.14 132.76 42.02 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.852 1.661 . . . . 0.0 109.473 178.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.9 mp -96.04 92.04 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 O-C-N 121.197 -0.939 . . . . 0.0 109.63 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.41 165.1 8.16 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-O 122.276 1.036 . . . . 0.0 112.839 175.124 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 18.2 mmm180 . . . . . 0 C--O 1.252 1.227 0 C-N-CA 125.182 1.393 . . . . 0.0 111.171 -176.82 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 60.0 m . . . . . 0 N--CA 1.482 1.152 0 CA-C-O 120.816 0.341 . . . . 0.0 111.51 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -133.26 -72.29 0.51 Allowed 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.483 1.513 . . . . 0.0 111.116 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 32.1 tp 52.76 15.01 0.48 Allowed 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 127.041 2.137 . . . . 0.0 114.928 -175.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -128.95 120.98 27.07 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 127.273 2.229 . . . . 0.0 107.776 178.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -73.05 -101.16 0.07 OUTLIER Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.046 0.831 . . . . 0.0 112.305 -178.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 38.8 p -131.18 170.67 14.25 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.756 1.222 . . . . 0.0 111.33 175.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -124.47 16.19 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 125.248 1.419 . . . . 0.0 111.886 179.508 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.3 pt -53.31 168.69 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 124.945 1.298 . . . . 0.0 111.561 175.003 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -40.6 132.64 2.12 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.62 1.168 . . . . 0.0 112.873 -178.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -53.71 -22.5 18.28 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 124.937 1.256 . . . . 0.0 114.322 -176.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.18 -33.07 71.69 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.273 1.429 . . . . 0.0 112.452 175.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.2 t -96.36 -44.52 7.18 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.214 1.406 . . . . 0.0 112.314 175.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.3 tp -69.15 89.55 0.45 Allowed 'General case' 0 CA--C 1.545 0.752 0 CA-C-O 122.168 0.985 . . . . 0.0 110.632 175.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 58.1 p -126.93 -176.14 3.62 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 126.884 2.074 . . . . 0.0 111.512 -178.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -52.19 -36.93 53.3 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.165 0.986 . . . . 0.0 113.174 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -56.02 -43.63 77.96 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.645 1.178 . . . . 0.0 112.001 176.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 88.5 t -65.97 -42.52 91.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 124.342 1.057 . . . . 0.0 110.85 175.011 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 42.4 mt -68.52 -38.36 80.84 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 120.837 -1.164 . . . . 0.0 112.5 -179.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -64.6 -47.93 76.8 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.725 1.21 . . . . 0.0 111.105 178.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.32 -35.18 77.41 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 118.064 -0.97 . . . . 0.0 113.083 175.014 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.4 t -53.93 -44.08 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 CA-C-N 120.209 1.368 . . . . 0.0 111.982 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 71.0 mt -60.33 -13.78 14.87 Favored 'General case' 0 CA--C 1.55 0.964 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 175.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -106.06 -46.86 1.13 Allowed Glycine 0 CA--C 1.536 1.354 0 C-N-CA 126.681 2.086 . . . . 0.0 114.034 178.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -66.24 -25.5 66.92 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 119.075 1.438 . . . . 0.0 113.445 175.079 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -111.06 158.42 18.85 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.84 1.256 . . . . 0.0 111.656 175.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -175.77 86.49 0.07 OUTLIER Glycine 0 CA--C 1.53 1.015 0 O-C-N 121.474 -0.766 . . . . 0.0 113.901 -175.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.7 mttt -74.82 -54.8 6.64 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.946 1.298 . . . . 0.0 112.525 177.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 16.2 m -141.03 -179.11 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 127.917 2.487 . . . . 0.0 111.158 -178.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 25.9 m -49.54 -48.69 48.17 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 126.334 1.854 . . . . 0.0 114.517 -177.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.0 tpm_? -120.42 129.6 53.98 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.318 1.447 . . . . 0.0 109.497 175.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.9 ptpt -131.93 152.53 51.02 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.824 2.05 . . . . 0.0 110.502 -174.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -121.37 131.12 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 124.674 1.19 . . . . 0.0 109.559 177.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -134.61 97.54 3.82 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.473 1.909 . . . . 0.0 110.318 177.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.769 HG22 ' HB2' ' A' ' 72' ' ' TYR . 1.6 m -99.52 160.78 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 C-N-CA 123.305 0.642 . . . . 0.0 111.189 178.523 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -133.53 112.11 1.05 Allowed Glycine 0 CA--C 1.526 0.749 0 CA-C-O 119.308 -0.718 . . . . 0.0 113.526 174.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.9 mp -100.68 147.05 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 119.286 1.543 . . . . 0.0 109.456 175.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.448 ' HB3' ' HA ' ' A' ' 173' ' ' LYS . 21.7 t0 -117.2 102.76 9.55 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.116 1.366 . . . . 0.0 110.645 177.029 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -71.54 92.25 1.12 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 127.14 2.176 . . . . 0.0 111.221 176.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -119.01 -0.19 11.19 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.445 1.098 . . . . 0.0 113.802 175.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 30.3 t -47.81 -34.56 8.82 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 127.024 2.13 . . . . 0.0 114.63 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 110.23 60.49 0.5 Allowed Glycine 0 N--CA 1.468 0.777 0 C-N-CA 124.822 1.201 . . . . 0.0 112.264 177.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 167.81 150.34 6.49 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 125.327 1.441 . . . . 0.0 111.918 177.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.673 HG22 ' HA ' ' A' ' 65' ' ' PRO . 10.0 p -68.43 130.99 44.5 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.504 1.122 . . . . 0.0 110.92 174.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 43.1 m0 -91.35 101.79 14.49 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 123.849 0.86 . . . . 0.0 111.634 -179.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.9 m -83.45 125.4 31.68 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.069 1.348 . . . . 0.0 109.907 175.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.77 131.69 47.52 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.036 0.534 . . . . 0.0 110.582 174.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -117.12 -45.37 2.75 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.034 0.934 . . . . 0.0 112.125 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -174.25 149.14 1.36 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.76 2.024 . . . . 0.0 111.436 -178.31 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -131.26 164.82 24.74 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.778 1.631 . . . . 0.0 111.945 176.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -142.89 109.13 5.27 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.902 1.281 . . . . 0.0 111.45 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.498 ' CE1' ' HB1' ' A' ' 87' ' ' ALA . 3.0 m-85 -113.62 128.01 56.27 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.914 0.886 . . . . 0.0 110.498 -177.168 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.57 -39.77 4.53 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -177.024 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.8 t -116.74 -53.89 2.47 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 126.099 1.759 . . . . 0.0 109.801 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -65.36 12.46 0.3 Allowed Glycine 0 CA--C 1.534 1.239 0 C-N-CA 126.929 2.204 . . . . 0.0 115.754 -175.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 53.1 p -31.16 111.15 0.08 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 129.288 3.035 . . . . 0.0 112.938 -174.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 t -129.42 179.62 5.69 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.794 1.238 . . . . 0.0 113.713 -175.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -82.51 -69.65 0.61 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.29 1.436 . . . . 0.0 111.573 176.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.1 p -132.4 130.28 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 125.688 1.595 . . . . 0.0 111.685 -177.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.5 pp -141.15 -26.15 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.896 1.678 . . . . 0.0 114.478 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -99.35 95.26 3.34 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 125.45 1.5 . . . . 0.0 109.181 178.466 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -65.57 151.55 84.42 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.781 2.987 . . . . 0.0 111.026 176.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -46.52 -49.19 18.89 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.991 1.316 . . . . 0.0 113.595 -179.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.7 p -157.5 139.91 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 126.497 1.919 . . . . 0.0 110.073 175.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.407 HG21 HD13 ' A' ' 70' ' ' LEU . 46.1 t -113.89 130.12 24.13 Favored Pre-proline 0 N--CA 1.474 0.753 0 C-N-CA 124.542 1.137 . . . . 0.0 109.069 174.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.673 ' HA ' HG22 ' A' ' 43' ' ' THR . 66.5 Cg_endo -67.71 152.84 77.32 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.436 2.091 . . . . 0.0 112.527 176.135 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -67.12 166.01 14.77 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.05 174.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . 0.267 66.8 p 52.9 22.65 2.47 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 127.668 2.387 . . . . 0.0 114.574 -174.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 20.9 mttt -124.57 172.84 8.9 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 126.834 2.053 . . . . 0.0 112.351 -178.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -131.48 163.94 26.86 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 122.799 0.439 . . . . 0.0 110.123 -178.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.407 HD13 HG21 ' A' ' 64' ' ' VAL . 2.4 pt? -143.76 171.0 14.81 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 124.267 1.027 . . . . 0.0 112.49 -178.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.583 HD13 ' O ' ' A' ' 34' ' ' VAL . 0.9 OUTLIER -117.49 154.78 30.85 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.91 1.284 . . . . 0.0 113.45 179.667 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.769 ' HB2' HG22 ' A' ' 34' ' ' VAL . 16.1 m-85 -129.34 133.5 47.45 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.034 1.334 . . . . 0.0 109.258 175.017 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.0 p -107.82 149.2 28.53 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 126.443 1.897 . . . . 0.0 110.287 175.089 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -167.9 144.52 8.96 Favored Glycine 0 CA--C 1.522 0.524 0 O-C-N 121.738 -0.601 . . . . 0.0 112.852 174.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 40.2 mtm180 -107.09 140.52 39.79 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.47 1.508 . . . . 0.0 110.676 -176.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.27 -33.59 74.92 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.439 1.496 . . . . 0.0 114.564 175.004 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 49.5 m -71.23 89.73 0.88 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 127.369 2.268 . . . . 0.0 113.456 -177.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 35.6 t -78.88 -33.12 45.97 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 176.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 122.0 -74.66 0.36 Allowed Glycine 0 CA--C 1.537 1.467 0 C-N-CA 125.797 1.665 . . . . 0.0 112.501 -174.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -71.3 -42.32 2.02 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 123.196 2.597 . . . . 0.0 113.095 -178.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 20.9 m -140.9 111.38 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 126.322 1.849 . . . . 0.0 111.49 -175.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.51 125.76 27.19 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 121.401 -0.812 . . . . 0.0 110.814 175.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 97.6 m -135.19 154.57 51.56 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 126.237 1.815 . . . . 0.0 108.877 178.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -54.32 -82.44 0.05 OUTLIER Glycine 0 N--CA 1.475 1.299 0 C-N-CA 124.968 1.27 . . . . 0.0 114.526 -174.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -158.82 109.45 2.06 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.509 0.671 . . . . 0.0 111.723 174.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.9 t -138.24 121.07 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 124.897 1.279 . . . . 0.0 109.375 -177.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.498 ' HB1' ' CE1' ' A' ' 51' ' ' PHE . . . -157.66 167.47 30.01 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 122.211 1.005 . . . . 0.0 110.982 176.123 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -147.91 158.15 43.9 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.208 1.003 . . . . 0.0 109.501 175.068 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.482 ' CZ ' HG11 ' A' ' 101' ' ' VAL . 48.0 p90 -155.19 174.48 15.14 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 121.323 -0.861 . . . . 0.0 110.101 175.038 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.482 ' HB1' ' CG2' ' A' ' 98' ' ' THR . . . -133.52 148.28 51.66 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.537 175.071 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -125.93 148.57 49.19 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.372 1.069 . . . . 0.0 113.8 176.138 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -89.12 123.69 33.63 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -178.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 5.8 tpp -89.22 144.07 26.37 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.586 0.754 . . . . 0.0 111.345 176.089 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 10.8 t -66.34 -23.08 66.29 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.828 0.851 . . . . 0.0 112.829 175.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -73.84 -11.15 60.28 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.981 1.313 . . . . 0.0 112.605 174.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 96.71 38.81 4.31 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 125.051 1.31 . . . . 0.0 114.649 178.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -135.7 173.15 12.04 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 118.812 1.306 . . . . 0.0 110.998 -179.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.482 ' CG2' ' HB1' ' A' ' 90' ' ' ALA . 3.4 m -122.63 103.44 8.68 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.731 1.212 . . . . 0.0 112.221 -177.074 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.3 tt -64.53 92.51 0.09 Allowed 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 126.369 1.868 . . . . 0.0 111.957 175.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -91.96 95.2 2.01 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 125.924 1.726 . . . . 0.0 112.211 -178.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.503 HG23 HG22 ' A' ' 118' ' ' VAL . 2.3 p -82.33 153.63 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 123.704 0.802 . . . . 0.0 111.635 177.22 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.74 116.67 7.77 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.697 1.599 . . . . 0.0 110.583 177.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.449 ' CE2' ' HB3' ' A' ' 87' ' ' ALA . 24.6 p90 -134.49 131.08 37.63 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 122.201 1.001 . . . . 0.0 112.706 -176.258 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 23.3 t -143.56 97.38 3.06 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 124.564 1.146 . . . . 0.0 110.643 -175.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 24.1 t -94.37 119.62 66.24 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 126.19 1.796 . . . . 0.0 108.975 177.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.41 ' HD3' ' CB ' ' A' ' 114' ' ' ASN . 59.8 Cg_endo -70.29 162.74 41.22 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 122.54 2.16 . . . . 0.0 111.927 179.041 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -97.34 -62.35 1.27 Allowed 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.919 0.888 . . . . 0.0 111.47 174.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -63.43 -36.87 85.16 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.44 1.496 . . . . 0.0 112.955 -176.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 52.9 21.17 1.89 Allowed 'General case' 0 CA--C 1.556 1.187 0 C-N-CA 126.262 1.825 . . . . 0.0 114.496 -177.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -91.6 -71.41 0.64 Allowed 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.316 1.447 . . . . 0.0 113.967 -174.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -126.4 25.04 6.64 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 127.248 2.219 . . . . 0.0 114.077 -174.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -119.91 124.63 46.5 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.379 1.471 . . . . 0.0 112.883 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 7.3 m -80.73 122.2 26.84 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.283 1.433 . . . . 0.0 110.191 174.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.41 ' CB ' ' HD3' ' A' ' 106' ' ' PRO . 1.8 m-80 -123.11 116.23 23.12 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 124.944 1.297 . . . . 0.0 111.359 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 44.5 m0 -109.03 161.23 15.36 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.251 1.421 . . . . 0.0 111.1 -175.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 43.7 p-90 -150.21 137.2 19.37 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.004 0.922 . . . . 0.0 111.771 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -147.75 163.96 35.07 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 122.881 1.324 . . . . 0.0 113.598 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.503 HG22 HG23 ' A' ' 101' ' ' VAL . 19.6 t -145.98 140.73 21.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 C-N-CA 124.699 1.199 . . . . 0.0 108.656 175.033 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.6 173.36 14.74 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 128.032 2.533 . . . . 0.0 108.85 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.486 ' HB ' ' CE2' ' A' ' 154' ' ' TYR . 7.4 mt -129.86 113.34 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 123.883 0.873 . . . . 0.0 109.135 177.543 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -64.76 138.14 97.37 Favored Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 124.108 0.963 . . . . 0.0 111.521 177.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -74.48 84.07 1.62 Allowed 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 124.336 3.357 . . . . 0.0 112.124 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 114.62 175.76 18.74 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 126.348 1.928 . . . . 0.0 112.955 -178.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 7.5 tttt -61.84 102.36 0.26 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.289 1.436 . . . . 0.0 111.015 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 1.4 mmt85 -123.18 -175.2 3.12 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 126.434 1.894 . . . . 0.0 111.959 -175.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.3 ptp180 -132.12 175.92 8.83 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.735 1.214 . . . . 0.0 112.581 175.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -119.53 111.69 18.41 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 105.258 -2.127 . . . . 0.0 105.258 174.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -128.9 166.26 19.47 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.485 1.514 . . . . 0.0 109.275 177.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -50.01 -40.23 43.93 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 119.8 1.182 . . . . 0.0 113.389 -178.388 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -56.23 -62.59 6.16 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 124.065 0.841 . . . . 0.0 111.843 174.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 4.6 mtm -60.79 -37.3 81.46 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.045 1.338 . . . . 0.0 113.723 178.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -57.84 -62.49 1.76 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.256 1.422 . . . . 0.0 109.494 175.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -69.47 -31.54 69.89 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -177.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -57.05 -59.1 5.57 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.032 1.333 . . . . 0.0 110.864 174.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.13 -20.54 59.36 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -53.75 -57.27 11.48 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.639 1.176 . . . . 0.0 109.954 175.029 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -71.4 -0.73 10.94 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -89.82 -9.55 65.99 Favored Glycine 0 CA--C 1.537 1.454 0 C-N-CA 126.112 1.815 . . . . 0.0 114.924 177.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -145.6 91.33 5.74 Favored Pre-proline 0 CA--C 1.549 0.918 0 CA-C-N 119.64 1.72 . . . . 0.0 113.43 179.208 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -74.41 81.12 2.11 Favored 'Trans proline' 0 CA--C 1.543 0.968 0 C-N-CA 123.556 2.837 . . . . 0.0 112.656 -178.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -113.41 116.16 29.21 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.493 1.517 . . . . 0.0 109.233 177.315 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 4.4 ttm180 -103.43 50.6 0.8 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.992 1.317 . . . . 0.0 114.052 -174.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 56.96 56.21 26.15 Favored Glycine 0 CA--C 1.534 1.239 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 -175.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -68.08 108.09 2.97 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.002 1.321 . . . . 0.0 110.873 -175.086 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -77.04 91.81 3.68 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.171 1.388 . . . . 0.0 114.24 -174.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.71 50.77 0.01 OUTLIER Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.318 0.961 . . . . 0.0 114.381 174.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' TRP . . . . . 0.535 ' H ' HD13 ' A' ' 161' ' ' ILE . 8.8 m95 46.36 62.38 2.32 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.602 1.561 . . . . 0.0 112.704 -174.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -90.51 125.37 35.58 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.112 1.365 . . . . 0.0 112.361 179.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -160.03 -175.12 4.91 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.235 1.014 . . . . 0.0 113.104 -175.076 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 8.9 mtmt -134.76 160.8 37.04 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.375 1.47 . . . . 0.0 111.176 174.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -81.36 146.62 30.24 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.066 0.946 . . . . 0.0 109.397 175.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.427 ' CD2' ' H ' ' A' ' 158' ' ' MET . 3.1 mm? -102.03 128.2 48.58 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 122.733 0.413 . . . . 0.0 110.013 -177.062 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -53.32 -24.67 23.63 Favored Glycine 0 N--CA 1.475 1.289 0 C-N-CA 125.628 1.585 . . . . 0.0 116.005 -175.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.486 ' CE2' ' HB ' ' A' ' 120' ' ' ILE . 0.1 OUTLIER -74.06 1.54 10.79 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 127.539 2.336 . . . . 0.0 113.453 177.612 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 90.28 10.85 63.53 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.882 1.706 . . . . 0.0 114.381 -177.263 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 2.6 mt -98.32 166.44 11.39 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.722 2.009 . . . . 0.0 111.187 -178.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 57.7 mtt180 -139.87 105.6 5.14 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.294 1.038 . . . . 0.0 110.524 178.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' MET . . . . . 0.427 ' H ' ' CD2' ' A' ' 152' ' ' LEU . 18.0 ttp -91.68 135.5 33.84 Favored 'General case' 0 C--N 1.318 -0.762 0 O-C-N 120.755 -1.215 . . . . 0.0 107.888 176.29 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.21 124.57 52.36 Favored 'General case' 0 C--O 1.221 -0.414 0 C-N-CA 126.145 1.778 . . . . 0.0 109.482 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -133.1 155.6 21.74 Favored Glycine 0 N--CA 1.469 0.842 0 CA-C-N 120.807 1.64 . . . . 0.0 114.833 -178.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.535 HD13 ' H ' ' A' ' 147' ' ' TRP . 4.2 tp -152.7 135.06 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-O 122.777 1.275 . . . . 0.0 110.846 -175.361 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 11.5 mtp -153.05 168.94 24.2 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 128.058 2.543 . . . . 0.0 109.209 176.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 13.2 t -151.66 162.66 40.62 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.726 1.21 . . . . 0.0 109.451 174.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 89.5 p -97.68 26.2 5.24 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.047 1.339 . . . . 0.0 113.115 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -68.48 12.77 0.11 Allowed 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 126.843 2.057 . . . . 0.0 115.4 -176.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 85.93 -62.82 4.33 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 125.735 1.636 . . . . 0.0 112.69 178.024 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -95.61 9.96 38.4 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 177.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -58.04 159.75 5.44 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 123.116 1.436 . . . . 0.0 114.189 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.45 175.41 6.2 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 128.002 2.521 . . . . 0.0 110.758 -177.013 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 35.6 ttp -118.97 130.5 55.73 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 125.012 1.325 . . . . 0.0 110.363 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -137.03 126.84 25.61 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.148 0.579 . . . . 0.0 110.806 175.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.403 HG21 ' SD ' ' A' ' 158' ' ' MET . 4.8 mp -131.11 113.75 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 C-N-CA 123.668 0.787 . . . . 0.0 110.068 176.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.448 ' HA ' ' HB3' ' A' ' 37' ' ' ASP . 0.3 OUTLIER -109.61 129.09 55.61 Favored 'General case' 0 C--O 1.222 -0.352 0 C-N-CA 125.11 1.364 . . . . 0.0 111.693 176.277 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.8 mp -79.61 137.18 22.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 175.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 3.2 m -122.21 159.21 27.75 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.699 2.0 . . . . 0.0 110.631 175.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 39.1 mtp180 . . . . . 0 C--O 1.251 1.182 0 C-N-CA 126.403 1.881 . . . . 0.0 112.161 -178.586 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 5.4 t . . . . . 0 N--CA 1.482 1.172 0 N-CA-C 110.695 -0.113 . . . . 0.0 110.695 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -67.8 174.29 3.75 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.397 1.079 . . . . 0.0 112.342 175.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 11.9 tp -131.66 8.21 4.52 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 175.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -132.3 137.78 47.59 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.706 1.602 . . . . 0.0 110.805 175.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.425 ' H ' ' HG ' ' A' ' 71' ' ' LEU . . . -81.75 -153.88 11.88 Favored Glycine 0 CA--C 1.544 1.878 0 C-N-CA 125.351 1.453 . . . . 0.0 110.257 176.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 42.5 p -76.06 173.76 10.88 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.609 1.164 . . . . 0.0 113.063 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -129.77 15.91 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.987 0 C-N-CA 125.92 1.688 . . . . 0.0 112.16 176.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.419 HD12 ' HB3' ' A' ' 12' ' ' SER . 4.7 pt -52.92 166.3 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 O-C-N 120.587 -1.32 . . . . 0.0 111.733 175.01 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -39.81 132.42 1.72 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.267 1.427 . . . . 0.0 113.244 -179.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -57.36 -16.89 22.9 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 124.889 1.233 . . . . 0.0 114.402 -177.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.2 -23.63 67.38 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.542 1.137 . . . . 0.0 111.701 174.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.419 ' HB3' HD12 ' A' ' 8' ' ' ILE . 4.1 t -109.82 -40.29 4.84 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.592 1.957 . . . . 0.0 112.604 175.703 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.6 tp -76.47 97.43 4.32 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 121.476 -0.765 . . . . 0.0 109.827 175.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -134.99 -177.82 4.81 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 126.541 1.937 . . . . 0.0 111.87 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -50.23 -36.24 30.13 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.212 1.405 . . . . 0.0 112.91 -178.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -52.85 -37.83 60.69 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.015 1.326 . . . . 0.0 112.543 175.138 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 78.5 t -73.25 -42.01 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 125.788 1.635 . . . . 0.0 111.115 175.067 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 57.7 mt -65.4 -42.24 92.81 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 120.961 -1.087 . . . . 0.0 111.964 178.182 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -61.04 -41.21 96.15 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.289 1.036 . . . . 0.0 111.882 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.98 -38.47 64.16 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 118.834 -0.603 . . . . 0.0 111.215 175.002 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.402 HG13 HD12 ' A' ' 25' ' ' LEU . 19.3 t -56.01 -39.66 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 C-N-CA 125.398 1.479 . . . . 0.0 111.534 177.673 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -56.57 -20.57 21.41 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 125.865 1.666 . . . . 0.0 112.727 174.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -108.38 -50.3 0.77 Allowed Glycine 0 CA--C 1.533 1.206 0 C-N-CA 126.356 1.931 . . . . 0.0 114.151 -178.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -64.19 -27.41 69.05 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 118.966 1.383 . . . . 0.0 113.503 178.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.402 HD12 HG13 ' A' ' 21' ' ' VAL . 14.3 mt -109.99 119.64 39.96 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.114 1.366 . . . . 0.0 109.549 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -162.32 81.1 0.13 Allowed Glycine 0 CA--C 1.534 1.24 0 O-C-N 121.604 -0.685 . . . . 0.0 114.156 -175.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.6 mttt -72.69 -60.13 2.38 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.945 1.698 . . . . 0.0 112.985 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.5 m -109.46 -178.7 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 126.794 2.038 . . . . 0.0 110.756 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.6 t -51.27 -46.64 62.47 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.512 1.125 . . . . 0.0 113.568 -175.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.69 144.2 51.17 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.948 1.699 . . . . 0.0 111.176 174.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.92 166.35 22.54 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.194 1.797 . . . . 0.0 111.615 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -129.07 137.42 57.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 124.927 1.291 . . . . 0.0 109.387 176.506 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -141.0 119.24 12.08 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 126.004 1.721 . . . . 0.0 109.416 175.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.532 HG22 ' HB2' ' A' ' 72' ' ' TYR . 2.6 m -124.77 139.03 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 123.084 0.553 . . . . 0.0 110.779 -179.189 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -111.51 103.6 1.58 Allowed Glycine 0 N--CA 1.461 0.334 0 C-N-CA 124.754 1.168 . . . . 0.0 110.857 -178.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.4 mp -100.16 132.81 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 121.527 0.68 . . . . 0.0 110.806 175.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -100.99 104.15 15.3 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.755 2.022 . . . . 0.0 109.859 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 29.1 t30 -78.51 99.05 6.31 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.651 0.78 . . . . 0.0 111.033 175.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.54 13.41 10.13 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.002 0.921 . . . . 0.0 112.2 175.228 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.43 -34.88 71.29 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.892 1.277 . . . . 0.0 114.072 -175.279 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 139.0 -35.75 1.95 Allowed Glycine 0 CA--C 1.531 1.051 0 C-N-CA 125.535 1.54 . . . . 0.0 113.817 175.1 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -114.54 158.24 14.45 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 125.167 1.365 . . . . 0.0 112.935 175.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.42 149.17 34.89 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.922 0.867 . . . . 0.0 110.964 175.001 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.401 ' HB3' ' CD1' ' A' ' 91' ' ' TYR . 40.9 m0 -101.26 107.81 19.29 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 125.139 1.376 . . . . 0.0 110.199 178.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 54.2 m -92.91 128.62 38.84 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 124.805 1.242 . . . . 0.0 109.054 175.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.47 138.15 58.26 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.654 -0.653 . . . . 0.0 111.705 174.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.603 HD21 HG23 ' A' ' 98' ' ' THR . 3.1 pp -118.65 -51.58 2.38 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.054 0.942 . . . . 0.0 112.241 177.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 25.1 t30 -170.83 150.07 3.15 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.09 1.756 . . . . 0.0 109.954 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.611 ' HB2' HD12 ' A' ' 60' ' ' LEU . . . -131.32 158.52 40.45 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.089 1.356 . . . . 0.0 110.849 175.376 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -136.82 108.6 7.05 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.699 1.6 . . . . 0.0 111.151 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.475 ' CE1' ' HB1' ' A' ' 87' ' ' ALA . 2.9 m-85 -112.59 127.23 56.03 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 120.989 -1.069 . . . . 0.0 110.205 -176.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.55 -32.09 6.57 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -175.042 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 38.1 t -130.94 -36.06 1.37 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.361 1.464 . . . . 0.0 112.128 175.038 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -69.64 12.33 1.49 Allowed Glycine 0 CA--C 1.537 1.433 0 C-N-CA 125.553 1.549 . . . . 0.0 115.871 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 75.8 p -28.34 99.36 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 129.992 3.317 . . . . 0.0 114.436 -174.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.606 HG21 HG23 ' A' ' 59' ' ' ILE . 3.2 t -119.25 177.59 4.84 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.467 1.507 . . . . 0.0 112.655 -174.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -82.16 -52.08 7.34 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.442 1.097 . . . . 0.0 112.421 175.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.2 p -155.62 139.19 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.752 1.621 . . . . 0.0 111.618 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.606 HG23 HG21 ' A' ' 56' ' ' THR . 0.1 OUTLIER -133.83 -46.28 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 125.53 1.532 . . . . 0.0 112.693 179.14 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.611 HD12 ' HB2' ' A' ' 49' ' ' ALA . 11.9 mt -79.33 103.46 1.59 Allowed Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 127.002 2.121 . . . . 0.0 109.272 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.5 ' HG2' HG23 ' A' ' 64' ' ' VAL . 48.7 Cg_endo -73.44 159.18 46.95 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 123.874 3.05 . . . . 0.0 110.549 177.615 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -52.97 -48.77 67.16 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 57.7 t -152.98 136.3 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 127.184 2.194 . . . . 0.0 109.272 -175.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.584 HG21 HD23 ' A' ' 70' ' ' LEU . 57.9 t -128.43 114.48 19.69 Favored Pre-proline 0 N--CA 1.479 1.016 0 C-N-CA 124.208 1.003 . . . . 0.0 110.583 174.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -59.93 145.56 98.01 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.495 2.13 . . . . 0.0 112.385 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -68.11 166.36 16.24 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.692 0.797 . . . . 0.0 110.703 175.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 39.8 p 62.39 16.92 8.99 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 127.198 2.199 . . . . 0.0 113.531 -175.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 19.0 mttt -125.86 -173.76 2.92 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.518 1.927 . . . . 0.0 111.102 -178.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -138.8 166.74 23.62 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 122.912 0.485 . . . . 0.0 109.988 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.584 HD23 HG21 ' A' ' 64' ' ' VAL . 2.8 pp -139.29 171.39 14.35 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 124.549 1.139 . . . . 0.0 111.145 -179.055 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.425 ' HG ' ' H ' ' A' ' 5' ' ' GLY . 0.9 OUTLIER -119.13 153.98 33.98 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 124.746 1.218 . . . . 0.0 110.475 175.013 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.532 ' HB2' HG22 ' A' ' 34' ' ' VAL . 2.7 m-85 -126.41 151.73 47.29 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 126.215 1.806 . . . . 0.0 109.931 177.442 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.403 ' H ' HG22 ' A' ' 59' ' ' ILE . 11.0 p -128.7 148.2 50.81 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.85 2.06 . . . . 0.0 111.747 -179.252 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -169.26 146.62 10.33 Favored Glycine 0 CA--C 1.519 0.306 0 CA-C-O 121.627 0.57 . . . . 0.0 112.619 175.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 63.5 mtm180 -128.64 138.59 52.26 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 126.74 2.016 . . . . 0.0 109.21 -174.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -66.37 172.69 3.77 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 174.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 63.8 p -120.49 -171.71 2.22 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 127.452 2.301 . . . . 0.0 112.473 179.143 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 72.7 m 52.64 34.41 15.82 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 175.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 53.19 -98.31 0.03 OUTLIER Glycine 0 CA--C 1.539 1.58 0 C-N-CA 127.325 2.393 . . . . 0.0 113.585 176.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -66.69 -82.55 0.01 OUTLIER 'Trans proline' 0 CA--C 1.546 1.093 0 C-N-CA 124.055 3.17 . . . . 0.0 113.169 177.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 16.4 m -70.68 143.64 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.665 1.186 . . . . 0.0 111.185 177.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -154.87 178.82 9.74 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.47 1.108 . . . . 0.0 110.559 177.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -81.62 13.37 3.15 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.552 1.541 . . . . 0.0 113.064 174.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 76.98 -98.48 1.32 Allowed Glycine 0 CA--C 1.528 0.892 0 C-N-CA 126.518 2.009 . . . . 0.0 112.269 -175.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -148.46 93.44 2.15 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 117.677 0.739 . . . . 0.0 110.866 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.4 t -122.2 120.69 61.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 124.46 1.104 . . . . 0.0 112.066 -175.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.475 ' HB1' ' CE1' ' A' ' 51' ' ' PHE . . . -160.02 168.71 25.0 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.489 1.116 . . . . 0.0 112.282 178.138 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -150.5 132.96 15.63 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.42 1.088 . . . . 0.0 109.326 174.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.463 ' CD2' ' CE2' ' A' ' 72' ' ' TYR . 43.9 p90 -132.17 170.01 15.6 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 120.946 -1.096 . . . . 0.0 110.27 177.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.438 ' HB1' ' CG2' ' A' ' 98' ' ' THR . . . -139.61 142.87 37.06 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -179.194 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.401 ' CD1' ' HB3' ' A' ' 44' ' ' TRP . 20.0 m-85 -120.43 139.12 53.3 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.675 1.19 . . . . 0.0 112.788 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -84.76 126.9 33.81 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.997 -0.439 . . . . 0.0 111.453 -177.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -97.53 141.12 30.97 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.016 1.327 . . . . 0.0 111.855 178.63 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 24.9 m -64.04 -20.26 65.79 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.47 1.108 . . . . 0.0 113.731 174.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 36.2 m-80 -72.22 -10.59 59.98 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.445 1.098 . . . . 0.0 112.81 174.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 89.68 44.32 4.91 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 124.755 1.169 . . . . 0.0 112.987 -176.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.497 ' HB3' HG22 ' A' ' 120' ' ' ILE . 37.3 m-80 -140.06 175.11 9.86 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.956 1.302 . . . . 0.0 110.481 175.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.603 HG23 HD21 ' A' ' 47' ' ' LEU . 12.9 m -126.87 110.7 13.32 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.395 1.478 . . . . 0.0 112.045 178.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.7 tt -70.86 98.02 1.5 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.954 1.302 . . . . 0.0 112.208 174.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -91.22 104.28 3.15 Favored Glycine 0 N--CA 1.469 0.896 0 C-N-CA 125.142 1.353 . . . . 0.0 113.372 177.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 94.0 t -85.39 130.62 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 125.106 1.363 . . . . 0.0 111.344 175.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 2.4 tmm? -119.99 124.27 45.52 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.798 1.639 . . . . 0.0 110.337 178.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.469 ' CZ ' ' HB3' ' A' ' 87' ' ' ALA . 4.3 p90 -148.95 122.67 9.24 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 122.901 1.334 . . . . 0.0 111.946 -178.482 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 15.1 p -139.94 100.53 3.96 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 124.418 1.087 . . . . 0.0 110.008 -175.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 97.0 t -90.52 95.85 0.82 Allowed Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 127.125 2.17 . . . . 0.0 108.654 178.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.18 121.36 7.46 Favored 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 123.145 2.563 . . . . 0.0 112.273 -177.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -64.67 -28.64 69.75 Favored 'General case' 0 CA--C 1.548 0.885 0 O-C-N 121.547 -0.721 . . . . 0.0 111.496 174.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 24.5 p30 -73.52 45.7 0.19 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 126.103 1.761 . . . . 0.0 114.619 176.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -49.96 -18.1 0.48 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 126.341 1.856 . . . . 0.0 114.905 175.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -58.89 -19.73 44.96 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 125.875 1.67 . . . . 0.0 112.452 174.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 24.5 m95 -97.55 -20.56 17.62 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 128.306 2.642 . . . . 0.0 114.012 175.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER 58.23 42.26 22.19 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 127.002 2.121 . . . . 0.0 115.271 177.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.2 p -124.2 74.11 1.28 Allowed 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 125.372 1.469 . . . . 0.0 114.715 -176.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -98.81 108.5 21.2 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.418 1.887 . . . . 0.0 108.093 175.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 35.7 m0 -105.66 142.75 34.86 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 119.671 1.123 . . . . 0.0 109.942 175.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 29.7 p-90 -146.86 143.65 28.72 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 121.309 -0.87 . . . . 0.0 113.112 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -151.38 164.49 36.58 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 122.654 1.216 . . . . 0.0 112.957 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 54.6 t -153.41 136.66 7.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 175.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.37 177.81 10.2 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 126.645 1.978 . . . . 0.0 109.552 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.518 ' HB ' ' CE2' ' A' ' 154' ' ' TYR . 15.8 mt -126.52 141.79 44.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -101.05 144.4 28.48 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 125.172 1.389 . . . . 0.0 110.312 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.06 132.48 21.33 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 123.077 2.518 . . . . 0.0 111.455 179.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 62.85 -160.87 33.36 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 123.47 0.557 . . . . 0.0 113.017 -175.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.8 tttt -73.88 114.46 12.2 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.292 1.037 . . . . 0.0 109.532 175.018 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 2.4 mmt-85 -133.09 148.85 52.17 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.542 1.137 . . . . 0.0 111.057 175.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -93.64 179.57 5.33 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-O 121.686 0.755 . . . . 0.0 110.256 176.334 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -126.07 113.77 17.53 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 127.205 2.202 . . . . 0.0 105.093 175.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -126.91 172.83 10.09 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.388 1.475 . . . . 0.0 110.406 178.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -53.75 -40.78 66.48 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 119.62 1.1 . . . . 0.0 113.323 -178.225 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -59.73 -54.89 33.81 Favored Glycine 0 N--CA 1.467 0.736 0 CA-C-O 119.364 -0.687 . . . . 0.0 111.824 176.093 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 4.5 mpp? -62.24 -42.37 99.25 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 118.199 1.0 . . . . 0.0 112.388 177.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -54.94 -56.28 21.4 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.811 0.845 . . . . 0.0 109.646 176.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -66.37 -37.18 84.71 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -60.77 -44.49 96.7 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.298 1.439 . . . . 0.0 112.305 177.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 42.4 mmm -81.6 -30.01 33.08 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.074 -1.016 . . . . 0.0 112.615 177.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -54.47 -57.99 9.18 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.969 1.308 . . . . 0.0 109.457 174.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -73.8 -10.51 59.74 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -177.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -79.92 -15.42 79.12 Favored Glycine 0 CA--C 1.537 1.432 0 C-N-CA 125.893 1.711 . . . . 0.0 114.868 177.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -140.91 90.61 9.42 Favored Pre-proline 0 CA--C 1.552 1.041 0 CA-C-N 119.37 1.585 . . . . 0.0 112.522 176.403 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -74.66 78.08 2.85 Favored 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 123.912 3.074 . . . . 0.0 112.434 178.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -111.87 120.43 41.9 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.654 1.182 . . . . 0.0 110.462 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.38 -173.82 4.93 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.562 1.145 . . . . 0.0 112.584 176.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -75.16 53.07 2.63 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 125.602 1.572 . . . . 0.0 111.076 175.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -64.72 97.11 0.2 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 127.14 2.176 . . . . 0.0 110.039 178.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -75.31 93.43 2.88 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.554 1.142 . . . . 0.0 113.005 -174.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 162.89 54.93 0.02 OUTLIER Glycine 0 CA--C 1.537 1.407 0 C-N-CA 124.376 0.989 . . . . 0.0 115.011 175.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 8.0 m95 52.1 44.97 29.14 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.619 1.568 . . . . 0.0 114.667 -177.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -78.15 129.5 35.23 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 120.862 -1.148 . . . . 0.0 111.857 -177.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.64 -174.59 4.71 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.394 -0.816 . . . . 0.0 113.165 -175.137 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.96 151.89 51.64 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.972 1.309 . . . . 0.0 110.733 175.097 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -69.64 150.63 46.83 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 175.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 60.8 mt -109.91 145.54 36.69 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 175.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -64.5 -166.62 1.19 Allowed Glycine 0 CA--C 1.545 1.917 0 N-CA-C 110.266 -1.134 . . . . 0.0 110.266 176.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.518 ' CE2' ' HB ' ' A' ' 120' ' ' ILE . 0.0 OUTLIER 54.76 10.77 0.39 Allowed 'General case' 0 CA--C 1.558 1.275 0 N-CA-C 115.316 1.598 . . . . 0.0 115.316 175.038 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 80.96 41.27 10.64 Favored Glycine 0 CA--C 1.539 1.584 0 C-N-CA 126.416 1.96 . . . . 0.0 114.666 -175.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 2.4 mp -123.91 160.11 28.22 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 119.445 1.623 . . . . 0.0 112.305 177.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 10.5 mtt-85 -147.37 121.63 9.58 Favored 'General case' 0 N--CA 1.481 1.086 0 O-C-N 120.424 -1.423 . . . . 0.0 110.397 174.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' MET . . . . . 0.421 ' SD ' HG21 ' A' ' 172' ' ' ILE . 9.1 ttp -108.9 132.99 53.52 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 123.589 0.756 . . . . 0.0 109.069 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 2.7 tppt? -107.36 129.53 54.9 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 127.226 2.21 . . . . 0.0 110.385 -178.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -138.4 158.44 24.92 Favored Glycine 0 N--CA 1.473 1.106 0 CA-C-N 121.255 1.843 . . . . 0.0 115.57 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 3.4 tp -148.1 124.69 2.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-O 122.607 1.194 . . . . 0.0 111.362 -178.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 51.4 mtp -137.56 149.19 46.51 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 128.06 2.544 . . . . 0.0 107.998 175.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 8.8 t -134.66 161.16 35.9 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.335 1.054 . . . . 0.0 110.196 175.138 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 55.0 p -108.04 21.87 16.76 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.981 1.712 . . . . 0.0 112.428 -176.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -64.3 20.73 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.237 0 C-N-CA 128.617 2.767 . . . . 0.0 115.395 178.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 82.76 -68.64 3.51 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 126.995 2.236 . . . . 0.0 112.177 -177.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 -111.93 67.33 0.65 Allowed 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.538 1.535 . . . . 0.0 110.221 -177.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -95.76 174.66 6.86 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.946 1.698 . . . . 0.0 112.796 175.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.95 -178.78 3.94 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.845 2.058 . . . . 0.0 110.768 175.008 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' MET . . . . . 0.459 ' HB3' HG12 ' A' ' 34' ' ' VAL . 20.4 ttp -128.78 122.1 29.8 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.087 1.355 . . . . 0.0 109.812 176.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.482 ' C ' HD12 ' A' ' 172' ' ' ILE . 1.9 tt0 -131.47 130.31 42.28 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.053 0.941 . . . . 0.0 110.06 177.004 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.482 HD12 ' C ' ' A' ' 171' ' ' GLN . 4.3 mp -135.28 125.6 43.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 123.989 0.915 . . . . 0.0 109.297 177.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.85 128.88 50.97 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 125.811 1.644 . . . . 0.0 111.635 177.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.8 mp -74.69 133.06 32.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 175.018 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 1.2 m -144.87 97.08 2.96 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.044 1.337 . . . . 0.0 111.691 176.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 72.6 mtp180 . . . . . 0 C--O 1.254 1.327 0 C-N-CA 126.676 1.99 . . . . 0.0 113.018 177.581 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 37.2 m . . . . . 0 N--CA 1.48 1.065 0 CA-C-O 120.583 0.23 . . . . 0.0 111.526 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -98.48 -178.97 4.18 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.469 1.908 . . . . 0.0 112.59 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.59 HD21 ' HB2' ' A' ' 31' ' ' LYS . 0.1 OUTLIER -130.35 -59.54 1.03 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.688 1.595 . . . . 0.0 111.445 177.703 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -68.41 126.86 30.96 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 121.507 -0.745 . . . . 0.0 109.365 174.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -69.73 -90.69 0.07 OUTLIER Glycine 0 CA--C 1.535 1.293 0 C-N-CA 123.851 0.739 . . . . 0.0 113.181 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.7 p -149.81 166.28 29.95 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 125.776 1.631 . . . . 0.0 111.845 -175.026 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -114.04 22.74 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 CA-C-O 123.032 1.396 . . . . 0.0 112.996 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -45.24 152.38 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 125.624 1.57 . . . . 0.0 111.959 174.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -44.77 139.31 3.04 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 126.041 1.737 . . . . 0.0 112.901 -176.367 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -54.35 -25.98 35.5 Favored Glycine 0 CA--C 1.54 1.603 0 C-N-CA 124.225 0.917 . . . . 0.0 114.713 -175.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.83 -33.6 76.04 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.257 1.423 . . . . 0.0 112.551 174.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.4 m -96.47 -38.35 10.05 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.991 2.116 . . . . 0.0 112.637 175.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.4 tp -78.33 85.08 4.48 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.961 1.304 . . . . 0.0 110.674 176.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 48.6 p -114.12 176.07 5.2 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.771 2.028 . . . . 0.0 110.534 179.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -51.09 -39.47 56.18 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.404 -0.81 . . . . 0.0 112.569 177.648 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -54.89 -37.51 66.4 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 118.54 0.609 . . . . 0.0 112.432 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 92.4 t -68.13 -40.34 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.067 1.347 . . . . 0.0 111.169 174.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 41.1 mt -68.2 -40.45 82.18 Favored 'General case' 0 N--CA 1.471 0.575 0 O-C-N 120.865 -1.147 . . . . 0.0 112.229 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -61.88 -49.52 75.88 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.317 1.047 . . . . 0.0 111.609 177.047 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.58 -33.58 76.25 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 118.155 -0.926 . . . . 0.0 113.089 174.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.1 t -54.7 -42.3 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-N 119.792 1.178 . . . . 0.0 111.594 177.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.5 mt -55.77 -23.55 30.28 Favored 'General case' 0 CA--C 1.55 0.972 0 CA-C-N 119.544 1.065 . . . . 0.0 113.486 175.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -93.65 -60.76 1.14 Allowed Glycine 0 CA--C 1.532 1.132 0 C-N-CA 125.689 1.614 . . . . 0.0 112.7 177.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -67.47 -27.04 66.69 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 -177.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -111.94 87.95 2.69 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.663 1.585 . . . . 0.0 110.298 177.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -134.77 155.26 21.88 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 125.06 1.314 . . . . 0.0 113.004 175.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.529 ' HD3' ' HE ' ' A' ' 75' ' ' ARG . 16.3 mtpt -141.85 -49.37 0.39 Allowed 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 125.549 1.539 . . . . 0.0 112.143 -177.071 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.475 HG22 ' CZ ' ' A' ' 75' ' ' ARG . 3.2 m -115.89 -177.17 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 C-N-CA 126.297 1.839 . . . . 0.0 110.636 176.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.8 t -49.3 -44.4 44.11 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 126.374 1.869 . . . . 0.0 115.068 -176.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.8 161.61 35.1 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 126.28 1.832 . . . . 0.0 111.074 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.59 ' HB2' HD21 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -155.31 165.61 36.11 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.089 0.956 . . . . 0.0 112.711 179.604 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.564 HD12 HG12 ' A' ' 34' ' ' VAL . 0.3 OUTLIER -119.34 123.73 71.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 124.125 0.97 . . . . 0.0 108.44 175.0 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -127.64 120.8 28.88 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 126.513 1.925 . . . . 0.0 106.706 174.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.642 HG13 ' CB ' ' A' ' 72' ' ' TYR . 0.2 OUTLIER -136.56 140.43 43.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 126.459 1.904 . . . . 0.0 108.527 -174.993 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -123.07 132.75 8.73 Favored Glycine 0 CA--C 1.523 0.575 0 CA-C-O 119.981 -0.344 . . . . 0.0 112.538 175.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.4 mp -112.64 152.22 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 117.71 0.755 . . . . 0.0 109.343 174.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -122.22 106.61 11.29 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 122.63 1.205 . . . . 0.0 110.709 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -76.07 85.15 2.94 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 128.451 2.7 . . . . 0.0 111.054 -175.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -120.99 4.65 10.43 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.644 1.177 . . . . 0.0 113.926 176.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.418 ' HA ' HG21 ' A' ' 174' ' ' ILE . 0.6 OUTLIER -53.98 -50.41 66.6 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.475 1.11 . . . . 0.0 112.133 174.982 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 127.7 103.87 1.23 Allowed Glycine 0 CA--C 1.526 0.776 0 C-N-CA 123.928 0.775 . . . . 0.0 111.684 177.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 114.48 153.93 10.82 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 126.15 1.833 . . . . 0.0 111.127 -174.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.705 HG22 ' HA ' ' A' ' 65' ' ' PRO . 68.4 p -69.72 142.18 53.36 Favored 'General case' 0 N--CA 1.466 0.359 0 O-C-N 121.887 -0.773 . . . . 0.0 111.062 175.093 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 39.4 m0 -96.64 107.6 20.07 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.367 0.667 . . . . 0.0 109.434 -179.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 36.4 m -87.58 127.33 35.26 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.609 0.763 . . . . 0.0 109.972 178.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.409 ' HB1' ' HB3' ' A' ' 60' ' ' LEU . . . -63.42 130.39 44.25 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 122.763 0.425 . . . . 0.0 111.429 174.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.8 pp -114.13 -55.76 2.46 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.79 0.836 . . . . 0.0 111.632 178.243 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -166.68 160.32 14.82 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.894 1.677 . . . . 0.0 110.867 175.011 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -140.69 165.71 26.74 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.427 1.091 . . . . 0.0 111.981 174.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -142.0 119.69 11.8 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.704 1.202 . . . . 0.0 111.887 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.474 ' CE1' ' HB1' ' A' ' 87' ' ' ALA . 2.6 m-85 -108.74 139.2 43.88 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.362 -0.836 . . . . 0.0 111.646 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.1 tpp180 -110.78 -65.91 1.12 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.859 1.663 . . . . 0.0 111.262 -177.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -37.58 -58.06 0.9 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 128.257 2.623 . . . . 0.0 113.52 -175.49 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -153.05 -116.63 0.65 Allowed Glycine 0 CA--C 1.526 0.731 0 C-N-CA 125.971 1.748 . . . . 0.0 109.133 175.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 39.0 p -143.33 178.52 7.68 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.036 1.334 . . . . 0.0 112.23 -175.05 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.2 t -154.0 179.58 8.78 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.43 1.492 . . . . 0.0 111.417 174.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -111.67 -38.5 4.87 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.02 1.328 . . . . 0.0 112.41 179.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.9 p -159.28 127.76 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 126.076 1.75 . . . . 0.0 110.636 175.049 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.429 HG22 ' H ' ' A' ' 73' ' ' SER . 1.7 pp -132.8 -32.36 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 114.606 1.335 . . . . 0.0 114.606 175.014 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.409 ' HB3' ' HB1' ' A' ' 46' ' ' ALA . 10.4 mt -100.85 95.53 4.64 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 125.43 1.492 . . . . 0.0 109.403 178.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.453 ' HG2' HG23 ' A' ' 64' ' ' VAL . 98.8 Cg_endo -65.97 151.62 83.52 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 123.402 2.735 . . . . 0.0 110.676 174.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -44.35 -49.64 9.46 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.894 1.677 . . . . 0.0 114.023 -177.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 5.1 p -159.42 137.73 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 126.978 2.111 . . . . 0.0 109.208 175.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.494 HG21 HD13 ' A' ' 70' ' ' LEU . 98.8 t -114.74 125.88 28.55 Favored Pre-proline 0 N--CA 1.479 0.988 0 C-N-CA 123.927 0.891 . . . . 0.0 109.211 175.263 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.705 ' HA ' HG22 ' A' ' 43' ' ' THR . 60.5 Cg_endo -65.64 155.73 67.49 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 122.882 2.388 . . . . 0.0 113.099 177.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -71.71 169.59 15.31 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.582 0.753 . . . . 0.0 111.374 175.011 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 65.2 p 52.34 26.25 3.97 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 126.415 1.886 . . . . 0.0 113.217 -175.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.3 mttt -138.25 174.68 10.3 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 126.441 1.896 . . . . 0.0 111.107 -175.037 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -135.66 160.81 37.36 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -176.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.494 HD13 HG21 ' A' ' 64' ' ' VAL . 2.4 pt? -133.18 170.49 15.34 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.786 1.234 . . . . 0.0 111.552 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -114.29 149.91 35.24 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 124.494 1.118 . . . . 0.0 109.995 175.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.642 ' CB ' HG13 ' A' ' 34' ' ' VAL . 1.5 m-85 -122.36 160.32 25.66 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 127.353 2.261 . . . . 0.0 108.775 175.072 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.429 ' H ' HG22 ' A' ' 59' ' ' ILE . 5.9 p -145.34 166.77 24.61 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 125.443 1.497 . . . . 0.0 112.105 -175.174 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 173.9 151.76 8.48 Favored Glycine 0 C--O 1.237 0.301 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.681 174.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.529 ' HE ' ' HD3' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -111.9 139.17 47.6 Favored 'General case' 0 CA--C 1.521 -0.145 0 C-N-CA 124.883 1.273 . . . . 0.0 111.88 179.321 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.466 ' HE2' ' HB1' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -72.17 -32.52 66.92 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.172 0.989 . . . . 0.0 112.853 174.968 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 24.8 m -54.85 128.04 31.34 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 126.817 2.047 . . . . 0.0 113.019 -174.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -161.27 112.49 1.77 Allowed 'General case' 0 C--O 1.233 0.205 0 C-N-CA 125.371 1.468 . . . . 0.0 108.905 -175.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -35.98 -50.07 1.15 Allowed Glycine 0 CA--C 1.545 1.94 0 C-N-CA 126.181 1.848 . . . . 0.0 115.215 175.034 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -69.76 -59.62 0.08 OUTLIER 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 122.713 2.275 . . . . 0.0 113.118 175.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.4 p -155.67 103.33 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 125.138 1.375 . . . . 0.0 112.11 -175.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.466 ' HB1' ' HE2' ' A' ' 76' ' ' LYS . . . -70.81 129.6 39.51 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 123.524 0.73 . . . . 0.0 111.422 175.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 34.7 m -126.41 134.98 50.87 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.903 1.281 . . . . 0.0 110.363 178.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -26.75 -66.96 0.06 OUTLIER Glycine 0 N--CA 1.473 1.127 0 C-N-CA 127.991 2.71 . . . . 0.0 116.693 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.461 ' HB3' ' HB ' ' A' ' 105' ' ' VAL . . . -167.47 106.66 0.56 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.066 0.947 . . . . 0.0 112.219 -178.081 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.7 t -149.51 109.67 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 124.749 1.22 . . . . 0.0 112.062 -174.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.645 ' HB3' ' CZ ' ' A' ' 103' ' ' PHE . . . -153.69 169.64 22.81 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 179.131 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -147.2 160.61 42.26 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.92 1.288 . . . . 0.0 112.543 175.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.451 ' CZ ' HG11 ' A' ' 101' ' ' VAL . 37.4 p90 -164.11 171.41 15.14 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.332 1.053 . . . . 0.0 111.62 -178.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -143.95 155.94 44.24 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.468 -0.77 . . . . 0.0 112.201 174.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -131.72 129.29 40.48 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 126.472 1.909 . . . . 0.0 113.19 -175.015 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -90.66 130.53 36.66 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 120.882 0.372 . . . . 0.0 111.343 -176.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 3.9 mtm -108.27 139.01 43.6 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 125.503 1.521 . . . . 0.0 111.705 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.2 t -64.79 -18.7 65.32 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.223 1.409 . . . . 0.0 112.962 176.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -69.74 -17.5 63.45 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.998 1.319 . . . . 0.0 113.616 175.167 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 106.47 21.32 8.41 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.92 1.248 . . . . 0.0 115.362 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -131.44 174.81 9.71 Favored 'General case' 0 CA--C 1.555 1.142 0 CA-C-N 119.824 1.812 . . . . 0.0 111.422 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.8 m -129.31 105.87 8.42 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.403 1.081 . . . . 0.0 112.959 -178.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 59.0 tp -68.81 101.23 1.3 Allowed 'General case' 0 N--CA 1.47 0.567 0 O-C-N 121.762 -0.586 . . . . 0.0 110.247 174.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -94.65 138.65 14.12 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 124.176 0.893 . . . . 0.0 112.232 175.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.451 HG11 ' CZ ' ' A' ' 89' ' ' PHE . 54.1 t -128.17 133.03 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.225 1.41 . . . . 0.0 110.71 -175.012 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.84 124.29 20.74 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.895 1.678 . . . . 0.0 109.386 -177.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.645 ' CZ ' ' HB3' ' A' ' 87' ' ' ALA . 26.9 p90 -138.42 135.35 35.16 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -178.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 12.2 m -148.79 100.51 3.1 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 122.224 1.011 . . . . 0.0 111.193 -175.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.461 ' HB ' ' HB3' ' A' ' 85' ' ' ALA . 51.3 t -80.45 141.77 53.26 Favored Pre-proline 0 N--CA 1.471 0.588 0 C-N-CA 127.144 2.178 . . . . 0.0 109.761 -177.091 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -69.84 128.88 16.58 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.278 1.985 . . . . 0.0 112.697 -178.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -138.21 -72.54 0.41 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.446 1.099 . . . . 0.0 111.88 178.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -117.22 11.75 14.18 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.911 1.685 . . . . 0.0 113.955 -177.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -44.87 112.51 0.44 Allowed 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.118 1.367 . . . . 0.0 112.932 177.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -58.53 -13.54 5.87 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.301 1.44 . . . . 0.0 113.884 175.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 28.5 m95 -122.12 6.32 9.75 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 127.641 2.376 . . . . 0.0 113.354 -179.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 1.1 p90 42.84 46.27 4.49 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 126.562 1.945 . . . . 0.0 112.518 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 5.5 m -127.07 93.57 3.79 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.714 2.006 . . . . 0.0 114.042 -174.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -80.58 115.81 20.29 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 124.324 1.05 . . . . 0.0 108.973 174.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 42.1 m0 -116.25 145.66 42.96 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.134 0.973 . . . . 0.0 109.45 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 34.3 p-90 -150.78 139.83 21.07 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.403 0.681 . . . . 0.0 112.248 -179.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -140.57 145.85 37.28 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 122.299 1.047 . . . . 0.0 112.81 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 86.1 t -146.8 123.96 3.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 125.093 1.357 . . . . 0.0 107.783 176.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.426 ' HE2' ' CZ ' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -156.14 176.18 13.0 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.403 1.081 . . . . 0.0 111.336 174.969 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.524 ' HB ' ' CE2' ' A' ' 154' ' ' TYR . 38.8 mt -111.51 105.31 18.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 123.765 0.826 . . . . 0.0 109.804 -177.053 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.426 ' CZ ' ' HE2' ' A' ' 119' ' ' LYS . 91.0 m-85 -60.3 143.82 88.65 Favored Pre-proline 0 CA--C 1.548 0.899 0 O-C-N 121.318 -0.864 . . . . 0.0 111.889 178.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -76.11 80.25 2.72 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 124.449 3.432 . . . . 0.0 112.435 -176.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 118.89 -170.83 13.96 Favored Glycine 0 N--CA 1.471 1.004 0 C-N-CA 125.684 1.611 . . . . 0.0 112.778 -178.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 23.3 tttt -66.27 109.53 2.7 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.018 0.927 . . . . 0.0 109.51 174.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.413 ' HG3' ' H ' ' A' ' 126' ' ' ARG . 5.7 tpt180 -120.01 173.04 7.32 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.723 1.609 . . . . 0.0 110.242 176.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.413 ' H ' ' HG3' ' A' ' 125' ' ' ARG . 2.2 ptp180 -127.04 173.17 9.88 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 127.172 2.189 . . . . 0.0 111.292 174.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -128.35 98.01 4.92 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 126.44 1.896 . . . . 0.0 107.422 175.015 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -117.73 173.1 6.93 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.425 1.89 . . . . 0.0 109.115 175.026 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -49.84 -42.74 48.01 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.057 0.943 . . . . 0.0 113.477 177.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -57.34 -63.66 5.1 Favored Glycine 0 C--N 1.339 0.718 0 C-N-CA 124.173 0.892 . . . . 0.0 111.624 175.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 15.0 mtm -59.81 -34.12 72.63 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 118.141 0.97 . . . . 0.0 113.297 178.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -59.53 -60.42 3.87 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 119.304 0.956 . . . . 0.0 109.93 175.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -70.03 -30.7 68.06 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -177.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -60.75 -54.23 47.74 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.417 1.087 . . . . 0.0 110.024 174.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 2.0 tpp -75.21 -26.48 58.98 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -177.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -52.44 -55.84 19.11 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.464 1.505 . . . . 0.0 110.586 174.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -69.8 -8.65 50.07 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 179.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -79.21 -31.33 42.75 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 126.224 1.869 . . . . 0.0 115.076 -177.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -128.65 85.19 60.95 Favored Pre-proline 0 CA--C 1.548 0.887 0 CA-C-N 118.717 1.259 . . . . 0.0 111.047 178.158 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -73.42 75.94 2.83 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 123.661 2.908 . . . . 0.0 112.086 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -111.28 114.41 27.57 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.058 0.943 . . . . 0.0 110.86 -177.191 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 57.4 mtp180 -81.65 -71.41 0.48 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.813 1.245 . . . . 0.0 111.499 175.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 136.86 122.62 2.16 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 124.568 1.08 . . . . 0.0 113.589 -177.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.9 7.1 9.5 Favored 'General case' 0 CA--C 1.559 1.296 0 C-N-CA 127.175 2.19 . . . . 0.0 115.081 177.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 57.57 55.83 5.36 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 128.282 2.633 . . . . 0.0 112.595 -175.056 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -158.24 -66.73 0.01 OUTLIER Glycine 0 CA--C 1.538 1.479 0 N-CA-C 115.971 1.148 . . . . 0.0 115.971 -177.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 29.8 m95 174.11 117.1 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 130.414 3.486 . . . . 0.0 108.361 -174.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -129.9 121.03 25.86 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 126.801 2.04 . . . . 0.0 111.846 -175.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -162.33 178.3 8.81 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 -175.072 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.76 154.46 48.52 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.542 1.537 . . . . 0.0 110.849 175.373 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -71.34 137.69 48.65 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 175.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 91.1 mt -93.92 102.76 14.87 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.667 0.787 . . . . 0.0 109.947 -176.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -36.22 -37.51 0.19 Allowed Glycine 0 N--CA 1.476 1.32 0 C-N-CA 128.711 3.053 . . . . 0.0 117.629 -174.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.524 ' CE2' ' HB ' ' A' ' 120' ' ' ILE . 0.1 OUTLIER -61.61 -30.85 70.95 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.968 2.107 . . . . 0.0 113.239 -179.252 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 132.65 30.38 0.5 Allowed Glycine 0 CA--C 1.536 1.397 0 C-N-CA 125.763 1.649 . . . . 0.0 114.582 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 12.8 mt -130.6 175.85 8.66 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 126.082 1.753 . . . . 0.0 110.555 -174.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 60.7 mtt-85 -147.21 100.7 3.31 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.534 -1.354 . . . . 0.0 112.701 178.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -82.1 148.69 28.41 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 124.157 0.983 . . . . 0.0 108.632 175.314 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 3.3 tppt? -139.68 120.46 14.37 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.331 1.852 . . . . 0.0 111.214 178.243 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -131.59 154.89 21.11 Favored Glycine 0 N--CA 1.479 1.518 0 CA-C-N 121.123 1.783 . . . . 0.0 116.311 -176.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 2.1 tp -146.19 130.55 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.132 1.373 . . . . 0.0 110.651 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 1.9 ttp -154.61 117.62 4.44 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.958 1.703 . . . . 0.0 110.249 174.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 4.9 t -110.4 101.44 10.15 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 121.122 -0.986 . . . . 0.0 111.411 -177.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 49.0 p -69.12 28.45 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.02 -27.2 68.15 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.309 1.844 . . . . 0.0 114.332 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 159.78 -53.75 0.36 Allowed Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.776 1.179 . . . . 0.0 113.507 175.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -134.5 87.32 2.34 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.81 1.244 . . . . 0.0 110.771 178.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -136.26 -174.6 3.73 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.682 1.593 . . . . 0.0 111.582 175.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.402 ' HE2' ' O ' ' A' ' 169' ' ' LYS . 0.0 OUTLIER -133.51 175.35 9.5 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 127.462 2.305 . . . . 0.0 111.437 -178.671 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 32.6 ttp -110.04 138.3 46.61 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 123.965 0.906 . . . . 0.0 110.479 173.021 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -143.86 123.72 13.47 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 123.595 0.758 . . . . 0.0 110.361 176.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 4.7 mp -127.48 121.02 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 123.481 0.712 . . . . 0.0 109.754 176.015 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 2.8 tmmm? -121.05 139.07 53.82 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 125.32 1.448 . . . . 0.0 110.705 177.007 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.418 HG21 ' HA ' ' A' ' 40' ' ' SER . 1.6 mp -87.4 125.79 41.11 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 174.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -137.4 96.64 3.3 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.256 1.422 . . . . 0.0 111.724 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 10.8 mtp-105 . . . . . 0 C--O 1.254 1.29 0 C-N-CA 128.119 2.568 . . . . 0.0 113.638 -177.737 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.1 t . . . . . 0 N--CA 1.484 1.232 0 CA-C-O 120.836 0.35 . . . . 0.0 111.392 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -98.17 167.69 10.72 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.768 1.627 . . . . 0.0 112.449 178.211 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 3' ' ' LEU . 10.4 tp -123.46 -37.99 2.6 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.313 1.445 . . . . 0.0 111.835 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -85.78 130.26 34.61 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.9 1.28 . . . . 0.0 108.464 174.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -77.12 -151.23 4.2 Favored Glycine 0 CA--C 1.538 1.503 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 175.005 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.6 p -78.86 169.96 17.42 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 121.441 -1.035 . . . . 0.0 113.747 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -120.64 20.72 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 126.339 1.856 . . . . 0.0 112.593 177.435 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -48.82 159.85 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 125.221 1.409 . . . . 0.0 112.517 175.008 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -46.75 140.47 4.55 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.682 1.593 . . . . 0.0 112.564 -175.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -57.24 -20.22 35.18 Favored Glycine 0 CA--C 1.542 1.751 0 C-N-CA 124.083 0.849 . . . . 0.0 114.418 -175.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.74 -27.47 66.81 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.008 1.323 . . . . 0.0 112.357 175.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.7 t -104.55 -42.35 5.46 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 127.15 2.18 . . . . 0.0 111.334 177.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 12.4 tp -83.33 98.59 9.53 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.644 1.578 . . . . 0.0 110.366 174.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 69.0 p -126.57 177.34 6.57 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.997 1.319 . . . . 0.0 110.898 177.252 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.408 ' C ' ' CD1' ' A' ' 15' ' ' PHE . 0.1 OUTLIER -45.73 -37.89 6.39 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.446 1.098 . . . . 0.0 112.827 177.801 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -57.62 -42.72 83.92 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.329 1.452 . . . . 0.0 112.289 -179.316 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.4 t -61.97 -37.29 77.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.72 1.208 . . . . 0.0 110.933 174.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.7 mt -71.73 -40.4 69.45 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.549 1.14 . . . . 0.0 111.663 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -60.77 -43.95 97.38 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.55 1.14 . . . . 0.0 110.429 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.35 -28.1 59.44 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.207 1.003 . . . . 0.0 113.127 174.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -55.79 -38.22 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 124.301 1.04 . . . . 0.0 111.461 177.607 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 15.7 mt -55.6 -20.85 14.96 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.287 1.435 . . . . 0.0 113.977 174.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -98.11 -63.27 0.87 Allowed Glycine 0 CA--C 1.532 1.113 0 C-N-CA 125.172 1.368 . . . . 0.0 112.584 175.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -65.65 -33.82 76.78 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 -174.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -105.37 94.98 5.51 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.66 1.584 . . . . 0.0 108.025 175.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -140.88 145.06 15.52 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 123.954 0.788 . . . . 0.0 113.648 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.7 mtpp -127.31 -39.08 1.91 Allowed 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 126.294 1.838 . . . . 0.0 113.788 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.3 m -133.0 174.71 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 126.425 1.89 . . . . 0.0 111.06 -178.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 54.4 m -54.29 -46.5 72.78 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.241 1.816 . . . . 0.0 114.557 -176.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.72 126.95 44.34 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.99 1.316 . . . . 0.0 111.051 175.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.39 161.29 31.66 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 124.85 1.26 . . . . 0.0 111.485 179.492 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.486 HD13 ' H ' ' A' ' 33' ' ' ALA . 0.3 OUTLIER -107.48 140.87 24.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 174.955 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.486 ' H ' HD13 ' A' ' 32' ' ' ILE . . . -132.91 131.52 40.98 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 126.483 1.913 . . . . 0.0 109.819 175.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.483 ' O ' HD13 ' A' ' 71' ' ' LEU . 25.2 t -140.62 156.15 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 123.305 0.642 . . . . 0.0 110.306 178.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -138.57 98.51 0.26 Allowed Glycine 0 CA--C 1.524 0.598 0 C-N-CA 125.677 1.608 . . . . 0.0 111.904 176.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.7 mp -81.71 144.84 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-N 117.272 0.536 . . . . 0.0 109.739 175.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -116.29 99.43 7.2 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.024 1.73 . . . . 0.0 110.66 178.382 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -67.68 97.17 0.6 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.818 1.647 . . . . 0.0 110.203 175.002 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -124.89 4.87 8.05 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.625 0.77 . . . . 0.0 112.326 174.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.9 t -57.59 -45.25 85.51 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.376 1.47 . . . . 0.0 112.875 -176.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 130.11 40.33 0.26 Allowed Glycine 0 CA--C 1.535 1.29 0 C-N-CA 124.31 0.957 . . . . 0.0 115.25 177.082 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -178.09 165.71 35.34 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.561 1.077 . . . . 0.0 112.605 175.015 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.534 HG22 ' HA ' ' A' ' 65' ' ' PRO . 8.4 p -68.76 137.68 54.23 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.485 -1.009 . . . . 0.0 110.34 174.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.548 ' HA ' ' CE1' ' A' ' 91' ' ' TYR . 35.6 m0 -93.87 100.52 12.68 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 123.232 0.613 . . . . 0.0 111.546 -178.205 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 29.1 m -84.6 115.48 22.65 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.004 0.922 . . . . 0.0 109.121 177.069 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.421 ' HB1' ' HB3' ' A' ' 60' ' ' LEU . . . -60.05 143.5 51.83 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 122.709 0.403 . . . . 0.0 111.547 175.002 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.5 pp -119.2 -55.07 2.18 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.651 0.781 . . . . 0.0 111.966 178.104 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 22.7 t30 -173.15 150.47 1.94 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.991 2.117 . . . . 0.0 109.997 -177.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -129.05 163.67 24.91 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.837 1.255 . . . . 0.0 111.489 175.003 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -131.77 106.87 8.39 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.324 1.45 . . . . 0.0 110.663 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.624 ' CE1' ' HB1' ' A' ' 87' ' ' ALA . 2.7 m-85 -115.58 112.18 21.79 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.948 0.899 . . . . 0.0 110.118 -174.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.05 -41.27 7.63 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -178.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.0 t -116.13 -45.72 2.84 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.549 1.539 . . . . 0.0 111.002 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -69.26 11.57 1.46 Allowed Glycine 0 CA--C 1.538 1.503 0 CA-C-O 118.226 -1.319 . . . . 0.0 115.764 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.7 p -32.75 108.27 0.05 Allowed 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 128.472 2.709 . . . . 0.0 113.987 -175.03 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.523 HG21 HG23 ' A' ' 59' ' ' ILE . 1.5 t -130.02 175.41 8.91 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 114.125 1.158 . . . . 0.0 114.125 -174.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -79.58 -48.84 13.13 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.64 1.176 . . . . 0.0 112.79 -178.227 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.4 p -144.07 132.44 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.818 1.647 . . . . 0.0 111.604 176.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.592 HD12 ' H ' ' A' ' 60' ' ' LEU . 1.0 OUTLIER -137.02 -47.92 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.171 1.388 . . . . 0.0 113.903 179.315 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.592 ' H ' HD12 ' A' ' 59' ' ' ILE . 8.2 mt -86.69 102.6 3.11 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 123.977 0.911 . . . . 0.0 109.836 174.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.44 ' HG2' HG23 ' A' ' 64' ' ' VAL . 73.3 Cg_endo -68.0 141.64 53.94 Favored 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 122.729 2.286 . . . . 0.0 110.898 174.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -38.73 -52.96 1.69 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 126.949 2.1 . . . . 0.0 114.116 178.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.6 p -153.24 135.45 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 126.475 1.91 . . . . 0.0 109.927 174.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.44 HG23 ' HG2' ' A' ' 61' ' ' PRO . 59.5 t -116.24 131.18 23.93 Favored Pre-proline 0 N--CA 1.483 1.207 0 C-N-CA 124.671 1.188 . . . . 0.0 109.681 176.202 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.534 ' HA ' HG22 ' A' ' 43' ' ' THR . 56.8 Cg_endo -65.93 152.91 80.17 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 122.714 2.276 . . . . 0.0 113.656 177.559 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -69.24 162.95 26.06 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.17 0.988 . . . . 0.0 111.232 175.006 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . 0.257 76.4 p 51.37 28.22 4.22 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 126.787 2.035 . . . . 0.0 114.006 -174.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.8 mttp -131.1 175.98 8.64 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 127.537 2.335 . . . . 0.0 111.34 -178.208 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -127.35 158.92 35.97 Favored 'General case' 0 C--O 1.224 -0.249 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -178.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.413 ' C ' HD12 ' A' ' 70' ' ' LEU . 2.4 pp -121.84 171.85 8.6 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.313 1.445 . . . . 0.0 110.52 175.076 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.483 HD13 ' O ' ' A' ' 34' ' ' VAL . 0.3 OUTLIER -117.17 145.6 43.74 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 124.051 0.94 . . . . 0.0 108.95 174.959 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -127.16 143.74 51.19 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 125.585 1.554 . . . . 0.0 108.845 177.16 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 82.9 p -143.57 170.8 15.14 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.963 -178.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 174.48 142.84 4.17 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.223 -0.899 . . . . 0.0 112.357 176.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -109.44 128.97 55.54 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 124.869 1.267 . . . . 0.0 108.087 177.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.7 ptpt -48.45 147.85 2.23 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.724 1.21 . . . . 0.0 113.291 176.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -165.27 146.23 7.29 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 125.149 1.38 . . . . 0.0 111.524 178.001 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.8 t 176.73 114.77 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 127.906 2.483 . . . . 0.0 108.744 175.004 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -38.82 -54.56 2.34 Favored Glycine 0 CA--C 1.547 2.046 0 C-N-CA 125.844 1.688 . . . . 0.0 115.516 175.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.75 -76.53 0.01 OUTLIER 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 123.637 2.891 . . . . 0.0 113.147 176.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 15.7 m -127.52 109.06 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 126.575 1.95 . . . . 0.0 110.336 -178.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -41.49 113.81 0.45 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.149 1.78 . . . . 0.0 112.741 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.1 m -75.4 175.01 8.83 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.885 1.274 . . . . 0.0 110.193 177.279 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -84.03 -90.21 0.77 Allowed Glycine 0 N--CA 1.47 0.948 0 O-C-N 120.538 -1.351 . . . . 0.0 114.524 -175.03 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.596 ' HB3' ' HB ' ' A' ' 105' ' ' VAL . . . -143.33 82.73 1.75 Allowed 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 124.815 1.246 . . . . 0.0 109.066 -175.017 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.7 t -122.29 111.95 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 124.929 1.292 . . . . 0.0 111.007 -175.037 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.624 ' HB1' ' CE1' ' A' ' 51' ' ' PHE . . . -158.03 167.7 29.16 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 122.177 0.989 . . . . 0.0 111.166 177.489 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -148.92 160.88 42.87 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.284 1.433 . . . . 0.0 109.58 175.018 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -156.41 174.67 15.08 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 121.42 -0.8 . . . . 0.0 112.122 175.068 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -145.16 150.89 37.58 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.849 0.833 . . . . 0.0 113.203 174.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.548 ' CE1' ' HA ' ' A' ' 44' ' ' TRP . 0.1 OUTLIER -121.87 127.07 50.07 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 127.205 2.202 . . . . 0.0 109.181 -179.232 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -84.11 104.68 14.37 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.269 0.627 . . . . 0.0 112.423 179.179 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -72.38 126.2 29.26 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 125.401 1.48 . . . . 0.0 112.657 -176.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 37.1 m -58.62 -21.18 52.88 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.652 0.781 . . . . 0.0 113.095 175.048 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 23.7 m-20 -69.38 -14.02 62.68 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 124.693 1.197 . . . . 0.0 112.907 174.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 109.26 31.99 3.13 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 125.295 1.426 . . . . 0.0 115.055 177.016 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -142.72 -179.44 6.33 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.855 1.262 . . . . 0.0 112.044 -175.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 25.1 m -132.55 107.26 8.33 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 120.994 -1.067 . . . . 0.0 111.973 177.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 35.7 tp -74.69 107.74 7.0 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 121.224 -0.923 . . . . 0.0 110.57 175.053 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -107.13 114.6 4.36 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 124.79 1.186 . . . . 0.0 113.742 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.464 ' HA ' HG22 ' A' ' 118' ' ' VAL . 98.4 t -97.27 137.28 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.134 1.374 . . . . 0.0 112.614 -175.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -129.11 126.06 38.51 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 126.352 1.861 . . . . 0.0 111.788 -175.258 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.422 ' CE2' ' HB3' ' A' ' 87' ' ' ALA . 3.8 p90 -148.48 123.82 10.27 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.6 1.16 . . . . 0.0 112.018 -178.278 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 22.4 t -137.47 133.94 35.23 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.758 0.823 . . . . 0.0 111.612 178.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.596 ' HB ' ' HB3' ' A' ' 85' ' ' ALA . 19.0 t -139.24 134.23 16.52 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 126.88 2.072 . . . . 0.0 108.885 -176.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -72.54 168.03 25.46 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 123.7 2.933 . . . . 0.0 112.338 176.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -97.28 -33.15 11.56 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.662 1.185 . . . . 0.0 111.872 174.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -89.27 -22.8 22.52 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -174.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 49.67 32.2 4.91 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 126.564 1.946 . . . . 0.0 114.824 -179.279 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -121.43 118.45 29.43 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.535 1.534 . . . . 0.0 111.42 -178.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 67.3 m95 53.79 21.22 2.61 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.756 1.622 . . . . 0.0 114.647 178.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -100.87 176.53 5.25 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 126.29 1.836 . . . . 0.0 113.39 -174.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 20.1 m -139.87 93.46 2.65 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 125.275 1.43 . . . . 0.0 112.131 -175.269 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -77.03 91.8 3.67 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.954 1.302 . . . . 0.0 111.297 176.033 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 42.8 m0 -98.01 149.16 22.75 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 119.463 1.029 . . . . 0.0 111.226 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 31.6 p-90 -155.95 135.64 12.57 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.653 0.781 . . . . 0.0 112.498 -176.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -145.57 174.84 10.82 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 120.553 -1.342 . . . . 0.0 112.825 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.464 HG22 ' HA ' ' A' ' 101' ' ' VAL . 99.3 t -148.9 139.81 17.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 C-N-CA 123.768 0.827 . . . . 0.0 109.135 175.22 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.467 ' HE2' ' CG ' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -144.4 169.54 17.73 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 125.566 1.546 . . . . 0.0 109.538 175.133 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 59.9 mt -113.27 128.47 70.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 175.036 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.467 ' CG ' ' HE2' ' A' ' 119' ' ' LYS . 96.2 m-85 -88.38 147.5 40.14 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 124.683 1.193 . . . . 0.0 110.48 175.554 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -70.01 130.92 19.84 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 123.151 2.568 . . . . 0.0 111.075 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 59.96 -141.64 47.64 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 123.607 0.622 . . . . 0.0 113.133 -178.391 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 4.6 tmtt? -86.49 118.05 25.66 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.492 1.517 . . . . 0.0 110.4 176.362 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 12.2 tpp180 -135.51 170.61 15.68 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 126.088 1.755 . . . . 0.0 109.998 175.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 24.8 ptt180 -116.2 -176.55 2.97 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 127.133 2.173 . . . . 0.0 111.258 175.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -127.16 105.48 8.6 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 175.046 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -121.81 168.04 12.3 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.788 1.635 . . . . 0.0 109.751 177.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -51.84 -41.1 61.55 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 -177.584 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -59.12 -56.25 26.31 Favored Glycine 0 N--CA 1.47 0.912 0 CA-C-N 119.278 0.945 . . . . 0.0 112.164 175.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 4.9 mtt -59.01 -46.19 88.79 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.414 1.086 . . . . 0.0 111.287 177.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -51.78 -58.48 6.3 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.554 1.542 . . . . 0.0 111.096 174.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -68.89 -30.62 69.16 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -178.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -59.49 -41.75 90.56 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.998 0.919 . . . . 0.0 111.446 174.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 12.8 mmm -86.18 -27.66 24.42 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -51.2 -63.71 1.05 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.861 1.665 . . . . 0.0 110.883 175.018 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -69.42 -6.23 28.82 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -175.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -88.18 -15.57 60.52 Favored Glycine 0 CA--C 1.537 1.442 0 C-N-CA 126.974 2.226 . . . . 0.0 115.459 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -144.77 95.49 5.28 Favored Pre-proline 0 CA--C 1.552 1.049 0 CA-C-N 119.771 1.786 . . . . 0.0 112.688 178.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -75.95 77.31 3.47 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 123.783 2.989 . . . . 0.0 112.591 -178.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -107.98 110.01 21.62 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.346 1.458 . . . . 0.0 109.827 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 9.6 mtp180 -118.56 111.39 18.53 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 126.944 2.098 . . . . 0.0 111.541 -175.031 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 76.96 -56.73 3.55 Favored Glycine 0 C--O 1.218 -0.867 0 CA-C-O 118.609 -1.106 . . . . 0.0 111.728 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 57.21 33.86 23.94 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 119.975 1.887 . . . . 0.0 114.655 174.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -70.31 40.9 0.05 Allowed 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 127.933 2.493 . . . . 0.0 115.163 -177.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -160.17 34.29 0.43 Allowed Glycine 0 CA--C 1.539 1.576 0 C-N-CA 126.319 1.914 . . . . 0.0 114.555 178.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' TRP . . . . . 0.588 ' H ' HD12 ' A' ' 161' ' ' ILE . 3.6 m95 57.5 49.48 12.72 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 126.769 2.028 . . . . 0.0 112.372 -174.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -84.68 130.56 34.69 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 121.319 -0.863 . . . . 0.0 111.23 -177.129 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -171.29 -176.93 2.0 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.034 0.933 . . . . 0.0 112.797 177.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 9.8 ttpp -126.48 157.14 39.44 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 126.339 1.855 . . . . 0.0 111.37 -174.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -68.48 158.13 34.43 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.293 0.568 . . . . 0.0 110.559 174.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.465 HD11 ' HB2' ' A' ' 158' ' ' MET . 98.5 mt -112.81 159.77 18.67 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.996 1.319 . . . . 0.0 109.45 175.176 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -63.33 -171.57 1.79 Allowed Glycine 0 CA--C 1.538 1.501 0 C-N-CA 124.085 0.85 . . . . 0.0 111.743 174.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 52.74 13.22 0.32 Allowed 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 125.486 1.515 . . . . 0.0 114.954 175.358 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 79.26 36.93 25.97 Favored Glycine 0 CA--C 1.54 1.6 0 C-N-CA 125.724 1.63 . . . . 0.0 113.803 -175.008 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -115.93 167.12 11.24 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 119.181 1.491 . . . . 0.0 112.436 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 80.2 mtt85 -146.48 127.55 14.64 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 120.924 -1.11 . . . . 0.0 111.053 175.034 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' MET . . . . . 0.465 ' HB2' HD11 ' A' ' 152' ' ' LEU . 7.3 ttp -99.99 154.23 18.56 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 174.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.42 ' N ' ' HG2' ' A' ' 158' ' ' MET . 0.0 OUTLIER -126.43 147.89 49.72 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 127.691 2.396 . . . . 0.0 110.972 176.236 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -152.39 151.44 23.29 Favored Glycine 0 CA--C 1.524 0.65 0 CA-C-O 121.933 0.74 . . . . 0.0 113.47 175.037 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.588 HD12 ' H ' ' A' ' 147' ' ' TRP . 1.1 tp -142.72 133.76 24.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 127.005 2.122 . . . . 0.0 108.8 -179.147 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 1.4 mtp -149.02 -176.07 5.2 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 127.313 2.245 . . . . 0.0 107.698 175.055 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' THR . . . . . 0.515 HG23 ' HB1' ' A' ' 168' ' ' ALA . 1.3 t -162.32 149.18 13.47 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 174.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 36.0 p -106.2 26.15 10.13 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.067 1.747 . . . . 0.0 112.001 -178.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.82 14.85 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.266 0 C-N-CA 127.864 2.466 . . . . 0.0 115.701 176.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 82.71 -37.19 2.64 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 127.605 2.526 . . . . 0.0 114.216 -178.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -135.05 75.74 1.59 Allowed 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 126.678 1.991 . . . . 0.0 108.272 -176.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.515 ' HB1' HG23 ' A' ' 163' ' ' THR . . . -135.89 162.65 32.22 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.397 1.479 . . . . 0.0 113.204 -175.034 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.4 ' H ' ' HG3' ' A' ' 169' ' ' LYS . 0.0 OUTLIER -110.28 172.06 7.09 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 128.998 2.919 . . . . 0.0 112.261 -175.029 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 170' ' ' MET . . . . . 0.428 ' HB3' HG22 ' A' ' 34' ' ' VAL . 12.9 ttt -117.66 143.11 46.48 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 126.017 1.727 . . . . 0.0 112.177 176.628 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.485 ' C ' HD12 ' A' ' 172' ' ' ILE . 7.5 tt0 -149.13 123.85 9.85 Favored 'General case' 0 N--CA 1.466 0.325 0 O-C-N 120.627 -1.296 . . . . 0.0 110.691 174.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.485 HD12 ' C ' ' A' ' 171' ' ' GLN . 1.9 mp -125.08 125.77 69.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 124.786 1.235 . . . . 0.0 108.744 179.158 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.52 142.78 51.3 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.827 1.251 . . . . 0.0 109.987 178.696 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.7 mp -89.44 114.15 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 O-C-N 121.173 -0.955 . . . . 0.0 109.162 176.203 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 5.4 m -85.5 154.36 21.83 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.434 1.094 . . . . 0.0 112.192 174.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 69.3 mtp180 . . . . . 0 C--O 1.252 1.224 0 C-N-CA 125.379 1.472 . . . . 0.0 111.175 176.528 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.4 t . . . . . 0 N--CA 1.485 1.278 0 CA-C-O 121.932 0.872 . . . . 0.0 110.801 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -128.92 156.64 43.41 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 126.475 1.91 . . . . 0.0 109.691 176.55 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.448 ' H ' ' HG ' ' A' ' 3' ' ' LEU . 1.8 mt -48.83 -20.75 0.53 Allowed 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 126.698 1.999 . . . . 0.0 113.264 -178.498 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.432 ' HA ' ' HB3' ' A' ' 71' ' ' LEU . . . -72.74 78.05 1.12 Allowed 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 125.68 1.592 . . . . 0.0 109.56 175.076 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -68.05 -90.68 0.06 OUTLIER Glycine 0 CA--C 1.536 1.374 0 C-N-CA 125.614 1.578 . . . . 0.0 114.689 -175.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 24.2 p -128.18 164.57 22.22 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.408 1.483 . . . . 0.0 110.949 175.331 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -125.85 19.76 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 CA-C-O 123.545 1.64 . . . . 0.0 111.695 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.9 pp -54.97 166.57 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 125.21 1.404 . . . . 0.0 111.877 175.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -40.44 129.24 2.42 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.261 1.824 . . . . 0.0 114.83 -174.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -55.49 -21.11 26.35 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 125.169 1.366 . . . . 0.0 114.607 -176.201 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.39 -30.98 70.89 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.013 1.325 . . . . 0.0 112.041 174.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.4 t -101.95 -38.7 7.67 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.878 1.671 . . . . 0.0 111.558 174.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.567 HD11 ' CD2' ' A' ' 71' ' ' LEU . 45.4 tp -79.39 90.71 5.03 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.895 0.878 . . . . 0.0 112.069 176.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 70.8 p -123.17 -176.98 3.56 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 126.326 1.85 . . . . 0.0 112.292 -178.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -55.02 -37.66 66.93 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.337 1.055 . . . . 0.0 112.261 -175.659 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -57.58 -38.29 74.61 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 125.379 1.472 . . . . 0.0 111.605 178.051 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 89.4 t -66.51 -37.7 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.336 1.054 . . . . 0.0 111.38 175.009 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.475 ' CD2' HD21 ' A' ' 71' ' ' LEU . 9.4 mt -68.17 -44.39 76.02 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.897 0.879 . . . . 0.0 110.69 178.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -58.27 -50.89 72.0 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.879 1.272 . . . . 0.0 111.926 176.282 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.55 -32.56 73.99 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 118.381 -0.819 . . . . 0.0 113.147 174.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -54.96 -40.18 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 CA-C-N 119.636 1.107 . . . . 0.0 111.518 -179.005 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 16.2 mt -57.18 -20.66 27.98 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.99 1.716 . . . . 0.0 113.355 178.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -108.77 -51.4 0.7 Allowed Glycine 0 CA--C 1.533 1.192 0 C-N-CA 126.356 1.931 . . . . 0.0 113.855 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -63.92 -28.34 69.76 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 119.031 1.416 . . . . 0.0 113.643 -178.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -97.59 86.77 3.91 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.542 1.137 . . . . 0.0 109.266 174.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -54.29 119.1 10.64 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 125.363 1.459 . . . . 0.0 113.537 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.1 mtpp -142.0 -173.35 3.79 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 127.726 2.41 . . . . 0.0 111.357 179.367 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.7 m -57.81 168.4 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 126.23 1.812 . . . . 0.0 112.329 175.04 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.8 m -51.3 -37.69 48.87 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 116.389 1.996 . . . . 0.0 116.389 -175.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.71 131.79 54.28 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.574 1.549 . . . . 0.0 108.547 174.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.52 150.15 37.08 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 126.095 1.758 . . . . 0.0 109.745 -175.01 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -116.26 120.58 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 123.998 0.919 . . . . 0.0 110.434 177.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -117.47 124.89 49.88 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 124.516 1.126 . . . . 0.0 109.573 175.016 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.521 HG13 ' HB2' ' A' ' 72' ' ' TYR . 2.7 p -142.56 139.92 28.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.731 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -125.37 125.07 5.5 Favored Glycine 0 CA--C 1.522 0.505 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.491 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.44 ' H ' HD12 ' A' ' 70' ' ' LEU . 2.9 mp -112.48 142.27 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 123.822 0.849 . . . . 0.0 110.371 176.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -105.59 106.48 17.01 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.486 1.114 . . . . 0.0 111.127 178.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -74.86 93.0 2.58 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.359 1.864 . . . . 0.0 110.577 176.134 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -121.57 8.1 10.09 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.906 1.282 . . . . 0.0 113.131 175.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 30.0 t -46.03 -51.01 14.4 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.149 1.78 . . . . 0.0 113.343 178.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 154.5 -26.33 0.67 Allowed Glycine 0 N--CA 1.472 1.065 0 O-C-N 121.281 -0.887 . . . . 0.0 114.517 175.003 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -128.18 171.47 19.36 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 125.682 1.61 . . . . 0.0 112.178 174.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.762 HG22 ' HA ' ' A' ' 65' ' ' PRO . 76.5 p -64.68 149.65 48.64 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.618 0.767 . . . . 0.0 112.147 176.758 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 38.4 m0 -101.62 108.27 19.76 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 124.654 1.182 . . . . 0.0 111.048 178.435 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 33.2 m -90.7 128.74 36.75 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.993 1.317 . . . . 0.0 110.123 177.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.29 114.5 3.51 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.915 0.886 . . . . 0.0 111.729 174.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.489 HD21 HG23 ' A' ' 98' ' ' THR . 3.6 pp -98.44 -51.65 3.89 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 123.556 0.742 . . . . 0.0 111.536 177.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.487 ' HB3' HD12 ' A' ' 47' ' ' LEU . 7.8 t30 -172.92 154.47 2.87 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 127.5 2.32 . . . . 0.0 109.848 -177.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -137.64 168.0 20.55 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.916 1.286 . . . . 0.0 112.052 174.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -141.42 114.07 8.34 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.424 1.09 . . . . 0.0 111.652 179.211 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.408 ' CD1' ' HB1' ' A' ' 87' ' ' ALA . 3.2 m-85 -116.06 139.18 50.54 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.38 -0.825 . . . . 0.0 110.941 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -117.54 -67.05 1.02 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 126.071 1.749 . . . . 0.0 111.492 -175.431 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 26.3 t -105.39 -38.67 6.4 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 126.8 2.04 . . . . 0.0 110.28 -176.235 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -68.77 10.2 1.63 Allowed Glycine 0 CA--C 1.537 1.45 0 C-N-CA 126.792 2.139 . . . . 0.0 115.491 178.017 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 34.0 p -30.22 123.94 0.18 Allowed 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 129.014 2.925 . . . . 0.0 114.832 -175.025 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.423 HG21 HG23 ' A' ' 59' ' ' ILE . 1.5 t -146.39 178.28 8.38 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.47 1.108 . . . . 0.0 113.513 -174.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -83.24 -62.8 1.49 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.364 1.465 . . . . 0.0 112.4 177.129 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.2 p -138.93 138.21 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.901 1.68 . . . . 0.0 111.824 178.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.423 HG23 HG21 ' A' ' 56' ' ' THR . 1.4 pp -141.09 -27.75 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.921 1.688 . . . . 0.0 114.048 -179.145 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 mp -97.45 96.35 3.06 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 125.687 1.595 . . . . 0.0 109.06 177.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -64.02 152.28 81.62 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.878 2.385 . . . . 0.0 110.503 175.013 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -43.66 -50.2 7.53 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.011 1.725 . . . . 0.0 113.477 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 5.6 p -158.59 143.81 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 C-N-CA 126.93 2.092 . . . . 0.0 109.511 175.088 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.702 HG21 HD23 ' A' ' 70' ' ' LEU . 99.7 t -118.0 128.95 25.67 Favored Pre-proline 0 N--CA 1.476 0.828 0 C-N-CA 124.956 1.302 . . . . 0.0 108.771 175.063 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.762 ' HA ' HG22 ' A' ' 43' ' ' THR . 53.9 Cg_endo -67.13 150.36 82.12 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.611 2.207 . . . . 0.0 113.139 176.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -65.23 163.65 14.87 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.293 0.637 . . . . 0.0 111.033 175.034 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . 0.312 50.1 p 55.48 20.75 3.9 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 127.779 2.431 . . . . 0.0 114.742 -174.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 20.0 mttt -120.35 -178.49 3.7 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 126.459 1.903 . . . . 0.0 112.115 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.402 ' HB3' HD23 ' A' ' 13' ' ' LEU . . . -133.76 166.19 23.21 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 175.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.702 HD23 HG21 ' A' ' 64' ' ' VAL . 0.5 OUTLIER -134.25 174.26 10.7 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 124.3 1.04 . . . . 0.0 110.993 179.539 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.567 ' CD2' HD11 ' A' ' 13' ' ' LEU . 0.9 OUTLIER -127.33 154.89 44.4 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 124.699 1.199 . . . . 0.0 111.481 175.185 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.521 ' HB2' HG13 ' A' ' 34' ' ' VAL . 12.4 m-85 -129.49 148.09 51.36 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 125.987 1.715 . . . . 0.0 109.795 178.407 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 54.5 p -126.21 146.69 49.87 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 126.186 1.795 . . . . 0.0 111.129 175.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -163.26 148.78 15.67 Favored Glycine 0 CA--C 1.519 0.286 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 174.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.48 173.61 6.66 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.16 1.384 . . . . 0.0 110.134 177.557 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.407 ' CE ' ' HB1' ' A' ' 82' ' ' ALA . 12.2 ptmt -101.0 -19.66 15.74 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 174.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.2 t -81.76 80.87 7.97 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 125.334 1.453 . . . . 0.0 109.98 -174.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.5 t -55.75 -28.36 55.56 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.236 1.414 . . . . 0.0 112.77 178.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 123.06 -69.07 0.45 Allowed Glycine 0 CA--C 1.535 1.329 0 C-N-CA 126.644 2.069 . . . . 0.0 112.175 -178.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.36 -49.42 0.36 Allowed 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.245 2.63 . . . . 0.0 112.796 -177.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 83.9 t -141.89 130.23 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 126.455 1.902 . . . . 0.0 109.61 -177.296 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.407 ' HB1' ' CE ' ' A' ' 76' ' ' LYS . . . -68.17 125.63 27.0 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.241 1.016 . . . . 0.0 111.122 175.307 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 90.1 m -112.1 -85.38 0.57 Allowed 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.853 0.861 . . . . 0.0 110.08 178.166 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 179.74 -93.09 0.09 OUTLIER Glycine 0 CA--C 1.531 1.069 0 CA-C-N 119.696 1.135 . . . . 0.0 113.253 -175.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -153.56 100.62 2.42 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.137 0.975 . . . . 0.0 111.585 176.278 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.2 t -141.23 115.27 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 124.455 1.102 . . . . 0.0 109.753 -177.22 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.408 ' HB1' ' CD1' ' A' ' 51' ' ' PHE . . . -157.45 170.93 21.32 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.374 1.07 . . . . 0.0 112.05 175.533 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -152.11 160.84 43.33 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.47 1.508 . . . . 0.0 111.082 175.421 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.587 ' CZ ' HG11 ' A' ' 101' ' ' VAL . 41.6 p90 -155.33 170.07 22.75 Favored 'General case' 0 C--O 1.234 0.285 0 O-C-N 121.079 -1.013 . . . . 0.0 111.154 175.042 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.403 ' HA ' ' O ' ' A' ' 99' ' ' LEU . . . -136.31 151.7 49.9 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 176.323 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -131.29 134.88 46.81 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.545 1.538 . . . . 0.0 112.727 -177.012 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -82.62 123.56 29.35 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 111.618 0.229 . . . . 0.0 111.618 -179.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 4.6 tpp -88.55 145.49 25.69 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.317 1.047 . . . . 0.0 112.165 175.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 61.3 m -69.65 -23.35 63.47 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 175.006 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -70.98 -13.94 62.18 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.852 1.261 . . . . 0.0 113.787 175.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 98.54 42.63 2.89 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 124.546 1.069 . . . . 0.0 114.176 -179.02 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.511 ' HB3' HG22 ' A' ' 120' ' ' ILE . 17.0 m-80 -141.33 174.15 10.81 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.354 1.462 . . . . 0.0 110.431 178.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.489 HG23 HD21 ' A' ' 47' ' ' LEU . 6.0 m -128.55 107.18 9.5 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.178 0.991 . . . . 0.0 112.424 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.403 ' O ' ' HA ' ' A' ' 90' ' ' ALA . 21.1 tp -68.03 105.02 1.9 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.756 0.823 . . . . 0.0 109.65 174.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -106.63 103.09 1.98 Allowed Glycine 0 CA--C 1.525 0.695 0 C-N-CA 125.395 1.474 . . . . 0.0 112.337 177.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.587 HG11 ' CZ ' ' A' ' 89' ' ' PHE . 9.5 p -86.32 161.47 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 123.755 0.822 . . . . 0.0 112.407 175.582 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 2.5 tmm? -150.3 126.96 10.91 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.257 1.823 . . . . 0.0 109.725 178.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -139.03 118.51 12.9 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 122.158 0.98 . . . . 0.0 112.948 177.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 26.0 t -124.6 118.34 26.32 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.452 1.501 . . . . 0.0 110.723 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 96.2 t -105.88 134.42 19.74 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 126.728 2.011 . . . . 0.0 108.852 178.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -65.28 139.17 58.87 Favored 'Trans proline' 0 CA--C 1.534 0.486 0 C-N-CA 123.63 2.887 . . . . 0.0 110.196 178.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -44.27 -50.79 8.77 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.625 1.97 . . . . 0.0 114.631 -174.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -132.74 20.08 4.21 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.63 1.572 . . . . 0.0 112.077 -176.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 53.74 30.95 12.0 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.079 1.752 . . . . 0.0 113.738 -175.02 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -71.74 -170.75 0.59 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 128.066 2.546 . . . . 0.0 111.669 174.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 2.0 p90 -51.75 -21.15 2.55 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 126.424 1.889 . . . . 0.0 115.122 176.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -56.48 115.04 2.28 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.775 1.63 . . . . 0.0 111.465 175.145 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 11.0 m -61.5 144.58 54.01 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.497 0.665 . . . . 0.0 112.359 177.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -100.05 118.11 35.73 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.285 1.434 . . . . 0.0 107.382 174.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 36.7 m0 -116.73 135.65 53.59 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 19.8 p-90 -145.82 143.49 29.68 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.548 0.739 . . . . 0.0 112.029 -176.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -148.59 161.83 40.89 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.981 0.896 . . . . 0.0 112.571 -176.321 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.453 HG13 ' SD ' ' A' ' 158' ' ' MET . 5.6 p -166.12 127.76 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 125.028 1.331 . . . . 0.0 109.269 175.017 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.546 ' HE3' ' CE1' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -151.78 168.44 25.05 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 126.199 1.799 . . . . 0.0 109.566 178.31 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.511 HG22 ' HB3' ' A' ' 97' ' ' ASN . 24.6 mt -111.1 111.73 37.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -177.385 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.546 ' CE1' ' HE3' ' A' ' 119' ' ' LYS . 54.2 m-85 -63.01 142.66 97.67 Favored Pre-proline 0 CA--C 1.544 0.731 0 O-C-N 121.203 -0.936 . . . . 0.0 111.063 -179.099 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -73.92 92.5 0.89 Allowed 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 124.2 3.266 . . . . 0.0 110.902 -179.162 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 101.2 -171.69 22.61 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 124.805 1.193 . . . . 0.0 112.736 -174.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 8.8 tttt -67.57 118.51 10.97 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.893 0.877 . . . . 0.0 110.931 176.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 9.4 tpp180 -134.18 178.25 7.12 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.222 1.409 . . . . 0.0 109.704 175.049 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 8.6 ptt180 -123.34 179.74 4.61 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 126.372 1.869 . . . . 0.0 110.231 174.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -131.7 103.65 6.48 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 126.572 1.949 . . . . 0.0 107.016 175.112 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -126.66 171.37 11.21 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.348 1.859 . . . . 0.0 110.093 178.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -50.69 -41.73 56.13 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -177.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -60.72 -53.76 42.6 Favored Glycine 0 N--CA 1.468 0.775 0 CA-C-O 119.484 -0.62 . . . . 0.0 112.267 176.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -63.24 -40.05 96.34 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 118.176 0.988 . . . . 0.0 111.916 178.085 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -55.84 -63.73 1.08 Allowed 'General case' 0 C--N 1.34 0.167 0 C-N-CA 124.224 1.01 . . . . 0.0 108.846 175.038 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -64.62 -33.9 77.01 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 118.667 0.667 . . . . 0.0 112.739 -175.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -64.56 -42.94 95.36 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.272 1.029 . . . . 0.0 113.069 176.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -86.32 -29.01 23.34 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 121.28 -0.888 . . . . 0.0 112.291 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -52.04 -57.61 9.02 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 126.831 2.053 . . . . 0.0 108.902 174.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -71.85 -12.1 61.12 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -177.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -86.72 -8.14 77.21 Favored Glycine 0 CA--C 1.54 1.599 0 C-N-CA 126.701 2.096 . . . . 0.0 114.958 176.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -140.09 80.3 20.52 Favored Pre-proline 0 CA--C 1.55 0.954 0 CA-C-N 119.105 1.452 . . . . 0.0 111.192 175.012 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -73.16 70.25 3.82 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 124.109 3.206 . . . . 0.0 112.471 177.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -102.43 116.76 33.28 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.97 0.908 . . . . 0.0 110.637 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 34.5 mtm180 -83.59 -68.43 0.71 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.11 1.364 . . . . 0.0 111.884 174.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 134.73 114.43 1.43 Allowed Glycine 0 CA--C 1.53 0.981 0 C-N-CA 124.976 1.274 . . . . 0.0 113.569 -178.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.58 14.73 0.32 Allowed 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 126.912 2.085 . . . . 0.0 115.295 176.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . 0.258 0.8 OUTLIER 45.51 65.01 1.23 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 126.953 2.101 . . . . 0.0 112.56 -175.011 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -168.44 -67.33 0.03 OUTLIER Glycine 0 CA--C 1.541 1.672 0 C-N-CA 125.098 1.332 . . . . 0.0 115.926 -174.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 43.2 m95 173.23 114.19 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 130.86 3.664 . . . . 0.0 108.799 -175.035 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -131.93 126.09 33.24 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 128.463 2.705 . . . . 0.0 110.277 -177.376 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -166.76 -175.31 3.06 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.08 0.952 . . . . 0.0 112.078 -174.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.3 mtmt -139.54 145.51 38.76 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.702 1.201 . . . . 0.0 109.946 175.047 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -67.6 149.79 49.63 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 175.006 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 66.7 mt -108.78 102.32 11.37 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.277 0.631 . . . . 0.0 110.4 -174.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -43.52 -30.58 1.43 Allowed Glycine 0 N--CA 1.475 1.283 0 C-N-CA 127.722 2.582 . . . . 0.0 117.136 -175.022 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.47 ' CE2' ' HB ' ' A' ' 120' ' ' ILE . 0.0 OUTLIER -64.29 -18.85 64.98 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.623 1.969 . . . . 0.0 113.799 178.164 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 118.86 30.14 1.7 Allowed Glycine 0 CA--C 1.537 1.409 0 C-N-CA 125.915 1.721 . . . . 0.0 114.288 -178.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 2.2 mt -128.96 174.92 9.08 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.508 1.923 . . . . 0.0 110.859 -176.473 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 80.7 mtt180 -143.75 108.77 4.97 Favored 'General case' 0 N--CA 1.479 1.007 0 O-C-N 120.913 -1.117 . . . . 0.0 111.081 178.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' MET . . . . . 0.453 ' SD ' HG13 ' A' ' 118' ' ' VAL . 0.0 OUTLIER -84.73 148.54 26.31 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 175.049 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.9 122.28 17.16 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 126.087 1.755 . . . . 0.0 110.899 176.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -138.85 158.74 25.26 Favored Glycine 0 N--CA 1.479 1.56 0 CA-C-N 121.552 1.978 . . . . 0.0 116.62 -177.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.523 HD13 ' N ' ' A' ' 162' ' ' MET . 0.0 OUTLIER -151.3 134.3 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-N 118.896 1.348 . . . . 0.0 111.051 179.407 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 162' ' ' MET . . . . . 0.523 ' N ' HD13 ' A' ' 161' ' ' ILE . 1.1 ttt -156.91 105.98 2.21 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.752 1.621 . . . . 0.0 110.089 174.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 4.0 t -81.66 126.76 32.16 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 120.921 -1.112 . . . . 0.0 109.977 175.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 34.9 p -75.15 21.89 0.12 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.1 1.36 . . . . 0.0 114.292 177.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -56.06 -45.33 79.33 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.282 1.833 . . . . 0.0 114.692 -175.191 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 164.45 -60.59 0.25 Allowed Glycine 0 CA--C 1.533 1.192 0 C-N-CA 123.685 0.66 . . . . 0.0 114.706 178.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -120.07 21.77 11.7 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.625 1.17 . . . . 0.0 112.819 -178.23 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -64.16 168.59 5.28 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 122.784 1.278 . . . . 0.0 112.887 175.193 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.09 167.05 11.83 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 127.089 2.156 . . . . 0.0 110.976 -179.253 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 13.7 ttp -108.3 135.5 49.51 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.634 1.174 . . . . 0.0 110.329 178.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -141.62 127.64 19.52 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.007 0.923 . . . . 0.0 110.896 175.019 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 5.1 mp -133.38 121.32 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 124.241 1.016 . . . . 0.0 110.01 175.111 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -116.61 132.31 56.72 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 125.409 1.484 . . . . 0.0 110.321 175.002 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.7 mp -84.3 119.5 33.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 175.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 5.0 m -92.61 171.08 9.24 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.64 1.576 . . . . 0.0 109.825 174.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 2.2 mtt180 . . . . . 0 C--O 1.253 1.274 0 C-N-CA 125.335 1.454 . . . . 0.0 112.624 176.363 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 75.3 m . . . . . 0 N--CA 1.484 1.227 0 CA-C-O 121.806 0.812 . . . . 0.0 112.098 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -87.22 176.59 7.49 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 126.333 1.853 . . . . 0.0 112.13 176.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.447 HD11 ' HB2' ' A' ' 31' ' ' LYS . 11.8 tp -128.74 -34.66 1.96 Allowed 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 113.847 1.054 . . . . 0.0 113.847 175.072 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -86.58 138.7 31.49 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.313 1.045 . . . . 0.0 109.124 175.062 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -79.66 -122.81 0.4 Allowed Glycine 0 CA--C 1.535 1.319 0 C-N-CA 124.143 0.877 . . . . 0.0 112.031 175.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 35.8 p -113.74 173.43 6.42 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.482 1.513 . . . . 0.0 112.018 -178.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -123.14 19.84 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.326 1.05 . . . . 0.0 112.121 178.165 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.42 HD12 ' HB3' ' A' ' 12' ' ' SER . 0.9 OUTLIER -47.15 156.87 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.784 1.234 . . . . 0.0 112.846 175.007 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -41.92 130.45 3.44 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.279 1.832 . . . . 0.0 112.999 -175.166 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -54.03 -22.86 21.8 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 124.869 1.223 . . . . 0.0 114.885 -174.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.93 -30.58 71.65 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.417 1.087 . . . . 0.0 112.077 175.069 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.42 ' HB3' HD12 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -100.89 -41.92 6.64 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.629 1.972 . . . . 0.0 111.872 176.75 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.2 tp -73.29 94.23 1.99 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.139 0.976 . . . . 0.0 110.898 175.035 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 82.6 p -129.19 -175.3 3.52 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.422 1.889 . . . . 0.0 112.046 -178.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.478 ' CE1' HG21 ' A' ' 161' ' ' ILE . 6.4 m-85 -51.52 -33.11 30.45 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.959 1.304 . . . . 0.0 113.993 179.076 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -57.83 -43.17 85.64 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.102 0.561 . . . . 0.0 111.852 174.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.416 ' O ' HG23 ' A' ' 21' ' ' VAL . 72.8 t -67.03 -40.23 85.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.229 1.012 . . . . 0.0 110.922 175.483 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 59.8 mt -67.54 -40.08 85.02 Favored 'General case' 0 N--CA 1.469 0.475 0 O-C-N 120.963 -1.086 . . . . 0.0 112.059 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -63.91 -47.57 80.02 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.164 0.986 . . . . 0.0 111.781 176.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.51 -36.7 84.6 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 118.456 -0.783 . . . . 0.0 112.287 174.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 17' ' ' VAL . 19.0 t -55.03 -46.12 77.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-N 119.295 0.952 . . . . 0.0 110.92 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.3 mt -54.89 -19.62 7.01 Favored 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 176.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.62 -60.48 1.09 Allowed Glycine 0 CA--C 1.535 1.323 0 C-N-CA 126.324 1.916 . . . . 0.0 113.182 175.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -65.75 -34.89 79.23 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -178.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -100.8 133.56 45.09 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.637 1.575 . . . . 0.0 109.923 175.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 170.27 145.72 4.84 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 124.504 1.049 . . . . 0.0 112.155 -178.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -129.73 -76.91 0.54 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.027 1.331 . . . . 0.0 110.938 -178.448 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 30' ' ' ARG . 26.9 m -78.08 173.93 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 126.107 1.763 . . . . 0.0 111.361 175.197 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -53.67 -35.31 60.92 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 115.546 1.684 . . . . 0.0 115.546 -175.04 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.534 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.2 OUTLIER -127.32 152.13 47.86 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 127.544 2.337 . . . . 0.0 109.035 175.003 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.447 ' HB2' HD11 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -151.02 159.47 44.53 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.803 1.641 . . . . 0.0 111.012 -178.088 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.465 HG13 ' HB1' ' A' ' 85' ' ' ALA . 0.3 OUTLIER -122.26 129.9 74.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 125.075 1.35 . . . . 0.0 108.214 175.078 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -135.79 115.3 12.72 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.11 1.364 . . . . 0.0 108.965 175.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.475 HG12 ' HB3' ' A' ' 170' ' ' MET . 2.6 m -125.72 144.1 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 123.313 0.645 . . . . 0.0 111.146 -177.182 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -111.03 115.26 3.92 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 124.255 0.931 . . . . 0.0 111.656 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 mp -105.1 144.16 15.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 118.037 0.918 . . . . 0.0 108.782 174.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -115.95 111.5 20.48 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 124.588 1.155 . . . . 0.0 111.049 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.474 ' HA ' ' CZ2' ' A' ' 44' ' ' TRP . 1.6 m-20 -80.54 78.25 7.29 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 128.141 2.576 . . . . 0.0 111.226 -175.123 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -113.99 3.43 15.35 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.779 1.232 . . . . 0.0 112.389 178.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.31 -54.5 43.15 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.918 1.687 . . . . 0.0 114.304 -175.032 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 151.93 99.52 0.19 Allowed Glycine 0 CA--C 1.533 1.195 0 O-C-N 121.478 -0.764 . . . . 0.0 114.278 178.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.15 163.74 38.94 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 125.871 1.701 . . . . 0.0 112.94 -177.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.669 HG22 ' HA ' ' A' ' 65' ' ' PRO . 69.1 p -63.98 138.74 58.6 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 121.965 -0.727 . . . . 0.0 111.616 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.474 ' CZ2' ' HA ' ' A' ' 38' ' ' ASN . 40.6 m0 -87.99 106.47 18.15 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.077 0.551 . . . . 0.0 110.827 -178.676 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 15.9 m -86.27 122.64 30.54 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.319 1.048 . . . . 0.0 109.577 175.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.41 140.02 57.4 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.087 0.47 . . . . 0.0 111.671 175.018 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.546 HD12 ' N ' ' A' ' 48' ' ' ASN . 4.0 pp -121.92 -56.84 1.83 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.912 1.285 . . . . 0.0 111.312 -178.207 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.546 ' N ' HD12 ' A' ' 47' ' ' LEU . 0.1 OUTLIER -171.16 156.22 4.66 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.65 1.98 . . . . 0.0 110.596 176.5 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.416 ' HB2' HD12 ' A' ' 60' ' ' LEU . . . -133.57 165.45 24.88 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.269 1.428 . . . . 0.0 110.718 174.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -141.12 101.8 4.11 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.953 1.701 . . . . 0.0 111.444 -178.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.506 ' CD1' ' HB1' ' A' ' 87' ' ' ALA . 3.1 m-85 -107.74 127.32 53.59 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.127 0.971 . . . . 0.0 110.582 -177.702 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.67 -37.75 4.8 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.372 1.069 . . . . 0.0 113.486 -179.62 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.8 t -123.36 -41.93 2.27 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 126.31 1.844 . . . . 0.0 111.556 -178.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -69.01 16.2 0.63 Allowed Glycine 0 CA--C 1.536 1.362 0 C-N-CA 125.145 1.355 . . . . 0.0 115.529 179.277 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.6 p -27.35 115.25 0.07 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 129.604 3.161 . . . . 0.0 113.863 -176.156 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.639 HG21 HG23 ' A' ' 59' ' ' ILE . 3.1 t -139.11 176.71 8.46 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.779 0.831 . . . . 0.0 112.794 -175.054 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -80.94 -57.4 3.56 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.909 1.284 . . . . 0.0 110.668 175.101 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.4 p -151.0 137.23 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 126.071 1.748 . . . . 0.0 111.573 -177.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.639 HG23 HG21 ' A' ' 56' ' ' THR . 0.1 OUTLIER -130.8 -42.5 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 125.337 1.455 . . . . 0.0 112.778 176.001 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.416 HD12 ' HB2' ' A' ' 49' ' ' ALA . 13.8 mt -82.59 100.15 0.79 Allowed Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 126.398 1.879 . . . . 0.0 109.725 179.21 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.479 ' HG2' HG23 ' A' ' 64' ' ' VAL . 84.0 Cg_endo -69.43 155.31 67.38 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.57 2.846 . . . . 0.0 110.385 175.014 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -48.52 -52.14 23.96 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.902 0.881 . . . . 0.0 112.966 -176.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.4 t -154.6 135.43 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 128.307 2.643 . . . . 0.0 108.694 -178.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.555 HG21 HD13 ' A' ' 70' ' ' LEU . 48.3 t -120.43 134.19 24.12 Favored Pre-proline 0 N--CA 1.479 1.016 0 C-N-CA 123.94 0.896 . . . . 0.0 109.448 174.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.669 ' HA ' HG22 ' A' ' 43' ' ' THR . 51.8 Cg_endo -63.09 151.1 86.5 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.202 1.935 . . . . 0.0 113.157 176.66 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -74.59 173.1 10.9 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.537 0.735 . . . . 0.0 110.428 175.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 78.8 p 49.23 27.78 1.97 Allowed 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 126.79 2.036 . . . . 0.0 112.789 -175.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 8.2 tttt -133.58 178.41 6.95 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 126.611 1.964 . . . . 0.0 111.633 -175.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -137.69 161.14 37.29 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 121.35 -0.843 . . . . 0.0 109.4 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.555 HD13 HG21 ' A' ' 64' ' ' VAL . 2.0 pt? -137.88 168.56 19.45 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.255 1.022 . . . . 0.0 111.681 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.411 HD13 ' O ' ' A' ' 34' ' ' VAL . 1.4 mm? -109.17 149.68 29.0 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 124.165 0.986 . . . . 0.0 110.748 175.031 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -126.83 149.46 49.7 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 127.371 2.268 . . . . 0.0 109.686 177.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.5 p -131.75 151.67 51.49 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 127.023 2.129 . . . . 0.0 111.879 -175.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -170.51 135.52 3.56 Favored Glycine 0 CA--C 1.521 0.433 0 O-C-N 121.396 -0.815 . . . . 0.0 113.142 174.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 27.7 mtm180 -104.06 121.35 43.01 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.57 1.148 . . . . 0.0 110.368 -177.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.27 -33.49 69.47 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 126.221 1.808 . . . . 0.0 115.236 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 29.3 p -75.62 86.71 2.69 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.699 2.0 . . . . 0.0 111.971 -177.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 29.6 t -61.9 -32.74 73.15 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.834 0.853 . . . . 0.0 113.238 178.208 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 121.24 -74.51 0.34 Allowed Glycine 0 CA--C 1.535 1.297 0 C-N-CA 125.996 1.76 . . . . 0.0 112.041 -179.358 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.15 -24.55 16.89 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 123.467 2.778 . . . . 0.0 113.692 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.6 p -134.86 145.29 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 126.329 1.851 . . . . 0.0 110.019 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -98.78 123.11 42.81 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.104 1.362 . . . . 0.0 110.401 175.015 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.2 p -130.81 -170.99 2.45 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 126.473 1.909 . . . . 0.0 110.76 -178.516 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -104.96 -105.79 3.06 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 125.335 1.445 . . . . 0.0 112.042 -177.158 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.465 ' HB1' HG13 ' A' ' 32' ' ' ILE . . . -139.63 93.2 2.64 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.423 -1.045 . . . . 0.0 110.056 177.392 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.3 t -133.12 116.6 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 123.904 0.882 . . . . 0.0 110.266 -176.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.754 ' HB3' ' CZ ' ' A' ' 103' ' ' PHE . . . -163.55 161.26 23.86 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.916 0.865 . . . . 0.0 111.382 178.157 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -142.82 151.17 40.86 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.678 1.191 . . . . 0.0 110.166 175.148 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -149.92 170.03 19.76 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 124.236 1.014 . . . . 0.0 110.061 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.473 ' HB3' HD11 ' A' ' 47' ' ' LEU . . . -142.52 157.4 44.77 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.389 -0.819 . . . . 0.0 111.891 175.002 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -132.12 141.44 49.15 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 126.131 1.773 . . . . 0.0 112.446 -174.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -98.32 119.12 36.45 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 120.673 0.273 . . . . 0.0 110.678 -175.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 15.4 mtm -95.88 133.69 39.75 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 123.906 0.882 . . . . 0.0 110.713 -176.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.4 t -58.84 -23.84 61.25 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.781 1.232 . . . . 0.0 112.624 178.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -64.53 -18.88 65.24 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.438 1.495 . . . . 0.0 113.515 175.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 108.53 14.0 17.27 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 124.959 1.266 . . . . 0.0 115.312 -179.203 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.425 ' HB3' HG22 ' A' ' 120' ' ' ILE . 15.3 m-80 -122.51 172.25 8.51 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-N 119.171 1.486 . . . . 0.0 111.394 -179.659 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 95.6 m -124.91 102.16 7.41 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.598 1.159 . . . . 0.0 111.734 -177.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 21.4 tp -66.73 97.09 0.44 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.016 1.327 . . . . 0.0 111.682 176.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -90.61 124.65 7.6 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 125.534 1.54 . . . . 0.0 112.22 176.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 47.7 t -124.88 142.7 40.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 124.894 1.277 . . . . 0.0 110.777 -175.197 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' MET . . . . . 0.423 ' CE ' ' HA ' ' A' ' 116' ' ' TRP . 0.0 OUTLIER -149.33 160.09 43.71 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.427 -0.795 . . . . 0.0 112.026 175.04 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.754 ' CZ ' ' HB3' ' A' ' 87' ' ' ALA . 44.4 p90 -143.23 143.07 31.6 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.13 0.972 . . . . 0.0 110.436 176.273 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 9.9 t -134.25 119.96 19.39 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.833 1.253 . . . . 0.0 110.662 179.183 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 62.4 t -129.96 134.87 26.65 Favored Pre-proline 0 N--CA 1.469 0.513 0 C-N-CA 126.061 1.744 . . . . 0.0 109.206 -176.011 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -64.4 157.08 56.56 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 123.742 2.961 . . . . 0.0 113.581 -179.165 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -82.23 -54.62 5.11 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.519 1.127 . . . . 0.0 110.631 178.041 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.79 -25.74 32.46 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.258 1.423 . . . . 0.0 113.637 -178.099 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 58.6 26.33 14.3 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 126.395 1.878 . . . . 0.0 114.834 179.078 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 29.6 m-20 -93.36 -77.59 0.45 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.981 1.312 . . . . 0.0 113.677 -178.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 33.8 p-90 -119.43 12.04 12.32 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 126.946 2.099 . . . . 0.0 114.501 -174.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -80.2 175.58 10.52 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 125.453 1.501 . . . . 0.0 113.084 176.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 31.9 m -117.8 108.92 15.94 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 127.068 2.147 . . . . 0.0 111.872 178.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -84.18 104.03 13.89 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.549 1.14 . . . . 0.0 110.064 175.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 53.6 m0 -114.3 152.26 31.66 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 119.825 1.193 . . . . 0.0 112.673 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' TRP . . . . . 0.423 ' HA ' ' CE ' ' A' ' 102' ' ' MET . 53.9 p-90 -144.1 133.6 23.41 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -134.4 161.65 34.42 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.37 1.868 . . . . 0.0 111.829 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 78.5 t -154.62 150.19 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 126.961 2.104 . . . . 0.0 108.077 175.097 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.75 166.21 29.1 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.591 1.956 . . . . 0.0 109.97 175.203 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.474 ' HB ' ' CE2' ' A' ' 154' ' ' TYR . 3.1 mt -118.18 112.05 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-O 121.787 0.803 . . . . 0.0 109.454 176.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -68.76 145.05 96.64 Favored Pre-proline 0 CA--C 1.548 0.883 0 O-C-N 121.478 -0.764 . . . . 0.0 111.629 179.303 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -75.79 91.33 1.09 Allowed 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 123.834 3.023 . . . . 0.0 112.005 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 97.28 179.0 34.21 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 125.827 1.68 . . . . 0.0 112.952 -178.189 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 6.6 tttt -51.6 121.66 6.82 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.837 1.255 . . . . 0.0 111.567 -176.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.98 -173.45 3.38 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.606 1.563 . . . . 0.0 112.101 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.8 ptt180 -134.14 -179.22 5.43 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 126.9 2.08 . . . . 0.0 110.948 175.287 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -126.63 115.92 20.22 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 127.539 2.336 . . . . 0.0 104.984 175.048 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -135.55 169.6 17.27 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.835 1.254 . . . . 0.0 110.303 175.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -56.61 -36.15 69.09 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.049 0.94 . . . . 0.0 112.962 -178.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -60.9 -58.78 12.01 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-N 118.742 0.701 . . . . 0.0 111.998 175.026 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 1.4 null -62.73 -36.94 84.64 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 118.07 0.935 . . . . 0.0 112.801 178.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.41 -64.39 0.97 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.48 1.112 . . . . 0.0 109.151 174.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -65.27 -28.65 69.49 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -175.034 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -63.69 -36.88 85.3 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.778 1.231 . . . . 0.0 112.569 175.042 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 8.8 tpp -94.07 -23.63 17.91 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 177.011 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -49.89 -56.9 8.74 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.779 1.631 . . . . 0.0 111.145 175.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -70.4 -13.37 62.11 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -85.04 -30.61 25.31 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 127.153 2.311 . . . . 0.0 112.987 -175.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -123.57 81.96 53.98 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 123.833 0.853 . . . . 0.0 112.46 175.01 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -75.04 73.06 4.46 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 123.928 3.086 . . . . 0.0 112.775 -179.143 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -103.84 114.98 29.64 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.698 0.799 . . . . 0.0 111.552 176.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 46.8 mtm180 -86.26 -82.18 0.2 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.049 1.339 . . . . 0.0 111.138 175.027 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -115.88 -76.72 0.65 Allowed Glycine 0 C--N 1.328 0.102 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 178.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 56.69 43.26 25.68 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-O 122.044 0.926 . . . . 0.0 109.796 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -49.69 91.81 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 127.67 2.388 . . . . 0.0 113.805 -175.014 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 161.5 50.51 0.02 OUTLIER Glycine 0 CA--C 1.535 1.314 0 C-N-CA 124.993 1.283 . . . . 0.0 114.178 -175.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' TRP . . . . . 0.641 ' H ' HD13 ' A' ' 161' ' ' ILE . 4.7 m95 48.79 51.05 16.51 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.219 1.808 . . . . 0.0 113.953 -178.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -81.67 124.53 29.66 Favored 'General case' 0 N--CA 1.467 0.425 0 O-C-N 121.31 -0.869 . . . . 0.0 111.971 -177.063 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -167.27 -169.22 1.2 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.433 0.693 . . . . 0.0 112.754 178.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.77 164.49 25.03 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 126.64 1.976 . . . . 0.0 111.53 -178.703 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -81.8 157.7 24.37 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.872 0.869 . . . . 0.0 109.838 175.015 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.709 HD21 ' HB2' ' A' ' 158' ' ' MET . 3.0 mm? -104.71 118.06 35.62 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.125 0.57 . . . . 0.0 110.536 175.62 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -48.99 -29.57 8.54 Favored Glycine 0 CA--C 1.537 1.45 0 C-N-CA 125.8 1.667 . . . . 0.0 115.977 -177.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.474 ' CE2' ' HB ' ' A' ' 120' ' ' ILE . 0.1 OUTLIER -62.5 -25.39 67.99 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.4 1.88 . . . . 0.0 113.112 176.977 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 125.18 7.75 5.78 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 126.626 2.06 . . . . 0.0 114.961 -179.221 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 5.3 mp -101.5 176.78 5.12 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.216 1.406 . . . . 0.0 112.235 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 38.5 mtt180 -139.16 113.52 8.92 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.963 1.305 . . . . 0.0 110.703 -178.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' MET . . . . . 0.709 ' HB2' HD21 ' A' ' 152' ' ' LEU . 4.3 ttt -98.15 147.36 24.66 Favored 'General case' 0 C--N 1.319 -0.755 0 O-C-N 120.305 -1.497 . . . . 0.0 107.88 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.09 144.56 51.41 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 125.949 1.699 . . . . 0.0 110.163 177.056 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -152.02 156.97 26.99 Favored Glycine 0 CA--C 1.519 0.297 0 CA-C-O 121.893 0.719 . . . . 0.0 112.043 177.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.641 HD13 ' H ' ' A' ' 147' ' ' TRP . 4.7 tp -153.21 123.62 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 122.686 1.231 . . . . 0.0 110.175 -175.122 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.58 171.97 14.29 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 125.475 1.51 . . . . 0.0 110.21 175.165 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 15.1 t -162.2 166.82 25.03 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.251 1.42 . . . . 0.0 108.977 176.12 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 60.2 p -116.66 30.9 7.06 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.741 1.616 . . . . 0.0 111.604 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -65.38 23.2 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 128.541 2.736 . . . . 0.0 115.113 177.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 81.01 -55.49 4.79 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 127.14 2.305 . . . . 0.0 113.433 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -116.05 24.02 11.76 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.67 1.588 . . . . 0.0 112.818 -175.125 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -61.83 168.31 3.17 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 127.021 2.128 . . . . 0.0 114.599 175.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.5 171.35 10.58 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 127.661 2.385 . . . . 0.0 111.651 177.733 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' MET . . . . . 0.475 ' HB3' HG12 ' A' ' 34' ' ' VAL . 3.0 tmm? -118.76 135.58 54.43 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.223 1.409 . . . . 0.0 111.151 175.752 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.453 ' C ' HD12 ' A' ' 172' ' ' ILE . 6.2 tm0? -145.06 131.56 19.77 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.124 0.97 . . . . 0.0 110.156 178.011 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.453 HD12 ' C ' ' A' ' 171' ' ' GLN . 1.8 mp -131.74 127.97 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 125.382 1.473 . . . . 0.0 109.613 175.022 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -130.87 131.11 44.35 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.933 1.693 . . . . 0.0 110.335 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.7 mp -89.17 96.56 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 O-C-N 121.527 -0.733 . . . . 0.0 111.426 177.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 2.5 t -66.06 173.02 3.28 Favored 'General case' 0 CA--C 1.565 1.521 0 C-N-CA 123.631 0.772 . . . . 0.0 111.477 177.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 18.1 mtp180 . . . . . 0 C--O 1.252 1.208 0 C-N-CA 125.73 1.612 . . . . 0.0 112.618 175.711 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 77.0 p . . . . . 0 N--CA 1.484 1.244 0 CA-C-O 118.423 -0.799 . . . . 0.0 109.443 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.21 -173.72 0.07 Allowed 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 121.013 1.733 . . . . 0.0 112.363 174.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.814 HD12 ' H ' ' A' ' 74' ' ' GLY . 1.5 mt -126.3 8.18 7.17 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 125.18 1.392 . . . . 0.0 112.168 175.041 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -114.98 114.36 25.33 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.884 1.674 . . . . 0.0 111.024 -175.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -72.73 -155.52 2.89 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 125.29 1.424 . . . . 0.0 113.137 178.231 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 25.7 p -61.9 161.4 10.55 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.61 0.764 . . . . 0.0 111.791 174.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -122.81 18.07 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 CA-C-O 122.993 1.378 . . . . 0.0 111.47 174.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.8 pp -58.62 172.63 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 C-N-CA 125.463 1.505 . . . . 0.0 112.642 174.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -42.27 130.93 3.7 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 127.177 2.191 . . . . 0.0 114.155 -174.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.76 -19.47 43.31 Favored Glycine 0 CA--C 1.538 1.491 0 C-N-CA 124.187 0.899 . . . . 0.0 114.213 -175.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.97 -31.97 72.37 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.504 1.122 . . . . 0.0 112.539 174.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.6 t -101.39 -37.78 8.31 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.644 1.578 . . . . 0.0 111.69 175.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.442 HD23 ' HB3' ' A' ' 69' ' ' ALA . 13.0 tp -78.45 87.99 4.44 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.214 1.005 . . . . 0.0 110.802 175.023 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.2 p -121.46 178.96 4.6 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 127.188 2.195 . . . . 0.0 111.913 176.327 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -40.96 -42.01 1.77 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.834 1.654 . . . . 0.0 113.927 175.02 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -53.73 -46.46 70.85 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 119.159 0.89 . . . . 0.0 111.744 178.152 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 93.9 t -64.42 -39.57 86.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 125.383 1.473 . . . . 0.0 111.138 174.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 24.2 mt -66.11 -41.86 90.01 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 121.189 -0.944 . . . . 0.0 111.303 178.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -64.74 -46.26 82.96 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.979 1.311 . . . . 0.0 111.57 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.5 -37.25 84.66 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 118.798 -0.62 . . . . 0.0 111.441 174.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.8 t -54.74 -45.75 73.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 124.504 1.122 . . . . 0.0 111.196 -179.163 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.562 HD11 ' HB3' ' A' ' 169' ' ' LYS . 1.4 mt -59.19 -22.48 61.07 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 119.125 0.875 . . . . 0.0 113.356 178.025 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -89.37 -59.34 1.56 Allowed Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.574 1.559 . . . . 0.0 112.552 178.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -66.13 -30.37 70.84 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.3 mt -111.83 109.61 19.52 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.737 1.615 . . . . 0.0 110.001 -174.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -148.72 139.9 7.89 Favored Glycine 0 CA--C 1.54 1.643 0 C-N-CA 124.563 1.078 . . . . 0.0 114.781 -174.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.3 mtpt -109.22 -67.12 1.0 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 126.243 1.817 . . . . 0.0 112.136 178.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 15.3 m -118.2 -172.12 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 126.127 1.771 . . . . 0.0 110.891 -177.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.2 m -46.9 -38.38 10.38 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 125.359 1.464 . . . . 0.0 114.251 179.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 -127.63 162.0 27.54 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.742 1.617 . . . . 0.0 109.844 174.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.46 ' HB2' HD13 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -155.16 155.87 34.71 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 125.937 1.695 . . . . 0.0 108.98 -176.121 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -120.65 129.41 75.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 124.633 1.173 . . . . 0.0 107.838 174.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -133.26 121.89 23.12 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.237 1.415 . . . . 0.0 109.564 175.055 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.718 HG22 ' HB2' ' A' ' 72' ' ' TYR . 1.0 OUTLIER -128.49 144.48 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.111 0.964 . . . . 0.0 110.685 -176.721 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -124.79 110.22 1.35 Allowed Glycine 0 CA--C 1.519 0.323 0 C-N-CA 123.716 0.674 . . . . 0.0 112.44 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.46 ' HB ' HD11 ' A' ' 70' ' ' LEU . 3.5 mp -100.3 129.43 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 117.767 0.784 . . . . 0.0 110.687 175.561 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.73 106.3 18.27 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.639 1.576 . . . . 0.0 110.38 175.713 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.79 96.25 3.04 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.304 1.442 . . . . 0.0 109.585 176.607 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -129.73 6.63 5.15 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.836 1.254 . . . . 0.0 113.484 176.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.5 t -58.44 -18.4 28.24 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.62 1.568 . . . . 0.0 113.921 175.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 94.94 5.96 60.71 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 125.747 1.641 . . . . 0.0 114.573 176.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -128.8 147.41 17.59 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 125.813 1.673 . . . . 0.0 111.509 175.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.8 HG22 ' HA ' ' A' ' 65' ' ' PRO . 32.4 p -74.24 129.39 37.73 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 174.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 38.9 m0 -93.38 132.03 37.99 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 122.084 -0.385 . . . . 0.0 110.892 178.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 97.6 m -114.64 128.61 56.41 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.439 1.096 . . . . 0.0 110.073 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.65 106.99 0.74 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.266 1.026 . . . . 0.0 111.877 175.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.2 pp -98.91 -40.12 8.24 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.121 0.568 . . . . 0.0 112.516 179.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -170.58 163.35 8.24 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.875 2.07 . . . . 0.0 111.639 176.53 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -156.54 154.38 30.2 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.195 0.998 . . . . 0.0 111.355 174.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -132.46 107.24 8.36 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.422 1.489 . . . . 0.0 111.744 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.547 ' CD1' ' HB1' ' A' ' 87' ' ' ALA . 2.1 m-85 -98.82 110.85 23.39 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.844 0.858 . . . . 0.0 110.476 175.056 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.3 tpp180 -74.19 -73.33 0.23 Allowed 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.935 1.294 . . . . 0.0 109.291 175.012 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 9.3 t -106.37 -178.34 3.62 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 126.607 1.963 . . . . 0.0 109.081 176.006 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 48.65 35.4 16.45 Favored Glycine 0 CA--C 1.54 1.648 0 CA-C-O 119.581 -0.566 . . . . 0.0 112.314 -174.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.7 p -48.7 141.45 7.22 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.596 1.958 . . . . 0.0 112.199 -174.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.405 HG21 HG23 ' A' ' 59' ' ' ILE . 3.2 t -136.95 173.41 11.73 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 121.346 -0.846 . . . . 0.0 113.135 -175.191 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -80.47 -58.1 3.28 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.648 1.179 . . . . 0.0 111.337 176.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.2 p -142.75 133.07 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.418 1.487 . . . . 0.0 111.615 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.405 HG23 HG21 ' A' ' 56' ' ' THR . 1.1 pp -138.13 -24.33 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 126.372 1.869 . . . . 0.0 113.863 178.553 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.4 mp -97.65 98.96 5.76 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 124.797 1.239 . . . . 0.0 110.233 179.542 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -67.33 159.94 49.97 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 124.714 3.61 . . . . 0.0 111.031 174.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -57.93 -48.25 80.49 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -178.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 87.7 t -149.16 143.7 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 127.196 2.198 . . . . 0.0 108.809 -176.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.486 HG21 HD23 ' A' ' 70' ' ' LEU . 11.2 t -125.78 102.12 29.07 Favored Pre-proline 0 C--N 1.33 -0.259 0 C-N-CA 125.69 1.596 . . . . 0.0 107.451 175.548 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.8 ' HA ' HG22 ' A' ' 43' ' ' THR . 64.8 Cg_endo -72.12 161.39 44.8 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 121.234 1.289 . . . . 0.0 112.492 175.505 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -69.37 172.27 7.38 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.05 0.54 . . . . 0.0 110.259 174.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 58.8 p 57.03 20.64 5.59 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 125.494 1.518 . . . . 0.0 111.954 -174.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.79 173.35 11.46 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 125.359 1.464 . . . . 0.0 111.06 -174.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.442 ' HB3' HD23 ' A' ' 13' ' ' LEU . . . -142.8 156.52 44.98 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 175.028 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.486 HD23 HG21 ' A' ' 64' ' ' VAL . 1.0 OUTLIER -121.04 175.67 5.96 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 123.882 0.873 . . . . 0.0 111.073 -179.529 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.498 HD13 ' O ' ' A' ' 34' ' ' VAL . 0.8 OUTLIER -132.62 149.53 52.29 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.699 1.2 . . . . 0.0 110.965 175.052 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.718 ' HB2' HG22 ' A' ' 34' ' ' VAL . 3.7 m-85 -123.3 147.06 47.37 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.713 1.205 . . . . 0.0 109.286 174.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.2 p -121.3 147.84 45.12 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 127.047 2.139 . . . . 0.0 110.138 174.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.814 ' H ' HD12 ' A' ' 3' ' ' LEU . . . -165.2 130.72 2.22 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 124.351 0.977 . . . . 0.0 112.695 174.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 7.5 ptt180 -123.09 149.31 44.62 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.943 1.697 . . . . 0.0 110.687 -175.042 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 11.8 mtpt -62.86 149.17 45.04 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 121.212 -0.93 . . . . 0.0 111.862 -176.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.5 t -104.17 -165.8 1.18 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.525 1.53 . . . . 0.0 112.272 -177.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 58.2 m 50.74 39.67 22.52 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 126.183 1.793 . . . . 0.0 114.359 174.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 45.14 -94.38 0.01 OUTLIER Glycine 0 CA--C 1.541 1.68 0 C-N-CA 128.24 2.829 . . . . 0.0 114.089 178.189 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -65.56 -83.02 0.01 OUTLIER 'Trans proline' 0 CA--C 1.55 1.296 0 C-N-CA 124.264 3.309 . . . . 0.0 113.604 175.359 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 15.5 m -70.67 135.47 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 126.271 1.828 . . . . 0.0 112.316 -178.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -156.69 179.95 8.78 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -178.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 53.0 m -113.2 148.5 35.32 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.633 1.973 . . . . 0.0 109.015 175.001 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -43.67 -77.05 0.1 OUTLIER Glycine 0 N--CA 1.476 1.339 0 C-N-CA 126.962 2.22 . . . . 0.0 115.416 -175.008 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -169.1 123.59 0.84 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.534 1.934 . . . . 0.0 109.865 178.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.5 t -151.41 114.3 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.845 0.858 . . . . 0.0 110.716 -175.045 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.547 ' HB1' ' CD1' ' A' ' 51' ' ' PHE . . . -159.23 157.75 31.29 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -141.93 132.66 25.6 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.478 1.111 . . . . 0.0 112.173 178.432 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -136.01 171.62 14.21 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.189 -0.944 . . . . 0.0 111.688 -178.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -137.67 155.92 48.59 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.26 -0.9 . . . . 0.0 112.906 174.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -133.17 118.33 18.53 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 126.025 1.73 . . . . 0.0 114.409 -175.023 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -77.13 122.78 25.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.666 -0.243 . . . . 0.0 110.972 -178.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 13.3 mtm -101.67 134.47 44.76 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.514 1.526 . . . . 0.0 111.304 177.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 98.5 p -61.68 -17.26 54.83 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 178.157 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -69.05 -0.32 5.61 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 125.965 1.706 . . . . 0.0 113.037 174.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 91.1 24.9 25.82 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.456 1.503 . . . . 0.0 113.276 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -132.58 174.82 9.88 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.906 1.283 . . . . 0.0 111.702 -175.012 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 71.1 m -136.57 113.92 10.82 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.355 1.062 . . . . 0.0 111.504 174.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 65.1 tp -76.03 104.48 6.58 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.512 1.125 . . . . 0.0 110.506 175.004 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -93.63 117.94 5.58 Favored Glycine 0 CA--C 1.529 0.947 0 O-C-N 121.239 -0.913 . . . . 0.0 112.973 175.005 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 93.3 t -104.83 147.5 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 125.525 1.53 . . . . 0.0 111.067 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 1.5 tpt -151.55 126.1 9.5 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.546 1.138 . . . . 0.0 111.03 -178.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.479 ' CZ ' ' HB3' ' A' ' 87' ' ' ALA . 44.7 p90 -133.81 139.95 46.61 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.456 1.503 . . . . 0.0 114.159 177.36 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -136.3 138.96 42.26 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.245 1.818 . . . . 0.0 111.294 -177.44 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 96.3 t -118.92 124.35 28.38 Favored Pre-proline 0 N--CA 1.469 0.494 0 C-N-CA 125.098 1.359 . . . . 0.0 110.776 -178.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -66.84 114.55 3.19 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.891 3.061 . . . . 0.0 111.684 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -134.9 -57.61 0.82 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.01 0.924 . . . . 0.0 112.08 179.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -96.29 -22.15 17.39 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.789 1.236 . . . . 0.0 113.758 176.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 8.7 m-30 -40.72 99.2 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 127.508 2.323 . . . . 0.0 113.527 -174.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -62.5 -12.44 22.23 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.582 1.153 . . . . 0.0 113.588 -176.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -115.37 4.11 14.3 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 128.79 2.836 . . . . 0.0 112.975 -178.354 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 47.13 45.66 16.11 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 126.186 1.794 . . . . 0.0 113.587 -177.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 51.6 m -113.71 80.66 1.4 Allowed 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.225 1.41 . . . . 0.0 112.263 -174.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -88.2 113.82 24.2 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 124.44 1.096 . . . . 0.0 110.974 174.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 31.5 m0 -118.52 135.58 54.32 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.112 0.965 . . . . 0.0 109.673 -176.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' TRP . . . . . 0.413 ' HE1' ' CA ' ' A' ' 143' ' ' GLY . 30.5 p-90 -142.19 134.47 27.74 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.49 1.116 . . . . 0.0 111.873 -175.006 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -160.3 164.46 32.56 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 122.526 1.155 . . . . 0.0 112.989 -176.529 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.2 t -138.64 124.7 24.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 125.142 1.377 . . . . 0.0 107.747 -179.195 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.66 166.0 13.29 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.208 1.403 . . . . 0.0 110.198 175.053 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.416 ' CD1' HD13 ' A' ' 152' ' ' LEU . 41.7 mt -122.97 147.76 27.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 174.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -110.2 143.37 27.89 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 124.87 1.268 . . . . 0.0 110.071 177.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -77.21 12.5 1.78 Allowed 'Trans proline' 0 CA--C 1.548 1.219 0 C-N-CA 124.594 3.529 . . . . 0.0 114.407 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -161.12 -179.86 36.12 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 126.475 1.988 . . . . 0.0 111.44 176.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.93 101.83 0.71 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.825 1.25 . . . . 0.0 110.807 177.507 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 3.8 mmt-85 -124.79 141.8 51.86 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.71 1.204 . . . . 0.0 112.466 -178.223 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.41 171.99 12.13 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 177.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -128.35 91.63 3.29 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.5 1.92 . . . . 0.0 108.503 176.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -107.37 173.99 6.08 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.793 1.637 . . . . 0.0 109.922 174.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -49.76 -37.0 27.92 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.805 0.842 . . . . 0.0 113.265 176.477 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -59.14 -65.72 3.27 Favored Glycine 0 CA--C 1.531 1.035 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 174.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -58.08 -36.74 73.27 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 118.176 0.988 . . . . 0.0 113.522 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -56.28 -64.21 0.94 Allowed 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 125.267 1.427 . . . . 0.0 109.718 174.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -67.78 -32.8 73.64 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -176.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -57.87 -47.65 82.12 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.01 0.924 . . . . 0.0 112.265 177.056 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 5.2 tpp -84.51 -21.86 30.41 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 113.669 0.989 . . . . 0.0 113.669 176.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -49.33 -57.97 5.92 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.741 1.216 . . . . 0.0 109.773 174.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -74.64 5.05 5.24 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -178.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -93.9 -11.9 57.23 Favored Glycine 0 CA--C 1.539 1.59 0 C-N-CA 126.015 1.769 . . . . 0.0 114.765 178.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -145.26 94.71 5.2 Favored Pre-proline 0 CA--C 1.552 1.053 0 CA-C-N 119.523 1.662 . . . . 0.0 112.397 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -74.02 81.84 1.88 Allowed 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 123.587 2.858 . . . . 0.0 112.584 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -116.88 110.2 18.03 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.446 1.499 . . . . 0.0 110.846 -178.708 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 37.2 mtm105 -96.27 50.94 1.18 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 126.907 2.083 . . . . 0.0 111.336 -178.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.413 ' CA ' ' HE1' ' A' ' 116' ' ' TRP . . . 85.95 -53.06 4.63 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 124.117 0.865 . . . . 0.0 111.185 -174.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 51.38 52.71 14.22 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.235 1.814 . . . . 0.0 111.399 178.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 14.7 p-10 -48.17 92.82 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 128.48 2.712 . . . . 0.0 115.115 -174.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 160.46 40.12 0.02 OUTLIER Glycine 0 CA--C 1.537 1.427 0 C-N-CA 125.232 1.396 . . . . 0.0 114.506 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' TRP . . . . . 0.723 ' H ' HD12 ' A' ' 161' ' ' ILE . 7.5 m95 53.42 48.81 21.03 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.81 1.644 . . . . 0.0 113.363 -176.021 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -82.66 126.3 32.19 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.987 0.915 . . . . 0.0 112.094 -179.049 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' GLN . . . . . 0.5 ' HG3' ' H ' ' A' ' 150' ' ' LYS . 10.5 tp60 -161.65 -168.98 2.11 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.345 0.658 . . . . 0.0 112.312 175.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.5 ' H ' ' HG3' ' A' ' 149' ' ' GLN . 0.6 OUTLIER -131.59 160.67 34.64 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.245 1.818 . . . . 0.0 110.781 -179.205 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 18.7 m-80 -75.55 148.98 38.47 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.391 1.076 . . . . 0.0 109.95 174.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.416 HD13 ' CD1' ' A' ' 120' ' ' ILE . 94.3 mt -100.93 136.9 40.04 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.955 0.902 . . . . 0.0 110.621 178.354 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -53.0 -35.59 49.1 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 125.717 1.627 . . . . 0.0 116.476 -174.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.536 ' HB2' HD12 ' A' ' 156' ' ' LEU . 0.1 OUTLIER -73.46 14.21 0.37 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 128.081 2.552 . . . . 0.0 113.942 -178.326 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 76.36 20.5 76.96 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 124.908 1.242 . . . . 0.0 113.58 -174.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.536 HD12 ' HB2' ' A' ' 154' ' ' TYR . 6.1 mt -101.01 169.01 9.24 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 127.144 2.178 . . . . 0.0 110.519 178.716 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 50.4 mtt180 -138.76 114.03 9.54 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 120.841 -1.162 . . . . 0.0 110.451 177.075 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -92.16 150.79 20.72 Favored 'General case' 0 C--N 1.32 -0.711 0 O-C-N 120.138 -1.601 . . . . 0.0 108.433 174.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 2.3 tptt -133.45 142.5 48.33 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.578 1.551 . . . . 0.0 111.097 175.041 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -147.59 143.43 11.22 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-N 118.885 0.766 . . . . 0.0 113.671 175.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.723 HD12 ' H ' ' A' ' 147' ' ' TRP . 0.5 OUTLIER -130.55 126.16 60.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 126.36 1.864 . . . . 0.0 110.604 177.509 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -149.93 148.49 29.16 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 125.412 1.485 . . . . 0.0 109.297 175.02 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 13.5 t -139.81 112.84 8.15 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.0 0.52 . . . . 0.0 110.543 178.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 67.7 m -72.51 35.02 0.07 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.566 1.146 . . . . 0.0 113.232 178.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -65.99 -44.23 85.45 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.653 1.981 . . . . 0.0 113.019 -179.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 165.13 -68.72 0.2 Allowed Glycine 0 CA--C 1.531 1.059 0 C-N-CA 124.546 1.069 . . . . 0.0 113.838 178.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -111.88 17.01 20.14 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 125.054 1.341 . . . . 0.0 114.392 -174.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -60.98 175.36 0.52 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.349 1.859 . . . . 0.0 114.289 174.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.562 ' HB3' HD11 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -125.14 174.83 7.8 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 126.986 2.114 . . . . 0.0 112.042 -178.6 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 5.5 ttt -115.21 132.9 56.46 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.172 1.389 . . . . 0.0 110.685 175.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -144.79 120.88 10.76 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 123.351 0.66 . . . . 0.0 110.293 177.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 2.7 mp -119.67 126.03 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 C-N-CA 125.125 1.37 . . . . 0.0 107.471 177.381 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -127.43 126.52 42.53 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 120.879 -1.138 . . . . 0.0 108.794 176.25 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.8 mp -78.1 124.9 37.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 175.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 2.1 m -95.83 168.01 10.91 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.882 1.673 . . . . 0.0 109.984 175.091 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 49.3 mtp85 . . . . . 0 C--O 1.253 1.254 0 C-N-CA 125.37 1.468 . . . . 0.0 111.856 176.708 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 118.602 -0.713 . . . . 0.0 110.922 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.92 174.14 0.67 Allowed 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 121.09 1.768 . . . . 0.0 111.497 174.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.678 HD12 ' H ' ' A' ' 74' ' ' GLY . 0.7 OUTLIER -106.16 16.37 25.03 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 125.539 1.536 . . . . 0.0 112.687 -179.8 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.475 ' HB1' ' HB3' ' A' ' 71' ' ' LEU . . . -119.42 125.25 48.52 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.669 1.988 . . . . 0.0 111.056 178.026 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -77.37 -147.74 2.87 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 125.036 1.303 . . . . 0.0 112.443 175.007 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 18.3 p -68.06 169.08 10.74 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.076 1.35 . . . . 0.0 112.867 176.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -128.89 21.0 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 126.131 1.772 . . . . 0.0 111.257 176.299 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.2 pt -57.07 171.92 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 O-C-N 120.276 -1.515 . . . . 0.0 112.798 176.054 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -44.12 131.63 5.89 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.734 1.614 . . . . 0.0 112.292 -177.102 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -54.79 -20.94 20.86 Favored Glycine 0 CA--C 1.54 1.651 0 C-N-CA 124.367 0.984 . . . . 0.0 114.303 -177.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.73 -36.25 78.39 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.732 1.613 . . . . 0.0 112.031 175.003 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.44 -40.2 8.39 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.302 1.441 . . . . 0.0 111.528 175.193 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.405 HD23 ' HB3' ' A' ' 69' ' ' ALA . 9.4 tp -71.78 87.32 0.97 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.663 1.185 . . . . 0.0 111.205 175.042 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 80.6 p -123.33 -177.9 3.84 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.741 2.016 . . . . 0.0 111.401 -176.33 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -45.49 -37.9 5.74 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.426 1.49 . . . . 0.0 113.985 176.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -59.66 -40.94 89.4 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.676 0.791 . . . . 0.0 111.958 178.28 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 85.6 t -70.66 -37.72 70.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 123.754 0.822 . . . . 0.0 111.055 174.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 32.2 mt -65.54 -41.17 93.34 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 120.971 -1.081 . . . . 0.0 111.32 177.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -75.06 -42.92 56.02 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.85 0.86 . . . . 0.0 112.815 -179.313 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.88 -37.86 88.57 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 118.764 0.711 . . . . 0.0 111.543 175.1 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.508 HG13 HD12 ' A' ' 25' ' ' LEU . 20.2 t -56.35 -46.85 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 124.922 1.289 . . . . 0.0 111.738 176.011 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 78.1 mt -56.27 -25.32 47.68 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 119.213 0.915 . . . . 0.0 112.887 175.028 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -86.3 -57.81 2.06 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 124.899 1.237 . . . . 0.0 113.202 176.292 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -66.47 -27.54 67.88 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -177.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.508 HD12 HG13 ' A' ' 21' ' ' VAL . 19.3 mt -108.18 88.05 2.64 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.33 1.452 . . . . 0.0 110.838 -175.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -125.34 85.24 0.35 Allowed Glycine 0 CA--C 1.533 1.193 0 C-N-CA 125.129 1.347 . . . . 0.0 115.302 -175.027 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -75.41 -43.01 52.26 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.096 0.959 . . . . 0.0 113.467 175.052 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.8 m -137.12 -177.12 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 126.351 1.86 . . . . 0.0 112.078 -174.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -46.65 -45.54 19.29 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 126.448 1.899 . . . . 0.0 114.289 179.383 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 17.4 mtt85 -139.02 149.12 44.29 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.768 1.627 . . . . 0.0 111.548 178.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.671 ' HB2' HD13 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -139.12 157.44 45.94 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 127.234 2.214 . . . . 0.0 110.632 -175.015 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.717 HG13 ' HB1' ' A' ' 85' ' ' ALA . 0.3 OUTLIER -118.2 128.33 75.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 125.14 1.376 . . . . 0.0 107.597 174.974 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -135.9 104.12 5.61 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.727 2.011 . . . . 0.0 109.335 176.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.728 HG22 ' HB2' ' A' ' 72' ' ' TYR . 2.1 m -107.46 158.64 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 123.753 0.821 . . . . 0.0 111.123 178.005 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -135.68 109.45 0.75 Allowed Glycine 0 N--CA 1.462 0.384 0 CA-C-N 118.293 0.497 . . . . 0.0 113.298 175.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.464 ' HB ' HD11 ' A' ' 70' ' ' LEU . 2.8 mp -101.73 132.35 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-N 117.108 0.454 . . . . 0.0 111.185 176.108 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -93.11 105.87 17.9 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.555 1.542 . . . . 0.0 110.972 177.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -71.62 100.69 2.34 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.223 1.809 . . . . 0.0 110.481 175.025 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -140.09 11.64 2.4 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.988 0.915 . . . . 0.0 112.522 175.152 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 12.7 t -57.89 -31.9 67.19 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.895 1.678 . . . . 0.0 114.027 179.317 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 124.82 53.93 0.18 Allowed Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.75 1.167 . . . . 0.0 115.148 174.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 152.5 171.4 20.0 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 125.442 1.496 . . . . 0.0 112.263 175.446 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.565 HG22 ' HA ' ' A' ' 65' ' ' PRO . 75.6 p -63.6 145.72 55.14 Favored 'General case' 0 N--CA 1.471 0.625 0 O-C-N 121.601 -0.941 . . . . 0.0 111.212 176.524 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.539 ' HA ' ' CE1' ' A' ' 91' ' ' TYR . 38.0 m0 -93.57 98.35 11.1 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 121.619 -0.676 . . . . 0.0 111.334 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.3 m -83.63 108.52 16.78 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.469 1.107 . . . . 0.0 108.776 176.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.9 142.85 52.85 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.842 -0.536 . . . . 0.0 112.405 175.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.2 pp -119.14 -52.37 2.3 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.048 0.939 . . . . 0.0 112.876 176.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -163.7 153.98 15.42 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.557 1.543 . . . . 0.0 110.72 174.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -131.6 152.37 50.86 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.83 0.852 . . . . 0.0 110.365 175.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -128.05 95.81 4.29 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.687 1.595 . . . . 0.0 110.007 -178.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.532 ' CZ ' HG21 ' A' ' 59' ' ' ILE . 1.5 m-85 -94.54 111.04 22.8 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.852 0.861 . . . . 0.0 110.34 176.106 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.54 -38.03 12.15 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.048 0.939 . . . . 0.0 111.949 -178.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.2 t -126.63 -173.82 2.97 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 128.415 2.686 . . . . 0.0 107.45 175.036 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 44.42 49.37 8.42 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-O 118.428 -1.207 . . . . 0.0 111.189 -179.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.9 p -44.8 145.21 0.97 Allowed 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 118.35 1.075 . . . . 0.0 112.8 -175.07 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.518 ' CG2' HD12 ' A' ' 59' ' ' ILE . 2.6 t -155.33 179.04 9.55 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.249 -0.907 . . . . 0.0 113.047 -175.168 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -98.71 -62.76 1.2 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.479 1.511 . . . . 0.0 112.208 178.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.0 p -129.4 131.54 67.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 125.232 1.413 . . . . 0.0 110.921 -177.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.532 HG21 ' CZ ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -137.22 -49.17 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 C-N-CA 125.071 1.348 . . . . 0.0 112.593 -175.117 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.404 ' HA ' ' HD2' ' A' ' 61' ' ' PRO . 4.3 mt -85.49 104.09 4.52 Favored Pre-proline 0 N--CA 1.449 -0.478 0 C-N-CA 124.313 1.045 . . . . 0.0 109.948 175.114 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 60' ' ' LEU . 56.6 Cg_endo -66.08 128.57 19.89 Favored 'Trans proline' 0 CA--C 1.535 0.547 0 C-N-CA 122.789 2.326 . . . . 0.0 110.366 175.028 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -35.29 -47.86 0.43 Allowed 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 127.474 2.31 . . . . 0.0 113.79 176.248 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 5.9 p -154.09 134.57 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 126.576 1.95 . . . . 0.0 109.424 174.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 95.5 t -122.17 133.58 24.41 Favored Pre-proline 0 N--CA 1.482 1.16 0 C-N-CA 124.986 1.314 . . . . 0.0 109.865 175.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.565 ' HA ' HG22 ' A' ' 43' ' ' THR . 58.0 Cg_endo -62.41 148.85 92.62 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.871 2.381 . . . . 0.0 113.209 175.043 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 13.1 p30 -67.83 170.19 8.46 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.206 1.002 . . . . 0.0 113.071 175.037 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 74.4 p 48.1 28.62 1.55 Allowed 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 127.109 2.164 . . . . 0.0 114.235 -175.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.51 -179.84 4.8 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 127.442 2.297 . . . . 0.0 110.817 -174.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.405 ' HB3' HD23 ' A' ' 13' ' ' LEU . . . -136.37 152.79 51.02 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 120.77 -1.206 . . . . 0.0 109.86 175.597 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.464 HD11 ' HB ' ' A' ' 36' ' ' ILE . 0.8 OUTLIER -117.88 172.51 7.34 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 124.642 1.177 . . . . 0.0 111.279 -178.407 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.537 HD13 ' O ' ' A' ' 34' ' ' VAL . 0.5 OUTLIER -129.05 151.85 49.3 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.133 1.373 . . . . 0.0 111.191 175.14 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.728 ' HB2' HG22 ' A' ' 34' ' ' VAL . 5.2 m-85 -127.2 133.54 50.25 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.395 1.078 . . . . 0.0 110.214 174.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.3 p -102.41 154.88 18.65 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 126.491 1.917 . . . . 0.0 111.36 175.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.678 ' H ' HD12 ' A' ' 3' ' ' LEU . . . -176.37 126.91 1.17 Allowed Glycine 0 CA--C 1.529 0.917 0 N-CA-C 114.269 0.468 . . . . 0.0 114.269 175.189 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 9.3 ptt180 -116.26 105.03 12.1 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.513 1.925 . . . . 0.0 112.751 -175.046 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.03 -34.33 77.35 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 -179.444 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 22.8 t -68.47 88.73 0.34 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.683 1.193 . . . . 0.0 111.734 178.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 61.0 m -110.46 -21.0 12.39 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.493 1.517 . . . . 0.0 113.703 175.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 117.44 -66.97 0.33 Allowed Glycine 0 CA--C 1.54 1.643 0 C-N-CA 125.414 1.483 . . . . 0.0 113.78 -175.035 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -71.67 -41.64 2.15 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 123.321 2.68 . . . . 0.0 113.632 -174.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.9 m -132.78 149.07 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 126.283 1.833 . . . . 0.0 110.241 177.122 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -154.07 76.36 1.05 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.518 1.527 . . . . 0.0 110.967 -178.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 53.8 m -92.3 141.32 28.68 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 125.545 1.538 . . . . 0.0 110.05 174.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -27.71 -77.61 0.01 OUTLIER Glycine 0 N--CA 1.477 1.381 0 C-N-CA 127.69 2.567 . . . . 0.0 116.177 -178.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.717 ' HB1' HG13 ' A' ' 32' ' ' ILE . . . -165.73 112.55 0.92 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.363 1.865 . . . . 0.0 110.599 -176.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.8 t -149.97 120.68 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 O-C-N 121.211 -0.931 . . . . 0.0 111.631 -177.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.513 ' HB3' ' CE2' ' A' ' 103' ' ' PHE . . . -162.03 173.39 14.47 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 122.67 1.224 . . . . 0.0 113.397 175.389 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -147.69 157.38 43.52 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.686 1.594 . . . . 0.0 110.755 174.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.449 ' CD2' ' CE2' ' A' ' 72' ' ' TYR . 49.0 p90 -158.05 172.1 19.04 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 124.41 1.084 . . . . 0.0 110.858 175.174 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.76 147.82 31.31 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 175.05 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.539 ' CE1' ' HA ' ' A' ' 44' ' ' TRP . 0.1 OUTLIER -114.54 126.98 55.55 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 126.309 1.844 . . . . 0.0 109.726 -178.281 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -82.83 108.23 16.02 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 123.518 0.727 . . . . 0.0 111.768 178.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.416 ' HE2' HG21 ' A' ' 120' ' ' ILE . 0.5 OUTLIER -79.91 137.8 36.98 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.441 1.096 . . . . 0.0 111.603 -174.998 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.9 t -59.44 -22.63 61.77 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.791 0.837 . . . . 0.0 113.206 177.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 28.3 m-80 -69.23 -1.79 8.89 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 125.69 1.596 . . . . 0.0 113.529 174.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 89.75 16.33 56.7 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 125.066 1.317 . . . . 0.0 113.894 -179.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 23.6 m-20 -116.47 177.32 4.74 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.878 1.671 . . . . 0.0 111.07 -176.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.2 m -131.66 117.51 18.77 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 121.473 -0.767 . . . . 0.0 112.007 175.11 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 13.5 tp -80.09 97.53 6.88 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 175.003 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -91.21 135.76 12.98 Favored Glycine 0 CA--C 1.532 1.126 0 O-C-N 121.347 -0.845 . . . . 0.0 112.067 176.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 74.3 t -122.46 133.87 67.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 126.951 2.1 . . . . 0.0 111.61 -174.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -137.78 128.36 26.68 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 126.009 1.724 . . . . 0.0 111.01 -176.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.513 ' CE2' ' HB3' ' A' ' 87' ' ' ALA . 3.6 p90 -145.77 121.83 10.75 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.873 1.269 . . . . 0.0 112.312 -175.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 19.3 m -139.07 110.8 7.14 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.878 1.271 . . . . 0.0 112.064 -175.022 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.7 m -84.21 151.23 59.51 Favored Pre-proline 0 N--CA 1.479 1.021 0 N-CA-C 112.654 0.612 . . . . 0.0 112.654 -179.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.405 ' HA ' ' CE2' ' A' ' 109' ' ' TYR . 67.6 Cg_endo -73.29 109.26 2.8 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 123.628 2.885 . . . . 0.0 112.154 177.485 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -131.6 -47.65 0.97 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.177 0.991 . . . . 0.0 113.264 177.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -107.56 -8.54 16.15 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 177.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.405 ' CE2' ' HA ' ' A' ' 106' ' ' PRO . 6.5 m-30 -59.64 106.71 0.5 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.853 1.261 . . . . 0.0 111.969 -175.1 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 99.8 m-20 -62.16 -4.49 1.74 Allowed 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 124.923 1.289 . . . . 0.0 114.03 176.394 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 18.9 m95 -123.46 3.84 9.04 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 127.546 2.338 . . . . 0.0 113.711 -177.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 49.92 40.74 21.59 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 125.839 1.656 . . . . 0.0 114.19 -176.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 2.1 m -106.91 83.95 1.91 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.491 1.516 . . . . 0.0 113.157 -175.117 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -79.89 107.41 12.65 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.18 0.992 . . . . 0.0 110.272 174.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 31.2 m0 -112.03 141.82 45.23 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 55.6 p-90 -146.82 130.73 17.15 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 123.864 0.865 . . . . 0.0 112.007 -174.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -132.49 144.46 50.46 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 122.81 1.291 . . . . 0.0 112.192 179.378 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.419 ' HB ' ' CE ' ' A' ' 158' ' ' MET . 79.6 t -151.17 131.5 3.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 175.326 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.86 165.99 13.68 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 125.161 1.384 . . . . 0.0 110.505 175.169 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.416 HG21 ' HE2' ' A' ' 93' ' ' MET . 14.3 mt -86.24 148.51 4.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 175.075 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -110.38 142.63 26.43 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 126.771 2.028 . . . . 0.0 109.519 -178.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -74.77 87.24 1.31 Allowed 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 124.319 3.346 . . . . 0.0 111.547 -177.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.53 -174.97 19.96 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 125.112 1.339 . . . . 0.0 113.201 -174.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 2.3 tttt -69.73 105.81 2.87 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.234 1.414 . . . . 0.0 110.714 177.33 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 17.4 tpp180 -135.45 101.18 4.73 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.241 1.417 . . . . 0.0 111.451 178.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.8 168.58 1.2 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.711 0.804 . . . . 0.0 112.954 175.014 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -111.06 101.73 10.25 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.784 1.234 . . . . 0.0 107.882 177.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -113.23 171.17 7.71 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.794 1.238 . . . . 0.0 109.848 174.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -50.24 -36.61 31.81 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.006 -1.059 . . . . 0.0 112.775 175.108 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -60.02 -61.6 6.98 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 124.087 0.851 . . . . 0.0 111.634 174.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.48 -34.63 74.32 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 118.43 1.115 . . . . 0.0 112.324 178.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -58.4 -66.2 0.53 Allowed 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.866 0.866 . . . . 0.0 109.277 174.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -67.67 -30.89 70.54 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -175.018 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -63.88 -54.4 35.44 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.976 1.31 . . . . 0.0 112.142 175.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 51.8 mmm -75.13 -24.14 57.95 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.159 -0.963 . . . . 0.0 113.266 178.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -55.68 -56.58 18.78 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.383 1.473 . . . . 0.0 108.903 174.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -66.91 -23.11 65.95 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -75.3 -19.09 79.81 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 125.868 1.699 . . . . 0.0 115.212 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -132.56 83.64 53.36 Favored Pre-proline 0 CA--C 1.549 0.942 0 CA-C-N 119.024 1.412 . . . . 0.0 111.102 175.03 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -72.97 72.63 3.23 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 124.239 3.293 . . . . 0.0 112.1 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -96.64 112.01 23.93 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 121.372 -0.83 . . . . 0.0 110.551 -175.031 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 10.0 mtm180 -113.41 -3.45 13.75 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 115.467 1.655 . . . . 0.0 115.467 176.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -50.43 152.15 4.55 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 125.159 1.361 . . . . 0.0 114.427 177.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 10.4 p30 -119.35 -155.75 0.63 Allowed 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 -175.011 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -49.52 114.28 1.01 Allowed 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.79 1.636 . . . . 0.0 113.027 -178.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 152.8 24.79 0.05 OUTLIER Glycine 0 CA--C 1.535 1.342 0 N-CA-C 115.425 0.93 . . . . 0.0 115.425 -175.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 3.4 m95 49.6 47.57 22.56 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.545 1.538 . . . . 0.0 113.393 -175.035 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -66.9 109.57 2.98 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 126.999 2.12 . . . . 0.0 112.787 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -158.65 -169.01 2.58 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 175.006 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.4 mtmt -134.86 172.32 13.15 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 127.564 2.346 . . . . 0.0 110.277 -179.13 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -71.1 160.62 32.55 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.042 0.537 . . . . 0.0 109.898 174.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 10.3 mt -118.7 155.48 30.98 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 122.385 1.088 . . . . 0.0 110.659 175.005 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -62.46 -175.45 2.48 Favored Glycine 0 CA--C 1.537 1.415 0 CA-C-N 114.92 -1.036 . . . . 0.0 111.17 175.012 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 55.82 12.05 0.8 Allowed 'General case' 0 N--CA 1.482 1.141 0 O-C-N 121.055 -1.262 . . . . 0.0 114.127 178.814 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 79.41 24.33 61.16 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 125.576 1.56 . . . . 0.0 114.079 -174.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 52.7 mt -103.94 176.66 5.08 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 118.699 1.249 . . . . 0.0 111.534 -175.05 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -145.85 131.6 18.99 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 120.862 -1.149 . . . . 0.0 110.598 177.095 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' MET . . . . . 0.419 ' CE ' ' HB ' ' A' ' 118' ' ' VAL . 2.9 ttt -106.32 150.94 25.47 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 119.892 -1.755 . . . . 0.0 107.154 175.06 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 1.9 tppt? -126.54 136.96 53.25 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 126.236 1.814 . . . . 0.0 108.834 175.052 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -147.95 157.79 27.47 Favored Glycine 0 N--CA 1.463 0.477 0 O-C-N 121.152 -0.968 . . . . 0.0 112.733 -178.352 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -158.21 128.34 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 122.137 0.97 . . . . 0.0 110.334 -179.398 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -155.23 117.68 4.23 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.708 1.603 . . . . 0.0 110.088 174.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 8.6 t -103.4 151.57 22.62 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 175.042 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 8.4 t -105.87 36.73 2.45 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.623 1.169 . . . . 0.0 111.384 -177.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -72.29 23.73 0.05 Allowed 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 127.795 2.438 . . . . 0.0 114.565 -178.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 80.83 -61.65 4.5 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 126.239 1.875 . . . . 0.0 113.015 -177.184 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -114.58 84.03 1.99 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 126.152 1.781 . . . . 0.0 109.992 177.305 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -136.7 163.93 29.43 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.318 1.847 . . . . 0.0 111.872 177.122 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.62 177.72 4.54 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 127.772 2.429 . . . . 0.0 111.523 -177.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' MET . . . . . 0.475 ' SD ' HD13 ' A' ' 172' ' ' ILE . 1.5 tmt? -121.97 131.07 53.82 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.864 1.266 . . . . 0.0 111.218 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.499 ' C ' HD12 ' A' ' 172' ' ' ILE . 5.7 tt0 -143.26 124.01 14.18 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.43 0.692 . . . . 0.0 111.739 179.075 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.499 HD12 ' C ' ' A' ' 171' ' ' GLN . 1.9 mp -128.78 130.95 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 125.805 1.642 . . . . 0.0 108.57 178.624 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 1.9 tmmm? -130.67 129.16 42.27 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 126.069 1.748 . . . . 0.0 108.993 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.7 mp -83.89 133.4 29.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 174.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 87.4 p -116.79 161.75 18.77 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.932 1.693 . . . . 0.0 112.45 176.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 19.0 mtp180 . . . . . 0 C--O 1.253 1.269 0 O-C-N 120.315 -1.49 . . . . 0.0 111.825 -175.307 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 57.3 p . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 118.076 -0.964 . . . . 0.0 109.564 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.401 ' O ' HD23 ' A' ' 3' ' ' LEU . 14.7 pt-20 -63.86 -172.17 0.06 Allowed 'General case' 0 N--CA 1.485 1.287 0 CA-C-N 120.606 1.548 . . . . 0.0 113.241 175.023 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.61 HD12 ' H ' ' A' ' 74' ' ' GLY . 1.9 mt -121.06 -9.08 9.25 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.588 1.155 . . . . 0.0 112.921 178.623 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.537 ' HA ' HD12 ' A' ' 71' ' ' LEU . . . -99.42 114.02 26.7 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 127.404 2.282 . . . . 0.0 109.14 178.856 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -63.3 -89.12 0.03 OUTLIER Glycine 0 CA--C 1.535 1.295 0 C-N-CA 124.243 0.925 . . . . 0.0 113.934 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 17.2 p -143.85 174.47 10.8 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.86 1.664 . . . . 0.0 111.452 -175.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -124.95 15.2 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 125.38 1.472 . . . . 0.0 112.011 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.5 pt -50.11 156.73 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 124.481 1.112 . . . . 0.0 110.976 174.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -40.06 140.27 0.59 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.896 1.678 . . . . 0.0 112.695 -176.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -53.42 -24.2 22.35 Favored Glycine 0 CA--C 1.543 1.798 0 C-N-CA 124.028 0.823 . . . . 0.0 113.982 -174.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.24 -32.69 72.49 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.662 1.585 . . . . 0.0 112.618 175.005 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -93.41 -50.93 5.21 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 125.886 1.674 . . . . 0.0 110.911 175.058 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.2 tp -71.05 91.2 0.88 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.537 1.135 . . . . 0.0 111.086 177.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 62.5 p -126.68 -178.54 4.41 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.376 1.87 . . . . 0.0 111.6 -178.393 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -53.97 -37.65 64.17 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.512 1.125 . . . . 0.0 113.077 178.242 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -58.91 -46.76 87.16 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.372 0.669 . . . . 0.0 110.961 175.008 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 81.6 t -61.63 -43.66 97.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.669 1.188 . . . . 0.0 111.339 175.45 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 96.7 mt -64.6 -43.45 93.74 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 121.267 -0.895 . . . . 0.0 111.987 178.609 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -69.36 -42.37 75.32 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.275 0.63 . . . . 0.0 112.243 -179.494 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.01 -36.35 83.04 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 118.791 0.723 . . . . 0.0 111.716 175.008 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.2 t -56.17 -41.43 69.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 124.013 0.925 . . . . 0.0 110.923 179.035 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.417 HD22 ' HE3' ' A' ' 31' ' ' LYS . 41.0 mt -55.18 -20.23 9.94 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 175.419 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -92.71 -59.68 1.25 Allowed Glycine 0 CA--C 1.534 1.245 0 C-N-CA 125.246 1.403 . . . . 0.0 112.722 175.068 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -68.45 -29.41 68.06 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 -176.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -109.05 118.14 36.01 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 126.605 1.962 . . . . 0.0 109.365 -179.108 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -160.87 117.5 0.77 Allowed Glycine 0 CA--C 1.542 1.762 0 C-N-CA 125.701 1.619 . . . . 0.0 114.732 -175.316 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.543 ' HB2' HD21 ' A' ' 3' ' ' LEU . 9.1 mttm -87.54 -57.92 2.77 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 126.882 2.073 . . . . 0.0 112.988 176.619 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.3 m -132.36 -172.36 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 127.143 2.177 . . . . 0.0 112.066 -174.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.2 t -50.48 -37.15 37.11 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.778 1.631 . . . . 0.0 114.081 -175.228 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.5 tpt180 -130.28 144.93 51.66 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.129 1.372 . . . . 0.0 109.581 174.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.456 ' CB ' HD22 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -144.82 133.94 22.77 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 125.707 1.603 . . . . 0.0 110.357 -175.067 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -103.84 131.31 52.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 124.054 0.942 . . . . 0.0 108.882 175.028 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -130.11 105.61 8.06 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.501 1.92 . . . . 0.0 109.901 175.232 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.681 HG22 ' HB2' ' A' ' 72' ' ' TYR . 1.2 m -108.19 162.89 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 C-N-CA 123.979 0.912 . . . . 0.0 110.747 176.479 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -135.02 109.15 0.75 Allowed Glycine 0 C--O 1.228 -0.251 0 C-N-CA 123.275 0.465 . . . . 0.0 112.603 175.586 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.3 mp -92.35 133.86 32.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 174.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -109.31 99.63 8.86 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.436 1.894 . . . . 0.0 110.342 178.31 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -73.43 112.13 9.21 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.98 1.712 . . . . 0.0 112.199 175.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -140.06 18.68 2.45 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.785 0.834 . . . . 0.0 112.005 174.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 44.1 t -64.61 -39.06 93.04 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 120.889 -1.132 . . . . 0.0 113.15 -178.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 119.97 63.01 0.26 Allowed Glycine 0 CA--C 1.53 0.99 0 C-N-CA 124.805 1.193 . . . . 0.0 112.715 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 157.15 161.13 10.58 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 125.674 1.606 . . . . 0.0 112.444 176.527 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.61 HG22 ' HA ' ' A' ' 65' ' ' PRO . 71.5 p -67.82 148.47 51.17 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 121.784 -0.833 . . . . 0.0 111.732 175.413 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.562 ' HA ' ' CE1' ' A' ' 91' ' ' TYR . 35.3 m0 -103.72 98.25 8.14 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.415 1.086 . . . . 0.0 111.866 -177.508 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 35.9 m -84.24 116.66 23.07 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 125.07 1.348 . . . . 0.0 109.86 177.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.496 ' HB1' HD23 ' A' ' 60' ' ' LEU . . . -64.02 141.84 58.62 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 121.686 -0.634 . . . . 0.0 111.647 174.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.534 HD12 ' HB3' ' A' ' 48' ' ' ASN . 3.0 pp -114.31 -48.41 2.88 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.153 0.981 . . . . 0.0 112.587 177.265 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.534 ' HB3' HD12 ' A' ' 47' ' ' LEU . 2.4 t30 -170.19 148.88 3.39 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.964 2.106 . . . . 0.0 109.53 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.48 ' HB2' HD22 ' A' ' 60' ' ' LEU . . . -125.98 147.59 49.49 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.151 1.38 . . . . 0.0 109.803 174.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -124.52 101.61 7.22 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 125.344 1.458 . . . . 0.0 109.629 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.478 ' CD1' ' HB1' ' A' ' 87' ' ' ALA . 3.1 m-85 -105.13 133.53 49.75 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.586 -0.696 . . . . 0.0 110.427 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -107.07 -68.45 0.89 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.334 1.453 . . . . 0.0 111.244 -177.17 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.9 t -102.6 -38.92 7.3 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.671 1.588 . . . . 0.0 110.056 -179.379 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -69.44 7.7 3.49 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 125.482 1.515 . . . . 0.0 114.338 -178.185 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 53.4 p -33.2 123.25 0.4 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 128.151 2.581 . . . . 0.0 113.532 -175.023 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.478 HG21 HG23 ' A' ' 59' ' ' ILE . 1.9 t -138.35 177.96 7.49 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.175 0.99 . . . . 0.0 112.754 -174.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -77.37 -60.81 2.21 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.764 1.226 . . . . 0.0 112.538 177.433 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.8 p -141.57 138.27 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 126.161 1.784 . . . . 0.0 111.348 176.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.478 HG23 HG21 ' A' ' 56' ' ' THR . 1.1 pp -144.58 -34.2 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 126.114 1.765 . . . . 0.0 113.793 -177.317 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.496 HD23 ' HB1' ' A' ' 46' ' ' ALA . 1.1 mp -95.13 98.19 3.19 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 125.154 1.382 . . . . 0.0 109.681 176.067 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -66.83 151.87 81.54 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.749 2.299 . . . . 0.0 110.332 175.289 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -50.04 -50.25 48.23 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.686 0.794 . . . . 0.0 112.893 -177.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 60.0 t -150.14 142.15 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 128.296 2.638 . . . . 0.0 108.691 178.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.555 HG21 HD13 ' A' ' 70' ' ' LEU . 98.9 t -120.64 133.97 24.15 Favored Pre-proline 0 N--CA 1.477 0.893 0 C-N-CA 124.742 1.217 . . . . 0.0 109.117 175.017 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.61 ' HA ' HG22 ' A' ' 43' ' ' THR . 55.7 Cg_endo -65.06 154.58 72.73 Favored 'Trans proline' 0 CA--C 1.544 1.014 0 C-N-CA 122.707 2.271 . . . . 0.0 113.565 177.482 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -70.23 160.24 32.54 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.566 1.146 . . . . 0.0 113.273 175.125 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 40.9 p 52.7 23.78 2.87 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 126.314 1.846 . . . . 0.0 114.405 -175.02 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 18.6 mttt -119.48 -172.81 2.39 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 126.087 1.755 . . . . 0.0 111.31 -177.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -143.9 157.94 44.02 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 122.068 -0.395 . . . . 0.0 109.997 179.069 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.555 HD13 HG21 ' A' ' 64' ' ' VAL . 2.4 pt? -134.81 167.21 21.29 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 124.58 1.152 . . . . 0.0 111.689 177.365 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.541 HD13 ' O ' ' A' ' 34' ' ' VAL . 0.6 OUTLIER -114.0 154.85 26.94 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 125.121 1.369 . . . . 0.0 111.849 -179.118 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.681 ' HB2' HG22 ' A' ' 34' ' ' VAL . 29.0 m-85 -129.19 137.82 51.37 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.356 1.062 . . . . 0.0 110.764 175.079 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 8.7 p -111.93 144.04 41.9 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 126.86 2.064 . . . . 0.0 110.241 174.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.61 ' H ' HD12 ' A' ' 3' ' ' LEU . . . -165.63 133.69 3.05 Favored Glycine 0 CA--C 1.523 0.592 0 CA-C-O 121.388 0.438 . . . . 0.0 113.119 175.004 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 66.3 mtm180 -90.62 172.14 8.89 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.343 1.457 . . . . 0.0 110.617 -175.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.39 140.42 31.07 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.823 -0.548 . . . . 0.0 109.824 174.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.5 m -171.39 152.01 3.2 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.988 1.315 . . . . 0.0 112.337 175.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.428 ' HB2' ' H ' ' A' ' 83' ' ' THR . 0.5 OUTLIER 175.99 118.79 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 127.91 2.484 . . . . 0.0 108.596 175.527 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -38.69 -50.83 2.49 Favored Glycine 0 CA--C 1.545 1.937 0 C-N-CA 126.009 1.766 . . . . 0.0 115.64 174.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.88 -54.74 0.16 Allowed 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.667 2.245 . . . . 0.0 113.077 176.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.4 p -156.41 116.4 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 126.603 1.961 . . . . 0.0 110.02 -177.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -42.49 101.89 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 126.656 1.982 . . . . 0.0 114.803 -179.407 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.428 ' H ' ' HB2' ' A' ' 78' ' ' SER . 87.7 m -74.29 152.29 39.69 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.814 1.646 . . . . 0.0 110.598 178.52 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -57.34 -76.06 0.22 Allowed Glycine 0 CA--C 1.532 1.141 0 C-N-CA 125.726 1.631 . . . . 0.0 114.644 -174.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -162.24 104.96 1.13 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.377 1.071 . . . . 0.0 111.376 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 41.8 t -127.67 114.58 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 O-C-N 121.086 -1.009 . . . . 0.0 109.891 -177.063 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.529 ' HB3' ' CE2' ' A' ' 103' ' ' PHE . . . -157.26 169.45 24.72 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 122.693 1.235 . . . . 0.0 112.061 179.49 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -150.88 161.38 42.8 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.828 1.651 . . . . 0.0 109.563 175.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -159.97 176.47 11.82 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 121.093 -1.004 . . . . 0.0 111.342 175.079 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.03 156.47 43.5 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.666 0.746 . . . . 0.0 112.556 174.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.562 ' CE1' ' HA ' ' A' ' 44' ' ' TRP . 0.1 OUTLIER -119.94 127.5 52.72 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.697 1.999 . . . . 0.0 109.184 -178.81 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -83.45 105.59 14.51 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.494 0.718 . . . . 0.0 111.911 178.609 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -75.37 137.59 41.17 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.576 1.151 . . . . 0.0 112.009 -175.708 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.3 m -59.95 -17.31 36.86 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 113.583 0.956 . . . . 0.0 113.583 175.027 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -74.32 -2.53 25.56 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 125.142 1.377 . . . . 0.0 112.532 174.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.41 14.89 58.0 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 125.352 1.453 . . . . 0.0 114.168 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -117.25 178.18 4.46 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.504 1.522 . . . . 0.0 110.655 -177.174 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.416 HG21 ' O ' ' A' ' 125' ' ' ARG . 16.3 m -130.29 114.01 15.1 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 120.998 -1.064 . . . . 0.0 111.839 178.364 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 32.5 tp -78.99 98.77 6.57 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.391 0.996 . . . . 0.0 109.383 174.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.6 139.33 15.08 Favored Glycine 0 CA--C 1.532 1.154 0 O-C-N 121.075 -1.016 . . . . 0.0 112.294 175.433 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 60.9 t -122.55 134.21 66.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 128.174 2.589 . . . . 0.0 112.002 -175.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -131.75 125.39 31.85 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 126.163 1.785 . . . . 0.0 111.779 -175.307 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.529 ' CE2' ' HB3' ' A' ' 87' ' ' ALA . 10.8 p90 -146.03 116.04 7.37 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.362 1.065 . . . . 0.0 113.521 -177.125 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 72.3 m -123.36 122.26 37.87 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.397 1.479 . . . . 0.0 111.719 -177.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 47.4 t -120.97 93.77 48.88 Favored Pre-proline 0 N--CA 1.469 0.506 0 C-N-CA 126.124 1.77 . . . . 0.0 108.873 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.27 139.6 42.33 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 123.281 2.654 . . . . 0.0 110.975 178.042 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -75.62 -55.62 5.48 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.047 0.939 . . . . 0.0 111.725 177.051 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -63.94 -37.53 87.74 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.164 0.985 . . . . 0.0 113.456 -177.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER 49.67 45.34 24.52 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 125.981 1.712 . . . . 0.0 113.278 179.021 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -113.62 -76.41 0.58 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.557 1.143 . . . . 0.0 112.29 -175.478 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -97.97 13.47 30.68 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 127.643 2.377 . . . . 0.0 113.159 -179.098 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -143.65 103.11 4.03 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.182 1.393 . . . . 0.0 111.216 -177.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 67.8 m -65.6 148.71 51.29 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.055 0.942 . . . . 0.0 112.512 175.154 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -84.11 106.67 15.93 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.965 1.306 . . . . 0.0 109.081 174.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' TRP . . . . . 0.414 ' CG ' ' HA ' ' A' ' 140' ' ' PRO . 53.5 m0 -110.73 155.83 21.92 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.398 0.999 . . . . 0.0 108.912 174.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 58.1 p-90 -154.32 132.93 12.12 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.132 0.973 . . . . 0.0 111.214 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -135.94 154.97 50.95 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 122.84 1.305 . . . . 0.0 112.097 178.489 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 95.1 t -152.6 135.2 6.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 175.239 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.03 170.68 11.78 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.943 1.697 . . . . 0.0 110.014 175.026 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 20.5 mt -91.29 154.1 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 CA-C-O 121.507 0.67 . . . . 0.0 109.312 179.03 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -117.77 144.04 33.66 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 125.296 1.438 . . . . 0.0 109.64 178.321 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -70.96 108.11 2.24 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 123.891 3.06 . . . . 0.0 111.301 -178.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 83.61 -178.55 52.48 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 124.447 1.022 . . . . 0.0 113.711 -175.018 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 14.2 tttt -63.61 104.58 0.67 Allowed 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.911 1.285 . . . . 0.0 110.659 175.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.416 ' O ' HG21 ' A' ' 98' ' ' THR . 19.6 tpp180 -132.34 101.47 5.37 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.82 1.248 . . . . 0.0 111.29 -175.517 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.7 163.33 1.9 Allowed 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.852 0.834 . . . . 0.0 111.754 174.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -109.64 105.1 14.24 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 106.565 -1.642 . . . . 0.0 106.565 174.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -112.32 173.9 6.14 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.029 1.332 . . . . 0.0 109.86 175.007 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -50.57 -40.27 51.72 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 119.276 0.944 . . . . 0.0 113.282 176.119 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -58.28 -62.01 6.77 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 123.659 0.647 . . . . 0.0 111.717 175.046 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 5.3 mpp? -58.44 -39.33 79.53 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 118.134 0.967 . . . . 0.0 112.742 177.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -55.14 -60.87 2.79 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.397 1.079 . . . . 0.0 109.962 175.013 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -68.25 -33.29 74.11 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -178.035 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -61.1 -46.81 89.08 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.079 0.951 . . . . 0.0 111.599 176.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 46.6 mmm -84.88 -22.65 29.26 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -178.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -54.1 -55.54 26.63 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.765 1.626 . . . . 0.0 109.844 175.012 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -69.53 -16.49 63.44 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 179.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -74.29 -24.84 72.26 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 125.841 1.686 . . . . 0.0 114.333 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -135.74 87.98 24.47 Favored Pre-proline 0 CA--C 1.546 0.796 0 CA-C-N 118.721 1.26 . . . . 0.0 112.607 175.47 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.414 ' HA ' ' CG ' ' A' ' 115' ' ' TRP . 95.5 Cg_endo -74.19 76.68 2.99 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 123.752 2.968 . . . . 0.0 112.773 -178.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -104.29 105.32 15.42 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.991 0.916 . . . . 0.0 111.316 179.606 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 23.2 mtm105 -91.0 74.43 6.38 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.268 1.427 . . . . 0.0 111.472 174.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 31.37 64.79 0.2 Allowed Glycine 0 CA--C 1.534 1.242 0 C-N-CA 125.613 1.577 . . . . 0.0 112.948 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -71.86 93.92 1.37 Allowed 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 122.284 1.04 . . . . 0.0 110.153 -175.003 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 -54.76 98.94 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 126.934 2.093 . . . . 0.0 114.373 -175.006 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' GLY . . . . . 0.475 ' H ' HD13 ' A' ' 161' ' ' ILE . . . 146.7 54.6 0.02 OUTLIER Glycine 0 CA--C 1.535 1.335 0 C-N-CA 125.431 1.491 . . . . 0.0 114.38 177.145 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 5.0 m95 44.12 50.08 7.49 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.796 1.638 . . . . 0.0 114.129 -176.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -81.39 131.68 35.29 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 121.149 -0.97 . . . . 0.0 112.476 -177.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -167.77 -169.59 1.2 Allowed 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.845 178.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.83 160.52 27.22 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.701 2.001 . . . . 0.0 111.851 175.33 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -87.87 127.9 35.35 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.631 1.173 . . . . 0.0 108.217 174.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 12.8 mt -73.41 112.23 9.28 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.191 0.996 . . . . 0.0 112.052 -174.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -43.76 -46.16 7.41 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 127.349 2.404 . . . . 0.0 117.769 -175.005 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.411 ' CD1' ' N ' ' A' ' 154' ' ' TYR . 0.0 OUTLIER -51.77 -33.74 36.54 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 127.378 2.271 . . . . 0.0 113.658 178.162 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 132.17 40.88 0.2 Allowed Glycine 0 CA--C 1.533 1.215 0 C-N-CA 125.459 1.504 . . . . 0.0 113.896 -178.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 4.8 mp -134.56 179.46 6.27 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.605 1.562 . . . . 0.0 110.874 178.328 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 5.8 mtt180 -136.88 142.11 42.77 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.709 1.204 . . . . 0.0 109.028 174.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 3.5 ttt -134.75 145.57 48.56 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 121.076 -1.015 . . . . 0.0 108.692 175.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 4.9 tptt -124.59 147.93 48.17 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 127.12 2.168 . . . . 0.0 111.172 178.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -150.24 147.81 18.37 Favored Glycine 0 CA--C 1.528 0.848 0 O-C-N 121.458 -0.776 . . . . 0.0 112.872 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.475 HD13 ' H ' ' A' ' 146' ' ' GLY . 4.8 tp -146.59 124.94 4.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 124.943 1.297 . . . . 0.0 110.42 179.281 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -151.32 156.01 39.9 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.933 2.093 . . . . 0.0 107.412 174.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' THR . . . . . 0.496 HG23 ' HB3' ' A' ' 168' ' ' ALA . 0.1 OUTLIER -150.51 132.42 15.12 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.199 1.4 . . . . 0.0 107.923 174.952 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -105.5 32.75 4.08 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.342 1.057 . . . . 0.0 112.127 -176.271 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -116.3 -71.42 0.74 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.341 1.056 . . . . 0.0 112.583 -175.019 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -77.29 14.07 9.27 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 125.974 1.749 . . . . 0.0 111.384 175.031 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 56.28 56.14 6.05 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 127.551 2.34 . . . . 0.0 112.063 176.278 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.496 ' HB3' HG23 ' A' ' 163' ' ' THR . . . -78.54 -170.71 2.18 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 113.779 -1.555 . . . . 0.0 112.857 178.087 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.402 ' H ' ' HD3' ' A' ' 169' ' ' LYS . 0.0 OUTLIER -116.3 165.97 12.58 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 128.665 2.786 . . . . 0.0 111.435 -178.571 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 17.9 ttp -95.59 136.88 35.42 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.732 1.213 . . . . 0.0 111.527 179.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -144.82 119.27 9.65 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.251 1.02 . . . . 0.0 110.329 176.137 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 1.9 mp -114.31 120.79 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 124.905 1.282 . . . . 0.0 108.158 175.037 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.435 ' HE2' ' O ' ' A' ' 174' ' ' ILE . 0.0 OUTLIER -121.54 127.31 50.85 Favored 'General case' 0 CA--C 1.51 -0.574 0 C-N-CA 126.447 1.899 . . . . 0.0 108.88 -179.224 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.435 ' O ' ' HE2' ' A' ' 173' ' ' LYS . 1.3 mp -79.0 117.83 25.31 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 O-C-N 121.141 -0.975 . . . . 0.0 111.957 177.373 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 6.1 t -84.67 172.63 11.39 Favored 'General case' 0 N--CA 1.479 1.005 0 O-C-N 120.864 -1.147 . . . . 0.0 109.88 175.058 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 1.1 mtt-85 . . . . . 0 C--O 1.251 1.147 0 O-C-N 120.432 -1.417 . . . . 0.0 114.418 174.942 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 71.0 m . . . . . 0 N--CA 1.486 1.332 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -137.84 169.92 16.95 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 126.436 1.894 . . . . 0.0 109.265 174.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.739 HD12 ' H ' ' A' ' 74' ' ' GLY . 2.2 mt -108.68 15.62 23.54 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.527 1.531 . . . . 0.0 112.496 177.739 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -116.29 130.07 56.59 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 127.366 2.266 . . . . 0.0 110.361 -176.281 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -85.65 -96.04 0.76 Allowed Glycine 0 CA--C 1.531 1.087 0 C-N-CA 123.929 0.776 . . . . 0.0 112.865 -178.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 36.1 p -120.93 170.02 9.89 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.965 1.706 . . . . 0.0 111.764 -179.094 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -129.65 18.68 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 125.928 1.691 . . . . 0.0 111.712 177.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 pt -56.9 171.62 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 O-C-N 120.367 -1.458 . . . . 0.0 112.258 176.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -43.02 126.96 4.06 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.331 1.452 . . . . 0.0 113.335 -174.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -54.5 -23.3 27.12 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 125.229 1.395 . . . . 0.0 114.292 -177.113 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.14 -29.06 70.08 Favored 'General case' 0 CA--C 1.548 0.894 0 O-C-N 121.678 -0.895 . . . . 0.0 111.99 175.213 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.0 t -101.99 -40.11 7.02 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.956 1.702 . . . . 0.0 112.064 175.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 12.8 tp -73.44 90.11 1.69 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.265 1.026 . . . . 0.0 110.567 175.013 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.9 p -125.9 -178.95 4.46 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.918 2.087 . . . . 0.0 111.634 178.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -48.26 -38.82 19.62 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.801 1.641 . . . . 0.0 113.289 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -55.06 -40.53 70.4 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 118.685 0.675 . . . . 0.0 112.497 176.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.416 ' O ' HG23 ' A' ' 21' ' ' VAL . 96.2 t -70.05 -39.77 77.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.301 1.44 . . . . 0.0 110.804 174.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 28.1 mt -65.49 -43.75 89.2 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.166 -0.959 . . . . 0.0 111.419 179.142 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.408 ' HA ' HD12 ' A' ' 22' ' ' LEU . 24.7 t0 -57.22 -51.41 69.44 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.222 1.409 . . . . 0.0 110.716 178.773 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.76 -36.86 84.76 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 118.03 -0.986 . . . . 0.0 112.846 175.007 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 17' ' ' VAL . 17.7 t -55.42 -47.07 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 CA-C-N 119.864 1.211 . . . . 0.0 110.996 -179.532 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.581 HD11 ' HB3' ' A' ' 169' ' ' LYS . 1.9 mt -55.63 -24.66 34.68 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.067 0.947 . . . . 0.0 113.069 177.641 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -88.2 -61.66 1.47 Allowed Glycine 0 CA--C 1.532 1.097 0 C-N-CA 125.986 1.755 . . . . 0.0 112.633 176.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -62.87 -39.08 93.33 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 118.533 1.167 . . . . 0.0 113.768 -178.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -90.41 1.18 56.87 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.872 1.269 . . . . 0.0 112.124 175.023 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -52.91 96.9 0.02 OUTLIER Glycine 0 CA--C 1.537 1.455 0 C-N-CA 127.047 2.261 . . . . 0.0 114.366 178.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -87.3 -79.93 0.27 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.596 1.558 . . . . 0.0 111.947 178.316 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 23.8 m -87.51 173.07 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.564 1.546 . . . . 0.0 111.793 -177.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 58.0 m -63.29 -26.65 68.87 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 175.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.04 96.49 4.06 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.421 1.088 . . . . 0.0 112.236 176.775 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.415 ' HE2' ' HB3' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -111.32 155.04 23.66 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 128.551 2.74 . . . . 0.0 111.558 -179.71 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -128.21 133.01 67.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 126.328 1.851 . . . . 0.0 108.689 174.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.59 105.69 5.71 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.13 1.772 . . . . 0.0 109.357 175.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.727 HG22 ' HB2' ' A' ' 72' ' ' TYR . 2.0 m -111.28 151.58 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 123.203 0.601 . . . . 0.0 111.13 179.238 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -123.97 111.68 1.68 Allowed Glycine 0 CA--C 1.523 0.567 0 C-N-CA 124.088 0.851 . . . . 0.0 112.912 179.087 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.5 mp -104.59 134.55 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-N 119.018 1.409 . . . . 0.0 110.981 176.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -102.06 102.47 12.97 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 124.714 1.206 . . . . 0.0 110.51 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.9 t30 -73.73 92.47 2.0 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.963 1.305 . . . . 0.0 110.825 175.011 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -121.29 13.05 11.06 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.723 1.209 . . . . 0.0 112.212 175.103 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.8 t -61.81 -42.3 98.85 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.932 1.693 . . . . 0.0 113.87 -176.029 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 130.88 32.48 0.51 Allowed Glycine 0 CA--C 1.533 1.173 0 N-CA-C 115.11 0.804 . . . . 0.0 115.11 178.406 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -178.09 162.19 29.58 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 118.061 0.931 . . . . 0.0 112.852 175.053 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.716 HG22 ' HA ' ' A' ' 65' ' ' PRO . 80.6 p -68.23 129.75 40.86 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 121.858 -0.789 . . . . 0.0 110.999 175.002 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 42.2 m0 -87.04 107.5 18.46 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 123.813 0.845 . . . . 0.0 110.07 179.182 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 92.9 m -91.44 128.72 37.38 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.206 1.002 . . . . 0.0 109.747 177.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.86 131.42 48.71 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 122.823 0.449 . . . . 0.0 111.513 174.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.453 HD11 ' HB3' ' A' ' 90' ' ' ALA . 2.9 pp -113.74 -52.03 2.77 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.729 1.211 . . . . 0.0 111.616 179.719 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -171.73 145.74 2.01 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.343 1.857 . . . . 0.0 110.419 179.053 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.512 ' HB2' HD12 ' A' ' 60' ' ' LEU . . . -125.09 164.32 20.47 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.721 1.208 . . . . 0.0 110.837 174.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -141.9 102.02 4.06 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.157 1.383 . . . . 0.0 111.778 179.084 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.567 ' CE1' ' HB1' ' A' ' 87' ' ' ALA . 3.3 m-85 -110.67 123.91 50.91 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.457 1.103 . . . . 0.0 110.211 -178.283 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.77 -47.1 2.9 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -175.16 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.442 ' HB3' ' HB ' ' A' ' 86' ' ' VAL . 11.6 t -103.5 -48.14 4.06 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.135 1.374 . . . . 0.0 111.038 175.026 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -75.64 12.59 7.85 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 125.393 1.473 . . . . 0.0 114.564 -175.496 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 54.8 p -30.38 105.53 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 129.239 3.016 . . . . 0.0 113.961 -175.286 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.62 HG21 HG23 ' A' ' 59' ' ' ILE . 2.4 t -118.22 175.71 5.57 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.726 1.211 . . . . 0.0 112.171 -175.265 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -74.52 -55.45 5.93 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.516 1.126 . . . . 0.0 112.585 175.249 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.4 p -147.59 143.11 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 126.139 1.776 . . . . 0.0 110.893 175.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.62 HG23 HG21 ' A' ' 56' ' ' THR . 1.3 pp -143.21 -34.01 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 125.779 1.632 . . . . 0.0 113.947 179.045 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.539 ' H ' HD12 ' A' ' 59' ' ' ILE . 7.3 mt -89.66 98.11 1.21 Allowed Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 125.267 1.427 . . . . 0.0 109.135 175.533 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -66.03 148.62 85.83 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 123.887 3.058 . . . . 0.0 110.669 174.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -46.78 -51.15 17.0 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.834 1.254 . . . . 0.0 113.342 -177.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 63.2 t -149.31 139.88 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 128.026 2.531 . . . . 0.0 108.699 177.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.551 HG21 HD23 ' A' ' 70' ' ' LEU . 60.3 t -120.04 125.42 27.34 Favored Pre-proline 0 N--CA 1.473 0.683 0 C-N-CA 124.442 1.097 . . . . 0.0 108.457 175.029 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.716 ' HA ' HG22 ' A' ' 43' ' ' THR . 58.4 Cg_endo -64.45 151.64 84.75 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 121.934 1.756 . . . . 0.0 112.898 175.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -71.52 170.65 12.9 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.549 0.74 . . . . 0.0 109.254 174.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . 0.272 2.7 t 53.67 23.31 3.56 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.612 1.565 . . . . 0.0 113.817 -175.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.3 mttt -134.93 172.93 12.3 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.375 1.87 . . . . 0.0 111.645 -179.031 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -129.43 164.46 23.61 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 -178.062 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.551 HD23 HG21 ' A' ' 64' ' ' VAL . 3.2 pp -137.08 171.14 14.94 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 123.983 0.913 . . . . 0.0 111.078 -175.367 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.496 HD13 ' O ' ' A' ' 34' ' ' VAL . 0.8 OUTLIER -123.44 153.69 40.1 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.497 1.119 . . . . 0.0 111.035 177.033 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.727 ' HB2' HG22 ' A' ' 34' ' ' VAL . 5.8 m-85 -129.46 134.94 48.07 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 126.176 1.791 . . . . 0.0 109.377 176.54 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 59.6 p -107.7 153.87 22.3 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.145 1.778 . . . . 0.0 111.019 175.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.739 ' H ' HD12 ' A' ' 3' ' ' LEU . . . -176.8 131.93 1.94 Allowed Glycine 0 CA--C 1.518 0.257 0 O-C-N 121.196 -0.94 . . . . 0.0 113.017 175.312 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 9.2 ptt85 -129.46 155.16 46.17 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 125.767 1.627 . . . . 0.0 110.491 -175.07 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.9 ptpt -61.97 174.91 0.76 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.509 1.524 . . . . 0.0 112.886 174.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.1 t -127.16 26.7 6.02 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 -175.026 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.0 107.66 1.67 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.788 1.235 . . . . 0.0 111.069 177.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -36.49 -54.05 1.34 Allowed Glycine 0 CA--C 1.548 2.14 0 C-N-CA 125.272 1.415 . . . . 0.0 115.363 174.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.27 -80.8 0.0 OUTLIER 'Trans proline' 0 CA--C 1.548 1.207 0 C-N-CA 123.75 2.967 . . . . 0.0 113.92 177.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.0 m -117.56 108.72 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 127.137 2.175 . . . . 0.0 111.169 -175.032 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -135.89 175.89 9.18 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.746 1.218 . . . . 0.0 112.251 -179.177 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 17.8 p -78.38 139.0 38.8 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.117 0.967 . . . . 0.0 109.4 175.004 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -52.62 -81.38 0.06 OUTLIER Glycine 0 CA--C 1.537 1.411 0 C-N-CA 126.337 1.922 . . . . 0.0 114.021 -175.059 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -160.4 112.86 2.01 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.298 1.439 . . . . 0.0 111.077 175.018 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.442 ' HB ' ' HB3' ' A' ' 53' ' ' SER . 5.0 t -139.16 125.53 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.471 1.109 . . . . 0.0 110.665 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.567 ' HB1' ' CE1' ' A' ' 51' ' ' PHE . . . -161.57 165.62 28.18 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 122.701 1.239 . . . . 0.0 112.063 177.694 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -149.22 146.22 27.5 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 124.913 1.285 . . . . 0.0 108.99 174.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.507 ' CD2' ' CE2' ' A' ' 72' ' ' TYR . 48.8 p90 -144.02 172.72 12.49 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 121.236 -0.915 . . . . 0.0 110.03 176.548 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.453 ' HB3' HD11 ' A' ' 47' ' ' LEU . . . -138.43 149.04 45.08 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 175.754 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -125.41 140.15 53.04 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.632 1.173 . . . . 0.0 113.123 178.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -87.44 122.16 30.81 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.873 -175.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 31.8 mtm -101.73 128.14 48.19 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.495 1.118 . . . . 0.0 110.742 -176.613 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.4 t -56.26 -22.41 29.79 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.936 1.294 . . . . 0.0 113.493 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -67.05 -9.96 44.78 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 125.941 1.696 . . . . 0.0 113.154 175.011 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 101.52 28.3 6.78 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.754 1.645 . . . . 0.0 114.366 177.257 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.43 ' HA ' ' H ' ' A' ' 123' ' ' GLY . 29.0 m-80 -135.44 175.18 9.82 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.857 1.263 . . . . 0.0 112.558 -174.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.575 HG21 ' O ' ' A' ' 125' ' ' ARG . 38.3 m -130.31 108.69 10.2 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.353 1.061 . . . . 0.0 112.683 177.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.5 tt -69.89 94.24 0.82 Allowed 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 127.151 2.18 . . . . 0.0 111.999 177.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -87.21 96.18 2.14 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 125.568 1.556 . . . . 0.0 113.595 178.311 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.411 HG11 ' CZ ' ' A' ' 89' ' ' PHE . 55.5 t -78.07 138.59 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 124.718 1.207 . . . . 0.0 110.827 174.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.33 128.22 31.33 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.581 1.552 . . . . 0.0 110.303 179.156 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.531 ' CZ ' ' HB3' ' A' ' 87' ' ' ALA . 10.3 p90 -148.08 120.31 8.36 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.008 1.323 . . . . 0.0 111.465 -177.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 39.6 t -140.82 129.96 23.48 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.531 1.133 . . . . 0.0 110.22 -175.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.6 m -118.55 148.48 44.23 Favored Pre-proline 0 N--CA 1.471 0.604 0 C-N-CA 124.147 0.979 . . . . 0.0 110.848 178.35 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.433 ' HD3' ' CB ' ' A' ' 114' ' ' ASN . 58.0 Cg_endo -70.26 142.28 45.3 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 123.815 3.01 . . . . 0.0 109.804 -177.784 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -71.19 -50.91 28.19 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -175.026 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -84.12 -11.38 56.71 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.127 1.371 . . . . 0.0 113.169 178.153 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 59.19 28.25 17.49 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 127.587 2.355 . . . . 0.0 115.463 177.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -154.34 147.6 24.86 Favored 'General case' 0 CA--C 1.55 0.957 0 O-C-N 120.79 -1.194 . . . . 0.0 112.048 -175.175 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 22.6 m95 55.03 23.49 5.2 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 125.373 1.469 . . . . 0.0 114.632 175.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -134.74 155.76 50.01 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.597 1.959 . . . . 0.0 112.174 -176.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.63 138.71 31.35 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.342 1.457 . . . . 0.0 110.357 174.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.433 ' CB ' ' HD3' ' A' ' 106' ' ' PRO . 13.1 p-10 -132.95 82.61 2.01 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.25 1.42 . . . . 0.0 112.286 -177.102 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 21.1 m0 -92.67 162.26 14.23 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 121.441 -0.787 . . . . 0.0 111.843 -175.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 40.2 p-90 -160.53 132.38 5.96 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 121.561 -0.712 . . . . 0.0 111.24 -176.388 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -145.87 173.55 12.03 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 121.3 -0.875 . . . . 0.0 111.744 178.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 98.5 t -137.69 133.18 45.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 175.186 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.59 168.2 12.94 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 125.584 1.554 . . . . 0.0 110.244 175.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.693 HD11 HD13 ' A' ' 152' ' ' LEU . 32.3 mt -135.87 121.74 30.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 175.001 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -83.81 145.42 47.03 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 123.311 0.644 . . . . 0.0 111.289 178.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -76.23 83.74 1.96 Allowed 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 124.133 3.222 . . . . 0.0 111.929 179.15 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.43 ' H ' ' HA ' ' A' ' 97' ' ' ASN . . . 101.45 175.53 28.61 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 126.494 1.997 . . . . 0.0 112.811 -177.439 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 1.3 mttt -45.01 106.67 0.08 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 126.47 1.908 . . . . 0.0 112.737 -176.372 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.575 ' O ' HG21 ' A' ' 98' ' ' THR . 7.9 tpt180 -141.37 138.21 32.87 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.48 1.112 . . . . 0.0 113.402 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -80.4 173.69 12.35 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.722 0.809 . . . . 0.0 110.729 174.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -117.01 104.86 11.69 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.149 1.779 . . . . 0.0 107.028 175.034 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -108.0 169.94 8.3 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.385 1.074 . . . . 0.0 111.831 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -53.38 -45.83 69.39 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.535 0.734 . . . . 0.0 112.827 177.567 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -54.58 -56.05 24.1 Favored Glycine 0 N--CA 1.469 0.836 0 CA-C-O 119.38 -0.678 . . . . 0.0 112.239 176.604 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 4.1 mpp? -63.76 -33.65 76.12 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 118.533 1.167 . . . . 0.0 113.376 176.083 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -61.39 -61.56 2.45 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 119.642 1.11 . . . . 0.0 108.958 175.013 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -62.45 -43.86 97.81 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.178 0.991 . . . . 0.0 112.526 -176.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -62.81 -45.67 91.57 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.626 1.17 . . . . 0.0 111.711 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.23 -33.33 59.22 Favored 'General case' 0 CA--C 1.547 0.829 0 O-C-N 120.468 -1.395 . . . . 0.0 112.752 176.625 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -54.2 -60.38 3.41 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 126.587 1.955 . . . . 0.0 109.758 175.077 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -72.65 4.45 3.97 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-O 121.726 0.774 . . . . 0.0 112.596 -176.394 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -101.57 -7.75 47.75 Favored Glycine 0 CA--C 1.541 1.678 0 C-N-CA 126.964 2.221 . . . . 0.0 114.975 175.118 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -144.06 88.61 7.45 Favored Pre-proline 0 CA--C 1.553 1.059 0 CA-C-N 119.897 1.849 . . . . 0.0 113.268 -178.272 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -73.51 81.36 1.82 Allowed 'Trans proline' 0 CA--C 1.545 1.056 0 C-N-CA 124.096 3.197 . . . . 0.0 113.024 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -104.22 9.95 35.89 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.894 1.277 . . . . 0.0 114.337 -178.026 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 28.4 ptt85 -29.97 119.93 0.17 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 129.03 2.932 . . . . 0.0 115.728 175.039 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 39.25 68.4 0.5 Allowed Glycine 0 N--CA 1.468 0.804 0 C-N-CA 126.31 1.909 . . . . 0.0 112.151 -175.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.91 -24.4 37.41 Favored 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -174.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . 0.267 0.2 OUTLIER 13.93 72.18 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 130.766 3.626 . . . . 0.0 116.349 177.959 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 154.39 42.79 0.02 OUTLIER Glycine 0 CA--C 1.532 1.118 0 C-N-CA 123.865 0.745 . . . . 0.0 114.576 178.246 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' TRP . . . . . 0.834 ' H ' HD13 ' A' ' 161' ' ' ILE . 0.1 OUTLIER 49.79 48.55 21.51 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 125.434 1.494 . . . . 0.0 113.035 -176.836 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -91.31 134.27 34.73 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 122.325 1.059 . . . . 0.0 113.026 -174.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -156.52 -177.19 6.41 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.067 0.947 . . . . 0.0 112.884 -174.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 21.1 ttpp -131.97 148.13 52.5 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.753 1.221 . . . . 0.0 110.905 174.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -63.75 149.53 46.56 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 175.001 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.693 HD13 HD11 ' A' ' 120' ' ' ILE . 98.7 mt -107.9 145.26 34.01 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 175.005 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -64.48 -165.67 1.02 Allowed Glycine 0 CA--C 1.538 1.47 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 175.31 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 54.5 11.2 0.4 Allowed 'General case' 0 CA--C 1.557 1.242 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 175.27 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 81.33 40.9 10.62 Favored Glycine 0 CA--C 1.539 1.562 0 C-N-CA 126.557 2.027 . . . . 0.0 114.424 -175.007 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.2 mp -124.82 162.19 24.85 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 119.267 1.533 . . . . 0.0 112.813 -178.459 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -150.63 118.48 6.21 Favored 'General case' 0 N--CA 1.482 1.128 0 O-C-N 120.691 -1.256 . . . . 0.0 111.594 176.007 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 6.6 ttp -111.3 130.85 55.54 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 118.108 -0.949 . . . . 0.0 109.093 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 6.3 tppt? -106.9 134.14 50.5 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 127.681 2.393 . . . . 0.0 110.089 -179.211 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -136.41 152.31 21.14 Favored Glycine 0 N--CA 1.476 1.34 0 CA-C-N 121.208 1.822 . . . . 0.0 115.79 179.498 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.834 HD13 ' H ' ' A' ' 147' ' ' TRP . 6.1 tp -148.66 122.42 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 125.134 1.374 . . . . 0.0 113.332 -177.712 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 5.3 ttp -153.61 145.37 23.43 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 128.968 2.907 . . . . 0.0 109.589 177.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 9.6 t -120.22 146.3 46.18 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 120.87 -1.144 . . . . 0.0 109.778 175.366 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 28.8 p -91.34 18.96 6.45 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.305 1.442 . . . . 0.0 113.29 -178.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.8 -33.73 64.66 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.012 1.725 . . . . 0.0 115.005 -176.335 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 157.8 -62.76 0.32 Allowed Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.534 1.064 . . . . 0.0 114.17 176.27 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -125.25 27.02 6.73 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 125.652 1.581 . . . . 0.0 112.656 -174.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.87 175.66 2.37 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.28 1.432 . . . . 0.0 113.388 175.008 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.581 ' HB3' HD11 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -115.78 178.81 4.17 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 127.453 2.301 . . . . 0.0 111.914 -177.814 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 40.2 ttp -126.89 137.89 53.22 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 125.381 1.473 . . . . 0.0 109.825 178.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.404 ' C ' HD12 ' A' ' 172' ' ' ILE . 5.8 tt0 -143.08 131.9 22.72 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 121.562 -0.711 . . . . 0.0 109.657 174.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.404 HD12 ' C ' ' A' ' 171' ' ' GLN . 3.8 mp -129.79 120.87 51.12 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.296 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 176.401 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -115.82 129.91 56.63 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 125.232 1.413 . . . . 0.0 111.125 177.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.8 mp -78.94 131.84 33.5 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 O-C-N 121.064 -1.023 . . . . 0.0 109.398 174.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 13.8 m -137.66 94.03 2.86 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.497 1.519 . . . . 0.0 113.116 176.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 79.0 mtp180 . . . . . 0 C--O 1.253 1.272 0 C-N-CA 125.544 1.538 . . . . 0.0 112.433 174.972 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 7.9 t . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 122.009 0.909 . . . . 0.0 110.887 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -131.91 -73.37 0.52 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.418 1.487 . . . . 0.0 110.042 -179.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.652 HD11 ' HB2' ' A' ' 31' ' ' LYS . 17.1 tp 55.5 17.37 2.2 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 125.958 1.703 . . . . 0.0 114.45 -177.439 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -136.53 130.27 32.19 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 128.037 2.535 . . . . 0.0 107.087 176.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.406 ' H ' ' HG ' ' A' ' 71' ' ' LEU . . . -73.08 -126.49 0.1 OUTLIER Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.171 0.891 . . . . 0.0 111.2 174.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 25.4 p -101.95 174.64 5.85 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.389 1.076 . . . . 0.0 111.413 177.095 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -124.65 16.07 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 125.498 1.519 . . . . 0.0 110.971 175.007 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.9 pp -55.05 165.57 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 125.352 1.461 . . . . 0.0 112.111 174.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -40.99 130.16 2.66 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.727 1.611 . . . . 0.0 113.246 -174.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -54.77 -21.14 21.55 Favored Glycine 0 N--CA 1.472 1.097 0 C-N-CA 124.766 1.174 . . . . 0.0 114.456 -177.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.75 -31.87 68.73 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.65 1.18 . . . . 0.0 111.306 174.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.63 -43.24 5.42 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.392 1.477 . . . . 0.0 111.602 174.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.427 HD23 ' HB3' ' A' ' 69' ' ' ALA . 14.3 tp -71.26 94.22 1.17 Allowed 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.902 0.858 . . . . 0.0 110.849 174.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.0 p -131.42 -179.92 5.65 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 126.982 2.113 . . . . 0.0 111.899 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -46.91 -39.99 13.28 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.55 1.54 . . . . 0.0 113.051 177.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -54.85 -39.51 68.68 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.448 1.099 . . . . 0.0 112.077 177.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.4 ' O ' HG23 ' A' ' 21' ' ' VAL . 65.2 t -70.45 -36.92 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 125.862 1.665 . . . . 0.0 111.182 174.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.408 ' CD2' HD21 ' A' ' 71' ' ' LEU . 9.2 mt -71.1 -43.13 68.31 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 120.965 -1.084 . . . . 0.0 111.249 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -58.34 -47.06 84.97 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.459 1.104 . . . . 0.0 111.308 178.468 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.68 -37.71 82.71 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 118.15 -0.929 . . . . 0.0 111.953 175.069 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 17' ' ' VAL . 16.2 t -54.36 -42.47 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 CA-C-N 119.923 1.238 . . . . 0.0 111.26 179.091 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.6 mt -58.65 -17.33 21.47 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.397 1.079 . . . . 0.0 113.845 177.201 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -105.38 -45.05 1.38 Allowed Glycine 0 CA--C 1.536 1.395 0 C-N-CA 126.992 2.234 . . . . 0.0 114.05 -179.474 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -67.82 -31.82 71.93 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 119.134 1.467 . . . . 0.0 112.725 175.029 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -101.66 173.33 6.46 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 125.181 1.392 . . . . 0.0 111.049 174.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 154.02 86.72 0.06 OUTLIER Glycine 0 CA--C 1.534 1.252 0 C-N-CA 124.332 0.967 . . . . 0.0 113.827 -178.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.5 mtpt -67.9 -46.11 72.52 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.714 1.206 . . . . 0.0 112.966 176.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 33.4 m -133.64 -176.96 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 126.799 2.04 . . . . 0.0 111.596 -178.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.9 m -47.28 -46.44 24.82 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 126.436 1.894 . . . . 0.0 115.123 -178.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.429 ' CB ' ' HE3' ' A' ' 76' ' ' LYS . 0.1 OUTLIER -128.91 146.02 51.06 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.534 1.133 . . . . 0.0 110.541 174.963 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.652 ' HB2' HD11 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -143.81 161.18 39.29 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 124.466 1.106 . . . . 0.0 111.62 -175.855 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.428 HD12 ' CG1' ' A' ' 34' ' ' VAL . 0.3 OUTLIER -120.08 133.28 67.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 124.78 1.232 . . . . 0.0 108.999 175.007 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -136.0 100.93 4.57 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.131 1.772 . . . . 0.0 109.065 175.01 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.91 HG22 ' HB2' ' A' ' 72' ' ' TYR . 1.5 m -103.97 161.44 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 123.859 0.864 . . . . 0.0 111.728 178.687 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -140.62 101.05 0.28 Allowed Glycine 0 N--CA 1.461 0.361 0 C-N-CA 123.613 0.625 . . . . 0.0 113.156 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 mp -93.98 151.11 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 117.91 0.855 . . . . 0.0 110.761 175.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -116.42 104.43 11.44 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.327 1.051 . . . . 0.0 110.822 174.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -72.62 98.84 2.42 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.743 1.617 . . . . 0.0 111.05 174.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -135.31 22.63 3.45 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.971 1.309 . . . . 0.0 110.444 174.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 33.1 t -61.79 -42.69 99.31 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 120.788 -1.195 . . . . 0.0 112.749 174.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 132.35 33.97 0.38 Allowed Glycine 0 CA--C 1.534 1.244 0 C-N-CA 124.375 0.988 . . . . 0.0 115.181 176.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -174.52 162.28 32.4 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 124.673 1.13 . . . . 0.0 112.094 175.235 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.711 HG22 ' HA ' ' A' ' 65' ' ' PRO . 50.4 p -70.42 139.32 51.79 Favored 'General case' 0 C--O 1.234 0.261 0 O-C-N 121.782 -0.834 . . . . 0.0 110.893 174.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.43 ' HB3' ' CD1' ' A' ' 91' ' ' TYR . 40.2 m0 -96.05 104.14 16.07 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 124.172 0.989 . . . . 0.0 110.767 -178.511 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.9 m -87.36 139.29 30.7 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.019 1.328 . . . . 0.0 110.539 178.401 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.74 131.44 48.9 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.456 0.702 . . . . 0.0 111.249 174.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.701 HD11 ' HB3' ' A' ' 90' ' ' ALA . 4.6 pp -120.2 -48.36 2.33 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.029 0.931 . . . . 0.0 112.854 177.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.502 ' N ' HD12 ' A' ' 47' ' ' LEU . 0.2 OUTLIER 178.36 153.88 0.35 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 127.189 2.196 . . . . 0.0 110.378 -175.167 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -138.67 164.78 28.64 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.497 1.519 . . . . 0.0 111.215 174.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -136.7 102.87 5.03 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 125.309 1.443 . . . . 0.0 110.092 176.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.549 ' CE1' ' HB1' ' A' ' 87' ' ' ALA . 3.0 m-85 -111.03 131.43 55.06 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.719 0.808 . . . . 0.0 109.962 -179.275 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.38 -33.16 4.16 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -177.551 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 33.9 t -125.43 -46.62 1.75 Allowed 'General case' 0 C--O 1.219 -0.541 0 C-N-CA 124.961 1.304 . . . . 0.0 109.202 174.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -60.35 -0.15 1.14 Allowed Glycine 0 CA--C 1.544 1.868 0 O-C-N 119.586 -1.946 . . . . 0.0 116.449 176.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.1 p -27.15 89.01 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 130.97 3.708 . . . . 0.0 114.564 -175.043 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.676 HG21 HG23 ' A' ' 59' ' ' ILE . 0.7 OUTLIER -105.28 175.2 5.57 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.928 -174.911 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -73.17 -56.16 5.49 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.388 1.075 . . . . 0.0 111.127 174.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.4 p -144.44 137.69 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 125.806 1.643 . . . . 0.0 112.021 176.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.676 HG23 HG21 ' A' ' 56' ' ' THR . 1.2 pp -135.82 -33.58 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 125.885 1.674 . . . . 0.0 114.298 176.5 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.415 ' H ' HD12 ' A' ' 59' ' ' ILE . 16.0 mt -89.09 100.32 2.09 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 125.312 1.445 . . . . 0.0 109.34 176.806 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.506 ' HG2' HG23 ' A' ' 64' ' ' VAL . 90.8 Cg_endo -65.43 154.64 72.72 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.38 2.72 . . . . 0.0 109.27 175.06 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -45.02 -50.98 10.44 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.504 1.522 . . . . 0.0 113.415 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.7 p -160.17 137.77 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 127.053 2.141 . . . . 0.0 109.612 176.182 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.635 HG21 HD13 ' A' ' 70' ' ' LEU . 94.6 t -113.56 130.75 23.44 Favored Pre-proline 0 N--CA 1.482 1.128 0 C-N-CA 124.495 1.118 . . . . 0.0 109.311 175.162 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.711 ' HA ' HG22 ' A' ' 43' ' ' THR . 59.9 Cg_endo -65.37 161.65 37.01 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 122.469 2.112 . . . . 0.0 112.801 177.71 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -76.69 170.51 16.3 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.83 0.852 . . . . 0.0 109.897 174.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . 0.266 10.7 t 46.95 30.55 1.27 Allowed 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 126.892 2.077 . . . . 0.0 113.376 -174.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.9 mttt -135.78 171.94 13.73 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 127.262 2.225 . . . . 0.0 111.821 -174.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.427 ' HB3' HD23 ' A' ' 13' ' ' LEU . . . -128.63 166.08 19.57 Favored 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 122.77 0.428 . . . . 0.0 110.245 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.635 HD13 HG21 ' A' ' 64' ' ' VAL . 2.0 pt? -143.78 171.07 14.72 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 124.617 1.167 . . . . 0.0 111.656 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.536 HD13 ' O ' ' A' ' 34' ' ' VAL . 0.6 OUTLIER -117.66 156.1 28.76 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.442 1.097 . . . . 0.0 112.503 177.566 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.91 ' HB2' HG22 ' A' ' 34' ' ' VAL . 7.5 m-85 -128.03 134.39 49.21 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.72 1.608 . . . . 0.0 109.103 174.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.1 p -108.08 142.76 37.78 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 126.831 2.053 . . . . 0.0 110.741 176.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -163.79 142.68 8.0 Favored Glycine 0 N--CA 1.461 0.326 0 O-C-N 120.514 -1.366 . . . . 0.0 111.898 174.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 3.8 ptm180 -129.26 104.33 7.46 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.289 1.436 . . . . 0.0 111.353 -174.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.515 ' HE2' ' O ' ' A' ' 83' ' ' THR . 2.6 ptpt -29.91 -70.07 0.06 Allowed 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 127.492 2.317 . . . . 0.0 114.597 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 11.5 t 17.79 54.02 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 128.57 2.748 . . . . 0.0 114.837 175.042 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.87 -24.81 67.99 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 121.371 -0.831 . . . . 0.0 112.61 -174.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 120.31 -76.44 0.32 Allowed Glycine 0 CA--C 1.531 1.047 0 C-N-CA 127.042 2.258 . . . . 0.0 110.613 175.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.84 -35.18 3.48 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 123.204 2.603 . . . . 0.0 113.169 -178.472 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 26.8 m -137.29 129.01 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 126.52 1.928 . . . . 0.0 109.68 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -77.0 76.22 3.56 Favored 'General case' 0 CA--C 1.549 0.939 0 O-C-N 121.015 -1.053 . . . . 0.0 111.826 -178.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.515 ' O ' ' HE2' ' A' ' 76' ' ' LYS . 3.7 m -59.22 174.33 0.4 Allowed 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 127.869 2.468 . . . . 0.0 112.811 -177.243 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.479 ' H ' HG22 ' A' ' 83' ' ' THR . . . -78.65 -154.27 7.58 Favored Glycine 0 N--CA 1.47 0.934 0 O-C-N 119.741 -1.849 . . . . 0.0 113.323 176.735 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.566 ' HB3' HG22 ' A' ' 105' ' ' VAL . . . -94.7 97.98 10.46 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.081 -1.247 . . . . 0.0 110.526 -179.387 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.9 t -124.76 107.15 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 124.299 1.04 . . . . 0.0 110.578 -175.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.549 ' HB1' ' CE1' ' A' ' 51' ' ' PHE . . . -159.94 167.57 27.68 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.867 0.842 . . . . 0.0 111.494 178.532 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -150.86 159.8 44.31 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.758 1.223 . . . . 0.0 109.937 175.005 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.476 ' CD2' ' CE2' ' A' ' 72' ' ' TYR . 52.9 p90 -155.78 174.55 15.14 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 121.422 -0.799 . . . . 0.0 110.554 175.028 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.701 ' HB3' HD11 ' A' ' 47' ' ' LEU . . . -138.65 151.34 47.13 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 176.412 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.43 ' CD1' ' HB3' ' A' ' 44' ' ' TRP . 10.4 m-85 -126.3 140.11 52.78 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.38 1.072 . . . . 0.0 113.789 179.164 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -84.59 118.73 24.53 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 111.592 0.219 . . . . 0.0 111.592 -177.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 4.7 ttm -86.97 147.0 25.93 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.776 0.831 . . . . 0.0 112.31 177.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 24.6 m -67.1 -23.96 65.89 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 174.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -70.5 -17.39 62.96 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 175.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 100.71 40.13 3.0 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.845 1.212 . . . . 0.0 113.412 -175.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -135.5 175.1 9.9 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 118.382 1.091 . . . . 0.0 110.476 177.407 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.56 HG23 HD21 ' A' ' 47' ' ' LEU . 12.4 m -129.49 106.15 8.57 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.026 1.331 . . . . 0.0 111.946 -177.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.2 tt -70.79 96.35 1.24 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.699 1.6 . . . . 0.0 112.154 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -91.87 95.43 2.04 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 126.065 1.793 . . . . 0.0 113.876 -178.239 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 72.5 t -78.08 138.18 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 125.211 1.405 . . . . 0.0 111.444 176.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.6 126.54 29.43 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.367 1.467 . . . . 0.0 111.383 -178.359 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -146.64 121.79 10.15 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.0 1.32 . . . . 0.0 112.016 -177.113 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 47.1 t -142.45 109.73 5.63 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.657 1.183 . . . . 0.0 110.039 -178.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.566 HG22 ' HB3' ' A' ' 85' ' ' ALA . 17.5 m -118.51 110.91 38.46 Favored Pre-proline 0 N--CA 1.469 0.523 0 C-N-CA 124.831 1.252 . . . . 0.0 108.365 175.003 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.2 136.6 37.96 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 122.389 2.059 . . . . 0.0 110.689 177.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -78.61 -43.54 26.13 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 120.808 -1.183 . . . . 0.0 110.526 174.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.1 p30 -67.62 9.75 0.24 Allowed 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 126.706 2.003 . . . . 0.0 115.922 -174.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -10.42 85.0 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 130.174 3.39 . . . . 0.0 115.303 -178.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -121.61 -10.3 8.81 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.015 1.326 . . . . 0.0 113.287 -178.24 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 21.8 m95 -130.47 -12.69 3.91 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.67 1.988 . . . . 0.0 113.876 -175.022 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 58.23 49.75 10.75 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.156 1.782 . . . . 0.0 113.522 -178.335 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 45.1 p -125.47 91.19 3.36 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.197 1.799 . . . . 0.0 112.24 -178.124 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -121.87 101.53 7.62 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.132 1.773 . . . . 0.0 109.138 175.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 32.0 m0 -102.52 144.98 30.26 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.398 0.679 . . . . 0.0 109.94 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 27.4 p-90 -146.77 138.53 24.5 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.119 0.968 . . . . 0.0 111.978 -177.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -149.31 170.05 19.4 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 122.285 1.041 . . . . 0.0 113.072 179.115 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.3 t -150.27 139.31 15.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 C-N-CA 125.226 1.41 . . . . 0.0 107.655 175.008 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.79 175.44 10.18 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 126.27 1.828 . . . . 0.0 109.72 175.626 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.458 ' HB ' ' CE2' ' A' ' 154' ' ' TYR . 50.9 mt -130.56 105.74 11.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.953 0.882 . . . . 0.0 108.967 178.196 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -67.38 149.54 98.34 Favored Pre-proline 0 CA--C 1.546 0.793 0 O-C-N 121.522 -0.736 . . . . 0.0 111.842 178.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.6 131.73 17.8 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 123.212 2.608 . . . . 0.0 111.727 178.293 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 61.86 -165.99 18.75 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 124.549 1.071 . . . . 0.0 113.9 -176.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -67.89 110.78 4.0 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.654 1.182 . . . . 0.0 108.985 175.004 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 20.0 tpp180 -123.32 157.84 32.34 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.692 1.597 . . . . 0.0 110.066 178.221 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -96.99 -173.72 2.77 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.261 1.424 . . . . 0.0 110.397 174.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -138.58 121.45 16.55 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 127.317 2.247 . . . . 0.0 106.504 174.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -132.68 169.69 16.3 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.579 1.552 . . . . 0.0 110.016 175.156 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -52.71 -39.9 62.48 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.337 1.055 . . . . 0.0 113.086 176.386 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -59.03 -53.64 44.72 Favored Glycine 0 N--CA 1.469 0.853 0 CA-C-N 118.875 0.761 . . . . 0.0 112.094 176.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 1.2 mpp? -61.48 -42.97 99.6 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 118.036 0.918 . . . . 0.0 112.049 176.413 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -54.0 -58.44 7.29 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.381 0.672 . . . . 0.0 110.171 175.015 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -65.85 -38.07 87.87 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 -177.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -61.73 -45.3 94.53 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.55 1.14 . . . . 0.0 112.096 178.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 73.8 mmm -79.17 -32.59 44.29 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.351 -0.843 . . . . 0.0 112.879 176.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -54.08 -59.08 5.12 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.772 1.629 . . . . 0.0 109.511 174.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -71.24 -6.06 36.79 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -176.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -88.42 -9.27 69.78 Favored Glycine 0 CA--C 1.539 1.59 0 C-N-CA 126.292 1.901 . . . . 0.0 114.937 177.064 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -144.14 86.72 8.22 Favored Pre-proline 0 CA--C 1.553 1.058 0 CA-C-N 119.448 1.624 . . . . 0.0 111.89 -179.519 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -74.0 79.21 2.38 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 123.643 2.895 . . . . 0.0 112.274 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -119.07 126.21 51.14 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.287 1.435 . . . . 0.0 111.044 -176.793 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.1 ptt180 -99.17 -162.63 0.97 Allowed 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 127.285 2.234 . . . . 0.0 113.74 -175.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -71.95 62.27 1.31 Allowed Glycine 0 CA--C 1.538 1.471 0 C-N-CA 126.421 1.962 . . . . 0.0 113.72 175.292 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 10.1 p30 -67.49 74.99 0.16 Allowed 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 130.163 3.385 . . . . 0.0 114.796 177.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -70.29 62.83 0.23 Allowed 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 126.948 2.099 . . . . 0.0 114.875 -175.024 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -169.66 31.44 0.16 Allowed Glycine 0 CA--C 1.536 1.355 0 C-N-CA 124.536 1.065 . . . . 0.0 115.709 -175.461 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 5.1 m95 53.88 56.53 7.01 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.31 1.444 . . . . 0.0 113.154 -174.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -89.68 131.14 35.81 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.661 1.584 . . . . 0.0 112.613 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -160.12 -175.8 5.28 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -174.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 4.8 mtmt -130.19 160.38 33.99 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.159 1.384 . . . . 0.0 110.711 174.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -80.07 131.78 35.84 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.848 0.859 . . . . 0.0 108.918 175.01 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 78.2 mt -83.99 127.38 33.83 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.479 0.712 . . . . 0.0 110.599 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -51.74 -27.45 19.91 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 126.063 1.792 . . . . 0.0 116.49 -174.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.458 ' CE2' ' HB ' ' A' ' 120' ' ' ILE . 0.2 OUTLIER -74.95 6.88 3.63 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 128.076 2.55 . . . . 0.0 113.621 -179.459 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 84.58 10.58 79.24 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 125.602 1.572 . . . . 0.0 114.194 -175.01 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 17.5 mt -96.54 171.48 8.52 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.33 1.852 . . . . 0.0 110.475 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 3.4 mtt-85 -146.05 107.39 4.21 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 120.973 -1.08 . . . . 0.0 110.225 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 9.3 ttp -98.73 131.07 45.17 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 117.795 -1.098 . . . . 0.0 108.327 178.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 1.5 tppp? -109.44 129.41 55.55 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 127.915 2.486 . . . . 0.0 110.149 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -135.17 154.42 21.6 Favored Glycine 0 N--CA 1.474 1.197 0 CA-C-N 121.17 1.804 . . . . 0.0 115.562 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.31 129.42 6.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 C-N-CA 124.282 1.033 . . . . 0.0 112.402 -178.837 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -146.62 160.69 41.86 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 126.975 2.11 . . . . 0.0 109.554 175.001 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 9.4 t -131.38 168.76 17.03 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.589 1.155 . . . . 0.0 108.99 175.004 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 4.3 t -111.67 28.92 8.3 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.022 1.329 . . . . 0.0 111.414 178.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -67.65 21.76 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 127.77 2.428 . . . . 0.0 115.028 179.07 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 80.6 -59.51 4.65 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 126.641 2.067 . . . . 0.0 113.168 -178.299 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -116.39 65.36 0.71 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.072 1.749 . . . . 0.0 110.313 176.153 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.19 179.01 7.84 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 121.915 0.864 . . . . 0.0 111.708 174.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.3 176.84 5.64 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.456 1.902 . . . . 0.0 110.108 175.001 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 2.3 tmm? -125.51 125.59 43.5 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.918 1.287 . . . . 0.0 110.395 175.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 17.5 tt0 -138.11 124.59 20.72 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 123.772 0.829 . . . . 0.0 110.529 176.519 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 5.0 mp -132.66 119.71 39.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 123.974 0.91 . . . . 0.0 110.508 176.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.63 134.39 55.1 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.488 1.515 . . . . 0.0 111.939 177.606 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.8 mp -82.35 127.01 40.03 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 O-C-N 121.019 -1.05 . . . . 0.0 108.633 175.022 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 1.7 m -126.3 93.48 3.82 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.524 1.53 . . . . 0.0 111.499 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 80.0 mtm-85 . . . . . 0 C--O 1.253 1.27 0 C-N-CA 124.509 1.124 . . . . 0.0 113.214 176.528 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.483 1.192 0 CA-C-O 117.785 -1.103 . . . . 0.0 109.332 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.668 ' HG2' HD12 ' A' ' 25' ' ' LEU . 0.7 OUTLIER -60.04 -172.63 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 125.034 1.334 . . . . 0.0 113.366 -179.431 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.81 HD12 ' H ' ' A' ' 74' ' ' GLY . 0.2 OUTLIER -120.71 30.06 7.09 Favored 'General case' 0 N--CA 1.483 1.204 0 O-C-N 120.603 -1.311 . . . . 0.0 111.999 179.991 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.41 ' HA ' HD12 ' A' ' 71' ' ' LEU . . . -144.58 121.2 11.12 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.856 2.062 . . . . 0.0 109.833 -175.538 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -73.91 -92.45 0.13 Allowed Glycine 0 CA--C 1.531 1.052 0 C-N-CA 123.988 0.804 . . . . 0.0 112.917 -176.283 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 41.0 p -141.4 173.61 11.33 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.544 1.538 . . . . 0.0 111.079 177.034 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -120.42 10.35 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 125.623 1.569 . . . . 0.0 112.213 -178.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -29.05 -77.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 127.627 2.371 . . . . 0.0 115.014 -176.481 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -158.2 147.55 19.51 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.56 1.944 . . . . 0.0 110.745 175.012 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -64.3 -26.96 70.96 Favored Glycine 0 N--CA 1.476 1.304 0 C-N-CA 124.592 1.091 . . . . 0.0 115.474 -178.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.43 -35.11 73.41 Favored 'General case' 0 CA--C 1.546 0.816 0 O-C-N 121.755 -0.85 . . . . 0.0 111.789 175.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.4 t -96.2 -37.89 10.36 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.082 1.353 . . . . 0.0 111.611 174.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.528 HD11 ' CD2' ' A' ' 71' ' ' LEU . 58.2 tp -82.77 84.41 7.35 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.651 1.981 . . . . 0.0 111.977 176.377 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.4 p -120.55 178.8 4.54 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 126.595 1.958 . . . . 0.0 111.396 175.047 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -40.14 -44.63 1.85 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.768 1.627 . . . . 0.0 113.474 175.196 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -52.92 -44.66 67.16 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 118.801 0.728 . . . . 0.0 112.154 178.074 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 93.1 t -64.54 -40.77 90.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 124.546 1.138 . . . . 0.0 111.135 175.034 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.475 ' CD2' HD21 ' A' ' 71' ' ' LEU . 39.4 mt -66.82 -38.12 85.83 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.355 -0.841 . . . . 0.0 111.593 178.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -68.16 -47.69 67.33 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 120.94 -1.1 . . . . 0.0 111.624 177.292 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.92 -37.51 87.29 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-O 118.594 -0.717 . . . . 0.0 111.495 175.045 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.445 HG22 ' HB2' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -62.84 -36.33 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 119.15 0.886 . . . . 0.0 111.159 -176.104 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.416 HD12 ' HB3' ' A' ' 33' ' ' ALA . 0.3 OUTLIER -56.28 -25.41 48.12 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 119.112 0.869 . . . . 0.0 112.413 175.076 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -81.87 -65.3 1.67 Allowed Glycine 0 CA--C 1.533 1.179 0 O-C-N 120.603 -1.311 . . . . 0.0 112.173 174.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -66.65 -35.6 80.55 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 115.149 1.537 . . . . 0.0 115.149 -175.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.668 HD12 ' HG2' ' A' ' 2' ' ' GLU . 3.3 mm? -106.42 104.77 14.54 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 126.76 2.024 . . . . 0.0 108.358 -177.13 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -161.59 135.4 3.91 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 125.243 1.401 . . . . 0.0 114.381 -175.02 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.2 mtpt -112.35 -45.99 3.22 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 126.437 1.895 . . . . 0.0 113.286 177.362 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 20.8 m -116.9 177.96 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 126.202 1.801 . . . . 0.0 110.929 -176.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.6 t -51.86 -49.46 62.86 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.896 1.279 . . . . 0.0 112.909 -175.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.9 mtt-85 -122.86 129.34 51.53 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.751 1.62 . . . . 0.0 110.527 174.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.603 ' HB2' HD13 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -118.38 157.45 27.14 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 126.12 1.768 . . . . 0.0 110.665 179.894 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.682 HG13 ' HB1' ' A' ' 85' ' ' ALA . 0.3 OUTLIER -118.25 130.78 72.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 175.045 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.416 ' HB3' HD12 ' A' ' 22' ' ' LEU . . . -134.77 99.44 4.32 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 126.75 2.02 . . . . 0.0 109.232 178.685 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.838 HG22 ' HB2' ' A' ' 72' ' ' TYR . 1.8 m -100.9 160.23 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-O 118.489 -0.767 . . . . 0.0 111.249 179.161 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -137.4 109.44 0.7 Allowed Glycine 0 N--CA 1.464 0.538 0 CA-C-N 119.112 0.869 . . . . 0.0 114.215 175.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.3 mp -100.66 145.57 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 CA-C-N 118.639 1.22 . . . . 0.0 110.722 176.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.419 ' HB3' ' HA ' ' A' ' 173' ' ' LYS . 24.7 t0 -108.55 105.86 15.68 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.905 1.282 . . . . 0.0 110.495 175.532 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -69.97 96.66 1.05 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.534 1.534 . . . . 0.0 111.222 175.052 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -126.56 3.43 6.85 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.26 1.824 . . . . 0.0 112.837 176.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.87 4.71 0.16 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 126.087 1.755 . . . . 0.0 115.663 177.086 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.01 61.96 4.28 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 125.977 1.751 . . . . 0.0 113.166 177.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 165.19 143.42 3.72 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 125.229 1.395 . . . . 0.0 111.079 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.753 HG22 ' HA ' ' A' ' 65' ' ' PRO . 31.9 p -67.15 142.57 57.0 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.682 0.753 . . . . 0.0 111.302 174.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.435 ' CZ2' ' CD2' ' A' ' 99' ' ' LEU . 48.6 m0 -101.97 102.66 13.22 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.627 1.171 . . . . 0.0 110.502 -179.477 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 28.0 m -90.27 128.63 36.46 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.01 0.924 . . . . 0.0 109.436 177.566 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.8 108.69 0.69 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.934 0.894 . . . . 0.0 112.429 175.282 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.545 HD12 ' HB3' ' A' ' 48' ' ' ASN . 3.1 pp -93.38 -45.7 7.68 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.637 0.775 . . . . 0.0 111.799 178.189 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.545 ' HB3' HD12 ' A' ' 47' ' ' LEU . 5.1 t30 -171.6 146.13 2.13 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 127.22 2.208 . . . . 0.0 110.294 179.254 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.673 ' HB2' HD22 ' A' ' 60' ' ' LEU . . . -134.99 151.27 50.67 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.346 1.458 . . . . 0.0 110.981 175.029 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -139.19 109.78 6.63 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.189 1.396 . . . . 0.0 112.013 -175.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.506 ' CD1' ' HB1' ' A' ' 87' ' ' ALA . 3.1 m-85 -106.66 127.75 53.62 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 120.991 -1.068 . . . . 0.0 111.142 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -88.76 -68.32 0.78 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.508 1.523 . . . . 0.0 111.178 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 32.5 t -107.46 -35.29 6.8 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.989 1.315 . . . . 0.0 112.16 -174.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -61.91 -26.41 67.16 Favored Glycine 0 CA--C 1.536 1.36 0 CA-C-O 118.831 -0.983 . . . . 0.0 114.02 177.024 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.5 p 21.14 55.13 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 128.046 2.538 . . . . 0.0 116.128 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.433 HG21 HG23 ' A' ' 59' ' ' ILE . 3.9 t -75.89 173.24 11.45 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.16 -175.676 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -82.21 -51.91 7.48 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.388 0.675 . . . . 0.0 112.084 176.177 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.5 p -148.18 135.82 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.08 1.352 . . . . 0.0 112.217 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.433 HG23 HG21 ' A' ' 56' ' ' THR . 1.0 OUTLIER -143.42 -32.09 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 126.059 1.744 . . . . 0.0 113.816 -175.595 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.673 HD22 ' HB2' ' A' ' 49' ' ' ALA . 1.0 OUTLIER -94.69 96.88 2.07 Favored Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 125.748 1.619 . . . . 0.0 109.256 177.823 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.44 ' HG2' HG23 ' A' ' 64' ' ' VAL . 77.6 Cg_endo -64.49 157.84 52.81 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.809 2.339 . . . . 0.0 110.404 175.037 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -45.22 -49.96 11.94 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.723 1.609 . . . . 0.0 113.379 178.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 5.5 p -160.17 142.28 4.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 126.247 1.819 . . . . 0.0 110.078 175.009 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.698 HG21 HD13 ' A' ' 70' ' ' LEU . 73.6 t -113.79 122.62 34.53 Favored Pre-proline 0 N--CA 1.473 0.676 0 C-N-CA 124.472 1.109 . . . . 0.0 108.325 174.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.753 ' HA ' HG22 ' A' ' 43' ' ' THR . 56.3 Cg_endo -68.12 159.42 53.19 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.767 2.312 . . . . 0.0 112.875 175.402 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -71.15 168.2 17.71 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.952 0.901 . . . . 0.0 110.705 175.015 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 30.5 p 53.1 21.9 2.33 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 127.11 2.164 . . . . 0.0 113.991 -175.086 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.8 172.67 10.17 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 127.648 2.379 . . . . 0.0 110.497 -175.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.469 ' HB3' HD23 ' A' ' 13' ' ' LEU . . . -134.9 161.84 34.1 Favored 'General case' 0 C--O 1.222 -0.381 0 O-C-N 121.85 -0.532 . . . . 0.0 110.009 176.251 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.698 HD13 HG21 ' A' ' 64' ' ' VAL . 2.6 pt? -136.38 171.11 14.96 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 124.387 1.075 . . . . 0.0 112.454 -179.42 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.528 ' CD2' HD11 ' A' ' 13' ' ' LEU . 0.6 OUTLIER -119.47 156.01 31.02 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 124.826 1.25 . . . . 0.0 113.138 -179.061 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.838 ' HB2' HG22 ' A' ' 34' ' ' VAL . 23.8 m-85 -133.22 133.66 43.01 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 124.217 1.007 . . . . 0.0 112.191 175.105 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.1 p -101.44 151.53 21.82 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 126.155 1.782 . . . . 0.0 110.692 175.261 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.81 ' H ' HD12 ' A' ' 3' ' ' LEU . . . -169.0 124.43 1.17 Allowed Glycine 0 CA--C 1.531 1.08 0 C-N-CA 124.212 0.91 . . . . 0.0 113.192 175.033 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.546 ' HG2' HD11 ' A' ' 3' ' ' LEU . 22.9 mtm180 -96.04 80.89 3.32 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 129.462 3.105 . . . . 0.0 111.245 -174.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.482 ' HE2' ' HB2' ' A' ' 85' ' ' ALA . 10.2 ptpt -56.0 -37.05 68.6 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 30.7 p -98.32 78.72 2.47 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.737 1.615 . . . . 0.0 112.091 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.6 m -69.99 -18.74 63.34 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 176.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 121.43 -65.78 0.47 Allowed Glycine 0 CA--C 1.538 1.498 0 C-N-CA 125.189 1.376 . . . . 0.0 113.672 -176.047 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.73 -41.14 3.23 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 123.177 2.585 . . . . 0.0 112.962 -175.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.3 p -141.49 142.07 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 C-N-CA 126.556 1.943 . . . . 0.0 109.107 178.155 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -129.04 96.52 4.36 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.824 1.25 . . . . 0.0 108.092 175.011 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 24.6 m -85.46 -16.97 37.88 Favored 'General case' 0 N--CA 1.479 0.978 0 O-C-N 121.913 -0.492 . . . . 0.0 111.772 178.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 114.83 -171.45 13.71 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 125.829 1.68 . . . . 0.0 112.137 178.005 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.682 ' HB1' HG13 ' A' ' 32' ' ' ILE . . . -72.11 84.52 1.01 Allowed 'General case' 0 CA--C 1.547 0.855 0 O-C-N 120.956 -1.32 . . . . 0.0 110.983 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.2 t -125.65 118.21 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 124.155 0.982 . . . . 0.0 113.031 -174.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.56 ' HB3' ' CZ ' ' A' ' 103' ' ' PHE . . . -164.87 168.65 17.46 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.144 1.377 . . . . 0.0 113.09 176.505 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -154.19 137.67 15.9 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.346 1.059 . . . . 0.0 111.961 174.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -137.59 169.28 18.06 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 120.595 -1.316 . . . . 0.0 111.574 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -141.46 160.62 39.75 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 175.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -137.82 143.35 40.95 Favored 'General case' 0 CA--C 1.513 -0.463 0 C-N-CA 125.779 1.632 . . . . 0.0 114.33 -174.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -97.94 106.53 18.85 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.352 -175.018 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 1.9 mtm -78.87 128.95 34.01 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 124.051 0.94 . . . . 0.0 110.789 178.287 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -58.96 -20.66 54.52 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 177.651 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -70.01 -12.52 61.67 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 124.521 1.128 . . . . 0.0 113.853 176.257 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 109.79 25.61 5.35 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 125.34 1.448 . . . . 0.0 114.963 177.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -134.3 173.84 11.18 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.928 1.291 . . . . 0.0 112.108 -175.028 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 16.8 m -129.33 108.44 10.31 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 177.36 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.435 ' CD2' ' CZ2' ' A' ' 44' ' ' TRP . 69.3 tp -75.12 108.07 7.62 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.675 0.79 . . . . 0.0 112.267 175.072 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -102.42 135.49 12.29 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 123.816 0.722 . . . . 0.0 112.344 174.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 95.6 t -115.7 136.6 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.952 1.301 . . . . 0.0 111.25 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -133.34 122.8 24.34 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.739 1.616 . . . . 0.0 111.945 -174.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.56 ' CZ ' ' HB3' ' A' ' 87' ' ' ALA . 2.1 p90 -147.17 117.53 7.41 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.735 1.214 . . . . 0.0 111.562 -176.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 48.4 t -139.02 105.98 5.43 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.186 0.994 . . . . 0.0 112.598 -177.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.486 ' HB ' ' HB3' ' A' ' 85' ' ' ALA . 19.6 t -110.02 125.44 31.09 Favored Pre-proline 0 C--N 1.328 -0.338 0 C-N-CA 125.893 1.677 . . . . 0.0 109.008 179.398 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.32 141.52 39.24 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 124.077 3.185 . . . . 0.0 110.357 174.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -59.73 -34.69 73.28 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.654 1.182 . . . . 0.0 112.688 175.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -91.73 -46.24 8.0 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.555 1.142 . . . . 0.0 113.43 -178.525 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER 59.49 36.51 23.0 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.569 1.548 . . . . 0.0 113.478 -175.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -126.87 -1.58 6.6 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.323 1.449 . . . . 0.0 114.42 -179.113 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 12.6 m95 -133.55 -65.45 0.68 Allowed 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 125.198 1.399 . . . . 0.0 111.227 -175.031 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -91.14 152.56 20.53 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.11 1.364 . . . . 0.0 111.527 175.084 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 2.0 t -85.07 159.95 20.09 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.273 1.029 . . . . 0.0 109.211 175.144 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -102.29 101.52 11.81 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.942 1.697 . . . . 0.0 109.454 175.487 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 38.5 m0 -100.52 141.31 33.55 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.961 1.255 . . . . 0.0 110.476 178.113 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 37.7 p-90 -137.51 129.0 28.24 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.143 0.977 . . . . 0.0 111.268 -177.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -133.54 156.12 48.37 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 122.509 1.147 . . . . 0.0 112.553 176.516 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 95.9 t -148.22 123.76 2.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 176.2 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.91 170.89 21.08 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.596 1.158 . . . . 0.0 110.885 175.021 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.521 ' HB ' ' CZ ' ' A' ' 154' ' ' TYR . 7.2 mt -104.27 136.19 38.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.917 0.865 . . . . 0.0 110.523 176.1 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -89.58 153.09 47.88 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 125.302 1.441 . . . . 0.0 111.18 176.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -74.19 88.98 1.08 Allowed 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 124.248 3.299 . . . . 0.0 112.107 179.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 91.64 -172.51 35.89 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 125.239 1.399 . . . . 0.0 113.006 -177.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 12.3 tttt -51.85 118.08 3.17 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.997 1.319 . . . . 0.0 111.571 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.38 147.67 41.8 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.023 0.929 . . . . 0.0 112.225 177.027 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 19.6 ptt-85 -99.07 -178.34 3.9 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.25 1.02 . . . . 0.0 110.409 175.096 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -128.8 107.47 9.68 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 104.91 -2.255 . . . . 0.0 104.91 174.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -128.39 171.24 12.23 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.277 1.431 . . . . 0.0 109.299 176.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -51.87 -44.29 63.65 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 119.642 1.11 . . . . 0.0 113.595 -177.744 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -56.75 -58.44 14.47 Favored Glycine 0 N--CA 1.471 0.986 0 CA-C-N 119.327 0.967 . . . . 0.0 112.57 175.259 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 6.1 mtm -60.89 -39.92 91.07 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 118.068 0.934 . . . . 0.0 112.714 178.279 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -56.2 -60.89 2.85 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.071 1.349 . . . . 0.0 109.569 174.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -67.06 -32.57 73.84 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -178.452 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -62.02 -47.15 86.04 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.752 0.821 . . . . 0.0 111.562 176.215 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 46.8 mmm -84.45 -20.36 31.91 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -54.5 -55.67 26.69 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.664 1.586 . . . . 0.0 109.252 174.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -68.65 -9.68 51.5 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -73.44 -41.6 44.3 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 125.825 1.679 . . . . 0.0 114.036 -177.408 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -123.0 91.32 49.94 Favored Pre-proline 0 CA--C 1.547 0.831 0 CA-C-N 118.215 1.007 . . . . 0.0 111.452 179.111 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -72.45 78.64 1.94 Allowed 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 123.776 2.984 . . . . 0.0 112.156 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -114.84 124.15 51.01 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.953 1.301 . . . . 0.0 110.233 174.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.87 96.93 3.31 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 127.101 2.16 . . . . 0.0 112.6 -174.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 52.53 37.83 50.41 Favored Glycine 0 CA--C 1.537 1.423 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.462 -177.509 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.67 79.65 0.6 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.408 1.883 . . . . 0.0 110.93 -178.374 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -65.84 123.37 19.61 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.185 1.794 . . . . 0.0 110.611 175.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 128.02 41.41 0.28 Allowed Glycine 0 CA--C 1.534 1.258 0 C-N-CA 125.341 1.448 . . . . 0.0 114.754 178.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' TRP . . . . . 0.453 ' H ' HD13 ' A' ' 161' ' ' ILE . 9.7 m95 45.29 60.09 3.21 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.803 1.641 . . . . 0.0 112.738 -175.1 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -85.05 128.31 34.58 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.456 1.102 . . . . 0.0 113.229 179.347 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -162.68 -170.28 2.34 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.219 1.008 . . . . 0.0 112.693 -174.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -137.9 151.53 48.11 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.562 1.145 . . . . 0.0 110.159 174.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -70.6 153.18 43.13 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 122.99 0.516 . . . . 0.0 110.95 176.14 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.482 ' HB3' ' CD2' ' A' ' 154' ' ' TYR . 1.9 mm? -115.7 127.67 55.32 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 122.189 0.995 . . . . 0.0 112.398 -178.278 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -58.07 -18.37 33.87 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 125.436 1.493 . . . . 0.0 116.02 179.127 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.521 ' CZ ' ' HB ' ' A' ' 120' ' ' ILE . 0.1 OUTLIER -74.35 14.33 0.46 Allowed 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 126.62 1.968 . . . . 0.0 113.776 179.778 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 75.16 24.86 70.2 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 124.171 0.891 . . . . 0.0 113.751 -174.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.6 pp -135.33 177.58 7.71 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.152 1.381 . . . . 0.0 113.215 -178.363 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -142.37 124.33 15.27 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.602 1.561 . . . . 0.0 109.448 -178.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 5.1 ttp -98.24 142.06 30.38 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 175.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 3.5 tppt? -123.78 121.72 36.17 Favored 'General case' 0 C--O 1.219 -0.543 0 C-N-CA 125.707 1.603 . . . . 0.0 109.383 -176.53 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -130.35 152.1 19.67 Favored Glycine 0 N--CA 1.466 0.682 0 CA-C-N 120.305 1.412 . . . . 0.0 114.581 -176.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.453 HD13 ' H ' ' A' ' 147' ' ' TRP . 4.4 tp -146.35 128.27 7.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 C-N-CA 124.516 1.126 . . . . 0.0 110.589 -176.588 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' MET . . . . . 0.42 ' HG2' ' HA ' ' A' ' 170' ' ' MET . 1.1 tmm? -151.37 157.2 42.14 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 125.296 1.438 . . . . 0.0 109.982 177.639 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' THR . . . . . 0.424 ' O ' ' HB3' ' A' ' 168' ' ' ALA . 12.8 t -148.67 148.45 30.08 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.506 0.722 . . . . 0.0 110.329 174.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 75.1 m -117.08 32.11 6.35 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.277 1.031 . . . . 0.0 111.352 -177.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.85 -24.41 65.88 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.692 1.597 . . . . 0.0 113.713 176.347 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 158.4 -54.7 0.37 Allowed Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.22 1.39 . . . . 0.0 113.414 175.005 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -139.96 61.2 1.54 Allowed 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 122.311 1.053 . . . . 0.0 112.161 -175.024 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 163' ' ' THR . . . -98.08 -174.09 2.77 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 122.44 1.114 . . . . 0.0 112.727 175.033 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.5 178.68 6.12 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 128.167 2.587 . . . . 0.0 111.035 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' MET . . . . . 0.42 ' HA ' ' HG2' ' A' ' 162' ' ' MET . 4.7 tmm? -119.39 136.46 54.27 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.328 1.451 . . . . 0.0 111.207 174.359 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -146.74 129.73 16.37 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 121.591 -0.693 . . . . 0.0 110.279 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 4.6 mp -134.18 118.57 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 123.572 0.749 . . . . 0.0 110.363 175.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.419 ' HA ' ' HB3' ' A' ' 37' ' ' ASP . 0.0 OUTLIER -113.83 133.13 55.59 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 125.411 1.485 . . . . 0.0 111.583 176.161 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.8 mp -82.59 136.68 22.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 O-C-N 121.466 -0.771 . . . . 0.0 109.498 175.01 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -118.23 130.85 56.31 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.164 1.386 . . . . 0.0 111.593 175.028 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 8.2 mmm180 . . . . . 0 C--O 1.252 1.231 0 C-N-CA 126.778 2.031 . . . . 0.0 110.869 -175.008 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.482 1.148 0 CA-C-O 121.145 0.498 . . . . 0.0 110.69 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -83.06 -174.36 5.24 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 124.557 1.143 . . . . 0.0 111.92 177.319 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.421 ' HA ' ' HB3' ' A' ' 25' ' ' LEU . 10.4 tp -120.62 -39.44 2.75 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.382 1.073 . . . . 0.0 113.239 175.305 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.619 ' HB1' ' HB3' ' A' ' 71' ' ' LEU . . . -77.56 130.62 37.17 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.316 1.047 . . . . 0.0 109.41 174.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -64.55 -101.14 0.01 OUTLIER Glycine 0 CA--C 1.537 1.453 0 CA-C-N 120.211 1.369 . . . . 0.0 114.764 -178.214 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 16.5 p -133.25 167.4 20.44 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.307 1.443 . . . . 0.0 110.16 176.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -120.73 14.59 6.34 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 C-N-CA 125.021 1.328 . . . . 0.0 112.406 -178.803 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.439 HD12 ' HB3' ' A' ' 12' ' ' SER . 0.8 OUTLIER -30.95 -72.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 128.427 2.691 . . . . 0.0 114.092 -179.38 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -171.62 151.5 2.95 Favored 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 125.127 1.371 . . . . 0.0 110.947 175.173 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -59.57 -33.23 75.99 Favored Glycine 0 N--CA 1.468 0.798 0 N-CA-C 115.605 1.002 . . . . 0.0 115.605 -174.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.09 -38.44 88.84 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 122.022 -0.693 . . . . 0.0 111.188 174.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.439 ' HB3' HD12 ' A' ' 8' ' ' ILE . 5.9 t -92.22 -11.77 34.5 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.398 1.879 . . . . 0.0 113.778 177.599 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.572 HD23 ' CB ' ' A' ' 69' ' ' ALA . 67.8 tp -119.53 80.67 1.6 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 128.851 2.86 . . . . 0.0 109.845 179.016 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -111.84 177.34 4.68 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.591 1.557 . . . . 0.0 111.981 176.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -39.98 -45.29 1.86 Allowed 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 126.125 1.77 . . . . 0.0 113.439 175.022 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -52.59 -44.86 66.24 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.921 0.888 . . . . 0.0 111.623 178.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.494 ' O ' HG23 ' A' ' 21' ' ' VAL . 59.3 t -67.87 -40.82 84.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 125.54 1.536 . . . . 0.0 110.887 176.214 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.476 ' CD2' HD21 ' A' ' 71' ' ' LEU . 25.7 mt -65.4 -42.67 92.34 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 120.704 -1.247 . . . . 0.0 111.331 178.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -59.76 -51.52 69.4 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.79 1.236 . . . . 0.0 112.059 175.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.57 -36.37 83.56 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-O 118.424 -0.798 . . . . 0.0 112.52 175.141 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 17' ' ' VAL . 24.2 t -53.65 -46.31 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.234 1.014 . . . . 0.0 110.363 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.573 HD22 ' HE3' ' A' ' 31' ' ' LYS . 18.5 mt -53.53 -18.49 2.85 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.562 1.545 . . . . 0.0 114.464 178.34 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -99.64 -62.24 0.83 Allowed Glycine 0 CA--C 1.534 1.268 0 C-N-CA 126.646 2.07 . . . . 0.0 112.899 175.513 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -60.85 -35.43 76.55 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -178.57 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.421 ' HB3' ' HA ' ' A' ' 3' ' ' LEU . 3.1 mm? -114.41 105.89 13.66 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.267 1.827 . . . . 0.0 108.092 175.012 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -143.78 162.74 27.72 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 125.502 1.525 . . . . 0.0 111.405 178.204 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.22 -83.14 0.57 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.733 1.213 . . . . 0.0 110.638 174.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 30.6 m -91.43 173.72 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 126.014 1.725 . . . . 0.0 109.282 178.365 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -51.28 -44.8 61.92 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.977 0.911 . . . . 0.0 112.439 -178.435 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.63 120.81 43.63 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.47 1.908 . . . . 0.0 112.514 177.32 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.573 ' HE3' HD22 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -133.46 163.12 30.08 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 125.46 1.504 . . . . 0.0 111.115 -179.049 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -128.95 132.67 67.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 124.709 1.204 . . . . 0.0 109.037 175.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -136.73 104.76 5.62 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.146 1.778 . . . . 0.0 109.439 174.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.821 HG22 ' HB2' ' A' ' 72' ' ' TYR . 1.3 m -106.4 159.09 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 124.233 1.013 . . . . 0.0 111.901 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -137.44 109.1 0.68 Allowed Glycine 0 N--CA 1.465 0.569 0 CA-C-N 119.072 0.851 . . . . 0.0 113.643 -178.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 mp -99.43 142.07 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 117.632 0.716 . . . . 0.0 110.136 176.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -108.87 101.99 11.05 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 124.873 1.269 . . . . 0.0 109.848 176.141 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.62 100.09 1.08 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.584 1.554 . . . . 0.0 109.343 176.528 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -133.79 13.39 4.02 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.908 1.283 . . . . 0.0 112.282 175.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.0 p -62.31 -12.95 23.78 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 126.082 1.753 . . . . 0.0 114.834 175.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.38 16.29 66.93 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 125.499 1.523 . . . . 0.0 114.183 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -140.49 136.47 7.67 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 126.506 2.003 . . . . 0.0 110.633 175.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.803 HG22 ' HA ' ' A' ' 65' ' ' PRO . 19.9 p -73.63 127.47 32.85 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.281 0.632 . . . . 0.0 109.939 174.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 15.8 m0 -88.02 159.1 18.42 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 122.066 -0.396 . . . . 0.0 111.742 177.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 89.4 m -136.61 143.86 43.77 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.574 1.15 . . . . 0.0 110.288 -179.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.7 110.85 0.86 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.466 1.106 . . . . 0.0 111.829 175.019 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.602 HD12 ' N ' ' A' ' 48' ' ' ASN . 4.2 pp -101.25 -57.67 2.04 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.475 0.71 . . . . 0.0 111.284 175.073 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.602 ' N ' HD12 ' A' ' 47' ' ' LEU . 4.1 t30 -173.43 140.03 0.79 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.446 1.898 . . . . 0.0 110.262 -175.654 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -121.83 150.61 41.67 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.354 1.062 . . . . 0.0 110.195 175.105 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -138.52 94.32 2.83 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 123.037 1.399 . . . . 0.0 112.104 -175.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.611 ' CD1' ' HB1' ' A' ' 87' ' ' ALA . 5.2 m-30 -101.91 133.15 47.15 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 121.16 -0.962 . . . . 0.0 110.393 -175.714 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.38 -37.77 6.13 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.217 1.007 . . . . 0.0 113.64 -178.594 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 37.5 t -122.58 -47.74 2.08 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.494 1.518 . . . . 0.0 110.92 178.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -69.76 11.44 1.82 Allowed Glycine 0 CA--C 1.533 1.173 0 C-N-CA 126.051 1.786 . . . . 0.0 115.002 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 67.8 p -35.22 113.28 0.19 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 128.864 2.866 . . . . 0.0 112.773 -176.253 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.663 HG21 HG23 ' A' ' 59' ' ' ILE . 1.1 t -126.75 179.94 5.11 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.803 1.241 . . . . 0.0 112.014 -175.023 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -79.29 -53.98 6.4 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.959 0.904 . . . . 0.0 112.75 177.005 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.2 p -151.48 138.84 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.673 1.589 . . . . 0.0 111.386 -178.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.663 HG23 HG21 ' A' ' 56' ' ' THR . 0.0 OUTLIER -136.72 -47.27 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 C-N-CA 125.083 1.353 . . . . 0.0 112.982 -178.772 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 73.3 mt -71.42 108.62 4.1 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 124.717 1.207 . . . . 0.0 109.474 175.316 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -72.07 168.02 25.15 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 124.046 3.164 . . . . 0.0 110.819 175.271 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -53.52 -45.57 69.82 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 178.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 85.5 t -150.09 146.75 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 127.526 2.33 . . . . 0.0 108.83 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.0 t -116.66 97.26 50.01 Favored Pre-proline 0 C--N 1.331 -0.21 0 C-N-CA 125.567 1.547 . . . . 0.0 107.247 174.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.803 ' HA ' HG22 ' A' ' 43' ' ' THR . 51.4 Cg_endo -67.71 144.78 67.12 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 121.328 1.352 . . . . 0.0 111.99 175.475 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -69.11 168.89 13.0 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.438 0.695 . . . . 0.0 110.658 174.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 29.1 p 62.94 13.85 7.0 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 126.614 1.966 . . . . 0.0 111.889 -175.011 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 27.6 mttp -138.41 169.05 18.47 Favored 'General case' 0 C--N 1.343 0.302 0 C-N-CA 126.525 1.93 . . . . 0.0 111.655 -176.239 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.572 ' CB ' HD23 ' A' ' 13' ' ' LEU . . . -133.35 159.72 39.45 Favored 'General case' 0 C--O 1.222 -0.359 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -175.054 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.519 HD23 ' H ' ' A' ' 70' ' ' LEU . 2.2 pt? -136.76 167.86 20.63 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 124.296 1.038 . . . . 0.0 111.966 -177.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.619 ' HB3' ' HB1' ' A' ' 4' ' ' ALA . 0.6 OUTLIER -117.35 153.55 32.81 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.253 1.021 . . . . 0.0 112.139 179.068 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.821 ' HB2' HG22 ' A' ' 34' ' ' VAL . 6.7 m-85 -125.56 142.2 51.63 Favored 'General case' 0 CA--C 1.511 -0.521 0 C-N-CA 125.047 1.339 . . . . 0.0 109.335 174.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 58.3 p -109.41 156.45 20.03 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 125.035 1.334 . . . . 0.0 110.346 174.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -174.13 135.45 3.18 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.872 175.018 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 30.5 mtm105 -117.5 142.5 47.09 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 125.428 1.491 . . . . 0.0 108.852 -177.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.5 ptpt -71.7 -168.14 0.33 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.038 0.935 . . . . 0.0 112.346 175.035 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.3 t 62.96 57.14 1.71 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.828 1.651 . . . . 0.0 111.636 176.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 52.0 p -60.8 -20.48 61.64 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.842 1.257 . . . . 0.0 113.87 177.091 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 126.9 -72.22 0.46 Allowed Glycine 0 CA--C 1.533 1.187 0 C-N-CA 126.995 2.236 . . . . 0.0 111.428 179.348 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.36 -42.67 1.8 Allowed 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 123.163 2.576 . . . . 0.0 113.247 -178.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 28.6 m -133.5 110.09 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 126.082 1.753 . . . . 0.0 111.156 -174.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -88.31 81.78 7.2 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 120.572 -1.33 . . . . 0.0 111.843 176.496 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -85.26 170.2 13.05 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 175.007 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -61.6 -68.58 1.61 Allowed Glycine 0 N--CA 1.475 1.246 0 O-C-N 120.282 -1.511 . . . . 0.0 113.654 -179.389 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -160.14 114.98 2.29 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.838 1.255 . . . . 0.0 110.923 175.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.9 t -141.83 119.12 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 123.796 0.838 . . . . 0.0 109.933 -177.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.611 ' HB1' ' CD1' ' A' ' 51' ' ' PHE . . . -156.79 153.86 29.01 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.901 0.858 . . . . 0.0 112.031 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -134.57 139.43 45.37 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.401 1.48 . . . . 0.0 108.985 178.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.557 ' CE2' ' CE2' ' A' ' 72' ' ' TYR . 26.3 p90 -149.49 171.3 16.82 Favored 'General case' 0 C--N 1.323 -0.58 0 O-C-N 120.521 -1.362 . . . . 0.0 109.346 174.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.476 ' HB3' HD11 ' A' ' 47' ' ' LEU . . . -138.58 161.7 36.43 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 120.908 0.385 . . . . 0.0 111.977 174.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -130.16 135.52 48.27 Favored 'General case' 0 CA--C 1.518 -0.269 0 C-N-CA 125.718 1.607 . . . . 0.0 113.471 -174.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -86.53 116.78 24.89 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -175.015 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 3.3 mtm -93.2 140.89 29.03 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.01 0.924 . . . . 0.0 112.297 -177.229 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.14 -21.64 65.2 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 114.309 1.225 . . . . 0.0 114.309 177.652 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -72.09 -2.22 17.67 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.257 1.023 . . . . 0.0 113.146 175.116 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 85.83 42.39 6.81 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.62 1.105 . . . . 0.0 112.543 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -140.96 176.48 8.77 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.222 1.409 . . . . 0.0 111.549 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.441 HG23 HD21 ' A' ' 47' ' ' LEU . 12.9 m -130.07 107.54 9.4 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.285 1.034 . . . . 0.0 112.929 178.627 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 57.1 tp -69.94 96.31 1.01 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.764 1.625 . . . . 0.0 111.217 174.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -91.43 120.38 5.98 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 125.485 1.516 . . . . 0.0 112.76 178.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.557 HG11 ' CE2' ' A' ' 89' ' ' PHE . 0.3 OUTLIER -104.79 161.65 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 125.419 1.488 . . . . 0.0 111.127 178.436 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 5.0 tpt -155.91 123.22 5.44 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.66 1.184 . . . . 0.0 111.031 174.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.491 ' CZ ' ' HB3' ' A' ' 87' ' ' ALA . 15.5 p90 -135.18 124.18 24.19 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.933 1.293 . . . . 0.0 114.226 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.6 t -133.02 102.32 5.56 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.086 0.954 . . . . 0.0 111.557 -176.151 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.0 m -77.13 144.94 72.4 Favored Pre-proline 0 N--CA 1.47 0.543 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.409 -178.186 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.452 ' HA ' ' CD2' ' A' ' 109' ' ' TYR . 30.7 Cg_endo -72.11 134.77 23.83 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.502 2.134 . . . . 0.0 112.978 175.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -142.37 -74.23 0.3 Allowed 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.987 -179.373 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -124.4 26.29 7.38 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.018 1.727 . . . . 0.0 111.552 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.452 ' CD2' ' HA ' ' A' ' 106' ' ' PRO . 10.7 m-85 -53.32 99.38 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.057 1.743 . . . . 0.0 112.756 176.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 43.2 m-20 -110.02 -6.47 15.14 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.124 1.77 . . . . 0.0 113.043 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 9.4 m95 -133.8 -49.42 0.82 Allowed 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.946 1.698 . . . . 0.0 112.196 -175.599 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -100.66 -173.03 2.3 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.88 2.072 . . . . 0.0 111.651 175.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -132.0 163.17 28.99 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.942 1.697 . . . . 0.0 110.64 174.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -63.16 99.55 0.18 Allowed 'General case' 0 CA--C 1.521 -0.164 0 C-N-CA 126.134 1.774 . . . . 0.0 111.807 175.087 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 46.5 m0 -119.56 142.11 48.65 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.691 1.197 . . . . 0.0 110.129 -175.611 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 31.5 p-90 -145.82 133.83 21.43 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.195 0.998 . . . . 0.0 110.658 -175.634 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -146.92 157.38 43.62 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 122.464 1.126 . . . . 0.0 113.441 -178.703 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.419 HG22 HG23 ' A' ' 101' ' ' VAL . 21.4 t -149.19 128.14 3.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 114.394 -1.275 . . . . 0.0 108.277 -178.648 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.0 162.99 40.79 Favored 'General case' 0 CA--C 1.514 -0.434 0 C-N-CA 125.614 1.566 . . . . 0.0 109.13 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 20.4 mt -108.47 146.28 14.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 121.487 0.66 . . . . 0.0 109.998 176.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -103.19 145.81 31.29 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 126.244 1.818 . . . . 0.0 111.023 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.62 103.0 1.37 Allowed 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 124.152 3.235 . . . . 0.0 111.558 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 88.06 -177.06 45.98 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.518 1.056 . . . . 0.0 114.068 -177.139 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 16.4 tttt -64.56 102.13 0.53 Allowed 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.462 1.105 . . . . 0.0 109.426 175.028 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 6.4 mmt180 -116.35 158.25 23.75 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.803 1.641 . . . . 0.0 109.54 178.597 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.82 -174.0 2.77 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.506 1.122 . . . . 0.0 110.265 175.041 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -138.27 113.25 9.19 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 126.315 1.846 . . . . 0.0 106.113 174.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -127.5 175.56 8.14 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.707 2.003 . . . . 0.0 109.253 174.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -47.97 -49.4 30.65 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.112 0.965 . . . . 0.0 113.473 177.231 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -56.94 -52.99 47.74 Favored Glycine 0 N--CA 1.471 0.967 0 CA-C-N 119.052 0.842 . . . . 0.0 112.832 178.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 20.4 mtm -62.88 -41.6 99.46 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 117.828 0.814 . . . . 0.0 112.558 176.058 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -56.95 -62.74 1.54 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.767 0.827 . . . . 0.0 109.623 175.004 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -59.22 -42.09 90.18 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 118.561 -0.733 . . . . 0.0 112.184 -176.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -58.09 -42.11 84.92 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.426 1.09 . . . . 0.0 113.027 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 40.9 mmm -84.48 -36.29 22.37 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 177.383 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -53.47 -57.27 11.27 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.501 1.52 . . . . 0.0 109.444 174.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -70.95 -9.7 58.36 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -178.444 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -87.02 -11.23 70.36 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 126.254 1.883 . . . . 0.0 114.624 178.456 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -138.67 88.67 13.93 Favored Pre-proline 0 CA--C 1.548 0.884 0 CA-C-N 119.205 1.503 . . . . 0.0 112.636 177.407 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -74.76 77.86 2.94 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.857 3.038 . . . . 0.0 112.46 178.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -114.71 124.21 51.21 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.061 0.944 . . . . 0.0 110.684 -178.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -92.59 -167.9 1.85 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.406 1.082 . . . . 0.0 111.72 179.165 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -73.94 66.51 1.78 Allowed Glycine 0 CA--C 1.53 0.989 0 C-N-CA 125.824 1.678 . . . . 0.0 111.433 175.032 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.418 ' HB3' ' CG ' ' A' ' 148' ' ' TYR . 0.9 OUTLIER -80.96 88.75 5.89 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 125.404 1.481 . . . . 0.0 109.805 -178.07 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -70.38 86.41 0.61 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.862 1.665 . . . . 0.0 112.347 -176.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 169.04 40.7 0.03 OUTLIER Glycine 0 N--CA 1.472 1.099 0 O-C-N 121.171 -0.956 . . . . 0.0 114.614 -178.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 2.3 m95 53.56 55.17 8.94 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 125.576 1.55 . . . . 0.0 113.909 -177.608 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' TYR . . . . . 0.418 ' CG ' ' HB3' ' A' ' 144' ' ' ASP . 26.0 m-85 -86.23 124.4 32.57 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.443 1.497 . . . . 0.0 112.684 -178.782 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -159.0 -179.36 7.97 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.108 0.963 . . . . 0.0 112.902 -175.654 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -136.57 166.42 23.58 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.24 1.416 . . . . 0.0 111.086 174.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -69.14 143.65 54.06 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.888 0.875 . . . . 0.0 109.735 174.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.475 HD11 ' HB2' ' A' ' 158' ' ' MET . 48.4 mt -99.48 92.64 5.48 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.275 1.03 . . . . 0.0 110.744 176.236 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 33.05 -79.9 0.0 OUTLIER Glycine 0 N--CA 1.478 1.473 0 C-N-CA 130.051 3.691 . . . . 0.0 116.247 175.092 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -67.89 -157.02 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 128.266 2.626 . . . . 0.0 110.372 175.023 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -79.09 42.91 2.39 Favored Glycine 0 CA--C 1.539 1.557 0 O-C-N 119.813 -1.804 . . . . 0.0 112.253 175.077 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.54 149.98 33.64 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 119.571 1.686 . . . . 0.0 111.061 175.179 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 23.8 mtm180 -142.54 109.26 5.41 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.496 1.118 . . . . 0.0 111.015 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' MET . . . . . 0.508 ' SD ' HG21 ' A' ' 172' ' ' ILE . 9.9 ttp -101.53 132.23 47.27 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 118.038 -0.982 . . . . 0.0 108.934 179.398 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.74 130.45 54.46 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 127.075 2.15 . . . . 0.0 110.893 178.616 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -135.72 160.11 24.42 Favored Glycine 0 N--CA 1.47 0.937 0 CA-C-N 120.312 1.414 . . . . 0.0 115.45 178.506 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.518 HG23 ' HZ1' ' A' ' 169' ' ' LYS . 0.0 OUTLIER -150.63 134.57 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 123.954 0.901 . . . . 0.0 111.366 179.395 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 7.0 mtm -148.36 167.29 25.61 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 127.09 2.156 . . . . 0.0 109.974 175.466 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 3.6 t -140.35 148.9 42.01 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.989 1.316 . . . . 0.0 109.479 174.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 77.4 p -92.25 26.57 2.5 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.508 1.123 . . . . 0.0 112.805 177.287 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -67.18 22.68 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 127.601 2.36 . . . . 0.0 115.232 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 81.4 -60.64 4.7 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 126.664 2.078 . . . . 0.0 112.901 -176.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -122.77 71.04 1.02 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.786 1.234 . . . . 0.0 111.47 -179.267 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -92.89 -177.06 4.4 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.733 1.213 . . . . 0.0 112.707 175.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.518 ' HZ1' HG23 ' A' ' 161' ' ' ILE . 0.0 OUTLIER -123.42 163.84 20.06 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 126.842 2.057 . . . . 0.0 109.532 174.966 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 170' ' ' MET . . . . . 0.413 ' SD ' ' CD1' ' A' ' 172' ' ' ILE . 1.3 tmt? -113.12 127.13 56.11 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 124.876 1.27 . . . . 0.0 109.459 174.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -138.21 127.66 24.74 Favored 'General case' 0 CA--C 1.518 -0.253 0 C-N-CA 123.279 0.632 . . . . 0.0 110.044 177.271 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.508 HG21 ' SD ' ' A' ' 158' ' ' MET . 4.2 mp -136.43 119.68 22.59 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.279 0 C-N-CA 122.978 0.511 . . . . 0.0 110.505 178.537 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -112.36 131.89 55.29 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.987 1.315 . . . . 0.0 111.578 175.552 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.8 mp -82.07 131.46 33.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 175.041 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -135.42 102.47 5.15 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.219 1.007 . . . . 0.0 111.442 175.669 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 5.9 mtt180 . . . . . 0 C--O 1.253 1.285 0 C-N-CA 124.846 1.259 . . . . 0.0 112.852 174.983 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.578 HD12 ' H ' ' A' ' 74' ' ' GLY . 1.8 mt . . . . . 0 CA--C 1.548 0.89 0 CA-C-O 121.513 0.673 . . . . 0.0 112.51 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.417 ' HA ' ' HB3' ' A' ' 71' ' ' LEU . . . -120.98 94.02 4.21 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 127.637 2.375 . . . . 0.0 109.632 178.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -69.71 -84.05 0.16 Allowed Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.531 1.062 . . . . 0.0 112.665 -175.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 33.7 p -140.24 167.34 22.37 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.705 1.602 . . . . 0.0 111.004 175.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -125.39 14.36 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 CA-C-O 123.174 1.464 . . . . 0.0 111.796 -179.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.419 HD12 ' HB3' ' A' ' 12' ' ' SER . 8.2 pt -53.23 167.39 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 125.494 1.517 . . . . 0.0 112.086 175.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -42.31 134.02 3.03 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.72 1.608 . . . . 0.0 112.549 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -54.9 -18.98 12.68 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 124.202 0.906 . . . . 0.0 114.557 -175.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.18 -28.14 69.46 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.718 1.207 . . . . 0.0 111.932 175.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.419 ' HB3' HD12 ' A' ' 8' ' ' ILE . 6.4 t -102.09 -44.9 5.32 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 126.32 1.848 . . . . 0.0 111.415 175.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.2 tp -75.97 94.16 3.35 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 121.614 0.721 . . . . 0.0 110.463 175.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 65.0 p -125.52 -179.8 4.79 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.507 1.523 . . . . 0.0 112.451 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -45.83 -41.0 10.56 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.446 1.498 . . . . 0.0 112.911 176.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -57.39 -43.39 83.61 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.661 1.185 . . . . 0.0 111.598 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 74.6 t -59.54 -35.4 58.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.733 1.213 . . . . 0.0 110.792 175.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.3 mt -72.52 -42.85 64.31 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.722 -0.611 . . . . 0.0 111.263 177.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -62.42 -49.35 75.81 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.616 -0.678 . . . . 0.0 111.267 178.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.08 -48.86 76.82 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 176.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.423 HG23 HD23 ' A' ' 25' ' ' LEU . 1.6 p -57.38 -30.73 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 CA-C-N 120.269 1.395 . . . . 0.0 113.414 -175.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 17.1 mt -57.4 -34.42 68.87 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.544 1.138 . . . . 0.0 110.806 174.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -85.54 -36.25 10.86 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 124.282 0.944 . . . . 0.0 113.455 177.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -69.62 -57.99 4.49 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.657 1.183 . . . . 0.0 112.38 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.423 HD23 HG23 ' A' ' 21' ' ' VAL . 3.1 mm? -91.32 -15.49 28.99 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.55 1.54 . . . . 0.0 112.005 -175.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -18.19 86.71 0.0 OUTLIER Glycine 0 CA--C 1.536 1.405 0 C-N-CA 129.952 3.644 . . . . 0.0 117.426 177.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.455 ' H ' HD21 ' A' ' 3' ' ' LEU . 15.3 mtpt -59.86 -61.11 2.86 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 127.224 2.21 . . . . 0.0 113.315 -175.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.1 m -132.66 -177.95 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 126.891 2.076 . . . . 0.0 110.835 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.2 t -52.19 -39.89 60.76 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.714 1.606 . . . . 0.0 114.354 -175.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -117.86 116.14 26.38 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 126.228 1.811 . . . . 0.0 108.258 175.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.15 150.54 49.46 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 126.125 1.77 . . . . 0.0 109.52 -175.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -128.21 123.59 60.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 124.336 1.054 . . . . 0.0 111.262 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -125.21 116.64 22.31 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 125.914 1.685 . . . . 0.0 108.558 174.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.732 HG22 ' HB2' ' A' ' 72' ' ' TYR . 1.3 m -116.1 158.75 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.639 0.776 . . . . 0.0 110.186 176.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -135.84 92.81 0.23 Allowed Glycine 0 CA--C 1.521 0.41 0 C-N-CA 124.073 0.844 . . . . 0.0 112.215 -178.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.8 mp -89.61 137.27 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 117.768 0.784 . . . . 0.0 110.503 175.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -108.15 112.1 24.45 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.989 1.316 . . . . 0.0 111.313 174.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 27.2 t30 -78.69 98.12 6.1 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.84 1.656 . . . . 0.0 111.975 175.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -134.21 13.74 3.87 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-O 122.551 1.167 . . . . 0.0 111.014 174.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.4 t -61.8 -26.88 68.37 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.082 1.753 . . . . 0.0 114.34 176.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 110.14 77.56 0.94 Allowed Glycine 0 CA--C 1.531 1.042 0 C-N-CA 125.247 1.403 . . . . 0.0 112.597 177.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 144.69 155.93 6.63 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 126.016 1.77 . . . . 0.0 112.805 175.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 41.4 p -68.88 129.43 39.9 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 121.526 -0.985 . . . . 0.0 110.289 174.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 45.2 m0 -86.6 111.15 20.35 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.261 0.553 . . . . 0.0 110.706 178.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 88.7 m -90.92 127.89 36.57 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 124.333 1.053 . . . . 0.0 109.501 175.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.414 ' HB1' ' HB3' ' A' ' 60' ' ' LEU . . . -62.21 138.41 58.41 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 122.651 0.38 . . . . 0.0 111.639 174.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.593 HD12 ' N ' ' A' ' 48' ' ' ASN . 4.1 pp -120.44 -54.65 2.07 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.059 0.943 . . . . 0.0 111.971 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.593 ' N ' HD12 ' A' ' 47' ' ' LEU . 0.1 OUTLIER -170.78 154.38 4.34 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.535 1.934 . . . . 0.0 110.241 178.704 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -133.17 162.99 30.28 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.679 1.192 . . . . 0.0 110.386 174.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 29.3 t80 -140.24 106.2 5.19 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.971 1.309 . . . . 0.0 112.391 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.541 ' CD1' ' HB1' ' A' ' 87' ' ' ALA . 3.1 m-85 -111.1 118.24 35.48 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.992 1.317 . . . . 0.0 110.982 -175.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.37 -35.9 7.78 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -177.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.421 ' HB3' ' HB ' ' A' ' 86' ' ' VAL . 11.3 t -123.96 -41.83 2.2 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.97 1.708 . . . . 0.0 111.654 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -74.03 16.66 2.61 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 125.246 1.403 . . . . 0.0 115.272 -178.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 65.8 p -32.9 110.29 0.08 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 128.689 2.796 . . . . 0.0 114.321 -174.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.536 HG21 HG23 ' A' ' 59' ' ' ILE . 1.7 t -131.37 -177.09 4.25 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.002 1.321 . . . . 0.0 112.845 -174.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -85.41 -64.97 1.06 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.963 1.305 . . . . 0.0 113.205 176.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.6 p -137.4 134.23 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 125.455 1.502 . . . . 0.0 111.638 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.536 HG23 HG21 ' A' ' 56' ' ' THR . 0.1 OUTLIER -136.68 -29.97 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.825 1.65 . . . . 0.0 113.799 177.596 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.414 ' HB3' ' HB1' ' A' ' 46' ' ' ALA . 11.0 mt -94.38 97.07 2.07 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 125.298 1.439 . . . . 0.0 109.85 179.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -66.87 154.29 75.07 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.932 3.088 . . . . 0.0 110.922 174.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -50.39 -50.8 50.57 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.634 1.174 . . . . 0.0 113.302 -176.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 80.4 t -149.45 140.9 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 127.902 2.481 . . . . 0.0 108.347 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.3 t -120.87 125.4 27.07 Favored Pre-proline 0 N--CA 1.471 0.583 0 C-N-CA 124.658 1.183 . . . . 0.0 109.508 175.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -66.2 152.02 82.15 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 121.88 1.72 . . . . 0.0 112.373 175.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -74.53 171.04 14.53 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.686 0.794 . . . . 0.0 111.425 174.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 66.5 p 55.41 20.36 3.6 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 127.597 2.359 . . . . 0.0 113.906 -174.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 49.4 mttt -133.57 174.03 10.86 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 127.623 2.369 . . . . 0.0 111.559 -175.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -130.94 166.86 20.03 Favored 'General case' 0 C--O 1.222 -0.373 0 C-N-CA 122.619 0.368 . . . . 0.0 110.549 -177.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.5 pp -140.49 172.66 12.41 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 124.962 1.305 . . . . 0.0 111.516 -178.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.417 ' HB3' ' HA ' ' A' ' 4' ' ' ALA . 0.5 OUTLIER -123.4 151.76 42.27 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 124.331 1.052 . . . . 0.0 112.038 178.991 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.732 ' HB2' HG22 ' A' ' 34' ' ' VAL . 3.5 m-85 -126.21 144.08 50.9 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.464 1.106 . . . . 0.0 108.556 174.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 90.4 p -115.69 152.95 32.21 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 125.879 1.671 . . . . 0.0 110.68 176.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.578 ' H ' HD12 ' A' ' 3' ' ' LEU . . . -173.97 141.91 6.23 Favored Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 174.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 13.3 ptt180 -132.42 163.84 27.85 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 127.098 2.159 . . . . 0.0 108.294 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 24.6 mtmt . . . . . 0 N--CA 1.472 0.627 0 N-CA-C 115.341 1.608 . . . . 0.0 115.341 -174.969 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 56.7 m . . . . . 0 N--CA 1.476 0.841 0 N-CA-C 111.201 0.074 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -53.05 -75.72 0.21 Allowed Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.938 1.732 . . . . 0.0 114.862 -175.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -165.97 102.62 0.66 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.316 1.446 . . . . 0.0 112.844 -178.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.421 ' HB ' ' HB3' ' A' ' 53' ' ' SER . 6.0 t -129.0 124.69 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 O-C-N 120.977 -1.077 . . . . 0.0 110.87 -178.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.593 ' HB3' ' CZ ' ' A' ' 103' ' ' PHE . . . -167.8 159.47 11.69 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.036 1.334 . . . . 0.0 112.233 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -141.06 143.87 34.61 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 124.396 1.078 . . . . 0.0 109.813 174.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -140.58 168.54 19.56 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 121.402 -0.811 . . . . 0.0 109.958 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -137.1 155.01 50.14 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 175.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -130.89 127.22 38.07 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.925 1.69 . . . . 0.0 111.985 -175.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -82.54 114.56 21.03 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.868 0.366 . . . . 0.0 111.067 -178.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 2.0 mtm -84.1 136.5 33.98 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.647 1.179 . . . . 0.0 111.169 176.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.2 t -64.32 -19.15 65.25 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.77 0.828 . . . . 0.0 113.213 176.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -69.35 -13.72 62.53 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 125.34 1.456 . . . . 0.0 113.496 175.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 104.31 23.07 8.23 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 124.736 1.16 . . . . 0.0 115.09 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.507 ' HB3' HG22 ' A' ' 120' ' ' ILE . 7.5 m-80 -129.98 173.87 10.3 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 118.911 1.356 . . . . 0.0 110.035 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.6 m -130.47 107.75 9.46 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.403 1.081 . . . . 0.0 111.083 178.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 55.4 tp -70.68 105.49 3.18 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.245 1.018 . . . . 0.0 111.079 175.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -97.16 95.09 1.67 Allowed Glycine 0 CA--C 1.525 0.663 0 C-N-CA 125.639 1.59 . . . . 0.0 112.323 176.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 79.4 t -76.25 139.91 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 123.845 0.858 . . . . 0.0 110.51 174.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 2.6 tmm? -129.75 125.75 36.59 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.481 1.112 . . . . 0.0 111.056 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.593 ' CZ ' ' HB3' ' A' ' 87' ' ' ALA . 48.9 p90 -136.94 134.95 37.29 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 122.417 1.104 . . . . 0.0 113.601 174.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 71.9 m -137.63 121.28 17.37 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.482 1.113 . . . . 0.0 111.563 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 41.4 t . . . . . 0 CA--C 1.541 0.613 0 C-N-CA 126.576 1.95 . . . . 0.0 107.455 175.037 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.7 m . . . . . 0 N--CA 1.473 0.704 0 CA-C-O 121.314 0.578 . . . . 0.0 111.907 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -125.96 72.64 1.3 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.407 1.483 . . . . 0.0 112.258 -175.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 22.8 m0 -71.82 143.99 49.28 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 121.334 -0.854 . . . . 0.0 112.292 -174.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 34.3 p-90 -140.82 137.0 32.98 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.168 0.987 . . . . 0.0 111.881 -179.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -144.76 168.56 19.91 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 125.198 1.399 . . . . 0.0 111.684 -176.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 72.2 t -147.55 129.67 6.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 124.7 1.2 . . . . 0.0 107.894 174.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.58 170.2 15.07 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.434 1.094 . . . . 0.0 110.518 174.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.507 HG22 ' HB3' ' A' ' 97' ' ' ASN . 12.7 mt -132.01 104.77 8.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 177.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -62.18 145.8 93.2 Favored Pre-proline 0 CA--C 1.546 0.818 0 O-C-N 121.485 -0.759 . . . . 0.0 110.886 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -73.81 8.91 1.79 Allowed 'Trans proline' 0 CA--C 1.548 1.188 0 C-N-CA 124.413 3.408 . . . . 0.0 114.862 -175.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -172.98 179.77 44.2 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 126.95 2.214 . . . . 0.0 111.406 177.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -53.94 102.71 0.06 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 126.645 1.978 . . . . 0.0 111.565 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 11.1 tpp180 -132.45 141.6 48.89 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.538 1.535 . . . . 0.0 111.776 -177.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 8.7 ptt180 -76.82 179.53 6.06 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.262 1.025 . . . . 0.0 113.536 174.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -124.4 116.39 22.48 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 128.326 2.651 . . . . 0.0 104.681 174.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -140.12 169.18 18.18 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.143 1.377 . . . . 0.0 110.422 177.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.77 -43.19 65.65 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.56 1.144 . . . . 0.0 113.261 -178.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -56.13 -56.44 24.18 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 123.72 0.676 . . . . 0.0 112.744 174.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 2.9 mtm -64.17 -33.3 75.47 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 118.321 1.06 . . . . 0.0 112.973 177.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.28 -63.91 1.13 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.231 1.013 . . . . 0.0 108.895 174.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -63.81 -32.81 74.45 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.621 0.601 . . . . 0.0 112.621 -176.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -64.18 -34.13 77.38 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.506 1.122 . . . . 0.0 113.446 176.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 6.4 tpp -97.72 -21.88 16.74 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 175.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -51.84 -54.99 22.71 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 126.638 1.975 . . . . 0.0 109.783 174.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -64.61 -12.1 42.0 Favored 'General case' 0 CA--C 1.552 1.045 0 N-CA-C 113.72 1.008 . . . . 0.0 113.72 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -79.16 -33.12 36.99 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 126.832 2.158 . . . . 0.0 113.925 -175.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -127.61 90.73 47.51 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 124.593 1.157 . . . . 0.0 111.21 177.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -72.51 72.92 2.9 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 123.561 2.84 . . . . 0.0 112.376 178.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -113.39 119.48 37.78 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 124.659 1.184 . . . . 0.0 109.848 174.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -89.03 0.43 56.68 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.591 1.557 . . . . 0.0 114.557 175.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 85.01 75.07 1.24 Allowed Glycine 0 CA--C 1.522 0.511 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 -175.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -74.53 122.2 22.72 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.907 0.883 . . . . 0.0 109.229 174.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -56.34 144.16 31.58 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.09 0.956 . . . . 0.0 112.395 -177.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . 0.477 ' C ' HD13 ' A' ' 161' ' ' ILE . . . 117.19 -78.97 0.29 Allowed Glycine 0 CA--C 1.532 1.141 0 C-N-CA 126.095 1.807 . . . . 0.0 113.037 -176.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 32.2 m95 171.99 104.84 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 130.816 3.646 . . . . 0.0 108.629 -175.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -134.59 137.0 43.36 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 126.456 1.902 . . . . 0.0 111.868 -177.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -160.38 -172.01 3.4 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -174.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.422 ' HA ' ' HE2' ' A' ' 150' ' ' LYS . 1.5 mmpt? -133.33 155.13 49.99 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 126.285 1.834 . . . . 0.0 111.158 174.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -78.23 144.09 36.55 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 174.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.3 mt -107.38 153.6 22.53 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 122.22 1.009 . . . . 0.0 109.732 178.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -64.38 -166.78 1.18 Allowed Glycine 0 CA--C 1.535 1.304 0 C-N-CA 123.673 0.654 . . . . 0.0 112.262 174.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.47 ' CE2' ' HB ' ' A' ' 120' ' ' ILE . 0.0 OUTLIER 56.78 9.47 0.6 Allowed 'General case' 0 CA--C 1.556 1.2 0 N-CA-C 114.844 1.424 . . . . 0.0 114.844 174.968 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 81.48 38.32 14.88 Favored Glycine 0 CA--C 1.538 1.514 0 C-N-CA 126.736 2.112 . . . . 0.0 114.693 -175.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.7 mp -126.79 159.64 33.21 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 119.868 1.834 . . . . 0.0 113.671 -176.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 74.1 mtt180 -144.69 118.71 9.39 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.316 1.047 . . . . 0.0 110.181 -178.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 3.1 ttp -103.51 138.94 39.52 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 124.313 1.045 . . . . 0.0 108.443 177.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -111.06 133.82 53.14 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 127.031 2.132 . . . . 0.0 110.131 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -141.39 160.88 26.93 Favored Glycine 0 N--CA 1.478 1.459 0 CA-C-N 121.849 2.113 . . . . 0.0 116.191 178.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.477 HD13 ' C ' ' A' ' 146' ' ' GLY . 1.4 tp -149.51 127.22 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 125.166 1.386 . . . . 0.0 110.978 -177.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . 0.423 ' N ' HD12 ' A' ' 161' ' ' ILE . 29.4 mtp -148.48 164.95 32.63 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 128.807 2.843 . . . . 0.0 108.224 174.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 10.2 t -138.0 154.98 49.29 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.999 0.52 . . . . 0.0 111.124 175.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 94.9 p -77.57 13.87 1.16 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.726 1.611 . . . . 0.0 114.275 179.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.26 1.08 0.13 Allowed 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 126.794 2.038 . . . . 0.0 115.548 175.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 87.75 -62.3 3.99 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 126.14 1.829 . . . . 0.0 113.151 174.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -102.53 20.06 17.81 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.32 1.448 . . . . 0.0 113.076 -177.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -60.57 161.58 7.47 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.118 1.367 . . . . 0.0 113.579 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.41 173.41 9.15 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 126.446 1.899 . . . . 0.0 111.653 174.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 44.8 ttp -134.05 118.51 17.86 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.97 1.308 . . . . 0.0 111.794 177.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -124.62 128.55 49.04 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 121.141 -0.975 . . . . 0.0 109.525 177.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 4.6 mp -133.89 124.51 47.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 123.735 0.814 . . . . 0.0 109.915 176.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -123.34 132.11 53.88 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.36 1.464 . . . . 0.0 111.391 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.8 mp -79.31 127.57 39.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 O-C-N 121.207 -0.933 . . . . 0.0 109.338 176.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 4.2 m -132.3 98.9 4.52 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.093 1.357 . . . . 0.0 112.04 178.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 49.9 mtp85 . . . . . 0 C--O 1.253 1.242 0 C-N-CA 127.357 2.263 . . . . 0.0 113.032 175.02 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.537 HD13 ' HB2' ' A' ' 31' ' ' LYS . 1.5 mt . . . . . 0 N--CA 1.484 1.249 0 CA-C-O 121.016 0.436 . . . . 0.0 111.944 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -115.83 116.24 27.67 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 127.227 2.211 . . . . 0.0 110.491 -175.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -77.85 -82.95 0.58 Allowed Glycine 0 CA--C 1.533 1.201 0 C-N-CA 124.744 1.164 . . . . 0.0 113.551 -178.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 54.2 p -139.27 174.17 10.79 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 126.406 1.882 . . . . 0.0 111.451 -175.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -135.57 15.64 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 C-N-CA 125.702 1.601 . . . . 0.0 111.638 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 15.3 pt -54.36 171.56 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 126.272 1.829 . . . . 0.0 113.402 178.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -43.09 132.42 4.12 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.044 1.737 . . . . 0.0 113.258 178.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -54.75 -31.03 53.54 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 125.487 1.518 . . . . 0.0 116.147 -174.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.47 -22.58 67.0 Favored 'General case' 0 CA--C 1.547 0.834 0 O-C-N 121.648 -0.913 . . . . 0.0 112.636 174.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.3 t -98.25 -45.36 6.21 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.187 2.195 . . . . 0.0 111.722 176.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.522 HD23 ' HB3' ' A' ' 69' ' ' ALA . 3.2 tp -78.77 88.25 4.64 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.449 1.5 . . . . 0.0 111.062 174.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.2 p -120.28 -179.67 4.02 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 126.994 2.118 . . . . 0.0 111.976 177.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -45.4 -42.03 9.78 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.11 1.764 . . . . 0.0 113.523 175.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -52.91 -44.25 66.82 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 118.953 0.797 . . . . 0.0 111.819 177.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 61.4 t -64.13 -41.87 93.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 125.587 1.555 . . . . 0.0 111.651 175.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 29.3 mt -67.72 -40.13 84.26 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 120.845 -1.159 . . . . 0.0 111.933 179.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -63.64 -45.99 87.72 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.824 0.849 . . . . 0.0 111.786 178.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.74 -32.83 74.38 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-O 118.371 -0.823 . . . . 0.0 112.961 175.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 25.2 t -56.59 -42.02 75.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 CA-C-N 119.796 1.18 . . . . 0.0 111.48 177.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 49.2 mt -59.56 -13.29 8.68 Favored 'General case' 0 CA--C 1.552 1.045 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 175.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -104.67 -49.69 1.01 Allowed Glycine 0 CA--C 1.539 1.539 0 C-N-CA 126.855 2.169 . . . . 0.0 114.229 176.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -74.17 -30.41 62.23 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 119.186 1.493 . . . . 0.0 114.389 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -100.34 171.88 7.5 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.277 1.431 . . . . 0.0 110.463 174.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 154.83 131.49 1.48 Allowed Glycine 0 CA--C 1.534 1.22 0 O-C-N 121.122 -0.986 . . . . 0.0 114.601 177.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.4 mtpm? -113.5 -50.74 2.84 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 126.097 1.759 . . . . 0.0 114.0 176.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.7 m -132.25 -179.32 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 124.285 1.034 . . . . 0.0 112.348 -174.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.3 t -48.88 -42.37 36.49 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 126.082 1.753 . . . . 0.0 114.322 -175.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 8.8 tpp180 -124.69 136.35 53.82 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 126.297 1.839 . . . . 0.0 108.964 174.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.537 ' HB2' HD13 ' A' ' 3' ' ' LEU . 0.1 OUTLIER -130.58 167.64 18.39 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.333 1.453 . . . . 0.0 110.8 178.292 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -137.41 133.04 46.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 124.187 0.995 . . . . 0.0 108.38 174.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -134.21 95.84 3.49 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 127.61 2.364 . . . . 0.0 109.855 -178.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.672 HG22 ' HB2' ' A' ' 72' ' ' TYR . 1.4 m -98.91 167.02 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 123.212 0.605 . . . . 0.0 111.552 179.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -142.59 108.69 0.53 Allowed Glycine 0 CA--C 1.523 0.562 0 CA-C-O 119.645 -0.53 . . . . 0.0 113.414 174.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.9 mp -98.51 144.31 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 117.929 0.865 . . . . 0.0 109.184 175.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -119.61 102.83 8.9 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.143 1.377 . . . . 0.0 111.161 -178.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -70.73 85.29 0.65 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 129.44 3.096 . . . . 0.0 113.047 -175.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.57 3.37 13.99 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.746 1.619 . . . . 0.0 113.658 175.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.5 m -55.56 -30.89 61.59 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 115.335 1.605 . . . . 0.0 115.335 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 111.06 95.68 2.31 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.576 1.084 . . . . 0.0 112.098 -177.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 113.51 160.11 13.78 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 126.102 1.81 . . . . 0.0 112.625 -178.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.623 HG22 ' HA ' ' A' ' 65' ' ' PRO . 80.8 p -69.34 148.2 50.03 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 121.975 -0.721 . . . . 0.0 111.563 175.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 34.9 m0 -103.32 105.85 16.22 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.925 0.89 . . . . 0.0 109.584 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 59.4 m -92.75 129.98 38.51 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.269 1.027 . . . . 0.0 110.466 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.85 127.98 33.83 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.045 0.938 . . . . 0.0 112.22 174.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -117.14 -43.6 2.84 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.698 1.199 . . . . 0.0 112.269 175.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -170.04 149.64 3.63 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.467 1.907 . . . . 0.0 110.955 -178.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -133.38 155.84 48.74 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.382 1.473 . . . . 0.0 110.231 175.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -138.2 97.69 3.45 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.048 1.339 . . . . 0.0 111.413 -178.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.496 ' CD1' ' HB1' ' A' ' 87' ' ' ALA . 2.3 m-85 -99.17 111.99 24.25 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.356 1.062 . . . . 0.0 110.646 177.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.13 -39.45 16.69 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.278 0.631 . . . . 0.0 111.563 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.5 t -129.3 -177.08 4.09 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.623 2.369 . . . . 0.0 107.591 174.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 55.52 24.33 38.56 Favored Glycine 0 CA--C 1.538 1.493 0 O-C-N 121.178 -0.951 . . . . 0.0 113.783 -179.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.3 p -33.18 106.01 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 129.185 2.994 . . . . 0.0 112.719 -175.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.509 HG21 HG23 ' A' ' 59' ' ' ILE . 5.0 t -109.92 -177.22 3.21 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -174.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -92.44 -64.1 1.15 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.781 2.032 . . . . 0.0 112.21 175.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.2 p -144.06 131.91 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.989 1.315 . . . . 0.0 111.686 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.509 HG23 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -131.01 -20.01 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 126.046 1.739 . . . . 0.0 113.595 178.21 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.3 mp -106.8 88.47 3.56 Favored Pre-proline 0 N--CA 1.45 -0.434 0 C-N-CA 125.902 1.681 . . . . 0.0 107.279 -174.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -59.14 151.9 63.45 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.615 2.21 . . . . 0.0 110.843 176.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -42.87 -49.02 5.89 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.335 1.854 . . . . 0.0 113.523 -178.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.6 p -160.79 140.63 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 127.039 2.136 . . . . 0.0 109.259 175.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 66.3 t -116.91 127.46 26.71 Favored Pre-proline 0 N--CA 1.477 0.92 0 C-N-CA 124.63 1.172 . . . . 0.0 108.325 175.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.623 ' HA ' HG22 ' A' ' 43' ' ' THR . 60.4 Cg_endo -66.23 157.65 58.87 Favored 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 122.123 1.882 . . . . 0.0 112.424 178.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -70.47 160.63 32.06 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 121.785 -0.572 . . . . 0.0 110.66 175.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 31.8 p 60.96 19.14 9.56 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 126.621 1.969 . . . . 0.0 113.697 -174.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 42.2 mttt -131.65 171.24 13.7 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.612 1.565 . . . . 0.0 111.489 -178.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.522 ' HB3' HD23 ' A' ' 13' ' ' LEU . . . -122.52 179.11 4.7 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 123.855 0.862 . . . . 0.0 111.839 -174.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -149.75 168.99 22.11 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 125.526 1.53 . . . . 0.0 110.948 174.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.412 HD13 ' O ' ' A' ' 34' ' ' VAL . 0.4 OUTLIER -119.08 158.14 26.45 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.879 1.672 . . . . 0.0 111.323 178.548 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.672 ' HB2' HG22 ' A' ' 34' ' ' VAL . 9.1 m-85 -130.27 144.25 51.26 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.343 1.057 . . . . 0.0 110.051 174.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.5 p -120.58 138.57 53.81 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 126.812 2.045 . . . . 0.0 110.365 175.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.503 ' N ' HD12 ' A' ' 3' ' ' LEU . . . -150.85 129.73 2.98 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 174.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.06 107.2 9.41 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 127.67 2.388 . . . . 0.0 111.599 -175.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.476 0.837 0 C-N-CA 126.092 1.757 . . . . 0.0 112.875 176.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 42.2 m . . . . . 0 N--CA 1.483 1.215 0 CA-C-O 117.896 -1.05 . . . . 0.0 108.929 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -21.98 -74.9 0.01 OUTLIER Glycine 0 N--CA 1.485 1.937 0 C-N-CA 127.452 2.453 . . . . 0.0 113.742 -178.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -163.05 120.4 1.92 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.869 1.668 . . . . 0.0 109.839 174.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.9 t -144.1 114.55 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.168 0.987 . . . . 0.0 109.826 -178.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.566 ' HB3' ' CZ ' ' A' ' 103' ' ' PHE . . . -163.29 164.36 24.93 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.964 0.888 . . . . 0.0 113.186 -176.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -144.52 162.19 37.19 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.252 1.421 . . . . 0.0 112.076 174.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -160.78 172.65 16.66 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 124.672 1.189 . . . . 0.0 110.575 179.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.49 ' HB2' ' HB2' ' A' ' 127' ' ' ALA . . . -136.81 160.38 39.04 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 175.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -137.37 131.18 31.72 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.835 1.254 . . . . 0.0 113.892 175.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -79.36 109.04 13.34 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.947 0.899 . . . . 0.0 110.691 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 4.0 ttm -72.1 145.08 48.42 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.143 0.977 . . . . 0.0 111.937 175.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 14.3 t -61.69 -28.16 69.2 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.296 1.038 . . . . 0.0 112.955 175.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 -69.44 -8.09 43.66 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.825 1.25 . . . . 0.0 113.782 175.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 91.95 39.53 5.46 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.318 0.961 . . . . 0.0 113.951 177.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -138.34 171.88 13.72 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.184 1.393 . . . . 0.0 110.484 175.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.432 HG21 ' O ' ' A' ' 125' ' ' ARG . 53.5 m -122.22 111.9 17.52 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 119.075 0.852 . . . . 0.0 113.163 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 61.9 tp -73.32 101.44 3.42 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.583 1.953 . . . . 0.0 110.404 174.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -91.01 117.6 5.18 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 126.221 1.867 . . . . 0.0 112.318 176.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 91.1 t -119.17 141.62 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 125.642 1.577 . . . . 0.0 110.68 -175.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 2.9 ppp? -148.37 170.22 18.44 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.897 0.856 . . . . 0.0 113.296 174.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.566 ' CZ ' ' HB3' ' A' ' 87' ' ' ALA . 18.0 p90 -152.71 149.28 28.22 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.625 1.57 . . . . 0.0 113.89 175.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 22.4 t -143.1 107.71 4.84 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.585 1.554 . . . . 0.0 110.086 175.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 10.8 m . . . . . 0 CA--C 1.539 0.533 0 C-N-CA 125.597 1.559 . . . . 0.0 109.021 175.03 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 19.3 m . . . . . 0 N--CA 1.468 0.461 0 CA-C-O 120.905 0.383 . . . . 0.0 111.276 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -124.66 95.69 4.61 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.239 1.015 . . . . 0.0 109.898 -176.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 51.9 m0 -110.74 148.24 32.74 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.19 0.519 . . . . 0.0 111.656 -177.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 17.5 p-90 -149.13 135.17 19.03 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.366 0.667 . . . . 0.0 112.566 -174.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -161.4 173.39 14.99 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 122.732 1.253 . . . . 0.0 113.111 175.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 60.3 t -138.59 143.85 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 126.462 1.905 . . . . 0.0 107.98 176.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.67 174.56 11.34 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.601 1.561 . . . . 0.0 110.565 178.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 26.0 mt -127.09 138.77 53.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 174.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 99.7 m-85 -102.35 149.56 36.77 Favored Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 125.103 1.361 . . . . 0.0 111.966 176.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -69.48 113.39 3.31 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.861 3.041 . . . . 0.0 111.321 176.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 69.16 -171.63 39.14 Favored Glycine 0 CA--C 1.537 1.421 0 O-C-N 121.896 -0.503 . . . . 0.0 114.119 -175.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 11.8 tmtt? -58.15 113.15 1.79 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.565 1.546 . . . . 0.0 111.594 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.432 ' O ' HG21 ' A' ' 98' ' ' THR . 0.0 OUTLIER -134.08 113.69 12.37 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.768 1.227 . . . . 0.0 111.465 -178.782 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 4.5 ptp180 -57.65 161.72 3.49 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.711 -0.618 . . . . 0.0 112.308 175.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.49 ' HB2' ' HB2' ' A' ' 90' ' ' ALA . . . -113.12 99.02 7.51 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 175.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -124.5 167.48 14.38 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.591 1.556 . . . . 0.0 109.988 -177.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -53.25 -38.94 63.46 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.185 0.994 . . . . 0.0 113.425 -177.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -60.61 -57.67 17.77 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 123.753 0.692 . . . . 0.0 112.151 176.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 3.3 mtm -61.4 -37.22 82.65 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.326 0.65 . . . . 0.0 112.524 178.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.82 -62.91 1.46 Allowed 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.768 0.713 . . . . 0.0 110.0 174.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -60.37 -40.4 90.68 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.104 0.962 . . . . 0.0 113.145 -175.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -60.53 -46.48 90.02 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.062 0.945 . . . . 0.0 112.441 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 78.1 mmm -82.25 -30.84 30.49 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 177.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -55.19 -57.21 12.7 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.295 1.838 . . . . 0.0 110.769 175.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.32 -20.09 65.99 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-O 121.439 0.638 . . . . 0.0 112.166 -177.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -80.35 -2.55 89.41 Favored Glycine 0 CA--C 1.538 1.483 0 C-N-CA 126.744 2.116 . . . . 0.0 114.839 175.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -141.77 77.32 19.06 Favored Pre-proline 0 CA--C 1.553 1.081 0 CA-C-N 119.62 1.71 . . . . 0.0 114.145 -175.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.89 101.05 1.27 Allowed 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 123.688 2.925 . . . . 0.0 113.266 -176.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -138.2 123.31 19.16 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.583 1.153 . . . . 0.0 110.704 178.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 4.6 mpt_? -93.34 -157.29 0.53 Allowed 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 125.297 1.439 . . . . 0.0 111.081 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -86.12 77.5 2.03 Favored Glycine 0 CA--C 1.531 1.037 0 O-C-N 120.132 -1.605 . . . . 0.0 110.116 175.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -75.99 85.14 2.89 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.152 1.781 . . . . 0.0 111.171 -175.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -54.43 116.39 2.62 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 -174.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 141.78 -73.01 0.38 Allowed Glycine 0 CA--C 1.533 1.212 0 C-N-CA 125.251 1.405 . . . . 0.0 114.057 175.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 27.9 m95 169.19 106.33 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 131.199 3.8 . . . . 0.0 108.485 -174.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -137.92 132.19 32.04 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 127.327 2.251 . . . . 0.0 110.471 -177.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -158.38 -173.66 4.42 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -175.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.3 mtmm -140.4 162.84 34.36 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 126.501 1.921 . . . . 0.0 111.564 175.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -73.29 137.34 44.8 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.431 1.092 . . . . 0.0 109.456 174.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 45.1 mt -92.97 88.74 6.26 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.294 1.038 . . . . 0.0 110.478 177.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 35.81 -76.45 0.0 OUTLIER Glycine 0 N--CA 1.477 1.405 1 C-N-CA 130.83 4.062 . . . . 0.0 116.592 175.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -70.02 -153.45 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 128.311 2.645 . . . . 0.0 110.472 175.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -75.42 24.52 1.42 Allowed Glycine 0 CA--C 1.542 1.742 0 O-C-N 120.15 -1.594 . . . . 0.0 115.072 174.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.84 149.06 24.58 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 120.211 2.005 . . . . 0.0 111.698 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 61.5 mtt85 -140.89 114.33 8.73 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.736 1.214 . . . . 0.0 111.433 177.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . 0.402 ' SD ' HG21 ' A' ' 172' ' ' ILE . 8.0 ttp -94.96 143.17 26.68 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 125.28 1.432 . . . . 0.0 108.803 175.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 4.4 tppt? -121.98 124.9 45.11 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 127.199 2.199 . . . . 0.0 109.853 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -137.58 158.61 24.59 Favored Glycine 0 N--CA 1.478 1.439 0 N-CA-C 117.974 1.95 . . . . 0.0 117.974 -175.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.518 HD13 ' N ' ' A' ' 162' ' ' MET . 0.0 OUTLIER -147.69 131.72 9.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 C-N-CA 125.372 1.469 . . . . 0.0 111.668 -177.049 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . 0.518 ' N ' HD13 ' A' ' 161' ' ' ILE . 3.5 mtm -149.77 160.93 43.16 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 128.537 2.735 . . . . 0.0 108.231 174.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 5.5 t -140.89 133.91 29.28 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 121.133 -0.979 . . . . 0.0 112.003 174.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 45.6 m -74.4 12.29 0.8 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.433 1.493 . . . . 0.0 114.187 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -51.01 -43.0 60.76 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.77 1.628 . . . . 0.0 114.21 176.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 146.91 -77.79 0.25 Allowed Glycine 0 CA--C 1.532 1.105 0 C-N-CA 125.139 1.352 . . . . 0.0 112.845 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 27.5 tp10 -95.83 43.81 1.08 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 125.145 1.378 . . . . 0.0 110.831 -177.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -77.24 172.57 13.07 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.301 1.04 . . . . 0.0 112.928 178.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . 0.402 ' HE2' ' O ' ' A' ' 169' ' ' LYS . 0.0 OUTLIER -114.07 173.93 6.19 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 126.711 2.004 . . . . 0.0 109.633 174.919 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 2.0 tmm? -126.85 123.17 36.7 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 125.385 1.474 . . . . 0.0 109.12 178.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -132.4 128.46 37.6 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.504 0.721 . . . . 0.0 110.532 177.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.402 HG21 ' SD ' ' A' ' 158' ' ' MET . 4.8 mp -135.61 122.97 35.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 123.428 0.691 . . . . 0.0 110.11 175.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -118.88 136.1 54.22 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.556 1.542 . . . . 0.0 110.043 176.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.8 mp -82.93 137.15 21.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 O-C-N 121.315 -0.866 . . . . 0.0 109.241 175.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 9.3 m -128.78 95.9 4.23 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.229 1.012 . . . . 0.0 111.85 176.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 7.2 mmm180 . . . . . 0 C--O 1.253 1.288 0 C-N-CA 126.296 1.838 . . . . 0.0 111.75 174.945 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.502 HD11 ' HB2' ' A' ' 31' ' ' LYS . 16.1 mt . . . . . 0 N--CA 1.485 1.316 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -75.14 96.08 3.21 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.626 -0.671 . . . . 0.0 110.083 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -60.94 -75.48 0.29 Allowed Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.426 1.013 . . . . 0.0 112.314 -176.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 27.4 p -150.85 172.3 15.85 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 127.189 2.196 . . . . 0.0 110.423 174.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -124.79 5.51 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 124.934 1.294 . . . . 0.0 112.75 175.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 pt -24.42 -75.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 129.591 3.156 . . . . 0.0 116.673 -176.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -162.47 137.59 6.97 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.218 1.407 . . . . 0.0 111.324 -177.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.65 -21.49 58.07 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 124.577 1.084 . . . . 0.0 114.641 -178.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.27 -31.11 72.18 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.233 1.013 . . . . 0.0 113.175 174.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.5 t -102.96 -40.87 6.32 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 125.083 1.353 . . . . 0.0 111.726 175.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 14.3 tp -74.24 82.74 1.85 Allowed 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.235 1.414 . . . . 0.0 111.099 175.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.8 p -113.98 179.68 3.89 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 126.654 1.981 . . . . 0.0 112.425 176.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -47.47 -42.2 22.2 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.064 1.346 . . . . 0.0 113.019 176.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -57.55 -37.88 73.86 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.759 0.823 . . . . 0.0 112.174 178.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.6 t -67.48 -41.16 85.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.083 0.953 . . . . 0.0 110.283 175.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 21.3 mt -63.71 -41.08 98.15 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 121.33 -0.856 . . . . 0.0 110.961 177.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.39 -44.15 92.23 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.793 0.837 . . . . 0.0 112.641 178.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.68 -32.6 62.26 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 175.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.1 t -51.4 -46.49 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 C-N-CA 125.601 1.56 . . . . 0.0 111.933 175.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 15.0 mt -53.97 -20.15 5.76 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.188 1.395 . . . . 0.0 113.716 178.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -108.42 -40.08 1.68 Allowed Glycine 0 CA--C 1.537 1.415 0 C-N-CA 126.134 1.826 . . . . 0.0 114.926 178.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -72.05 -28.61 63.46 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 119.768 1.784 . . . . 0.0 113.965 179.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -92.24 133.36 35.89 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.83 1.252 . . . . 0.0 110.992 176.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.12 125.11 7.19 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 125.261 1.41 . . . . 0.0 113.852 -175.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.94 -172.19 4.15 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 126.366 1.866 . . . . 0.0 112.053 -177.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.9 m -72.47 -177.96 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 126.085 1.754 . . . . 0.0 110.898 174.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 60.9 m -49.7 -50.01 45.53 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.517 1.527 . . . . 0.0 113.529 -177.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -117.43 138.21 51.99 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.041 1.337 . . . . 0.0 110.662 175.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.502 ' HB2' HD11 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -141.42 161.09 38.75 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 126.132 1.773 . . . . 0.0 111.593 -175.062 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -131.25 114.25 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-O 122.238 1.018 . . . . 0.0 112.018 -179.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -117.31 111.51 19.48 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.735 2.014 . . . . 0.0 109.111 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.811 HG22 ' HB2' ' A' ' 72' ' ' TYR . 1.8 m -116.67 151.98 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 CA-C-O 119.097 -0.478 . . . . 0.0 111.272 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -131.12 101.34 0.48 Allowed Glycine 0 CA--C 1.524 0.649 0 C-N-CA 123.815 0.722 . . . . 0.0 112.872 -179.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.9 mp -91.93 136.22 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-N 118.209 1.005 . . . . 0.0 110.318 175.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -101.13 104.48 15.58 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.185 1.394 . . . . 0.0 110.666 178.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -70.39 82.74 0.56 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 127.889 2.476 . . . . 0.0 111.057 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -120.85 11.64 11.14 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 125.109 1.364 . . . . 0.0 114.144 175.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 99.8 p -60.15 -7.51 1.92 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 126.67 1.988 . . . . 0.0 116.351 174.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 93.57 21.05 30.1 Favored Glycine 0 CA--C 1.54 1.626 0 N-CA-C 116.281 1.272 . . . . 0.0 116.281 177.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -166.49 169.56 40.63 Favored Glycine 0 CA--C 1.535 1.305 0 CA-C-N 119.27 1.535 . . . . 0.0 114.196 176.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.556 HG22 ' HA ' ' A' ' 65' ' ' PRO . 7.3 p -72.98 141.75 47.75 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.81 1.244 . . . . 0.0 111.396 175.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.56 ' HA ' ' CE1' ' A' ' 91' ' ' TYR . 34.7 m0 -100.97 98.04 8.55 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 123.586 0.755 . . . . 0.0 112.353 -177.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.1 m -81.72 120.41 25.09 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.266 1.026 . . . . 0.0 108.704 175.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.08 150.51 45.33 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.685 -0.634 . . . . 0.0 112.145 174.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.8 pp -124.25 -51.02 1.77 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.639 0.776 . . . . 0.0 112.976 177.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -171.06 142.89 1.88 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 127.043 2.137 . . . . 0.0 109.738 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.431 ' HB2' HD12 ' A' ' 60' ' ' LEU . . . -121.17 151.44 39.93 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.614 1.166 . . . . 0.0 109.94 174.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -132.67 106.54 7.84 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.413 1.485 . . . . 0.0 111.27 -177.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.498 ' CD1' ' HB1' ' A' ' 87' ' ' ALA . 2.7 m-85 -111.58 124.64 52.71 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.481 1.112 . . . . 0.0 110.248 -175.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.13 -34.2 6.01 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 114.174 1.175 . . . . 0.0 114.174 -174.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 43.7 t -119.0 -47.92 2.47 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.657 1.183 . . . . 0.0 110.375 175.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -67.55 12.27 0.74 Allowed Glycine 0 CA--C 1.54 1.603 0 C-N-CA 126.865 2.174 . . . . 0.0 117.623 -174.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 76.0 p -27.14 107.69 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 129.597 3.159 . . . . 0.0 114.671 -175.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.482 HG21 HG23 ' A' ' 59' ' ' ILE . 3.9 t -128.75 -177.05 4.04 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.826 2.05 . . . . 0.0 113.509 -175.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -88.44 -54.79 4.01 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.051 1.341 . . . . 0.0 113.897 177.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.9 p -149.89 133.45 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 124.898 1.279 . . . . 0.0 111.99 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.482 HG23 HG21 ' A' ' 56' ' ' THR . 0.1 OUTLIER -136.68 -35.18 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 N-CA-C 114.838 1.422 . . . . 0.0 114.838 179.29 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.431 HD12 ' HB2' ' A' ' 49' ' ' ALA . 7.2 mt -88.5 100.05 1.78 Allowed Pre-proline 0 CA--C 1.543 0.694 0 C-N-CA 125.665 1.586 . . . . 0.0 108.599 176.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.576 ' HG2' HG23 ' A' ' 64' ' ' VAL . 89.3 Cg_endo -68.51 150.53 75.34 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 122.554 2.17 . . . . 0.0 110.985 176.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -48.1 -45.54 32.85 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.983 1.313 . . . . 0.0 113.446 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.2 p -156.26 136.19 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 126.398 1.879 . . . . 0.0 110.287 175.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.576 HG23 ' HG2' ' A' ' 61' ' ' PRO . 72.7 t -113.71 129.96 24.22 Favored Pre-proline 0 N--CA 1.481 1.079 0 C-N-CA 124.55 1.14 . . . . 0.0 108.691 174.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.556 ' HA ' HG22 ' A' ' 43' ' ' THR . 66.4 Cg_endo -70.43 158.25 56.63 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 122.667 2.245 . . . . 0.0 113.271 178.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -72.94 160.72 31.67 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 121.421 -0.799 . . . . 0.0 112.726 175.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . 0.275 51.4 p 57.64 23.77 9.74 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 127.077 2.151 . . . . 0.0 113.689 -175.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -119.03 -178.32 3.54 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 126.765 2.026 . . . . 0.0 110.732 178.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -136.54 152.54 50.61 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 175.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.452 HD23 HG21 ' A' ' 64' ' ' VAL . 1.5 pp -117.7 171.01 8.32 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 124.417 1.087 . . . . 0.0 110.963 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.464 HD13 ' O ' ' A' ' 34' ' ' VAL . 0.3 OUTLIER -126.22 153.41 44.75 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.624 1.17 . . . . 0.0 111.004 175.47 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.811 ' HB2' HG22 ' A' ' 34' ' ' VAL . 6.3 m-85 -125.88 153.39 44.24 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.832 1.653 . . . . 0.0 108.835 174.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.402 ' H ' HG22 ' A' ' 59' ' ' ILE . 95.8 p -133.97 141.36 47.26 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 126.197 1.799 . . . . 0.0 111.3 176.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.473 ' H ' HD12 ' A' ' 3' ' ' LEU . . . -162.12 150.38 19.62 Favored Glycine 0 CA--C 1.524 0.624 0 O-C-N 121.916 -0.49 . . . . 0.0 113.092 174.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 11.4 mtm180 -112.24 130.83 55.8 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 126.289 1.836 . . . . 0.0 111.968 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.479 1.002 0 C-N-CA 125.688 1.595 . . . . 0.0 115.12 175.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 42.9 m . . . . . 0 N--CA 1.475 0.81 0 CA-C-O 121.045 0.45 . . . . 0.0 111.263 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 37.82 -114.26 0.28 Allowed Glycine 0 CA--C 1.533 1.193 0 C-N-CA 126.103 1.811 . . . . 0.0 113.969 -178.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.593 ' HB3' HG22 ' A' ' 105' ' ' VAL . . . -141.45 114.84 8.84 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 118.458 1.129 . . . . 0.0 111.274 176.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.2 t -137.33 122.25 24.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 C-N-CA 124.323 1.049 . . . . 0.0 110.18 -176.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.498 ' HB1' ' CD1' ' A' ' 51' ' ' PHE . . . -163.51 171.34 16.0 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.302 1.441 . . . . 0.0 111.359 175.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -151.48 134.38 15.75 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.889 1.275 . . . . 0.0 109.943 174.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.424 ' CD2' ' CE2' ' A' ' 72' ' ' TYR . 54.3 p90 -129.72 171.24 12.87 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 121.27 -0.894 . . . . 0.0 110.285 177.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -143.26 143.9 31.91 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 175.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.56 ' CE1' ' HA ' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -109.98 131.36 55.13 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.497 1.119 . . . . 0.0 109.995 177.289 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -84.51 107.6 16.84 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.364 0.665 . . . . 0.0 112.593 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -68.38 141.64 55.68 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.45 1.1 . . . . 0.0 112.94 -178.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 58.0 p -60.15 -28.24 67.75 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.845 1.258 . . . . 0.0 112.548 174.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 -72.24 -8.23 53.68 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.731 1.612 . . . . 0.0 112.757 174.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 99.99 -6.71 58.52 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 126.662 2.077 . . . . 0.0 114.362 -178.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 53.5 m-20 -78.12 178.33 7.64 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 118.339 1.07 . . . . 0.0 111.34 178.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 19.0 m -139.31 109.12 6.28 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 120.453 -1.404 . . . . 0.0 111.22 174.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.6 tt -72.8 101.81 3.22 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.566 1.146 . . . . 0.0 111.289 175.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -92.79 127.78 9.14 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 125.171 1.367 . . . . 0.0 113.333 175.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 63.5 t -114.44 127.02 72.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 125.763 1.625 . . . . 0.0 111.224 -175.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.11 118.61 24.71 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 126.733 2.013 . . . . 0.0 112.438 -175.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -141.69 121.28 13.34 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.33 1.452 . . . . 0.0 111.642 -175.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 30.4 t -137.3 92.53 2.72 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.473 1.509 . . . . 0.0 110.92 -175.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.593 HG22 ' HB3' ' A' ' 85' ' ' ALA . 2.1 m . . . . . 0 N--CA 1.473 0.68 0 C-N-CA 125.105 1.362 . . . . 0.0 109.669 -179.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 17.1 m . . . . . 0 N--CA 1.477 0.89 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 32.5 t-20 -74.34 106.29 5.9 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.08 1.752 . . . . 0.0 107.912 175.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 44.3 m0 -113.16 145.68 40.53 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 120.297 1.408 . . . . 0.0 108.31 174.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 39.2 p-90 -149.02 142.82 25.63 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.095 0.958 . . . . 0.0 113.047 -177.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -151.69 165.77 33.34 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 123.292 1.52 . . . . 0.0 113.821 -177.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 94.7 t -147.41 129.54 7.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 125.894 1.678 . . . . 0.0 107.349 175.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.33 171.6 14.23 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.515 1.526 . . . . 0.0 110.127 175.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 35.3 mt -134.32 118.59 27.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.762 0.792 . . . . 0.0 109.231 -176.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -80.59 139.12 50.97 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 124.185 0.994 . . . . 0.0 109.23 178.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -72.97 -1.53 10.63 Favored 'Trans proline' 0 CA--C 1.546 1.119 0 C-N-CA 123.706 2.937 . . . . 0.0 114.948 -178.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -141.74 176.27 22.04 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 126.857 2.17 . . . . 0.0 111.94 175.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 9.9 tttm -64.26 105.61 0.94 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.934 1.294 . . . . 0.0 110.884 176.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 11.2 tpp180 -138.77 117.96 12.67 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 124.381 1.072 . . . . 0.0 113.22 -174.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 15.4 ptt180 -62.98 165.42 6.9 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 175.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -110.22 103.18 11.84 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 174.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -111.8 170.82 7.88 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.329 1.051 . . . . 0.0 109.642 175.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -50.07 -39.52 42.46 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.377 0.99 . . . . 0.0 113.304 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -59.42 -59.72 10.11 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 123.869 0.747 . . . . 0.0 112.175 175.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 14.6 mtm -61.82 -35.33 77.9 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 118.058 0.929 . . . . 0.0 113.298 178.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -60.56 -60.49 3.73 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.088 1.355 . . . . 0.0 109.756 175.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -67.26 -29.75 69.45 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -63.96 -36.73 84.91 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.34 1.056 . . . . 0.0 113.019 176.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 7.9 tpp -94.53 -22.23 18.36 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 119.695 1.134 . . . . 0.0 113.463 175.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -49.28 -56.6 8.88 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.602 1.561 . . . . 0.0 110.316 175.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -71.19 -7.02 43.93 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -178.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -84.89 -12.83 73.52 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 126.983 2.23 . . . . 0.0 114.946 -178.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -145.54 90.27 6.04 Favored Pre-proline 0 CA--C 1.552 1.025 0 CA-C-N 119.309 1.555 . . . . 0.0 112.956 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -75.48 81.8 2.23 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 123.674 2.916 . . . . 0.0 112.19 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -116.97 111.64 19.87 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.985 1.314 . . . . 0.0 110.182 -177.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -92.61 41.36 1.07 Allowed 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 127.564 2.346 . . . . 0.0 114.05 -174.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 55.77 51.76 53.03 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 123.704 0.669 . . . . 0.0 112.538 -177.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -61.01 113.63 2.65 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.613 1.165 . . . . 0.0 111.418 -176.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -75.96 83.18 2.85 Favored 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 -175.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 173.09 55.07 0.05 OUTLIER Glycine 0 CA--C 1.539 1.544 0 C-N-CA 125.107 1.336 . . . . 0.0 114.135 175.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' TRP . . . . . 0.63 ' H ' HD13 ' A' ' 161' ' ' ILE . 7.5 m95 48.16 41.72 16.15 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 126.81 2.044 . . . . 0.0 114.077 -174.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -72.75 126.96 31.15 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 120.845 -1.16 . . . . 0.0 111.784 -175.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.15 -170.23 3.06 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -174.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.71 140.92 36.92 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 126.043 1.737 . . . . 0.0 110.447 175.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -67.0 149.36 50.74 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 174.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 29.3 mt -119.79 158.42 26.59 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-O 123.824 1.773 . . . . 0.0 111.435 178.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -64.45 -157.5 0.23 Allowed Glycine 0 CA--C 1.54 1.623 0 C-N-CA 125.62 1.581 . . . . 0.0 111.2 174.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 51.46 15.12 0.3 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.944 -1.327 . . . . 0.0 114.527 175.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 72.66 34.83 59.46 Favored Glycine 0 CA--C 1.54 1.608 0 CA-C-O 117.141 -1.922 . . . . 0.0 113.805 -175.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -139.21 159.41 42.23 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 121.21 2.505 . . . . 0.0 115.188 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 19.4 mtt-85 -135.33 123.7 23.28 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 120.439 -1.413 . . . . 0.0 108.693 -177.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 13.7 ttp -96.14 136.38 36.69 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 176.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.85 129.21 56.33 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 126.803 2.041 . . . . 0.0 109.867 -178.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -136.8 156.36 23.16 Favored Glycine 0 N--CA 1.476 1.36 0 CA-C-N 121.684 2.038 . . . . 0.0 116.293 -177.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.63 HD13 ' H ' ' A' ' 147' ' ' TRP . 6.1 tp -154.56 126.43 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 124.96 1.304 . . . . 0.0 112.527 -174.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 19.5 ttm -148.82 -176.27 5.27 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 128.641 2.776 . . . . 0.0 108.509 177.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 8.9 t -163.01 127.31 2.98 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.527 1.131 . . . . 0.0 111.631 174.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.37 19.61 0.1 Allowed 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.027 1.331 . . . . 0.0 114.11 178.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -58.34 -25.94 62.55 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 127.291 2.236 . . . . 0.0 115.631 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 147.14 -57.87 0.49 Allowed Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.562 1.077 . . . . 0.0 114.48 175.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -133.28 37.9 3.34 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.144 1.378 . . . . 0.0 112.001 -178.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.33 174.58 4.65 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-O 122.61 1.195 . . . . 0.0 113.849 175.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.64 176.26 5.22 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 127.741 2.416 . . . . 0.0 111.527 175.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 1.8 tmm? -128.18 130.91 48.76 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 126.277 1.831 . . . . 0.0 109.648 175.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.448 ' C ' HD12 ' A' ' 172' ' ' ILE . 47.1 tt0 -141.14 131.39 24.96 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.48 1.112 . . . . 0.0 110.203 -178.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.448 HD12 ' C ' ' A' ' 171' ' ' GLN . 4.0 mp -136.11 126.01 40.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 123.883 0.873 . . . . 0.0 109.612 175.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -119.39 129.27 54.72 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 126.516 1.926 . . . . 0.0 111.119 178.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.6 mp -88.55 93.1 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 O-C-N 121.278 -0.889 . . . . 0.0 109.692 -177.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.04 107.51 19.26 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.628 1.571 . . . . 0.0 112.691 179.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.252 1.188 0 C-N-CA 125.547 1.539 . . . . 0.0 112.836 175.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.479 HD22 ' HD3' ' A' ' 27' ' ' LYS . 13.7 tp . . . . . 0 N--CA 1.48 1.042 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -126.1 141.11 52.08 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 127.813 2.445 . . . . 0.0 109.213 175.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -79.75 -136.95 1.51 Allowed Glycine 0 CA--C 1.538 1.504 0 C-N-CA 124.844 1.212 . . . . 0.0 110.989 174.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.0 p -107.31 176.01 5.3 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 125.5 1.52 . . . . 0.0 112.941 -175.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -119.13 17.26 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 126.352 1.861 . . . . 0.0 111.945 -178.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.3 pt -50.39 159.64 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 125.662 1.585 . . . . 0.0 111.349 175.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -42.82 140.26 1.4 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.456 1.502 . . . . 0.0 113.328 -176.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -56.29 -20.9 31.01 Favored Glycine 0 CA--C 1.543 1.788 0 C-N-CA 124.28 0.943 . . . . 0.0 113.745 -176.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.2 -28.55 69.82 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.621 1.568 . . . . 0.0 112.609 174.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 t -101.28 -44.57 5.61 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.974 1.71 . . . . 0.0 111.515 175.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.7 tp -75.81 88.49 2.84 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.278 1.031 . . . . 0.0 111.429 175.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 55.1 p -124.65 -175.09 3.18 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 126.156 1.782 . . . . 0.0 111.344 176.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -50.3 -31.36 14.13 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.851 1.26 . . . . 0.0 113.645 175.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -59.46 -50.31 74.4 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 118.97 0.805 . . . . 0.0 110.902 175.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 73.8 t -64.53 -39.13 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 123.915 0.886 . . . . 0.0 110.974 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 90.2 mt -70.58 -42.12 71.48 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 123.349 0.66 . . . . 0.0 112.62 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -71.17 -44.21 65.93 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.953 0.901 . . . . 0.0 111.607 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.72 -39.8 95.2 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 118.426 -0.797 . . . . 0.0 110.826 175.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.0 t -53.5 -43.59 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 125.054 1.342 . . . . 0.0 112.271 175.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.486 ' HA ' ' HE3' ' A' ' 31' ' ' LYS . 0.1 OUTLIER -60.39 -25.99 66.33 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 175.015 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.57 -48.92 3.33 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.203 0.906 . . . . 0.0 112.979 178.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -70.61 -27.44 64.09 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 17.8 mt -109.31 102.22 11.15 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.737 1.215 . . . . 0.0 110.461 -177.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -131.77 73.15 0.47 Allowed Glycine 0 CA--C 1.534 1.252 0 C-N-CA 125.112 1.339 . . . . 0.0 113.364 -175.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.479 ' HD3' HD22 ' A' ' 3' ' ' LEU . 0.1 OUTLIER -62.0 -58.68 6.96 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 126.416 1.886 . . . . 0.0 113.683 -178.646 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 16.4 m -127.27 -176.92 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 126.497 1.919 . . . . 0.0 110.748 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -47.98 -36.49 12.71 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 115.576 1.695 . . . . 0.0 115.576 -175.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.8 155.69 49.48 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.711 2.004 . . . . 0.0 108.01 174.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.486 ' HE3' ' HA ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -145.67 164.19 32.55 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.919 1.287 . . . . 0.0 110.768 175.988 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.501 ' CG1' ' HB1' ' A' ' 85' ' ' ALA . 0.3 OUTLIER -118.49 138.16 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 124.572 1.149 . . . . 0.0 108.439 175.018 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.452 ' HB3' HD12 ' A' ' 22' ' ' LEU . . . -138.68 132.04 30.22 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.147 1.379 . . . . 0.0 109.597 175.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.402 HG22 ' HB3' ' A' ' 170' ' ' MET . 16.5 t -137.91 148.29 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 123.364 0.666 . . . . 0.0 111.398 -177.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -119.47 93.13 0.54 Allowed Glycine 0 CA--C 1.525 0.677 0 C-N-CA 126.658 2.075 . . . . 0.0 113.161 175.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.7 mp -81.4 136.43 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-N 119.424 1.612 . . . . 0.0 108.788 174.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -112.65 102.46 10.52 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.164 1.786 . . . . 0.0 109.868 178.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -70.32 92.43 0.79 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.867 1.267 . . . . 0.0 109.563 177.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -117.29 0.26 12.2 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.052 1.741 . . . . 0.0 112.722 174.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 23.0 t -50.77 -58.89 4.82 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 126.141 1.776 . . . . 0.0 113.249 -178.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 149.49 -26.4 1.21 Allowed Glycine 0 N--CA 1.473 1.15 0 C-N-CA 124.165 0.888 . . . . 0.0 114.113 178.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -115.96 162.79 12.47 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.541 1.544 . . . . 0.0 111.226 175.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.4 t -85.13 155.58 21.41 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 123.879 0.872 . . . . 0.0 110.781 175.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 7.7 m0 -111.46 153.57 25.95 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 125.352 1.461 . . . . 0.0 112.031 176.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 95.0 m -130.24 141.46 50.63 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.853 1.261 . . . . 0.0 109.925 177.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.47 108.83 0.52 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.749 1.22 . . . . 0.0 112.571 177.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.508 HD11 ' HB3' ' A' ' 90' ' ' ALA . 3.5 pp -104.85 -53.71 2.63 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.286 1.034 . . . . 0.0 112.234 -179.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.476 ' N ' HD12 ' A' ' 47' ' ' LEU . 29.3 t30 -177.73 144.8 0.38 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 127.907 2.483 . . . . 0.0 110.415 -178.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -130.54 159.31 37.5 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.111 1.365 . . . . 0.0 111.512 175.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -142.92 104.2 4.29 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.878 1.271 . . . . 0.0 112.944 -175.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.482 ' CD1' ' HB1' ' A' ' 87' ' ' ALA . 3.1 m-85 -94.09 137.37 33.36 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.376 -0.827 . . . . 0.0 111.902 178.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.3 ttt-85 -98.49 -70.12 0.74 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.138 1.775 . . . . 0.0 111.24 178.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.428 ' CB ' ' H ' ' A' ' 86' ' ' VAL . 0.9 OUTLIER -39.72 -54.62 2.05 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 128.21 2.604 . . . . 0.0 113.722 -175.034 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -157.69 -118.53 0.55 Allowed Glycine 0 CA--C 1.526 0.751 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 175.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.6 p -141.93 175.67 9.54 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.822 1.649 . . . . 0.0 111.87 -174.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.497 ' CG2' HD12 ' A' ' 59' ' ' ILE . 5.7 t -156.51 -176.92 6.23 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.313 1.045 . . . . 0.0 112.755 176.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -102.63 -65.03 1.02 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.39 1.476 . . . . 0.0 112.786 177.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.2 p -130.19 131.68 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 125.551 1.541 . . . . 0.0 111.187 -177.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.497 HD12 ' CG2' ' A' ' 56' ' ' THR . 0.1 OUTLIER -136.85 -63.54 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 125.346 1.458 . . . . 0.0 111.712 -174.969 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.461 ' H ' HG12 ' A' ' 59' ' ' ILE . 80.5 mt -88.37 105.53 9.78 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 125.355 1.462 . . . . 0.0 110.265 175.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -73.33 168.48 24.64 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 123.305 2.67 . . . . 0.0 110.992 175.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -49.45 -44.92 46.02 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.139 0.976 . . . . 0.0 113.544 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 53.7 t -151.13 147.83 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 C-N-CA 126.838 2.055 . . . . 0.0 109.426 -176.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.6 t -125.9 95.07 40.52 Favored Pre-proline 0 N--CA 1.468 0.443 0 C-N-CA 124.913 1.285 . . . . 0.0 108.132 174.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.31 158.04 55.43 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.153 1.902 . . . . 0.0 112.253 176.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -71.53 169.52 15.28 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.092 0.557 . . . . 0.0 111.593 175.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . 0.252 26.0 p 56.79 18.76 3.97 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 127.442 2.297 . . . . 0.0 112.954 -174.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -130.9 172.0 12.54 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 126.86 2.064 . . . . 0.0 110.683 -178.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -134.89 167.43 20.92 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.345 0.658 . . . . 0.0 109.344 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.8 pp -139.16 166.43 24.56 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 124.68 1.192 . . . . 0.0 111.745 177.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.05 152.57 23.84 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 122.134 0.969 . . . . 0.0 111.07 174.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -132.8 149.03 52.31 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 126.64 1.976 . . . . 0.0 109.738 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 94.8 p -148.03 159.9 43.42 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.023 0.929 . . . . 0.0 113.198 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -170.49 148.47 11.54 Favored Glycine 0 N--CA 1.463 0.46 0 CA-C-N 115.738 -0.664 . . . . 0.0 114.316 177.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 58.4 mtm180 -110.33 148.77 31.29 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 125.937 1.695 . . . . 0.0 110.271 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt . . . . . 0 N--CA 1.473 0.703 0 C-N-CA 125.551 1.54 . . . . 0.0 114.053 176.827 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.6 m . . . . . 0 N--CA 1.477 0.908 0 CA-C-O 119.367 -0.349 . . . . 0.0 110.349 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -34.47 -74.98 0.07 OUTLIER Glycine 0 N--CA 1.471 0.991 0 C-N-CA 126.715 2.102 . . . . 0.0 117.518 -175.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.564 ' HB3' ' HB ' ' A' ' 105' ' ' VAL . . . -165.63 91.83 0.51 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.329 1.052 . . . . 0.0 111.51 -174.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.428 ' H ' ' CB ' ' A' ' 53' ' ' SER . 20.4 t -140.11 122.38 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 O-C-N 120.566 -1.333 . . . . 0.0 112.616 -175.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.482 ' HB1' ' CD1' ' A' ' 51' ' ' PHE . . . -155.38 167.6 29.86 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 122.353 1.073 . . . . 0.0 112.882 176.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -146.16 149.97 34.99 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 124.064 0.946 . . . . 0.0 109.84 174.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -151.2 174.12 13.62 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 121.039 -1.038 . . . . 0.0 110.356 178.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.508 ' HB3' HD11 ' A' ' 47' ' ' LEU . . . -138.21 150.61 46.9 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-O 121.176 0.512 . . . . 0.0 112.358 176.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -129.63 117.1 19.84 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 126.939 2.096 . . . . 0.0 112.597 -175.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -80.89 99.72 8.49 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -174.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 20.2 mtm -72.0 127.42 32.51 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.415 1.086 . . . . 0.0 112.237 178.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.6 m -57.56 -18.88 21.79 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.851 1.26 . . . . 0.0 113.414 174.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -64.27 -28.13 69.51 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.631 1.572 . . . . 0.0 112.139 174.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 120.07 19.19 4.03 Favored Glycine 0 CA--C 1.538 1.502 0 C-N-CA 125.819 1.676 . . . . 0.0 115.229 -178.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -128.04 175.82 8.1 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 119.14 1.47 . . . . 0.0 110.899 -178.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 22.7 m -134.48 103.91 5.89 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 121.064 -1.022 . . . . 0.0 111.621 176.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 42.1 tp -68.82 103.49 1.79 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.729 0.812 . . . . 0.0 112.026 175.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -91.71 96.18 2.14 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 126.316 1.912 . . . . 0.0 110.858 175.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 53.8 t -79.93 136.97 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 O-C-N 121.895 -0.768 . . . . 0.0 110.771 175.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.74 141.1 47.37 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.287 1.035 . . . . 0.0 111.593 176.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.47 ' CZ ' ' HB3' ' A' ' 87' ' ' ALA . 3.4 p90 -153.64 120.08 5.52 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 120.887 -1.133 . . . . 0.0 111.501 -174.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 32.8 t -127.47 107.24 9.78 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.915 1.286 . . . . 0.0 110.987 -177.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.564 ' HB ' ' HB3' ' A' ' 85' ' ' ALA . 4.4 t . . . . . 0 CA--C 1.542 0.654 0 C-N-CA 126.599 1.96 . . . . 0.0 108.674 -176.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 55.0 m . . . . . 0 N--CA 1.471 0.613 0 CA-C-O 120.258 0.075 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -137.76 107.1 6.1 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.645 1.178 . . . . 0.0 110.66 -178.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 41.5 m0 -109.83 162.36 14.56 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 125.284 1.434 . . . . 0.0 113.442 -174.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 61.0 p-90 -145.57 132.41 20.1 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.776 0.798 . . . . 0.0 112.273 177.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -144.25 174.47 10.86 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.826 1.65 . . . . 0.0 111.652 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.445 HG22 ' SD ' ' A' ' 158' ' ' MET . 2.5 m -145.03 159.72 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 175.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.63 170.97 14.93 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.764 0.826 . . . . 0.0 111.045 175.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.423 ' HB ' ' CE2' ' A' ' 154' ' ' TYR . 45.5 mt -131.54 104.6 8.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 176.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -71.97 148.91 92.2 Favored Pre-proline 0 CA--C 1.55 0.964 0 O-C-N 121.938 -0.476 . . . . 0.0 110.94 178.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -77.87 82.67 2.36 Favored 'Trans proline' 0 CA--C 1.545 1.037 0 C-N-CA 123.802 3.002 . . . . 0.0 112.37 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 98.54 178.03 32.56 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 125.958 1.742 . . . . 0.0 112.892 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 5.9 mttt -47.7 122.02 4.54 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.116 1.366 . . . . 0.0 112.508 -174.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -135.23 -161.55 1.16 Allowed 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 126.608 1.963 . . . . 0.0 111.433 -177.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 23.5 ptt-85 -140.17 -178.17 5.35 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 128.553 2.741 . . . . 0.0 109.181 175.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -131.67 124.21 29.38 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 174.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -135.72 168.66 18.87 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.375 1.07 . . . . 0.0 111.162 178.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.93 -40.77 73.62 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.538 -0.726 . . . . 0.0 112.5 -176.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -57.22 -58.64 13.56 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 124.53 1.062 . . . . 0.0 112.177 175.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 3.3 mpp? -59.58 -32.67 70.58 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 118.528 1.164 . . . . 0.0 112.5 177.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.27 -63.2 1.31 Allowed 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 175.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -67.17 -30.03 69.88 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -175.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -64.78 -43.46 93.17 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.219 1.008 . . . . 0.0 112.101 175.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.15 -25.81 23.91 Favored 'General case' 0 CA--C 1.546 0.799 0 O-C-N 121.558 -0.714 . . . . 0.0 112.558 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -47.2 -53.65 12.64 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 127.744 2.418 . . . . 0.0 111.859 175.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -63.39 -15.61 58.05 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -74.03 -32.4 58.67 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 128.312 2.863 . . . . 0.0 115.666 -175.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -129.15 90.23 45.82 Favored Pre-proline 0 CA--C 1.546 0.826 0 CA-C-N 119.032 1.416 . . . . 0.0 111.274 175.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -73.2 83.35 1.47 Allowed 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 123.58 2.853 . . . . 0.0 112.87 -176.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -122.46 122.28 38.6 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.739 1.215 . . . . 0.0 112.05 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -104.31 63.91 0.75 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.736 1.614 . . . . 0.0 111.276 -174.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 51.38 60.05 7.71 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 123.971 0.796 . . . . 0.0 112.683 -175.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.83 101.81 3.24 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 126.186 1.794 . . . . 0.0 112.362 -175.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -74.03 55.13 0.55 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 127.627 2.371 . . . . 0.0 116.516 -174.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -166.29 43.78 0.27 Allowed Glycine 0 CA--C 1.533 1.202 0 O-C-N 120.921 -1.112 . . . . 0.0 115.672 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 1.1 m95 52.65 40.51 30.32 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 125.276 1.43 . . . . 0.0 113.773 -176.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -78.9 124.06 27.87 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 126.099 1.76 . . . . 0.0 112.123 -176.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -167.89 -171.54 1.61 Allowed 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.781 0.832 . . . . 0.0 111.785 177.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 4.8 mtpp -138.18 160.91 38.18 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 127.89 2.476 . . . . 0.0 110.977 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 37.7 m-20 -67.26 152.5 45.62 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 122.144 -0.347 . . . . 0.0 110.426 174.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 37.6 mt -108.09 162.03 14.42 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 122.19 0.995 . . . . 0.0 109.06 175.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -62.45 -167.47 0.68 Allowed Glycine 0 CA--C 1.536 1.358 0 C-N-CA 124.512 1.053 . . . . 0.0 111.616 175.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.423 ' CE2' ' HB ' ' A' ' 120' ' ' ILE . 0.0 OUTLIER 55.09 6.28 0.13 Allowed 'General case' 0 CA--C 1.558 1.281 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 174.957 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 82.02 44.88 7.4 Favored Glycine 0 CA--C 1.54 1.607 0 C-N-CA 127.438 2.447 . . . . 0.0 114.427 -175.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.1 mp -127.82 158.03 38.84 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 119.866 1.833 . . . . 0.0 113.123 -178.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -124.65 117.31 23.97 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 121.061 -1.024 . . . . 0.0 110.478 175.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . 0.445 ' SD ' HG22 ' A' ' 118' ' ' VAL . 0.0 OUTLIER -98.21 150.24 21.71 Favored 'General case' 0 C--N 1.322 -0.623 0 O-C-N 120.623 -1.298 . . . . 0.0 108.784 174.996 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -131.4 149.02 52.71 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 127.076 2.151 . . . . 0.0 110.35 176.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -157.52 159.39 29.77 Favored Glycine 0 N--CA 1.464 0.525 0 O-C-N 121.542 -0.724 . . . . 0.0 113.446 176.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.43 HD13 ' N ' ' A' ' 162' ' ' MET . 0.0 OUTLIER -155.15 137.54 6.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 125.222 1.409 . . . . 0.0 109.894 -178.174 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . 0.43 ' N ' HD13 ' A' ' 161' ' ' ILE . 2.5 mtm -150.1 167.22 27.44 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 127.388 2.275 . . . . 0.0 108.345 174.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 9.7 t -145.42 133.45 21.42 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 118.942 0.792 . . . . 0.0 109.858 174.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 81.9 p -82.05 30.05 0.4 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.526 1.131 . . . . 0.0 113.729 -176.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -65.61 21.64 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 128.322 2.649 . . . . 0.0 115.432 -177.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 79.84 -44.19 2.73 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 127.554 2.502 . . . . 0.0 113.333 -177.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -143.18 77.24 1.56 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.351 1.46 . . . . 0.0 110.153 -177.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -130.71 166.35 20.93 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.033 1.333 . . . . 0.0 114.047 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.14 169.74 10.38 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 126.948 2.099 . . . . 0.0 113.782 -176.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . 0.408 ' HE2' HD13 ' A' ' 172' ' ' ILE . 11.3 ttt -115.87 145.79 42.57 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.255 1.822 . . . . 0.0 110.891 173.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.45 ' C ' HD12 ' A' ' 172' ' ' ILE . 24.8 tt0 -149.32 119.14 7.06 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 120.753 -1.217 . . . . 0.0 110.237 174.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.45 HD12 ' C ' ' A' ' 171' ' ' GLN . 1.8 mp -121.25 130.56 74.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 125.485 1.514 . . . . 0.0 108.267 178.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.8 137.79 43.68 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.876 1.27 . . . . 0.0 110.448 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.6 mp -95.3 95.13 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-N 119.352 0.978 . . . . 0.0 109.518 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 19.3 m -64.55 138.62 58.51 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.981 1.312 . . . . 0.0 111.79 175.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 7.0 mtp180 . . . . . 0 C--O 1.253 1.26 0 O-C-N 120.238 -1.539 . . . . 0.0 112.608 174.938 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.672 HD13 ' HB2' ' A' ' 31' ' ' LYS . 2.6 mt . . . . . 0 N--CA 1.477 0.882 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.45 ' HB1' ' HB3' ' A' ' 71' ' ' LEU . . . -113.21 126.77 55.78 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 127.544 2.338 . . . . 0.0 111.391 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -79.69 -121.54 0.37 Allowed Glycine 0 CA--C 1.536 1.402 0 C-N-CA 125.036 1.303 . . . . 0.0 112.79 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 30.8 p -94.78 171.57 8.69 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.754 1.222 . . . . 0.0 112.397 177.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -130.53 12.32 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 C-N-CA 125.764 1.626 . . . . 0.0 112.002 177.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.6 pp -58.63 172.03 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 O-C-N 120.563 -1.336 . . . . 0.0 112.103 176.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -35.38 129.39 0.54 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.798 2.039 . . . . 0.0 114.729 -175.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -55.57 -21.81 29.57 Favored Glycine 0 CA--C 1.537 1.424 0 C-N-CA 124.673 1.13 . . . . 0.0 114.444 -178.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.1 -31.76 72.25 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.874 1.269 . . . . 0.0 112.048 174.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -100.7 -36.61 9.06 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.963 1.705 . . . . 0.0 112.059 175.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.451 HD23 ' HB3' ' A' ' 69' ' ' ALA . 12.5 tp -79.0 86.16 4.88 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-O 122.1 0.952 . . . . 0.0 110.562 174.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -121.23 178.21 4.86 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 127.565 2.346 . . . . 0.0 112.131 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -42.28 -45.3 4.14 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.562 1.545 . . . . 0.0 113.765 174.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -53.4 -43.53 67.96 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 118.934 0.788 . . . . 0.0 112.449 178.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 86.6 t -64.11 -43.96 97.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.738 1.215 . . . . 0.0 110.799 174.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 68.1 mt -63.82 -41.8 97.78 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.2 -0.938 . . . . 0.0 111.737 179.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -67.28 -44.63 78.81 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.734 1.214 . . . . 0.0 112.576 178.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.08 -37.77 78.65 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 121.476 -0.765 . . . . 0.0 111.357 175.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.9 t -56.67 -38.11 56.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.951 1.3 . . . . 0.0 110.956 178.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.676 HD23 ' HD2' ' A' ' 31' ' ' LYS . 11.1 mt -56.65 -25.89 54.78 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.499 1.519 . . . . 0.0 113.239 175.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -106.28 -46.52 1.15 Allowed Glycine 0 CA--C 1.534 1.243 0 C-N-CA 125.566 1.555 . . . . 0.0 114.692 -178.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -63.96 -27.97 69.5 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 119.243 1.521 . . . . 0.0 113.288 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 19.7 mt -96.54 76.8 2.9 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.9 1.28 . . . . 0.0 110.635 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.59 114.9 5.09 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 126.14 1.829 . . . . 0.0 112.387 178.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -132.47 -74.03 0.51 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.655 1.582 . . . . 0.0 111.919 -179.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.3 m -131.68 177.79 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 126.419 1.887 . . . . 0.0 111.129 -177.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.87 -30.08 68.75 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -177.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.79 117.01 10.07 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.755 1.622 . . . . 0.0 111.443 178.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.676 ' HD2' HD23 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -124.24 152.56 42.82 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 125.399 1.48 . . . . 0.0 109.559 -177.845 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -114.62 133.06 61.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 123.58 0.752 . . . . 0.0 109.438 177.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -134.91 104.77 6.11 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 127.119 2.167 . . . . 0.0 109.795 176.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.704 HG22 ' HB2' ' A' ' 72' ' ' TYR . 1.4 m -103.82 160.77 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 123.517 0.727 . . . . 0.0 110.358 178.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -138.64 109.83 0.69 Allowed Glycine 0 CA--C 1.519 0.328 0 CA-C-N 118.645 0.657 . . . . 0.0 112.69 174.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.482 ' HB ' HD11 ' A' ' 70' ' ' LEU . 3.1 mp -103.96 139.14 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-N 117.313 0.556 . . . . 0.0 110.724 176.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -110.55 104.16 12.85 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.006 1.322 . . . . 0.0 110.704 -177.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -72.6 91.5 1.43 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 127.162 2.185 . . . . 0.0 110.616 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -120.88 9.24 10.61 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.498 1.519 . . . . 0.0 113.331 174.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 37.5 t -50.94 -47.04 61.16 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 125.987 1.715 . . . . 0.0 113.672 177.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 139.99 -21.41 2.82 Favored Glycine 0 N--CA 1.473 1.161 0 C-N-CA 124.452 1.025 . . . . 0.0 114.208 175.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -122.56 167.18 14.97 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 125.724 1.631 . . . . 0.0 111.564 174.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.656 HG22 ' HA ' ' A' ' 65' ' ' PRO . 44.3 p -74.28 145.71 43.78 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.177 0.513 . . . . 0.0 110.674 174.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 49.5 m0 -98.95 104.71 16.78 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 123.593 0.757 . . . . 0.0 110.898 178.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.0 m -82.67 125.3 31.06 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.186 0.994 . . . . 0.0 110.117 176.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.79 117.51 5.95 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.109 0.964 . . . . 0.0 111.309 174.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.551 HD12 ' N ' ' A' ' 48' ' ' ASN . 4.6 pp -98.23 -48.99 4.87 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.483 0.713 . . . . 0.0 112.758 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.551 ' N ' HD12 ' A' ' 47' ' ' LEU . 10.4 t30 -174.56 152.17 1.63 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 128.213 2.605 . . . . 0.0 109.263 -177.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -136.38 160.54 38.43 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.616 1.166 . . . . 0.0 111.793 174.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -137.78 107.48 6.24 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.653 1.181 . . . . 0.0 112.284 -179.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.497 ' CD1' ' HB1' ' A' ' 87' ' ' ALA . 2.9 m-85 -107.94 128.7 54.87 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.421 1.088 . . . . 0.0 110.987 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.66 -34.27 5.57 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -176.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.9 t -121.47 -49.46 2.14 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 125.602 1.561 . . . . 0.0 110.594 176.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -66.91 12.56 0.54 Allowed Glycine 0 CA--C 1.536 1.373 0 C-N-CA 125.911 1.72 . . . . 0.0 115.658 -176.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 74.6 p -30.95 109.39 0.06 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 129.089 2.956 . . . . 0.0 114.271 -174.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.529 HG21 HG23 ' A' ' 59' ' ' ILE . 2.5 t -129.25 179.17 5.93 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.437 1.495 . . . . 0.0 113.215 -175.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -78.77 -59.15 2.89 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.994 1.718 . . . . 0.0 112.225 174.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.9 p -143.42 136.64 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 125.597 1.559 . . . . 0.0 111.977 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.529 HG23 HG21 ' A' ' 56' ' ' THR . 1.4 pp -140.2 -26.3 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 126.07 1.748 . . . . 0.0 114.296 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -99.22 93.54 2.22 Favored Pre-proline 0 CA--C 1.541 0.611 0 C-N-CA 125.212 1.405 . . . . 0.0 108.995 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -61.64 143.06 96.37 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.775 2.316 . . . . 0.0 110.389 174.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -40.11 -48.92 2.56 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.429 1.891 . . . . 0.0 113.84 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.7 p -156.1 138.66 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 127.295 2.238 . . . . 0.0 109.188 175.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.468 HG21 HD23 ' A' ' 70' ' ' LEU . 22.0 t -112.27 121.99 37.79 Favored Pre-proline 0 N--CA 1.477 0.897 0 C-N-CA 124.233 1.013 . . . . 0.0 108.902 175.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.656 ' HA ' HG22 ' A' ' 43' ' ' THR . 58.6 Cg_endo -67.8 157.78 60.23 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 122.015 1.81 . . . . 0.0 112.946 177.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -71.65 168.58 17.39 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.575 0.75 . . . . 0.0 111.52 175.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 43.7 p 54.44 19.11 2.18 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 127.286 2.234 . . . . 0.0 113.79 -174.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.8 mttt -134.29 171.72 13.87 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 126.918 2.087 . . . . 0.0 110.951 -175.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.451 ' HB3' HD23 ' A' ' 13' ' ' LEU . . . -127.97 177.16 7.06 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.071 0.462 . . . . 0.0 110.146 -175.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.482 HD11 ' HB ' ' A' ' 36' ' ' ILE . 1.9 pp -142.84 173.47 11.52 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 124.181 0.992 . . . . 0.0 111.255 -178.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.526 HD13 ' O ' ' A' ' 34' ' ' VAL . 0.5 OUTLIER -132.47 151.62 51.83 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.937 1.295 . . . . 0.0 111.007 174.964 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.704 ' HB2' HG22 ' A' ' 34' ' ' VAL . 4.2 m-85 -124.14 146.04 48.91 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.162 0.985 . . . . 0.0 108.595 174.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.8 p -121.28 137.1 54.84 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 126.401 1.88 . . . . 0.0 110.997 175.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.606 ' H ' HD12 ' A' ' 3' ' ' LEU . . . -160.95 133.34 3.17 Favored Glycine 0 CA--C 1.525 0.7 0 O-C-N 121.785 -0.572 . . . . 0.0 113.822 174.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 26.3 mtm180 -90.68 149.7 21.96 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.946 1.298 . . . . 0.0 110.988 -174.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 9.9 ptmt . . . . . 0 N--CA 1.48 1.075 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 174.961 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 97.7 m . . . . . 0 N--CA 1.478 0.948 0 CA-C-O 118.745 -0.645 . . . . 0.0 109.62 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -26.05 -68.07 0.05 OUTLIER Glycine 0 N--CA 1.48 1.628 0 C-N-CA 127.422 2.439 . . . . 0.0 115.013 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -177.58 135.79 0.19 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.371 1.868 . . . . 0.0 111.82 175.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.9 t -154.85 129.42 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 125.139 1.376 . . . . 0.0 109.094 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.497 ' HB1' ' CD1' ' A' ' 51' ' ' PHE . . . -173.32 174.48 3.32 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.442 1.497 . . . . 0.0 111.732 177.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -151.18 141.49 22.36 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.108 1.363 . . . . 0.0 110.169 174.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -138.45 171.52 14.25 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 121.233 -0.917 . . . . 0.0 111.231 178.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.501 ' HB3' HD11 ' A' ' 47' ' ' LEU . . . -139.43 156.24 47.09 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.391 0.615 . . . . 0.0 112.551 177.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -135.08 129.09 33.44 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 125.833 1.653 . . . . 0.0 112.421 -174.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -83.4 135.11 34.82 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -176.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.24 138.18 44.96 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 125.086 1.355 . . . . 0.0 111.917 178.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.8 t -62.8 -22.5 66.67 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.493 1.117 . . . . 0.0 113.164 176.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -67.41 -16.15 64.07 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.121 1.368 . . . . 0.0 113.321 175.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 101.28 33.89 4.71 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 124.845 1.212 . . . . 0.0 114.558 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.559 ' HB3' HG22 ' A' ' 120' ' ' ILE . 48.3 m-80 -140.6 177.07 8.28 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-N 119.204 1.502 . . . . 0.0 110.95 177.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.473 HG23 HD21 ' A' ' 47' ' ' LEU . 19.2 m -130.67 105.83 8.08 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.668 1.587 . . . . 0.0 112.457 -176.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 59.6 tp -68.4 104.42 1.89 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.715 1.206 . . . . 0.0 111.271 175.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -99.32 116.95 5.72 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 125.947 1.737 . . . . 0.0 113.084 179.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 57.3 t -105.14 129.07 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 126.218 1.807 . . . . 0.0 111.341 -174.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -127.12 130.24 49.44 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.673 1.589 . . . . 0.0 112.273 -174.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.445 ' CZ ' ' HB3' ' A' ' 87' ' ' ALA . 5.4 p90 -146.02 140.56 26.91 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.644 1.177 . . . . 0.0 112.484 -176.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.28 123.37 10.79 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.181 1.392 . . . . 0.0 111.967 -174.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 96.4 t . . . . . 0 N--CA 1.481 1.084 0 C-N-CA 125.065 1.346 . . . . 0.0 111.686 -177.432 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.4 m . . . . . 0 N--CA 1.468 0.461 0 CA-C-O 121.186 0.517 . . . . 0.0 111.623 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -73.36 117.68 15.4 Favored 'General case' 0 C--O 1.226 -0.18 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 174.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 34.4 m0 -113.68 143.59 44.35 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 176.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 37.3 p-90 -148.85 138.58 21.99 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.206 1.002 . . . . 0.0 111.268 -177.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -150.04 162.86 39.57 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 122.801 1.286 . . . . 0.0 113.279 -177.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 61.7 t -145.53 144.34 21.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 124.24 1.016 . . . . 0.0 108.311 175.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.448 ' HE2' ' SD ' ' A' ' 135' ' ' MET . 0.0 OUTLIER -155.9 176.71 12.28 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.908 1.683 . . . . 0.0 110.141 175.577 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.559 HG22 ' HB3' ' A' ' 97' ' ' ASN . 11.7 mt -126.32 99.59 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-O 121.86 0.838 . . . . 0.0 108.955 178.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -59.68 148.25 75.64 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 124.105 0.962 . . . . 0.0 111.84 178.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -70.5 135.54 28.94 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.986 2.457 . . . . 0.0 111.838 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 59.13 -157.82 22.42 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 124.057 0.837 . . . . 0.0 113.528 -177.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 9.9 tttt -72.75 120.02 17.78 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.975 0.91 . . . . 0.0 108.735 174.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 25.0 tpp180 -130.68 169.62 15.42 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 125.868 1.667 . . . . 0.0 109.447 175.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 25.6 ptt180 -119.89 175.33 5.95 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 126.549 1.94 . . . . 0.0 110.6 174.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -120.3 108.11 13.77 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 175.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -126.27 165.7 18.48 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.901 1.28 . . . . 0.0 110.01 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -55.66 -36.81 67.49 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 121.302 -0.874 . . . . 0.0 113.203 -176.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -59.7 -61.29 7.39 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.442 -0.663 . . . . 0.0 111.442 174.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -62.98 -33.11 74.7 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 118.367 1.084 . . . . 0.0 112.833 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -58.35 -63.11 1.39 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.625 1.17 . . . . 0.0 108.987 174.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -69.27 -27.2 65.22 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -177.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -68.23 -32.06 71.99 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.741 1.216 . . . . 0.0 113.418 175.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . 0.448 ' SD ' ' HE2' ' A' ' 119' ' ' LYS . 0.7 OUTLIER -94.89 -25.48 16.56 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 121.274 -0.891 . . . . 0.0 112.076 176.667 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -51.99 -57.6 9.01 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.769 2.028 . . . . 0.0 110.02 174.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -67.22 -10.19 48.01 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 113.526 0.935 . . . . 0.0 113.526 -178.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -83.6 -16.03 69.45 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 126.638 2.066 . . . . 0.0 114.273 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -142.14 87.26 9.76 Favored Pre-proline 0 CA--C 1.549 0.925 0 CA-C-N 118.661 1.231 . . . . 0.0 112.001 179.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.95 77.97 1.85 Allowed 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 123.675 2.916 . . . . 0.0 112.472 177.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -108.59 115.05 29.36 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.32 1.448 . . . . 0.0 109.826 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 9.5 mtp180 -92.93 26.88 2.6 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 126.909 2.083 . . . . 0.0 115.969 -174.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 62.38 59.69 9.01 Favored Glycine 0 CA--C 1.531 1.051 0 N-CA-C 109.106 -1.597 . . . . 0.0 109.106 -175.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -64.28 105.81 0.98 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.182 0.993 . . . . 0.0 110.006 176.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -68.02 83.48 0.22 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.213 1.405 . . . . 0.0 114.33 -174.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 170.24 48.71 0.03 OUTLIER Glycine 0 CA--C 1.537 1.462 0 C-N-CA 124.967 1.27 . . . . 0.0 114.468 177.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' TRP . . . . . 0.56 ' H ' HD13 ' A' ' 161' ' ' ILE . 2.2 m95 54.65 44.09 29.16 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 125.782 1.633 . . . . 0.0 114.728 -177.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -79.62 130.62 35.53 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 120.61 -1.306 . . . . 0.0 112.77 -175.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . 0.419 ' HG3' ' HA ' ' A' ' 159' ' ' LYS . 0.0 OUTLIER -160.02 -175.16 4.93 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -175.015 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.2 pttt -131.0 156.72 44.64 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.194 1.397 . . . . 0.0 111.672 174.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 28.6 m-80 -78.14 124.17 27.74 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 174.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 69.3 mt -81.52 149.11 28.85 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 122.201 1.001 . . . . 0.0 109.33 174.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -66.08 -166.48 2.04 Favored Glycine 0 CA--C 1.535 1.303 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 174.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.52 ' CE1' ' HB ' ' A' ' 120' ' ' ILE . 0.0 OUTLIER 54.3 11.49 0.4 Allowed 'General case' 0 CA--C 1.557 1.233 0 N-CA-C 114.988 1.477 . . . . 0.0 114.988 174.969 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 84.94 37.3 10.26 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 126.542 2.02 . . . . 0.0 113.208 -178.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.7 mp -122.74 160.21 26.41 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 119.843 1.822 . . . . 0.0 113.038 -178.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 72.2 mtt85 -149.06 109.77 4.26 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 120.636 -1.29 . . . . 0.0 111.082 -178.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . 0.451 ' SD ' HG21 ' A' ' 172' ' ' ILE . 9.0 ttp -104.73 132.77 50.58 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 124.025 0.93 . . . . 0.0 108.893 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.419 ' HA ' ' HG3' ' A' ' 149' ' ' GLN . 7.1 tppt? -111.14 129.65 55.87 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 127.967 2.507 . . . . 0.0 110.593 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -137.21 156.17 23.25 Favored Glycine 0 N--CA 1.474 1.208 0 CA-C-N 120.7 1.591 . . . . 0.0 115.959 -177.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.56 HD13 ' H ' ' A' ' 147' ' ' TRP . 4.5 tp -148.58 127.8 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 124.77 1.228 . . . . 0.0 112.069 -175.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 16.1 mtm -151.5 169.81 21.17 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 128.489 2.716 . . . . 0.0 109.892 174.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 14.5 t -156.23 135.27 12.0 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.714 1.606 . . . . 0.0 109.597 174.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 61.7 p -81.32 20.04 0.9 Allowed 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 179.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.85 -34.7 65.68 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.486 1.914 . . . . 0.0 115.108 -177.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 154.01 -63.45 0.36 Allowed Glycine 0 CA--C 1.533 1.176 0 C-N-CA 124.386 0.993 . . . . 0.0 114.29 176.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -119.79 27.82 8.49 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 125.718 1.607 . . . . 0.0 112.669 -175.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -64.03 174.59 1.47 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.839 1.255 . . . . 0.0 113.269 174.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.57 168.14 13.01 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.735 2.014 . . . . 0.0 111.248 177.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 48.5 ttp -111.51 123.87 51.11 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.816 1.246 . . . . 0.0 110.45 176.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -137.46 128.02 26.77 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 123.255 0.622 . . . . 0.0 110.325 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.451 HG21 ' SD ' ' A' ' 158' ' ' MET . 5.1 mp -134.9 119.27 27.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 123.461 0.704 . . . . 0.0 109.853 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -114.57 134.96 54.64 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.188 1.395 . . . . 0.0 111.067 177.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.8 mp -81.83 129.97 36.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 O-C-N 120.906 -1.121 . . . . 0.0 109.013 175.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -137.93 94.43 2.89 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.854 1.262 . . . . 0.0 112.328 177.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 72.1 mtp180 . . . . . 0 C--O 1.252 1.185 0 C-N-CA 126.604 1.961 . . . . 0.0 113.245 175.002 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.559 HD11 ' HG3' ' A' ' 31' ' ' LYS . 3.0 mm? . . . . . 0 N--CA 1.48 1.059 0 N-CA-C 115.724 1.75 . . . . 0.0 115.724 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.54 78.67 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.121 1.368 . . . . 0.0 112.425 175.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -72.63 -66.3 2.1 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 125.984 1.754 . . . . 0.0 112.238 -175.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 39.7 p -142.61 166.83 23.59 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.73 1.612 . . . . 0.0 112.097 176.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -131.48 10.06 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 125.993 1.717 . . . . 0.0 112.607 175.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.524 HD12 ' HB3' ' A' ' 12' ' ' SER . 1.0 OUTLIER -53.67 163.32 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 O-C-N 120.223 -1.548 . . . . 0.0 112.648 177.017 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -38.92 136.29 0.79 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 127.001 2.121 . . . . 0.0 113.82 -174.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -55.38 -21.22 26.03 Favored Glycine 0 CA--C 1.54 1.605 0 C-N-CA 124.858 1.218 . . . . 0.0 114.399 -176.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.66 -29.04 69.81 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.032 1.333 . . . . 0.0 112.577 174.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.524 ' HB3' HD12 ' A' ' 8' ' ' ILE . 20.5 t -104.99 -43.98 4.92 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.808 1.643 . . . . 0.0 111.299 175.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.4 tp -75.16 93.47 2.81 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.81 0.844 . . . . 0.0 111.537 175.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 44.1 p -130.69 -177.99 4.59 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 126.901 2.081 . . . . 0.0 111.583 177.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -39.89 -43.99 1.58 Allowed 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 127.207 2.203 . . . . 0.0 113.59 175.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -54.67 -41.44 70.19 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.651 0.78 . . . . 0.0 112.055 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.0 t -68.35 -38.19 79.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.804 1.242 . . . . 0.0 111.233 175.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 24.5 mt -68.62 -42.47 78.03 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 121.355 -0.841 . . . . 0.0 111.414 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -65.38 -50.45 65.46 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.498 1.119 . . . . 0.0 111.915 178.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.13 -33.88 76.42 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 118.876 -0.583 . . . . 0.0 112.062 174.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.9 t -55.38 -47.0 78.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 124.85 1.26 . . . . 0.0 112.355 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.82 -23.86 46.88 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 119.838 1.199 . . . . 0.0 113.022 175.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -82.45 -61.44 1.98 Allowed Glycine 0 CA--C 1.534 1.233 0 C-N-CA 126.049 1.785 . . . . 0.0 112.919 174.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -66.49 -35.86 81.31 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -177.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -94.88 73.65 3.54 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 122.773 1.273 . . . . 0.0 110.468 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -76.2 64.13 2.82 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 126.302 1.906 . . . . 0.0 115.151 -174.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.506 ' HD2' HD22 ' A' ' 3' ' ' LEU . 6.1 mttt -55.59 -75.47 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 126.69 1.996 . . . . 0.0 113.972 178.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 18.0 m -141.77 -179.37 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 127.438 2.295 . . . . 0.0 110.708 178.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 36.8 m -52.39 -34.31 47.43 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 126.721 2.009 . . . . 0.0 114.878 -177.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.8 mmp_? -136.7 111.99 9.14 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 127.23 2.212 . . . . 0.0 109.185 175.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.559 ' HG3' HD11 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -123.0 166.06 15.72 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.381 1.472 . . . . 0.0 110.543 178.696 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -128.85 123.16 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 123.949 0.9 . . . . 0.0 110.911 -178.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -120.13 118.17 29.86 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.883 1.673 . . . . 0.0 109.806 175.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.402 HG22 ' HB2' ' A' ' 72' ' ' TYR . 2.4 m -124.47 148.4 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 122.715 0.406 . . . . 0.0 110.602 175.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -121.52 111.06 1.78 Allowed Glycine 0 C--N 1.329 0.16 0 C-N-CA 124.285 0.945 . . . . 0.0 111.044 -178.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 mp -100.24 139.94 20.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 117.703 0.752 . . . . 0.0 109.282 175.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -114.91 101.91 9.48 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.893 1.277 . . . . 0.0 109.305 -178.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 40.9 t-20 -73.68 107.17 5.78 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.051 1.34 . . . . 0.0 110.515 -178.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -135.12 19.27 3.43 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.386 1.474 . . . . 0.0 111.8 175.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.8 p -76.19 178.21 6.59 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.072 1.749 . . . . 0.0 112.433 176.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -91.25 56.06 3.2 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 126.379 1.942 . . . . 0.0 113.167 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 157.34 137.5 2.31 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.453 1.025 . . . . 0.0 113.636 177.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.79 HG22 ' HA ' ' A' ' 65' ' ' PRO . 37.9 p -62.47 141.19 58.51 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.456 0.702 . . . . 0.0 110.428 175.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.445 ' HB3' ' CD1' ' A' ' 91' ' ' TYR . 30.0 m0 -97.56 109.2 22.0 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.694 0.283 . . . . 0.0 111.553 178.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 37.4 m -87.75 142.74 27.59 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.172 0.589 . . . . 0.0 109.541 175.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.67 126.86 29.38 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.689 0.796 . . . . 0.0 111.457 174.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.56 HD12 ' N ' ' A' ' 48' ' ' ASN . 4.1 pp -116.7 -58.6 2.06 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.271 1.028 . . . . 0.0 111.854 177.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.56 ' N ' HD12 ' A' ' 47' ' ' LEU . 13.1 t30 -176.07 152.38 1.17 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 127.215 2.206 . . . . 0.0 110.617 -177.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -134.28 158.84 42.74 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.151 1.38 . . . . 0.0 111.063 175.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 91.2 t80 -140.04 100.21 3.87 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.036 1.334 . . . . 0.0 112.169 -175.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.477 ' CD1' ' HB1' ' A' ' 87' ' ' ALA . 3.8 m-30 -105.04 124.26 49.23 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.559 1.144 . . . . 0.0 111.614 -175.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.71 -37.4 7.92 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -177.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 29.5 t -120.61 -49.59 2.23 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.33 1.452 . . . . 0.0 110.725 177.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -68.63 17.37 0.49 Allowed Glycine 0 CA--C 1.533 1.166 0 C-N-CA 126.587 2.042 . . . . 0.0 115.272 -175.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.2 p -35.52 121.02 0.59 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 128.739 2.816 . . . . 0.0 112.995 -175.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -139.13 172.4 12.89 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.651 1.181 . . . . 0.0 113.571 -174.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -76.82 -68.85 0.56 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.524 1.53 . . . . 0.0 113.309 175.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.7 p -135.9 129.67 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 125.126 1.371 . . . . 0.0 112.425 -176.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -138.43 -34.3 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.672 1.589 . . . . 0.0 114.443 -175.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 48.5 mt -91.33 104.14 9.15 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 125.169 1.388 . . . . 0.0 109.621 175.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -72.52 165.24 33.26 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.763 2.975 . . . . 0.0 110.413 175.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -47.57 -44.23 26.08 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.9 p -157.81 152.26 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 127.014 2.125 . . . . 0.0 110.057 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.526 ' HA ' ' HE3' ' A' ' 68' ' ' LYS . 60.5 t -126.89 99.14 29.56 Favored Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 126.375 1.87 . . . . 0.0 106.778 175.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.79 ' HA ' HG22 ' A' ' 43' ' ' THR . 42.2 Cg_endo -69.71 171.62 14.08 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 120.97 1.113 . . . . 0.0 112.628 175.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -75.71 166.13 24.0 Favored 'General case' 0 CA--C 1.548 0.869 0 O-C-N 121.297 -0.877 . . . . 0.0 110.355 174.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . 0.276 5.8 p 62.39 18.27 10.15 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 128.058 2.543 . . . . 0.0 115.141 -177.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.526 ' HE3' ' HA ' ' A' ' 64' ' ' VAL . 0.0 OUTLIER -131.34 170.9 14.01 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 126.086 1.755 . . . . 0.0 111.585 -177.986 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -131.18 165.76 22.61 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-O 121.637 0.732 . . . . 0.0 111.633 177.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -134.79 171.45 14.36 Favored 'General case' 0 C--N 1.321 -0.667 0 O-C-N 120.225 -1.547 . . . . 0.0 110.806 175.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -112.91 162.83 15.38 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 125.315 1.446 . . . . 0.0 108.654 174.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.402 ' HB2' HG22 ' A' ' 34' ' ' VAL . 0.2 OUTLIER -136.55 149.66 48.22 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 125.118 1.367 . . . . 0.0 108.938 175.054 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 85.8 p -129.49 148.81 51.43 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.924 1.69 . . . . 0.0 112.191 -177.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -171.8 146.4 9.37 Favored Glycine 0 CA--C 1.521 0.45 0 N-CA-C 111.984 -0.446 . . . . 0.0 111.984 174.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 41.6 mtm-85 -108.31 150.44 27.32 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.784 1.234 . . . . 0.0 110.733 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.48 1.03 0 N-CA-C 114.934 1.457 . . . . 0.0 114.934 175.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 24.9 m . . . . . 0 N--CA 1.474 0.755 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -45.28 -67.41 1.23 Allowed Glycine 0 N--CA 1.473 1.127 0 C-N-CA 125.899 1.714 . . . . 0.0 113.888 -174.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -171.77 119.78 0.45 Allowed 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.482 1.113 . . . . 0.0 111.339 175.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.8 t -141.35 118.64 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 O-C-N 121.765 -0.585 . . . . 0.0 110.081 -178.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.482 ' HB3' ' CE1' ' A' ' 103' ' ' PHE . . . -155.66 157.9 37.42 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 122.53 1.157 . . . . 0.0 112.074 -179.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -137.5 147.99 45.66 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.88 1.272 . . . . 0.0 108.442 175.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -155.13 166.51 33.34 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 121.03 -1.044 . . . . 0.0 109.127 178.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.544 ' HB1' ' CG2' ' A' ' 98' ' ' THR . . . -137.4 156.16 48.51 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -179.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.445 ' CD1' ' HB3' ' A' ' 44' ' ' TRP . 2.3 m-85 -132.46 130.62 40.75 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.272 1.029 . . . . 0.0 113.504 -174.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -82.76 112.99 20.11 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -175.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -93.81 143.01 26.72 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.097 1.359 . . . . 0.0 113.107 -178.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.24 -20.67 64.48 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.556 1.142 . . . . 0.0 113.61 177.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 48.1 m-20 -67.53 -11.6 58.38 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.563 1.145 . . . . 0.0 112.727 174.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 96.58 27.03 10.11 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 124.993 1.282 . . . . 0.0 113.746 -178.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -132.5 172.84 11.97 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.986 1.314 . . . . 0.0 111.588 -176.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.544 ' CG2' ' HB1' ' A' ' 90' ' ' ALA . 3.5 m -126.38 107.57 10.41 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.06 1.344 . . . . 0.0 111.641 -179.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.0 tt -70.53 98.84 1.53 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.978 1.711 . . . . 0.0 111.918 179.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -94.19 97.07 2.13 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 124.765 1.174 . . . . 0.0 114.881 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 99.3 t -75.45 140.53 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.381 1.072 . . . . 0.0 110.123 174.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 3.1 tmm? -136.13 129.16 31.36 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.651 1.581 . . . . 0.0 110.348 177.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.482 ' CE1' ' HB3' ' A' ' 87' ' ' ALA . 22.7 p90 -144.79 142.85 30.3 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.442 -0.786 . . . . 0.0 112.426 175.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 13.2 m -142.9 114.48 8.01 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.395 1.078 . . . . 0.0 112.361 -177.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 26.1 t . . . . . 0 CA--C 1.538 0.488 0 C-N-CA 127.445 2.298 . . . . 0.0 109.229 178.496 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 31.7 m . . . . . 0 N--CA 1.463 0.199 0 CA-C-O 121.243 0.544 . . . . 0.0 111.378 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -67.51 101.39 0.98 Allowed 'General case' 0 C--O 1.223 -0.316 0 C-N-CA 125.041 1.336 . . . . 0.0 107.929 174.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 47.7 m0 -107.78 144.27 35.18 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 120.622 1.555 . . . . 0.0 110.185 176.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 43.9 p-90 -147.99 139.9 24.01 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.659 0.784 . . . . 0.0 111.509 -177.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -149.86 159.42 44.38 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 122.656 1.217 . . . . 0.0 112.294 -177.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 22.0 t -144.43 136.27 21.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 174.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.98 179.91 6.9 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 126.242 1.817 . . . . 0.0 109.191 176.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 10.5 mt -132.41 134.04 59.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 123.197 0.599 . . . . 0.0 109.399 176.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -90.43 151.68 44.6 Favored Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 125.329 1.452 . . . . 0.0 112.493 177.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.74 139.9 28.48 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 123.198 2.599 . . . . 0.0 110.939 174.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 61.29 -166.21 15.17 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 123.726 0.679 . . . . 0.0 113.475 -176.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.46 99.5 5.67 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.716 1.606 . . . . 0.0 109.771 174.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -111.44 -172.38 2.02 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 125.744 1.618 . . . . 0.0 111.199 -177.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 25.7 ptt180 -139.01 177.54 7.82 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 127.222 2.209 . . . . 0.0 111.229 175.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -118.46 121.22 39.77 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 174.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -129.81 167.11 18.62 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.703 1.601 . . . . 0.0 109.353 175.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -48.87 -45.83 41.56 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 119.641 1.109 . . . . 0.0 113.232 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -52.55 -62.94 5.35 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 123.997 0.808 . . . . 0.0 112.252 175.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 5.0 mpp? -60.76 -38.42 85.17 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 113.583 0.956 . . . . 0.0 113.583 178.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -57.0 -61.87 2.15 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.934 0.788 . . . . 0.0 109.527 175.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -62.97 -37.17 86.03 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.863 0.865 . . . . 0.0 112.731 -177.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -63.65 -43.54 96.47 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.012 1.325 . . . . 0.0 112.36 179.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.81 -26.16 24.22 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 121.053 -1.029 . . . . 0.0 113.42 176.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -52.02 -58.29 6.97 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.257 1.823 . . . . 0.0 110.678 175.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -70.47 -12.85 61.84 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -177.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -81.69 -5.63 89.71 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 127.203 2.335 . . . . 0.0 114.345 177.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -145.11 86.45 7.63 Favored Pre-proline 0 CA--C 1.548 0.87 0 CA-C-N 119.052 1.426 . . . . 0.0 113.301 175.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -76.64 74.79 4.68 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 123.513 2.809 . . . . 0.0 112.946 -179.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -107.26 107.36 18.26 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.022 0.929 . . . . 0.0 111.385 -175.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 59.1 mtm180 -89.76 48.14 1.55 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 126.074 1.75 . . . . 0.0 114.505 -175.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 49.46 57.86 8.83 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.815 -176.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -63.14 106.52 0.87 Allowed 'General case' 0 CA--C 1.546 0.802 0 CA-C-O 122.141 0.972 . . . . 0.0 109.86 -176.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 17.3 p-10 -68.23 73.69 0.21 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 127.336 2.255 . . . . 0.0 114.968 -174.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 178.35 48.75 0.07 OUTLIER Glycine 0 CA--C 1.536 1.4 0 C-N-CA 124.382 0.991 . . . . 0.0 115.003 175.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' TRP . . . . . 0.708 ' H ' HD13 ' A' ' 161' ' ' ILE . 8.1 m95 49.33 56.28 8.05 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 126.204 1.802 . . . . 0.0 112.795 -175.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -85.9 127.5 34.61 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.281 1.032 . . . . 0.0 112.818 -178.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -157.86 -176.09 5.73 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -175.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 5.7 mtmt -140.24 169.33 17.88 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 126.144 1.777 . . . . 0.0 111.581 175.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -72.66 155.66 39.77 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 174.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.542 HD11 ' HB2' ' A' ' 158' ' ' MET . 71.0 mt -109.01 89.02 2.87 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.736 0.814 . . . . 0.0 110.375 177.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 40.86 -82.06 0.0 OUTLIER Glycine 0 N--CA 1.476 1.341 0 C-N-CA 129.608 3.48 . . . . 0.0 115.27 175.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -68.53 -154.2 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 128.839 2.855 . . . . 0.0 110.541 174.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -73.68 20.24 1.41 Allowed Glycine 0 CA--C 1.541 1.693 0 O-C-N 120.217 -1.552 . . . . 0.0 114.928 175.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.04 154.07 17.34 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 120.448 2.124 . . . . 0.0 112.038 177.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 87.4 mtt180 -145.95 115.82 7.32 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.322 1.449 . . . . 0.0 110.877 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . 0.542 ' HB2' HD11 ' A' ' 152' ' ' LEU . 5.9 ttp -114.25 132.42 56.15 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 124.273 1.029 . . . . 0.0 109.682 -178.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -103.84 132.83 49.72 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 128.477 2.711 . . . . 0.0 110.005 -179.039 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -135.2 150.83 20.31 Favored Glycine 0 N--CA 1.47 0.918 0 CA-C-N 120.313 1.415 . . . . 0.0 114.23 178.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.708 HD13 ' H ' ' A' ' 147' ' ' TRP . 6.6 tp -145.81 131.93 13.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 125.147 1.379 . . . . 0.0 110.957 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 3.6 ttt -152.42 176.4 11.69 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 127.606 2.362 . . . . 0.0 107.717 175.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 10.1 t -152.39 163.62 39.15 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.194 1.397 . . . . 0.0 109.161 175.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 5.4 t -106.52 31.43 5.22 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.396 1.478 . . . . 0.0 111.511 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -68.44 23.76 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 128.09 2.556 . . . . 0.0 115.112 179.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 84.36 -60.24 4.85 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 126.181 1.848 . . . . 0.0 113.342 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -126.5 63.0 1.28 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.333 1.453 . . . . 0.0 111.051 178.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -86.61 -177.46 6.15 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.311 1.044 . . . . 0.0 112.794 174.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . 0.447 ' HE2' ' O ' ' A' ' 169' ' ' LYS . 0.0 OUTLIER -124.85 174.43 7.95 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 127.991 2.516 . . . . 0.0 109.708 174.993 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 42.5 ttp -126.12 132.12 51.93 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.055 1.342 . . . . 0.0 110.189 176.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -135.86 127.18 28.38 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.104 0.962 . . . . 0.0 110.163 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.413 HG21 ' SD ' ' A' ' 158' ' ' MET . 4.6 mp -129.58 120.66 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 C-N-CA 123.19 0.596 . . . . 0.0 109.95 177.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.06 132.42 56.03 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.827 1.651 . . . . 0.0 111.341 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.8 mp -76.81 133.67 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 O-C-N 120.683 -1.26 . . . . 0.0 110.382 175.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 6.7 m -140.24 92.5 2.54 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 125.144 1.378 . . . . 0.0 112.22 177.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 60.5 mtp180 . . . . . 0 C--O 1.254 1.29 0 C-N-CA 126.311 1.844 . . . . 0.0 111.48 175.033 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.448 ' HB2' ' HD2' ' A' ' 27' ' ' LYS . 15.5 tp . . . . . 0 N--CA 1.476 0.831 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -75.62 129.96 38.0 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 175.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -71.93 -113.02 0.05 OUTLIER Glycine 0 CA--C 1.533 1.192 0 C-N-CA 124.036 0.827 . . . . 0.0 112.636 177.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 19.3 p -113.58 172.82 6.74 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.872 1.269 . . . . 0.0 111.578 176.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -124.81 24.56 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 125.226 1.41 . . . . 0.0 111.871 175.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -52.49 166.4 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 O-C-N 120.633 -1.292 . . . . 0.0 112.684 174.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -48.87 144.3 4.71 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.947 1.299 . . . . 0.0 113.404 -177.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.06 -24.33 54.37 Favored Glycine 0 CA--C 1.538 1.492 0 N-CA-C 115.78 1.072 . . . . 0.0 115.78 -174.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.89 -34.43 64.42 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 121.289 -1.124 . . . . 0.0 111.797 174.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.9 t -84.21 -41.27 17.14 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.684 1.993 . . . . 0.0 112.837 175.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 13.0 tp -89.23 96.29 10.66 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 127.415 2.286 . . . . 0.0 111.357 175.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.58 178.77 6.49 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 126.734 2.014 . . . . 0.0 110.731 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -41.36 -40.91 1.83 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.683 1.593 . . . . 0.0 113.786 175.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -49.89 -45.23 50.56 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.219 1.407 . . . . 0.0 112.639 175.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 88.0 t -69.86 -38.88 76.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 125.777 1.631 . . . . 0.0 111.669 175.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 44.6 mt -70.75 -36.77 73.29 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 120.706 -1.246 . . . . 0.0 112.457 -178.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -65.48 -51.14 62.19 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.343 1.457 . . . . 0.0 111.186 175.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.71 -34.31 75.56 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 118.08 -0.962 . . . . 0.0 111.915 175.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.2 t -56.35 -48.53 79.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-N 119.679 1.127 . . . . 0.0 111.485 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 55.4 mt -56.85 -19.8 19.44 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 175.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.03 -61.24 1.28 Allowed Glycine 0 CA--C 1.535 1.293 0 C-N-CA 126.306 1.908 . . . . 0.0 113.12 175.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -64.11 -32.54 74.14 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -178.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -90.55 97.76 11.37 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.179 0.992 . . . . 0.0 109.917 176.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -109.82 109.42 2.7 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 126.333 1.921 . . . . 0.0 112.475 -178.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.448 ' HD2' ' HB2' ' A' ' 3' ' ' LEU . 17.7 mtpt -129.59 -69.86 0.67 Allowed 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 125.793 1.637 . . . . 0.0 112.07 -176.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.4 m -121.17 169.36 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 127.848 2.459 . . . . 0.0 110.491 -176.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.0 t -65.76 -31.85 73.07 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -179.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.5 mmt180 -132.4 105.58 7.36 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.303 1.841 . . . . 0.0 111.041 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.4 ptpt -120.56 159.43 25.26 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 126.539 1.935 . . . . 0.0 110.149 -177.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -128.75 132.95 67.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 123.941 0.897 . . . . 0.0 109.437 175.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.33 102.63 4.85 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.077 1.751 . . . . 0.0 109.673 177.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.799 HG22 ' HB2' ' A' ' 72' ' ' TYR . 1.3 m -107.7 162.29 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 123.73 0.812 . . . . 0.0 110.927 178.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -134.84 124.28 3.39 Favored Glycine 0 N--CA 1.463 0.452 0 N-CA-C 111.531 -0.628 . . . . 0.0 111.531 177.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.42 ' HB ' HD11 ' A' ' 70' ' ' LEU . 3.3 mp -113.02 132.35 62.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-N 118.459 1.13 . . . . 0.0 110.536 175.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -96.22 99.69 11.39 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.67 1.588 . . . . 0.0 110.214 177.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -67.73 94.35 0.44 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.319 1.448 . . . . 0.0 110.552 175.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -125.34 7.29 7.75 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 125.576 1.55 . . . . 0.0 111.801 174.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 42.8 p -57.03 -34.9 68.67 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.366 1.066 . . . . 0.0 113.616 -177.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 158.47 -63.52 0.3 Allowed Glycine 0 CA--C 1.53 1.02 0 C-N-CA 125.271 1.415 . . . . 0.0 113.639 175.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -107.18 171.08 16.29 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 125.549 1.547 . . . . 0.0 113.092 -178.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.17 150.84 28.64 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.803 -0.822 . . . . 0.0 110.874 175.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.404 ' HB3' ' CD1' ' A' ' 91' ' ' TYR . 45.2 m0 -104.35 100.52 10.23 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 124.876 1.271 . . . . 0.0 111.346 -177.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.5 m -80.73 117.97 21.86 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 124.689 1.195 . . . . 0.0 108.44 175.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.86 126.46 27.08 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.129 0.571 . . . . 0.0 111.676 175.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.47 HD12 ' N ' ' A' ' 48' ' ' ASN . 3.1 pp -100.37 -53.48 3.1 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 122.844 0.458 . . . . 0.0 111.937 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.47 ' N ' HD12 ' A' ' 47' ' ' LEU . 5.8 t30 -171.6 138.87 1.17 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.618 1.967 . . . . 0.0 109.56 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.599 ' HB2' HD12 ' A' ' 60' ' ' LEU . . . -121.31 155.53 34.51 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.797 1.239 . . . . 0.0 111.404 175.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -136.45 113.42 10.44 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.589 1.555 . . . . 0.0 111.409 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.533 ' CD1' ' HB1' ' A' ' 87' ' ' ALA . 2.8 m-85 -114.31 132.5 56.15 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 123.772 0.829 . . . . 0.0 110.02 -178.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.58 -31.33 4.31 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 114.973 1.471 . . . . 0.0 114.973 -175.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.0 t -123.18 -46.58 2.06 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.503 1.521 . . . . 0.0 110.943 175.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -72.48 10.97 4.48 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 124.711 1.148 . . . . 0.0 115.046 -178.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.3 p -31.06 104.03 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 128.982 2.913 . . . . 0.0 114.182 -174.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.642 HG21 HG23 ' A' ' 59' ' ' ILE . 1.6 t -120.92 178.6 4.66 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.945 1.298 . . . . 0.0 112.786 -174.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -77.42 -59.03 2.95 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.86 1.264 . . . . 0.0 111.554 174.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.3 p -138.09 131.41 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 125.918 1.687 . . . . 0.0 112.32 -178.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.642 HG23 HG21 ' A' ' 56' ' ' THR . 1.1 pp -140.78 -39.62 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.92 1.688 . . . . 0.0 114.154 -177.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.606 ' H ' HD12 ' A' ' 59' ' ' ILE . 4.9 mt -92.17 94.94 0.87 Allowed Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 124.933 1.293 . . . . 0.0 108.883 175.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -61.83 132.91 42.03 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 123.137 2.558 . . . . 0.0 110.258 175.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -40.0 -44.43 1.73 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 126.457 1.903 . . . . 0.0 113.962 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.4 p -155.13 139.7 9.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 C-N-CA 126.613 1.965 . . . . 0.0 110.028 176.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 58.6 t -133.72 121.35 16.02 Favored Pre-proline 0 N--CA 1.484 1.246 0 C-N-CA 124.623 1.169 . . . . 0.0 110.672 178.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -58.17 152.32 53.3 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.982 2.455 . . . . 0.0 113.21 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -72.49 168.21 19.01 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.51 0.724 . . . . 0.0 110.657 175.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 72.7 p 51.72 28.56 4.95 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 126.904 2.082 . . . . 0.0 112.687 -175.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.25 171.85 12.83 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 128.443 2.697 . . . . 0.0 109.42 -175.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -131.15 167.36 19.27 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 121.716 -0.615 . . . . 0.0 109.746 177.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.42 HD11 ' HB ' ' A' ' 36' ' ' ILE . 2.9 pp -137.14 174.16 10.91 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 125.045 1.338 . . . . 0.0 111.03 -176.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.461 HD13 ' O ' ' A' ' 34' ' ' VAL . 0.5 OUTLIER -127.95 152.65 47.63 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.819 1.248 . . . . 0.0 111.397 176.166 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.799 ' HB2' HG22 ' A' ' 34' ' ' VAL . 8.2 m-85 -127.25 136.68 52.33 Favored 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 125.109 1.364 . . . . 0.0 107.76 174.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.0 p -114.96 153.29 30.87 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 125.666 1.587 . . . . 0.0 110.935 176.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -170.84 145.45 8.98 Favored Glycine 0 N--CA 1.452 -0.263 0 CA-C-O 121.587 0.548 . . . . 0.0 112.422 176.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 19.0 mtm180 -128.45 132.43 48.41 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 125.942 1.697 . . . . 0.0 109.759 -175.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.8 ptmt . . . . . 0 N--CA 1.474 0.753 0 C-N-CA 123.894 0.878 . . . . 0.0 112.734 174.994 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.48 1.069 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -68.26 -64.59 3.04 Favored Glycine 0 N--CA 1.474 1.193 0 O-C-N 120.598 -1.314 . . . . 0.0 113.191 -177.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -158.44 114.08 2.67 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.238 1.015 . . . . 0.0 111.058 178.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.8 t -147.57 123.23 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 O-C-N 121.246 -0.909 . . . . 0.0 110.577 -176.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.533 ' HB1' ' CD1' ' A' ' 51' ' ' PHE . . . -165.03 167.24 18.58 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.974 1.31 . . . . 0.0 112.022 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -150.1 139.72 21.62 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.655 1.182 . . . . 0.0 110.645 174.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.453 ' CD2' ' CE2' ' A' ' 72' ' ' TYR . 46.8 p90 -139.73 170.91 15.01 Favored 'General case' 0 N--CA 1.467 0.383 0 O-C-N 121.012 -1.055 . . . . 0.0 110.622 176.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -137.16 156.39 48.4 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.843 -0.536 . . . . 0.0 112.295 175.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.404 ' CD1' ' HB3' ' A' ' 44' ' ' TRP . 8.5 m-85 -130.39 129.14 42.71 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 125.492 1.517 . . . . 0.0 112.314 -177.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -85.88 117.29 24.64 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.065 0.46 . . . . 0.0 111.133 -178.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 7.6 mtp -93.92 132.17 38.62 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.05 1.34 . . . . 0.0 110.981 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 39.5 m -57.92 -18.21 21.64 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 125.246 1.418 . . . . 0.0 113.856 175.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -69.48 -9.18 52.66 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 124.911 1.285 . . . . 0.0 113.06 175.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 99.54 19.77 19.39 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 125.746 1.641 . . . . 0.0 114.549 178.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 16.4 m-80 -130.55 175.86 8.64 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.003 1.321 . . . . 0.0 111.053 -175.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 16.4 m -128.85 114.21 16.23 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.852 0.861 . . . . 0.0 111.955 177.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 52.1 tp -79.39 104.43 10.0 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.598 1.159 . . . . 0.0 109.737 175.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -99.21 113.92 4.87 Favored Glycine 0 N--CA 1.466 0.69 0 C-N-CA 124.477 1.037 . . . . 0.0 112.737 -179.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 90.1 t -96.31 135.46 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.529 1.131 . . . . 0.0 111.076 -178.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -134.51 125.65 27.79 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.927 1.291 . . . . 0.0 110.772 -175.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.465 ' CZ ' ' HB3' ' A' ' 87' ' ' ALA . 5.6 p90 -145.94 122.94 11.39 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.759 1.224 . . . . 0.0 111.599 -174.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 38.3 t -133.92 136.31 44.17 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 124.179 0.992 . . . . 0.0 110.46 176.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 45.4 t . . . . . 0 C--O 1.238 0.47 0 C-N-CA 127.897 2.479 . . . . 0.0 106.533 -178.358 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.7 m . . . . . 0 N--CA 1.474 0.732 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -81.37 130.93 35.24 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.627 1.971 . . . . 0.0 106.759 175.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 9.7 m0 -117.8 120.64 38.55 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.983 1.313 . . . . 0.0 110.233 176.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 11.6 p-90 -144.46 152.65 40.92 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 126.361 1.865 . . . . 0.0 111.728 -175.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 9.7 t70 164.76 150.17 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 128.743 2.817 . . . . 0.0 109.648 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 62.0 t -120.83 139.49 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.183 1.393 . . . . 0.0 109.035 -175.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.485 ' HE2' ' HG3' ' A' ' 135' ' ' MET . 0.0 OUTLIER -129.46 171.19 12.81 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.287 1.035 . . . . 0.0 111.795 -178.968 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 54.5 mt -124.96 116.78 48.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 175.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -77.12 149.76 79.94 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 123.119 0.568 . . . . 0.0 110.589 174.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.78 -0.67 7.26 Favored 'Trans proline' 0 CA--C 1.545 1.051 0 C-N-CA 124.471 3.448 . . . . 0.0 115.027 -176.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -174.0 -175.49 41.68 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 127.055 2.264 . . . . 0.0 111.003 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 24.6 tttt -52.77 116.83 2.52 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.117 1.367 . . . . 0.0 112.059 -177.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -133.24 117.71 17.72 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.382 1.473 . . . . 0.0 111.738 -177.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.3 ptt180 -65.12 175.11 1.71 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.026 0.93 . . . . 0.0 111.855 174.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -127.58 103.27 7.24 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.989 1.716 . . . . 0.0 106.809 176.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -132.51 172.63 12.25 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.69 1.996 . . . . 0.0 109.425 177.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -53.72 -38.85 64.71 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -177.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -60.96 -58.72 12.29 Favored Glycine 0 N--CA 1.469 0.86 0 CA-C-N 118.885 0.766 . . . . 0.0 111.376 174.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 2.2 mpp? -59.1 -39.59 82.68 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 117.851 0.825 . . . . 0.0 112.171 178.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -59.78 -59.01 6.11 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.367 1.067 . . . . 0.0 110.75 175.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -67.97 -34.31 76.3 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 118.927 0.785 . . . . 0.0 113.01 -177.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -63.45 -41.53 98.63 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.447 0.699 . . . . 0.0 111.382 175.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . 0.485 ' HG3' ' HE2' ' A' ' 119' ' ' LYS . 37.4 mmm -77.48 -28.47 52.27 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 121.06 -1.025 . . . . 0.0 113.033 175.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -54.56 -55.19 31.87 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 119.412 1.005 . . . . 0.0 111.386 176.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -65.11 -18.99 65.76 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 119.659 -0.816 . . . . 0.0 112.129 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -81.38 3.8 75.91 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 126.773 2.13 . . . . 0.0 114.472 174.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 34.9 m-20 -115.67 64.31 2.22 Favored Pre-proline 0 CA--C 1.552 1.045 0 C-N-CA 125.804 1.642 . . . . 0.0 114.966 -175.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -76.1 73.33 4.97 Favored 'Trans proline' 0 CA--C 1.546 1.08 0 C-N-CA 123.551 2.834 . . . . 0.0 112.87 -177.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.98 116.43 7.05 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.423 1.089 . . . . 0.0 109.723 -178.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 2.9 ttm105 -81.79 -172.81 4.09 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.534 1.533 . . . . 0.0 111.362 177.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -78.06 57.13 3.98 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 124.114 0.864 . . . . 0.0 111.027 174.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -62.61 98.81 0.13 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 128.095 2.558 . . . . 0.0 110.376 175.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 11.2 p-10 -64.08 66.04 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 127.851 2.46 . . . . 0.0 116.343 -175.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -178.44 167.94 38.78 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 128.368 2.89 . . . . 0.0 109.825 175.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' TRP . . . . . 0.44 ' CE3' ' HG3' ' A' ' 159' ' ' LYS . 59.6 m95 -64.78 67.91 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.998 2.119 . . . . 0.0 111.215 175.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -85.73 116.12 23.81 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 128.796 2.838 . . . . 0.0 111.452 -177.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -166.55 -172.63 2.23 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 177.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.68 167.37 22.27 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.494 1.918 . . . . 0.0 112.543 177.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 54.5 m-20 -64.56 142.59 58.37 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.904 -0.498 . . . . 0.0 109.782 175.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 11.0 mt -89.97 158.76 17.23 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 122.165 0.983 . . . . 0.0 109.359 175.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -65.6 -171.87 3.64 Favored Glycine 0 CA--C 1.536 1.399 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 175.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 54.73 8.78 0.24 Allowed 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 175.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 82.07 42.51 8.73 Favored Glycine 0 CA--C 1.54 1.645 0 C-N-CA 126.279 1.895 . . . . 0.0 113.087 -175.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.7 mp -120.17 172.33 7.85 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 119.025 1.413 . . . . 0.0 112.678 179.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 24.2 mtt180 -137.99 117.32 12.77 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 120.746 -1.221 . . . . 0.0 111.548 176.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 5.3 ttt -98.45 151.37 20.66 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 120.108 -1.62 . . . . 0.0 108.636 174.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.44 ' HG3' ' CE3' ' A' ' 147' ' ' TRP . 5.4 tppt? -136.86 142.47 42.82 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.503 1.921 . . . . 0.0 109.877 176.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -155.79 152.19 23.66 Favored Glycine 0 N--CA 1.473 1.146 0 O-C-N 120.64 -1.287 . . . . 0.0 112.858 176.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 2.2 tp -135.19 124.53 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 126.676 1.99 . . . . 0.0 108.143 -176.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 8.7 mtp -145.29 113.02 6.33 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.662 1.585 . . . . 0.0 108.991 174.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 9.5 t -100.66 125.17 47.05 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 118.517 0.599 . . . . 0.0 110.997 178.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 23.1 p -74.18 39.01 0.11 Allowed 'General case' 0 N--CA 1.481 1.097 0 O-C-N 120.738 -1.226 . . . . 0.0 113.764 175.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -72.41 -2.29 18.85 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 126.192 1.797 . . . . 0.0 114.516 177.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 108.89 -59.77 0.35 Allowed Glycine 0 CA--C 1.531 1.088 0 C-N-CA 126.264 1.887 . . . . 0.0 113.03 176.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -118.79 27.02 9.15 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.416 1.486 . . . . 0.0 112.482 -177.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.91 170.59 6.44 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 122.558 1.17 . . . . 0.0 114.129 175.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.67 -178.88 3.92 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 126.819 2.047 . . . . 0.0 110.89 175.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 14.8 ttp -125.85 139.12 53.75 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.588 1.555 . . . . 0.0 110.288 171.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.418 ' C ' HD12 ' A' ' 172' ' ' ILE . 39.8 tt0 -143.48 126.9 16.78 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 121.981 -0.449 . . . . 0.0 110.67 174.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.418 HD12 ' C ' ' A' ' 171' ' ' GLN . 2.7 mp -123.28 133.95 67.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.664 1.186 . . . . 0.0 108.642 176.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -133.14 132.76 42.02 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.852 1.661 . . . . 0.0 109.473 178.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.9 mp -96.04 92.04 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 O-C-N 121.197 -0.939 . . . . 0.0 109.63 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.41 165.1 8.16 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-O 122.276 1.036 . . . . 0.0 112.839 175.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 18.2 mmm180 . . . . . 0 C--O 1.252 1.227 0 C-N-CA 125.182 1.393 . . . . 0.0 111.171 -176.82 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 32.1 tp . . . . . 0 N--CA 1.484 1.23 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -128.95 120.98 27.07 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 127.273 2.229 . . . . 0.0 107.776 178.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -73.05 -101.16 0.07 OUTLIER Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.046 0.831 . . . . 0.0 112.305 -178.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 38.8 p -131.18 170.67 14.25 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.756 1.222 . . . . 0.0 111.33 175.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -124.47 16.19 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 125.248 1.419 . . . . 0.0 111.886 179.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.3 pt -53.31 168.69 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 124.945 1.298 . . . . 0.0 111.561 175.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -40.6 132.64 2.12 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.62 1.168 . . . . 0.0 112.873 -178.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -53.71 -22.5 18.28 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 124.937 1.256 . . . . 0.0 114.322 -176.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.18 -33.07 71.69 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.273 1.429 . . . . 0.0 112.452 175.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.2 t -96.36 -44.52 7.18 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.214 1.406 . . . . 0.0 112.314 175.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.3 tp -69.15 89.55 0.45 Allowed 'General case' 0 CA--C 1.545 0.752 0 CA-C-O 122.168 0.985 . . . . 0.0 110.632 175.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 58.1 p -126.93 -176.14 3.62 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 126.884 2.074 . . . . 0.0 111.512 -178.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -52.19 -36.93 53.3 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.165 0.986 . . . . 0.0 113.174 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -56.02 -43.63 77.96 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.645 1.178 . . . . 0.0 112.001 176.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 88.5 t -65.97 -42.52 91.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 124.342 1.057 . . . . 0.0 110.85 175.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 42.4 mt -68.52 -38.36 80.84 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 120.837 -1.164 . . . . 0.0 112.5 -179.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -64.6 -47.93 76.8 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.725 1.21 . . . . 0.0 111.105 178.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.32 -35.18 77.41 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 118.064 -0.97 . . . . 0.0 113.083 175.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.4 t -53.93 -44.08 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 CA-C-N 120.209 1.368 . . . . 0.0 111.982 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 71.0 mt -60.33 -13.78 14.87 Favored 'General case' 0 CA--C 1.55 0.964 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 175.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -106.06 -46.86 1.13 Allowed Glycine 0 CA--C 1.536 1.354 0 C-N-CA 126.681 2.086 . . . . 0.0 114.034 178.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -66.24 -25.5 66.92 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 119.075 1.438 . . . . 0.0 113.445 175.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -111.06 158.42 18.85 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.84 1.256 . . . . 0.0 111.656 175.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -175.77 86.49 0.07 OUTLIER Glycine 0 CA--C 1.53 1.015 0 O-C-N 121.474 -0.766 . . . . 0.0 113.901 -175.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.7 mttt -74.82 -54.8 6.64 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.946 1.298 . . . . 0.0 112.525 177.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 16.2 m -141.03 -179.11 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 127.917 2.487 . . . . 0.0 111.158 -178.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 25.9 m -49.54 -48.69 48.17 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 126.334 1.854 . . . . 0.0 114.517 -177.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.0 tpm_? -120.42 129.6 53.98 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.318 1.447 . . . . 0.0 109.497 175.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.9 ptpt -131.93 152.53 51.02 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.824 2.05 . . . . 0.0 110.502 -174.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -121.37 131.12 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 124.674 1.19 . . . . 0.0 109.559 177.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -134.61 97.54 3.82 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.473 1.909 . . . . 0.0 110.318 177.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.769 HG22 ' HB2' ' A' ' 72' ' ' TYR . 1.6 m -99.52 160.78 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 C-N-CA 123.305 0.642 . . . . 0.0 111.189 178.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -133.53 112.11 1.05 Allowed Glycine 0 CA--C 1.526 0.749 0 CA-C-O 119.308 -0.718 . . . . 0.0 113.526 174.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.9 mp -100.68 147.05 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 119.286 1.543 . . . . 0.0 109.456 175.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.448 ' HB3' ' HA ' ' A' ' 173' ' ' LYS . 21.7 t0 -117.2 102.76 9.55 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.116 1.366 . . . . 0.0 110.645 177.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -71.54 92.25 1.12 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 127.14 2.176 . . . . 0.0 111.221 176.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -119.01 -0.19 11.19 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.445 1.098 . . . . 0.0 113.802 175.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 30.3 t -47.81 -34.56 8.82 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 127.024 2.13 . . . . 0.0 114.63 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 110.23 60.49 0.5 Allowed Glycine 0 N--CA 1.468 0.777 0 C-N-CA 124.822 1.201 . . . . 0.0 112.264 177.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 167.81 150.34 6.49 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 125.327 1.441 . . . . 0.0 111.918 177.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.673 HG22 ' HA ' ' A' ' 65' ' ' PRO . 10.0 p -68.43 130.99 44.5 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.504 1.122 . . . . 0.0 110.92 174.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 43.1 m0 -91.35 101.79 14.49 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 123.849 0.86 . . . . 0.0 111.634 -179.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.9 m -83.45 125.4 31.68 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.069 1.348 . . . . 0.0 109.907 175.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.77 131.69 47.52 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.036 0.534 . . . . 0.0 110.582 174.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -117.12 -45.37 2.75 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.034 0.934 . . . . 0.0 112.125 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -174.25 149.14 1.36 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.76 2.024 . . . . 0.0 111.436 -178.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -131.26 164.82 24.74 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.778 1.631 . . . . 0.0 111.945 176.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -142.89 109.13 5.27 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.902 1.281 . . . . 0.0 111.45 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.498 ' CE1' ' HB1' ' A' ' 87' ' ' ALA . 3.0 m-85 -113.62 128.01 56.27 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.914 0.886 . . . . 0.0 110.498 -177.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.57 -39.77 4.53 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -177.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.8 t -116.74 -53.89 2.47 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 126.099 1.759 . . . . 0.0 109.801 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -65.36 12.46 0.3 Allowed Glycine 0 CA--C 1.534 1.239 0 C-N-CA 126.929 2.204 . . . . 0.0 115.754 -175.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 53.1 p -31.16 111.15 0.08 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 129.288 3.035 . . . . 0.0 112.938 -174.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 t -129.42 179.62 5.69 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.794 1.238 . . . . 0.0 113.713 -175.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -82.51 -69.65 0.61 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.29 1.436 . . . . 0.0 111.573 176.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.1 p -132.4 130.28 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 125.688 1.595 . . . . 0.0 111.685 -177.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.5 pp -141.15 -26.15 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.896 1.678 . . . . 0.0 114.478 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -99.35 95.26 3.34 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 125.45 1.5 . . . . 0.0 109.181 178.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -65.57 151.55 84.42 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.781 2.987 . . . . 0.0 111.026 176.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -46.52 -49.19 18.89 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.991 1.316 . . . . 0.0 113.595 -179.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.7 p -157.5 139.91 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 126.497 1.919 . . . . 0.0 110.073 175.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.407 HG21 HD13 ' A' ' 70' ' ' LEU . 46.1 t -113.89 130.12 24.13 Favored Pre-proline 0 N--CA 1.474 0.753 0 C-N-CA 124.542 1.137 . . . . 0.0 109.069 174.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.673 ' HA ' HG22 ' A' ' 43' ' ' THR . 66.5 Cg_endo -67.71 152.84 77.32 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.436 2.091 . . . . 0.0 112.527 176.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -67.12 166.01 14.77 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.05 174.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . 0.267 66.8 p 52.9 22.65 2.47 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 127.668 2.387 . . . . 0.0 114.574 -174.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 20.9 mttt -124.57 172.84 8.9 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 126.834 2.053 . . . . 0.0 112.351 -178.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -131.48 163.94 26.86 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 122.799 0.439 . . . . 0.0 110.123 -178.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.407 HD13 HG21 ' A' ' 64' ' ' VAL . 2.4 pt? -143.76 171.0 14.81 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 124.267 1.027 . . . . 0.0 112.49 -178.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.583 HD13 ' O ' ' A' ' 34' ' ' VAL . 0.9 OUTLIER -117.49 154.78 30.85 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.91 1.284 . . . . 0.0 113.45 179.667 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.769 ' HB2' HG22 ' A' ' 34' ' ' VAL . 16.1 m-85 -129.34 133.5 47.45 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.034 1.334 . . . . 0.0 109.258 175.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.0 p -107.82 149.2 28.53 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 126.443 1.897 . . . . 0.0 110.287 175.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -167.9 144.52 8.96 Favored Glycine 0 CA--C 1.522 0.524 0 O-C-N 121.738 -0.601 . . . . 0.0 112.852 174.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 40.2 mtm180 -107.09 140.52 39.79 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.47 1.508 . . . . 0.0 110.676 -176.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.925 0 C-N-CA 125.439 1.496 . . . . 0.0 114.564 175.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 97.6 m . . . . . 0 N--CA 1.478 0.963 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -54.32 -82.44 0.05 OUTLIER Glycine 0 N--CA 1.475 1.299 0 C-N-CA 124.968 1.27 . . . . 0.0 114.526 -174.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -158.82 109.45 2.06 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.509 0.671 . . . . 0.0 111.723 174.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.9 t -138.24 121.07 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 124.897 1.279 . . . . 0.0 109.375 -177.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.498 ' HB1' ' CE1' ' A' ' 51' ' ' PHE . . . -157.66 167.47 30.01 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 122.211 1.005 . . . . 0.0 110.982 176.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -147.91 158.15 43.9 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.208 1.003 . . . . 0.0 109.501 175.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.482 ' CZ ' HG11 ' A' ' 101' ' ' VAL . 48.0 p90 -155.19 174.48 15.14 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 121.323 -0.861 . . . . 0.0 110.101 175.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.482 ' HB1' ' CG2' ' A' ' 98' ' ' THR . . . -133.52 148.28 51.66 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.537 175.071 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -125.93 148.57 49.19 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.372 1.069 . . . . 0.0 113.8 176.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -89.12 123.69 33.63 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -178.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 5.8 tpp -89.22 144.07 26.37 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.586 0.754 . . . . 0.0 111.345 176.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 10.8 t -66.34 -23.08 66.29 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.828 0.851 . . . . 0.0 112.829 175.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -73.84 -11.15 60.28 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.981 1.313 . . . . 0.0 112.605 174.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 96.71 38.81 4.31 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 125.051 1.31 . . . . 0.0 114.649 178.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -135.7 173.15 12.04 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 118.812 1.306 . . . . 0.0 110.998 -179.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.482 ' CG2' ' HB1' ' A' ' 90' ' ' ALA . 3.4 m -122.63 103.44 8.68 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.731 1.212 . . . . 0.0 112.221 -177.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.3 tt -64.53 92.51 0.09 Allowed 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 126.369 1.868 . . . . 0.0 111.957 175.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -91.96 95.2 2.01 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 125.924 1.726 . . . . 0.0 112.211 -178.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.503 HG23 HG22 ' A' ' 118' ' ' VAL . 2.3 p -82.33 153.63 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 123.704 0.802 . . . . 0.0 111.635 177.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.74 116.67 7.77 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.697 1.599 . . . . 0.0 110.583 177.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.449 ' CE2' ' HB3' ' A' ' 87' ' ' ALA . 24.6 p90 -134.49 131.08 37.63 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 122.201 1.001 . . . . 0.0 112.706 -176.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 23.3 t -143.56 97.38 3.06 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 124.564 1.146 . . . . 0.0 110.643 -175.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 24.1 t . . . . . 0 CA--C 1.541 0.623 0 C-N-CA 126.19 1.796 . . . . 0.0 108.975 177.453 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 7.3 m . . . . . 0 N--CA 1.469 0.515 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -123.11 116.23 23.12 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 124.944 1.297 . . . . 0.0 111.359 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 44.5 m0 -109.03 161.23 15.36 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.251 1.421 . . . . 0.0 111.1 -175.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 43.7 p-90 -150.21 137.2 19.37 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.004 0.922 . . . . 0.0 111.771 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -147.75 163.96 35.07 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 122.881 1.324 . . . . 0.0 113.598 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.503 HG22 HG23 ' A' ' 101' ' ' VAL . 19.6 t -145.98 140.73 21.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 C-N-CA 124.699 1.199 . . . . 0.0 108.656 175.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.6 173.36 14.74 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 128.032 2.533 . . . . 0.0 108.85 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.486 ' HB ' ' CE2' ' A' ' 154' ' ' TYR . 7.4 mt -129.86 113.34 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 123.883 0.873 . . . . 0.0 109.135 177.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -64.76 138.14 97.37 Favored Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 124.108 0.963 . . . . 0.0 111.521 177.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -74.48 84.07 1.62 Allowed 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 124.336 3.357 . . . . 0.0 112.124 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 114.62 175.76 18.74 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 126.348 1.928 . . . . 0.0 112.955 -178.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 7.5 tttt -61.84 102.36 0.26 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.289 1.436 . . . . 0.0 111.015 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 1.4 mmt85 -123.18 -175.2 3.12 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 126.434 1.894 . . . . 0.0 111.959 -175.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.3 ptp180 -132.12 175.92 8.83 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.735 1.214 . . . . 0.0 112.581 175.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -119.53 111.69 18.41 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 105.258 -2.127 . . . . 0.0 105.258 174.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -128.9 166.26 19.47 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.485 1.514 . . . . 0.0 109.275 177.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -50.01 -40.23 43.93 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 119.8 1.182 . . . . 0.0 113.389 -178.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -56.23 -62.59 6.16 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 124.065 0.841 . . . . 0.0 111.843 174.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 4.6 mtm -60.79 -37.3 81.46 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.045 1.338 . . . . 0.0 113.723 178.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -57.84 -62.49 1.76 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.256 1.422 . . . . 0.0 109.494 175.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -69.47 -31.54 69.89 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -177.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -57.05 -59.1 5.57 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.032 1.333 . . . . 0.0 110.864 174.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.13 -20.54 59.36 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -53.75 -57.27 11.48 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.639 1.176 . . . . 0.0 109.954 175.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -71.4 -0.73 10.94 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -89.82 -9.55 65.99 Favored Glycine 0 CA--C 1.537 1.454 0 C-N-CA 126.112 1.815 . . . . 0.0 114.924 177.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -145.6 91.33 5.74 Favored Pre-proline 0 CA--C 1.549 0.918 0 CA-C-N 119.64 1.72 . . . . 0.0 113.43 179.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -74.41 81.12 2.11 Favored 'Trans proline' 0 CA--C 1.543 0.968 0 C-N-CA 123.556 2.837 . . . . 0.0 112.656 -178.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -113.41 116.16 29.21 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.493 1.517 . . . . 0.0 109.233 177.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 4.4 ttm180 -103.43 50.6 0.8 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.992 1.317 . . . . 0.0 114.052 -174.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 56.96 56.21 26.15 Favored Glycine 0 CA--C 1.534 1.239 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 -175.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -68.08 108.09 2.97 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.002 1.321 . . . . 0.0 110.873 -175.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -77.04 91.81 3.68 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.171 1.388 . . . . 0.0 114.24 -174.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.71 50.77 0.01 OUTLIER Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.318 0.961 . . . . 0.0 114.381 174.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' TRP . . . . . 0.535 ' H ' HD13 ' A' ' 161' ' ' ILE . 8.8 m95 46.36 62.38 2.32 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.602 1.561 . . . . 0.0 112.704 -174.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -90.51 125.37 35.58 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.112 1.365 . . . . 0.0 112.361 179.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -160.03 -175.12 4.91 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.235 1.014 . . . . 0.0 113.104 -175.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 8.9 mtmt -134.76 160.8 37.04 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.375 1.47 . . . . 0.0 111.176 174.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -81.36 146.62 30.24 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.066 0.946 . . . . 0.0 109.397 175.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.427 ' CD2' ' H ' ' A' ' 158' ' ' MET . 3.1 mm? -102.03 128.2 48.58 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 122.733 0.413 . . . . 0.0 110.013 -177.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -53.32 -24.67 23.63 Favored Glycine 0 N--CA 1.475 1.289 0 C-N-CA 125.628 1.585 . . . . 0.0 116.005 -175.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.486 ' CE2' ' HB ' ' A' ' 120' ' ' ILE . 0.1 OUTLIER -74.06 1.54 10.79 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 127.539 2.336 . . . . 0.0 113.453 177.612 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 90.28 10.85 63.53 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.882 1.706 . . . . 0.0 114.381 -177.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 2.6 mt -98.32 166.44 11.39 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.722 2.009 . . . . 0.0 111.187 -178.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 57.7 mtt180 -139.87 105.6 5.14 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.294 1.038 . . . . 0.0 110.524 178.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . 0.427 ' H ' ' CD2' ' A' ' 152' ' ' LEU . 18.0 ttp -91.68 135.5 33.84 Favored 'General case' 0 C--N 1.318 -0.762 0 O-C-N 120.755 -1.215 . . . . 0.0 107.888 176.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.21 124.57 52.36 Favored 'General case' 0 C--O 1.221 -0.414 0 C-N-CA 126.145 1.778 . . . . 0.0 109.482 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -133.1 155.6 21.74 Favored Glycine 0 N--CA 1.469 0.842 0 CA-C-N 120.807 1.64 . . . . 0.0 114.833 -178.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.535 HD13 ' H ' ' A' ' 147' ' ' TRP . 4.2 tp -152.7 135.06 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-O 122.777 1.275 . . . . 0.0 110.846 -175.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 11.5 mtp -153.05 168.94 24.2 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 128.058 2.543 . . . . 0.0 109.209 176.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 13.2 t -151.66 162.66 40.62 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.726 1.21 . . . . 0.0 109.451 174.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 89.5 p -97.68 26.2 5.24 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.047 1.339 . . . . 0.0 113.115 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -68.48 12.77 0.11 Allowed 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 126.843 2.057 . . . . 0.0 115.4 -176.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 85.93 -62.82 4.33 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 125.735 1.636 . . . . 0.0 112.69 178.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -95.61 9.96 38.4 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 177.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -58.04 159.75 5.44 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 123.116 1.436 . . . . 0.0 114.189 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.45 175.41 6.2 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 128.002 2.521 . . . . 0.0 110.758 -177.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 35.6 ttp -118.97 130.5 55.73 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 125.012 1.325 . . . . 0.0 110.363 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -137.03 126.84 25.61 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.148 0.579 . . . . 0.0 110.806 175.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.403 HG21 ' SD ' ' A' ' 158' ' ' MET . 4.8 mp -131.11 113.75 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 C-N-CA 123.668 0.787 . . . . 0.0 110.068 176.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.448 ' HA ' ' HB3' ' A' ' 37' ' ' ASP . 0.3 OUTLIER -109.61 129.09 55.61 Favored 'General case' 0 C--O 1.222 -0.352 0 C-N-CA 125.11 1.364 . . . . 0.0 111.693 176.277 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.8 mp -79.61 137.18 22.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 175.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 3.2 m -122.21 159.21 27.75 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.699 2.0 . . . . 0.0 110.631 175.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 39.1 mtp180 . . . . . 0 C--O 1.251 1.182 0 C-N-CA 126.403 1.881 . . . . 0.0 112.161 -178.586 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 11.9 tp . . . . . 0 N--CA 1.477 0.892 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -132.3 137.78 47.59 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.706 1.602 . . . . 0.0 110.805 175.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.425 ' H ' ' HG ' ' A' ' 71' ' ' LEU . . . -81.75 -153.88 11.88 Favored Glycine 0 CA--C 1.544 1.878 0 C-N-CA 125.351 1.453 . . . . 0.0 110.257 176.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 42.5 p -76.06 173.76 10.88 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.609 1.164 . . . . 0.0 113.063 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -129.77 15.91 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.987 0 C-N-CA 125.92 1.688 . . . . 0.0 112.16 176.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.419 HD12 ' HB3' ' A' ' 12' ' ' SER . 4.7 pt -52.92 166.3 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 O-C-N 120.587 -1.32 . . . . 0.0 111.733 175.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -39.81 132.42 1.72 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.267 1.427 . . . . 0.0 113.244 -179.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -57.36 -16.89 22.9 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 124.889 1.233 . . . . 0.0 114.402 -177.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.2 -23.63 67.38 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.542 1.137 . . . . 0.0 111.701 174.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.419 ' HB3' HD12 ' A' ' 8' ' ' ILE . 4.1 t -109.82 -40.29 4.84 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.592 1.957 . . . . 0.0 112.604 175.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.6 tp -76.47 97.43 4.32 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 121.476 -0.765 . . . . 0.0 109.827 175.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -134.99 -177.82 4.81 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 126.541 1.937 . . . . 0.0 111.87 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -50.23 -36.24 30.13 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.212 1.405 . . . . 0.0 112.91 -178.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -52.85 -37.83 60.69 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.015 1.326 . . . . 0.0 112.543 175.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 78.5 t -73.25 -42.01 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 125.788 1.635 . . . . 0.0 111.115 175.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 57.7 mt -65.4 -42.24 92.81 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 120.961 -1.087 . . . . 0.0 111.964 178.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -61.04 -41.21 96.15 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.289 1.036 . . . . 0.0 111.882 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.98 -38.47 64.16 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 118.834 -0.603 . . . . 0.0 111.215 175.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.402 HG13 HD12 ' A' ' 25' ' ' LEU . 19.3 t -56.01 -39.66 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 C-N-CA 125.398 1.479 . . . . 0.0 111.534 177.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -56.57 -20.57 21.41 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 125.865 1.666 . . . . 0.0 112.727 174.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -108.38 -50.3 0.77 Allowed Glycine 0 CA--C 1.533 1.206 0 C-N-CA 126.356 1.931 . . . . 0.0 114.151 -178.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -64.19 -27.41 69.05 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 118.966 1.383 . . . . 0.0 113.503 178.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.402 HD12 HG13 ' A' ' 21' ' ' VAL . 14.3 mt -109.99 119.64 39.96 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.114 1.366 . . . . 0.0 109.549 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -162.32 81.1 0.13 Allowed Glycine 0 CA--C 1.534 1.24 0 O-C-N 121.604 -0.685 . . . . 0.0 114.156 -175.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.6 mttt -72.69 -60.13 2.38 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.945 1.698 . . . . 0.0 112.985 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.5 m -109.46 -178.7 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 126.794 2.038 . . . . 0.0 110.756 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.6 t -51.27 -46.64 62.47 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.512 1.125 . . . . 0.0 113.568 -175.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.69 144.2 51.17 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.948 1.699 . . . . 0.0 111.176 174.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.92 166.35 22.54 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.194 1.797 . . . . 0.0 111.615 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -129.07 137.42 57.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 124.927 1.291 . . . . 0.0 109.387 176.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -141.0 119.24 12.08 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 126.004 1.721 . . . . 0.0 109.416 175.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.532 HG22 ' HB2' ' A' ' 72' ' ' TYR . 2.6 m -124.77 139.03 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 123.084 0.553 . . . . 0.0 110.779 -179.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -111.51 103.6 1.58 Allowed Glycine 0 N--CA 1.461 0.334 0 C-N-CA 124.754 1.168 . . . . 0.0 110.857 -178.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.4 mp -100.16 132.81 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 121.527 0.68 . . . . 0.0 110.806 175.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -100.99 104.15 15.3 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.755 2.022 . . . . 0.0 109.859 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 29.1 t30 -78.51 99.05 6.31 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.651 0.78 . . . . 0.0 111.033 175.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.54 13.41 10.13 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.002 0.921 . . . . 0.0 112.2 175.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.43 -34.88 71.29 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.892 1.277 . . . . 0.0 114.072 -175.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 139.0 -35.75 1.95 Allowed Glycine 0 CA--C 1.531 1.051 0 C-N-CA 125.535 1.54 . . . . 0.0 113.817 175.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -114.54 158.24 14.45 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 125.167 1.365 . . . . 0.0 112.935 175.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.42 149.17 34.89 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.922 0.867 . . . . 0.0 110.964 175.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.401 ' HB3' ' CD1' ' A' ' 91' ' ' TYR . 40.9 m0 -101.26 107.81 19.29 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 125.139 1.376 . . . . 0.0 110.199 178.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 54.2 m -92.91 128.62 38.84 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 124.805 1.242 . . . . 0.0 109.054 175.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.47 138.15 58.26 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.654 -0.653 . . . . 0.0 111.705 174.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.603 HD21 HG23 ' A' ' 98' ' ' THR . 3.1 pp -118.65 -51.58 2.38 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.054 0.942 . . . . 0.0 112.241 177.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 25.1 t30 -170.83 150.07 3.15 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.09 1.756 . . . . 0.0 109.954 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.611 ' HB2' HD12 ' A' ' 60' ' ' LEU . . . -131.32 158.52 40.45 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.089 1.356 . . . . 0.0 110.849 175.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -136.82 108.6 7.05 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.699 1.6 . . . . 0.0 111.151 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.475 ' CE1' ' HB1' ' A' ' 87' ' ' ALA . 2.9 m-85 -112.59 127.23 56.03 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 120.989 -1.069 . . . . 0.0 110.205 -176.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.55 -32.09 6.57 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -175.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 38.1 t -130.94 -36.06 1.37 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.361 1.464 . . . . 0.0 112.128 175.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -69.64 12.33 1.49 Allowed Glycine 0 CA--C 1.537 1.433 0 C-N-CA 125.553 1.549 . . . . 0.0 115.871 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 75.8 p -28.34 99.36 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 129.992 3.317 . . . . 0.0 114.436 -174.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.606 HG21 HG23 ' A' ' 59' ' ' ILE . 3.2 t -119.25 177.59 4.84 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.467 1.507 . . . . 0.0 112.655 -174.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -82.16 -52.08 7.34 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.442 1.097 . . . . 0.0 112.421 175.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.2 p -155.62 139.19 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.752 1.621 . . . . 0.0 111.618 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.606 HG23 HG21 ' A' ' 56' ' ' THR . 0.1 OUTLIER -133.83 -46.28 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 125.53 1.532 . . . . 0.0 112.693 179.14 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.611 HD12 ' HB2' ' A' ' 49' ' ' ALA . 11.9 mt -79.33 103.46 1.59 Allowed Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 127.002 2.121 . . . . 0.0 109.272 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.5 ' HG2' HG23 ' A' ' 64' ' ' VAL . 48.7 Cg_endo -73.44 159.18 46.95 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 123.874 3.05 . . . . 0.0 110.549 177.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -52.97 -48.77 67.16 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 57.7 t -152.98 136.3 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 127.184 2.194 . . . . 0.0 109.272 -175.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.584 HG21 HD23 ' A' ' 70' ' ' LEU . 57.9 t -128.43 114.48 19.69 Favored Pre-proline 0 N--CA 1.479 1.016 0 C-N-CA 124.208 1.003 . . . . 0.0 110.583 174.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -59.93 145.56 98.01 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.495 2.13 . . . . 0.0 112.385 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -68.11 166.36 16.24 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.692 0.797 . . . . 0.0 110.703 175.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 39.8 p 62.39 16.92 8.99 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 127.198 2.199 . . . . 0.0 113.531 -175.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 19.0 mttt -125.86 -173.76 2.92 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.518 1.927 . . . . 0.0 111.102 -178.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -138.8 166.74 23.62 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 122.912 0.485 . . . . 0.0 109.988 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.584 HD23 HG21 ' A' ' 64' ' ' VAL . 2.8 pp -139.29 171.39 14.35 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 124.549 1.139 . . . . 0.0 111.145 -179.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.425 ' HG ' ' H ' ' A' ' 5' ' ' GLY . 0.9 OUTLIER -119.13 153.98 33.98 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 124.746 1.218 . . . . 0.0 110.475 175.013 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.532 ' HB2' HG22 ' A' ' 34' ' ' VAL . 2.7 m-85 -126.41 151.73 47.29 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 126.215 1.806 . . . . 0.0 109.931 177.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.403 ' H ' HG22 ' A' ' 59' ' ' ILE . 11.0 p -128.7 148.2 50.81 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.85 2.06 . . . . 0.0 111.747 -179.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -169.26 146.62 10.33 Favored Glycine 0 CA--C 1.519 0.306 0 CA-C-O 121.627 0.57 . . . . 0.0 112.619 175.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 63.5 mtm180 -128.64 138.59 52.26 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 126.74 2.016 . . . . 0.0 109.21 -174.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt . . . . . 0 CA--C 1.542 0.665 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 174.961 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.547 0.86 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 76.98 -98.48 1.32 Allowed Glycine 0 CA--C 1.528 0.892 0 C-N-CA 126.518 2.009 . . . . 0.0 112.269 -175.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -148.46 93.44 2.15 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 117.677 0.739 . . . . 0.0 110.866 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.4 t -122.2 120.69 61.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 124.46 1.104 . . . . 0.0 112.066 -175.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.475 ' HB1' ' CE1' ' A' ' 51' ' ' PHE . . . -160.02 168.71 25.0 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.489 1.116 . . . . 0.0 112.282 178.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -150.5 132.96 15.63 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.42 1.088 . . . . 0.0 109.326 174.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.463 ' CD2' ' CE2' ' A' ' 72' ' ' TYR . 43.9 p90 -132.17 170.01 15.6 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 120.946 -1.096 . . . . 0.0 110.27 177.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.438 ' HB1' ' CG2' ' A' ' 98' ' ' THR . . . -139.61 142.87 37.06 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -179.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.401 ' CD1' ' HB3' ' A' ' 44' ' ' TRP . 20.0 m-85 -120.43 139.12 53.3 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.675 1.19 . . . . 0.0 112.788 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -84.76 126.9 33.81 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.997 -0.439 . . . . 0.0 111.453 -177.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -97.53 141.12 30.97 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.016 1.327 . . . . 0.0 111.855 178.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 24.9 m -64.04 -20.26 65.79 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.47 1.108 . . . . 0.0 113.731 174.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 36.2 m-80 -72.22 -10.59 59.98 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.445 1.098 . . . . 0.0 112.81 174.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 89.68 44.32 4.91 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 124.755 1.169 . . . . 0.0 112.987 -176.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.497 ' HB3' HG22 ' A' ' 120' ' ' ILE . 37.3 m-80 -140.06 175.11 9.86 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.956 1.302 . . . . 0.0 110.481 175.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.603 HG23 HD21 ' A' ' 47' ' ' LEU . 12.9 m -126.87 110.7 13.32 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.395 1.478 . . . . 0.0 112.045 178.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.7 tt -70.86 98.02 1.5 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.954 1.302 . . . . 0.0 112.208 174.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -91.22 104.28 3.15 Favored Glycine 0 N--CA 1.469 0.896 0 C-N-CA 125.142 1.353 . . . . 0.0 113.372 177.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 94.0 t -85.39 130.62 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 125.106 1.363 . . . . 0.0 111.344 175.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 2.4 tmm? -119.99 124.27 45.52 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.798 1.639 . . . . 0.0 110.337 178.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.469 ' CZ ' ' HB3' ' A' ' 87' ' ' ALA . 4.3 p90 -148.95 122.67 9.24 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 122.901 1.334 . . . . 0.0 111.946 -178.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 15.1 p -139.94 100.53 3.96 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 124.418 1.087 . . . . 0.0 110.008 -175.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 97.0 t . . . . . 0 CA--C 1.54 0.583 0 C-N-CA 127.125 2.17 . . . . 0.0 108.654 178.535 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.2 p . . . . . 0 N--CA 1.483 1.177 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -98.81 108.5 21.2 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.418 1.887 . . . . 0.0 108.093 175.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 35.7 m0 -105.66 142.75 34.86 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 119.671 1.123 . . . . 0.0 109.942 175.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 29.7 p-90 -146.86 143.65 28.72 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 121.309 -0.87 . . . . 0.0 113.112 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -151.38 164.49 36.58 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 122.654 1.216 . . . . 0.0 112.957 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 54.6 t -153.41 136.66 7.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 175.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.37 177.81 10.2 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 126.645 1.978 . . . . 0.0 109.552 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.518 ' HB ' ' CE2' ' A' ' 154' ' ' TYR . 15.8 mt -126.52 141.79 44.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -101.05 144.4 28.48 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 125.172 1.389 . . . . 0.0 110.312 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.06 132.48 21.33 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 123.077 2.518 . . . . 0.0 111.455 179.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 62.85 -160.87 33.36 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 123.47 0.557 . . . . 0.0 113.017 -175.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.8 tttt -73.88 114.46 12.2 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.292 1.037 . . . . 0.0 109.532 175.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 2.4 mmt-85 -133.09 148.85 52.17 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.542 1.137 . . . . 0.0 111.057 175.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -93.64 179.57 5.33 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-O 121.686 0.755 . . . . 0.0 110.256 176.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -126.07 113.77 17.53 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 127.205 2.202 . . . . 0.0 105.093 175.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -126.91 172.83 10.09 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.388 1.475 . . . . 0.0 110.406 178.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -53.75 -40.78 66.48 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 119.62 1.1 . . . . 0.0 113.323 -178.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -59.73 -54.89 33.81 Favored Glycine 0 N--CA 1.467 0.736 0 CA-C-O 119.364 -0.687 . . . . 0.0 111.824 176.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 4.5 mpp? -62.24 -42.37 99.25 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 118.199 1.0 . . . . 0.0 112.388 177.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -54.94 -56.28 21.4 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.811 0.845 . . . . 0.0 109.646 176.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -66.37 -37.18 84.71 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -60.77 -44.49 96.7 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.298 1.439 . . . . 0.0 112.305 177.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 42.4 mmm -81.6 -30.01 33.08 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.074 -1.016 . . . . 0.0 112.615 177.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -54.47 -57.99 9.18 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.969 1.308 . . . . 0.0 109.457 174.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -73.8 -10.51 59.74 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -177.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -79.92 -15.42 79.12 Favored Glycine 0 CA--C 1.537 1.432 0 C-N-CA 125.893 1.711 . . . . 0.0 114.868 177.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -140.91 90.61 9.42 Favored Pre-proline 0 CA--C 1.552 1.041 0 CA-C-N 119.37 1.585 . . . . 0.0 112.522 176.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -74.66 78.08 2.85 Favored 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 123.912 3.074 . . . . 0.0 112.434 178.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -111.87 120.43 41.9 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.654 1.182 . . . . 0.0 110.462 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.38 -173.82 4.93 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.562 1.145 . . . . 0.0 112.584 176.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -75.16 53.07 2.63 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 125.602 1.572 . . . . 0.0 111.076 175.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -64.72 97.11 0.2 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 127.14 2.176 . . . . 0.0 110.039 178.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -75.31 93.43 2.88 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.554 1.142 . . . . 0.0 113.005 -174.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 162.89 54.93 0.02 OUTLIER Glycine 0 CA--C 1.537 1.407 0 C-N-CA 124.376 0.989 . . . . 0.0 115.011 175.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 8.0 m95 52.1 44.97 29.14 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.619 1.568 . . . . 0.0 114.667 -177.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -78.15 129.5 35.23 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 120.862 -1.148 . . . . 0.0 111.857 -177.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.64 -174.59 4.71 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.394 -0.816 . . . . 0.0 113.165 -175.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.96 151.89 51.64 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.972 1.309 . . . . 0.0 110.733 175.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -69.64 150.63 46.83 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 175.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 60.8 mt -109.91 145.54 36.69 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 175.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -64.5 -166.62 1.19 Allowed Glycine 0 CA--C 1.545 1.917 0 N-CA-C 110.266 -1.134 . . . . 0.0 110.266 176.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.518 ' CE2' ' HB ' ' A' ' 120' ' ' ILE . 0.0 OUTLIER 54.76 10.77 0.39 Allowed 'General case' 0 CA--C 1.558 1.275 0 N-CA-C 115.316 1.598 . . . . 0.0 115.316 175.038 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 80.96 41.27 10.64 Favored Glycine 0 CA--C 1.539 1.584 0 C-N-CA 126.416 1.96 . . . . 0.0 114.666 -175.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 2.4 mp -123.91 160.11 28.22 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 119.445 1.623 . . . . 0.0 112.305 177.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 10.5 mtt-85 -147.37 121.63 9.58 Favored 'General case' 0 N--CA 1.481 1.086 0 O-C-N 120.424 -1.423 . . . . 0.0 110.397 174.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . 0.421 ' SD ' HG21 ' A' ' 172' ' ' ILE . 9.1 ttp -108.9 132.99 53.52 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 123.589 0.756 . . . . 0.0 109.069 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 2.7 tppt? -107.36 129.53 54.9 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 127.226 2.21 . . . . 0.0 110.385 -178.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -138.4 158.44 24.92 Favored Glycine 0 N--CA 1.473 1.106 0 CA-C-N 121.255 1.843 . . . . 0.0 115.57 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 3.4 tp -148.1 124.69 2.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-O 122.607 1.194 . . . . 0.0 111.362 -178.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 51.4 mtp -137.56 149.19 46.51 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 128.06 2.544 . . . . 0.0 107.998 175.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 8.8 t -134.66 161.16 35.9 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.335 1.054 . . . . 0.0 110.196 175.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 55.0 p -108.04 21.87 16.76 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.981 1.712 . . . . 0.0 112.428 -176.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -64.3 20.73 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.237 0 C-N-CA 128.617 2.767 . . . . 0.0 115.395 178.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 82.76 -68.64 3.51 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 126.995 2.236 . . . . 0.0 112.177 -177.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 -111.93 67.33 0.65 Allowed 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.538 1.535 . . . . 0.0 110.221 -177.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -95.76 174.66 6.86 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.946 1.698 . . . . 0.0 112.796 175.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.95 -178.78 3.94 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.845 2.058 . . . . 0.0 110.768 175.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . 0.459 ' HB3' HG12 ' A' ' 34' ' ' VAL . 20.4 ttp -128.78 122.1 29.8 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.087 1.355 . . . . 0.0 109.812 176.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.482 ' C ' HD12 ' A' ' 172' ' ' ILE . 1.9 tt0 -131.47 130.31 42.28 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.053 0.941 . . . . 0.0 110.06 177.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.482 HD12 ' C ' ' A' ' 171' ' ' GLN . 4.3 mp -135.28 125.6 43.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 123.989 0.915 . . . . 0.0 109.297 177.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.85 128.88 50.97 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 125.811 1.644 . . . . 0.0 111.635 177.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.8 mp -74.69 133.06 32.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 175.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 1.2 m -144.87 97.08 2.96 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.044 1.337 . . . . 0.0 111.691 176.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 72.6 mtp180 . . . . . 0 C--O 1.254 1.327 0 C-N-CA 126.676 1.99 . . . . 0.0 113.018 177.581 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.59 HD21 ' HB2' ' A' ' 31' ' ' LYS . 0.1 OUTLIER . . . . . 0 CA--C 1.541 0.61 0 CA-C-O 121.038 0.447 . . . . 0.0 111.445 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -68.41 126.86 30.96 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 121.507 -0.745 . . . . 0.0 109.365 174.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -69.73 -90.69 0.07 OUTLIER Glycine 0 CA--C 1.535 1.293 0 C-N-CA 123.851 0.739 . . . . 0.0 113.181 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.7 p -149.81 166.28 29.95 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 125.776 1.631 . . . . 0.0 111.845 -175.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -114.04 22.74 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 CA-C-O 123.032 1.396 . . . . 0.0 112.996 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -45.24 152.38 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 125.624 1.57 . . . . 0.0 111.959 174.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -44.77 139.31 3.04 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 126.041 1.737 . . . . 0.0 112.901 -176.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -54.35 -25.98 35.5 Favored Glycine 0 CA--C 1.54 1.603 0 C-N-CA 124.225 0.917 . . . . 0.0 114.713 -175.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.83 -33.6 76.04 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.257 1.423 . . . . 0.0 112.551 174.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.4 m -96.47 -38.35 10.05 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.991 2.116 . . . . 0.0 112.637 175.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.4 tp -78.33 85.08 4.48 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.961 1.304 . . . . 0.0 110.674 176.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 48.6 p -114.12 176.07 5.2 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.771 2.028 . . . . 0.0 110.534 179.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -51.09 -39.47 56.18 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.404 -0.81 . . . . 0.0 112.569 177.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -54.89 -37.51 66.4 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 118.54 0.609 . . . . 0.0 112.432 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 92.4 t -68.13 -40.34 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.067 1.347 . . . . 0.0 111.169 174.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 41.1 mt -68.2 -40.45 82.18 Favored 'General case' 0 N--CA 1.471 0.575 0 O-C-N 120.865 -1.147 . . . . 0.0 112.229 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -61.88 -49.52 75.88 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.317 1.047 . . . . 0.0 111.609 177.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.58 -33.58 76.25 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 118.155 -0.926 . . . . 0.0 113.089 174.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.1 t -54.7 -42.3 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-N 119.792 1.178 . . . . 0.0 111.594 177.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.5 mt -55.77 -23.55 30.28 Favored 'General case' 0 CA--C 1.55 0.972 0 CA-C-N 119.544 1.065 . . . . 0.0 113.486 175.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -93.65 -60.76 1.14 Allowed Glycine 0 CA--C 1.532 1.132 0 C-N-CA 125.689 1.614 . . . . 0.0 112.7 177.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -67.47 -27.04 66.69 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 -177.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -111.94 87.95 2.69 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.663 1.585 . . . . 0.0 110.298 177.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -134.77 155.26 21.88 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 125.06 1.314 . . . . 0.0 113.004 175.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.529 ' HD3' ' HE ' ' A' ' 75' ' ' ARG . 16.3 mtpt -141.85 -49.37 0.39 Allowed 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 125.549 1.539 . . . . 0.0 112.143 -177.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.475 HG22 ' CZ ' ' A' ' 75' ' ' ARG . 3.2 m -115.89 -177.17 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 C-N-CA 126.297 1.839 . . . . 0.0 110.636 176.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.8 t -49.3 -44.4 44.11 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 126.374 1.869 . . . . 0.0 115.068 -176.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.8 161.61 35.1 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 126.28 1.832 . . . . 0.0 111.074 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.59 ' HB2' HD21 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -155.31 165.61 36.11 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.089 0.956 . . . . 0.0 112.711 179.604 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.564 HD12 HG12 ' A' ' 34' ' ' VAL . 0.3 OUTLIER -119.34 123.73 71.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 124.125 0.97 . . . . 0.0 108.44 175.0 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -127.64 120.8 28.88 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 126.513 1.925 . . . . 0.0 106.706 174.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.642 HG13 ' CB ' ' A' ' 72' ' ' TYR . 0.2 OUTLIER -136.56 140.43 43.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 126.459 1.904 . . . . 0.0 108.527 -174.993 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -123.07 132.75 8.73 Favored Glycine 0 CA--C 1.523 0.575 0 CA-C-O 119.981 -0.344 . . . . 0.0 112.538 175.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.4 mp -112.64 152.22 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 117.71 0.755 . . . . 0.0 109.343 174.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -122.22 106.61 11.29 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 122.63 1.205 . . . . 0.0 110.709 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -76.07 85.15 2.94 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 128.451 2.7 . . . . 0.0 111.054 -175.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -120.99 4.65 10.43 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.644 1.177 . . . . 0.0 113.926 176.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.418 ' HA ' HG21 ' A' ' 174' ' ' ILE . 0.6 OUTLIER -53.98 -50.41 66.6 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.475 1.11 . . . . 0.0 112.133 174.982 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 127.7 103.87 1.23 Allowed Glycine 0 CA--C 1.526 0.776 0 C-N-CA 123.928 0.775 . . . . 0.0 111.684 177.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 114.48 153.93 10.82 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 126.15 1.833 . . . . 0.0 111.127 -174.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.705 HG22 ' HA ' ' A' ' 65' ' ' PRO . 68.4 p -69.72 142.18 53.36 Favored 'General case' 0 N--CA 1.466 0.359 0 O-C-N 121.887 -0.773 . . . . 0.0 111.062 175.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 39.4 m0 -96.64 107.6 20.07 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.367 0.667 . . . . 0.0 109.434 -179.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 36.4 m -87.58 127.33 35.26 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.609 0.763 . . . . 0.0 109.972 178.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.409 ' HB1' ' HB3' ' A' ' 60' ' ' LEU . . . -63.42 130.39 44.25 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 122.763 0.425 . . . . 0.0 111.429 174.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.8 pp -114.13 -55.76 2.46 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.79 0.836 . . . . 0.0 111.632 178.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -166.68 160.32 14.82 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.894 1.677 . . . . 0.0 110.867 175.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -140.69 165.71 26.74 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.427 1.091 . . . . 0.0 111.981 174.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -142.0 119.69 11.8 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.704 1.202 . . . . 0.0 111.887 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.474 ' CE1' ' HB1' ' A' ' 87' ' ' ALA . 2.6 m-85 -108.74 139.2 43.88 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.362 -0.836 . . . . 0.0 111.646 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.1 tpp180 -110.78 -65.91 1.12 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.859 1.663 . . . . 0.0 111.262 -177.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -37.58 -58.06 0.9 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 128.257 2.623 . . . . 0.0 113.52 -175.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -153.05 -116.63 0.65 Allowed Glycine 0 CA--C 1.526 0.731 0 C-N-CA 125.971 1.748 . . . . 0.0 109.133 175.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 39.0 p -143.33 178.52 7.68 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.036 1.334 . . . . 0.0 112.23 -175.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.2 t -154.0 179.58 8.78 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.43 1.492 . . . . 0.0 111.417 174.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -111.67 -38.5 4.87 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.02 1.328 . . . . 0.0 112.41 179.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.9 p -159.28 127.76 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 126.076 1.75 . . . . 0.0 110.636 175.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.429 HG22 ' H ' ' A' ' 73' ' ' SER . 1.7 pp -132.8 -32.36 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 114.606 1.335 . . . . 0.0 114.606 175.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.409 ' HB3' ' HB1' ' A' ' 46' ' ' ALA . 10.4 mt -100.85 95.53 4.64 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 125.43 1.492 . . . . 0.0 109.403 178.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.453 ' HG2' HG23 ' A' ' 64' ' ' VAL . 98.8 Cg_endo -65.97 151.62 83.52 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 123.402 2.735 . . . . 0.0 110.676 174.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -44.35 -49.64 9.46 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.894 1.677 . . . . 0.0 114.023 -177.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 5.1 p -159.42 137.73 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 126.978 2.111 . . . . 0.0 109.208 175.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.494 HG21 HD13 ' A' ' 70' ' ' LEU . 98.8 t -114.74 125.88 28.55 Favored Pre-proline 0 N--CA 1.479 0.988 0 C-N-CA 123.927 0.891 . . . . 0.0 109.211 175.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.705 ' HA ' HG22 ' A' ' 43' ' ' THR . 60.5 Cg_endo -65.64 155.73 67.49 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 122.882 2.388 . . . . 0.0 113.099 177.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -71.71 169.59 15.31 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.582 0.753 . . . . 0.0 111.374 175.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 65.2 p 52.34 26.25 3.97 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 126.415 1.886 . . . . 0.0 113.217 -175.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.3 mttt -138.25 174.68 10.3 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 126.441 1.896 . . . . 0.0 111.107 -175.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -135.66 160.81 37.36 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -176.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.494 HD13 HG21 ' A' ' 64' ' ' VAL . 2.4 pt? -133.18 170.49 15.34 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.786 1.234 . . . . 0.0 111.552 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -114.29 149.91 35.24 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 124.494 1.118 . . . . 0.0 109.995 175.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.642 ' CB ' HG13 ' A' ' 34' ' ' VAL . 1.5 m-85 -122.36 160.32 25.66 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 127.353 2.261 . . . . 0.0 108.775 175.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.429 ' H ' HG22 ' A' ' 59' ' ' ILE . 5.9 p -145.34 166.77 24.61 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 125.443 1.497 . . . . 0.0 112.105 -175.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 173.9 151.76 8.48 Favored Glycine 0 C--O 1.237 0.301 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.681 174.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.529 ' HE ' ' HD3' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -111.9 139.17 47.6 Favored 'General case' 0 CA--C 1.521 -0.145 0 C-N-CA 124.883 1.273 . . . . 0.0 111.88 179.321 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.469 0.518 0 C-N-CA 124.172 0.989 . . . . 0.0 112.853 174.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 34.7 m . . . . . 0 N--CA 1.484 1.234 0 CA-C-O 119.04 -0.505 . . . . 0.0 110.363 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -26.75 -66.96 0.06 OUTLIER Glycine 0 N--CA 1.473 1.127 0 C-N-CA 127.991 2.71 . . . . 0.0 116.693 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.461 ' HB3' ' HB ' ' A' ' 105' ' ' VAL . . . -167.47 106.66 0.56 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.066 0.947 . . . . 0.0 112.219 -178.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.7 t -149.51 109.67 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 124.749 1.22 . . . . 0.0 112.062 -174.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.645 ' HB3' ' CZ ' ' A' ' 103' ' ' PHE . . . -153.69 169.64 22.81 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 179.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -147.2 160.61 42.26 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.92 1.288 . . . . 0.0 112.543 175.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.451 ' CZ ' HG11 ' A' ' 101' ' ' VAL . 37.4 p90 -164.11 171.41 15.14 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.332 1.053 . . . . 0.0 111.62 -178.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -143.95 155.94 44.24 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.468 -0.77 . . . . 0.0 112.201 174.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -131.72 129.29 40.48 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 126.472 1.909 . . . . 0.0 113.19 -175.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -90.66 130.53 36.66 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 120.882 0.372 . . . . 0.0 111.343 -176.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 3.9 mtm -108.27 139.01 43.6 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 125.503 1.521 . . . . 0.0 111.705 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.2 t -64.79 -18.7 65.32 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.223 1.409 . . . . 0.0 112.962 176.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -69.74 -17.5 63.45 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.998 1.319 . . . . 0.0 113.616 175.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 106.47 21.32 8.41 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.92 1.248 . . . . 0.0 115.362 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -131.44 174.81 9.71 Favored 'General case' 0 CA--C 1.555 1.142 0 CA-C-N 119.824 1.812 . . . . 0.0 111.422 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.8 m -129.31 105.87 8.42 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.403 1.081 . . . . 0.0 112.959 -178.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 59.0 tp -68.81 101.23 1.3 Allowed 'General case' 0 N--CA 1.47 0.567 0 O-C-N 121.762 -0.586 . . . . 0.0 110.247 174.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -94.65 138.65 14.12 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 124.176 0.893 . . . . 0.0 112.232 175.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.451 HG11 ' CZ ' ' A' ' 89' ' ' PHE . 54.1 t -128.17 133.03 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.225 1.41 . . . . 0.0 110.71 -175.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.84 124.29 20.74 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.895 1.678 . . . . 0.0 109.386 -177.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.645 ' CZ ' ' HB3' ' A' ' 87' ' ' ALA . 26.9 p90 -138.42 135.35 35.16 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -178.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 12.2 m -148.79 100.51 3.1 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 122.224 1.011 . . . . 0.0 111.193 -175.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.461 ' HB ' ' HB3' ' A' ' 85' ' ' ALA . 51.3 t . . . . . 0 N--CA 1.471 0.588 0 C-N-CA 127.144 2.178 . . . . 0.0 109.761 -177.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 5.5 m . . . . . 0 N--CA 1.468 0.433 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -80.58 115.81 20.29 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 124.324 1.05 . . . . 0.0 108.973 174.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 42.1 m0 -116.25 145.66 42.96 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.134 0.973 . . . . 0.0 109.45 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 34.3 p-90 -150.78 139.83 21.07 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.403 0.681 . . . . 0.0 112.248 -179.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -140.57 145.85 37.28 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 122.299 1.047 . . . . 0.0 112.81 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 86.1 t -146.8 123.96 3.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 125.093 1.357 . . . . 0.0 107.783 176.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.426 ' HE2' ' CZ ' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -156.14 176.18 13.0 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.403 1.081 . . . . 0.0 111.336 174.969 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.524 ' HB ' ' CE2' ' A' ' 154' ' ' TYR . 38.8 mt -111.51 105.31 18.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 123.765 0.826 . . . . 0.0 109.804 -177.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.426 ' CZ ' ' HE2' ' A' ' 119' ' ' LYS . 91.0 m-85 -60.3 143.82 88.65 Favored Pre-proline 0 CA--C 1.548 0.899 0 O-C-N 121.318 -0.864 . . . . 0.0 111.889 178.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -76.11 80.25 2.72 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 124.449 3.432 . . . . 0.0 112.435 -176.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 118.89 -170.83 13.96 Favored Glycine 0 N--CA 1.471 1.004 0 C-N-CA 125.684 1.611 . . . . 0.0 112.778 -178.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 23.3 tttt -66.27 109.53 2.7 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.018 0.927 . . . . 0.0 109.51 174.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.413 ' HG3' ' H ' ' A' ' 126' ' ' ARG . 5.7 tpt180 -120.01 173.04 7.32 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.723 1.609 . . . . 0.0 110.242 176.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.413 ' H ' ' HG3' ' A' ' 125' ' ' ARG . 2.2 ptp180 -127.04 173.17 9.88 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 127.172 2.189 . . . . 0.0 111.292 174.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -128.35 98.01 4.92 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 126.44 1.896 . . . . 0.0 107.422 175.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -117.73 173.1 6.93 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.425 1.89 . . . . 0.0 109.115 175.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -49.84 -42.74 48.01 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.057 0.943 . . . . 0.0 113.477 177.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -57.34 -63.66 5.1 Favored Glycine 0 C--N 1.339 0.718 0 C-N-CA 124.173 0.892 . . . . 0.0 111.624 175.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 15.0 mtm -59.81 -34.12 72.63 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 118.141 0.97 . . . . 0.0 113.297 178.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -59.53 -60.42 3.87 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 119.304 0.956 . . . . 0.0 109.93 175.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -70.03 -30.7 68.06 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -177.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -60.75 -54.23 47.74 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.417 1.087 . . . . 0.0 110.024 174.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 2.0 tpp -75.21 -26.48 58.98 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -177.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -52.44 -55.84 19.11 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.464 1.505 . . . . 0.0 110.586 174.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -69.8 -8.65 50.07 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 179.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -79.21 -31.33 42.75 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 126.224 1.869 . . . . 0.0 115.076 -177.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -128.65 85.19 60.95 Favored Pre-proline 0 CA--C 1.548 0.887 0 CA-C-N 118.717 1.259 . . . . 0.0 111.047 178.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -73.42 75.94 2.83 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 123.661 2.908 . . . . 0.0 112.086 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -111.28 114.41 27.57 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.058 0.943 . . . . 0.0 110.86 -177.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 57.4 mtp180 -81.65 -71.41 0.48 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.813 1.245 . . . . 0.0 111.499 175.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 136.86 122.62 2.16 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 124.568 1.08 . . . . 0.0 113.589 -177.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.9 7.1 9.5 Favored 'General case' 0 CA--C 1.559 1.296 0 C-N-CA 127.175 2.19 . . . . 0.0 115.081 177.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 57.57 55.83 5.36 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 128.282 2.633 . . . . 0.0 112.595 -175.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -158.24 -66.73 0.01 OUTLIER Glycine 0 CA--C 1.538 1.479 0 N-CA-C 115.971 1.148 . . . . 0.0 115.971 -177.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 29.8 m95 174.11 117.1 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 130.414 3.486 . . . . 0.0 108.361 -174.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -129.9 121.03 25.86 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 126.801 2.04 . . . . 0.0 111.846 -175.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -162.33 178.3 8.81 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 -175.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.76 154.46 48.52 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.542 1.537 . . . . 0.0 110.849 175.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -71.34 137.69 48.65 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 175.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 91.1 mt -93.92 102.76 14.87 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.667 0.787 . . . . 0.0 109.947 -176.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -36.22 -37.51 0.19 Allowed Glycine 0 N--CA 1.476 1.32 0 C-N-CA 128.711 3.053 . . . . 0.0 117.629 -174.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.524 ' CE2' ' HB ' ' A' ' 120' ' ' ILE . 0.1 OUTLIER -61.61 -30.85 70.95 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.968 2.107 . . . . 0.0 113.239 -179.252 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 132.65 30.38 0.5 Allowed Glycine 0 CA--C 1.536 1.397 0 C-N-CA 125.763 1.649 . . . . 0.0 114.582 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 12.8 mt -130.6 175.85 8.66 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 126.082 1.753 . . . . 0.0 110.555 -174.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 60.7 mtt-85 -147.21 100.7 3.31 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.534 -1.354 . . . . 0.0 112.701 178.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -82.1 148.69 28.41 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 124.157 0.983 . . . . 0.0 108.632 175.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 3.3 tppt? -139.68 120.46 14.37 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.331 1.852 . . . . 0.0 111.214 178.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -131.59 154.89 21.11 Favored Glycine 0 N--CA 1.479 1.518 0 CA-C-N 121.123 1.783 . . . . 0.0 116.311 -176.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 2.1 tp -146.19 130.55 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.132 1.373 . . . . 0.0 110.651 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 1.9 ttp -154.61 117.62 4.44 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.958 1.703 . . . . 0.0 110.249 174.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 4.9 t -110.4 101.44 10.15 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 121.122 -0.986 . . . . 0.0 111.411 -177.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 49.0 p -69.12 28.45 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.02 -27.2 68.15 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.309 1.844 . . . . 0.0 114.332 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 159.78 -53.75 0.36 Allowed Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.776 1.179 . . . . 0.0 113.507 175.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -134.5 87.32 2.34 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.81 1.244 . . . . 0.0 110.771 178.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -136.26 -174.6 3.73 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.682 1.593 . . . . 0.0 111.582 175.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . 0.402 ' HE2' ' O ' ' A' ' 169' ' ' LYS . 0.0 OUTLIER -133.51 175.35 9.5 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 127.462 2.305 . . . . 0.0 111.437 -178.671 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 32.6 ttp -110.04 138.3 46.61 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 123.965 0.906 . . . . 0.0 110.479 173.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -143.86 123.72 13.47 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 123.595 0.758 . . . . 0.0 110.361 176.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 4.7 mp -127.48 121.02 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 123.481 0.712 . . . . 0.0 109.754 176.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 2.8 tmmm? -121.05 139.07 53.82 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 125.32 1.448 . . . . 0.0 110.705 177.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.418 HG21 ' HA ' ' A' ' 40' ' ' SER . 1.6 mp -87.4 125.79 41.11 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 174.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -137.4 96.64 3.3 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.256 1.422 . . . . 0.0 111.724 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 10.8 mtp-105 . . . . . 0 C--O 1.254 1.29 0 C-N-CA 128.119 2.568 . . . . 0.0 113.638 -177.737 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 3' ' ' LEU . 10.4 tp . . . . . 0 N--CA 1.471 0.61 0 CA-C-O 121.112 0.482 . . . . 0.0 111.835 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -85.78 130.26 34.61 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.9 1.28 . . . . 0.0 108.464 174.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -77.12 -151.23 4.2 Favored Glycine 0 CA--C 1.538 1.503 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 175.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.6 p -78.86 169.96 17.42 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 121.441 -1.035 . . . . 0.0 113.747 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -120.64 20.72 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 126.339 1.856 . . . . 0.0 112.593 177.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -48.82 159.85 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 125.221 1.409 . . . . 0.0 112.517 175.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -46.75 140.47 4.55 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.682 1.593 . . . . 0.0 112.564 -175.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -57.24 -20.22 35.18 Favored Glycine 0 CA--C 1.542 1.751 0 C-N-CA 124.083 0.849 . . . . 0.0 114.418 -175.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.74 -27.47 66.81 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.008 1.323 . . . . 0.0 112.357 175.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.7 t -104.55 -42.35 5.46 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 127.15 2.18 . . . . 0.0 111.334 177.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 12.4 tp -83.33 98.59 9.53 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.644 1.578 . . . . 0.0 110.366 174.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 69.0 p -126.57 177.34 6.57 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.997 1.319 . . . . 0.0 110.898 177.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.408 ' C ' ' CD1' ' A' ' 15' ' ' PHE . 0.1 OUTLIER -45.73 -37.89 6.39 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.446 1.098 . . . . 0.0 112.827 177.801 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -57.62 -42.72 83.92 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.329 1.452 . . . . 0.0 112.289 -179.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.4 t -61.97 -37.29 77.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.72 1.208 . . . . 0.0 110.933 174.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.7 mt -71.73 -40.4 69.45 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.549 1.14 . . . . 0.0 111.663 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -60.77 -43.95 97.38 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.55 1.14 . . . . 0.0 110.429 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.35 -28.1 59.44 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.207 1.003 . . . . 0.0 113.127 174.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -55.79 -38.22 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 124.301 1.04 . . . . 0.0 111.461 177.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 15.7 mt -55.6 -20.85 14.96 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.287 1.435 . . . . 0.0 113.977 174.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -98.11 -63.27 0.87 Allowed Glycine 0 CA--C 1.532 1.113 0 C-N-CA 125.172 1.368 . . . . 0.0 112.584 175.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -65.65 -33.82 76.78 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 -174.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -105.37 94.98 5.51 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.66 1.584 . . . . 0.0 108.025 175.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -140.88 145.06 15.52 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 123.954 0.788 . . . . 0.0 113.648 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.7 mtpp -127.31 -39.08 1.91 Allowed 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 126.294 1.838 . . . . 0.0 113.788 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.3 m -133.0 174.71 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 126.425 1.89 . . . . 0.0 111.06 -178.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 54.4 m -54.29 -46.5 72.78 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.241 1.816 . . . . 0.0 114.557 -176.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.72 126.95 44.34 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.99 1.316 . . . . 0.0 111.051 175.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.39 161.29 31.66 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 124.85 1.26 . . . . 0.0 111.485 179.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.486 HD13 ' H ' ' A' ' 33' ' ' ALA . 0.3 OUTLIER -107.48 140.87 24.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 174.955 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.486 ' H ' HD13 ' A' ' 32' ' ' ILE . . . -132.91 131.52 40.98 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 126.483 1.913 . . . . 0.0 109.819 175.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.483 ' O ' HD13 ' A' ' 71' ' ' LEU . 25.2 t -140.62 156.15 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 123.305 0.642 . . . . 0.0 110.306 178.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -138.57 98.51 0.26 Allowed Glycine 0 CA--C 1.524 0.598 0 C-N-CA 125.677 1.608 . . . . 0.0 111.904 176.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.7 mp -81.71 144.84 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-N 117.272 0.536 . . . . 0.0 109.739 175.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -116.29 99.43 7.2 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.024 1.73 . . . . 0.0 110.66 178.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -67.68 97.17 0.6 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.818 1.647 . . . . 0.0 110.203 175.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -124.89 4.87 8.05 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.625 0.77 . . . . 0.0 112.326 174.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.9 t -57.59 -45.25 85.51 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.376 1.47 . . . . 0.0 112.875 -176.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 130.11 40.33 0.26 Allowed Glycine 0 CA--C 1.535 1.29 0 C-N-CA 124.31 0.957 . . . . 0.0 115.25 177.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -178.09 165.71 35.34 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.561 1.077 . . . . 0.0 112.605 175.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.534 HG22 ' HA ' ' A' ' 65' ' ' PRO . 8.4 p -68.76 137.68 54.23 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.485 -1.009 . . . . 0.0 110.34 174.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.548 ' HA ' ' CE1' ' A' ' 91' ' ' TYR . 35.6 m0 -93.87 100.52 12.68 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 123.232 0.613 . . . . 0.0 111.546 -178.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 29.1 m -84.6 115.48 22.65 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.004 0.922 . . . . 0.0 109.121 177.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.421 ' HB1' ' HB3' ' A' ' 60' ' ' LEU . . . -60.05 143.5 51.83 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 122.709 0.403 . . . . 0.0 111.547 175.002 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.5 pp -119.2 -55.07 2.18 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.651 0.781 . . . . 0.0 111.966 178.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 22.7 t30 -173.15 150.47 1.94 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.991 2.117 . . . . 0.0 109.997 -177.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -129.05 163.67 24.91 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.837 1.255 . . . . 0.0 111.489 175.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -131.77 106.87 8.39 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.324 1.45 . . . . 0.0 110.663 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.624 ' CE1' ' HB1' ' A' ' 87' ' ' ALA . 2.7 m-85 -115.58 112.18 21.79 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.948 0.899 . . . . 0.0 110.118 -174.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.05 -41.27 7.63 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -178.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.0 t -116.13 -45.72 2.84 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.549 1.539 . . . . 0.0 111.002 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -69.26 11.57 1.46 Allowed Glycine 0 CA--C 1.538 1.503 0 CA-C-O 118.226 -1.319 . . . . 0.0 115.764 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.7 p -32.75 108.27 0.05 Allowed 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 128.472 2.709 . . . . 0.0 113.987 -175.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.523 HG21 HG23 ' A' ' 59' ' ' ILE . 1.5 t -130.02 175.41 8.91 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 114.125 1.158 . . . . 0.0 114.125 -174.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -79.58 -48.84 13.13 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.64 1.176 . . . . 0.0 112.79 -178.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.4 p -144.07 132.44 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.818 1.647 . . . . 0.0 111.604 176.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.592 HD12 ' H ' ' A' ' 60' ' ' LEU . 1.0 OUTLIER -137.02 -47.92 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.171 1.388 . . . . 0.0 113.903 179.315 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.592 ' H ' HD12 ' A' ' 59' ' ' ILE . 8.2 mt -86.69 102.6 3.11 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 123.977 0.911 . . . . 0.0 109.836 174.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.44 ' HG2' HG23 ' A' ' 64' ' ' VAL . 73.3 Cg_endo -68.0 141.64 53.94 Favored 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 122.729 2.286 . . . . 0.0 110.898 174.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -38.73 -52.96 1.69 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 126.949 2.1 . . . . 0.0 114.116 178.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.6 p -153.24 135.45 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 126.475 1.91 . . . . 0.0 109.927 174.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.44 HG23 ' HG2' ' A' ' 61' ' ' PRO . 59.5 t -116.24 131.18 23.93 Favored Pre-proline 0 N--CA 1.483 1.207 0 C-N-CA 124.671 1.188 . . . . 0.0 109.681 176.202 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.534 ' HA ' HG22 ' A' ' 43' ' ' THR . 56.8 Cg_endo -65.93 152.91 80.17 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 122.714 2.276 . . . . 0.0 113.656 177.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -69.24 162.95 26.06 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.17 0.988 . . . . 0.0 111.232 175.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . 0.257 76.4 p 51.37 28.22 4.22 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 126.787 2.035 . . . . 0.0 114.006 -174.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.8 mttp -131.1 175.98 8.64 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 127.537 2.335 . . . . 0.0 111.34 -178.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -127.35 158.92 35.97 Favored 'General case' 0 C--O 1.224 -0.249 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -178.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.413 ' C ' HD12 ' A' ' 70' ' ' LEU . 2.4 pp -121.84 171.85 8.6 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.313 1.445 . . . . 0.0 110.52 175.076 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.483 HD13 ' O ' ' A' ' 34' ' ' VAL . 0.3 OUTLIER -117.17 145.6 43.74 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 124.051 0.94 . . . . 0.0 108.95 174.959 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -127.16 143.74 51.19 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 125.585 1.554 . . . . 0.0 108.845 177.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 82.9 p -143.57 170.8 15.14 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.963 -178.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 174.48 142.84 4.17 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.223 -0.899 . . . . 0.0 112.357 176.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -109.44 128.97 55.54 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 124.869 1.267 . . . . 0.0 108.087 177.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.7 ptpt . . . . . 0 N--CA 1.472 0.65 0 C-N-CA 124.724 1.21 . . . . 0.0 113.291 176.474 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.1 m . . . . . 0 N--CA 1.475 0.801 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -84.03 -90.21 0.77 Allowed Glycine 0 N--CA 1.47 0.948 0 O-C-N 120.538 -1.351 . . . . 0.0 114.524 -175.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.596 ' HB3' ' HB ' ' A' ' 105' ' ' VAL . . . -143.33 82.73 1.75 Allowed 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 124.815 1.246 . . . . 0.0 109.066 -175.017 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.7 t -122.29 111.95 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 124.929 1.292 . . . . 0.0 111.007 -175.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.624 ' HB1' ' CE1' ' A' ' 51' ' ' PHE . . . -158.03 167.7 29.16 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 122.177 0.989 . . . . 0.0 111.166 177.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -148.92 160.88 42.87 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.284 1.433 . . . . 0.0 109.58 175.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -156.41 174.67 15.08 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 121.42 -0.8 . . . . 0.0 112.122 175.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -145.16 150.89 37.58 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.849 0.833 . . . . 0.0 113.203 174.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.548 ' CE1' ' HA ' ' A' ' 44' ' ' TRP . 0.1 OUTLIER -121.87 127.07 50.07 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 127.205 2.202 . . . . 0.0 109.181 -179.232 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -84.11 104.68 14.37 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.269 0.627 . . . . 0.0 112.423 179.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -72.38 126.2 29.26 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 125.401 1.48 . . . . 0.0 112.657 -176.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 37.1 m -58.62 -21.18 52.88 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.652 0.781 . . . . 0.0 113.095 175.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 23.7 m-20 -69.38 -14.02 62.68 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 124.693 1.197 . . . . 0.0 112.907 174.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 109.26 31.99 3.13 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 125.295 1.426 . . . . 0.0 115.055 177.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -142.72 -179.44 6.33 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.855 1.262 . . . . 0.0 112.044 -175.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 25.1 m -132.55 107.26 8.33 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 120.994 -1.067 . . . . 0.0 111.973 177.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 35.7 tp -74.69 107.74 7.0 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 121.224 -0.923 . . . . 0.0 110.57 175.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -107.13 114.6 4.36 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 124.79 1.186 . . . . 0.0 113.742 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.464 ' HA ' HG22 ' A' ' 118' ' ' VAL . 98.4 t -97.27 137.28 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.134 1.374 . . . . 0.0 112.614 -175.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -129.11 126.06 38.51 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 126.352 1.861 . . . . 0.0 111.788 -175.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.422 ' CE2' ' HB3' ' A' ' 87' ' ' ALA . 3.8 p90 -148.48 123.82 10.27 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.6 1.16 . . . . 0.0 112.018 -178.278 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 22.4 t -137.47 133.94 35.23 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.758 0.823 . . . . 0.0 111.612 178.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.596 ' HB ' ' HB3' ' A' ' 85' ' ' ALA . 19.0 t . . . . . 0 CA--C 1.539 0.556 0 C-N-CA 126.88 2.072 . . . . 0.0 108.885 -176.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 20.1 m . . . . . 0 N--CA 1.467 0.383 0 CA-C-O 121.142 0.496 . . . . 0.0 112.131 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -77.03 91.8 3.67 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.954 1.302 . . . . 0.0 111.297 176.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 42.8 m0 -98.01 149.16 22.75 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 119.463 1.029 . . . . 0.0 111.226 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 31.6 p-90 -155.95 135.64 12.57 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.653 0.781 . . . . 0.0 112.498 -176.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -145.57 174.84 10.82 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 120.553 -1.342 . . . . 0.0 112.825 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.464 HG22 ' HA ' ' A' ' 101' ' ' VAL . 99.3 t -148.9 139.81 17.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 C-N-CA 123.768 0.827 . . . . 0.0 109.135 175.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.467 ' HE2' ' CG ' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -144.4 169.54 17.73 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 125.566 1.546 . . . . 0.0 109.538 175.133 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 59.9 mt -113.27 128.47 70.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 175.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.467 ' CG ' ' HE2' ' A' ' 119' ' ' LYS . 96.2 m-85 -88.38 147.5 40.14 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 124.683 1.193 . . . . 0.0 110.48 175.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -70.01 130.92 19.84 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 123.151 2.568 . . . . 0.0 111.075 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 59.96 -141.64 47.64 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 123.607 0.622 . . . . 0.0 113.133 -178.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 4.6 tmtt? -86.49 118.05 25.66 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.492 1.517 . . . . 0.0 110.4 176.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 12.2 tpp180 -135.51 170.61 15.68 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 126.088 1.755 . . . . 0.0 109.998 175.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 24.8 ptt180 -116.2 -176.55 2.97 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 127.133 2.173 . . . . 0.0 111.258 175.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -127.16 105.48 8.6 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 175.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -121.81 168.04 12.3 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.788 1.635 . . . . 0.0 109.751 177.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -51.84 -41.1 61.55 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 -177.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -59.12 -56.25 26.31 Favored Glycine 0 N--CA 1.47 0.912 0 CA-C-N 119.278 0.945 . . . . 0.0 112.164 175.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 4.9 mtt -59.01 -46.19 88.79 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.414 1.086 . . . . 0.0 111.287 177.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -51.78 -58.48 6.3 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.554 1.542 . . . . 0.0 111.096 174.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -68.89 -30.62 69.16 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -178.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -59.49 -41.75 90.56 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.998 0.919 . . . . 0.0 111.446 174.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 12.8 mmm -86.18 -27.66 24.42 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -51.2 -63.71 1.05 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.861 1.665 . . . . 0.0 110.883 175.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -69.42 -6.23 28.82 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -175.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -88.18 -15.57 60.52 Favored Glycine 0 CA--C 1.537 1.442 0 C-N-CA 126.974 2.226 . . . . 0.0 115.459 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -144.77 95.49 5.28 Favored Pre-proline 0 CA--C 1.552 1.049 0 CA-C-N 119.771 1.786 . . . . 0.0 112.688 178.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -75.95 77.31 3.47 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 123.783 2.989 . . . . 0.0 112.591 -178.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -107.98 110.01 21.62 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.346 1.458 . . . . 0.0 109.827 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 9.6 mtp180 -118.56 111.39 18.53 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 126.944 2.098 . . . . 0.0 111.541 -175.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 76.96 -56.73 3.55 Favored Glycine 0 C--O 1.218 -0.867 0 CA-C-O 118.609 -1.106 . . . . 0.0 111.728 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 57.21 33.86 23.94 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 119.975 1.887 . . . . 0.0 114.655 174.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -70.31 40.9 0.05 Allowed 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 127.933 2.493 . . . . 0.0 115.163 -177.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -160.17 34.29 0.43 Allowed Glycine 0 CA--C 1.539 1.576 0 C-N-CA 126.319 1.914 . . . . 0.0 114.555 178.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' TRP . . . . . 0.588 ' H ' HD12 ' A' ' 161' ' ' ILE . 3.6 m95 57.5 49.48 12.72 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 126.769 2.028 . . . . 0.0 112.372 -174.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -84.68 130.56 34.69 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 121.319 -0.863 . . . . 0.0 111.23 -177.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -171.29 -176.93 2.0 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.034 0.933 . . . . 0.0 112.797 177.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 9.8 ttpp -126.48 157.14 39.44 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 126.339 1.855 . . . . 0.0 111.37 -174.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -68.48 158.13 34.43 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.293 0.568 . . . . 0.0 110.559 174.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.465 HD11 ' HB2' ' A' ' 158' ' ' MET . 98.5 mt -112.81 159.77 18.67 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.996 1.319 . . . . 0.0 109.45 175.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -63.33 -171.57 1.79 Allowed Glycine 0 CA--C 1.538 1.501 0 C-N-CA 124.085 0.85 . . . . 0.0 111.743 174.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 52.74 13.22 0.32 Allowed 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 125.486 1.515 . . . . 0.0 114.954 175.358 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 79.26 36.93 25.97 Favored Glycine 0 CA--C 1.54 1.6 0 C-N-CA 125.724 1.63 . . . . 0.0 113.803 -175.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -115.93 167.12 11.24 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 119.181 1.491 . . . . 0.0 112.436 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 80.2 mtt85 -146.48 127.55 14.64 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 120.924 -1.11 . . . . 0.0 111.053 175.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . 0.465 ' HB2' HD11 ' A' ' 152' ' ' LEU . 7.3 ttp -99.99 154.23 18.56 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 174.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.42 ' N ' ' HG2' ' A' ' 158' ' ' MET . 0.0 OUTLIER -126.43 147.89 49.72 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 127.691 2.396 . . . . 0.0 110.972 176.236 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -152.39 151.44 23.29 Favored Glycine 0 CA--C 1.524 0.65 0 CA-C-O 121.933 0.74 . . . . 0.0 113.47 175.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.588 HD12 ' H ' ' A' ' 147' ' ' TRP . 1.1 tp -142.72 133.76 24.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 127.005 2.122 . . . . 0.0 108.8 -179.147 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 1.4 mtp -149.02 -176.07 5.2 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 127.313 2.245 . . . . 0.0 107.698 175.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . 0.515 HG23 ' HB1' ' A' ' 168' ' ' ALA . 1.3 t -162.32 149.18 13.47 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 174.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 36.0 p -106.2 26.15 10.13 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.067 1.747 . . . . 0.0 112.001 -178.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.82 14.85 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.266 0 C-N-CA 127.864 2.466 . . . . 0.0 115.701 176.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 82.71 -37.19 2.64 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 127.605 2.526 . . . . 0.0 114.216 -178.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -135.05 75.74 1.59 Allowed 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 126.678 1.991 . . . . 0.0 108.272 -176.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.515 ' HB1' HG23 ' A' ' 163' ' ' THR . . . -135.89 162.65 32.22 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.397 1.479 . . . . 0.0 113.204 -175.034 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . 0.4 ' H ' ' HG3' ' A' ' 169' ' ' LYS . 0.0 OUTLIER -110.28 172.06 7.09 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 128.998 2.919 . . . . 0.0 112.261 -175.029 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . 0.428 ' HB3' HG22 ' A' ' 34' ' ' VAL . 12.9 ttt -117.66 143.11 46.48 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 126.017 1.727 . . . . 0.0 112.177 176.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.485 ' C ' HD12 ' A' ' 172' ' ' ILE . 7.5 tt0 -149.13 123.85 9.85 Favored 'General case' 0 N--CA 1.466 0.325 0 O-C-N 120.627 -1.296 . . . . 0.0 110.691 174.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.485 HD12 ' C ' ' A' ' 171' ' ' GLN . 1.9 mp -125.08 125.77 69.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 124.786 1.235 . . . . 0.0 108.744 179.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.52 142.78 51.3 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.827 1.251 . . . . 0.0 109.987 178.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.7 mp -89.44 114.15 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 O-C-N 121.173 -0.955 . . . . 0.0 109.162 176.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 5.4 m -85.5 154.36 21.83 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.434 1.094 . . . . 0.0 112.192 174.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 69.3 mtp180 . . . . . 0 C--O 1.252 1.224 0 C-N-CA 125.379 1.472 . . . . 0.0 111.175 176.528 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.8 mt . . . . . 0 N--CA 1.483 1.212 0 N-CA-C 113.264 0.839 . . . . 0.0 113.264 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.432 ' HA ' ' HB3' ' A' ' 71' ' ' LEU . . . -72.74 78.05 1.12 Allowed 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 125.68 1.592 . . . . 0.0 109.56 175.076 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -68.05 -90.68 0.06 OUTLIER Glycine 0 CA--C 1.536 1.374 0 C-N-CA 125.614 1.578 . . . . 0.0 114.689 -175.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 24.2 p -128.18 164.57 22.22 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.408 1.483 . . . . 0.0 110.949 175.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -125.85 19.76 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 CA-C-O 123.545 1.64 . . . . 0.0 111.695 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.9 pp -54.97 166.57 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 125.21 1.404 . . . . 0.0 111.877 175.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -40.44 129.24 2.42 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.261 1.824 . . . . 0.0 114.83 -174.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -55.49 -21.11 26.35 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 125.169 1.366 . . . . 0.0 114.607 -176.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.39 -30.98 70.89 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.013 1.325 . . . . 0.0 112.041 174.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.4 t -101.95 -38.7 7.67 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.878 1.671 . . . . 0.0 111.558 174.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.567 HD11 ' CD2' ' A' ' 71' ' ' LEU . 45.4 tp -79.39 90.71 5.03 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.895 0.878 . . . . 0.0 112.069 176.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 70.8 p -123.17 -176.98 3.56 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 126.326 1.85 . . . . 0.0 112.292 -178.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -55.02 -37.66 66.93 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.337 1.055 . . . . 0.0 112.261 -175.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -57.58 -38.29 74.61 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 125.379 1.472 . . . . 0.0 111.605 178.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 89.4 t -66.51 -37.7 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.336 1.054 . . . . 0.0 111.38 175.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.475 ' CD2' HD21 ' A' ' 71' ' ' LEU . 9.4 mt -68.17 -44.39 76.02 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.897 0.879 . . . . 0.0 110.69 178.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -58.27 -50.89 72.0 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.879 1.272 . . . . 0.0 111.926 176.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.55 -32.56 73.99 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 118.381 -0.819 . . . . 0.0 113.147 174.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -54.96 -40.18 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 CA-C-N 119.636 1.107 . . . . 0.0 111.518 -179.005 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 16.2 mt -57.18 -20.66 27.98 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.99 1.716 . . . . 0.0 113.355 178.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -108.77 -51.4 0.7 Allowed Glycine 0 CA--C 1.533 1.192 0 C-N-CA 126.356 1.931 . . . . 0.0 113.855 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -63.92 -28.34 69.76 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 119.031 1.416 . . . . 0.0 113.643 -178.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -97.59 86.77 3.91 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.542 1.137 . . . . 0.0 109.266 174.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -54.29 119.1 10.64 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 125.363 1.459 . . . . 0.0 113.537 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.1 mtpp -142.0 -173.35 3.79 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 127.726 2.41 . . . . 0.0 111.357 179.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.7 m -57.81 168.4 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 126.23 1.812 . . . . 0.0 112.329 175.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.8 m -51.3 -37.69 48.87 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 116.389 1.996 . . . . 0.0 116.389 -175.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.71 131.79 54.28 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.574 1.549 . . . . 0.0 108.547 174.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.52 150.15 37.08 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 126.095 1.758 . . . . 0.0 109.745 -175.01 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -116.26 120.58 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 123.998 0.919 . . . . 0.0 110.434 177.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -117.47 124.89 49.88 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 124.516 1.126 . . . . 0.0 109.573 175.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.521 HG13 ' HB2' ' A' ' 72' ' ' TYR . 2.7 p -142.56 139.92 28.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.731 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -125.37 125.07 5.5 Favored Glycine 0 CA--C 1.522 0.505 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.491 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.44 ' H ' HD12 ' A' ' 70' ' ' LEU . 2.9 mp -112.48 142.27 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 123.822 0.849 . . . . 0.0 110.371 176.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -105.59 106.48 17.01 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.486 1.114 . . . . 0.0 111.127 178.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -74.86 93.0 2.58 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.359 1.864 . . . . 0.0 110.577 176.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -121.57 8.1 10.09 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.906 1.282 . . . . 0.0 113.131 175.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 30.0 t -46.03 -51.01 14.4 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.149 1.78 . . . . 0.0 113.343 178.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 154.5 -26.33 0.67 Allowed Glycine 0 N--CA 1.472 1.065 0 O-C-N 121.281 -0.887 . . . . 0.0 114.517 175.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -128.18 171.47 19.36 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 125.682 1.61 . . . . 0.0 112.178 174.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.762 HG22 ' HA ' ' A' ' 65' ' ' PRO . 76.5 p -64.68 149.65 48.64 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.618 0.767 . . . . 0.0 112.147 176.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 38.4 m0 -101.62 108.27 19.76 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 124.654 1.182 . . . . 0.0 111.048 178.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 33.2 m -90.7 128.74 36.75 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.993 1.317 . . . . 0.0 110.123 177.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.29 114.5 3.51 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.915 0.886 . . . . 0.0 111.729 174.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.489 HD21 HG23 ' A' ' 98' ' ' THR . 3.6 pp -98.44 -51.65 3.89 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 123.556 0.742 . . . . 0.0 111.536 177.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.487 ' HB3' HD12 ' A' ' 47' ' ' LEU . 7.8 t30 -172.92 154.47 2.87 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 127.5 2.32 . . . . 0.0 109.848 -177.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -137.64 168.0 20.55 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.916 1.286 . . . . 0.0 112.052 174.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -141.42 114.07 8.34 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.424 1.09 . . . . 0.0 111.652 179.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.408 ' CD1' ' HB1' ' A' ' 87' ' ' ALA . 3.2 m-85 -116.06 139.18 50.54 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.38 -0.825 . . . . 0.0 110.941 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -117.54 -67.05 1.02 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 126.071 1.749 . . . . 0.0 111.492 -175.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 26.3 t -105.39 -38.67 6.4 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 126.8 2.04 . . . . 0.0 110.28 -176.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -68.77 10.2 1.63 Allowed Glycine 0 CA--C 1.537 1.45 0 C-N-CA 126.792 2.139 . . . . 0.0 115.491 178.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 34.0 p -30.22 123.94 0.18 Allowed 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 129.014 2.925 . . . . 0.0 114.832 -175.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.423 HG21 HG23 ' A' ' 59' ' ' ILE . 1.5 t -146.39 178.28 8.38 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.47 1.108 . . . . 0.0 113.513 -174.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -83.24 -62.8 1.49 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.364 1.465 . . . . 0.0 112.4 177.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.2 p -138.93 138.21 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.901 1.68 . . . . 0.0 111.824 178.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.423 HG23 HG21 ' A' ' 56' ' ' THR . 1.4 pp -141.09 -27.75 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.921 1.688 . . . . 0.0 114.048 -179.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 mp -97.45 96.35 3.06 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 125.687 1.595 . . . . 0.0 109.06 177.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -64.02 152.28 81.62 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.878 2.385 . . . . 0.0 110.503 175.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -43.66 -50.2 7.53 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.011 1.725 . . . . 0.0 113.477 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 5.6 p -158.59 143.81 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 C-N-CA 126.93 2.092 . . . . 0.0 109.511 175.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.702 HG21 HD23 ' A' ' 70' ' ' LEU . 99.7 t -118.0 128.95 25.67 Favored Pre-proline 0 N--CA 1.476 0.828 0 C-N-CA 124.956 1.302 . . . . 0.0 108.771 175.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.762 ' HA ' HG22 ' A' ' 43' ' ' THR . 53.9 Cg_endo -67.13 150.36 82.12 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.611 2.207 . . . . 0.0 113.139 176.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -65.23 163.65 14.87 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.293 0.637 . . . . 0.0 111.033 175.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . 0.312 50.1 p 55.48 20.75 3.9 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 127.779 2.431 . . . . 0.0 114.742 -174.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 20.0 mttt -120.35 -178.49 3.7 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 126.459 1.903 . . . . 0.0 112.115 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.402 ' HB3' HD23 ' A' ' 13' ' ' LEU . . . -133.76 166.19 23.21 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 175.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.702 HD23 HG21 ' A' ' 64' ' ' VAL . 0.5 OUTLIER -134.25 174.26 10.7 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 124.3 1.04 . . . . 0.0 110.993 179.539 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.567 ' CD2' HD11 ' A' ' 13' ' ' LEU . 0.9 OUTLIER -127.33 154.89 44.4 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 124.699 1.199 . . . . 0.0 111.481 175.185 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.521 ' HB2' HG13 ' A' ' 34' ' ' VAL . 12.4 m-85 -129.49 148.09 51.36 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 125.987 1.715 . . . . 0.0 109.795 178.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 54.5 p -126.21 146.69 49.87 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 126.186 1.795 . . . . 0.0 111.129 175.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -163.26 148.78 15.67 Favored Glycine 0 CA--C 1.519 0.286 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 174.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.48 173.61 6.66 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.16 1.384 . . . . 0.0 110.134 177.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 12.2 ptmt . . . . . 0 N--CA 1.482 1.171 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 174.948 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 90.1 m . . . . . 0 N--CA 1.475 0.798 0 CA-C-O 119.108 -0.472 . . . . 0.0 110.08 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 179.74 -93.09 0.09 OUTLIER Glycine 0 CA--C 1.531 1.069 0 CA-C-N 119.696 1.135 . . . . 0.0 113.253 -175.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -153.56 100.62 2.42 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.137 0.975 . . . . 0.0 111.585 176.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.2 t -141.23 115.27 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 124.455 1.102 . . . . 0.0 109.753 -177.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.408 ' HB1' ' CD1' ' A' ' 51' ' ' PHE . . . -157.45 170.93 21.32 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.374 1.07 . . . . 0.0 112.05 175.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -152.11 160.84 43.33 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.47 1.508 . . . . 0.0 111.082 175.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.587 ' CZ ' HG11 ' A' ' 101' ' ' VAL . 41.6 p90 -155.33 170.07 22.75 Favored 'General case' 0 C--O 1.234 0.285 0 O-C-N 121.079 -1.013 . . . . 0.0 111.154 175.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.403 ' HA ' ' O ' ' A' ' 99' ' ' LEU . . . -136.31 151.7 49.9 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 176.323 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -131.29 134.88 46.81 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.545 1.538 . . . . 0.0 112.727 -177.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -82.62 123.56 29.35 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 111.618 0.229 . . . . 0.0 111.618 -179.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 4.6 tpp -88.55 145.49 25.69 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.317 1.047 . . . . 0.0 112.165 175.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 61.3 m -69.65 -23.35 63.47 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 175.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -70.98 -13.94 62.18 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.852 1.261 . . . . 0.0 113.787 175.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 98.54 42.63 2.89 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 124.546 1.069 . . . . 0.0 114.176 -179.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.511 ' HB3' HG22 ' A' ' 120' ' ' ILE . 17.0 m-80 -141.33 174.15 10.81 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.354 1.462 . . . . 0.0 110.431 178.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.489 HG23 HD21 ' A' ' 47' ' ' LEU . 6.0 m -128.55 107.18 9.5 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.178 0.991 . . . . 0.0 112.424 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.403 ' O ' ' HA ' ' A' ' 90' ' ' ALA . 21.1 tp -68.03 105.02 1.9 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.756 0.823 . . . . 0.0 109.65 174.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -106.63 103.09 1.98 Allowed Glycine 0 CA--C 1.525 0.695 0 C-N-CA 125.395 1.474 . . . . 0.0 112.337 177.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.587 HG11 ' CZ ' ' A' ' 89' ' ' PHE . 9.5 p -86.32 161.47 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 123.755 0.822 . . . . 0.0 112.407 175.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 2.5 tmm? -150.3 126.96 10.91 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.257 1.823 . . . . 0.0 109.725 178.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -139.03 118.51 12.9 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 122.158 0.98 . . . . 0.0 112.948 177.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 26.0 t -124.6 118.34 26.32 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.452 1.501 . . . . 0.0 110.723 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 96.2 t . . . . . 0 CA--C 1.539 0.557 0 C-N-CA 126.728 2.011 . . . . 0.0 108.852 178.775 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 11.0 m . . . . . 0 N--CA 1.467 0.424 0 CA-C-O 121.497 0.665 . . . . 0.0 112.359 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -100.05 118.11 35.73 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.285 1.434 . . . . 0.0 107.382 174.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 36.7 m0 -116.73 135.65 53.59 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 19.8 p-90 -145.82 143.49 29.68 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.548 0.739 . . . . 0.0 112.029 -176.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -148.59 161.83 40.89 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.981 0.896 . . . . 0.0 112.571 -176.321 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.453 HG13 ' SD ' ' A' ' 158' ' ' MET . 5.6 p -166.12 127.76 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 125.028 1.331 . . . . 0.0 109.269 175.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.546 ' HE3' ' CE1' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -151.78 168.44 25.05 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 126.199 1.799 . . . . 0.0 109.566 178.31 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.511 HG22 ' HB3' ' A' ' 97' ' ' ASN . 24.6 mt -111.1 111.73 37.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -177.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.546 ' CE1' ' HE3' ' A' ' 119' ' ' LYS . 54.2 m-85 -63.01 142.66 97.67 Favored Pre-proline 0 CA--C 1.544 0.731 0 O-C-N 121.203 -0.936 . . . . 0.0 111.063 -179.099 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -73.92 92.5 0.89 Allowed 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 124.2 3.266 . . . . 0.0 110.902 -179.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 101.2 -171.69 22.61 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 124.805 1.193 . . . . 0.0 112.736 -174.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 8.8 tttt -67.57 118.51 10.97 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.893 0.877 . . . . 0.0 110.931 176.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 9.4 tpp180 -134.18 178.25 7.12 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.222 1.409 . . . . 0.0 109.704 175.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 8.6 ptt180 -123.34 179.74 4.61 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 126.372 1.869 . . . . 0.0 110.231 174.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -131.7 103.65 6.48 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 126.572 1.949 . . . . 0.0 107.016 175.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -126.66 171.37 11.21 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.348 1.859 . . . . 0.0 110.093 178.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -50.69 -41.73 56.13 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -177.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -60.72 -53.76 42.6 Favored Glycine 0 N--CA 1.468 0.775 0 CA-C-O 119.484 -0.62 . . . . 0.0 112.267 176.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -63.24 -40.05 96.34 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 118.176 0.988 . . . . 0.0 111.916 178.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -55.84 -63.73 1.08 Allowed 'General case' 0 C--N 1.34 0.167 0 C-N-CA 124.224 1.01 . . . . 0.0 108.846 175.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -64.62 -33.9 77.01 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 118.667 0.667 . . . . 0.0 112.739 -175.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -64.56 -42.94 95.36 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.272 1.029 . . . . 0.0 113.069 176.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -86.32 -29.01 23.34 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 121.28 -0.888 . . . . 0.0 112.291 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -52.04 -57.61 9.02 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 126.831 2.053 . . . . 0.0 108.902 174.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -71.85 -12.1 61.12 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -177.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -86.72 -8.14 77.21 Favored Glycine 0 CA--C 1.54 1.599 0 C-N-CA 126.701 2.096 . . . . 0.0 114.958 176.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -140.09 80.3 20.52 Favored Pre-proline 0 CA--C 1.55 0.954 0 CA-C-N 119.105 1.452 . . . . 0.0 111.192 175.012 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -73.16 70.25 3.82 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 124.109 3.206 . . . . 0.0 112.471 177.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -102.43 116.76 33.28 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.97 0.908 . . . . 0.0 110.637 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 34.5 mtm180 -83.59 -68.43 0.71 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.11 1.364 . . . . 0.0 111.884 174.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 134.73 114.43 1.43 Allowed Glycine 0 CA--C 1.53 0.981 0 C-N-CA 124.976 1.274 . . . . 0.0 113.569 -178.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.58 14.73 0.32 Allowed 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 126.912 2.085 . . . . 0.0 115.295 176.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . 0.258 0.8 OUTLIER 45.51 65.01 1.23 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 126.953 2.101 . . . . 0.0 112.56 -175.011 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -168.44 -67.33 0.03 OUTLIER Glycine 0 CA--C 1.541 1.672 0 C-N-CA 125.098 1.332 . . . . 0.0 115.926 -174.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 43.2 m95 173.23 114.19 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 130.86 3.664 . . . . 0.0 108.799 -175.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -131.93 126.09 33.24 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 128.463 2.705 . . . . 0.0 110.277 -177.376 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -166.76 -175.31 3.06 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.08 0.952 . . . . 0.0 112.078 -174.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.3 mtmt -139.54 145.51 38.76 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.702 1.201 . . . . 0.0 109.946 175.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -67.6 149.79 49.63 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 175.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 66.7 mt -108.78 102.32 11.37 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.277 0.631 . . . . 0.0 110.4 -174.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -43.52 -30.58 1.43 Allowed Glycine 0 N--CA 1.475 1.283 0 C-N-CA 127.722 2.582 . . . . 0.0 117.136 -175.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.47 ' CE2' ' HB ' ' A' ' 120' ' ' ILE . 0.0 OUTLIER -64.29 -18.85 64.98 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.623 1.969 . . . . 0.0 113.799 178.164 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 118.86 30.14 1.7 Allowed Glycine 0 CA--C 1.537 1.409 0 C-N-CA 125.915 1.721 . . . . 0.0 114.288 -178.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 2.2 mt -128.96 174.92 9.08 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.508 1.923 . . . . 0.0 110.859 -176.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 80.7 mtt180 -143.75 108.77 4.97 Favored 'General case' 0 N--CA 1.479 1.007 0 O-C-N 120.913 -1.117 . . . . 0.0 111.081 178.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . 0.453 ' SD ' HG13 ' A' ' 118' ' ' VAL . 0.0 OUTLIER -84.73 148.54 26.31 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 175.049 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.9 122.28 17.16 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 126.087 1.755 . . . . 0.0 110.899 176.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -138.85 158.74 25.26 Favored Glycine 0 N--CA 1.479 1.56 0 CA-C-N 121.552 1.978 . . . . 0.0 116.62 -177.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.523 HD13 ' N ' ' A' ' 162' ' ' MET . 0.0 OUTLIER -151.3 134.3 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-N 118.896 1.348 . . . . 0.0 111.051 179.407 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . 0.523 ' N ' HD13 ' A' ' 161' ' ' ILE . 1.1 ttt -156.91 105.98 2.21 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.752 1.621 . . . . 0.0 110.089 174.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 4.0 t -81.66 126.76 32.16 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 120.921 -1.112 . . . . 0.0 109.977 175.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 34.9 p -75.15 21.89 0.12 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.1 1.36 . . . . 0.0 114.292 177.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -56.06 -45.33 79.33 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.282 1.833 . . . . 0.0 114.692 -175.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 164.45 -60.59 0.25 Allowed Glycine 0 CA--C 1.533 1.192 0 C-N-CA 123.685 0.66 . . . . 0.0 114.706 178.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -120.07 21.77 11.7 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.625 1.17 . . . . 0.0 112.819 -178.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -64.16 168.59 5.28 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 122.784 1.278 . . . . 0.0 112.887 175.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.09 167.05 11.83 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 127.089 2.156 . . . . 0.0 110.976 -179.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 13.7 ttp -108.3 135.5 49.51 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.634 1.174 . . . . 0.0 110.329 178.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -141.62 127.64 19.52 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.007 0.923 . . . . 0.0 110.896 175.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 5.1 mp -133.38 121.32 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 124.241 1.016 . . . . 0.0 110.01 175.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -116.61 132.31 56.72 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 125.409 1.484 . . . . 0.0 110.321 175.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.7 mp -84.3 119.5 33.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 175.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 5.0 m -92.61 171.08 9.24 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.64 1.576 . . . . 0.0 109.825 174.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 2.2 mtt180 . . . . . 0 C--O 1.253 1.274 0 C-N-CA 125.335 1.454 . . . . 0.0 112.624 176.363 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.447 HD11 ' HB2' ' A' ' 31' ' ' LYS . 11.8 tp . . . . . 0 N--CA 1.474 0.731 0 N-CA-C 113.847 1.054 . . . . 0.0 113.847 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -86.58 138.7 31.49 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.313 1.045 . . . . 0.0 109.124 175.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -79.66 -122.81 0.4 Allowed Glycine 0 CA--C 1.535 1.319 0 C-N-CA 124.143 0.877 . . . . 0.0 112.031 175.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 35.8 p -113.74 173.43 6.42 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.482 1.513 . . . . 0.0 112.018 -178.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -123.14 19.84 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.326 1.05 . . . . 0.0 112.121 178.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.42 HD12 ' HB3' ' A' ' 12' ' ' SER . 0.9 OUTLIER -47.15 156.87 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.784 1.234 . . . . 0.0 112.846 175.007 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -41.92 130.45 3.44 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.279 1.832 . . . . 0.0 112.999 -175.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -54.03 -22.86 21.8 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 124.869 1.223 . . . . 0.0 114.885 -174.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.93 -30.58 71.65 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.417 1.087 . . . . 0.0 112.077 175.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.42 ' HB3' HD12 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -100.89 -41.92 6.64 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.629 1.972 . . . . 0.0 111.872 176.75 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.2 tp -73.29 94.23 1.99 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.139 0.976 . . . . 0.0 110.898 175.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 82.6 p -129.19 -175.3 3.52 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.422 1.889 . . . . 0.0 112.046 -178.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.478 ' CE1' HG21 ' A' ' 161' ' ' ILE . 6.4 m-85 -51.52 -33.11 30.45 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.959 1.304 . . . . 0.0 113.993 179.076 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -57.83 -43.17 85.64 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.102 0.561 . . . . 0.0 111.852 174.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.416 ' O ' HG23 ' A' ' 21' ' ' VAL . 72.8 t -67.03 -40.23 85.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.229 1.012 . . . . 0.0 110.922 175.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 59.8 mt -67.54 -40.08 85.02 Favored 'General case' 0 N--CA 1.469 0.475 0 O-C-N 120.963 -1.086 . . . . 0.0 112.059 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -63.91 -47.57 80.02 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.164 0.986 . . . . 0.0 111.781 176.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.51 -36.7 84.6 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 118.456 -0.783 . . . . 0.0 112.287 174.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 17' ' ' VAL . 19.0 t -55.03 -46.12 77.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-N 119.295 0.952 . . . . 0.0 110.92 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.3 mt -54.89 -19.62 7.01 Favored 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 176.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.62 -60.48 1.09 Allowed Glycine 0 CA--C 1.535 1.323 0 C-N-CA 126.324 1.916 . . . . 0.0 113.182 175.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -65.75 -34.89 79.23 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -178.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -100.8 133.56 45.09 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.637 1.575 . . . . 0.0 109.923 175.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 170.27 145.72 4.84 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 124.504 1.049 . . . . 0.0 112.155 -178.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -129.73 -76.91 0.54 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.027 1.331 . . . . 0.0 110.938 -178.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 30' ' ' ARG . 26.9 m -78.08 173.93 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 126.107 1.763 . . . . 0.0 111.361 175.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -53.67 -35.31 60.92 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 115.546 1.684 . . . . 0.0 115.546 -175.04 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.534 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.2 OUTLIER -127.32 152.13 47.86 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 127.544 2.337 . . . . 0.0 109.035 175.003 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.447 ' HB2' HD11 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -151.02 159.47 44.53 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.803 1.641 . . . . 0.0 111.012 -178.088 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.465 HG13 ' HB1' ' A' ' 85' ' ' ALA . 0.3 OUTLIER -122.26 129.9 74.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 125.075 1.35 . . . . 0.0 108.214 175.078 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -135.79 115.3 12.72 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.11 1.364 . . . . 0.0 108.965 175.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.475 HG12 ' HB3' ' A' ' 170' ' ' MET . 2.6 m -125.72 144.1 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 123.313 0.645 . . . . 0.0 111.146 -177.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -111.03 115.26 3.92 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 124.255 0.931 . . . . 0.0 111.656 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 mp -105.1 144.16 15.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 118.037 0.918 . . . . 0.0 108.782 174.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -115.95 111.5 20.48 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 124.588 1.155 . . . . 0.0 111.049 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.474 ' HA ' ' CZ2' ' A' ' 44' ' ' TRP . 1.6 m-20 -80.54 78.25 7.29 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 128.141 2.576 . . . . 0.0 111.226 -175.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -113.99 3.43 15.35 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.779 1.232 . . . . 0.0 112.389 178.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.31 -54.5 43.15 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.918 1.687 . . . . 0.0 114.304 -175.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 151.93 99.52 0.19 Allowed Glycine 0 CA--C 1.533 1.195 0 O-C-N 121.478 -0.764 . . . . 0.0 114.278 178.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.15 163.74 38.94 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 125.871 1.701 . . . . 0.0 112.94 -177.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.669 HG22 ' HA ' ' A' ' 65' ' ' PRO . 69.1 p -63.98 138.74 58.6 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 121.965 -0.727 . . . . 0.0 111.616 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.474 ' CZ2' ' HA ' ' A' ' 38' ' ' ASN . 40.6 m0 -87.99 106.47 18.15 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.077 0.551 . . . . 0.0 110.827 -178.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 15.9 m -86.27 122.64 30.54 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.319 1.048 . . . . 0.0 109.577 175.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.41 140.02 57.4 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.087 0.47 . . . . 0.0 111.671 175.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.546 HD12 ' N ' ' A' ' 48' ' ' ASN . 4.0 pp -121.92 -56.84 1.83 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.912 1.285 . . . . 0.0 111.312 -178.207 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.546 ' N ' HD12 ' A' ' 47' ' ' LEU . 0.1 OUTLIER -171.16 156.22 4.66 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.65 1.98 . . . . 0.0 110.596 176.5 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.416 ' HB2' HD12 ' A' ' 60' ' ' LEU . . . -133.57 165.45 24.88 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.269 1.428 . . . . 0.0 110.718 174.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -141.12 101.8 4.11 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.953 1.701 . . . . 0.0 111.444 -178.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.506 ' CD1' ' HB1' ' A' ' 87' ' ' ALA . 3.1 m-85 -107.74 127.32 53.59 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.127 0.971 . . . . 0.0 110.582 -177.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.67 -37.75 4.8 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.372 1.069 . . . . 0.0 113.486 -179.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.8 t -123.36 -41.93 2.27 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 126.31 1.844 . . . . 0.0 111.556 -178.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -69.01 16.2 0.63 Allowed Glycine 0 CA--C 1.536 1.362 0 C-N-CA 125.145 1.355 . . . . 0.0 115.529 179.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.6 p -27.35 115.25 0.07 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 129.604 3.161 . . . . 0.0 113.863 -176.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.639 HG21 HG23 ' A' ' 59' ' ' ILE . 3.1 t -139.11 176.71 8.46 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.779 0.831 . . . . 0.0 112.794 -175.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -80.94 -57.4 3.56 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.909 1.284 . . . . 0.0 110.668 175.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.4 p -151.0 137.23 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 126.071 1.748 . . . . 0.0 111.573 -177.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.639 HG23 HG21 ' A' ' 56' ' ' THR . 0.1 OUTLIER -130.8 -42.5 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 125.337 1.455 . . . . 0.0 112.778 176.001 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.416 HD12 ' HB2' ' A' ' 49' ' ' ALA . 13.8 mt -82.59 100.15 0.79 Allowed Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 126.398 1.879 . . . . 0.0 109.725 179.21 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.479 ' HG2' HG23 ' A' ' 64' ' ' VAL . 84.0 Cg_endo -69.43 155.31 67.38 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.57 2.846 . . . . 0.0 110.385 175.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -48.52 -52.14 23.96 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.902 0.881 . . . . 0.0 112.966 -176.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.4 t -154.6 135.43 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 128.307 2.643 . . . . 0.0 108.694 -178.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.555 HG21 HD13 ' A' ' 70' ' ' LEU . 48.3 t -120.43 134.19 24.12 Favored Pre-proline 0 N--CA 1.479 1.016 0 C-N-CA 123.94 0.896 . . . . 0.0 109.448 174.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.669 ' HA ' HG22 ' A' ' 43' ' ' THR . 51.8 Cg_endo -63.09 151.1 86.5 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.202 1.935 . . . . 0.0 113.157 176.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -74.59 173.1 10.9 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.537 0.735 . . . . 0.0 110.428 175.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 78.8 p 49.23 27.78 1.97 Allowed 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 126.79 2.036 . . . . 0.0 112.789 -175.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 8.2 tttt -133.58 178.41 6.95 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 126.611 1.964 . . . . 0.0 111.633 -175.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -137.69 161.14 37.29 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 121.35 -0.843 . . . . 0.0 109.4 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.555 HD13 HG21 ' A' ' 64' ' ' VAL . 2.0 pt? -137.88 168.56 19.45 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.255 1.022 . . . . 0.0 111.681 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.411 HD13 ' O ' ' A' ' 34' ' ' VAL . 1.4 mm? -109.17 149.68 29.0 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 124.165 0.986 . . . . 0.0 110.748 175.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -126.83 149.46 49.7 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 127.371 2.268 . . . . 0.0 109.686 177.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.5 p -131.75 151.67 51.49 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 127.023 2.129 . . . . 0.0 111.879 -175.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -170.51 135.52 3.56 Favored Glycine 0 CA--C 1.521 0.433 0 O-C-N 121.396 -0.815 . . . . 0.0 113.142 174.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 27.7 mtm180 -104.06 121.35 43.01 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.57 1.148 . . . . 0.0 110.368 -177.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.715 0 C-N-CA 126.221 1.808 . . . . 0.0 115.236 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.2 p . . . . . 0 N--CA 1.476 0.871 0 N-CA-C 110.76 -0.089 . . . . 0.0 110.76 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -104.96 -105.79 3.06 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 125.335 1.445 . . . . 0.0 112.042 -177.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.465 ' HB1' HG13 ' A' ' 32' ' ' ILE . . . -139.63 93.2 2.64 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.423 -1.045 . . . . 0.0 110.056 177.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.3 t -133.12 116.6 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 123.904 0.882 . . . . 0.0 110.266 -176.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.754 ' HB3' ' CZ ' ' A' ' 103' ' ' PHE . . . -163.55 161.26 23.86 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.916 0.865 . . . . 0.0 111.382 178.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -142.82 151.17 40.86 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.678 1.191 . . . . 0.0 110.166 175.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -149.92 170.03 19.76 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 124.236 1.014 . . . . 0.0 110.061 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.473 ' HB3' HD11 ' A' ' 47' ' ' LEU . . . -142.52 157.4 44.77 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.389 -0.819 . . . . 0.0 111.891 175.002 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -132.12 141.44 49.15 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 126.131 1.773 . . . . 0.0 112.446 -174.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -98.32 119.12 36.45 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 120.673 0.273 . . . . 0.0 110.678 -175.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 15.4 mtm -95.88 133.69 39.75 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 123.906 0.882 . . . . 0.0 110.713 -176.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.4 t -58.84 -23.84 61.25 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.781 1.232 . . . . 0.0 112.624 178.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -64.53 -18.88 65.24 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.438 1.495 . . . . 0.0 113.515 175.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 108.53 14.0 17.27 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 124.959 1.266 . . . . 0.0 115.312 -179.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.425 ' HB3' HG22 ' A' ' 120' ' ' ILE . 15.3 m-80 -122.51 172.25 8.51 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-N 119.171 1.486 . . . . 0.0 111.394 -179.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 95.6 m -124.91 102.16 7.41 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.598 1.159 . . . . 0.0 111.734 -177.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 21.4 tp -66.73 97.09 0.44 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.016 1.327 . . . . 0.0 111.682 176.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -90.61 124.65 7.6 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 125.534 1.54 . . . . 0.0 112.22 176.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 47.7 t -124.88 142.7 40.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 124.894 1.277 . . . . 0.0 110.777 -175.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . 0.423 ' CE ' ' HA ' ' A' ' 116' ' ' TRP . 0.0 OUTLIER -149.33 160.09 43.71 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.427 -0.795 . . . . 0.0 112.026 175.04 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.754 ' CZ ' ' HB3' ' A' ' 87' ' ' ALA . 44.4 p90 -143.23 143.07 31.6 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.13 0.972 . . . . 0.0 110.436 176.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 9.9 t -134.25 119.96 19.39 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.833 1.253 . . . . 0.0 110.662 179.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 62.4 t . . . . . 0 N--CA 1.469 0.513 0 C-N-CA 126.061 1.744 . . . . 0.0 109.206 -176.011 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 31.9 m . . . . . 0 N--CA 1.474 0.761 0 CA-C-O 121.02 0.438 . . . . 0.0 111.872 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -84.18 104.03 13.89 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.549 1.14 . . . . 0.0 110.064 175.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 53.6 m0 -114.3 152.26 31.66 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 119.825 1.193 . . . . 0.0 112.673 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' TRP . . . . . 0.423 ' HA ' ' CE ' ' A' ' 102' ' ' MET . 53.9 p-90 -144.1 133.6 23.41 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -134.4 161.65 34.42 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.37 1.868 . . . . 0.0 111.829 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 78.5 t -154.62 150.19 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 126.961 2.104 . . . . 0.0 108.077 175.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.75 166.21 29.1 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.591 1.956 . . . . 0.0 109.97 175.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.474 ' HB ' ' CE2' ' A' ' 154' ' ' TYR . 3.1 mt -118.18 112.05 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-O 121.787 0.803 . . . . 0.0 109.454 176.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -68.76 145.05 96.64 Favored Pre-proline 0 CA--C 1.548 0.883 0 O-C-N 121.478 -0.764 . . . . 0.0 111.629 179.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -75.79 91.33 1.09 Allowed 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 123.834 3.023 . . . . 0.0 112.005 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 97.28 179.0 34.21 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 125.827 1.68 . . . . 0.0 112.952 -178.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 6.6 tttt -51.6 121.66 6.82 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.837 1.255 . . . . 0.0 111.567 -176.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.98 -173.45 3.38 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.606 1.563 . . . . 0.0 112.101 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.8 ptt180 -134.14 -179.22 5.43 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 126.9 2.08 . . . . 0.0 110.948 175.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -126.63 115.92 20.22 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 127.539 2.336 . . . . 0.0 104.984 175.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -135.55 169.6 17.27 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.835 1.254 . . . . 0.0 110.303 175.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -56.61 -36.15 69.09 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.049 0.94 . . . . 0.0 112.962 -178.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -60.9 -58.78 12.01 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-N 118.742 0.701 . . . . 0.0 111.998 175.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 1.4 null -62.73 -36.94 84.64 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 118.07 0.935 . . . . 0.0 112.801 178.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.41 -64.39 0.97 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.48 1.112 . . . . 0.0 109.151 174.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -65.27 -28.65 69.49 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -175.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -63.69 -36.88 85.3 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.778 1.231 . . . . 0.0 112.569 175.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 8.8 tpp -94.07 -23.63 17.91 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 177.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -49.89 -56.9 8.74 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.779 1.631 . . . . 0.0 111.145 175.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -70.4 -13.37 62.11 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -85.04 -30.61 25.31 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 127.153 2.311 . . . . 0.0 112.987 -175.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -123.57 81.96 53.98 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 123.833 0.853 . . . . 0.0 112.46 175.01 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -75.04 73.06 4.46 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 123.928 3.086 . . . . 0.0 112.775 -179.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -103.84 114.98 29.64 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.698 0.799 . . . . 0.0 111.552 176.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 46.8 mtm180 -86.26 -82.18 0.2 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.049 1.339 . . . . 0.0 111.138 175.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -115.88 -76.72 0.65 Allowed Glycine 0 C--N 1.328 0.102 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 178.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 56.69 43.26 25.68 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-O 122.044 0.926 . . . . 0.0 109.796 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -49.69 91.81 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 127.67 2.388 . . . . 0.0 113.805 -175.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 161.5 50.51 0.02 OUTLIER Glycine 0 CA--C 1.535 1.314 0 C-N-CA 124.993 1.283 . . . . 0.0 114.178 -175.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' TRP . . . . . 0.641 ' H ' HD13 ' A' ' 161' ' ' ILE . 4.7 m95 48.79 51.05 16.51 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.219 1.808 . . . . 0.0 113.953 -178.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -81.67 124.53 29.66 Favored 'General case' 0 N--CA 1.467 0.425 0 O-C-N 121.31 -0.869 . . . . 0.0 111.971 -177.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -167.27 -169.22 1.2 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.433 0.693 . . . . 0.0 112.754 178.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.77 164.49 25.03 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 126.64 1.976 . . . . 0.0 111.53 -178.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -81.8 157.7 24.37 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.872 0.869 . . . . 0.0 109.838 175.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.709 HD21 ' HB2' ' A' ' 158' ' ' MET . 3.0 mm? -104.71 118.06 35.62 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.125 0.57 . . . . 0.0 110.536 175.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -48.99 -29.57 8.54 Favored Glycine 0 CA--C 1.537 1.45 0 C-N-CA 125.8 1.667 . . . . 0.0 115.977 -177.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.474 ' CE2' ' HB ' ' A' ' 120' ' ' ILE . 0.1 OUTLIER -62.5 -25.39 67.99 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.4 1.88 . . . . 0.0 113.112 176.977 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 125.18 7.75 5.78 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 126.626 2.06 . . . . 0.0 114.961 -179.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 5.3 mp -101.5 176.78 5.12 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.216 1.406 . . . . 0.0 112.235 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 38.5 mtt180 -139.16 113.52 8.92 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.963 1.305 . . . . 0.0 110.703 -178.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . 0.709 ' HB2' HD21 ' A' ' 152' ' ' LEU . 4.3 ttt -98.15 147.36 24.66 Favored 'General case' 0 C--N 1.319 -0.755 0 O-C-N 120.305 -1.497 . . . . 0.0 107.88 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.09 144.56 51.41 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 125.949 1.699 . . . . 0.0 110.163 177.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -152.02 156.97 26.99 Favored Glycine 0 CA--C 1.519 0.297 0 CA-C-O 121.893 0.719 . . . . 0.0 112.043 177.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.641 HD13 ' H ' ' A' ' 147' ' ' TRP . 4.7 tp -153.21 123.62 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 122.686 1.231 . . . . 0.0 110.175 -175.122 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.58 171.97 14.29 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 125.475 1.51 . . . . 0.0 110.21 175.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 15.1 t -162.2 166.82 25.03 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.251 1.42 . . . . 0.0 108.977 176.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 60.2 p -116.66 30.9 7.06 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.741 1.616 . . . . 0.0 111.604 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -65.38 23.2 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 128.541 2.736 . . . . 0.0 115.113 177.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 81.01 -55.49 4.79 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 127.14 2.305 . . . . 0.0 113.433 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -116.05 24.02 11.76 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.67 1.588 . . . . 0.0 112.818 -175.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -61.83 168.31 3.17 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 127.021 2.128 . . . . 0.0 114.599 175.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.5 171.35 10.58 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 127.661 2.385 . . . . 0.0 111.651 177.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . 0.475 ' HB3' HG12 ' A' ' 34' ' ' VAL . 3.0 tmm? -118.76 135.58 54.43 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.223 1.409 . . . . 0.0 111.151 175.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.453 ' C ' HD12 ' A' ' 172' ' ' ILE . 6.2 tm0? -145.06 131.56 19.77 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.124 0.97 . . . . 0.0 110.156 178.011 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.453 HD12 ' C ' ' A' ' 171' ' ' GLN . 1.8 mp -131.74 127.97 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 125.382 1.473 . . . . 0.0 109.613 175.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -130.87 131.11 44.35 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.933 1.693 . . . . 0.0 110.335 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.7 mp -89.17 96.56 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 O-C-N 121.527 -0.733 . . . . 0.0 111.426 177.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 2.5 t -66.06 173.02 3.28 Favored 'General case' 0 CA--C 1.565 1.521 0 C-N-CA 123.631 0.772 . . . . 0.0 111.477 177.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 18.1 mtp180 . . . . . 0 C--O 1.252 1.208 0 C-N-CA 125.73 1.612 . . . . 0.0 112.618 175.711 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.814 HD12 ' H ' ' A' ' 74' ' ' GLY . 1.5 mt . . . . . 0 N--CA 1.485 1.283 0 N-CA-C 112.168 0.432 . . . . 0.0 112.168 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -114.98 114.36 25.33 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.884 1.674 . . . . 0.0 111.024 -175.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -72.73 -155.52 2.89 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 125.29 1.424 . . . . 0.0 113.137 178.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 25.7 p -61.9 161.4 10.55 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.61 0.764 . . . . 0.0 111.791 174.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -122.81 18.07 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 CA-C-O 122.993 1.378 . . . . 0.0 111.47 174.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.8 pp -58.62 172.63 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 C-N-CA 125.463 1.505 . . . . 0.0 112.642 174.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -42.27 130.93 3.7 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 127.177 2.191 . . . . 0.0 114.155 -174.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.76 -19.47 43.31 Favored Glycine 0 CA--C 1.538 1.491 0 C-N-CA 124.187 0.899 . . . . 0.0 114.213 -175.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.97 -31.97 72.37 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.504 1.122 . . . . 0.0 112.539 174.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.6 t -101.39 -37.78 8.31 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.644 1.578 . . . . 0.0 111.69 175.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.442 HD23 ' HB3' ' A' ' 69' ' ' ALA . 13.0 tp -78.45 87.99 4.44 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.214 1.005 . . . . 0.0 110.802 175.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.2 p -121.46 178.96 4.6 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 127.188 2.195 . . . . 0.0 111.913 176.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -40.96 -42.01 1.77 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.834 1.654 . . . . 0.0 113.927 175.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -53.73 -46.46 70.85 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 119.159 0.89 . . . . 0.0 111.744 178.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 93.9 t -64.42 -39.57 86.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 125.383 1.473 . . . . 0.0 111.138 174.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 24.2 mt -66.11 -41.86 90.01 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 121.189 -0.944 . . . . 0.0 111.303 178.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -64.74 -46.26 82.96 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.979 1.311 . . . . 0.0 111.57 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.5 -37.25 84.66 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 118.798 -0.62 . . . . 0.0 111.441 174.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.8 t -54.74 -45.75 73.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 124.504 1.122 . . . . 0.0 111.196 -179.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.562 HD11 ' HB3' ' A' ' 169' ' ' LYS . 1.4 mt -59.19 -22.48 61.07 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 119.125 0.875 . . . . 0.0 113.356 178.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -89.37 -59.34 1.56 Allowed Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.574 1.559 . . . . 0.0 112.552 178.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -66.13 -30.37 70.84 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.3 mt -111.83 109.61 19.52 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.737 1.615 . . . . 0.0 110.001 -174.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -148.72 139.9 7.89 Favored Glycine 0 CA--C 1.54 1.643 0 C-N-CA 124.563 1.078 . . . . 0.0 114.781 -174.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.3 mtpt -109.22 -67.12 1.0 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 126.243 1.817 . . . . 0.0 112.136 178.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 15.3 m -118.2 -172.12 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 126.127 1.771 . . . . 0.0 110.891 -177.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.2 m -46.9 -38.38 10.38 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 125.359 1.464 . . . . 0.0 114.251 179.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 -127.63 162.0 27.54 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.742 1.617 . . . . 0.0 109.844 174.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.46 ' HB2' HD13 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -155.16 155.87 34.71 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 125.937 1.695 . . . . 0.0 108.98 -176.121 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -120.65 129.41 75.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 124.633 1.173 . . . . 0.0 107.838 174.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -133.26 121.89 23.12 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.237 1.415 . . . . 0.0 109.564 175.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.718 HG22 ' HB2' ' A' ' 72' ' ' TYR . 1.0 OUTLIER -128.49 144.48 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.111 0.964 . . . . 0.0 110.685 -176.721 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -124.79 110.22 1.35 Allowed Glycine 0 CA--C 1.519 0.323 0 C-N-CA 123.716 0.674 . . . . 0.0 112.44 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.46 ' HB ' HD11 ' A' ' 70' ' ' LEU . 3.5 mp -100.3 129.43 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 117.767 0.784 . . . . 0.0 110.687 175.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.73 106.3 18.27 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.639 1.576 . . . . 0.0 110.38 175.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.79 96.25 3.04 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.304 1.442 . . . . 0.0 109.585 176.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -129.73 6.63 5.15 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.836 1.254 . . . . 0.0 113.484 176.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.5 t -58.44 -18.4 28.24 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.62 1.568 . . . . 0.0 113.921 175.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 94.94 5.96 60.71 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 125.747 1.641 . . . . 0.0 114.573 176.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -128.8 147.41 17.59 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 125.813 1.673 . . . . 0.0 111.509 175.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.8 HG22 ' HA ' ' A' ' 65' ' ' PRO . 32.4 p -74.24 129.39 37.73 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 174.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 38.9 m0 -93.38 132.03 37.99 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 122.084 -0.385 . . . . 0.0 110.892 178.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 97.6 m -114.64 128.61 56.41 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.439 1.096 . . . . 0.0 110.073 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.65 106.99 0.74 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.266 1.026 . . . . 0.0 111.877 175.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.2 pp -98.91 -40.12 8.24 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.121 0.568 . . . . 0.0 112.516 179.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -170.58 163.35 8.24 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.875 2.07 . . . . 0.0 111.639 176.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -156.54 154.38 30.2 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.195 0.998 . . . . 0.0 111.355 174.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -132.46 107.24 8.36 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.422 1.489 . . . . 0.0 111.744 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.547 ' CD1' ' HB1' ' A' ' 87' ' ' ALA . 2.1 m-85 -98.82 110.85 23.39 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.844 0.858 . . . . 0.0 110.476 175.056 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.3 tpp180 -74.19 -73.33 0.23 Allowed 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.935 1.294 . . . . 0.0 109.291 175.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 9.3 t -106.37 -178.34 3.62 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 126.607 1.963 . . . . 0.0 109.081 176.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 48.65 35.4 16.45 Favored Glycine 0 CA--C 1.54 1.648 0 CA-C-O 119.581 -0.566 . . . . 0.0 112.314 -174.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.7 p -48.7 141.45 7.22 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.596 1.958 . . . . 0.0 112.199 -174.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.405 HG21 HG23 ' A' ' 59' ' ' ILE . 3.2 t -136.95 173.41 11.73 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 121.346 -0.846 . . . . 0.0 113.135 -175.191 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -80.47 -58.1 3.28 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.648 1.179 . . . . 0.0 111.337 176.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.2 p -142.75 133.07 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.418 1.487 . . . . 0.0 111.615 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.405 HG23 HG21 ' A' ' 56' ' ' THR . 1.1 pp -138.13 -24.33 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 126.372 1.869 . . . . 0.0 113.863 178.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.4 mp -97.65 98.96 5.76 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 124.797 1.239 . . . . 0.0 110.233 179.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -67.33 159.94 49.97 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 124.714 3.61 . . . . 0.0 111.031 174.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -57.93 -48.25 80.49 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -178.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 87.7 t -149.16 143.7 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 127.196 2.198 . . . . 0.0 108.809 -176.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.486 HG21 HD23 ' A' ' 70' ' ' LEU . 11.2 t -125.78 102.12 29.07 Favored Pre-proline 0 C--N 1.33 -0.259 0 C-N-CA 125.69 1.596 . . . . 0.0 107.451 175.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.8 ' HA ' HG22 ' A' ' 43' ' ' THR . 64.8 Cg_endo -72.12 161.39 44.8 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 121.234 1.289 . . . . 0.0 112.492 175.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -69.37 172.27 7.38 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.05 0.54 . . . . 0.0 110.259 174.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 58.8 p 57.03 20.64 5.59 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 125.494 1.518 . . . . 0.0 111.954 -174.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.79 173.35 11.46 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 125.359 1.464 . . . . 0.0 111.06 -174.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.442 ' HB3' HD23 ' A' ' 13' ' ' LEU . . . -142.8 156.52 44.98 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 175.028 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.486 HD23 HG21 ' A' ' 64' ' ' VAL . 1.0 OUTLIER -121.04 175.67 5.96 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 123.882 0.873 . . . . 0.0 111.073 -179.529 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.498 HD13 ' O ' ' A' ' 34' ' ' VAL . 0.8 OUTLIER -132.62 149.53 52.29 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.699 1.2 . . . . 0.0 110.965 175.052 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.718 ' HB2' HG22 ' A' ' 34' ' ' VAL . 3.7 m-85 -123.3 147.06 47.37 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.713 1.205 . . . . 0.0 109.286 174.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.2 p -121.3 147.84 45.12 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 127.047 2.139 . . . . 0.0 110.138 174.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.814 ' H ' HD12 ' A' ' 3' ' ' LEU . . . -165.2 130.72 2.22 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 124.351 0.977 . . . . 0.0 112.695 174.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 7.5 ptt180 -123.09 149.31 44.62 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.943 1.697 . . . . 0.0 110.687 -175.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 11.8 mtpt . . . . . 0 N--CA 1.475 0.784 0 O-C-N 121.212 -0.93 . . . . 0.0 111.862 -176.841 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 53.0 m . . . . . 0 N--CA 1.474 0.737 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -43.67 -77.05 0.1 OUTLIER Glycine 0 N--CA 1.476 1.339 0 C-N-CA 126.962 2.22 . . . . 0.0 115.416 -175.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -169.1 123.59 0.84 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.534 1.934 . . . . 0.0 109.865 178.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.5 t -151.41 114.3 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.845 0.858 . . . . 0.0 110.716 -175.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.547 ' HB1' ' CD1' ' A' ' 51' ' ' PHE . . . -159.23 157.75 31.29 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -141.93 132.66 25.6 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.478 1.111 . . . . 0.0 112.173 178.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -136.01 171.62 14.21 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.189 -0.944 . . . . 0.0 111.688 -178.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -137.67 155.92 48.59 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.26 -0.9 . . . . 0.0 112.906 174.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -133.17 118.33 18.53 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 126.025 1.73 . . . . 0.0 114.409 -175.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -77.13 122.78 25.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.666 -0.243 . . . . 0.0 110.972 -178.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 13.3 mtm -101.67 134.47 44.76 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.514 1.526 . . . . 0.0 111.304 177.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 98.5 p -61.68 -17.26 54.83 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 178.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -69.05 -0.32 5.61 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 125.965 1.706 . . . . 0.0 113.037 174.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 91.1 24.9 25.82 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.456 1.503 . . . . 0.0 113.276 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -132.58 174.82 9.88 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.906 1.283 . . . . 0.0 111.702 -175.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 71.1 m -136.57 113.92 10.82 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.355 1.062 . . . . 0.0 111.504 174.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 65.1 tp -76.03 104.48 6.58 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.512 1.125 . . . . 0.0 110.506 175.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -93.63 117.94 5.58 Favored Glycine 0 CA--C 1.529 0.947 0 O-C-N 121.239 -0.913 . . . . 0.0 112.973 175.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 93.3 t -104.83 147.5 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 125.525 1.53 . . . . 0.0 111.067 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 1.5 tpt -151.55 126.1 9.5 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.546 1.138 . . . . 0.0 111.03 -178.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.479 ' CZ ' ' HB3' ' A' ' 87' ' ' ALA . 44.7 p90 -133.81 139.95 46.61 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.456 1.503 . . . . 0.0 114.159 177.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -136.3 138.96 42.26 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.245 1.818 . . . . 0.0 111.294 -177.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 96.3 t . . . . . 0 N--CA 1.469 0.494 0 C-N-CA 125.098 1.359 . . . . 0.0 110.776 -178.785 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 51.6 m . . . . . 0 N--CA 1.472 0.638 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -88.2 113.82 24.2 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 124.44 1.096 . . . . 0.0 110.974 174.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 31.5 m0 -118.52 135.58 54.32 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.112 0.965 . . . . 0.0 109.673 -176.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' TRP . . . . . 0.413 ' HE1' ' CA ' ' A' ' 143' ' ' GLY . 30.5 p-90 -142.19 134.47 27.74 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.49 1.116 . . . . 0.0 111.873 -175.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -160.3 164.46 32.56 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 122.526 1.155 . . . . 0.0 112.989 -176.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.2 t -138.64 124.7 24.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 125.142 1.377 . . . . 0.0 107.747 -179.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.66 166.0 13.29 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.208 1.403 . . . . 0.0 110.198 175.053 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.416 ' CD1' HD13 ' A' ' 152' ' ' LEU . 41.7 mt -122.97 147.76 27.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 174.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -110.2 143.37 27.89 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 124.87 1.268 . . . . 0.0 110.071 177.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -77.21 12.5 1.78 Allowed 'Trans proline' 0 CA--C 1.548 1.219 0 C-N-CA 124.594 3.529 . . . . 0.0 114.407 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -161.12 -179.86 36.12 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 126.475 1.988 . . . . 0.0 111.44 176.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.93 101.83 0.71 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.825 1.25 . . . . 0.0 110.807 177.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 3.8 mmt-85 -124.79 141.8 51.86 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.71 1.204 . . . . 0.0 112.466 -178.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.41 171.99 12.13 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 177.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -128.35 91.63 3.29 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.5 1.92 . . . . 0.0 108.503 176.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -107.37 173.99 6.08 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.793 1.637 . . . . 0.0 109.922 174.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -49.76 -37.0 27.92 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.805 0.842 . . . . 0.0 113.265 176.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -59.14 -65.72 3.27 Favored Glycine 0 CA--C 1.531 1.035 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 174.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -58.08 -36.74 73.27 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 118.176 0.988 . . . . 0.0 113.522 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -56.28 -64.21 0.94 Allowed 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 125.267 1.427 . . . . 0.0 109.718 174.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -67.78 -32.8 73.64 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -176.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -57.87 -47.65 82.12 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.01 0.924 . . . . 0.0 112.265 177.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 5.2 tpp -84.51 -21.86 30.41 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 113.669 0.989 . . . . 0.0 113.669 176.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -49.33 -57.97 5.92 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.741 1.216 . . . . 0.0 109.773 174.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -74.64 5.05 5.24 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -178.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -93.9 -11.9 57.23 Favored Glycine 0 CA--C 1.539 1.59 0 C-N-CA 126.015 1.769 . . . . 0.0 114.765 178.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -145.26 94.71 5.2 Favored Pre-proline 0 CA--C 1.552 1.053 0 CA-C-N 119.523 1.662 . . . . 0.0 112.397 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -74.02 81.84 1.88 Allowed 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 123.587 2.858 . . . . 0.0 112.584 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -116.88 110.2 18.03 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.446 1.499 . . . . 0.0 110.846 -178.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 37.2 mtm105 -96.27 50.94 1.18 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 126.907 2.083 . . . . 0.0 111.336 -178.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.413 ' CA ' ' HE1' ' A' ' 116' ' ' TRP . . . 85.95 -53.06 4.63 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 124.117 0.865 . . . . 0.0 111.185 -174.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 51.38 52.71 14.22 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.235 1.814 . . . . 0.0 111.399 178.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 14.7 p-10 -48.17 92.82 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 128.48 2.712 . . . . 0.0 115.115 -174.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 160.46 40.12 0.02 OUTLIER Glycine 0 CA--C 1.537 1.427 0 C-N-CA 125.232 1.396 . . . . 0.0 114.506 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' TRP . . . . . 0.723 ' H ' HD12 ' A' ' 161' ' ' ILE . 7.5 m95 53.42 48.81 21.03 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.81 1.644 . . . . 0.0 113.363 -176.021 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -82.66 126.3 32.19 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.987 0.915 . . . . 0.0 112.094 -179.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . 0.5 ' HG3' ' H ' ' A' ' 150' ' ' LYS . 10.5 tp60 -161.65 -168.98 2.11 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.345 0.658 . . . . 0.0 112.312 175.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.5 ' H ' ' HG3' ' A' ' 149' ' ' GLN . 0.6 OUTLIER -131.59 160.67 34.64 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.245 1.818 . . . . 0.0 110.781 -179.205 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 18.7 m-80 -75.55 148.98 38.47 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.391 1.076 . . . . 0.0 109.95 174.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.416 HD13 ' CD1' ' A' ' 120' ' ' ILE . 94.3 mt -100.93 136.9 40.04 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.955 0.902 . . . . 0.0 110.621 178.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -53.0 -35.59 49.1 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 125.717 1.627 . . . . 0.0 116.476 -174.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.536 ' HB2' HD12 ' A' ' 156' ' ' LEU . 0.1 OUTLIER -73.46 14.21 0.37 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 128.081 2.552 . . . . 0.0 113.942 -178.326 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 76.36 20.5 76.96 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 124.908 1.242 . . . . 0.0 113.58 -174.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.536 HD12 ' HB2' ' A' ' 154' ' ' TYR . 6.1 mt -101.01 169.01 9.24 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 127.144 2.178 . . . . 0.0 110.519 178.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 50.4 mtt180 -138.76 114.03 9.54 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 120.841 -1.162 . . . . 0.0 110.451 177.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -92.16 150.79 20.72 Favored 'General case' 0 C--N 1.32 -0.711 0 O-C-N 120.138 -1.601 . . . . 0.0 108.433 174.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 2.3 tptt -133.45 142.5 48.33 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.578 1.551 . . . . 0.0 111.097 175.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -147.59 143.43 11.22 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-N 118.885 0.766 . . . . 0.0 113.671 175.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.723 HD12 ' H ' ' A' ' 147' ' ' TRP . 0.5 OUTLIER -130.55 126.16 60.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 126.36 1.864 . . . . 0.0 110.604 177.509 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -149.93 148.49 29.16 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 125.412 1.485 . . . . 0.0 109.297 175.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 13.5 t -139.81 112.84 8.15 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.0 0.52 . . . . 0.0 110.543 178.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 67.7 m -72.51 35.02 0.07 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.566 1.146 . . . . 0.0 113.232 178.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -65.99 -44.23 85.45 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.653 1.981 . . . . 0.0 113.019 -179.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 165.13 -68.72 0.2 Allowed Glycine 0 CA--C 1.531 1.059 0 C-N-CA 124.546 1.069 . . . . 0.0 113.838 178.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -111.88 17.01 20.14 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 125.054 1.341 . . . . 0.0 114.392 -174.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -60.98 175.36 0.52 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.349 1.859 . . . . 0.0 114.289 174.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . 0.562 ' HB3' HD11 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -125.14 174.83 7.8 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 126.986 2.114 . . . . 0.0 112.042 -178.6 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 5.5 ttt -115.21 132.9 56.46 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.172 1.389 . . . . 0.0 110.685 175.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -144.79 120.88 10.76 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 123.351 0.66 . . . . 0.0 110.293 177.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 2.7 mp -119.67 126.03 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 C-N-CA 125.125 1.37 . . . . 0.0 107.471 177.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -127.43 126.52 42.53 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 120.879 -1.138 . . . . 0.0 108.794 176.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.8 mp -78.1 124.9 37.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 175.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 2.1 m -95.83 168.01 10.91 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.882 1.673 . . . . 0.0 109.984 175.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 49.3 mtp85 . . . . . 0 C--O 1.253 1.254 0 C-N-CA 125.37 1.468 . . . . 0.0 111.856 176.708 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.678 HD12 ' H ' ' A' ' 74' ' ' GLY . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.338 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.475 ' HB1' ' HB3' ' A' ' 71' ' ' LEU . . . -119.42 125.25 48.52 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.669 1.988 . . . . 0.0 111.056 178.026 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -77.37 -147.74 2.87 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 125.036 1.303 . . . . 0.0 112.443 175.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 18.3 p -68.06 169.08 10.74 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.076 1.35 . . . . 0.0 112.867 176.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -128.89 21.0 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 126.131 1.772 . . . . 0.0 111.257 176.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.2 pt -57.07 171.92 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 O-C-N 120.276 -1.515 . . . . 0.0 112.798 176.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -44.12 131.63 5.89 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.734 1.614 . . . . 0.0 112.292 -177.102 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -54.79 -20.94 20.86 Favored Glycine 0 CA--C 1.54 1.651 0 C-N-CA 124.367 0.984 . . . . 0.0 114.303 -177.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.73 -36.25 78.39 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.732 1.613 . . . . 0.0 112.031 175.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.44 -40.2 8.39 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.302 1.441 . . . . 0.0 111.528 175.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.405 HD23 ' HB3' ' A' ' 69' ' ' ALA . 9.4 tp -71.78 87.32 0.97 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.663 1.185 . . . . 0.0 111.205 175.042 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 80.6 p -123.33 -177.9 3.84 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.741 2.016 . . . . 0.0 111.401 -176.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -45.49 -37.9 5.74 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.426 1.49 . . . . 0.0 113.985 176.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -59.66 -40.94 89.4 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.676 0.791 . . . . 0.0 111.958 178.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 85.6 t -70.66 -37.72 70.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 123.754 0.822 . . . . 0.0 111.055 174.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 32.2 mt -65.54 -41.17 93.34 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 120.971 -1.081 . . . . 0.0 111.32 177.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -75.06 -42.92 56.02 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.85 0.86 . . . . 0.0 112.815 -179.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.88 -37.86 88.57 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 118.764 0.711 . . . . 0.0 111.543 175.1 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.508 HG13 HD12 ' A' ' 25' ' ' LEU . 20.2 t -56.35 -46.85 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 124.922 1.289 . . . . 0.0 111.738 176.011 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 78.1 mt -56.27 -25.32 47.68 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 119.213 0.915 . . . . 0.0 112.887 175.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -86.3 -57.81 2.06 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 124.899 1.237 . . . . 0.0 113.202 176.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -66.47 -27.54 67.88 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -177.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.508 HD12 HG13 ' A' ' 21' ' ' VAL . 19.3 mt -108.18 88.05 2.64 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.33 1.452 . . . . 0.0 110.838 -175.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -125.34 85.24 0.35 Allowed Glycine 0 CA--C 1.533 1.193 0 C-N-CA 125.129 1.347 . . . . 0.0 115.302 -175.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -75.41 -43.01 52.26 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.096 0.959 . . . . 0.0 113.467 175.052 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.8 m -137.12 -177.12 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 126.351 1.86 . . . . 0.0 112.078 -174.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -46.65 -45.54 19.29 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 126.448 1.899 . . . . 0.0 114.289 179.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 17.4 mtt85 -139.02 149.12 44.29 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.768 1.627 . . . . 0.0 111.548 178.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.671 ' HB2' HD13 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -139.12 157.44 45.94 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 127.234 2.214 . . . . 0.0 110.632 -175.015 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.717 HG13 ' HB1' ' A' ' 85' ' ' ALA . 0.3 OUTLIER -118.2 128.33 75.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 125.14 1.376 . . . . 0.0 107.597 174.974 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -135.9 104.12 5.61 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.727 2.011 . . . . 0.0 109.335 176.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.728 HG22 ' HB2' ' A' ' 72' ' ' TYR . 2.1 m -107.46 158.64 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 123.753 0.821 . . . . 0.0 111.123 178.005 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -135.68 109.45 0.75 Allowed Glycine 0 N--CA 1.462 0.384 0 CA-C-N 118.293 0.497 . . . . 0.0 113.298 175.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.464 ' HB ' HD11 ' A' ' 70' ' ' LEU . 2.8 mp -101.73 132.35 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-N 117.108 0.454 . . . . 0.0 111.185 176.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -93.11 105.87 17.9 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.555 1.542 . . . . 0.0 110.972 177.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -71.62 100.69 2.34 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.223 1.809 . . . . 0.0 110.481 175.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -140.09 11.64 2.4 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.988 0.915 . . . . 0.0 112.522 175.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 12.7 t -57.89 -31.9 67.19 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.895 1.678 . . . . 0.0 114.027 179.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 124.82 53.93 0.18 Allowed Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.75 1.167 . . . . 0.0 115.148 174.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 152.5 171.4 20.0 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 125.442 1.496 . . . . 0.0 112.263 175.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.565 HG22 ' HA ' ' A' ' 65' ' ' PRO . 75.6 p -63.6 145.72 55.14 Favored 'General case' 0 N--CA 1.471 0.625 0 O-C-N 121.601 -0.941 . . . . 0.0 111.212 176.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.539 ' HA ' ' CE1' ' A' ' 91' ' ' TYR . 38.0 m0 -93.57 98.35 11.1 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 121.619 -0.676 . . . . 0.0 111.334 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.3 m -83.63 108.52 16.78 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.469 1.107 . . . . 0.0 108.776 176.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.9 142.85 52.85 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.842 -0.536 . . . . 0.0 112.405 175.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.2 pp -119.14 -52.37 2.3 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.048 0.939 . . . . 0.0 112.876 176.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -163.7 153.98 15.42 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.557 1.543 . . . . 0.0 110.72 174.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -131.6 152.37 50.86 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.83 0.852 . . . . 0.0 110.365 175.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -128.05 95.81 4.29 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.687 1.595 . . . . 0.0 110.007 -178.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.532 ' CZ ' HG21 ' A' ' 59' ' ' ILE . 1.5 m-85 -94.54 111.04 22.8 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.852 0.861 . . . . 0.0 110.34 176.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.54 -38.03 12.15 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.048 0.939 . . . . 0.0 111.949 -178.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.2 t -126.63 -173.82 2.97 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 128.415 2.686 . . . . 0.0 107.45 175.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 44.42 49.37 8.42 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-O 118.428 -1.207 . . . . 0.0 111.189 -179.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.9 p -44.8 145.21 0.97 Allowed 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 118.35 1.075 . . . . 0.0 112.8 -175.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.518 ' CG2' HD12 ' A' ' 59' ' ' ILE . 2.6 t -155.33 179.04 9.55 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.249 -0.907 . . . . 0.0 113.047 -175.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -98.71 -62.76 1.2 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.479 1.511 . . . . 0.0 112.208 178.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.0 p -129.4 131.54 67.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 125.232 1.413 . . . . 0.0 110.921 -177.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.532 HG21 ' CZ ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -137.22 -49.17 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 C-N-CA 125.071 1.348 . . . . 0.0 112.593 -175.117 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.404 ' HA ' ' HD2' ' A' ' 61' ' ' PRO . 4.3 mt -85.49 104.09 4.52 Favored Pre-proline 0 N--CA 1.449 -0.478 0 C-N-CA 124.313 1.045 . . . . 0.0 109.948 175.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 60' ' ' LEU . 56.6 Cg_endo -66.08 128.57 19.89 Favored 'Trans proline' 0 CA--C 1.535 0.547 0 C-N-CA 122.789 2.326 . . . . 0.0 110.366 175.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -35.29 -47.86 0.43 Allowed 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 127.474 2.31 . . . . 0.0 113.79 176.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 5.9 p -154.09 134.57 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 126.576 1.95 . . . . 0.0 109.424 174.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 95.5 t -122.17 133.58 24.41 Favored Pre-proline 0 N--CA 1.482 1.16 0 C-N-CA 124.986 1.314 . . . . 0.0 109.865 175.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.565 ' HA ' HG22 ' A' ' 43' ' ' THR . 58.0 Cg_endo -62.41 148.85 92.62 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.871 2.381 . . . . 0.0 113.209 175.043 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 13.1 p30 -67.83 170.19 8.46 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.206 1.002 . . . . 0.0 113.071 175.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 74.4 p 48.1 28.62 1.55 Allowed 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 127.109 2.164 . . . . 0.0 114.235 -175.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.51 -179.84 4.8 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 127.442 2.297 . . . . 0.0 110.817 -174.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.405 ' HB3' HD23 ' A' ' 13' ' ' LEU . . . -136.37 152.79 51.02 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 120.77 -1.206 . . . . 0.0 109.86 175.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.464 HD11 ' HB ' ' A' ' 36' ' ' ILE . 0.8 OUTLIER -117.88 172.51 7.34 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 124.642 1.177 . . . . 0.0 111.279 -178.407 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.537 HD13 ' O ' ' A' ' 34' ' ' VAL . 0.5 OUTLIER -129.05 151.85 49.3 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.133 1.373 . . . . 0.0 111.191 175.14 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.728 ' HB2' HG22 ' A' ' 34' ' ' VAL . 5.2 m-85 -127.2 133.54 50.25 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.395 1.078 . . . . 0.0 110.214 174.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.3 p -102.41 154.88 18.65 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 126.491 1.917 . . . . 0.0 111.36 175.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.678 ' H ' HD12 ' A' ' 3' ' ' LEU . . . -176.37 126.91 1.17 Allowed Glycine 0 CA--C 1.529 0.917 0 N-CA-C 114.269 0.468 . . . . 0.0 114.269 175.189 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 9.3 ptt180 -116.26 105.03 12.1 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.513 1.925 . . . . 0.0 112.751 -175.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.586 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 53.8 m . . . . . 0 N--CA 1.48 1.03 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -27.71 -77.61 0.01 OUTLIER Glycine 0 N--CA 1.477 1.381 0 C-N-CA 127.69 2.567 . . . . 0.0 116.177 -178.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.717 ' HB1' HG13 ' A' ' 32' ' ' ILE . . . -165.73 112.55 0.92 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.363 1.865 . . . . 0.0 110.599 -176.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.8 t -149.97 120.68 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 O-C-N 121.211 -0.931 . . . . 0.0 111.631 -177.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.513 ' HB3' ' CE2' ' A' ' 103' ' ' PHE . . . -162.03 173.39 14.47 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 122.67 1.224 . . . . 0.0 113.397 175.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -147.69 157.38 43.52 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.686 1.594 . . . . 0.0 110.755 174.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.449 ' CD2' ' CE2' ' A' ' 72' ' ' TYR . 49.0 p90 -158.05 172.1 19.04 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 124.41 1.084 . . . . 0.0 110.858 175.174 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.76 147.82 31.31 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 175.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.539 ' CE1' ' HA ' ' A' ' 44' ' ' TRP . 0.1 OUTLIER -114.54 126.98 55.55 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 126.309 1.844 . . . . 0.0 109.726 -178.281 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -82.83 108.23 16.02 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 123.518 0.727 . . . . 0.0 111.768 178.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.416 ' HE2' HG21 ' A' ' 120' ' ' ILE . 0.5 OUTLIER -79.91 137.8 36.98 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.441 1.096 . . . . 0.0 111.603 -174.998 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.9 t -59.44 -22.63 61.77 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.791 0.837 . . . . 0.0 113.206 177.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 28.3 m-80 -69.23 -1.79 8.89 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 125.69 1.596 . . . . 0.0 113.529 174.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 89.75 16.33 56.7 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 125.066 1.317 . . . . 0.0 113.894 -179.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 23.6 m-20 -116.47 177.32 4.74 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.878 1.671 . . . . 0.0 111.07 -176.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.2 m -131.66 117.51 18.77 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 121.473 -0.767 . . . . 0.0 112.007 175.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 13.5 tp -80.09 97.53 6.88 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 175.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -91.21 135.76 12.98 Favored Glycine 0 CA--C 1.532 1.126 0 O-C-N 121.347 -0.845 . . . . 0.0 112.067 176.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 74.3 t -122.46 133.87 67.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 126.951 2.1 . . . . 0.0 111.61 -174.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -137.78 128.36 26.68 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 126.009 1.724 . . . . 0.0 111.01 -176.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.513 ' CE2' ' HB3' ' A' ' 87' ' ' ALA . 3.6 p90 -145.77 121.83 10.75 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.873 1.269 . . . . 0.0 112.312 -175.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 19.3 m -139.07 110.8 7.14 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.878 1.271 . . . . 0.0 112.064 -175.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.7 m . . . . . 0 N--CA 1.479 1.021 0 N-CA-C 112.654 0.612 . . . . 0.0 112.654 -179.091 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 2.1 m . . . . . 0 N--CA 1.475 0.796 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -79.89 107.41 12.65 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.18 0.992 . . . . 0.0 110.272 174.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 31.2 m0 -112.03 141.82 45.23 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 55.6 p-90 -146.82 130.73 17.15 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 123.864 0.865 . . . . 0.0 112.007 -174.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -132.49 144.46 50.46 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 122.81 1.291 . . . . 0.0 112.192 179.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.419 ' HB ' ' CE ' ' A' ' 158' ' ' MET . 79.6 t -151.17 131.5 3.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 175.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.86 165.99 13.68 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 125.161 1.384 . . . . 0.0 110.505 175.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.416 HG21 ' HE2' ' A' ' 93' ' ' MET . 14.3 mt -86.24 148.51 4.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 175.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -110.38 142.63 26.43 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 126.771 2.028 . . . . 0.0 109.519 -178.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -74.77 87.24 1.31 Allowed 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 124.319 3.346 . . . . 0.0 111.547 -177.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.53 -174.97 19.96 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 125.112 1.339 . . . . 0.0 113.201 -174.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 2.3 tttt -69.73 105.81 2.87 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.234 1.414 . . . . 0.0 110.714 177.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 17.4 tpp180 -135.45 101.18 4.73 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.241 1.417 . . . . 0.0 111.451 178.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.8 168.58 1.2 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.711 0.804 . . . . 0.0 112.954 175.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -111.06 101.73 10.25 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.784 1.234 . . . . 0.0 107.882 177.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -113.23 171.17 7.71 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.794 1.238 . . . . 0.0 109.848 174.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -50.24 -36.61 31.81 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.006 -1.059 . . . . 0.0 112.775 175.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -60.02 -61.6 6.98 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 124.087 0.851 . . . . 0.0 111.634 174.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.48 -34.63 74.32 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 118.43 1.115 . . . . 0.0 112.324 178.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -58.4 -66.2 0.53 Allowed 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.866 0.866 . . . . 0.0 109.277 174.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -67.67 -30.89 70.54 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -175.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -63.88 -54.4 35.44 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.976 1.31 . . . . 0.0 112.142 175.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 51.8 mmm -75.13 -24.14 57.95 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.159 -0.963 . . . . 0.0 113.266 178.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -55.68 -56.58 18.78 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.383 1.473 . . . . 0.0 108.903 174.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -66.91 -23.11 65.95 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -75.3 -19.09 79.81 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 125.868 1.699 . . . . 0.0 115.212 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -132.56 83.64 53.36 Favored Pre-proline 0 CA--C 1.549 0.942 0 CA-C-N 119.024 1.412 . . . . 0.0 111.102 175.03 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -72.97 72.63 3.23 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 124.239 3.293 . . . . 0.0 112.1 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -96.64 112.01 23.93 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 121.372 -0.83 . . . . 0.0 110.551 -175.031 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 10.0 mtm180 -113.41 -3.45 13.75 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 115.467 1.655 . . . . 0.0 115.467 176.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -50.43 152.15 4.55 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 125.159 1.361 . . . . 0.0 114.427 177.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 10.4 p30 -119.35 -155.75 0.63 Allowed 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 -175.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -49.52 114.28 1.01 Allowed 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.79 1.636 . . . . 0.0 113.027 -178.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 152.8 24.79 0.05 OUTLIER Glycine 0 CA--C 1.535 1.342 0 N-CA-C 115.425 0.93 . . . . 0.0 115.425 -175.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 3.4 m95 49.6 47.57 22.56 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.545 1.538 . . . . 0.0 113.393 -175.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -66.9 109.57 2.98 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 126.999 2.12 . . . . 0.0 112.787 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -158.65 -169.01 2.58 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 175.006 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.4 mtmt -134.86 172.32 13.15 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 127.564 2.346 . . . . 0.0 110.277 -179.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -71.1 160.62 32.55 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.042 0.537 . . . . 0.0 109.898 174.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 10.3 mt -118.7 155.48 30.98 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 122.385 1.088 . . . . 0.0 110.659 175.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -62.46 -175.45 2.48 Favored Glycine 0 CA--C 1.537 1.415 0 CA-C-N 114.92 -1.036 . . . . 0.0 111.17 175.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 55.82 12.05 0.8 Allowed 'General case' 0 N--CA 1.482 1.141 0 O-C-N 121.055 -1.262 . . . . 0.0 114.127 178.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 79.41 24.33 61.16 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 125.576 1.56 . . . . 0.0 114.079 -174.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 52.7 mt -103.94 176.66 5.08 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 118.699 1.249 . . . . 0.0 111.534 -175.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -145.85 131.6 18.99 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 120.862 -1.149 . . . . 0.0 110.598 177.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . 0.419 ' CE ' ' HB ' ' A' ' 118' ' ' VAL . 2.9 ttt -106.32 150.94 25.47 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 119.892 -1.755 . . . . 0.0 107.154 175.06 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 1.9 tppt? -126.54 136.96 53.25 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 126.236 1.814 . . . . 0.0 108.834 175.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -147.95 157.79 27.47 Favored Glycine 0 N--CA 1.463 0.477 0 O-C-N 121.152 -0.968 . . . . 0.0 112.733 -178.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -158.21 128.34 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 122.137 0.97 . . . . 0.0 110.334 -179.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -155.23 117.68 4.23 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.708 1.603 . . . . 0.0 110.088 174.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 8.6 t -103.4 151.57 22.62 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 175.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 8.4 t -105.87 36.73 2.45 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.623 1.169 . . . . 0.0 111.384 -177.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -72.29 23.73 0.05 Allowed 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 127.795 2.438 . . . . 0.0 114.565 -178.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 80.83 -61.65 4.5 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 126.239 1.875 . . . . 0.0 113.015 -177.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -114.58 84.03 1.99 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 126.152 1.781 . . . . 0.0 109.992 177.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -136.7 163.93 29.43 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.318 1.847 . . . . 0.0 111.872 177.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.62 177.72 4.54 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 127.772 2.429 . . . . 0.0 111.523 -177.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . 0.475 ' SD ' HD13 ' A' ' 172' ' ' ILE . 1.5 tmt? -121.97 131.07 53.82 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.864 1.266 . . . . 0.0 111.218 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.499 ' C ' HD12 ' A' ' 172' ' ' ILE . 5.7 tt0 -143.26 124.01 14.18 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.43 0.692 . . . . 0.0 111.739 179.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.499 HD12 ' C ' ' A' ' 171' ' ' GLN . 1.9 mp -128.78 130.95 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 125.805 1.642 . . . . 0.0 108.57 178.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 1.9 tmmm? -130.67 129.16 42.27 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 126.069 1.748 . . . . 0.0 108.993 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.7 mp -83.89 133.4 29.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 174.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 87.4 p -116.79 161.75 18.77 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.932 1.693 . . . . 0.0 112.45 176.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 19.0 mtp180 . . . . . 0 C--O 1.253 1.269 0 O-C-N 120.315 -1.49 . . . . 0.0 111.825 -175.307 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.61 HD12 ' H ' ' A' ' 74' ' ' GLY . 1.9 mt . . . . . 0 N--CA 1.484 1.231 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.537 ' HA ' HD12 ' A' ' 71' ' ' LEU . . . -99.42 114.02 26.7 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 127.404 2.282 . . . . 0.0 109.14 178.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -63.3 -89.12 0.03 OUTLIER Glycine 0 CA--C 1.535 1.295 0 C-N-CA 124.243 0.925 . . . . 0.0 113.934 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 17.2 p -143.85 174.47 10.8 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.86 1.664 . . . . 0.0 111.452 -175.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -124.95 15.2 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 125.38 1.472 . . . . 0.0 112.011 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.5 pt -50.11 156.73 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 124.481 1.112 . . . . 0.0 110.976 174.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -40.06 140.27 0.59 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.896 1.678 . . . . 0.0 112.695 -176.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -53.42 -24.2 22.35 Favored Glycine 0 CA--C 1.543 1.798 0 C-N-CA 124.028 0.823 . . . . 0.0 113.982 -174.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.24 -32.69 72.49 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.662 1.585 . . . . 0.0 112.618 175.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -93.41 -50.93 5.21 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 125.886 1.674 . . . . 0.0 110.911 175.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.2 tp -71.05 91.2 0.88 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.537 1.135 . . . . 0.0 111.086 177.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 62.5 p -126.68 -178.54 4.41 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.376 1.87 . . . . 0.0 111.6 -178.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -53.97 -37.65 64.17 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.512 1.125 . . . . 0.0 113.077 178.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -58.91 -46.76 87.16 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.372 0.669 . . . . 0.0 110.961 175.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 81.6 t -61.63 -43.66 97.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.669 1.188 . . . . 0.0 111.339 175.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 96.7 mt -64.6 -43.45 93.74 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 121.267 -0.895 . . . . 0.0 111.987 178.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -69.36 -42.37 75.32 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.275 0.63 . . . . 0.0 112.243 -179.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.01 -36.35 83.04 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 118.791 0.723 . . . . 0.0 111.716 175.008 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.2 t -56.17 -41.43 69.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 124.013 0.925 . . . . 0.0 110.923 179.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.417 HD22 ' HE3' ' A' ' 31' ' ' LYS . 41.0 mt -55.18 -20.23 9.94 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 175.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -92.71 -59.68 1.25 Allowed Glycine 0 CA--C 1.534 1.245 0 C-N-CA 125.246 1.403 . . . . 0.0 112.722 175.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -68.45 -29.41 68.06 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 -176.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -109.05 118.14 36.01 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 126.605 1.962 . . . . 0.0 109.365 -179.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -160.87 117.5 0.77 Allowed Glycine 0 CA--C 1.542 1.762 0 C-N-CA 125.701 1.619 . . . . 0.0 114.732 -175.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.543 ' HB2' HD21 ' A' ' 3' ' ' LEU . 9.1 mttm -87.54 -57.92 2.77 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 126.882 2.073 . . . . 0.0 112.988 176.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.3 m -132.36 -172.36 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 127.143 2.177 . . . . 0.0 112.066 -174.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.2 t -50.48 -37.15 37.11 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.778 1.631 . . . . 0.0 114.081 -175.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.5 tpt180 -130.28 144.93 51.66 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.129 1.372 . . . . 0.0 109.581 174.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.456 ' CB ' HD22 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -144.82 133.94 22.77 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 125.707 1.603 . . . . 0.0 110.357 -175.067 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -103.84 131.31 52.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 124.054 0.942 . . . . 0.0 108.882 175.028 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -130.11 105.61 8.06 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.501 1.92 . . . . 0.0 109.901 175.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.681 HG22 ' HB2' ' A' ' 72' ' ' TYR . 1.2 m -108.19 162.89 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 C-N-CA 123.979 0.912 . . . . 0.0 110.747 176.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -135.02 109.15 0.75 Allowed Glycine 0 C--O 1.228 -0.251 0 C-N-CA 123.275 0.465 . . . . 0.0 112.603 175.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.3 mp -92.35 133.86 32.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 174.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -109.31 99.63 8.86 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.436 1.894 . . . . 0.0 110.342 178.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -73.43 112.13 9.21 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.98 1.712 . . . . 0.0 112.199 175.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -140.06 18.68 2.45 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.785 0.834 . . . . 0.0 112.005 174.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 44.1 t -64.61 -39.06 93.04 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 120.889 -1.132 . . . . 0.0 113.15 -178.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 119.97 63.01 0.26 Allowed Glycine 0 CA--C 1.53 0.99 0 C-N-CA 124.805 1.193 . . . . 0.0 112.715 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 157.15 161.13 10.58 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 125.674 1.606 . . . . 0.0 112.444 176.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.61 HG22 ' HA ' ' A' ' 65' ' ' PRO . 71.5 p -67.82 148.47 51.17 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 121.784 -0.833 . . . . 0.0 111.732 175.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.562 ' HA ' ' CE1' ' A' ' 91' ' ' TYR . 35.3 m0 -103.72 98.25 8.14 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.415 1.086 . . . . 0.0 111.866 -177.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 35.9 m -84.24 116.66 23.07 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 125.07 1.348 . . . . 0.0 109.86 177.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.496 ' HB1' HD23 ' A' ' 60' ' ' LEU . . . -64.02 141.84 58.62 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 121.686 -0.634 . . . . 0.0 111.647 174.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.534 HD12 ' HB3' ' A' ' 48' ' ' ASN . 3.0 pp -114.31 -48.41 2.88 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.153 0.981 . . . . 0.0 112.587 177.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.534 ' HB3' HD12 ' A' ' 47' ' ' LEU . 2.4 t30 -170.19 148.88 3.39 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.964 2.106 . . . . 0.0 109.53 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.48 ' HB2' HD22 ' A' ' 60' ' ' LEU . . . -125.98 147.59 49.49 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.151 1.38 . . . . 0.0 109.803 174.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -124.52 101.61 7.22 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 125.344 1.458 . . . . 0.0 109.629 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.478 ' CD1' ' HB1' ' A' ' 87' ' ' ALA . 3.1 m-85 -105.13 133.53 49.75 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.586 -0.696 . . . . 0.0 110.427 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -107.07 -68.45 0.89 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.334 1.453 . . . . 0.0 111.244 -177.17 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.9 t -102.6 -38.92 7.3 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.671 1.588 . . . . 0.0 110.056 -179.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -69.44 7.7 3.49 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 125.482 1.515 . . . . 0.0 114.338 -178.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 53.4 p -33.2 123.25 0.4 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 128.151 2.581 . . . . 0.0 113.532 -175.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.478 HG21 HG23 ' A' ' 59' ' ' ILE . 1.9 t -138.35 177.96 7.49 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.175 0.99 . . . . 0.0 112.754 -174.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -77.37 -60.81 2.21 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.764 1.226 . . . . 0.0 112.538 177.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.8 p -141.57 138.27 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 126.161 1.784 . . . . 0.0 111.348 176.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.478 HG23 HG21 ' A' ' 56' ' ' THR . 1.1 pp -144.58 -34.2 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 126.114 1.765 . . . . 0.0 113.793 -177.317 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.496 HD23 ' HB1' ' A' ' 46' ' ' ALA . 1.1 mp -95.13 98.19 3.19 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 125.154 1.382 . . . . 0.0 109.681 176.067 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -66.83 151.87 81.54 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.749 2.299 . . . . 0.0 110.332 175.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -50.04 -50.25 48.23 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.686 0.794 . . . . 0.0 112.893 -177.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 60.0 t -150.14 142.15 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 128.296 2.638 . . . . 0.0 108.691 178.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.555 HG21 HD13 ' A' ' 70' ' ' LEU . 98.9 t -120.64 133.97 24.15 Favored Pre-proline 0 N--CA 1.477 0.893 0 C-N-CA 124.742 1.217 . . . . 0.0 109.117 175.017 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.61 ' HA ' HG22 ' A' ' 43' ' ' THR . 55.7 Cg_endo -65.06 154.58 72.73 Favored 'Trans proline' 0 CA--C 1.544 1.014 0 C-N-CA 122.707 2.271 . . . . 0.0 113.565 177.482 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -70.23 160.24 32.54 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.566 1.146 . . . . 0.0 113.273 175.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 40.9 p 52.7 23.78 2.87 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 126.314 1.846 . . . . 0.0 114.405 -175.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 18.6 mttt -119.48 -172.81 2.39 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 126.087 1.755 . . . . 0.0 111.31 -177.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -143.9 157.94 44.02 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 122.068 -0.395 . . . . 0.0 109.997 179.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.555 HD13 HG21 ' A' ' 64' ' ' VAL . 2.4 pt? -134.81 167.21 21.29 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 124.58 1.152 . . . . 0.0 111.689 177.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.541 HD13 ' O ' ' A' ' 34' ' ' VAL . 0.6 OUTLIER -114.0 154.85 26.94 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 125.121 1.369 . . . . 0.0 111.849 -179.118 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.681 ' HB2' HG22 ' A' ' 34' ' ' VAL . 29.0 m-85 -129.19 137.82 51.37 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.356 1.062 . . . . 0.0 110.764 175.079 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 8.7 p -111.93 144.04 41.9 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 126.86 2.064 . . . . 0.0 110.241 174.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.61 ' H ' HD12 ' A' ' 3' ' ' LEU . . . -165.63 133.69 3.05 Favored Glycine 0 CA--C 1.523 0.592 0 CA-C-O 121.388 0.438 . . . . 0.0 113.119 175.004 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 66.3 mtm180 -90.62 172.14 8.89 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.343 1.457 . . . . 0.0 110.617 -175.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.587 0 O-C-N 121.823 -0.548 . . . . 0.0 109.824 174.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 87.7 m . . . . . 0 N--CA 1.471 0.59 0 N-CA-C 110.598 -0.149 . . . . 0.0 110.598 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -57.34 -76.06 0.22 Allowed Glycine 0 CA--C 1.532 1.141 0 C-N-CA 125.726 1.631 . . . . 0.0 114.644 -174.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -162.24 104.96 1.13 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.377 1.071 . . . . 0.0 111.376 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 41.8 t -127.67 114.58 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 O-C-N 121.086 -1.009 . . . . 0.0 109.891 -177.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.529 ' HB3' ' CE2' ' A' ' 103' ' ' PHE . . . -157.26 169.45 24.72 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 122.693 1.235 . . . . 0.0 112.061 179.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -150.88 161.38 42.8 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.828 1.651 . . . . 0.0 109.563 175.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -159.97 176.47 11.82 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 121.093 -1.004 . . . . 0.0 111.342 175.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.03 156.47 43.5 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.666 0.746 . . . . 0.0 112.556 174.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.562 ' CE1' ' HA ' ' A' ' 44' ' ' TRP . 0.1 OUTLIER -119.94 127.5 52.72 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.697 1.999 . . . . 0.0 109.184 -178.81 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -83.45 105.59 14.51 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.494 0.718 . . . . 0.0 111.911 178.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -75.37 137.59 41.17 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.576 1.151 . . . . 0.0 112.009 -175.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.3 m -59.95 -17.31 36.86 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 113.583 0.956 . . . . 0.0 113.583 175.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -74.32 -2.53 25.56 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 125.142 1.377 . . . . 0.0 112.532 174.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.41 14.89 58.0 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 125.352 1.453 . . . . 0.0 114.168 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -117.25 178.18 4.46 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.504 1.522 . . . . 0.0 110.655 -177.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.416 HG21 ' O ' ' A' ' 125' ' ' ARG . 16.3 m -130.29 114.01 15.1 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 120.998 -1.064 . . . . 0.0 111.839 178.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 32.5 tp -78.99 98.77 6.57 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.391 0.996 . . . . 0.0 109.383 174.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.6 139.33 15.08 Favored Glycine 0 CA--C 1.532 1.154 0 O-C-N 121.075 -1.016 . . . . 0.0 112.294 175.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 60.9 t -122.55 134.21 66.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 128.174 2.589 . . . . 0.0 112.002 -175.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -131.75 125.39 31.85 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 126.163 1.785 . . . . 0.0 111.779 -175.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.529 ' CE2' ' HB3' ' A' ' 87' ' ' ALA . 10.8 p90 -146.03 116.04 7.37 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.362 1.065 . . . . 0.0 113.521 -177.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 72.3 m -123.36 122.26 37.87 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.397 1.479 . . . . 0.0 111.719 -177.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 47.4 t . . . . . 0 N--CA 1.469 0.506 0 C-N-CA 126.124 1.77 . . . . 0.0 108.873 -179.861 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 67.8 m . . . . . 0 N--CA 1.471 0.609 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -84.11 106.67 15.93 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.965 1.306 . . . . 0.0 109.081 174.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . 0.414 ' CG ' ' HA ' ' A' ' 140' ' ' PRO . 53.5 m0 -110.73 155.83 21.92 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.398 0.999 . . . . 0.0 108.912 174.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 58.1 p-90 -154.32 132.93 12.12 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.132 0.973 . . . . 0.0 111.214 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -135.94 154.97 50.95 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 122.84 1.305 . . . . 0.0 112.097 178.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 95.1 t -152.6 135.2 6.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 175.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.03 170.68 11.78 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.943 1.697 . . . . 0.0 110.014 175.026 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 20.5 mt -91.29 154.1 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 CA-C-O 121.507 0.67 . . . . 0.0 109.312 179.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -117.77 144.04 33.66 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 125.296 1.438 . . . . 0.0 109.64 178.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -70.96 108.11 2.24 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 123.891 3.06 . . . . 0.0 111.301 -178.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 83.61 -178.55 52.48 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 124.447 1.022 . . . . 0.0 113.711 -175.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 14.2 tttt -63.61 104.58 0.67 Allowed 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.911 1.285 . . . . 0.0 110.659 175.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.416 ' O ' HG21 ' A' ' 98' ' ' THR . 19.6 tpp180 -132.34 101.47 5.37 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.82 1.248 . . . . 0.0 111.29 -175.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.7 163.33 1.9 Allowed 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.852 0.834 . . . . 0.0 111.754 174.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -109.64 105.1 14.24 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 106.565 -1.642 . . . . 0.0 106.565 174.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -112.32 173.9 6.14 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.029 1.332 . . . . 0.0 109.86 175.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -50.57 -40.27 51.72 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 119.276 0.944 . . . . 0.0 113.282 176.119 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -58.28 -62.01 6.77 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 123.659 0.647 . . . . 0.0 111.717 175.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 5.3 mpp? -58.44 -39.33 79.53 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 118.134 0.967 . . . . 0.0 112.742 177.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -55.14 -60.87 2.79 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.397 1.079 . . . . 0.0 109.962 175.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -68.25 -33.29 74.11 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -178.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -61.1 -46.81 89.08 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.079 0.951 . . . . 0.0 111.599 176.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 46.6 mmm -84.88 -22.65 29.26 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -178.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -54.1 -55.54 26.63 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.765 1.626 . . . . 0.0 109.844 175.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -69.53 -16.49 63.44 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 179.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -74.29 -24.84 72.26 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 125.841 1.686 . . . . 0.0 114.333 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -135.74 87.98 24.47 Favored Pre-proline 0 CA--C 1.546 0.796 0 CA-C-N 118.721 1.26 . . . . 0.0 112.607 175.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.414 ' HA ' ' CG ' ' A' ' 115' ' ' TRP . 95.5 Cg_endo -74.19 76.68 2.99 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 123.752 2.968 . . . . 0.0 112.773 -178.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -104.29 105.32 15.42 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.991 0.916 . . . . 0.0 111.316 179.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 23.2 mtm105 -91.0 74.43 6.38 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.268 1.427 . . . . 0.0 111.472 174.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 31.37 64.79 0.2 Allowed Glycine 0 CA--C 1.534 1.242 0 C-N-CA 125.613 1.577 . . . . 0.0 112.948 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -71.86 93.92 1.37 Allowed 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 122.284 1.04 . . . . 0.0 110.153 -175.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 -54.76 98.94 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 126.934 2.093 . . . . 0.0 114.373 -175.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . 0.475 ' H ' HD13 ' A' ' 161' ' ' ILE . . . 146.7 54.6 0.02 OUTLIER Glycine 0 CA--C 1.535 1.335 0 C-N-CA 125.431 1.491 . . . . 0.0 114.38 177.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 5.0 m95 44.12 50.08 7.49 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.796 1.638 . . . . 0.0 114.129 -176.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -81.39 131.68 35.29 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 121.149 -0.97 . . . . 0.0 112.476 -177.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . 0.588 ' NE2' ' H ' ' A' ' 150' ' ' LYS . 0.0 OUTLIER -167.77 -169.59 1.2 Allowed 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.845 178.92 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.588 ' H ' ' NE2' ' A' ' 149' ' ' GLN . 0.0 OUTLIER -123.83 160.52 27.22 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.701 2.001 . . . . 0.0 111.851 175.33 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -87.87 127.9 35.35 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.631 1.173 . . . . 0.0 108.217 174.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 12.8 mt -73.41 112.23 9.28 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.191 0.996 . . . . 0.0 112.052 -174.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -43.76 -46.16 7.41 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 127.349 2.404 . . . . 0.0 117.769 -175.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.411 ' CD1' ' N ' ' A' ' 154' ' ' TYR . 0.0 OUTLIER -51.77 -33.74 36.54 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 127.378 2.271 . . . . 0.0 113.658 178.162 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 132.17 40.88 0.2 Allowed Glycine 0 CA--C 1.533 1.215 0 C-N-CA 125.459 1.504 . . . . 0.0 113.896 -178.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 4.8 mp -134.56 179.46 6.27 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.605 1.562 . . . . 0.0 110.874 178.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 5.8 mtt180 -136.88 142.11 42.77 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.709 1.204 . . . . 0.0 109.028 174.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 3.5 ttt -134.75 145.57 48.56 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 121.076 -1.015 . . . . 0.0 108.692 175.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 4.9 tptt -124.59 147.93 48.17 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 127.12 2.168 . . . . 0.0 111.172 178.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -150.24 147.81 18.37 Favored Glycine 0 CA--C 1.528 0.848 0 O-C-N 121.458 -0.776 . . . . 0.0 112.872 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.475 HD13 ' H ' ' A' ' 146' ' ' GLY . 4.8 tp -146.59 124.94 4.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 124.943 1.297 . . . . 0.0 110.42 179.281 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -151.32 156.01 39.9 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.933 2.093 . . . . 0.0 107.412 174.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . 0.496 HG23 ' HB3' ' A' ' 168' ' ' ALA . 0.1 OUTLIER -150.51 132.42 15.12 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.199 1.4 . . . . 0.0 107.923 174.952 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -105.5 32.75 4.08 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.342 1.057 . . . . 0.0 112.127 -176.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -116.3 -71.42 0.74 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.341 1.056 . . . . 0.0 112.583 -175.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -77.29 14.07 9.27 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 125.974 1.749 . . . . 0.0 111.384 175.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 56.28 56.14 6.05 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 127.551 2.34 . . . . 0.0 112.063 176.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.496 ' HB3' HG23 ' A' ' 163' ' ' THR . . . -78.54 -170.71 2.18 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 113.779 -1.555 . . . . 0.0 112.857 178.087 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . 0.402 ' H ' ' HD3' ' A' ' 169' ' ' LYS . 0.0 OUTLIER -116.3 165.97 12.58 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 128.665 2.786 . . . . 0.0 111.435 -178.571 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 17.9 ttp -95.59 136.88 35.42 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.732 1.213 . . . . 0.0 111.527 179.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -144.82 119.27 9.65 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.251 1.02 . . . . 0.0 110.329 176.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 1.9 mp -114.31 120.79 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 124.905 1.282 . . . . 0.0 108.158 175.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.435 ' HE2' ' O ' ' A' ' 174' ' ' ILE . 0.0 OUTLIER -121.54 127.31 50.85 Favored 'General case' 0 CA--C 1.51 -0.574 0 C-N-CA 126.447 1.899 . . . . 0.0 108.88 -179.224 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.435 ' O ' ' HE2' ' A' ' 173' ' ' LYS . 1.3 mp -79.0 117.83 25.31 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 O-C-N 121.141 -0.975 . . . . 0.0 111.957 177.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 6.1 t -84.67 172.63 11.39 Favored 'General case' 0 N--CA 1.479 1.005 0 O-C-N 120.864 -1.147 . . . . 0.0 109.88 175.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 1.1 mtt-85 . . . . . 0 C--O 1.251 1.147 0 O-C-N 120.432 -1.417 . . . . 0.0 114.418 174.942 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.739 HD12 ' H ' ' A' ' 74' ' ' GLY . 2.2 mt . . . . . 0 N--CA 1.48 1.064 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -116.29 130.07 56.59 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 127.366 2.266 . . . . 0.0 110.361 -176.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -85.65 -96.04 0.76 Allowed Glycine 0 CA--C 1.531 1.087 0 C-N-CA 123.929 0.776 . . . . 0.0 112.865 -178.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 36.1 p -120.93 170.02 9.89 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.965 1.706 . . . . 0.0 111.764 -179.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -129.65 18.68 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 125.928 1.691 . . . . 0.0 111.712 177.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 pt -56.9 171.62 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 O-C-N 120.367 -1.458 . . . . 0.0 112.258 176.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -43.02 126.96 4.06 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.331 1.452 . . . . 0.0 113.335 -174.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -54.5 -23.3 27.12 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 125.229 1.395 . . . . 0.0 114.292 -177.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.14 -29.06 70.08 Favored 'General case' 0 CA--C 1.548 0.894 0 O-C-N 121.678 -0.895 . . . . 0.0 111.99 175.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.0 t -101.99 -40.11 7.02 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.956 1.702 . . . . 0.0 112.064 175.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 12.8 tp -73.44 90.11 1.69 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.265 1.026 . . . . 0.0 110.567 175.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.9 p -125.9 -178.95 4.46 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.918 2.087 . . . . 0.0 111.634 178.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -48.26 -38.82 19.62 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.801 1.641 . . . . 0.0 113.289 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -55.06 -40.53 70.4 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 118.685 0.675 . . . . 0.0 112.497 176.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.416 ' O ' HG23 ' A' ' 21' ' ' VAL . 96.2 t -70.05 -39.77 77.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.301 1.44 . . . . 0.0 110.804 174.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 28.1 mt -65.49 -43.75 89.2 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.166 -0.959 . . . . 0.0 111.419 179.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.408 ' HA ' HD12 ' A' ' 22' ' ' LEU . 24.7 t0 -57.22 -51.41 69.44 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.222 1.409 . . . . 0.0 110.716 178.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.76 -36.86 84.76 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 118.03 -0.986 . . . . 0.0 112.846 175.007 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 17' ' ' VAL . 17.7 t -55.42 -47.07 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 CA-C-N 119.864 1.211 . . . . 0.0 110.996 -179.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.581 HD11 ' HB3' ' A' ' 169' ' ' LYS . 1.9 mt -55.63 -24.66 34.68 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.067 0.947 . . . . 0.0 113.069 177.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -88.2 -61.66 1.47 Allowed Glycine 0 CA--C 1.532 1.097 0 C-N-CA 125.986 1.755 . . . . 0.0 112.633 176.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -62.87 -39.08 93.33 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 118.533 1.167 . . . . 0.0 113.768 -178.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -90.41 1.18 56.87 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.872 1.269 . . . . 0.0 112.124 175.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -52.91 96.9 0.02 OUTLIER Glycine 0 CA--C 1.537 1.455 0 C-N-CA 127.047 2.261 . . . . 0.0 114.366 178.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -87.3 -79.93 0.27 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.596 1.558 . . . . 0.0 111.947 178.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 23.8 m -87.51 173.07 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.564 1.546 . . . . 0.0 111.793 -177.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 58.0 m -63.29 -26.65 68.87 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 175.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.04 96.49 4.06 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.421 1.088 . . . . 0.0 112.236 176.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.415 ' HE2' ' HB3' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -111.32 155.04 23.66 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 128.551 2.74 . . . . 0.0 111.558 -179.71 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -128.21 133.01 67.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 126.328 1.851 . . . . 0.0 108.689 174.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.59 105.69 5.71 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.13 1.772 . . . . 0.0 109.357 175.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.727 HG22 ' HB2' ' A' ' 72' ' ' TYR . 2.0 m -111.28 151.58 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 123.203 0.601 . . . . 0.0 111.13 179.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -123.97 111.68 1.68 Allowed Glycine 0 CA--C 1.523 0.567 0 C-N-CA 124.088 0.851 . . . . 0.0 112.912 179.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.5 mp -104.59 134.55 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-N 119.018 1.409 . . . . 0.0 110.981 176.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -102.06 102.47 12.97 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 124.714 1.206 . . . . 0.0 110.51 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.9 t30 -73.73 92.47 2.0 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.963 1.305 . . . . 0.0 110.825 175.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -121.29 13.05 11.06 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.723 1.209 . . . . 0.0 112.212 175.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.8 t -61.81 -42.3 98.85 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.932 1.693 . . . . 0.0 113.87 -176.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 130.88 32.48 0.51 Allowed Glycine 0 CA--C 1.533 1.173 0 N-CA-C 115.11 0.804 . . . . 0.0 115.11 178.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -178.09 162.19 29.58 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 118.061 0.931 . . . . 0.0 112.852 175.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.716 HG22 ' HA ' ' A' ' 65' ' ' PRO . 80.6 p -68.23 129.75 40.86 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 121.858 -0.789 . . . . 0.0 110.999 175.002 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 42.2 m0 -87.04 107.5 18.46 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 123.813 0.845 . . . . 0.0 110.07 179.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 92.9 m -91.44 128.72 37.38 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.206 1.002 . . . . 0.0 109.747 177.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.86 131.42 48.71 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 122.823 0.449 . . . . 0.0 111.513 174.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.453 HD11 ' HB3' ' A' ' 90' ' ' ALA . 2.9 pp -113.74 -52.03 2.77 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.729 1.211 . . . . 0.0 111.616 179.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -171.73 145.74 2.01 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.343 1.857 . . . . 0.0 110.419 179.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.512 ' HB2' HD12 ' A' ' 60' ' ' LEU . . . -125.09 164.32 20.47 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.721 1.208 . . . . 0.0 110.837 174.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -141.9 102.02 4.06 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.157 1.383 . . . . 0.0 111.778 179.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.567 ' CE1' ' HB1' ' A' ' 87' ' ' ALA . 3.3 m-85 -110.67 123.91 50.91 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.457 1.103 . . . . 0.0 110.211 -178.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.483 ' HD2' HE22 ' A' ' 129' ' ' GLN . 0.0 OUTLIER -114.77 -47.1 2.9 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -175.16 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.442 ' HB3' ' HB ' ' A' ' 86' ' ' VAL . 11.6 t -103.5 -48.14 4.06 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.135 1.374 . . . . 0.0 111.038 175.026 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -75.64 12.59 7.85 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 125.393 1.473 . . . . 0.0 114.564 -175.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 54.8 p -30.38 105.53 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 129.239 3.016 . . . . 0.0 113.961 -175.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.62 HG21 HG23 ' A' ' 59' ' ' ILE . 2.4 t -118.22 175.71 5.57 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.726 1.211 . . . . 0.0 112.171 -175.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -74.52 -55.45 5.93 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.516 1.126 . . . . 0.0 112.585 175.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.4 p -147.59 143.11 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 126.139 1.776 . . . . 0.0 110.893 175.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.62 HG23 HG21 ' A' ' 56' ' ' THR . 1.3 pp -143.21 -34.01 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 125.779 1.632 . . . . 0.0 113.947 179.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.539 ' H ' HD12 ' A' ' 59' ' ' ILE . 7.3 mt -89.66 98.11 1.21 Allowed Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 125.267 1.427 . . . . 0.0 109.135 175.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -66.03 148.62 85.83 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 123.887 3.058 . . . . 0.0 110.669 174.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -46.78 -51.15 17.0 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.834 1.254 . . . . 0.0 113.342 -177.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 63.2 t -149.31 139.88 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 128.026 2.531 . . . . 0.0 108.699 177.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.551 HG21 HD23 ' A' ' 70' ' ' LEU . 60.3 t -120.04 125.42 27.34 Favored Pre-proline 0 N--CA 1.473 0.683 0 C-N-CA 124.442 1.097 . . . . 0.0 108.457 175.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.716 ' HA ' HG22 ' A' ' 43' ' ' THR . 58.4 Cg_endo -64.45 151.64 84.75 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 121.934 1.756 . . . . 0.0 112.898 175.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -71.52 170.65 12.9 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.549 0.74 . . . . 0.0 109.254 174.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . 0.272 2.7 t 53.67 23.31 3.56 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.612 1.565 . . . . 0.0 113.817 -175.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.3 mttt -134.93 172.93 12.3 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.375 1.87 . . . . 0.0 111.645 -179.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -129.43 164.46 23.61 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 -178.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.551 HD23 HG21 ' A' ' 64' ' ' VAL . 3.2 pp -137.08 171.14 14.94 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 123.983 0.913 . . . . 0.0 111.078 -175.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.496 HD13 ' O ' ' A' ' 34' ' ' VAL . 0.8 OUTLIER -123.44 153.69 40.1 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.497 1.119 . . . . 0.0 111.035 177.033 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.727 ' HB2' HG22 ' A' ' 34' ' ' VAL . 5.8 m-85 -129.46 134.94 48.07 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 126.176 1.791 . . . . 0.0 109.377 176.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 59.6 p -107.7 153.87 22.3 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.145 1.778 . . . . 0.0 111.019 175.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.739 ' H ' HD12 ' A' ' 3' ' ' LEU . . . -176.8 131.93 1.94 Allowed Glycine 0 CA--C 1.518 0.257 0 O-C-N 121.196 -0.94 . . . . 0.0 113.017 175.312 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 9.2 ptt85 -129.46 155.16 46.17 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 125.767 1.627 . . . . 0.0 110.491 -175.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.9 ptpt . . . . . 0 CA--C 1.543 0.708 0 C-N-CA 125.509 1.524 . . . . 0.0 112.886 174.947 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 17.8 p . . . . . 0 CA--C 1.537 0.462 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -52.62 -81.38 0.06 OUTLIER Glycine 0 CA--C 1.537 1.411 0 C-N-CA 126.337 1.922 . . . . 0.0 114.021 -175.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -160.4 112.86 2.01 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.298 1.439 . . . . 0.0 111.077 175.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.442 ' HB ' ' HB3' ' A' ' 53' ' ' SER . 5.0 t -139.16 125.53 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.471 1.109 . . . . 0.0 110.665 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.567 ' HB1' ' CE1' ' A' ' 51' ' ' PHE . . . -161.57 165.62 28.18 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 122.701 1.239 . . . . 0.0 112.063 177.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -149.22 146.22 27.5 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 124.913 1.285 . . . . 0.0 108.99 174.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.507 ' CD2' ' CE2' ' A' ' 72' ' ' TYR . 48.8 p90 -144.02 172.72 12.49 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 121.236 -0.915 . . . . 0.0 110.03 176.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.453 ' HB3' HD11 ' A' ' 47' ' ' LEU . . . -138.43 149.04 45.08 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 175.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -125.41 140.15 53.04 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.632 1.173 . . . . 0.0 113.123 178.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -87.44 122.16 30.81 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.873 -175.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 31.8 mtm -101.73 128.14 48.19 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.495 1.118 . . . . 0.0 110.742 -176.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.4 t -56.26 -22.41 29.79 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.936 1.294 . . . . 0.0 113.493 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -67.05 -9.96 44.78 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 125.941 1.696 . . . . 0.0 113.154 175.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 101.52 28.3 6.78 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.754 1.645 . . . . 0.0 114.366 177.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.43 ' HA ' ' H ' ' A' ' 123' ' ' GLY . 29.0 m-80 -135.44 175.18 9.82 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.857 1.263 . . . . 0.0 112.558 -174.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.575 HG21 ' O ' ' A' ' 125' ' ' ARG . 38.3 m -130.31 108.69 10.2 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.353 1.061 . . . . 0.0 112.683 177.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.5 tt -69.89 94.24 0.82 Allowed 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 127.151 2.18 . . . . 0.0 111.999 177.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -87.21 96.18 2.14 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 125.568 1.556 . . . . 0.0 113.595 178.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.411 HG11 ' CZ ' ' A' ' 89' ' ' PHE . 55.5 t -78.07 138.59 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 124.718 1.207 . . . . 0.0 110.827 174.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.33 128.22 31.33 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.581 1.552 . . . . 0.0 110.303 179.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.531 ' CZ ' ' HB3' ' A' ' 87' ' ' ALA . 10.3 p90 -148.08 120.31 8.36 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.008 1.323 . . . . 0.0 111.465 -177.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 39.6 t -140.82 129.96 23.48 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.531 1.133 . . . . 0.0 110.22 -175.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.6 m . . . . . 0 N--CA 1.471 0.604 0 C-N-CA 124.147 0.979 . . . . 0.0 110.848 178.35 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.473 0.697 0 N-CA-C 110.357 -0.238 . . . . 0.0 110.357 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -132.95 82.61 2.01 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.25 1.42 . . . . 0.0 112.286 -177.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 21.1 m0 -92.67 162.26 14.23 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 121.441 -0.787 . . . . 0.0 111.843 -175.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 40.2 p-90 -160.53 132.38 5.96 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 121.561 -0.712 . . . . 0.0 111.24 -176.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -145.87 173.55 12.03 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 121.3 -0.875 . . . . 0.0 111.744 178.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 98.5 t -137.69 133.18 45.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 175.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.59 168.2 12.94 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 125.584 1.554 . . . . 0.0 110.244 175.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.693 HD11 HD13 ' A' ' 152' ' ' LEU . 32.3 mt -135.87 121.74 30.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 175.001 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -83.81 145.42 47.03 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 123.311 0.644 . . . . 0.0 111.289 178.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -76.23 83.74 1.96 Allowed 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 124.133 3.222 . . . . 0.0 111.929 179.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.43 ' H ' ' HA ' ' A' ' 97' ' ' ASN . . . 101.45 175.53 28.61 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 126.494 1.997 . . . . 0.0 112.811 -177.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 1.3 mttt -45.01 106.67 0.08 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 126.47 1.908 . . . . 0.0 112.737 -176.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.575 ' O ' HG21 ' A' ' 98' ' ' THR . 7.9 tpt180 -141.37 138.21 32.87 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.48 1.112 . . . . 0.0 113.402 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -80.4 173.69 12.35 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.722 0.809 . . . . 0.0 110.729 174.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -117.01 104.86 11.69 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.149 1.779 . . . . 0.0 107.028 175.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -108.0 169.94 8.3 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.385 1.074 . . . . 0.0 111.831 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.483 HE22 ' HD2' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -53.38 -45.83 69.39 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.535 0.734 . . . . 0.0 112.827 177.567 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -54.58 -56.05 24.1 Favored Glycine 0 N--CA 1.469 0.836 0 CA-C-O 119.38 -0.678 . . . . 0.0 112.239 176.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 4.1 mpp? -63.76 -33.65 76.12 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 118.533 1.167 . . . . 0.0 113.376 176.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -61.39 -61.56 2.45 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 119.642 1.11 . . . . 0.0 108.958 175.013 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -62.45 -43.86 97.81 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.178 0.991 . . . . 0.0 112.526 -176.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -62.81 -45.67 91.57 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.626 1.17 . . . . 0.0 111.711 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.23 -33.33 59.22 Favored 'General case' 0 CA--C 1.547 0.829 0 O-C-N 120.468 -1.395 . . . . 0.0 112.752 176.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -54.2 -60.38 3.41 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 126.587 1.955 . . . . 0.0 109.758 175.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -72.65 4.45 3.97 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-O 121.726 0.774 . . . . 0.0 112.596 -176.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -101.57 -7.75 47.75 Favored Glycine 0 CA--C 1.541 1.678 0 C-N-CA 126.964 2.221 . . . . 0.0 114.975 175.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -144.06 88.61 7.45 Favored Pre-proline 0 CA--C 1.553 1.059 0 CA-C-N 119.897 1.849 . . . . 0.0 113.268 -178.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -73.51 81.36 1.82 Allowed 'Trans proline' 0 CA--C 1.545 1.056 0 C-N-CA 124.096 3.197 . . . . 0.0 113.024 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -104.22 9.95 35.89 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.894 1.277 . . . . 0.0 114.337 -178.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 28.4 ptt85 -29.97 119.93 0.17 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 129.03 2.932 . . . . 0.0 115.728 175.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 39.25 68.4 0.5 Allowed Glycine 0 N--CA 1.468 0.804 0 C-N-CA 126.31 1.909 . . . . 0.0 112.151 -175.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.91 -24.4 37.41 Favored 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -174.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . 0.267 0.2 OUTLIER 13.93 72.18 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 130.766 3.626 . . . . 0.0 116.349 177.959 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 154.39 42.79 0.02 OUTLIER Glycine 0 CA--C 1.532 1.118 0 C-N-CA 123.865 0.745 . . . . 0.0 114.576 178.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' TRP . . . . . 0.834 ' H ' HD13 ' A' ' 161' ' ' ILE . 0.1 OUTLIER 49.79 48.55 21.51 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 125.434 1.494 . . . . 0.0 113.035 -176.836 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -91.31 134.27 34.73 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 122.325 1.059 . . . . 0.0 113.026 -174.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -156.52 -177.19 6.41 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.067 0.947 . . . . 0.0 112.884 -174.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 21.1 ttpp -131.97 148.13 52.5 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.753 1.221 . . . . 0.0 110.905 174.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -63.75 149.53 46.56 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 175.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.693 HD13 HD11 ' A' ' 120' ' ' ILE . 98.7 mt -107.9 145.26 34.01 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 175.005 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -64.48 -165.67 1.02 Allowed Glycine 0 CA--C 1.538 1.47 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 175.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 54.5 11.2 0.4 Allowed 'General case' 0 CA--C 1.557 1.242 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 175.27 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 81.33 40.9 10.62 Favored Glycine 0 CA--C 1.539 1.562 0 C-N-CA 126.557 2.027 . . . . 0.0 114.424 -175.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.2 mp -124.82 162.19 24.85 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 119.267 1.533 . . . . 0.0 112.813 -178.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -150.63 118.48 6.21 Favored 'General case' 0 N--CA 1.482 1.128 0 O-C-N 120.691 -1.256 . . . . 0.0 111.594 176.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 6.6 ttp -111.3 130.85 55.54 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 118.108 -0.949 . . . . 0.0 109.093 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 6.3 tppt? -106.9 134.14 50.5 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 127.681 2.393 . . . . 0.0 110.089 -179.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -136.41 152.31 21.14 Favored Glycine 0 N--CA 1.476 1.34 0 CA-C-N 121.208 1.822 . . . . 0.0 115.79 179.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.834 HD13 ' H ' ' A' ' 147' ' ' TRP . 6.1 tp -148.66 122.42 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 125.134 1.374 . . . . 0.0 113.332 -177.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 5.3 ttp -153.61 145.37 23.43 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 128.968 2.907 . . . . 0.0 109.589 177.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 9.6 t -120.22 146.3 46.18 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 120.87 -1.144 . . . . 0.0 109.778 175.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 28.8 p -91.34 18.96 6.45 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.305 1.442 . . . . 0.0 113.29 -178.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.8 -33.73 64.66 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.012 1.725 . . . . 0.0 115.005 -176.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 157.8 -62.76 0.32 Allowed Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.534 1.064 . . . . 0.0 114.17 176.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -125.25 27.02 6.73 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 125.652 1.581 . . . . 0.0 112.656 -174.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.87 175.66 2.37 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.28 1.432 . . . . 0.0 113.388 175.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . 0.581 ' HB3' HD11 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -115.78 178.81 4.17 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 127.453 2.301 . . . . 0.0 111.914 -177.814 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 40.2 ttp -126.89 137.89 53.22 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 125.381 1.473 . . . . 0.0 109.825 178.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.404 ' C ' HD12 ' A' ' 172' ' ' ILE . 5.8 tt0 -143.08 131.9 22.72 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 121.562 -0.711 . . . . 0.0 109.657 174.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.404 HD12 ' C ' ' A' ' 171' ' ' GLN . 3.8 mp -129.79 120.87 51.12 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.296 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 176.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -115.82 129.91 56.63 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 125.232 1.413 . . . . 0.0 111.125 177.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.8 mp -78.94 131.84 33.5 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 O-C-N 121.064 -1.023 . . . . 0.0 109.398 174.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 13.8 m -137.66 94.03 2.86 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.497 1.519 . . . . 0.0 113.116 176.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 79.0 mtp180 . . . . . 0 C--O 1.253 1.272 0 C-N-CA 125.544 1.538 . . . . 0.0 112.433 174.972 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.652 HD11 ' HB2' ' A' ' 31' ' ' LYS . 17.1 tp . . . . . 0 N--CA 1.483 1.182 0 CA-C-O 123.046 1.403 . . . . 0.0 114.45 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -136.53 130.27 32.19 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 128.037 2.535 . . . . 0.0 107.087 176.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.406 ' H ' ' HG ' ' A' ' 71' ' ' LEU . . . -73.08 -126.49 0.1 OUTLIER Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.171 0.891 . . . . 0.0 111.2 174.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 25.4 p -101.95 174.64 5.85 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.389 1.076 . . . . 0.0 111.413 177.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -124.65 16.07 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 125.498 1.519 . . . . 0.0 110.971 175.007 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.9 pp -55.05 165.57 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 125.352 1.461 . . . . 0.0 112.111 174.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -40.99 130.16 2.66 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.727 1.611 . . . . 0.0 113.246 -174.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -54.77 -21.14 21.55 Favored Glycine 0 N--CA 1.472 1.097 0 C-N-CA 124.766 1.174 . . . . 0.0 114.456 -177.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.75 -31.87 68.73 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.65 1.18 . . . . 0.0 111.306 174.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.63 -43.24 5.42 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.392 1.477 . . . . 0.0 111.602 174.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.427 HD23 ' HB3' ' A' ' 69' ' ' ALA . 14.3 tp -71.26 94.22 1.17 Allowed 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.902 0.858 . . . . 0.0 110.849 174.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.0 p -131.42 -179.92 5.65 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 126.982 2.113 . . . . 0.0 111.899 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -46.91 -39.99 13.28 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.55 1.54 . . . . 0.0 113.051 177.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -54.85 -39.51 68.68 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.448 1.099 . . . . 0.0 112.077 177.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.4 ' O ' HG23 ' A' ' 21' ' ' VAL . 65.2 t -70.45 -36.92 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 125.862 1.665 . . . . 0.0 111.182 174.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.408 ' CD2' HD21 ' A' ' 71' ' ' LEU . 9.2 mt -71.1 -43.13 68.31 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 120.965 -1.084 . . . . 0.0 111.249 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -58.34 -47.06 84.97 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.459 1.104 . . . . 0.0 111.308 178.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.68 -37.71 82.71 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 118.15 -0.929 . . . . 0.0 111.953 175.069 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 17' ' ' VAL . 16.2 t -54.36 -42.47 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 CA-C-N 119.923 1.238 . . . . 0.0 111.26 179.091 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.6 mt -58.65 -17.33 21.47 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.397 1.079 . . . . 0.0 113.845 177.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -105.38 -45.05 1.38 Allowed Glycine 0 CA--C 1.536 1.395 0 C-N-CA 126.992 2.234 . . . . 0.0 114.05 -179.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -67.82 -31.82 71.93 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 119.134 1.467 . . . . 0.0 112.725 175.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -101.66 173.33 6.46 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 125.181 1.392 . . . . 0.0 111.049 174.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 154.02 86.72 0.06 OUTLIER Glycine 0 CA--C 1.534 1.252 0 C-N-CA 124.332 0.967 . . . . 0.0 113.827 -178.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.5 mtpt -67.9 -46.11 72.52 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.714 1.206 . . . . 0.0 112.966 176.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 33.4 m -133.64 -176.96 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 126.799 2.04 . . . . 0.0 111.596 -178.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.9 m -47.28 -46.44 24.82 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 126.436 1.894 . . . . 0.0 115.123 -178.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.429 ' CB ' ' HE3' ' A' ' 76' ' ' LYS . 0.1 OUTLIER -128.91 146.02 51.06 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.534 1.133 . . . . 0.0 110.541 174.963 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.652 ' HB2' HD11 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -143.81 161.18 39.29 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 124.466 1.106 . . . . 0.0 111.62 -175.855 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.428 HD12 ' CG1' ' A' ' 34' ' ' VAL . 0.3 OUTLIER -120.08 133.28 67.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 124.78 1.232 . . . . 0.0 108.999 175.007 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -136.0 100.93 4.57 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.131 1.772 . . . . 0.0 109.065 175.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.91 HG22 ' HB2' ' A' ' 72' ' ' TYR . 1.5 m -103.97 161.44 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 123.859 0.864 . . . . 0.0 111.728 178.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -140.62 101.05 0.28 Allowed Glycine 0 N--CA 1.461 0.361 0 C-N-CA 123.613 0.625 . . . . 0.0 113.156 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 mp -93.98 151.11 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 117.91 0.855 . . . . 0.0 110.761 175.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -116.42 104.43 11.44 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.327 1.051 . . . . 0.0 110.822 174.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -72.62 98.84 2.42 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.743 1.617 . . . . 0.0 111.05 174.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -135.31 22.63 3.45 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.971 1.309 . . . . 0.0 110.444 174.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 33.1 t -61.79 -42.69 99.31 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 120.788 -1.195 . . . . 0.0 112.749 174.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 132.35 33.97 0.38 Allowed Glycine 0 CA--C 1.534 1.244 0 C-N-CA 124.375 0.988 . . . . 0.0 115.181 176.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -174.52 162.28 32.4 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 124.673 1.13 . . . . 0.0 112.094 175.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.711 HG22 ' HA ' ' A' ' 65' ' ' PRO . 50.4 p -70.42 139.32 51.79 Favored 'General case' 0 C--O 1.234 0.261 0 O-C-N 121.782 -0.834 . . . . 0.0 110.893 174.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.43 ' HB3' ' CD1' ' A' ' 91' ' ' TYR . 40.2 m0 -96.05 104.14 16.07 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 124.172 0.989 . . . . 0.0 110.767 -178.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.9 m -87.36 139.29 30.7 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.019 1.328 . . . . 0.0 110.539 178.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.74 131.44 48.9 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.456 0.702 . . . . 0.0 111.249 174.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.701 HD11 ' HB3' ' A' ' 90' ' ' ALA . 4.6 pp -120.2 -48.36 2.33 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.029 0.931 . . . . 0.0 112.854 177.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.502 ' N ' HD12 ' A' ' 47' ' ' LEU . 0.2 OUTLIER 178.36 153.88 0.35 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 127.189 2.196 . . . . 0.0 110.378 -175.167 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -138.67 164.78 28.64 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.497 1.519 . . . . 0.0 111.215 174.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -136.7 102.87 5.03 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 125.309 1.443 . . . . 0.0 110.092 176.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.549 ' CE1' ' HB1' ' A' ' 87' ' ' ALA . 3.0 m-85 -111.03 131.43 55.06 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.719 0.808 . . . . 0.0 109.962 -179.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.38 -33.16 4.16 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -177.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 33.9 t -125.43 -46.62 1.75 Allowed 'General case' 0 C--O 1.219 -0.541 0 C-N-CA 124.961 1.304 . . . . 0.0 109.202 174.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -60.35 -0.15 1.14 Allowed Glycine 0 CA--C 1.544 1.868 0 O-C-N 119.586 -1.946 . . . . 0.0 116.449 176.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.1 p -27.15 89.01 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 130.97 3.708 . . . . 0.0 114.564 -175.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.676 HG21 HG23 ' A' ' 59' ' ' ILE . 0.7 OUTLIER -105.28 175.2 5.57 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.928 -174.911 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -73.17 -56.16 5.49 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.388 1.075 . . . . 0.0 111.127 174.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.4 p -144.44 137.69 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 125.806 1.643 . . . . 0.0 112.021 176.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.676 HG23 HG21 ' A' ' 56' ' ' THR . 1.2 pp -135.82 -33.58 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 125.885 1.674 . . . . 0.0 114.298 176.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.415 ' H ' HD12 ' A' ' 59' ' ' ILE . 16.0 mt -89.09 100.32 2.09 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 125.312 1.445 . . . . 0.0 109.34 176.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.506 ' HG2' HG23 ' A' ' 64' ' ' VAL . 90.8 Cg_endo -65.43 154.64 72.72 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.38 2.72 . . . . 0.0 109.27 175.06 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -45.02 -50.98 10.44 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.504 1.522 . . . . 0.0 113.415 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.7 p -160.17 137.77 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 127.053 2.141 . . . . 0.0 109.612 176.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.635 HG21 HD13 ' A' ' 70' ' ' LEU . 94.6 t -113.56 130.75 23.44 Favored Pre-proline 0 N--CA 1.482 1.128 0 C-N-CA 124.495 1.118 . . . . 0.0 109.311 175.162 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.711 ' HA ' HG22 ' A' ' 43' ' ' THR . 59.9 Cg_endo -65.37 161.65 37.01 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 122.469 2.112 . . . . 0.0 112.801 177.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -76.69 170.51 16.3 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.83 0.852 . . . . 0.0 109.897 174.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . 0.266 10.7 t 46.95 30.55 1.27 Allowed 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 126.892 2.077 . . . . 0.0 113.376 -174.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.9 mttt -135.78 171.94 13.73 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 127.262 2.225 . . . . 0.0 111.821 -174.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.427 ' HB3' HD23 ' A' ' 13' ' ' LEU . . . -128.63 166.08 19.57 Favored 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 122.77 0.428 . . . . 0.0 110.245 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.635 HD13 HG21 ' A' ' 64' ' ' VAL . 2.0 pt? -143.78 171.07 14.72 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 124.617 1.167 . . . . 0.0 111.656 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.536 HD13 ' O ' ' A' ' 34' ' ' VAL . 0.6 OUTLIER -117.66 156.1 28.76 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.442 1.097 . . . . 0.0 112.503 177.566 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.91 ' HB2' HG22 ' A' ' 34' ' ' VAL . 7.5 m-85 -128.03 134.39 49.21 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.72 1.608 . . . . 0.0 109.103 174.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.1 p -108.08 142.76 37.78 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 126.831 2.053 . . . . 0.0 110.741 176.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -163.79 142.68 8.0 Favored Glycine 0 N--CA 1.461 0.326 0 O-C-N 120.514 -1.366 . . . . 0.0 111.898 174.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 3.8 ptm180 -129.26 104.33 7.46 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.289 1.436 . . . . 0.0 111.353 -174.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.515 ' HE2' ' O ' ' A' ' 83' ' ' THR . 2.6 ptpt . . . . . 0 N--CA 1.474 0.731 0 C-N-CA 127.492 2.317 . . . . 0.0 114.597 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.515 ' O ' ' HE2' ' A' ' 76' ' ' LYS . 3.7 m . . . . . 0 N--CA 1.487 1.386 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.479 ' H ' HG22 ' A' ' 83' ' ' THR . . . -78.65 -154.27 7.58 Favored Glycine 0 N--CA 1.47 0.934 0 O-C-N 119.741 -1.849 . . . . 0.0 113.323 176.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.566 ' HB3' HG22 ' A' ' 105' ' ' VAL . . . -94.7 97.98 10.46 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.081 -1.247 . . . . 0.0 110.526 -179.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.9 t -124.76 107.15 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 124.299 1.04 . . . . 0.0 110.578 -175.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.549 ' HB1' ' CE1' ' A' ' 51' ' ' PHE . . . -159.94 167.57 27.68 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.867 0.842 . . . . 0.0 111.494 178.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -150.86 159.8 44.31 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.758 1.223 . . . . 0.0 109.937 175.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.476 ' CD2' ' CE2' ' A' ' 72' ' ' TYR . 52.9 p90 -155.78 174.55 15.14 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 121.422 -0.799 . . . . 0.0 110.554 175.028 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.701 ' HB3' HD11 ' A' ' 47' ' ' LEU . . . -138.65 151.34 47.13 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 176.412 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.43 ' CD1' ' HB3' ' A' ' 44' ' ' TRP . 10.4 m-85 -126.3 140.11 52.78 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.38 1.072 . . . . 0.0 113.789 179.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -84.59 118.73 24.53 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 111.592 0.219 . . . . 0.0 111.592 -177.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 4.7 ttm -86.97 147.0 25.93 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.776 0.831 . . . . 0.0 112.31 177.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 24.6 m -67.1 -23.96 65.89 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 174.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -70.5 -17.39 62.96 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 175.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 100.71 40.13 3.0 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.845 1.212 . . . . 0.0 113.412 -175.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -135.5 175.1 9.9 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 118.382 1.091 . . . . 0.0 110.476 177.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.56 HG23 HD21 ' A' ' 47' ' ' LEU . 12.4 m -129.49 106.15 8.57 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.026 1.331 . . . . 0.0 111.946 -177.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.2 tt -70.79 96.35 1.24 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.699 1.6 . . . . 0.0 112.154 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -91.87 95.43 2.04 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 126.065 1.793 . . . . 0.0 113.876 -178.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 72.5 t -78.08 138.18 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 125.211 1.405 . . . . 0.0 111.444 176.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.6 126.54 29.43 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.367 1.467 . . . . 0.0 111.383 -178.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -146.64 121.79 10.15 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.0 1.32 . . . . 0.0 112.016 -177.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 47.1 t -142.45 109.73 5.63 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.657 1.183 . . . . 0.0 110.039 -178.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.566 HG22 ' HB3' ' A' ' 85' ' ' ALA . 17.5 m . . . . . 0 N--CA 1.469 0.523 0 C-N-CA 124.831 1.252 . . . . 0.0 108.365 175.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 45.1 p . . . . . 0 N--CA 1.475 0.781 0 CA-C-O 121.809 0.814 . . . . 0.0 112.24 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -121.87 101.53 7.62 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.132 1.773 . . . . 0.0 109.138 175.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 32.0 m0 -102.52 144.98 30.26 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.398 0.679 . . . . 0.0 109.94 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 27.4 p-90 -146.77 138.53 24.5 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.119 0.968 . . . . 0.0 111.978 -177.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -149.31 170.05 19.4 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 122.285 1.041 . . . . 0.0 113.072 179.115 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.3 t -150.27 139.31 15.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 C-N-CA 125.226 1.41 . . . . 0.0 107.655 175.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.79 175.44 10.18 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 126.27 1.828 . . . . 0.0 109.72 175.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.458 ' HB ' ' CE2' ' A' ' 154' ' ' TYR . 50.9 mt -130.56 105.74 11.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.953 0.882 . . . . 0.0 108.967 178.196 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -67.38 149.54 98.34 Favored Pre-proline 0 CA--C 1.546 0.793 0 O-C-N 121.522 -0.736 . . . . 0.0 111.842 178.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.6 131.73 17.8 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 123.212 2.608 . . . . 0.0 111.727 178.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 61.86 -165.99 18.75 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 124.549 1.071 . . . . 0.0 113.9 -176.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -67.89 110.78 4.0 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.654 1.182 . . . . 0.0 108.985 175.004 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 20.0 tpp180 -123.32 157.84 32.34 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.692 1.597 . . . . 0.0 110.066 178.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -96.99 -173.72 2.77 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.261 1.424 . . . . 0.0 110.397 174.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -138.58 121.45 16.55 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 127.317 2.247 . . . . 0.0 106.504 174.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -132.68 169.69 16.3 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.579 1.552 . . . . 0.0 110.016 175.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -52.71 -39.9 62.48 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.337 1.055 . . . . 0.0 113.086 176.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -59.03 -53.64 44.72 Favored Glycine 0 N--CA 1.469 0.853 0 CA-C-N 118.875 0.761 . . . . 0.0 112.094 176.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 1.2 mpp? -61.48 -42.97 99.6 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 118.036 0.918 . . . . 0.0 112.049 176.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -54.0 -58.44 7.29 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.381 0.672 . . . . 0.0 110.171 175.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -65.85 -38.07 87.87 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 -177.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -61.73 -45.3 94.53 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.55 1.14 . . . . 0.0 112.096 178.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 73.8 mmm -79.17 -32.59 44.29 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.351 -0.843 . . . . 0.0 112.879 176.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -54.08 -59.08 5.12 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.772 1.629 . . . . 0.0 109.511 174.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -71.24 -6.06 36.79 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -176.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -88.42 -9.27 69.78 Favored Glycine 0 CA--C 1.539 1.59 0 C-N-CA 126.292 1.901 . . . . 0.0 114.937 177.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -144.14 86.72 8.22 Favored Pre-proline 0 CA--C 1.553 1.058 0 CA-C-N 119.448 1.624 . . . . 0.0 111.89 -179.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -74.0 79.21 2.38 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 123.643 2.895 . . . . 0.0 112.274 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -119.07 126.21 51.14 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.287 1.435 . . . . 0.0 111.044 -176.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.1 ptt180 -99.17 -162.63 0.97 Allowed 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 127.285 2.234 . . . . 0.0 113.74 -175.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -71.95 62.27 1.31 Allowed Glycine 0 CA--C 1.538 1.471 0 C-N-CA 126.421 1.962 . . . . 0.0 113.72 175.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 10.1 p30 -67.49 74.99 0.16 Allowed 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 130.163 3.385 . . . . 0.0 114.796 177.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -70.29 62.83 0.23 Allowed 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 126.948 2.099 . . . . 0.0 114.875 -175.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -169.66 31.44 0.16 Allowed Glycine 0 CA--C 1.536 1.355 0 C-N-CA 124.536 1.065 . . . . 0.0 115.709 -175.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 5.1 m95 53.88 56.53 7.01 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.31 1.444 . . . . 0.0 113.154 -174.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -89.68 131.14 35.81 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.661 1.584 . . . . 0.0 112.613 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -160.12 -175.8 5.28 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -174.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 4.8 mtmt -130.19 160.38 33.99 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.159 1.384 . . . . 0.0 110.711 174.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -80.07 131.78 35.84 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.848 0.859 . . . . 0.0 108.918 175.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 78.2 mt -83.99 127.38 33.83 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.479 0.712 . . . . 0.0 110.599 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -51.74 -27.45 19.91 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 126.063 1.792 . . . . 0.0 116.49 -174.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.458 ' CE2' ' HB ' ' A' ' 120' ' ' ILE . 0.2 OUTLIER -74.95 6.88 3.63 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 128.076 2.55 . . . . 0.0 113.621 -179.459 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 84.58 10.58 79.24 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 125.602 1.572 . . . . 0.0 114.194 -175.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 17.5 mt -96.54 171.48 8.52 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.33 1.852 . . . . 0.0 110.475 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 3.4 mtt-85 -146.05 107.39 4.21 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 120.973 -1.08 . . . . 0.0 110.225 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 9.3 ttp -98.73 131.07 45.17 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 117.795 -1.098 . . . . 0.0 108.327 178.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 1.5 tppp? -109.44 129.41 55.55 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 127.915 2.486 . . . . 0.0 110.149 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -135.17 154.42 21.6 Favored Glycine 0 N--CA 1.474 1.197 0 CA-C-N 121.17 1.804 . . . . 0.0 115.562 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.31 129.42 6.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 C-N-CA 124.282 1.033 . . . . 0.0 112.402 -178.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -146.62 160.69 41.86 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 126.975 2.11 . . . . 0.0 109.554 175.001 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 9.4 t -131.38 168.76 17.03 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.589 1.155 . . . . 0.0 108.99 175.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 4.3 t -111.67 28.92 8.3 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.022 1.329 . . . . 0.0 111.414 178.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -67.65 21.76 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 127.77 2.428 . . . . 0.0 115.028 179.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 80.6 -59.51 4.65 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 126.641 2.067 . . . . 0.0 113.168 -178.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -116.39 65.36 0.71 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.072 1.749 . . . . 0.0 110.313 176.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.19 179.01 7.84 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 121.915 0.864 . . . . 0.0 111.708 174.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.3 176.84 5.64 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.456 1.902 . . . . 0.0 110.108 175.001 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 2.3 tmm? -125.51 125.59 43.5 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.918 1.287 . . . . 0.0 110.395 175.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 17.5 tt0 -138.11 124.59 20.72 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 123.772 0.829 . . . . 0.0 110.529 176.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 5.0 mp -132.66 119.71 39.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 123.974 0.91 . . . . 0.0 110.508 176.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.63 134.39 55.1 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.488 1.515 . . . . 0.0 111.939 177.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.8 mp -82.35 127.01 40.03 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 O-C-N 121.019 -1.05 . . . . 0.0 108.633 175.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 1.7 m -126.3 93.48 3.82 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.524 1.53 . . . . 0.0 111.499 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 80.0 mtm-85 . . . . . 0 C--O 1.253 1.27 0 C-N-CA 124.509 1.124 . . . . 0.0 113.214 176.528 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.81 HD12 ' H ' ' A' ' 74' ' ' GLY . 0.2 OUTLIER . . . . . 0 N--CA 1.483 1.204 0 CA-C-O 121.988 0.899 . . . . 0.0 111.999 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.41 ' HA ' HD12 ' A' ' 71' ' ' LEU . . . -144.58 121.2 11.12 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.856 2.062 . . . . 0.0 109.833 -175.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -73.91 -92.45 0.13 Allowed Glycine 0 CA--C 1.531 1.052 0 C-N-CA 123.988 0.804 . . . . 0.0 112.917 -176.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 41.0 p -141.4 173.61 11.33 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.544 1.538 . . . . 0.0 111.079 177.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -120.42 10.35 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 125.623 1.569 . . . . 0.0 112.213 -178.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -29.05 -77.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 127.627 2.371 . . . . 0.0 115.014 -176.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -158.2 147.55 19.51 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.56 1.944 . . . . 0.0 110.745 175.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -64.3 -26.96 70.96 Favored Glycine 0 N--CA 1.476 1.304 0 C-N-CA 124.592 1.091 . . . . 0.0 115.474 -178.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.43 -35.11 73.41 Favored 'General case' 0 CA--C 1.546 0.816 0 O-C-N 121.755 -0.85 . . . . 0.0 111.789 175.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.4 t -96.2 -37.89 10.36 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.082 1.353 . . . . 0.0 111.611 174.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.528 HD11 ' CD2' ' A' ' 71' ' ' LEU . 58.2 tp -82.77 84.41 7.35 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.651 1.981 . . . . 0.0 111.977 176.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.4 p -120.55 178.8 4.54 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 126.595 1.958 . . . . 0.0 111.396 175.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -40.14 -44.63 1.85 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.768 1.627 . . . . 0.0 113.474 175.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -52.92 -44.66 67.16 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 118.801 0.728 . . . . 0.0 112.154 178.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 93.1 t -64.54 -40.77 90.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 124.546 1.138 . . . . 0.0 111.135 175.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.475 ' CD2' HD21 ' A' ' 71' ' ' LEU . 39.4 mt -66.82 -38.12 85.83 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.355 -0.841 . . . . 0.0 111.593 178.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -68.16 -47.69 67.33 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 120.94 -1.1 . . . . 0.0 111.624 177.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.92 -37.51 87.29 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-O 118.594 -0.717 . . . . 0.0 111.495 175.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.445 HG22 ' HB2' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -62.84 -36.33 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 119.15 0.886 . . . . 0.0 111.159 -176.104 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.416 HD12 ' HB3' ' A' ' 33' ' ' ALA . 0.3 OUTLIER -56.28 -25.41 48.12 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 119.112 0.869 . . . . 0.0 112.413 175.076 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -81.87 -65.3 1.67 Allowed Glycine 0 CA--C 1.533 1.179 0 O-C-N 120.603 -1.311 . . . . 0.0 112.173 174.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -66.65 -35.6 80.55 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 115.149 1.537 . . . . 0.0 115.149 -175.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.445 ' HB2' HG22 ' A' ' 21' ' ' VAL . 3.3 mm? -106.42 104.77 14.54 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 126.76 2.024 . . . . 0.0 108.358 -177.13 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -161.59 135.4 3.91 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 125.243 1.401 . . . . 0.0 114.381 -175.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.2 mtpt -112.35 -45.99 3.22 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 126.437 1.895 . . . . 0.0 113.286 177.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 20.8 m -116.9 177.96 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 126.202 1.801 . . . . 0.0 110.929 -176.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.6 t -51.86 -49.46 62.86 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.896 1.279 . . . . 0.0 112.909 -175.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.9 mtt-85 -122.86 129.34 51.53 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.751 1.62 . . . . 0.0 110.527 174.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.603 ' HB2' HD13 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -118.38 157.45 27.14 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 126.12 1.768 . . . . 0.0 110.665 179.894 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.682 HG13 ' HB1' ' A' ' 85' ' ' ALA . 0.3 OUTLIER -118.25 130.78 72.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 175.045 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.416 ' HB3' HD12 ' A' ' 22' ' ' LEU . . . -134.77 99.44 4.32 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 126.75 2.02 . . . . 0.0 109.232 178.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.838 HG22 ' HB2' ' A' ' 72' ' ' TYR . 1.8 m -100.9 160.23 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-O 118.489 -0.767 . . . . 0.0 111.249 179.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -137.4 109.44 0.7 Allowed Glycine 0 N--CA 1.464 0.538 0 CA-C-N 119.112 0.869 . . . . 0.0 114.215 175.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.3 mp -100.66 145.57 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 CA-C-N 118.639 1.22 . . . . 0.0 110.722 176.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.419 ' HB3' ' HA ' ' A' ' 173' ' ' LYS . 24.7 t0 -108.55 105.86 15.68 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.905 1.282 . . . . 0.0 110.495 175.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -69.97 96.66 1.05 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.534 1.534 . . . . 0.0 111.222 175.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -126.56 3.43 6.85 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.26 1.824 . . . . 0.0 112.837 176.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.87 4.71 0.16 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 126.087 1.755 . . . . 0.0 115.663 177.086 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.01 61.96 4.28 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 125.977 1.751 . . . . 0.0 113.166 177.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 165.19 143.42 3.72 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 125.229 1.395 . . . . 0.0 111.079 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.753 HG22 ' HA ' ' A' ' 65' ' ' PRO . 31.9 p -67.15 142.57 57.0 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.682 0.753 . . . . 0.0 111.302 174.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.435 ' CZ2' ' CD2' ' A' ' 99' ' ' LEU . 48.6 m0 -101.97 102.66 13.22 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.627 1.171 . . . . 0.0 110.502 -179.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 28.0 m -90.27 128.63 36.46 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.01 0.924 . . . . 0.0 109.436 177.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.8 108.69 0.69 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.934 0.894 . . . . 0.0 112.429 175.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.545 HD12 ' HB3' ' A' ' 48' ' ' ASN . 3.1 pp -93.38 -45.7 7.68 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.637 0.775 . . . . 0.0 111.799 178.189 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.545 ' HB3' HD12 ' A' ' 47' ' ' LEU . 5.1 t30 -171.6 146.13 2.13 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 127.22 2.208 . . . . 0.0 110.294 179.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.673 ' HB2' HD22 ' A' ' 60' ' ' LEU . . . -134.99 151.27 50.67 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.346 1.458 . . . . 0.0 110.981 175.029 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -139.19 109.78 6.63 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.189 1.396 . . . . 0.0 112.013 -175.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.506 ' CD1' ' HB1' ' A' ' 87' ' ' ALA . 3.1 m-85 -106.66 127.75 53.62 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 120.991 -1.068 . . . . 0.0 111.142 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -88.76 -68.32 0.78 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.508 1.523 . . . . 0.0 111.178 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 32.5 t -107.46 -35.29 6.8 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.989 1.315 . . . . 0.0 112.16 -174.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -61.91 -26.41 67.16 Favored Glycine 0 CA--C 1.536 1.36 0 CA-C-O 118.831 -0.983 . . . . 0.0 114.02 177.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.5 p 21.14 55.13 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 128.046 2.538 . . . . 0.0 116.128 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.433 HG21 HG23 ' A' ' 59' ' ' ILE . 3.9 t -75.89 173.24 11.45 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.16 -175.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -82.21 -51.91 7.48 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.388 0.675 . . . . 0.0 112.084 176.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.5 p -148.18 135.82 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.08 1.352 . . . . 0.0 112.217 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.433 HG23 HG21 ' A' ' 56' ' ' THR . 1.0 OUTLIER -143.42 -32.09 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 126.059 1.744 . . . . 0.0 113.816 -175.595 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.673 HD22 ' HB2' ' A' ' 49' ' ' ALA . 1.0 OUTLIER -94.69 96.88 2.07 Favored Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 125.748 1.619 . . . . 0.0 109.256 177.823 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.44 ' HG2' HG23 ' A' ' 64' ' ' VAL . 77.6 Cg_endo -64.49 157.84 52.81 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.809 2.339 . . . . 0.0 110.404 175.037 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -45.22 -49.96 11.94 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.723 1.609 . . . . 0.0 113.379 178.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 5.5 p -160.17 142.28 4.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 126.247 1.819 . . . . 0.0 110.078 175.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.698 HG21 HD13 ' A' ' 70' ' ' LEU . 73.6 t -113.79 122.62 34.53 Favored Pre-proline 0 N--CA 1.473 0.676 0 C-N-CA 124.472 1.109 . . . . 0.0 108.325 174.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.753 ' HA ' HG22 ' A' ' 43' ' ' THR . 56.3 Cg_endo -68.12 159.42 53.19 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.767 2.312 . . . . 0.0 112.875 175.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -71.15 168.2 17.71 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.952 0.901 . . . . 0.0 110.705 175.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 30.5 p 53.1 21.9 2.33 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 127.11 2.164 . . . . 0.0 113.991 -175.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.8 172.67 10.17 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 127.648 2.379 . . . . 0.0 110.497 -175.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.469 ' HB3' HD23 ' A' ' 13' ' ' LEU . . . -134.9 161.84 34.1 Favored 'General case' 0 C--O 1.222 -0.381 0 O-C-N 121.85 -0.532 . . . . 0.0 110.009 176.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.698 HD13 HG21 ' A' ' 64' ' ' VAL . 2.6 pt? -136.38 171.11 14.96 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 124.387 1.075 . . . . 0.0 112.454 -179.42 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.528 ' CD2' HD11 ' A' ' 13' ' ' LEU . 0.6 OUTLIER -119.47 156.01 31.02 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 124.826 1.25 . . . . 0.0 113.138 -179.061 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.838 ' HB2' HG22 ' A' ' 34' ' ' VAL . 23.8 m-85 -133.22 133.66 43.01 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 124.217 1.007 . . . . 0.0 112.191 175.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.1 p -101.44 151.53 21.82 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 126.155 1.782 . . . . 0.0 110.692 175.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.81 ' H ' HD12 ' A' ' 3' ' ' LEU . . . -169.0 124.43 1.17 Allowed Glycine 0 CA--C 1.531 1.08 0 C-N-CA 124.212 0.91 . . . . 0.0 113.192 175.033 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.546 ' HG2' HD11 ' A' ' 3' ' ' LEU . 22.9 mtm180 -96.04 80.89 3.32 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 129.462 3.105 . . . . 0.0 111.245 -174.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.482 ' HE2' ' HB2' ' A' ' 85' ' ' ALA . 10.2 ptpt . . . . . 0 N--CA 1.471 0.585 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 24.6 m . . . . . 0 N--CA 1.479 0.978 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 114.83 -171.45 13.71 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 125.829 1.68 . . . . 0.0 112.137 178.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.682 ' HB1' HG13 ' A' ' 32' ' ' ILE . . . -72.11 84.52 1.01 Allowed 'General case' 0 CA--C 1.547 0.855 0 O-C-N 120.956 -1.32 . . . . 0.0 110.983 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.2 t -125.65 118.21 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 124.155 0.982 . . . . 0.0 113.031 -174.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.56 ' HB3' ' CZ ' ' A' ' 103' ' ' PHE . . . -164.87 168.65 17.46 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.144 1.377 . . . . 0.0 113.09 176.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -154.19 137.67 15.9 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.346 1.059 . . . . 0.0 111.961 174.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -137.59 169.28 18.06 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 120.595 -1.316 . . . . 0.0 111.574 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -141.46 160.62 39.75 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 175.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -137.82 143.35 40.95 Favored 'General case' 0 CA--C 1.513 -0.463 0 C-N-CA 125.779 1.632 . . . . 0.0 114.33 -174.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -97.94 106.53 18.85 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.352 -175.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 1.9 mtm -78.87 128.95 34.01 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 124.051 0.94 . . . . 0.0 110.789 178.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -58.96 -20.66 54.52 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 177.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -70.01 -12.52 61.67 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 124.521 1.128 . . . . 0.0 113.853 176.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 109.79 25.61 5.35 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 125.34 1.448 . . . . 0.0 114.963 177.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -134.3 173.84 11.18 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.928 1.291 . . . . 0.0 112.108 -175.028 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 16.8 m -129.33 108.44 10.31 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 177.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.435 ' CD2' ' CZ2' ' A' ' 44' ' ' TRP . 69.3 tp -75.12 108.07 7.62 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.675 0.79 . . . . 0.0 112.267 175.072 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -102.42 135.49 12.29 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 123.816 0.722 . . . . 0.0 112.344 174.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 95.6 t -115.7 136.6 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.952 1.301 . . . . 0.0 111.25 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -133.34 122.8 24.34 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.739 1.616 . . . . 0.0 111.945 -174.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.56 ' CZ ' ' HB3' ' A' ' 87' ' ' ALA . 2.1 p90 -147.17 117.53 7.41 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.735 1.214 . . . . 0.0 111.562 -176.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 48.4 t -139.02 105.98 5.43 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.186 0.994 . . . . 0.0 112.598 -177.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.486 ' HB ' ' HB3' ' A' ' 85' ' ' ALA . 19.6 t . . . . . 0 C--N 1.328 -0.338 0 C-N-CA 125.893 1.677 . . . . 0.0 109.008 179.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 2.0 t . . . . . 0 CA--C 1.543 0.711 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.439 HD21 ' CE ' ' A' ' 162' ' ' MET . 0.4 OUTLIER -102.29 101.52 11.81 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.942 1.697 . . . . 0.0 109.454 175.487 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 38.5 m0 -100.52 141.31 33.55 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.961 1.255 . . . . 0.0 110.476 178.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 37.7 p-90 -137.51 129.0 28.24 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.143 0.977 . . . . 0.0 111.268 -177.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -133.54 156.12 48.37 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 122.509 1.147 . . . . 0.0 112.553 176.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 95.9 t -148.22 123.76 2.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 176.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.91 170.89 21.08 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.596 1.158 . . . . 0.0 110.885 175.021 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.521 ' HB ' ' CZ ' ' A' ' 154' ' ' TYR . 7.2 mt -104.27 136.19 38.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.917 0.865 . . . . 0.0 110.523 176.1 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -89.58 153.09 47.88 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 125.302 1.441 . . . . 0.0 111.18 176.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -74.19 88.98 1.08 Allowed 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 124.248 3.299 . . . . 0.0 112.107 179.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 91.64 -172.51 35.89 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 125.239 1.399 . . . . 0.0 113.006 -177.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 12.3 tttt -51.85 118.08 3.17 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.997 1.319 . . . . 0.0 111.571 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.38 147.67 41.8 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.023 0.929 . . . . 0.0 112.225 177.027 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 19.6 ptt-85 -99.07 -178.34 3.9 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.25 1.02 . . . . 0.0 110.409 175.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -128.8 107.47 9.68 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 104.91 -2.255 . . . . 0.0 104.91 174.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -128.39 171.24 12.23 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.277 1.431 . . . . 0.0 109.299 176.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -51.87 -44.29 63.65 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 119.642 1.11 . . . . 0.0 113.595 -177.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -56.75 -58.44 14.47 Favored Glycine 0 N--CA 1.471 0.986 0 CA-C-N 119.327 0.967 . . . . 0.0 112.57 175.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 6.1 mtm -60.89 -39.92 91.07 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 118.068 0.934 . . . . 0.0 112.714 178.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -56.2 -60.89 2.85 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.071 1.349 . . . . 0.0 109.569 174.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -67.06 -32.57 73.84 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -178.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -62.02 -47.15 86.04 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.752 0.821 . . . . 0.0 111.562 176.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 46.8 mmm -84.45 -20.36 31.91 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -54.5 -55.67 26.69 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.664 1.586 . . . . 0.0 109.252 174.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -68.65 -9.68 51.5 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -73.44 -41.6 44.3 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 125.825 1.679 . . . . 0.0 114.036 -177.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -123.0 91.32 49.94 Favored Pre-proline 0 CA--C 1.547 0.831 0 CA-C-N 118.215 1.007 . . . . 0.0 111.452 179.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -72.45 78.64 1.94 Allowed 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 123.776 2.984 . . . . 0.0 112.156 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -114.84 124.15 51.01 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.953 1.301 . . . . 0.0 110.233 174.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.87 96.93 3.31 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 127.101 2.16 . . . . 0.0 112.6 -174.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 52.53 37.83 50.41 Favored Glycine 0 CA--C 1.537 1.423 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.462 -177.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.67 79.65 0.6 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.408 1.883 . . . . 0.0 110.93 -178.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -65.84 123.37 19.61 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.185 1.794 . . . . 0.0 110.611 175.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 128.02 41.41 0.28 Allowed Glycine 0 CA--C 1.534 1.258 0 C-N-CA 125.341 1.448 . . . . 0.0 114.754 178.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' TRP . . . . . 0.453 ' H ' HD13 ' A' ' 161' ' ' ILE . 9.7 m95 45.29 60.09 3.21 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.803 1.641 . . . . 0.0 112.738 -175.1 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -85.05 128.31 34.58 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.456 1.102 . . . . 0.0 113.229 179.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -162.68 -170.28 2.34 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.219 1.008 . . . . 0.0 112.693 -174.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -137.9 151.53 48.11 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.562 1.145 . . . . 0.0 110.159 174.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -70.6 153.18 43.13 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 122.99 0.516 . . . . 0.0 110.95 176.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.482 ' HB3' ' CD2' ' A' ' 154' ' ' TYR . 1.9 mm? -115.7 127.67 55.32 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 122.189 0.995 . . . . 0.0 112.398 -178.278 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -58.07 -18.37 33.87 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 125.436 1.493 . . . . 0.0 116.02 179.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.521 ' CZ ' ' HB ' ' A' ' 120' ' ' ILE . 0.1 OUTLIER -74.35 14.33 0.46 Allowed 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 126.62 1.968 . . . . 0.0 113.776 179.778 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 75.16 24.86 70.2 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 124.171 0.891 . . . . 0.0 113.751 -174.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.6 pp -135.33 177.58 7.71 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.152 1.381 . . . . 0.0 113.215 -178.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -142.37 124.33 15.27 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.602 1.561 . . . . 0.0 109.448 -178.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 5.1 ttp -98.24 142.06 30.38 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 175.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 3.5 tppt? -123.78 121.72 36.17 Favored 'General case' 0 C--O 1.219 -0.543 0 C-N-CA 125.707 1.603 . . . . 0.0 109.383 -176.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -130.35 152.1 19.67 Favored Glycine 0 N--CA 1.466 0.682 0 CA-C-N 120.305 1.412 . . . . 0.0 114.581 -176.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.453 HD13 ' H ' ' A' ' 147' ' ' TRP . 4.4 tp -146.35 128.27 7.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 C-N-CA 124.516 1.126 . . . . 0.0 110.589 -176.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . 0.439 ' CE ' HD21 ' A' ' 114' ' ' ASN . 1.1 tmm? -151.37 157.2 42.14 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 125.296 1.438 . . . . 0.0 109.982 177.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . 0.424 ' O ' ' HB3' ' A' ' 168' ' ' ALA . 12.8 t -148.67 148.45 30.08 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.506 0.722 . . . . 0.0 110.329 174.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 75.1 m -117.08 32.11 6.35 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.277 1.031 . . . . 0.0 111.352 -177.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.85 -24.41 65.88 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.692 1.597 . . . . 0.0 113.713 176.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 158.4 -54.7 0.37 Allowed Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.22 1.39 . . . . 0.0 113.414 175.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -139.96 61.2 1.54 Allowed 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 122.311 1.053 . . . . 0.0 112.161 -175.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 163' ' ' THR . . . -98.08 -174.09 2.77 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 122.44 1.114 . . . . 0.0 112.727 175.033 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.5 178.68 6.12 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 128.167 2.587 . . . . 0.0 111.035 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . 0.42 ' HA ' ' HG2' ' A' ' 162' ' ' MET . 4.7 tmm? -119.39 136.46 54.27 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.328 1.451 . . . . 0.0 111.207 174.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -146.74 129.73 16.37 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 121.591 -0.693 . . . . 0.0 110.279 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 4.6 mp -134.18 118.57 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 123.572 0.749 . . . . 0.0 110.363 175.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.419 ' HA ' ' HB3' ' A' ' 37' ' ' ASP . 0.0 OUTLIER -113.83 133.13 55.59 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 125.411 1.485 . . . . 0.0 111.583 176.161 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.8 mp -82.59 136.68 22.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 O-C-N 121.466 -0.771 . . . . 0.0 109.498 175.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -118.23 130.85 56.31 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.164 1.386 . . . . 0.0 111.593 175.028 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 8.2 mmm180 . . . . . 0 C--O 1.252 1.231 0 C-N-CA 126.778 2.031 . . . . 0.0 110.869 -175.008 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.421 ' HA ' ' HB3' ' A' ' 25' ' ' LEU . 10.4 tp . . . . . 0 N--CA 1.479 1.007 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.619 ' HB1' ' HB3' ' A' ' 71' ' ' LEU . . . -77.56 130.62 37.17 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.316 1.047 . . . . 0.0 109.41 174.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -64.55 -101.14 0.01 OUTLIER Glycine 0 CA--C 1.537 1.453 0 CA-C-N 120.211 1.369 . . . . 0.0 114.764 -178.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 16.5 p -133.25 167.4 20.44 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.307 1.443 . . . . 0.0 110.16 176.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -120.73 14.59 6.34 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 C-N-CA 125.021 1.328 . . . . 0.0 112.406 -178.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.439 HD12 ' HB3' ' A' ' 12' ' ' SER . 0.8 OUTLIER -30.95 -72.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 128.427 2.691 . . . . 0.0 114.092 -179.38 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -171.62 151.5 2.95 Favored 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 125.127 1.371 . . . . 0.0 110.947 175.173 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -59.57 -33.23 75.99 Favored Glycine 0 N--CA 1.468 0.798 0 N-CA-C 115.605 1.002 . . . . 0.0 115.605 -174.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.09 -38.44 88.84 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 122.022 -0.693 . . . . 0.0 111.188 174.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.439 ' HB3' HD12 ' A' ' 8' ' ' ILE . 5.9 t -92.22 -11.77 34.5 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.398 1.879 . . . . 0.0 113.778 177.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.572 HD23 ' CB ' ' A' ' 69' ' ' ALA . 67.8 tp -119.53 80.67 1.6 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 128.851 2.86 . . . . 0.0 109.845 179.016 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -111.84 177.34 4.68 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.591 1.557 . . . . 0.0 111.981 176.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -39.98 -45.29 1.86 Allowed 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 126.125 1.77 . . . . 0.0 113.439 175.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -52.59 -44.86 66.24 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.921 0.888 . . . . 0.0 111.623 178.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.494 ' O ' HG23 ' A' ' 21' ' ' VAL . 59.3 t -67.87 -40.82 84.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 125.54 1.536 . . . . 0.0 110.887 176.214 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.476 ' CD2' HD21 ' A' ' 71' ' ' LEU . 25.7 mt -65.4 -42.67 92.34 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 120.704 -1.247 . . . . 0.0 111.331 178.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -59.76 -51.52 69.4 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.79 1.236 . . . . 0.0 112.059 175.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.57 -36.37 83.56 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-O 118.424 -0.798 . . . . 0.0 112.52 175.141 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 17' ' ' VAL . 24.2 t -53.65 -46.31 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.234 1.014 . . . . 0.0 110.363 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.573 HD22 ' HE3' ' A' ' 31' ' ' LYS . 18.5 mt -53.53 -18.49 2.85 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.562 1.545 . . . . 0.0 114.464 178.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -99.64 -62.24 0.83 Allowed Glycine 0 CA--C 1.534 1.268 0 C-N-CA 126.646 2.07 . . . . 0.0 112.899 175.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -60.85 -35.43 76.55 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -178.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.421 ' HB3' ' HA ' ' A' ' 3' ' ' LEU . 3.1 mm? -114.41 105.89 13.66 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.267 1.827 . . . . 0.0 108.092 175.012 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -143.78 162.74 27.72 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 125.502 1.525 . . . . 0.0 111.405 178.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.22 -83.14 0.57 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.733 1.213 . . . . 0.0 110.638 174.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 30.6 m -91.43 173.72 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 126.014 1.725 . . . . 0.0 109.282 178.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -51.28 -44.8 61.92 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.977 0.911 . . . . 0.0 112.439 -178.435 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.63 120.81 43.63 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.47 1.908 . . . . 0.0 112.514 177.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.573 ' HE3' HD22 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -133.46 163.12 30.08 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 125.46 1.504 . . . . 0.0 111.115 -179.049 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -128.95 132.67 67.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 124.709 1.204 . . . . 0.0 109.037 175.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -136.73 104.76 5.62 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.146 1.778 . . . . 0.0 109.439 174.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.821 HG22 ' HB2' ' A' ' 72' ' ' TYR . 1.3 m -106.4 159.09 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 124.233 1.013 . . . . 0.0 111.901 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -137.44 109.1 0.68 Allowed Glycine 0 N--CA 1.465 0.569 0 CA-C-N 119.072 0.851 . . . . 0.0 113.643 -178.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 mp -99.43 142.07 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 117.632 0.716 . . . . 0.0 110.136 176.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -108.87 101.99 11.05 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 124.873 1.269 . . . . 0.0 109.848 176.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.62 100.09 1.08 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.584 1.554 . . . . 0.0 109.343 176.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -133.79 13.39 4.02 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.908 1.283 . . . . 0.0 112.282 175.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.0 p -62.31 -12.95 23.78 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 126.082 1.753 . . . . 0.0 114.834 175.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.38 16.29 66.93 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 125.499 1.523 . . . . 0.0 114.183 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -140.49 136.47 7.67 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 126.506 2.003 . . . . 0.0 110.633 175.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.803 HG22 ' HA ' ' A' ' 65' ' ' PRO . 19.9 p -73.63 127.47 32.85 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.281 0.632 . . . . 0.0 109.939 174.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 15.8 m0 -88.02 159.1 18.42 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 122.066 -0.396 . . . . 0.0 111.742 177.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 89.4 m -136.61 143.86 43.77 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.574 1.15 . . . . 0.0 110.288 -179.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.7 110.85 0.86 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.466 1.106 . . . . 0.0 111.829 175.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.602 HD12 ' N ' ' A' ' 48' ' ' ASN . 4.2 pp -101.25 -57.67 2.04 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.475 0.71 . . . . 0.0 111.284 175.073 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.602 ' N ' HD12 ' A' ' 47' ' ' LEU . 4.1 t30 -173.43 140.03 0.79 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.446 1.898 . . . . 0.0 110.262 -175.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -121.83 150.61 41.67 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.354 1.062 . . . . 0.0 110.195 175.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -138.52 94.32 2.83 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 123.037 1.399 . . . . 0.0 112.104 -175.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.611 ' CD1' ' HB1' ' A' ' 87' ' ' ALA . 5.2 m-30 -101.91 133.15 47.15 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 121.16 -0.962 . . . . 0.0 110.393 -175.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.38 -37.77 6.13 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.217 1.007 . . . . 0.0 113.64 -178.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 37.5 t -122.58 -47.74 2.08 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.494 1.518 . . . . 0.0 110.92 178.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -69.76 11.44 1.82 Allowed Glycine 0 CA--C 1.533 1.173 0 C-N-CA 126.051 1.786 . . . . 0.0 115.002 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 67.8 p -35.22 113.28 0.19 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 128.864 2.866 . . . . 0.0 112.773 -176.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.663 HG21 HG23 ' A' ' 59' ' ' ILE . 1.1 t -126.75 179.94 5.11 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.803 1.241 . . . . 0.0 112.014 -175.023 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -79.29 -53.98 6.4 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.959 0.904 . . . . 0.0 112.75 177.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.2 p -151.48 138.84 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.673 1.589 . . . . 0.0 111.386 -178.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.663 HG23 HG21 ' A' ' 56' ' ' THR . 0.0 OUTLIER -136.72 -47.27 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 C-N-CA 125.083 1.353 . . . . 0.0 112.982 -178.772 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 73.3 mt -71.42 108.62 4.1 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 124.717 1.207 . . . . 0.0 109.474 175.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -72.07 168.02 25.15 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 124.046 3.164 . . . . 0.0 110.819 175.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -53.52 -45.57 69.82 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 178.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 85.5 t -150.09 146.75 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 127.526 2.33 . . . . 0.0 108.83 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.0 t -116.66 97.26 50.01 Favored Pre-proline 0 C--N 1.331 -0.21 0 C-N-CA 125.567 1.547 . . . . 0.0 107.247 174.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.803 ' HA ' HG22 ' A' ' 43' ' ' THR . 51.4 Cg_endo -67.71 144.78 67.12 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 121.328 1.352 . . . . 0.0 111.99 175.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -69.11 168.89 13.0 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.438 0.695 . . . . 0.0 110.658 174.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 29.1 p 62.94 13.85 7.0 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 126.614 1.966 . . . . 0.0 111.889 -175.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 27.6 mttp -138.41 169.05 18.47 Favored 'General case' 0 C--N 1.343 0.302 0 C-N-CA 126.525 1.93 . . . . 0.0 111.655 -176.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.572 ' CB ' HD23 ' A' ' 13' ' ' LEU . . . -133.35 159.72 39.45 Favored 'General case' 0 C--O 1.222 -0.359 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -175.054 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.519 ' H ' HD23 ' A' ' 70' ' ' LEU . 2.2 pt? -136.76 167.86 20.63 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 124.296 1.038 . . . . 0.0 111.966 -177.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.619 ' HB3' ' HB1' ' A' ' 4' ' ' ALA . 0.6 OUTLIER -117.35 153.55 32.81 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.253 1.021 . . . . 0.0 112.139 179.068 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.821 ' HB2' HG22 ' A' ' 34' ' ' VAL . 6.7 m-85 -125.56 142.2 51.63 Favored 'General case' 0 CA--C 1.511 -0.521 0 C-N-CA 125.047 1.339 . . . . 0.0 109.335 174.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 58.3 p -109.41 156.45 20.03 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 125.035 1.334 . . . . 0.0 110.346 174.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -174.13 135.45 3.18 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.872 175.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 30.5 mtm105 -117.5 142.5 47.09 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 125.428 1.491 . . . . 0.0 108.852 -177.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.5 ptpt . . . . . 0 CA--C 1.542 0.65 0 C-N-CA 124.038 0.935 . . . . 0.0 112.346 175.035 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.481 1.089 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -61.6 -68.58 1.61 Allowed Glycine 0 N--CA 1.475 1.246 0 O-C-N 120.282 -1.511 . . . . 0.0 113.654 -179.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -160.14 114.98 2.29 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.838 1.255 . . . . 0.0 110.923 175.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.9 t -141.83 119.12 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 123.796 0.838 . . . . 0.0 109.933 -177.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.611 ' HB1' ' CD1' ' A' ' 51' ' ' PHE . . . -156.79 153.86 29.01 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.901 0.858 . . . . 0.0 112.031 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -134.57 139.43 45.37 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.401 1.48 . . . . 0.0 108.985 178.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.557 ' CE2' ' CE2' ' A' ' 72' ' ' TYR . 26.3 p90 -149.49 171.3 16.82 Favored 'General case' 0 C--N 1.323 -0.58 0 O-C-N 120.521 -1.362 . . . . 0.0 109.346 174.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.476 ' HB3' HD11 ' A' ' 47' ' ' LEU . . . -138.58 161.7 36.43 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 120.908 0.385 . . . . 0.0 111.977 174.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -130.16 135.52 48.27 Favored 'General case' 0 CA--C 1.518 -0.269 0 C-N-CA 125.718 1.607 . . . . 0.0 113.471 -174.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -86.53 116.78 24.89 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -175.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 3.3 mtm -93.2 140.89 29.03 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.01 0.924 . . . . 0.0 112.297 -177.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.14 -21.64 65.2 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 114.309 1.225 . . . . 0.0 114.309 177.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -72.09 -2.22 17.67 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.257 1.023 . . . . 0.0 113.146 175.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 85.83 42.39 6.81 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.62 1.105 . . . . 0.0 112.543 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -140.96 176.48 8.77 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.222 1.409 . . . . 0.0 111.549 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.441 HG23 HD21 ' A' ' 47' ' ' LEU . 12.9 m -130.07 107.54 9.4 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.285 1.034 . . . . 0.0 112.929 178.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 57.1 tp -69.94 96.31 1.01 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.764 1.625 . . . . 0.0 111.217 174.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -91.43 120.38 5.98 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 125.485 1.516 . . . . 0.0 112.76 178.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.557 HG11 ' CE2' ' A' ' 89' ' ' PHE . 0.3 OUTLIER -104.79 161.65 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 125.419 1.488 . . . . 0.0 111.127 178.436 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 5.0 tpt -155.91 123.22 5.44 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.66 1.184 . . . . 0.0 111.031 174.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.491 ' CZ ' ' HB3' ' A' ' 87' ' ' ALA . 15.5 p90 -135.18 124.18 24.19 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.933 1.293 . . . . 0.0 114.226 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.6 t -133.02 102.32 5.56 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.086 0.954 . . . . 0.0 111.557 -176.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.0 m . . . . . 0 N--CA 1.47 0.543 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.409 -178.186 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.468 0.429 0 CA-C-O 121.466 0.65 . . . . 0.0 110.64 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -63.16 99.55 0.18 Allowed 'General case' 0 CA--C 1.521 -0.164 0 C-N-CA 126.134 1.774 . . . . 0.0 111.807 175.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 46.5 m0 -119.56 142.11 48.65 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.691 1.197 . . . . 0.0 110.129 -175.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 31.5 p-90 -145.82 133.83 21.43 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.195 0.998 . . . . 0.0 110.658 -175.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -146.92 157.38 43.62 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 122.464 1.126 . . . . 0.0 113.441 -178.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.419 HG22 HG23 ' A' ' 101' ' ' VAL . 21.4 t -149.19 128.14 3.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 114.394 -1.275 . . . . 0.0 108.277 -178.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.0 162.99 40.79 Favored 'General case' 0 CA--C 1.514 -0.434 0 C-N-CA 125.614 1.566 . . . . 0.0 109.13 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 20.4 mt -108.47 146.28 14.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 121.487 0.66 . . . . 0.0 109.998 176.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -103.19 145.81 31.29 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 126.244 1.818 . . . . 0.0 111.023 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.62 103.0 1.37 Allowed 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 124.152 3.235 . . . . 0.0 111.558 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 88.06 -177.06 45.98 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.518 1.056 . . . . 0.0 114.068 -177.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 16.4 tttt -64.56 102.13 0.53 Allowed 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.462 1.105 . . . . 0.0 109.426 175.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 6.4 mmt180 -116.35 158.25 23.75 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.803 1.641 . . . . 0.0 109.54 178.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.82 -174.0 2.77 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.506 1.122 . . . . 0.0 110.265 175.041 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -138.27 113.25 9.19 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 126.315 1.846 . . . . 0.0 106.113 174.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -127.5 175.56 8.14 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.707 2.003 . . . . 0.0 109.253 174.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -47.97 -49.4 30.65 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.112 0.965 . . . . 0.0 113.473 177.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -56.94 -52.99 47.74 Favored Glycine 0 N--CA 1.471 0.967 0 CA-C-N 119.052 0.842 . . . . 0.0 112.832 178.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 20.4 mtm -62.88 -41.6 99.46 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 117.828 0.814 . . . . 0.0 112.558 176.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -56.95 -62.74 1.54 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.767 0.827 . . . . 0.0 109.623 175.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -59.22 -42.09 90.18 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 118.561 -0.733 . . . . 0.0 112.184 -176.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -58.09 -42.11 84.92 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.426 1.09 . . . . 0.0 113.027 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 40.9 mmm -84.48 -36.29 22.37 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 177.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -53.47 -57.27 11.27 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.501 1.52 . . . . 0.0 109.444 174.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -70.95 -9.7 58.36 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -178.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -87.02 -11.23 70.36 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 126.254 1.883 . . . . 0.0 114.624 178.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -138.67 88.67 13.93 Favored Pre-proline 0 CA--C 1.548 0.884 0 CA-C-N 119.205 1.503 . . . . 0.0 112.636 177.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -74.76 77.86 2.94 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.857 3.038 . . . . 0.0 112.46 178.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -114.71 124.21 51.21 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.061 0.944 . . . . 0.0 110.684 -178.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -92.59 -167.9 1.85 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.406 1.082 . . . . 0.0 111.72 179.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -73.94 66.51 1.78 Allowed Glycine 0 CA--C 1.53 0.989 0 C-N-CA 125.824 1.678 . . . . 0.0 111.433 175.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . 0.418 ' HB3' ' CG ' ' A' ' 148' ' ' TYR . 0.9 OUTLIER -80.96 88.75 5.89 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 125.404 1.481 . . . . 0.0 109.805 -178.07 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -70.38 86.41 0.61 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.862 1.665 . . . . 0.0 112.347 -176.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 169.04 40.7 0.03 OUTLIER Glycine 0 N--CA 1.472 1.099 0 O-C-N 121.171 -0.956 . . . . 0.0 114.614 -178.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 2.3 m95 53.56 55.17 8.94 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 125.576 1.55 . . . . 0.0 113.909 -177.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . 0.418 ' CG ' ' HB3' ' A' ' 144' ' ' ASP . 26.0 m-85 -86.23 124.4 32.57 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.443 1.497 . . . . 0.0 112.684 -178.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -159.0 -179.36 7.97 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.108 0.963 . . . . 0.0 112.902 -175.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -136.57 166.42 23.58 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.24 1.416 . . . . 0.0 111.086 174.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -69.14 143.65 54.06 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.888 0.875 . . . . 0.0 109.735 174.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.475 HD11 ' HB2' ' A' ' 158' ' ' MET . 48.4 mt -99.48 92.64 5.48 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.275 1.03 . . . . 0.0 110.744 176.236 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 33.05 -79.9 0.0 OUTLIER Glycine 0 N--CA 1.478 1.473 0 C-N-CA 130.051 3.691 . . . . 0.0 116.247 175.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -67.89 -157.02 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 128.266 2.626 . . . . 0.0 110.372 175.023 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -79.09 42.91 2.39 Favored Glycine 0 CA--C 1.539 1.557 0 O-C-N 119.813 -1.804 . . . . 0.0 112.253 175.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.54 149.98 33.64 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 119.571 1.686 . . . . 0.0 111.061 175.179 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 23.8 mtm180 -142.54 109.26 5.41 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.496 1.118 . . . . 0.0 111.015 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . 0.508 ' SD ' HG21 ' A' ' 172' ' ' ILE . 9.9 ttp -101.53 132.23 47.27 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 118.038 -0.982 . . . . 0.0 108.934 179.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.74 130.45 54.46 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 127.075 2.15 . . . . 0.0 110.893 178.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -135.72 160.11 24.42 Favored Glycine 0 N--CA 1.47 0.937 0 CA-C-N 120.312 1.414 . . . . 0.0 115.45 178.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.518 HG23 ' HZ1' ' A' ' 169' ' ' LYS . 0.0 OUTLIER -150.63 134.57 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 123.954 0.901 . . . . 0.0 111.366 179.395 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 7.0 mtm -148.36 167.29 25.61 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 127.09 2.156 . . . . 0.0 109.974 175.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 3.6 t -140.35 148.9 42.01 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.989 1.316 . . . . 0.0 109.479 174.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 77.4 p -92.25 26.57 2.5 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.508 1.123 . . . . 0.0 112.805 177.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -67.18 22.68 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 127.601 2.36 . . . . 0.0 115.232 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 81.4 -60.64 4.7 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 126.664 2.078 . . . . 0.0 112.901 -176.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -122.77 71.04 1.02 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.786 1.234 . . . . 0.0 111.47 -179.267 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -92.89 -177.06 4.4 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.733 1.213 . . . . 0.0 112.707 175.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . 0.518 ' HZ1' HG23 ' A' ' 161' ' ' ILE . 0.0 OUTLIER -123.42 163.84 20.06 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 126.842 2.057 . . . . 0.0 109.532 174.966 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . 0.413 ' SD ' ' CD1' ' A' ' 172' ' ' ILE . 1.3 tmt? -113.12 127.13 56.11 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 124.876 1.27 . . . . 0.0 109.459 174.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -138.21 127.66 24.74 Favored 'General case' 0 CA--C 1.518 -0.253 0 C-N-CA 123.279 0.632 . . . . 0.0 110.044 177.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.508 HG21 ' SD ' ' A' ' 158' ' ' MET . 4.2 mp -136.43 119.68 22.59 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.279 0 C-N-CA 122.978 0.511 . . . . 0.0 110.505 178.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -112.36 131.89 55.29 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.987 1.315 . . . . 0.0 111.578 175.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.8 mp -82.07 131.46 33.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 175.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -135.42 102.47 5.15 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.219 1.007 . . . . 0.0 111.442 175.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 5.9 mtt180 . . . . . 0 C--O 1.253 1.285 0 C-N-CA 124.846 1.259 . . . . 0.0 112.852 174.983 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 25.5 m . . . . . 0 N--CA 1.479 0.996 0 CA-C-O 120.919 0.39 . . . . 0.0 111.427 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -84.17 156.55 22.02 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 120.75 -1.219 . . . . 0.0 111.074 174.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.578 HD12 ' H ' ' A' ' 74' ' ' GLY . 1.8 mt -74.64 43.65 0.19 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.73 1.612 . . . . 0.0 112.51 -175.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.417 ' HA ' ' HB3' ' A' ' 71' ' ' LEU . . . -120.98 94.02 4.21 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 127.637 2.375 . . . . 0.0 109.632 178.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -69.71 -84.05 0.16 Allowed Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.531 1.062 . . . . 0.0 112.665 -175.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 33.7 p -140.24 167.34 22.37 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.705 1.602 . . . . 0.0 111.004 175.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -125.39 14.36 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 CA-C-O 123.174 1.464 . . . . 0.0 111.796 -179.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.419 HD12 ' HB3' ' A' ' 12' ' ' SER . 8.2 pt -53.23 167.39 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 125.494 1.517 . . . . 0.0 112.086 175.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -42.31 134.02 3.03 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.72 1.608 . . . . 0.0 112.549 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -54.9 -18.98 12.68 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 124.202 0.906 . . . . 0.0 114.557 -175.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.18 -28.14 69.46 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.718 1.207 . . . . 0.0 111.932 175.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.419 ' HB3' HD12 ' A' ' 8' ' ' ILE . 6.4 t -102.09 -44.9 5.32 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 126.32 1.848 . . . . 0.0 111.415 175.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.2 tp -75.97 94.16 3.35 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 121.614 0.721 . . . . 0.0 110.463 175.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 65.0 p -125.52 -179.8 4.79 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.507 1.523 . . . . 0.0 112.451 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -45.83 -41.0 10.56 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.446 1.498 . . . . 0.0 112.911 176.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -57.39 -43.39 83.61 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.661 1.185 . . . . 0.0 111.598 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 74.6 t -59.54 -35.4 58.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.733 1.213 . . . . 0.0 110.792 175.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.3 mt -72.52 -42.85 64.31 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.722 -0.611 . . . . 0.0 111.263 177.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -62.42 -49.35 75.81 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.616 -0.678 . . . . 0.0 111.267 178.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.08 -48.86 76.82 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 176.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.423 HG23 HD23 ' A' ' 25' ' ' LEU . 1.6 p -57.38 -30.73 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 CA-C-N 120.269 1.395 . . . . 0.0 113.414 -175.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 17.1 mt -57.4 -34.42 68.87 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.544 1.138 . . . . 0.0 110.806 174.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -85.54 -36.25 10.86 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 124.282 0.944 . . . . 0.0 113.455 177.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -69.62 -57.99 4.49 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.657 1.183 . . . . 0.0 112.38 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.423 HD23 HG23 ' A' ' 21' ' ' VAL . 3.1 mm? -91.32 -15.49 28.99 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.55 1.54 . . . . 0.0 112.005 -175.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -18.19 86.71 0.0 OUTLIER Glycine 0 CA--C 1.536 1.405 0 C-N-CA 129.952 3.644 . . . . 0.0 117.426 177.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.455 ' H ' HD21 ' A' ' 3' ' ' LEU . 15.3 mtpt -59.86 -61.11 2.86 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 127.224 2.21 . . . . 0.0 113.315 -175.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.1 m -132.66 -177.95 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 126.891 2.076 . . . . 0.0 110.835 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.2 t -52.19 -39.89 60.76 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.714 1.606 . . . . 0.0 114.354 -175.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -117.86 116.14 26.38 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 126.228 1.811 . . . . 0.0 108.258 175.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.15 150.54 49.46 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 126.125 1.77 . . . . 0.0 109.52 -175.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -128.21 123.59 60.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 124.336 1.054 . . . . 0.0 111.262 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -125.21 116.64 22.31 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 125.914 1.685 . . . . 0.0 108.558 174.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.732 HG22 ' HB2' ' A' ' 72' ' ' TYR . 1.3 m -116.1 158.75 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.639 0.776 . . . . 0.0 110.186 176.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -135.84 92.81 0.23 Allowed Glycine 0 CA--C 1.521 0.41 0 C-N-CA 124.073 0.844 . . . . 0.0 112.215 -178.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.8 mp -89.61 137.27 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 117.768 0.784 . . . . 0.0 110.503 175.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -108.15 112.1 24.45 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.989 1.316 . . . . 0.0 111.313 174.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 27.2 t30 -78.69 98.12 6.1 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.84 1.656 . . . . 0.0 111.975 175.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -134.21 13.74 3.87 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-O 122.551 1.167 . . . . 0.0 111.014 174.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.4 t -61.8 -26.88 68.37 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.082 1.753 . . . . 0.0 114.34 176.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 110.14 77.56 0.94 Allowed Glycine 0 CA--C 1.531 1.042 0 C-N-CA 125.247 1.403 . . . . 0.0 112.597 177.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 144.69 155.93 6.63 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 126.016 1.77 . . . . 0.0 112.805 175.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 41.4 p -68.88 129.43 39.9 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 121.526 -0.985 . . . . 0.0 110.289 174.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 45.2 m0 -86.6 111.15 20.35 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.261 0.553 . . . . 0.0 110.706 178.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 88.7 m -90.92 127.89 36.57 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 124.333 1.053 . . . . 0.0 109.501 175.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.414 ' HB1' ' HB3' ' A' ' 60' ' ' LEU . . . -62.21 138.41 58.41 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 122.651 0.38 . . . . 0.0 111.639 174.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.593 HD12 ' N ' ' A' ' 48' ' ' ASN . 4.1 pp -120.44 -54.65 2.07 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.059 0.943 . . . . 0.0 111.971 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.593 ' N ' HD12 ' A' ' 47' ' ' LEU . 0.1 OUTLIER -170.78 154.38 4.34 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.535 1.934 . . . . 0.0 110.241 178.704 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -133.17 162.99 30.28 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.679 1.192 . . . . 0.0 110.386 174.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 29.3 t80 -140.24 106.2 5.19 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.971 1.309 . . . . 0.0 112.391 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.541 ' CD1' ' HB1' ' A' ' 87' ' ' ALA . 3.1 m-85 -111.1 118.24 35.48 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.992 1.317 . . . . 0.0 110.982 -175.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.37 -35.9 7.78 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -177.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.421 ' HB3' ' HB ' ' A' ' 86' ' ' VAL . 11.3 t -123.96 -41.83 2.2 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.97 1.708 . . . . 0.0 111.654 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -74.03 16.66 2.61 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 125.246 1.403 . . . . 0.0 115.272 -178.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 65.8 p -32.9 110.29 0.08 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 128.689 2.796 . . . . 0.0 114.321 -174.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.536 HG21 HG23 ' A' ' 59' ' ' ILE . 1.7 t -131.37 -177.09 4.25 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.002 1.321 . . . . 0.0 112.845 -174.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -85.41 -64.97 1.06 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.963 1.305 . . . . 0.0 113.205 176.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.6 p -137.4 134.23 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 125.455 1.502 . . . . 0.0 111.638 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.536 HG23 HG21 ' A' ' 56' ' ' THR . 0.1 OUTLIER -136.68 -29.97 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.825 1.65 . . . . 0.0 113.799 177.596 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.414 ' HB3' ' HB1' ' A' ' 46' ' ' ALA . 11.0 mt -94.38 97.07 2.07 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 125.298 1.439 . . . . 0.0 109.85 179.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -66.87 154.29 75.07 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.932 3.088 . . . . 0.0 110.922 174.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -50.39 -50.8 50.57 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.634 1.174 . . . . 0.0 113.302 -176.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 80.4 t -149.45 140.9 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 127.902 2.481 . . . . 0.0 108.347 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.3 t -120.87 125.4 27.07 Favored Pre-proline 0 N--CA 1.471 0.583 0 C-N-CA 124.658 1.183 . . . . 0.0 109.508 175.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -66.2 152.02 82.15 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 121.88 1.72 . . . . 0.0 112.373 175.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -74.53 171.04 14.53 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.686 0.794 . . . . 0.0 111.425 174.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 66.5 p 55.41 20.36 3.6 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 127.597 2.359 . . . . 0.0 113.906 -174.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 49.4 mttt -133.57 174.03 10.86 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 127.623 2.369 . . . . 0.0 111.559 -175.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -130.94 166.86 20.03 Favored 'General case' 0 C--O 1.222 -0.373 0 C-N-CA 122.619 0.368 . . . . 0.0 110.549 -177.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.5 pp -140.49 172.66 12.41 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 124.962 1.305 . . . . 0.0 111.516 -178.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.417 ' HB3' ' HA ' ' A' ' 4' ' ' ALA . 0.5 OUTLIER -123.4 151.76 42.27 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 124.331 1.052 . . . . 0.0 112.038 178.991 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.732 ' HB2' HG22 ' A' ' 34' ' ' VAL . 3.5 m-85 -126.21 144.08 50.9 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.464 1.106 . . . . 0.0 108.556 174.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 90.4 p -115.69 152.95 32.21 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 125.879 1.671 . . . . 0.0 110.68 176.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.578 ' H ' HD12 ' A' ' 3' ' ' LEU . . . -173.97 141.91 6.23 Favored Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 174.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 13.3 ptt180 -132.42 163.84 27.85 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 127.098 2.159 . . . . 0.0 108.294 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.613 ' HB3' ' HB3' ' A' ' 82' ' ' ALA . 24.6 mtmt -60.65 162.79 6.13 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 115.341 1.608 . . . . 0.0 115.341 -174.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 27.0 t -67.71 -62.91 1.19 Allowed 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.317 1.447 . . . . 0.0 111.654 -175.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.24 -27.09 62.29 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.84 0.856 . . . . 0.0 113.036 174.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 113.55 -81.07 0.29 Allowed Glycine 0 CA--C 1.536 1.392 0 C-N-CA 126.14 1.828 . . . . 0.0 112.759 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -75.76 -36.88 1.9 Allowed 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 123.04 2.494 . . . . 0.0 113.216 -176.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 30.2 m -135.72 122.8 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 126.276 1.83 . . . . 0.0 110.803 -179.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.613 ' HB3' ' HB3' ' A' ' 76' ' ' LYS . . . 172.95 -177.02 0.06 Allowed 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 128.366 2.666 . . . . 0.0 110.41 -175.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 56.7 m -60.66 150.09 33.15 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.866 1.666 . . . . 0.0 111.201 174.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -53.05 -75.72 0.21 Allowed Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.938 1.732 . . . . 0.0 114.862 -175.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -165.97 102.62 0.66 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.316 1.446 . . . . 0.0 112.844 -178.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.421 ' HB ' ' HB3' ' A' ' 53' ' ' SER . 6.0 t -129.0 124.69 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 O-C-N 120.977 -1.077 . . . . 0.0 110.87 -178.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.593 ' HB3' ' CZ ' ' A' ' 103' ' ' PHE . . . -167.8 159.47 11.69 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.036 1.334 . . . . 0.0 112.233 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -141.06 143.87 34.61 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 124.396 1.078 . . . . 0.0 109.813 174.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -140.58 168.54 19.56 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 121.402 -0.811 . . . . 0.0 109.958 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -137.1 155.01 50.14 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 175.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -130.89 127.22 38.07 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.925 1.69 . . . . 0.0 111.985 -175.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -82.54 114.56 21.03 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.868 0.366 . . . . 0.0 111.067 -178.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 2.0 mtm -84.1 136.5 33.98 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.647 1.179 . . . . 0.0 111.169 176.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.2 t -64.32 -19.15 65.25 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.77 0.828 . . . . 0.0 113.213 176.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -69.35 -13.72 62.53 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 125.34 1.456 . . . . 0.0 113.496 175.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 104.31 23.07 8.23 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 124.736 1.16 . . . . 0.0 115.09 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.507 ' HB3' HG22 ' A' ' 120' ' ' ILE . 7.5 m-80 -129.98 173.87 10.3 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 118.911 1.356 . . . . 0.0 110.035 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.6 m -130.47 107.75 9.46 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.403 1.081 . . . . 0.0 111.083 178.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 55.4 tp -70.68 105.49 3.18 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.245 1.018 . . . . 0.0 111.079 175.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -97.16 95.09 1.67 Allowed Glycine 0 CA--C 1.525 0.663 0 C-N-CA 125.639 1.59 . . . . 0.0 112.323 176.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 79.4 t -76.25 139.91 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 123.845 0.858 . . . . 0.0 110.51 174.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 2.6 tmm? -129.75 125.75 36.59 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.481 1.112 . . . . 0.0 111.056 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.593 ' CZ ' ' HB3' ' A' ' 87' ' ' ALA . 48.9 p90 -136.94 134.95 37.29 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 122.417 1.104 . . . . 0.0 113.601 174.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 71.9 m -137.63 121.28 17.37 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.482 1.113 . . . . 0.0 111.563 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 41.4 t -125.76 98.86 33.28 Favored Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 126.576 1.95 . . . . 0.0 107.455 175.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -71.35 -158.08 0.05 OUTLIER 'Trans proline' 0 CA--C 1.547 1.149 0 C-N-CA 124.675 3.583 . . . . 0.0 111.215 175.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -131.94 -34.33 1.3 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.988 1.315 . . . . 0.0 111.816 175.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -90.01 52.38 2.26 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.128 1.371 . . . . 0.0 111.309 175.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -56.12 -19.34 12.87 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.058 1.343 . . . . 0.0 113.164 175.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 59.9 m-80 -58.99 -18.72 36.77 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.918 2.087 . . . . 0.0 113.493 174.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 6.8 m95 -132.25 -63.87 0.79 Allowed 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 126.37 1.868 . . . . 0.0 111.161 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -80.81 126.54 31.46 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.117 1.367 . . . . 0.0 111.714 -176.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.7 m -74.46 171.64 13.41 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 121.689 -0.632 . . . . 0.0 111.907 175.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -125.96 72.64 1.3 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.407 1.483 . . . . 0.0 112.258 -175.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 22.8 m0 -71.82 143.99 49.28 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 121.334 -0.854 . . . . 0.0 112.292 -174.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 34.3 p-90 -140.82 137.0 32.98 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.168 0.987 . . . . 0.0 111.881 -179.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -144.76 168.56 19.91 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 125.198 1.399 . . . . 0.0 111.684 -176.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 72.2 t -147.55 129.67 6.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 124.7 1.2 . . . . 0.0 107.894 174.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.58 170.2 15.07 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.434 1.094 . . . . 0.0 110.518 174.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.507 HG22 ' HB3' ' A' ' 97' ' ' ASN . 12.7 mt -132.01 104.77 8.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 177.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -62.18 145.8 93.2 Favored Pre-proline 0 CA--C 1.546 0.818 0 O-C-N 121.485 -0.759 . . . . 0.0 110.886 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -73.81 8.91 1.79 Allowed 'Trans proline' 0 CA--C 1.548 1.188 0 C-N-CA 124.413 3.408 . . . . 0.0 114.862 -175.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -172.98 179.77 44.2 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 126.95 2.214 . . . . 0.0 111.406 177.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -53.94 102.71 0.06 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 126.645 1.978 . . . . 0.0 111.565 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 11.1 tpp180 -132.45 141.6 48.89 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.538 1.535 . . . . 0.0 111.776 -177.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 8.7 ptt180 -76.82 179.53 6.06 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.262 1.025 . . . . 0.0 113.536 174.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -124.4 116.39 22.48 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 128.326 2.651 . . . . 0.0 104.681 174.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -140.12 169.18 18.18 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.143 1.377 . . . . 0.0 110.422 177.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.77 -43.19 65.65 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.56 1.144 . . . . 0.0 113.261 -178.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -56.13 -56.44 24.18 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 123.72 0.676 . . . . 0.0 112.744 174.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 2.9 mtm -64.17 -33.3 75.47 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 118.321 1.06 . . . . 0.0 112.973 177.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.28 -63.91 1.13 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.231 1.013 . . . . 0.0 108.895 174.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -63.81 -32.81 74.45 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.621 0.601 . . . . 0.0 112.621 -176.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -64.18 -34.13 77.38 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.506 1.122 . . . . 0.0 113.446 176.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 6.4 tpp -97.72 -21.88 16.74 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 175.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -51.84 -54.99 22.71 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 126.638 1.975 . . . . 0.0 109.783 174.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -64.61 -12.1 42.0 Favored 'General case' 0 CA--C 1.552 1.045 0 N-CA-C 113.72 1.008 . . . . 0.0 113.72 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -79.16 -33.12 36.99 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 126.832 2.158 . . . . 0.0 113.925 -175.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -127.61 90.73 47.51 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 124.593 1.157 . . . . 0.0 111.21 177.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -72.51 72.92 2.9 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 123.561 2.84 . . . . 0.0 112.376 178.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -113.39 119.48 37.78 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 124.659 1.184 . . . . 0.0 109.848 174.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -89.03 0.43 56.68 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.591 1.557 . . . . 0.0 114.557 175.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 85.01 75.07 1.24 Allowed Glycine 0 CA--C 1.522 0.511 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 -175.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -74.53 122.2 22.72 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.907 0.883 . . . . 0.0 109.229 174.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -56.34 144.16 31.58 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.09 0.956 . . . . 0.0 112.395 -177.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . 0.477 ' C ' HD13 ' A' ' 161' ' ' ILE . . . 117.19 -78.97 0.29 Allowed Glycine 0 CA--C 1.532 1.141 0 C-N-CA 126.095 1.807 . . . . 0.0 113.037 -176.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 32.2 m95 171.99 104.84 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 130.816 3.646 . . . . 0.0 108.629 -175.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -134.59 137.0 43.36 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 126.456 1.902 . . . . 0.0 111.868 -177.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -160.38 -172.01 3.4 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -174.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.422 ' HE2' ' HA ' ' A' ' 150' ' ' LYS . 1.5 mmpt? -133.33 155.13 49.99 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 126.285 1.834 . . . . 0.0 111.158 174.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -78.23 144.09 36.55 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 174.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.3 mt -107.38 153.6 22.53 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 122.22 1.009 . . . . 0.0 109.732 178.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -64.38 -166.78 1.18 Allowed Glycine 0 CA--C 1.535 1.304 0 C-N-CA 123.673 0.654 . . . . 0.0 112.262 174.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.47 ' CE2' ' HB ' ' A' ' 120' ' ' ILE . 0.0 OUTLIER 56.78 9.47 0.6 Allowed 'General case' 0 CA--C 1.556 1.2 0 N-CA-C 114.844 1.424 . . . . 0.0 114.844 174.968 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 81.48 38.32 14.88 Favored Glycine 0 CA--C 1.538 1.514 0 C-N-CA 126.736 2.112 . . . . 0.0 114.693 -175.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.7 mp -126.79 159.64 33.21 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 119.868 1.834 . . . . 0.0 113.671 -176.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 74.1 mtt180 -144.69 118.71 9.39 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.316 1.047 . . . . 0.0 110.181 -178.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 3.1 ttp -103.51 138.94 39.52 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 124.313 1.045 . . . . 0.0 108.443 177.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -111.06 133.82 53.14 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 127.031 2.132 . . . . 0.0 110.131 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -141.39 160.88 26.93 Favored Glycine 0 N--CA 1.478 1.459 0 CA-C-N 121.849 2.113 . . . . 0.0 116.191 178.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.477 HD13 ' C ' ' A' ' 146' ' ' GLY . 1.4 tp -149.51 127.22 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 125.166 1.386 . . . . 0.0 110.978 -177.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . 0.423 ' N ' HD12 ' A' ' 161' ' ' ILE . 29.4 mtp -148.48 164.95 32.63 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 128.807 2.843 . . . . 0.0 108.224 174.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 10.2 t -138.0 154.98 49.29 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.999 0.52 . . . . 0.0 111.124 175.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 94.9 p -77.57 13.87 1.16 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.726 1.611 . . . . 0.0 114.275 179.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.26 1.08 0.13 Allowed 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 126.794 2.038 . . . . 0.0 115.548 175.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 87.75 -62.3 3.99 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 126.14 1.829 . . . . 0.0 113.151 174.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -102.53 20.06 17.81 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.32 1.448 . . . . 0.0 113.076 -177.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -60.57 161.58 7.47 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.118 1.367 . . . . 0.0 113.579 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.41 173.41 9.15 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 126.446 1.899 . . . . 0.0 111.653 174.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 44.8 ttp -134.05 118.51 17.86 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.97 1.308 . . . . 0.0 111.794 177.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -124.62 128.55 49.04 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 121.141 -0.975 . . . . 0.0 109.525 177.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 4.6 mp -133.89 124.51 47.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 123.735 0.814 . . . . 0.0 109.915 176.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -123.34 132.11 53.88 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.36 1.464 . . . . 0.0 111.391 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.8 mp -79.31 127.57 39.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 O-C-N 121.207 -0.933 . . . . 0.0 109.338 176.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 4.2 m -132.3 98.9 4.52 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.093 1.357 . . . . 0.0 112.04 178.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 49.9 mtp85 . . . . . 0 C--O 1.253 1.242 0 C-N-CA 127.357 2.263 . . . . 0.0 113.032 175.02 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 6.3 t . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.246 0.069 . . . . 0.0 110.835 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.453 ' O ' HD23 ' A' ' 3' ' ' LEU . 0.5 OUTLIER -136.4 -175.83 4.13 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 128.305 2.642 . . . . 0.0 110.595 177.014 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.537 HD13 ' HB2' ' A' ' 31' ' ' LYS . 1.5 mt -128.51 15.42 6.56 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 126.664 1.986 . . . . 0.0 111.944 178.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -115.83 116.24 27.67 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 127.227 2.211 . . . . 0.0 110.491 -175.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -77.85 -82.95 0.58 Allowed Glycine 0 CA--C 1.533 1.201 0 C-N-CA 124.744 1.164 . . . . 0.0 113.551 -178.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 54.2 p -139.27 174.17 10.79 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 126.406 1.882 . . . . 0.0 111.451 -175.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -135.57 15.64 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 C-N-CA 125.702 1.601 . . . . 0.0 111.638 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 15.3 pt -54.36 171.56 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 126.272 1.829 . . . . 0.0 113.402 178.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -43.09 132.42 4.12 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.044 1.737 . . . . 0.0 113.258 178.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -54.75 -31.03 53.54 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 125.487 1.518 . . . . 0.0 116.147 -174.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.47 -22.58 67.0 Favored 'General case' 0 CA--C 1.547 0.834 0 O-C-N 121.648 -0.913 . . . . 0.0 112.636 174.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.3 t -98.25 -45.36 6.21 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.187 2.195 . . . . 0.0 111.722 176.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.522 HD23 ' HB3' ' A' ' 69' ' ' ALA . 3.2 tp -78.77 88.25 4.64 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.449 1.5 . . . . 0.0 111.062 174.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.2 p -120.28 -179.67 4.02 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 126.994 2.118 . . . . 0.0 111.976 177.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -45.4 -42.03 9.78 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.11 1.764 . . . . 0.0 113.523 175.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -52.91 -44.25 66.82 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 118.953 0.797 . . . . 0.0 111.819 177.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 61.4 t -64.13 -41.87 93.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 125.587 1.555 . . . . 0.0 111.651 175.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 29.3 mt -67.72 -40.13 84.26 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 120.845 -1.159 . . . . 0.0 111.933 179.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -63.64 -45.99 87.72 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.824 0.849 . . . . 0.0 111.786 178.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.74 -32.83 74.38 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-O 118.371 -0.823 . . . . 0.0 112.961 175.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 25.2 t -56.59 -42.02 75.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 CA-C-N 119.796 1.18 . . . . 0.0 111.48 177.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 49.2 mt -59.56 -13.29 8.68 Favored 'General case' 0 CA--C 1.552 1.045 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 175.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -104.67 -49.69 1.01 Allowed Glycine 0 CA--C 1.539 1.539 0 C-N-CA 126.855 2.169 . . . . 0.0 114.229 176.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -74.17 -30.41 62.23 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 119.186 1.493 . . . . 0.0 114.389 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -100.34 171.88 7.5 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.277 1.431 . . . . 0.0 110.463 174.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 154.83 131.49 1.48 Allowed Glycine 0 CA--C 1.534 1.22 0 O-C-N 121.122 -0.986 . . . . 0.0 114.601 177.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.4 mtpm? -113.5 -50.74 2.84 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 126.097 1.759 . . . . 0.0 114.0 176.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.7 m -132.25 -179.32 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 124.285 1.034 . . . . 0.0 112.348 -174.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.3 t -48.88 -42.37 36.49 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 126.082 1.753 . . . . 0.0 114.322 -175.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 8.8 tpp180 -124.69 136.35 53.82 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 126.297 1.839 . . . . 0.0 108.964 174.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.537 ' HB2' HD13 ' A' ' 3' ' ' LEU . 0.1 OUTLIER -130.58 167.64 18.39 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.333 1.453 . . . . 0.0 110.8 178.292 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -137.41 133.04 46.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 124.187 0.995 . . . . 0.0 108.38 174.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -134.21 95.84 3.49 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 127.61 2.364 . . . . 0.0 109.855 -178.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.672 HG22 ' HB2' ' A' ' 72' ' ' TYR . 1.4 m -98.91 167.02 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 123.212 0.605 . . . . 0.0 111.552 179.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -142.59 108.69 0.53 Allowed Glycine 0 CA--C 1.523 0.562 0 CA-C-O 119.645 -0.53 . . . . 0.0 113.414 174.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.9 mp -98.51 144.31 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 117.929 0.865 . . . . 0.0 109.184 175.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -119.61 102.83 8.9 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.143 1.377 . . . . 0.0 111.161 -178.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -70.73 85.29 0.65 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 129.44 3.096 . . . . 0.0 113.047 -175.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.57 3.37 13.99 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.746 1.619 . . . . 0.0 113.658 175.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.5 m -55.56 -30.89 61.59 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 115.335 1.605 . . . . 0.0 115.335 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 111.06 95.68 2.31 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.576 1.084 . . . . 0.0 112.098 -177.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 113.51 160.11 13.78 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 126.102 1.81 . . . . 0.0 112.625 -178.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.623 HG22 ' HA ' ' A' ' 65' ' ' PRO . 80.8 p -69.34 148.2 50.03 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 121.975 -0.721 . . . . 0.0 111.563 175.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 34.9 m0 -103.32 105.85 16.22 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.925 0.89 . . . . 0.0 109.584 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 59.4 m -92.75 129.98 38.51 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.269 1.027 . . . . 0.0 110.466 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.85 127.98 33.83 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.045 0.938 . . . . 0.0 112.22 174.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -117.14 -43.6 2.84 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.698 1.199 . . . . 0.0 112.269 175.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -170.04 149.64 3.63 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.467 1.907 . . . . 0.0 110.955 -178.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -133.38 155.84 48.74 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.382 1.473 . . . . 0.0 110.231 175.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -138.2 97.69 3.45 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.048 1.339 . . . . 0.0 111.413 -178.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.496 ' CD1' ' HB1' ' A' ' 87' ' ' ALA . 2.3 m-85 -99.17 111.99 24.25 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.356 1.062 . . . . 0.0 110.646 177.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.13 -39.45 16.69 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.278 0.631 . . . . 0.0 111.563 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.5 t -129.3 -177.08 4.09 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.623 2.369 . . . . 0.0 107.591 174.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 55.52 24.33 38.56 Favored Glycine 0 CA--C 1.538 1.493 0 O-C-N 121.178 -0.951 . . . . 0.0 113.783 -179.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.3 p -33.18 106.01 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 129.185 2.994 . . . . 0.0 112.719 -175.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.509 HG21 HG23 ' A' ' 59' ' ' ILE . 5.0 t -109.92 -177.22 3.21 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -174.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -92.44 -64.1 1.15 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.781 2.032 . . . . 0.0 112.21 175.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.2 p -144.06 131.91 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.989 1.315 . . . . 0.0 111.686 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.509 HG23 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -131.01 -20.01 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 126.046 1.739 . . . . 0.0 113.595 178.21 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.3 mp -106.8 88.47 3.56 Favored Pre-proline 0 N--CA 1.45 -0.434 0 C-N-CA 125.902 1.681 . . . . 0.0 107.279 -174.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -59.14 151.9 63.45 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.615 2.21 . . . . 0.0 110.843 176.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -42.87 -49.02 5.89 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.335 1.854 . . . . 0.0 113.523 -178.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.6 p -160.79 140.63 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 127.039 2.136 . . . . 0.0 109.259 175.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 66.3 t -116.91 127.46 26.71 Favored Pre-proline 0 N--CA 1.477 0.92 0 C-N-CA 124.63 1.172 . . . . 0.0 108.325 175.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.623 ' HA ' HG22 ' A' ' 43' ' ' THR . 60.4 Cg_endo -66.23 157.65 58.87 Favored 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 122.123 1.882 . . . . 0.0 112.424 178.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -70.47 160.63 32.06 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 121.785 -0.572 . . . . 0.0 110.66 175.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 31.8 p 60.96 19.14 9.56 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 126.621 1.969 . . . . 0.0 113.697 -174.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 42.2 mttt -131.65 171.24 13.7 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.612 1.565 . . . . 0.0 111.489 -178.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.522 ' HB3' HD23 ' A' ' 13' ' ' LEU . . . -122.52 179.11 4.7 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 123.855 0.862 . . . . 0.0 111.839 -174.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -149.75 168.99 22.11 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 125.526 1.53 . . . . 0.0 110.948 174.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.412 HD13 ' O ' ' A' ' 34' ' ' VAL . 0.4 OUTLIER -119.08 158.14 26.45 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.879 1.672 . . . . 0.0 111.323 178.548 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.672 ' HB2' HG22 ' A' ' 34' ' ' VAL . 9.1 m-85 -130.27 144.25 51.26 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.343 1.057 . . . . 0.0 110.051 174.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.5 p -120.58 138.57 53.81 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 126.812 2.045 . . . . 0.0 110.365 175.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.503 ' N ' HD12 ' A' ' 3' ' ' LEU . . . -150.85 129.73 2.98 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 174.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.06 107.2 9.41 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 127.67 2.388 . . . . 0.0 111.599 -175.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.96 -174.11 0.43 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 126.092 1.757 . . . . 0.0 112.875 176.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.4 t 69.57 37.74 1.88 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.883 1.673 . . . . 0.0 113.476 175.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.7 t -66.53 -24.12 66.33 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.833 1.253 . . . . 0.0 114.119 177.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 130.13 -64.98 0.6 Allowed Glycine 0 CA--C 1.538 1.507 0 C-N-CA 125.259 1.409 . . . . 0.0 113.373 -175.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -71.74 -31.97 12.34 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.97 2.447 . . . . 0.0 114.017 -175.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.8 p -151.13 157.1 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 125.365 1.466 . . . . 0.0 111.083 177.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -153.5 96.84 2.07 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.213 1.405 . . . . 0.0 112.021 -177.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 42.2 m -124.29 141.39 52.11 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 125.658 1.583 . . . . 0.0 108.929 175.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -21.98 -74.9 0.01 OUTLIER Glycine 0 N--CA 1.485 1.937 0 C-N-CA 127.452 2.453 . . . . 0.0 113.742 -178.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -163.05 120.4 1.92 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.869 1.668 . . . . 0.0 109.839 174.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.9 t -144.1 114.55 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.168 0.987 . . . . 0.0 109.826 -178.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.566 ' HB3' ' CZ ' ' A' ' 103' ' ' PHE . . . -163.29 164.36 24.93 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.964 0.888 . . . . 0.0 113.186 -176.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -144.52 162.19 37.19 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.252 1.421 . . . . 0.0 112.076 174.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -160.78 172.65 16.66 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 124.672 1.189 . . . . 0.0 110.575 179.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.49 ' HB2' ' HB2' ' A' ' 127' ' ' ALA . . . -136.81 160.38 39.04 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 175.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -137.37 131.18 31.72 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.835 1.254 . . . . 0.0 113.892 175.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -79.36 109.04 13.34 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.947 0.899 . . . . 0.0 110.691 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 4.0 ttm -72.1 145.08 48.42 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.143 0.977 . . . . 0.0 111.937 175.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 14.3 t -61.69 -28.16 69.2 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.296 1.038 . . . . 0.0 112.955 175.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 -69.44 -8.09 43.66 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.825 1.25 . . . . 0.0 113.782 175.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 91.95 39.53 5.46 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.318 0.961 . . . . 0.0 113.951 177.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -138.34 171.88 13.72 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.184 1.393 . . . . 0.0 110.484 175.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.432 HG21 ' O ' ' A' ' 125' ' ' ARG . 53.5 m -122.22 111.9 17.52 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 119.075 0.852 . . . . 0.0 113.163 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 61.9 tp -73.32 101.44 3.42 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.583 1.953 . . . . 0.0 110.404 174.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -91.01 117.6 5.18 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 126.221 1.867 . . . . 0.0 112.318 176.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 91.1 t -119.17 141.62 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 125.642 1.577 . . . . 0.0 110.68 -175.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 2.9 ppp? -148.37 170.22 18.44 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.897 0.856 . . . . 0.0 113.296 174.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.566 ' CZ ' ' HB3' ' A' ' 87' ' ' ALA . 18.0 p90 -152.71 149.28 28.22 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.625 1.57 . . . . 0.0 113.89 175.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 22.4 t -143.1 107.71 4.84 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.585 1.554 . . . . 0.0 110.086 175.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 10.8 m -127.48 97.69 30.46 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 125.597 1.559 . . . . 0.0 109.021 175.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -69.54 172.09 13.05 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 122.564 2.176 . . . . 0.0 111.46 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -87.62 -58.18 2.67 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.387 0.675 . . . . 0.0 110.732 174.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -61.93 -35.53 78.69 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.249 1.42 . . . . 0.0 113.961 -174.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 54.38 9.16 0.23 Allowed 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 126.805 2.042 . . . . 0.0 115.886 -176.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -74.62 -75.55 0.16 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.111 1.765 . . . . 0.0 113.82 -175.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 75.7 m95 -108.05 -42.18 4.73 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.327 1.451 . . . . 0.0 114.105 -175.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -59.22 109.03 0.77 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.73 1.212 . . . . 0.0 111.437 178.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 19.3 m -57.0 143.21 39.03 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.528 1.131 . . . . 0.0 111.276 175.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -124.66 95.69 4.61 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.239 1.015 . . . . 0.0 109.898 -176.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 51.9 m0 -110.74 148.24 32.74 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.19 0.519 . . . . 0.0 111.656 -177.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 17.5 p-90 -149.13 135.17 19.03 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.366 0.667 . . . . 0.0 112.566 -174.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -161.4 173.39 14.99 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 122.732 1.253 . . . . 0.0 113.111 175.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 60.3 t -138.59 143.85 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 126.462 1.905 . . . . 0.0 107.98 176.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.67 174.56 11.34 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.601 1.561 . . . . 0.0 110.565 178.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 26.0 mt -127.09 138.77 53.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 174.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 99.7 m-85 -102.35 149.56 36.77 Favored Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 125.103 1.361 . . . . 0.0 111.966 176.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -69.48 113.39 3.31 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.861 3.041 . . . . 0.0 111.321 176.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 69.16 -171.63 39.14 Favored Glycine 0 CA--C 1.537 1.421 0 O-C-N 121.896 -0.503 . . . . 0.0 114.119 -175.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 11.8 tmtt? -58.15 113.15 1.79 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.565 1.546 . . . . 0.0 111.594 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.432 ' O ' HG21 ' A' ' 98' ' ' THR . 0.0 OUTLIER -134.08 113.69 12.37 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.768 1.227 . . . . 0.0 111.465 -178.782 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 4.5 ptp180 -57.65 161.72 3.49 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.711 -0.618 . . . . 0.0 112.308 175.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.49 ' HB2' ' HB2' ' A' ' 90' ' ' ALA . . . -113.12 99.02 7.51 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 175.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -124.5 167.48 14.38 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.591 1.556 . . . . 0.0 109.988 -177.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -53.25 -38.94 63.46 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.185 0.994 . . . . 0.0 113.425 -177.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -60.61 -57.67 17.77 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 123.753 0.692 . . . . 0.0 112.151 176.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 3.3 mtm -61.4 -37.22 82.65 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.326 0.65 . . . . 0.0 112.524 178.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.82 -62.91 1.46 Allowed 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.768 0.713 . . . . 0.0 110.0 174.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -60.37 -40.4 90.68 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.104 0.962 . . . . 0.0 113.145 -175.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -60.53 -46.48 90.02 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.062 0.945 . . . . 0.0 112.441 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 78.1 mmm -82.25 -30.84 30.49 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 177.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -55.19 -57.21 12.7 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.295 1.838 . . . . 0.0 110.769 175.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.32 -20.09 65.99 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-O 121.439 0.638 . . . . 0.0 112.166 -177.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -80.35 -2.55 89.41 Favored Glycine 0 CA--C 1.538 1.483 0 C-N-CA 126.744 2.116 . . . . 0.0 114.839 175.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -141.77 77.32 19.06 Favored Pre-proline 0 CA--C 1.553 1.081 0 CA-C-N 119.62 1.71 . . . . 0.0 114.145 -175.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.89 101.05 1.27 Allowed 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 123.688 2.925 . . . . 0.0 113.266 -176.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -138.2 123.31 19.16 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.583 1.153 . . . . 0.0 110.704 178.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 4.6 mpt_? -93.34 -157.29 0.53 Allowed 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 125.297 1.439 . . . . 0.0 111.081 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -86.12 77.5 2.03 Favored Glycine 0 CA--C 1.531 1.037 0 O-C-N 120.132 -1.605 . . . . 0.0 110.116 175.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -75.99 85.14 2.89 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.152 1.781 . . . . 0.0 111.171 -175.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -54.43 116.39 2.62 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 -174.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 141.78 -73.01 0.38 Allowed Glycine 0 CA--C 1.533 1.212 0 C-N-CA 125.251 1.405 . . . . 0.0 114.057 175.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 27.9 m95 169.19 106.33 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 131.199 3.8 . . . . 0.0 108.485 -174.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -137.92 132.19 32.04 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 127.327 2.251 . . . . 0.0 110.471 -177.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -158.38 -173.66 4.42 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -175.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.3 mtmm -140.4 162.84 34.36 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 126.501 1.921 . . . . 0.0 111.564 175.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -73.29 137.34 44.8 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.431 1.092 . . . . 0.0 109.456 174.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 45.1 mt -92.97 88.74 6.26 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.294 1.038 . . . . 0.0 110.478 177.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 35.81 -76.45 0.0 OUTLIER Glycine 0 N--CA 1.477 1.405 1 C-N-CA 130.83 4.062 . . . . 0.0 116.592 175.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -70.02 -153.45 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 128.311 2.645 . . . . 0.0 110.472 175.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -75.42 24.52 1.42 Allowed Glycine 0 CA--C 1.542 1.742 0 O-C-N 120.15 -1.594 . . . . 0.0 115.072 174.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.84 149.06 24.58 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 120.211 2.005 . . . . 0.0 111.698 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 61.5 mtt85 -140.89 114.33 8.73 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.736 1.214 . . . . 0.0 111.433 177.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . 0.402 ' SD ' HG21 ' A' ' 172' ' ' ILE . 8.0 ttp -94.96 143.17 26.68 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 125.28 1.432 . . . . 0.0 108.803 175.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 4.4 tppt? -121.98 124.9 45.11 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 127.199 2.199 . . . . 0.0 109.853 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -137.58 158.61 24.59 Favored Glycine 0 N--CA 1.478 1.439 0 N-CA-C 117.974 1.95 . . . . 0.0 117.974 -175.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.518 HD13 ' N ' ' A' ' 162' ' ' MET . 0.0 OUTLIER -147.69 131.72 9.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 C-N-CA 125.372 1.469 . . . . 0.0 111.668 -177.049 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . 0.518 ' N ' HD13 ' A' ' 161' ' ' ILE . 3.5 mtm -149.77 160.93 43.16 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 128.537 2.735 . . . . 0.0 108.231 174.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 5.5 t -140.89 133.91 29.28 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 121.133 -0.979 . . . . 0.0 112.003 174.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 45.6 m -74.4 12.29 0.8 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.433 1.493 . . . . 0.0 114.187 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -51.01 -43.0 60.76 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.77 1.628 . . . . 0.0 114.21 176.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 146.91 -77.79 0.25 Allowed Glycine 0 CA--C 1.532 1.105 0 C-N-CA 125.139 1.352 . . . . 0.0 112.845 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 27.5 tp10 -95.83 43.81 1.08 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 125.145 1.378 . . . . 0.0 110.831 -177.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -77.24 172.57 13.07 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.301 1.04 . . . . 0.0 112.928 178.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.402 ' HE2' ' O ' ' A' ' 169' ' ' LYS . 0.0 OUTLIER -114.07 173.93 6.19 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 126.711 2.004 . . . . 0.0 109.633 174.919 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 2.0 tmm? -126.85 123.17 36.7 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 125.385 1.474 . . . . 0.0 109.12 178.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -132.4 128.46 37.6 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.504 0.721 . . . . 0.0 110.532 177.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.402 HG21 ' SD ' ' A' ' 158' ' ' MET . 4.8 mp -135.61 122.97 35.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 123.428 0.691 . . . . 0.0 110.11 175.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -118.88 136.1 54.22 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.556 1.542 . . . . 0.0 110.043 176.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.8 mp -82.93 137.15 21.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 O-C-N 121.315 -0.866 . . . . 0.0 109.241 175.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 9.3 m -128.78 95.9 4.23 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.229 1.012 . . . . 0.0 111.85 176.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 7.2 mmm180 . . . . . 0 C--O 1.253 1.288 0 C-N-CA 126.296 1.838 . . . . 0.0 111.75 174.945 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 37.4 m . . . . . 0 N--CA 1.478 0.954 0 CA-C-O 121.042 0.448 . . . . 0.0 110.555 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -143.4 177.87 8.14 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 128.295 2.638 . . . . 0.0 109.615 -177.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.502 HD11 ' HB2' ' A' ' 31' ' ' LYS . 16.1 mt -121.28 -10.84 8.88 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.736 1.214 . . . . 0.0 112.908 174.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -75.14 96.08 3.21 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.626 -0.671 . . . . 0.0 110.083 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -60.94 -75.48 0.29 Allowed Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.426 1.013 . . . . 0.0 112.314 -176.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 27.4 p -150.85 172.3 15.85 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 127.189 2.196 . . . . 0.0 110.423 174.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -124.79 5.51 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 124.934 1.294 . . . . 0.0 112.75 175.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 pt -24.42 -75.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 129.591 3.156 . . . . 0.0 116.673 -176.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -162.47 137.59 6.97 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.218 1.407 . . . . 0.0 111.324 -177.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.65 -21.49 58.07 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 124.577 1.084 . . . . 0.0 114.641 -178.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.27 -31.11 72.18 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.233 1.013 . . . . 0.0 113.175 174.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.5 t -102.96 -40.87 6.32 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 125.083 1.353 . . . . 0.0 111.726 175.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 14.3 tp -74.24 82.74 1.85 Allowed 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.235 1.414 . . . . 0.0 111.099 175.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.8 p -113.98 179.68 3.89 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 126.654 1.981 . . . . 0.0 112.425 176.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -47.47 -42.2 22.2 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.064 1.346 . . . . 0.0 113.019 176.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -57.55 -37.88 73.86 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.759 0.823 . . . . 0.0 112.174 178.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.6 t -67.48 -41.16 85.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.083 0.953 . . . . 0.0 110.283 175.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 21.3 mt -63.71 -41.08 98.15 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 121.33 -0.856 . . . . 0.0 110.961 177.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.39 -44.15 92.23 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.793 0.837 . . . . 0.0 112.641 178.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.68 -32.6 62.26 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 175.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.1 t -51.4 -46.49 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 C-N-CA 125.601 1.56 . . . . 0.0 111.933 175.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 15.0 mt -53.97 -20.15 5.76 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.188 1.395 . . . . 0.0 113.716 178.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -108.42 -40.08 1.68 Allowed Glycine 0 CA--C 1.537 1.415 0 C-N-CA 126.134 1.826 . . . . 0.0 114.926 178.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -72.05 -28.61 63.46 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 119.768 1.784 . . . . 0.0 113.965 179.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -92.24 133.36 35.89 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.83 1.252 . . . . 0.0 110.992 176.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.12 125.11 7.19 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 125.261 1.41 . . . . 0.0 113.852 -175.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.94 -172.19 4.15 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 126.366 1.866 . . . . 0.0 112.053 -177.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.9 m -72.47 -177.96 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 126.085 1.754 . . . . 0.0 110.898 174.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 60.9 m -49.7 -50.01 45.53 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.517 1.527 . . . . 0.0 113.529 -177.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -117.43 138.21 51.99 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.041 1.337 . . . . 0.0 110.662 175.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.502 ' HB2' HD11 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -141.42 161.09 38.75 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 126.132 1.773 . . . . 0.0 111.593 -175.062 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -131.25 114.25 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-O 122.238 1.018 . . . . 0.0 112.018 -179.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -117.31 111.51 19.48 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.735 2.014 . . . . 0.0 109.111 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.811 HG22 ' HB2' ' A' ' 72' ' ' TYR . 1.8 m -116.67 151.98 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 CA-C-O 119.097 -0.478 . . . . 0.0 111.272 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -131.12 101.34 0.48 Allowed Glycine 0 CA--C 1.524 0.649 0 C-N-CA 123.815 0.722 . . . . 0.0 112.872 -179.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.9 mp -91.93 136.22 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-N 118.209 1.005 . . . . 0.0 110.318 175.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -101.13 104.48 15.58 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.185 1.394 . . . . 0.0 110.666 178.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -70.39 82.74 0.56 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 127.889 2.476 . . . . 0.0 111.057 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -120.85 11.64 11.14 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 125.109 1.364 . . . . 0.0 114.144 175.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 99.8 p -60.15 -7.51 1.92 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 126.67 1.988 . . . . 0.0 116.351 174.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 93.57 21.05 30.1 Favored Glycine 0 CA--C 1.54 1.626 0 N-CA-C 116.281 1.272 . . . . 0.0 116.281 177.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -166.49 169.56 40.63 Favored Glycine 0 CA--C 1.535 1.305 0 CA-C-N 119.27 1.535 . . . . 0.0 114.196 176.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.556 HG22 ' HA ' ' A' ' 65' ' ' PRO . 7.3 p -72.98 141.75 47.75 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.81 1.244 . . . . 0.0 111.396 175.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.56 ' HA ' ' CE1' ' A' ' 91' ' ' TYR . 34.7 m0 -100.97 98.04 8.55 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 123.586 0.755 . . . . 0.0 112.353 -177.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.1 m -81.72 120.41 25.09 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.266 1.026 . . . . 0.0 108.704 175.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.08 150.51 45.33 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.685 -0.634 . . . . 0.0 112.145 174.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.8 pp -124.25 -51.02 1.77 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.639 0.776 . . . . 0.0 112.976 177.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -171.06 142.89 1.88 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 127.043 2.137 . . . . 0.0 109.738 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.431 ' HB2' HD12 ' A' ' 60' ' ' LEU . . . -121.17 151.44 39.93 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.614 1.166 . . . . 0.0 109.94 174.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -132.67 106.54 7.84 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.413 1.485 . . . . 0.0 111.27 -177.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.498 ' CD1' ' HB1' ' A' ' 87' ' ' ALA . 2.7 m-85 -111.58 124.64 52.71 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.481 1.112 . . . . 0.0 110.248 -175.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.13 -34.2 6.01 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 114.174 1.175 . . . . 0.0 114.174 -174.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 43.7 t -119.0 -47.92 2.47 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.657 1.183 . . . . 0.0 110.375 175.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -67.55 12.27 0.74 Allowed Glycine 0 CA--C 1.54 1.603 0 C-N-CA 126.865 2.174 . . . . 0.0 117.623 -174.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 76.0 p -27.14 107.69 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 129.597 3.159 . . . . 0.0 114.671 -175.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.482 HG21 HG23 ' A' ' 59' ' ' ILE . 3.9 t -128.75 -177.05 4.04 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.826 2.05 . . . . 0.0 113.509 -175.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -88.44 -54.79 4.01 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.051 1.341 . . . . 0.0 113.897 177.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.9 p -149.89 133.45 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 124.898 1.279 . . . . 0.0 111.99 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.482 HG23 HG21 ' A' ' 56' ' ' THR . 0.1 OUTLIER -136.68 -35.18 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 N-CA-C 114.838 1.422 . . . . 0.0 114.838 179.29 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.431 HD12 ' HB2' ' A' ' 49' ' ' ALA . 7.2 mt -88.5 100.05 1.78 Allowed Pre-proline 0 CA--C 1.543 0.694 0 C-N-CA 125.665 1.586 . . . . 0.0 108.599 176.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.576 ' HG2' HG23 ' A' ' 64' ' ' VAL . 89.3 Cg_endo -68.51 150.53 75.34 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 122.554 2.17 . . . . 0.0 110.985 176.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -48.1 -45.54 32.85 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.983 1.313 . . . . 0.0 113.446 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.2 p -156.26 136.19 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 126.398 1.879 . . . . 0.0 110.287 175.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.576 HG23 ' HG2' ' A' ' 61' ' ' PRO . 72.7 t -113.71 129.96 24.22 Favored Pre-proline 0 N--CA 1.481 1.079 0 C-N-CA 124.55 1.14 . . . . 0.0 108.691 174.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.556 ' HA ' HG22 ' A' ' 43' ' ' THR . 66.4 Cg_endo -70.43 158.25 56.63 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 122.667 2.245 . . . . 0.0 113.271 178.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -72.94 160.72 31.67 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 121.421 -0.799 . . . . 0.0 112.726 175.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . 0.275 51.4 p 57.64 23.77 9.74 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 127.077 2.151 . . . . 0.0 113.689 -175.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -119.03 -178.32 3.54 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 126.765 2.026 . . . . 0.0 110.732 178.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -136.54 152.54 50.61 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 175.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.452 HD23 HG21 ' A' ' 64' ' ' VAL . 1.5 pp -117.7 171.01 8.32 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 124.417 1.087 . . . . 0.0 110.963 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.464 HD13 ' O ' ' A' ' 34' ' ' VAL . 0.3 OUTLIER -126.22 153.41 44.75 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.624 1.17 . . . . 0.0 111.004 175.47 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.811 ' HB2' HG22 ' A' ' 34' ' ' VAL . 6.3 m-85 -125.88 153.39 44.24 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.832 1.653 . . . . 0.0 108.835 174.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.402 ' H ' HG22 ' A' ' 59' ' ' ILE . 95.8 p -133.97 141.36 47.26 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 126.197 1.799 . . . . 0.0 111.3 176.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.473 ' H ' HD12 ' A' ' 3' ' ' LEU . . . -162.12 150.38 19.62 Favored Glycine 0 CA--C 1.524 0.624 0 O-C-N 121.916 -0.49 . . . . 0.0 113.092 174.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 11.4 mtm180 -112.24 130.83 55.8 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 126.289 1.836 . . . . 0.0 111.968 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -61.15 -30.85 70.63 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.688 1.595 . . . . 0.0 115.12 175.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 26.0 m -74.69 72.99 2.02 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 127.25 2.22 . . . . 0.0 113.898 -175.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 52.2 p -66.61 -21.68 66.13 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 177.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 126.37 -74.69 0.42 Allowed Glycine 0 CA--C 1.537 1.448 0 C-N-CA 126.494 1.997 . . . . 0.0 112.036 -175.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.62 -50.46 0.29 Allowed 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 123.723 2.949 . . . . 0.0 113.946 -175.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.1 m -142.67 126.94 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 125.695 1.598 . . . . 0.0 111.646 -176.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -83.38 103.64 12.91 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.48 1.112 . . . . 0.0 111.965 178.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 42.9 m -112.63 71.69 0.75 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.064 1.346 . . . . 0.0 111.263 -174.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 37.82 -114.26 0.28 Allowed Glycine 0 CA--C 1.533 1.193 0 C-N-CA 126.103 1.811 . . . . 0.0 113.969 -178.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.593 ' HB3' HG22 ' A' ' 105' ' ' VAL . . . -141.45 114.84 8.84 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 118.458 1.129 . . . . 0.0 111.274 176.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.2 t -137.33 122.25 24.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 C-N-CA 124.323 1.049 . . . . 0.0 110.18 -176.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.498 ' HB1' ' CD1' ' A' ' 51' ' ' PHE . . . -163.51 171.34 16.0 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.302 1.441 . . . . 0.0 111.359 175.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -151.48 134.38 15.75 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.889 1.275 . . . . 0.0 109.943 174.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.424 ' CD2' ' CE2' ' A' ' 72' ' ' TYR . 54.3 p90 -129.72 171.24 12.87 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 121.27 -0.894 . . . . 0.0 110.285 177.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -143.26 143.9 31.91 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 175.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.56 ' CE1' ' HA ' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -109.98 131.36 55.13 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.497 1.119 . . . . 0.0 109.995 177.289 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -84.51 107.6 16.84 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.364 0.665 . . . . 0.0 112.593 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -68.38 141.64 55.68 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.45 1.1 . . . . 0.0 112.94 -178.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 58.0 p -60.15 -28.24 67.75 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.845 1.258 . . . . 0.0 112.548 174.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 -72.24 -8.23 53.68 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.731 1.612 . . . . 0.0 112.757 174.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 99.99 -6.71 58.52 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 126.662 2.077 . . . . 0.0 114.362 -178.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 53.5 m-20 -78.12 178.33 7.64 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 118.339 1.07 . . . . 0.0 111.34 178.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 19.0 m -139.31 109.12 6.28 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 120.453 -1.404 . . . . 0.0 111.22 174.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.6 tt -72.8 101.81 3.22 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.566 1.146 . . . . 0.0 111.289 175.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -92.79 127.78 9.14 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 125.171 1.367 . . . . 0.0 113.333 175.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 63.5 t -114.44 127.02 72.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 125.763 1.625 . . . . 0.0 111.224 -175.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.11 118.61 24.71 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 126.733 2.013 . . . . 0.0 112.438 -175.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -141.69 121.28 13.34 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.33 1.452 . . . . 0.0 111.642 -175.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 30.4 t -137.3 92.53 2.72 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.473 1.509 . . . . 0.0 110.92 -175.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.593 HG22 ' HB3' ' A' ' 85' ' ' ALA . 2.1 m -103.09 125.73 34.4 Favored Pre-proline 0 N--CA 1.473 0.68 0 C-N-CA 125.105 1.362 . . . . 0.0 109.669 -179.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -75.72 175.25 11.53 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 122.933 2.422 . . . . 0.0 111.582 176.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -95.98 -52.62 3.98 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.581 1.153 . . . . 0.0 112.401 178.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 26.1 p30 -95.0 -4.5 46.47 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.691 1.596 . . . . 0.0 114.72 -176.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 47.15 31.25 1.6 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 127.005 2.122 . . . . 0.0 113.974 -177.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -122.06 143.5 49.48 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.189 1.795 . . . . 0.0 111.716 -175.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 22.8 m95 55.89 14.48 1.38 Allowed 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 126.574 1.95 . . . . 0.0 114.636 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -149.86 175.94 11.18 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 127.408 2.283 . . . . 0.0 111.858 -174.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 17.1 m -139.37 136.11 34.41 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.648 1.179 . . . . 0.0 113.93 175.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 32.5 t-20 -74.34 106.29 5.9 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.08 1.752 . . . . 0.0 107.912 175.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 44.3 m0 -113.16 145.68 40.53 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 120.297 1.408 . . . . 0.0 108.31 174.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 39.2 p-90 -149.02 142.82 25.63 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.095 0.958 . . . . 0.0 113.047 -177.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -151.69 165.77 33.34 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 123.292 1.52 . . . . 0.0 113.821 -177.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 94.7 t -147.41 129.54 7.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 125.894 1.678 . . . . 0.0 107.349 175.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.33 171.6 14.23 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.515 1.526 . . . . 0.0 110.127 175.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 35.3 mt -134.32 118.59 27.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.762 0.792 . . . . 0.0 109.231 -176.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -80.59 139.12 50.97 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 124.185 0.994 . . . . 0.0 109.23 178.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -72.97 -1.53 10.63 Favored 'Trans proline' 0 CA--C 1.546 1.119 0 C-N-CA 123.706 2.937 . . . . 0.0 114.948 -178.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -141.74 176.27 22.04 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 126.857 2.17 . . . . 0.0 111.94 175.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 9.9 tttm -64.26 105.61 0.94 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.934 1.294 . . . . 0.0 110.884 176.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 11.2 tpp180 -138.77 117.96 12.67 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 124.381 1.072 . . . . 0.0 113.22 -174.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 15.4 ptt180 -62.98 165.42 6.9 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 175.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -110.22 103.18 11.84 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 174.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -111.8 170.82 7.88 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.329 1.051 . . . . 0.0 109.642 175.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -50.07 -39.52 42.46 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.377 0.99 . . . . 0.0 113.304 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -59.42 -59.72 10.11 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 123.869 0.747 . . . . 0.0 112.175 175.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 14.6 mtm -61.82 -35.33 77.9 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 118.058 0.929 . . . . 0.0 113.298 178.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -60.56 -60.49 3.73 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.088 1.355 . . . . 0.0 109.756 175.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -67.26 -29.75 69.45 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -63.96 -36.73 84.91 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.34 1.056 . . . . 0.0 113.019 176.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 7.9 tpp -94.53 -22.23 18.36 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 119.695 1.134 . . . . 0.0 113.463 175.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -49.28 -56.6 8.88 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.602 1.561 . . . . 0.0 110.316 175.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -71.19 -7.02 43.93 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -178.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -84.89 -12.83 73.52 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 126.983 2.23 . . . . 0.0 114.946 -178.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -145.54 90.27 6.04 Favored Pre-proline 0 CA--C 1.552 1.025 0 CA-C-N 119.309 1.555 . . . . 0.0 112.956 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -75.48 81.8 2.23 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 123.674 2.916 . . . . 0.0 112.19 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -116.97 111.64 19.87 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.985 1.314 . . . . 0.0 110.182 -177.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -92.61 41.36 1.07 Allowed 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 127.564 2.346 . . . . 0.0 114.05 -174.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 55.77 51.76 53.03 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 123.704 0.669 . . . . 0.0 112.538 -177.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -61.01 113.63 2.65 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.613 1.165 . . . . 0.0 111.418 -176.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -75.96 83.18 2.85 Favored 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 -175.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 173.09 55.07 0.05 OUTLIER Glycine 0 CA--C 1.539 1.544 0 C-N-CA 125.107 1.336 . . . . 0.0 114.135 175.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' TRP . . . . . 0.63 ' H ' HD13 ' A' ' 161' ' ' ILE . 7.5 m95 48.16 41.72 16.15 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 126.81 2.044 . . . . 0.0 114.077 -174.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -72.75 126.96 31.15 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 120.845 -1.16 . . . . 0.0 111.784 -175.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.15 -170.23 3.06 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -174.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.71 140.92 36.92 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 126.043 1.737 . . . . 0.0 110.447 175.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -67.0 149.36 50.74 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 174.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 29.3 mt -119.79 158.42 26.59 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-O 123.824 1.773 . . . . 0.0 111.435 178.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -64.45 -157.5 0.23 Allowed Glycine 0 CA--C 1.54 1.623 0 C-N-CA 125.62 1.581 . . . . 0.0 111.2 174.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 51.46 15.12 0.3 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.944 -1.327 . . . . 0.0 114.527 175.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 72.66 34.83 59.46 Favored Glycine 0 CA--C 1.54 1.608 0 CA-C-O 117.141 -1.922 . . . . 0.0 113.805 -175.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -139.21 159.41 42.23 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 121.21 2.505 . . . . 0.0 115.188 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 19.4 mtt-85 -135.33 123.7 23.28 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 120.439 -1.413 . . . . 0.0 108.693 -177.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 13.7 ttp -96.14 136.38 36.69 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 176.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.85 129.21 56.33 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 126.803 2.041 . . . . 0.0 109.867 -178.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -136.8 156.36 23.16 Favored Glycine 0 N--CA 1.476 1.36 0 CA-C-N 121.684 2.038 . . . . 0.0 116.293 -177.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.63 HD13 ' H ' ' A' ' 147' ' ' TRP . 6.1 tp -154.56 126.43 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 124.96 1.304 . . . . 0.0 112.527 -174.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 19.5 ttm -148.82 -176.27 5.27 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 128.641 2.776 . . . . 0.0 108.509 177.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 8.9 t -163.01 127.31 2.98 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.527 1.131 . . . . 0.0 111.631 174.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.37 19.61 0.1 Allowed 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.027 1.331 . . . . 0.0 114.11 178.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -58.34 -25.94 62.55 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 127.291 2.236 . . . . 0.0 115.631 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 147.14 -57.87 0.49 Allowed Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.562 1.077 . . . . 0.0 114.48 175.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -133.28 37.9 3.34 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.144 1.378 . . . . 0.0 112.001 -178.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.33 174.58 4.65 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-O 122.61 1.195 . . . . 0.0 113.849 175.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.64 176.26 5.22 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 127.741 2.416 . . . . 0.0 111.527 175.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 1.8 tmm? -128.18 130.91 48.76 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 126.277 1.831 . . . . 0.0 109.648 175.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.448 ' C ' HD12 ' A' ' 172' ' ' ILE . 47.1 tt0 -141.14 131.39 24.96 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.48 1.112 . . . . 0.0 110.203 -178.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.448 HD12 ' C ' ' A' ' 171' ' ' GLN . 4.0 mp -136.11 126.01 40.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 123.883 0.873 . . . . 0.0 109.612 175.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -119.39 129.27 54.72 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 126.516 1.926 . . . . 0.0 111.119 178.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.6 mp -88.55 93.1 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 O-C-N 121.278 -0.889 . . . . 0.0 109.692 -177.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.04 107.51 19.26 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.628 1.571 . . . . 0.0 112.691 179.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.252 1.188 0 C-N-CA 125.547 1.539 . . . . 0.0 112.836 175.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 16.0 m . . . . . 0 N--CA 1.482 1.138 0 CA-C-O 120.33 0.11 . . . . 0.0 110.815 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -84.3 169.43 14.69 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.785 1.234 . . . . 0.0 112.781 177.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.479 HD22 ' HD3' ' A' ' 27' ' ' LYS . 13.7 tp -130.11 -7.82 4.35 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.716 1.206 . . . . 0.0 113.779 174.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -126.1 141.11 52.08 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 127.813 2.445 . . . . 0.0 109.213 175.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -79.75 -136.95 1.51 Allowed Glycine 0 CA--C 1.538 1.504 0 C-N-CA 124.844 1.212 . . . . 0.0 110.989 174.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.0 p -107.31 176.01 5.3 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 125.5 1.52 . . . . 0.0 112.941 -175.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -119.13 17.26 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 126.352 1.861 . . . . 0.0 111.945 -178.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.3 pt -50.39 159.64 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 125.662 1.585 . . . . 0.0 111.349 175.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -42.82 140.26 1.4 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.456 1.502 . . . . 0.0 113.328 -176.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -56.29 -20.9 31.01 Favored Glycine 0 CA--C 1.543 1.788 0 C-N-CA 124.28 0.943 . . . . 0.0 113.745 -176.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.2 -28.55 69.82 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.621 1.568 . . . . 0.0 112.609 174.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 t -101.28 -44.57 5.61 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.974 1.71 . . . . 0.0 111.515 175.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.7 tp -75.81 88.49 2.84 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.278 1.031 . . . . 0.0 111.429 175.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 55.1 p -124.65 -175.09 3.18 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 126.156 1.782 . . . . 0.0 111.344 176.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -50.3 -31.36 14.13 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.851 1.26 . . . . 0.0 113.645 175.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -59.46 -50.31 74.4 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 118.97 0.805 . . . . 0.0 110.902 175.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 73.8 t -64.53 -39.13 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 123.915 0.886 . . . . 0.0 110.974 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 90.2 mt -70.58 -42.12 71.48 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 123.349 0.66 . . . . 0.0 112.62 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -71.17 -44.21 65.93 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.953 0.901 . . . . 0.0 111.607 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.72 -39.8 95.2 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 118.426 -0.797 . . . . 0.0 110.826 175.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.0 t -53.5 -43.59 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 125.054 1.342 . . . . 0.0 112.271 175.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.486 ' HA ' ' HE3' ' A' ' 31' ' ' LYS . 0.1 OUTLIER -60.39 -25.99 66.33 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 175.015 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.57 -48.92 3.33 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.203 0.906 . . . . 0.0 112.979 178.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -70.61 -27.44 64.09 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 17.8 mt -109.31 102.22 11.15 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.737 1.215 . . . . 0.0 110.461 -177.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -131.77 73.15 0.47 Allowed Glycine 0 CA--C 1.534 1.252 0 C-N-CA 125.112 1.339 . . . . 0.0 113.364 -175.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.479 ' HD3' HD22 ' A' ' 3' ' ' LEU . 0.1 OUTLIER -62.0 -58.68 6.96 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 126.416 1.886 . . . . 0.0 113.683 -178.646 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 16.4 m -127.27 -176.92 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 126.497 1.919 . . . . 0.0 110.748 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -47.98 -36.49 12.71 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 115.576 1.695 . . . . 0.0 115.576 -175.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.8 155.69 49.48 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.711 2.004 . . . . 0.0 108.01 174.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.486 ' HE3' ' HA ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -145.67 164.19 32.55 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.919 1.287 . . . . 0.0 110.768 175.988 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.501 ' CG1' ' HB1' ' A' ' 85' ' ' ALA . 0.3 OUTLIER -118.49 138.16 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 124.572 1.149 . . . . 0.0 108.439 175.018 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.452 ' HB3' HD12 ' A' ' 22' ' ' LEU . . . -138.68 132.04 30.22 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.147 1.379 . . . . 0.0 109.597 175.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.402 HG22 ' HB3' ' A' ' 170' ' ' MET . 16.5 t -137.91 148.29 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 123.364 0.666 . . . . 0.0 111.398 -177.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -119.47 93.13 0.54 Allowed Glycine 0 CA--C 1.525 0.677 0 C-N-CA 126.658 2.075 . . . . 0.0 113.161 175.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.7 mp -81.4 136.43 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-N 119.424 1.612 . . . . 0.0 108.788 174.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -112.65 102.46 10.52 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.164 1.786 . . . . 0.0 109.868 178.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -70.32 92.43 0.79 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.867 1.267 . . . . 0.0 109.563 177.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -117.29 0.26 12.2 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.052 1.741 . . . . 0.0 112.722 174.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 23.0 t -50.77 -58.89 4.82 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 126.141 1.776 . . . . 0.0 113.249 -178.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 149.49 -26.4 1.21 Allowed Glycine 0 N--CA 1.473 1.15 0 C-N-CA 124.165 0.888 . . . . 0.0 114.113 178.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -115.96 162.79 12.47 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.541 1.544 . . . . 0.0 111.226 175.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.4 t -85.13 155.58 21.41 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 123.879 0.872 . . . . 0.0 110.781 175.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 7.7 m0 -111.46 153.57 25.95 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 125.352 1.461 . . . . 0.0 112.031 176.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 95.0 m -130.24 141.46 50.63 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.853 1.261 . . . . 0.0 109.925 177.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.47 108.83 0.52 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.749 1.22 . . . . 0.0 112.571 177.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.508 HD11 ' HB3' ' A' ' 90' ' ' ALA . 3.5 pp -104.85 -53.71 2.63 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.286 1.034 . . . . 0.0 112.234 -179.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.476 ' N ' HD12 ' A' ' 47' ' ' LEU . 29.3 t30 -177.73 144.8 0.38 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 127.907 2.483 . . . . 0.0 110.415 -178.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -130.54 159.31 37.5 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.111 1.365 . . . . 0.0 111.512 175.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -142.92 104.2 4.29 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.878 1.271 . . . . 0.0 112.944 -175.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.482 ' CD1' ' HB1' ' A' ' 87' ' ' ALA . 3.1 m-85 -94.09 137.37 33.36 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.376 -0.827 . . . . 0.0 111.902 178.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.3 ttt-85 -98.49 -70.12 0.74 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.138 1.775 . . . . 0.0 111.24 178.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.428 ' CB ' ' H ' ' A' ' 86' ' ' VAL . 0.9 OUTLIER -39.72 -54.62 2.05 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 128.21 2.604 . . . . 0.0 113.722 -175.034 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -157.69 -118.53 0.55 Allowed Glycine 0 CA--C 1.526 0.751 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 175.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.6 p -141.93 175.67 9.54 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.822 1.649 . . . . 0.0 111.87 -174.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.497 ' CG2' HD12 ' A' ' 59' ' ' ILE . 5.7 t -156.51 -176.92 6.23 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.313 1.045 . . . . 0.0 112.755 176.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -102.63 -65.03 1.02 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.39 1.476 . . . . 0.0 112.786 177.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.2 p -130.19 131.68 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 125.551 1.541 . . . . 0.0 111.187 -177.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.497 HD12 ' CG2' ' A' ' 56' ' ' THR . 0.1 OUTLIER -136.85 -63.54 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 125.346 1.458 . . . . 0.0 111.712 -174.969 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.461 ' H ' HG12 ' A' ' 59' ' ' ILE . 80.5 mt -88.37 105.53 9.78 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 125.355 1.462 . . . . 0.0 110.265 175.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -73.33 168.48 24.64 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 123.305 2.67 . . . . 0.0 110.992 175.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -49.45 -44.92 46.02 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.139 0.976 . . . . 0.0 113.544 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 53.7 t -151.13 147.83 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 C-N-CA 126.838 2.055 . . . . 0.0 109.426 -176.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.6 t -125.9 95.07 40.52 Favored Pre-proline 0 N--CA 1.468 0.443 0 C-N-CA 124.913 1.285 . . . . 0.0 108.132 174.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.31 158.04 55.43 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.153 1.902 . . . . 0.0 112.253 176.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -71.53 169.52 15.28 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.092 0.557 . . . . 0.0 111.593 175.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . 0.252 26.0 p 56.79 18.76 3.97 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 127.442 2.297 . . . . 0.0 112.954 -174.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -130.9 172.0 12.54 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 126.86 2.064 . . . . 0.0 110.683 -178.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -134.89 167.43 20.92 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.345 0.658 . . . . 0.0 109.344 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.8 pp -139.16 166.43 24.56 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 124.68 1.192 . . . . 0.0 111.745 177.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.05 152.57 23.84 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 122.134 0.969 . . . . 0.0 111.07 174.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -132.8 149.03 52.31 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 126.64 1.976 . . . . 0.0 109.738 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 94.8 p -148.03 159.9 43.42 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.023 0.929 . . . . 0.0 113.198 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -170.49 148.47 11.54 Favored Glycine 0 N--CA 1.463 0.46 0 CA-C-N 115.738 -0.664 . . . . 0.0 114.316 177.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 58.4 mtm180 -110.33 148.77 31.29 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 125.937 1.695 . . . . 0.0 110.271 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -89.35 -33.52 16.87 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.551 1.54 . . . . 0.0 114.053 176.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 28.6 t -64.31 105.47 0.92 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.634 1.174 . . . . 0.0 112.363 -174.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 42.8 t -112.32 -18.31 12.53 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.817 1.647 . . . . 0.0 113.125 178.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 121.48 -75.2 0.34 Allowed Glycine 0 CA--C 1.537 1.468 0 C-N-CA 125.842 1.687 . . . . 0.0 112.595 -178.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -73.17 -37.36 3.46 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.371 2.714 . . . . 0.0 113.5 -175.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.2 p -146.56 155.79 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 126.935 2.094 . . . . 0.0 109.31 179.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -136.47 83.98 2.04 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.16 0.984 . . . . 0.0 111.319 -178.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.6 m -66.26 138.04 57.37 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.306 1.042 . . . . 0.0 110.349 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -34.47 -74.98 0.07 OUTLIER Glycine 0 N--CA 1.471 0.991 0 C-N-CA 126.715 2.102 . . . . 0.0 117.518 -175.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.564 ' HB3' ' HB ' ' A' ' 105' ' ' VAL . . . -165.63 91.83 0.51 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.329 1.052 . . . . 0.0 111.51 -174.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.428 ' H ' ' CB ' ' A' ' 53' ' ' SER . 20.4 t -140.11 122.38 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 O-C-N 120.566 -1.333 . . . . 0.0 112.616 -175.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.482 ' HB1' ' CD1' ' A' ' 51' ' ' PHE . . . -155.38 167.6 29.86 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 122.353 1.073 . . . . 0.0 112.882 176.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -146.16 149.97 34.99 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 124.064 0.946 . . . . 0.0 109.84 174.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -151.2 174.12 13.62 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 121.039 -1.038 . . . . 0.0 110.356 178.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.508 ' HB3' HD11 ' A' ' 47' ' ' LEU . . . -138.21 150.61 46.9 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-O 121.176 0.512 . . . . 0.0 112.358 176.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -129.63 117.1 19.84 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 126.939 2.096 . . . . 0.0 112.597 -175.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -80.89 99.72 8.49 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -174.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 20.2 mtm -72.0 127.42 32.51 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.415 1.086 . . . . 0.0 112.237 178.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.6 m -57.56 -18.88 21.79 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.851 1.26 . . . . 0.0 113.414 174.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -64.27 -28.13 69.51 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.631 1.572 . . . . 0.0 112.139 174.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 120.07 19.19 4.03 Favored Glycine 0 CA--C 1.538 1.502 0 C-N-CA 125.819 1.676 . . . . 0.0 115.229 -178.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -128.04 175.82 8.1 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 119.14 1.47 . . . . 0.0 110.899 -178.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 22.7 m -134.48 103.91 5.89 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 121.064 -1.022 . . . . 0.0 111.621 176.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 42.1 tp -68.82 103.49 1.79 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.729 0.812 . . . . 0.0 112.026 175.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -91.71 96.18 2.14 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 126.316 1.912 . . . . 0.0 110.858 175.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 53.8 t -79.93 136.97 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 O-C-N 121.895 -0.768 . . . . 0.0 110.771 175.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.74 141.1 47.37 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.287 1.035 . . . . 0.0 111.593 176.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.47 ' CZ ' ' HB3' ' A' ' 87' ' ' ALA . 3.4 p90 -153.64 120.08 5.52 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 120.887 -1.133 . . . . 0.0 111.501 -174.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 32.8 t -127.47 107.24 9.78 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.915 1.286 . . . . 0.0 110.987 -177.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.564 ' HB ' ' HB3' ' A' ' 85' ' ' ALA . 4.4 t -118.69 127.3 26.63 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 126.599 1.96 . . . . 0.0 108.674 -176.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -72.77 169.78 21.19 Favored 'Trans proline' 0 CA--C 1.532 0.403 0 C-N-CA 123.388 2.726 . . . . 0.0 113.407 -175.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -74.62 -66.48 0.73 Allowed 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.323 1.049 . . . . 0.0 111.562 175.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -106.22 7.22 31.39 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.215 1.806 . . . . 0.0 115.063 -174.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 54.88 41.99 31.46 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 125.65 1.58 . . . . 0.0 113.467 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 40.5 p-10 -60.56 -179.23 0.11 Allowed 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 126.932 2.093 . . . . 0.0 114.945 176.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 4.2 p90 -53.5 -30.01 39.21 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 126.986 2.114 . . . . 0.0 114.665 176.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -59.29 120.28 8.97 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.408 1.083 . . . . 0.0 108.663 175.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 55.0 m -62.48 150.45 40.08 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 121.426 -0.796 . . . . 0.0 110.907 177.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -137.76 107.1 6.1 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.645 1.178 . . . . 0.0 110.66 -178.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 41.5 m0 -109.83 162.36 14.56 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 125.284 1.434 . . . . 0.0 113.442 -174.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 61.0 p-90 -145.57 132.41 20.1 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.776 0.798 . . . . 0.0 112.273 177.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -144.25 174.47 10.86 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.826 1.65 . . . . 0.0 111.652 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.445 HG22 ' SD ' ' A' ' 158' ' ' MET . 2.5 m -145.03 159.72 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 175.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.63 170.97 14.93 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.764 0.826 . . . . 0.0 111.045 175.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.423 ' HB ' ' CE2' ' A' ' 154' ' ' TYR . 45.5 mt -131.54 104.6 8.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 176.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -71.97 148.91 92.2 Favored Pre-proline 0 CA--C 1.55 0.964 0 O-C-N 121.938 -0.476 . . . . 0.0 110.94 178.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -77.87 82.67 2.36 Favored 'Trans proline' 0 CA--C 1.545 1.037 0 C-N-CA 123.802 3.002 . . . . 0.0 112.37 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 98.54 178.03 32.56 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 125.958 1.742 . . . . 0.0 112.892 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 5.9 mttt -47.7 122.02 4.54 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.116 1.366 . . . . 0.0 112.508 -174.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -135.23 -161.55 1.16 Allowed 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 126.608 1.963 . . . . 0.0 111.433 -177.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 23.5 ptt-85 -140.17 -178.17 5.35 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 128.553 2.741 . . . . 0.0 109.181 175.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -131.67 124.21 29.38 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 174.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -135.72 168.66 18.87 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.375 1.07 . . . . 0.0 111.162 178.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.93 -40.77 73.62 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.538 -0.726 . . . . 0.0 112.5 -176.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -57.22 -58.64 13.56 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 124.53 1.062 . . . . 0.0 112.177 175.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 3.3 mpp? -59.58 -32.67 70.58 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 118.528 1.164 . . . . 0.0 112.5 177.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.27 -63.2 1.31 Allowed 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 175.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -67.17 -30.03 69.88 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -175.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -64.78 -43.46 93.17 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.219 1.008 . . . . 0.0 112.101 175.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.15 -25.81 23.91 Favored 'General case' 0 CA--C 1.546 0.799 0 O-C-N 121.558 -0.714 . . . . 0.0 112.558 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -47.2 -53.65 12.64 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 127.744 2.418 . . . . 0.0 111.859 175.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -63.39 -15.61 58.05 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -74.03 -32.4 58.67 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 128.312 2.863 . . . . 0.0 115.666 -175.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -129.15 90.23 45.82 Favored Pre-proline 0 CA--C 1.546 0.826 0 CA-C-N 119.032 1.416 . . . . 0.0 111.274 175.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -73.2 83.35 1.47 Allowed 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 123.58 2.853 . . . . 0.0 112.87 -176.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -122.46 122.28 38.6 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.739 1.215 . . . . 0.0 112.05 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -104.31 63.91 0.75 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.736 1.614 . . . . 0.0 111.276 -174.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 51.38 60.05 7.71 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 123.971 0.796 . . . . 0.0 112.683 -175.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.83 101.81 3.24 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 126.186 1.794 . . . . 0.0 112.362 -175.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -74.03 55.13 0.55 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 127.627 2.371 . . . . 0.0 116.516 -174.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -166.29 43.78 0.27 Allowed Glycine 0 CA--C 1.533 1.202 0 O-C-N 120.921 -1.112 . . . . 0.0 115.672 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 1.1 m95 52.65 40.51 30.32 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 125.276 1.43 . . . . 0.0 113.773 -176.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -78.9 124.06 27.87 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 126.099 1.76 . . . . 0.0 112.123 -176.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -167.89 -171.54 1.61 Allowed 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.781 0.832 . . . . 0.0 111.785 177.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 4.8 mtpp -138.18 160.91 38.18 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 127.89 2.476 . . . . 0.0 110.977 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 37.7 m-20 -67.26 152.5 45.62 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 122.144 -0.347 . . . . 0.0 110.426 174.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 37.6 mt -108.09 162.03 14.42 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 122.19 0.995 . . . . 0.0 109.06 175.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -62.45 -167.47 0.68 Allowed Glycine 0 CA--C 1.536 1.358 0 C-N-CA 124.512 1.053 . . . . 0.0 111.616 175.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.423 ' CE2' ' HB ' ' A' ' 120' ' ' ILE . 0.0 OUTLIER 55.09 6.28 0.13 Allowed 'General case' 0 CA--C 1.558 1.281 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 174.957 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 82.02 44.88 7.4 Favored Glycine 0 CA--C 1.54 1.607 0 C-N-CA 127.438 2.447 . . . . 0.0 114.427 -175.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.1 mp -127.82 158.03 38.84 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 119.866 1.833 . . . . 0.0 113.123 -178.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -124.65 117.31 23.97 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 121.061 -1.024 . . . . 0.0 110.478 175.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . 0.445 ' SD ' HG22 ' A' ' 118' ' ' VAL . 0.0 OUTLIER -98.21 150.24 21.71 Favored 'General case' 0 C--N 1.322 -0.623 0 O-C-N 120.623 -1.298 . . . . 0.0 108.784 174.996 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -131.4 149.02 52.71 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 127.076 2.151 . . . . 0.0 110.35 176.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -157.52 159.39 29.77 Favored Glycine 0 N--CA 1.464 0.525 0 O-C-N 121.542 -0.724 . . . . 0.0 113.446 176.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.43 HD13 ' N ' ' A' ' 162' ' ' MET . 0.0 OUTLIER -155.15 137.54 6.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 125.222 1.409 . . . . 0.0 109.894 -178.174 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . 0.43 ' N ' HD13 ' A' ' 161' ' ' ILE . 2.5 mtm -150.1 167.22 27.44 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 127.388 2.275 . . . . 0.0 108.345 174.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 9.7 t -145.42 133.45 21.42 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 118.942 0.792 . . . . 0.0 109.858 174.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 81.9 p -82.05 30.05 0.4 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.526 1.131 . . . . 0.0 113.729 -176.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -65.61 21.64 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 128.322 2.649 . . . . 0.0 115.432 -177.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 79.84 -44.19 2.73 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 127.554 2.502 . . . . 0.0 113.333 -177.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -143.18 77.24 1.56 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.351 1.46 . . . . 0.0 110.153 -177.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -130.71 166.35 20.93 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.033 1.333 . . . . 0.0 114.047 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.14 169.74 10.38 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 126.948 2.099 . . . . 0.0 113.782 -176.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . 0.408 ' HE2' HD13 ' A' ' 172' ' ' ILE . 11.3 ttt -115.87 145.79 42.57 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.255 1.822 . . . . 0.0 110.891 173.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.45 ' C ' HD12 ' A' ' 172' ' ' ILE . 24.8 tt0 -149.32 119.14 7.06 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 120.753 -1.217 . . . . 0.0 110.237 174.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.45 HD12 ' C ' ' A' ' 171' ' ' GLN . 1.8 mp -121.25 130.56 74.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 125.485 1.514 . . . . 0.0 108.267 178.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.8 137.79 43.68 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.876 1.27 . . . . 0.0 110.448 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.6 mp -95.3 95.13 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-N 119.352 0.978 . . . . 0.0 109.518 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 19.3 m -64.55 138.62 58.51 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.981 1.312 . . . . 0.0 111.79 175.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 7.0 mtp180 . . . . . 0 C--O 1.253 1.26 0 O-C-N 120.238 -1.539 . . . . 0.0 112.608 174.938 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 6.9 t . . . . . 0 N--CA 1.488 1.46 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -64.42 178.64 0.7 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.884 1.273 . . . . 0.0 111.878 174.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.672 HD13 ' HB2' ' A' ' 31' ' ' LYS . 2.6 mt -109.65 9.21 25.08 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.833 1.653 . . . . 0.0 112.603 178.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.45 ' HB1' ' HB3' ' A' ' 71' ' ' LEU . . . -113.21 126.77 55.78 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 127.544 2.338 . . . . 0.0 111.391 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -79.69 -121.54 0.37 Allowed Glycine 0 CA--C 1.536 1.402 0 C-N-CA 125.036 1.303 . . . . 0.0 112.79 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 30.8 p -94.78 171.57 8.69 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.754 1.222 . . . . 0.0 112.397 177.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -130.53 12.32 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 C-N-CA 125.764 1.626 . . . . 0.0 112.002 177.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.6 pp -58.63 172.03 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 O-C-N 120.563 -1.336 . . . . 0.0 112.103 176.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -35.38 129.39 0.54 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.798 2.039 . . . . 0.0 114.729 -175.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -55.57 -21.81 29.57 Favored Glycine 0 CA--C 1.537 1.424 0 C-N-CA 124.673 1.13 . . . . 0.0 114.444 -178.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.1 -31.76 72.25 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.874 1.269 . . . . 0.0 112.048 174.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -100.7 -36.61 9.06 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.963 1.705 . . . . 0.0 112.059 175.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.451 HD23 ' HB3' ' A' ' 69' ' ' ALA . 12.5 tp -79.0 86.16 4.88 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-O 122.1 0.952 . . . . 0.0 110.562 174.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -121.23 178.21 4.86 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 127.565 2.346 . . . . 0.0 112.131 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -42.28 -45.3 4.14 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.562 1.545 . . . . 0.0 113.765 174.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -53.4 -43.53 67.96 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 118.934 0.788 . . . . 0.0 112.449 178.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 86.6 t -64.11 -43.96 97.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.738 1.215 . . . . 0.0 110.799 174.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 68.1 mt -63.82 -41.8 97.78 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.2 -0.938 . . . . 0.0 111.737 179.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -67.28 -44.63 78.81 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.734 1.214 . . . . 0.0 112.576 178.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.08 -37.77 78.65 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 121.476 -0.765 . . . . 0.0 111.357 175.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.9 t -56.67 -38.11 56.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.951 1.3 . . . . 0.0 110.956 178.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.676 HD23 ' HD2' ' A' ' 31' ' ' LYS . 11.1 mt -56.65 -25.89 54.78 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.499 1.519 . . . . 0.0 113.239 175.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -106.28 -46.52 1.15 Allowed Glycine 0 CA--C 1.534 1.243 0 C-N-CA 125.566 1.555 . . . . 0.0 114.692 -178.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -63.96 -27.97 69.5 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 119.243 1.521 . . . . 0.0 113.288 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 19.7 mt -96.54 76.8 2.9 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.9 1.28 . . . . 0.0 110.635 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.59 114.9 5.09 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 126.14 1.829 . . . . 0.0 112.387 178.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -132.47 -74.03 0.51 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.655 1.582 . . . . 0.0 111.919 -179.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.3 m -131.68 177.79 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 126.419 1.887 . . . . 0.0 111.129 -177.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.87 -30.08 68.75 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -177.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.79 117.01 10.07 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.755 1.622 . . . . 0.0 111.443 178.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.676 ' HD2' HD23 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -124.24 152.56 42.82 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 125.399 1.48 . . . . 0.0 109.559 -177.845 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -114.62 133.06 61.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 123.58 0.752 . . . . 0.0 109.438 177.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -134.91 104.77 6.11 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 127.119 2.167 . . . . 0.0 109.795 176.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.704 HG22 ' HB2' ' A' ' 72' ' ' TYR . 1.4 m -103.82 160.77 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 123.517 0.727 . . . . 0.0 110.358 178.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -138.64 109.83 0.69 Allowed Glycine 0 CA--C 1.519 0.328 0 CA-C-N 118.645 0.657 . . . . 0.0 112.69 174.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.482 ' HB ' HD11 ' A' ' 70' ' ' LEU . 3.1 mp -103.96 139.14 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-N 117.313 0.556 . . . . 0.0 110.724 176.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -110.55 104.16 12.85 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.006 1.322 . . . . 0.0 110.704 -177.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -72.6 91.5 1.43 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 127.162 2.185 . . . . 0.0 110.616 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -120.88 9.24 10.61 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.498 1.519 . . . . 0.0 113.331 174.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 37.5 t -50.94 -47.04 61.16 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 125.987 1.715 . . . . 0.0 113.672 177.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 139.99 -21.41 2.82 Favored Glycine 0 N--CA 1.473 1.161 0 C-N-CA 124.452 1.025 . . . . 0.0 114.208 175.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -122.56 167.18 14.97 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 125.724 1.631 . . . . 0.0 111.564 174.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.656 HG22 ' HA ' ' A' ' 65' ' ' PRO . 44.3 p -74.28 145.71 43.78 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.177 0.513 . . . . 0.0 110.674 174.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 49.5 m0 -98.95 104.71 16.78 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 123.593 0.757 . . . . 0.0 110.898 178.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.0 m -82.67 125.3 31.06 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.186 0.994 . . . . 0.0 110.117 176.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.79 117.51 5.95 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.109 0.964 . . . . 0.0 111.309 174.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.551 HD12 ' N ' ' A' ' 48' ' ' ASN . 4.6 pp -98.23 -48.99 4.87 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.483 0.713 . . . . 0.0 112.758 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.551 ' N ' HD12 ' A' ' 47' ' ' LEU . 10.4 t30 -174.56 152.17 1.63 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 128.213 2.605 . . . . 0.0 109.263 -177.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -136.38 160.54 38.43 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.616 1.166 . . . . 0.0 111.793 174.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -137.78 107.48 6.24 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.653 1.181 . . . . 0.0 112.284 -179.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.497 ' CD1' ' HB1' ' A' ' 87' ' ' ALA . 2.9 m-85 -107.94 128.7 54.87 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.421 1.088 . . . . 0.0 110.987 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.66 -34.27 5.57 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -176.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.9 t -121.47 -49.46 2.14 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 125.602 1.561 . . . . 0.0 110.594 176.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -66.91 12.56 0.54 Allowed Glycine 0 CA--C 1.536 1.373 0 C-N-CA 125.911 1.72 . . . . 0.0 115.658 -176.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 74.6 p -30.95 109.39 0.06 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 129.089 2.956 . . . . 0.0 114.271 -174.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.529 HG21 HG23 ' A' ' 59' ' ' ILE . 2.5 t -129.25 179.17 5.93 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.437 1.495 . . . . 0.0 113.215 -175.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -78.77 -59.15 2.89 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.994 1.718 . . . . 0.0 112.225 174.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.9 p -143.42 136.64 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 125.597 1.559 . . . . 0.0 111.977 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.529 HG23 HG21 ' A' ' 56' ' ' THR . 1.4 pp -140.2 -26.3 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 126.07 1.748 . . . . 0.0 114.296 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -99.22 93.54 2.22 Favored Pre-proline 0 CA--C 1.541 0.611 0 C-N-CA 125.212 1.405 . . . . 0.0 108.995 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -61.64 143.06 96.37 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.775 2.316 . . . . 0.0 110.389 174.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -40.11 -48.92 2.56 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.429 1.891 . . . . 0.0 113.84 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.7 p -156.1 138.66 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 127.295 2.238 . . . . 0.0 109.188 175.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.468 HG21 HD23 ' A' ' 70' ' ' LEU . 22.0 t -112.27 121.99 37.79 Favored Pre-proline 0 N--CA 1.477 0.897 0 C-N-CA 124.233 1.013 . . . . 0.0 108.902 175.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.656 ' HA ' HG22 ' A' ' 43' ' ' THR . 58.6 Cg_endo -67.8 157.78 60.23 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 122.015 1.81 . . . . 0.0 112.946 177.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -71.65 168.58 17.39 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.575 0.75 . . . . 0.0 111.52 175.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 43.7 p 54.44 19.11 2.18 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 127.286 2.234 . . . . 0.0 113.79 -174.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.8 mttt -134.29 171.72 13.87 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 126.918 2.087 . . . . 0.0 110.951 -175.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.451 ' HB3' HD23 ' A' ' 13' ' ' LEU . . . -127.97 177.16 7.06 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.071 0.462 . . . . 0.0 110.146 -175.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.482 HD11 ' HB ' ' A' ' 36' ' ' ILE . 1.9 pp -142.84 173.47 11.52 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 124.181 0.992 . . . . 0.0 111.255 -178.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.526 HD13 ' O ' ' A' ' 34' ' ' VAL . 0.5 OUTLIER -132.47 151.62 51.83 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.937 1.295 . . . . 0.0 111.007 174.964 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.704 ' HB2' HG22 ' A' ' 34' ' ' VAL . 4.2 m-85 -124.14 146.04 48.91 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.162 0.985 . . . . 0.0 108.595 174.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.8 p -121.28 137.1 54.84 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 126.401 1.88 . . . . 0.0 110.997 175.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.606 ' H ' HD12 ' A' ' 3' ' ' LEU . . . -160.95 133.34 3.17 Favored Glycine 0 CA--C 1.525 0.7 0 O-C-N 121.785 -0.572 . . . . 0.0 113.822 174.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 26.3 mtm180 -90.68 149.7 21.96 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.946 1.298 . . . . 0.0 110.988 -174.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.583 ' CE ' ' HB1' ' A' ' 82' ' ' ALA . 9.9 ptmt -76.56 -20.47 56.81 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 174.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.4 t -81.76 74.41 8.75 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.027 1.331 . . . . 0.0 112.719 -174.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.9 t -65.9 -26.94 67.84 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.512 0.931 . . . . 0.0 113.512 178.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 123.21 -72.96 0.4 Allowed Glycine 0 CA--C 1.538 1.485 0 C-N-CA 126.027 1.775 . . . . 0.0 112.797 -178.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -70.82 -44.16 1.47 Allowed 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.399 2.733 . . . . 0.0 112.731 -177.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.5 m -137.64 126.37 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 126.268 1.827 . . . . 0.0 110.925 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.583 ' HB1' ' CE ' ' A' ' 76' ' ' LYS . . . -78.38 125.81 29.88 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.998 1.319 . . . . 0.0 111.012 174.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 97.7 m -144.17 131.45 20.78 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.143 1.377 . . . . 0.0 109.62 -177.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -26.05 -68.07 0.05 OUTLIER Glycine 0 N--CA 1.48 1.628 0 C-N-CA 127.422 2.439 . . . . 0.0 115.013 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -177.58 135.79 0.19 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.371 1.868 . . . . 0.0 111.82 175.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.9 t -154.85 129.42 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 125.139 1.376 . . . . 0.0 109.094 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.497 ' HB1' ' CD1' ' A' ' 51' ' ' PHE . . . -173.32 174.48 3.32 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.442 1.497 . . . . 0.0 111.732 177.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -151.18 141.49 22.36 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.108 1.363 . . . . 0.0 110.169 174.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -138.45 171.52 14.25 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 121.233 -0.917 . . . . 0.0 111.231 178.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.501 ' HB3' HD11 ' A' ' 47' ' ' LEU . . . -139.43 156.24 47.09 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.391 0.615 . . . . 0.0 112.551 177.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -135.08 129.09 33.44 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 125.833 1.653 . . . . 0.0 112.421 -174.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -83.4 135.11 34.82 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -176.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.24 138.18 44.96 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 125.086 1.355 . . . . 0.0 111.917 178.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.8 t -62.8 -22.5 66.67 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.493 1.117 . . . . 0.0 113.164 176.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -67.41 -16.15 64.07 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.121 1.368 . . . . 0.0 113.321 175.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 101.28 33.89 4.71 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 124.845 1.212 . . . . 0.0 114.558 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.559 ' HB3' HG22 ' A' ' 120' ' ' ILE . 48.3 m-80 -140.6 177.07 8.28 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-N 119.204 1.502 . . . . 0.0 110.95 177.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.473 HG23 HD21 ' A' ' 47' ' ' LEU . 19.2 m -130.67 105.83 8.08 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.668 1.587 . . . . 0.0 112.457 -176.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 59.6 tp -68.4 104.42 1.89 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.715 1.206 . . . . 0.0 111.271 175.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -99.32 116.95 5.72 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 125.947 1.737 . . . . 0.0 113.084 179.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 57.3 t -105.14 129.07 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 126.218 1.807 . . . . 0.0 111.341 -174.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -127.12 130.24 49.44 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.673 1.589 . . . . 0.0 112.273 -174.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.445 ' CZ ' ' HB3' ' A' ' 87' ' ' ALA . 5.4 p90 -146.02 140.56 26.91 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.644 1.177 . . . . 0.0 112.484 -176.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.28 123.37 10.79 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.181 1.392 . . . . 0.0 111.967 -174.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 96.4 t -100.33 123.74 45.47 Favored Pre-proline 0 N--CA 1.481 1.084 0 C-N-CA 125.065 1.346 . . . . 0.0 111.686 -177.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.406 ' HA ' ' CE2' ' A' ' 109' ' ' TYR . 76.5 Cg_endo -71.02 84.26 0.87 Allowed 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 124.795 3.663 . . . . 0.0 112.768 -178.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -128.43 -29.53 2.44 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.081 1.352 . . . . 0.0 113.073 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -98.91 -37.88 9.23 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.837 1.255 . . . . 0.0 111.519 174.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.406 ' CE2' ' HA ' ' A' ' 106' ' ' PRO . 0.1 OUTLIER -85.41 84.25 7.7 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.386 1.474 . . . . 0.0 111.641 177.996 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -74.65 -9.78 58.9 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 123.881 0.873 . . . . 0.0 113.05 175.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 55.8 m95 -115.95 -46.01 2.84 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 127.017 2.127 . . . . 0.0 111.622 -176.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -68.56 173.07 5.37 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.708 1.203 . . . . 0.0 110.13 174.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.4 m -109.57 153.97 23.4 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 121.389 -0.819 . . . . 0.0 111.623 174.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -73.36 117.68 15.4 Favored 'General case' 0 C--O 1.226 -0.18 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 174.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 34.4 m0 -113.68 143.59 44.35 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 176.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 37.3 p-90 -148.85 138.58 21.99 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.206 1.002 . . . . 0.0 111.268 -177.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -150.04 162.86 39.57 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 122.801 1.286 . . . . 0.0 113.279 -177.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 61.7 t -145.53 144.34 21.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 124.24 1.016 . . . . 0.0 108.311 175.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.448 ' HE2' ' SD ' ' A' ' 135' ' ' MET . 0.0 OUTLIER -155.9 176.71 12.28 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.908 1.683 . . . . 0.0 110.141 175.577 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.559 HG22 ' HB3' ' A' ' 97' ' ' ASN . 11.7 mt -126.32 99.59 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-O 121.86 0.838 . . . . 0.0 108.955 178.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -59.68 148.25 75.64 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 124.105 0.962 . . . . 0.0 111.84 178.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -70.5 135.54 28.94 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.986 2.457 . . . . 0.0 111.838 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 59.13 -157.82 22.42 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 124.057 0.837 . . . . 0.0 113.528 -177.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 9.9 tttt -72.75 120.02 17.78 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.975 0.91 . . . . 0.0 108.735 174.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 25.0 tpp180 -130.68 169.62 15.42 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 125.868 1.667 . . . . 0.0 109.447 175.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 25.6 ptt180 -119.89 175.33 5.95 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 126.549 1.94 . . . . 0.0 110.6 174.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -120.3 108.11 13.77 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 175.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -126.27 165.7 18.48 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.901 1.28 . . . . 0.0 110.01 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -55.66 -36.81 67.49 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 121.302 -0.874 . . . . 0.0 113.203 -176.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -59.7 -61.29 7.39 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.442 -0.663 . . . . 0.0 111.442 174.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -62.98 -33.11 74.7 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 118.367 1.084 . . . . 0.0 112.833 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -58.35 -63.11 1.39 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.625 1.17 . . . . 0.0 108.987 174.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -69.27 -27.2 65.22 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -177.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -68.23 -32.06 71.99 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.741 1.216 . . . . 0.0 113.418 175.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . 0.448 ' SD ' ' HE2' ' A' ' 119' ' ' LYS . 0.7 OUTLIER -94.89 -25.48 16.56 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 121.274 -0.891 . . . . 0.0 112.076 176.667 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -51.99 -57.6 9.01 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.769 2.028 . . . . 0.0 110.02 174.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -67.22 -10.19 48.01 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 113.526 0.935 . . . . 0.0 113.526 -178.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -83.6 -16.03 69.45 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 126.638 2.066 . . . . 0.0 114.273 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -142.14 87.26 9.76 Favored Pre-proline 0 CA--C 1.549 0.925 0 CA-C-N 118.661 1.231 . . . . 0.0 112.001 179.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.95 77.97 1.85 Allowed 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 123.675 2.916 . . . . 0.0 112.472 177.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -108.59 115.05 29.36 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.32 1.448 . . . . 0.0 109.826 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 9.5 mtp180 -92.93 26.88 2.6 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 126.909 2.083 . . . . 0.0 115.969 -174.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 62.38 59.69 9.01 Favored Glycine 0 CA--C 1.531 1.051 0 N-CA-C 109.106 -1.597 . . . . 0.0 109.106 -175.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -64.28 105.81 0.98 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.182 0.993 . . . . 0.0 110.006 176.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -68.02 83.48 0.22 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.213 1.405 . . . . 0.0 114.33 -174.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 170.24 48.71 0.03 OUTLIER Glycine 0 CA--C 1.537 1.462 0 C-N-CA 124.967 1.27 . . . . 0.0 114.468 177.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' TRP . . . . . 0.56 ' H ' HD13 ' A' ' 161' ' ' ILE . 2.2 m95 54.65 44.09 29.16 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 125.782 1.633 . . . . 0.0 114.728 -177.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -79.62 130.62 35.53 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 120.61 -1.306 . . . . 0.0 112.77 -175.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . 0.419 ' HG3' ' HA ' ' A' ' 159' ' ' LYS . 0.0 OUTLIER -160.02 -175.16 4.93 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -175.015 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.2 pttt -131.0 156.72 44.64 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.194 1.397 . . . . 0.0 111.672 174.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 28.6 m-80 -78.14 124.17 27.74 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 174.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 69.3 mt -81.52 149.11 28.85 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 122.201 1.001 . . . . 0.0 109.33 174.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -66.08 -166.48 2.04 Favored Glycine 0 CA--C 1.535 1.303 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 174.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.52 ' CE1' ' HB ' ' A' ' 120' ' ' ILE . 0.0 OUTLIER 54.3 11.49 0.4 Allowed 'General case' 0 CA--C 1.557 1.233 0 N-CA-C 114.988 1.477 . . . . 0.0 114.988 174.969 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 84.94 37.3 10.26 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 126.542 2.02 . . . . 0.0 113.208 -178.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.7 mp -122.74 160.21 26.41 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 119.843 1.822 . . . . 0.0 113.038 -178.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 72.2 mtt85 -149.06 109.77 4.26 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 120.636 -1.29 . . . . 0.0 111.082 -178.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . 0.451 ' SD ' HG21 ' A' ' 172' ' ' ILE . 9.0 ttp -104.73 132.77 50.58 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 124.025 0.93 . . . . 0.0 108.893 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.419 ' HA ' ' HG3' ' A' ' 149' ' ' GLN . 7.1 tppt? -111.14 129.65 55.87 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 127.967 2.507 . . . . 0.0 110.593 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -137.21 156.17 23.25 Favored Glycine 0 N--CA 1.474 1.208 0 CA-C-N 120.7 1.591 . . . . 0.0 115.959 -177.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.56 HD13 ' H ' ' A' ' 147' ' ' TRP . 4.5 tp -148.58 127.8 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 124.77 1.228 . . . . 0.0 112.069 -175.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 16.1 mtm -151.5 169.81 21.17 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 128.489 2.716 . . . . 0.0 109.892 174.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 14.5 t -156.23 135.27 12.0 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.714 1.606 . . . . 0.0 109.597 174.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 61.7 p -81.32 20.04 0.9 Allowed 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 179.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.85 -34.7 65.68 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.486 1.914 . . . . 0.0 115.108 -177.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 154.01 -63.45 0.36 Allowed Glycine 0 CA--C 1.533 1.176 0 C-N-CA 124.386 0.993 . . . . 0.0 114.29 176.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -119.79 27.82 8.49 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 125.718 1.607 . . . . 0.0 112.669 -175.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -64.03 174.59 1.47 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.839 1.255 . . . . 0.0 113.269 174.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.57 168.14 13.01 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.735 2.014 . . . . 0.0 111.248 177.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 48.5 ttp -111.51 123.87 51.11 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.816 1.246 . . . . 0.0 110.45 176.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -137.46 128.02 26.77 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 123.255 0.622 . . . . 0.0 110.325 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.451 HG21 ' SD ' ' A' ' 158' ' ' MET . 5.1 mp -134.9 119.27 27.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 123.461 0.704 . . . . 0.0 109.853 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -114.57 134.96 54.64 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.188 1.395 . . . . 0.0 111.067 177.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.8 mp -81.83 129.97 36.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 O-C-N 120.906 -1.121 . . . . 0.0 109.013 175.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -137.93 94.43 2.89 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.854 1.262 . . . . 0.0 112.328 177.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 72.1 mtp180 . . . . . 0 C--O 1.252 1.185 0 C-N-CA 126.604 1.961 . . . . 0.0 113.245 175.002 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 74.6 m . . . . . 0 N--CA 1.482 1.136 0 N-CA-C 111.695 0.258 . . . . 0.0 111.695 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.91 177.09 6.77 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.854 1.261 . . . . 0.0 111.113 174.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.559 HD11 ' HG3' ' A' ' 31' ' ' LYS . 3.0 mm? -44.28 -26.47 0.33 Allowed 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 115.724 1.75 . . . . 0.0 115.724 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.54 78.67 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.121 1.368 . . . . 0.0 112.425 175.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -72.63 -66.3 2.1 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 125.984 1.754 . . . . 0.0 112.238 -175.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 39.7 p -142.61 166.83 23.59 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.73 1.612 . . . . 0.0 112.097 176.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -131.48 10.06 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 125.993 1.717 . . . . 0.0 112.607 175.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.524 HD12 ' HB3' ' A' ' 12' ' ' SER . 1.0 OUTLIER -53.67 163.32 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 O-C-N 120.223 -1.548 . . . . 0.0 112.648 177.017 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -38.92 136.29 0.79 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 127.001 2.121 . . . . 0.0 113.82 -174.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -55.38 -21.22 26.03 Favored Glycine 0 CA--C 1.54 1.605 0 C-N-CA 124.858 1.218 . . . . 0.0 114.399 -176.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.66 -29.04 69.81 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.032 1.333 . . . . 0.0 112.577 174.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.524 ' HB3' HD12 ' A' ' 8' ' ' ILE . 20.5 t -104.99 -43.98 4.92 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.808 1.643 . . . . 0.0 111.299 175.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.4 tp -75.16 93.47 2.81 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.81 0.844 . . . . 0.0 111.537 175.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 44.1 p -130.69 -177.99 4.59 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 126.901 2.081 . . . . 0.0 111.583 177.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -39.89 -43.99 1.58 Allowed 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 127.207 2.203 . . . . 0.0 113.59 175.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -54.67 -41.44 70.19 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.651 0.78 . . . . 0.0 112.055 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.0 t -68.35 -38.19 79.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.804 1.242 . . . . 0.0 111.233 175.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 24.5 mt -68.62 -42.47 78.03 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 121.355 -0.841 . . . . 0.0 111.414 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -65.38 -50.45 65.46 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.498 1.119 . . . . 0.0 111.915 178.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.13 -33.88 76.42 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 118.876 -0.583 . . . . 0.0 112.062 174.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.9 t -55.38 -47.0 78.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 124.85 1.26 . . . . 0.0 112.355 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.82 -23.86 46.88 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 119.838 1.199 . . . . 0.0 113.022 175.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -82.45 -61.44 1.98 Allowed Glycine 0 CA--C 1.534 1.233 0 C-N-CA 126.049 1.785 . . . . 0.0 112.919 174.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -66.49 -35.86 81.31 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -177.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -94.88 73.65 3.54 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 122.773 1.273 . . . . 0.0 110.468 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -76.2 64.13 2.82 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 126.302 1.906 . . . . 0.0 115.151 -174.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.506 ' HD2' HD22 ' A' ' 3' ' ' LEU . 6.1 mttt -55.59 -75.47 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 126.69 1.996 . . . . 0.0 113.972 178.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 18.0 m -141.77 -179.37 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 127.438 2.295 . . . . 0.0 110.708 178.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 36.8 m -52.39 -34.31 47.43 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 126.721 2.009 . . . . 0.0 114.878 -177.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.8 mmp_? -136.7 111.99 9.14 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 127.23 2.212 . . . . 0.0 109.185 175.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.559 ' HG3' HD11 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -123.0 166.06 15.72 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.381 1.472 . . . . 0.0 110.543 178.696 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -128.85 123.16 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 123.949 0.9 . . . . 0.0 110.911 -178.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -120.13 118.17 29.86 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.883 1.673 . . . . 0.0 109.806 175.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.402 HG22 ' HB2' ' A' ' 72' ' ' TYR . 2.4 m -124.47 148.4 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 122.715 0.406 . . . . 0.0 110.602 175.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -121.52 111.06 1.78 Allowed Glycine 0 C--N 1.329 0.16 0 C-N-CA 124.285 0.945 . . . . 0.0 111.044 -178.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 mp -100.24 139.94 20.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 117.703 0.752 . . . . 0.0 109.282 175.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -114.91 101.91 9.48 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.893 1.277 . . . . 0.0 109.305 -178.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 40.9 t-20 -73.68 107.17 5.78 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.051 1.34 . . . . 0.0 110.515 -178.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -135.12 19.27 3.43 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.386 1.474 . . . . 0.0 111.8 175.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.8 p -76.19 178.21 6.59 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.072 1.749 . . . . 0.0 112.433 176.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -91.25 56.06 3.2 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 126.379 1.942 . . . . 0.0 113.167 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 157.34 137.5 2.31 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.453 1.025 . . . . 0.0 113.636 177.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.79 HG22 ' HA ' ' A' ' 65' ' ' PRO . 37.9 p -62.47 141.19 58.51 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.456 0.702 . . . . 0.0 110.428 175.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.445 ' HB3' ' CD1' ' A' ' 91' ' ' TYR . 30.0 m0 -97.56 109.2 22.0 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.694 0.283 . . . . 0.0 111.553 178.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 37.4 m -87.75 142.74 27.59 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.172 0.589 . . . . 0.0 109.541 175.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.67 126.86 29.38 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.689 0.796 . . . . 0.0 111.457 174.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.56 HD12 ' N ' ' A' ' 48' ' ' ASN . 4.1 pp -116.7 -58.6 2.06 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.271 1.028 . . . . 0.0 111.854 177.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.56 ' N ' HD12 ' A' ' 47' ' ' LEU . 13.1 t30 -176.07 152.38 1.17 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 127.215 2.206 . . . . 0.0 110.617 -177.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -134.28 158.84 42.74 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.151 1.38 . . . . 0.0 111.063 175.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 91.2 t80 -140.04 100.21 3.87 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.036 1.334 . . . . 0.0 112.169 -175.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.477 ' CD1' ' HB1' ' A' ' 87' ' ' ALA . 3.8 m-30 -105.04 124.26 49.23 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.559 1.144 . . . . 0.0 111.614 -175.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.71 -37.4 7.92 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -177.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 29.5 t -120.61 -49.59 2.23 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.33 1.452 . . . . 0.0 110.725 177.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -68.63 17.37 0.49 Allowed Glycine 0 CA--C 1.533 1.166 0 C-N-CA 126.587 2.042 . . . . 0.0 115.272 -175.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.2 p -35.52 121.02 0.59 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 128.739 2.816 . . . . 0.0 112.995 -175.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -139.13 172.4 12.89 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.651 1.181 . . . . 0.0 113.571 -174.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -76.82 -68.85 0.56 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.524 1.53 . . . . 0.0 113.309 175.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.7 p -135.9 129.67 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 125.126 1.371 . . . . 0.0 112.425 -176.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -138.43 -34.3 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.672 1.589 . . . . 0.0 114.443 -175.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 48.5 mt -91.33 104.14 9.15 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 125.169 1.388 . . . . 0.0 109.621 175.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -72.52 165.24 33.26 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.763 2.975 . . . . 0.0 110.413 175.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -47.57 -44.23 26.08 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.9 p -157.81 152.26 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 127.014 2.125 . . . . 0.0 110.057 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.526 ' HA ' ' HE3' ' A' ' 68' ' ' LYS . 60.5 t -126.89 99.14 29.56 Favored Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 126.375 1.87 . . . . 0.0 106.778 175.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.79 ' HA ' HG22 ' A' ' 43' ' ' THR . 42.2 Cg_endo -69.71 171.62 14.08 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 120.97 1.113 . . . . 0.0 112.628 175.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -75.71 166.13 24.0 Favored 'General case' 0 CA--C 1.548 0.869 0 O-C-N 121.297 -0.877 . . . . 0.0 110.355 174.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . 0.276 5.8 p 62.39 18.27 10.15 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 128.058 2.543 . . . . 0.0 115.141 -177.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.526 ' HE3' ' HA ' ' A' ' 64' ' ' VAL . 0.0 OUTLIER -131.34 170.9 14.01 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 126.086 1.755 . . . . 0.0 111.585 -177.986 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -131.18 165.76 22.61 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-O 121.637 0.732 . . . . 0.0 111.633 177.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -134.79 171.45 14.36 Favored 'General case' 0 C--N 1.321 -0.667 0 O-C-N 120.225 -1.547 . . . . 0.0 110.806 175.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -112.91 162.83 15.38 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 125.315 1.446 . . . . 0.0 108.654 174.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.402 ' HB2' HG22 ' A' ' 34' ' ' VAL . 0.2 OUTLIER -136.55 149.66 48.22 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 125.118 1.367 . . . . 0.0 108.938 175.054 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 85.8 p -129.49 148.81 51.43 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.924 1.69 . . . . 0.0 112.191 -177.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -171.8 146.4 9.37 Favored Glycine 0 CA--C 1.521 0.45 0 N-CA-C 111.984 -0.446 . . . . 0.0 111.984 174.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 41.6 mtm-85 -108.31 150.44 27.32 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.784 1.234 . . . . 0.0 110.733 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.536 ' CE ' ' HB1' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -69.33 -21.27 63.85 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 114.934 1.457 . . . . 0.0 114.934 175.039 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 6.5 t -83.59 83.44 7.9 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.239 1.416 . . . . 0.0 113.299 -174.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 21.1 t -75.42 -31.8 60.5 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.399 0.888 . . . . 0.0 113.399 175.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 126.06 -71.34 0.47 Allowed Glycine 0 CA--C 1.537 1.447 0 C-N-CA 125.606 1.574 . . . . 0.0 113.068 -175.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -70.68 -40.8 3.57 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 123.276 2.65 . . . . 0.0 112.874 -176.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 35.3 m -136.46 158.69 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 126.47 1.908 . . . . 0.0 110.536 178.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.536 ' HB1' ' CE ' ' A' ' 76' ' ' LYS . . . -116.75 87.43 2.69 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.913 1.685 . . . . 0.0 109.613 -178.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 24.9 m -100.49 151.68 21.28 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.172 1.389 . . . . 0.0 108.592 176.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -45.28 -67.41 1.23 Allowed Glycine 0 N--CA 1.473 1.127 0 C-N-CA 125.899 1.714 . . . . 0.0 113.888 -174.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -171.77 119.78 0.45 Allowed 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.482 1.113 . . . . 0.0 111.339 175.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.8 t -141.35 118.64 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 O-C-N 121.765 -0.585 . . . . 0.0 110.081 -178.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.482 ' HB3' ' CE1' ' A' ' 103' ' ' PHE . . . -155.66 157.9 37.42 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 122.53 1.157 . . . . 0.0 112.074 -179.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -137.5 147.99 45.66 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.88 1.272 . . . . 0.0 108.442 175.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -155.13 166.51 33.34 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 121.03 -1.044 . . . . 0.0 109.127 178.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.544 ' HB1' ' CG2' ' A' ' 98' ' ' THR . . . -137.4 156.16 48.51 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -179.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.445 ' CD1' ' HB3' ' A' ' 44' ' ' TRP . 2.3 m-85 -132.46 130.62 40.75 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.272 1.029 . . . . 0.0 113.504 -174.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -82.76 112.99 20.11 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -175.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -93.81 143.01 26.72 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.097 1.359 . . . . 0.0 113.107 -178.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.24 -20.67 64.48 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.556 1.142 . . . . 0.0 113.61 177.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 48.1 m-20 -67.53 -11.6 58.38 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.563 1.145 . . . . 0.0 112.727 174.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 96.58 27.03 10.11 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 124.993 1.282 . . . . 0.0 113.746 -178.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -132.5 172.84 11.97 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.986 1.314 . . . . 0.0 111.588 -176.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.544 ' CG2' ' HB1' ' A' ' 90' ' ' ALA . 3.5 m -126.38 107.57 10.41 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.06 1.344 . . . . 0.0 111.641 -179.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.0 tt -70.53 98.84 1.53 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.978 1.711 . . . . 0.0 111.918 179.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -94.19 97.07 2.13 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 124.765 1.174 . . . . 0.0 114.881 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 99.3 t -75.45 140.53 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.381 1.072 . . . . 0.0 110.123 174.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 3.1 tmm? -136.13 129.16 31.36 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.651 1.581 . . . . 0.0 110.348 177.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.482 ' CE1' ' HB3' ' A' ' 87' ' ' ALA . 22.7 p90 -144.79 142.85 30.3 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.442 -0.786 . . . . 0.0 112.426 175.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 13.2 m -142.9 114.48 8.01 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.395 1.078 . . . . 0.0 112.361 -177.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 26.1 t -113.16 97.35 42.38 Favored Pre-proline 0 CA--C 1.538 0.488 0 C-N-CA 127.445 2.298 . . . . 0.0 109.229 178.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.7 127.35 15.31 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 122.712 2.274 . . . . 0.0 109.73 175.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -73.98 -58.52 3.24 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 121.585 -0.697 . . . . 0.0 110.597 176.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -63.85 -28.91 70.17 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.661 0.785 . . . . 0.0 111.508 -175.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 55.57 7.68 0.26 Allowed 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 127.679 2.391 . . . . 0.0 114.233 -177.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.34 112.52 1.98 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 127.986 2.514 . . . . 0.0 110.003 -177.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER 43.57 30.6 0.36 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 126.593 1.957 . . . . 0.0 114.091 -178.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.28 171.89 12.42 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.738 1.615 . . . . 0.0 111.941 -175.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 31.7 m -142.63 139.67 31.35 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 124.729 1.212 . . . . 0.0 111.378 -178.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -67.51 101.39 0.98 Allowed 'General case' 0 C--O 1.223 -0.316 0 C-N-CA 125.041 1.336 . . . . 0.0 107.929 174.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 47.7 m0 -107.78 144.27 35.18 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 120.622 1.555 . . . . 0.0 110.185 176.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 43.9 p-90 -147.99 139.9 24.01 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.659 0.784 . . . . 0.0 111.509 -177.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -149.86 159.42 44.38 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 122.656 1.217 . . . . 0.0 112.294 -177.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 22.0 t -144.43 136.27 21.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 174.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.98 179.91 6.9 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 126.242 1.817 . . . . 0.0 109.191 176.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 10.5 mt -132.41 134.04 59.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 123.197 0.599 . . . . 0.0 109.399 176.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -90.43 151.68 44.6 Favored Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 125.329 1.452 . . . . 0.0 112.493 177.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.74 139.9 28.48 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 123.198 2.599 . . . . 0.0 110.939 174.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 61.29 -166.21 15.17 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 123.726 0.679 . . . . 0.0 113.475 -176.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.46 99.5 5.67 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.716 1.606 . . . . 0.0 109.771 174.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -111.44 -172.38 2.02 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 125.744 1.618 . . . . 0.0 111.199 -177.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 25.7 ptt180 -139.01 177.54 7.82 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 127.222 2.209 . . . . 0.0 111.229 175.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -118.46 121.22 39.77 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 174.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -129.81 167.11 18.62 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.703 1.601 . . . . 0.0 109.353 175.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -48.87 -45.83 41.56 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 119.641 1.109 . . . . 0.0 113.232 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -52.55 -62.94 5.35 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 123.997 0.808 . . . . 0.0 112.252 175.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 5.0 mpp? -60.76 -38.42 85.17 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 113.583 0.956 . . . . 0.0 113.583 178.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -57.0 -61.87 2.15 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.934 0.788 . . . . 0.0 109.527 175.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -62.97 -37.17 86.03 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.863 0.865 . . . . 0.0 112.731 -177.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -63.65 -43.54 96.47 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.012 1.325 . . . . 0.0 112.36 179.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.81 -26.16 24.22 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 121.053 -1.029 . . . . 0.0 113.42 176.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -52.02 -58.29 6.97 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.257 1.823 . . . . 0.0 110.678 175.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -70.47 -12.85 61.84 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -177.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -81.69 -5.63 89.71 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 127.203 2.335 . . . . 0.0 114.345 177.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -145.11 86.45 7.63 Favored Pre-proline 0 CA--C 1.548 0.87 0 CA-C-N 119.052 1.426 . . . . 0.0 113.301 175.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -76.64 74.79 4.68 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 123.513 2.809 . . . . 0.0 112.946 -179.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -107.26 107.36 18.26 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.022 0.929 . . . . 0.0 111.385 -175.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 59.1 mtm180 -89.76 48.14 1.55 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 126.074 1.75 . . . . 0.0 114.505 -175.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 49.46 57.86 8.83 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.815 -176.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -63.14 106.52 0.87 Allowed 'General case' 0 CA--C 1.546 0.802 0 CA-C-O 122.141 0.972 . . . . 0.0 109.86 -176.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 17.3 p-10 -68.23 73.69 0.21 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 127.336 2.255 . . . . 0.0 114.968 -174.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 178.35 48.75 0.07 OUTLIER Glycine 0 CA--C 1.536 1.4 0 C-N-CA 124.382 0.991 . . . . 0.0 115.003 175.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' TRP . . . . . 0.708 ' H ' HD13 ' A' ' 161' ' ' ILE . 8.1 m95 49.33 56.28 8.05 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 126.204 1.802 . . . . 0.0 112.795 -175.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -85.9 127.5 34.61 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.281 1.032 . . . . 0.0 112.818 -178.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -157.86 -176.09 5.73 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -175.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 5.7 mtmt -140.24 169.33 17.88 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 126.144 1.777 . . . . 0.0 111.581 175.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -72.66 155.66 39.77 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 174.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.542 HD11 ' HB2' ' A' ' 158' ' ' MET . 71.0 mt -109.01 89.02 2.87 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.736 0.814 . . . . 0.0 110.375 177.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 40.86 -82.06 0.0 OUTLIER Glycine 0 N--CA 1.476 1.341 0 C-N-CA 129.608 3.48 . . . . 0.0 115.27 175.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -68.53 -154.2 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 128.839 2.855 . . . . 0.0 110.541 174.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -73.68 20.24 1.41 Allowed Glycine 0 CA--C 1.541 1.693 0 O-C-N 120.217 -1.552 . . . . 0.0 114.928 175.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.04 154.07 17.34 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 120.448 2.124 . . . . 0.0 112.038 177.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 87.4 mtt180 -145.95 115.82 7.32 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.322 1.449 . . . . 0.0 110.877 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . 0.542 ' HB2' HD11 ' A' ' 152' ' ' LEU . 5.9 ttp -114.25 132.42 56.15 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 124.273 1.029 . . . . 0.0 109.682 -178.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -103.84 132.83 49.72 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 128.477 2.711 . . . . 0.0 110.005 -179.039 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -135.2 150.83 20.31 Favored Glycine 0 N--CA 1.47 0.918 0 CA-C-N 120.313 1.415 . . . . 0.0 114.23 178.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.708 HD13 ' H ' ' A' ' 147' ' ' TRP . 6.6 tp -145.81 131.93 13.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 125.147 1.379 . . . . 0.0 110.957 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 3.6 ttt -152.42 176.4 11.69 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 127.606 2.362 . . . . 0.0 107.717 175.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 10.1 t -152.39 163.62 39.15 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.194 1.397 . . . . 0.0 109.161 175.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 5.4 t -106.52 31.43 5.22 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.396 1.478 . . . . 0.0 111.511 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -68.44 23.76 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 128.09 2.556 . . . . 0.0 115.112 179.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 84.36 -60.24 4.85 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 126.181 1.848 . . . . 0.0 113.342 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -126.5 63.0 1.28 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.333 1.453 . . . . 0.0 111.051 178.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -86.61 -177.46 6.15 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.311 1.044 . . . . 0.0 112.794 174.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.447 ' HE2' ' O ' ' A' ' 169' ' ' LYS . 0.0 OUTLIER -124.85 174.43 7.95 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 127.991 2.516 . . . . 0.0 109.708 174.993 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 42.5 ttp -126.12 132.12 51.93 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.055 1.342 . . . . 0.0 110.189 176.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -135.86 127.18 28.38 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.104 0.962 . . . . 0.0 110.163 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.413 HG21 ' SD ' ' A' ' 158' ' ' MET . 4.6 mp -129.58 120.66 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 C-N-CA 123.19 0.596 . . . . 0.0 109.95 177.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.06 132.42 56.03 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.827 1.651 . . . . 0.0 111.341 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.8 mp -76.81 133.67 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 O-C-N 120.683 -1.26 . . . . 0.0 110.382 175.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 6.7 m -140.24 92.5 2.54 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 125.144 1.378 . . . . 0.0 112.22 177.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 60.5 mtp180 . . . . . 0 C--O 1.254 1.29 0 C-N-CA 126.311 1.844 . . . . 0.0 111.48 175.033 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 38.4 m . . . . . 0 N--CA 1.482 1.169 0 CA-C-O 121.57 0.7 . . . . 0.0 111.283 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.515 ' O ' HD12 ' A' ' 25' ' ' LEU . 1.0 OUTLIER -136.65 166.39 23.66 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 126.798 2.039 . . . . 0.0 110.303 179.68 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.448 ' HB2' ' HD2' ' A' ' 27' ' ' LYS . 15.5 tp -132.5 -35.42 1.14 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.902 1.281 . . . . 0.0 112.385 176.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -75.62 129.96 38.0 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 175.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -71.93 -113.02 0.05 OUTLIER Glycine 0 CA--C 1.533 1.192 0 C-N-CA 124.036 0.827 . . . . 0.0 112.636 177.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 19.3 p -113.58 172.82 6.74 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.872 1.269 . . . . 0.0 111.578 176.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -124.81 24.56 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 125.226 1.41 . . . . 0.0 111.871 175.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -52.49 166.4 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 O-C-N 120.633 -1.292 . . . . 0.0 112.684 174.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -48.87 144.3 4.71 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.947 1.299 . . . . 0.0 113.404 -177.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.06 -24.33 54.37 Favored Glycine 0 CA--C 1.538 1.492 0 N-CA-C 115.78 1.072 . . . . 0.0 115.78 -174.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.89 -34.43 64.42 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 121.289 -1.124 . . . . 0.0 111.797 174.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.9 t -84.21 -41.27 17.14 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.684 1.993 . . . . 0.0 112.837 175.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 13.0 tp -89.23 96.29 10.66 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 127.415 2.286 . . . . 0.0 111.357 175.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.58 178.77 6.49 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 126.734 2.014 . . . . 0.0 110.731 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -41.36 -40.91 1.83 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.683 1.593 . . . . 0.0 113.786 175.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -49.89 -45.23 50.56 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.219 1.407 . . . . 0.0 112.639 175.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 88.0 t -69.86 -38.88 76.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 125.777 1.631 . . . . 0.0 111.669 175.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 44.6 mt -70.75 -36.77 73.29 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 120.706 -1.246 . . . . 0.0 112.457 -178.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -65.48 -51.14 62.19 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.343 1.457 . . . . 0.0 111.186 175.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.71 -34.31 75.56 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 118.08 -0.962 . . . . 0.0 111.915 175.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.2 t -56.35 -48.53 79.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-N 119.679 1.127 . . . . 0.0 111.485 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 55.4 mt -56.85 -19.8 19.44 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 175.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.03 -61.24 1.28 Allowed Glycine 0 CA--C 1.535 1.293 0 C-N-CA 126.306 1.908 . . . . 0.0 113.12 175.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -64.11 -32.54 74.14 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -178.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.515 HD12 ' O ' ' A' ' 2' ' ' GLU . 2.6 mm? -90.55 97.76 11.37 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.179 0.992 . . . . 0.0 109.917 176.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -109.82 109.42 2.7 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 126.333 1.921 . . . . 0.0 112.475 -178.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.448 ' HD2' ' HB2' ' A' ' 3' ' ' LEU . 17.7 mtpt -129.59 -69.86 0.67 Allowed 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 125.793 1.637 . . . . 0.0 112.07 -176.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.4 m -121.17 169.36 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 127.848 2.459 . . . . 0.0 110.491 -176.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.0 t -65.76 -31.85 73.07 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -179.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.5 mmt180 -132.4 105.58 7.36 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.303 1.841 . . . . 0.0 111.041 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.4 ptpt -120.56 159.43 25.26 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 126.539 1.935 . . . . 0.0 110.149 -177.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -128.75 132.95 67.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 123.941 0.897 . . . . 0.0 109.437 175.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.33 102.63 4.85 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.077 1.751 . . . . 0.0 109.673 177.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.799 HG22 ' HB2' ' A' ' 72' ' ' TYR . 1.3 m -107.7 162.29 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 123.73 0.812 . . . . 0.0 110.927 178.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -134.84 124.28 3.39 Favored Glycine 0 N--CA 1.463 0.452 0 N-CA-C 111.531 -0.628 . . . . 0.0 111.531 177.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.42 ' HB ' HD11 ' A' ' 70' ' ' LEU . 3.3 mp -113.02 132.35 62.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-N 118.459 1.13 . . . . 0.0 110.536 175.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -96.22 99.69 11.39 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.67 1.588 . . . . 0.0 110.214 177.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -67.73 94.35 0.44 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.319 1.448 . . . . 0.0 110.552 175.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -125.34 7.29 7.75 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 125.576 1.55 . . . . 0.0 111.801 174.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 42.8 p -57.03 -34.9 68.67 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.366 1.066 . . . . 0.0 113.616 -177.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 158.47 -63.52 0.3 Allowed Glycine 0 CA--C 1.53 1.02 0 C-N-CA 125.271 1.415 . . . . 0.0 113.639 175.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -107.18 171.08 16.29 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 125.549 1.547 . . . . 0.0 113.092 -178.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.17 150.84 28.64 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.803 -0.822 . . . . 0.0 110.874 175.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.404 ' HB3' ' CD1' ' A' ' 91' ' ' TYR . 45.2 m0 -104.35 100.52 10.23 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 124.876 1.271 . . . . 0.0 111.346 -177.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.5 m -80.73 117.97 21.86 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 124.689 1.195 . . . . 0.0 108.44 175.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.86 126.46 27.08 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.129 0.571 . . . . 0.0 111.676 175.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.47 HD12 ' N ' ' A' ' 48' ' ' ASN . 3.1 pp -100.37 -53.48 3.1 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 122.844 0.458 . . . . 0.0 111.937 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.47 ' N ' HD12 ' A' ' 47' ' ' LEU . 5.8 t30 -171.6 138.87 1.17 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.618 1.967 . . . . 0.0 109.56 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.599 ' HB2' HD12 ' A' ' 60' ' ' LEU . . . -121.31 155.53 34.51 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.797 1.239 . . . . 0.0 111.404 175.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -136.45 113.42 10.44 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.589 1.555 . . . . 0.0 111.409 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.533 ' CD1' ' HB1' ' A' ' 87' ' ' ALA . 2.8 m-85 -114.31 132.5 56.15 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 123.772 0.829 . . . . 0.0 110.02 -178.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.58 -31.33 4.31 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 114.973 1.471 . . . . 0.0 114.973 -175.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.0 t -123.18 -46.58 2.06 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.503 1.521 . . . . 0.0 110.943 175.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -72.48 10.97 4.48 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 124.711 1.148 . . . . 0.0 115.046 -178.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.3 p -31.06 104.03 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 128.982 2.913 . . . . 0.0 114.182 -174.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.642 HG21 HG23 ' A' ' 59' ' ' ILE . 1.6 t -120.92 178.6 4.66 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.945 1.298 . . . . 0.0 112.786 -174.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -77.42 -59.03 2.95 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.86 1.264 . . . . 0.0 111.554 174.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.3 p -138.09 131.41 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 125.918 1.687 . . . . 0.0 112.32 -178.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.642 HG23 HG21 ' A' ' 56' ' ' THR . 1.1 pp -140.78 -39.62 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.92 1.688 . . . . 0.0 114.154 -177.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.606 ' H ' HD12 ' A' ' 59' ' ' ILE . 4.9 mt -92.17 94.94 0.87 Allowed Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 124.933 1.293 . . . . 0.0 108.883 175.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -61.83 132.91 42.03 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 123.137 2.558 . . . . 0.0 110.258 175.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -40.0 -44.43 1.73 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 126.457 1.903 . . . . 0.0 113.962 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.4 p -155.13 139.7 9.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 C-N-CA 126.613 1.965 . . . . 0.0 110.028 176.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 58.6 t -133.72 121.35 16.02 Favored Pre-proline 0 N--CA 1.484 1.246 0 C-N-CA 124.623 1.169 . . . . 0.0 110.672 178.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -58.17 152.32 53.3 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.982 2.455 . . . . 0.0 113.21 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -72.49 168.21 19.01 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.51 0.724 . . . . 0.0 110.657 175.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 72.7 p 51.72 28.56 4.95 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 126.904 2.082 . . . . 0.0 112.687 -175.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.25 171.85 12.83 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 128.443 2.697 . . . . 0.0 109.42 -175.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -131.15 167.36 19.27 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 121.716 -0.615 . . . . 0.0 109.746 177.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.42 HD11 ' HB ' ' A' ' 36' ' ' ILE . 2.9 pp -137.14 174.16 10.91 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 125.045 1.338 . . . . 0.0 111.03 -176.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.461 HD13 ' O ' ' A' ' 34' ' ' VAL . 0.5 OUTLIER -127.95 152.65 47.63 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.819 1.248 . . . . 0.0 111.397 176.166 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.799 ' HB2' HG22 ' A' ' 34' ' ' VAL . 8.2 m-85 -127.25 136.68 52.33 Favored 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 125.109 1.364 . . . . 0.0 107.76 174.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.0 p -114.96 153.29 30.87 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 125.666 1.587 . . . . 0.0 110.935 176.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -170.84 145.45 8.98 Favored Glycine 0 N--CA 1.452 -0.263 0 CA-C-O 121.587 0.548 . . . . 0.0 112.422 176.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 19.0 mtm180 -128.45 132.43 48.41 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 125.942 1.697 . . . . 0.0 109.759 -175.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.8 ptmt -65.61 -177.97 0.49 Allowed 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.894 0.878 . . . . 0.0 112.734 174.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 64.93 54.24 1.32 Allowed 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.667 1.587 . . . . 0.0 112.47 174.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 27.3 t -54.42 -32.82 58.16 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.679 1.592 . . . . 0.0 112.502 175.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 129.91 -70.65 0.51 Allowed Glycine 0 CA--C 1.533 1.192 0 C-N-CA 126.085 1.802 . . . . 0.0 111.862 177.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.58 -19.71 27.82 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 123.347 2.698 . . . . 0.0 113.329 176.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 6.3 p -139.33 146.47 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 126.218 1.807 . . . . 0.0 111.064 175.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -131.15 104.88 7.33 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.631 1.973 . . . . 0.0 110.32 177.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -129.9 171.77 12.39 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.912 1.685 . . . . 0.0 109.078 175.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -68.26 -64.59 3.04 Favored Glycine 0 N--CA 1.474 1.193 0 O-C-N 120.598 -1.314 . . . . 0.0 113.191 -177.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -158.44 114.08 2.67 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.238 1.015 . . . . 0.0 111.058 178.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.8 t -147.57 123.23 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 O-C-N 121.246 -0.909 . . . . 0.0 110.577 -176.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.533 ' HB1' ' CD1' ' A' ' 51' ' ' PHE . . . -165.03 167.24 18.58 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.974 1.31 . . . . 0.0 112.022 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -150.1 139.72 21.62 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.655 1.182 . . . . 0.0 110.645 174.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.453 ' CD2' ' CE2' ' A' ' 72' ' ' TYR . 46.8 p90 -139.73 170.91 15.01 Favored 'General case' 0 N--CA 1.467 0.383 0 O-C-N 121.012 -1.055 . . . . 0.0 110.622 176.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -137.16 156.39 48.4 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.843 -0.536 . . . . 0.0 112.295 175.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.404 ' CD1' ' HB3' ' A' ' 44' ' ' TRP . 8.5 m-85 -130.39 129.14 42.71 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 125.492 1.517 . . . . 0.0 112.314 -177.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -85.88 117.29 24.64 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.065 0.46 . . . . 0.0 111.133 -178.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 7.6 mtp -93.92 132.17 38.62 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.05 1.34 . . . . 0.0 110.981 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 39.5 m -57.92 -18.21 21.64 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 125.246 1.418 . . . . 0.0 113.856 175.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -69.48 -9.18 52.66 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 124.911 1.285 . . . . 0.0 113.06 175.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 99.54 19.77 19.39 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 125.746 1.641 . . . . 0.0 114.549 178.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 16.4 m-80 -130.55 175.86 8.64 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.003 1.321 . . . . 0.0 111.053 -175.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 16.4 m -128.85 114.21 16.23 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.852 0.861 . . . . 0.0 111.955 177.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 52.1 tp -79.39 104.43 10.0 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.598 1.159 . . . . 0.0 109.737 175.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -99.21 113.92 4.87 Favored Glycine 0 N--CA 1.466 0.69 0 C-N-CA 124.477 1.037 . . . . 0.0 112.737 -179.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 90.1 t -96.31 135.46 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.529 1.131 . . . . 0.0 111.076 -178.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -134.51 125.65 27.79 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.927 1.291 . . . . 0.0 110.772 -175.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.465 ' CZ ' ' HB3' ' A' ' 87' ' ' ALA . 5.6 p90 -145.94 122.94 11.39 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.759 1.224 . . . . 0.0 111.599 -174.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 38.3 t -133.92 136.31 44.17 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 124.179 0.992 . . . . 0.0 110.46 176.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 45.4 t -126.42 88.83 53.56 Favored Pre-proline 0 C--O 1.238 0.47 0 C-N-CA 127.897 2.479 . . . . 0.0 106.533 -178.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -67.29 102.07 0.66 Allowed 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 123.157 2.572 . . . . 0.0 109.48 177.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -49.29 -30.87 7.97 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.57 1.148 . . . . 0.0 112.559 176.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.47 44.56 0.44 Allowed 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 125.358 1.463 . . . . 0.0 110.969 174.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -49.05 -33.27 11.09 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 125.896 1.679 . . . . 0.0 112.572 -176.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -49.49 111.08 0.44 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 127.585 2.354 . . . . 0.0 109.993 174.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 16.4 m95 63.67 22.74 13.25 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 125.336 1.454 . . . . 0.0 113.701 177.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -129.49 178.74 6.25 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.594 1.958 . . . . 0.0 112.063 -175.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.7 m -142.06 141.57 32.78 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.653 1.181 . . . . 0.0 113.843 176.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -81.37 130.93 35.24 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.627 1.971 . . . . 0.0 106.759 175.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 9.7 m0 -117.8 120.64 38.55 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.983 1.313 . . . . 0.0 110.233 176.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 11.6 p-90 -144.46 152.65 40.92 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 126.361 1.865 . . . . 0.0 111.728 -175.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 9.7 t70 164.76 150.17 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 128.743 2.817 . . . . 0.0 109.648 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 62.0 t -120.83 139.49 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.183 1.393 . . . . 0.0 109.035 -175.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.485 ' HE2' ' HG3' ' A' ' 135' ' ' MET . 0.0 OUTLIER -129.46 171.19 12.81 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.287 1.035 . . . . 0.0 111.795 -178.968 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 54.5 mt -124.96 116.78 48.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 175.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -77.12 149.76 79.94 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 123.119 0.568 . . . . 0.0 110.589 174.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.78 -0.67 7.26 Favored 'Trans proline' 0 CA--C 1.545 1.051 0 C-N-CA 124.471 3.448 . . . . 0.0 115.027 -176.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -174.0 -175.49 41.68 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 127.055 2.264 . . . . 0.0 111.003 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 24.6 tttt -52.77 116.83 2.52 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.117 1.367 . . . . 0.0 112.059 -177.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -133.24 117.71 17.72 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.382 1.473 . . . . 0.0 111.738 -177.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.3 ptt180 -65.12 175.11 1.71 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.026 0.93 . . . . 0.0 111.855 174.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -127.58 103.27 7.24 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.989 1.716 . . . . 0.0 106.809 176.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -132.51 172.63 12.25 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.69 1.996 . . . . 0.0 109.425 177.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -53.72 -38.85 64.71 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -177.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -60.96 -58.72 12.29 Favored Glycine 0 N--CA 1.469 0.86 0 CA-C-N 118.885 0.766 . . . . 0.0 111.376 174.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 2.2 mpp? -59.1 -39.59 82.68 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 117.851 0.825 . . . . 0.0 112.171 178.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -59.78 -59.01 6.11 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.367 1.067 . . . . 0.0 110.75 175.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -67.97 -34.31 76.3 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 118.927 0.785 . . . . 0.0 113.01 -177.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -63.45 -41.53 98.63 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.447 0.699 . . . . 0.0 111.382 175.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . 0.485 ' HG3' ' HE2' ' A' ' 119' ' ' LYS . 37.4 mmm -77.48 -28.47 52.27 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 121.06 -1.025 . . . . 0.0 113.033 175.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -54.56 -55.19 31.87 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 119.412 1.005 . . . . 0.0 111.386 176.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -65.11 -18.99 65.76 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 119.659 -0.816 . . . . 0.0 112.129 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -81.38 3.8 75.91 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 126.773 2.13 . . . . 0.0 114.472 174.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 34.9 m-20 -115.67 64.31 2.22 Favored Pre-proline 0 CA--C 1.552 1.045 0 C-N-CA 125.804 1.642 . . . . 0.0 114.966 -175.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -76.1 73.33 4.97 Favored 'Trans proline' 0 CA--C 1.546 1.08 0 C-N-CA 123.551 2.834 . . . . 0.0 112.87 -177.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.98 116.43 7.05 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.423 1.089 . . . . 0.0 109.723 -178.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 2.9 ttm105 -81.79 -172.81 4.09 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.534 1.533 . . . . 0.0 111.362 177.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -78.06 57.13 3.98 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 124.114 0.864 . . . . 0.0 111.027 174.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -62.61 98.81 0.13 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 128.095 2.558 . . . . 0.0 110.376 175.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 11.2 p-10 -64.08 66.04 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 127.851 2.46 . . . . 0.0 116.343 -175.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -178.44 167.94 38.78 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 128.368 2.89 . . . . 0.0 109.825 175.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' TRP . . . . . 0.44 ' CE3' ' HG3' ' A' ' 159' ' ' LYS . 59.6 m95 -64.78 67.91 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.998 2.119 . . . . 0.0 111.215 175.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -85.73 116.12 23.81 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 128.796 2.838 . . . . 0.0 111.452 -177.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -166.55 -172.63 2.23 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 177.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.68 167.37 22.27 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.494 1.918 . . . . 0.0 112.543 177.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 54.5 m-20 -64.56 142.59 58.37 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.904 -0.498 . . . . 0.0 109.782 175.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 11.0 mt -89.97 158.76 17.23 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 122.165 0.983 . . . . 0.0 109.359 175.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -65.6 -171.87 3.64 Favored Glycine 0 CA--C 1.536 1.399 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 175.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 54.73 8.78 0.24 Allowed 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 175.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 82.07 42.51 8.73 Favored Glycine 0 CA--C 1.54 1.645 0 C-N-CA 126.279 1.895 . . . . 0.0 113.087 -175.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.7 mp -120.17 172.33 7.85 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 119.025 1.413 . . . . 0.0 112.678 179.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 24.2 mtt180 -137.99 117.32 12.77 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 120.746 -1.221 . . . . 0.0 111.548 176.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 5.3 ttt -98.45 151.37 20.66 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 120.108 -1.62 . . . . 0.0 108.636 174.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.44 ' HG3' ' CE3' ' A' ' 147' ' ' TRP . 5.4 tppt? -136.86 142.47 42.82 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.503 1.921 . . . . 0.0 109.877 176.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -155.79 152.19 23.66 Favored Glycine 0 N--CA 1.473 1.146 0 O-C-N 120.64 -1.287 . . . . 0.0 112.858 176.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 2.2 tp -135.19 124.53 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 126.676 1.99 . . . . 0.0 108.143 -176.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 8.7 mtp -145.29 113.02 6.33 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.662 1.585 . . . . 0.0 108.991 174.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 9.5 t -100.66 125.17 47.05 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 118.517 0.599 . . . . 0.0 110.997 178.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 23.1 p -74.18 39.01 0.11 Allowed 'General case' 0 N--CA 1.481 1.097 0 O-C-N 120.738 -1.226 . . . . 0.0 113.764 175.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -72.41 -2.29 18.85 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 126.192 1.797 . . . . 0.0 114.516 177.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 108.89 -59.77 0.35 Allowed Glycine 0 CA--C 1.531 1.088 0 C-N-CA 126.264 1.887 . . . . 0.0 113.03 176.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -118.79 27.02 9.15 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.416 1.486 . . . . 0.0 112.482 -177.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.91 170.59 6.44 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 122.558 1.17 . . . . 0.0 114.129 175.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.67 -178.88 3.92 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 126.819 2.047 . . . . 0.0 110.89 175.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 14.8 ttp -125.85 139.12 53.75 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.588 1.555 . . . . 0.0 110.288 171.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.418 ' C ' HD12 ' A' ' 172' ' ' ILE . 39.8 tt0 -143.48 126.9 16.78 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 121.981 -0.449 . . . . 0.0 110.67 174.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.418 HD12 ' C ' ' A' ' 171' ' ' GLN . 2.7 mp -123.28 133.95 67.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.664 1.186 . . . . 0.0 108.642 176.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -133.14 132.76 42.02 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.852 1.661 . . . . 0.0 109.473 178.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.9 mp -96.04 92.04 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 O-C-N 121.197 -0.939 . . . . 0.0 109.63 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.41 165.1 8.16 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-O 122.276 1.036 . . . . 0.0 112.839 175.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 18.2 mmm180 . . . . . 0 C--O 1.252 1.227 0 C-N-CA 125.182 1.393 . . . . 0.0 111.171 -176.82 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 60.0 m . . . . . 0 N--CA 1.482 1.152 0 CA-C-O 120.816 0.341 . . . . 0.0 111.51 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -133.26 -72.29 0.51 Allowed 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.483 1.513 . . . . 0.0 111.116 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 32.1 tp 52.76 15.01 0.48 Allowed 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 127.041 2.137 . . . . 0.0 114.928 -175.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -128.95 120.98 27.07 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 127.273 2.229 . . . . 0.0 107.776 178.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -73.05 -101.16 0.07 OUTLIER Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.046 0.831 . . . . 0.0 112.305 -178.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 38.8 p -131.18 170.67 14.25 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.756 1.222 . . . . 0.0 111.33 175.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -124.47 16.19 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 125.248 1.419 . . . . 0.0 111.886 179.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.3 pt -53.31 168.69 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 124.945 1.298 . . . . 0.0 111.561 175.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -40.6 132.64 2.12 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.62 1.168 . . . . 0.0 112.873 -178.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -53.71 -22.5 18.28 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 124.937 1.256 . . . . 0.0 114.322 -176.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.18 -33.07 71.69 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.273 1.429 . . . . 0.0 112.452 175.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.2 t -96.36 -44.52 7.18 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.214 1.406 . . . . 0.0 112.314 175.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.3 tp -69.15 89.55 0.45 Allowed 'General case' 0 CA--C 1.545 0.752 0 CA-C-O 122.168 0.985 . . . . 0.0 110.632 175.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 58.1 p -126.93 -176.14 3.62 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 126.884 2.074 . . . . 0.0 111.512 -178.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -52.19 -36.93 53.3 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.165 0.986 . . . . 0.0 113.174 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -56.02 -43.63 77.96 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.645 1.178 . . . . 0.0 112.001 176.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 88.5 t -65.97 -42.52 91.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 124.342 1.057 . . . . 0.0 110.85 175.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 42.4 mt -68.52 -38.36 80.84 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 120.837 -1.164 . . . . 0.0 112.5 -179.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -64.6 -47.93 76.8 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.725 1.21 . . . . 0.0 111.105 178.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.32 -35.18 77.41 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 118.064 -0.97 . . . . 0.0 113.083 175.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.4 t -53.93 -44.08 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 CA-C-N 120.209 1.368 . . . . 0.0 111.982 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 71.0 mt -60.33 -13.78 14.87 Favored 'General case' 0 CA--C 1.55 0.964 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 175.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -106.06 -46.86 1.13 Allowed Glycine 0 CA--C 1.536 1.354 0 C-N-CA 126.681 2.086 . . . . 0.0 114.034 178.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -66.24 -25.5 66.92 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 119.075 1.438 . . . . 0.0 113.445 175.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -111.06 158.42 18.85 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.84 1.256 . . . . 0.0 111.656 175.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -175.77 86.49 0.07 OUTLIER Glycine 0 CA--C 1.53 1.015 0 O-C-N 121.474 -0.766 . . . . 0.0 113.901 -175.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.7 mttt -74.82 -54.8 6.64 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.946 1.298 . . . . 0.0 112.525 177.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 16.2 m -141.03 -179.11 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 127.917 2.487 . . . . 0.0 111.158 -178.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 25.9 m -49.54 -48.69 48.17 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 126.334 1.854 . . . . 0.0 114.517 -177.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.0 tpm_? -120.42 129.6 53.98 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.318 1.447 . . . . 0.0 109.497 175.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.9 ptpt -131.93 152.53 51.02 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.824 2.05 . . . . 0.0 110.502 -174.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -121.37 131.12 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 124.674 1.19 . . . . 0.0 109.559 177.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -134.61 97.54 3.82 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.473 1.909 . . . . 0.0 110.318 177.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.769 HG22 ' HB2' ' A' ' 72' ' ' TYR . 1.6 m -99.52 160.78 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 C-N-CA 123.305 0.642 . . . . 0.0 111.189 178.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -133.53 112.11 1.05 Allowed Glycine 0 CA--C 1.526 0.749 0 CA-C-O 119.308 -0.718 . . . . 0.0 113.526 174.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.9 mp -100.68 147.05 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 119.286 1.543 . . . . 0.0 109.456 175.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.448 ' HB3' ' HA ' ' A' ' 173' ' ' LYS . 21.7 t0 -117.2 102.76 9.55 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.116 1.366 . . . . 0.0 110.645 177.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -71.54 92.25 1.12 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 127.14 2.176 . . . . 0.0 111.221 176.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -119.01 -0.19 11.19 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.445 1.098 . . . . 0.0 113.802 175.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 30.3 t -47.81 -34.56 8.82 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 127.024 2.13 . . . . 0.0 114.63 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 110.23 60.49 0.5 Allowed Glycine 0 N--CA 1.468 0.777 0 C-N-CA 124.822 1.201 . . . . 0.0 112.264 177.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 167.81 150.34 6.49 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 125.327 1.441 . . . . 0.0 111.918 177.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.673 HG22 ' HA ' ' A' ' 65' ' ' PRO . 10.0 p -68.43 130.99 44.5 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.504 1.122 . . . . 0.0 110.92 174.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 43.1 m0 -91.35 101.79 14.49 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 123.849 0.86 . . . . 0.0 111.634 -179.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.9 m -83.45 125.4 31.68 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.069 1.348 . . . . 0.0 109.907 175.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.77 131.69 47.52 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.036 0.534 . . . . 0.0 110.582 174.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -117.12 -45.37 2.75 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.034 0.934 . . . . 0.0 112.125 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -174.25 149.14 1.36 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.76 2.024 . . . . 0.0 111.436 -178.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -131.26 164.82 24.74 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.778 1.631 . . . . 0.0 111.945 176.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -142.89 109.13 5.27 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.902 1.281 . . . . 0.0 111.45 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.498 ' CE1' ' HB1' ' A' ' 87' ' ' ALA . 3.0 m-85 -113.62 128.01 56.27 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.914 0.886 . . . . 0.0 110.498 -177.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.57 -39.77 4.53 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -177.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.8 t -116.74 -53.89 2.47 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 126.099 1.759 . . . . 0.0 109.801 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -65.36 12.46 0.3 Allowed Glycine 0 CA--C 1.534 1.239 0 C-N-CA 126.929 2.204 . . . . 0.0 115.754 -175.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 53.1 p -31.16 111.15 0.08 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 129.288 3.035 . . . . 0.0 112.938 -174.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 t -129.42 179.62 5.69 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.794 1.238 . . . . 0.0 113.713 -175.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -82.51 -69.65 0.61 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.29 1.436 . . . . 0.0 111.573 176.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.1 p -132.4 130.28 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 125.688 1.595 . . . . 0.0 111.685 -177.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.5 pp -141.15 -26.15 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.896 1.678 . . . . 0.0 114.478 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -99.35 95.26 3.34 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 125.45 1.5 . . . . 0.0 109.181 178.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -65.57 151.55 84.42 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.781 2.987 . . . . 0.0 111.026 176.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -46.52 -49.19 18.89 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.991 1.316 . . . . 0.0 113.595 -179.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.7 p -157.5 139.91 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 126.497 1.919 . . . . 0.0 110.073 175.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.407 HG21 HD13 ' A' ' 70' ' ' LEU . 46.1 t -113.89 130.12 24.13 Favored Pre-proline 0 N--CA 1.474 0.753 0 C-N-CA 124.542 1.137 . . . . 0.0 109.069 174.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.673 ' HA ' HG22 ' A' ' 43' ' ' THR . 66.5 Cg_endo -67.71 152.84 77.32 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.436 2.091 . . . . 0.0 112.527 176.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -67.12 166.01 14.77 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.05 174.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . 0.267 66.8 p 52.9 22.65 2.47 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 127.668 2.387 . . . . 0.0 114.574 -174.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 20.9 mttt -124.57 172.84 8.9 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 126.834 2.053 . . . . 0.0 112.351 -178.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -131.48 163.94 26.86 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 122.799 0.439 . . . . 0.0 110.123 -178.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.407 HD13 HG21 ' A' ' 64' ' ' VAL . 2.4 pt? -143.76 171.0 14.81 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 124.267 1.027 . . . . 0.0 112.49 -178.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.583 HD13 ' O ' ' A' ' 34' ' ' VAL . 0.9 OUTLIER -117.49 154.78 30.85 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.91 1.284 . . . . 0.0 113.45 179.667 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.769 ' HB2' HG22 ' A' ' 34' ' ' VAL . 16.1 m-85 -129.34 133.5 47.45 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.034 1.334 . . . . 0.0 109.258 175.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.0 p -107.82 149.2 28.53 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 126.443 1.897 . . . . 0.0 110.287 175.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -167.9 144.52 8.96 Favored Glycine 0 CA--C 1.522 0.524 0 O-C-N 121.738 -0.601 . . . . 0.0 112.852 174.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 40.2 mtm180 -107.09 140.52 39.79 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.47 1.508 . . . . 0.0 110.676 -176.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.27 -33.59 74.92 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.439 1.496 . . . . 0.0 114.564 175.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 49.5 m -71.23 89.73 0.88 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 127.369 2.268 . . . . 0.0 113.456 -177.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 35.6 t -78.88 -33.12 45.97 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 176.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 122.0 -74.66 0.36 Allowed Glycine 0 CA--C 1.537 1.467 0 C-N-CA 125.797 1.665 . . . . 0.0 112.501 -174.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -71.3 -42.32 2.02 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 123.196 2.597 . . . . 0.0 113.095 -178.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 20.9 m -140.9 111.38 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 126.322 1.849 . . . . 0.0 111.49 -175.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.51 125.76 27.19 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 121.401 -0.812 . . . . 0.0 110.814 175.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 97.6 m -135.19 154.57 51.56 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 126.237 1.815 . . . . 0.0 108.877 178.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -54.32 -82.44 0.05 OUTLIER Glycine 0 N--CA 1.475 1.299 0 C-N-CA 124.968 1.27 . . . . 0.0 114.526 -174.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -158.82 109.45 2.06 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.509 0.671 . . . . 0.0 111.723 174.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.9 t -138.24 121.07 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 124.897 1.279 . . . . 0.0 109.375 -177.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.498 ' HB1' ' CE1' ' A' ' 51' ' ' PHE . . . -157.66 167.47 30.01 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 122.211 1.005 . . . . 0.0 110.982 176.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -147.91 158.15 43.9 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.208 1.003 . . . . 0.0 109.501 175.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.482 ' CZ ' HG11 ' A' ' 101' ' ' VAL . 48.0 p90 -155.19 174.48 15.14 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 121.323 -0.861 . . . . 0.0 110.101 175.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.482 ' HB1' ' CG2' ' A' ' 98' ' ' THR . . . -133.52 148.28 51.66 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.537 175.071 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -125.93 148.57 49.19 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.372 1.069 . . . . 0.0 113.8 176.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -89.12 123.69 33.63 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -178.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 5.8 tpp -89.22 144.07 26.37 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.586 0.754 . . . . 0.0 111.345 176.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 10.8 t -66.34 -23.08 66.29 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.828 0.851 . . . . 0.0 112.829 175.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -73.84 -11.15 60.28 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.981 1.313 . . . . 0.0 112.605 174.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 96.71 38.81 4.31 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 125.051 1.31 . . . . 0.0 114.649 178.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -135.7 173.15 12.04 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 118.812 1.306 . . . . 0.0 110.998 -179.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.482 ' CG2' ' HB1' ' A' ' 90' ' ' ALA . 3.4 m -122.63 103.44 8.68 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.731 1.212 . . . . 0.0 112.221 -177.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.3 tt -64.53 92.51 0.09 Allowed 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 126.369 1.868 . . . . 0.0 111.957 175.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -91.96 95.2 2.01 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 125.924 1.726 . . . . 0.0 112.211 -178.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.503 HG23 HG22 ' A' ' 118' ' ' VAL . 2.3 p -82.33 153.63 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 123.704 0.802 . . . . 0.0 111.635 177.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.74 116.67 7.77 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.697 1.599 . . . . 0.0 110.583 177.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.449 ' CE2' ' HB3' ' A' ' 87' ' ' ALA . 24.6 p90 -134.49 131.08 37.63 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 122.201 1.001 . . . . 0.0 112.706 -176.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 23.3 t -143.56 97.38 3.06 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 124.564 1.146 . . . . 0.0 110.643 -175.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 24.1 t -94.37 119.62 66.24 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 126.19 1.796 . . . . 0.0 108.975 177.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.41 ' HD3' ' CB ' ' A' ' 114' ' ' ASN . 59.8 Cg_endo -70.29 162.74 41.22 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 122.54 2.16 . . . . 0.0 111.927 179.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -97.34 -62.35 1.27 Allowed 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.919 0.888 . . . . 0.0 111.47 174.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -63.43 -36.87 85.16 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.44 1.496 . . . . 0.0 112.955 -176.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 52.9 21.17 1.89 Allowed 'General case' 0 CA--C 1.556 1.187 0 C-N-CA 126.262 1.825 . . . . 0.0 114.496 -177.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -91.6 -71.41 0.64 Allowed 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.316 1.447 . . . . 0.0 113.967 -174.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -126.4 25.04 6.64 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 127.248 2.219 . . . . 0.0 114.077 -174.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -119.91 124.63 46.5 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.379 1.471 . . . . 0.0 112.883 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 7.3 m -80.73 122.2 26.84 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.283 1.433 . . . . 0.0 110.191 174.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.41 ' CB ' ' HD3' ' A' ' 106' ' ' PRO . 2.4 m120 -123.11 116.23 23.12 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 124.944 1.297 . . . . 0.0 111.359 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 44.5 m0 -109.03 161.23 15.36 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.251 1.421 . . . . 0.0 111.1 -175.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 43.7 p-90 -150.21 137.2 19.37 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.004 0.922 . . . . 0.0 111.771 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -147.75 163.96 35.07 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 122.881 1.324 . . . . 0.0 113.598 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.503 HG22 HG23 ' A' ' 101' ' ' VAL . 19.6 t -145.98 140.73 21.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 C-N-CA 124.699 1.199 . . . . 0.0 108.656 175.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.6 173.36 14.74 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 128.032 2.533 . . . . 0.0 108.85 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.486 ' HB ' ' CE2' ' A' ' 154' ' ' TYR . 7.4 mt -129.86 113.34 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 123.883 0.873 . . . . 0.0 109.135 177.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -64.76 138.14 97.37 Favored Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 124.108 0.963 . . . . 0.0 111.521 177.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -74.48 84.07 1.62 Allowed 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 124.336 3.357 . . . . 0.0 112.124 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 114.62 175.76 18.74 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 126.348 1.928 . . . . 0.0 112.955 -178.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 7.5 tttt -61.84 102.36 0.26 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.289 1.436 . . . . 0.0 111.015 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 1.4 mmt85 -123.18 -175.2 3.12 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 126.434 1.894 . . . . 0.0 111.959 -175.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.3 ptp180 -132.12 175.92 8.83 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.735 1.214 . . . . 0.0 112.581 175.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -119.53 111.69 18.41 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 105.258 -2.127 . . . . 0.0 105.258 174.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -128.9 166.26 19.47 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.485 1.514 . . . . 0.0 109.275 177.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -50.01 -40.23 43.93 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 119.8 1.182 . . . . 0.0 113.389 -178.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -56.23 -62.59 6.16 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 124.065 0.841 . . . . 0.0 111.843 174.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 4.6 mtm -60.79 -37.3 81.46 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.045 1.338 . . . . 0.0 113.723 178.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -57.84 -62.49 1.76 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.256 1.422 . . . . 0.0 109.494 175.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -69.47 -31.54 69.89 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -177.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -57.05 -59.1 5.57 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.032 1.333 . . . . 0.0 110.864 174.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.13 -20.54 59.36 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -53.75 -57.27 11.48 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.639 1.176 . . . . 0.0 109.954 175.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -71.4 -0.73 10.94 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -89.82 -9.55 65.99 Favored Glycine 0 CA--C 1.537 1.454 0 C-N-CA 126.112 1.815 . . . . 0.0 114.924 177.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -145.6 91.33 5.74 Favored Pre-proline 0 CA--C 1.549 0.918 0 CA-C-N 119.64 1.72 . . . . 0.0 113.43 179.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -74.41 81.12 2.11 Favored 'Trans proline' 0 CA--C 1.543 0.968 0 C-N-CA 123.556 2.837 . . . . 0.0 112.656 -178.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -113.41 116.16 29.21 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.493 1.517 . . . . 0.0 109.233 177.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 4.4 ttm180 -103.43 50.6 0.8 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.992 1.317 . . . . 0.0 114.052 -174.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 56.96 56.21 26.15 Favored Glycine 0 CA--C 1.534 1.239 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 -175.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -68.08 108.09 2.97 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.002 1.321 . . . . 0.0 110.873 -175.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -77.04 91.81 3.68 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.171 1.388 . . . . 0.0 114.24 -174.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.71 50.77 0.01 OUTLIER Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.318 0.961 . . . . 0.0 114.381 174.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' TRP . . . . . 0.535 ' H ' HD13 ' A' ' 161' ' ' ILE . 8.8 m95 46.36 62.38 2.32 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.602 1.561 . . . . 0.0 112.704 -174.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -90.51 125.37 35.58 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.112 1.365 . . . . 0.0 112.361 179.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -160.03 -175.12 4.91 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.235 1.014 . . . . 0.0 113.104 -175.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 8.9 mtmt -134.76 160.8 37.04 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.375 1.47 . . . . 0.0 111.176 174.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -81.36 146.62 30.24 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.066 0.946 . . . . 0.0 109.397 175.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.427 ' CD2' ' H ' ' A' ' 158' ' ' MET . 3.1 mm? -102.03 128.2 48.58 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 122.733 0.413 . . . . 0.0 110.013 -177.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -53.32 -24.67 23.63 Favored Glycine 0 N--CA 1.475 1.289 0 C-N-CA 125.628 1.585 . . . . 0.0 116.005 -175.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.486 ' CE2' ' HB ' ' A' ' 120' ' ' ILE . 0.1 OUTLIER -74.06 1.54 10.79 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 127.539 2.336 . . . . 0.0 113.453 177.612 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 90.28 10.85 63.53 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.882 1.706 . . . . 0.0 114.381 -177.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 2.6 mt -98.32 166.44 11.39 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.722 2.009 . . . . 0.0 111.187 -178.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 57.7 mtt180 -139.87 105.6 5.14 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.294 1.038 . . . . 0.0 110.524 178.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . 0.427 ' H ' ' CD2' ' A' ' 152' ' ' LEU . 18.0 ttp -91.68 135.5 33.84 Favored 'General case' 0 C--N 1.318 -0.762 0 O-C-N 120.755 -1.215 . . . . 0.0 107.888 176.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.21 124.57 52.36 Favored 'General case' 0 C--O 1.221 -0.414 0 C-N-CA 126.145 1.778 . . . . 0.0 109.482 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -133.1 155.6 21.74 Favored Glycine 0 N--CA 1.469 0.842 0 CA-C-N 120.807 1.64 . . . . 0.0 114.833 -178.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.535 HD13 ' H ' ' A' ' 147' ' ' TRP . 4.2 tp -152.7 135.06 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-O 122.777 1.275 . . . . 0.0 110.846 -175.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 11.5 mtp -153.05 168.94 24.2 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 128.058 2.543 . . . . 0.0 109.209 176.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 13.2 t -151.66 162.66 40.62 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.726 1.21 . . . . 0.0 109.451 174.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 89.5 p -97.68 26.2 5.24 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.047 1.339 . . . . 0.0 113.115 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -68.48 12.77 0.11 Allowed 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 126.843 2.057 . . . . 0.0 115.4 -176.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 85.93 -62.82 4.33 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 125.735 1.636 . . . . 0.0 112.69 178.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -95.61 9.96 38.4 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 177.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -58.04 159.75 5.44 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 123.116 1.436 . . . . 0.0 114.189 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.45 175.41 6.2 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 128.002 2.521 . . . . 0.0 110.758 -177.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 35.6 ttp -118.97 130.5 55.73 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 125.012 1.325 . . . . 0.0 110.363 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -137.03 126.84 25.61 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.148 0.579 . . . . 0.0 110.806 175.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.403 HG21 ' SD ' ' A' ' 158' ' ' MET . 4.8 mp -131.11 113.75 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 C-N-CA 123.668 0.787 . . . . 0.0 110.068 176.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.448 ' HA ' ' HB3' ' A' ' 37' ' ' ASP . 0.3 OUTLIER -109.61 129.09 55.61 Favored 'General case' 0 C--O 1.222 -0.352 0 C-N-CA 125.11 1.364 . . . . 0.0 111.693 176.277 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.8 mp -79.61 137.18 22.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 175.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 3.2 m -122.21 159.21 27.75 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.699 2.0 . . . . 0.0 110.631 175.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 39.1 mtp180 . . . . . 0 C--O 1.251 1.182 0 C-N-CA 126.403 1.881 . . . . 0.0 112.161 -178.586 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 5.4 t . . . . . 0 N--CA 1.482 1.172 0 N-CA-C 110.695 -0.113 . . . . 0.0 110.695 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -67.8 174.29 3.75 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.397 1.079 . . . . 0.0 112.342 175.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 11.9 tp -131.66 8.21 4.52 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 175.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -132.3 137.78 47.59 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.706 1.602 . . . . 0.0 110.805 175.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.425 ' H ' ' HG ' ' A' ' 71' ' ' LEU . . . -81.75 -153.88 11.88 Favored Glycine 0 CA--C 1.544 1.878 0 C-N-CA 125.351 1.453 . . . . 0.0 110.257 176.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 42.5 p -76.06 173.76 10.88 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.609 1.164 . . . . 0.0 113.063 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -129.77 15.91 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.987 0 C-N-CA 125.92 1.688 . . . . 0.0 112.16 176.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.419 HD12 ' HB3' ' A' ' 12' ' ' SER . 4.7 pt -52.92 166.3 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 O-C-N 120.587 -1.32 . . . . 0.0 111.733 175.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -39.81 132.42 1.72 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.267 1.427 . . . . 0.0 113.244 -179.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -57.36 -16.89 22.9 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 124.889 1.233 . . . . 0.0 114.402 -177.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.2 -23.63 67.38 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.542 1.137 . . . . 0.0 111.701 174.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.419 ' HB3' HD12 ' A' ' 8' ' ' ILE . 4.1 t -109.82 -40.29 4.84 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.592 1.957 . . . . 0.0 112.604 175.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.6 tp -76.47 97.43 4.32 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 121.476 -0.765 . . . . 0.0 109.827 175.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -134.99 -177.82 4.81 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 126.541 1.937 . . . . 0.0 111.87 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -50.23 -36.24 30.13 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.212 1.405 . . . . 0.0 112.91 -178.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -52.85 -37.83 60.69 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.015 1.326 . . . . 0.0 112.543 175.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 78.5 t -73.25 -42.01 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 125.788 1.635 . . . . 0.0 111.115 175.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 57.7 mt -65.4 -42.24 92.81 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 120.961 -1.087 . . . . 0.0 111.964 178.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -61.04 -41.21 96.15 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.289 1.036 . . . . 0.0 111.882 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.98 -38.47 64.16 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 118.834 -0.603 . . . . 0.0 111.215 175.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.402 HG13 HD12 ' A' ' 25' ' ' LEU . 19.3 t -56.01 -39.66 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 C-N-CA 125.398 1.479 . . . . 0.0 111.534 177.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -56.57 -20.57 21.41 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 125.865 1.666 . . . . 0.0 112.727 174.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -108.38 -50.3 0.77 Allowed Glycine 0 CA--C 1.533 1.206 0 C-N-CA 126.356 1.931 . . . . 0.0 114.151 -178.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -64.19 -27.41 69.05 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 118.966 1.383 . . . . 0.0 113.503 178.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.402 HD12 HG13 ' A' ' 21' ' ' VAL . 14.3 mt -109.99 119.64 39.96 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.114 1.366 . . . . 0.0 109.549 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -162.32 81.1 0.13 Allowed Glycine 0 CA--C 1.534 1.24 0 O-C-N 121.604 -0.685 . . . . 0.0 114.156 -175.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.6 mttt -72.69 -60.13 2.38 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.945 1.698 . . . . 0.0 112.985 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.5 m -109.46 -178.7 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 126.794 2.038 . . . . 0.0 110.756 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.6 t -51.27 -46.64 62.47 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.512 1.125 . . . . 0.0 113.568 -175.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.69 144.2 51.17 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.948 1.699 . . . . 0.0 111.176 174.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.92 166.35 22.54 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.194 1.797 . . . . 0.0 111.615 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -129.07 137.42 57.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 124.927 1.291 . . . . 0.0 109.387 176.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -141.0 119.24 12.08 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 126.004 1.721 . . . . 0.0 109.416 175.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.532 HG22 ' HB2' ' A' ' 72' ' ' TYR . 2.6 m -124.77 139.03 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 123.084 0.553 . . . . 0.0 110.779 -179.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -111.51 103.6 1.58 Allowed Glycine 0 N--CA 1.461 0.334 0 C-N-CA 124.754 1.168 . . . . 0.0 110.857 -178.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.4 mp -100.16 132.81 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 121.527 0.68 . . . . 0.0 110.806 175.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -100.99 104.15 15.3 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.755 2.022 . . . . 0.0 109.859 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 29.1 t30 -78.51 99.05 6.31 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.651 0.78 . . . . 0.0 111.033 175.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.54 13.41 10.13 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.002 0.921 . . . . 0.0 112.2 175.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.43 -34.88 71.29 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.892 1.277 . . . . 0.0 114.072 -175.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 139.0 -35.75 1.95 Allowed Glycine 0 CA--C 1.531 1.051 0 C-N-CA 125.535 1.54 . . . . 0.0 113.817 175.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -114.54 158.24 14.45 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 125.167 1.365 . . . . 0.0 112.935 175.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.42 149.17 34.89 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.922 0.867 . . . . 0.0 110.964 175.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.401 ' HB3' ' CD1' ' A' ' 91' ' ' TYR . 40.9 m0 -101.26 107.81 19.29 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 125.139 1.376 . . . . 0.0 110.199 178.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 54.2 m -92.91 128.62 38.84 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 124.805 1.242 . . . . 0.0 109.054 175.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.47 138.15 58.26 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.654 -0.653 . . . . 0.0 111.705 174.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.603 HD21 HG23 ' A' ' 98' ' ' THR . 3.1 pp -118.65 -51.58 2.38 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.054 0.942 . . . . 0.0 112.241 177.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 25.1 t30 -170.83 150.07 3.15 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.09 1.756 . . . . 0.0 109.954 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.611 ' HB2' HD12 ' A' ' 60' ' ' LEU . . . -131.32 158.52 40.45 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.089 1.356 . . . . 0.0 110.849 175.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -136.82 108.6 7.05 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.699 1.6 . . . . 0.0 111.151 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.475 ' CE1' ' HB1' ' A' ' 87' ' ' ALA . 2.9 m-85 -112.59 127.23 56.03 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 120.989 -1.069 . . . . 0.0 110.205 -176.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.55 -32.09 6.57 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -175.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 38.1 t -130.94 -36.06 1.37 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.361 1.464 . . . . 0.0 112.128 175.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -69.64 12.33 1.49 Allowed Glycine 0 CA--C 1.537 1.433 0 C-N-CA 125.553 1.549 . . . . 0.0 115.871 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 75.8 p -28.34 99.36 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 129.992 3.317 . . . . 0.0 114.436 -174.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.606 HG21 HG23 ' A' ' 59' ' ' ILE . 3.2 t -119.25 177.59 4.84 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.467 1.507 . . . . 0.0 112.655 -174.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -82.16 -52.08 7.34 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.442 1.097 . . . . 0.0 112.421 175.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.2 p -155.62 139.19 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.752 1.621 . . . . 0.0 111.618 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.606 HG23 HG21 ' A' ' 56' ' ' THR . 0.1 OUTLIER -133.83 -46.28 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 125.53 1.532 . . . . 0.0 112.693 179.14 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.611 HD12 ' HB2' ' A' ' 49' ' ' ALA . 11.9 mt -79.33 103.46 1.59 Allowed Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 127.002 2.121 . . . . 0.0 109.272 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.5 ' HG2' HG23 ' A' ' 64' ' ' VAL . 48.7 Cg_endo -73.44 159.18 46.95 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 123.874 3.05 . . . . 0.0 110.549 177.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -52.97 -48.77 67.16 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 57.7 t -152.98 136.3 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 127.184 2.194 . . . . 0.0 109.272 -175.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.584 HG21 HD23 ' A' ' 70' ' ' LEU . 57.9 t -128.43 114.48 19.69 Favored Pre-proline 0 N--CA 1.479 1.016 0 C-N-CA 124.208 1.003 . . . . 0.0 110.583 174.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -59.93 145.56 98.01 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.495 2.13 . . . . 0.0 112.385 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -68.11 166.36 16.24 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.692 0.797 . . . . 0.0 110.703 175.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 39.8 p 62.39 16.92 8.99 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 127.198 2.199 . . . . 0.0 113.531 -175.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 19.0 mttt -125.86 -173.76 2.92 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.518 1.927 . . . . 0.0 111.102 -178.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -138.8 166.74 23.62 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 122.912 0.485 . . . . 0.0 109.988 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.584 HD23 HG21 ' A' ' 64' ' ' VAL . 2.8 pp -139.29 171.39 14.35 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 124.549 1.139 . . . . 0.0 111.145 -179.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.425 ' HG ' ' H ' ' A' ' 5' ' ' GLY . 0.9 OUTLIER -119.13 153.98 33.98 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 124.746 1.218 . . . . 0.0 110.475 175.013 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.532 ' HB2' HG22 ' A' ' 34' ' ' VAL . 2.7 m-85 -126.41 151.73 47.29 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 126.215 1.806 . . . . 0.0 109.931 177.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.403 ' H ' HG22 ' A' ' 59' ' ' ILE . 11.0 p -128.7 148.2 50.81 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.85 2.06 . . . . 0.0 111.747 -179.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -169.26 146.62 10.33 Favored Glycine 0 CA--C 1.519 0.306 0 CA-C-O 121.627 0.57 . . . . 0.0 112.619 175.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 63.5 mtm180 -128.64 138.59 52.26 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 126.74 2.016 . . . . 0.0 109.21 -174.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -66.37 172.69 3.77 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 174.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 63.8 p -120.49 -171.71 2.22 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 127.452 2.301 . . . . 0.0 112.473 179.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 72.7 m 52.64 34.41 15.82 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 175.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 53.19 -98.31 0.03 OUTLIER Glycine 0 CA--C 1.539 1.58 0 C-N-CA 127.325 2.393 . . . . 0.0 113.585 176.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -66.69 -82.55 0.01 OUTLIER 'Trans proline' 0 CA--C 1.546 1.093 0 C-N-CA 124.055 3.17 . . . . 0.0 113.169 177.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 16.4 m -70.68 143.64 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.665 1.186 . . . . 0.0 111.185 177.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -154.87 178.82 9.74 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.47 1.108 . . . . 0.0 110.559 177.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -81.62 13.37 3.15 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.552 1.541 . . . . 0.0 113.064 174.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 76.98 -98.48 1.32 Allowed Glycine 0 CA--C 1.528 0.892 0 C-N-CA 126.518 2.009 . . . . 0.0 112.269 -175.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -148.46 93.44 2.15 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 117.677 0.739 . . . . 0.0 110.866 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.4 t -122.2 120.69 61.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 124.46 1.104 . . . . 0.0 112.066 -175.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.475 ' HB1' ' CE1' ' A' ' 51' ' ' PHE . . . -160.02 168.71 25.0 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.489 1.116 . . . . 0.0 112.282 178.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -150.5 132.96 15.63 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.42 1.088 . . . . 0.0 109.326 174.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.463 ' CD2' ' CE2' ' A' ' 72' ' ' TYR . 43.9 p90 -132.17 170.01 15.6 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 120.946 -1.096 . . . . 0.0 110.27 177.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.438 ' HB1' ' CG2' ' A' ' 98' ' ' THR . . . -139.61 142.87 37.06 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -179.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.401 ' CD1' ' HB3' ' A' ' 44' ' ' TRP . 20.0 m-85 -120.43 139.12 53.3 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.675 1.19 . . . . 0.0 112.788 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -84.76 126.9 33.81 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.997 -0.439 . . . . 0.0 111.453 -177.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -97.53 141.12 30.97 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.016 1.327 . . . . 0.0 111.855 178.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 24.9 m -64.04 -20.26 65.79 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.47 1.108 . . . . 0.0 113.731 174.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 36.2 m-80 -72.22 -10.59 59.98 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.445 1.098 . . . . 0.0 112.81 174.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 89.68 44.32 4.91 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 124.755 1.169 . . . . 0.0 112.987 -176.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.497 ' HB3' HG22 ' A' ' 120' ' ' ILE . 37.3 m-80 -140.06 175.11 9.86 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.956 1.302 . . . . 0.0 110.481 175.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.603 HG23 HD21 ' A' ' 47' ' ' LEU . 12.9 m -126.87 110.7 13.32 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.395 1.478 . . . . 0.0 112.045 178.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.7 tt -70.86 98.02 1.5 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.954 1.302 . . . . 0.0 112.208 174.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -91.22 104.28 3.15 Favored Glycine 0 N--CA 1.469 0.896 0 C-N-CA 125.142 1.353 . . . . 0.0 113.372 177.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 94.0 t -85.39 130.62 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 125.106 1.363 . . . . 0.0 111.344 175.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 2.4 tmm? -119.99 124.27 45.52 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.798 1.639 . . . . 0.0 110.337 178.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.469 ' CZ ' ' HB3' ' A' ' 87' ' ' ALA . 4.3 p90 -148.95 122.67 9.24 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 122.901 1.334 . . . . 0.0 111.946 -178.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 15.1 p -139.94 100.53 3.96 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 124.418 1.087 . . . . 0.0 110.008 -175.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 97.0 t -90.52 95.85 0.82 Allowed Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 127.125 2.17 . . . . 0.0 108.654 178.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.18 121.36 7.46 Favored 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 123.145 2.563 . . . . 0.0 112.273 -177.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -64.67 -28.64 69.75 Favored 'General case' 0 CA--C 1.548 0.885 0 O-C-N 121.547 -0.721 . . . . 0.0 111.496 174.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 24.5 p30 -73.52 45.7 0.19 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 126.103 1.761 . . . . 0.0 114.619 176.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -49.96 -18.1 0.48 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 126.341 1.856 . . . . 0.0 114.905 175.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -58.89 -19.73 44.96 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 125.875 1.67 . . . . 0.0 112.452 174.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 24.5 m95 -97.55 -20.56 17.62 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 128.306 2.642 . . . . 0.0 114.012 175.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER 58.23 42.26 22.19 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 127.002 2.121 . . . . 0.0 115.271 177.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.2 p -124.2 74.11 1.28 Allowed 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 125.372 1.469 . . . . 0.0 114.715 -176.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -98.81 108.5 21.2 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.418 1.887 . . . . 0.0 108.093 175.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 35.7 m0 -105.66 142.75 34.86 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 119.671 1.123 . . . . 0.0 109.942 175.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 29.7 p-90 -146.86 143.65 28.72 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 121.309 -0.87 . . . . 0.0 113.112 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -151.38 164.49 36.58 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 122.654 1.216 . . . . 0.0 112.957 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 54.6 t -153.41 136.66 7.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 175.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.37 177.81 10.2 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 126.645 1.978 . . . . 0.0 109.552 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.518 ' HB ' ' CE2' ' A' ' 154' ' ' TYR . 15.8 mt -126.52 141.79 44.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -101.05 144.4 28.48 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 125.172 1.389 . . . . 0.0 110.312 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.06 132.48 21.33 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 123.077 2.518 . . . . 0.0 111.455 179.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 62.85 -160.87 33.36 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 123.47 0.557 . . . . 0.0 113.017 -175.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.8 tttt -73.88 114.46 12.2 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.292 1.037 . . . . 0.0 109.532 175.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 2.4 mmt-85 -133.09 148.85 52.17 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.542 1.137 . . . . 0.0 111.057 175.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -93.64 179.57 5.33 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-O 121.686 0.755 . . . . 0.0 110.256 176.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -126.07 113.77 17.53 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 127.205 2.202 . . . . 0.0 105.093 175.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -126.91 172.83 10.09 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.388 1.475 . . . . 0.0 110.406 178.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -53.75 -40.78 66.48 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 119.62 1.1 . . . . 0.0 113.323 -178.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -59.73 -54.89 33.81 Favored Glycine 0 N--CA 1.467 0.736 0 CA-C-O 119.364 -0.687 . . . . 0.0 111.824 176.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 4.5 mpp? -62.24 -42.37 99.25 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 118.199 1.0 . . . . 0.0 112.388 177.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -54.94 -56.28 21.4 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.811 0.845 . . . . 0.0 109.646 176.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -66.37 -37.18 84.71 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -60.77 -44.49 96.7 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.298 1.439 . . . . 0.0 112.305 177.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 42.4 mmm -81.6 -30.01 33.08 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.074 -1.016 . . . . 0.0 112.615 177.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -54.47 -57.99 9.18 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.969 1.308 . . . . 0.0 109.457 174.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -73.8 -10.51 59.74 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -177.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -79.92 -15.42 79.12 Favored Glycine 0 CA--C 1.537 1.432 0 C-N-CA 125.893 1.711 . . . . 0.0 114.868 177.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -140.91 90.61 9.42 Favored Pre-proline 0 CA--C 1.552 1.041 0 CA-C-N 119.37 1.585 . . . . 0.0 112.522 176.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -74.66 78.08 2.85 Favored 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 123.912 3.074 . . . . 0.0 112.434 178.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -111.87 120.43 41.9 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.654 1.182 . . . . 0.0 110.462 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.38 -173.82 4.93 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.562 1.145 . . . . 0.0 112.584 176.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -75.16 53.07 2.63 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 125.602 1.572 . . . . 0.0 111.076 175.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -64.72 97.11 0.2 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 127.14 2.176 . . . . 0.0 110.039 178.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -75.31 93.43 2.88 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.554 1.142 . . . . 0.0 113.005 -174.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 162.89 54.93 0.02 OUTLIER Glycine 0 CA--C 1.537 1.407 0 C-N-CA 124.376 0.989 . . . . 0.0 115.011 175.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 8.0 m95 52.1 44.97 29.14 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.619 1.568 . . . . 0.0 114.667 -177.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -78.15 129.5 35.23 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 120.862 -1.148 . . . . 0.0 111.857 -177.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.64 -174.59 4.71 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.394 -0.816 . . . . 0.0 113.165 -175.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.96 151.89 51.64 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.972 1.309 . . . . 0.0 110.733 175.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -69.64 150.63 46.83 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 175.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 60.8 mt -109.91 145.54 36.69 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 175.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -64.5 -166.62 1.19 Allowed Glycine 0 CA--C 1.545 1.917 0 N-CA-C 110.266 -1.134 . . . . 0.0 110.266 176.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.518 ' CE2' ' HB ' ' A' ' 120' ' ' ILE . 0.0 OUTLIER 54.76 10.77 0.39 Allowed 'General case' 0 CA--C 1.558 1.275 0 N-CA-C 115.316 1.598 . . . . 0.0 115.316 175.038 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 80.96 41.27 10.64 Favored Glycine 0 CA--C 1.539 1.584 0 C-N-CA 126.416 1.96 . . . . 0.0 114.666 -175.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 2.4 mp -123.91 160.11 28.22 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 119.445 1.623 . . . . 0.0 112.305 177.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 10.5 mtt-85 -147.37 121.63 9.58 Favored 'General case' 0 N--CA 1.481 1.086 0 O-C-N 120.424 -1.423 . . . . 0.0 110.397 174.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . 0.421 ' SD ' HG21 ' A' ' 172' ' ' ILE . 9.1 ttp -108.9 132.99 53.52 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 123.589 0.756 . . . . 0.0 109.069 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 2.7 tppt? -107.36 129.53 54.9 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 127.226 2.21 . . . . 0.0 110.385 -178.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -138.4 158.44 24.92 Favored Glycine 0 N--CA 1.473 1.106 0 CA-C-N 121.255 1.843 . . . . 0.0 115.57 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 3.4 tp -148.1 124.69 2.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-O 122.607 1.194 . . . . 0.0 111.362 -178.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 51.4 mtp -137.56 149.19 46.51 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 128.06 2.544 . . . . 0.0 107.998 175.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 8.8 t -134.66 161.16 35.9 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.335 1.054 . . . . 0.0 110.196 175.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 55.0 p -108.04 21.87 16.76 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.981 1.712 . . . . 0.0 112.428 -176.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -64.3 20.73 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.237 0 C-N-CA 128.617 2.767 . . . . 0.0 115.395 178.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 82.76 -68.64 3.51 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 126.995 2.236 . . . . 0.0 112.177 -177.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 -111.93 67.33 0.65 Allowed 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.538 1.535 . . . . 0.0 110.221 -177.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -95.76 174.66 6.86 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.946 1.698 . . . . 0.0 112.796 175.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.95 -178.78 3.94 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.845 2.058 . . . . 0.0 110.768 175.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . 0.459 ' HB3' HG12 ' A' ' 34' ' ' VAL . 20.4 ttp -128.78 122.1 29.8 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.087 1.355 . . . . 0.0 109.812 176.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.482 ' C ' HD12 ' A' ' 172' ' ' ILE . 1.9 tt0 -131.47 130.31 42.28 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.053 0.941 . . . . 0.0 110.06 177.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.482 HD12 ' C ' ' A' ' 171' ' ' GLN . 4.3 mp -135.28 125.6 43.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 123.989 0.915 . . . . 0.0 109.297 177.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.85 128.88 50.97 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 125.811 1.644 . . . . 0.0 111.635 177.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.8 mp -74.69 133.06 32.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 175.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 1.2 m -144.87 97.08 2.96 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.044 1.337 . . . . 0.0 111.691 176.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 72.6 mtp180 . . . . . 0 C--O 1.254 1.327 0 C-N-CA 126.676 1.99 . . . . 0.0 113.018 177.581 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 37.2 m . . . . . 0 N--CA 1.48 1.065 0 CA-C-O 120.583 0.23 . . . . 0.0 111.526 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -98.48 -178.97 4.18 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.469 1.908 . . . . 0.0 112.59 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.59 HD21 ' HB2' ' A' ' 31' ' ' LYS . 0.1 OUTLIER -130.35 -59.54 1.03 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.688 1.595 . . . . 0.0 111.445 177.703 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -68.41 126.86 30.96 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 121.507 -0.745 . . . . 0.0 109.365 174.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -69.73 -90.69 0.07 OUTLIER Glycine 0 CA--C 1.535 1.293 0 C-N-CA 123.851 0.739 . . . . 0.0 113.181 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.7 p -149.81 166.28 29.95 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 125.776 1.631 . . . . 0.0 111.845 -175.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -114.04 22.74 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 CA-C-O 123.032 1.396 . . . . 0.0 112.996 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -45.24 152.38 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 125.624 1.57 . . . . 0.0 111.959 174.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -44.77 139.31 3.04 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 126.041 1.737 . . . . 0.0 112.901 -176.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -54.35 -25.98 35.5 Favored Glycine 0 CA--C 1.54 1.603 0 C-N-CA 124.225 0.917 . . . . 0.0 114.713 -175.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.83 -33.6 76.04 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.257 1.423 . . . . 0.0 112.551 174.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.4 m -96.47 -38.35 10.05 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.991 2.116 . . . . 0.0 112.637 175.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.4 tp -78.33 85.08 4.48 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.961 1.304 . . . . 0.0 110.674 176.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 48.6 p -114.12 176.07 5.2 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.771 2.028 . . . . 0.0 110.534 179.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -51.09 -39.47 56.18 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.404 -0.81 . . . . 0.0 112.569 177.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -54.89 -37.51 66.4 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 118.54 0.609 . . . . 0.0 112.432 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 92.4 t -68.13 -40.34 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.067 1.347 . . . . 0.0 111.169 174.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 41.1 mt -68.2 -40.45 82.18 Favored 'General case' 0 N--CA 1.471 0.575 0 O-C-N 120.865 -1.147 . . . . 0.0 112.229 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -61.88 -49.52 75.88 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.317 1.047 . . . . 0.0 111.609 177.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.58 -33.58 76.25 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 118.155 -0.926 . . . . 0.0 113.089 174.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.1 t -54.7 -42.3 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-N 119.792 1.178 . . . . 0.0 111.594 177.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.5 mt -55.77 -23.55 30.28 Favored 'General case' 0 CA--C 1.55 0.972 0 CA-C-N 119.544 1.065 . . . . 0.0 113.486 175.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -93.65 -60.76 1.14 Allowed Glycine 0 CA--C 1.532 1.132 0 C-N-CA 125.689 1.614 . . . . 0.0 112.7 177.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -67.47 -27.04 66.69 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 -177.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -111.94 87.95 2.69 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.663 1.585 . . . . 0.0 110.298 177.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -134.77 155.26 21.88 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 125.06 1.314 . . . . 0.0 113.004 175.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.529 ' HD3' ' HE ' ' A' ' 75' ' ' ARG . 16.3 mtpt -141.85 -49.37 0.39 Allowed 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 125.549 1.539 . . . . 0.0 112.143 -177.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.475 HG22 ' CZ ' ' A' ' 75' ' ' ARG . 3.2 m -115.89 -177.17 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 C-N-CA 126.297 1.839 . . . . 0.0 110.636 176.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.8 t -49.3 -44.4 44.11 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 126.374 1.869 . . . . 0.0 115.068 -176.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.8 161.61 35.1 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 126.28 1.832 . . . . 0.0 111.074 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.59 ' HB2' HD21 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -155.31 165.61 36.11 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.089 0.956 . . . . 0.0 112.711 179.604 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.564 HD12 HG12 ' A' ' 34' ' ' VAL . 0.3 OUTLIER -119.34 123.73 71.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 124.125 0.97 . . . . 0.0 108.44 175.0 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -127.64 120.8 28.88 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 126.513 1.925 . . . . 0.0 106.706 174.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.642 HG13 ' CB ' ' A' ' 72' ' ' TYR . 0.2 OUTLIER -136.56 140.43 43.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 126.459 1.904 . . . . 0.0 108.527 -174.993 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -123.07 132.75 8.73 Favored Glycine 0 CA--C 1.523 0.575 0 CA-C-O 119.981 -0.344 . . . . 0.0 112.538 175.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.4 mp -112.64 152.22 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 117.71 0.755 . . . . 0.0 109.343 174.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -122.22 106.61 11.29 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 122.63 1.205 . . . . 0.0 110.709 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -76.07 85.15 2.94 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 128.451 2.7 . . . . 0.0 111.054 -175.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -120.99 4.65 10.43 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.644 1.177 . . . . 0.0 113.926 176.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.418 ' HA ' HG21 ' A' ' 174' ' ' ILE . 0.6 OUTLIER -53.98 -50.41 66.6 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.475 1.11 . . . . 0.0 112.133 174.982 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 127.7 103.87 1.23 Allowed Glycine 0 CA--C 1.526 0.776 0 C-N-CA 123.928 0.775 . . . . 0.0 111.684 177.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 114.48 153.93 10.82 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 126.15 1.833 . . . . 0.0 111.127 -174.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.705 HG22 ' HA ' ' A' ' 65' ' ' PRO . 68.4 p -69.72 142.18 53.36 Favored 'General case' 0 N--CA 1.466 0.359 0 O-C-N 121.887 -0.773 . . . . 0.0 111.062 175.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 39.4 m0 -96.64 107.6 20.07 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.367 0.667 . . . . 0.0 109.434 -179.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 36.4 m -87.58 127.33 35.26 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.609 0.763 . . . . 0.0 109.972 178.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.409 ' HB1' ' HB3' ' A' ' 60' ' ' LEU . . . -63.42 130.39 44.25 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 122.763 0.425 . . . . 0.0 111.429 174.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.8 pp -114.13 -55.76 2.46 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.79 0.836 . . . . 0.0 111.632 178.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -166.68 160.32 14.82 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.894 1.677 . . . . 0.0 110.867 175.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -140.69 165.71 26.74 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.427 1.091 . . . . 0.0 111.981 174.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -142.0 119.69 11.8 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.704 1.202 . . . . 0.0 111.887 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.474 ' CE1' ' HB1' ' A' ' 87' ' ' ALA . 2.6 m-85 -108.74 139.2 43.88 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.362 -0.836 . . . . 0.0 111.646 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.1 tpp180 -110.78 -65.91 1.12 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.859 1.663 . . . . 0.0 111.262 -177.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -37.58 -58.06 0.9 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 128.257 2.623 . . . . 0.0 113.52 -175.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -153.05 -116.63 0.65 Allowed Glycine 0 CA--C 1.526 0.731 0 C-N-CA 125.971 1.748 . . . . 0.0 109.133 175.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 39.0 p -143.33 178.52 7.68 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.036 1.334 . . . . 0.0 112.23 -175.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.2 t -154.0 179.58 8.78 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.43 1.492 . . . . 0.0 111.417 174.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -111.67 -38.5 4.87 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.02 1.328 . . . . 0.0 112.41 179.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.9 p -159.28 127.76 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 126.076 1.75 . . . . 0.0 110.636 175.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.429 HG22 ' H ' ' A' ' 73' ' ' SER . 1.7 pp -132.8 -32.36 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 114.606 1.335 . . . . 0.0 114.606 175.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.409 ' HB3' ' HB1' ' A' ' 46' ' ' ALA . 10.4 mt -100.85 95.53 4.64 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 125.43 1.492 . . . . 0.0 109.403 178.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.453 ' HG2' HG23 ' A' ' 64' ' ' VAL . 98.8 Cg_endo -65.97 151.62 83.52 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 123.402 2.735 . . . . 0.0 110.676 174.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -44.35 -49.64 9.46 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.894 1.677 . . . . 0.0 114.023 -177.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 5.1 p -159.42 137.73 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 126.978 2.111 . . . . 0.0 109.208 175.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.494 HG21 HD13 ' A' ' 70' ' ' LEU . 98.8 t -114.74 125.88 28.55 Favored Pre-proline 0 N--CA 1.479 0.988 0 C-N-CA 123.927 0.891 . . . . 0.0 109.211 175.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.705 ' HA ' HG22 ' A' ' 43' ' ' THR . 60.5 Cg_endo -65.64 155.73 67.49 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 122.882 2.388 . . . . 0.0 113.099 177.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -71.71 169.59 15.31 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.582 0.753 . . . . 0.0 111.374 175.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 65.2 p 52.34 26.25 3.97 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 126.415 1.886 . . . . 0.0 113.217 -175.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.3 mttt -138.25 174.68 10.3 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 126.441 1.896 . . . . 0.0 111.107 -175.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -135.66 160.81 37.36 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -176.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.494 HD13 HG21 ' A' ' 64' ' ' VAL . 2.4 pt? -133.18 170.49 15.34 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.786 1.234 . . . . 0.0 111.552 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -114.29 149.91 35.24 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 124.494 1.118 . . . . 0.0 109.995 175.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.642 ' CB ' HG13 ' A' ' 34' ' ' VAL . 1.5 m-85 -122.36 160.32 25.66 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 127.353 2.261 . . . . 0.0 108.775 175.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.429 ' H ' HG22 ' A' ' 59' ' ' ILE . 5.9 p -145.34 166.77 24.61 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 125.443 1.497 . . . . 0.0 112.105 -175.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 173.9 151.76 8.48 Favored Glycine 0 C--O 1.237 0.301 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.681 174.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.529 ' HE ' ' HD3' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -111.9 139.17 47.6 Favored 'General case' 0 CA--C 1.521 -0.145 0 C-N-CA 124.883 1.273 . . . . 0.0 111.88 179.321 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.466 ' HE2' ' HB1' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -72.17 -32.52 66.92 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.172 0.989 . . . . 0.0 112.853 174.968 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 24.8 m -54.85 128.04 31.34 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 126.817 2.047 . . . . 0.0 113.019 -174.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -161.27 112.49 1.77 Allowed 'General case' 0 C--O 1.233 0.205 0 C-N-CA 125.371 1.468 . . . . 0.0 108.905 -175.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -35.98 -50.07 1.15 Allowed Glycine 0 CA--C 1.545 1.94 0 C-N-CA 126.181 1.848 . . . . 0.0 115.215 175.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -69.76 -59.62 0.08 OUTLIER 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 122.713 2.275 . . . . 0.0 113.118 175.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.4 p -155.67 103.33 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 125.138 1.375 . . . . 0.0 112.11 -175.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.466 ' HB1' ' HE2' ' A' ' 76' ' ' LYS . . . -70.81 129.6 39.51 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 123.524 0.73 . . . . 0.0 111.422 175.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 34.7 m -126.41 134.98 50.87 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.903 1.281 . . . . 0.0 110.363 178.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -26.75 -66.96 0.06 OUTLIER Glycine 0 N--CA 1.473 1.127 0 C-N-CA 127.991 2.71 . . . . 0.0 116.693 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.461 ' HB3' ' HB ' ' A' ' 105' ' ' VAL . . . -167.47 106.66 0.56 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.066 0.947 . . . . 0.0 112.219 -178.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.7 t -149.51 109.67 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 124.749 1.22 . . . . 0.0 112.062 -174.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.645 ' HB3' ' CZ ' ' A' ' 103' ' ' PHE . . . -153.69 169.64 22.81 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 179.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -147.2 160.61 42.26 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.92 1.288 . . . . 0.0 112.543 175.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.451 ' CZ ' HG11 ' A' ' 101' ' ' VAL . 37.4 p90 -164.11 171.41 15.14 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.332 1.053 . . . . 0.0 111.62 -178.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -143.95 155.94 44.24 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.468 -0.77 . . . . 0.0 112.201 174.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -131.72 129.29 40.48 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 126.472 1.909 . . . . 0.0 113.19 -175.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -90.66 130.53 36.66 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 120.882 0.372 . . . . 0.0 111.343 -176.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 3.9 mtm -108.27 139.01 43.6 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 125.503 1.521 . . . . 0.0 111.705 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.2 t -64.79 -18.7 65.32 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.223 1.409 . . . . 0.0 112.962 176.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -69.74 -17.5 63.45 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.998 1.319 . . . . 0.0 113.616 175.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 106.47 21.32 8.41 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.92 1.248 . . . . 0.0 115.362 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -131.44 174.81 9.71 Favored 'General case' 0 CA--C 1.555 1.142 0 CA-C-N 119.824 1.812 . . . . 0.0 111.422 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.8 m -129.31 105.87 8.42 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.403 1.081 . . . . 0.0 112.959 -178.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 59.0 tp -68.81 101.23 1.3 Allowed 'General case' 0 N--CA 1.47 0.567 0 O-C-N 121.762 -0.586 . . . . 0.0 110.247 174.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -94.65 138.65 14.12 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 124.176 0.893 . . . . 0.0 112.232 175.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.451 HG11 ' CZ ' ' A' ' 89' ' ' PHE . 54.1 t -128.17 133.03 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.225 1.41 . . . . 0.0 110.71 -175.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.84 124.29 20.74 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.895 1.678 . . . . 0.0 109.386 -177.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.645 ' CZ ' ' HB3' ' A' ' 87' ' ' ALA . 26.9 p90 -138.42 135.35 35.16 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -178.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 12.2 m -148.79 100.51 3.1 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 122.224 1.011 . . . . 0.0 111.193 -175.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.461 ' HB ' ' HB3' ' A' ' 85' ' ' ALA . 51.3 t -80.45 141.77 53.26 Favored Pre-proline 0 N--CA 1.471 0.588 0 C-N-CA 127.144 2.178 . . . . 0.0 109.761 -177.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -69.84 128.88 16.58 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.278 1.985 . . . . 0.0 112.697 -178.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -138.21 -72.54 0.41 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.446 1.099 . . . . 0.0 111.88 178.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -117.22 11.75 14.18 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.911 1.685 . . . . 0.0 113.955 -177.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -44.87 112.51 0.44 Allowed 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.118 1.367 . . . . 0.0 112.932 177.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -58.53 -13.54 5.87 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.301 1.44 . . . . 0.0 113.884 175.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 28.5 m95 -122.12 6.32 9.75 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 127.641 2.376 . . . . 0.0 113.354 -179.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 1.1 p90 42.84 46.27 4.49 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 126.562 1.945 . . . . 0.0 112.518 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 5.5 m -127.07 93.57 3.79 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.714 2.006 . . . . 0.0 114.042 -174.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -80.58 115.81 20.29 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 124.324 1.05 . . . . 0.0 108.973 174.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 42.1 m0 -116.25 145.66 42.96 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.134 0.973 . . . . 0.0 109.45 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 34.3 p-90 -150.78 139.83 21.07 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.403 0.681 . . . . 0.0 112.248 -179.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -140.57 145.85 37.28 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 122.299 1.047 . . . . 0.0 112.81 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 86.1 t -146.8 123.96 3.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 125.093 1.357 . . . . 0.0 107.783 176.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.426 ' HE2' ' CZ ' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -156.14 176.18 13.0 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.403 1.081 . . . . 0.0 111.336 174.969 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.524 ' HB ' ' CE2' ' A' ' 154' ' ' TYR . 38.8 mt -111.51 105.31 18.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 123.765 0.826 . . . . 0.0 109.804 -177.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.426 ' CZ ' ' HE2' ' A' ' 119' ' ' LYS . 91.0 m-85 -60.3 143.82 88.65 Favored Pre-proline 0 CA--C 1.548 0.899 0 O-C-N 121.318 -0.864 . . . . 0.0 111.889 178.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -76.11 80.25 2.72 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 124.449 3.432 . . . . 0.0 112.435 -176.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 118.89 -170.83 13.96 Favored Glycine 0 N--CA 1.471 1.004 0 C-N-CA 125.684 1.611 . . . . 0.0 112.778 -178.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 23.3 tttt -66.27 109.53 2.7 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.018 0.927 . . . . 0.0 109.51 174.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.413 ' HG3' ' H ' ' A' ' 126' ' ' ARG . 5.7 tpt180 -120.01 173.04 7.32 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.723 1.609 . . . . 0.0 110.242 176.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.413 ' H ' ' HG3' ' A' ' 125' ' ' ARG . 2.2 ptp180 -127.04 173.17 9.88 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 127.172 2.189 . . . . 0.0 111.292 174.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -128.35 98.01 4.92 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 126.44 1.896 . . . . 0.0 107.422 175.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -117.73 173.1 6.93 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.425 1.89 . . . . 0.0 109.115 175.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -49.84 -42.74 48.01 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.057 0.943 . . . . 0.0 113.477 177.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -57.34 -63.66 5.1 Favored Glycine 0 C--N 1.339 0.718 0 C-N-CA 124.173 0.892 . . . . 0.0 111.624 175.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 15.0 mtm -59.81 -34.12 72.63 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 118.141 0.97 . . . . 0.0 113.297 178.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -59.53 -60.42 3.87 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 119.304 0.956 . . . . 0.0 109.93 175.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -70.03 -30.7 68.06 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -177.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -60.75 -54.23 47.74 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.417 1.087 . . . . 0.0 110.024 174.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 2.0 tpp -75.21 -26.48 58.98 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -177.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -52.44 -55.84 19.11 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.464 1.505 . . . . 0.0 110.586 174.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -69.8 -8.65 50.07 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 179.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -79.21 -31.33 42.75 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 126.224 1.869 . . . . 0.0 115.076 -177.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -128.65 85.19 60.95 Favored Pre-proline 0 CA--C 1.548 0.887 0 CA-C-N 118.717 1.259 . . . . 0.0 111.047 178.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -73.42 75.94 2.83 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 123.661 2.908 . . . . 0.0 112.086 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -111.28 114.41 27.57 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.058 0.943 . . . . 0.0 110.86 -177.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 57.4 mtp180 -81.65 -71.41 0.48 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.813 1.245 . . . . 0.0 111.499 175.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 136.86 122.62 2.16 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 124.568 1.08 . . . . 0.0 113.589 -177.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.9 7.1 9.5 Favored 'General case' 0 CA--C 1.559 1.296 0 C-N-CA 127.175 2.19 . . . . 0.0 115.081 177.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 57.57 55.83 5.36 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 128.282 2.633 . . . . 0.0 112.595 -175.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -158.24 -66.73 0.01 OUTLIER Glycine 0 CA--C 1.538 1.479 0 N-CA-C 115.971 1.148 . . . . 0.0 115.971 -177.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 29.8 m95 174.11 117.1 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 130.414 3.486 . . . . 0.0 108.361 -174.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -129.9 121.03 25.86 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 126.801 2.04 . . . . 0.0 111.846 -175.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -162.33 178.3 8.81 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 -175.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.76 154.46 48.52 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.542 1.537 . . . . 0.0 110.849 175.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -71.34 137.69 48.65 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 175.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 91.1 mt -93.92 102.76 14.87 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.667 0.787 . . . . 0.0 109.947 -176.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -36.22 -37.51 0.19 Allowed Glycine 0 N--CA 1.476 1.32 0 C-N-CA 128.711 3.053 . . . . 0.0 117.629 -174.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.524 ' CE2' ' HB ' ' A' ' 120' ' ' ILE . 0.1 OUTLIER -61.61 -30.85 70.95 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.968 2.107 . . . . 0.0 113.239 -179.252 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 132.65 30.38 0.5 Allowed Glycine 0 CA--C 1.536 1.397 0 C-N-CA 125.763 1.649 . . . . 0.0 114.582 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 12.8 mt -130.6 175.85 8.66 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 126.082 1.753 . . . . 0.0 110.555 -174.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 60.7 mtt-85 -147.21 100.7 3.31 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.534 -1.354 . . . . 0.0 112.701 178.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -82.1 148.69 28.41 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 124.157 0.983 . . . . 0.0 108.632 175.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 3.3 tppt? -139.68 120.46 14.37 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.331 1.852 . . . . 0.0 111.214 178.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -131.59 154.89 21.11 Favored Glycine 0 N--CA 1.479 1.518 0 CA-C-N 121.123 1.783 . . . . 0.0 116.311 -176.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 2.1 tp -146.19 130.55 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.132 1.373 . . . . 0.0 110.651 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 1.9 ttp -154.61 117.62 4.44 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.958 1.703 . . . . 0.0 110.249 174.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 4.9 t -110.4 101.44 10.15 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 121.122 -0.986 . . . . 0.0 111.411 -177.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 49.0 p -69.12 28.45 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.02 -27.2 68.15 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.309 1.844 . . . . 0.0 114.332 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 159.78 -53.75 0.36 Allowed Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.776 1.179 . . . . 0.0 113.507 175.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -134.5 87.32 2.34 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.81 1.244 . . . . 0.0 110.771 178.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -136.26 -174.6 3.73 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.682 1.593 . . . . 0.0 111.582 175.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.402 ' HE2' ' O ' ' A' ' 169' ' ' LYS . 0.0 OUTLIER -133.51 175.35 9.5 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 127.462 2.305 . . . . 0.0 111.437 -178.671 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 32.6 ttp -110.04 138.3 46.61 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 123.965 0.906 . . . . 0.0 110.479 173.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -143.86 123.72 13.47 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 123.595 0.758 . . . . 0.0 110.361 176.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 4.7 mp -127.48 121.02 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 123.481 0.712 . . . . 0.0 109.754 176.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 2.8 tmmm? -121.05 139.07 53.82 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 125.32 1.448 . . . . 0.0 110.705 177.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.418 HG21 ' HA ' ' A' ' 40' ' ' SER . 1.6 mp -87.4 125.79 41.11 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 174.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -137.4 96.64 3.3 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.256 1.422 . . . . 0.0 111.724 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 10.8 mtp-105 . . . . . 0 C--O 1.254 1.29 0 C-N-CA 128.119 2.568 . . . . 0.0 113.638 -177.737 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.1 t . . . . . 0 N--CA 1.484 1.232 0 CA-C-O 120.836 0.35 . . . . 0.0 111.392 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -98.17 167.69 10.72 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.768 1.627 . . . . 0.0 112.449 178.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 3' ' ' LEU . 10.4 tp -123.46 -37.99 2.6 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.313 1.445 . . . . 0.0 111.835 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -85.78 130.26 34.61 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.9 1.28 . . . . 0.0 108.464 174.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -77.12 -151.23 4.2 Favored Glycine 0 CA--C 1.538 1.503 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 175.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.6 p -78.86 169.96 17.42 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 121.441 -1.035 . . . . 0.0 113.747 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -120.64 20.72 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 126.339 1.856 . . . . 0.0 112.593 177.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -48.82 159.85 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 125.221 1.409 . . . . 0.0 112.517 175.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -46.75 140.47 4.55 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.682 1.593 . . . . 0.0 112.564 -175.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -57.24 -20.22 35.18 Favored Glycine 0 CA--C 1.542 1.751 0 C-N-CA 124.083 0.849 . . . . 0.0 114.418 -175.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.74 -27.47 66.81 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.008 1.323 . . . . 0.0 112.357 175.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.7 t -104.55 -42.35 5.46 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 127.15 2.18 . . . . 0.0 111.334 177.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 12.4 tp -83.33 98.59 9.53 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.644 1.578 . . . . 0.0 110.366 174.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 69.0 p -126.57 177.34 6.57 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.997 1.319 . . . . 0.0 110.898 177.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.408 ' C ' ' CD1' ' A' ' 15' ' ' PHE . 0.1 OUTLIER -45.73 -37.89 6.39 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.446 1.098 . . . . 0.0 112.827 177.801 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -57.62 -42.72 83.92 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.329 1.452 . . . . 0.0 112.289 -179.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.4 t -61.97 -37.29 77.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.72 1.208 . . . . 0.0 110.933 174.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.7 mt -71.73 -40.4 69.45 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.549 1.14 . . . . 0.0 111.663 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -60.77 -43.95 97.38 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.55 1.14 . . . . 0.0 110.429 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.35 -28.1 59.44 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.207 1.003 . . . . 0.0 113.127 174.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -55.79 -38.22 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 124.301 1.04 . . . . 0.0 111.461 177.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 15.7 mt -55.6 -20.85 14.96 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.287 1.435 . . . . 0.0 113.977 174.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -98.11 -63.27 0.87 Allowed Glycine 0 CA--C 1.532 1.113 0 C-N-CA 125.172 1.368 . . . . 0.0 112.584 175.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -65.65 -33.82 76.78 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 -174.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -105.37 94.98 5.51 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.66 1.584 . . . . 0.0 108.025 175.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -140.88 145.06 15.52 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 123.954 0.788 . . . . 0.0 113.648 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.7 mtpp -127.31 -39.08 1.91 Allowed 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 126.294 1.838 . . . . 0.0 113.788 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.3 m -133.0 174.71 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 126.425 1.89 . . . . 0.0 111.06 -178.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 54.4 m -54.29 -46.5 72.78 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.241 1.816 . . . . 0.0 114.557 -176.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.72 126.95 44.34 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.99 1.316 . . . . 0.0 111.051 175.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.39 161.29 31.66 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 124.85 1.26 . . . . 0.0 111.485 179.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.486 HD13 ' H ' ' A' ' 33' ' ' ALA . 0.3 OUTLIER -107.48 140.87 24.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 174.955 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.486 ' H ' HD13 ' A' ' 32' ' ' ILE . . . -132.91 131.52 40.98 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 126.483 1.913 . . . . 0.0 109.819 175.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.483 ' O ' HD13 ' A' ' 71' ' ' LEU . 25.2 t -140.62 156.15 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 123.305 0.642 . . . . 0.0 110.306 178.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -138.57 98.51 0.26 Allowed Glycine 0 CA--C 1.524 0.598 0 C-N-CA 125.677 1.608 . . . . 0.0 111.904 176.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.7 mp -81.71 144.84 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-N 117.272 0.536 . . . . 0.0 109.739 175.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -116.29 99.43 7.2 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.024 1.73 . . . . 0.0 110.66 178.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -67.68 97.17 0.6 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.818 1.647 . . . . 0.0 110.203 175.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -124.89 4.87 8.05 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.625 0.77 . . . . 0.0 112.326 174.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.9 t -57.59 -45.25 85.51 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.376 1.47 . . . . 0.0 112.875 -176.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 130.11 40.33 0.26 Allowed Glycine 0 CA--C 1.535 1.29 0 C-N-CA 124.31 0.957 . . . . 0.0 115.25 177.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -178.09 165.71 35.34 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.561 1.077 . . . . 0.0 112.605 175.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.534 HG22 ' HA ' ' A' ' 65' ' ' PRO . 8.4 p -68.76 137.68 54.23 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.485 -1.009 . . . . 0.0 110.34 174.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.548 ' HA ' ' CE1' ' A' ' 91' ' ' TYR . 35.6 m0 -93.87 100.52 12.68 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 123.232 0.613 . . . . 0.0 111.546 -178.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 29.1 m -84.6 115.48 22.65 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.004 0.922 . . . . 0.0 109.121 177.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.421 ' HB1' ' HB3' ' A' ' 60' ' ' LEU . . . -60.05 143.5 51.83 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 122.709 0.403 . . . . 0.0 111.547 175.002 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.5 pp -119.2 -55.07 2.18 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.651 0.781 . . . . 0.0 111.966 178.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 22.7 t30 -173.15 150.47 1.94 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.991 2.117 . . . . 0.0 109.997 -177.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -129.05 163.67 24.91 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.837 1.255 . . . . 0.0 111.489 175.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -131.77 106.87 8.39 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.324 1.45 . . . . 0.0 110.663 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.624 ' CE1' ' HB1' ' A' ' 87' ' ' ALA . 2.7 m-85 -115.58 112.18 21.79 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.948 0.899 . . . . 0.0 110.118 -174.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.05 -41.27 7.63 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -178.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.0 t -116.13 -45.72 2.84 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.549 1.539 . . . . 0.0 111.002 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -69.26 11.57 1.46 Allowed Glycine 0 CA--C 1.538 1.503 0 CA-C-O 118.226 -1.319 . . . . 0.0 115.764 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.7 p -32.75 108.27 0.05 Allowed 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 128.472 2.709 . . . . 0.0 113.987 -175.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.523 HG21 HG23 ' A' ' 59' ' ' ILE . 1.5 t -130.02 175.41 8.91 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 114.125 1.158 . . . . 0.0 114.125 -174.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -79.58 -48.84 13.13 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.64 1.176 . . . . 0.0 112.79 -178.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.4 p -144.07 132.44 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.818 1.647 . . . . 0.0 111.604 176.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.592 HD12 ' H ' ' A' ' 60' ' ' LEU . 1.0 OUTLIER -137.02 -47.92 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.171 1.388 . . . . 0.0 113.903 179.315 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.592 ' H ' HD12 ' A' ' 59' ' ' ILE . 8.2 mt -86.69 102.6 3.11 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 123.977 0.911 . . . . 0.0 109.836 174.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.44 ' HG2' HG23 ' A' ' 64' ' ' VAL . 73.3 Cg_endo -68.0 141.64 53.94 Favored 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 122.729 2.286 . . . . 0.0 110.898 174.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -38.73 -52.96 1.69 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 126.949 2.1 . . . . 0.0 114.116 178.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.6 p -153.24 135.45 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 126.475 1.91 . . . . 0.0 109.927 174.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.44 HG23 ' HG2' ' A' ' 61' ' ' PRO . 59.5 t -116.24 131.18 23.93 Favored Pre-proline 0 N--CA 1.483 1.207 0 C-N-CA 124.671 1.188 . . . . 0.0 109.681 176.202 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.534 ' HA ' HG22 ' A' ' 43' ' ' THR . 56.8 Cg_endo -65.93 152.91 80.17 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 122.714 2.276 . . . . 0.0 113.656 177.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -69.24 162.95 26.06 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.17 0.988 . . . . 0.0 111.232 175.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . 0.257 76.4 p 51.37 28.22 4.22 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 126.787 2.035 . . . . 0.0 114.006 -174.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.8 mttp -131.1 175.98 8.64 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 127.537 2.335 . . . . 0.0 111.34 -178.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -127.35 158.92 35.97 Favored 'General case' 0 C--O 1.224 -0.249 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -178.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.413 ' C ' HD12 ' A' ' 70' ' ' LEU . 2.4 pp -121.84 171.85 8.6 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.313 1.445 . . . . 0.0 110.52 175.076 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.483 HD13 ' O ' ' A' ' 34' ' ' VAL . 0.3 OUTLIER -117.17 145.6 43.74 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 124.051 0.94 . . . . 0.0 108.95 174.959 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -127.16 143.74 51.19 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 125.585 1.554 . . . . 0.0 108.845 177.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 82.9 p -143.57 170.8 15.14 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.963 -178.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 174.48 142.84 4.17 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.223 -0.899 . . . . 0.0 112.357 176.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -109.44 128.97 55.54 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 124.869 1.267 . . . . 0.0 108.087 177.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.7 ptpt -48.45 147.85 2.23 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.724 1.21 . . . . 0.0 113.291 176.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -165.27 146.23 7.29 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 125.149 1.38 . . . . 0.0 111.524 178.001 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.8 t 176.73 114.77 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 127.906 2.483 . . . . 0.0 108.744 175.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -38.82 -54.56 2.34 Favored Glycine 0 CA--C 1.547 2.046 0 C-N-CA 125.844 1.688 . . . . 0.0 115.516 175.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.75 -76.53 0.01 OUTLIER 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 123.637 2.891 . . . . 0.0 113.147 176.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 15.7 m -127.52 109.06 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 126.575 1.95 . . . . 0.0 110.336 -178.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -41.49 113.81 0.45 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.149 1.78 . . . . 0.0 112.741 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.1 m -75.4 175.01 8.83 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.885 1.274 . . . . 0.0 110.193 177.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -84.03 -90.21 0.77 Allowed Glycine 0 N--CA 1.47 0.948 0 O-C-N 120.538 -1.351 . . . . 0.0 114.524 -175.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.596 ' HB3' ' HB ' ' A' ' 105' ' ' VAL . . . -143.33 82.73 1.75 Allowed 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 124.815 1.246 . . . . 0.0 109.066 -175.017 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.7 t -122.29 111.95 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 124.929 1.292 . . . . 0.0 111.007 -175.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.624 ' HB1' ' CE1' ' A' ' 51' ' ' PHE . . . -158.03 167.7 29.16 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 122.177 0.989 . . . . 0.0 111.166 177.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -148.92 160.88 42.87 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.284 1.433 . . . . 0.0 109.58 175.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -156.41 174.67 15.08 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 121.42 -0.8 . . . . 0.0 112.122 175.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -145.16 150.89 37.58 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.849 0.833 . . . . 0.0 113.203 174.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.548 ' CE1' ' HA ' ' A' ' 44' ' ' TRP . 0.1 OUTLIER -121.87 127.07 50.07 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 127.205 2.202 . . . . 0.0 109.181 -179.232 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -84.11 104.68 14.37 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.269 0.627 . . . . 0.0 112.423 179.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -72.38 126.2 29.26 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 125.401 1.48 . . . . 0.0 112.657 -176.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 37.1 m -58.62 -21.18 52.88 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.652 0.781 . . . . 0.0 113.095 175.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 23.7 m-20 -69.38 -14.02 62.68 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 124.693 1.197 . . . . 0.0 112.907 174.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 109.26 31.99 3.13 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 125.295 1.426 . . . . 0.0 115.055 177.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -142.72 -179.44 6.33 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.855 1.262 . . . . 0.0 112.044 -175.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 25.1 m -132.55 107.26 8.33 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 120.994 -1.067 . . . . 0.0 111.973 177.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 35.7 tp -74.69 107.74 7.0 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 121.224 -0.923 . . . . 0.0 110.57 175.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -107.13 114.6 4.36 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 124.79 1.186 . . . . 0.0 113.742 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.464 ' HA ' HG22 ' A' ' 118' ' ' VAL . 98.4 t -97.27 137.28 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.134 1.374 . . . . 0.0 112.614 -175.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -129.11 126.06 38.51 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 126.352 1.861 . . . . 0.0 111.788 -175.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.422 ' CE2' ' HB3' ' A' ' 87' ' ' ALA . 3.8 p90 -148.48 123.82 10.27 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.6 1.16 . . . . 0.0 112.018 -178.278 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 22.4 t -137.47 133.94 35.23 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.758 0.823 . . . . 0.0 111.612 178.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.596 ' HB ' ' HB3' ' A' ' 85' ' ' ALA . 19.0 t -139.24 134.23 16.52 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 126.88 2.072 . . . . 0.0 108.885 -176.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -72.54 168.03 25.46 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 123.7 2.933 . . . . 0.0 112.338 176.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -97.28 -33.15 11.56 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.662 1.185 . . . . 0.0 111.872 174.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -89.27 -22.8 22.52 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -174.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 49.67 32.2 4.91 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 126.564 1.946 . . . . 0.0 114.824 -179.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -121.43 118.45 29.43 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.535 1.534 . . . . 0.0 111.42 -178.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 67.3 m95 53.79 21.22 2.61 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.756 1.622 . . . . 0.0 114.647 178.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -100.87 176.53 5.25 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 126.29 1.836 . . . . 0.0 113.39 -174.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 20.1 m -139.87 93.46 2.65 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 125.275 1.43 . . . . 0.0 112.131 -175.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -77.03 91.8 3.67 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.954 1.302 . . . . 0.0 111.297 176.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 42.8 m0 -98.01 149.16 22.75 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 119.463 1.029 . . . . 0.0 111.226 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 31.6 p-90 -155.95 135.64 12.57 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.653 0.781 . . . . 0.0 112.498 -176.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -145.57 174.84 10.82 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 120.553 -1.342 . . . . 0.0 112.825 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.464 HG22 ' HA ' ' A' ' 101' ' ' VAL . 99.3 t -148.9 139.81 17.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 C-N-CA 123.768 0.827 . . . . 0.0 109.135 175.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.467 ' HE2' ' CG ' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -144.4 169.54 17.73 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 125.566 1.546 . . . . 0.0 109.538 175.133 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 59.9 mt -113.27 128.47 70.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 175.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.467 ' CG ' ' HE2' ' A' ' 119' ' ' LYS . 96.2 m-85 -88.38 147.5 40.14 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 124.683 1.193 . . . . 0.0 110.48 175.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -70.01 130.92 19.84 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 123.151 2.568 . . . . 0.0 111.075 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 59.96 -141.64 47.64 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 123.607 0.622 . . . . 0.0 113.133 -178.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 4.6 tmtt? -86.49 118.05 25.66 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.492 1.517 . . . . 0.0 110.4 176.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 12.2 tpp180 -135.51 170.61 15.68 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 126.088 1.755 . . . . 0.0 109.998 175.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 24.8 ptt180 -116.2 -176.55 2.97 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 127.133 2.173 . . . . 0.0 111.258 175.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -127.16 105.48 8.6 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 175.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -121.81 168.04 12.3 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.788 1.635 . . . . 0.0 109.751 177.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -51.84 -41.1 61.55 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 -177.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -59.12 -56.25 26.31 Favored Glycine 0 N--CA 1.47 0.912 0 CA-C-N 119.278 0.945 . . . . 0.0 112.164 175.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 4.9 mtt -59.01 -46.19 88.79 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.414 1.086 . . . . 0.0 111.287 177.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -51.78 -58.48 6.3 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.554 1.542 . . . . 0.0 111.096 174.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -68.89 -30.62 69.16 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -178.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -59.49 -41.75 90.56 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.998 0.919 . . . . 0.0 111.446 174.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 12.8 mmm -86.18 -27.66 24.42 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -51.2 -63.71 1.05 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.861 1.665 . . . . 0.0 110.883 175.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -69.42 -6.23 28.82 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -175.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -88.18 -15.57 60.52 Favored Glycine 0 CA--C 1.537 1.442 0 C-N-CA 126.974 2.226 . . . . 0.0 115.459 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -144.77 95.49 5.28 Favored Pre-proline 0 CA--C 1.552 1.049 0 CA-C-N 119.771 1.786 . . . . 0.0 112.688 178.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -75.95 77.31 3.47 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 123.783 2.989 . . . . 0.0 112.591 -178.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -107.98 110.01 21.62 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.346 1.458 . . . . 0.0 109.827 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 9.6 mtp180 -118.56 111.39 18.53 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 126.944 2.098 . . . . 0.0 111.541 -175.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 76.96 -56.73 3.55 Favored Glycine 0 C--O 1.218 -0.867 0 CA-C-O 118.609 -1.106 . . . . 0.0 111.728 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 57.21 33.86 23.94 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 119.975 1.887 . . . . 0.0 114.655 174.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -70.31 40.9 0.05 Allowed 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 127.933 2.493 . . . . 0.0 115.163 -177.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -160.17 34.29 0.43 Allowed Glycine 0 CA--C 1.539 1.576 0 C-N-CA 126.319 1.914 . . . . 0.0 114.555 178.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' TRP . . . . . 0.588 ' H ' HD12 ' A' ' 161' ' ' ILE . 3.6 m95 57.5 49.48 12.72 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 126.769 2.028 . . . . 0.0 112.372 -174.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -84.68 130.56 34.69 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 121.319 -0.863 . . . . 0.0 111.23 -177.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -171.29 -176.93 2.0 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.034 0.933 . . . . 0.0 112.797 177.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 9.8 ttpp -126.48 157.14 39.44 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 126.339 1.855 . . . . 0.0 111.37 -174.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -68.48 158.13 34.43 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.293 0.568 . . . . 0.0 110.559 174.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.465 HD11 ' HB2' ' A' ' 158' ' ' MET . 98.5 mt -112.81 159.77 18.67 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.996 1.319 . . . . 0.0 109.45 175.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -63.33 -171.57 1.79 Allowed Glycine 0 CA--C 1.538 1.501 0 C-N-CA 124.085 0.85 . . . . 0.0 111.743 174.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 52.74 13.22 0.32 Allowed 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 125.486 1.515 . . . . 0.0 114.954 175.358 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 79.26 36.93 25.97 Favored Glycine 0 CA--C 1.54 1.6 0 C-N-CA 125.724 1.63 . . . . 0.0 113.803 -175.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -115.93 167.12 11.24 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 119.181 1.491 . . . . 0.0 112.436 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 80.2 mtt85 -146.48 127.55 14.64 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 120.924 -1.11 . . . . 0.0 111.053 175.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . 0.465 ' HB2' HD11 ' A' ' 152' ' ' LEU . 7.3 ttp -99.99 154.23 18.56 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 174.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.42 ' N ' ' HG2' ' A' ' 158' ' ' MET . 0.0 OUTLIER -126.43 147.89 49.72 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 127.691 2.396 . . . . 0.0 110.972 176.236 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -152.39 151.44 23.29 Favored Glycine 0 CA--C 1.524 0.65 0 CA-C-O 121.933 0.74 . . . . 0.0 113.47 175.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.588 HD12 ' H ' ' A' ' 147' ' ' TRP . 1.1 tp -142.72 133.76 24.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 127.005 2.122 . . . . 0.0 108.8 -179.147 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 1.4 mtp -149.02 -176.07 5.2 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 127.313 2.245 . . . . 0.0 107.698 175.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . 0.515 HG23 ' HB1' ' A' ' 168' ' ' ALA . 1.3 t -162.32 149.18 13.47 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 174.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 36.0 p -106.2 26.15 10.13 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.067 1.747 . . . . 0.0 112.001 -178.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.82 14.85 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.266 0 C-N-CA 127.864 2.466 . . . . 0.0 115.701 176.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 82.71 -37.19 2.64 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 127.605 2.526 . . . . 0.0 114.216 -178.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -135.05 75.74 1.59 Allowed 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 126.678 1.991 . . . . 0.0 108.272 -176.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.515 ' HB1' HG23 ' A' ' 163' ' ' THR . . . -135.89 162.65 32.22 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.397 1.479 . . . . 0.0 113.204 -175.034 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.4 ' H ' ' HG3' ' A' ' 169' ' ' LYS . 0.0 OUTLIER -110.28 172.06 7.09 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 128.998 2.919 . . . . 0.0 112.261 -175.029 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . 0.428 ' HB3' HG22 ' A' ' 34' ' ' VAL . 12.9 ttt -117.66 143.11 46.48 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 126.017 1.727 . . . . 0.0 112.177 176.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.485 ' C ' HD12 ' A' ' 172' ' ' ILE . 7.5 tt0 -149.13 123.85 9.85 Favored 'General case' 0 N--CA 1.466 0.325 0 O-C-N 120.627 -1.296 . . . . 0.0 110.691 174.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.485 HD12 ' C ' ' A' ' 171' ' ' GLN . 1.9 mp -125.08 125.77 69.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 124.786 1.235 . . . . 0.0 108.744 179.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.52 142.78 51.3 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.827 1.251 . . . . 0.0 109.987 178.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.7 mp -89.44 114.15 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 O-C-N 121.173 -0.955 . . . . 0.0 109.162 176.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 5.4 m -85.5 154.36 21.83 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.434 1.094 . . . . 0.0 112.192 174.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 69.3 mtp180 . . . . . 0 C--O 1.252 1.224 0 C-N-CA 125.379 1.472 . . . . 0.0 111.175 176.528 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.4 t . . . . . 0 N--CA 1.485 1.278 0 CA-C-O 121.932 0.872 . . . . 0.0 110.801 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -128.92 156.64 43.41 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 126.475 1.91 . . . . 0.0 109.691 176.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.448 ' H ' ' HG ' ' A' ' 3' ' ' LEU . 1.8 mt -48.83 -20.75 0.53 Allowed 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 126.698 1.999 . . . . 0.0 113.264 -178.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.432 ' HA ' ' HB3' ' A' ' 71' ' ' LEU . . . -72.74 78.05 1.12 Allowed 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 125.68 1.592 . . . . 0.0 109.56 175.076 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -68.05 -90.68 0.06 OUTLIER Glycine 0 CA--C 1.536 1.374 0 C-N-CA 125.614 1.578 . . . . 0.0 114.689 -175.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 24.2 p -128.18 164.57 22.22 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.408 1.483 . . . . 0.0 110.949 175.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -125.85 19.76 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 CA-C-O 123.545 1.64 . . . . 0.0 111.695 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.9 pp -54.97 166.57 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 125.21 1.404 . . . . 0.0 111.877 175.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -40.44 129.24 2.42 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.261 1.824 . . . . 0.0 114.83 -174.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -55.49 -21.11 26.35 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 125.169 1.366 . . . . 0.0 114.607 -176.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.39 -30.98 70.89 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.013 1.325 . . . . 0.0 112.041 174.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.4 t -101.95 -38.7 7.67 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.878 1.671 . . . . 0.0 111.558 174.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.567 HD11 ' CD2' ' A' ' 71' ' ' LEU . 45.4 tp -79.39 90.71 5.03 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.895 0.878 . . . . 0.0 112.069 176.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 70.8 p -123.17 -176.98 3.56 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 126.326 1.85 . . . . 0.0 112.292 -178.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -55.02 -37.66 66.93 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.337 1.055 . . . . 0.0 112.261 -175.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -57.58 -38.29 74.61 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 125.379 1.472 . . . . 0.0 111.605 178.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 89.4 t -66.51 -37.7 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.336 1.054 . . . . 0.0 111.38 175.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.475 ' CD2' HD21 ' A' ' 71' ' ' LEU . 9.4 mt -68.17 -44.39 76.02 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.897 0.879 . . . . 0.0 110.69 178.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -58.27 -50.89 72.0 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.879 1.272 . . . . 0.0 111.926 176.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.55 -32.56 73.99 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 118.381 -0.819 . . . . 0.0 113.147 174.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -54.96 -40.18 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 CA-C-N 119.636 1.107 . . . . 0.0 111.518 -179.005 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 16.2 mt -57.18 -20.66 27.98 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.99 1.716 . . . . 0.0 113.355 178.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -108.77 -51.4 0.7 Allowed Glycine 0 CA--C 1.533 1.192 0 C-N-CA 126.356 1.931 . . . . 0.0 113.855 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -63.92 -28.34 69.76 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 119.031 1.416 . . . . 0.0 113.643 -178.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -97.59 86.77 3.91 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.542 1.137 . . . . 0.0 109.266 174.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -54.29 119.1 10.64 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 125.363 1.459 . . . . 0.0 113.537 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.1 mtpp -142.0 -173.35 3.79 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 127.726 2.41 . . . . 0.0 111.357 179.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.7 m -57.81 168.4 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 126.23 1.812 . . . . 0.0 112.329 175.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.8 m -51.3 -37.69 48.87 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 116.389 1.996 . . . . 0.0 116.389 -175.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.71 131.79 54.28 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.574 1.549 . . . . 0.0 108.547 174.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.52 150.15 37.08 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 126.095 1.758 . . . . 0.0 109.745 -175.01 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -116.26 120.58 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 123.998 0.919 . . . . 0.0 110.434 177.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -117.47 124.89 49.88 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 124.516 1.126 . . . . 0.0 109.573 175.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.521 HG13 ' HB2' ' A' ' 72' ' ' TYR . 2.7 p -142.56 139.92 28.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.731 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -125.37 125.07 5.5 Favored Glycine 0 CA--C 1.522 0.505 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.491 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.44 ' H ' HD12 ' A' ' 70' ' ' LEU . 2.9 mp -112.48 142.27 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 123.822 0.849 . . . . 0.0 110.371 176.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -105.59 106.48 17.01 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.486 1.114 . . . . 0.0 111.127 178.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -74.86 93.0 2.58 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.359 1.864 . . . . 0.0 110.577 176.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -121.57 8.1 10.09 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.906 1.282 . . . . 0.0 113.131 175.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 30.0 t -46.03 -51.01 14.4 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.149 1.78 . . . . 0.0 113.343 178.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 154.5 -26.33 0.67 Allowed Glycine 0 N--CA 1.472 1.065 0 O-C-N 121.281 -0.887 . . . . 0.0 114.517 175.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -128.18 171.47 19.36 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 125.682 1.61 . . . . 0.0 112.178 174.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.762 HG22 ' HA ' ' A' ' 65' ' ' PRO . 76.5 p -64.68 149.65 48.64 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.618 0.767 . . . . 0.0 112.147 176.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 38.4 m0 -101.62 108.27 19.76 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 124.654 1.182 . . . . 0.0 111.048 178.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 33.2 m -90.7 128.74 36.75 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.993 1.317 . . . . 0.0 110.123 177.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.29 114.5 3.51 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.915 0.886 . . . . 0.0 111.729 174.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.489 HD21 HG23 ' A' ' 98' ' ' THR . 3.6 pp -98.44 -51.65 3.89 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 123.556 0.742 . . . . 0.0 111.536 177.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.487 ' HB3' HD12 ' A' ' 47' ' ' LEU . 7.8 t30 -172.92 154.47 2.87 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 127.5 2.32 . . . . 0.0 109.848 -177.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -137.64 168.0 20.55 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.916 1.286 . . . . 0.0 112.052 174.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -141.42 114.07 8.34 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.424 1.09 . . . . 0.0 111.652 179.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.408 ' CD1' ' HB1' ' A' ' 87' ' ' ALA . 3.2 m-85 -116.06 139.18 50.54 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.38 -0.825 . . . . 0.0 110.941 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -117.54 -67.05 1.02 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 126.071 1.749 . . . . 0.0 111.492 -175.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 26.3 t -105.39 -38.67 6.4 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 126.8 2.04 . . . . 0.0 110.28 -176.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -68.77 10.2 1.63 Allowed Glycine 0 CA--C 1.537 1.45 0 C-N-CA 126.792 2.139 . . . . 0.0 115.491 178.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 34.0 p -30.22 123.94 0.18 Allowed 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 129.014 2.925 . . . . 0.0 114.832 -175.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.423 HG21 HG23 ' A' ' 59' ' ' ILE . 1.5 t -146.39 178.28 8.38 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.47 1.108 . . . . 0.0 113.513 -174.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -83.24 -62.8 1.49 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.364 1.465 . . . . 0.0 112.4 177.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.2 p -138.93 138.21 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.901 1.68 . . . . 0.0 111.824 178.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.423 HG23 HG21 ' A' ' 56' ' ' THR . 1.4 pp -141.09 -27.75 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.921 1.688 . . . . 0.0 114.048 -179.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 mp -97.45 96.35 3.06 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 125.687 1.595 . . . . 0.0 109.06 177.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -64.02 152.28 81.62 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.878 2.385 . . . . 0.0 110.503 175.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -43.66 -50.2 7.53 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.011 1.725 . . . . 0.0 113.477 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 5.6 p -158.59 143.81 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 C-N-CA 126.93 2.092 . . . . 0.0 109.511 175.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.702 HG21 HD23 ' A' ' 70' ' ' LEU . 99.7 t -118.0 128.95 25.67 Favored Pre-proline 0 N--CA 1.476 0.828 0 C-N-CA 124.956 1.302 . . . . 0.0 108.771 175.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.762 ' HA ' HG22 ' A' ' 43' ' ' THR . 53.9 Cg_endo -67.13 150.36 82.12 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.611 2.207 . . . . 0.0 113.139 176.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -65.23 163.65 14.87 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.293 0.637 . . . . 0.0 111.033 175.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . 0.312 50.1 p 55.48 20.75 3.9 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 127.779 2.431 . . . . 0.0 114.742 -174.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 20.0 mttt -120.35 -178.49 3.7 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 126.459 1.903 . . . . 0.0 112.115 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.402 ' HB3' HD23 ' A' ' 13' ' ' LEU . . . -133.76 166.19 23.21 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 175.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.702 HD23 HG21 ' A' ' 64' ' ' VAL . 0.5 OUTLIER -134.25 174.26 10.7 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 124.3 1.04 . . . . 0.0 110.993 179.539 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.567 ' CD2' HD11 ' A' ' 13' ' ' LEU . 0.9 OUTLIER -127.33 154.89 44.4 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 124.699 1.199 . . . . 0.0 111.481 175.185 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.521 ' HB2' HG13 ' A' ' 34' ' ' VAL . 12.4 m-85 -129.49 148.09 51.36 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 125.987 1.715 . . . . 0.0 109.795 178.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 54.5 p -126.21 146.69 49.87 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 126.186 1.795 . . . . 0.0 111.129 175.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -163.26 148.78 15.67 Favored Glycine 0 CA--C 1.519 0.286 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 174.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.48 173.61 6.66 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.16 1.384 . . . . 0.0 110.134 177.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.407 ' CE ' ' HB1' ' A' ' 82' ' ' ALA . 12.2 ptmt -101.0 -19.66 15.74 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 174.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.2 t -81.76 80.87 7.97 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 125.334 1.453 . . . . 0.0 109.98 -174.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.5 t -55.75 -28.36 55.56 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.236 1.414 . . . . 0.0 112.77 178.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 123.06 -69.07 0.45 Allowed Glycine 0 CA--C 1.535 1.329 0 C-N-CA 126.644 2.069 . . . . 0.0 112.175 -178.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.36 -49.42 0.36 Allowed 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.245 2.63 . . . . 0.0 112.796 -177.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 83.9 t -141.89 130.23 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 126.455 1.902 . . . . 0.0 109.61 -177.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.407 ' HB1' ' CE ' ' A' ' 76' ' ' LYS . . . -68.17 125.63 27.0 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.241 1.016 . . . . 0.0 111.122 175.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 90.1 m -112.1 -85.38 0.57 Allowed 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.853 0.861 . . . . 0.0 110.08 178.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 179.74 -93.09 0.09 OUTLIER Glycine 0 CA--C 1.531 1.069 0 CA-C-N 119.696 1.135 . . . . 0.0 113.253 -175.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -153.56 100.62 2.42 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.137 0.975 . . . . 0.0 111.585 176.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.2 t -141.23 115.27 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 124.455 1.102 . . . . 0.0 109.753 -177.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.408 ' HB1' ' CD1' ' A' ' 51' ' ' PHE . . . -157.45 170.93 21.32 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.374 1.07 . . . . 0.0 112.05 175.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -152.11 160.84 43.33 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.47 1.508 . . . . 0.0 111.082 175.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.587 ' CZ ' HG11 ' A' ' 101' ' ' VAL . 41.6 p90 -155.33 170.07 22.75 Favored 'General case' 0 C--O 1.234 0.285 0 O-C-N 121.079 -1.013 . . . . 0.0 111.154 175.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.403 ' HA ' ' O ' ' A' ' 99' ' ' LEU . . . -136.31 151.7 49.9 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 176.323 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -131.29 134.88 46.81 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.545 1.538 . . . . 0.0 112.727 -177.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -82.62 123.56 29.35 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 111.618 0.229 . . . . 0.0 111.618 -179.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 4.6 tpp -88.55 145.49 25.69 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.317 1.047 . . . . 0.0 112.165 175.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 61.3 m -69.65 -23.35 63.47 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 175.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -70.98 -13.94 62.18 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.852 1.261 . . . . 0.0 113.787 175.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 98.54 42.63 2.89 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 124.546 1.069 . . . . 0.0 114.176 -179.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.511 ' HB3' HG22 ' A' ' 120' ' ' ILE . 17.0 m-80 -141.33 174.15 10.81 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.354 1.462 . . . . 0.0 110.431 178.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.489 HG23 HD21 ' A' ' 47' ' ' LEU . 6.0 m -128.55 107.18 9.5 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.178 0.991 . . . . 0.0 112.424 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.403 ' O ' ' HA ' ' A' ' 90' ' ' ALA . 21.1 tp -68.03 105.02 1.9 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.756 0.823 . . . . 0.0 109.65 174.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -106.63 103.09 1.98 Allowed Glycine 0 CA--C 1.525 0.695 0 C-N-CA 125.395 1.474 . . . . 0.0 112.337 177.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.587 HG11 ' CZ ' ' A' ' 89' ' ' PHE . 9.5 p -86.32 161.47 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 123.755 0.822 . . . . 0.0 112.407 175.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 2.5 tmm? -150.3 126.96 10.91 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.257 1.823 . . . . 0.0 109.725 178.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -139.03 118.51 12.9 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 122.158 0.98 . . . . 0.0 112.948 177.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 26.0 t -124.6 118.34 26.32 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.452 1.501 . . . . 0.0 110.723 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 96.2 t -105.88 134.42 19.74 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 126.728 2.011 . . . . 0.0 108.852 178.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -65.28 139.17 58.87 Favored 'Trans proline' 0 CA--C 1.534 0.486 0 C-N-CA 123.63 2.887 . . . . 0.0 110.196 178.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -44.27 -50.79 8.77 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.625 1.97 . . . . 0.0 114.631 -174.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -132.74 20.08 4.21 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.63 1.572 . . . . 0.0 112.077 -176.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 53.74 30.95 12.0 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.079 1.752 . . . . 0.0 113.738 -175.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -71.74 -170.75 0.59 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 128.066 2.546 . . . . 0.0 111.669 174.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 2.0 p90 -51.75 -21.15 2.55 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 126.424 1.889 . . . . 0.0 115.122 176.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -56.48 115.04 2.28 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.775 1.63 . . . . 0.0 111.465 175.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 11.0 m -61.5 144.58 54.01 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.497 0.665 . . . . 0.0 112.359 177.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -100.05 118.11 35.73 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.285 1.434 . . . . 0.0 107.382 174.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 36.7 m0 -116.73 135.65 53.59 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 19.8 p-90 -145.82 143.49 29.68 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.548 0.739 . . . . 0.0 112.029 -176.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -148.59 161.83 40.89 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.981 0.896 . . . . 0.0 112.571 -176.321 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.453 HG13 ' SD ' ' A' ' 158' ' ' MET . 5.6 p -166.12 127.76 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 125.028 1.331 . . . . 0.0 109.269 175.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.546 ' HE3' ' CE1' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -151.78 168.44 25.05 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 126.199 1.799 . . . . 0.0 109.566 178.31 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.511 HG22 ' HB3' ' A' ' 97' ' ' ASN . 24.6 mt -111.1 111.73 37.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -177.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.546 ' CE1' ' HE3' ' A' ' 119' ' ' LYS . 54.2 m-85 -63.01 142.66 97.67 Favored Pre-proline 0 CA--C 1.544 0.731 0 O-C-N 121.203 -0.936 . . . . 0.0 111.063 -179.099 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -73.92 92.5 0.89 Allowed 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 124.2 3.266 . . . . 0.0 110.902 -179.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 101.2 -171.69 22.61 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 124.805 1.193 . . . . 0.0 112.736 -174.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 8.8 tttt -67.57 118.51 10.97 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.893 0.877 . . . . 0.0 110.931 176.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 9.4 tpp180 -134.18 178.25 7.12 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.222 1.409 . . . . 0.0 109.704 175.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 8.6 ptt180 -123.34 179.74 4.61 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 126.372 1.869 . . . . 0.0 110.231 174.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -131.7 103.65 6.48 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 126.572 1.949 . . . . 0.0 107.016 175.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -126.66 171.37 11.21 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.348 1.859 . . . . 0.0 110.093 178.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -50.69 -41.73 56.13 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -177.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -60.72 -53.76 42.6 Favored Glycine 0 N--CA 1.468 0.775 0 CA-C-O 119.484 -0.62 . . . . 0.0 112.267 176.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -63.24 -40.05 96.34 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 118.176 0.988 . . . . 0.0 111.916 178.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -55.84 -63.73 1.08 Allowed 'General case' 0 C--N 1.34 0.167 0 C-N-CA 124.224 1.01 . . . . 0.0 108.846 175.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -64.62 -33.9 77.01 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 118.667 0.667 . . . . 0.0 112.739 -175.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -64.56 -42.94 95.36 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.272 1.029 . . . . 0.0 113.069 176.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -86.32 -29.01 23.34 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 121.28 -0.888 . . . . 0.0 112.291 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -52.04 -57.61 9.02 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 126.831 2.053 . . . . 0.0 108.902 174.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -71.85 -12.1 61.12 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -177.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -86.72 -8.14 77.21 Favored Glycine 0 CA--C 1.54 1.599 0 C-N-CA 126.701 2.096 . . . . 0.0 114.958 176.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -140.09 80.3 20.52 Favored Pre-proline 0 CA--C 1.55 0.954 0 CA-C-N 119.105 1.452 . . . . 0.0 111.192 175.012 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -73.16 70.25 3.82 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 124.109 3.206 . . . . 0.0 112.471 177.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -102.43 116.76 33.28 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.97 0.908 . . . . 0.0 110.637 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 34.5 mtm180 -83.59 -68.43 0.71 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.11 1.364 . . . . 0.0 111.884 174.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 134.73 114.43 1.43 Allowed Glycine 0 CA--C 1.53 0.981 0 C-N-CA 124.976 1.274 . . . . 0.0 113.569 -178.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.58 14.73 0.32 Allowed 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 126.912 2.085 . . . . 0.0 115.295 176.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . 0.258 0.8 OUTLIER 45.51 65.01 1.23 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 126.953 2.101 . . . . 0.0 112.56 -175.011 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -168.44 -67.33 0.03 OUTLIER Glycine 0 CA--C 1.541 1.672 0 C-N-CA 125.098 1.332 . . . . 0.0 115.926 -174.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 43.2 m95 173.23 114.19 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 130.86 3.664 . . . . 0.0 108.799 -175.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -131.93 126.09 33.24 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 128.463 2.705 . . . . 0.0 110.277 -177.376 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -166.76 -175.31 3.06 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.08 0.952 . . . . 0.0 112.078 -174.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.3 mtmt -139.54 145.51 38.76 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.702 1.201 . . . . 0.0 109.946 175.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -67.6 149.79 49.63 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 175.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 66.7 mt -108.78 102.32 11.37 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.277 0.631 . . . . 0.0 110.4 -174.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -43.52 -30.58 1.43 Allowed Glycine 0 N--CA 1.475 1.283 0 C-N-CA 127.722 2.582 . . . . 0.0 117.136 -175.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.47 ' CE2' ' HB ' ' A' ' 120' ' ' ILE . 0.0 OUTLIER -64.29 -18.85 64.98 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.623 1.969 . . . . 0.0 113.799 178.164 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 118.86 30.14 1.7 Allowed Glycine 0 CA--C 1.537 1.409 0 C-N-CA 125.915 1.721 . . . . 0.0 114.288 -178.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 2.2 mt -128.96 174.92 9.08 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.508 1.923 . . . . 0.0 110.859 -176.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 80.7 mtt180 -143.75 108.77 4.97 Favored 'General case' 0 N--CA 1.479 1.007 0 O-C-N 120.913 -1.117 . . . . 0.0 111.081 178.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . 0.453 ' SD ' HG13 ' A' ' 118' ' ' VAL . 0.0 OUTLIER -84.73 148.54 26.31 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 175.049 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.9 122.28 17.16 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 126.087 1.755 . . . . 0.0 110.899 176.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -138.85 158.74 25.26 Favored Glycine 0 N--CA 1.479 1.56 0 CA-C-N 121.552 1.978 . . . . 0.0 116.62 -177.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.523 HD13 ' N ' ' A' ' 162' ' ' MET . 0.0 OUTLIER -151.3 134.3 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-N 118.896 1.348 . . . . 0.0 111.051 179.407 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . 0.523 ' N ' HD13 ' A' ' 161' ' ' ILE . 1.1 ttt -156.91 105.98 2.21 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.752 1.621 . . . . 0.0 110.089 174.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 4.0 t -81.66 126.76 32.16 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 120.921 -1.112 . . . . 0.0 109.977 175.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 34.9 p -75.15 21.89 0.12 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.1 1.36 . . . . 0.0 114.292 177.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -56.06 -45.33 79.33 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.282 1.833 . . . . 0.0 114.692 -175.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 164.45 -60.59 0.25 Allowed Glycine 0 CA--C 1.533 1.192 0 C-N-CA 123.685 0.66 . . . . 0.0 114.706 178.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -120.07 21.77 11.7 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.625 1.17 . . . . 0.0 112.819 -178.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -64.16 168.59 5.28 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 122.784 1.278 . . . . 0.0 112.887 175.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.09 167.05 11.83 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 127.089 2.156 . . . . 0.0 110.976 -179.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 13.7 ttp -108.3 135.5 49.51 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.634 1.174 . . . . 0.0 110.329 178.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -141.62 127.64 19.52 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.007 0.923 . . . . 0.0 110.896 175.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 5.1 mp -133.38 121.32 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 124.241 1.016 . . . . 0.0 110.01 175.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -116.61 132.31 56.72 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 125.409 1.484 . . . . 0.0 110.321 175.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.7 mp -84.3 119.5 33.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 175.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 5.0 m -92.61 171.08 9.24 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.64 1.576 . . . . 0.0 109.825 174.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 2.2 mtt180 . . . . . 0 C--O 1.253 1.274 0 C-N-CA 125.335 1.454 . . . . 0.0 112.624 176.363 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 75.3 m . . . . . 0 N--CA 1.484 1.227 0 CA-C-O 121.806 0.812 . . . . 0.0 112.098 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -87.22 176.59 7.49 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 126.333 1.853 . . . . 0.0 112.13 176.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.447 HD11 ' HB2' ' A' ' 31' ' ' LYS . 11.8 tp -128.74 -34.66 1.96 Allowed 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 113.847 1.054 . . . . 0.0 113.847 175.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -86.58 138.7 31.49 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.313 1.045 . . . . 0.0 109.124 175.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -79.66 -122.81 0.4 Allowed Glycine 0 CA--C 1.535 1.319 0 C-N-CA 124.143 0.877 . . . . 0.0 112.031 175.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 35.8 p -113.74 173.43 6.42 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.482 1.513 . . . . 0.0 112.018 -178.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -123.14 19.84 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.326 1.05 . . . . 0.0 112.121 178.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.42 HD12 ' HB3' ' A' ' 12' ' ' SER . 0.9 OUTLIER -47.15 156.87 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.784 1.234 . . . . 0.0 112.846 175.007 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -41.92 130.45 3.44 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.279 1.832 . . . . 0.0 112.999 -175.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -54.03 -22.86 21.8 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 124.869 1.223 . . . . 0.0 114.885 -174.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.93 -30.58 71.65 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.417 1.087 . . . . 0.0 112.077 175.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.42 ' HB3' HD12 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -100.89 -41.92 6.64 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.629 1.972 . . . . 0.0 111.872 176.75 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.2 tp -73.29 94.23 1.99 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.139 0.976 . . . . 0.0 110.898 175.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 82.6 p -129.19 -175.3 3.52 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.422 1.889 . . . . 0.0 112.046 -178.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.478 ' CE1' HG21 ' A' ' 161' ' ' ILE . 6.4 m-85 -51.52 -33.11 30.45 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.959 1.304 . . . . 0.0 113.993 179.076 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -57.83 -43.17 85.64 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.102 0.561 . . . . 0.0 111.852 174.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.416 ' O ' HG23 ' A' ' 21' ' ' VAL . 72.8 t -67.03 -40.23 85.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.229 1.012 . . . . 0.0 110.922 175.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 59.8 mt -67.54 -40.08 85.02 Favored 'General case' 0 N--CA 1.469 0.475 0 O-C-N 120.963 -1.086 . . . . 0.0 112.059 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -63.91 -47.57 80.02 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.164 0.986 . . . . 0.0 111.781 176.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.51 -36.7 84.6 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 118.456 -0.783 . . . . 0.0 112.287 174.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 17' ' ' VAL . 19.0 t -55.03 -46.12 77.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-N 119.295 0.952 . . . . 0.0 110.92 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.3 mt -54.89 -19.62 7.01 Favored 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 176.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.62 -60.48 1.09 Allowed Glycine 0 CA--C 1.535 1.323 0 C-N-CA 126.324 1.916 . . . . 0.0 113.182 175.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -65.75 -34.89 79.23 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -178.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -100.8 133.56 45.09 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.637 1.575 . . . . 0.0 109.923 175.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 170.27 145.72 4.84 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 124.504 1.049 . . . . 0.0 112.155 -178.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -129.73 -76.91 0.54 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.027 1.331 . . . . 0.0 110.938 -178.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 30' ' ' ARG . 26.9 m -78.08 173.93 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 126.107 1.763 . . . . 0.0 111.361 175.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -53.67 -35.31 60.92 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 115.546 1.684 . . . . 0.0 115.546 -175.04 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.534 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.2 OUTLIER -127.32 152.13 47.86 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 127.544 2.337 . . . . 0.0 109.035 175.003 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.447 ' HB2' HD11 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -151.02 159.47 44.53 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.803 1.641 . . . . 0.0 111.012 -178.088 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.465 HG13 ' HB1' ' A' ' 85' ' ' ALA . 0.3 OUTLIER -122.26 129.9 74.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 125.075 1.35 . . . . 0.0 108.214 175.078 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -135.79 115.3 12.72 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.11 1.364 . . . . 0.0 108.965 175.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.475 HG12 ' HB3' ' A' ' 170' ' ' MET . 2.6 m -125.72 144.1 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 123.313 0.645 . . . . 0.0 111.146 -177.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -111.03 115.26 3.92 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 124.255 0.931 . . . . 0.0 111.656 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 mp -105.1 144.16 15.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 118.037 0.918 . . . . 0.0 108.782 174.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -115.95 111.5 20.48 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 124.588 1.155 . . . . 0.0 111.049 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.474 ' HA ' ' CZ2' ' A' ' 44' ' ' TRP . 1.6 m-20 -80.54 78.25 7.29 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 128.141 2.576 . . . . 0.0 111.226 -175.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -113.99 3.43 15.35 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.779 1.232 . . . . 0.0 112.389 178.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.31 -54.5 43.15 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.918 1.687 . . . . 0.0 114.304 -175.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 151.93 99.52 0.19 Allowed Glycine 0 CA--C 1.533 1.195 0 O-C-N 121.478 -0.764 . . . . 0.0 114.278 178.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.15 163.74 38.94 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 125.871 1.701 . . . . 0.0 112.94 -177.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.669 HG22 ' HA ' ' A' ' 65' ' ' PRO . 69.1 p -63.98 138.74 58.6 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 121.965 -0.727 . . . . 0.0 111.616 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.474 ' CZ2' ' HA ' ' A' ' 38' ' ' ASN . 40.6 m0 -87.99 106.47 18.15 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.077 0.551 . . . . 0.0 110.827 -178.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 15.9 m -86.27 122.64 30.54 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.319 1.048 . . . . 0.0 109.577 175.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.41 140.02 57.4 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.087 0.47 . . . . 0.0 111.671 175.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.546 HD12 ' N ' ' A' ' 48' ' ' ASN . 4.0 pp -121.92 -56.84 1.83 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.912 1.285 . . . . 0.0 111.312 -178.207 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.546 ' N ' HD12 ' A' ' 47' ' ' LEU . 0.1 OUTLIER -171.16 156.22 4.66 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.65 1.98 . . . . 0.0 110.596 176.5 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.416 ' HB2' HD12 ' A' ' 60' ' ' LEU . . . -133.57 165.45 24.88 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.269 1.428 . . . . 0.0 110.718 174.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -141.12 101.8 4.11 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.953 1.701 . . . . 0.0 111.444 -178.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.506 ' CD1' ' HB1' ' A' ' 87' ' ' ALA . 3.1 m-85 -107.74 127.32 53.59 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.127 0.971 . . . . 0.0 110.582 -177.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.67 -37.75 4.8 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.372 1.069 . . . . 0.0 113.486 -179.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.8 t -123.36 -41.93 2.27 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 126.31 1.844 . . . . 0.0 111.556 -178.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -69.01 16.2 0.63 Allowed Glycine 0 CA--C 1.536 1.362 0 C-N-CA 125.145 1.355 . . . . 0.0 115.529 179.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.6 p -27.35 115.25 0.07 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 129.604 3.161 . . . . 0.0 113.863 -176.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.639 HG21 HG23 ' A' ' 59' ' ' ILE . 3.1 t -139.11 176.71 8.46 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.779 0.831 . . . . 0.0 112.794 -175.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -80.94 -57.4 3.56 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.909 1.284 . . . . 0.0 110.668 175.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.4 p -151.0 137.23 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 126.071 1.748 . . . . 0.0 111.573 -177.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.639 HG23 HG21 ' A' ' 56' ' ' THR . 0.1 OUTLIER -130.8 -42.5 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 125.337 1.455 . . . . 0.0 112.778 176.001 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.416 HD12 ' HB2' ' A' ' 49' ' ' ALA . 13.8 mt -82.59 100.15 0.79 Allowed Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 126.398 1.879 . . . . 0.0 109.725 179.21 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.479 ' HG2' HG23 ' A' ' 64' ' ' VAL . 84.0 Cg_endo -69.43 155.31 67.38 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.57 2.846 . . . . 0.0 110.385 175.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -48.52 -52.14 23.96 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.902 0.881 . . . . 0.0 112.966 -176.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.4 t -154.6 135.43 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 128.307 2.643 . . . . 0.0 108.694 -178.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.555 HG21 HD13 ' A' ' 70' ' ' LEU . 48.3 t -120.43 134.19 24.12 Favored Pre-proline 0 N--CA 1.479 1.016 0 C-N-CA 123.94 0.896 . . . . 0.0 109.448 174.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.669 ' HA ' HG22 ' A' ' 43' ' ' THR . 51.8 Cg_endo -63.09 151.1 86.5 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.202 1.935 . . . . 0.0 113.157 176.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -74.59 173.1 10.9 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.537 0.735 . . . . 0.0 110.428 175.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 78.8 p 49.23 27.78 1.97 Allowed 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 126.79 2.036 . . . . 0.0 112.789 -175.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 8.2 tttt -133.58 178.41 6.95 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 126.611 1.964 . . . . 0.0 111.633 -175.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -137.69 161.14 37.29 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 121.35 -0.843 . . . . 0.0 109.4 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.555 HD13 HG21 ' A' ' 64' ' ' VAL . 2.0 pt? -137.88 168.56 19.45 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.255 1.022 . . . . 0.0 111.681 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.411 HD13 ' O ' ' A' ' 34' ' ' VAL . 1.4 mm? -109.17 149.68 29.0 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 124.165 0.986 . . . . 0.0 110.748 175.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -126.83 149.46 49.7 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 127.371 2.268 . . . . 0.0 109.686 177.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.5 p -131.75 151.67 51.49 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 127.023 2.129 . . . . 0.0 111.879 -175.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -170.51 135.52 3.56 Favored Glycine 0 CA--C 1.521 0.433 0 O-C-N 121.396 -0.815 . . . . 0.0 113.142 174.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 27.7 mtm180 -104.06 121.35 43.01 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.57 1.148 . . . . 0.0 110.368 -177.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.27 -33.49 69.47 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 126.221 1.808 . . . . 0.0 115.236 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 29.3 p -75.62 86.71 2.69 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.699 2.0 . . . . 0.0 111.971 -177.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 29.6 t -61.9 -32.74 73.15 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.834 0.853 . . . . 0.0 113.238 178.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 121.24 -74.51 0.34 Allowed Glycine 0 CA--C 1.535 1.297 0 C-N-CA 125.996 1.76 . . . . 0.0 112.041 -179.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.15 -24.55 16.89 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 123.467 2.778 . . . . 0.0 113.692 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.6 p -134.86 145.29 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 126.329 1.851 . . . . 0.0 110.019 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -98.78 123.11 42.81 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.104 1.362 . . . . 0.0 110.401 175.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.2 p -130.81 -170.99 2.45 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 126.473 1.909 . . . . 0.0 110.76 -178.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -104.96 -105.79 3.06 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 125.335 1.445 . . . . 0.0 112.042 -177.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.465 ' HB1' HG13 ' A' ' 32' ' ' ILE . . . -139.63 93.2 2.64 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.423 -1.045 . . . . 0.0 110.056 177.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.3 t -133.12 116.6 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 123.904 0.882 . . . . 0.0 110.266 -176.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.754 ' HB3' ' CZ ' ' A' ' 103' ' ' PHE . . . -163.55 161.26 23.86 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.916 0.865 . . . . 0.0 111.382 178.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -142.82 151.17 40.86 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.678 1.191 . . . . 0.0 110.166 175.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -149.92 170.03 19.76 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 124.236 1.014 . . . . 0.0 110.061 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.473 ' HB3' HD11 ' A' ' 47' ' ' LEU . . . -142.52 157.4 44.77 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.389 -0.819 . . . . 0.0 111.891 175.002 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -132.12 141.44 49.15 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 126.131 1.773 . . . . 0.0 112.446 -174.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -98.32 119.12 36.45 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 120.673 0.273 . . . . 0.0 110.678 -175.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 15.4 mtm -95.88 133.69 39.75 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 123.906 0.882 . . . . 0.0 110.713 -176.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.4 t -58.84 -23.84 61.25 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.781 1.232 . . . . 0.0 112.624 178.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -64.53 -18.88 65.24 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.438 1.495 . . . . 0.0 113.515 175.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 108.53 14.0 17.27 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 124.959 1.266 . . . . 0.0 115.312 -179.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.425 ' HB3' HG22 ' A' ' 120' ' ' ILE . 15.3 m-80 -122.51 172.25 8.51 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-N 119.171 1.486 . . . . 0.0 111.394 -179.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 95.6 m -124.91 102.16 7.41 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.598 1.159 . . . . 0.0 111.734 -177.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 21.4 tp -66.73 97.09 0.44 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.016 1.327 . . . . 0.0 111.682 176.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -90.61 124.65 7.6 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 125.534 1.54 . . . . 0.0 112.22 176.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 47.7 t -124.88 142.7 40.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 124.894 1.277 . . . . 0.0 110.777 -175.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . 0.423 ' CE ' ' HA ' ' A' ' 116' ' ' TRP . 0.0 OUTLIER -149.33 160.09 43.71 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.427 -0.795 . . . . 0.0 112.026 175.04 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.754 ' CZ ' ' HB3' ' A' ' 87' ' ' ALA . 44.4 p90 -143.23 143.07 31.6 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.13 0.972 . . . . 0.0 110.436 176.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 9.9 t -134.25 119.96 19.39 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.833 1.253 . . . . 0.0 110.662 179.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 62.4 t -129.96 134.87 26.65 Favored Pre-proline 0 N--CA 1.469 0.513 0 C-N-CA 126.061 1.744 . . . . 0.0 109.206 -176.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -64.4 157.08 56.56 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 123.742 2.961 . . . . 0.0 113.581 -179.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -82.23 -54.62 5.11 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.519 1.127 . . . . 0.0 110.631 178.041 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.79 -25.74 32.46 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.258 1.423 . . . . 0.0 113.637 -178.099 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 58.6 26.33 14.3 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 126.395 1.878 . . . . 0.0 114.834 179.078 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 29.6 m-20 -93.36 -77.59 0.45 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.981 1.312 . . . . 0.0 113.677 -178.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 33.8 p-90 -119.43 12.04 12.32 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 126.946 2.099 . . . . 0.0 114.501 -174.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -80.2 175.58 10.52 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 125.453 1.501 . . . . 0.0 113.084 176.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 31.9 m -117.8 108.92 15.94 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 127.068 2.147 . . . . 0.0 111.872 178.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -84.18 104.03 13.89 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.549 1.14 . . . . 0.0 110.064 175.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 53.6 m0 -114.3 152.26 31.66 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 119.825 1.193 . . . . 0.0 112.673 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' TRP . . . . . 0.423 ' HA ' ' CE ' ' A' ' 102' ' ' MET . 53.9 p-90 -144.1 133.6 23.41 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -134.4 161.65 34.42 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.37 1.868 . . . . 0.0 111.829 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 78.5 t -154.62 150.19 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 126.961 2.104 . . . . 0.0 108.077 175.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.75 166.21 29.1 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.591 1.956 . . . . 0.0 109.97 175.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.474 ' HB ' ' CE2' ' A' ' 154' ' ' TYR . 3.1 mt -118.18 112.05 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-O 121.787 0.803 . . . . 0.0 109.454 176.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -68.76 145.05 96.64 Favored Pre-proline 0 CA--C 1.548 0.883 0 O-C-N 121.478 -0.764 . . . . 0.0 111.629 179.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -75.79 91.33 1.09 Allowed 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 123.834 3.023 . . . . 0.0 112.005 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 97.28 179.0 34.21 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 125.827 1.68 . . . . 0.0 112.952 -178.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 6.6 tttt -51.6 121.66 6.82 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.837 1.255 . . . . 0.0 111.567 -176.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.98 -173.45 3.38 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.606 1.563 . . . . 0.0 112.101 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.8 ptt180 -134.14 -179.22 5.43 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 126.9 2.08 . . . . 0.0 110.948 175.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -126.63 115.92 20.22 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 127.539 2.336 . . . . 0.0 104.984 175.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -135.55 169.6 17.27 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.835 1.254 . . . . 0.0 110.303 175.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -56.61 -36.15 69.09 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.049 0.94 . . . . 0.0 112.962 -178.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -60.9 -58.78 12.01 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-N 118.742 0.701 . . . . 0.0 111.998 175.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 1.4 null -62.73 -36.94 84.64 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 118.07 0.935 . . . . 0.0 112.801 178.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.41 -64.39 0.97 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.48 1.112 . . . . 0.0 109.151 174.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -65.27 -28.65 69.49 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -175.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -63.69 -36.88 85.3 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.778 1.231 . . . . 0.0 112.569 175.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 8.8 tpp -94.07 -23.63 17.91 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 177.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -49.89 -56.9 8.74 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.779 1.631 . . . . 0.0 111.145 175.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -70.4 -13.37 62.11 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -85.04 -30.61 25.31 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 127.153 2.311 . . . . 0.0 112.987 -175.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -123.57 81.96 53.98 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 123.833 0.853 . . . . 0.0 112.46 175.01 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -75.04 73.06 4.46 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 123.928 3.086 . . . . 0.0 112.775 -179.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -103.84 114.98 29.64 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.698 0.799 . . . . 0.0 111.552 176.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 46.8 mtm180 -86.26 -82.18 0.2 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.049 1.339 . . . . 0.0 111.138 175.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -115.88 -76.72 0.65 Allowed Glycine 0 C--N 1.328 0.102 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 178.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 56.69 43.26 25.68 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-O 122.044 0.926 . . . . 0.0 109.796 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -49.69 91.81 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 127.67 2.388 . . . . 0.0 113.805 -175.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 161.5 50.51 0.02 OUTLIER Glycine 0 CA--C 1.535 1.314 0 C-N-CA 124.993 1.283 . . . . 0.0 114.178 -175.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' TRP . . . . . 0.641 ' H ' HD13 ' A' ' 161' ' ' ILE . 4.7 m95 48.79 51.05 16.51 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.219 1.808 . . . . 0.0 113.953 -178.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -81.67 124.53 29.66 Favored 'General case' 0 N--CA 1.467 0.425 0 O-C-N 121.31 -0.869 . . . . 0.0 111.971 -177.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -167.27 -169.22 1.2 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.433 0.693 . . . . 0.0 112.754 178.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.77 164.49 25.03 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 126.64 1.976 . . . . 0.0 111.53 -178.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -81.8 157.7 24.37 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.872 0.869 . . . . 0.0 109.838 175.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.709 HD21 ' HB2' ' A' ' 158' ' ' MET . 3.0 mm? -104.71 118.06 35.62 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.125 0.57 . . . . 0.0 110.536 175.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -48.99 -29.57 8.54 Favored Glycine 0 CA--C 1.537 1.45 0 C-N-CA 125.8 1.667 . . . . 0.0 115.977 -177.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.474 ' CE2' ' HB ' ' A' ' 120' ' ' ILE . 0.1 OUTLIER -62.5 -25.39 67.99 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.4 1.88 . . . . 0.0 113.112 176.977 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 125.18 7.75 5.78 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 126.626 2.06 . . . . 0.0 114.961 -179.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 5.3 mp -101.5 176.78 5.12 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.216 1.406 . . . . 0.0 112.235 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 38.5 mtt180 -139.16 113.52 8.92 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.963 1.305 . . . . 0.0 110.703 -178.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . 0.709 ' HB2' HD21 ' A' ' 152' ' ' LEU . 4.3 ttt -98.15 147.36 24.66 Favored 'General case' 0 C--N 1.319 -0.755 0 O-C-N 120.305 -1.497 . . . . 0.0 107.88 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.09 144.56 51.41 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 125.949 1.699 . . . . 0.0 110.163 177.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -152.02 156.97 26.99 Favored Glycine 0 CA--C 1.519 0.297 0 CA-C-O 121.893 0.719 . . . . 0.0 112.043 177.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.641 HD13 ' H ' ' A' ' 147' ' ' TRP . 4.7 tp -153.21 123.62 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 122.686 1.231 . . . . 0.0 110.175 -175.122 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.58 171.97 14.29 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 125.475 1.51 . . . . 0.0 110.21 175.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 15.1 t -162.2 166.82 25.03 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.251 1.42 . . . . 0.0 108.977 176.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 60.2 p -116.66 30.9 7.06 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.741 1.616 . . . . 0.0 111.604 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -65.38 23.2 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 128.541 2.736 . . . . 0.0 115.113 177.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 81.01 -55.49 4.79 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 127.14 2.305 . . . . 0.0 113.433 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -116.05 24.02 11.76 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.67 1.588 . . . . 0.0 112.818 -175.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -61.83 168.31 3.17 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 127.021 2.128 . . . . 0.0 114.599 175.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.5 171.35 10.58 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 127.661 2.385 . . . . 0.0 111.651 177.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . 0.475 ' HB3' HG12 ' A' ' 34' ' ' VAL . 3.0 tmm? -118.76 135.58 54.43 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.223 1.409 . . . . 0.0 111.151 175.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.453 ' C ' HD12 ' A' ' 172' ' ' ILE . 6.2 tm0? -145.06 131.56 19.77 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.124 0.97 . . . . 0.0 110.156 178.011 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.453 HD12 ' C ' ' A' ' 171' ' ' GLN . 1.8 mp -131.74 127.97 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 125.382 1.473 . . . . 0.0 109.613 175.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -130.87 131.11 44.35 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.933 1.693 . . . . 0.0 110.335 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.7 mp -89.17 96.56 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 O-C-N 121.527 -0.733 . . . . 0.0 111.426 177.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 2.5 t -66.06 173.02 3.28 Favored 'General case' 0 CA--C 1.565 1.521 0 C-N-CA 123.631 0.772 . . . . 0.0 111.477 177.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 18.1 mtp180 . . . . . 0 C--O 1.252 1.208 0 C-N-CA 125.73 1.612 . . . . 0.0 112.618 175.711 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 77.0 p . . . . . 0 N--CA 1.484 1.244 0 CA-C-O 118.423 -0.799 . . . . 0.0 109.443 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.21 -173.72 0.07 Allowed 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 121.013 1.733 . . . . 0.0 112.363 174.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.814 HD12 ' H ' ' A' ' 74' ' ' GLY . 1.5 mt -126.3 8.18 7.17 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 125.18 1.392 . . . . 0.0 112.168 175.041 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -114.98 114.36 25.33 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.884 1.674 . . . . 0.0 111.024 -175.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -72.73 -155.52 2.89 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 125.29 1.424 . . . . 0.0 113.137 178.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 25.7 p -61.9 161.4 10.55 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.61 0.764 . . . . 0.0 111.791 174.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -122.81 18.07 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 CA-C-O 122.993 1.378 . . . . 0.0 111.47 174.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.8 pp -58.62 172.63 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 C-N-CA 125.463 1.505 . . . . 0.0 112.642 174.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -42.27 130.93 3.7 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 127.177 2.191 . . . . 0.0 114.155 -174.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.76 -19.47 43.31 Favored Glycine 0 CA--C 1.538 1.491 0 C-N-CA 124.187 0.899 . . . . 0.0 114.213 -175.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.97 -31.97 72.37 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.504 1.122 . . . . 0.0 112.539 174.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.6 t -101.39 -37.78 8.31 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.644 1.578 . . . . 0.0 111.69 175.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.442 HD23 ' HB3' ' A' ' 69' ' ' ALA . 13.0 tp -78.45 87.99 4.44 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.214 1.005 . . . . 0.0 110.802 175.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.2 p -121.46 178.96 4.6 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 127.188 2.195 . . . . 0.0 111.913 176.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -40.96 -42.01 1.77 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.834 1.654 . . . . 0.0 113.927 175.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -53.73 -46.46 70.85 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 119.159 0.89 . . . . 0.0 111.744 178.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 93.9 t -64.42 -39.57 86.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 125.383 1.473 . . . . 0.0 111.138 174.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 24.2 mt -66.11 -41.86 90.01 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 121.189 -0.944 . . . . 0.0 111.303 178.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -64.74 -46.26 82.96 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.979 1.311 . . . . 0.0 111.57 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.5 -37.25 84.66 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 118.798 -0.62 . . . . 0.0 111.441 174.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.8 t -54.74 -45.75 73.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 124.504 1.122 . . . . 0.0 111.196 -179.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.562 HD11 ' HB3' ' A' ' 169' ' ' LYS . 1.4 mt -59.19 -22.48 61.07 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 119.125 0.875 . . . . 0.0 113.356 178.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -89.37 -59.34 1.56 Allowed Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.574 1.559 . . . . 0.0 112.552 178.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -66.13 -30.37 70.84 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.3 mt -111.83 109.61 19.52 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.737 1.615 . . . . 0.0 110.001 -174.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -148.72 139.9 7.89 Favored Glycine 0 CA--C 1.54 1.643 0 C-N-CA 124.563 1.078 . . . . 0.0 114.781 -174.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.3 mtpt -109.22 -67.12 1.0 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 126.243 1.817 . . . . 0.0 112.136 178.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 15.3 m -118.2 -172.12 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 126.127 1.771 . . . . 0.0 110.891 -177.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.2 m -46.9 -38.38 10.38 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 125.359 1.464 . . . . 0.0 114.251 179.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 -127.63 162.0 27.54 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.742 1.617 . . . . 0.0 109.844 174.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.46 ' HB2' HD13 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -155.16 155.87 34.71 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 125.937 1.695 . . . . 0.0 108.98 -176.121 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -120.65 129.41 75.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 124.633 1.173 . . . . 0.0 107.838 174.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -133.26 121.89 23.12 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.237 1.415 . . . . 0.0 109.564 175.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.718 HG22 ' HB2' ' A' ' 72' ' ' TYR . 1.0 OUTLIER -128.49 144.48 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.111 0.964 . . . . 0.0 110.685 -176.721 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -124.79 110.22 1.35 Allowed Glycine 0 CA--C 1.519 0.323 0 C-N-CA 123.716 0.674 . . . . 0.0 112.44 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.46 ' HB ' HD11 ' A' ' 70' ' ' LEU . 3.5 mp -100.3 129.43 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 117.767 0.784 . . . . 0.0 110.687 175.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.73 106.3 18.27 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.639 1.576 . . . . 0.0 110.38 175.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.79 96.25 3.04 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.304 1.442 . . . . 0.0 109.585 176.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -129.73 6.63 5.15 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.836 1.254 . . . . 0.0 113.484 176.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.5 t -58.44 -18.4 28.24 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.62 1.568 . . . . 0.0 113.921 175.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 94.94 5.96 60.71 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 125.747 1.641 . . . . 0.0 114.573 176.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -128.8 147.41 17.59 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 125.813 1.673 . . . . 0.0 111.509 175.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.8 HG22 ' HA ' ' A' ' 65' ' ' PRO . 32.4 p -74.24 129.39 37.73 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 174.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 38.9 m0 -93.38 132.03 37.99 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 122.084 -0.385 . . . . 0.0 110.892 178.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 97.6 m -114.64 128.61 56.41 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.439 1.096 . . . . 0.0 110.073 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.65 106.99 0.74 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.266 1.026 . . . . 0.0 111.877 175.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.2 pp -98.91 -40.12 8.24 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.121 0.568 . . . . 0.0 112.516 179.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -170.58 163.35 8.24 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.875 2.07 . . . . 0.0 111.639 176.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -156.54 154.38 30.2 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.195 0.998 . . . . 0.0 111.355 174.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -132.46 107.24 8.36 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.422 1.489 . . . . 0.0 111.744 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.547 ' CD1' ' HB1' ' A' ' 87' ' ' ALA . 2.1 m-85 -98.82 110.85 23.39 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.844 0.858 . . . . 0.0 110.476 175.056 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.3 tpp180 -74.19 -73.33 0.23 Allowed 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.935 1.294 . . . . 0.0 109.291 175.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 9.3 t -106.37 -178.34 3.62 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 126.607 1.963 . . . . 0.0 109.081 176.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 48.65 35.4 16.45 Favored Glycine 0 CA--C 1.54 1.648 0 CA-C-O 119.581 -0.566 . . . . 0.0 112.314 -174.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.7 p -48.7 141.45 7.22 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.596 1.958 . . . . 0.0 112.199 -174.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.405 HG21 HG23 ' A' ' 59' ' ' ILE . 3.2 t -136.95 173.41 11.73 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 121.346 -0.846 . . . . 0.0 113.135 -175.191 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -80.47 -58.1 3.28 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.648 1.179 . . . . 0.0 111.337 176.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.2 p -142.75 133.07 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.418 1.487 . . . . 0.0 111.615 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.405 HG23 HG21 ' A' ' 56' ' ' THR . 1.1 pp -138.13 -24.33 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 126.372 1.869 . . . . 0.0 113.863 178.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.4 mp -97.65 98.96 5.76 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 124.797 1.239 . . . . 0.0 110.233 179.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -67.33 159.94 49.97 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 124.714 3.61 . . . . 0.0 111.031 174.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -57.93 -48.25 80.49 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -178.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 87.7 t -149.16 143.7 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 127.196 2.198 . . . . 0.0 108.809 -176.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.486 HG21 HD23 ' A' ' 70' ' ' LEU . 11.2 t -125.78 102.12 29.07 Favored Pre-proline 0 C--N 1.33 -0.259 0 C-N-CA 125.69 1.596 . . . . 0.0 107.451 175.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.8 ' HA ' HG22 ' A' ' 43' ' ' THR . 64.8 Cg_endo -72.12 161.39 44.8 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 121.234 1.289 . . . . 0.0 112.492 175.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -69.37 172.27 7.38 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.05 0.54 . . . . 0.0 110.259 174.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 58.8 p 57.03 20.64 5.59 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 125.494 1.518 . . . . 0.0 111.954 -174.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.79 173.35 11.46 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 125.359 1.464 . . . . 0.0 111.06 -174.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.442 ' HB3' HD23 ' A' ' 13' ' ' LEU . . . -142.8 156.52 44.98 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 175.028 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.486 HD23 HG21 ' A' ' 64' ' ' VAL . 1.0 OUTLIER -121.04 175.67 5.96 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 123.882 0.873 . . . . 0.0 111.073 -179.529 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.498 HD13 ' O ' ' A' ' 34' ' ' VAL . 0.8 OUTLIER -132.62 149.53 52.29 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.699 1.2 . . . . 0.0 110.965 175.052 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.718 ' HB2' HG22 ' A' ' 34' ' ' VAL . 3.7 m-85 -123.3 147.06 47.37 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.713 1.205 . . . . 0.0 109.286 174.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.2 p -121.3 147.84 45.12 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 127.047 2.139 . . . . 0.0 110.138 174.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.814 ' H ' HD12 ' A' ' 3' ' ' LEU . . . -165.2 130.72 2.22 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 124.351 0.977 . . . . 0.0 112.695 174.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 7.5 ptt180 -123.09 149.31 44.62 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.943 1.697 . . . . 0.0 110.687 -175.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 11.8 mtpt -62.86 149.17 45.04 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 121.212 -0.93 . . . . 0.0 111.862 -176.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.5 t -104.17 -165.8 1.18 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.525 1.53 . . . . 0.0 112.272 -177.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 58.2 m 50.74 39.67 22.52 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 126.183 1.793 . . . . 0.0 114.359 174.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 45.14 -94.38 0.01 OUTLIER Glycine 0 CA--C 1.541 1.68 0 C-N-CA 128.24 2.829 . . . . 0.0 114.089 178.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -65.56 -83.02 0.01 OUTLIER 'Trans proline' 0 CA--C 1.55 1.296 0 C-N-CA 124.264 3.309 . . . . 0.0 113.604 175.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 15.5 m -70.67 135.47 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 126.271 1.828 . . . . 0.0 112.316 -178.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -156.69 179.95 8.78 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -178.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 53.0 m -113.2 148.5 35.32 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.633 1.973 . . . . 0.0 109.015 175.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -43.67 -77.05 0.1 OUTLIER Glycine 0 N--CA 1.476 1.339 0 C-N-CA 126.962 2.22 . . . . 0.0 115.416 -175.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -169.1 123.59 0.84 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.534 1.934 . . . . 0.0 109.865 178.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.5 t -151.41 114.3 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.845 0.858 . . . . 0.0 110.716 -175.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.547 ' HB1' ' CD1' ' A' ' 51' ' ' PHE . . . -159.23 157.75 31.29 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -141.93 132.66 25.6 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.478 1.111 . . . . 0.0 112.173 178.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -136.01 171.62 14.21 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.189 -0.944 . . . . 0.0 111.688 -178.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -137.67 155.92 48.59 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.26 -0.9 . . . . 0.0 112.906 174.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -133.17 118.33 18.53 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 126.025 1.73 . . . . 0.0 114.409 -175.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -77.13 122.78 25.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.666 -0.243 . . . . 0.0 110.972 -178.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 13.3 mtm -101.67 134.47 44.76 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.514 1.526 . . . . 0.0 111.304 177.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 98.5 p -61.68 -17.26 54.83 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 178.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -69.05 -0.32 5.61 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 125.965 1.706 . . . . 0.0 113.037 174.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 91.1 24.9 25.82 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.456 1.503 . . . . 0.0 113.276 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -132.58 174.82 9.88 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.906 1.283 . . . . 0.0 111.702 -175.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 71.1 m -136.57 113.92 10.82 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.355 1.062 . . . . 0.0 111.504 174.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 65.1 tp -76.03 104.48 6.58 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.512 1.125 . . . . 0.0 110.506 175.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -93.63 117.94 5.58 Favored Glycine 0 CA--C 1.529 0.947 0 O-C-N 121.239 -0.913 . . . . 0.0 112.973 175.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 93.3 t -104.83 147.5 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 125.525 1.53 . . . . 0.0 111.067 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 1.5 tpt -151.55 126.1 9.5 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.546 1.138 . . . . 0.0 111.03 -178.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.479 ' CZ ' ' HB3' ' A' ' 87' ' ' ALA . 44.7 p90 -133.81 139.95 46.61 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.456 1.503 . . . . 0.0 114.159 177.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -136.3 138.96 42.26 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.245 1.818 . . . . 0.0 111.294 -177.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 96.3 t -118.92 124.35 28.38 Favored Pre-proline 0 N--CA 1.469 0.494 0 C-N-CA 125.098 1.359 . . . . 0.0 110.776 -178.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -66.84 114.55 3.19 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.891 3.061 . . . . 0.0 111.684 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -134.9 -57.61 0.82 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.01 0.924 . . . . 0.0 112.08 179.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -96.29 -22.15 17.39 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.789 1.236 . . . . 0.0 113.758 176.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 8.7 m-30 -40.72 99.2 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 127.508 2.323 . . . . 0.0 113.527 -174.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -62.5 -12.44 22.23 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.582 1.153 . . . . 0.0 113.588 -176.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -115.37 4.11 14.3 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 128.79 2.836 . . . . 0.0 112.975 -178.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 47.13 45.66 16.11 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 126.186 1.794 . . . . 0.0 113.587 -177.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 51.6 m -113.71 80.66 1.4 Allowed 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.225 1.41 . . . . 0.0 112.263 -174.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -88.2 113.82 24.2 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 124.44 1.096 . . . . 0.0 110.974 174.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 31.5 m0 -118.52 135.58 54.32 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.112 0.965 . . . . 0.0 109.673 -176.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' TRP . . . . . 0.413 ' HE1' ' CA ' ' A' ' 143' ' ' GLY . 30.5 p-90 -142.19 134.47 27.74 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.49 1.116 . . . . 0.0 111.873 -175.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -160.3 164.46 32.56 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 122.526 1.155 . . . . 0.0 112.989 -176.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.2 t -138.64 124.7 24.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 125.142 1.377 . . . . 0.0 107.747 -179.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.66 166.0 13.29 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.208 1.403 . . . . 0.0 110.198 175.053 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.416 ' CD1' HD13 ' A' ' 152' ' ' LEU . 41.7 mt -122.97 147.76 27.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 174.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -110.2 143.37 27.89 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 124.87 1.268 . . . . 0.0 110.071 177.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -77.21 12.5 1.78 Allowed 'Trans proline' 0 CA--C 1.548 1.219 0 C-N-CA 124.594 3.529 . . . . 0.0 114.407 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -161.12 -179.86 36.12 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 126.475 1.988 . . . . 0.0 111.44 176.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.93 101.83 0.71 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.825 1.25 . . . . 0.0 110.807 177.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 3.8 mmt-85 -124.79 141.8 51.86 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.71 1.204 . . . . 0.0 112.466 -178.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.41 171.99 12.13 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 177.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -128.35 91.63 3.29 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.5 1.92 . . . . 0.0 108.503 176.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -107.37 173.99 6.08 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.793 1.637 . . . . 0.0 109.922 174.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -49.76 -37.0 27.92 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.805 0.842 . . . . 0.0 113.265 176.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -59.14 -65.72 3.27 Favored Glycine 0 CA--C 1.531 1.035 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 174.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -58.08 -36.74 73.27 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 118.176 0.988 . . . . 0.0 113.522 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -56.28 -64.21 0.94 Allowed 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 125.267 1.427 . . . . 0.0 109.718 174.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -67.78 -32.8 73.64 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -176.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -57.87 -47.65 82.12 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.01 0.924 . . . . 0.0 112.265 177.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 5.2 tpp -84.51 -21.86 30.41 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 113.669 0.989 . . . . 0.0 113.669 176.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -49.33 -57.97 5.92 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.741 1.216 . . . . 0.0 109.773 174.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -74.64 5.05 5.24 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -178.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -93.9 -11.9 57.23 Favored Glycine 0 CA--C 1.539 1.59 0 C-N-CA 126.015 1.769 . . . . 0.0 114.765 178.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -145.26 94.71 5.2 Favored Pre-proline 0 CA--C 1.552 1.053 0 CA-C-N 119.523 1.662 . . . . 0.0 112.397 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -74.02 81.84 1.88 Allowed 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 123.587 2.858 . . . . 0.0 112.584 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -116.88 110.2 18.03 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.446 1.499 . . . . 0.0 110.846 -178.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 37.2 mtm105 -96.27 50.94 1.18 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 126.907 2.083 . . . . 0.0 111.336 -178.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.413 ' CA ' ' HE1' ' A' ' 116' ' ' TRP . . . 85.95 -53.06 4.63 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 124.117 0.865 . . . . 0.0 111.185 -174.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 51.38 52.71 14.22 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.235 1.814 . . . . 0.0 111.399 178.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 14.7 p-10 -48.17 92.82 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 128.48 2.712 . . . . 0.0 115.115 -174.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 160.46 40.12 0.02 OUTLIER Glycine 0 CA--C 1.537 1.427 0 C-N-CA 125.232 1.396 . . . . 0.0 114.506 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' TRP . . . . . 0.723 ' H ' HD12 ' A' ' 161' ' ' ILE . 7.5 m95 53.42 48.81 21.03 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.81 1.644 . . . . 0.0 113.363 -176.021 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -82.66 126.3 32.19 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.987 0.915 . . . . 0.0 112.094 -179.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . 0.5 ' HG3' ' H ' ' A' ' 150' ' ' LYS . 10.5 tp60 -161.65 -168.98 2.11 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.345 0.658 . . . . 0.0 112.312 175.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.5 ' H ' ' HG3' ' A' ' 149' ' ' GLN . 0.6 OUTLIER -131.59 160.67 34.64 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.245 1.818 . . . . 0.0 110.781 -179.205 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 18.7 m-80 -75.55 148.98 38.47 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.391 1.076 . . . . 0.0 109.95 174.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.416 HD13 ' CD1' ' A' ' 120' ' ' ILE . 94.3 mt -100.93 136.9 40.04 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.955 0.902 . . . . 0.0 110.621 178.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -53.0 -35.59 49.1 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 125.717 1.627 . . . . 0.0 116.476 -174.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.536 ' HB2' HD12 ' A' ' 156' ' ' LEU . 0.1 OUTLIER -73.46 14.21 0.37 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 128.081 2.552 . . . . 0.0 113.942 -178.326 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 76.36 20.5 76.96 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 124.908 1.242 . . . . 0.0 113.58 -174.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.536 HD12 ' HB2' ' A' ' 154' ' ' TYR . 6.1 mt -101.01 169.01 9.24 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 127.144 2.178 . . . . 0.0 110.519 178.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 50.4 mtt180 -138.76 114.03 9.54 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 120.841 -1.162 . . . . 0.0 110.451 177.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -92.16 150.79 20.72 Favored 'General case' 0 C--N 1.32 -0.711 0 O-C-N 120.138 -1.601 . . . . 0.0 108.433 174.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 2.3 tptt -133.45 142.5 48.33 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.578 1.551 . . . . 0.0 111.097 175.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -147.59 143.43 11.22 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-N 118.885 0.766 . . . . 0.0 113.671 175.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.723 HD12 ' H ' ' A' ' 147' ' ' TRP . 0.5 OUTLIER -130.55 126.16 60.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 126.36 1.864 . . . . 0.0 110.604 177.509 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -149.93 148.49 29.16 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 125.412 1.485 . . . . 0.0 109.297 175.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 13.5 t -139.81 112.84 8.15 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.0 0.52 . . . . 0.0 110.543 178.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 67.7 m -72.51 35.02 0.07 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.566 1.146 . . . . 0.0 113.232 178.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -65.99 -44.23 85.45 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.653 1.981 . . . . 0.0 113.019 -179.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 165.13 -68.72 0.2 Allowed Glycine 0 CA--C 1.531 1.059 0 C-N-CA 124.546 1.069 . . . . 0.0 113.838 178.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -111.88 17.01 20.14 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 125.054 1.341 . . . . 0.0 114.392 -174.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -60.98 175.36 0.52 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.349 1.859 . . . . 0.0 114.289 174.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.562 ' HB3' HD11 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -125.14 174.83 7.8 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 126.986 2.114 . . . . 0.0 112.042 -178.6 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 5.5 ttt -115.21 132.9 56.46 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.172 1.389 . . . . 0.0 110.685 175.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -144.79 120.88 10.76 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 123.351 0.66 . . . . 0.0 110.293 177.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 2.7 mp -119.67 126.03 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 C-N-CA 125.125 1.37 . . . . 0.0 107.471 177.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -127.43 126.52 42.53 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 120.879 -1.138 . . . . 0.0 108.794 176.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.8 mp -78.1 124.9 37.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 175.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 2.1 m -95.83 168.01 10.91 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.882 1.673 . . . . 0.0 109.984 175.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 49.3 mtp85 . . . . . 0 C--O 1.253 1.254 0 C-N-CA 125.37 1.468 . . . . 0.0 111.856 176.708 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 118.602 -0.713 . . . . 0.0 110.922 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.92 174.14 0.67 Allowed 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 121.09 1.768 . . . . 0.0 111.497 174.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.678 HD12 ' H ' ' A' ' 74' ' ' GLY . 0.7 OUTLIER -106.16 16.37 25.03 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 125.539 1.536 . . . . 0.0 112.687 -179.8 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.475 ' HB1' ' HB3' ' A' ' 71' ' ' LEU . . . -119.42 125.25 48.52 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.669 1.988 . . . . 0.0 111.056 178.026 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -77.37 -147.74 2.87 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 125.036 1.303 . . . . 0.0 112.443 175.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 18.3 p -68.06 169.08 10.74 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.076 1.35 . . . . 0.0 112.867 176.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -128.89 21.0 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 126.131 1.772 . . . . 0.0 111.257 176.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.2 pt -57.07 171.92 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 O-C-N 120.276 -1.515 . . . . 0.0 112.798 176.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -44.12 131.63 5.89 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.734 1.614 . . . . 0.0 112.292 -177.102 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -54.79 -20.94 20.86 Favored Glycine 0 CA--C 1.54 1.651 0 C-N-CA 124.367 0.984 . . . . 0.0 114.303 -177.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.73 -36.25 78.39 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.732 1.613 . . . . 0.0 112.031 175.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.44 -40.2 8.39 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.302 1.441 . . . . 0.0 111.528 175.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.405 HD23 ' HB3' ' A' ' 69' ' ' ALA . 9.4 tp -71.78 87.32 0.97 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.663 1.185 . . . . 0.0 111.205 175.042 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 80.6 p -123.33 -177.9 3.84 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.741 2.016 . . . . 0.0 111.401 -176.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -45.49 -37.9 5.74 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.426 1.49 . . . . 0.0 113.985 176.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -59.66 -40.94 89.4 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.676 0.791 . . . . 0.0 111.958 178.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 85.6 t -70.66 -37.72 70.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 123.754 0.822 . . . . 0.0 111.055 174.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 32.2 mt -65.54 -41.17 93.34 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 120.971 -1.081 . . . . 0.0 111.32 177.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -75.06 -42.92 56.02 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.85 0.86 . . . . 0.0 112.815 -179.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.88 -37.86 88.57 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 118.764 0.711 . . . . 0.0 111.543 175.1 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.508 HG13 HD12 ' A' ' 25' ' ' LEU . 20.2 t -56.35 -46.85 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 124.922 1.289 . . . . 0.0 111.738 176.011 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 78.1 mt -56.27 -25.32 47.68 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 119.213 0.915 . . . . 0.0 112.887 175.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -86.3 -57.81 2.06 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 124.899 1.237 . . . . 0.0 113.202 176.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -66.47 -27.54 67.88 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -177.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.508 HD12 HG13 ' A' ' 21' ' ' VAL . 19.3 mt -108.18 88.05 2.64 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.33 1.452 . . . . 0.0 110.838 -175.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -125.34 85.24 0.35 Allowed Glycine 0 CA--C 1.533 1.193 0 C-N-CA 125.129 1.347 . . . . 0.0 115.302 -175.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -75.41 -43.01 52.26 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.096 0.959 . . . . 0.0 113.467 175.052 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.8 m -137.12 -177.12 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 126.351 1.86 . . . . 0.0 112.078 -174.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -46.65 -45.54 19.29 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 126.448 1.899 . . . . 0.0 114.289 179.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 17.4 mtt85 -139.02 149.12 44.29 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.768 1.627 . . . . 0.0 111.548 178.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.671 ' HB2' HD13 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -139.12 157.44 45.94 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 127.234 2.214 . . . . 0.0 110.632 -175.015 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.717 HG13 ' HB1' ' A' ' 85' ' ' ALA . 0.3 OUTLIER -118.2 128.33 75.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 125.14 1.376 . . . . 0.0 107.597 174.974 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -135.9 104.12 5.61 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.727 2.011 . . . . 0.0 109.335 176.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.728 HG22 ' HB2' ' A' ' 72' ' ' TYR . 2.1 m -107.46 158.64 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 123.753 0.821 . . . . 0.0 111.123 178.005 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -135.68 109.45 0.75 Allowed Glycine 0 N--CA 1.462 0.384 0 CA-C-N 118.293 0.497 . . . . 0.0 113.298 175.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.464 ' HB ' HD11 ' A' ' 70' ' ' LEU . 2.8 mp -101.73 132.35 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-N 117.108 0.454 . . . . 0.0 111.185 176.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -93.11 105.87 17.9 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.555 1.542 . . . . 0.0 110.972 177.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -71.62 100.69 2.34 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.223 1.809 . . . . 0.0 110.481 175.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -140.09 11.64 2.4 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.988 0.915 . . . . 0.0 112.522 175.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 12.7 t -57.89 -31.9 67.19 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.895 1.678 . . . . 0.0 114.027 179.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 124.82 53.93 0.18 Allowed Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.75 1.167 . . . . 0.0 115.148 174.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 152.5 171.4 20.0 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 125.442 1.496 . . . . 0.0 112.263 175.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.565 HG22 ' HA ' ' A' ' 65' ' ' PRO . 75.6 p -63.6 145.72 55.14 Favored 'General case' 0 N--CA 1.471 0.625 0 O-C-N 121.601 -0.941 . . . . 0.0 111.212 176.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.539 ' HA ' ' CE1' ' A' ' 91' ' ' TYR . 38.0 m0 -93.57 98.35 11.1 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 121.619 -0.676 . . . . 0.0 111.334 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.3 m -83.63 108.52 16.78 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.469 1.107 . . . . 0.0 108.776 176.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.9 142.85 52.85 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.842 -0.536 . . . . 0.0 112.405 175.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.2 pp -119.14 -52.37 2.3 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.048 0.939 . . . . 0.0 112.876 176.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -163.7 153.98 15.42 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.557 1.543 . . . . 0.0 110.72 174.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -131.6 152.37 50.86 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.83 0.852 . . . . 0.0 110.365 175.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -128.05 95.81 4.29 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.687 1.595 . . . . 0.0 110.007 -178.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.532 ' CZ ' HG21 ' A' ' 59' ' ' ILE . 1.5 m-85 -94.54 111.04 22.8 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.852 0.861 . . . . 0.0 110.34 176.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.54 -38.03 12.15 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.048 0.939 . . . . 0.0 111.949 -178.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.2 t -126.63 -173.82 2.97 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 128.415 2.686 . . . . 0.0 107.45 175.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 44.42 49.37 8.42 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-O 118.428 -1.207 . . . . 0.0 111.189 -179.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.9 p -44.8 145.21 0.97 Allowed 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 118.35 1.075 . . . . 0.0 112.8 -175.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.518 ' CG2' HD12 ' A' ' 59' ' ' ILE . 2.6 t -155.33 179.04 9.55 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.249 -0.907 . . . . 0.0 113.047 -175.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -98.71 -62.76 1.2 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.479 1.511 . . . . 0.0 112.208 178.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.0 p -129.4 131.54 67.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 125.232 1.413 . . . . 0.0 110.921 -177.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.532 HG21 ' CZ ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -137.22 -49.17 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 C-N-CA 125.071 1.348 . . . . 0.0 112.593 -175.117 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.404 ' HA ' ' HD2' ' A' ' 61' ' ' PRO . 4.3 mt -85.49 104.09 4.52 Favored Pre-proline 0 N--CA 1.449 -0.478 0 C-N-CA 124.313 1.045 . . . . 0.0 109.948 175.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 60' ' ' LEU . 56.6 Cg_endo -66.08 128.57 19.89 Favored 'Trans proline' 0 CA--C 1.535 0.547 0 C-N-CA 122.789 2.326 . . . . 0.0 110.366 175.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -35.29 -47.86 0.43 Allowed 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 127.474 2.31 . . . . 0.0 113.79 176.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 5.9 p -154.09 134.57 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 126.576 1.95 . . . . 0.0 109.424 174.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 95.5 t -122.17 133.58 24.41 Favored Pre-proline 0 N--CA 1.482 1.16 0 C-N-CA 124.986 1.314 . . . . 0.0 109.865 175.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.565 ' HA ' HG22 ' A' ' 43' ' ' THR . 58.0 Cg_endo -62.41 148.85 92.62 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.871 2.381 . . . . 0.0 113.209 175.043 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 13.1 p30 -67.83 170.19 8.46 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.206 1.002 . . . . 0.0 113.071 175.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 74.4 p 48.1 28.62 1.55 Allowed 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 127.109 2.164 . . . . 0.0 114.235 -175.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.51 -179.84 4.8 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 127.442 2.297 . . . . 0.0 110.817 -174.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.405 ' HB3' HD23 ' A' ' 13' ' ' LEU . . . -136.37 152.79 51.02 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 120.77 -1.206 . . . . 0.0 109.86 175.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.464 HD11 ' HB ' ' A' ' 36' ' ' ILE . 0.8 OUTLIER -117.88 172.51 7.34 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 124.642 1.177 . . . . 0.0 111.279 -178.407 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.537 HD13 ' O ' ' A' ' 34' ' ' VAL . 0.5 OUTLIER -129.05 151.85 49.3 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.133 1.373 . . . . 0.0 111.191 175.14 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.728 ' HB2' HG22 ' A' ' 34' ' ' VAL . 5.2 m-85 -127.2 133.54 50.25 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.395 1.078 . . . . 0.0 110.214 174.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.3 p -102.41 154.88 18.65 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 126.491 1.917 . . . . 0.0 111.36 175.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.678 ' H ' HD12 ' A' ' 3' ' ' LEU . . . -176.37 126.91 1.17 Allowed Glycine 0 CA--C 1.529 0.917 0 N-CA-C 114.269 0.468 . . . . 0.0 114.269 175.189 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 9.3 ptt180 -116.26 105.03 12.1 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.513 1.925 . . . . 0.0 112.751 -175.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.03 -34.33 77.35 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 -179.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 22.8 t -68.47 88.73 0.34 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.683 1.193 . . . . 0.0 111.734 178.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 61.0 m -110.46 -21.0 12.39 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.493 1.517 . . . . 0.0 113.703 175.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 117.44 -66.97 0.33 Allowed Glycine 0 CA--C 1.54 1.643 0 C-N-CA 125.414 1.483 . . . . 0.0 113.78 -175.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -71.67 -41.64 2.15 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 123.321 2.68 . . . . 0.0 113.632 -174.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.9 m -132.78 149.07 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 126.283 1.833 . . . . 0.0 110.241 177.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -154.07 76.36 1.05 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.518 1.527 . . . . 0.0 110.967 -178.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 53.8 m -92.3 141.32 28.68 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 125.545 1.538 . . . . 0.0 110.05 174.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -27.71 -77.61 0.01 OUTLIER Glycine 0 N--CA 1.477 1.381 0 C-N-CA 127.69 2.567 . . . . 0.0 116.177 -178.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.717 ' HB1' HG13 ' A' ' 32' ' ' ILE . . . -165.73 112.55 0.92 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.363 1.865 . . . . 0.0 110.599 -176.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.8 t -149.97 120.68 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 O-C-N 121.211 -0.931 . . . . 0.0 111.631 -177.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.513 ' HB3' ' CE2' ' A' ' 103' ' ' PHE . . . -162.03 173.39 14.47 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 122.67 1.224 . . . . 0.0 113.397 175.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -147.69 157.38 43.52 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.686 1.594 . . . . 0.0 110.755 174.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.449 ' CD2' ' CE2' ' A' ' 72' ' ' TYR . 49.0 p90 -158.05 172.1 19.04 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 124.41 1.084 . . . . 0.0 110.858 175.174 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.76 147.82 31.31 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 175.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.539 ' CE1' ' HA ' ' A' ' 44' ' ' TRP . 0.1 OUTLIER -114.54 126.98 55.55 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 126.309 1.844 . . . . 0.0 109.726 -178.281 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -82.83 108.23 16.02 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 123.518 0.727 . . . . 0.0 111.768 178.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.416 ' HE2' HG21 ' A' ' 120' ' ' ILE . 0.5 OUTLIER -79.91 137.8 36.98 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.441 1.096 . . . . 0.0 111.603 -174.998 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.9 t -59.44 -22.63 61.77 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.791 0.837 . . . . 0.0 113.206 177.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 28.3 m-80 -69.23 -1.79 8.89 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 125.69 1.596 . . . . 0.0 113.529 174.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 89.75 16.33 56.7 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 125.066 1.317 . . . . 0.0 113.894 -179.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 23.6 m-20 -116.47 177.32 4.74 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.878 1.671 . . . . 0.0 111.07 -176.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.2 m -131.66 117.51 18.77 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 121.473 -0.767 . . . . 0.0 112.007 175.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 13.5 tp -80.09 97.53 6.88 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 175.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -91.21 135.76 12.98 Favored Glycine 0 CA--C 1.532 1.126 0 O-C-N 121.347 -0.845 . . . . 0.0 112.067 176.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 74.3 t -122.46 133.87 67.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 126.951 2.1 . . . . 0.0 111.61 -174.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -137.78 128.36 26.68 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 126.009 1.724 . . . . 0.0 111.01 -176.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.513 ' CE2' ' HB3' ' A' ' 87' ' ' ALA . 3.6 p90 -145.77 121.83 10.75 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.873 1.269 . . . . 0.0 112.312 -175.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 19.3 m -139.07 110.8 7.14 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.878 1.271 . . . . 0.0 112.064 -175.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.7 m -84.21 151.23 59.51 Favored Pre-proline 0 N--CA 1.479 1.021 0 N-CA-C 112.654 0.612 . . . . 0.0 112.654 -179.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.405 ' HA ' ' CE2' ' A' ' 109' ' ' TYR . 67.6 Cg_endo -73.29 109.26 2.8 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 123.628 2.885 . . . . 0.0 112.154 177.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -131.6 -47.65 0.97 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.177 0.991 . . . . 0.0 113.264 177.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -107.56 -8.54 16.15 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 177.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.405 ' CE2' ' HA ' ' A' ' 106' ' ' PRO . 6.5 m-30 -59.64 106.71 0.5 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.853 1.261 . . . . 0.0 111.969 -175.1 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 99.8 m-20 -62.16 -4.49 1.74 Allowed 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 124.923 1.289 . . . . 0.0 114.03 176.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 18.9 m95 -123.46 3.84 9.04 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 127.546 2.338 . . . . 0.0 113.711 -177.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 49.92 40.74 21.59 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 125.839 1.656 . . . . 0.0 114.19 -176.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 2.1 m -106.91 83.95 1.91 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.491 1.516 . . . . 0.0 113.157 -175.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -79.89 107.41 12.65 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.18 0.992 . . . . 0.0 110.272 174.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 31.2 m0 -112.03 141.82 45.23 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 55.6 p-90 -146.82 130.73 17.15 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 123.864 0.865 . . . . 0.0 112.007 -174.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -132.49 144.46 50.46 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 122.81 1.291 . . . . 0.0 112.192 179.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.419 ' HB ' ' CE ' ' A' ' 158' ' ' MET . 79.6 t -151.17 131.5 3.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 175.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.86 165.99 13.68 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 125.161 1.384 . . . . 0.0 110.505 175.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.416 HG21 ' HE2' ' A' ' 93' ' ' MET . 14.3 mt -86.24 148.51 4.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 175.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -110.38 142.63 26.43 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 126.771 2.028 . . . . 0.0 109.519 -178.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -74.77 87.24 1.31 Allowed 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 124.319 3.346 . . . . 0.0 111.547 -177.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.53 -174.97 19.96 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 125.112 1.339 . . . . 0.0 113.201 -174.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 2.3 tttt -69.73 105.81 2.87 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.234 1.414 . . . . 0.0 110.714 177.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 17.4 tpp180 -135.45 101.18 4.73 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.241 1.417 . . . . 0.0 111.451 178.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.8 168.58 1.2 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.711 0.804 . . . . 0.0 112.954 175.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -111.06 101.73 10.25 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.784 1.234 . . . . 0.0 107.882 177.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -113.23 171.17 7.71 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.794 1.238 . . . . 0.0 109.848 174.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -50.24 -36.61 31.81 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.006 -1.059 . . . . 0.0 112.775 175.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -60.02 -61.6 6.98 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 124.087 0.851 . . . . 0.0 111.634 174.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.48 -34.63 74.32 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 118.43 1.115 . . . . 0.0 112.324 178.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -58.4 -66.2 0.53 Allowed 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.866 0.866 . . . . 0.0 109.277 174.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -67.67 -30.89 70.54 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -175.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -63.88 -54.4 35.44 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.976 1.31 . . . . 0.0 112.142 175.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 51.8 mmm -75.13 -24.14 57.95 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.159 -0.963 . . . . 0.0 113.266 178.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -55.68 -56.58 18.78 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.383 1.473 . . . . 0.0 108.903 174.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -66.91 -23.11 65.95 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -75.3 -19.09 79.81 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 125.868 1.699 . . . . 0.0 115.212 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -132.56 83.64 53.36 Favored Pre-proline 0 CA--C 1.549 0.942 0 CA-C-N 119.024 1.412 . . . . 0.0 111.102 175.03 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -72.97 72.63 3.23 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 124.239 3.293 . . . . 0.0 112.1 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -96.64 112.01 23.93 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 121.372 -0.83 . . . . 0.0 110.551 -175.031 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 10.0 mtm180 -113.41 -3.45 13.75 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 115.467 1.655 . . . . 0.0 115.467 176.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -50.43 152.15 4.55 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 125.159 1.361 . . . . 0.0 114.427 177.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 10.4 p30 -119.35 -155.75 0.63 Allowed 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 -175.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -49.52 114.28 1.01 Allowed 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.79 1.636 . . . . 0.0 113.027 -178.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 152.8 24.79 0.05 OUTLIER Glycine 0 CA--C 1.535 1.342 0 N-CA-C 115.425 0.93 . . . . 0.0 115.425 -175.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 3.4 m95 49.6 47.57 22.56 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.545 1.538 . . . . 0.0 113.393 -175.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -66.9 109.57 2.98 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 126.999 2.12 . . . . 0.0 112.787 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -158.65 -169.01 2.58 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 175.006 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.4 mtmt -134.86 172.32 13.15 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 127.564 2.346 . . . . 0.0 110.277 -179.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -71.1 160.62 32.55 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.042 0.537 . . . . 0.0 109.898 174.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 10.3 mt -118.7 155.48 30.98 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 122.385 1.088 . . . . 0.0 110.659 175.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -62.46 -175.45 2.48 Favored Glycine 0 CA--C 1.537 1.415 0 CA-C-N 114.92 -1.036 . . . . 0.0 111.17 175.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 55.82 12.05 0.8 Allowed 'General case' 0 N--CA 1.482 1.141 0 O-C-N 121.055 -1.262 . . . . 0.0 114.127 178.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 79.41 24.33 61.16 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 125.576 1.56 . . . . 0.0 114.079 -174.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 52.7 mt -103.94 176.66 5.08 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 118.699 1.249 . . . . 0.0 111.534 -175.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -145.85 131.6 18.99 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 120.862 -1.149 . . . . 0.0 110.598 177.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . 0.419 ' CE ' ' HB ' ' A' ' 118' ' ' VAL . 2.9 ttt -106.32 150.94 25.47 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 119.892 -1.755 . . . . 0.0 107.154 175.06 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 1.9 tppt? -126.54 136.96 53.25 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 126.236 1.814 . . . . 0.0 108.834 175.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -147.95 157.79 27.47 Favored Glycine 0 N--CA 1.463 0.477 0 O-C-N 121.152 -0.968 . . . . 0.0 112.733 -178.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -158.21 128.34 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 122.137 0.97 . . . . 0.0 110.334 -179.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -155.23 117.68 4.23 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.708 1.603 . . . . 0.0 110.088 174.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 8.6 t -103.4 151.57 22.62 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 175.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 8.4 t -105.87 36.73 2.45 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.623 1.169 . . . . 0.0 111.384 -177.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -72.29 23.73 0.05 Allowed 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 127.795 2.438 . . . . 0.0 114.565 -178.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 80.83 -61.65 4.5 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 126.239 1.875 . . . . 0.0 113.015 -177.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -114.58 84.03 1.99 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 126.152 1.781 . . . . 0.0 109.992 177.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -136.7 163.93 29.43 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.318 1.847 . . . . 0.0 111.872 177.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.62 177.72 4.54 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 127.772 2.429 . . . . 0.0 111.523 -177.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . 0.475 ' SD ' HD13 ' A' ' 172' ' ' ILE . 1.5 tmt? -121.97 131.07 53.82 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.864 1.266 . . . . 0.0 111.218 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.499 ' C ' HD12 ' A' ' 172' ' ' ILE . 5.7 tt0 -143.26 124.01 14.18 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.43 0.692 . . . . 0.0 111.739 179.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.499 HD12 ' C ' ' A' ' 171' ' ' GLN . 1.9 mp -128.78 130.95 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 125.805 1.642 . . . . 0.0 108.57 178.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 1.9 tmmm? -130.67 129.16 42.27 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 126.069 1.748 . . . . 0.0 108.993 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.7 mp -83.89 133.4 29.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 174.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 87.4 p -116.79 161.75 18.77 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.932 1.693 . . . . 0.0 112.45 176.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 19.0 mtp180 . . . . . 0 C--O 1.253 1.269 0 O-C-N 120.315 -1.49 . . . . 0.0 111.825 -175.307 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 57.3 p . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 118.076 -0.964 . . . . 0.0 109.564 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.401 ' O ' HD23 ' A' ' 3' ' ' LEU . 14.7 pt-20 -63.86 -172.17 0.06 Allowed 'General case' 0 N--CA 1.485 1.287 0 CA-C-N 120.606 1.548 . . . . 0.0 113.241 175.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.61 HD12 ' H ' ' A' ' 74' ' ' GLY . 1.9 mt -121.06 -9.08 9.25 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.588 1.155 . . . . 0.0 112.921 178.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.537 ' HA ' HD12 ' A' ' 71' ' ' LEU . . . -99.42 114.02 26.7 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 127.404 2.282 . . . . 0.0 109.14 178.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -63.3 -89.12 0.03 OUTLIER Glycine 0 CA--C 1.535 1.295 0 C-N-CA 124.243 0.925 . . . . 0.0 113.934 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 17.2 p -143.85 174.47 10.8 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.86 1.664 . . . . 0.0 111.452 -175.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -124.95 15.2 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 125.38 1.472 . . . . 0.0 112.011 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.5 pt -50.11 156.73 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 124.481 1.112 . . . . 0.0 110.976 174.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -40.06 140.27 0.59 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.896 1.678 . . . . 0.0 112.695 -176.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -53.42 -24.2 22.35 Favored Glycine 0 CA--C 1.543 1.798 0 C-N-CA 124.028 0.823 . . . . 0.0 113.982 -174.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.24 -32.69 72.49 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.662 1.585 . . . . 0.0 112.618 175.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -93.41 -50.93 5.21 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 125.886 1.674 . . . . 0.0 110.911 175.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.2 tp -71.05 91.2 0.88 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.537 1.135 . . . . 0.0 111.086 177.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 62.5 p -126.68 -178.54 4.41 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.376 1.87 . . . . 0.0 111.6 -178.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -53.97 -37.65 64.17 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.512 1.125 . . . . 0.0 113.077 178.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -58.91 -46.76 87.16 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.372 0.669 . . . . 0.0 110.961 175.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 81.6 t -61.63 -43.66 97.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.669 1.188 . . . . 0.0 111.339 175.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 96.7 mt -64.6 -43.45 93.74 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 121.267 -0.895 . . . . 0.0 111.987 178.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -69.36 -42.37 75.32 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.275 0.63 . . . . 0.0 112.243 -179.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.01 -36.35 83.04 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 118.791 0.723 . . . . 0.0 111.716 175.008 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.2 t -56.17 -41.43 69.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 124.013 0.925 . . . . 0.0 110.923 179.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.417 HD22 ' HE3' ' A' ' 31' ' ' LYS . 41.0 mt -55.18 -20.23 9.94 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 175.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -92.71 -59.68 1.25 Allowed Glycine 0 CA--C 1.534 1.245 0 C-N-CA 125.246 1.403 . . . . 0.0 112.722 175.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -68.45 -29.41 68.06 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 -176.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -109.05 118.14 36.01 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 126.605 1.962 . . . . 0.0 109.365 -179.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -160.87 117.5 0.77 Allowed Glycine 0 CA--C 1.542 1.762 0 C-N-CA 125.701 1.619 . . . . 0.0 114.732 -175.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.543 ' HB2' HD21 ' A' ' 3' ' ' LEU . 9.1 mttm -87.54 -57.92 2.77 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 126.882 2.073 . . . . 0.0 112.988 176.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.3 m -132.36 -172.36 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 127.143 2.177 . . . . 0.0 112.066 -174.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.2 t -50.48 -37.15 37.11 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.778 1.631 . . . . 0.0 114.081 -175.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.5 tpt180 -130.28 144.93 51.66 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.129 1.372 . . . . 0.0 109.581 174.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.456 ' CB ' HD22 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -144.82 133.94 22.77 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 125.707 1.603 . . . . 0.0 110.357 -175.067 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -103.84 131.31 52.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 124.054 0.942 . . . . 0.0 108.882 175.028 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -130.11 105.61 8.06 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.501 1.92 . . . . 0.0 109.901 175.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.681 HG22 ' HB2' ' A' ' 72' ' ' TYR . 1.2 m -108.19 162.89 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 C-N-CA 123.979 0.912 . . . . 0.0 110.747 176.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -135.02 109.15 0.75 Allowed Glycine 0 C--O 1.228 -0.251 0 C-N-CA 123.275 0.465 . . . . 0.0 112.603 175.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.3 mp -92.35 133.86 32.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 174.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -109.31 99.63 8.86 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.436 1.894 . . . . 0.0 110.342 178.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -73.43 112.13 9.21 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.98 1.712 . . . . 0.0 112.199 175.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -140.06 18.68 2.45 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.785 0.834 . . . . 0.0 112.005 174.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 44.1 t -64.61 -39.06 93.04 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 120.889 -1.132 . . . . 0.0 113.15 -178.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 119.97 63.01 0.26 Allowed Glycine 0 CA--C 1.53 0.99 0 C-N-CA 124.805 1.193 . . . . 0.0 112.715 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 157.15 161.13 10.58 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 125.674 1.606 . . . . 0.0 112.444 176.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.61 HG22 ' HA ' ' A' ' 65' ' ' PRO . 71.5 p -67.82 148.47 51.17 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 121.784 -0.833 . . . . 0.0 111.732 175.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.562 ' HA ' ' CE1' ' A' ' 91' ' ' TYR . 35.3 m0 -103.72 98.25 8.14 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.415 1.086 . . . . 0.0 111.866 -177.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 35.9 m -84.24 116.66 23.07 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 125.07 1.348 . . . . 0.0 109.86 177.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.496 ' HB1' HD23 ' A' ' 60' ' ' LEU . . . -64.02 141.84 58.62 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 121.686 -0.634 . . . . 0.0 111.647 174.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.534 HD12 ' HB3' ' A' ' 48' ' ' ASN . 3.0 pp -114.31 -48.41 2.88 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.153 0.981 . . . . 0.0 112.587 177.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.534 ' HB3' HD12 ' A' ' 47' ' ' LEU . 2.4 t30 -170.19 148.88 3.39 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.964 2.106 . . . . 0.0 109.53 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.48 ' HB2' HD22 ' A' ' 60' ' ' LEU . . . -125.98 147.59 49.49 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.151 1.38 . . . . 0.0 109.803 174.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -124.52 101.61 7.22 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 125.344 1.458 . . . . 0.0 109.629 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.478 ' CD1' ' HB1' ' A' ' 87' ' ' ALA . 3.1 m-85 -105.13 133.53 49.75 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.586 -0.696 . . . . 0.0 110.427 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -107.07 -68.45 0.89 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.334 1.453 . . . . 0.0 111.244 -177.17 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.9 t -102.6 -38.92 7.3 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.671 1.588 . . . . 0.0 110.056 -179.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -69.44 7.7 3.49 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 125.482 1.515 . . . . 0.0 114.338 -178.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 53.4 p -33.2 123.25 0.4 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 128.151 2.581 . . . . 0.0 113.532 -175.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.478 HG21 HG23 ' A' ' 59' ' ' ILE . 1.9 t -138.35 177.96 7.49 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.175 0.99 . . . . 0.0 112.754 -174.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -77.37 -60.81 2.21 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.764 1.226 . . . . 0.0 112.538 177.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.8 p -141.57 138.27 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 126.161 1.784 . . . . 0.0 111.348 176.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.478 HG23 HG21 ' A' ' 56' ' ' THR . 1.1 pp -144.58 -34.2 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 126.114 1.765 . . . . 0.0 113.793 -177.317 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.496 HD23 ' HB1' ' A' ' 46' ' ' ALA . 1.1 mp -95.13 98.19 3.19 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 125.154 1.382 . . . . 0.0 109.681 176.067 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -66.83 151.87 81.54 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.749 2.299 . . . . 0.0 110.332 175.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -50.04 -50.25 48.23 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.686 0.794 . . . . 0.0 112.893 -177.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 60.0 t -150.14 142.15 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 128.296 2.638 . . . . 0.0 108.691 178.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.555 HG21 HD13 ' A' ' 70' ' ' LEU . 98.9 t -120.64 133.97 24.15 Favored Pre-proline 0 N--CA 1.477 0.893 0 C-N-CA 124.742 1.217 . . . . 0.0 109.117 175.017 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.61 ' HA ' HG22 ' A' ' 43' ' ' THR . 55.7 Cg_endo -65.06 154.58 72.73 Favored 'Trans proline' 0 CA--C 1.544 1.014 0 C-N-CA 122.707 2.271 . . . . 0.0 113.565 177.482 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -70.23 160.24 32.54 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.566 1.146 . . . . 0.0 113.273 175.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 40.9 p 52.7 23.78 2.87 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 126.314 1.846 . . . . 0.0 114.405 -175.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 18.6 mttt -119.48 -172.81 2.39 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 126.087 1.755 . . . . 0.0 111.31 -177.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -143.9 157.94 44.02 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 122.068 -0.395 . . . . 0.0 109.997 179.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.555 HD13 HG21 ' A' ' 64' ' ' VAL . 2.4 pt? -134.81 167.21 21.29 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 124.58 1.152 . . . . 0.0 111.689 177.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.541 HD13 ' O ' ' A' ' 34' ' ' VAL . 0.6 OUTLIER -114.0 154.85 26.94 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 125.121 1.369 . . . . 0.0 111.849 -179.118 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.681 ' HB2' HG22 ' A' ' 34' ' ' VAL . 29.0 m-85 -129.19 137.82 51.37 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.356 1.062 . . . . 0.0 110.764 175.079 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 8.7 p -111.93 144.04 41.9 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 126.86 2.064 . . . . 0.0 110.241 174.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.61 ' H ' HD12 ' A' ' 3' ' ' LEU . . . -165.63 133.69 3.05 Favored Glycine 0 CA--C 1.523 0.592 0 CA-C-O 121.388 0.438 . . . . 0.0 113.119 175.004 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 66.3 mtm180 -90.62 172.14 8.89 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.343 1.457 . . . . 0.0 110.617 -175.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.39 140.42 31.07 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.823 -0.548 . . . . 0.0 109.824 174.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.5 m -171.39 152.01 3.2 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.988 1.315 . . . . 0.0 112.337 175.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.428 ' HB2' ' H ' ' A' ' 83' ' ' THR . 0.5 OUTLIER 175.99 118.79 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 127.91 2.484 . . . . 0.0 108.596 175.527 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -38.69 -50.83 2.49 Favored Glycine 0 CA--C 1.545 1.937 0 C-N-CA 126.009 1.766 . . . . 0.0 115.64 174.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.88 -54.74 0.16 Allowed 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.667 2.245 . . . . 0.0 113.077 176.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.4 p -156.41 116.4 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 126.603 1.961 . . . . 0.0 110.02 -177.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -42.49 101.89 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 126.656 1.982 . . . . 0.0 114.803 -179.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.428 ' H ' ' HB2' ' A' ' 78' ' ' SER . 87.7 m -74.29 152.29 39.69 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.814 1.646 . . . . 0.0 110.598 178.52 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -57.34 -76.06 0.22 Allowed Glycine 0 CA--C 1.532 1.141 0 C-N-CA 125.726 1.631 . . . . 0.0 114.644 -174.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -162.24 104.96 1.13 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.377 1.071 . . . . 0.0 111.376 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 41.8 t -127.67 114.58 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 O-C-N 121.086 -1.009 . . . . 0.0 109.891 -177.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.529 ' HB3' ' CE2' ' A' ' 103' ' ' PHE . . . -157.26 169.45 24.72 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 122.693 1.235 . . . . 0.0 112.061 179.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -150.88 161.38 42.8 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.828 1.651 . . . . 0.0 109.563 175.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -159.97 176.47 11.82 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 121.093 -1.004 . . . . 0.0 111.342 175.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.03 156.47 43.5 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.666 0.746 . . . . 0.0 112.556 174.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.562 ' CE1' ' HA ' ' A' ' 44' ' ' TRP . 0.1 OUTLIER -119.94 127.5 52.72 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.697 1.999 . . . . 0.0 109.184 -178.81 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -83.45 105.59 14.51 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.494 0.718 . . . . 0.0 111.911 178.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -75.37 137.59 41.17 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.576 1.151 . . . . 0.0 112.009 -175.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.3 m -59.95 -17.31 36.86 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 113.583 0.956 . . . . 0.0 113.583 175.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -74.32 -2.53 25.56 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 125.142 1.377 . . . . 0.0 112.532 174.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.41 14.89 58.0 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 125.352 1.453 . . . . 0.0 114.168 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -117.25 178.18 4.46 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.504 1.522 . . . . 0.0 110.655 -177.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.416 HG21 ' O ' ' A' ' 125' ' ' ARG . 16.3 m -130.29 114.01 15.1 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 120.998 -1.064 . . . . 0.0 111.839 178.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 32.5 tp -78.99 98.77 6.57 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.391 0.996 . . . . 0.0 109.383 174.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.6 139.33 15.08 Favored Glycine 0 CA--C 1.532 1.154 0 O-C-N 121.075 -1.016 . . . . 0.0 112.294 175.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 60.9 t -122.55 134.21 66.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 128.174 2.589 . . . . 0.0 112.002 -175.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -131.75 125.39 31.85 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 126.163 1.785 . . . . 0.0 111.779 -175.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.529 ' CE2' ' HB3' ' A' ' 87' ' ' ALA . 10.8 p90 -146.03 116.04 7.37 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.362 1.065 . . . . 0.0 113.521 -177.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 72.3 m -123.36 122.26 37.87 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.397 1.479 . . . . 0.0 111.719 -177.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 47.4 t -120.97 93.77 48.88 Favored Pre-proline 0 N--CA 1.469 0.506 0 C-N-CA 126.124 1.77 . . . . 0.0 108.873 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.27 139.6 42.33 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 123.281 2.654 . . . . 0.0 110.975 178.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -75.62 -55.62 5.48 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.047 0.939 . . . . 0.0 111.725 177.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -63.94 -37.53 87.74 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.164 0.985 . . . . 0.0 113.456 -177.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER 49.67 45.34 24.52 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 125.981 1.712 . . . . 0.0 113.278 179.021 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -113.62 -76.41 0.58 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.557 1.143 . . . . 0.0 112.29 -175.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -97.97 13.47 30.68 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 127.643 2.377 . . . . 0.0 113.159 -179.098 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -143.65 103.11 4.03 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.182 1.393 . . . . 0.0 111.216 -177.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 67.8 m -65.6 148.71 51.29 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.055 0.942 . . . . 0.0 112.512 175.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -84.11 106.67 15.93 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.965 1.306 . . . . 0.0 109.081 174.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . 0.414 ' CG ' ' HA ' ' A' ' 140' ' ' PRO . 53.5 m0 -110.73 155.83 21.92 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.398 0.999 . . . . 0.0 108.912 174.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 58.1 p-90 -154.32 132.93 12.12 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.132 0.973 . . . . 0.0 111.214 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -135.94 154.97 50.95 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 122.84 1.305 . . . . 0.0 112.097 178.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 95.1 t -152.6 135.2 6.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 175.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.03 170.68 11.78 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.943 1.697 . . . . 0.0 110.014 175.026 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 20.5 mt -91.29 154.1 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 CA-C-O 121.507 0.67 . . . . 0.0 109.312 179.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -117.77 144.04 33.66 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 125.296 1.438 . . . . 0.0 109.64 178.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -70.96 108.11 2.24 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 123.891 3.06 . . . . 0.0 111.301 -178.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 83.61 -178.55 52.48 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 124.447 1.022 . . . . 0.0 113.711 -175.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 14.2 tttt -63.61 104.58 0.67 Allowed 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.911 1.285 . . . . 0.0 110.659 175.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.416 ' O ' HG21 ' A' ' 98' ' ' THR . 19.6 tpp180 -132.34 101.47 5.37 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.82 1.248 . . . . 0.0 111.29 -175.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.7 163.33 1.9 Allowed 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.852 0.834 . . . . 0.0 111.754 174.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -109.64 105.1 14.24 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 106.565 -1.642 . . . . 0.0 106.565 174.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -112.32 173.9 6.14 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.029 1.332 . . . . 0.0 109.86 175.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -50.57 -40.27 51.72 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 119.276 0.944 . . . . 0.0 113.282 176.119 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -58.28 -62.01 6.77 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 123.659 0.647 . . . . 0.0 111.717 175.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 5.3 mpp? -58.44 -39.33 79.53 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 118.134 0.967 . . . . 0.0 112.742 177.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -55.14 -60.87 2.79 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.397 1.079 . . . . 0.0 109.962 175.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -68.25 -33.29 74.11 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -178.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -61.1 -46.81 89.08 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.079 0.951 . . . . 0.0 111.599 176.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 46.6 mmm -84.88 -22.65 29.26 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -178.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -54.1 -55.54 26.63 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.765 1.626 . . . . 0.0 109.844 175.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -69.53 -16.49 63.44 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 179.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -74.29 -24.84 72.26 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 125.841 1.686 . . . . 0.0 114.333 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -135.74 87.98 24.47 Favored Pre-proline 0 CA--C 1.546 0.796 0 CA-C-N 118.721 1.26 . . . . 0.0 112.607 175.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.414 ' HA ' ' CG ' ' A' ' 115' ' ' TRP . 95.5 Cg_endo -74.19 76.68 2.99 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 123.752 2.968 . . . . 0.0 112.773 -178.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -104.29 105.32 15.42 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.991 0.916 . . . . 0.0 111.316 179.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 23.2 mtm105 -91.0 74.43 6.38 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.268 1.427 . . . . 0.0 111.472 174.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 31.37 64.79 0.2 Allowed Glycine 0 CA--C 1.534 1.242 0 C-N-CA 125.613 1.577 . . . . 0.0 112.948 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -71.86 93.92 1.37 Allowed 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 122.284 1.04 . . . . 0.0 110.153 -175.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 -54.76 98.94 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 126.934 2.093 . . . . 0.0 114.373 -175.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . 0.475 ' H ' HD13 ' A' ' 161' ' ' ILE . . . 146.7 54.6 0.02 OUTLIER Glycine 0 CA--C 1.535 1.335 0 C-N-CA 125.431 1.491 . . . . 0.0 114.38 177.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 5.0 m95 44.12 50.08 7.49 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.796 1.638 . . . . 0.0 114.129 -176.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -81.39 131.68 35.29 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 121.149 -0.97 . . . . 0.0 112.476 -177.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . 0.588 ' NE2' ' H ' ' A' ' 150' ' ' LYS . 0.0 OUTLIER -167.77 -169.59 1.2 Allowed 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.845 178.92 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.588 ' H ' ' NE2' ' A' ' 149' ' ' GLN . 0.0 OUTLIER -123.83 160.52 27.22 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.701 2.001 . . . . 0.0 111.851 175.33 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -87.87 127.9 35.35 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.631 1.173 . . . . 0.0 108.217 174.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 12.8 mt -73.41 112.23 9.28 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.191 0.996 . . . . 0.0 112.052 -174.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -43.76 -46.16 7.41 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 127.349 2.404 . . . . 0.0 117.769 -175.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.411 ' CD1' ' N ' ' A' ' 154' ' ' TYR . 0.0 OUTLIER -51.77 -33.74 36.54 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 127.378 2.271 . . . . 0.0 113.658 178.162 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 132.17 40.88 0.2 Allowed Glycine 0 CA--C 1.533 1.215 0 C-N-CA 125.459 1.504 . . . . 0.0 113.896 -178.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 4.8 mp -134.56 179.46 6.27 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.605 1.562 . . . . 0.0 110.874 178.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 5.8 mtt180 -136.88 142.11 42.77 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.709 1.204 . . . . 0.0 109.028 174.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 3.5 ttt -134.75 145.57 48.56 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 121.076 -1.015 . . . . 0.0 108.692 175.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 4.9 tptt -124.59 147.93 48.17 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 127.12 2.168 . . . . 0.0 111.172 178.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -150.24 147.81 18.37 Favored Glycine 0 CA--C 1.528 0.848 0 O-C-N 121.458 -0.776 . . . . 0.0 112.872 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.475 HD13 ' H ' ' A' ' 146' ' ' GLY . 4.8 tp -146.59 124.94 4.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 124.943 1.297 . . . . 0.0 110.42 179.281 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -151.32 156.01 39.9 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.933 2.093 . . . . 0.0 107.412 174.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . 0.496 HG23 ' HB3' ' A' ' 168' ' ' ALA . 0.1 OUTLIER -150.51 132.42 15.12 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.199 1.4 . . . . 0.0 107.923 174.952 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -105.5 32.75 4.08 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.342 1.057 . . . . 0.0 112.127 -176.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -116.3 -71.42 0.74 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.341 1.056 . . . . 0.0 112.583 -175.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -77.29 14.07 9.27 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 125.974 1.749 . . . . 0.0 111.384 175.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 56.28 56.14 6.05 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 127.551 2.34 . . . . 0.0 112.063 176.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.496 ' HB3' HG23 ' A' ' 163' ' ' THR . . . -78.54 -170.71 2.18 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 113.779 -1.555 . . . . 0.0 112.857 178.087 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.402 ' H ' ' HD3' ' A' ' 169' ' ' LYS . 0.0 OUTLIER -116.3 165.97 12.58 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 128.665 2.786 . . . . 0.0 111.435 -178.571 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 17.9 ttp -95.59 136.88 35.42 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.732 1.213 . . . . 0.0 111.527 179.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -144.82 119.27 9.65 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.251 1.02 . . . . 0.0 110.329 176.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 1.9 mp -114.31 120.79 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 124.905 1.282 . . . . 0.0 108.158 175.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.435 ' HE2' ' O ' ' A' ' 174' ' ' ILE . 0.0 OUTLIER -121.54 127.31 50.85 Favored 'General case' 0 CA--C 1.51 -0.574 0 C-N-CA 126.447 1.899 . . . . 0.0 108.88 -179.224 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.435 ' O ' ' HE2' ' A' ' 173' ' ' LYS . 1.3 mp -79.0 117.83 25.31 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 O-C-N 121.141 -0.975 . . . . 0.0 111.957 177.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 6.1 t -84.67 172.63 11.39 Favored 'General case' 0 N--CA 1.479 1.005 0 O-C-N 120.864 -1.147 . . . . 0.0 109.88 175.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 1.1 mtt-85 . . . . . 0 C--O 1.251 1.147 0 O-C-N 120.432 -1.417 . . . . 0.0 114.418 174.942 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 71.0 m . . . . . 0 N--CA 1.486 1.332 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -137.84 169.92 16.95 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 126.436 1.894 . . . . 0.0 109.265 174.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.739 HD12 ' H ' ' A' ' 74' ' ' GLY . 2.2 mt -108.68 15.62 23.54 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.527 1.531 . . . . 0.0 112.496 177.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -116.29 130.07 56.59 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 127.366 2.266 . . . . 0.0 110.361 -176.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -85.65 -96.04 0.76 Allowed Glycine 0 CA--C 1.531 1.087 0 C-N-CA 123.929 0.776 . . . . 0.0 112.865 -178.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 36.1 p -120.93 170.02 9.89 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.965 1.706 . . . . 0.0 111.764 -179.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -129.65 18.68 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 125.928 1.691 . . . . 0.0 111.712 177.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 pt -56.9 171.62 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 O-C-N 120.367 -1.458 . . . . 0.0 112.258 176.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -43.02 126.96 4.06 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.331 1.452 . . . . 0.0 113.335 -174.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -54.5 -23.3 27.12 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 125.229 1.395 . . . . 0.0 114.292 -177.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.14 -29.06 70.08 Favored 'General case' 0 CA--C 1.548 0.894 0 O-C-N 121.678 -0.895 . . . . 0.0 111.99 175.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.0 t -101.99 -40.11 7.02 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.956 1.702 . . . . 0.0 112.064 175.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 12.8 tp -73.44 90.11 1.69 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.265 1.026 . . . . 0.0 110.567 175.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.9 p -125.9 -178.95 4.46 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.918 2.087 . . . . 0.0 111.634 178.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -48.26 -38.82 19.62 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.801 1.641 . . . . 0.0 113.289 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -55.06 -40.53 70.4 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 118.685 0.675 . . . . 0.0 112.497 176.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.416 ' O ' HG23 ' A' ' 21' ' ' VAL . 96.2 t -70.05 -39.77 77.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.301 1.44 . . . . 0.0 110.804 174.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 28.1 mt -65.49 -43.75 89.2 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.166 -0.959 . . . . 0.0 111.419 179.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.408 ' HA ' HD12 ' A' ' 22' ' ' LEU . 24.7 t0 -57.22 -51.41 69.44 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.222 1.409 . . . . 0.0 110.716 178.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.76 -36.86 84.76 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 118.03 -0.986 . . . . 0.0 112.846 175.007 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 17' ' ' VAL . 17.7 t -55.42 -47.07 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 CA-C-N 119.864 1.211 . . . . 0.0 110.996 -179.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.581 HD11 ' HB3' ' A' ' 169' ' ' LYS . 1.9 mt -55.63 -24.66 34.68 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.067 0.947 . . . . 0.0 113.069 177.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -88.2 -61.66 1.47 Allowed Glycine 0 CA--C 1.532 1.097 0 C-N-CA 125.986 1.755 . . . . 0.0 112.633 176.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -62.87 -39.08 93.33 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 118.533 1.167 . . . . 0.0 113.768 -178.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -90.41 1.18 56.87 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.872 1.269 . . . . 0.0 112.124 175.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -52.91 96.9 0.02 OUTLIER Glycine 0 CA--C 1.537 1.455 0 C-N-CA 127.047 2.261 . . . . 0.0 114.366 178.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -87.3 -79.93 0.27 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.596 1.558 . . . . 0.0 111.947 178.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 23.8 m -87.51 173.07 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.564 1.546 . . . . 0.0 111.793 -177.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 58.0 m -63.29 -26.65 68.87 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 175.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.04 96.49 4.06 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.421 1.088 . . . . 0.0 112.236 176.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.415 ' HE2' ' HB3' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -111.32 155.04 23.66 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 128.551 2.74 . . . . 0.0 111.558 -179.71 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -128.21 133.01 67.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 126.328 1.851 . . . . 0.0 108.689 174.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.59 105.69 5.71 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.13 1.772 . . . . 0.0 109.357 175.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.727 HG22 ' HB2' ' A' ' 72' ' ' TYR . 2.0 m -111.28 151.58 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 123.203 0.601 . . . . 0.0 111.13 179.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -123.97 111.68 1.68 Allowed Glycine 0 CA--C 1.523 0.567 0 C-N-CA 124.088 0.851 . . . . 0.0 112.912 179.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.5 mp -104.59 134.55 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-N 119.018 1.409 . . . . 0.0 110.981 176.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -102.06 102.47 12.97 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 124.714 1.206 . . . . 0.0 110.51 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.9 t30 -73.73 92.47 2.0 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.963 1.305 . . . . 0.0 110.825 175.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -121.29 13.05 11.06 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.723 1.209 . . . . 0.0 112.212 175.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.8 t -61.81 -42.3 98.85 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.932 1.693 . . . . 0.0 113.87 -176.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 130.88 32.48 0.51 Allowed Glycine 0 CA--C 1.533 1.173 0 N-CA-C 115.11 0.804 . . . . 0.0 115.11 178.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -178.09 162.19 29.58 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 118.061 0.931 . . . . 0.0 112.852 175.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.716 HG22 ' HA ' ' A' ' 65' ' ' PRO . 80.6 p -68.23 129.75 40.86 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 121.858 -0.789 . . . . 0.0 110.999 175.002 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 42.2 m0 -87.04 107.5 18.46 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 123.813 0.845 . . . . 0.0 110.07 179.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 92.9 m -91.44 128.72 37.38 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.206 1.002 . . . . 0.0 109.747 177.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.86 131.42 48.71 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 122.823 0.449 . . . . 0.0 111.513 174.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.453 HD11 ' HB3' ' A' ' 90' ' ' ALA . 2.9 pp -113.74 -52.03 2.77 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.729 1.211 . . . . 0.0 111.616 179.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -171.73 145.74 2.01 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.343 1.857 . . . . 0.0 110.419 179.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.512 ' HB2' HD12 ' A' ' 60' ' ' LEU . . . -125.09 164.32 20.47 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.721 1.208 . . . . 0.0 110.837 174.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -141.9 102.02 4.06 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.157 1.383 . . . . 0.0 111.778 179.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.567 ' CE1' ' HB1' ' A' ' 87' ' ' ALA . 3.3 m-85 -110.67 123.91 50.91 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.457 1.103 . . . . 0.0 110.211 -178.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.483 ' HD2' HE22 ' A' ' 129' ' ' GLN . 0.0 OUTLIER -114.77 -47.1 2.9 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -175.16 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.442 ' HB3' ' HB ' ' A' ' 86' ' ' VAL . 11.6 t -103.5 -48.14 4.06 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.135 1.374 . . . . 0.0 111.038 175.026 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -75.64 12.59 7.85 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 125.393 1.473 . . . . 0.0 114.564 -175.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 54.8 p -30.38 105.53 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 129.239 3.016 . . . . 0.0 113.961 -175.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.62 HG21 HG23 ' A' ' 59' ' ' ILE . 2.4 t -118.22 175.71 5.57 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.726 1.211 . . . . 0.0 112.171 -175.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -74.52 -55.45 5.93 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.516 1.126 . . . . 0.0 112.585 175.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.4 p -147.59 143.11 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 126.139 1.776 . . . . 0.0 110.893 175.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.62 HG23 HG21 ' A' ' 56' ' ' THR . 1.3 pp -143.21 -34.01 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 125.779 1.632 . . . . 0.0 113.947 179.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.539 ' H ' HD12 ' A' ' 59' ' ' ILE . 7.3 mt -89.66 98.11 1.21 Allowed Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 125.267 1.427 . . . . 0.0 109.135 175.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -66.03 148.62 85.83 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 123.887 3.058 . . . . 0.0 110.669 174.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -46.78 -51.15 17.0 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.834 1.254 . . . . 0.0 113.342 -177.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 63.2 t -149.31 139.88 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 128.026 2.531 . . . . 0.0 108.699 177.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.551 HG21 HD23 ' A' ' 70' ' ' LEU . 60.3 t -120.04 125.42 27.34 Favored Pre-proline 0 N--CA 1.473 0.683 0 C-N-CA 124.442 1.097 . . . . 0.0 108.457 175.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.716 ' HA ' HG22 ' A' ' 43' ' ' THR . 58.4 Cg_endo -64.45 151.64 84.75 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 121.934 1.756 . . . . 0.0 112.898 175.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -71.52 170.65 12.9 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.549 0.74 . . . . 0.0 109.254 174.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . 0.272 2.7 t 53.67 23.31 3.56 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.612 1.565 . . . . 0.0 113.817 -175.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.3 mttt -134.93 172.93 12.3 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.375 1.87 . . . . 0.0 111.645 -179.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -129.43 164.46 23.61 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 -178.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.551 HD23 HG21 ' A' ' 64' ' ' VAL . 3.2 pp -137.08 171.14 14.94 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 123.983 0.913 . . . . 0.0 111.078 -175.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.496 HD13 ' O ' ' A' ' 34' ' ' VAL . 0.8 OUTLIER -123.44 153.69 40.1 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.497 1.119 . . . . 0.0 111.035 177.033 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.727 ' HB2' HG22 ' A' ' 34' ' ' VAL . 5.8 m-85 -129.46 134.94 48.07 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 126.176 1.791 . . . . 0.0 109.377 176.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 59.6 p -107.7 153.87 22.3 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.145 1.778 . . . . 0.0 111.019 175.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.739 ' H ' HD12 ' A' ' 3' ' ' LEU . . . -176.8 131.93 1.94 Allowed Glycine 0 CA--C 1.518 0.257 0 O-C-N 121.196 -0.94 . . . . 0.0 113.017 175.312 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 9.2 ptt85 -129.46 155.16 46.17 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 125.767 1.627 . . . . 0.0 110.491 -175.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.9 ptpt -61.97 174.91 0.76 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.509 1.524 . . . . 0.0 112.886 174.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.1 t -127.16 26.7 6.02 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 -175.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.0 107.66 1.67 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.788 1.235 . . . . 0.0 111.069 177.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -36.49 -54.05 1.34 Allowed Glycine 0 CA--C 1.548 2.14 0 C-N-CA 125.272 1.415 . . . . 0.0 115.363 174.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.27 -80.8 0.0 OUTLIER 'Trans proline' 0 CA--C 1.548 1.207 0 C-N-CA 123.75 2.967 . . . . 0.0 113.92 177.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.0 m -117.56 108.72 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 127.137 2.175 . . . . 0.0 111.169 -175.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -135.89 175.89 9.18 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.746 1.218 . . . . 0.0 112.251 -179.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 17.8 p -78.38 139.0 38.8 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.117 0.967 . . . . 0.0 109.4 175.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -52.62 -81.38 0.06 OUTLIER Glycine 0 CA--C 1.537 1.411 0 C-N-CA 126.337 1.922 . . . . 0.0 114.021 -175.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -160.4 112.86 2.01 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.298 1.439 . . . . 0.0 111.077 175.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.442 ' HB ' ' HB3' ' A' ' 53' ' ' SER . 5.0 t -139.16 125.53 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.471 1.109 . . . . 0.0 110.665 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.567 ' HB1' ' CE1' ' A' ' 51' ' ' PHE . . . -161.57 165.62 28.18 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 122.701 1.239 . . . . 0.0 112.063 177.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -149.22 146.22 27.5 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 124.913 1.285 . . . . 0.0 108.99 174.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.507 ' CD2' ' CE2' ' A' ' 72' ' ' TYR . 48.8 p90 -144.02 172.72 12.49 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 121.236 -0.915 . . . . 0.0 110.03 176.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.453 ' HB3' HD11 ' A' ' 47' ' ' LEU . . . -138.43 149.04 45.08 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 175.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -125.41 140.15 53.04 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.632 1.173 . . . . 0.0 113.123 178.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -87.44 122.16 30.81 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.873 -175.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 31.8 mtm -101.73 128.14 48.19 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.495 1.118 . . . . 0.0 110.742 -176.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.4 t -56.26 -22.41 29.79 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.936 1.294 . . . . 0.0 113.493 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -67.05 -9.96 44.78 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 125.941 1.696 . . . . 0.0 113.154 175.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 101.52 28.3 6.78 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.754 1.645 . . . . 0.0 114.366 177.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.43 ' HA ' ' H ' ' A' ' 123' ' ' GLY . 29.0 m-80 -135.44 175.18 9.82 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.857 1.263 . . . . 0.0 112.558 -174.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.575 HG21 ' O ' ' A' ' 125' ' ' ARG . 38.3 m -130.31 108.69 10.2 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.353 1.061 . . . . 0.0 112.683 177.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.5 tt -69.89 94.24 0.82 Allowed 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 127.151 2.18 . . . . 0.0 111.999 177.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -87.21 96.18 2.14 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 125.568 1.556 . . . . 0.0 113.595 178.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.411 HG11 ' CZ ' ' A' ' 89' ' ' PHE . 55.5 t -78.07 138.59 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 124.718 1.207 . . . . 0.0 110.827 174.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.33 128.22 31.33 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.581 1.552 . . . . 0.0 110.303 179.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.531 ' CZ ' ' HB3' ' A' ' 87' ' ' ALA . 10.3 p90 -148.08 120.31 8.36 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.008 1.323 . . . . 0.0 111.465 -177.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 39.6 t -140.82 129.96 23.48 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.531 1.133 . . . . 0.0 110.22 -175.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.6 m -118.55 148.48 44.23 Favored Pre-proline 0 N--CA 1.471 0.604 0 C-N-CA 124.147 0.979 . . . . 0.0 110.848 178.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.433 ' HD3' ' CB ' ' A' ' 114' ' ' ASN . 58.0 Cg_endo -70.26 142.28 45.3 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 123.815 3.01 . . . . 0.0 109.804 -177.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -71.19 -50.91 28.19 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -175.026 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -84.12 -11.38 56.71 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.127 1.371 . . . . 0.0 113.169 178.153 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 59.19 28.25 17.49 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 127.587 2.355 . . . . 0.0 115.463 177.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -154.34 147.6 24.86 Favored 'General case' 0 CA--C 1.55 0.957 0 O-C-N 120.79 -1.194 . . . . 0.0 112.048 -175.175 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 22.6 m95 55.03 23.49 5.2 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 125.373 1.469 . . . . 0.0 114.632 175.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -134.74 155.76 50.01 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.597 1.959 . . . . 0.0 112.174 -176.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.63 138.71 31.35 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.342 1.457 . . . . 0.0 110.357 174.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.433 ' CB ' ' HD3' ' A' ' 106' ' ' PRO . 13.1 p-10 -132.95 82.61 2.01 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.25 1.42 . . . . 0.0 112.286 -177.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 21.1 m0 -92.67 162.26 14.23 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 121.441 -0.787 . . . . 0.0 111.843 -175.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 40.2 p-90 -160.53 132.38 5.96 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 121.561 -0.712 . . . . 0.0 111.24 -176.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -145.87 173.55 12.03 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 121.3 -0.875 . . . . 0.0 111.744 178.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 98.5 t -137.69 133.18 45.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 175.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.59 168.2 12.94 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 125.584 1.554 . . . . 0.0 110.244 175.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.693 HD11 HD13 ' A' ' 152' ' ' LEU . 32.3 mt -135.87 121.74 30.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 175.001 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -83.81 145.42 47.03 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 123.311 0.644 . . . . 0.0 111.289 178.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -76.23 83.74 1.96 Allowed 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 124.133 3.222 . . . . 0.0 111.929 179.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.43 ' H ' ' HA ' ' A' ' 97' ' ' ASN . . . 101.45 175.53 28.61 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 126.494 1.997 . . . . 0.0 112.811 -177.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 1.3 mttt -45.01 106.67 0.08 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 126.47 1.908 . . . . 0.0 112.737 -176.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.575 ' O ' HG21 ' A' ' 98' ' ' THR . 7.9 tpt180 -141.37 138.21 32.87 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.48 1.112 . . . . 0.0 113.402 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -80.4 173.69 12.35 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.722 0.809 . . . . 0.0 110.729 174.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -117.01 104.86 11.69 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.149 1.779 . . . . 0.0 107.028 175.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -108.0 169.94 8.3 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.385 1.074 . . . . 0.0 111.831 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.483 HE22 ' HD2' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -53.38 -45.83 69.39 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.535 0.734 . . . . 0.0 112.827 177.567 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -54.58 -56.05 24.1 Favored Glycine 0 N--CA 1.469 0.836 0 CA-C-O 119.38 -0.678 . . . . 0.0 112.239 176.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 4.1 mpp? -63.76 -33.65 76.12 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 118.533 1.167 . . . . 0.0 113.376 176.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -61.39 -61.56 2.45 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 119.642 1.11 . . . . 0.0 108.958 175.013 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -62.45 -43.86 97.81 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.178 0.991 . . . . 0.0 112.526 -176.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -62.81 -45.67 91.57 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.626 1.17 . . . . 0.0 111.711 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.23 -33.33 59.22 Favored 'General case' 0 CA--C 1.547 0.829 0 O-C-N 120.468 -1.395 . . . . 0.0 112.752 176.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -54.2 -60.38 3.41 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 126.587 1.955 . . . . 0.0 109.758 175.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -72.65 4.45 3.97 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-O 121.726 0.774 . . . . 0.0 112.596 -176.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -101.57 -7.75 47.75 Favored Glycine 0 CA--C 1.541 1.678 0 C-N-CA 126.964 2.221 . . . . 0.0 114.975 175.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -144.06 88.61 7.45 Favored Pre-proline 0 CA--C 1.553 1.059 0 CA-C-N 119.897 1.849 . . . . 0.0 113.268 -178.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -73.51 81.36 1.82 Allowed 'Trans proline' 0 CA--C 1.545 1.056 0 C-N-CA 124.096 3.197 . . . . 0.0 113.024 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -104.22 9.95 35.89 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.894 1.277 . . . . 0.0 114.337 -178.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 28.4 ptt85 -29.97 119.93 0.17 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 129.03 2.932 . . . . 0.0 115.728 175.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 39.25 68.4 0.5 Allowed Glycine 0 N--CA 1.468 0.804 0 C-N-CA 126.31 1.909 . . . . 0.0 112.151 -175.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.91 -24.4 37.41 Favored 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -174.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . 0.267 0.2 OUTLIER 13.93 72.18 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 130.766 3.626 . . . . 0.0 116.349 177.959 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 154.39 42.79 0.02 OUTLIER Glycine 0 CA--C 1.532 1.118 0 C-N-CA 123.865 0.745 . . . . 0.0 114.576 178.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' TRP . . . . . 0.834 ' H ' HD13 ' A' ' 161' ' ' ILE . 0.1 OUTLIER 49.79 48.55 21.51 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 125.434 1.494 . . . . 0.0 113.035 -176.836 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -91.31 134.27 34.73 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 122.325 1.059 . . . . 0.0 113.026 -174.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -156.52 -177.19 6.41 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.067 0.947 . . . . 0.0 112.884 -174.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 21.1 ttpp -131.97 148.13 52.5 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.753 1.221 . . . . 0.0 110.905 174.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -63.75 149.53 46.56 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 175.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.693 HD13 HD11 ' A' ' 120' ' ' ILE . 98.7 mt -107.9 145.26 34.01 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 175.005 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -64.48 -165.67 1.02 Allowed Glycine 0 CA--C 1.538 1.47 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 175.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 54.5 11.2 0.4 Allowed 'General case' 0 CA--C 1.557 1.242 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 175.27 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 81.33 40.9 10.62 Favored Glycine 0 CA--C 1.539 1.562 0 C-N-CA 126.557 2.027 . . . . 0.0 114.424 -175.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.2 mp -124.82 162.19 24.85 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 119.267 1.533 . . . . 0.0 112.813 -178.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -150.63 118.48 6.21 Favored 'General case' 0 N--CA 1.482 1.128 0 O-C-N 120.691 -1.256 . . . . 0.0 111.594 176.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 6.6 ttp -111.3 130.85 55.54 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 118.108 -0.949 . . . . 0.0 109.093 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 6.3 tppt? -106.9 134.14 50.5 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 127.681 2.393 . . . . 0.0 110.089 -179.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -136.41 152.31 21.14 Favored Glycine 0 N--CA 1.476 1.34 0 CA-C-N 121.208 1.822 . . . . 0.0 115.79 179.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.834 HD13 ' H ' ' A' ' 147' ' ' TRP . 6.1 tp -148.66 122.42 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 125.134 1.374 . . . . 0.0 113.332 -177.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 5.3 ttp -153.61 145.37 23.43 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 128.968 2.907 . . . . 0.0 109.589 177.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 9.6 t -120.22 146.3 46.18 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 120.87 -1.144 . . . . 0.0 109.778 175.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 28.8 p -91.34 18.96 6.45 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.305 1.442 . . . . 0.0 113.29 -178.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.8 -33.73 64.66 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.012 1.725 . . . . 0.0 115.005 -176.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 157.8 -62.76 0.32 Allowed Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.534 1.064 . . . . 0.0 114.17 176.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -125.25 27.02 6.73 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 125.652 1.581 . . . . 0.0 112.656 -174.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.87 175.66 2.37 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.28 1.432 . . . . 0.0 113.388 175.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.581 ' HB3' HD11 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -115.78 178.81 4.17 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 127.453 2.301 . . . . 0.0 111.914 -177.814 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 40.2 ttp -126.89 137.89 53.22 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 125.381 1.473 . . . . 0.0 109.825 178.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.404 ' C ' HD12 ' A' ' 172' ' ' ILE . 5.8 tt0 -143.08 131.9 22.72 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 121.562 -0.711 . . . . 0.0 109.657 174.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.404 HD12 ' C ' ' A' ' 171' ' ' GLN . 3.8 mp -129.79 120.87 51.12 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.296 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 176.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -115.82 129.91 56.63 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 125.232 1.413 . . . . 0.0 111.125 177.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.8 mp -78.94 131.84 33.5 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 O-C-N 121.064 -1.023 . . . . 0.0 109.398 174.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 13.8 m -137.66 94.03 2.86 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.497 1.519 . . . . 0.0 113.116 176.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 79.0 mtp180 . . . . . 0 C--O 1.253 1.272 0 C-N-CA 125.544 1.538 . . . . 0.0 112.433 174.972 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 7.9 t . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 122.009 0.909 . . . . 0.0 110.887 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -131.91 -73.37 0.52 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.418 1.487 . . . . 0.0 110.042 -179.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.652 HD11 ' HB2' ' A' ' 31' ' ' LYS . 17.1 tp 55.5 17.37 2.2 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 125.958 1.703 . . . . 0.0 114.45 -177.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -136.53 130.27 32.19 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 128.037 2.535 . . . . 0.0 107.087 176.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.406 ' H ' ' HG ' ' A' ' 71' ' ' LEU . . . -73.08 -126.49 0.1 OUTLIER Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.171 0.891 . . . . 0.0 111.2 174.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 25.4 p -101.95 174.64 5.85 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.389 1.076 . . . . 0.0 111.413 177.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -124.65 16.07 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 125.498 1.519 . . . . 0.0 110.971 175.007 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.9 pp -55.05 165.57 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 125.352 1.461 . . . . 0.0 112.111 174.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -40.99 130.16 2.66 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.727 1.611 . . . . 0.0 113.246 -174.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -54.77 -21.14 21.55 Favored Glycine 0 N--CA 1.472 1.097 0 C-N-CA 124.766 1.174 . . . . 0.0 114.456 -177.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.75 -31.87 68.73 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.65 1.18 . . . . 0.0 111.306 174.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.63 -43.24 5.42 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.392 1.477 . . . . 0.0 111.602 174.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.427 HD23 ' HB3' ' A' ' 69' ' ' ALA . 14.3 tp -71.26 94.22 1.17 Allowed 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.902 0.858 . . . . 0.0 110.849 174.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.0 p -131.42 -179.92 5.65 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 126.982 2.113 . . . . 0.0 111.899 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -46.91 -39.99 13.28 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.55 1.54 . . . . 0.0 113.051 177.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -54.85 -39.51 68.68 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.448 1.099 . . . . 0.0 112.077 177.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.4 ' O ' HG23 ' A' ' 21' ' ' VAL . 65.2 t -70.45 -36.92 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 125.862 1.665 . . . . 0.0 111.182 174.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.408 ' CD2' HD21 ' A' ' 71' ' ' LEU . 9.2 mt -71.1 -43.13 68.31 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 120.965 -1.084 . . . . 0.0 111.249 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -58.34 -47.06 84.97 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.459 1.104 . . . . 0.0 111.308 178.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.68 -37.71 82.71 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 118.15 -0.929 . . . . 0.0 111.953 175.069 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 17' ' ' VAL . 16.2 t -54.36 -42.47 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 CA-C-N 119.923 1.238 . . . . 0.0 111.26 179.091 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.6 mt -58.65 -17.33 21.47 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.397 1.079 . . . . 0.0 113.845 177.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -105.38 -45.05 1.38 Allowed Glycine 0 CA--C 1.536 1.395 0 C-N-CA 126.992 2.234 . . . . 0.0 114.05 -179.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -67.82 -31.82 71.93 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 119.134 1.467 . . . . 0.0 112.725 175.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -101.66 173.33 6.46 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 125.181 1.392 . . . . 0.0 111.049 174.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 154.02 86.72 0.06 OUTLIER Glycine 0 CA--C 1.534 1.252 0 C-N-CA 124.332 0.967 . . . . 0.0 113.827 -178.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.5 mtpt -67.9 -46.11 72.52 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.714 1.206 . . . . 0.0 112.966 176.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 33.4 m -133.64 -176.96 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 126.799 2.04 . . . . 0.0 111.596 -178.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.9 m -47.28 -46.44 24.82 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 126.436 1.894 . . . . 0.0 115.123 -178.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.429 ' CB ' ' HE3' ' A' ' 76' ' ' LYS . 0.1 OUTLIER -128.91 146.02 51.06 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.534 1.133 . . . . 0.0 110.541 174.963 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.652 ' HB2' HD11 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -143.81 161.18 39.29 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 124.466 1.106 . . . . 0.0 111.62 -175.855 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.428 HD12 ' CG1' ' A' ' 34' ' ' VAL . 0.3 OUTLIER -120.08 133.28 67.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 124.78 1.232 . . . . 0.0 108.999 175.007 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -136.0 100.93 4.57 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.131 1.772 . . . . 0.0 109.065 175.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.91 HG22 ' HB2' ' A' ' 72' ' ' TYR . 1.5 m -103.97 161.44 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 123.859 0.864 . . . . 0.0 111.728 178.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -140.62 101.05 0.28 Allowed Glycine 0 N--CA 1.461 0.361 0 C-N-CA 123.613 0.625 . . . . 0.0 113.156 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 mp -93.98 151.11 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 117.91 0.855 . . . . 0.0 110.761 175.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -116.42 104.43 11.44 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.327 1.051 . . . . 0.0 110.822 174.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -72.62 98.84 2.42 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.743 1.617 . . . . 0.0 111.05 174.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -135.31 22.63 3.45 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.971 1.309 . . . . 0.0 110.444 174.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 33.1 t -61.79 -42.69 99.31 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 120.788 -1.195 . . . . 0.0 112.749 174.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 132.35 33.97 0.38 Allowed Glycine 0 CA--C 1.534 1.244 0 C-N-CA 124.375 0.988 . . . . 0.0 115.181 176.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -174.52 162.28 32.4 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 124.673 1.13 . . . . 0.0 112.094 175.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.711 HG22 ' HA ' ' A' ' 65' ' ' PRO . 50.4 p -70.42 139.32 51.79 Favored 'General case' 0 C--O 1.234 0.261 0 O-C-N 121.782 -0.834 . . . . 0.0 110.893 174.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.43 ' HB3' ' CD1' ' A' ' 91' ' ' TYR . 40.2 m0 -96.05 104.14 16.07 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 124.172 0.989 . . . . 0.0 110.767 -178.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.9 m -87.36 139.29 30.7 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.019 1.328 . . . . 0.0 110.539 178.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.74 131.44 48.9 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.456 0.702 . . . . 0.0 111.249 174.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.701 HD11 ' HB3' ' A' ' 90' ' ' ALA . 4.6 pp -120.2 -48.36 2.33 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.029 0.931 . . . . 0.0 112.854 177.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.502 ' N ' HD12 ' A' ' 47' ' ' LEU . 0.2 OUTLIER 178.36 153.88 0.35 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 127.189 2.196 . . . . 0.0 110.378 -175.167 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -138.67 164.78 28.64 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.497 1.519 . . . . 0.0 111.215 174.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -136.7 102.87 5.03 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 125.309 1.443 . . . . 0.0 110.092 176.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.549 ' CE1' ' HB1' ' A' ' 87' ' ' ALA . 3.0 m-85 -111.03 131.43 55.06 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.719 0.808 . . . . 0.0 109.962 -179.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.38 -33.16 4.16 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -177.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 33.9 t -125.43 -46.62 1.75 Allowed 'General case' 0 C--O 1.219 -0.541 0 C-N-CA 124.961 1.304 . . . . 0.0 109.202 174.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -60.35 -0.15 1.14 Allowed Glycine 0 CA--C 1.544 1.868 0 O-C-N 119.586 -1.946 . . . . 0.0 116.449 176.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.1 p -27.15 89.01 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 130.97 3.708 . . . . 0.0 114.564 -175.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.676 HG21 HG23 ' A' ' 59' ' ' ILE . 0.7 OUTLIER -105.28 175.2 5.57 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.928 -174.911 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -73.17 -56.16 5.49 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.388 1.075 . . . . 0.0 111.127 174.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.4 p -144.44 137.69 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 125.806 1.643 . . . . 0.0 112.021 176.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.676 HG23 HG21 ' A' ' 56' ' ' THR . 1.2 pp -135.82 -33.58 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 125.885 1.674 . . . . 0.0 114.298 176.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.415 ' H ' HD12 ' A' ' 59' ' ' ILE . 16.0 mt -89.09 100.32 2.09 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 125.312 1.445 . . . . 0.0 109.34 176.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.506 ' HG2' HG23 ' A' ' 64' ' ' VAL . 90.8 Cg_endo -65.43 154.64 72.72 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.38 2.72 . . . . 0.0 109.27 175.06 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -45.02 -50.98 10.44 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.504 1.522 . . . . 0.0 113.415 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.7 p -160.17 137.77 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 127.053 2.141 . . . . 0.0 109.612 176.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.635 HG21 HD13 ' A' ' 70' ' ' LEU . 94.6 t -113.56 130.75 23.44 Favored Pre-proline 0 N--CA 1.482 1.128 0 C-N-CA 124.495 1.118 . . . . 0.0 109.311 175.162 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.711 ' HA ' HG22 ' A' ' 43' ' ' THR . 59.9 Cg_endo -65.37 161.65 37.01 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 122.469 2.112 . . . . 0.0 112.801 177.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -76.69 170.51 16.3 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.83 0.852 . . . . 0.0 109.897 174.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . 0.266 10.7 t 46.95 30.55 1.27 Allowed 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 126.892 2.077 . . . . 0.0 113.376 -174.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.9 mttt -135.78 171.94 13.73 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 127.262 2.225 . . . . 0.0 111.821 -174.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.427 ' HB3' HD23 ' A' ' 13' ' ' LEU . . . -128.63 166.08 19.57 Favored 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 122.77 0.428 . . . . 0.0 110.245 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.635 HD13 HG21 ' A' ' 64' ' ' VAL . 2.0 pt? -143.78 171.07 14.72 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 124.617 1.167 . . . . 0.0 111.656 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.536 HD13 ' O ' ' A' ' 34' ' ' VAL . 0.6 OUTLIER -117.66 156.1 28.76 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.442 1.097 . . . . 0.0 112.503 177.566 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.91 ' HB2' HG22 ' A' ' 34' ' ' VAL . 7.5 m-85 -128.03 134.39 49.21 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.72 1.608 . . . . 0.0 109.103 174.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.1 p -108.08 142.76 37.78 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 126.831 2.053 . . . . 0.0 110.741 176.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -163.79 142.68 8.0 Favored Glycine 0 N--CA 1.461 0.326 0 O-C-N 120.514 -1.366 . . . . 0.0 111.898 174.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 3.8 ptm180 -129.26 104.33 7.46 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.289 1.436 . . . . 0.0 111.353 -174.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.515 ' HE2' ' O ' ' A' ' 83' ' ' THR . 2.6 ptpt -29.91 -70.07 0.06 Allowed 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 127.492 2.317 . . . . 0.0 114.597 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 11.5 t 17.79 54.02 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 128.57 2.748 . . . . 0.0 114.837 175.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.87 -24.81 67.99 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 121.371 -0.831 . . . . 0.0 112.61 -174.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 120.31 -76.44 0.32 Allowed Glycine 0 CA--C 1.531 1.047 0 C-N-CA 127.042 2.258 . . . . 0.0 110.613 175.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.84 -35.18 3.48 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 123.204 2.603 . . . . 0.0 113.169 -178.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 26.8 m -137.29 129.01 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 126.52 1.928 . . . . 0.0 109.68 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -77.0 76.22 3.56 Favored 'General case' 0 CA--C 1.549 0.939 0 O-C-N 121.015 -1.053 . . . . 0.0 111.826 -178.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.515 ' O ' ' HE2' ' A' ' 76' ' ' LYS . 3.7 m -59.22 174.33 0.4 Allowed 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 127.869 2.468 . . . . 0.0 112.811 -177.243 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.479 ' H ' HG22 ' A' ' 83' ' ' THR . . . -78.65 -154.27 7.58 Favored Glycine 0 N--CA 1.47 0.934 0 O-C-N 119.741 -1.849 . . . . 0.0 113.323 176.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.566 ' HB3' HG22 ' A' ' 105' ' ' VAL . . . -94.7 97.98 10.46 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.081 -1.247 . . . . 0.0 110.526 -179.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.9 t -124.76 107.15 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 124.299 1.04 . . . . 0.0 110.578 -175.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.549 ' HB1' ' CE1' ' A' ' 51' ' ' PHE . . . -159.94 167.57 27.68 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.867 0.842 . . . . 0.0 111.494 178.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -150.86 159.8 44.31 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.758 1.223 . . . . 0.0 109.937 175.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.476 ' CD2' ' CE2' ' A' ' 72' ' ' TYR . 52.9 p90 -155.78 174.55 15.14 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 121.422 -0.799 . . . . 0.0 110.554 175.028 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.701 ' HB3' HD11 ' A' ' 47' ' ' LEU . . . -138.65 151.34 47.13 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 176.412 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.43 ' CD1' ' HB3' ' A' ' 44' ' ' TRP . 10.4 m-85 -126.3 140.11 52.78 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.38 1.072 . . . . 0.0 113.789 179.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -84.59 118.73 24.53 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 111.592 0.219 . . . . 0.0 111.592 -177.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 4.7 ttm -86.97 147.0 25.93 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.776 0.831 . . . . 0.0 112.31 177.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 24.6 m -67.1 -23.96 65.89 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 174.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -70.5 -17.39 62.96 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 175.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 100.71 40.13 3.0 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.845 1.212 . . . . 0.0 113.412 -175.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -135.5 175.1 9.9 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 118.382 1.091 . . . . 0.0 110.476 177.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.56 HG23 HD21 ' A' ' 47' ' ' LEU . 12.4 m -129.49 106.15 8.57 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.026 1.331 . . . . 0.0 111.946 -177.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.2 tt -70.79 96.35 1.24 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.699 1.6 . . . . 0.0 112.154 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -91.87 95.43 2.04 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 126.065 1.793 . . . . 0.0 113.876 -178.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 72.5 t -78.08 138.18 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 125.211 1.405 . . . . 0.0 111.444 176.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.6 126.54 29.43 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.367 1.467 . . . . 0.0 111.383 -178.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -146.64 121.79 10.15 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.0 1.32 . . . . 0.0 112.016 -177.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 47.1 t -142.45 109.73 5.63 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.657 1.183 . . . . 0.0 110.039 -178.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.566 HG22 ' HB3' ' A' ' 85' ' ' ALA . 17.5 m -118.51 110.91 38.46 Favored Pre-proline 0 N--CA 1.469 0.523 0 C-N-CA 124.831 1.252 . . . . 0.0 108.365 175.003 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.2 136.6 37.96 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 122.389 2.059 . . . . 0.0 110.689 177.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -78.61 -43.54 26.13 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 120.808 -1.183 . . . . 0.0 110.526 174.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.1 p30 -67.62 9.75 0.24 Allowed 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 126.706 2.003 . . . . 0.0 115.922 -174.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -10.42 85.0 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 130.174 3.39 . . . . 0.0 115.303 -178.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -121.61 -10.3 8.81 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.015 1.326 . . . . 0.0 113.287 -178.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 21.8 m95 -130.47 -12.69 3.91 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.67 1.988 . . . . 0.0 113.876 -175.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 58.23 49.75 10.75 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.156 1.782 . . . . 0.0 113.522 -178.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 45.1 p -125.47 91.19 3.36 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.197 1.799 . . . . 0.0 112.24 -178.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -121.87 101.53 7.62 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.132 1.773 . . . . 0.0 109.138 175.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 32.0 m0 -102.52 144.98 30.26 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.398 0.679 . . . . 0.0 109.94 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 27.4 p-90 -146.77 138.53 24.5 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.119 0.968 . . . . 0.0 111.978 -177.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -149.31 170.05 19.4 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 122.285 1.041 . . . . 0.0 113.072 179.115 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.3 t -150.27 139.31 15.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 C-N-CA 125.226 1.41 . . . . 0.0 107.655 175.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.79 175.44 10.18 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 126.27 1.828 . . . . 0.0 109.72 175.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.458 ' HB ' ' CE2' ' A' ' 154' ' ' TYR . 50.9 mt -130.56 105.74 11.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.953 0.882 . . . . 0.0 108.967 178.196 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -67.38 149.54 98.34 Favored Pre-proline 0 CA--C 1.546 0.793 0 O-C-N 121.522 -0.736 . . . . 0.0 111.842 178.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.6 131.73 17.8 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 123.212 2.608 . . . . 0.0 111.727 178.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 61.86 -165.99 18.75 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 124.549 1.071 . . . . 0.0 113.9 -176.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -67.89 110.78 4.0 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.654 1.182 . . . . 0.0 108.985 175.004 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 20.0 tpp180 -123.32 157.84 32.34 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.692 1.597 . . . . 0.0 110.066 178.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -96.99 -173.72 2.77 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.261 1.424 . . . . 0.0 110.397 174.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -138.58 121.45 16.55 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 127.317 2.247 . . . . 0.0 106.504 174.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -132.68 169.69 16.3 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.579 1.552 . . . . 0.0 110.016 175.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -52.71 -39.9 62.48 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.337 1.055 . . . . 0.0 113.086 176.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -59.03 -53.64 44.72 Favored Glycine 0 N--CA 1.469 0.853 0 CA-C-N 118.875 0.761 . . . . 0.0 112.094 176.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 1.2 mpp? -61.48 -42.97 99.6 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 118.036 0.918 . . . . 0.0 112.049 176.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -54.0 -58.44 7.29 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.381 0.672 . . . . 0.0 110.171 175.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -65.85 -38.07 87.87 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 -177.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -61.73 -45.3 94.53 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.55 1.14 . . . . 0.0 112.096 178.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 73.8 mmm -79.17 -32.59 44.29 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.351 -0.843 . . . . 0.0 112.879 176.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -54.08 -59.08 5.12 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.772 1.629 . . . . 0.0 109.511 174.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -71.24 -6.06 36.79 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -176.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -88.42 -9.27 69.78 Favored Glycine 0 CA--C 1.539 1.59 0 C-N-CA 126.292 1.901 . . . . 0.0 114.937 177.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -144.14 86.72 8.22 Favored Pre-proline 0 CA--C 1.553 1.058 0 CA-C-N 119.448 1.624 . . . . 0.0 111.89 -179.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -74.0 79.21 2.38 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 123.643 2.895 . . . . 0.0 112.274 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -119.07 126.21 51.14 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.287 1.435 . . . . 0.0 111.044 -176.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.1 ptt180 -99.17 -162.63 0.97 Allowed 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 127.285 2.234 . . . . 0.0 113.74 -175.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -71.95 62.27 1.31 Allowed Glycine 0 CA--C 1.538 1.471 0 C-N-CA 126.421 1.962 . . . . 0.0 113.72 175.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 10.1 p30 -67.49 74.99 0.16 Allowed 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 130.163 3.385 . . . . 0.0 114.796 177.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -70.29 62.83 0.23 Allowed 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 126.948 2.099 . . . . 0.0 114.875 -175.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -169.66 31.44 0.16 Allowed Glycine 0 CA--C 1.536 1.355 0 C-N-CA 124.536 1.065 . . . . 0.0 115.709 -175.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 5.1 m95 53.88 56.53 7.01 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.31 1.444 . . . . 0.0 113.154 -174.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -89.68 131.14 35.81 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.661 1.584 . . . . 0.0 112.613 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -160.12 -175.8 5.28 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -174.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 4.8 mtmt -130.19 160.38 33.99 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.159 1.384 . . . . 0.0 110.711 174.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -80.07 131.78 35.84 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.848 0.859 . . . . 0.0 108.918 175.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 78.2 mt -83.99 127.38 33.83 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.479 0.712 . . . . 0.0 110.599 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -51.74 -27.45 19.91 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 126.063 1.792 . . . . 0.0 116.49 -174.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.458 ' CE2' ' HB ' ' A' ' 120' ' ' ILE . 0.2 OUTLIER -74.95 6.88 3.63 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 128.076 2.55 . . . . 0.0 113.621 -179.459 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 84.58 10.58 79.24 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 125.602 1.572 . . . . 0.0 114.194 -175.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 17.5 mt -96.54 171.48 8.52 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.33 1.852 . . . . 0.0 110.475 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 3.4 mtt-85 -146.05 107.39 4.21 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 120.973 -1.08 . . . . 0.0 110.225 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 9.3 ttp -98.73 131.07 45.17 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 117.795 -1.098 . . . . 0.0 108.327 178.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 1.5 tppp? -109.44 129.41 55.55 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 127.915 2.486 . . . . 0.0 110.149 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -135.17 154.42 21.6 Favored Glycine 0 N--CA 1.474 1.197 0 CA-C-N 121.17 1.804 . . . . 0.0 115.562 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.31 129.42 6.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 C-N-CA 124.282 1.033 . . . . 0.0 112.402 -178.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -146.62 160.69 41.86 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 126.975 2.11 . . . . 0.0 109.554 175.001 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 9.4 t -131.38 168.76 17.03 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.589 1.155 . . . . 0.0 108.99 175.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 4.3 t -111.67 28.92 8.3 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.022 1.329 . . . . 0.0 111.414 178.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -67.65 21.76 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 127.77 2.428 . . . . 0.0 115.028 179.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 80.6 -59.51 4.65 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 126.641 2.067 . . . . 0.0 113.168 -178.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -116.39 65.36 0.71 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.072 1.749 . . . . 0.0 110.313 176.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.19 179.01 7.84 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 121.915 0.864 . . . . 0.0 111.708 174.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.3 176.84 5.64 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.456 1.902 . . . . 0.0 110.108 175.001 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 2.3 tmm? -125.51 125.59 43.5 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.918 1.287 . . . . 0.0 110.395 175.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 17.5 tt0 -138.11 124.59 20.72 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 123.772 0.829 . . . . 0.0 110.529 176.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 5.0 mp -132.66 119.71 39.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 123.974 0.91 . . . . 0.0 110.508 176.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.63 134.39 55.1 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.488 1.515 . . . . 0.0 111.939 177.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.8 mp -82.35 127.01 40.03 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 O-C-N 121.019 -1.05 . . . . 0.0 108.633 175.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 1.7 m -126.3 93.48 3.82 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.524 1.53 . . . . 0.0 111.499 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 80.0 mtm-85 . . . . . 0 C--O 1.253 1.27 0 C-N-CA 124.509 1.124 . . . . 0.0 113.214 176.528 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.483 1.192 0 CA-C-O 117.785 -1.103 . . . . 0.0 109.332 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.668 ' HG2' HD12 ' A' ' 25' ' ' LEU . 0.7 OUTLIER -60.04 -172.63 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 125.034 1.334 . . . . 0.0 113.366 -179.431 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.81 HD12 ' H ' ' A' ' 74' ' ' GLY . 0.2 OUTLIER -120.71 30.06 7.09 Favored 'General case' 0 N--CA 1.483 1.204 0 O-C-N 120.603 -1.311 . . . . 0.0 111.999 179.991 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.41 ' HA ' HD12 ' A' ' 71' ' ' LEU . . . -144.58 121.2 11.12 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.856 2.062 . . . . 0.0 109.833 -175.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -73.91 -92.45 0.13 Allowed Glycine 0 CA--C 1.531 1.052 0 C-N-CA 123.988 0.804 . . . . 0.0 112.917 -176.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 41.0 p -141.4 173.61 11.33 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.544 1.538 . . . . 0.0 111.079 177.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -120.42 10.35 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 125.623 1.569 . . . . 0.0 112.213 -178.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -29.05 -77.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 127.627 2.371 . . . . 0.0 115.014 -176.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -158.2 147.55 19.51 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.56 1.944 . . . . 0.0 110.745 175.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -64.3 -26.96 70.96 Favored Glycine 0 N--CA 1.476 1.304 0 C-N-CA 124.592 1.091 . . . . 0.0 115.474 -178.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.43 -35.11 73.41 Favored 'General case' 0 CA--C 1.546 0.816 0 O-C-N 121.755 -0.85 . . . . 0.0 111.789 175.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.4 t -96.2 -37.89 10.36 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.082 1.353 . . . . 0.0 111.611 174.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.528 HD11 ' CD2' ' A' ' 71' ' ' LEU . 58.2 tp -82.77 84.41 7.35 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.651 1.981 . . . . 0.0 111.977 176.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.4 p -120.55 178.8 4.54 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 126.595 1.958 . . . . 0.0 111.396 175.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -40.14 -44.63 1.85 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.768 1.627 . . . . 0.0 113.474 175.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -52.92 -44.66 67.16 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 118.801 0.728 . . . . 0.0 112.154 178.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 93.1 t -64.54 -40.77 90.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 124.546 1.138 . . . . 0.0 111.135 175.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.475 ' CD2' HD21 ' A' ' 71' ' ' LEU . 39.4 mt -66.82 -38.12 85.83 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.355 -0.841 . . . . 0.0 111.593 178.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -68.16 -47.69 67.33 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 120.94 -1.1 . . . . 0.0 111.624 177.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.92 -37.51 87.29 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-O 118.594 -0.717 . . . . 0.0 111.495 175.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.445 HG22 ' HB2' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -62.84 -36.33 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 119.15 0.886 . . . . 0.0 111.159 -176.104 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.416 HD12 ' HB3' ' A' ' 33' ' ' ALA . 0.3 OUTLIER -56.28 -25.41 48.12 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 119.112 0.869 . . . . 0.0 112.413 175.076 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -81.87 -65.3 1.67 Allowed Glycine 0 CA--C 1.533 1.179 0 O-C-N 120.603 -1.311 . . . . 0.0 112.173 174.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -66.65 -35.6 80.55 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 115.149 1.537 . . . . 0.0 115.149 -175.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.668 HD12 ' HG2' ' A' ' 2' ' ' GLU . 3.3 mm? -106.42 104.77 14.54 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 126.76 2.024 . . . . 0.0 108.358 -177.13 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -161.59 135.4 3.91 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 125.243 1.401 . . . . 0.0 114.381 -175.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.2 mtpt -112.35 -45.99 3.22 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 126.437 1.895 . . . . 0.0 113.286 177.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 20.8 m -116.9 177.96 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 126.202 1.801 . . . . 0.0 110.929 -176.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.6 t -51.86 -49.46 62.86 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.896 1.279 . . . . 0.0 112.909 -175.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.9 mtt-85 -122.86 129.34 51.53 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.751 1.62 . . . . 0.0 110.527 174.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.603 ' HB2' HD13 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -118.38 157.45 27.14 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 126.12 1.768 . . . . 0.0 110.665 179.894 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.682 HG13 ' HB1' ' A' ' 85' ' ' ALA . 0.3 OUTLIER -118.25 130.78 72.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 175.045 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.416 ' HB3' HD12 ' A' ' 22' ' ' LEU . . . -134.77 99.44 4.32 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 126.75 2.02 . . . . 0.0 109.232 178.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.838 HG22 ' HB2' ' A' ' 72' ' ' TYR . 1.8 m -100.9 160.23 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-O 118.489 -0.767 . . . . 0.0 111.249 179.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -137.4 109.44 0.7 Allowed Glycine 0 N--CA 1.464 0.538 0 CA-C-N 119.112 0.869 . . . . 0.0 114.215 175.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.3 mp -100.66 145.57 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 CA-C-N 118.639 1.22 . . . . 0.0 110.722 176.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.419 ' HB3' ' HA ' ' A' ' 173' ' ' LYS . 24.7 t0 -108.55 105.86 15.68 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.905 1.282 . . . . 0.0 110.495 175.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -69.97 96.66 1.05 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.534 1.534 . . . . 0.0 111.222 175.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -126.56 3.43 6.85 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.26 1.824 . . . . 0.0 112.837 176.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.87 4.71 0.16 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 126.087 1.755 . . . . 0.0 115.663 177.086 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.01 61.96 4.28 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 125.977 1.751 . . . . 0.0 113.166 177.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 165.19 143.42 3.72 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 125.229 1.395 . . . . 0.0 111.079 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.753 HG22 ' HA ' ' A' ' 65' ' ' PRO . 31.9 p -67.15 142.57 57.0 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.682 0.753 . . . . 0.0 111.302 174.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.435 ' CZ2' ' CD2' ' A' ' 99' ' ' LEU . 48.6 m0 -101.97 102.66 13.22 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.627 1.171 . . . . 0.0 110.502 -179.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 28.0 m -90.27 128.63 36.46 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.01 0.924 . . . . 0.0 109.436 177.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.8 108.69 0.69 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.934 0.894 . . . . 0.0 112.429 175.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.545 HD12 ' HB3' ' A' ' 48' ' ' ASN . 3.1 pp -93.38 -45.7 7.68 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.637 0.775 . . . . 0.0 111.799 178.189 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.545 ' HB3' HD12 ' A' ' 47' ' ' LEU . 5.1 t30 -171.6 146.13 2.13 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 127.22 2.208 . . . . 0.0 110.294 179.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.673 ' HB2' HD22 ' A' ' 60' ' ' LEU . . . -134.99 151.27 50.67 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.346 1.458 . . . . 0.0 110.981 175.029 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -139.19 109.78 6.63 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.189 1.396 . . . . 0.0 112.013 -175.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.506 ' CD1' ' HB1' ' A' ' 87' ' ' ALA . 3.1 m-85 -106.66 127.75 53.62 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 120.991 -1.068 . . . . 0.0 111.142 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -88.76 -68.32 0.78 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.508 1.523 . . . . 0.0 111.178 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 32.5 t -107.46 -35.29 6.8 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.989 1.315 . . . . 0.0 112.16 -174.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -61.91 -26.41 67.16 Favored Glycine 0 CA--C 1.536 1.36 0 CA-C-O 118.831 -0.983 . . . . 0.0 114.02 177.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.5 p 21.14 55.13 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 128.046 2.538 . . . . 0.0 116.128 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.433 HG21 HG23 ' A' ' 59' ' ' ILE . 3.9 t -75.89 173.24 11.45 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.16 -175.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -82.21 -51.91 7.48 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.388 0.675 . . . . 0.0 112.084 176.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.5 p -148.18 135.82 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.08 1.352 . . . . 0.0 112.217 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.433 HG23 HG21 ' A' ' 56' ' ' THR . 1.0 OUTLIER -143.42 -32.09 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 126.059 1.744 . . . . 0.0 113.816 -175.595 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.673 HD22 ' HB2' ' A' ' 49' ' ' ALA . 1.0 OUTLIER -94.69 96.88 2.07 Favored Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 125.748 1.619 . . . . 0.0 109.256 177.823 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.44 ' HG2' HG23 ' A' ' 64' ' ' VAL . 77.6 Cg_endo -64.49 157.84 52.81 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.809 2.339 . . . . 0.0 110.404 175.037 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -45.22 -49.96 11.94 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.723 1.609 . . . . 0.0 113.379 178.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 5.5 p -160.17 142.28 4.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 126.247 1.819 . . . . 0.0 110.078 175.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.698 HG21 HD13 ' A' ' 70' ' ' LEU . 73.6 t -113.79 122.62 34.53 Favored Pre-proline 0 N--CA 1.473 0.676 0 C-N-CA 124.472 1.109 . . . . 0.0 108.325 174.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.753 ' HA ' HG22 ' A' ' 43' ' ' THR . 56.3 Cg_endo -68.12 159.42 53.19 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.767 2.312 . . . . 0.0 112.875 175.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -71.15 168.2 17.71 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.952 0.901 . . . . 0.0 110.705 175.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 30.5 p 53.1 21.9 2.33 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 127.11 2.164 . . . . 0.0 113.991 -175.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.8 172.67 10.17 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 127.648 2.379 . . . . 0.0 110.497 -175.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.469 ' HB3' HD23 ' A' ' 13' ' ' LEU . . . -134.9 161.84 34.1 Favored 'General case' 0 C--O 1.222 -0.381 0 O-C-N 121.85 -0.532 . . . . 0.0 110.009 176.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.698 HD13 HG21 ' A' ' 64' ' ' VAL . 2.6 pt? -136.38 171.11 14.96 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 124.387 1.075 . . . . 0.0 112.454 -179.42 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.528 ' CD2' HD11 ' A' ' 13' ' ' LEU . 0.6 OUTLIER -119.47 156.01 31.02 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 124.826 1.25 . . . . 0.0 113.138 -179.061 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.838 ' HB2' HG22 ' A' ' 34' ' ' VAL . 23.8 m-85 -133.22 133.66 43.01 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 124.217 1.007 . . . . 0.0 112.191 175.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.1 p -101.44 151.53 21.82 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 126.155 1.782 . . . . 0.0 110.692 175.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.81 ' H ' HD12 ' A' ' 3' ' ' LEU . . . -169.0 124.43 1.17 Allowed Glycine 0 CA--C 1.531 1.08 0 C-N-CA 124.212 0.91 . . . . 0.0 113.192 175.033 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.546 ' HG2' HD11 ' A' ' 3' ' ' LEU . 22.9 mtm180 -96.04 80.89 3.32 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 129.462 3.105 . . . . 0.0 111.245 -174.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.482 ' HE2' ' HB2' ' A' ' 85' ' ' ALA . 10.2 ptpt -56.0 -37.05 68.6 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 30.7 p -98.32 78.72 2.47 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.737 1.615 . . . . 0.0 112.091 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.6 m -69.99 -18.74 63.34 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 176.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 121.43 -65.78 0.47 Allowed Glycine 0 CA--C 1.538 1.498 0 C-N-CA 125.189 1.376 . . . . 0.0 113.672 -176.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.73 -41.14 3.23 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 123.177 2.585 . . . . 0.0 112.962 -175.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.3 p -141.49 142.07 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 C-N-CA 126.556 1.943 . . . . 0.0 109.107 178.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -129.04 96.52 4.36 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.824 1.25 . . . . 0.0 108.092 175.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 24.6 m -85.46 -16.97 37.88 Favored 'General case' 0 N--CA 1.479 0.978 0 O-C-N 121.913 -0.492 . . . . 0.0 111.772 178.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 114.83 -171.45 13.71 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 125.829 1.68 . . . . 0.0 112.137 178.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.682 ' HB1' HG13 ' A' ' 32' ' ' ILE . . . -72.11 84.52 1.01 Allowed 'General case' 0 CA--C 1.547 0.855 0 O-C-N 120.956 -1.32 . . . . 0.0 110.983 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.2 t -125.65 118.21 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 124.155 0.982 . . . . 0.0 113.031 -174.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.56 ' HB3' ' CZ ' ' A' ' 103' ' ' PHE . . . -164.87 168.65 17.46 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.144 1.377 . . . . 0.0 113.09 176.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -154.19 137.67 15.9 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.346 1.059 . . . . 0.0 111.961 174.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -137.59 169.28 18.06 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 120.595 -1.316 . . . . 0.0 111.574 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -141.46 160.62 39.75 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 175.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -137.82 143.35 40.95 Favored 'General case' 0 CA--C 1.513 -0.463 0 C-N-CA 125.779 1.632 . . . . 0.0 114.33 -174.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -97.94 106.53 18.85 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.352 -175.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 1.9 mtm -78.87 128.95 34.01 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 124.051 0.94 . . . . 0.0 110.789 178.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -58.96 -20.66 54.52 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 177.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -70.01 -12.52 61.67 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 124.521 1.128 . . . . 0.0 113.853 176.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 109.79 25.61 5.35 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 125.34 1.448 . . . . 0.0 114.963 177.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -134.3 173.84 11.18 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.928 1.291 . . . . 0.0 112.108 -175.028 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 16.8 m -129.33 108.44 10.31 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 177.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.435 ' CD2' ' CZ2' ' A' ' 44' ' ' TRP . 69.3 tp -75.12 108.07 7.62 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.675 0.79 . . . . 0.0 112.267 175.072 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -102.42 135.49 12.29 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 123.816 0.722 . . . . 0.0 112.344 174.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 95.6 t -115.7 136.6 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.952 1.301 . . . . 0.0 111.25 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -133.34 122.8 24.34 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.739 1.616 . . . . 0.0 111.945 -174.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.56 ' CZ ' ' HB3' ' A' ' 87' ' ' ALA . 2.1 p90 -147.17 117.53 7.41 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.735 1.214 . . . . 0.0 111.562 -176.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 48.4 t -139.02 105.98 5.43 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.186 0.994 . . . . 0.0 112.598 -177.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.486 ' HB ' ' HB3' ' A' ' 85' ' ' ALA . 19.6 t -110.02 125.44 31.09 Favored Pre-proline 0 C--N 1.328 -0.338 0 C-N-CA 125.893 1.677 . . . . 0.0 109.008 179.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.32 141.52 39.24 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 124.077 3.185 . . . . 0.0 110.357 174.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -59.73 -34.69 73.28 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.654 1.182 . . . . 0.0 112.688 175.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -91.73 -46.24 8.0 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.555 1.142 . . . . 0.0 113.43 -178.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER 59.49 36.51 23.0 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.569 1.548 . . . . 0.0 113.478 -175.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -126.87 -1.58 6.6 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.323 1.449 . . . . 0.0 114.42 -179.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 12.6 m95 -133.55 -65.45 0.68 Allowed 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 125.198 1.399 . . . . 0.0 111.227 -175.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -91.14 152.56 20.53 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.11 1.364 . . . . 0.0 111.527 175.084 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 2.0 t -85.07 159.95 20.09 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.273 1.029 . . . . 0.0 109.211 175.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.439 HD21 ' CE ' ' A' ' 162' ' ' MET . 0.4 OUTLIER -102.29 101.52 11.81 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.942 1.697 . . . . 0.0 109.454 175.487 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 38.5 m0 -100.52 141.31 33.55 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.961 1.255 . . . . 0.0 110.476 178.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 37.7 p-90 -137.51 129.0 28.24 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.143 0.977 . . . . 0.0 111.268 -177.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -133.54 156.12 48.37 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 122.509 1.147 . . . . 0.0 112.553 176.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 95.9 t -148.22 123.76 2.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 176.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.91 170.89 21.08 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.596 1.158 . . . . 0.0 110.885 175.021 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.521 ' HB ' ' CZ ' ' A' ' 154' ' ' TYR . 7.2 mt -104.27 136.19 38.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.917 0.865 . . . . 0.0 110.523 176.1 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -89.58 153.09 47.88 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 125.302 1.441 . . . . 0.0 111.18 176.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -74.19 88.98 1.08 Allowed 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 124.248 3.299 . . . . 0.0 112.107 179.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 91.64 -172.51 35.89 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 125.239 1.399 . . . . 0.0 113.006 -177.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 12.3 tttt -51.85 118.08 3.17 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.997 1.319 . . . . 0.0 111.571 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.38 147.67 41.8 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.023 0.929 . . . . 0.0 112.225 177.027 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 19.6 ptt-85 -99.07 -178.34 3.9 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.25 1.02 . . . . 0.0 110.409 175.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -128.8 107.47 9.68 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 104.91 -2.255 . . . . 0.0 104.91 174.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -128.39 171.24 12.23 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.277 1.431 . . . . 0.0 109.299 176.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -51.87 -44.29 63.65 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 119.642 1.11 . . . . 0.0 113.595 -177.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -56.75 -58.44 14.47 Favored Glycine 0 N--CA 1.471 0.986 0 CA-C-N 119.327 0.967 . . . . 0.0 112.57 175.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 6.1 mtm -60.89 -39.92 91.07 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 118.068 0.934 . . . . 0.0 112.714 178.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -56.2 -60.89 2.85 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.071 1.349 . . . . 0.0 109.569 174.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -67.06 -32.57 73.84 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -178.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -62.02 -47.15 86.04 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.752 0.821 . . . . 0.0 111.562 176.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 46.8 mmm -84.45 -20.36 31.91 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -54.5 -55.67 26.69 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.664 1.586 . . . . 0.0 109.252 174.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -68.65 -9.68 51.5 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -73.44 -41.6 44.3 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 125.825 1.679 . . . . 0.0 114.036 -177.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -123.0 91.32 49.94 Favored Pre-proline 0 CA--C 1.547 0.831 0 CA-C-N 118.215 1.007 . . . . 0.0 111.452 179.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -72.45 78.64 1.94 Allowed 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 123.776 2.984 . . . . 0.0 112.156 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -114.84 124.15 51.01 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.953 1.301 . . . . 0.0 110.233 174.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.87 96.93 3.31 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 127.101 2.16 . . . . 0.0 112.6 -174.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 52.53 37.83 50.41 Favored Glycine 0 CA--C 1.537 1.423 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.462 -177.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.67 79.65 0.6 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.408 1.883 . . . . 0.0 110.93 -178.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -65.84 123.37 19.61 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.185 1.794 . . . . 0.0 110.611 175.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 128.02 41.41 0.28 Allowed Glycine 0 CA--C 1.534 1.258 0 C-N-CA 125.341 1.448 . . . . 0.0 114.754 178.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' TRP . . . . . 0.453 ' H ' HD13 ' A' ' 161' ' ' ILE . 9.7 m95 45.29 60.09 3.21 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.803 1.641 . . . . 0.0 112.738 -175.1 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -85.05 128.31 34.58 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.456 1.102 . . . . 0.0 113.229 179.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -162.68 -170.28 2.34 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.219 1.008 . . . . 0.0 112.693 -174.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -137.9 151.53 48.11 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.562 1.145 . . . . 0.0 110.159 174.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -70.6 153.18 43.13 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 122.99 0.516 . . . . 0.0 110.95 176.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.482 ' HB3' ' CD2' ' A' ' 154' ' ' TYR . 1.9 mm? -115.7 127.67 55.32 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 122.189 0.995 . . . . 0.0 112.398 -178.278 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -58.07 -18.37 33.87 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 125.436 1.493 . . . . 0.0 116.02 179.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.521 ' CZ ' ' HB ' ' A' ' 120' ' ' ILE . 0.1 OUTLIER -74.35 14.33 0.46 Allowed 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 126.62 1.968 . . . . 0.0 113.776 179.778 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 75.16 24.86 70.2 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 124.171 0.891 . . . . 0.0 113.751 -174.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.6 pp -135.33 177.58 7.71 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.152 1.381 . . . . 0.0 113.215 -178.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -142.37 124.33 15.27 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.602 1.561 . . . . 0.0 109.448 -178.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 5.1 ttp -98.24 142.06 30.38 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 175.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 3.5 tppt? -123.78 121.72 36.17 Favored 'General case' 0 C--O 1.219 -0.543 0 C-N-CA 125.707 1.603 . . . . 0.0 109.383 -176.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -130.35 152.1 19.67 Favored Glycine 0 N--CA 1.466 0.682 0 CA-C-N 120.305 1.412 . . . . 0.0 114.581 -176.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.453 HD13 ' H ' ' A' ' 147' ' ' TRP . 4.4 tp -146.35 128.27 7.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 C-N-CA 124.516 1.126 . . . . 0.0 110.589 -176.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . 0.439 ' CE ' HD21 ' A' ' 114' ' ' ASN . 1.1 tmm? -151.37 157.2 42.14 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 125.296 1.438 . . . . 0.0 109.982 177.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . 0.424 ' O ' ' HB3' ' A' ' 168' ' ' ALA . 12.8 t -148.67 148.45 30.08 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.506 0.722 . . . . 0.0 110.329 174.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 75.1 m -117.08 32.11 6.35 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.277 1.031 . . . . 0.0 111.352 -177.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.85 -24.41 65.88 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.692 1.597 . . . . 0.0 113.713 176.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 158.4 -54.7 0.37 Allowed Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.22 1.39 . . . . 0.0 113.414 175.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -139.96 61.2 1.54 Allowed 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 122.311 1.053 . . . . 0.0 112.161 -175.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 163' ' ' THR . . . -98.08 -174.09 2.77 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 122.44 1.114 . . . . 0.0 112.727 175.033 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.5 178.68 6.12 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 128.167 2.587 . . . . 0.0 111.035 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . 0.42 ' HA ' ' HG2' ' A' ' 162' ' ' MET . 4.7 tmm? -119.39 136.46 54.27 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.328 1.451 . . . . 0.0 111.207 174.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -146.74 129.73 16.37 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 121.591 -0.693 . . . . 0.0 110.279 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 4.6 mp -134.18 118.57 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 123.572 0.749 . . . . 0.0 110.363 175.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.419 ' HA ' ' HB3' ' A' ' 37' ' ' ASP . 0.0 OUTLIER -113.83 133.13 55.59 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 125.411 1.485 . . . . 0.0 111.583 176.161 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.8 mp -82.59 136.68 22.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 O-C-N 121.466 -0.771 . . . . 0.0 109.498 175.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -118.23 130.85 56.31 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.164 1.386 . . . . 0.0 111.593 175.028 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 8.2 mmm180 . . . . . 0 C--O 1.252 1.231 0 C-N-CA 126.778 2.031 . . . . 0.0 110.869 -175.008 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.482 1.148 0 CA-C-O 121.145 0.498 . . . . 0.0 110.69 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -83.06 -174.36 5.24 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 124.557 1.143 . . . . 0.0 111.92 177.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.421 ' HA ' ' HB3' ' A' ' 25' ' ' LEU . 10.4 tp -120.62 -39.44 2.75 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.382 1.073 . . . . 0.0 113.239 175.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.619 ' HB1' ' HB3' ' A' ' 71' ' ' LEU . . . -77.56 130.62 37.17 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.316 1.047 . . . . 0.0 109.41 174.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -64.55 -101.14 0.01 OUTLIER Glycine 0 CA--C 1.537 1.453 0 CA-C-N 120.211 1.369 . . . . 0.0 114.764 -178.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 16.5 p -133.25 167.4 20.44 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.307 1.443 . . . . 0.0 110.16 176.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -120.73 14.59 6.34 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 C-N-CA 125.021 1.328 . . . . 0.0 112.406 -178.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.439 HD12 ' HB3' ' A' ' 12' ' ' SER . 0.8 OUTLIER -30.95 -72.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 128.427 2.691 . . . . 0.0 114.092 -179.38 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -171.62 151.5 2.95 Favored 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 125.127 1.371 . . . . 0.0 110.947 175.173 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -59.57 -33.23 75.99 Favored Glycine 0 N--CA 1.468 0.798 0 N-CA-C 115.605 1.002 . . . . 0.0 115.605 -174.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.09 -38.44 88.84 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 122.022 -0.693 . . . . 0.0 111.188 174.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.439 ' HB3' HD12 ' A' ' 8' ' ' ILE . 5.9 t -92.22 -11.77 34.5 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.398 1.879 . . . . 0.0 113.778 177.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.572 HD23 ' CB ' ' A' ' 69' ' ' ALA . 67.8 tp -119.53 80.67 1.6 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 128.851 2.86 . . . . 0.0 109.845 179.016 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -111.84 177.34 4.68 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.591 1.557 . . . . 0.0 111.981 176.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -39.98 -45.29 1.86 Allowed 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 126.125 1.77 . . . . 0.0 113.439 175.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -52.59 -44.86 66.24 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.921 0.888 . . . . 0.0 111.623 178.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.494 ' O ' HG23 ' A' ' 21' ' ' VAL . 59.3 t -67.87 -40.82 84.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 125.54 1.536 . . . . 0.0 110.887 176.214 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.476 ' CD2' HD21 ' A' ' 71' ' ' LEU . 25.7 mt -65.4 -42.67 92.34 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 120.704 -1.247 . . . . 0.0 111.331 178.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -59.76 -51.52 69.4 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.79 1.236 . . . . 0.0 112.059 175.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.57 -36.37 83.56 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-O 118.424 -0.798 . . . . 0.0 112.52 175.141 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 17' ' ' VAL . 24.2 t -53.65 -46.31 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.234 1.014 . . . . 0.0 110.363 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.573 HD22 ' HE3' ' A' ' 31' ' ' LYS . 18.5 mt -53.53 -18.49 2.85 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.562 1.545 . . . . 0.0 114.464 178.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -99.64 -62.24 0.83 Allowed Glycine 0 CA--C 1.534 1.268 0 C-N-CA 126.646 2.07 . . . . 0.0 112.899 175.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -60.85 -35.43 76.55 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -178.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.421 ' HB3' ' HA ' ' A' ' 3' ' ' LEU . 3.1 mm? -114.41 105.89 13.66 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.267 1.827 . . . . 0.0 108.092 175.012 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -143.78 162.74 27.72 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 125.502 1.525 . . . . 0.0 111.405 178.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.22 -83.14 0.57 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.733 1.213 . . . . 0.0 110.638 174.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 30.6 m -91.43 173.72 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 126.014 1.725 . . . . 0.0 109.282 178.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -51.28 -44.8 61.92 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.977 0.911 . . . . 0.0 112.439 -178.435 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.63 120.81 43.63 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.47 1.908 . . . . 0.0 112.514 177.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.573 ' HE3' HD22 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -133.46 163.12 30.08 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 125.46 1.504 . . . . 0.0 111.115 -179.049 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -128.95 132.67 67.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 124.709 1.204 . . . . 0.0 109.037 175.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -136.73 104.76 5.62 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.146 1.778 . . . . 0.0 109.439 174.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.821 HG22 ' HB2' ' A' ' 72' ' ' TYR . 1.3 m -106.4 159.09 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 124.233 1.013 . . . . 0.0 111.901 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -137.44 109.1 0.68 Allowed Glycine 0 N--CA 1.465 0.569 0 CA-C-N 119.072 0.851 . . . . 0.0 113.643 -178.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 mp -99.43 142.07 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 117.632 0.716 . . . . 0.0 110.136 176.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -108.87 101.99 11.05 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 124.873 1.269 . . . . 0.0 109.848 176.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.62 100.09 1.08 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.584 1.554 . . . . 0.0 109.343 176.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -133.79 13.39 4.02 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.908 1.283 . . . . 0.0 112.282 175.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.0 p -62.31 -12.95 23.78 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 126.082 1.753 . . . . 0.0 114.834 175.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.38 16.29 66.93 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 125.499 1.523 . . . . 0.0 114.183 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -140.49 136.47 7.67 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 126.506 2.003 . . . . 0.0 110.633 175.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.803 HG22 ' HA ' ' A' ' 65' ' ' PRO . 19.9 p -73.63 127.47 32.85 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.281 0.632 . . . . 0.0 109.939 174.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 15.8 m0 -88.02 159.1 18.42 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 122.066 -0.396 . . . . 0.0 111.742 177.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 89.4 m -136.61 143.86 43.77 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.574 1.15 . . . . 0.0 110.288 -179.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.7 110.85 0.86 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.466 1.106 . . . . 0.0 111.829 175.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.602 HD12 ' N ' ' A' ' 48' ' ' ASN . 4.2 pp -101.25 -57.67 2.04 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.475 0.71 . . . . 0.0 111.284 175.073 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.602 ' N ' HD12 ' A' ' 47' ' ' LEU . 4.1 t30 -173.43 140.03 0.79 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.446 1.898 . . . . 0.0 110.262 -175.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -121.83 150.61 41.67 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.354 1.062 . . . . 0.0 110.195 175.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -138.52 94.32 2.83 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 123.037 1.399 . . . . 0.0 112.104 -175.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.611 ' CD1' ' HB1' ' A' ' 87' ' ' ALA . 5.2 m-30 -101.91 133.15 47.15 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 121.16 -0.962 . . . . 0.0 110.393 -175.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.38 -37.77 6.13 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.217 1.007 . . . . 0.0 113.64 -178.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 37.5 t -122.58 -47.74 2.08 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.494 1.518 . . . . 0.0 110.92 178.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -69.76 11.44 1.82 Allowed Glycine 0 CA--C 1.533 1.173 0 C-N-CA 126.051 1.786 . . . . 0.0 115.002 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 67.8 p -35.22 113.28 0.19 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 128.864 2.866 . . . . 0.0 112.773 -176.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.663 HG21 HG23 ' A' ' 59' ' ' ILE . 1.1 t -126.75 179.94 5.11 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.803 1.241 . . . . 0.0 112.014 -175.023 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -79.29 -53.98 6.4 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.959 0.904 . . . . 0.0 112.75 177.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.2 p -151.48 138.84 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.673 1.589 . . . . 0.0 111.386 -178.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.663 HG23 HG21 ' A' ' 56' ' ' THR . 0.0 OUTLIER -136.72 -47.27 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 C-N-CA 125.083 1.353 . . . . 0.0 112.982 -178.772 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 73.3 mt -71.42 108.62 4.1 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 124.717 1.207 . . . . 0.0 109.474 175.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -72.07 168.02 25.15 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 124.046 3.164 . . . . 0.0 110.819 175.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -53.52 -45.57 69.82 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 178.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 85.5 t -150.09 146.75 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 127.526 2.33 . . . . 0.0 108.83 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.0 t -116.66 97.26 50.01 Favored Pre-proline 0 C--N 1.331 -0.21 0 C-N-CA 125.567 1.547 . . . . 0.0 107.247 174.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.803 ' HA ' HG22 ' A' ' 43' ' ' THR . 51.4 Cg_endo -67.71 144.78 67.12 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 121.328 1.352 . . . . 0.0 111.99 175.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -69.11 168.89 13.0 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.438 0.695 . . . . 0.0 110.658 174.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 29.1 p 62.94 13.85 7.0 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 126.614 1.966 . . . . 0.0 111.889 -175.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 27.6 mttp -138.41 169.05 18.47 Favored 'General case' 0 C--N 1.343 0.302 0 C-N-CA 126.525 1.93 . . . . 0.0 111.655 -176.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.572 ' CB ' HD23 ' A' ' 13' ' ' LEU . . . -133.35 159.72 39.45 Favored 'General case' 0 C--O 1.222 -0.359 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -175.054 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.519 ' H ' HD23 ' A' ' 70' ' ' LEU . 2.2 pt? -136.76 167.86 20.63 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 124.296 1.038 . . . . 0.0 111.966 -177.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.619 ' HB3' ' HB1' ' A' ' 4' ' ' ALA . 0.6 OUTLIER -117.35 153.55 32.81 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.253 1.021 . . . . 0.0 112.139 179.068 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.821 ' HB2' HG22 ' A' ' 34' ' ' VAL . 6.7 m-85 -125.56 142.2 51.63 Favored 'General case' 0 CA--C 1.511 -0.521 0 C-N-CA 125.047 1.339 . . . . 0.0 109.335 174.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 58.3 p -109.41 156.45 20.03 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 125.035 1.334 . . . . 0.0 110.346 174.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -174.13 135.45 3.18 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.872 175.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 30.5 mtm105 -117.5 142.5 47.09 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 125.428 1.491 . . . . 0.0 108.852 -177.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.5 ptpt -71.7 -168.14 0.33 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.038 0.935 . . . . 0.0 112.346 175.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.3 t 62.96 57.14 1.71 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.828 1.651 . . . . 0.0 111.636 176.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 52.0 p -60.8 -20.48 61.64 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.842 1.257 . . . . 0.0 113.87 177.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 126.9 -72.22 0.46 Allowed Glycine 0 CA--C 1.533 1.187 0 C-N-CA 126.995 2.236 . . . . 0.0 111.428 179.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.36 -42.67 1.8 Allowed 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 123.163 2.576 . . . . 0.0 113.247 -178.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 28.6 m -133.5 110.09 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 126.082 1.753 . . . . 0.0 111.156 -174.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -88.31 81.78 7.2 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 120.572 -1.33 . . . . 0.0 111.843 176.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -85.26 170.2 13.05 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 175.007 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -61.6 -68.58 1.61 Allowed Glycine 0 N--CA 1.475 1.246 0 O-C-N 120.282 -1.511 . . . . 0.0 113.654 -179.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -160.14 114.98 2.29 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.838 1.255 . . . . 0.0 110.923 175.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.9 t -141.83 119.12 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 123.796 0.838 . . . . 0.0 109.933 -177.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.611 ' HB1' ' CD1' ' A' ' 51' ' ' PHE . . . -156.79 153.86 29.01 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.901 0.858 . . . . 0.0 112.031 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -134.57 139.43 45.37 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.401 1.48 . . . . 0.0 108.985 178.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.557 ' CE2' ' CE2' ' A' ' 72' ' ' TYR . 26.3 p90 -149.49 171.3 16.82 Favored 'General case' 0 C--N 1.323 -0.58 0 O-C-N 120.521 -1.362 . . . . 0.0 109.346 174.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.476 ' HB3' HD11 ' A' ' 47' ' ' LEU . . . -138.58 161.7 36.43 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 120.908 0.385 . . . . 0.0 111.977 174.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -130.16 135.52 48.27 Favored 'General case' 0 CA--C 1.518 -0.269 0 C-N-CA 125.718 1.607 . . . . 0.0 113.471 -174.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -86.53 116.78 24.89 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -175.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 3.3 mtm -93.2 140.89 29.03 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.01 0.924 . . . . 0.0 112.297 -177.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.14 -21.64 65.2 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 114.309 1.225 . . . . 0.0 114.309 177.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -72.09 -2.22 17.67 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.257 1.023 . . . . 0.0 113.146 175.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 85.83 42.39 6.81 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.62 1.105 . . . . 0.0 112.543 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -140.96 176.48 8.77 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.222 1.409 . . . . 0.0 111.549 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.441 HG23 HD21 ' A' ' 47' ' ' LEU . 12.9 m -130.07 107.54 9.4 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.285 1.034 . . . . 0.0 112.929 178.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 57.1 tp -69.94 96.31 1.01 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.764 1.625 . . . . 0.0 111.217 174.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -91.43 120.38 5.98 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 125.485 1.516 . . . . 0.0 112.76 178.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.557 HG11 ' CE2' ' A' ' 89' ' ' PHE . 0.3 OUTLIER -104.79 161.65 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 125.419 1.488 . . . . 0.0 111.127 178.436 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 5.0 tpt -155.91 123.22 5.44 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.66 1.184 . . . . 0.0 111.031 174.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.491 ' CZ ' ' HB3' ' A' ' 87' ' ' ALA . 15.5 p90 -135.18 124.18 24.19 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.933 1.293 . . . . 0.0 114.226 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.6 t -133.02 102.32 5.56 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.086 0.954 . . . . 0.0 111.557 -176.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.0 m -77.13 144.94 72.4 Favored Pre-proline 0 N--CA 1.47 0.543 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.409 -178.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.452 ' HA ' ' CD2' ' A' ' 109' ' ' TYR . 30.7 Cg_endo -72.11 134.77 23.83 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.502 2.134 . . . . 0.0 112.978 175.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -142.37 -74.23 0.3 Allowed 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.987 -179.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -124.4 26.29 7.38 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.018 1.727 . . . . 0.0 111.552 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.452 ' CD2' ' HA ' ' A' ' 106' ' ' PRO . 10.7 m-85 -53.32 99.38 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.057 1.743 . . . . 0.0 112.756 176.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 43.2 m-20 -110.02 -6.47 15.14 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.124 1.77 . . . . 0.0 113.043 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 9.4 m95 -133.8 -49.42 0.82 Allowed 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.946 1.698 . . . . 0.0 112.196 -175.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -100.66 -173.03 2.3 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.88 2.072 . . . . 0.0 111.651 175.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -132.0 163.17 28.99 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.942 1.697 . . . . 0.0 110.64 174.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -63.16 99.55 0.18 Allowed 'General case' 0 CA--C 1.521 -0.164 0 C-N-CA 126.134 1.774 . . . . 0.0 111.807 175.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 46.5 m0 -119.56 142.11 48.65 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.691 1.197 . . . . 0.0 110.129 -175.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 31.5 p-90 -145.82 133.83 21.43 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.195 0.998 . . . . 0.0 110.658 -175.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -146.92 157.38 43.62 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 122.464 1.126 . . . . 0.0 113.441 -178.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.419 HG22 HG23 ' A' ' 101' ' ' VAL . 21.4 t -149.19 128.14 3.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 114.394 -1.275 . . . . 0.0 108.277 -178.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.0 162.99 40.79 Favored 'General case' 0 CA--C 1.514 -0.434 0 C-N-CA 125.614 1.566 . . . . 0.0 109.13 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 20.4 mt -108.47 146.28 14.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 121.487 0.66 . . . . 0.0 109.998 176.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -103.19 145.81 31.29 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 126.244 1.818 . . . . 0.0 111.023 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.62 103.0 1.37 Allowed 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 124.152 3.235 . . . . 0.0 111.558 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 88.06 -177.06 45.98 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.518 1.056 . . . . 0.0 114.068 -177.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 16.4 tttt -64.56 102.13 0.53 Allowed 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.462 1.105 . . . . 0.0 109.426 175.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 6.4 mmt180 -116.35 158.25 23.75 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.803 1.641 . . . . 0.0 109.54 178.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.82 -174.0 2.77 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.506 1.122 . . . . 0.0 110.265 175.041 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -138.27 113.25 9.19 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 126.315 1.846 . . . . 0.0 106.113 174.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -127.5 175.56 8.14 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.707 2.003 . . . . 0.0 109.253 174.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -47.97 -49.4 30.65 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.112 0.965 . . . . 0.0 113.473 177.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -56.94 -52.99 47.74 Favored Glycine 0 N--CA 1.471 0.967 0 CA-C-N 119.052 0.842 . . . . 0.0 112.832 178.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 20.4 mtm -62.88 -41.6 99.46 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 117.828 0.814 . . . . 0.0 112.558 176.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -56.95 -62.74 1.54 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.767 0.827 . . . . 0.0 109.623 175.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -59.22 -42.09 90.18 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 118.561 -0.733 . . . . 0.0 112.184 -176.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -58.09 -42.11 84.92 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.426 1.09 . . . . 0.0 113.027 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 40.9 mmm -84.48 -36.29 22.37 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 177.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -53.47 -57.27 11.27 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.501 1.52 . . . . 0.0 109.444 174.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -70.95 -9.7 58.36 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -178.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -87.02 -11.23 70.36 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 126.254 1.883 . . . . 0.0 114.624 178.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -138.67 88.67 13.93 Favored Pre-proline 0 CA--C 1.548 0.884 0 CA-C-N 119.205 1.503 . . . . 0.0 112.636 177.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -74.76 77.86 2.94 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.857 3.038 . . . . 0.0 112.46 178.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -114.71 124.21 51.21 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.061 0.944 . . . . 0.0 110.684 -178.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -92.59 -167.9 1.85 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.406 1.082 . . . . 0.0 111.72 179.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -73.94 66.51 1.78 Allowed Glycine 0 CA--C 1.53 0.989 0 C-N-CA 125.824 1.678 . . . . 0.0 111.433 175.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.418 ' HB3' ' CG ' ' A' ' 148' ' ' TYR . 0.9 OUTLIER -80.96 88.75 5.89 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 125.404 1.481 . . . . 0.0 109.805 -178.07 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -70.38 86.41 0.61 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.862 1.665 . . . . 0.0 112.347 -176.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 169.04 40.7 0.03 OUTLIER Glycine 0 N--CA 1.472 1.099 0 O-C-N 121.171 -0.956 . . . . 0.0 114.614 -178.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 2.3 m95 53.56 55.17 8.94 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 125.576 1.55 . . . . 0.0 113.909 -177.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . 0.418 ' CG ' ' HB3' ' A' ' 144' ' ' ASP . 26.0 m-85 -86.23 124.4 32.57 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.443 1.497 . . . . 0.0 112.684 -178.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -159.0 -179.36 7.97 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.108 0.963 . . . . 0.0 112.902 -175.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -136.57 166.42 23.58 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.24 1.416 . . . . 0.0 111.086 174.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -69.14 143.65 54.06 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.888 0.875 . . . . 0.0 109.735 174.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.475 HD11 ' HB2' ' A' ' 158' ' ' MET . 48.4 mt -99.48 92.64 5.48 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.275 1.03 . . . . 0.0 110.744 176.236 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 33.05 -79.9 0.0 OUTLIER Glycine 0 N--CA 1.478 1.473 0 C-N-CA 130.051 3.691 . . . . 0.0 116.247 175.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -67.89 -157.02 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 128.266 2.626 . . . . 0.0 110.372 175.023 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -79.09 42.91 2.39 Favored Glycine 0 CA--C 1.539 1.557 0 O-C-N 119.813 -1.804 . . . . 0.0 112.253 175.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.54 149.98 33.64 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 119.571 1.686 . . . . 0.0 111.061 175.179 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 23.8 mtm180 -142.54 109.26 5.41 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.496 1.118 . . . . 0.0 111.015 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . 0.508 ' SD ' HG21 ' A' ' 172' ' ' ILE . 9.9 ttp -101.53 132.23 47.27 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 118.038 -0.982 . . . . 0.0 108.934 179.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.74 130.45 54.46 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 127.075 2.15 . . . . 0.0 110.893 178.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -135.72 160.11 24.42 Favored Glycine 0 N--CA 1.47 0.937 0 CA-C-N 120.312 1.414 . . . . 0.0 115.45 178.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.518 HG23 ' HZ1' ' A' ' 169' ' ' LYS . 0.0 OUTLIER -150.63 134.57 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 123.954 0.901 . . . . 0.0 111.366 179.395 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 7.0 mtm -148.36 167.29 25.61 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 127.09 2.156 . . . . 0.0 109.974 175.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 3.6 t -140.35 148.9 42.01 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.989 1.316 . . . . 0.0 109.479 174.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 77.4 p -92.25 26.57 2.5 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.508 1.123 . . . . 0.0 112.805 177.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -67.18 22.68 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 127.601 2.36 . . . . 0.0 115.232 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 81.4 -60.64 4.7 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 126.664 2.078 . . . . 0.0 112.901 -176.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -122.77 71.04 1.02 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.786 1.234 . . . . 0.0 111.47 -179.267 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -92.89 -177.06 4.4 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.733 1.213 . . . . 0.0 112.707 175.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.518 ' HZ1' HG23 ' A' ' 161' ' ' ILE . 0.0 OUTLIER -123.42 163.84 20.06 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 126.842 2.057 . . . . 0.0 109.532 174.966 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . 0.413 ' SD ' ' CD1' ' A' ' 172' ' ' ILE . 1.3 tmt? -113.12 127.13 56.11 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 124.876 1.27 . . . . 0.0 109.459 174.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -138.21 127.66 24.74 Favored 'General case' 0 CA--C 1.518 -0.253 0 C-N-CA 123.279 0.632 . . . . 0.0 110.044 177.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.508 HG21 ' SD ' ' A' ' 158' ' ' MET . 4.2 mp -136.43 119.68 22.59 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.279 0 C-N-CA 122.978 0.511 . . . . 0.0 110.505 178.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -112.36 131.89 55.29 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.987 1.315 . . . . 0.0 111.578 175.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.8 mp -82.07 131.46 33.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 175.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -135.42 102.47 5.15 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.219 1.007 . . . . 0.0 111.442 175.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 5.9 mtt180 . . . . . 0 C--O 1.253 1.285 0 C-N-CA 124.846 1.259 . . . . 0.0 112.852 174.983 . . . . . . . . 0 0 . 1 stop_ save_